PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Atallah, NJ; Warren, HM; Roberts, MB; Elshaboury, RH; Bidell, MR; Gandhi, RG; Adamsick, M; Ibrahim, MK; Sood, R; Eddine, SBZ; Cobler-Lichter, MJ; Alexander, NJ; Timmer, KD; Atallah, CJ; Viens, AL; Panossian, VS; Scherer, AK; Proctor, T; Smartt, S; Letourneau, AR; Paras, ML; Johannes, S; Wiemer, J; Mansour, MK				Atallah, Natalie J.; Warren, Hailey M.; Roberts, Matthew B.; Elshaboury, Ramy H.; Bidell, Monique R.; Gandhi, Ronak G.; Adamsick, Meagan; Ibrahim, Maryam K.; Sood, Rupali; Eddine, Savo Bou Zein; Cobler-Lichter, Matthew J.; Alexander, Natalie J.; Timmer, Kyle D.; Atallah, Christine J.; Viens, Adam L.; Panossian, Vahe S.; Scherer, Allison K.; Proctor, Teddie; Smartt, Sherrie; Letourneau, Alyssa R.; Paras, Molly L.; Johannes, Sascha; Wiemer, Jan; Mansour, Michael K.			Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ANTIBIOTIC STEWARDSHIP; DIAGNOSTIC-ACCURACY; WUHAN; RISK	Purpose Coronavirus disease-2019 (COVID-19) is associated with a wide spectrum of clinical symptoms including acute respiratory failure. Biomarkers that can predict outcomes in patients with COVID-19 can assist with patient management. The aim of this study is to evaluate whether procalcitonin (PCT) can predict clinical outcome and bacterial superinfection in patients infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Methods Adult patients diagnosed with SARS-CoV-2 by nasopharyngeal PCR who were admitted to a tertiary care center in Boston, MA with SARS-CoV-2 infection between March 17 and April 30, 2020 with a baseline PCT value were studied. Patients who were presumed positive for SARS-CoV-2, who lacked PCT levels, or who had a positive urinalysis with negative cultures were excluded. Demographics, clinical and laboratory data were extracted from the electronic medical records. Results 324 patient charts were reviewed and grouped by clinical and microbiologic outcomes by day 28. Baseline PCT levels were significantly higher for patients who were treated for true bacteremia (p = 0.0005) and bacterial pneumonia (p = 0.00077) compared with the non-bacterial infection group. Baseline PCT positively correlated with the NIAID ordinal scale and survival over time. When compared to other inflammatory biomarkers, PCT showed superiority in predicting bacteremia. Conclusions Baseline PCT levels are associated with outcome and bacterial superinfection in patients hospitalized with SARS-CoV-2.	[Atallah, Natalie J.; Warren, Hailey M.; Roberts, Matthew B.; Eddine, Savo Bou Zein; Alexander, Natalie J.; Timmer, Kyle D.; Viens, Adam L.; Scherer, Allison K.; Letourneau, Alyssa R.; Paras, Molly L.; Mansour, Michael K.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Atallah, Natalie J.; Roberts, Matthew B.; Scherer, Allison K.; Letourneau, Alyssa R.; Paras, Molly L.; Mansour, Michael K.] Harvard Med Sch, Boston, MA 02115 USA; [Atallah, Natalie J.; Roberts, Matthew B.; Ibrahim, Maryam K.; Sood, Rupali; Scherer, Allison K.; Letourneau, Alyssa R.; Paras, Molly L.; Mansour, Michael K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Elshaboury, Ramy H.; Bidell, Monique R.; Gandhi, Ronak G.; Adamsick, Meagan] Massachusetts Gen Hosp, Dept Pharm, Boston, MA 02114 USA; [Eddine, Savo Bou Zein] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Cobler-Lichter, Matthew J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Atallah, Christine J.] Univ Balamand, Fac Med, Beirut, Lebanon; [Panossian, Vahe S.] Amer Univ Beirut, Fac Med, Med Ctr, Beirut, Lebanon; [Proctor, Teddie; Smartt, Sherrie] Fisher Diagnost, Middletown, VA USA; [Johannes, Sascha; Wiemer, Jan] BRAHMS GmbH, Hennigsdorf, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University Balamand; American University of Beirut; Thermo Fisher Scientific; Brahms AG	Atallah, NJ; Mansour, MK (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.; Atallah, NJ; Mansour, MK (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Atallah, NJ; Mansour, MK (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	natallah@mgh.harvard.edu; mkmansour@mgh.harvard.edu	; Bou Zein Eddine, Savo/F-8274-2015	Timmer, Kyle/0000-0003-4295-0007; Bou Zein Eddine, Savo/0000-0003-3301-5367; Paras, Molly/0000-0001-6658-8634; Panossian, Vahe S./0000-0001-8085-1021; Adamsick, Meagan/0000-0002-7734-0383	Thermo Fisher Scientific [NCT04158804]; National Institutes of Allergy and Infectious Diseases [RO1 AI132638]	Thermo Fisher Scientific; National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by an unrestricted educational fund from Thermo Fisher Scientific to M.K.M. for clinical work including the trial, ProSAVE (NCT04158804) and, in part, by the National Institutes of Allergy and Infectious Diseases grant RO1 AI132638 to M.K.M. S.J. and J.W. are employees of Thermo Fisher Scientific and Brahms GmbH. Thermo Fisher had no role in the formation, design, or execution of the study. Otherwise, none of the authors have a conflict of interest to declare. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; C.Gillies, 2020, medRxiv, DOI 10.1101/2020.06.29.20136572; Cen Y, 2020, CLIN MICROBIOL INFEC, V26, P1242, DOI 10.1016/j.cmi.2020.05.041; Chen RC, 2020, CHEST, V158, P97, DOI 10.1016/j.chest.2020.04.010; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Du YZ, 2020, AM J RESP CRIT CARE, V201, P1372, DOI 10.1164/rccm.202003-0543OC; Dunkler D, 2020, TRANSPL INT, V33, P50, DOI 10.1111/tri.13535; Fabre V, 2022, INFECT CONT HOSP EP, V43, P570, DOI 10.1017/ice.2021.175; Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131; Feng XD, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00301; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Frater JL, 2020, INT J LAB HEMATOL, V42, P11, DOI 10.1111/ijlh.13229; Gilbert DN, 2021, DIAGN MICR INFEC DIS, V99, DOI 10.1016/j.diagmicrobio.2020.115246; Gilbert DN, 2020, J INFECT DIS, V222, pS96, DOI 10.1093/infdis/jiaa204; Gilbert DN, 2017, INFECT DIS CLIN N AM, V31, P435, DOI 10.1016/j.idc.2017.05.003; Neto AGM, 2021, J MED VIROL, V93, P1489, DOI 10.1002/jmv.26441; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heesom L, 2020, J GLOB ANTIMICROB RE, V22, P782, DOI 10.1016/j.jgar.2020.07.017; Henry BM, 2020, CLIN CHEM LAB MED, V58, P1021, DOI 10.1515/cclm-2020-0369; Hoeboer SH, 2015, CLIN MICROBIOL INFEC, V21, P474, DOI 10.1016/j.cmi.2014.12.026; Hu R, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106051; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang I, 2020, THER ADV RESPIR DIS, V14, DOI 10.1177/1753466620937175; Huang YH, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101606; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; Krause M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239174; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Langford BJ, 2021, CLIN MICROBIOL INFEC, V27, P520, DOI 10.1016/j.cmi.2020.12.018; LINK CL, 1984, BIOMETRICS, V40, P601, DOI 10.2307/2530904; Lippi G, 2020, CLIN CHIM ACTA, V505, P190, DOI 10.1016/j.cca.2020.03.004; Liu F, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104370; May M, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.02167-20; Mewes JC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214222; Morgenthaler Nils G, 2002, Clin Lab, V48, P263; Oussalah A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001774; Peters C, 2021, CLIN MED, V21, pE71, DOI 10.7861/clinmed.2020-0614; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Pickens CO, 2021, AM J RESP CRIT CARE, V204, P921, DOI 10.1164/rccm.202106-1354OC; Ponti G, 2020, CRIT REV CL LAB SCI, V57, P389, DOI 10.1080/10408363.2020.1770685; Rawson TM, 2020, CLIN INFECT DIS, V71, P2459, DOI 10.1093/cid/ciaa530; Rothe K, 2021, EUR J CLIN MICROBIOL, V40, P859, DOI 10.1007/s10096-020-04063-8; Shang WF, 2020, J MED VIROL, V92, P2188, DOI 10.1002/jmv.26031; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Urbanek S., 2014, R LANG ENV STAT COMP; van Berkel M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03291-w; Vaughn VM, 2021, CLIN INFECT DIS, V72, pE533, DOI 10.1093/cid/ciaa1239; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; WHO, 2020, NOV COR; Yu CZ, 2020, AM J PREV MED, V59, P168, DOI 10.1016/j.amepre.2020.05.002; Zhang GQ, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104364; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhang JJY, 2020, CLIN INFECT DIS, V71, P2199, DOI 10.1093/cid/ciaa576; Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021; Zhou B., 2020, PREPRINTS, DOI [10.21203/rs.3.rs-18079/v1, DOI 10.21203/RS.3.RS-18079/V1]	57	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262342	10.1371/journal.pone.0262342	http://dx.doi.org/10.1371/journal.pone.0262342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025929	Green Published, gold			2022-12-27	WOS:000796264200059
J	Hilpmann, S; Bader, M; Steudtner, R; Muller, K; Stumpf, T; Cherkouk, A				Hilpmann, Stephan; Bader, Miriam; Steudtner, Robin; Mueller, Katharina; Stumpf, Thorsten; Cherkouk, Andrea			Microscopic and spectroscopic bioassociation study of uranium(VI) with an archaeal Halobacterium isolate	PLOS ONE			English	Article							FLUORESCENCE SPECTROSCOPY; SALT; COMPLEXATION; SPECIATION; DIVERSITY; U(VI)	The safe disposal of high-level radioactive waste in a deep geological repository is a huge social and technical challenge. So far, one of the less considered factors needed for a long-term risk assessment, is the impact of microorganisms occurring in the different host rocks. Even under the harsh conditions of salt formations different bacterial and archaeal species were found, e. g. Halobacterium sp. GP5 1-1, which has been isolated from a German rock salt sample. The interactions of this archaeon with uranium(VI), one of the radionuclides of major concern for the long-term storage of high-level radioactive waste, were investigated. Different spectroscopic techniques, as well as microscopy, were used to examine the occurring mechanisms on a molecular level leading to a more profound process understanding. Batch experiments with different uranium(VI) concentrations showed that the interaction is not only a simple, but a more complex combination of different processes. With the help of in situ attenuated total reflection Fourier-transform infrared spectroscopy the association of uranium(VI) onto carboxylate groups was verified. In addition, time-resolved laser-induced luminescence spectroscopy revealed the formation of phosphate and carboxylate species within the cell pellets as a function of the uranium(VI) concentration and incubation time. The association behavior differs from another very closely related halophilic archaeon, especially with regard to uranium(VI) concentrations. This clearly demonstrates the importance of studying the interactions of different, at first sight very similar, microorganisms with uranium(VI). This work provides new insights into the microbe-uranium(VI) interactions at highly saline conditions relevant to the long-term storage of radioactive waste in rock salt.	[Hilpmann, Stephan; Bader, Miriam; Steudtner, Robin; Mueller, Katharina; Stumpf, Thorsten; Cherkouk, Andrea] Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Dresden, Germany; [Bader, Miriam] Forsch Inst Leder & Kunststoffbahnen gGmbH, Freiberg, Germany	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR)	Cherkouk, A (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Dresden, Germany.	a.cherkouk@hzdr.de	Müller, Katharina/B-8238-2014	Müller, Katharina/0000-0002-0038-1638; Hilpmann, Stephan/0000-0001-7906-6851	iCross project [02NUK053E]; Helmholtz Association [SO-093]	iCross project; Helmholtz Association(Helmholtz Association)	SH was partly funded by the iCross project with the grant number 02NUK053E (German Federal Ministry of Education and Research -BMBF) and SO-093 (Helmholtz Association). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers SV, 2011, NAT REV MICROBIOL, V9, P414, DOI 10.1038/nrmicro2576; Andrei AS, 2012, FEMS MICROBIOL LETT, V330, P1, DOI 10.1111/j.1574-6968.2012.02526.x; [Anonymous], 2020, NUCL POWER REACTORS; Bader M, 2018, WECHSELWIRKUNG HALOP; Bader M, 2018, ENVIRON SCI TECHNOL, V52, P12895, DOI 10.1021/acs.est.8b02667; Bader M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190953; Bader M, 2017, J HAZARD MATER, V327, P225, DOI 10.1016/j.jhazmat.2016.12.053; Barkleit A, 2008, APPL SPECTROSC, V62, P798, DOI 10.1366/000370208784909607; Bauerlein E, 2003, ANGEW CHEM INT EDIT, V42, P614, DOI 10.1002/anie.200390176; Drobot B, 2016, ANAL CHEM, V88, P3548, DOI 10.1021/acs.analchem.5b03958; Drobot B, 2015, CHEM SCI, V6, P964, DOI 10.1039/c4sc02022g; Faybishenko B., 2016, INT APPROACHES DEEP, V5th; Fendrihan S., 2007, LIFE EXTREM ENV, V5, P125; Frols S, 2012, ENVIRON MICROBIOL, V14, P3159, DOI 10.1111/j.1462-2920.2012.02895.x; Gadd GM, 2009, J CHEM TECHNOL BIOT, V84, P13, DOI 10.1002/jctb.1999; Gonzales E, 2006, OECD PAP; Gruber C, 2004, EXTREMOPHILES, V8, P431, DOI 10.1007/s00792-004-0403-6; Guillaumont R., 2003, UPDATE CHEM THERMODY; Hunsche U, 1999, ENG GEOL, V52, P271, DOI 10.1016/S0013-7952(99)00011-3; Jaakkola ST, 2016, ENVIRON MICROBIOL, V18, P565, DOI 10.1111/1462-2920.13130; Jaakkola ST, 2016, TRENDS MICROBIOL, V24, P148, DOI 10.1016/j.tim.2015.12.002; Jones DL, 2015, CHEM SCI, V6, P5133, DOI 10.1039/c5sc00661a; Li B, 2010, J INORG BIOCHEM, V104, P718, DOI 10.1016/j.jinorgbio.2010.03.004; Lloyd Jr, 2002, RADIOACTIV ENVIRONM, V2, P313; Madden T., 2013, NCBI HDB; McGenity TJ, 2000, ENVIRON MICROBIOL, V2, P243, DOI 10.1046/j.1462-2920.2000.00105.x; Meinrath G, 1996, RADIOCHIM ACTA, V74, P81; Merroun ML, 2003, BIOMETALS, V16, P331, DOI 10.1023/A:1020612600726; Muller K, 2008, INORG CHEM, V47, P10127, DOI 10.1021/ic8005103; Muller K, 2012, GEOCHIM COSMOCHIM AC, V76, P191, DOI 10.1016/j.gca.2011.10.004; Nuclear Energy Agency (NEA) report, 2018, MICROBIAL INFLUENCE; Opel K, 2007, RADIOCHIM ACTA, V95, P143, DOI 10.1524/ract.2007.95.3.143; Quiles F, 2000, VIB SPECTROSC, V23, P231, DOI 10.1016/S0924-2031(00)00067-9; Reitz T, 2011, U 6 BIOACCUMULATION; Selenska-Pobell S, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P483, DOI 10.1007/978-3-642-05062-6_17; Stan-Lotter H., 2019, MODEL ECOSYSTEMS EXT, P169; Steudtner R, 2011, RADIOCHIM ACTA, V99, P687, DOI 10.1524/ract.2011.1861; Steudtner R, 2010, J RADIOANAL NUCL CH, V284, P421, DOI 10.1007/s10967-010-0489-5; Swanson JS., 2021, MICROBIOLOGY NUCL WA, P97; Vreeland RH, 1998, EXTREMOPHILES, V2, P321, DOI 10.1007/s007920050075	40	1	1	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262275	10.1371/journal.pone.0262275	http://dx.doi.org/10.1371/journal.pone.0262275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025937	gold, Green Published			2022-12-27	WOS:000796264200055
J	Broniatowski, DA; Kerchner, D; Farooq, F; Huang, XL; Jamison, AM; Dredze, M; Quinn, SC; Ayers, JW				Broniatowski, David A.; Kerchner, Daniel; Farooq, Fouzia; Huang, Xiaolei; Jamison, Amelia M.; Dredze, Mark; Quinn, Sandra Crouse; Ayers, John W.			Twitter and Facebook posts about COVID-19 are less likely to spread misinformation compared to other health topics	PLOS ONE			English	Article							SCIENCE	The COVID-19 pandemic brought widespread attention to an "infodemic" of potential health misinformation. This claim has not been assessed based on evidence. We evaluated if health misinformation became more common during the pandemic. We gathered about 325 million posts sharing URLs from Twitter and Facebook during the beginning of the pandemic (March 8-May 1, 2020) compared to the same period in 2019. We relied on source credibility as an accepted proxy for misinformation across this database. Human annotators also coded a subsample of 3000 posts with URLs for misinformation. Posts about COVID-19 were 0.37 times as likely to link to "not credible" sources and 1.13 times more likely to link to "more credible" sources than prior to the pandemic. Posts linking to "not credible" sources were 3.67 times more likely to include misinformation compared to posts from "more credible" sources. Thus, during the earliest stages of the pandemic, when claims of an infodemic emerged, social media contained proportionally less misinformation than expected based on the prior year. Our results suggest that widespread health misinformation is not unique to COVID-19. Rather, it is a systemic feature of online health communication that can adversely impact public health behaviors and must therefore be addressed.	[Broniatowski, David A.] George Washington Univ, Sch Engn & Appl Sci, Dept Engn Management & Syst Engn, Washington, DC 20052 USA; [Broniatowski, David A.] George Washington Univ, Inst Data Democracy & Polit, Washington, DC 20052 USA; [Kerchner, Daniel] George Washington Univ, George Washington Univ Lib, Washington, DC USA; [Farooq, Fouzia] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Huang, Xiaolei] Univ Memphis, Dept Comp Sci, Memphis, TN 38152 USA; [Jamison, Amelia M.; Quinn, Sandra Crouse] Univ Maryland, Dept Family Sci, Ctr Hlth Equ, Sch Publ Hlth, College Pk, MD 20742 USA; [Dredze, Mark] Johns Hopkins Univ, Dept Comp Sci, Whiting Sch Engn, Baltimore, MD 21218 USA; [Ayers, John W.] Univ Calif San Diego, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA; [Jamison, Amelia M.] Johns Hopkins Univ, Dept Hlth Behav & Soc, Bloomberg Sch Publ Hlth, Baltimore, MD USA	George Washington University; George Washington University; George Washington University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Memphis; University System of Maryland; University of Maryland College Park; Johns Hopkins University; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Broniatowski, DA (corresponding author), George Washington Univ, Sch Engn & Appl Sci, Dept Engn Management & Syst Engn, Washington, DC 20052 USA.; Broniatowski, DA (corresponding author), George Washington Univ, Inst Data Democracy & Polit, Washington, DC 20052 USA.	broniatowski@gwu.edu	Huang, Xiaolei/CAE-9200-2022	Huang, Xiaolei/0000-0003-0478-8715; Kerchner, Daniel/0000-0002-5921-2193; Broniatowski, David/0000-0002-3302-9497	 [R01GM114771]		This work was supported in part by grant number R01GM114771 to D.A. Broniatowski and S.C. Quinn, and by the John S. and James L. Knight Foundation to the GW Institute for Data, Democracy, and Politics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allyn B., 2020, RES NEARLY HALF ACCO; [Anonymous], 2020, LANCET INFECT DIS, V20, P875, DOI 10.1016/S1473-3099(20)30565-X; Ball P, 2020, NATURE, V581, P371, DOI 10.1038/d41586-020-01452-z; Chou WYS, 2021, HEALTH EDUC BEHAV, V48, P9, DOI 10.1177/1090198120980675; Christopher Torres-Lugo, 2020, Arxiv, DOI arXiv:2004.14484; Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5; CrowdTangle Team, 2020, CROWDTANGLE; Gabrielle L, 2020, BRIEFING SPECIAL ENV; Galvao J, 2021, LANCET INFECT DIS, V21, pE114, DOI 10.1016/S1473-3099(20)30721-0; George Washington University Libraries, 2020, **DATA OBJECT**, DOI 10.5281/ZENODO.3784836; Grinberg N, 2019, SCIENCE, V363, P374, DOI 10.1126/science.aau2706; Kerchner D., 2020, **DATA OBJECT**, DOI 10.7910/DVN/LW0BTB; Kurkowski J, 2020, PYTHON PACKAGE TLDEX; Lazer DMJ, 2018, SCIENCE, V359, P1094, DOI 10.1126/science.aao2998; McGinty M., 2020, HARVARD KENNEDY SCH, P1; Paul MJ, 2014, PLOS ONE, V9, DOI [10.1371/currents.outbreaks.90b9ed0f59bae4ccaa683a39865d9117, 10.1371/journal.pone.0103408]; Pennycook G, 2019, P NATL ACAD SCI USA, V116, P2521, DOI 10.1073/pnas.1806781116; Pulido CM, 2020, INT SOCIOL, V35, P377, DOI 10.1177/0268580920914755; Singh L, 2020, J COMPUT SOC SCI, V3, P343, DOI 10.1007/s42001-020-00093-6; Smith M., 2020, INFODEMIC, DOI [10.37016/mr-2020-38, DOI 10.37016/MR-2020-38]; Union PO of the E, 2020, TACKLING COVID 19 DI; World Health Organization, 2020, NOV COR 2019 NCOV SI, V3	22	7	7	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261768	10.1371/journal.pone.0261768	http://dx.doi.org/10.1371/journal.pone.0261768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020727	Green Published, gold			2022-12-27	WOS:000834207700022
J	Cohen, DA; Talarowski, M; Awomolo, O; Han, B; Williamson, S; McKenzie, TL				Cohen, Deborah A.; Talarowski, Meghan; Awomolo, Olaitan; Han, Bing; Williamson, Stephanie; McKenzie, Thomas L.			Increased mask adherence after important politician infected with COVID-19	PLOS ONE			English	Article								Objectives To quantify changes in adherence to mask and distancing guidelines in outdoor settings in Philadelphia, PA before and after President Trump announced he was infected with COVID-19. Methods We used Systematic Observation of Masking Adherence and Distancing (SOMAD) to assess mask adherence in parks, playgrounds, and commercial streets in the 10 City Council districts in Philadelphia PA. We compared adherence rates between August and September 2020 and after October 2, 2020. Results Disparities in mask adherence existed by age group, gender, and race/ethnicity, with females wearing masks correctly more often than males, seniors having higher mask use than other age groups, and Asians having higher adherence than other race/ethnicities. Correct mask use did not increase after the City released additional mask guidance in September but did after Oct 2. Incorrect mask use also decreased, but the percentage not having masks at all was unchanged. Conclusions Vulnerability of leadership appears to influence population behavior. Public health departments likely need more resources to effectively and persuasively communicate critical safety messages related to COVID-19 transmission.	[Cohen, Deborah A.] Kaiser Permanente Southern Calif Res & Evaluat, Pasadena, CA 91101 USA; [Talarowski, Meghan; Awomolo, Olaitan] Studio Ludo, Philadelphia, PA USA; [Han, Bing; Williamson, Stephanie] RAND Corp, Santa Monica, CA USA; [McKenzie, Thomas L.] San Diego State Univ, San Diego, CA 92182 USA	Kaiser Permanente; RAND Corporation; California State University System; San Diego State University	Cohen, DA (corresponding author), Kaiser Permanente Southern Calif Res & Evaluat, Pasadena, CA 91101 USA.	Deborah.a.cohen@kp.org		/0000-0002-1506-3739	NHLBI [R01HL145145]	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by NHLBI #R01HL145145 (PI is DC).	[Anonymous], 2015, MINORITY MARKETING I, DOI [10.1007/978-3-319-17392-4_24, DOI 10.1007/978-3-319-17392-4_24]; Banholzer N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252827; Chen HQ, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00672-w; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Chu Q, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-047231; Cohen DA, 2021, PREV MED REP, V23, DOI 10.1016/j.pmedr.2021.101449; Cowell AJ, 2009, ETHNIC HEALTH, V14, P75, DOI 10.1080/13557850802257715; Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI 10.1016/j.idm.2020.04.001; Fowler JH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248849; Fraser MR, 2021, J PUBLIC HEALTH MAN, V27, pS106, DOI 10.1097/PHH.0000000000001289; Gandhi M, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2026913; Green LW, 2002, J HEALTH COMMUN, V7, P245, DOI 10.1080/10810730290001710; Honein MA., 2020, MMWR, V4; Ibrahim JK, 2007, AM J PUBLIC HEALTH, V97, P1383, DOI 10.2105/AJPH.2006.097006; McKenzie TL, 2016, RES Q EXERCISE SPORT, V87, P334, DOI 10.1080/02701367.2016.1234302; McKenzie TL, 2015, RES Q EXERCISE SPORT, V86, P13, DOI 10.1080/02701367.2015.991264; Pierce JP, 1998, JAMA-J AM MED ASSOC, V280, P893, DOI 10.1001/jama.280.10.893; Porco TC, 2020, MEDRXIV; Teslya A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003166; van den Broek-Altenburg E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250302; Wiese AD, 2021, CLIN INFECT DIS, V73, pE141, DOI 10.1093/cid/ciaa834; Worby CJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17922-x	22	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261398	10.1371/journal.pone.0261398	http://dx.doi.org/10.1371/journal.pone.0261398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020749	Green Published, gold			2022-12-27	WOS:000834207700016
J	Mawatari, S; Kumagai, K; Oda, K; Tabu, K; Ijuin, S; Fujisaki, K; Tashima, S; Inada, Y; Uto, H; Saisyoji, A; Hiramine, Y; Hashiguchi, M; Tamai, T; Hori, T; Taniyama, O; Toyodome, A; Sakae, H; Kure, T; Sakurai, K; Moriuchi, A; Kanmura, S; Ido, A				Mawatari, Seiichi; Kumagai, Kotaro; Oda, Kohei; Tabu, Kazuaki; Ijuin, Sho; Fujisaki, Kunio; Tashima, Shuzo; Inada, Yukiko; Uto, Hirofumi; Saisyoji, Akiko; Hiramine, Yasunari; Hashiguchi, Masafumi; Tamai, Tsutomu; Hori, Takeshi; Taniyama, Ohki; Toyodome, Ai; Sakae, Haruka; Kure, Takeshi; Sakurai, Kazuhiro; Moriuchi, Akihiro; Kanmura, Shuji; Ido, Akio			Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ALPHA-FETOPROTEIN; LIVER FIBROSIS; PROGENITOR CELLS; HCV INFECTION; TERM RISK; ERADICATION; RECURRENCE; THERAPY; EXPRESSION	Background The features of hepatitis C virus patients with a sustained virologic response (SVR) who developed hepatocellular carcinoma (HCC) after direct-acting antiviral (DAA) therapy are unclear. Methods The study population included 1494 DAA-SVR patients without a history of HCC. The cumulative carcinogenesis rate after the end of treatment (EOT) and factors related to HCC were analyzed. Results Sixty (4.0%) patients developed HCC during a median observation period of 47.6 months. At four years, the cumulative carcinogenesis rate was 4.7%. A Cox proportional hazards analysis showed that age >= 73 years (hazard ratio [HR]: 2.148), male sex (HR: 3.060), hyaluronic acid (HA) >= 75 ng/mL (HR: 3.996), alpha-fetoprotein at EOT (EOT-AFP) >= 5.3 ng/mL (HR: 4.773), and albumin at EOT (EOT-Alb) <3.9 g/dL (HR: 2.305) were associated with HCC development. Especially, EOT-AFP >= 5.3 ng/mL was associated with HCC development after 3 years from EOT (HR: 6.237). Among patients who developed HCC, AFP did not increase in patients with EOT-AFP <5.3 ng/mL at the onset of HCC. Of these 5 factors, EOT-AFP >= 5.3 ng/mL was scored as 2 points; the others were scored as 1 point. The 4-year cumulative carcinogenesis rate for patients with total scores of 0-2, 3-4, and 5-6 points were 0.6%, 11.9%, and 27.1%, respectively (p<0.001). Conclusions EOT-AFP >= 5.3 ng/mL is useful for predicting HCC development after an SVR. However, AFP does not increase in patients with EOT-AFP <5.3 ng/mL at the onset of HCC. The combination of EOT-AFP, age, sex, HA, and EOT-Alb is important for predicting carcinogenesis.	[Mawatari, Seiichi; Kumagai, Kotaro; Oda, Kohei; Tabu, Kazuaki; Ijuin, Sho; Tashima, Shuzo; Uto, Hirofumi; Saisyoji, Akiko; Hashiguchi, Masafumi; Tamai, Tsutomu; Taniyama, Ohki; Toyodome, Ai; Sakae, Haruka; Kure, Takeshi; Moriuchi, Akihiro; Kanmura, Shuji; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci Digest & Lifestyle Dis, Kagoshima, Japan; [Fujisaki, Kunio; Tashima, Shuzo] Kirishima Med Ctr, Dept Hepatol, Hayato Cho, Kirishima, Kagoshima, Japan; [Inada, Yukiko; Uto, Hirofumi] Miyazaki Med Ctr Hosp, Ctr Digest & Liver Dis, Miyazaki, Japan; [Saisyoji, Akiko; Hiramine, Yasunari] Kagoshima Kouseiren Hosp, Dept Internal Med, Kagoshima, Japan; [Hashiguchi, Masafumi; Tamai, Tsutomu; Hori, Takeshi] Kagoshima City Hosp, Dept Gastroenterol & Hepatol, Kagoshima, Japan; [Kure, Takeshi] Kagoshima Med Assoc Hosp, Dept Gastroenterol, Kagoshima, Japan; [Sakurai, Kazuhiro; Moriuchi, Akihiro] Kagoshima Med Ctr, Dept Gastroenterol, Natl Hosp Org, Kagoshima, Japan	Kagoshima University; Kagoshima City Hospital	Mawatari, S (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci Digest & Lifestyle Dis, Kagoshima, Japan.	mawatari@m2.kufm.kagoshima-u.ac.jp			Ministry of Health, Labour and Welfare of Japan [18K15821]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a grant-in-aid from the Ministry of Health, Labour and Welfare of Japan (grant number: 18K15821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; [Anonymous], GUIDELINES MANAGEMEN; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Backus LI, 2018, HEPATOLOGY, V68, P827, DOI 10.1002/hep.29811; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; BERGSTRAND CG, 1956, SCAND J CLIN LAB INV, V8, P174, DOI 10.3109/00365515609049266; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; Cucchetti A, 2016, HEPATOL RES, V46, P1275, DOI 10.1111/hepr.12672; Dhar D, 2018, CANCER CELL, V33, P1061, DOI 10.1016/j.ccell.2018.05.003; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Forns X, 2017, LANCET INFECT DIS, V17, P1062, DOI 10.1016/S1473-3099(17)30496-6; Hansen JF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212036; Heffernan A, 2019, LANCET, V393, P1319, DOI 10.1016/S0140-6736(18)32277-3; Hiramatsu N, 2015, HEPATOL RES, V45, P152, DOI 10.1111/hepr.12393; Ide T, 2019, HEPATOL INT, V13, P293, DOI 10.1007/s12072-019-09939-2; Ioannou GN, 2018, J HEPATOL, V68, P25, DOI 10.1016/j.jhep.2017.08.030; Ioannou GN, 2016, GASTROENTEROLOGY, V151, P457, DOI 10.1053/j.gastro.2016.05.049; Itami-Matsumoto S, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7040087; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kakisaka K, 2015, HEPATOL RES, V45, pE12, DOI 10.1111/hepr.12448; Kanwal F, 2020, HEPATOLOGY, V71, P44, DOI 10.1002/hep.30823; Kanwal F, 2017, GASTROENTEROLOGY, V153, P996, DOI 10.1053/j.gastro.2017.06.012; Kokudo N, 2015, HEPATOL RES, V45, DOI 10.1111/hepr.12464; Kuhlmann WD, 2006, INT J EXP PATHOL, V87, P343, DOI 10.1111/j.1365-2613.2006.00485.x; Liu YR, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-145; Marino Z, 2019, J HEPATOL, V70, P874, DOI 10.1016/j.jhep.2019.01.005; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; Nagata H, 2017, J HEPATOL, V67, P933, DOI 10.1016/j.jhep.2017.05.028; Nakano Y, 2017, HEPATOL COMMUN, V1, P215, DOI [10.1002/hep4.1026/suppinfo, 10.1002/hep4.1026]; Nakao Y, 2018, J HEPATOL, V68, P854, DOI 10.1016/j.jhep.2017.11.011; Ogawa E, 2018, ALIMENT PHARM THER, V47, P104, DOI 10.1111/apt.14380; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9; Ooka Y, 2018, HEPATOL INT, V12, P523, DOI 10.1007/s12072-018-9895-5; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Sangiovanni A, 2020, J HEPATOL, V73, P593, DOI 10.1016/j.jhep.2020.03.030; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Tabu K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237475; TAKETA K, 1990, HEPATOLOGY, V12, P1420, DOI 10.1002/hep.1840120625; Tamori A, 2016, HEPATOL RES, V46, pE26, DOI 10.1111/hepr.12518; Tanaka J, 2019, HEPATOL RES, V49, P990, DOI 10.1111/hepr.13417; Toyoda H, 2017, J HEPATOL, V66, P521, DOI 10.1016/j.jhep.2016.11.012; Villani R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167934; Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263; Watanabe T, 2019, HEPATOL RES, V49, P136, DOI 10.1111/hepr.13278; Waziry R, 2017, J HEPATOL, V67, P1204, DOI 10.1016/j.jhep.2017.07.025; World Health Organization, 2019, HEP C FACT SHEET WHO; Yamada R, 2019, HEPATOL RES, V49, P570, DOI 10.1111/hepr.13310; Yamaguchi T, 2013, HEPATOL RES, V43, P1327, DOI 10.1111/hepr.12082; Yasui Y, 2018, HEPATOL RES, V48, P1131, DOI 10.1111/hepr.13233; Yotsuyanagi H, 2009, HEPATOL RES, V39, P657, DOI 10.1111/j.1872-034X.2009.00517.x	53	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262267	10.1371/journal.pone.0262267	http://dx.doi.org/10.1371/journal.pone.0262267			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020772	Green Published, gold			2022-12-27	WOS:000834207700039
J	Vazquez, ML; Miranda-Mendizabal, A; Eguiguren, P; Mogollon-Perez, AS; Ferreira-de-Medeiros-Mendes, M; Lopez-Vazquez, J; Bertolotto, F; Vargas, I				Vazquez, Maria-Luisa; Miranda-Mendizabal, Andrea; Eguiguren, Pamela; Mogollon-Perez, Amparo-Susana; Ferreira-de-Medeiros-Mendes, Marina; Lopez-Vazquez, Julieta; Bertolotto, Fernando; Vargas, Ingrid		Equity LA II	Evaluating the effectiveness of care coordination interventions designed and implemented through a participatory action research process: Lessons learned from a quasi-experimental study in public healthcare networks in Latin America	PLOS ONE			English	Article							PREVENTION; PROMOTION	Background Despite increasing recommendations for health professionals to participate in intervention design and implementation to effect changes in clinical practice, little is known about this strategy's effectiveness. This study analyses the effectiveness of interventions designed and implemented through participatory action research (PAR) processes in healthcare networks of Brazil, Chile, Colombia, Mexico and Uruguay to improve clinical coordination across care levels, and offers recommendations for future research. Methods The study was quasi-experimental. Two comparable networks, one intervention (IN) and one control (CN), were selected in each country. Baseline (2015) and evaluation (2017) surveys of a sample of primary and secondary care doctors (174 doctors/network/year) were conducted using the COORDENA (R) questionnaire. Most of the interventions chosen were based on joint meetings, promoting cross-level clinical agreement and communication for patient follow-up. Outcome variables were: a) intermediate: interactional and organizational factors; b) distal: experience of cross-level clinical information coordination, of clinical management coordination and general perception of coordination between levels. Poisson regression models were estimated. Results A statistically significant increase in some of the interactional factors (intermediate outcomes) -knowing each other personally and mutual trust- was observed in Brazil and Chile INs; and in some organizational factors -institutional support- in Colombia and Mexico. Compared to CNs in 2017, INs of Brazil, Chile, Colombia and Mexico showed significant differences in some factors. In distal outcomes, care consistency items improved in Brazil, Colombia and Uruguay INs; and patient follow-up improved in Chile and Mexico. General perception of clinical coordination increased in Brazil, Colombia and Mexico INs. Compared to CNs in 2017, only Brazil showed significant differences. Conclusions Although more research is needed, results show that PAR-based interventions improved some outcomes regarding clinical coordination at network level, with differences between countries. However, a PAR process is, by definition, slow and gradual, and longer implementation periods are needed to achieve greater penetration and quantifiable changes. The participatory and flexible nature of interventions developed through PAR processes poses methodological challenges (such as defining outcomes or allocating individuals to different groups in advance), and requires a comprehensive mixed-methods approach that simultaneously evaluates effectiveness and the implementation process to better understand its outcomes.	[Vazquez, Maria-Luisa; Miranda-Mendizabal, Andrea; Vargas, Ingrid] Consortium Hlth Care & Social Serv Catalonia, Hlth Policy Res Unit, Hlth Policy & Hlth Serv Res Grp, Barcelona, Spain; [Miranda-Mendizabal, Andrea] Int Univ Catalonia UIC, Sch Med & Hlth Sci, Sant Cugat Del Valles, Spain; [Eguiguren, Pamela] Univ Chile, Fac Med, Escuela Salud Publ Dr Salvador Allende Gossens, Santiago, Chile; [Mogollon-Perez, Amparo-Susana] Univ Rosario, Escuela Med & Ciencias Salud, Bogota, Colombia; [Ferreira-de-Medeiros-Mendes, Marina] Inst Med Integral Prof Fernando Figueira, Grp Estudos Gestao & Avaliacao Saude, Recife, PE, Brazil; [Lopez-Vazquez, Julieta] Univ Veracruzana, Inst Salud Publ, Veracruz, Mexico; [Bertolotto, Fernando] Univ Republica, Fac Enfermeria, Montevideo, Uruguay	Universitat Internacional de Catalunya (UIC); Universidad de Chile; Universidad del Rosario; Instituto de Medicina Integral Professor Fernando Figueira (IMIP); Universidad Veracruzana; Universidad de la Republica, Uruguay	Vargas, I (corresponding author), Consortium Hlth Care & Social Serv Catalonia, Hlth Policy Res Unit, Hlth Policy & Hlth Serv Res Grp, Barcelona, Spain.	Ivargas@consorci.org	Navarrete, María-Luisa Vázquez/AAV-5498-2020	Navarrete, María-Luisa Vázquez/0000-0002-6091-8193; Miranda Mendizabal, Andrea/0000-0003-3649-7509; Vargas, Ingrid/0000-0002-1778-2411	Equity LA II project; European Commission [305197]	Equity LA II project; European Commission(European CommissionEuropean Commission Joint Research Centre)	The research leading to these results, the Equity LA II project, received funding from the European Commission Seventh Framework Programme (FP7/2007-2013) under grant agreement number 305197 (https://ec.europa.eu/research/fp7/index_en.cfm).	Aller MB, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0968-z; Atun R, 2015, LANCET, V385, P1230, DOI 10.1016/S0140-6736(14)61646-9; Beatriz ED, 2018, J FAM VIOLENCE, V33, P563, DOI 10.1007/s10896-018-9981-4; Bennett S, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0771-5; Breimaier HE, 2015, BMC NURS, V14, DOI 10.1186/s12912-015-0064-z; Briggs AM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021194; Bush PL, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0648-y; Campbell D. T., 1963, EXPT QUASIEXPERIMENT, P171; Congreso de la Republica de Colombia, 2011, LEY 1438 2011 EN 19; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Daniel M, 1999, SOC SCI MED, V48, P815, DOI 10.1016/S0277-9536(98)00403-1; Eccles M, 2003, QUAL SAF HEALTH CARE, V12, P47, DOI 10.1136/qhc.12.1.47; Equity-LA II, 2016, IMPACT ALTERNATIVE C; Espinel-Flores V, 2022, HEALTH POLICY PLANN, V37, P1, DOI 10.1093/heapol/czab130; Eyre L, 2017, BMJ QUAL SAF, V26, P588, DOI 10.1136/bmjqs-2016-005777; Garcia-Subirats I, 2014, SOC SCI MED, V106, P204, DOI 10.1016/j.socscimed.2014.01.054; Giovanella Ligia, 2015, Saúde debate, V39, P300, DOI 10.1590/0103-110420151050002002; Gobierno del estado de Veracruz, 2017, PROGR EST SAL 2017 2; Green LW, 2001, AM J PUBLIC HEALTH, V91, P1926, DOI 10.2105/AJPH.91.12.1926; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Hampshire AJ, 2000, J EVAL CLIN PRACT, V6, P337, DOI 10.1046/j.1365-2753.2000.00260.x; Harris M, 2007, REV PANAM SALUD PUBL, V21, P96; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; KOEPSELL TD, 1992, ANNU REV PUBL HEALTH, V13, P31, DOI 10.1146/annurev.pu.13.050192.000335; Leon-Arce HG, 2021, INT J HEALTH PLAN M, V36, P134, DOI 10.1002/hpm.3073; Levy JI, 2006, SOC SCI MED, V63, P2191, DOI 10.1016/j.socscimed.2006.05.006; Loewenson R., 2014, PARTICIPATORY ACTION; Longest B, 2000, HLTH CARE MANAGEMENT, P210; McDonald KM, 2007, CARE COORDINATION; Merzel C, 2003, AM J PUBLIC HEALTH, V93, P557, DOI 10.2105/AJPH.93.4.557; Ministerio de Salud y Proteccion Social, 2016, RES 429 DIAR OF 49 7; Miranda-Mendizabal A, 2020, GAC SANIT, V34, P340, DOI 10.1016/j.gaceta.2018.09.009; Munn-Giddings C, 2010, RECH SOINS INFIRM, P124, DOI 10.3917/rsi.100.0124; Murillo R, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9607803; Nickel S, 2020, J COMMUN HEALTH, V45, P419, DOI 10.1007/s10900-019-00733-7; Ovretveit J, 2011, DOES CLIN COORDINATI; Ovretveit J., 2014, PERSPECT CONTEXT, P60; Pan American Health Organization, 2010, REN PRIM HLTH CAR AM; Pardo L, 2008, REV MED URUG, V24, P69; Peters DH, 2013, INPLEMENTATION RESEARCH IN HEALTH: A PRACTICAL GUIDE, pCOVER1; Powers C, 2012, BERKMAN CTR RES PUBL, DOI DOI 10.2139/SSRN.2199500; Ramirez GC., 2009, REV HOSP JU REZ M XI, V76, P190; Secretaria de Saude Prefectura de Caruaru, 2015, NORM OP AC EQ INT CO, P1; Smith SM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004910.pub2; Smith SM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004910.pub3; Soh KL, 2011, INT J NURS STUD, V48, P258, DOI 10.1016/j.ijnurstu.2010.09.014; Vargas I., 2019, GAC SANIT; Vargas I, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05781-7; Vargas I, 2020, HEALTH POLICY PLANN, V35, P962, DOI 10.1093/heapol/czaa066; Vargas I, 2018, HEALTH POLICY PLANN, V33, P494, DOI 10.1093/heapol/czy016; Vargas I, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0882-4; Vazquez ML, 2017, SOC SCI MED, V182, P10, DOI 10.1016/j.socscimed.2017.04.001; Vazquez ML, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007037; Viswanathan M, 2004, Evid Rep Technol Assess (Summ), P1; Waterman H., 2001, HEALTH TECHNOL ASSES, V5, DOI [10.3310/hta5230, DOI 10.3310/HTA5230]	57	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261604	10.1371/journal.pone.0261604	http://dx.doi.org/10.1371/journal.pone.0261604			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020735	gold, Green Published			2022-12-27	WOS:000834207700019
J	Djebbari, F; Rampotas, A; Panitsas, F; Lim, WY; Lees, C; Tsagkaraki, I; Gomes, AR; Prideaux, S; Chen, L; Prodger, C; Khera, A; Gray, N; Ellis, L; Sangha, G; Eyre, TA; Moore, S; Kothari, J; Ramasamy, K				Djebbari, Faouzi; Rampotas, Alexandros; Panitsas, Fotios; Lim, Wen Yuen; Lees, Charlotte; Tsagkaraki, Ismini; Gomes, Ana Rita; Prideaux, Steve; Chen, Lucia; Prodger, Catherine; Khera, Akhil; Gray, Nicola; Ellis, Lauren; Sangha, Gina; Eyre, Toby A.; Moore, Sally; Kothari, Jaimal; Ramasamy, Karthik			Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients	PLOS ONE			English	Article							GERIATRIC ASSESSMENT; DEXAMETHASONE; LENALIDOMIDE	The management of myeloma in the elderly is shifting its focus towards reducing the risk of under-treating fit patients and the risk of over-treating frail patients. Frailty assessment is required in this patient group in order to individualise treatment decisions. In addition to the proven prognostic values of the International Myeloma Working Group (IMWG) frailty score and the revised Myeloma Co-morbidity Index (R-MCI), a new easy-to-use frailty-based risk profile score (high-risk (i.e. frail), medium risk (i.e. intermediate-fitness) and low-risk (i.e. fit)) named Myeloma Risk Profile (MRP) was shown to be predictive of survival in the clinical trial setting. In this retrospective real-world study, we set out to evaluate the frailty characteristics and clinical outcomes according to the different MRP scoring algorithm categories (frail vs. intermediate vs fit), in a high risk cohort of elderly newly diagnosed myeloma patients treated with the fixed-duration triplet therapy VCD (bortezomib with cyclophosphamide and dexamethasone). Clinical outcomes included: reason for treatment discontinuation, overall response rate (ORR), overall survival (OS), progression-free survival (PFS), and adverse events (AEs). Out of 100 patients, 62 were frail, 27 were intermediate and 11 were fit, according to MRP scores. To enable meaningful comparisons between comparable numbers, subgroups analyses for ORR, OS, PFS, and AEs focused on frail (n = 62) versus intermediate or fit (n = 38) patients. The proportion of patients in each subgroup who were able to complete the planned course of treatment was (frail: 43.5% vs. intermediate or fit: 55.3%). A higher proportion in the frail subgroup discontinued therapy due to progressive disease (19.4% vs. 2.6%). Discontinuation due to toxicity was comparable across subgroups (14.5% vs. 15.8%), ORR in the total cohort was 75%, and this was comparable between subgroups (frail: 74.2% vs. intermediate or fit: 76.3%). There was a trend for a shorter median OS in the frail subgroup but without a statistical significance: (frail vs. intermediate or fit): (46 months vs. not reached, HR: 1.94, 95% CI 0.89-4.2, p = 0.094). There was no difference in median PFS between subgroups: (frail vs. intermediate or fit): (11.8 vs. 9.9 months, HR: 0.99, 95% CI: 0.61-1.61, P = 0.982). This cohort demonstrated a higher incidence rate of AEs in frail patients compared to those in the intermediate or fit group: patients with at least one any grade toxicity (85.5% vs. 71.1%), patients with at least one >= G3 AE (37.1% vs. 21.1%). In conclusion, our study is to the first to evaluate clinical outcomes according to MRP in a high risk real-world cohort of patients treated exclusively with the proteasome inhibitor-based VCD therapy. Our study demonstrated a trend for worse OS in addition to worse AE outcomes in the frail group, but no difference in PFS with this fixedduration therapy. MRP is an easy-to-use tool in clinical practice; its prognostic value was validated in the real-world in a large cohort of patients from the Danish Registry. Further evaluation of MRP in the real-world when continuous therapies are used, can further support the generalisability of its prognostic value in elderly myeloma patients.	[Djebbari, Faouzi; Rampotas, Alexandros; Lim, Wen Yuen; Gomes, Ana Rita; Prodger, Catherine; Khera, Akhil; Sangha, Gina; Eyre, Toby A.; Moore, Sally; Kothari, Jaimal; Ramasamy, Karthik] Oxford Univ Hosp NHS Fdn Trust, Dept Clin Haematol, Oxford, England; [Panitsas, Fotios] Laikon Gen Hosp, Dept Haematol, Athens, Greece; [Lees, Charlotte] Royal Berkshire NHS Fdn Trust, Reading, Berks, England; [Tsagkaraki, Ismini] Buckinghamshire Healthcare NHS Trust, Aylesbury, Bucks, England; [Prideaux, Steve] Great Western Hosp NHS Fdn Trust, Swindon, Wilts, England; [Chen, Lucia] Milton Keynes Univ Hosp NHS Fdn Trust, Milton Keynes, Bucks, England; [Gray, Nicola] Wexham Pk Hosp, Slough, Berks, England; [Ellis, Lauren] Frimley Hlth NHS Fdn Trust, Frimley, England	Oxford University Hospitals NHS Foundation Trust; Laiko General Hospital; Royal Berkshire Hospital	Djebbari, F (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Dept Clin Haematol, Oxford, England.	faouzi.djebbari@ouh.nhs.uk		DJEBBARI, Faouzi/0000-0001-9578-7632; Rampotas, Alexandros/0000-0002-2681-5860; Ramasamy, Karthik/0000-0003-3385-3707; Sangha, Gina/0000-0002-8433-8994				[Anonymous], 2009, COMMON TERMINOLOGY C; Benboubker L, 2014, NEW ENGL J MED, V371, P906, DOI 10.1056/NEJMoa1402551; Cancer Research UK, CANC STAT MYEL INC S; Cook G, 2019, LANCET HAEMATOL, V6, pE154, DOI 10.1016/S2352-3026(18)30220-5; Engelhardt M, 2020, HAEMATOLOGICA, V105, P1183, DOI 10.3324/haematol.2019.242958; Engelhardt M, 2017, HAEMATOLOGICA, V102, P910, DOI 10.3324/haematol.2016.162693; Engelhardt M, 2016, HAEMATOLOGICA, V101, P1110, DOI 10.3324/haematol.2016.148189; Facon T, 2019, NEW ENGL J MED, V380, P2104, DOI 10.1056/NEJMoa1817249; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Mateos MV, 2018, NEW ENGL J MED, V378, P518, DOI 10.1056/NEJMoa1714678; Palumbo A, 2015, BLOOD, V125, P2068, DOI 10.1182/blood-2014-12-615187; Redder L, 2021, BRIT J HAEMATOL, V193, P119, DOI 10.1111/bjh.16806; Zweegman S, 2019, LANCET HAEMATOL, V6, pE117, DOI 10.1016/S2352-3026(19)30011-0	13	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262388	10.1371/journal.pone.0262388	http://dx.doi.org/10.1371/journal.pone.0262388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015781	Green Published, gold			2022-12-27	WOS:000814820600013
J	Fayed, A; Wahabi, HA; Esmaeil, S; Elkouny, R; Elmorshedy, H; Bakhsh, H				Fayed, Amel; Wahabi, Hayfaa A.; Esmaeil, Samia; Elkouny, Roaa; Elmorshedy, Hala; Bakhsh, Hanadi			Independent effect of gestational weight gain and prepregnancy obesity on pregnancy outcomes among Saudi women: A sub-cohort analysis from Riyadh mother and baby cohort study (RAHMA)	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; RISK; ASSOCIATION; PREVALENCE; DELIVERY; IMPACT; BIRTH	Background Gestational weight gain (GWG) and prepregnancy obesity are garnering more attention as determining factors of pregnancy outcomes when it comes to the wellbeing of both the mother and her baby. This study was conducted to describe the pattern of GWG among participants of Riyadh Mother and Baby Multicenter Cohort Study (RAHMA) and to investigate the detrimental effects of excessive GWG and prepregnancy obesity on pregnancy outcomes. Methods RAHMA is a multicentre cohort study conducted in three hospitals in Riyadh, Saudi Arabia. Participants were categorized according to the Institute of Medicine into inadequate, adequate, and excessive GWG, and stratified by body mass index (BMI) into under/normal weight, overweight, and obese. To examine the independent effect of maternal prepregnancy obesity and GWG, a multivariate regression model was used and adjusted odds ratio (AOR) and 95% Confidence Interval (CI) for each outcome were calculated. Results A total of 7029 participants were included in this study; 31.8% had adequate GWG, 25.9% had excessive GWG and 42.3% had inadequate GWG, while 29.7% had normal BMI, 33.3% were overweight, 34.8% were obese, and 2.2% were underweight. Excessive GWG was independently associated with increased risk of hypertensive events, (AOR = 1.77, 95% CI 1.20-2.63). Obesity was associated with higher risk of gestational diabetes (AOR 2.11, 95% CI 1.76-2.53), hypertensive events (AOR 2.06, 95% CI 1.48-3.01), and delivery by emergency caesarean section (AOR = 1.63, 95% CI 1.35-1.97). Infants of obese women had increased odds of macrosomia (AOR 3.11, 95% CI 1.94-4.99) and lower odds of low birth weight (AOR = 0.68, 95% CI 0.53-0.88). Conclusion In comparison to excessive GWG, which increases the risk of hypertensive events during pregnancy, prepregnancy obesity is associated with more adverse outcomes including GDM, hypertensive events in pregnancy and emergency CS.	[Fayed, Amel; Elmorshedy, Hala; Bakhsh, Hanadi] Princess Nourah Bint Abdulrahman Univ, Coll Med, Clin Sci Dept, Riyadh, Saudi Arabia; [Wahabi, Hayfaa A.; Esmaeil, Samia] King Saud Univ, Res Chair Evidence Based Healthcare & Knowledge T, Riyadh, Saudi Arabia; [Wahabi, Hayfaa A.] King Saud Univ Med City & Coll Med, Dept Family & Community Med, Riyadh, Saudi Arabia; [Elkouny, Roaa] AlFaisal Univ, Coll Med, Riyadh, Saudi Arabia	Princess Nourah bint Abdulrahman University; King Saud University; King Saud University; Alfaisal University	Wahabi, HA (corresponding author), King Saud Univ, Res Chair Evidence Based Healthcare & Knowledge T, Riyadh, Saudi Arabia.; Wahabi, HA (corresponding author), King Saud Univ Med City & Coll Med, Dept Family & Community Med, Riyadh, Saudi Arabia.	umlena@yahoo.com	Fayed, Amel/H-8588-2016	Fayed, Amel/0000-0003-3395-0486; Elkouny, Roaa/0000-0002-5344-5017	Center for Promising Research in Social Research and Women's Studies, Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University	Center for Promising Research in Social Research and Women's Studies, Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University(Princess Nourah bint Abdulrahman University)	The authors would like to thank the Center for Promising Research in Social Research and Women's Studies, Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University for funding this Project in 2020. Award/Grant number is not applicable. The funder did not play any role in collection of data, decision to publish or preparation of the manuscript.	Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012; Alsheef MA, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4071892; American College of Obstetricians and Gynecologists Committee on Practice BulletinsObstetrics, 2016, Obstet Gynecol, V128, pe155, DOI 10.1097/AOG.0000000000001711; [Anonymous], 2020, Obstet Gynecol, V135, P246, DOI 10.1097/AOG.0000000000003607; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Bahadoer S, 2015, EUR J OBSTET GYN R B, V193, P51, DOI 10.1016/j.ejogrb.2015.06.031; Beta J, 2019, ULTRASOUND OBST GYN, V54, P308, DOI 10.1002/uog.20279; Beyerlein A, 2010, OBSTET GYNECOL, V116, P1111, DOI 10.1097/AOG.0b013e3181f1ad8b; Beyerlein A, 2009, AM J CLIN NUTR, V90, P1552, DOI 10.3945/ajcn.2009.28026; Blomberg M, 2011, OBSTET GYNECOL, V117, P1065, DOI 10.1097/AOG.0b013e318214f1d1; Bodnar LM, 2010, AM J CLIN NUTR, V91, P1642, DOI 10.3945/ajcn.2009.29008; Bogaerts A, 2015, OBSTET GYNECOL, V125, P566, DOI 10.1097/AOG.0000000000000677; Catalano PM, 2017, BMJ-BRIT MED J, V356, DOI [10.1136/bmj.j1, 10.1136/bmj.j1631]; Chen CN, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17041221; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Corp S., 2019, STATA STAT SOFTWARE; Cutland CL, 2017, VACCINE, V35, P6492, DOI 10.1016/j.vaccine.2017.01.049; Deputy NP, 2015, OBSTET GYNECOL, V125, P773, DOI 10.1097/AOG.0000000000000739; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Durst JK, 2016, AM J PERINAT, V33, P849, DOI 10.1055/s-0036-1579650; El-Gilany AH, 2009, OBESITY FACTS, V2, P217, DOI 10.1159/000226597; Fallatah Anas M, 2019, Med Arch, V73, P425, DOI 10.5455/medarh.2019.73.425-432; Fernandez-Twinn DS, 2019, DIABETOLOGIA, V62, P1789, DOI 10.1007/s00125-019-4951-9; Frolova AI, 2018, AM J PERINAT, V35, P59, DOI 10.1055/s-0037-1605574; Gaillard R, 2013, OBESITY, V21, P1046, DOI 10.1002/oby.20088; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635; Guo YF, 2019, CAN J PUBLIC HEALTH, V110, P657, DOI 10.17269/s41997-019-00250-z; Haugen M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-201; Heude B, 2012, MATERN CHILD HLTH J, V16, P355, DOI 10.1007/s10995-011-0741-9; Hillesund E R, 2018, BMC Res Notes, V11, P282, DOI 10.1186/s13104-018-3396-4; IBM, 2021, CIT IBM SPSS STAT EA; Institute of M., 2009, WEIGHT GAIN PREGNANC; Institute of Medicine Committee on Nutritional Status During P Lactation, 1990, NUTR PREGNANCY 1; Jain AP, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.018; Kominiarek MA, 2018, OBSTET GYNECOL, V132, P875, DOI 10.1097/AOG.0000000000002854; Kominiarek MA, 2017, AM J OBSTET GYNECOL, V217, P642, DOI 10.1016/j.ajog.2017.05.040; Li CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136850; Lim S, 2015, OBES REV, V16, P972, DOI 10.1111/obr.12312; Liu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12863; Marchi J, 2015, OBES REV, V16, P621, DOI 10.1111/obr.12288; Mastroeni MF, 2017, MATERN CHILD HLTH J, V21, P705, DOI 10.1007/s10995-016-2156-0; Mohammadi M, 2019, J MATERN-FETAL NEO M, V32, P3818, DOI 10.1080/14767058.2018.1473366; Morgan ES, 2012, INT J OBSTET ANESTH, V21, P253, DOI 10.1016/j.ijoa.2012.01.002; Muktabhant B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub3; O'Dwyer V, 2013, J OBSTET GYNAECOL, V33, P671, DOI 10.3109/01443615.2013.821461; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Rahman MM, 2015, OBES REV, V16, P758, DOI 10.1111/obr.12293; Santos S, 2019, BJOG-INT J OBSTET GY, V126, P984, DOI 10.1111/1471-0528.15661; Tieu J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006674.pub3; Vinter CA, 2011, DIABETES CARE, V34, P2502, DOI 10.2337/dc11-1150; Voerman E, 2019, JAMA-J AM MED ASSOC, V321, P1702, DOI 10.1001/jama.2019.3820; Wahabi H, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6655942; Wahabi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150297; Wahabi HA, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2957429; World Health Organization, HLTH TOP OB	58	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262437	10.1371/journal.pone.0262437	http://dx.doi.org/10.1371/journal.pone.0262437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015784	Green Published, gold			2022-12-27	WOS:000814820600017
J	Bajos, N; Spire, A; Silberzan, L				Bajos, Nathalie; Spire, Alexis; Silberzan, Lena		EPICOV Study Grp	The social specificities of hostility toward vaccination against Covid-19 in France	PLOS ONE			English	Article							HEALTH; WOMEN; HESITANCY; REFUSAL; GENDER; IMPACT; RISKS	Equal Access to the COVID-19 vaccine for all remains a major public health issue. The current study compared the prevalence of vaccination reluctance in general and COVID-19 vaccine hesitancy and social and health factors associated with intentions to receive the vaccine. A random socio-epidemiological population-based survey was conducted in France in November 2020, in which 85,855 adults participants were included in this study. We used logistic regressions to study being "not at all in favor" to vaccination in general, and being "certainly not willing to get vaccinated against Covid-19. Our analysis highlighted a gendered reluctance toward vaccination in general but even more so regarding vaccination against COVID-19 (OR = 1.88 (95% CI: 1.79-1.97)). We also found that people at the bottom of the social hierarchy, in terms of level of education, financial resources, were more likely to refuse the COVID-19 vaccine (from OR = 1.22 (95% CI:1.10-1.35) for respondents without diploma to OR = 0.52 (95% CI:0.47-0.57) for High school +5 or more years level). People from the French overseas departments, immigrants and descendants of immigrants, were all more reluctant to the Covid-19 vaccine (first-generation Africa/Asia immigrants OR = 1.16 (95% CI:1.04-1.30)) versus OR = 2.19 (95% CI:1.96-2.43) for the majority population). Finally, our analysis showed that those who reported not trusting the government were more likely to be Covid-19 vaccine-reluctant (OR = 3.29 (95% CI: 3.13-3.45)). Specific campaigns should be thought beforehand to reach women and people at the bottom of the social hierarchy to avoid furthering social inequalities in terms of morbidity and mortality.	[Bajos, Nathalie; Spire, Alexis; Silberzan, Lena] INSERM, IRIS, EHESS, CNRS, Aubervilliers, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bajos, N (corresponding author), INSERM, IRIS, EHESS, CNRS, Aubervilliers, France.	nathalie.bajos@inserm.fr	Bajos, Nathalie/M-4170-2018	Bajos, Nathalie/0000-0001-8073-9056; Spire, Alexis/0000-0002-2589-9804; , Lena Silberzan/0000-0002-3482-1128	European Research Council (ERC) under the European Union [856478]	European Research Council (ERC) under the European Union(European Research Council (ERC))	NB has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No. [856478]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, FRANCE 24; Bajos N., 2020, PUBLIC GLOBAL HLTH, DOI [10.1101/2020.10.07.20208595, DOI 10.1101/2020.10.07.20208595]; Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; Benet T., 2021, COVIPREV; Bergeron H., 2020, COVID 19 CRISE ORGAN, DOI [10.3917/scpo.berge.2020.01, DOI 10.3917/SCPO.BERGE.2020.01]; Bryden GM, 2018, VACCINE, V36, P1227, DOI 10.1016/j.vaccine.2017.12.068; Byrne T, 2021, VACCINE, V39, P7108, DOI 10.1016/j.vaccine.2021.09.066; Callaghan T, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2020.113638; Conis E, 2013, B HIST MED, V87, P407, DOI 10.1353/bhm.2013.0047; Connor J, 2020, SOC SCI MED, V266, DOI 10.1016/j.socscimed.2020.113364; Davidson DJ, 1996, ENVIRON BEHAV, V28, P302, DOI 10.1177/0013916596283003; Dubbin LA, 2013, SOC SCI MED, V93, P113, DOI 10.1016/j.socscimed.2013.06.014; Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212; Gengler AM, 2014, J HEALTH SOC BEHAV, V55, P342, DOI 10.1177/0022146514544172; Hacquin A-S., 2020, PSYARXIV, DOI [10.31234/osf.io/r8h6z, DOI 10.31234/OSF.IO/R8H6Z]; Hsu HE, 2020, MMWR-MORBID MORTAL W, V69, P864, DOI 10.15585/mmwr.mm6927a3; Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812; J. WARSZAWSKI, 2021, medRxiv, DOI 10.1101/2021.02.24.21252316; Kazemian S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254127; Kricorian K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256122; Lachenal G., 2014, MEDICAMENT QUI DEVAI; Larson H, 2018, STATE VACCINE CONFID, V10, DOI DOI 10.2875/241099; Latkin CA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246970; Lin C, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010016; Loomba S, 2021, NAT HUM BEHAV, V5, P337, DOI 10.1038/s41562-021-01056-1; Lunz Trujillo K, US NEWS WORLD REP; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Maxfield S, 2010, GEND MANAG, V25, P586, DOI 10.1108/17542411011081383; Meleis AI, 2016, J WOMENS HEALTH, V25, P329, DOI 10.1089/jwh.2015.5717; Milner A, 2020, LANCET PUBLIC HEALTH, V5, pE419, DOI 10.1016/S2468-2667(20)30162-6; Peretti-Watel P, 2020, LANCET INFECT DIS, V20, P769, DOI 10.1016/S1473-3099(20)30426-6; Peretti-Watel Patrick, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289; Pogue K, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040582; Reich JA, 2014, GENDER SOC, V28, P679, DOI 10.1177/0891243214532711; Robertson E, 2021, BRAIN BEHAV IMMUN, V94, P41, DOI 10.1016/j.bbi.2021.03.008; Roederer T, 2021, LANCET PUBLIC HEALTH, V6, pE202, DOI 10.1016/S2468-2667(21)00001-3; Schwarzinger M, 2021, LANCET PUBLIC HEALTH, V6, pE210, DOI 10.1016/S2468-2667(21)00012-8; Siegrist M, 2000, RISK ANAL, V20, P195, DOI 10.1111/0272-4332.202020; Singh-Manoux A, 2005, SOC SCI MED, V60, P2129, DOI 10.1016/j.socscimed.2004.08.070; Smith N, 2019, INFORM COMMUN SOC, V22, P1310, DOI 10.1080/1369118X.2017.1418406; Wachtler Benjamin, 2020, J Health Monit, V5, P3, DOI 10.25646/7059; Ward JK, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113414; Ward JK, 2019, NAT IMMUNOL, V20, P1257, DOI 10.1038/s41590-019-0488-9; Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8; Zintel S., 2021, SSRN ELECT J, DOI [10.2139/ssrn.3803323, DOI 10.2139/SSRN.3803323]	45	11	11	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262192	10.1371/journal.pone.0262192	http://dx.doi.org/10.1371/journal.pone.0262192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990482	Green Published, Green Submitted, gold			2022-12-27	WOS:000815783800019
J	Cerrejon, C; Valeria, O; Munoz, J; Fenton, NJ				Cerrejon, Carlos; Valeria, Osvaldo; Munoz, Jesus; Fenton, Nicole J.			Small but visible: Predicting rare bryophyte distribution and richness patterns using remote sensing-based ensembles of small models	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ECOSYSTEM BASED MANAGEMENT; FOREST MANAGEMENT; BOREAL FOREST; GAP ANALYSIS; SAMPLE-SIZE; DIVERSITY; MIXEDWOOD; CLIMATE; MOSS	In Canadian boreal forests, bryophytes represent an essential component of biodiversity and play a significant role in ecosystem functioning. Despite their ecological importance and sensitivity to disturbances, bryophytes are overlooked in conservation strategies due to knowledge gaps on their distribution, which is known as the Wallacean shortfall. Rare species deserve priority attention in conservation as they are at a high risk of extinction. This study aims to elaborate predictive models of rare bryophyte species in Canadian boreal forests using remote sensing-derived predictors in an Ensemble of Small Models (ESMs) framework. We hypothesize that high ESMs-based prediction accuracy can be achieved for rare bryophyte species despite their low number of occurrences. We also assess if there is a spatial correspondence between rare and overall bryophyte richness patterns. The study area is located in western Quebec and covers 72,292 km(2). We selected 52 bryophyte species with <30 occurrences from a presence-only database (214 species, 389 plots in total). ESMs were built from Random Forest and Maxent techniques using remote sensing-derived predictors related to topography and vegetation. Lee's L statistic was used to assess and map the spatial relationship between rare and overall bryophyte richness patterns. ESMs yielded poor to excellent prediction accuracy (AUC > 0.5) for 73% of the modeled species, with AUC values > 0.8 for 19 species, which confirmed our hypothesis. In fact, ESMs provided better predictions for the rarest bryophytes. Likewise, our study revealed a spatial concordance between rare and overall bryophyte richness patterns in different regions of the study area, which have important implications for conservation planning. This study demon-strates the potential of remote sensing for assessing and making predictions on inconspicuous and rare species across the landscape and lays the basis for the eventual inclusion of bryophytes into sustainable development planning.	[Cerrejon, Carlos; Valeria, Osvaldo; Fenton, Nicole J.] Univ Quebec Abitibi Temiscamingue, Inst Rech Sur Forets, Boul Univ, Rouyn Noranda, PQ, Canada; [Valeria, Osvaldo] Univ Mayor, Fac Ciencias, Hemera Ctr Observac Tierra, Santiago, Chile; [Munoz, Jesus] Real Jardin Bot RJB CSIC, Madrid, Spain	University of Quebec; University Quebec Abitibi-Temiscamingue; Universidad Mayor; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Cerrejon, C (corresponding author), Univ Quebec Abitibi Temiscamingue, Inst Rech Sur Forets, Boul Univ, Rouyn Noranda, PQ, Canada.	carlos.cerrejonlozano@uqat.ca			Environmental Damages Fund, Environment and Climate Change Canada	Environmental Damages Fund, Environment and Climate Change Canada	This research was funded by Environmental Damages Fund, Environment and Climate Change Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Amirkhiz RG, 2021, LANDSCAPE ECOL, V36, P1039, DOI 10.1007/s10980-021-01217-7; Austin M.P., 1986, P45; Barbe M, 2017, CAN FIELD NAT, V131, P258, DOI 10.22621/cfn.v131i3.1901; Barbe M, 2017, BIODIVERS CONSERV, V26, P943, DOI 10.1007/s10531-016-1281-9; Bartels SF, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00858; Bennie J, 2008, ECOL MODEL, V216, P47, DOI 10.1016/j.ecolmodel.2008.04.010; Bergeron Y, 2004, ECOLOGY, V85, P1916, DOI 10.1890/02-0716; Bergeron Y, 2007, FOREST CHRON, V83, P326, DOI 10.5558/tfc83326-3; Bivand RS, 2015, J STAT SOFTW, V63, P1; Bond-Lamberty B, 2007, OECOLOGIA, V151, P584, DOI 10.1007/s00442-006-0619-5; Boudreault C, 2002, CAN J FOREST RES, V32, P1080, DOI [10.1139/x02-027, 10.1139/X02-027]; Boudreault C, 2018, CAN J FOREST RES, V48, P821, DOI 10.1139/cjfr-2017-0352; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiner FT, 2015, METHODS ECOL EVOL, V6, P1210, DOI 10.1111/2041-210X.12403; Caners RT, 2013, FOREST ECOL MANAG, V289, P489, DOI 10.1016/j.foreco.2012.09.044; Castonguay J., 2016, THESIS U QUEBEC MONT; Cerrejon C., 2021, MENDELEY DATA, VV3, DOI 10.17632/9mtcx3jnxz.3; Cerrejon C, 2021, DIVERS DISTRIB, V27, P948, DOI 10.1111/ddi.13244; Cerrejon C, 2020, ECOL INDIC, V119, DOI 10.1016/j.ecolind.2020.106826; Chaieb C, 2015, FORESTS, V6, P1195, DOI 10.3390/f6041195; Chefaoui RM, 2011, ANIM BIODIV CONSERV, V34, P229; climate weather, 2010, ENV CANADA; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cole HA, 2008, CAN J FOREST RES, V38, P1867, DOI 10.1139/X08-036; Couvreur JM, 2016, INT J AGRON, V2016, DOI 10.1155/2016/5365412; Delso A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91651-z; Dimiceli C., 2015, NASA EOSDIS LAND PRO, DOI [10.5067/MODIS/MOD44B.006., DOI 10.5067/MODIS/MOD44B.006, 10.5067/MODIS/ MOD44B.006.]; ESRI (Environmental Systems Research Institute), 2016, ARCGIS DESKT 10 5; Faubert J., 2011, CARNETS BRYOL, V1, P29; Faubert J., 2010, BRYOPHYTES RARES QU; Faubert J., 2012, ESP CES PRIORITAIRES, V2, P53; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P882, DOI 10.1016/j.patrec.2005.10.012; Ficken CD, 2019, SCI TOTAL ENVIRON, V693, DOI 10.1016/j.scitotenv.2019.133647; Franch B, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11060632; Frego KA, 2007, FOREST ECOL MANAG, V242, P65, DOI 10.1016/j.foreco.2007.01.030; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Gignac LD, 2001, BRYOLOGIST, V104, P410, DOI 10.1639/0007-2745(2001)104[0410:BAIOCC]2.0.CO;2; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; He KS, 2015, REMOTE SENS ECOL CON, V1, P4, DOI 10.1002/rse2.7; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hespanhol H, 2015, ECOL EVOL, V5, P5443, DOI 10.1002/ece3.1796; Hespanhol H, 2011, PLANT ECOL DIVERS, V4, P251, DOI 10.1080/17550874.2011.616546; Hijmans R.J., 2020, RASTER GEOGRAPHIC DA; Hortal J, 2015, ANNU REV ECOL EVOL S, V46, P523, DOI 10.1146/annurev-ecolsys-112414-054400; Hylander K, 2002, ECOL APPL, V12, P797, DOI 10.1890/1051-0761(2002)012[0797:EBSABS]2.0.CO;2; Jiang YB, 2014, ECOL INDIC, V38, P72, DOI 10.1016/j.ecolind.2013.10.024; Jiang YB, 2013, J VEG SCI, V24, P214, DOI 10.1111/j.1654-1103.2012.01453.x; Jiang ZY, 2007, PROC SPIE, V6679, DOI 10.1117/12.734933; Lawler JJ, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P271, DOI 10.1007/978-1-4419-7390-0_14; Lee S.I., 2001, J GEOGR SYST, V15, P369, DOI [10.1007/s101090100064, DOI 10.1007/S101090100064]; Lomba A, 2010, BIOL CONSERV, V143, P2647, DOI 10.1016/j.biocon.2010.07.007; Mansuy N, 2018, GEODERMA REG, V15, DOI 10.1016/j.geodrs.2018.e00194; MARGULES CR, 1989, BIOL CONSERV, V50, P219, DOI 10.1016/0006-3207(89)90011-6; Mateo RG, 2016, SCI REP-UK, V6, DOI 10.1038/srep25546; Mateo RG, 2011, REV CHIL HIST NAT, V84, P217, DOI 10.4067/S0716-078X2011000200008; McCune JL, 2020, ECOL EVOL, V10, P5001, DOI 10.1002/ece3.6254; Mols T, 2013, BIODIVERS CONSERV, V22, P1537, DOI 10.1007/s10531-013-0492-6; Moreira EF, 2017, BIOTA NEOTROP, V17, DOI [10.1590/1676-0611-BN-2016-0294, 10.1590/1676-0611-bn-2016-0294]; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Natural Resources Canada, 2017, STAT CAN FOR ANN REP; Newmaster SG, 2005, DIVERS DISTRIB, V11, P57, DOI 10.1111/j.1366-9516.2005.00123.x; Newmaster SG, 2002, CAN J FOREST RES, V32, P38, DOI 10.1139/x01-163; Pearce J, 1998, RESTOR ECOL, V6, P238, DOI 10.1046/j.1526-100X.1998.00636.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pocs Tamas, 1996, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Botanica, V67, P109; Pouteau R, 2012, ECOL INFORM, V9, P37, DOI 10.1016/j.ecoinf.2012.03.003; Prendergast JR, 1999, CONSERV BIOL, V13, P484, DOI 10.1046/j.1523-1739.1999.97428.x; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; R Core Team, 2021, R LANG ENV STAT COMP; Raabe S, 2010, FOREST ECOL MANAG, V260, P1956, DOI 10.1016/j.foreco.2010.08.042; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rowntree JK, 2011, IN VITRO CELL DEV-PL, V47, P55, DOI 10.1007/s11627-010-9326-3; Roy PS, 1996, J BIOSCIENCES, V21, P723, DOI 10.1007/BF02703148; Saatchi S, 2008, REMOTE SENS ENVIRON, V112, P2000, DOI 10.1016/j.rse.2008.01.008; Saucier J., 2003, ZONES VEGETATION DOM; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Sousa-Silva R, 2014, GLOB ECOL CONSERV, V2, P226, DOI 10.1016/j.gecco.2014.09.011; Spiers JA, 2018, BIODIVERS CONSERV, V27, P2931, DOI 10.1007/s10531-018-1578-y; Syfert MM, 2014, BIOL CONSERV, V177, P174, DOI 10.1016/j.biocon.2014.06.012; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W., 2020, R PACKAGE VERSION 34; Turetsky MR, 2012, NEW PHYTOL, V196, P49, DOI 10.1111/j.1469-8137.2012.04254.x; Turetsky MR, 2003, BRYOLOGIST, V106, P395, DOI 10.1639/05; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Usher M.B., 1986, P3; Vanderpoorten A., 2009, BRYOPHYTE BIOL, P487, DOI DOI 10.1017/CBO9780511754807.013; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Vellak K, 2005, BIODIVERS CONSERV, V14, P3255, DOI 10.1007/s10531-004-0445-1; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zhang P., 2019, THESIS UTRECHT U; Zimmermann NE, 2007, J APPL ECOL, V44, P1057, DOI 10.1111/j.1365-2664.2007.01348.x	102	0	0	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0260543	10.1371/journal.pone.0260543	http://dx.doi.org/10.1371/journal.pone.0260543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990454	Green Published, gold			2022-12-27	WOS:000815783800004
J	Souza, MLF; de Sousa, JV; Guerreiro, JF				Ferreira Souza Junior, Mauro Lucio; de Sousa, Jaime Viana; Guerreiro, Joao Farias			Analysis of coding variants in the human FTO gene from the gnomAD database	PLOS ONE			English	Article							OBESITY; ASSOCIATION; CHILDHOOD	Single nucleotide polymorphisms (SNPs) in the first intron of the FTO gene reported in 2007 continue to be the known variants with the greatest effect on adiposity in different human populations. Coding variants in the FTO gene, on the other hand, have been little explored, although data from complete sequencing of the exomes of various populations are available in public databases and provide an excellent opportunity to investigate potential functional variants in FTO. In this context, this study aimed to track nonsynonymous variants in the exons of the FTO gene in different population groups employing the gnomAD database and analyze the potential functional impact of these variants on the FTO protein using five publicly available pathogenicity prediction programs. The findings revealed 345 rare mutations, of which 321 are missense (93%), 19 are stop gained (5.6%) and five mutations are located in the splice region (1.4%). Of these, 134 (38.8%) were classified as pathogenic, 144 (41.7%) as benign and 67 (19.5%) as unknown. The available data, however, suggest that these variants are probably not associated with BMI and obesity, but instead, with other diseases. Functional studies are, therefore, required to identify the role of these variants in disease genesis.	[Ferreira Souza Junior, Mauro Lucio; Guerreiro, Joao Farias] Fed Univ Para, Inst Biol Sci, Lab Human & Med Genet, Belem, Para, Brazil; [de Sousa, Jaime Viana] Fed Rural Univ Amazon, Capanema Campus, Capanema, PA, Brazil	Universidade Federal do Para	Guerreiro, JF (corresponding author), Fed Univ Para, Inst Biol Sci, Lab Human & Med Genet, Belem, Para, Brazil.	joao.guerreiro53@gmail.com		Guerreiro, Joao/0000-0003-1979-3656; Souza, Mauro Lucio/0000-0002-4161-0281	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [88887.465295/2019-00, 001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study received support from Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior 001, Process Number: 88887.465295/2019-00 (awarded to MLFSJ). No additional external funding was received.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Almen MS, 2013, INT J OBESITY, V37, P424, DOI 10.1038/ijo.2012.57; [Anonymous], 2020, AM J MED GENET A, V182, P1999, DOI 10.1002/ajmg.a.61819; Araujo GS, 2016, BIOINFORMATICS, V32, P1247, DOI 10.1093/bioinformatics/btv708; Babenko V, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-019-0491-x; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Caglayan AO, 2016, J HUM GENET, V61, P395, DOI 10.1038/jhg.2015.160; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Deliard S, 2013, OBESITY, V21, P159, DOI 10.1002/oby.20147; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kim HS, 2017, GUT, V66, P1926, DOI 10.1136/gutjnl-2016-311921; Kolackov K, 2016, ADV CLIN EXP MED, V25, P33, DOI 10.17219/acem/60645; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landfors M, 2016, FERTIL STERIL, V105, P1170, DOI 10.1016/j.fertnstert.2016.01.002; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Mao LY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4262-9; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Pshennikova Vera G, 2019, ScientificWorldJournal, V2019, P5198931, DOI 10.1155/2019/5198931; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Rohena L, 2016, AM J MED GENET A, V170, P1023, DOI 10.1002/ajmg.a.37515; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Walters-Sen LC, 2015, MOL GENET GENOM MED, V3, P99, DOI 10.1002/mgg3.116; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Zheng ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067039	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0248610	10.1371/journal.pone.0248610	http://dx.doi.org/10.1371/journal.pone.0248610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990463	gold, Green Published			2022-12-27	WOS:000815783800001
J	Jiang, W; Qi, X				Jiang, Wen; Qi, Xian			Pricing and assembly rate decisions for a prefabricated construction supply chain under subsidy policies	PLOS ONE			English	Article							CHINA; COORDINATION; MANAGEMENT; EMISSIONS; CONSUMERS; BARRIERS; DESIGN; URBAN; COST	Prefabricated construction has attracted worldwide concern and promotion due to its environmental friendliness, high quality, and high efficiency. In China, the application of prefabricated construction still lags due to its high cost. To improve prefabricated construction development, the Chinese government and provinces have launched subsidy policies for different objects that offer subsidies to the assembler, the manufacturer, or consumers. Subsidy policies for different subsidy objects have different impacts on the manufacturer wholesale price and assembler retail price and assembly rate and make their decisions more complicated. Therefore, this study uses game theory and builds three models to analyze the effects of government subsidies on manufacturer pricing, assembler pricing, assembly rate decisions, and profit. We find that government subsidy policies can bring more profit to prefabricated construction enterprises, reduce their costs, and benefit the promotion of prefabricated construction. Through comparison and numerical analysis, we also find that when the government subsidizes enterprises more, it is better to subsidize the assembler, because it is good for all three parties. First, consumers can obtain a lower retail price. Second, enterprises can obtain more profits. Finally, for the government, this approach can increase the demand for prefabricated construction and increase the assembly rate, which is conducive to the promotion of prefabricated construction. When the government subsidizes customers more, it is better for the assembler and the manufacturer to subsidize customers, because they can obtain more profits. It is better for the government and customers to subsidize the assembler or the manufacture, because consumers can get the lower retail price. Although the assembly rate and enterprises' profits are not optimal, they have also been improved. In addition, when the government directly subsidizes enterprises, the enterprises will actively cooperate with the subsidy policy and are more willing to adopt prefabricated construction. This approach will benefit the promotion of prefabricated construction.	[Jiang, Wen; Qi, Xian] Sichuan Agr Univ, Coll Architecture & Urban Rural Planning, Chengdu, Peoples R China	Sichuan Agricultural University	Jiang, W (corresponding author), Sichuan Agr Univ, Coll Architecture & Urban Rural Planning, Chengdu, Peoples R China.	xuezhongsha_wen@163.com		Jiang, Wen/0000-0001-6495-4215	Youth Foundation for Humanities and Social Sciences of Ministry of Education of China [19YJC630063]; Department of Science and Technology of Sichuan Province of China [2020YJ0365]; National Natural Science Foundation of China [71972136]; Social Science Special Project of Sichuan Agricultural University [2019PTYB08]	Youth Foundation for Humanities and Social Sciences of Ministry of Education of China; Department of Science and Technology of Sichuan Province of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Science Special Project of Sichuan Agricultural University	W. J. is sponsored by Youth Foundation for Humanities and Social Sciences of Ministry of Education of China (No.19YJC630063; Website: http://www.moe.gov.cn/), Department of Science and Technology of Sichuan Province of China (No.2020YJ0365; Website: http://kjt.sc.gov.cn/), National Natural Science Foundation of China (No.71972136; Website: http://www.nsfc.gov.cn/) and Social Science Special Project of Sichuan Agricultural University (No.2019PTYB08; Website: https://www.sicau.edu.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloini D, 2012, BUS PROCESS MANAG J, V18, P735, DOI 10.1108/14637151211270135; [Anonymous], 2020, ARCHITECTURE, P21; Aye L, 2012, ENERG BUILDINGS, V47, P159, DOI 10.1016/j.enbuild.2011.11.049; Baldwin A, 2009, RENEW ENERG, V34, P2067, DOI 10.1016/j.renene.2009.02.008; Butkovi L L, 2016, OFEL 2016 4 INT OFEL; Chen X, 2017, TRANSPORT RES E-LOG, V97, P268, DOI 10.1016/j.tre.2016.11.007; China Survey and Design Magazine, 2019, SUBS POL PREF CONSTR; Ding ZK, 2018, J CLEAN PROD, V176, P676, DOI 10.1016/j.jclepro.2017.12.101; Dou YD, 2019, J CLEAN PROD, V241, DOI 10.1016/j.jclepro.2019.118353; European Commission, 2019, FACTSH EN PERF CONST; Fan JL, 2015, ENERG BUILDINGS, V96, P201, DOI 10.1016/j.enbuild.2015.03.026; Ganzhou Municipal People's Government, 2021, NOT HAND HOUS PROV F; General Office of the State Council of the People's Republic of China, 2016, GUID GEN OFF STAT CO; Ghani NMAMA, 2018, ENERG POLICY, V116, P39, DOI 10.1016/j.enpol.2018.01.042; Goswein V, 2020, J IND ECOL, V24, DOI 10.1111/jiec.12916; Han YH, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9112069; Hong JK, 2018, J CLEAN PROD, V172, P649, DOI 10.1016/j.jclepro.2017.10.171; Hwang BG, 2018, J CLEAN PROD, V183, P183, DOI 10.1016/j.jclepro.2018.02.136; Jaillon L, 2008, CONSTR MANAG ECON, V26, P953, DOI 10.1080/01446190802259043; Jeong J, 2017, J CLEAN PROD, V142, P2393, DOI 10.1016/j.jclepro.2016.11.035; Jiang W, 2020, MATH PROBL ENG, V2020, DOI 10.1155/2020/3849561; Johnson W., 2007, UCL; Laroche M, 2001, J CONSUM MARK, V18, P503, DOI 10.1108/EUM0000000006155; Latruffe L, 2017, AM J AGR ECON, V99, P783, DOI 10.1093/ajae/aaw077; Li XZ, 2018, ENG ECON, V28, P57; Liu BY, 2015, INT J PROD RES, V53, P532, DOI 10.1080/00207543.2014.957875; Liu QR, 2015, ADV INTELL SYST, V362, P245, DOI 10.1007/978-3-662-47241-5_20; Liu Y, 2019, J CLEAN PROD, V208, P436, DOI 10.1016/j.jclepro.2018.10.121; Meng QF, 2021, SUSTAIN PROD CONSUMP, V26, P1021, DOI 10.1016/j.spc.2021.01.012; Morrissey J, 2011, ENERG BUILDINGS, V43, P915, DOI 10.1016/j.enbuild.2010.12.013; O'Brien W.J., 2004, ICFAI J OPER MANAG, V3, P64; Office of Quanzhou Municipal Governmentm, 2020, QUANZH MUN PEOPL GOV; Qiang D, 2020, J CLEAN PROD, V280; Rahman MM, 2014, J MANAGE ENG, V30, P69, DOI 10.1061/(ASCE)ME.1943-5479.0000173; RezaHoseini A, 2021, AUTOMAT CONSTR, V122, DOI 10.1016/j.autcon.2020.103485; Rma B, 2020, SUSTAIN CITIES SOC, V64; Shanghai Construction Trade Association, 2020, NOTIC ISS SPEC SUPP; Steinhardt DA., 2013, BUILDING CONSTRUCTIO; Su C, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12062281; Wang SL, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/4580651; Wang T, 2018, J CLEAN PROD, V205, P552, DOI 10.1016/j.jclepro.2018.09.127; Wang YZ, 2021, CELL MOL IMMUNOL, V18, P1032, DOI 10.1038/s41423-020-0431-x; Wu GB, 2019, J CLEAN PROD, V219, P753, DOI 10.1016/j.jclepro.2019.02.110; Wu HJ, 2019, J CLEAN PROD, V226, P550, DOI 10.1016/j.jclepro.2019.04.066; Xue J, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11082209; Xue XL, 2007, LECT NOTES COMPUT SC, V4674, P290; Xue XL, 2005, AUTOMAT CONSTR, V14, P413, DOI 10.1016/j.autcon.2004.08.010; Yang HX, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/4062871; Ying LC, 2018, J CIV ENG MANAG, V35, P155; Zhuo H., 2017, GAMING GREEN SUPPLY, P245	50	0	0	13	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261896	10.1371/journal.pone.0261896	http://dx.doi.org/10.1371/journal.pone.0261896			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990462	Green Published, gold			2022-12-27	WOS:000815783800013
J	Bashar, F; Islam, R; Khan, SM; Hossain, S; Sikder, AAS; Yusuf, SS; Adams, AM				Bashar, Farzana; Islam, Rubana; Khan, Shaan Muberra; Hossain, Shahed; Sikder, Adel A. S.; Yusuf, Sifat Shahana; Adams, Alayne M.			Making doctors stay: Rethinking doctor retention policy in a contracted-out primary healthcare setting in urban Bangladesh	PLOS ONE			English	Article							SECTOR	Background "Contracting Out" is a popular strategy to expand coverage and utilization of health services. Bangladesh began contracting out primary healthcare services to NGOs in urban areas through the Urban Primary Health Care Project (UPHCP) in 1998. Over the three phases of this project, retention of trained and skilled human resources, especially doctors, proved to be an intractable challenge. This paper highlights the issues influencing doctor's retention both in managerial as well as service provision level in the contracted-out setting. Methodology In this qualitative study, 42 Key Informant Interviews were undertaken with individuals involved with UPHCP in various levels including relevant ministries, project personnel representing the City Corporations and municipalities, NGO managers and doctors. Verbatim transcripts were coded in ATLAS.ti and analyzed using the thematic analysis. Document review was done for data triangulation. Results The most cited problem was a low salary structure in contrast to public sector pay scale followed by a dearth of other financial incentives such as performance-based incentives, provident funds and gratuities. Lack of career ladder, for those in both managerial and service delivery roles, was also identified as a factor hindering staff retention. Other disincentives included inadequate opportunities for training to improve clinical skills, ineffective staffing arrangements, security issues during night shifts, abuse from community members in the context of critical patient management, and lack of job security after project completion. Conclusions An adequate, efficient and dedicated health workforce is a pre-requisite for quality service provision and patient utilization of these services. Improved career development opportunities, the provision of salaries and incentives, and a safer working environment are necessary actions to retain and motivate those serving in managerial and service delivery positions in contracting out arrangements.	[Bashar, Farzana; Khan, Shaan Muberra; Hossain, Shahed; Yusuf, Sifat Shahana] Int Ctr Diarrheal Dis Res Bangladesh Icddr B, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Islam, Rubana] Univ New South Wales, Sch Populat Hlth, Sydney, NSW, Australia; [Sikder, Adel A. S.] Int Ctr Diarrheal Dis Res Bangladesh Icddr B, Div Infect Dis, Dhaka, Bangladesh; [Adams, Alayne M.] McGill Univ, Dept Family Med, Fac Med & Hlth Sci, Montreal, PQ, Canada	International Centre for Diarrhoeal Disease Research (ICDDR); University of New South Wales Sydney; International Centre for Diarrhoeal Disease Research (ICDDR); McGill University	Bashar, F (corresponding author), Int Ctr Diarrheal Dis Res Bangladesh Icddr B, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh.	jaimemgcc16@gmail.com	Hossain, Shahed/HDN-7819-2022	Sikder Adel, Ahammad Shafiq/0000-0002-3765-5153; Yusuf, Salim/0000-0003-4776-5601; Adams, Alayne/0000-0002-0961-9825; Bashar, Farzana/0000-0003-3751-8164	Alliance for Health Policy and Systems Research	Alliance for Health Policy and Systems Research	This study was funded by The Alliance for Health Policy and Systems Research,. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2015, HEALTH POLICY PLANN, V30, pi32, DOI 10.1093/heapol/czu094; Ahmed SM, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-3; Almeida N, 2011, LANCET, V377, P1898, DOI 10.1016/S0140-6736(11)60326-7; Aluttis C, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23611; Angeles G, 2019, J URBAN HEALTH, V96, P193, DOI 10.1007/s11524-018-0307-x; Bhattacharya I, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0055-x; Campbell J, 2013, B WORLD HEALTH ORGAN, V91, P853, DOI 10.2471/BLT.13.118729; Chhea C, 2010, RURAL REMOTE HEALTH, V10; Cockcroft A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-S2-S8; Darkwa EK, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1012-z; Dayrit Manuel M, 2011, Rev Peru Med Exp Salud Publica, V28, P327; Efendi F, 2018, GSTF J BIOSCIENCES J, V2; El-Saharty S, 2015, PATH UNIVERSAL HLTH; Gesesew HA, 2016, ETHIOP J HEALTH SCI, V26, P331, DOI 10.4314/ejhs.v26i4.5; Guilbert JJ, 2006, EDUC HEALTH, V19, P385, DOI 10.1080/13576280600937911; Hasan Md Imran, 2018, BMC Res Notes, V11, P702, DOI 10.1186/s13104-018-3795-6; Henderson LN, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-18; Ireland M, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0101-3; Islam R, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0805-1; Jimba M, 2010, 1 GLOB S HLTH SYST R; Kamal N, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0311-2; Kollar Eszter, 2013, Swiss Med Wkly, V143, pw13845, DOI 10.4414/smw.2013.13845; Kroezen M, 2015, HEALTH POLICY, V119, P1517, DOI 10.1016/j.healthpol.2015.08.003; Kumaresan JA, 2000, INT J TUBERC LUNG D, V4, P615; Liu X., 2004, CONTRACTING PRIMARY; Lopes SC, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0195-2; Mureithi L, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0830-0; Nabyonga-Orem J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0639-5; Osman FA, 2009, ASIA PAC DEV J, V16, P27; Rawal LB, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0030-6; Roy L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187238; Russell DJ, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-65; Sbarouni V, 2012, RURAL REMOTE HEALTH, V12; Shafique S, 2018, BMC MED ETHICS, V19, DOI 10.1186/s12910-018-0285-2; SHI LY, 1995, J ROY SOC MED, V88, P428; WALT G, 1994, HEALTH POLICY PLANN, V9, P353, DOI 10.1093/heapol/9.4.353; WHO, 2010, MONITORING BUILDING; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; World Health Organization (WHO), 2016, GLOB STRAT HUM RES H	39	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262358	10.1371/journal.pone.0262358	http://dx.doi.org/10.1371/journal.pone.0262358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZO8DB	34986200	gold, Green Published			2022-12-27	WOS:000765956200047
J	Gray, AD; Bernhardt, E				Gray, Austin D.; Bernhardt, Emily			Are nitrogen and carbon cycle processes impacted by common stream antibiotics? A comparative assessment of single vs. mixture exposures	PLOS ONE			English	Article							WASTE-WATER CONTAMINANTS; MICROBIAL RESPIRATION; UNITED-STATES; PHARMACEUTICALS; GENE; RESTORATION; REDUCTASE; DENITRIFICATION; SUSCEPTIBILITY; ANTIMICROBIALS	A variety of antibiotics are ubiquitous in all freshwater ecosystems that receive wastewater. A wide variety of antibiotics have been developed to kill problematic bacteria and fungi through targeted application, and their use has contributed significantly to public health and livestock management. Unfortunately, a substantial fraction of the antibiotics applied to humans, pets and livestock end up in wastewater, and ultimately many of these chemicals enter freshwater ecosystems. The effect of adding chemicals that are intentionally designed to kill microbes, on freshwater microbial communities remains poorly understood. There are reasons to be concerned, as microbes play an essential role in nutrient uptake, carbon fixation and denitrification in freshwater ecosystems. Chemicals that reduce or alter freshwater microbial communities might reduce their capacity to degrade the excess nutrients and organic matter that characterize wastewater. We performed a laboratory experiment in which we exposed microbial community from unexposed stream sediments to three commonly detected antibiotics found in urban wastewater and urban streams (sulfamethoxazole, danofloxacin, and erythromycin). We assessed how the form and concentration of inorganic nitrogen, microbial carbon, and nitrogen cycling processes changed in response to environmentally relevant doses (10 mu g/ L) of each of these antibiotics individually and in combination. We expected to find that all antibiotics suppressed rates of microbial mineralization and nitrogen transformations and we anticipated that this suppression of microbial activity would be greatest in the combined treatment. Contrary to our expectations we measured few significant changes in microbially mediated functions in response to our experimental antibiotic dosing. We found no difference in functional gene abundance of key nitrogen cycling genes nosZ, mcrA, nirK, and amoA genes, and we measured no treatment effects on NO3- uptake or N2O, N-2, CH4, CO2 production over the course of our seven-day experiment. In the mixture treatment, we measured significant increases in NH4+ concentrations over the first 24 hours of the experiment, which were indistinguishable from controls within six hours. Our results suggest remarkable community resistance to pressure antibiotic exposure poses on naive stream sediments.	[Gray, Austin D.] Univ North Carolina Greensboro, Dept Biol, Greensboro, NC 27412 USA; [Gray, Austin D.; Bernhardt, Emily] Duke Univ, Dept Biol, French Sci Ctr, Durham, NC 27706 USA; [Gray, Austin D.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	University of North Carolina; University of North Carolina Greensboro; Duke University; Virginia Polytechnic Institute & State University	Gray, AD (corresponding author), Univ North Carolina Greensboro, Dept Biol, Greensboro, NC 27412 USA.; Gray, AD (corresponding author), Duke Univ, Dept Biol, French Sci Ctr, Durham, NC 27706 USA.; Gray, AD (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA.	austindg@vt.edu	Gray, Austin/HDM-0092-2022; Bernhardt, Emily S/D-9940-2011; Gray, Austin/GSN-9971-2022	Gray, Austin/0000-0002-6090-6328; Bernhardt, Emily S/0000-0003-3031-621X; 	Society of Environmental Toxicology and Chemistry Student Training Exchange Opportunity Award or (STEO); North Carolina Sea Grant	Society of Environmental Toxicology and Chemistry Student Training Exchange Opportunity Award or (STEO); North Carolina Sea Grant	AG Society of Environmental Toxicology and Chemistry Student Training Exchange Opportunity Award or (STEO) https://awards.setac.org/student-training-exchange-opportunity/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was also supported by North Carolina Sea Grant.	Al-Odaini NA, 2013, INT J ENVIRON AN CH, V93, P245, DOI 10.1080/03067319.2011.592949; Angle JC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01753-4; [Anonymous], 2004, USEPA REP C IMP CONT; Ashfaq M, 2020, ADV ENV POLL RES, V1, P331, DOI 10.1016/B978-0-12-818882-8.00021-8; Baran W, 2011, J HAZARD MATER, V196, P1, DOI 10.1016/j.jhazmat.2011.08.082; Barnes KK, 2008, SCI TOTAL ENVIRON, V402, P192, DOI 10.1016/j.scitotenv.2008.04.028; Bernhardt ES, 2017, FRONT ECOL ENVIRON, V15, P84, DOI 10.1002/fee.1450; Blaszczak JR, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2318; Brigham J. S, 2018, THESIS U N CAROLINA; Bunch AR, 2011, ECOTOXICOLOGY, V20, P97, DOI 10.1007/s10646-010-0560-6; Carreira C, 2018, PEERJ, V6, DOI 10.7717/peerj.5603; Chen Z, 2007, AQUAT TOXICOL, V81, P256, DOI 10.1016/j.aquatox.2006.12.008; Conkle JL, 2012, J ENVIRON SCI HEAL A, V47, P1381, DOI 10.1080/10934529.2012.672315; Cordova-Kreylos AL, 2007, ISME J, V1, P585, DOI 10.1038/ismej.2007.71; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; DeVries SL, 2016, CURR POLLUT REP, V2, P51, DOI 10.1007/s40726-016-0027-3; Du Jingru, 2015, Journal of Water and Environment Technology, V13, P37, DOI 10.2965/jwet.2015.37; Fenton CS, 2015, IRISH VET J, V68, DOI 10.1186/s13620-015-0051-4; Friedrich MW, 2005, METHOD ENZYMOL, V397, P428, DOI 10.1016/S0076-6879(05)97026-2; Gonzalez-Pleiter M, 2013, WATER RES, V47, P2050, DOI 10.1016/j.watres.2013.01.020; Goolsby D. A., 2000, EOS, V81, P321, DOI DOI 10.1029/00EO00244; Gray A., 2020, THESIS U N CAROLINA; Gray A, 2021, J ENVIRON HEALTH SCI, V19, P1313, DOI 10.1007/s40201-021-00688-9; Gray AD, 2020, SCI TOTAL ENVIRON, V710, DOI 10.1016/j.scitotenv.2019.136286; Greaver TL, 2016, NAT CLIM CHANGE, V6, P836, DOI [10.1038/NCLIMATE3088, 10.1038/nclimate3088]; Grimm NB, 2005, J N AM BENTHOL SOC, V24, P626, DOI 10.1899/04-027.1; Haggard BE, 2009, J ENVIRON QUAL, V38, P343, DOI 10.2134/jeq2007.0540; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Ji GD, 2012, ECOL ENG, V44, P269, DOI 10.1016/j.ecoleng.2012.04.007; Kaushal SS, 2008, ECOL APPL, V18, P789, DOI 10.1890/07-1159.1; Kim A, 2018, MICROB DRUG RESIST, V24, P1226, DOI 10.1089/mdr.2017.0137; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Lee CM, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-6924-y; Lee SS, 2016, ENVIRON SCI TECHNOL, V50, P9727, DOI 10.1021/acs.est.6b03717; Lofton DD, 2007, BIOGEOCHEMISTRY, V86, P77, DOI 10.1007/s10533-007-9146-7; Ma DY, 2006, SCI TOTAL ENVIRON, V367, P273, DOI 10.1016/j.scitotenv.2005.10.014; McDermott PF, 2003, INT J TOXICOL, V22, P135, DOI 10.1080/10915810305089; McDowell RW, 2009, NEW ZEAL J MAR FRESH, V43, P985, DOI 10.1080/00288330909510055; McMillan SK, 2014, J AM WATER RESOUR AS, V50, P626, DOI 10.1111/jawr.12205; Patel M, 2019, CHEM REV, V119, P3510, DOI 10.1021/acs.chemrev.8b00299; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Rocca JD, 2015, ISME J, V9, P1693, DOI 10.1038/ismej.2014.252; Roose-Amsaleg C, 2016, ENVIRON SCI POLLUT R, V23, P4000, DOI 10.1007/s11356-015-4943-3; Rosi EJ, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2041; Rosi-Marshall EJ, 2013, ECOL APPL, V23, P583, DOI 10.1890/12-0491.1; Rosi-Marshall EJ, 2012, ECOSYSTEMS, V15, P867, DOI 10.1007/s10021-012-9553-z; Rossi N. A., 2019, COMMUN BIOL, V2, P1; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Santana LMBM, 2017, SCI TOTAL ENVIRON, V595, P920, DOI 10.1016/j.scitotenv.2017.03.020; Sobota DJ, 2013, FRONT ECOL ENVIRON, V11, P82, DOI 10.1890/110216; Sweeney MT, 2017, J VET DIAGN INVEST, V29, P224, DOI 10.1177/1040638716683212; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; Thiele-Bruhn S, 2005, CHEMOSPHERE, V59, P457, DOI 10.1016/j.chemosphere.2005.01.023; Toth JD, 2011, SOIL BIOL BIOCHEM, V43, P2470, DOI 10.1016/j.soilbio.2011.09.004; Underwood JC, 2011, ENVIRON SCI TECHNOL, V45, P3096, DOI 10.1021/es103605e; Vaksmaa A, 2017, APPL MICROBIOL BIOT, V101, P1631, DOI 10.1007/s00253-016-8065-8; Van Metre PC, 2016, J ENVIRON QUAL, V45, P1696, DOI 10.2134/jeq2015.12.0591; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Yan TF, 2003, ENVIRON MICROBIOL, V5, P13, DOI 10.1046/j.1462-2920.2003.00393.x	59	3	3	14	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0261714	10.1371/journal.pone.0261714	http://dx.doi.org/10.1371/journal.pone.0261714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986185	Green Published, gold			2022-12-27	WOS:000765956200013
J	Guo, Q; Sun, YH; Zhang, JT; Li, Y				Guo, Qi; Sun, Yuhan; Zhang, Jiangtao; Li, Yun			Variation of phenotypic and physiological traits of Robinia pseudoacacia L. from 20 provenances	PLOS ONE			English	Article							BLACK LOCUST PLANTATION; LOESS PLATEAU; POPULATIONS; FOREST; FRUIT; TREE; SEED	To select elite Robinia pseudoacacia L. germplasm resources for production, 13 phenotypes and three physiological indicators of 214 seedlings from 20 provenances were systematically evaluated and analyzed. The leaf phenotypic and physiological coefficients of variation among the genotypes ranged from 3.741% to 19.599% and from 8.260% to 42.363%, respectively. The Kentucky provenance had the largest coefficient of variation (18.541%). The average differentiation coefficients between and within provenances were 34.161% and 38.756%, respectively. These close percentages showed that R. pseudoacacia presented high genetic variation among and within provenances, which can be useful for assisted migration and breeding programs. Furthermore, based on the results of correlations, principal component analysis and cluster analysis, breeding improvements targeting R. pseudoacacia's ornamental value, food value, and stress resistance of were performed. Forty and 30 excellent individuals, accounting for 18.692% and 14.019%, respectively, of the total resources. They were ultimately screened, after comprehensively taking into considering leaf phenotypic traits including compound leaf length, leaflet number and leaflet area and physiological characteristics including proline and soluble protein contents. These selected individuals could provide a base material for improved variety conservation and selection.	[Guo, Qi] Henan Univ Sci & Technol, Coll Agr Tree Peony, Luoyang, Henan, Peoples R China; [Guo, Qi; Sun, Yuhan; Li, Yun] Beijing Forestry Univ, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing, Peoples R China; [Guo, Qi; Sun, Yuhan; Li, Yun] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Guo, Qi; Sun, Yuhan; Li, Yun] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Zhang, Jiangtao] Henan Acad Forestry, Zhengzhou, Peoples R China	Henan University of Science & Technology; Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	Li, Y (corresponding author), Beijing Forestry Univ, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing, Peoples R China.; Li, Y (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.; Li, Y (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.; Zhang, JT (corresponding author), Henan Acad Forestry, Zhengzhou, Peoples R China.	hnlky@163.com; yunli@bjfu.edu.cn		Li, Yun/0000-0002-8426-565X	Youth Science Foundation of Henan Province [202300410136]; National Nature Science Foundation of China [31570677]; National Key R&D Program of China [2017YFD0600503]; National Forestry and Grassland Administration of Science and Technology Development Center Project [2016007]	Youth Science Foundation of Henan Province; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; National Forestry and Grassland Administration of Science and Technology Development Center Project	Qi Guo: Youth Science Foundation of Henan Province (202300410136), Yun Li: National Nature Science Foundation of China (31570677), Yun Li: National Key R&D Program of China (2017YFD0600503), Yun Li: National Forestry and Grassland Administration of Science and Technology Development Center Project (2016007).	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Balapanov I, 2019, SCI HORTIC-AMSTERDAM, V253, P322, DOI 10.1016/j.scienta.2019.04.014; Bessega C, 2015, GENETICA, V143, P31, DOI 10.1007/s10709-014-9810-5; Carletti G, 2021, J FORESTRY RES, V32, P263, DOI 10.1007/s11676-019-00913-0; COHEN JI, 1991, SCIENCE, V253, P866, DOI 10.1126/science.253.5022.866; Dini-Papanastasi O, 2008, FORESTRY, V81, P91, DOI 10.1093/forestry/cpm047; [董承光 Dong Chengguang], 2016, [植物遗传资源学报, Journal of Plant Genetic Resources], V17, P438; [董胜君 Dong Shengjun], 2018, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V49, P686; El-Soda M, 2014, TRENDS PLANT SCI, V19, P390, DOI 10.1016/j.tplants.2014.01.001; Feng Qiuhong, 2020, Biodiversity Science, V28, P314, DOI 10.17520/biods.2019091; Fu M., 2018, FOREST RESOURCES MAN, P35, DOI [10.13466/j.cnki.lyzygl.2018.02.007, DOI 10.13466/J.CNKI.LYZYGL.2018.02.007]; Ge S., 1988, Scientia Silvae Sinicae, V24, P399; Granata MU, 2020, FLORA, V268, DOI 10.1016/j.flora.2020.151626; Gu J, 2006, THESIS HEBEI AGR U, DOI [10. 7666/d.y933406, DOI 10.7666/D.Y933406]; Gu WanChun, 2007, World Forestry Research, V20, P66; [郭琪 Guo Qi], 2019, [分子植物育种, Molecular Plant Breeding], V17, P4479; Guo Q, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092492; [郝蕾 Hao Lei], 2015, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V29, P112; Hawkins TS, 2009, J NAT CONSERV, V17, P123, DOI 10.1016/j.jnc.2008.12.007; [何清伟 He Qingwei], 2020, [四川农业大学学报, Journal of Sichuan Agricultural University], V38, P135; Hong T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208899; Huang TianCai, 2011, Biodiversity Science, V19, P319, DOI 10.3724/SP.J.1003.2011.08206; Huntley JC, 1990, SILVICS N AM, V2; Jiang R, 2011, J NORTHEAST FOR UNIV, V39, P23, DOI [10.3969/j.issn.1000-5382.2011.05.003, DOI 10.3969/J.ISSN.1000-5382.2011.05.003]; Jiang RongBo, 2011, Journal of Northeast Forestry University, V39, P9; Keeler H., 1907, OUR NATIVE TREES IDE, P186; [李斌 Li Bin], 2014, [植物遗传资源学报, Journal of Plant Genetic Resources], V15, P477; [李鸿雁 Li Hongyan], 2017, [植物遗传资源学报, Journal of Plant Genetic Resources], V18, P620; Li JM, 2008, GENETICA, V133, P227, DOI 10.1007/s10709-007-9204-z; Li M, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0772-x; Li Y, 2017, J SHANXI AGR ENCES, V45, P1061, DOI [10.3969/j.issn.1002-2481.2017.07.04, DOI 10.3969/J.ISSN.1002-2481.2017.07.04]; Li ZhongXi, 2015, Acta Agriculturae Shanghai, V31, P63; Lian YJ, 2019, J FUJIAN FORESTRY SC, V42, P55, DOI DOI 10.13428/J.CNKI.FJLK.2019.02.013; Liu Na, 2020, Plant Science Journal, V38, P378, DOI 10.11913/PSJ.2095-0837.2020.30378; Lv JB, 2020, IND CROP PROD, V145, DOI 10.1016/j.indcrop.2020.112157; Nezhad MS, 2011, LIFE SCI J, V8, P440; Ou HanBiao, 2020, Southwest China Journal of Agricultural Sciences, V33, P637, DOI 10.16213/j.cnki.scjas.2020.3.026; Pan YY, 2020, TREE GENET GENOMES, V16, DOI 10.1007/s11295-020-1420-z; [庞发虎 Pang Fahu], 2010, [生态学报, Acta Ecologica Sinica], V30, P3188; [彭祥 Peng Xiang], 2018, [分子植物育种, Molecular Plant Breeding], V16, P5731; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Pritchard HW, 2014, FOREST ECOL MANAG, V333, P88, DOI 10.1016/j.foreco.2014.08.012; Qiu LP, 2010, PLANT SOIL, V332, P207, DOI 10.1007/s11104-010-0286-5; Santiso X, 2015, TREE PHYSIOL, V35, P1118, DOI 10.1093/treephys/tpv081; Su Leyi, 2016, Journal of Plant Resources and Environment, V25, P76, DOI 10.3969/j.issn.674-7895.2016.04.10; [孙芳 SUN Fang], 2009, [植物遗传资源学报, Journal of Plant Genetic Resources], V10, P91; Sun YuHan, 2013, Journal of Northeast Forestry University, V41, P14; SURLES SE, 1989, CAN J FOREST RES, V19, P471, DOI 10.1139/x89-073; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tateno R, 2007, FOREST ECOL MANAG, V241, P84, DOI 10.1016/j.foreco.2006.12.026; Tian F, 2000, PHARM BIOL, V38, P229, DOI 10.1076/1388-0209(200007)3831-SFT229; Wang HongLing, 2019, Journal of Jiangsu Forestry Science & Technology, V46, P22, DOI 10.3969/j.issn.1001-7380.2019.05.004; Wang Kai, 2014, Bulletin of Botanical Research, V34, P634, DOI 10.7525/j.issn.1673-5102.2014.05.009; Wang XL, 2021, GENET RESOUR CROP EV, V68, P3219, DOI 10.1007/s10722-021-01182-9; Wen Shan-Na, 2017, Bulletin of Botanical Research, V37, P288, DOI 10.7525/j.issn.1673-5102.2017.02.018; Wen Y, 2012, SILVAE GENET, V61, P287, DOI 10.1515/sg-2012-0036; [解新明 Xie Xinming], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P31; Xie YangJiao, 2017, Guangxi Zhiwu / Guihaia, V37, P348; Xu YD, 2019, CATENA, V174, P316, DOI 10.1016/j.catena.2018.11.009; Xue D, 2018, HUBEI FORESTRY SCI T, V47, P20; Xun S, 2009, J SHANDONG FOR SCI T, V39, P92, DOI 10.3969/j.issn.1002-2724.2009.01.038; Yang M, 2004, ACTA GENET SIN, V31, P1440, DOI 10.1016/j.jce.2003.10; Yang Xiaoxia, 2016, Journal of Plant Resources and Environment, V25, P80, DOI 10.3969/j.issn.1674-7895.2016.03.10; Zhang DL, 1990, SHANDONG FOR SCI TEC, V2, P16; Zhang GuoJun, 2013, Journal of Beijing Forestry University, V35, P8; Zhang JG, 2015, ECOHYDROLOGY, V8, P137, DOI 10.1002/eco.1495; [张双 Zhang Shuang], 2017, [园艺学报, Acta Horticulturae Sinica], V44, P1609; [张燕 Zhang Yan], 2016, [分子植物育种, Molecular Plant Breeding], V14, P239; Zhou L, 2013, THESIS HENAN AGR U, DOI [10.7666/d.Y2691005, DOI 10.7666/D.Y2691005]; Zhou XinHua, 2021, Journal of South China Agricultural University, V42, P116, DOI 10.7671/j.issn.1001-411X.202003001	70	0	0	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262278	10.1371/journal.pone.0262278	http://dx.doi.org/10.1371/journal.pone.0262278			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986177	gold, Green Published			2022-12-27	WOS:000765956200035
J	Kim, MJ; Chu, KB; Lee, HA; Quan, FS; Kong, HH; Moon, EK				Kim, Min-Jeong; Chu, Ki-Back; Lee, Hae-Ahm; Quan, Fu-Shi; Kong, Hyun-Hee; Moon, Eun-Kyung			Detection of Acanthamoeba spp. using carboxylesterase antibody and its usage for diagnosing Acanthamoeba-keratitis	PLOS ONE			English	Article							CONFOCAL MICROSCOPY; GENUS ACANTHAMOEBA; CONTACT-LENS; IDENTIFICATION; MOUSE; WALL; PCR	Contact lens usage has contributed to increased incidence rates of Acanthamoeba keratitis (AK), a serious corneal infection that can lead to blindness. Since symptoms associated with AK closely resemble those incurred by bacterial or fungal keratitis, developing a diagnostic method enabling rapid detection with a high degree of Acanthamoeba-specificity would be beneficial. Here, we produced a polyclonal antibody targeting the carboxylesterase (CE) superfamily protein secreted by the pathogenic Acanthamoeba and evaluated its diagnostic potential. Western blot analysis revealed that the CE antibody specifically interacts with the cell lysates and conditioned media of pathogenic Acanthamoeba, which were not observed from the cell lysates and conditioned media of human corneal epithelial (HCE) cells, Fusarium solani, Staphylococcus aureus, and Pseudomonas aeruginosa. High titers of A. castellanii-specific antibody production were confirmed sera of immunized mice via ELISA, and these antibodies were capable of detecting A. castellanii from the cell lysates and their conditioned media. The specificity of the CE antibody was further confirmed on A. castellanii trophozoites and cysts co-cultured with HCE cells, F. solani, S. aureus, and P. aeruginosa using immunocytochemistry. Additionally, the CE antibody produced in this study successfully interacted with 7 different Acanthamoeba species. Our findings demonstrate that the polyclonal CE antibody specifically detects multiple species belong to the genus Acanthamoeba, thus highlighting its potential as AK diagnostic tool.	[Kim, Min-Jeong; Chu, Ki-Back] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Lee, Hae-Ahm; Quan, Fu-Shi] Kyung Hee Univ, Med Res Ctr Bioreact React Oxygen Species, Seoul, South Korea; [Lee, Hae-Ahm; Quan, Fu-Shi] Kyung Hee Univ, Sch Med, Grad Sch, Biomed Sci Inst, Seoul, South Korea; [Quan, Fu-Shi; Moon, Eun-Kyung] Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul, South Korea; [Kong, Hyun-Hee] Dong A Univ, Coll Med, Dept Parasitol, Busan, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Dong A University	Moon, EK (corresponding author), Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul, South Korea.	ekmoon@khu.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MIST) [2020R1A2C1005345]	National Research Foundation of Korea (NRF) - Korea government (MIST)(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MIST) (No. 2020R1A2C1005345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh H, 2001, CORNEA, V20, P622, DOI 10.1097/00003226-200108000-00013; CHYNN EW, 1995, OPHTHALMOLOGY, V102, P1369, DOI 10.1016/S0161-6420(95)30862-7; de Lacerda AG, 2021, OPHTHAL PHYSL OPT, V41, P116, DOI 10.1111/opo.12752; Duarte JL, 2013, EXP PARASITOL, V135, P9, DOI 10.1016/j.exppara.2013.05.013; Fanselow N, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10030323; Fuerst PA, 2015, J EUKARYOT MICROBIOL, V62, P69, DOI 10.1111/jeu.12186; Furihata T, 2004, DRUG METAB DISPOS, V32, P1170, DOI 10.1124/dmd.104.000620; Goh JWY, 2018, CORNEA, V37, P480, DOI 10.1097/ICO.0000000000001497; Hammersmith KM, 2006, CURR OPIN OPHTHALMOL, V17, P327, DOI 10.1097/01.icu.0000233949.56229.7d; Hatfield MJ, 2016, CHEM-BIOL INTERACT, V259, P327, DOI 10.1016/j.cbi.2016.02.011; HOSOKAWA M, 1995, DRUG METAB DISPOS, V23, P1022; Ikeda Y, 2012, OPHTHALMOLOGY, V119, P1111, DOI 10.1016/j.ophtha.2011.12.023; Jercic MI, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3302-5; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Ledee DR, 1996, INVEST OPHTH VIS SCI, V37, P544; Lee HA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250342; Lian JH, 2018, PROTEIN CELL, V9, P178, DOI 10.1007/s13238-017-0437-z; Lorenzo-Morales J, 2015, PARASITE, V22, DOI 10.1051/parasite/2015010; Lun SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/jbc.M700035200; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Mascarenhas J, 2014, AM J OPHTHALMOL, V157, P56, DOI 10.1016/j.ajo.2013.08.032; Moan EK, 2018, KOREAN J PARASITOL, V56, P553, DOI 10.3347/kjp.2018.56.6.553; Park SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239867; Pfister DR, 1996, AM J OPHTHALMOL, V121, P119, DOI 10.1016/S0002-9394(14)70576-8; PUSSARD M, 1977, PROTISTOLOGICA, V13, P557; Riviere D, 2006, J MICROBIOL METH, V64, P78, DOI 10.1016/j.mimet.2005.04.008; Schuster FL, 2006, CLIN INFECT DIS, V42, P1260, DOI 10.1086/503037; SEAL DV, 1993, J MED MICROBIOL, V39, P1, DOI 10.1099/00222615-39-1-1; Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6; Stothard DR, 1998, J EUKARYOT MICROBIOL, V45, P45, DOI 10.1111/j.1550-7408.1998.tb05068.x; Szentmary N, 2019, J CURR OPHTHALMOL, V31, P16, DOI 10.1016/j.joco.2018.09.008; Turner ML, 2005, INT J PARASITOL, V35, P981, DOI 10.1016/j.ijpara.2005.03.015; Walochnik J, 2000, APPL ENVIRON MICROB, V66, P4408, DOI 10.1128/AEM.66.10.4408-4413.2000; Xuan YH, 2008, KOREAN J PARASITOL, V46, P157, DOI 10.3347/kjp.2008.46.3.157; Yoder JS, 2012, OPHTHAL EPIDEMIOL, V19, P221, DOI 10.3109/09286586.2012.681336; Zamora A, 2014, Surg Neurol Int, V5, P68, DOI 10.4103/2152-7806.132239	36	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262223	10.1371/journal.pone.0262223	http://dx.doi.org/10.1371/journal.pone.0262223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986189	gold, Green Published			2022-12-27	WOS:000765956200025
J	Nemetski, SM; Ip, A; Josephs, J; Hellmann, M				Nemetski, Sondra Maureen; Ip, Andrew; Josephs, Joshua; Hellmann, Mira			Clotting events among hospitalized patients infected with COVID-19 in a large multisite cohort in the United States	PLOS ONE			English	Article							D-DIMER; THROMBOSIS	Introduction COVID-19 infection has been hypothesized to precipitate venous and arterial clotting events more frequently than other illnesses. Materials and methods We demonstrate this increased risk of blood clots by comparing rates of venous and arterial clotting events in 4400 hospitalized COVID-19 patients in a large multisite clinical network in the United States examined from April through June of 2020, to patients hospitalized for non-COVID illness and influenza during the same time period and in 2019. Results We demonstrate that COVID-19 increases the risk of venous thrombosis by two-fold compared to the general inpatient population and compared to people with influenza infection. Arterial and venous thrombosis were both common occurrences among patients with COVID-19 infection. Risk factors for thrombosis included male gender, older age, and diabetes. Patients with venous or arterial thrombosis had high rates of admission to the ICU, re-admission to the hospital, and death. Conclusion Given the ongoing scientific discussion about the impact of clotting on COVID-19 disease progression, these results highlight the need to further elucidate the role of anticoagulation in COVID-19 patients, particularly outside the intensive care unit setting. Additionally, concerns regarding clotting and COVID-19 vaccines highlight the importance of addressing the alarmingly high rate of clotting events during actual COVID-19 infection when weighing the risks and benefits of vaccination.	[Nemetski, Sondra Maureen] Hackensack Meridian Hlth, Div Pediat Emergency Med, Dept Emergency Med, Hackensack Univ Med Ctr,Joseph M Sanzari Children, Hackensack, NJ 07601 USA; [Nemetski, Sondra Maureen] Hackensack Meridian Sch Med, Dept Pediat, Nutley, NJ 07110 USA; [Ip, Andrew] Hackensack Meridian Hlth, Dept Hematol & Oncol, John Theurer Canc Ctr, Hackensack Univ Med Ctr, Hackensack, NJ USA; [Ip, Andrew; Josephs, Joshua] Hackensack Meridian Sch Med, Dept Med, Nutley, NJ USA; [Josephs, Joshua] Hackensack Meridian Hlth, Div Hosp Med, Dept Med, Hackensack Univ Med Ctr, Hackensack, NJ USA; [Hellmann, Mira] Hackensack Meridian Hlth, Dept Obstet & Gynecol, Hackensack Univ Med Ctr, Hackensack, NJ USA; [Hellmann, Mira] Hackensack Meridian Hlth, Div Gynecol Oncol, John Theurer Canc Ctr, Hackensack Univ Med Ctr, Hackensack, NJ USA; [Hellmann, Mira] Hackensack Meridian Sch Med, Dept Oncol, Nutley, NJ USA	Hackensack University Medical Center; Hackensack University Medical Center; Hackensack University Medical Center; Hackensack University Medical Center; Hackensack University Medical Center	Nemetski, SM (corresponding author), Hackensack Meridian Hlth, Div Pediat Emergency Med, Dept Emergency Med, Hackensack Univ Med Ctr,Joseph M Sanzari Children, Hackensack, NJ 07601 USA.; Nemetski, SM (corresponding author), Hackensack Meridian Sch Med, Dept Pediat, Nutley, NJ 07110 USA.	sondra.nemetski@hmhn.org		Nemetski, Sondra Maureen/0000-0002-0660-437X				Ahmed S, 2020, CLIN RHEUMATOL, V39, P2529, DOI 10.1007/s10067-020-05275-1; Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520; Benito N, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00557; CDC, COVID DAT TRACK; Chen SJ, 2021, J THROMB THROMBOLYS, V51, P33, DOI 10.1007/s11239-020-02181-w; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Demelo-Rodriguez P, 2020, THROMB RES, V192, P23, DOI 10.1016/j.thromres.2020.05.018; Elbadawi A, 2021, ARTERIOSCL THROM VAS, V41, P545, DOI 10.1161/ATVBAHA.120.315304; Eljilany I, 2020, VASC HEALTH RISK MAN, V16, P455, DOI 10.2147/VHRM.S280962; Fara MG, 2020, J THROMB HAEMOST, V18, P2031, DOI 10.1111/jth.14938; Frazer JS, 2020, TRENDS ANAESTH CRIT, V34, P4, DOI 10.1016/j.tacc.2020.07.004; Giannis D, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104362; Griffin DO, 2020, BRIT J HAEMATOL, V190, pE11, DOI 10.1111/bjh.16792; Hanff TC, 2020, AM J HEMATOL, V95, P1578, DOI 10.1002/ajh.25982; Hanif A, 2020, ANN HEMATOL, V99, P2323, DOI 10.1007/s00277-020-04216-x; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Hippensteel JA, 2020, BRIT J HAEMATOL, V190, pE134, DOI 10.1111/bjh.16908; Johns Hopkins University and Medicine, COVID 19 MAP; Kaminetzky Mark, 2020, Radiol Cardiothorac Imaging, V2, pe200308, DOI 10.1148/ryct.2020200308; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.041, 10.1016/j.thromres.2020.04.013]; Leonard-Lorant I, 2020, RADIOLOGY, V296, pE189, DOI 10.1148/radiol.2020201561; Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9; Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869; Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024; Longchamp A, 2020, RES PRACT THROMB HAE, V4, P842, DOI 10.1002/rth2.12376; Mackman N, 2020, ARTERIOSCL THROM VAS, V40, P2033, DOI 10.1161/ATVBAHA.120.314514; Mei F, 2020, ARTERIOSCL THROM VAS, V40, P2332, DOI 10.1161/ATVBAHA.120.314779; Merrill JT, 2020, NAT REV RHEUMATOL, V16, P581, DOI 10.1038/s41584-020-0474-5; Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888; Nahum J, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10478; Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001; Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430; Singh B, 2021, ANN VASC SURG, V70, P314, DOI 10.1016/j.avsg.2020.08.115; Stoneham SM, 2020, CLIN MED, V20, pE76, DOI 10.7861/clinmed.2020-0228; Tan BK, 2021, THORAX, V76, P970, DOI 10.1136/thoraxjnl-2020-215383; Visser C, 2020, THROMB UPDATE, V1, DOI [10.1016/j.tru.2020.100006, DOI 10.1016/J.TRU.2020.100006]; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Zhou B, 2020, J THROMB THROMBOLYS, V50, P229, DOI 10.1007/s11239-020-02084-w	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262352	10.1371/journal.pone.0262352	http://dx.doi.org/10.1371/journal.pone.0262352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986205	gold, Green Published			2022-12-27	WOS:000765956200045
J	Hemminki, K; Forsti, A; Hemminki, A; Ljungberg, B; Hemminki, O				Hemminki, Kari; Foersti, Asta; Hemminki, Akseli; Ljungberg, Borje; Hemminki, Otto			Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; EUROPEAN ASSOCIATION; UROLOGY GUIDELINES; SURGICAL-TREATMENT; TOBACCO USE; TRENDS; MORTALITY; END; IMMIGRANTS	Survival has improved in bladder cancer but few studies have considered extended periods or covered populations for which medical care is essentially free of charge. We analyzed survival in urothelial cancer (UC, of which vast majority are bladder cancers) in Finland and Sweden over a 50-year period (1967-2016) using data from the NORDCAN database. Finland and Sweden are neighboring countries with largely similar health care systems but higher economic resources and health care expenditure in Sweden. We present results on 1- and 5-year relative survival rates, and additionally provide a novel measure, the difference between 1- and 5-year relative survival, indicating how well survival was maintained between these two periods. Over the 50-year period the median diagnostic age has increased by several years and the incidence in the very old patients has increased vastly. Relative 1- year survival rates increased until early 1990s in both countries, and with minor gains later reaching about 90% in men and 85% in women. Although 5-year survival also developed favorably until early 1990s, subsequent gains were small. Over time, age specific differences in male 1-year survival narrowed but remained wide in 5-year survival. For women, age differences were larger than for men. The limitations of the study were lack of information on treatment and stage. In conclusion, challenges are to improve 5-year survival, to reduce the gender gap and to target specific care to the most common patient group, those of 70 years at diagnosis. The most effective methods to achieve survival gains are to target control of tobacco use, emphasis on early diagnosis with prompt action at hematuria, upfront curative treatment and awareness of high relapse requiring regular cystoscopy follow up.	[Hemminki, Kari] Charles Univ Pilsen, Fac Med, Biomed Ctr, Plzen, Czech Republic; [Hemminki, Kari] German Canc Res Ctr, Div Canc Epidemiol, Neuenheimer Feld, Heidelberg, Germany; [Foersti, Asta] Hopp Childrens Canc Ctr KiTZ, Heidelberg, Germany; [Foersti, Asta] German Canc Res Ctr, German Canc Consortium DKTK, Div Pediat Neu Rooncol, Heidelberg, Germany; [Hemminki, Akseli; Hemminki, Otto] Univ Helsinki, Translat Immunol Res Program, Canc Gene Therapy Grp, Helsinki, Finland; [Hemminki, Akseli] Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland; [Ljungberg, Borje] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Hemminki, Otto] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland; [Hemminki, Otto] Univ Helsinki, Helsinki, Finland; [Hemminki, Otto] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Oncol, Div Urol Oncol, Toronto, ON, Canada; [Hemminki, Otto] Univ Toronto, Toronto, ON, Canada	Charles University Prague; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Umea University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Hemminki, K (corresponding author), Charles Univ Pilsen, Fac Med, Biomed Ctr, Plzen, Czech Republic.; Hemminki, K (corresponding author), German Canc Res Ctr, Div Canc Epidemiol, Neuenheimer Feld, Heidelberg, Germany.	K.Hemminki@dkfz.de		Hemminki, Kari/0000-0002-2769-3316	European Union's Horizon 2020 research and innovation programme [856620]; Finnish Cancer Organizations [6-5156-32]; Helsinki University Central Hospital [TYH2019215, TYH2018306]; Paivikki and Sakari Sohlberg Foundation [10-6623-11]	European Union's Horizon 2020 research and innovation programme; Finnish Cancer Organizations; Helsinki University Central Hospital; Paivikki and Sakari Sohlberg Foundation	Supported by the European Union's Horizon 2020 research and innovation programme, grant No 856620, Finnish Cancer Organizations (6-5156-32), Helsinki University Central Hospital (TYH2019215 and TYH2018306) and Paivikki and Sakari Sohlberg Foundation (10-6623-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon-Ching JB, 2019, CLIN GENITOURIN CANC, V17, P436, DOI 10.1016/j.clgc.2019.07.011; Babjuk M, 2019, EUR UROL, V76, P639, DOI 10.1016/j.eururo.2019.08.016; Brown KF, 2018, BRIT J CANCER, V118, P1130, DOI 10.1038/s41416-018-0029-6; Cai QL, 2020, TRANSL ANDROL UROL, V9, P153, DOI 10.21037/tau.2020.02.24; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Ebrahimi H, 2019, J UROLOGY, V201, P893, DOI 10.1097/JU.0000000000000025; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Engholm G, 2010, ACTA ONCOL, V49, P545, DOI 10.3109/02841861003739322; Engholm G, 2010, ACTA ONCOL, V49, P655, DOI 10.3109/02841860903575299; Fahmy NM, 2006, EUR UROL, V50, P1176, DOI 10.1016/j.eururo.2006.05.046; Feldman AS, 2022, UROL ONCOL-SEMIN ORI, V40, P442, DOI 10.1016/j.urolonc.2021.01.013; Greene FL, 2008, CA-CANCER J CLIN, V58, P180, DOI 10.3322/CA.2008.0001; Haggstrom C, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016606; Hemminki K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253236; Hemminki K, 2022, EUR J CANCER PREV, V31, P228, DOI 10.1097/CEJ.0000000000000694; Hemminki K, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08371-w; Hemminki K, 2014, EUR J PUBLIC HEALTH, V24, P64, DOI 10.1093/eurpub/cku102; Hussain SK, 2008, ANN ONCOL, V19, P156, DOI 10.1093/annonc/mdm413; Inoue-Choi M, 2019, JNCI CANCER SPECT, V3, DOI 10.1093/jncics/pkz036; Jahnson S, 2016, SCAND J UROL, V50, P14, DOI 10.3109/21681805.2015.1085089; Jancke G, 2017, SCAND J UROL, V51, P124, DOI 10.1080/21681805.2017.1298156; Ji JG, 2012, INT J CANCER, V131, P2085, DOI 10.1002/ijc.27462; Kim M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1161-9; Kohlmann W., 1993, LYNCH SYNDROME, DOI [10.1093/ajh/6.9.794 8110434, DOI 10.1093/AJH/6.9.7948110434]; Liu XD, 2015, INT J CANCER, V137, P903, DOI 10.1002/ijc.29440; Malmstrom PU, 2019, SCAND J UROL, V53, P193, DOI 10.1080/21681805.2019.1632380; Malmstrom PU, 1996, J UROLOGY, V155, P1903, DOI 10.1016/S0022-5347(01)66042-7; Marcos-Gragera R, 2015, EUR J CANCER, V51, P2217, DOI 10.1016/j.ejca.2015.07.028; Moller P, 2018, GUT, V67, P1306, DOI 10.1136/gutjnl-2017-314057; Mousavi SM, 2010, EUR J CANCER PREV, V19, P275, DOI 10.1097/CEJ.0b013e3283387728; Nielsen ME, 2014, CANCER-AM CANCER SOC, V120, P86, DOI 10.1002/cncr.28397; Nilsson S, 2001, ACTA ONCOL, V40, P371, DOI 10.1080/02841860151116466; Oosterlinck W, 2002, EUR UROL, V41, P105, DOI 10.1016/S0302-2838(01)00026-4; Patja K, 2009, SCAND J PUBLIC HEALT, V37, P153, DOI 10.1177/1403494808100277; Radkiewicz C, 2020, CLIN GENITOURIN CANC, V18, P26, DOI 10.1016/j.clgc.2019.10.020; Rink M, 2013, EUR UROL, V63, P724, DOI 10.1016/j.eururo.2012.08.025; Roupret M, 2018, EUR UROL, V73, P111, DOI 10.1016/j.eururo.2017.07.036; Sjostrom C, 2018, SCAND J UROL, V52, P186, DOI 10.1080/21681805.2018.1462254; Storm HH, 2010, ACTA ONCOL, V49, P694, DOI 10.3109/02841861003631495; Sunela KL, 2014, BJU INT, V113, P228, DOI 10.1111/bju.12242; Tellini R, 2021, EUR UROL ONCOL, V4, P580, DOI 10.1016/j.euo.2020.10.006; Teoh JYC, 2020, EUR UROL, V78, P893, DOI 10.1016/j.eururo.2020.09.006; Thorstenson A, 2014, SCAND J UROL, V48, P231, DOI 10.3109/21681805.2013.864698; Welch HG, 2019, NEW ENGL J MED, V381, P1378, DOI 10.1056/NEJMsr1905447; Wischhusen JW, 2020, CANCER EPIDEM BIOMAR, V29, P193, DOI 10.1158/1055-9965.EPI-19-0213; Witjes JA, 2021, EUR UROL, V79, P82, DOI 10.1016/j.eururo.2020.03.055; Yu HY, 2020, MUTAGENESIS, V35, P207, DOI 10.1093/mutage/gez022; Zang Y, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-2108	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0261124	10.1371/journal.pone.0261124	http://dx.doi.org/10.1371/journal.pone.0261124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982793	Green Submitted, gold, Green Published			2022-12-27	WOS:000834805700006
J	Kim, HJ; Ryou, JH; Choi, KT; Kim, SM; Kim, JT; Han, DH				Kim, Hee Jin; Ryou, Jae Hyun; Choi, Kang Ta; Kim, Sun Mi; Kim, Jee Taek; Han, Doug Hyun			Deficits in color detection in patients with Alzheimer disease	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; DEMENTIA; TESTS	Deficits in color vision and related retinal changes hold promise as early screening biomarkers in patients with Alzheimer's disease. This study aimed to determine a cut-off score that can screen for Alzheimer's dementia using a novel color vision threshold test named the red, green, and blue (RGB) modified color vision plate test (RGB-vision plate). We developed the RGB-vision plate consisting of 30 plates in which the red and green hues of Ishihara Plate No.22 were sequentially adjusted. A total of 108 older people participated in the mini-mental state examination (MMSE), Ishihara plate, and RGB-vision plate. For the analyses, the participants were divided into two groups: Alzheimer's dementia (n = 42) and healthy controls (n = 38). K-means cluster analysis and ROC curve analysis were performed to identify the most appropriate cut-off score. As a result, the cut-off screening score for Alzheimer's dementia on the RGB-vision plate was set at 25, with an area under the curve of 0.773 (p<0.001). Moreover, there was a negative correlation between the RGB-vision plate thresholds and MMSE scores (r = -0.36, p = 0.02). In conclusion, patients with Alzheimer's dementia had a deficit in color vision. The RGB-vision plate is a potential early biomarker that may adequately detect Alzheimer's dementia.	[Kim, Hee Jin; Ryou, Jae Hyun; Choi, Kang Ta; Kim, Sun Mi; Han, Doug Hyun] Chung Ang Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kim, Jee Taek] Chung Ang Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Han, DH (corresponding author), Chung Ang Univ, Coll Med, Dept Psychiat, Seoul, South Korea.	hduk70@gmail.com		Choi, Gangta/0000-0001-5402-2158; Han, Doug Hyun/0000-0002-8314-0767; Kim, Heejin/0000-0002-8529-4786	Chung Ang University	Chung Ang University	This research was supported by the Chung Ang University Research Scholarship Grant in 2020.	Al-Qazzaz NK, 2014, SCI WORLD J, DOI 10.1155/2014/906038; Arnaoutoglou NA, 2017, INT PSYCHOGERIATR, V29, P1355, DOI 10.1017/S1041610217000096; Arvanitakis Z, 2019, JAMA-J AM MED ASSOC, V322, P1589, DOI 10.1001/jama.2019.4782; Attems J, 2006, CLIN NEUROPATHOL, V25, P265; Barbur J.L., 2010, ENCY EYE, P323, DOI 10.1016/B978-0-12-374203-2.00233-5; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Birch J, 1997, OPHTHAL PHYSL OPT, V17, P403, DOI 10.1111/j.1475-1313.1997.tb00072.x; Borson S, 2013, ALZHEIMERS DEMENT, V9, P151, DOI 10.1016/j.jalz.2012.08.008; BOYCOTT BB, 1969, PHILOS T ROY SOC B, V255, P109, DOI 10.1098/rstb.1969.0004; Bull ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034724; Byun MS, 2021, JAMA OPHTHALMOL, V139, P548, DOI 10.1001/jamaophthalmol.2021.0320; Chang LYL, 2014, ALZHEIMERS DEMENT, V10, P251, DOI 10.1016/j.jalz.2013.06.004; Choo IH, 2007, ALZ DIS ASSOC DIS, V21, P77, DOI 10.1097/WAD.0b013e3180687418; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; CRONINGOLOMB A, 1993, NEUROBIOL AGING, V14, P471, DOI 10.1016/0197-4580(93)90105-K; Danesh-Meyer HV, 2006, NEUROLOGY, V67, P1852, DOI 10.1212/01.wnl.0000244490.07925.8b; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; DEMARCO P, 1992, J OPT SOC AM A, V9, P1465, DOI 10.1364/JOSAA.9.001465; Gasparini L, 2011, NEUROBIOL AGING, V32, P419, DOI 10.1016/j.neurobiolaging.2009.03.002; Gietl Anton Franz, 2015, Rev Med Suisse, V11, P1944; HARDY LH, 1954, AMA ARCH OPHTHALMOL, V51, P216, DOI 10.1001/archopht.1954.00920040218009; Henry MS, 2013, INT J GERIATR PSYCH, V28, P331, DOI 10.1002/gps.3829; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; Humpel C, 2011, TRENDS BIOTECHNOL, V29, P26, DOI 10.1016/j.tibtech.2010.09.007; Huna-Baron R, 2013, GRAEF ARCH CLIN EXP, V251, P585, DOI 10.1007/s00417-012-2073-x; Kim SM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254357; Ko F, 2018, JAMA NEUROL, V75, P1198, DOI 10.1001/jamaneurol.2018.1578; Kwon YC, 1989, KOR NEUROPSYCHIAT AS, V28, P125; La Morgia C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00710; Liu BQ, 2009, AM J PATHOL, V175, P2099, DOI 10.2353/ajpath.2009.090159; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lorentz WJ, 2002, CAN J PSYCHIAT, V47, P723, DOI 10.1177/070674370204700803; Sosa-Ortiz AL, 2012, ARCH MED RES, V43, P600, DOI 10.1016/j.arcmed.2012.11.003; Martinez-Domingo MA, 2019, OPT EXPRESS, V27, P17954, DOI 10.1364/OE.27.017954; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Polo V, 2017, EYE, V31, P1034, DOI 10.1038/eye.2017.23; Scheltens P, 2002, LANCET NEUROL, V1, P13, DOI 10.1016/S1474-4422(02)00002-9; Shabani A, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.1894; Siddiqui QA, 2010, SAUDI MED J, V31, P895; Tuijl JP, 2012, INT J GERIATR PSYCH, V27, P755, DOI 10.1002/gps.2776; van Staden D, 2018, AFR VIS EYE HEALTH J, V77, DOI 10.4102/aveh.v77i1.370; Zhang Y, 2021, TRANSL NEURODEGENER, V10, DOI 10.1186/s40035-021-00230-9; Zhang-Nunes SX, 2006, BRAIN PATHOL, V16, P30, DOI 10.1111/j.1750-3639.2006.tb00559.x	44	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262226	10.1371/journal.pone.0262226	http://dx.doi.org/10.1371/journal.pone.0262226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982795	Green Published, gold			2022-12-27	WOS:000834805700022
J	Lee, MF; Chiang, CH; Lin, SJ; Wu, CS; Chen, YH				Lee, Mey-Fann; Chiang, Chu-Hui; Lin, Shyh-Jye; Wu, Chi-Sheng; Chen, Yi-Hsing			Effectiveness and safety of oral lactococci-based vaccine encoding triple common allergens to prevent airway allergy in mice	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; GRASS-POLLEN; ENVIRONMENTAL AEROALLERGENS; IMMUNOTHERAPY; PREVALENCE; MECHANISMS; EFFICACY; COVID-19	Allergic airway disease is the most common chronic airway inflammatory disorder in developed countries. House dust mite, cockroach, and mold are the leading allergens in most tropical and subtropical countries, including Taiwan. As allergen avoidance is difficult for patients allergic to these perennial indoor allergens, allergen-specific immunotherapy (ASIT) is the only available allergen-specific and disease-modifying treatment. However, for patients sensitized to multiple allergens, ASIT using each corresponding allergen is cumbersome. In the present study, we developed a recombinant L. lactis vaccine against the three most common indoor aeroallergens and investigated its effectiveness for preventing respiratory allergy and safety in mice. Three recombinant clones of Der p 2 (mite), Per a 2 (roach), and Cla c 14 (mold) were constructed individually in pNZ8149 vector and then electroporated into host strain L.lactis NZ3900. BALB/c mice were fed with the triple vaccine 5 times per week for 4 weeks prior to sensitization. The effectiveness and safety profile were then determined. Oral administration of the triple vaccine significantly alleviated allergen-induced airway hyper-responsiveness in the vaccinated mice. The allergen-specific IgG2a was upregulated. IL-4 and IL-13 mRNA expressions as well as inflammatory cell infiltration in the lungs decreased significantly in the vaccinated groups. No body weight loss or abnormal findings in the liver and kidneys were found in any of the groups of mice. This is the first report to describe a triple-aeroallergen vaccine using a food-grade lactococcal expression system. We developed a convenient oral delivery system and intend to extend this research to develop a vaccination that can be self-administered at home by patients.	[Lee, Mey-Fann] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chiang, Chu-Hui] Natl Pingtung Univ Sci & Technol, Dept Plant Med, Pingtung, Taiwan; [Lin, Shyh-Jye] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Wu, Chi-Sheng; Chen, Yi-Hsing] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Yi-Hsing] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan	Taichung Veterans General Hospital; National Pingtung University Science & Technology; Chung Shan Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, YH (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, YH (corresponding author), Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan.	ysanne@vghtc.gov.tw		Chen, Yi-Hsing/0000-0002-8135-9554	Taichung Veterans General Hospital [TCVGH-1077313C, 1087316C]	Taichung Veterans General Hospital	This study was supported by grants from Taichung Veterans General Hospital (TCVGH-1077313C and 1087316C).	[Anonymous], 2000, AIR IOMUCOTAOAAI; Bousquet PJ, 2007, ALLERGY, V62, P301, DOI 10.1111/j.1398-9995.2006.01293.x; Cianferoni A, 2020, PEDIAT ALLERG IMM-UK, V31, P96, DOI 10.1111/pai.13367; Clavel R, 1998, ALLERGY, V53, P493, DOI 10.1111/j.1398-9995.1998.tb04086.x; de Bot CMA, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-59; Demoly P, 2021, J ALLERGY CLIN IMMUN, V147, P1020, DOI 10.1016/j.jaci.2020.07.036; Dougherty JA, 2021, ANN PHARMACOTHER, V55, P344, DOI 10.1177/1060028020944370; Dunlop JH, 2020, J INVEST MED, V68, P1152, DOI 10.1136/jim-2020-001422; Huang Hung-Wei, 2006, Acta Paediatr Taiwan, V47, P127; Jalbert I, 2015, CURR OPIN ALLERGY CL, V15, P476, DOI 10.1097/ACI.0000000000000205; Krishna MT, 2021, J ALLER CL IMM-PRACT, V9, P709, DOI 10.1016/j.jaip.2020.11.038; Lee MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201281; Lee MF, 2016, ANN ALLERG ASTHMA IM, V117, P535, DOI 10.1016/j.anai.2016.09.432; Luo WT, 2021, ALLERGY, V76, P589, DOI 10.1111/all.14597; Lupinek Christian, 2016, Curr Treat Options Allergy, V3, P189; Garcia-Menaya JM, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.570721; Mosbech H, 2014, J ALLERGY CLIN IMMUN, V134, P568, DOI 10.1016/j.jaci.2014.03.019; Okamoto Y, 2019, PEDIAT ALLERG IMM-UK, V30, P66, DOI 10.1111/pai.12984; Orgel K, 2019, CLIN EXP ALLERGY, V49, P461, DOI 10.1111/cea.13305; Pfaar O, 2021, ALLERGY, V76, P648, DOI 10.1111/all.14453; Roberts G, 2018, ALLERGY, V73, P765, DOI 10.1111/all.13317; SABBAH A, 1994, ALLERGY, V49, P309, DOI 10.1111/j.1398-9995.1994.tb02273.x; Saito S, 2020, MOL IMMUNOL, V125, P63, DOI 10.1016/j.molimm.2020.06.019; Schauberger EM J.M.B., 2020, MIDDLETONS ALLERGY P, V9, P1676; Su HJ, 2001, ENVIRON RES, V85, P135, DOI 10.1006/enrs.2000.4113; Sun XX, 2019, ASIAN PAC J ALLERGY, V37, P57, DOI 10.12932/AP-160817-0137; Tang RB, 2020, J CHIN MED ASSOC, V83, P109, DOI 10.1097/JCMA.0000000000000231; TREDE NS, 1989, ALLERGY, V44, P272, DOI 10.1111/j.1398-9995.1989.tb01069.x; URBANEK R, 1990, EUR J PEDIATR, V149, P545, DOI 10.1007/BF01957689; Valenta R, 2017, IMMUNOL LETT, V189, P19, DOI 10.1016/j.imlet.2017.04.015; Valenta R, 2016, J ALLERGY CLIN IMMUN, V137, P351, DOI 10.1016/j.jaci.2015.12.1299; van den Berg H, 2010, IMMUNOBIOLOGY, V215, P163, DOI 10.1016/j.imbio.2009.01.012; Weiner HL, 1997, IMMUNOL TODAY, V18, P335, DOI 10.1016/S0167-5699(97)01053-0; Yang JM, 2020, J ALLERGY CLIN IMMUN, V146, P790, DOI 10.1016/j.jaci.2020.08.008; Zolkipli Z, 2015, J ALLERGY CLIN IMMUN, V136, P1541, DOI 10.1016/j.jaci.2015.04.045	35	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261333	10.1371/journal.pone.0261333	http://dx.doi.org/10.1371/journal.pone.0261333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972127	Green Published, gold			2022-12-27	WOS:000773555700030
J	Palukuri, MV; Marcotte, EM				Palukuri, Meghana Venkata; Marcotte, Edward M.			Super.Complex: A supervised machine learning pipeline for molecular complex detection in protein-interaction networks	PLOS ONE			English	Article								Characterization of protein complexes, i.e. sets of proteins assembling into a single larger physical entity, is important, as such assemblies play many essential roles in cells such as gene regulation. From networks of protein-protein interactions, potential protein complexes can be identified computationally through the application of community detection methods, which flag groups of entities interacting with each other in certain patterns. Most community detection algorithms tend to be unsupervised and assume that communities are dense network subgraphs, which is not always true, as protein complexes can exhibit diverse network topologies. The few existing supervised machine learning methods are serial and can potentially be improved in terms of accuracy and scalability by using better-suited machine learning models and parallel algorithms. Here, we present Super.Complex, a distributed, supervised AutoML-based pipeline for overlapping community detection in weighted networks. We also propose three new evaluation measures for the outstanding issue of comparing sets of learned and known communities satisfactorily. Super.Complex learns a community fitness function from known communities using an AutoML method and applies this fitness function to detect new communities. A heuristic local search algorithm finds maximally scoring communities, and a parallel implementation can be run on a computer cluster for scaling to large networks. On a yeast protein-interaction network, Super.Complex outperforms 6 other supervised and 4 unsupervised methods. Application of Super.Complex to a human protein-interaction network with similar to 8k nodes and similar to 60k edges yields 1,028 protein complexes, with 234 complexes linked to SARS-CoV-2, the COVID-19 virus, with 111 uncharacterized proteins present in 103 learned complexes. Super.Complex is generalizable with the ability to improve results by incorporating domain-specific features. Learned community characteristics can also be transferred from existing applications to detect communities in a new application with no known communities. Code and interactive visualizations of learned human protein complexes are freely available at: https://sites.google.com/view/supercomplex/super-complex-v3-0.	[Palukuri, Meghana Venkata] Univ Texas Austin, Oden Inst Computat Engn & Sci, Austin, TX 78712 USA; [Marcotte, Edward M.] Univ Texas Austin, Ctr Syst & Synthet Biol, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Palukuri, MV (corresponding author), Univ Texas Austin, Oden Inst Computat Engn & Sci, Austin, TX 78712 USA.; Marcotte, EM (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Dept Mol Biosci, Austin, TX 78712 USA.	meghana.palukuri@utexas.edu; marcotte@utexas.edu		Palukuri, Meghana/0000-0002-6529-6127	Welch Foundation [F-1515]; National Institutes of Health [R35 GM122480, R01 HD085901, R21 HD103588]	Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors gratefully acknowledge funding from the Welch Foundation (F-1515) and National Institutes of Health (R35 GM122480, R01 HD085901, R21 HD103588) to E.M.M. The funders' websites are https://www.welch1.org/and https://www.nih.gov/respectively.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Borgeson BC., 2016, THESIS; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Dong YD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194124; Drew K, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167490; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giurgiu M, 2019, NUCLEIC ACIDS RES, V47, pD559, DOI 10.1093/nar/gky973; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; KARP RM, 1980, NETWORKS, V10, P143, DOI 10.1002/net.3230100205; Lee C., 2010, ARXIV10021827PHYS; Li H, 2019, GENOME RES, V29, P2034, DOI 10.1101/gr.251983.119; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Mete M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S19; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Olson Randy., 2019, ZENODO; Palukuri M., 2019, TACCSTER 2019 P; Qi Y, 2008, BIOINFORMATICS, V24, pI250, DOI 10.1093/bioinformatics/btn164; Shi L, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S5; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; van Dongen SM., 2000, GRAPH CLUSTERING FLO; Wainberg M, 2021, NAT GENET, V53, P638, DOI 10.1038/s41588-021-00840-z; Wilson L.A., 2014, P 2014 ANN C EXTR SC, P40, DOI [DOI 10.1145/2616498.2616534, 10.1145/2616498.2616534]; Wu J., 2018 37 CHIN CONTR C, P8205; Wu M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-169; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yu FY, 2014, BMC SYST BIOL, V8, DOI [10.1186/1752-0509-8-S3-S5, 10.1186/1752-0509-8-S3-S4]; Zhou ZW, 2016, IEEE INT C BIOINFORM, P1296, DOI 10.1109/BIBM.2016.7822705	32	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262056	10.1371/journal.pone.0262056	http://dx.doi.org/10.1371/journal.pone.0262056			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972161	Green Published, gold, Green Submitted			2022-12-27	WOS:000773555700088
J	Thompson, HR; Pavlovic, A; D'Agostino, E; Napier, MD; Konty, K; Day, SE				Thompson, Hannah R.; Pavlovic, Andjelka; D'Agostino, Emily; Napier, Melanie D.; Konty, Kevin; Day, Sophia E.			The association between student body mass index and tests of flexibility assessed by the FITNESSGRAM (R): New York City public school students, 2017-18	PLOS ONE			English	Article							HEALTH-RELATED FITNESS; PHYSICAL-ACTIVITY; YOUTH FITNESS; MOTOR COMPETENCE; VALIDITY; CHILDREN; ADOLESCENTS; SURVEILLANCE; RELIABILITY; PREVALENCE	FITNESSGRAM (R) is the most widely used criterion-referenced tool to assess/report on student health-related fitness across the US. Potential weight-related biases with the two most common tests of musculoskeletal fitness-the trunk extension and Back-Saver Sit-and-Reach (sit-and-reach)-have been hypothesized, though have not been studied. To determine the association between musculoskeletal fitness test performance and weight status, we use data from 571,133 New York City public school 4(th)-12(th) grade students (85% non-White; 75% qualified for free or reduced-price meals) with valid/complete 2017-18 FITNESSGRAM (R) data. Adjusted logistic mixed effects models with a random effect for school examined the association between weight status and whether a student was in the Healthy Fitness Zone (HFZ; met sex- and age-specific criterion-referenced standards) for the trunk extension and sit-and-reach. Compared to students with normal weight, the odds of being in the HFZ for trunk extension were lower for students with underweight (OR = 0.77; 95% CI: 0.741, 0.795) and higher for students with overweight (OR = 1.10; 95% CI: 1.081, 1.122) and obesity (OR = 1.11; 95% CI: 1.090, 1.13). The odds of being in the HFZ for sit-and-reach were lower for students with underweight OR = 0.85; 95% CI: 0.826, 0.878), overweight (OR = 0.83; 95% CI: 0.819, 0.844) and obesity (OR = 0.65; 95% CI: 0.641, 0.661). Students with overweight and obesity perform better on the trunk extension, yet worse on the sit-and-reach, compared to students with normal weight. Teachers, administrators, and researchers should be aware of the relationship of BMI with student performance in these assessments.	[Thompson, Hannah R.] Univ Calif Berkeley, Sch Publ Hlth, Community Hlth Sci, Berkeley, CA 94720 USA; [Pavlovic, Andjelka] Cooper Inst, Div Youth Educ, Dallas, TX USA; [D'Agostino, Emily] Duke Univ, Dept Populat Hlth Sci, Dept Family Med & Community Hlth, Sch Med, Durham, NC USA; [Napier, Melanie D.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Konty, Kevin; Day, Sophia E.] New York City Dept Hlth & Mental Hyg, Off Sch Hlth, New York, NY USA	University of California System; University of California Berkeley; Cooper Institute; Duke University; University of North Carolina; University of North Carolina Chapel Hill; New York City Department of Health & Mental Hygiene	Thompson, HR (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Community Hlth Sci, Berkeley, CA 94720 USA.	ThompsonH@Berkeley.edu		Thompson, Hannah/0000-0003-0214-5003	National Heart Lung and Blood Institute (NHLBI) [1K01HL151805]	National Heart Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded, in part, by the National Heart Lung and Blood Institute (NHLBI), Grant 1K01HL151805.	Ajisafe T, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00142; Alvarez-Bueno C, 2020, J SPORT SCI, V38, P582, DOI 10.1080/02640414.2020.1720496; Artero EG, 2010, SCAND J MED SCI SPOR, V20, P418, DOI 10.1111/j.1600-0838.2009.00959.x; Aryana M, 2012, AM HEART J, V163, P302, DOI 10.1016/j.ahj.2011.10.020; Bai Y, 2015, J PEDIATR-US, V167, P662, DOI 10.1016/j.jpeds.2015.05.035; Barnett LM, 2016, SPORTS MED, V46, P1663, DOI 10.1007/s40279-016-0495-z; Berkson SS, 2013, J SCHOOL HEALTH, V83, P21, DOI 10.1111/j.1746-1561.2012.00743.x; Burns RD., 2014, ADV PHYS ED, V4; Cattuzzo MT, 2016, J SCI MED SPORT, V19, P123, DOI 10.1016/j.jsams.2014.12.004; cdc, NATL HLTH STAT REPOR; Centers for Disease Control and Prevention (CDC), OV OB; Chaddock-Heyman L, 2014, MONOGR SOC RES CHILD, V79, P25, DOI 10.1111/mono.12129; Chen G., 2018, PUBLIC SCH REV DIVER; Chen WY, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5107-4; Day SE, 2020, OBESITY, V28, P638, DOI 10.1002/oby.22732; Day SE, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130439; Institute of Medicine, 2013, ED STUD BOD TAK PHYS; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Konty KJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227185; Lang JJ, 2018, J SCI MED SPORT, V21, P383, DOI 10.1016/j.jsams.2017.08.002; Lee EY, 2020, J EXERC SCI FIT, V18, P129, DOI 10.1016/j.jesf.2020.04.002; Mayorga-Vega D, 2015, J SPORT SCI MED, V14, P536; Moreau CE, 2001, J MANIP PHYSIOL THER, V24, P110, DOI 10.1067/mmt.2001.112563; Morrow JR, 2013, AM J PREV MED, V44, P439, DOI 10.1016/j.amepre.2013.01.008; Morrow JR, 2010, RES Q EXERCISE SPORT, V81, pS24, DOI 10.1080/02701367.2010.10599691; Morrow James R Jr, 2009, Res Q Exerc Sport, V80, P696; Morrow JR, 2009, RES Q EXERCISE SPORT, V80, P1; Muyor JM, 2014, INT J SPORTS MED, V35, P664, DOI 10.1055/s-0033-1353217; NYC FITNESSGRAM: Assessment Protocol, FITNESSGRAM ASS MOD; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Pate R., 2012, HLTH OUTCOMES YOUTH, V7; PATE RR, 1993, RES Q EXERCISE SPORT, V64, P17, DOI 10.1080/02701367.1993.10608774; Patterson P, 2001, RES Q EXERCISE SPORT, V72, P117, DOI 10.1080/02701367.2001.10608941; Pereira SA, 2011, INT J PEDIATR OBES, V6, P53, DOI 10.3109/17477161003792549; Plowman S., 2013, FITNESSGRAM REFERENC, V4th; Plowman S A, 1992, Exerc Sport Sci Rev, V20, P221; Saint-Maurice PF, 2015, J SPORT MED PHYS FIT, V55, P1252; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; State of Childhood Obesity, OB RAT HIGH SCH STUD; Thompson HR, 2019, J SCHOOL HEALTH, V89, P629, DOI 10.1111/josh.12788; Tucker JS, 2014, J PHYS ACT HEALTH, V11, P1006, DOI 10.1123/jpah.2011-0431; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Weihrauch-Bluher S, 2018, CURR OBES REP, V7, P254, DOI 10.1007/s13679-018-0320-0; Welk GJ, 2011, AM J PREV MED, V41, pS63, DOI 10.1016/j.amepre.2011.07.012; Zhu WM, 2011, AM J PREV MED, V41, pS68, DOI 10.1016/j.amepre.2011.07.001	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262083	10.1371/journal.pone.0262083	http://dx.doi.org/10.1371/journal.pone.0262083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972179	gold, Green Published			2022-12-27	WOS:000773555700092
J	Bechman, K; Yates, M; Mann, K; Nagra, D; Smith, LJ; Rutherford, AI; Patel, A; Periselneris, J; Walder, D; Dobson, RJB; Kraljevic, Z; Teo, JHT; Bernal, W; Barker, R; Galloway, JB; Norton, S				Bechman, Katie; Yates, Mark; Mann, Kirsty; Nagra, Deepak; Smith, Laura-Jane; Rutherford, Andy I.; Patel, Amit; Periselneris, Jimstan; Walder, David; Dobson, Richard J. B.; Kraljevic, Zeljko; Teo, James H. T.; Bernal, William; Barker, Richard; Galloway, James B.; Norton, Sam			Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort	PLOS ONE			English	Article							SCORE; ADMISSION; RISK	Background The Covid-19 pandemic in the United Kingdom has seen two waves; the first starting in March 2020 and the second in late October 2020. It is not known whether outcomes for those admitted with severe Covid were different in the first and second waves. Methods The study population comprised all patients admitted to a 1,500-bed London Hospital Trust between March 2020 and March 2021, who tested positive for Covid-19 by PCR within 3-days of admissions. Primary outcome was death within 28-days of admission. Socio-demographics (age, sex, ethnicity), hypertension, diabetes, obesity, baseline physiological observations, CRP, neutrophil, chest x-ray abnormality, remdesivir and dexamethasone were incorporated as co-variates. Proportional subhazards models compared mortality risk between wave 1 and wave 2. Cox-proportional hazard model with propensity score adjustment were used to compare mortality in patients prescribed remdesivir and dexamethasone. Results There were 3,949 COVID-19 admissions, 3,195 hospital discharges and 733 deaths. There were notable differences in age, ethnicity, comorbidities, and admission disease severity between wave 1 and wave 2. Twenty-eight-day mortality was higher during wave 1 (26.1% versus 13.1%). Mortality risk adjusted for co-variates was significantly lower in wave 2 compared to wave 1 [adjSHR 0.49 (0.37, 0.65) p<0.001]. Analysis of treatment impact did not show statistically different effects of remdesivir [HR 0.84 (95%CI 0.65, 1.08), p = 0.17] or dexamethasone [HR 0.97 (95%CI 0.70, 1.35) p = 0.87]. Conclusion There has been substantial improvements in COVID-19 mortality in the second wave, even accounting for demographics, comorbidity, and disease severity. Neither dexamethasone nor remdesivir appeared to be key explanatory factors, although there may be unmeasured confounding present.	[Bechman, Katie; Yates, Mark; Mann, Kirsty; Nagra, Deepak; Barker, Richard; Galloway, James B.; Norton, Sam] Kings Coll London, Ctr Rheumat Dis, London, England; [Smith, Laura-Jane; Rutherford, Andy I.; Patel, Amit; Periselneris, Jimstan; Walder, David; Teo, James H. T.] Kings Coll Hosp NHS Fdn Trust, London, England; [Dobson, Richard J. B.; Kraljevic, Zeljko; Teo, James H. T.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, London, England; [Dobson, Richard J. B.] South London & Maudsley NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Dobson, Richard J. B.] Kings Coll London, London, England; [Dobson, Richard J. B.] UCL, Hlth Data Res UK London, London, England; [Bernal, William] Kings Coll London, Sch Immunol & Microbial Sci, London, England; [Norton, Sam] Kings Coll London, Dept Psychol, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; University of London; University College London; University of London; King's College London; University of London; King's College London	Bechman, K (corresponding author), Kings Coll London, Ctr Rheumat Dis, London, England.	katie.bechman@kcl.ac.uk	; Teo, James/D-9696-2011; Norton, Sam/A-1898-2009; dobson, richard/C-9269-2011	Galloway, James/0000-0002-1230-2781; Teo, James/0000-0002-6899-8319; Norton, Sam/0000-0003-1714-9963; dobson, richard/0000-0003-4224-9245	Medical Research Council as a Clinical Training Research Fellowship [CTRF-MR/R001332/1]	Medical Research Council as a Clinical Training Research Fellowship	K.B. is funded by Medical Research Council as a Clinical Training Research Fellowship (CTRF-MR/R001332/1 to K Bechman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Age UK, 2021, SOLITUDE LONELINESS; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; British Thoracic Society, 2020, BTS ICS GUID RESP CA; British Thoracic Society, 2020, BTS GUID VEN THROMB; Chowkwanyun M, 2020, NEW ENGL J MED, V383, P201, DOI 10.1056/NEJMp2012910; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Galloway JB, 2020, J INFECTION, V81, P282, DOI 10.1016/j.jinf.2020.05.064; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Intensive Care National Audit and Research Centre, 2021, ICNARC REPORT COVID; Knight SR, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3339; Kraljevi E, ABS201001165 ARXIV, V2020; Lopez L, 2021, JAMA-J AM MED ASSOC, V325, P719, DOI 10.1001/jama.2020.26443; National Institute for Health and Care Excellence, 2020, COVID 19 RAP GUID AN; National Institute for Health and Care Excellence, 2021, CLIN KNOWL SUMM COV; Public Health England, 2021, INV NOV SARS COV 2 V; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Royal College of Physicians, 2017, NAT EARL WARN SCOR N; Semple C., 2021, SAGE M REPORT, P5; Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016; The royal College of Emergencuy Medicine, 2020, AD ESC PLAN PAT CONF; United Kingdom Government Scientific Advisory Group for Emergencies, 2021, 77 SAGE M COVID 19; Williamson E, 2020, MEDRXIV, V7, P1, DOI [10.1101/2020.05.06.20092999v1, 10.1101/2020.05.06.20092999]; Wong HYF, 2020, RADIOLOGY, V296, pE72, DOI 10.1148/radiol.2020201160; Zakeri R, 2020, ECLINICALMEDICINE, V28, DOI 10.1016/j.eclinm.2020.100574	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261142	10.1371/journal.pone.0261142	http://dx.doi.org/10.1371/journal.pone.0261142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025917	Green Published, gold			2022-12-27	WOS:000796264200012
J	Kanguya, T; Koyuncu, A; Sharma, A; Kusanathan, T; Mubanga, M; Chi, BH; Vinikoor, MJ; Mubiana-Mbewe, M				Kanguya, Tukiya; Koyuncu, Aybueke; Sharma, Anjali; Kusanathan, Thankian; Mubanga, Martha; Chi, Benjamin H.; Vinikoor, Michael J.; Mubiana-Mbewe, Mwangelwa			Identifying barriers to ART initiation and adherence: An exploratory qualitative study on PMTCT in Zambia	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; MALE INVOLVEMENT; ANTIRETROVIRAL THERAPY; HIV CARE; PREVENTION; PREGNANCY; WOMEN; RETENTION; PROGRAMS	Background Though antiretroviral therapy (ART) is widely available, HIV positive pregnant women in Zambia are less likely to start and remain on therapy throughout pregnancy and after delivery. This study sought to understand readiness to start ART among HIV pregnant women from the perspectives of both women and men in order to suggest more holistic programs to support women to continue life-long ART after delivery. Methods We conducted a qualitative study with HIV positive pregnant women before and after ART initiation, and men with female partners, to understand readiness to start lifelong ART. We conducted 28 in-depth interviews among women and 2 focus group discussions among male partners. Data were transcribed verbatim and analyzed in NVivo 12 using thematic analysis. Emerging themes from the data were organized using the social ecological framework. Results Men thought of their female partners as young and needing their supervision to initiate and stay on ART. Women agreed that disclosure and partner support were necessary preconditions to ART initiation and adherence and, expressed fear of divorce as a prominent barrier to disclosure. Maternal love and desire to look after one's children instilled a sense of responsibility among women which motivated them to overcome individual, interpersonal and health system level barriers to initiation and adherence. Women preferred adherence strategies that were discrete, the effectiveness of which, depended on women's intrinsic motivation. Conclusion The results support current policies in Zambia to encourage male engagement in ART care. To appeal to male partners, messaging on ART should be centered on emphasizing the importance of male involvement to ensure women remain engaged in ART care. Programs aimed at supporting postpartum ART adherence should design messages that appeal to both men's role in couples' joint decision-making and women's maternal love as motivators for adherence.	[Kanguya, Tukiya; Koyuncu, Aybueke; Sharma, Anjali; Mubanga, Martha; Mubiana-Mbewe, Mwangelwa] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Kusanathan, Thankian] Univ Zambia, Dept Gender Studies, Lusaka, Zambia; [Chi, Benjamin H.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Vinikoor, Michael J.] Univ Alabama Birmingham, Birmingham, AL USA	University of Zambia; University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham	Kanguya, T; Koyuncu, A (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	Tukiya.Kanguya@cidrz.org; akoyuncu@berkeley.edu			President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control andPrevention (CDC) [U01GH000530]	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control andPrevention (CDC)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR; https://www.state.gov/pepfar/) through the United States Centers for Disease Control andPrevention (CDC) under the terms of cooperative agreement number U01GH000530 (Funding recipient MMM). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton P., 2001, CURR SOCIOL, V49, P23, DOI [DOI 10.1177/0011392101496005, 10.1177/0011392101496005]; Auvinen J, 2010, PSYCHOL HEALTH MED, V15, P288, DOI 10.1080/13548501003615290; Buregyeya E, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1276-x; Chadambuka A, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4611-2; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; Elwell K, 2016, AIDS CARE, V28, P971, DOI 10.1080/09540121.2016.1153586; Fernandez MI, 2011, AIDS CARE, V23, P1492, DOI 10.1080/09540121.2011.565020; Gill MM, 2017, AIDS PATIENT CARE ST, V31, P153, DOI 10.1089/apc.2016.0234; Golden SD, 2012, HEALTH EDUC BEHAV, V39, P364, DOI 10.1177/1090198111418634; Hampanda K, 2021, SOC SCI MED, V283, DOI 10.1016/j.socscimed.2021.114029; Harvey SM, 2002, J SEX RES, V39, P284, DOI 10.1080/00224490209552152; Hershow RB, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25293; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; Hommann K., 2019, WHICH WAY LIVABLE PR, DOI [10.1596/978-1-4648-1405-1, DOI 10.1596/978-1-4648-1405-1]; Katirayi L, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20919; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Knettel BA, 2018, JAIDS-J ACQ IMM DEF, V77, P427, DOI 10.1097/QAI.0000000000001616; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Kululanga LI, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-36; LeCompte MD., 1999, DESIGNING CONDUCTING; Loomba Foundation, 2015, GLOB WID REP 2015 GL; Lusaka (Province Zambia), POPULATION STAT CHAR; Masters SH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002166; Millennium Development Goals United Nations General Assembly Special Session World Health Organization, 2010, PMTCT STRAT VIS 2010; Ministry of Health Zambia, 2019, ZAMB POP BAS HIV IMP; Morfaw Frederick, 2013, Syst Rev, V2, P5, DOI 10.1186/2046-4053-2-5; Mubiana-Mbewe M, 2021, AIDS BEHAV, V25, P992, DOI 10.1007/s10461-020-03060-4; Musheke M, 2013, AIDS PATIENT CARE ST, V27, P231, DOI 10.1089/apc.2012.0341; Naigino R, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0367-5; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Orne-Gliemann J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-197; Patel RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168057; Peacock D., 2008, MEN CARE CONTEXT HIV; Simuyemba MC, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-019-2700-1; Takah NF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207060; The Republic of Zambia Ministry of Health, ELIMINATION MOTHER T; The World Bank, 2018, 124032ZM WORLD BANK; Theuring S, 2009, AIDS BEHAV, V13, pS92, DOI 10.1007/s10461-009-9543-0; Vermeulen E, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0853-8	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262392	10.1371/journal.pone.0262392	http://dx.doi.org/10.1371/journal.pone.0262392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025923	Green Published, gold			2022-12-27	WOS:000796264200065
J	Venkatesh, AK; Janke, AT; Kinsman, J; Rothenberg, C; Goyal, P; Malicki, C; D'Onofrio, G; Taylor, A; Hawk, K				Venkatesh, Arjun K.; Janke, Alexander T.; Kinsman, Jeremy; Rothenberg, Craig; Goyal, Pawan; Malicki, Caitlin; D'Onofrio, Gail; Taylor, Andrew; Hawk, Kathryn			Emergency department utilization for substance use disorders and mental health conditions during COVID-19	PLOS ONE			English	Article							MEDICAL-SERVICES; UNITED-STATES; VISITS	Background As the emergency department (ED) has evolved into the de-facto site of care for a variety of substance use disorder (SUD) presentations, trends in ED utilization are an essential public health surveillance tool. Changes in ED visit patterns during the COVID-19 pandemic may reflect changes in access to outpatient treatment, changes in SUD incidence, or the unintended effects of public policy to mitigate COVID-19. We use a national emergency medicine registry to describe and characterize trends in ED visitation for SUDs since 2019. Methods We included all ED visits identified in a national emergency medicine clinical quality registry, which included 174 sites across 33 states with data from January 2019 through June 2021. We defined SUD using ED visit diagnosis codes including: opioid overdose and opioid use disorder (OUD), alcohol use disorders (AUD), and other SUD. To characterize changes in ED utilization, we plotted the 3-week moving average ratio of visit counts in 2020 and 2021 as compared to visit counts in 2019. Findings While overall ED visits declined in the early pandemic period and had not returned to 2019 baseline by June 2021, ED visit counts for SUD demonstrated smaller declines in March and April of 2020, so that the proportion of overall ED visits that were for SUD increased. Furthermore, in the second half of 2020, ED visits for SUD returned to baseline, and increased above baseline for OUD ever since May 2020. Conclusions We observe distinct patterns in ED visitation for SUDs over the course of the COVID-19 pandemic, particularly for OUD for which ED visitation barely declined and now exceeds previous baselines. These trends likely demonstrate the essential role of hospital-based EDs in providing 24/7/365 care for people with SUDs and mental health conditions. Allocation of resources must be directed towards the ED as a de-facto safety net for populations in crisis.	[Venkatesh, Arjun K.; Janke, Alexander T.; Kinsman, Jeremy; Rothenberg, Craig; Malicki, Caitlin; D'Onofrio, Gail; Taylor, Andrew; Hawk, Kathryn] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06510 USA; [Venkatesh, Arjun K.] Yale Univ, Sch Med, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA; [Goyal, Pawan] Amer Coll Emergency Phys, Irving, TX USA; [Hawk, Kathryn] Yale Sch Publ Hlth, New Haven, CT USA	Yale University; Yale University; Yale University	Venkatesh, AK; Janke, AT (corresponding author), Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06510 USA.; Venkatesh, AK (corresponding author), Yale Univ, Sch Med, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA.	arjun.venkatesh@yale.edu; alexander.janke@yale.edu	Hawk, Kathryn/GPW-9108-2022; Hawk, Kathryn/AAS-7613-2021	Hawk, Kathryn/0000-0001-7435-5945; /0000-0002-9082-6644; Kinsman, Jeremiah/0000-0002-2794-2917; GOYAL, GoyalP/0000-0002-3863-6501	HHS Office of the Secretary Patient Centered Outcomes Research Trust Fund (PCORTF) under IDDA [ASPE-2018-001]; NIDA [UG1DA015831-18S2]; National Center for Advancing Translational Sciences of the NIH [KL2 TR000140]; American Board of Emergency Medicine -National Academy of Medicine Anniversary Fellowship	HHS Office of the Secretary Patient Centered Outcomes Research Trust Fund (PCORTF) under IDDA; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Board of Emergency Medicine -National Academy of Medicine Anniversary Fellowship	This work was supported by the HHS Office of the Secretary Patient Centered Outcomes Research Trust Fund (PCORTF) under IDDA#ASPE-2018-001 and NIDA UG1DA015831-18S2. In addition, AKV was supported by KL2 TR000140 from the National Center for Advancing Translational Sciences of the NIH and the American Board of Emergency Medicine -National Academy of Medicine Anniversary Fellowship. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official view of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FB, 2021, PS PROVISIONAL DRUG; ahrq, 2021, ALC DRUG DEP VAL SET; Alter A., 2020, COVID 19 IMPACT US N; Annual Survey: American Hospital Association, 2018, AHA ANN SURV DAT REP; [Anonymous], COVID 19 IMPACT ANAL; [Anonymous], ZIP Code RUCA Approximation; [Anonymous], RURAL URBAN COMMUTIN; [Anonymous], 2021, SPIK DRUG OV DEATHS; Bernstein SL, 2017, ADDICT SCI CLIN PRAC, V12, DOI 10.1186/s13722-017-0083-z; Census Regions and Divisions of the United States: U.S. Department of Commerce Economics and Statistics Administration U.S. Census Bureau, US; Clark SA, 2021, J SUBST ABUSE TREAT, V124, DOI 10.1016/j.jsat.2021.108283; Cone DC, 2020, J ADDICT MED, V14, pE369, DOI 10.1097/ADM.0000000000000746; Dasgupta N, 2018, AM J PUBLIC HEALTH, V108, P182, DOI 10.2105/AJPH.2017.304187; Friedman J, 2021, JAMA PSYCHIAT, V78, P562, DOI 10.1001/jamapsychiatry.2020.4218; Haley DF, 2020, JAMA-J AM MED ASSOC, V324, P1615, DOI 10.1001/jama.2020.18543; Han B, 2017, HEALTH AFFAIR, V36, P1739, DOI 10.1377/hlthaff.2017.0584; Hartnett KP, 2020, MMWR-MORBID MORTAL W, V69, P699, DOI 10.15585/mmwr.mm6923e1; Healthcare Cost and Utilization Project (HCUP), CLIN CLASSIFICATIONS; Holland KM, 2021, JAMA PSYCHIAT, V78, P372, DOI 10.1001/jamapsychiatry.2020.4402; Hopkins RS, 2018, PUBLIC HEALTH REP, V133, P523, DOI 10.1177/0033354918784913; Jeffery MM, 2020, JAMA INTERN MED, V180, P1328, DOI 10.1001/jamainternmed.2020.3288; Khatri UG, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.34878; Knapp EA, 2019, AM J EPIDEMIOL, V188, P2131, DOI 10.1093/aje/kwz103; Koob GF, 2020, AM J PSYCHIAT, V177, P1031, DOI 10.1176/appi.ajp.2020.20091375; Lord K, 2021, AM J EMERG MED, V45, P548, DOI 10.1016/j.ajem.2020.07.040; Lucero AD, 2020, WEST J EMERG MED, V21, P15, DOI 10.5811/westjem.2020.8.48632; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Ochalek TA, 2020, JAMA-J AM MED ASSOC, V324, P1673, DOI 10.1001/jama.2020.17477; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Pines JM, 2021, J SUBST ABUSE TREAT, V129, DOI 10.1016/j.jsat.2021.108391; Satty T, 2021, AM J EMERG MED, V42, P1, DOI 10.1016/j.ajem.2020.12.078; Savioli G, 2022, INTERN EMERG MED, V17, P503, DOI 10.1007/s11739-021-02732-w; Slavova S, 2020, DRUG ALCOHOL DEPEN, V214, DOI 10.1016/j.drugalcdep.2020.108176; Wang QQ, 2021, MOL PSYCHIATR, V26, P30, DOI 10.1038/s41380-020-00880-7; Woolf SH, 2019, JAMA-J AM MED ASSOC, V322, P1996, DOI 10.1001/jama.2019.16932	35	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262136	10.1371/journal.pone.0262136	http://dx.doi.org/10.1371/journal.pone.0262136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025921	gold, Green Published			2022-12-27	WOS:000796264200050
J	Li, WT; Huang, DJ; Wang, B; Hou, XM; Zhang, R; Yan, M; Lia, WB				Li, Weitai; Huang, Dengjing; Wang, Bo; Hou, Xuemei; Zhang, Rui; Yan, Mei; Lia, Weibiao			Changes of starch and sucrose content and related gene expression during the growth and development of Lanzhou lily bulb	PLOS ONE			English	Article							METABOLISM; CARBON; BIOSYNTHESIS; RHIZOSPHERE; LEAVES; ACIDS	As the main forms of carbohydrates, starch and sucrose play a vital role in the balance and coordination of various carbohydrates. Lanzhou lily is the most popular edible lily in China, mainly distributed in the central region of Gansu. To clarify the relationship between carbohydrate metabolism and bulb development of Lanzhou lily, so as to provide a basis for the promotion of the growth and development in Lanzhou lily and its important economic value, we studied lily bulbs in the squaring stage, flowering stage, half withering stage and withering stage. The plant height, fresh weight of mother and daughter bulbs continued to increase during the whole growth period and fresh weight of stem and leaf began to decrease in the half withering stage. The content of starch, sucrose and total soluble sugar in the lily mother bulb accumulated mostly in the flowering, withering and half withering stages, respectively. Starch, sucrose and total soluble sugar accumulated in the daughter bulb with the highest concentration during the withering stage. In the transcription level, sucrose synthase (SuSy1) and sucrose invertase (INV2) expressed the highest in squaring stage, and the expression was significantly higher in the mother bulb than in the daughter bulb. In flowering stage, the expression levels of soluble starch synthase (SSS1), starch-branching enzyme (SBE) and adenosine diphosphate-glucose pyrophosphorylase (AGP1) genes were higher in the mother bulb than in the daughter bulb. Altogether, our results indicate that starch and sucrose are important for the bulb growth and development of Lanzhou lily.	[Li, Weitai; Huang, Dengjing; Wang, Bo; Hou, Xuemei; Zhang, Rui; Yan, Mei; Lia, Weibiao] Gansu Agr Univ, Coll Hort, Lanzhou, Peoples R China	Gansu Agricultural University	Lia, WB (corresponding author), Gansu Agr Univ, Coll Hort, Lanzhou, Peoples R China.	liaowb@gsau.edu.cn			National Natural Science Foundation of China [31860568, 31560563, 31160398]; National Key Research and Development Program [2018YFD1000800]; Research Fund of Higher Education of Gansu, China [2018C-14]; Post-Doctoral Foundation of China [20100470887, 2012T50828]; Natural Science Foundation of Gansu Province, China [1606RJZA073, 1606RJZA077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; Research Fund of Higher Education of Gansu, China; Post-Doctoral Foundation of China(China Postdoctoral Science Foundation); Natural Science Foundation of Gansu Province, China	This work was supported by the National Natural Science Foundation of China (Nos. 31860568, 31560563 and 31160398); the National Key Research and Development Program (2018YFD1000800); the Research Fund of Higher Education of Gansu, China (No. 2018C-14); the Post-Doctoral Foundation of China (Nos. 20100470887 and 2012T50828) and the Natural Science Foundation of Gansu Province, China (Nos. 1606RJZA073 and 1606RJZA077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2019, RUSS J PLANT PHYSL+, V66, P41, DOI 10.1134/S1021443719010023; Cao X, 2020, PLANT DIS, V104, P291, DOI 10.1094/PDIS-02-19-0374-PDN; Chang L, 2013, SCI HORTIC-AMSTERDAM, V161, P118, DOI 10.1016/j.scienta.2013.07.005; Du F, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4303-4; Du YL, 2020, PLANT PHYSIOL BIOCH, V146, P1, DOI 10.1016/j.plaphy.2019.11.003; Durand M, 2018, PLANTA, V247, P587, DOI 10.1007/s00425-017-2807-4; Angeles-Nunez JG, 2010, PLANTA, V232, P701, DOI 10.1007/s00425-010-1207-9; Gao MP, 2018, GENE, V649, P99, DOI 10.1016/j.gene.2018.01.075; Gao SP, 2018, PLANT CELL TISS ORG, V135, P143, DOI 10.1007/s11240-018-1451-4; Ghobadi M, 2013, IND CROP PROD, V50, P29, DOI 10.1016/j.indcrop.2013.07.009; Gu JH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093092; Guidi L, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00174; Hua CP, 2019, HORTSCIENCE, V54, P253, DOI [10.21273/HORTSCI13527-18, 10.21273/hortsci13527-18]; Huang DJ, 2021, POSTHARVEST BIOL TEC, V176, DOI 10.1016/j.postharvbio.2021.111520; Jiang LL, 2013, TRANSGENIC RES, V22, P1133, DOI 10.1007/s11248-013-9717-4; Kuai J, 2014, PLANT SCI, V223, P79, DOI 10.1016/j.plantsci.2014.03.010; Li GH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01369; Li WM, 2020, ACTA PHYSIOL PLANT, V42, DOI 10.1007/s11738-020-03115-y; Li WM, 2020, J SCI FOOD AGR, V100, P5603, DOI 10.1002/jsfa.10613; Li XY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0358-4; LingFei X, 2009, SCI HORTIC-AMSTERDAM, V119, P458, DOI 10.1016/j.scienta.2008.08.026; Mukerjea R, 2002, CARBOHYD RES, V337, P1015, DOI 10.1016/S0008-6215(02)00067-8; Mukherjee S, 2015, PLANT SCI, V240, P143, DOI 10.1016/j.plantsci.2015.09.010; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Shen JL, 2019, SCI HORTIC-AMSTERDAM, V253, P99, DOI 10.1016/j.scienta.2019.04.010; Shin KS, 2002, SCI HORTIC-AMSTERDAM, V96, P195, DOI 10.1016/S0304-4238(02)00087-0; Tetlow IJ, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7040081; Tian XH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227921; Wang FX, 2018, APPL BIOCHEM BIOTECH, V186, P535, DOI 10.1007/s12010-018-2750-2; Wang HR., 2017, BIOTECHNOL J INT, V20, P1; Wu Y, 2019, J PLANT GROWTH REGUL, V38, P359, DOI 10.1007/s00344-018-9844-5; Wu Y, 2016, J ZHEJIANG UNIV-SC B, V17, P892, DOI 10.1631/jzus.B1600231; Yan ZQ, 2019, SCI HORTIC-AMSTERDAM, V250, P121, DOI 10.1016/j.scienta.2019.02.038; Yang PP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01508; Zhang CS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01425; Zhang YJ, 2015, RUSS J PLANT PHYSL+, V62, P334, DOI 10.1134/S1021443715030206; Zhang YB, 2018, CROP PROT, V110, P73, DOI 10.1016/j.cropro.2018.02.028; Zhang YB, 2015, J VIROL METHODS, V220, P13, DOI 10.1016/j.jviromet.2015.03.021; Zou HG., 2003, NO HORT, P60, DOI [10.21273/HORTSCI11463-16, DOI 10.21273/HORTSCI11463-16]	39	5	5	18	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262506	10.1371/journal.pone.0262506	http://dx.doi.org/10.1371/journal.pone.0262506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015792	Green Published, gold			2022-12-27	WOS:000814820600030
J	Min, HK; Choi, J; Lee, SY; Lee, AR; Min, BM; Cho, ML; Park, SH				Min, Hong Ki; Choi, JeongWon; Lee, Seon-Yeong; Lee, A. Ram; Min, Byung-Moo; Cho, Mi-La; Park, Sung-Hwan			Vitronectin-derived bioactive peptide prevents spondyloarthritis by modulating Th17/Treg imbalance in mice with curdlan-induced spondyloarthritis	PLOS ONE			English	Article							REGULATORY T-CELLS; ANKYLOSING-SPONDYLITIS; RADIOGRAPHIC PROGRESSION; TH17 CELLS; BISPHOSPHONATES; PATHOGENESIS; EXPRESSION	Purpose Spondyloarthritis (SpA) is a systemic inflammatory arthritis mediated mainly by interleukin (IL)-17. The vitronectin-derived bioactive peptide, VnP-16, exerts an anti-osteoporotic effect via beta 1 and alpha v beta 3 integrin signaling. SpA is associated with an increased risk of osteoporosis, and we investigated the effect of VnP-16 in mice with SpA. Methods SpA was induced by curdlan in SKG ZAP-70(W163C) mice, which were treated with vehicle, celecoxib, VnP-16, or VnP-16+celecoxib. The clinical score, arthritis score, spondylitis score, and proinflammatory cytokine expression of the spine were evaluated by immunohistochemical staining. Type 17 helper T cell (Th17) and regulatory T cell (Treg) differentiation in the spleen was evaluated by flow cytometry and in the spine by confocal staining. Splenocyte expression of signal transducer and activator of transcription (STAT) 3 and pSTAT3 was evaluated by in vitro Western blotting. Results The clinical score was significantly reduced in the VnP16+celecoxib group. The arthritis and spondylitis scores were significantly lower in the VnP-16 and VnP16+celecoxib groups than the vehicle group. In the spine, the levels of IL-1 beta, IL-6, tumor necrosis factor-alpha, and IL-17 expression were reduced and Th17/Treg imbalance was regulated in the VnP-16 alone and VnP-16+celecoxib groups. Flow cytometry of splenocytes showed increased polarization of Tregs in the VnP-16+celecoxib group. In vitro, VnP-16 suppressed pSTAT3. Conclusions VnP-16 plus celecoxib prevented SpA progression in a mouse model by regulating the Th17/Treg imbalance and suppressing the expression of proinflammatory cytokines.	[Min, Hong Ki] Konkuk Univ, Med Ctr, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Choi, JeongWon; Lee, Seon-Yeong; Lee, A. Ram; Cho, Mi-La; Park, Sung-Hwan] Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea; [Lee, A. Ram; Cho, Mi-La] Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea; [Min, Byung-Moo] Seoul Natl Univ, Sch Dent, Dent Res Inst, Dept Oral Biochem, Seoul, South Korea; [Min, Byung-Moo] Seoul Natl Univ, Sch Dent, Dent Res Inst, Program Canc & Dev Biol, Seoul, South Korea; [Cho, Mi-La] Catholic Univ Korea, Coll Med, Lab Immune Network, Conversant Res Consortium Immunol Dis, Seoul, South Korea; [Park, Sung-Hwan] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Catholic University of Korea; Catholic University of Korea; Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea; Catholic University of Korea	Cho, ML; Park, SH (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea.; Cho, ML (corresponding author), Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea.; Cho, ML (corresponding author), Catholic Univ Korea, Coll Med, Lab Immune Network, Conversant Res Consortium Immunol Dis, Seoul, South Korea.; Park, SH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea.	iammila@catholic.ac.kr; rapark@catholic.ac.kr	Min, Hong Ki/AHE-4068-2022	Min, Hong Ki/0000-0003-1147-1046	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare of the Republic of Korea [HI20C1496]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare of the Republic of Korea	This research was funded by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare of the Republic of Korea (grant number HI20C1496, grant receiver : SH Park). The funder had no role on the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya M, 2010, J CLIN INVEST, V120, P4445, DOI 10.1172/JCI43796; Baraliakos X, 2014, ANN RHEUM DIS, V73, P1819, DOI 10.1136/annrheumdis-2013-203425; Baraliakos X, 2019, ANN RHEUM DIS, V78, P1220, DOI 10.1136/annrheumdis-2018-214983; Bertoni A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020485; Briot K, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000052; Cairns AP, 2005, ANN RHEUM DIS, V64, P338, DOI 10.1136/ard.2004.022871; Dotan I, 2020, MED RES REV, V40, P245, DOI 10.1002/med.21601; Du F, 2016, CELL REP, V16, P1339, DOI 10.1016/j.celrep.2016.06.065; Haibel H, 2003, RHEUMATOLOGY, V42, DOI 10.1093/rheumatology/keg256; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Jo S, 2021, RHEUMATOLOGY, V60, P3923, DOI 10.1093/rheumatology/keaa846; Jo S, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1582-3; Jung YK, 2019, IMMUNE NETW, V19, DOI 10.4110/in.2019.19.e2; Karmacharya P, 2020, ARTHRITIS RHEUMATOL, V72, P733, DOI 10.1002/art.41206; Klann JE, 2018, J IMMUNOL, V200, P4012, DOI 10.4049/jimmunol.1800112; Koo BS, 2020, ANN RHEUM DIS, V79, P1327, DOI 10.1136/annrheumdis-2019-216741; Li XY, 2013, J CLIN IMMUNOL, V33, P151, DOI 10.1007/s10875-012-9774-0; Magrey Marina, 2010, Curr Rheumatol Rep, V12, P332, DOI 10.1007/s11926-010-0122-1; Marijnissen RJ, 2011, ARTHRITIS RHEUM-US, V63, P2939, DOI 10.1002/art.30469; McGonagle DG, 2019, ANN RHEUM DIS, V78, P1167, DOI 10.1136/annrheumdis-2019-215356; Min HK, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1774-x; Min HK, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0942-5; Min SK, 2018, CELL DEATH DIFFER, V25, P268, DOI 10.1038/cdd.2017.153; Molnar C, 2018, ANN RHEUM DIS, V77, P63, DOI 10.1136/annrheumdis-2017-211544; Park JW, 2019, ARTHRITIS RHEUMATOL, V71, P82, DOI 10.1002/art.40661; Reppert S, 2015, EUR J IMMUNOL, V45, P1426, DOI 10.1002/eji.201445150; Roelofs AJ, 2010, CURR PHARM DESIGN, V16, P2950; Roux C, 2011, OSTEOPOROSIS INT, V22, P421, DOI 10.1007/s00198-010-1319-x; Ruutu M, 2012, ARTHRITIS RHEUM-US, V64, P2211, DOI 10.1002/art.34423; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Sieper J, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.13; Smith JA, 2014, ARTHRITIS RHEUMATOL, V66, P231, DOI 10.1002/art.38291; Stolwijk C, 2016, ARTHRIT CARE RES, V68, P1320, DOI 10.1002/acr.22831; Tam LS, 2010, NAT REV RHEUMATOL, V6, P399, DOI 10.1038/nrrheum.2010.79; Tanaka T, 2014, CANCER IMMUNOL RES, V2, P288, DOI 10.1158/2326-6066.CIR-14-0022; Toussirot E, 2007, CURR OPIN RHEUMATOL, V19, P340; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wanders A, 2005, ARTHRITIS RHEUM-US, V52, P1756, DOI 10.1002/art.21054; Ward MM, 2019, ARTHRITIS RHEUMATOL, V71, P1599, DOI 10.1002/art.41042; Weiss RJ, 2010, J RHEUMATOL, V37, P2247, DOI 10.3899/jrheum.100363; WILL R, 1989, LANCET, V2, P1483; Zhang JR, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00214; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031000, 10.1371/journal.pone.0037865]; Zhao Z, 2019, CLIN RHEUMATOL, V38, P465, DOI 10.1007/s10067-018-4284-y	45	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262183	10.1371/journal.pone.0262183	http://dx.doi.org/10.1371/journal.pone.0262183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986165	gold, Green Published			2022-12-27	WOS:000765956200021
J	Rinta-Kokko, H; Palmu, AA; Ruokokoski, E; Nieminen, H; Moreira, M; Schuerman, L; Borys, D; Jokinen, J				Rinta-Kokko, Hanna; Palmu, Arto A.; Ruokokoski, Esa; Nieminen, Heta; Moreira, Marta; Schuerman, Lode; Borys, Dorota; Jokinen, Jukka			Evaluation of the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine in a cluster-randomised trial	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; OLDER-ADULTS; DISEASE; CARRIAGE; EPIDEMIOLOGY; PHID-CV10; CHILDREN; HOSPITALIZATIONS; SEROTYPES; ERA	Background In the nation-wide double-blind cluster-randomised Finnish Invasive Pneumococcal disease trial (FinIP, ClinicalTrials.gov NCT00861380, NCT00839254), we assessed the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against five pneumococcal disease syndromes. Methods Children 6 weeks to 18 months received PHiD-CV10 in 48 clusters or hepatitis B/A-vaccine as control in 24 clusters according to infant 3+1/2+1 or catch-up schedules in years 2009. 2011. Outcome data were collected from national health registers and included laboratory-confirmed and clinically suspected invasive pneumococcal disease (IPD), hospitaldiagnosed pneumonia, tympanostomy tube placements (TTP) and outpatient antimicrobial prescriptions. Incidence rates in the unvaccinated population in years 2010. 2015 were compared between PHiD-CV10 and control clusters in age groups < 5 and.5 years (5. 7 years for TTP and outpatient antimicrobial prescriptions), and in infants < 3 months. PHiDCV10 was introduced into the Finnish National Vaccination Programme (PCV-NVP) for 3-month-old infants without catch-up in 9/2010. Results From 2/2009 to 10/2010, 45398 children were enrolled. Vaccination coverage varied from 29 to 61% in PHiD-CV10 clusters. We detected no clear differences in the incidence rates between the unvaccinated cohorts of the treatment arms, except in single years. For example, the rates of vaccine-type IPD, non-laboratory-confirmed IPD and empyema were lower in PHiD-CV10 clusters compared to control clusters in 2012, 2015 and 2011, respectively, in the age-group >= 5 years. Conclusions This is the first report from a clinical trial evaluating the indirect impact of a PCV against clinical outcomes in an unvaccinated population. We did not observe consistent indirect effects in the PHiD-CV10 clusters compared to the control clusters. We consider that the sub-optimal trial vaccination coverage did not allow the development of detectable indirect effects and that the supervening PCV-NVP significantly diminished the differences in PHiD-CV10 vaccination coverage between the treatment arms.	[Rinta-Kokko, Hanna] Finnish Inst Hlth & Welf, Dept Publ Hlth & Welf, Helsinki, Finland; [Palmu, Arto A.; Nieminen, Heta] Finnish Inst Hlth & Welf, Dept Publ Hlth & Welf, Tampere, Finland; [Ruokokoski, Esa; Jokinen, Jukka] Finnish Inst Hlth & Welf, Dept Informat Serv, Helsinki, Finland; [Moreira, Marta; Schuerman, Lode; Borys, Dorota] GSK, Wavre, Belgium; [Rinta-Kokko, Hanna] IQVIA, Global Database Studies, Espoo, Finland; [Moreira, Marta] NIHDI Natl Inst Hlth & Disabil Insurance, Brussels, Belgium	GlaxoSmithKline	Rinta-Kokko, H (corresponding author), Finnish Inst Hlth & Welf, Dept Publ Hlth & Welf, Helsinki, Finland.; Rinta-Kokko, H (corresponding author), IQVIA, Global Database Studies, Espoo, Finland.	rintakokko.hanna@gmail.com		Palmu, Arto A./0000-0001-8071-8896; Rinta-Kokko, Hanna/0000-0002-6897-4923	GlaxoSmithKline Biologicals SA; Finnish Institute for Health and Welfare (THL), Finland	GlaxoSmithKline Biologicals SA(GlaxoSmithKline); Finnish Institute for Health and Welfare (THL), Finland	The study was funded by GlaxoSmithKline Biologicals SA and the Finnish Institute for Health and Welfare (THL), Finland. Both parties were involved in all stages of the study planning, conduct, data collection, analyses, and manuscript development. All authors had access to all the data and accept responsibility for its validity. All authors agreed on the final decision to submit for publication. The specific roles of all authors are articulated in the `author contributions' section.	Andrade AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184204; [Anonymous], 2019, Weekly Epidemiological Record, V94, P85; [Anonymous], VACC REG; [Anonymous], R LANG ENV STAT COMP; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Cohen O, 2017, PNEUMOCOCCAL CONJUGA; Corcoran M, 2017, EPIDEMIOL INFECT, V145, P2390, DOI 10.1017/S0950268817001194; De Wals P, 2018, VACCINE, V36, P421, DOI 10.1016/j.vaccine.2017.11.054; Dunne EM, 2018, LANCET GLOB HEALTH, V6, pE1375, DOI 10.1016/S2214-109X(18)30383-8; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Finnish Institute for Health and Welfare (THL) Finland, HLTH 2011 SURV; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Ganaie F, 2020, MBIO, V11, DOI 10.1128/mBio.00937-20; Givon-Lavi N, 2003, PEDIATR INFECT DIS J, V22, P524, DOI 10.1097/00006454-200306000-00008; Guevara M, 2016, EUROSURVEILLANCE, V21, P14, DOI 10.2807/1560-7917.ES.2016.21.14.30186; HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Hanquet G, 2019, THORAX, V74, P473, DOI 10.1136/thoraxjnl-2018-211767; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Jokinen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120290; Kahn R, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002632; Kayhty H, 2006, EXPERT REV VACCINES, V5, P651, DOI 10.1586/14760584.5.5.651; Kilpi TM, 2018, VACCINE, V36, P5891, DOI 10.1016/j.vaccine.2018.08.020; Kislaya I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209428; Knol MJ, 2015, EMERG INFECT DIS, V21, P2040, DOI 10.3201/eid2111.140780; Ladhani SN, 2018, LANCET INFECT DIS, V18, P441, DOI 10.1016/S1473-3099(18)30052-5; Lepoutre A, 2008, Euro Surveill, V13; Lewnard JA, 2019, LANCET INFECT DIS, V19, pE213, DOI 10.1016/S1473-3099(18)30660-1; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Menzies RI, 2015, CLIN INFECT DIS, V61, P927, DOI 10.1093/cid/civ429; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Nair H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1693-x; Naucler P, 2017, CLIN INFECT DIS, V65, P1780, DOI 10.1093/cid/cix685; Okasha O, 2018, THORAX, V73, P262, DOI 10.1136/thoraxjnl-2017-210440; Palmu AA, 2018, ACTA PAEDIATR, V107, P1610, DOI 10.1111/apa.14335; Palmu AA, 2014, LANCET RESP MED, V2, P717, DOI 10.1016/S2213-2600(14)70139-0; Palmu AA, 2017, PEDIATR INFECT DIS J, V36, P1193, DOI 10.1097/INF.0000000000001705; Palmu AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172690; Palmu AA, 2015, PEDIATR INFECT DIS J, V34, P1230, DOI 10.1097/INF.0000000000000857; Palmu AA, 2014, LANCET INFECT DIS, V14, P205, DOI [10.1016, 10.1016/S1473-3099(13)70338-4]; Palmu AA, 2013, LANCET, V381, P214, DOI 10.1016/S0140-6736(12)61854-6; Richter L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210081; Rodrigo C, 2015, EUR RESPIR J, V45, P1632, DOI 10.1183/09031936.00183614; Sigurdsson S, 2017, VACCINE, V35, P5242, DOI 10.1016/j.vaccine.2017.08.020; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Thorrington D, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1004-z; Usuf E, 2019, CLIN INFECT DIS, V68, P1512, DOI 10.1093/cid/ciy726; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Vesikari T, 2016, J PEDIAT INF DIS SOC, V5, P237, DOI 10.1093/jpids/piw010; Vestrheim DF, 2010, VACCINE, V28, P2214, DOI 10.1016/j.vaccine.2009.12.054; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; WHO Expert Committee on Biological Standardization, REPL ANN WHO TECHN R, V924	55	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0261750	10.1371/journal.pone.0261750	http://dx.doi.org/10.1371/journal.pone.0261750			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986178	Green Published, gold			2022-12-27	WOS:000765956200014
J	Aysan, AF; Guney, I; Isac, N; Khan, AU				Aysan, Ahmet Faruk; Guney, Ibrahim; Isac, Nicoleta; Khan, Asad Ul Islam			The probabilities of type I and II error of null of cointegration tests: A Monte Carlo comparison	PLOS ONE			English	Article							RESIDUAL-BASED TEST; HYPOTHESIS; POWER; INFERENCE; IMPACT	This paper evaluates the performance of eight tests with null hypothesis of cointegration on basis of probabilities of type I and II errors using Monte Carlo simulations. This study uses a variety of 132 different data generations covering three cases of deterministic part and four sample sizes. The three cases of deterministic part considered are: absence of both intercept and linear time trend, presence of only the intercept and presence of both the intercept and linear time trend. It is found that all of tests have either larger or smaller probabilities of type I error and concluded that tests face either problems of over rejection or under rejection, when asymptotic critical values are used. It is also concluded that use of simulated critical values leads to controlled probability of type I error. So, the use of asymptotic critical values may be avoided, and the use of simulated critical values is highly recommended. It is found and concluded that the simple LM test based on KPSS statistic performs better than rest for all specifications of deterministic part and sample sizes.	[Aysan, Ahmet Faruk] Hamad Bin Khalifa Univ, Coll Islamic Studies, Doha, Qatar; [Guney, Ibrahim] Istanbul Sabahattin Zaim Univ, Fac Educ, Istanbul, Turkey; [Isac, Nicoleta] Istanbul Sabahattin Zaim Univ, Fac Business & Management Sci, Istanbul, Turkey; [Khan, Asad Ul Islam] Ibn Haldun Univ, Fac Humanities & Social Sci, Istanbul, Turkey	Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Istanbul Sabahattin Zaim University; Istanbul Sabahattin Zaim University; Ibn Haldun University	Aysan, AF (corresponding author), Hamad Bin Khalifa Univ, Coll Islamic Studies, Doha, Qatar.	aaysan@hbku.edu.qa	Aysan, Ahmet/ABD-9167-2021; Khan, Asad ul Islam/AAJ-6453-2021	Aysan, Ahmet/0000-0001-7363-0116; Isac, Nicoleta/0000-0001-9435-7083; Khan, Asad ul Islam/0000-0002-5131-577X				Afroz R, 2020, J ASIAN FINANC ECON, V7, P155, DOI 10.13106/jafeb.2020.vol7.no4.155; Ahmed I, 2014, J ASIAN FINANC ECON, V1, P15, DOI 10.13106/jafeb.2014.vol1.no1.15; Ali MA, 2016, J ASIAN FINANC ECON, V3, P5, DOI 10.13106/jafeb.2016.vol3.no2.5; Aysan AF, 2021, SINGAP ECON REV, DOI 10.1142/S0217590821470020; Aysan AF, 2021, RISKS, V9, DOI 10.3390/risks9040074; BANERJEE A, 1986, OXFORD B ECON STAT, V48, P253; BOSWIJK P, 1992, OXFORD B ECON STAT, V54, P369, DOI 10.1111/j.1468-0084.1992.tb00007.x; BRADLEY JV, 1978, BRIT J MATH STAT PSY, V31, P144, DOI 10.1111/j.2044-8317.1978.tb00581.x; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Fernandez-Macho FJ, 1994, TESTING NULL COINTEG; Fort G, 2017, MONTE CARLO METHODS, V23, P21, DOI 10.1515/mcma-2017-0101; Gabriel VJ., 2003, EC REV INTERNET, V22, P411, DOI [10.1081/ETC-120025897, DOI 10.1081/ETC-120025897]; Gonzalo J, 1998, J ECONOMETRICS, V86, P129, DOI 10.1016/S0304-4076(97)00111-5; Gozgor G, 2016, RENEW SUST ENERG REV, V66, P913, DOI 10.1016/j.rser.2016.08.055; HANSEN BE, 1992, J BUS ECON STAT, V10, P321, DOI 10.2307/1391545; Haug AA, 1996, J ECONOMETRICS, V71, P89, DOI 10.1016/0304-4076(94)01696-8; Jansson M, 2005, J ECONOMETRICS, V124, P187, DOI 10.1016/j.jeconom.2004.02.011; JOHANSEN S, 1990, OXFORD B ECON STAT, V52, P169, DOI 10.1111/j.1468-0084.1990.mp52002003.x; Khan AU, 2022, COMMUN STAT-SIMUL C, V51, P2020, DOI 10.1080/03610918.2019.1691229; Khan WM, 2020, COMMUN STAT-SIMUL C, V49, P2808, DOI 10.1080/03610918.2018.1527350; KREMERS JJM, 1992, OXFORD B ECON STAT, V54, P325, DOI 10.1111/j.1468-0084.1992.tb00005.x; KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y; LEYBOURNE SJ, 1994, OXFORD B ECON STAT, V56, P97; Mariel P., 1996, APPL MATH, V41, P411; Maugeri N, 2014, COMPUT ECON, V44, P339, DOI 10.1007/s10614-013-9395-6; McCabe BPM., 1997, J TIME SER ANAL, V18, P395; Morales M, 2014, STAT METHOD APPL-GER, V23, P265, DOI 10.1007/s10260-014-0253-z; Pesaran MH, 2001, J APPL ECONOMET, V16, P289, DOI 10.1002/jae.616; Pesavento E, 2004, J ECONOMETRICS, V122, P349, DOI 10.1016/j.jeconom.2003.10.025; PHILLIPS PCB, 1990, REV ECON STUD, V57, P99, DOI 10.2307/2297545; PHILLIPS PCB, 1990, ECONOMETRICA, V58, P165, DOI 10.2307/2938339; SHIN YC, 1994, ECONOMET THEOR, V10, P91, DOI 10.1017/S0266466600008240; Xiao ZJ, 1999, ECON LETT, V64, P133, DOI 10.1016/S0165-1765(99)00079-8; Yalta AT, 2016, COMPUT ECON, V48, P339, DOI 10.1007/s10614-015-9530-7	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0259994	10.1371/journal.pone.0259994	http://dx.doi.org/10.1371/journal.pone.0259994			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982763	Green Published, gold			2022-12-27	WOS:000834805700003
J	Manuwald, U; Schoffer, O; Kugler, J; Riemenschneider, H; Kapellen, TM; Kiess, W; Rothe, U				Manuwald, Ulf; Schoffer, Olaf; Kugler, Joachim; Riemenschneider, Henna; Kapellen, Thomas Michael; Kiess, Wieland; Rothe, Ulrike			Trends in incidence and prevalence of type 1 diabetes between 1999 and 2019 based on the Childhood Diabetes Registry of Saxony, Germany	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; CHILDREN; TIME; EPIDEMIOLOGY; EUROPE; YOUNG; RISK	Objective The Childhood Diabetes Registry of Saxony has been existing since 1999. The aim of this study was to investigate the incidence rates, cohort and point prevalence, and the trends of type 1 diabetes among children and adolescents based on the registry data over the past 21 years. Methods A completeness check of the Childhood Diabetes Registry of Saxony for the observation period 2012-2019 was performed using the capture-recapture method. The age-standardized incidence rates per 100,000 person years (PY) were estimated for the observation period 1999-2019. Prevalence was estimated per 100,000 children and adolescents as the point prevalence of five consecutive years, and as a cohort prevalence for the birth cohorts, which result from the difference of age and year at diagnosis. Trend analyses were executed using join point regression. Results A completeness of 98% (95% CI 89-100) was determined for the period from 2012 to 2019. The standardized incidence rate of type 1 diabetes among children and adolescents increased from 17.1 per 100,000 PY in 1999 to 24.7 per 100,000 PY in 2019. If this trend continues, the incidence rate will increase to 34.8 (95% CI 24.4-49.6) per 100,000 PY in 2030. The point prevalence of 5 consecutive years did not show a continuous trend over time. According to this method, the prevalence reached a plateau in the last segment (2013-2019). The calculation of cohort prevalence indicated a continuous increase from 2013 to 2019 with no significant statistical difference in terms of sex. Conclusion The point prevalence and the last incidence rates indicate that type 1 diabetes of children and adolescents is slowing down or has reached a plateau in Saxony. Nevertheless, the cohort prevalence predicts a steady increase. Future studies should continue investigating these trends in a longer observation period and consider including possible correlating environmental factors.	[Manuwald, Ulf; Kugler, Joachim; Rothe, Ulrike] Tech Univ Dresden, Fac Med Carl Gustav Carus, Hlth Sci Publ Hlth, Dresden, Germany; [Schoffer, Olaf] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Ctr Evidence Based Healthcare, Dresden, Germany; [Riemenschneider, Henna] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dept Gen Practice MK3, Dresden, Germany; [Kapellen, Thomas Michael; Kiess, Wieland] Univ Leipzig, Hosp Children & Adolescents, Ctr Pediat Res, Dept Women & Child Hlth, Leipzig, Germany; [Kapellen, Thomas Michael] Median Childrens Hosp Bad Kosen, Bad Kosen, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Leipzig University	Manuwald, U (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Hlth Sci Publ Hlth, Dresden, Germany.	ulf.manuwald@tu-dresden.de	Schoffer, Olaf/R-1841-2016	Schoffer, Olaf/0000-0001-6922-7148				Bendas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132716; Berhan Y, 2011, DIABETES, V60, P577, DOI 10.2337/db10-0813; Breslow N E, 1987, IARC Sci Publ, P1; Cinek O, 2012, PEDIATR DIABETES, V13, P559, DOI 10.1111/j.1399-5448.2012.00858.x; Ferreira RC, 2014, DIABETES, V63, P2538, DOI 10.2337/db13-1777; Forlenza GP, 2011, CURR OPIN ENDOCRINOL, V18, P248, DOI 10.1097/MED.0b013e32834872ce; Galler A, 2010, HORM RES PAEDIAT, V74, P285, DOI 10.1159/000303141; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Jasser-Nitsche H, 2017, PEDIATR DIABETES, V18, P890, DOI 10.1111/pedi.12504; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Kondrashova A, 2005, ANN MED, V37, P67, DOI 10.1080/07853890410018952; Lin XL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71908-9; Lukacs K, 2021, ORVOSI HETILAP, V162, P13, DOI 10.1556/650.2021.31952; Manuwald U., 2020, KINDER JUGENDMEDIZIN, V20, P7, DOI [10.1055/a-1063-0177, DOI 10.1055/A-1063-0177]; Manuwald U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183665; Matthias T., 2016, INT J CELIAC DIS, V3, P151, DOI [DOI 10.12691/IJCD-3-4-8, 10.12691/ijcd-3-4-8]; Parviainen A, 2020, DIABETES CARE, V43, P2953, DOI 10.2337/dc20-0604; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Patterson C, 2014, DIABETES RES CLIN PR, V103, P161, DOI 10.1016/j.diabres.2013.11.005; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Peng H, 2006, REV ENDOCR METAB DIS, V7, P149, DOI 10.1007/s11154-006-9024-y; Rewers M, 2016, LANCET, V387, P2340, DOI 10.1016/S0140-6736(16)30507-4; Rush T, 2018, PEDIATR DIABETES, V19, P917, DOI 10.1111/pedi.12659; Soltesz G, 2007, PEDIATR DIABETES, V8, P6, DOI 10.1111/j.1399-5448.2007.00280.x	25	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262171	10.1371/journal.pone.0262171	http://dx.doi.org/10.1371/journal.pone.0262171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972197	gold, Green Published			2022-12-27	WOS:000773555700104
J	Naito, A; Kiyasu, Y; Akashi, Y; Sugiyama, A; Michibuchi, M; Takeuchi, Y; Notake, S; Nakamura, K; Ishikawa, H; Suzuki, H				Naito, Asami; Kiyasu, Yoshihiko; Akashi, Yusaku; Sugiyama, Akio; Michibuchi, Masashi; Takeuchi, Yuto; Notake, Shigeyuki; Nakamura, Koji; Ishikawa, Hiroichi; Suzuki, Hiromichi			The evaluation of the utility of the GENECUBE HQ SARS-CoV-2 for anterior nasal samples and saliva samples with a new rapid examination protocol	PLOS ONE			English	Article							DISCREPANT ANALYSIS; TEST SENSITIVITY; BIAS	Introduction GENECUBE((R)) is a rapid molecular identification system, and previous studies demonstrated that GENECUBE((R)) HQ SARS-CoV-2 showed excellent analytical performance for the detection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) with nasopharyngeal samples. However, other respiratory samples have not been evaluated. Methods This prospective comparison between GENECUBE((R)) HQ SARS-CoV-2 and reference real-time reverse transcriptase polymerase chain reaction (RT-PCR) was performed for the detection of SARS-CoV-2 using anterior nasal samples and saliva samples. Additionally, we evaluated a new rapid examination protocol using GENECUBE((R)) HQ SARS-CoV-2 for the detection of SARS-CoV-2 with saliva samples. For the rapid protocol, in the preparation of saliva samples, purification and extraction processes were adjusted, and the total process time was shortened to approximately 35 minutes. Results For 359 anterior nasal samples, the total-, positive-, and negative concordance of the two assays was 99.7% (358/359), 98.1% (51/52), and 100% (307/307), respectively. For saliva samples, the total-, positive-, and negative concordance of the two assays was 99.6% (239/240), 100% (56/56), and 99.5% (183/184), respectively. With the new protocol, total-, positive-, and negative concordance of the two assays was 98.8% (237/240), 100% (56/56), and 98.4% (181/184), respectively. In all discordance cases, SARS-CoV-2 was detected by additional molecular examinations. Conclusion GENECUBE((R)) HQ SARS-CoV-2 provided high analytical performance for the detection of SARS-CoV-2 in anterior nasal samples and saliva samples.	[Naito, Asami] Tsukuba Lab LLP, Tsukuba, Ibaraki, Japan; [Kiyasu, Yoshihiko; Akashi, Yusaku; Takeuchi, Yuto; Suzuki, Hiromichi] Tsukuba Med Ctr Hosp, Dept Med, Div Infect Dis, Tsukuba, Ibaraki, Japan; [Kiyasu, Yoshihiko; Takeuchi, Yuto; Suzuki, Hiromichi] Univ Tsukuba Hosp, Dept Infect Dis, Tsukuba, Ibaraki, Japan; [Akashi, Yusaku] Akashi Internal Med Clin, Kashiwara, Osaka, Japan; [Sugiyama, Akio; Michibuchi, Masashi] TOYOBO Co Ltd, Diagnost Syst Dept, Kita Ku, Osaka, Japan; [Notake, Shigeyuki; Nakamura, Koji] Tsukuba Med Ctr Hosp, Dept Clin Lab, Tsukuba, Ibaraki, Japan; [Ishikawa, Hiroichi] Tsukuba Med Ctr Hosp, Dept Resp Med, Tsukuba, Ibaraki, Japan; [Suzuki, Hiromichi] Univ Tsukuba, Fac Med, Dept Infect Dis, Tsukuba, Ibaraki, Japan	University of Tsukuba; Toyobo Co., Ltd; University of Tsukuba	Suzuki, H (corresponding author), Tsukuba Med Ctr Hosp, Dept Med, Div Infect Dis, Tsukuba, Ibaraki, Japan.; Suzuki, H (corresponding author), Univ Tsukuba Hosp, Dept Infect Dis, Tsukuba, Ibaraki, Japan.; Suzuki, H (corresponding author), Univ Tsukuba, Fac Med, Dept Infect Dis, Tsukuba, Ibaraki, Japan.	hsuzuki@md.tsukuba.ac.jp		Takeuchi, Yuto/0000-0002-6643-6208	TOYOBO Co., Ltd.	TOYOBO Co., Ltd.	This study was supported financially by TOYOBO Co., Ltd. PSS provided the MagDEA Dx SV and magLEAD Consumable Kit for the evaluation of the rapid protocol with magLEAD. TOYOBO Co., Ltd., provided support in the form of salaries for authors Akio Sugiyama and Masashi Michibuchi, lecture fees for author Hiromichi Suzuki, and advisory fees for author Hiromichi Suzuki. Hiromichi Suzuki also received advisory fees from PSS. The funder did not play any additional role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Fukumoto T, 2020, INT J INFECT DIS, V98, P16, DOI 10.1016/j.ijid.2020.06.074; Green TA, 1998, J CLIN MICROBIOL, V36, P375, DOI 10.1128/JCM.36.2.375-381.1998; Hadgu A, 1996, LANCET, V348, P592, DOI 10.1016/S0140-6736(96)05122-7; Hadgu A, 2000, J CLIN MICROBIOL, V38, P4301; Hadgu A, 1999, J CLIN EPIDEMIOL, V52, P1231, DOI 10.1016/S0895-4356(99)00101-8; Hanson KE, 2021, CLIN INFECT DIS, DOI [10.1093/cid/ciab557, 10.1093/cid/ciaa760]; Hara T, 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0234119, 10.1371/journal.pone.0234119.r001, 10.1371/journal.pone.0234119.r002, 10.1371/journal.pone.0234119.r003, 10.1371/journal.pone.0234119.r004]; Hida Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219819; Hida Y, 2012, J CLIN MICROBIOL, V50, P3604, DOI 10.1128/JCM.01654-12; Ito Y, 2018, MOL DIAGN THER, V22, P737, DOI 10.1007/s40291-018-0360-x; Kiyasu Y, 2021, J INFECT CHEMOTHER, V27, P1489, DOI 10.1016/j.jiac.2021.07.005; Kiyasu Y, 2021, MOL DIAGN THER, V25, P495, DOI 10.1007/s40291-021-00535-5; Loeffelholz MJ, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00926-20; Marty FM, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMvcm2010260; Marx GE., 2021, CLIN INFECT DIS, V73, pS65, DOI [10.1093/cid/ciab330, DOI 10.1093/CID/CIAB330]; McAdam AJ, 2017, J CLIN MICROBIOL, V55, P2878, DOI 10.1128/JCM.00969-17; McCormick-Baw C, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01109-20; Miller WC, 1998, CLIN INFECT DIS, V27, P1186, DOI 10.1086/514996; Miller WC, 1998, J CLIN EPIDEMIOL, V51, P219, DOI 10.1016/S0895-4356(97)00264-3; Miyazaki Narimi, 2016, Jpn J Antibiot, V69, P291; Mizoguchi M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252757; Morinaga Y, 2020, J MED MICROBIOL, V69, P1346, DOI 10.1099/jmm.0.001264; Nagura-Ikeda M, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01438-20; Ott Isabel M, 2020, medRxiv, DOI 10.1101/2020.08.03.20165233; Paz S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244271; Precision System Science Co. Ltd, 2021, MAGLEAD 6GC MAGLEAD; SARS-CoV-2 (COVID-19) Fact Sheet, 2021, NAS ANT NAS SPEC COL; Shirato K, 2020, JPN J INFECT DIS, V73, P304, DOI 10.7883/yoken.JJID.2020.061; Takeuchi Y, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90026-8; TOYOBO Co. Ltd, 2021, FULL AUT GEN AN GENE; Tsang NNY, 2021, LANCET INFECT DIS, V21, P1233, DOI 10.1016/S1473-3099(21)00146-8; Van Wesenbeeck Liesbeth, 2014, Virol J, V11, P233, DOI 10.1186/s12985-014-0233-9	32	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262159	10.1371/journal.pone.0262159	http://dx.doi.org/10.1371/journal.pone.0262159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972195	gold, Green Published			2022-12-27	WOS:000773555700103
J	Choi, SW				Choi, Seung-Whan			Outlier analysis: Natural resources and immigration policy	PLOS ONE			English	Article							FOREIGN DIRECT-INVESTMENT; POLITICS; WAR	This replication underlines the importance of outlier diagnostics since many researchers have long neglected influential observations in OLS regression analysis. In his article, entitled "Primary Resources, Secondary Labor," Shin finds that advanced democracies with increased natural resource wealth, particularly from oil and natural gas production, are more likely to restrict low-skill immigration policy. By performing outlier diagnostics, this replication shows that Shin's findings are a statistical artifact. When one outlying country, Norway, is removed from the sample data, I observe almost no significant and negative relationship between oil wealth and immigration policy. When two outlying countries are excluded, the effect of oil wealth completely disappears. Robust regression analysis, a widely used remedial method for outlier problems, confirms the results of my outlier diagnostics.	[Choi, Seung-Whan] Univ Illinois, Dept Polit Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Choi, SW (corresponding author), Univ Illinois, Dept Polit Sci, Chicago, IL 60607 USA.	whanchoi@uic.edu			Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago	Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago	Seung-Whan Choi appreciates the Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago for financial support towards the open access publishing fee for this article.	Achen CH, 2002, ANNU REV POLIT SCI, V5, P423, DOI 10.1146/annurev.polisci.5.112801.080943; [Anonymous], 2015, STAT BAS REF MAN 14; Ashworth S, 2008, AM POLIT SCI REV, V102, P269, DOI 10.1017/S0003055408080167; Bilgin MH, 2021, SINGAP ECON REV, V66, P685, DOI 10.1142/S0217590819500164; Cederman LE, 2007, AM POLIT SCI REV, V101, P173, DOI 10.1017/S0003055407070086; Choi SW, 2008, FOREIGN POL ANAL-US, V4, P83, DOI 10.1111/j.1743-8594.2008.00059.x; Choi SW, 2009, Q J POLIT SCI, V4, P183, DOI 10.1561/100.00009035; Clarke KA, 2008, AM POLIT SCI REV, V102, P387, DOI 10.1017/S0003055408080131; Crabtree C, 2017, BRIT J POLIT SCI, V47, P229, DOI 10.1017/S0007123415000344; Fearon JD, 2007, AM POLIT SCI REV, V101, P187, DOI 10.1017/S0003055407070219; Gilens M, 2014, PERSPECT POLIT, V12, P564, DOI 10.1017/S1537592714001595; Grytten O., 2016, EC HIST NORWAY; Gujarati D., 2003, BASIC ECONOMETRICS, V4th ed.; Hamilton L., 2004, STAT STATA; Imai K, 2020, J POLIT, V82, P714, DOI 10.1086/707059; JACKMAN RW, 1987, J POLIT, V49, P242, DOI 10.2307/2131143; Kerner A, 2014, INT STUD QUART, V58, P804, DOI 10.1111/isqu.12147; Park J, 2014, INT STUD QUART, V58, P118, DOI 10.1111/isqu.12114; Powell EN, 2014, BRIT J POLIT SCI, V44, P123, DOI 10.1017/S0007123412000531; Ray JL, 2003, CONFLICT MANAG PEACE, V20, P1; Replication King G., 1995, REPLICATION PS POLIT, V28, P444; Schmitter P., 1971, INTEREST C POLITICAL; Shin AJ, 2019, INT STUD QUART, V63, P805, DOI 10.1093/isq/sqz033; Welsch R, 1980, REGRESSION DIAGNOSTI; Zigerell L.J., 2015, RES POLITICS, V2, P1	25	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261533	10.1371/journal.pone.0261533	http://dx.doi.org/10.1371/journal.pone.0261533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025888	gold, Green Published			2022-12-27	WOS:000796264200018
J	Heron, P; Spanakis, P; Crosland, S; Johnston, G; Newbronner, E; Wadman, R; Walker, L; Gilbody, S; Peckham, E				Heron, Paul; Spanakis, Panagiotis; Crosland, Suzanne; Johnston, Gordon; Newbronner, Elizabeth; Wadman, Ruth; Walker, Lauren; Gilbody, Simon; Peckham, Emily			Loneliness among people with severe mental illness during the COVID-19 pandemic: Results from a linked UK population cohort study	PLOS ONE			English	Article							PERCEIVED SOCIAL SUPPORT; RISK-FACTORS; SCHIZOPHRENIA; PSYCHOSIS; PARTICIPATION; EXPERIENCE; NETWORKS	Aim/Goal/Purpose Population surveys underrepresent people with severe mental ill health. This paper aims to use multiple regression analyses to explore perceived social support, loneliness and factor associations from self-report survey data collected during the Covid-19 pandemic in a sample of individuals with severe mental ill health. Design/Methodology/Approach We sampled an already existing cohort of people with severe mental ill health. Researchers contacted participants by phone or by post to invite them to take part in a survey about how the pandemic restrictions had impacted health, Covid-19 experiences, perceived social support, employment and loneliness. Loneliness was measured by the three item UCLA loneliness scale. Findings In the pandemic sub-cohort, 367 adults with a severe mental ill health diagnosis completed a remote survey. 29-34% of participants reported being lonely. Loneliness was associated with being younger in age (adjusted OR = -.98, p = .02), living alone (adjusted OR = 2.04, p = .01), high levels of social and economic deprivation (adjusted OR = 2.49, p = .04), and lower perceived social support (B = -5.86, p < .001). Living alone was associated with lower perceived social support. Being lonely was associated with a self-reported deterioration in mental health during the pandemic (adjusted OR = 3.46, 95%CI 2.03-5.91). Practical implications Intervention strategies to tackle loneliness in the severe mental ill health population are needed. Further research is needed to follow-up the severe mental ill health population after pandemic restrictions are lifted to understand perceived social support and loneliness trends. Originality Loneliness was a substantial problem for the severe mental ill health population before the Covid-19 pandemic but there is limited evidence to understand perceived social support and loneliness trends during the pandemic.	[Heron, Paul; Spanakis, Panagiotis; Crosland, Suzanne; Newbronner, Elizabeth; Wadman, Ruth; Walker, Lauren; Gilbody, Simon; Peckham, Emily] Univ York, Mental Hlth & Addict Res Grp, York, N Yorkshire, England; [Gilbody, Simon] Hull York Med Sch, York, N Yorkshire, England	University of York - UK; University of Hull; University of York - UK	Heron, P (corresponding author), Univ York, Mental Hlth & Addict Res Grp, York, N Yorkshire, England.	paul.heron@york.ac.uk	Gilbody, Simon/AAY-3720-2021	Gilbody, Simon/0000-0002-8236-6983; Johnston, Gordon/0000-0003-4483-8932; Heron, Paul/0000-0003-3529-5737	Medical Research Council [MR/V028529]; Wellcome Trust through the Centre for Future Health at the University of York [204829]; UK Research and Innovation [ES/S004459/1]; NIHR Yorkshire and Humberside Applied Research Collaboration	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust through the Centre for Future Health at the University of York(Wellcome Trust); UK Research and Innovation(UK Research & Innovation (UKRI)); NIHR Yorkshire and Humberside Applied Research Collaboration	This study is supported by the Medical Research Council, https://mrc.ukri.org/, (grant reference MR/V028529) (author SG,EP) and links with the Closing the Gap cohort, which was partfunded by the Wellcome Trust, https://wellcome.org/, (reference 204829) (author SG,EP) through the Centre for Future Health at the University of York, UK Research and Innovation, https://www.york.ac.uk/future-health/, (reference ES/S004459/1) (author SG,EP), and the YYY, https://www.arc-yh.nihr.ac.uk/about-us (author RW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armour C, 2021, J PSYCHOPATHOL BEHAV, V43, P174, DOI 10.1007/s10862-020-09841-4; Badcock JC, 2020, CLIN PSYCHOL-SCI PR, V27, DOI 10.1111/cpsp.12345; Bu F, 2020, Public Health, V186, P31, DOI 10.1016/j.puhe.2020.06.036; Cacioppo JT, 2018, LANCET, V391, P426, DOI 10.1016/S0140-6736(18)30142-9; Chrostek A, 2016, COMPR PSYCHIAT, V70, P190, DOI 10.1016/j.comppsych.2016.07.015; COHEN CI, 1993, HOSP COMMUNITY PSYCH, V44, P951; Eglit GML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194021; Gayer-Anderson C, 2013, EPIDEMIOL PSYCH SCI, V22, P131, DOI 10.1017/S2045796012000406; Groarke JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239698; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Kliem S, 2015, J CLIN EPIDEMIOL, V68, P551, DOI 10.1016/j.jclinepi.2014.11.003; Lamster F, 2017, COMPR PSYCHIAT, V74, P35, DOI 10.1016/j.comppsych.2016.12.007; Marwaha S, 2004, SOC PSYCH PSYCH EPID, V39, P337, DOI 10.1007/s00127-004-0762-4; Matthews T, 2019, PSYCHOL MED, V49, P268, DOI 10.1017/S0033291718000788; Mishu MP, 2019, SOC PSYCH PSYCH EPID, V54, P887, DOI 10.1007/s00127-018-1639-2; Moller P, 2000, SCHIZOPHRENIA BULL, V26, P217, DOI 10.1093/oxfordjournals.schbul.a033442; Office of National Statistics, 2018, MEAS LON GUID US NAT; Prince JD, 2018, J NERV MENT DIS, V206, P136, DOI 10.1097/NMD.0000000000000768; Roe D, 2011, SCHIZOPHR RES, V131, P133, DOI 10.1016/j.schres.2011.05.023; Schwartz C, 2009, ISR J PSYCHIATR REL, V46, P120; Shioda A, 2016, J PSYCHIATR MENT HLT, V23, P399, DOI 10.1111/jpm.12318; Spanakis P, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.732735; Stain HJ, 2012, AUST NZ J PSYCHIAT, V46, P879, DOI 10.1177/0004867412449060; Sundermann O, 2014, SOC PSYCH PSYCH EPID, V49, P359, DOI 10.1007/s00127-013-0754-3; Tremeau F, 2016, PSYCHIAT RES, V246, P211, DOI 10.1016/j.psychres.2016.09.043; Valtorta NK, 2018, EUR J PREV CARDIOL, V25, P1387, DOI 10.1177/2047487318792696; Valtorta NK, 2016, HEART, V102, P1009, DOI 10.1136/heartjnl-2015-308790; van der Werf M, 2010, SCHIZOPHR RES, V122, P193, DOI 10.1016/j.schres.2010.05.020; Varga TV, 2021, LANCET REG HEALTH-EU, V2, DOI 10.1016/j.lanepe.2020.100020; Wang JY, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1736-5; Weiner A, 2010, COMMUNITY MENT HLT J, V46, P389, DOI 10.1007/s10597-009-9279-3; What Works Wellbeing, 2020, HAS COV 19 ASS LOCKD	33	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262363	10.1371/journal.pone.0262363	http://dx.doi.org/10.1371/journal.pone.0262363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025915	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000796264200063
J	Lungu, P; Njelesani, E; Sukwa, T; Ngalamika, O; Munsaka, S; Kilembe, W; Lakhi, S; Mwaba, P				Lungu, Patrick; Njelesani, Evarist; Sukwa, Thomas; Ngalamika, Owen; Munsaka, Sody; Kilembe, William; Lakhi, Shabir; Mwaba, Peter			Immune correlates of Mycobacterium Tuberculosis patients in Zambia stratified by HIV serostatus and level of immunity-a cross-sectional analytical laboratory based study	PLOS ONE			English	Article							INFECTION; RESPONSES; TH1	Background People living with HIV (PLHIV) co-infected with tuberculosis (TB) have a distinct clinical presentation and poorer treatment outcomes compared to HIV-seronegative TB patients. Excluding low CD4 count, innate immune factors associated with TB are not fully elucidated. We, therefore, characterised and compared the expression of IL-6, TNF-alpha, IFN-gamma, and IL-10 in whole blood of treatment naive TB patients stimulated with heat-killed Mycobacterium tuberculosis stratified by HIV status and the level of CD4 count. Results We recruited 39 HIV seropositive and 31 HIV seronegative TB patients. Median (IQR) age was 35(28-42) years and 31(25-36) years respectively, and a majority had pulmonary tuberculosis i.e. 38(95%) and 30(97%), respectively. The two groups were significantly different in the distribution of CD4 count, 563 [465-702.5 cells/mm3] vs 345 [157-483 cell/mm3] in HIV negative vs HIV positive respectively p = <0.001. Post stimulation, the expression of IL-6 in HIV negative TB patients was significantly higher than in the HIV positive 16,757366 [8,827-23,686 pg/ml] vs. 9,508 [5,514-15,008 pg/ml], respectively; p = 0.0360. TNF-alpha and IFN-gamma were highly expressed in HIV negative TB patients compared to the HIV positive though not statistically significant. We only observed higher expression of IL-6 in HIV negative patients in comparison to the HIV positive when stratified by level of CD4 counts as < 500 and >= 500 cell/mm(3) for both cohorts. 21,953 [8,990-24,206 pg/ml] vs 9,505 [5,400-15,313 pg/ml], p value = 0.0585 in patients with CD4 count < 500 cell/mm(3) and 13,168 [7,087-22,584 pg/ml] vs 10,413 [7,397-14,806 pg/ml], p value = 0.3744 for patients with CD4 count of >= 500 cell/mm(3) respectively. We found a positive pairwise correlation between TNF-alpha -alpha and IL-6 in both HIV positive and HIV negative patients, r = 0.61 (95% CI 0.36-0.72; p < 0.0001) and r = 0.48 (95% CI 0.15-0.68; p = 0.005) respectively. The IFN gamma/IL-10 ratio was higher in HIV negative when compared to HIV positive individuals, 0.052 [0.0-0.28] vs 0.007 [0-0.32] respectively; p = 0.05759. IL-6 independently reduced the probability of TB/HIV, Adjusted odds ratio 0.99, p value 0.007. Conclusions This study suggests that HIV seronegative TB patients have a higher pro-inflammatory response to MTB than HIV seropositive TB patients. Further, it also shows that the level of CD4 influences immunomodulation. The findings suggest that the difference in cytokine expression may be responsible for the distinct patterns of TB presentation between HIV positive and HIV negative patient.	[Lungu, Patrick; Lakhi, Shabir] Univ Zambia, Dept Internal Med, Sch Med, Lusaka, Zambia; [Njelesani, Evarist; Sukwa, Thomas; Mwaba, Peter] Lusaka Apex Med Univ, Fac Med, Lusaka, Zambia; [Njelesani, Evarist; Sukwa, Thomas; Mwaba, Peter] Lusaka Apex Med Univ, Directorate Postgrad Studies, Lusaka, Zambia; [Ngalamika, Owen] Univ Zambia, Sch Med, Dept Internal Med, Lusaka, Zambia; [Munsaka, Sody] Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia; [Kilembe, William] Ctr Family Hlth Res Zambia, Lusaka, Zambia	University of Zambia; University of Zambia; University of Zambia	Lungu, P (corresponding author), Univ Zambia, Dept Internal Med, Sch Med, Lusaka, Zambia.	lungupatrick99@gmail.com		, owen/0000-0002-0648-4128	Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE); DELTAS Africa Initiative [DEL-15-006]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trus [107752/Z/15/Z]; UK government	Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE); DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trus(Wellcome Trust); UK government	This work was supported through the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [grant #DEL-15-006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant #107752/Z/15/Z] and the UK government.	Babu H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01965; Basingnaa A, 2019, DISEASES-BASEL, V7, DOI 10.3390/diseases7010002; Bastard M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193491; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; BREEN EC, 1990, J IMMUNOL, V144, P480; Domingo-Gonzalez R, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0018-2016; Ellis PK., 2017, CD4 COUNT TUBERCULOS, V2015; Fekadu G, 2020, ANN MED SURG, V60, P531, DOI 10.1016/j.amsu.2020.11.032; Garcuia JI., 2020, SCI REP-UK, V10, P1, DOI DOI 10.1038/S41598-019-56847-4; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Henn L, 1999, MEM I OSWALDO CRUZ, V94, P377, DOI 10.1590/S0074-02761999000300017; Howard AD, 1999, CLIN EXP IMMUNOL, V115, P428; Jamil B, 2007, TUBERCULOSIS, V87, P279, DOI 10.1016/j.tube.2007.03.004; Khan Taj Ali, 2016, Chemother Res Pract, V2016, P7295390, DOI 10.1155/2016/7295390; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Lyadova IV, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/854507; Mihret A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-125; Morou A, 2014, CURR OPIN HIV AIDS, V9, P446, DOI 10.1097/COH.0000000000000094; Naidoo K, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/585919; Narazaki M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113528; Neta R, 1992, Immunol Ser, V56, P499; Osei E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234878; Osuji FN, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0490-9; Scheller J., 2011, BIOCH BIOPHYSICA ACT, V1813, P878, DOI [DOI 10.1016/J.BBAMCR.2011.01.034, 10.1016/j.bbamcr.2011.01.034]; Skolimowska KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046481; Sterling TR, 2010, CLIN INFECT DIS, V50, pS223, DOI 10.1086/651495; Waitt CJ, 2011, J INFECT DIS, V204, P358, DOI 10.1093/infdis/jir265; WHO, 2018, GLOBAL TUBERCULOSIS; World Health Organization, 2020, TUB GLOB REP	29	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262454	10.1371/journal.pone.0262454	http://dx.doi.org/10.1371/journal.pone.0262454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025927	gold, Green Published			2022-12-27	WOS:000796264200071
J	Zofkie, AC; Garner, WH; Schell, RC; Ragsdale, AS; McIntire, DD; Roberts, SW; Spong, CY				Zofkie, Amanda C.; Garner, W. Holt; Schell, Rachel C.; Ragsdale, Alexandra S.; McIntire, Donald D.; Roberts, Scott W.; Spong, Catherine Y.			An evidence-based definition of anemia for singleton, uncomplicated pregnancies	PLOS ONE			English	Article							SEVERE MATERNAL MORBIDITY; IRON	Background The definition for anemia in pregnancy is outdated, derived from Scandinavian studies in the 1970's to 1980's. To identity women at risk of blood transfusion, a common cause of Severe Maternal Morbidity, a standard definition of anemia in pregnancy in a modern, healthy United States cohort is needed. Objective To define anemia in pregnancy in a United States population including a large county vs. private hospital population using uncomplicated patients. Materials and methods Inclusion criteria were healthy women with the first prenatal visit before 20 weeks. Exclusion criteria included preterm birth, preeclampsia, hypertension, diabetes, short interval pregnancy (<18 months), multiple gestation, abruption, and fetal demise. All women had iron fortification (Ferrous sulfate 325 mg daily) recommended. The presentation to care and pre-delivery hematocrits were obtained, and the percentiles determined. A total of 2000 patients were included, 1000 from the public county hospital and 1000 from the private hospital. Each cohort had 250 patients in each 2011, 2013, 2015, and 2018. The cohorts were compared for differences in the fifth percentile for each antepartum epoch. Student's t-test and chi-squared statistical tests were used for analysis, p-value of <= 0.05 was considered significant. Results In the public and private populations, 777 and 785 women presented in the first trimester while 223 and 215 presented in the second. The women at the private hospital were more likely to be older, Caucasian race, nulliparous, and present earlier to care. The fifth percentile was compared between the women in the private and public hospitals and were clinically indistinguishable. When combining the cohorts, the fifth percentile for hemoglobin/hematocrit was 11 g/dL/32.8% in the first trimester, 10.3 g/dL/30.6% in the second trimester, and 10.0 g/dL/30.2% pre-delivery. Conclusions Fifth percentile determinations were made from a combined cohort of normal, uncomplicated pregnancies to define anemia in pregnancy. Comparison of two different cohorts confirms that the same definition for anemia is appropriate regardless of demographics or patient mix.	[Zofkie, Amanda C.; Garner, W. Holt; Schell, Rachel C.; Ragsdale, Alexandra S.; McIntire, Donald D.; Roberts, Scott W.; Spong, Catherine Y.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Maternal Fetal Med Div, Parkland Hlth & Hosp Syst, Dallas, TX 75225 USA; [Zofkie, Amanda C.] Washington Univ, Sch Med, Dept Obstet & Gynecol, Maternal Fetal Med Div, St Louis, MO 63110 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Zofkie, AC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Maternal Fetal Med Div, Parkland Hlth & Hosp Syst, Dallas, TX 75225 USA.; Zofkie, AC (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, Maternal Fetal Med Div, St Louis, MO 63110 USA.	azofkie@gmail.com		mcintire, donald/0000-0002-9799-7905; Garner, William Holt/0000-0003-2714-0938; Ragsdale, Alexandra/0000-0002-5126-3260				American College of Obstetricians and Gynecologists, 2008, Obstet Gynecol, V112, P201, DOI 10.1097/AOG.0b013e3181809c0d; [Anonymous], 1998, MMWR RECOMM REP, V47; Callaghan WM, 2012, OBSTET GYNECOL, V120, P1029, DOI [10.1097/AOG.0b013e31826d60c5, http://10.1097/AOG.0b013e31826d60c5]; Camaschella C, 2015, NEW ENGL J MED, V372, P1832, DOI 10.1056/NEJMra1401038; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P400; Hoyert DL, 2021, NCHS HLTH E STATS; JOHNSONSPEAR MA, 1994, AM J CLIN NUTR, V60, P117, DOI 10.1093/ajcn/60.1.117; Kilpatrick SK, 2016, AM J OBSTET GYNECOL, V215, pB17, DOI 10.1016/j.ajog.2016.07.050; Nijboer JMM, 2007, J TRAUMA, V62, P1310, DOI 10.1097/TA.0b013e3180341f54; PERRY GS, 1992, J NUTR, V122, P1417, DOI 10.1093/jn/122.7.1417; Puolakka J, 1980, Acta Obstet Gynecol Scand Suppl, V95, P43; Sienas L, 2013, OBSTET GYNECOL SURV, V68, P594, DOI 10.1097/OGX.0b013e3182a2d51c; Sjostedt J E, 1977, Acta Obstet Gynecol Scand, V56, P3, DOI 10.1111/aogs.1977.56.s60.3; Svanberg B, 1975, Acta Obstet Gynecol Scand Suppl, V48, P87; TAYLOR DJ, 1982, BRIT J OBSTET GYNAEC, V89, P1011, DOI 10.1111/j.1471-0528.1982.tb04656.x; Weatherall MS, 1997, CLIN LAB HAEMATOL, V19, P183, DOI 10.1046/j.1365-2257.1997.00076.x; WHO Guidelines Approved by the Guidelines Review Committee, 2016, WHO RECOMMENDATIONS; World Health Organization, 2001, CLIN US BLOOD MED OB	18	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262436	10.1371/journal.pone.0262436	http://dx.doi.org/10.1371/journal.pone.0262436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025925	Green Published, gold			2022-12-27	WOS:000796264200069
J	Gabri, AC; Galanti, MR; Orsini, N; Magnusson, C				Gabri, Alexander Carl; Galanti, Maria Rosaria; Orsini, Nicola; Magnusson, Cecilia			Changes in cannabis policy and prevalence of recreational cannabis use among adolescents and young adults in Europe-An interrupted time-series analysis	PLOS ONE			English	Article							MEDICAL MARIJUANA; PUBLIC-HEALTH; RISK; LAWS; LEGALIZATION; IMPACT	Background Cannabis policy varies greatly across European countries, but evidence of how such policy impacts on recreational cannabis use among young people is conflicting. This study aimed to clarify this association by investigating how changes in cannabis legislation influenced cannabis use. Methods Available data on self-reports of recreational cannabis use among individuals aged 15-34 years was retrieved from EMCDDA. Information on cannabis policy changes was categorized as more lenient (decriminalisation or depenalisation) or stricter (criminalisation, penalisation). Countries that had implemented changes in cannabis legislation or had information on prevalence of use for at least eight calendar years, were eligible for inclusion. We used interrupted time-series linear models to investigate changes in country-specific trajectories of prevalence over calendar time and in relation to policy changes. Results Data from Belgium, Czech Republic, Germany, Italy, Netherlands, Norway, Portugal, Slovakia, Spain, Sweden and United Kingdom, for 1994-2017 was available for analyses. Cannabis use varied considerably over the study period and between countries. On average, use was stable or weakly increasing in countries where legislation was not changed or changed at the extremes of the study period (+0.08 percent per year [95% CI -0.01, 0.17 percent]). In contrast, the pooled average use decreased after changes in legislation, regardless of whether it had become more lenient (-0.22 [-1.21, 0.77]) or stricter (-0.44 [-0.91, 0.03]). Conclusions Our findings do not support any considerable impact of cannabis legislation on the prevalence of recreational cannabis use among youth and young adults in Europe.	[Gabri, Alexander Carl; Galanti, Maria Rosaria; Orsini, Nicola; Magnusson, Cecilia] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden; [Galanti, Maria Rosaria; Orsini, Nicola; Magnusson, Cecilia] Ctr Epidemiol & Community Med, Reg Stockholm, Stockholm, Sweden	Karolinska Institutet	Gabri, AC (corresponding author), Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden.	alexander.gabri@stud.ki.se		Gabri, Alexander/0000-0001-6435-9491				Arria AM, 2015, PSYCHOL ADDICT BEHAV, V29, P564, DOI 10.1037/adb0000108; Beck F., 2007, SANT PUBLIQUE, V19; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Cambron C, 2020, PREV SCI, V21, P508, DOI 10.1007/s11121-019-01072-8; Castillo-Carniglia A, 2020, ADDICTION, V115, P2089, DOI 10.1111/add.15058; Cecho R, 2017, CENT EUR J PUBL HEAL, V25, P261, DOI 10.21101/cejph.a5019; Cerda M, 2017, INT J DRUG POLICY, V42, P118, DOI 10.1016/j.drugpo.2017.02.007; Cerda M, 2012, DRUG ALCOHOL DEPEN, V120, P22, DOI 10.1016/j.drugalcdep.2011.06.011; Chatwin C, 2017, INT J DRUG POLICY, V49, P80, DOI 10.1016/j.drugpo.2015.12.017; Choo EK, 2014, J ADOLESCENT HEALTH, V55, P160, DOI 10.1016/j.jadohealth.2014.02.018; Cox C, 2018, HEALTH POLICY, V122, P205, DOI 10.1016/j.healthpol.2018.01.009; Csete J, 2016, LANCET, V387, P1427, DOI 10.1016/S0140-6736(16)00619-X; Ebbert JO, 2018, MAYO CLIN PROC, V93, P1842, DOI 10.1016/j.mayocp.2018.09.005; EMCDDA, 2019, EUR DRUG REP; European Monitoring Centre for Drugs and Drug Addiction, 2019, STAT B 2019 PREV DRU; European Monitoring Centre for Drugs and Drug Addiction, 2002, HDB SURV DRUG US GEN; European Monitoring Centre for Drugs and Drug Addiction, 2018, CANN LEG EUR OV; Farrelly MC, 2001, J HEALTH ECON, V20, P51, DOI 10.1016/S0167-6296(00)00067-9; Grotenhermen F, 2007, CHEM BIODIVERS, V4, P1744, DOI 10.1002/cbdv.200790151; Grucza RA, 2018, INT J DRUG POLICY, V59, P67, DOI 10.1016/j.drugpo.2018.06.016; Hughes B, 2018, ADDICTION, V113, P2155, DOI 10.1111/add.14372; Kalant H, 2010, ADDICTION, V105, P1146, DOI 10.1111/j.1360-0443.2009.02830.x; Kotlaja MM, 2019, INT J OFFENDER THER, V63, P1082, DOI 10.1177/0306624X18814184; Laqueur H, 2020, INT J DRUG POLICY, V80, DOI 10.1016/j.drugpo.2020.102748; MacCoun R, 1997, SCIENCE, V278, P47, DOI 10.1126/science.278.5335.47; Maxwell JC, 2016, J ADDICT MED, V10, P3, DOI 10.1097/ADM.0000000000000188; Meier MH, 2015, DRUG ALCOHOL DEPEN, V156, P207, DOI 10.1016/j.drugalcdep.2015.09.010; Melchior M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025880; Mokwena K, 2019, AFR J PRIM HEALTH CA, V11, DOI 10.4102/phcfm.v11i1.2136; Olfson M, 2018, AM J PSYCHIAT, V175, P47, DOI [10.1176/appi.ajp.2017.17040413, 10.1176/appi.ajp.2017.17070808]; Pardo B, 2014, INT J DRUG POLICY, V25, P727, DOI 10.1016/j.drugpo.2014.05.010; Sagar KA, 2018, INT REV PSYCHIATR, V30, P251, DOI 10.1080/09540261.2018.1460334; Shi YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143562; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; UNESCO, 1968, ECN72020CRP19 WHO; United Nations, 2020, WORLD DRUG REPORT 20; Volkow ND, 2016, JAMA PSYCHIAT, V73, P292, DOI 10.1001/jamapsychiatry.2015.3278; Waldheim K., 1973, COMMENTARY SINGLE CO; Williams J, 2014, J HEALTH ECON, V36, P20, DOI 10.1016/j.jhealeco.2014.03.006	39	6	6	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261885	10.1371/journal.pone.0261885	http://dx.doi.org/10.1371/journal.pone.0261885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020763	Green Published, gold			2022-12-27	WOS:000834207700028
J	Mason, B; Piel, AK; Modry, D; Petrzelkova, KJ; Stewart, FA; Pafao, B				Mason, Bethan; Piel, Alex K.; Modry, David; Petrzelkova, Klara J.; Stewart, Fiona A.; Pafao, Barbora			Association of human disturbance and gastrointestinal parasite infection of yellow baboons in western Tanzania	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; FECAL EGG COUNTS; ENTAMOEBA-HISTOLYTICA INFECTION; PAPIO-CYNOCEPHALUS; MOLECULAR-IDENTIFICATION; INTESTINAL PARASITES; STRONGYLOIDES SPP.; NATIONAL-PARK; WORM BURDEN; GROUP-SIZE	Human disturbance is an ongoing threat to many wildlife species, manifesting as habitat destruction, resource overuse, or increased disease exposure, among others. With increasing human: non-human primate (NHP) encounters, NHPs are increasingly susceptible to human-introduced diseases, including those with parasitic origins. As such, epidemiology of parasitic disease is becoming an important consideration for NHP conservation strategies. To investigate the relationship between parasite infections and human disturbance we studied yellow baboons (Papio cynocephalus) living outside of national park boundaries in western Tanzania, collecting 135 fresh faecal samples from nine troops occupying areas with varying levels of human disturbance. We fixed all samples in 10% formalin and later evaluated parasite prevalence and abundance (of isotrichid ciliates and Strongylida). We identified seven protozoan and four helminth taxa. Taxa showed varied relationships with human disturbance, baboon troop size and host age. In four taxa, we found a positive association between prevalence and troop size. We also report a trend towards higher parasite prevalence of two taxa in less disturbed areas. To the contrary, high levels of human disturbance predicted increased abundance of isotrichid ciliates, although no relationship was found between disturbance and Strongylida abundance. Our results provide mixed evidence that human disturbance is associated with NHP parasite infections, highlighting the need to consider monitoring parasite infections when developing NHP conservation strategies.	[Mason, Bethan; Modry, David] Masaryk Univ, Fac Sci, Dept Bot & Zool, Brno, Czech Republic; [Mason, Bethan; Petrzelkova, Klara J.; Pafao, Barbora] Czech Acad Sci, Inst Vertebrate Biol, Brno, Czech Republic; [Piel, Alex K.; Stewart, Fiona A.] UCL, Dept Anthropol, London, England; [Piel, Alex K.; Stewart, Fiona A.] Greater Mahale Ecosyst Res & Conservat GMERC Proj, Busongola, Tanzania; [Modry, David; Petrzelkova, Klara J.] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic; [Modry, David] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources CINeZ, Dept Vet Sci, Prague, Czech Republic; [Stewart, Fiona A.] Liverpool John Moores Univ, Sch Biol & Environm Sci, Liverpool, Merseyside, England	Masaryk University Brno; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; University of London; University College London; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech University of Life Sciences Prague; Liverpool John Moores University	Mason, B (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Brno, Czech Republic.; Mason, B (corresponding author), Czech Acad Sci, Inst Vertebrate Biol, Brno, Czech Republic.; Piel, AK (corresponding author), UCL, Dept Anthropol, London, England.; Piel, AK (corresponding author), Greater Mahale Ecosyst Res & Conservat GMERC Proj, Busongola, Tanzania.	bethanmason@sky.com; a.piel@ucl.ac.uk		Mason, Bethan/0000-0003-4344-7243; Piel, Alexander/0000-0002-4674-537X				Alvarado-Villalobos MA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2532-7; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; ANDERSON RM, 1985, T ROY SOC TROP MED H, V79, P812, DOI 10.1016/0035-9203(85)90128-2; Arroyo-Rodriguez V, 2010, AM J PRIMATOL, V72, P1, DOI 10.1002/ajp.20753; Barelli C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67959-7; Barelli C, 2015, INT J PRIMATOL, V36, P209, DOI 10.1007/s10764-015-9815-7; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benavides JA, 2012, AM J PHYS ANTHROPOL, V147, P52, DOI 10.1002/ajpa.21627; Bentley-Condit VK, 2009, AM J PRIMATOL, V71, P432, DOI 10.1002/ajp.20670; Bhattacharjee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127626; Blickley JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050462; Bradley BJ, 2008, J ZOOL, V275, P333, DOI 10.1111/j.1469-7998.2008.00431.x; Cabaret J, 1998, PARASITE, V5, P137, DOI 10.1051/parasite/1998052137; Chapman CA, 2006, AM J PRIMATOL, V68, P397, DOI 10.1002/ajp.20233; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Chapman CA, 2007, AM J PHYS ANTHROPOL, V134, P240, DOI 10.1002/ajpa.20664; Chapman CA, 2006, AM J PHYS ANTHROPOL, V131, P525, DOI 10.1002/ajpa.20477; Chomitz KM, 2007, AT LOGGERHEADS: AGRICULTURAL EXPANSION, POVERTY REDUCTION, AND ENVIRONMENT IN THE TROPICAL FORESTS, P1, DOI 10.1596/978-0-8213-6735-3; COHEN S, 1992, PSYCHOL SCI, V3, P301, DOI 10.1111/j.1467-9280.1992.tb00677.x; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Deere JR, 2021, BEHAV ECOL SOCIOBIOL, V75, DOI 10.1007/s00265-021-03030-3; Deere JR, 2019, PARASITOLOGY, V146, P1116, DOI [10.1017/S0031182018001397, 10.1017/s0031182018001397]; DOYLE PW, 1990, J CLIN MICROBIOL, V28, P116, DOI 10.1128/JCM.28.1.116-121.1990; EAST IJ, 1988, INT J PARASITOL, V18, P863, DOI 10.1016/0020-7519(88)90130-0; Ebbert MA, 2015, PARASITOLOGY, V142, P958, DOI 10.1017/S0031182015000104; Ellis S, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1991; Fehlmann G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14871-2; Fotedar R, 2007, CLIN MICROBIOL REV, V20, P511, DOI 10.1128/CMR.00004-07; Furtbauer I, 2020, HORM BEHAV, V126, DOI 10.1016/j.yhbeh.2020.104846; Ghai RR, 2015, P ROY SOC B-BIOL SCI, V282, P181, DOI 10.1098/rspb.2015.1436; Ghai RR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002641; Gillespie TR, 2006, INT J PRIMATOL, V27, P1129, DOI 10.1007/s10764-006-9064-x; Gillespie TR, 2006, CONSERV BIOL, V20, P441, DOI 10.1111/j.1523-1739.2006.00290.x; Gillespie TR, 2005, J APPL ECOL, V42, P699, DOI 10.1111/j.1365-2664.2005.01049.x; Hahn NE, 2003, INT J PRIMATOL, V24, P271, DOI 10.1023/A:1023092915171; Hasegawa D., 2018, PARASITES APES ATLAS, P164; Hasegawa H., 2018, PARASITES APES ATLAS, P83; Hasegawa H., 2018, PARASITES APES ATLAS, P20, DOI [10.1016/j.exppara.2018.06.009 29959915, DOI 10.1016/J.EXPPARA.2018.06.00929959915]; Hasegawa H, 2010, PARASITOL INT, V59, P407, DOI 10.1016/j.parint.2010.05.007; Heistermann M, 2006, AM J PRIMATOL, V68, P257, DOI 10.1002/ajp.20222; Hilser H, 2014, FOLIA PRIMATOL, V85, P265, DOI 10.1159/000363740; Hoffman TS, 2011, INT J PRIMATOL, V32, P308, DOI 10.1007/s10764-010-9467-6; Holechek JL, 2017, RANGELAND ECOL MANAG, V70, P273, DOI 10.1016/j.rama.2016.09.004; Holsapple MP, 2003, BIRTH DEFECTS RES B, V68, P321, DOI 10.1002/bdrb.10035; Howells ME, 2011, AM J PRIMATOL, V73, P173, DOI 10.1002/ajp.20884; Hussain Shaik, 2013, PLoS One, V8, pe63685, DOI 10.1371/journal.pone.0063685; Jirku-Pomajbikova K, 2016, PARASITOLOGY, V143, P741, DOI 10.1017/S0031182016000263; Kalousova B, 2014, INT J PRIMATOL, V35, P463, DOI 10.1007/s10764-014-9753-9; Kigwangalla HA, 2019, GAZETTE UNITED REPUB, V38; Klein SL, 2003, PHYSIOL BEHAV, V79, P441, DOI 10.1016/S0031-9384(03)00163-X; Kleinschmidt LM, 2018, J MED PRIMATOL, V47, P201, DOI 10.1111/jmp.12338; Lane-DeGraaf KE, 2014, AM J PRIMATOL, V76, P159, DOI 10.1002/ajp.22218; MacIntosh AJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051144; Makunga J. E., 2017, Open Journal of Forestry, V7, P285, DOI 10.4236/ojf.2017.72018; Martínez-Mota Rodolfo, 2018, Therya, V9, P161, DOI 10.12933/therya-18-572; Mpasiwakomu AR., 2017, HURIA J OPEN U TANZA, V24, P150; Muller-Klein N, 2019, FUNCT ECOL, V33, P1088, DOI 10.1111/1365-2435.13313; MullerGraf CDM, 1996, PARASITOLOGY, V112, P489, DOI 10.1017/S0031182000076952; Murray S, 2000, J ZOO WILDLIFE MED, V31, P176, DOI 10.1638/1042-7260(2000)031[0176:IPOBPC]2.0.CO;2; MYERS BJ, 1971, T AM MICROSC SOC, V90, P80, DOI 10.2307/3224900; NORTON GW, 1987, FOLIA PRIMATOL, V48, P78, DOI 10.1159/000156287; Pafco B, 2019, MOL ECOL, V28, P4786, DOI 10.1111/mec.15257; Pafco B, 2017, PARASITOL RES, V116, P3401, DOI 10.1007/s00436-017-5667-8; Papkou A, 2016, ZOOLOGY, V119, P330, DOI 10.1016/j.zool.2016.02.001; Patterson JEH, 2013, PARASITOLOGY, V140, P803, DOI 10.1017/S0031182012002259; Petrzelkova KJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89283-4; Piel AK, 2017, J HUM EVOL, V112, P57, DOI 10.1016/j.jhevol.2017.08.016; Pomajbikova K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002140; Post D.G., 1982, International Journal of Primatology, V3, P403, DOI 10.1007/BF02693741; Poulsen JR, 2001, J TROP ECOL, V17, P787, DOI 10.1017/S0266467401001602; R Core Team, 2020, R LANG ENV STAT COMP; Ragazzo LJ, 2018, VET PARASITOL, V249, P98, DOI 10.1016/j.vetpar.2017.12.002; Raichlen DA, 2005, J HUM EVOL, V49, P452, DOI 10.1016/j.jhevol.2005.05.005; Rimbach R, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0110; Rothman JM, 2012, INT J PRIMATOL, V33, P542, DOI 10.1007/s10764-011-9568-x; Sa RM, 2013, AM J PRIMATOL, V75, P1032, DOI 10.1002/ajp.22170; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Scanlan PD, 2014, FEMS MICROBIOL ECOL, V90, P326, DOI 10.1111/1574-6941.12396; Schneider-Crease I, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22684; Schovancova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081374; Schuster FL, 2008, CLIN MICROBIOL REV, V21, P626, DOI 10.1128/CMR.00021-08; Seivwright LJ, 2004, J HELMINTHOL, V78, P69, DOI 10.1079/JOH2003220; Sheather A. L., 1923, Journal of Comparative Pathology and Therapeutics, V36, P266; Shutt-Phillips K, 2021, GEN COMP ENDOCR, V312, DOI 10.1016/j.ygcen.2021.113859; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Stear MJ, 1995, PARASITE IMMUNOL, V17, P643, DOI 10.1111/j.1365-3024.1995.tb01010.x; Stensvold CR, 2009, TRENDS PARASITOL, V25, P23, DOI 10.1016/j.pt.2008.09.010; Stoner KE, 1996, CONSERV BIOL, V10, P539, DOI 10.1046/j.1523-1739.1996.10020539.x; Thompson RCA, 2013, INT J PARASITOL, V43, P1079, DOI 10.1016/j.ijpara.2013.06.007; Tomley FM, 2009, PHILOS T R SOC B, V364, P2637, DOI 10.1098/rstb.2009.0133; Tonukari NJ, 2004, ELECTRON J BIOTECHN, V7, P5, DOI 10.2225/vol7-issue1-fulltext-i02; Vadlamudi Raja S, 2006, Clin Mol Allergy, V4, P8, DOI 10.1186/1476-7961-4-8; Vlckova K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01202; WARNICK LD, 1992, CORNELL VET, V82, P453; Weyher AH, 2006, INT J PRIMATOL, V27, P1519, DOI 10.1007/s10764-006-9089-1; Wolfe ND, 1998, EMERG INFECT DIS, V4, P149, DOI 10.3201/eid0402.980202; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0	98	1	1	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262481	10.1371/journal.pone.0262481	http://dx.doi.org/10.1371/journal.pone.0262481			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020760	Green Accepted, gold, Green Published			2022-12-27	WOS:000834207700043
J	Miao, H; Liu, LX; Wang, YL; Wang, YC; He, QL; Jafar, TH; Tang, SL; Zeng, Y; Ji, JS				Miao, Hui; Liu, Linxin; Wang, Yeli; Wang, Yucheng; He, Qile; Jafar, Tazeen Hasan; Tang, Shenglan; Zeng, Yi; Ji, John S.			Chronic kidney disease biomarkers and mortality among older adults: A comparison study of survey samples in China and the United States	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RISK-FACTORS; PREVALENCE; EQUATION; CKD	Objectives Among older adults in China and the US, we aimed to compare the biomarkers of chronic-kidney-diseases (CKD), factors associated with CKD, and the correlation between CKD and mortality. Setting China and the US. Study design Cross-sectional and prospective cohorts. Participants We included 2019 participants aged 65 and above from the Chinese Longitudinal Healthy Longevity Study (CLHLS) in 2012, and 2177 from US National Health and Nutrition Examination Survey (NHANES) in 2011-2014. Outcomes Urinary albumin, urinary creatinine, albumin creatinine ratio (ACR), serum creatinine, blood urea nitrogen, plasma albumin, uric acid, and estimated glomerular filtration rate (eGFR). CKD (ACR >= 30 mg/g or eGFR< 60 ml/min/1.73m(2)) and mortality. Analytical approach Logistic regression and Cox proportional hazard models. Covariates included age, sex, race, education, income, marital status, health condition, smoking and drinking status, physical activity and body mass index. Results Chinese participants had lower levels of urinary albumin, ACR, and uric acid than the US (mean: 25.0 vs 76.4 mg/L, 41.7 vs 85.0 mg/g, 292.9 vs 341.3 mu mol/L). In the fully-adjusted model, CKD was associated with the risk of mortality only in the US group (hazard ratio [HR], 95% CI: 2.179, 1.561-3.041 in NHANES, 1.091, 0.940-1.266 in CLHLS). Compared to eGFR >= 90, eGFR ranged 30-44 ml/min/1.73m(2) was only associated with mortality in the US population (HR, 95% CI: 2.249, 1.141-4.430), but not in the Chinese population (HR, 95% CI: 1.408, 0.884-2.241). Conclusions The elderly participants in the US sample had worse CKD-related biomarker levels than in China sample, and the association between CKD and mortality was also stronger among the US older adults. This may be due to the biological differences, or co-morbid conditions.	[Miao, Hui; Liu, Linxin; Wang, Yucheng; He, Qile; Ji, John S.] Tsinghua Univ, Vanke Sch Publ Hlth, Beijing, Peoples R China; [Wang, Yeli] Duke NUS Med Sch, Hlth Serv & Syst Res, Singapore, Singapore; [Wang, Yucheng] Peking Univ, Sch Hlth Humanities, Beijing, Peoples R China; [He, Qile] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Informat, Beijing, Peoples R China; [Jafar, Tazeen Hasan; Tang, Shenglan] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Jafar, Tazeen Hasan] Singapore Gen Hosp, Dept Renal Med, Singapore, Singapore; [Zeng, Yi] Duke Univ, Sch Med, Ctr Study Aging & Human Dev, Durham, NC USA; [Zeng, Yi] Peking Univ, Ctr Hlth Aging & Dev Studies, Beijing, Peoples R China; [Zeng, Yi] Peking Univ, Raissun Inst Adv Studies, Beijing, Peoples R China	Tsinghua University; National University of Singapore; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Duke University; Singapore General Hospital; Duke University; Peking University; Peking University	Ji, JS (corresponding author), Tsinghua Univ, Vanke Sch Publ Hlth, Beijing, Peoples R China.	johnji@tsinghua.edu.cn	Wang, Yu/GZL-9655-2022; Ji, John/AAT-4219-2021	Ji, John/0000-0002-5002-118X; Miao, Hui/0000-0002-9352-9768	National Key R&D Program of China [2018YFC2000400]; National Natural Sciences Foundation of China [72061137004]; Duke/Duke-NUS/RECA(Pilot) [2019/0051]; U.S. National Institute of Aging of National Institute of Health [P01AG031719]; U.S. National Institute of Aging/National Institute of Health [P01AG031719]	National Key R&D Program of China; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Duke/Duke-NUS/RECA(Pilot); U.S. National Institute of Aging of National Institute of Health; U.S. National Institute of Aging/National Institute of Health	The Chinese Longitudinal Healthy Longevity Study (CLHLS) datasets analyzed in this paper are jointly supported by the National Key R&D Program of China (2018YFC2000400), National Natural Sciences Foundation of China (72061137004), Duke/Duke-NUS/RECA(Pilot)/2019/0051, and the U.S. National Institute of Aging of National Institute of Health (P01AG031719). Collections of the Chinese Longitudinal Healthy Longevity Surveys (CLHLS) datasets analyzed in this paper were jointly supported by the National Key R&D Program of China (2018YFC2000400), National Natural Sciences Foundation of China (72061137004), and the U.S. National Institute of Aging/National Institute of Health (P01AG031719).	Alebiosu CO, 2005, ETHNIC DIS, V15, P418; Bikbov B, 2020, LANCET, V395, P709, DOI 10.1016/S0140-6736(20)30045-3; Borrud Lori, 2014, Vital Health Stat 2, P1; Center for Healthy Aging and Development Studies, **DATA OBJECT**, V1, ped2016, DOI 10.18170/DVN/XRV2WN; CHAVERS BM, 1984, KIDNEY INT, V25, P576, DOI 10.1038/ki.1984.57; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crews DC, 2013, SEMIN NEPHROL, V33, P468, DOI 10.1016/j.semnephrol.2013.07.008; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; GBD, 2020, GLOBAL BURDEN DIS CO; Gu DA, 2009, J GERONTOL B-PSYCHOL, V64, P279, DOI 10.1093/geronb/gbn009; Johnson Clifford L, 2014, Vital Health Stat 2, P1; Kong XL, 2013, NEPHROL DIAL TRANSPL, V28, P641, DOI 10.1093/ndt/gfs491; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luyckx VA, 2017, KIDNEY INT SUPPL, V7, P71, DOI 10.1016/j.kisu.2017.07.003; Lv YB, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026513; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; National Center for Health Statistics, 2019, OFF AN EP PUBL US MO; Pei YPC, 2000, KIDNEY INT, V58, P1293, DOI 10.1046/j.1523-1755.2000.00285.x; Tonelli M, 2015, KIDNEY INT, V88, P859, DOI 10.1038/ki.2015.228; Wang F, 2018, KIDNEY INT REP, V3, P1135, DOI 10.1016/j.ekir.2018.05.011; Wang JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193734; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; Wen CP, 2014, KIDNEY INT, V86, P819, DOI 10.1038/ki.2013.553; Xu R, 2009, NEPHROL DIAL TRANSPL, V24, P1220, DOI 10.1093/ndt/gfn609; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	26	2	2	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0260074	10.1371/journal.pone.0260074	http://dx.doi.org/10.1371/journal.pone.0260074			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020733	gold, Green Published			2022-12-27	WOS:000834207700009
J	Variane, GFT; Magalhaes, M; Pietrobom, RFR; Netto, A; Rodrigues, DP; Gasperini, R; Sant'Anna, GM				Todeschi Variane, Gabriel Fernando; Magalhaes, Mauricio; Rodrigues Pietrobom, Rafaela Fabri; Netto, Alexandre; Rodrigues, Daniela Pereira; Gasperini, Renato; Sant'Anna, Guilherme Mendes			Protecting brains and saving futures guidelines: A prospective, multicenter, and observational study on the use of telemedicine for neonatal neurocritical care in Brazil	PLOS ONE			English	Article							AMPLITUDE-INTEGRATED ELECTROENCEPHALOGRAPHY; NEAR-INFRARED SPECTROSCOPY; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; CONGENITAL HEART-DISEASE; PATENT DUCTUS-ARTERIOSUS; NEURODEVELOPMENTAL OUTCOMES; ELECTROGRAPHIC SEIZURES; OXYGEN-SATURATION; THERAPEUTIC HYPOTHERMIA; SYSTEMIC HYPOTHERMIA	Background Management of high-risk newborns should involve the use of standardized protocols and training, continuous and specialized brain monitoring with electroencephalography (EEG), amplitude integrated EEG, Near Infrared Spectroscopy, and neuroimaging. Brazil is a large country with disparities in health care assessment and some neonatal intensive care units (NICUs) are not well structured with trained personnel able to provide adequate neurocritical care. To reduce this existing gap, an advanced telemedicine model of neurocritical care called Protecting Brains and Saving Futures (PBSF) Guidelines was developed and implemented in a group of Brazilian NICUs. Methods A prospective, multicenter, and observational study will be conducted in all 20 Brazilian NICUs using the PBSF Guidelines as standard-of-care. All infants treated accordingly to the guidelines during Dec 2021 to Nov 2024 will be eligible. Ethical approval was obtained from participating centers. The primary objective is to describe adherence to the PBSF Guidelines and clinical outcomes, by center and over a 3-year period. Adherence will be measured by quantification of neuromonitoring, neuroimaging exams, sub-specialties consultation, and clinical case discussions and videoconference meetings. Clinical outcomes of interest are detection of seizures during hospitalization, use of anticonvulsants, inotropes, and fluid resuscitation, death before hospital discharge, length of hospital stay, and referral of patients to specialized follow-up. Discussion The study will provide evaluation of PBSF Guidelines adherence and its impact on clinical outcomes. Thus, data from this large prospective, multicenter, and observational study will help determine whether neonatal neurocritical care via telemedicine can be effective. Ultimately, it may offer the necessary framework for larger scale implementation and development of research projects using remote neuromonitoring.	[Todeschi Variane, Gabriel Fernando; Magalhaes, Mauricio; Rodrigues Pietrobom, Rafaela Fabri; Netto, Alexandre; Gasperini, Renato] Irmandade Santa Casa Misericordia Sao Paulo, Neonatal Div, Dept Pediat, Sao Paulo, Brazil; [Todeschi Variane, Gabriel Fernando] Grp Santa Joana, Neonatal Div, Sao Paulo, Brazil; [Todeschi Variane, Gabriel Fernando; Magalhaes, Mauricio; Rodrigues Pietrobom, Rafaela Fabri; Netto, Alexandre; Rodrigues, Daniela Pereira; Gasperini, Renato] Protecting Brains & Saving Futures Org, Sao Paulo, Brazil; [Magalhaes, Mauricio; Gasperini, Renato] Hosp Israelita Albert Einstein, Neonatal Unit, Sao Paulo, Brazil; [Magalhaes, Mauricio] Fac Ciencias Med Santa Casa Sao Paulo, Sao Paulo, Brazil; [Rodrigues, Daniela Pereira] Univ Fed Sao Paulo, Pediat Nursing Dept, Escola Paulista Enfermagem, Sao Paulo, Brazil; [Sant'Anna, Guilherme Mendes] McGill Univ, Neonatal Div, Hlth Ctr, Quebec City, PQ, Canada	Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Faculdade de Ciencias Medicas Santa Casa de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); McGill University	Variane, GFT (corresponding author), Irmandade Santa Casa Misericordia Sao Paulo, Neonatal Div, Dept Pediat, Sao Paulo, Brazil.; Variane, GFT (corresponding author), Grp Santa Joana, Neonatal Div, Sao Paulo, Brazil.	gabriel.variane@pbsf.com.br		Variane, Gabriel/0000-0001-9390-6562; Pereira Rodrigues, Daniela/0000-0002-8865-939X	Protecting Brain and Saving Futures (PBSF) Organization	Protecting Brain and Saving Futures (PBSF) Organization	GFTV and AN received funds from the Protecting Brain and Saving Futures (PBSF) Organization (www.pbsf.com.br).Both authors were involved in the design of the study, data collection and analysis, writing of the final manuscript, and decision to publish. PBSF Organization is registered with CNPJ 28.905.143/0001-61, headquartered at Av. Nove de Julho, 3229 -13rd floor, room 1301 -Jardim Paulista, Sao Paulo, SP, Brazil -01407-000, E-mail: contato@pbsf.com.br; Phone: + 55 (11) 30442557.	Abend NS, 2013, LANCET NEUROL, V12, P1170, DOI 10.1016/S1474-4422(13)70246-1; Alderliesten T, 2017, J CEREBR BLOOD F MET, V37, P902, DOI 10.1177/0271678X16647737; Ancora G, 2013, BRAIN DEV-JPN, V35, P26, DOI 10.1016/j.braindev.2011.09.008; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Bosi G, 2003, J PEDIATR-US, V142, P690, DOI 10.1067/mpd.2003.243; Burke BL, 2015, PEDIATRICS, V136, pE293, DOI 10.1542/peds.2015-1517; Burnett AC, 2018, CLIN PERINATOL, V45, P485, DOI 10.1016/j.clp.2018.05.005; Chandrasekaran M, 2017, J PERINATOL, V37, P684, DOI 10.1038/jp.2017.14; Cheong JL, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2016.4805; Chock VY, 2016, PEDIATR RES, V80, P675, DOI 10.1038/pr.2016.148; Clair MP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172991; Colasacco C, 2011, WORLD J PEDIATR CONG, V2, P536, DOI 10.1177/2150135111411932; de Vries LS, 2010, ARCH DIS CHILD-FETAL, V95, pF220, DOI 10.1136/adc.2008.148205; del Rio R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165744; Dimitropoulos A, 2013, NEUROLOGY, V81, P241, DOI 10.1212/WNL.0b013e31829bfdcf; Dodge-Khatami J, 2012, WORLD J PEDIATR CONG, V3, P221, DOI 10.1177/2150135111426298; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Frenkel N, 2011, CLIN NEUROPHYSIOL, V122, P1091, DOI 10.1016/j.clinph.2010.09.028; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunn JK, 2012, INTENS CARE MED, V38, P1539, DOI 10.1007/s00134-012-2608-y; Gunn JK, 2012, ANN THORAC SURG, V93, P170, DOI 10.1016/j.athoracsur.2011.08.014; Hall RW, 2010, ETHNIC DIS, V20, P136; Hanson SJ, 2009, PEDIATR EMERG CARE, V25, P150, DOI 10.1097/PEC.0b013e31819a7f60; Helderman JB, 2010, EARLY HUM DEV, V86, P509, DOI 10.1016/j.earlhumdev.2010.06.006; Hellstrom-Westas L., 2006, NEOREVIEWS, DOI [DOI 10.1542/NEO.7-2-E76, 10.1542/neo.7-2-e76]; Hellstrom-Westas L, 2006, SEMIN FETAL NEONAT M, V11, P503, DOI 10.1016/j.siny.2006.07.011; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF34, DOI 10.1136/fn.72.1.F34; HELLSTROMWESTAS L, 1991, NEUROPEDIATRICS, V22, P27, DOI 10.1055/s-2008-1071411; Hoffman GM, 2017, ANN THORAC SURG, V103, P1527, DOI 10.1016/j.athoracsur.2016.09.100; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hyttel-Sorensen S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7635; Jain SV, 2017, EARLY HUM DEV, V113, P55, DOI 10.1016/j.earlhumdev.2017.07.008; Johnson BA, 2009, ANN THORAC SURG, V87, P571, DOI 10.1016/j.athoracsur.2008.10.043; Joseph RM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4343; Kahn JM, 2016, MED CARE, V54, P319, DOI 10.1097/MLR.0000000000000485; Klebermass K, 2011, PEDIATR RES, V70, P102, DOI 10.1203/PDR.0b013e31821ba200; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Latal B, 2016, J PEDIATR-US, V178, P55, DOI 10.1016/j.jpeds.2016.06.050; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lemmers PMA, 2008, PEDIATRICS, V121, P142, DOI 10.1542/peds.2007-0925; Lemmers PMA, 2013, PEDIATR RES, V74, P180, DOI 10.1038/pr.2013.84; Limperopoulos C, 1999, PEDIATRICS, V103, P402, DOI 10.1542/peds.103.2.402; Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; Mastrangelo M, 2013, SEIZURE-EUR J EPILEP, V22, P703, DOI 10.1016/j.seizure.2013.05.006; McConnochie K, 2010, TELEMED J E-HEALTH, V16, P280, DOI 10.1089/tmj.2009.0112; Ministerio da Saude, DATASUS; Murray DM, 2008, ARCH DIS CHILD-FETAL, V93, pF187, DOI 10.1136/adc.2005.086314; Olischar M, 2012, NEONATOLOGY, V102, P203, DOI 10.1159/000339567; Pauliah SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058834; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Pichler G, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00015; Prempunpong C, 2018, J PERINATOL, V38, P80, DOI 10.1038/jp.2017.164; Rakshasbhuvankar A, 2015, SEIZURE-EUR J EPILEP, V33, P90, DOI 10.1016/j.seizure.2015.09.014; Robertson CMT., 2003, FETAL NEONATAL BRAIN, V3. Ed, P829; Maldonado JMSD, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00155615; Sarkar S, 2008, J PERINATOL, V28, P117, DOI 10.1038/sj.jp.7211882; Shah DK, 2008, PEDIATRICS, V121, P1146, DOI 10.1542/peds.2007-1839; Shah DK, 2010, PEDIATR RES, V67, P102, DOI 10.1203/PDR.0b013e3181bf5914; Shah NA, 2015, ARCH DIS CHILDHOOD-E, V100, P75, DOI 10.1136/archdischild-2013-305676; SHANKARAN S, 1991, EARLY HUM DEV, V25, P135, DOI 10.1016/0378-3782(91)90191-5; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Skranes JH, 2017, J PEDIATR-US, V187, P34, DOI 10.1016/j.jpeds.2017.04.041; Sood BG, 2015, SEMIN FETAL NEONAT M, V20, P164, DOI 10.1016/j.siny.2015.03.008; Soubasi V, 2012, EUR J PAEDIATR NEURO, V16, P625, DOI 10.1016/j.ejpn.2012.02.008; Srinivasakumar P, 2015, PEDIATRICS, V136, pE1302, DOI 10.1542/peds.2014-3777; Tekgul H, 2006, PEDIATRICS, V117, P1270, DOI 10.1542/peds.2005-1178; ter Horst HJ, 2010, EARLY HUM DEV, V86, P759, DOI 10.1016/j.earlhumdev.2010.08.028; Thoresen M, 2010, PEDIATRICS, V126, pE131, DOI 10.1542/peds.2009-2938; Variane GFT, 2017, J PEDIAT-BRAZIL, V93, P460, DOI 10.1016/j.jped.2016.12.003; Toso PA, 2014, J PEDIAT-BRAZIL, V90, P143, DOI 10.1016/j.jped.2013.07.004; Triulzi F, 2006, PEDIATR RADIOL, V36, P608, DOI 10.1007/s00247-006-0203-5; Udeh Chiedozie, 2018, Methodist Debakey Cardiovasc J, V14, P126, DOI 10.14797/mdcj-14-2-126; Underwood MA, 2007, NEONATOLOGY, V91, P134, DOI 10.1159/000097131; van Bel F, 2008, NEONATOLOGY, V94, P237, DOI 10.1159/000151642; van Rooij LGM, 2005, ARCH DIS CHILD-FETAL, V90, P245, DOI 10.1136/adc.2004.064964; van Rooij LGM, 2010, PEDIATRICS, V125, pE358, DOI 10.1542/peds.2009-0136; Variane GF, 2019, AM J PERINAT, V36, P1150, DOI 10.1055/s-0038-1676052; Variane GFT, 2020, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00560; Vesoulis ZA, 2014, PEDIATR RES, V75, P564, DOI 10.1038/pr.2013.245; WHO (World Health Organization), 2013, SCHIST PROGR REP 200; Wikstrom S, 2012, ACTA PAEDIATR, V101, P719, DOI 10.1111/j.1651-2227.2012.02677.x; World Health Organization, 1998, HLTH TEL POL SUPP WH; World Health Organization, 2010, TEL OPP DEV MEMB STA	86	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262581	10.1371/journal.pone.0262581	http://dx.doi.org/10.1371/journal.pone.0262581			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020756	Green Published, gold			2022-12-27	WOS:000834207700054
J	Acquah, GE; Hernandez-Allica, J; Thomas, CL; Dunham, SJ; Towett, EK; Drake, LB; Shepherd, KD; McGrath, SP; Haefele, SM				Acquah, Gifty E.; Hernandez-Allica, Javier; Thomas, Cathy L.; Dunham, Sarah J.; Towett, Erick K.; Drake, Lee B.; Shepherd, Keith D.; McGrath, Steve P.; Haefele, Stephan M.			Portable X-ray fluorescence (pXRF) calibration for analysis of nutrient concentrations and trace element contaminants in fertilisers	PLOS ONE			English	Article							CADMIUM CONTENT; SOILS; XRF; APPLICABILITY; SPECTROMETRY	With the increasing popularity of local blending of fertilisers, the fertiliser industry faces issues regarding quality control and fertiliser adulteration. Another problem is the contamination of fertilisers with trace elements that have been shown to subsequently accumulate in the soil and be taken up by plants, posing a danger to the environment and human health. Conventional characterisation methods necessary to ensure the quality of fertilisers and to comply with local regulations are costly, time consuming and sometimes not even accessible. Alternatively, using a wide range of unamended and intentionally amended fertilisers this study developed empirical calibrations for a portable handheld X-ray fluorescence (pXRF) spectrometer, determined the reliability for estimating the macro and micro nutrients and evaluated the use of the pXRF for the high-throughput detection of trace element contaminants in fertilisers. The models developed using pXRF for Mg, P, S, K, Ca, Mn, Fe, Zn and Mo had R-2 values greater or equal to 0.97. These models also performed well on validation, with R-2 values greater or equal to 0.97 (except for Fe, R-val(2 )= 0.55) and slope values ranging from 0.81 to 1.44. A second set of models were developed with a focus on trace elements in amended fertilisers. The R-2 values of calibration for Co, Ni, As, Se, Cd and Pb were greater than or equal to 0.80. At concentrations up to 1000 mg kg(-1), good validation statistics were also obtained; R-2 values ranged from 0.97-0.99, except in one instance. The regression coefficients of the validation also had good prediction in the range of 0-100 mg kg(-1) (R-2 values were from 0.78-0.99), but not as well at lower concentrations up to 20 mg kg(-1) (R-2 values ranged from 0.10-0.99), especially for Cd. This study has demonstrated that pXRF can measure several major (P, Ca) and micro (Mn, Fe, Cu) nutrients, as well as trace elements and potential contaminants (Cr, Ni, As) in fertilisers with high accuracy and precision. The results obtained in this study is good, especially considering that loose powders were scanned for a maximum of 90 seconds without the use of a vacuum pump.	[Acquah, Gifty E.; Hernandez-Allica, Javier; Thomas, Cathy L.; Dunham, Sarah J.; McGrath, Steve P.; Haefele, Stephan M.] Rothamsted Res, Dept Sustainable Agr Sci, Harpenden, Herts, England; [Towett, Erick K.; Shepherd, Keith D.] World Agroforestry ICRAF, Nairobi, Kenya; [Drake, Lee B.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; CGIAR; World Agroforestry (ICRAF); University of New Mexico	Acquah, GE (corresponding author), Rothamsted Res, Dept Sustainable Agr Sci, Harpenden, Herts, England.	gifty.acquah@rothamsted.ac.uk	McGrath, Steve P/B-5127-2008; Dunham, Sarah/C-3331-2017; Shepherd, Keith/N-6627-2016; Haefele, Stephan/E-1256-2017	McGrath, Steve P/0000-0003-0952-8947; Dunham, Sarah/0000-0003-4701-199X; Shepherd, Keith/0000-0001-7144-3915; Acquah, Gifty/0000-0003-4269-0903; Thomas, Cathy/0000-0002-6320-9923; Haefele, Stephan/0000-0003-0389-8373	UK-BBSRC [BBS/E/C/000I0310]; Bill & Melinda Gates Foundation (BMGF), through the Africa Soil Information Service (AfSIS); Innovative Solutions for Decision Agriculture Ltd (iSDA)	UK-BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bill & Melinda Gates Foundation (BMGF), through the Africa Soil Information Service (AfSIS); Innovative Solutions for Decision Agriculture Ltd (iSDA)	SPM and SMH were funded by the Institute Strategic Programme grant, "Soils to Nutrition", UK-BBSRC grant number BBS/E/C/000I0310. This work was also supported by the Bill & Melinda Gates Foundation (BMGF), through the Africa Soil Information Service (AfSIS) and Innovative Solutions for Decision Agriculture Ltd (iSDA), a social enterprise with a mission to improve smallholder farmer profitability across Africa. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bold T., 2015, LOW QUALITY LOW RETU; Brent RN, 2017, J ENVIRON CHEM ENG, V5, P768, DOI 10.1016/j.jece.2016.12.056; Bruker, 2010, APEXZ SAINT SADABS; EPA, 1988, 6200 USEPA; Food and Agricultural Organization of the United Nations (FAO), 2019, FAO YB FISHERY AQUAC, P1, DOI DOI 10.30875/E36CFD60-EN; Guerra MBB, 2018, J BRAZIL CHEM SOC, V29, P1086, DOI 10.21577/0103-5053.20170229; Hall WL., 2014, J AOAC INT, V97; Hasikova J, 2014, PROCEDIA ENGINEER, V83, P455, DOI 10.1016/j.proeng.2014.09.078; Higueras P, 2012, J GEOCHEM EXPLOR, V113, P3, DOI 10.1016/j.gexplo.2011.02.005; International Diabetes Federation, 2019, IDF DIABETES ATLAS, VNinth; Jang M, 2010, ENVIRON GEOCHEM HLTH, V32, P207, DOI 10.1007/s10653-009-9276-z; JONES KC, 1992, ENVIRON SCI TECHNOL, V26, P834, DOI 10.1021/es00028a026; Lucas-Tooth HJ., 1961, METALLURGIA, V64, P149; Mackey EA, 2007, ANAL BIOANAL CHEM, V387, P2401, DOI 10.1007/s00216-007-1124-3; Makinen E, 2006, WATER AIR SOIL POLL, V171, P95, DOI 10.1007/s11270-005-9017-6; MCGRATH SP, 1985, J SCI FOOD AGR, V36, P794, DOI 10.1002/jsfa.2740360906; McLaren TI, 2012, SOIL SCI SOC AM J, V76, P1446, DOI 10.2136/sssaj2011.0355; McLaren TI, 2012, SOIL SCI SOC AM J, V76, P1436, DOI 10.2136/sssaj2011.0354; Mortvedt JJ, 1996, FERT RES, V43, P55, DOI 10.1007/BF00747683; Nazaroff AJ, 2010, J ARCHAEOL SCI, V37, P885, DOI 10.1016/j.jas.2009.11.019; NICHOLSON FA, 1994, ENVIRON SCI TECHNOL, V28, P2170, DOI 10.1021/es00061a027; Paltridge NG, 2012, PLANT SOIL, V361, P251, DOI 10.1007/s11104-011-1104-4; Perroy RL, 2014, SCI TOTAL ENVIRON, V487, P72, DOI 10.1016/j.scitotenv.2014.03.102; Rademaker K, 2013, GEOLOGY, V41, P779, DOI 10.1130/G34313.1; Radu T, 2009, J HAZARD MATER, V171, P1168, DOI 10.1016/j.jhazmat.2009.06.062; Resende LV, 2016, TALANTA, V147, P485, DOI 10.1016/j.talanta.2015.10.007; Rouillon M, 2016, ENVIRON POLLUT, V214, P255, DOI 10.1016/j.envpol.2016.03.055; Sanabria J., 2013, QUALITY FERTILISER T; Smolders E., 2013, REVISITING UPDATING, P14; Stockmann U, 2016, CATENA, V139, P220, DOI 10.1016/j.catena.2016.01.007; Towett EK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242821; Towett EK, 2016, X-RAY SPECTROM, V45, P117, DOI 10.1002/xrs.2678; Vanhoof C, 2013, X-RAY SPECTROM, V42, P224, DOI 10.1002/xrs.2485; Weindorf DC, 2012, ENVIRON MONIT ASSESS, V184, P217, DOI 10.1007/s10661-011-1961-6	34	0	0	8	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262460	10.1371/journal.pone.0262460	http://dx.doi.org/10.1371/journal.pone.0262460			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015770	gold, Green Published			2022-12-27	WOS:000814820600023
J	Kim, KY; Kim, KM				Kim, Kyong Young; Kim, Kyoung Min			Similarities and differences between bone quality parameters, trabecular bone score and femur geometry	PLOS ONE			English	Article							FRACTURE RISK; OSTEOPOROTIC FRACTURES; MINERAL DENSITY; UNITED-STATES; FEMORAL-NECK; HIP; TBS; WOMEN; MICROARCHITECTURE; STRENGTH	Bone quality is a critical factor that, along with bone quantity, determines bone strength. Image-based parameters are used for assessing bone quality non-invasively. The trabecular bone score (TBS) is used to assess quality of trabecular bone and femur geometry for cortical bone. Little is known about the associations between these two bone quality parameters and whether they show differences in the relationships with age and body mass index (BMI). We investigated the associations between the trabecular bone score (TBS) and femur cortical geometry. Areal bone mineral density (BMD) was assessed using dual energy X-ray absorptiometry (DXA) and the TBS was assessed using iNsight software and, femur geometry using APEX (Hologic). A total of 452 men and 517 women aged 50 years and older with no medical history of a condition affecting bone metabolism were included. Z-scores for TBS and cortical thickness were calculated using the age-specific mean and SD for each parameter. A 'discrepancy group' was defined as patients whose absolute Z-score difference between TBS and cortical thickness was > 1 point. TBS and cortical thickness correlated negatively with age both in men and women, but the associations were stronger in women. Regarding the associations with BMI, TBS provided significant negative correlation with BMI in the range of BMI > 25 kg/m(2). By contrast, cortical thickness correlated positively with BMI for all BMI ranges. These bone quality-related parameters, TBS and cortical thickness, significantly correlated, but discordance between these two parameters was observed in about one-third of the men and women (32.7% and 33.4%, respectively). Conclusively, image-based bone quality parameters for trabecular and cortical bone exhibit both similarities and differences in terms of their associations with age and BMI. These different profiles in TBS and FN cortical thickness might results in different risk profiles for the vertebral fractures or hip fractures in a certain percentage of people.	[Kim, Kyong Young] Gyeongsang Natl Univ, Dept Internal Med, Changwon Hosp, Chang Won, South Korea; [Kim, Kyoung Min] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; [Kim, Kyoung Min] Seoul Natl Univ, Coll Med, Seongnam, South Korea; [Kim, Kyoung Min] Yonsei Univ, Yongin Severance Hosp, Dept Internal Med, Div Endocrinol,Coll Med, Yongin, South Korea	Gyeongsang National University; Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System	Kim, KM (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.; Kim, KM (corresponding author), Seoul Natl Univ, Coll Med, Seongnam, South Korea.; Kim, KM (corresponding author), Yonsei Univ, Yongin Severance Hosp, Dept Internal Med, Div Endocrinol,Coll Med, Yongin, South Korea.	kyoungmin.kim@yonsei.ac.kr						Albala C, 1996, INT J OBESITY, V20, P1027; Ayoub ML, 2016, J CLIN DENSITOM, V19, P544, DOI 10.1016/j.jocd.2016.03.004; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beck T., 2002, HIP STRUCTURAL ANAL, P11; Beck TJ, 2009, J BONE MINER RES, V24, P1369, DOI [10.1359/JBMR.090307, 10.1359/jbmr.090307]; Boutroy S, 2013, OSTEOPOROSIS INT, V24, P77, DOI 10.1007/s00198-012-2188-2; Broy SB, 2015, J CLIN DENSITOM, V18, P287, DOI 10.1016/j.jocd.2015.06.005; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Carda S, 2009, CEREBROVASC DIS, V28, P191, DOI 10.1159/000226578; Cohen A, 2013, J CLIN ENDOCR METAB, V98, P2562, DOI 10.1210/jc.2013-1047; Crabtree NJ, 2002, OSTEOPOROSIS INT, V13, P48, DOI 10.1007/s198-002-8337-y; Danielson ME, 2013, OSTEOPOROSIS INT, V24, P1379, DOI 10.1007/s00198-012-2066-y; Fink HA, 2008, J CLIN DENSITOM, V11, P250, DOI 10.1016/j.jocd.2007.12.018; Hans D, 2011, J BONE MINER RES, V26, P2762, DOI 10.1002/jbmr.499; Harvey NC, 2015, BONE, V78, P216, DOI 10.1016/j.bone.2015.05.016; Hong AR, 2019, J BONE MINER METAB, V37, P835, DOI 10.1007/s00774-018-0980-6; Iki M, 2014, J BONE MINER RES, V29, P399, DOI 10.1002/jbmr.2048; Kaptoge S, 2008, J BONE MINER RES, V23, P1892, DOI [10.1359/jbmr.080802, 10.1359/JBMR.080802]; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; KOHRT WM, 1995, J BONE MINER RES, V10, P1303, DOI 10.1002/jbmr.5650100906; Leib E, 2014, BONE, V62, P51, DOI 10.1016/j.bone.2013.12.015; Link Thomas M, 2004, Curr Osteoporos Rep, V2, P47, DOI 10.1007/s11914-004-0003-5; Lloyd M, 1998, NEW ENGL J MED, V339, P202; Martineau P, 2015, SEMIN NUCL MED, V45, P458, DOI 10.1053/j.semnuclmed.2015.02.001; Mayhew PM, 2005, LANCET, V366, P129, DOI 10.1016/S0140-6736(05)66870-5; MAZESS RB, 1990, J BONE MINER RES, V5, P645; Moayyeri Alireza, 2005, BMC Endocr Disord, V5, P3, DOI 10.1186/1472-6823-5-3; Mounach A., 2009, SEMIN ARTHRITIS RHEU; Paschalis EP, 2011, CLIN ORTHOP RELAT R, V469, P2170, DOI 10.1007/s11999-010-1751-4; Poole KES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038466; Pothuaud L, 2008, BONE, V42, P775, DOI 10.1016/j.bone.2007.11.018; Romagnoli E, 2016, ENDOCRINE, V54, P342, DOI 10.1007/s12020-016-0857-1; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Syed Zeba, 2002, J Obstet Gynaecol Can, V24, P476; Valderrabano RJ, 2017, J CLIN ENDOCR METAB, V102, P2199, DOI 10.1210/jc.2017-00266; Woodson G, 2000, J CLIN DENSITOM, V3, P319, DOI 10.1385/JCD:3:4:319; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	37	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0260924	10.1371/journal.pone.0260924	http://dx.doi.org/10.1371/journal.pone.0260924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015756	gold, Green Published			2022-12-27	WOS:000814820600001
J	Jorga, SD; Dessie, YL; Kedir, MR; Donacho, DO				Jorga, Sime Daba; Dessie, Yohannes Lulu; Kedir, Mohammed Reshad; Donacho, Dereje Oljira			Prevalence of Tungiasis and its risk factors of among children of Mettu woreda, southwest Ethiopia, 2020	PLOS ONE			English	Article							TUNGA-PENETRANS; COMMUNITIES	Tungiasis is caused by the flea tunga penetrans and results in painful skin lesions, skin infections, and permanent disability. However, limited information is available that shows the magnitude of the problem and its risk factors that help for intervention in Ethiopia. The goal of this study was to determine the prevalence and risk factors of tungiasis in children aged 5 to 14 in Mettu woreda in 2020. A community based cross sectional study was conducted among randomly selected kebeles of Mettu woreda, in Southwest Ethiopia. To select study participants, multistage sampling was used. The data were collected through physical examination of the children, interview of parents/guardians of the children, and observation of the home environment using checklists and questionnaires. The descriptive analysis was done for socio-demographic characteristics, prevalence of tungiasis, and housing conditions. A logistic regression analysis was performed, and variables in multivariable regression reported odds ratios and their 95% confidence intervals once the variables were identified using a p-value of 0.05 as a risk factor of statistical significance. The prevalence of tungiasis among children 5-14 years of age in Mettu rural woreda was 52 percent (n = 821). As a risk factor, large family size (AOR: 2.9, 95% CI: 2.13, 4.40); school attendance (AOR: 1.5, 95% CI: 1.02, 2.18), floor inside the house (AOR: 3.8, 95% CI: 1.76, 8.43); having sleeping bed (AOR: 0.16, 95% CI: 0.03, 0.82); access to protected water sources (AOR: 0.24, 95% CI: 0.15, 0.39); access to improved toilet facilities(AOR: 0.63: 95% CI: 0.44, 0.89); access to electric services (AOR: 0.30, 95% CI: 0.15, 0.62); and lack of own farmland (AOR: 0.36, 95% CI: 0.26, 0.50) were found. Therefore, planning and implementation of interventions focus on those risk factors that are particularly important. Water, sanitation and hygiene interventions, and livelihood improvement interventions are required to solve the problem in the setting.	[Jorga, Sime Daba; Kedir, Mohammed Reshad] Mettu Univ, Coll Hlth Sci, Dept Publ Hlth, Metu, Ethiopia; [Dessie, Yohannes Lulu] Mettu Univ, Coll Hlth Sci, Dept Nursing, Metu, Ethiopia; [Donacho, Dereje Oljira] Mettu Univ, Coll Hlth Sci, Dept Hlth Informat, Jimma, Ethiopia; [Donacho, Dereje Oljira] Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia	Jimma University	Donacho, DO (corresponding author), Mettu Univ, Coll Hlth Sci, Dept Hlth Informat, Jimma, Ethiopia.; Donacho, DO (corresponding author), Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia.	dodbau3687@gmail.com	Donacho, Dereje Oljira/AAS-7401-2021	Donacho, Dereje Oljira/0000-0001-6145-2914				[Anonymous], JIGGERS REMOVAL PROG; CSA Ethiopia, 2013, POPULATION PROJECTIO, P118; Feldmeier H, 2013, EUR J CLIN MICROBIOL, V32, P19, DOI 10.1007/s10096-012-1725-4; Feldmeier H, 2003, EMERG INFECT DIS, V9, P949; Feldmeier H, 2013, TRAVEL MED INFECT DI, V11, P357, DOI 10.1016/j.tmaid.2013.10.001; Feldmeier H, 2009, B WORLD HEALTH ORGAN, V87, P152, DOI 10.2471/BLT.07.047308; Franck Sabine, 2003, Travel Med Infect Dis, V1, P159, DOI 10.1016/j.tmaid.2003.09.005; Girma M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3373-5; Heukelbach J, 2004, B WORLD HEALTH ORGAN, V82, P563; Heukelbach J, 2007, J INFECT DEV COUNTR, V1; IBM Corp. Released, 2011, IBM SPSS STAT WINDOW; Karunamoorthi K, 2013, PARASITOL RES, V112, P3635, DOI 10.1007/s00436-013-3551-8; Lauritsen JM., 2004, EPIDATA VERSION 3 1; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Mazengia AL, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/7521751; Muehlen M, 2006, T ROY SOC TROP MED H, V100, P371, DOI 10.1016/j.trstmh.2005.06.033; Mutebi F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004126; Obebe OO, 2020, PATHOG GLOB HEALTH, V114, P360, DOI 10.1080/20477724.2020.1813489; Pilger D, 2008, PARASITOL RES, V102, P875, DOI 10.1007/s00436-007-0840-0; Ramaswamy V., 2016, INT J INTEGR MED SCI, V3, P211, DOI DOI 10.16965/IJIMS; Sachse MM, 2007, J EUR ACAD DERMATOL, V21, P11, DOI 10.1111/j.1468-3083.2006.01888.x; Ugbomoiko US, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000087; Ugbomoiko US, 2007, INT J DERMATOL, V46, P475, DOI 10.1111/j.1365-4632.2007.03245.x; Wafula ST, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.77.8916; Walker SL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005808; Winter B, 2009, J INFECT DEV COUNTR, V3, P458, DOI 10.3855/jidc.418	26	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262168	10.1371/journal.pone.0262168	http://dx.doi.org/10.1371/journal.pone.0262168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986188	Green Published, gold			2022-12-27	WOS:000765956200020
J	Kudzia, P; Jackson, E; Dumas, G				Kudzia, Pawel; Jackson, Erika; Dumas, Genevieve			Estimating body segment parameters from three-dimensional human body scans	PLOS ONE			English	Article							INERTIAL PARAMETERS; RELIABILITY; SENSITIVITY; VALIDATION; VOLUME; TRUNK; MODEL; ACCURACY; KINECT; ERROR	Body segment parameters are inputs for a range of applications. Participant-specific estimates of body segment parameters are desirable as this requires fewer prior assumptions and can reduce outcome measurement errors. Commonly used methods for estimating participant-specific body segment parameters are either expensive and out of reach (medical imaging), have many underlying assumptions (geometrical modelling) or are based on a specific subset of a population (regression models). Our objective was to develop a participant-specific 3D scanning and body segmentation method that estimates body segment parameters without any assumptions about the geometry of the body, ethnic background, and gender, is low-cost, fast, and can be readily available. Using a Microsoft Kinect Version 2 camera, we developed a 3D surface scanning protocol that enabled the estimation of participant-specific body segment parameters. To evaluate our system, we performed repeated 3D scans of 21 healthy participants (10 male, 11 female). We used open source tools to segment each body scan into 16 segments (head, torso, abdomen, pelvis, left and right hand, forearm, upper arm, foot, shank and thigh) and wrote custom software to estimate each segment's mass, mass moment of inertia in the three principal orthogonal axes relevant to the center of the segment, longitudinal length, and center of mass. We compared our body segment parameter estimates to those obtained using two comparison methods and found that our system was consistent in estimating total body volume between repeated scans (male p = 0.1194, female p = 0.2240), estimated total body mass without significant differences when compared to our comparison method and a medical scale (male p = 0.8529, female p = 0.6339), and generated consistent and comparable estimates across a range of the body segment parameters of interest. Our work here outlines and provides the code for an inexpensive 3D surface scanning method for estimating a range of participant-specific body segment parameters.	[Kudzia, Pawel] Simon Fraser Univ, Dept Engn Sci, Burnaby, BC, Canada; [Kudzia, Pawel; Jackson, Erika; Dumas, Genevieve] Queens Univ, Dept Mech & Mat Engn, Kingston, ON, Canada	Simon Fraser University; Queens University - Canada	Kudzia, P (corresponding author), Simon Fraser Univ, Dept Engn Sci, Burnaby, BC, Canada.; Kudzia, P (corresponding author), Queens Univ, Dept Mech & Mat Engn, Kingston, ON, Canada.	pawel.kudzia5@gmail.com		Kudzia, Pawel/0000-0002-6667-2913	NSERC Canada [A6858]	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	G.D received funding from NSERC Canada Discovery Grant A6858. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad O., 2017, P 3DBODY TECH 2017 8; Andrews JG, 1996, J BIOMECH, V29, P651, DOI 10.1016/0021-9290(95)00118-2; Arena SL, 2017, J APPL BIOMECH, V33, P76, DOI 10.1123/jab.2016-0029; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bourgeois B, 2017, EUR J CLIN NUTR, V71, P1329, DOI 10.1038/ejcn.2017.142; Buffa R, 2015, SENSORS-BASEL, V15, P12342, DOI 10.3390/s150612342; Chambers AJ, 2010, CLIN BIOMECH, V25, P131, DOI 10.1016/j.clinbiomech.2009.10.015; Chandler R., 1975, INVESTIGATION INERTI; Cheng CK, 2000, CLIN BIOMECH, V15, P559, DOI 10.1016/S0268-0033(00)00016-4; Chiu CY, 2016, INT J SPORTS MED, V37, P1117, DOI 10.1055/s-0042-112589; Chiu CY, 2016, IET SCI MEAS TECHNOL, V10, P553, DOI 10.1049/iet-smt.2015.0252; Cignoni p, 2008, P 6 EUR IT CHAPT C S; Clarkson S., 2012, P 3 INT C 3D BOD SCA, P153; Clauser C., 1969, WEIGHT VOLUME CTR MA, DOI DOI 10.21236/AD0710622; Damavandi M, 2009, MED ENG PHYS, V31, P880, DOI 10.1016/j.medengphy.2009.03.008; Das AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179264; Das B, 1996, APPL ERGON, V27, P157, DOI 10.1016/0003-6870(96)00008-7; Deffeyes J., 2005, ISBS C P ARCH; Dembia Christopher, 2014, F1000Res, V3, P223, DOI 10.12688/f1000research.5292.2; DEMPSTER WILFRED TAYLOR, 1955, U S A F WRIGHT AIR DEVELOPMENT CENTER TECH REPT, V55/159, P1; Durkin JL, 2006, ANN BIOMED ENG, V34, P1483, DOI 10.1007/s10439-006-9088-6; EBERLY D, 1991, CVGIP-GRAPH MODEL IM, V53, P550, DOI 10.1016/1049-9652(91)90005-5; Espitia-Contreras A, 2014, 2014 IEEE VIRTUAL REALITY (VR), P71, DOI 10.1109/VR.2014.6802056; Gerke O, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10050334; HATZE H, 1980, J BIOMECH, V13, P833, DOI 10.1016/0021-9290(80)90171-2; Ho WH, 2013, MED SCI SPORT EXER, V45, P1759, DOI 10.1249/MSS.0b013e3182923b2a; Jackson E, 2017, BODY SEGMENT INERTIA; JENSEN RK, 1978, J BIOMECH, V11, P349, DOI 10.1016/0021-9290(78)90069-6; Kongsro J, 2014, COMPUT ELECTRON AGR, V109, P32, DOI 10.1016/j.compag.2014.08.008; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kowalski M, 2015, 2015 INTERNATIONAL CONFERENCE ON 3D VISION, P318, DOI 10.1109/3DV.2015.43; Kudzia P, 2015, ESTIMATING BODY SEGM; Kwon YH, 1996, J APPL BIOMECH, V12, P413, DOI 10.1123/jab.12.4.413; Lachat E, 2015, INT ARCH PHOTOGRAMM, V40-5, P93, DOI 10.5194/isprsarchives-XL-5-W4-93-2015; Laschowski B, 2016, SPORTS ENG, V19, P155, DOI 10.1007/s12283-016-0200-3; McIlwain J, 1998, SLICER COMPUTER SOFT; Narang YS, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034168; Pandis P, 2017, P I MECH ENG H, V231, P1064, DOI 10.1177/0954411917727031; Pataky TC, 2003, CLIN BIOMECH, V18, P364, DOI 10.1016/S0268-0033(03)00015-9; Pearsall DJ, 1996, ANN BIOMED ENG, V24, P198, DOI 10.1007/BF02667349; Pearsall DJ, 1999, GAIT POSTURE, V9, P173, DOI 10.1016/S0966-6362(99)00011-9; Peyer KE, 2015, PEERJ, V3, DOI 10.7717/peerj.831; Rao G, 2006, J BIOMECH, V39, P1531, DOI 10.1016/j.jbiomech.2005.04.014; Sarbolandi H, 2015, COMPUT VIS IMAGE UND, V139, P1, DOI 10.1016/j.cviu.2015.05.006; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e509; Silva MPT, 2004, GAIT POSTURE, V19, P35, DOI 10.1016/S0966-6362(03)00013-4; Smith SHL, 2018, MED ENG PHYS, V62, P36, DOI 10.1016/j.medengphy.2018.10.001; Soileau L, 2016, EUR J CLIN NUTR, V70, P475, DOI 10.1038/ejcn.2015.132; Stancic I, 2013, MEASUREMENT, V46, P716, DOI 10.1016/j.measurement.2012.09.010; Sunaga Y, 2016, APPL ERGON, V55, P173, DOI 10.1016/j.apergo.2016.02.010; van Soest AJ, 2004, J MOTOR BEHAV, V36, P419, DOI 10.3200/JMBR.36.4.419-424; Wasenmuller O, 2017, LECT NOTES COMPUT SC, V10117, P34, DOI 10.1007/978-3-319-54427-4_3; Wicke J, 2003, J APPL BIOMECH, V19, P3, DOI 10.1123/jab.19.1.3; Wicke J, 2014, J BIOMECH, V47, P1869, DOI 10.1016/j.jbiomech.2014.03.020; Wicke J, 2010, J APPL BIOMECH, V26, P26, DOI 10.1123/jab.26.1.26; Winter D. A., 1990, BIOMECHANICS MOTOR C; Yang L, 2015, IEEE SENS J, V15, P4275, DOI 10.1109/JSEN.2015.2416651; Zatsiorsky VM., 2002, KINETICS HUMAN MOTIO	58	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262296	10.1371/journal.pone.0262296	http://dx.doi.org/10.1371/journal.pone.0262296			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986175	gold, Green Published, Green Submitted			2022-12-27	WOS:000765956200037
J	Dayal, R; Gundi, M				Dayal, Radhika; Gundi, Mukta			Assessment of the quality of sexual and reproductive health services delivered to adolescents at Ujala clinics: A qualitative study in Rajasthan, India	PLOS ONE			English	Article							CARE SERVICES	The Adolescent Friendly Health Clinic (AFHCs), a key component of the Government of India's National Adolescent Health Programme a.k.a. Rashtriya Kishor Swasthya Karyakram (RKSK), aims to increase the accessibility and utilization of sexual-reproductive health services by adolescents and youth. However, low quality of care provided at AFHCs by counsellors calls for attention. We, thus, explore both the clients' and providers' perspectives using the World Health Organization's (WHO) global standards for quality health-care services for adolescents to assess the quality of the sexual reproductive health service delivery at AFHCs in Rajasthan, India. We conducted a qualitative study, comprising observation of the service delivery using mystery clients (MCs) (n = 12) and in-depth interviews with the counsellors (n = 4) in four AFHCs. Interviews were transcribed in local language and were translated in English. The transcripts were coded thematically. Our study, using five of the eight WHO global standards for quality health-care services for adolescents highlighted several gaps in the quality-of-service delivery at AFHCs. We unearth various intricacies related to the quality of the services provided at the AFHCs by referring to the relevant input, process, and the output criteria of WHO global standards I, III, IV, V and VI. Our study calls for efforts to improve- (i) the counsellors' competencies to increase adolescents' health literacy on sensitive topics, (ii) the facilities at the clinic to ensure privacy, comfort and confidentiality of the adolescents seeking services, (iii) the referrals to improve appropriate package of services, and (iv) an overall environment to ensure an equity and non-discrimination for all the adolescents. Our findings unearth the barriers that both the service providers and the adolescents face at the AFHCs and underscore the need for regular monitoring and evaluation of the AFHCs to strengthen the facility-based intervention of the RKSK programme.	[Dayal, Radhika; Gundi, Mukta] Populat Council, Dept Poverty Gender & Youth, New Delhi, India		Dayal, R (corresponding author), Populat Council, Dept Poverty Gender & Youth, New Delhi, India.	radhikadayal@gmail.com			Children's Investment Fund Foundation	Children's Investment Fund Foundation	This paper was written as part of the Udaan project of the Population Council, through the generous support of the Children's Investment Fund Foundation. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Children's Investment Fund Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua A., 2017, INT J ADOLESC MED HL, V29, DOI [10.1515/ijamh-2016-0024/html, DOI 10.1515/IJAMH-2016-0024/HTML]; Boyce C., 2006, PATHFINDER INT TOOL; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Chandra-Mouli V, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1536412; Chandra-Mouli V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-579; Chauhan SL., 2018, INT J COMMUNITY MED, V5, P1639; Ekong I., 2016, INT RES J MED BIOMED, V1, P23, DOI [10.15739/irjmbs.016.005, DOI 10.15739/IRJMBS.016.005]; Hoopes AJ, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0251-8; James S, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3623-7; Jonas K, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2917-0; Mahalakshmy T, 2019, INDIAN J PEDIATR, V86, P132, DOI 10.1007/s12098-018-2755-4; Mchome Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120822; Miles M.B., 2014, QUALITATIVE DATA ANA, V3rd ed.; Ministry of Health and Family Welfare, 2014, RASHTR KISH SWASTH K; Ministry of Health and Family Welfare, 2014, STRAT HDB RASHTR KIS; Ministry of Health and Family Welfare, 2020, LOK SABH UNST QUEST; Ministry of Women and Child Development, 2009, INT CHILD DEV SCHEM; Nair M, 2015, J ADOLESCENT HEALTH, V57, P288, DOI 10.1016/j.jadohealth.2015.05.011; Santhya K.G., 2017, UDAYA UNDERSTANDING, DOI [10.1017/S0021932017000360, DOI 10.1017/S0021932017000360]; Santhya KG., 2014, ACCESSING ADOLESCENT, V7; Santhya KG., 2014, POPULATION REPROD HL, VFirst, P175; Saprii L, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0094-3; Sivagurunathan C, 2015, J CLIN DIAGN RES, V9, pLE01, DOI 10.7860/JCDR/2015/11199.5649; Uddin MJ, 2008, ASIA-PAC J PUBLIC HE, V20, P117, DOI 10.1177/1010539507311328; Uttekar BP., 2008, ASSESSMENT ADOLESCEN; World Health Organization, 2015, GLOB STAND QUAL HLTH; Yadav R. J., 2009, Health and Population - Perspectives and Issues, V32, P96	27	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0261757	10.1371/journal.pone.0261757	http://dx.doi.org/10.1371/journal.pone.0261757			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007310	Green Published, gold			2022-12-27	WOS:000741060700016
J	Kurihara, T; Terada, M; Numasawa, S; Kusagawa, Y; Maeo, S; Kanehisa, H; Isaka, T				Kurihara, Toshiyuki; Terada, Masafumi; Numasawa, Shun; Kusagawa, Yuki; Maeo, Sumiaki; Kanehisa, Hiroaki; Isaka, Tadao			Effects of age and sex on association between toe muscular strength and vertical jump performance in adolescent populations	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; FLEXOR STRENGTH; CHILDREN; MUSCLES; HEIGHT; FLEXIBILITY; SOCCER	Toe muscular strength plays an important role in enhancing athletic performance because the forefoot is the only part of the body touching the ground. In general, muscular strength increases with age throughout adolescence, and sex-related difference in muscular strength becomes evident during childhood and adolescence. However, toe muscular strength is known to be levelled off after late adolescence in both sexes. For adolescent populations, therefore, the association of toe muscular strength with physical performance might differ with age and/or sex. This study aimed to investigate differences in relationships between toe muscular strength and vertical jump performance across sex and age in adolescent populations. The maximum isometric strength of the toe muscles and vertical jump height (VJ) were assessed in 479 junior high school students (JH) aged 12-14 years (243 boys and 236 girls) and 465 high school students (HS) aged 15-18 years (265 boys and 200 girls). Two types of measurements were performed to evaluate the toe muscular strength: toe gripping strength (TGS) with the metatarsophalangeal joint in the plantar flexed position and toe push strength (TPS) with the metatarsophalangeal joint in the dorsiflexed position. TGS and TPS were normalized to body weight. Two-way ANOVA showed that TGS had significant main effects of sex (boys > girls) and age (HS > JH) while TPS only had a significant main effect of sex (boys > girls). When the effects of sex and age were separately analyzed, VJ was significantly correlated with TGS in JH girls, HS girls, and JH boys (r = 0.253-0.269, p < 0.05), but not in HS boys (r = 0.062, p = 0.3351). These results suggest that toe muscular strength is relatively weakly associated with vertical jump performance in adolescent boys and girls, but the association would not be established in high school boys.	[Kurihara, Toshiyuki] Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Shiga, Japan; [Terada, Masafumi; Maeo, Sumiaki; Kanehisa, Hiroaki; Isaka, Tadao] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Numasawa, Shun] Osaka Basketball Assoc, Med Comm, Osaka, Japan; [Kusagawa, Yuki] Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kusatsu, Shiga, Japan	Ritsumeikan University; Ritsumeikan University; Ritsumeikan University	Kurihara, T (corresponding author), Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Shiga, Japan.	t-kuri-a@st.ritsumei.ac.jp		Kusagawa, Yuki/0000-0003-4446-4723; Kurihara, Toshiyuki/0000-0001-9726-1255	JSPS KAKENHI [17K01540, 17H04756]; Japan Sports Agency	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Sports Agency	This work was supported by JSPS KAKENHI Grant Number 17K01540 and 17H04756, and Fund for Female Athletes Development and Support Projects in 2018-2019 by Japan Sports Agency.	BALE P, 1992, J SPORT MED PHYS FIT, V32, P142; Felser S, 2016, SCAND J MED SCI SPOR, V26, P165, DOI 10.1111/sms.12429; Focke A, 2013, EUR J SPORT SCI, V13, P518, DOI 10.1080/17461391.2012.756069; Goldmann JP, 2013, J SPORT SCI, V31, P424, DOI 10.1080/02640414.2012.736627; Goldmann JP, 2012, J ANAT, V221, P187, DOI 10.1111/j.1469-7580.2012.01524.x; Guimaraes E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020776; Hawley VS, 2022, J STRENGTH COND RES, V36, P1860, DOI 10.1519/JSC.0000000000003733; Isaacs LD, 1998, PERCEPT MOTOR SKILL, V86, P659, DOI 10.2466/pms.1998.86.2.659; Kanehisa H, 1995, EUR J APPL PHYSIOL O, V72, P150, DOI 10.1007/BF00964130; Laffaye G, 2016, BIOL SPORT, V33, P29, DOI 10.5604/20831862.1180169; Lloyd RS, 2011, J STRENGTH COND RES, V25, P1889, DOI 10.1519/JSC.0b013e3181e7faa8; Malina Robert, 2004, GROWTH MATURATION PH, DOI DOI 10.1016/j.jsams.2011.04.003; MANN R, 1964, J BONE JOINT SURG AM, V46, P469, DOI 10.2106/00004623-196446030-00001; McKay MJ, 2017, NEUROLOGY, V88, P36, DOI 10.1212/WNL.0000000000003466; Morita N, 2018, EUR J APPL PHYSIOL, V118, P1003, DOI 10.1007/s00421-018-3827-x; Naka H, 2005, J BONE MINER METAB, V23, P463, DOI 10.1007/s00774-005-0629-0; Nariyama K, 2001, AM J HUM BIOL, V13, P356, DOI 10.1002/ajhb.1059; Otsuka M., 2015, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V174, P307; Philippaerts RM, 2006, J SPORT SCI, V24, P221, DOI 10.1080/02640410500189371; Rodriguez-Rosell D, 2017, J STRENGTH COND RES, V31, P196, DOI 10.1519/JSC.0000000000001476; Rouis M, 2015, J SPORT MED PHYS FIT, V55, P1502; Rowley KM, 2015, MED PROBL PERFORM AR, V30, P152, DOI 10.21091/mppa.2015.3029; Smith G, 2012, J SPORT SCI, V30, P1521, DOI 10.1080/02640414.2012.713501; Stefanyshyn DJ, 2000, MED SCI SPORT EXER, V32, P471, DOI 10.1097/00005768-200002000-00032; Taylor MJD, 2010, J SPORT SCI, V28, P867, DOI 10.1080/02640411003770212; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Unger CL, 2000, J STRENGTH COND RES, V14, P373; Uritani D, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-28; van Werkhoven H, 2017, J BIOMECH, V57, P27, DOI 10.1016/j.jbiomech.2017.03.014; Vanezis A, 2005, ERGONOMICS, V48, P1594, DOI 10.1080/00140130500101262; Yamauchi J, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109719; Yuasa Y, 2018, J HUM KINET, V64, P47, DOI 10.1515/hukin-2017-0183	32	1	1	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262100	10.1371/journal.pone.0262100	http://dx.doi.org/10.1371/journal.pone.0262100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972181	gold, Green Published			2022-12-27	WOS:000773555700097
J	Liu, N; Shapira, P; Yue, XX; Guan, JC				Liu, Na; Shapira, Philip; Yue, Xiaoxu; Guan, Jiancheng			Mapping technological innovation dynamics in artificial intelligence domains: Evidence from a global patent analysis	PLOS ONE			English	Article							DIGITAL TRANSFORMATION; NETWORKS; TRENDS	Artificial intelligence (AI) is emerging as a technology at the center of many political, economic, and societal debates. This paper formulates a new AI patent search strategy and applies this to provide a landscape analysis of AI innovation dynamics and technology evolution. The paper uses patent analyses, network analyses, and source path link count algorithms to examine AI spatial and temporal trends, cooperation features, cross-organization knowledge flow and technological routes. Results indicate a growing yet concentrated, non-collaborative and multi-path development and protection profile for AI patenting, with cross-organization knowledge flows based mainly on interorganizational knowledge citation links.	[Liu, Na] Shandong Technol & Business Univ, Sch Management, Yantai, Peoples R China; [Shapira, Philip] Univ Manchester, Alliance Manchester Business Sch, Manchester Inst Innovat Res, Manchester, Lancs, England; [Shapira, Philip] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA; [Yue, Xiaoxu] Tsinghua Univ, Sch Publ Policy & Management, Beijing, Peoples R China; [Guan, Jiancheng] Univ Chinese Acad Sci, Sch Econ & Management, Beijing, Peoples R China	Shandong Technology & Business University; University of Manchester; Alliance Manchester Business School; University System of Georgia; Georgia Institute of Technology; Tsinghua University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shapira, P (corresponding author), Univ Manchester, Alliance Manchester Business Sch, Manchester Inst Innovat Res, Manchester, Lancs, England.; Shapira, P (corresponding author), Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA.	pshapira@manchester.ac.uk		Shapira, Philip/0000-0003-2488-5985	National Natural Science Foundation of China [72174112, 71874176]; Taishan Scholars Program of Shandong Province [Tsqn201909149]; Biotechnology and Biological Sciences Research Council [BB/M017702/1]; Partnership for the Organization of Innovation and New Technologies (Social Science and Humanities Research Council of Canada) [895-2018-1006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Program of Shandong Province; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Partnership for the Organization of Innovation and New Technologies (Social Science and Humanities Research Council of Canada)	NL: grant number 72174112, National Natural Science Foundation of China, http://www.nsfc.gov.cn; grant number Tsqn201909149, Taishan Scholars Program of Shandong Province. PS: grant number BB/M017702/1, Biotechnology and Biological Sciences Research Council, https://bbsrc.ukri.org/; grant number 895-2018-1006, Partnership for the Organization of Innovation and New Technologies (Social Science and Humanities Research Council of Canada), https://www.4point0.ca.JG: grant number 71874176, National Natural Science Foundation of China, http://www.nsfc.gov.cn.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi HHN, 2020, IEEE ACCESS, V8, P81633, DOI 10.1109/ACCESS.2020.2988815; Albino V, 2014, APPL ENERG, V135, P836, DOI 10.1016/j.apenergy.2014.08.012; [Anonymous], 2019, TECHN TRENDS 2019 AR; [Anonymous], 2020, FORTUNEBUSINESSINSIG; Ardito L, 2018, TECHNOL FORECAST SOC, V136, P317, DOI 10.1016/j.techfore.2017.04.022; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Crawford K., 2021, ATLAS; de Paulo AF, 2020, TECHNOL FORECAST SOC, V159, DOI 10.1016/j.techfore.2020.120054; de Rassenfosse G, 2013, RES POLICY, V42, P720, DOI 10.1016/j.respol.2012.11.002; Duguet E, 2005, ECON INNOV NEW TECH, V14, P375, DOI 10.1080/1043859042000307347; Dwivedi YK, 2021, INT J INFORM MANAGE, V57, DOI 10.1016/j.ijinfomgt.2019.08.002; Ernst H, 2001, RES POLICY, V30, P143, DOI 10.1016/S0048-7333(99)00098-0; Evangelista A, 2020, COMPUT IND, V118, DOI 10.1016/j.compind.2020.103221; Frietsch R, 2010, SCIENTOMETRICS, V82, P185, DOI 10.1007/s11192-009-0082-2; Fujii H, 2018, ECON ANAL POLICY, V58, P60, DOI 10.1016/j.eap.2017.12.006; Goralski MA, 2020, INT J MANAG EDUC-OXF, V18, DOI 10.1016/j.ijme.2019.100330; Griliches Z., 1986, VALUE PATENTS INDICA; Guan JC, 2016, RES POLICY, V45, P97, DOI 10.1016/j.respol.2015.08.002; Hinze S, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P215; Huang Y, 2015, SCIENTOMETRICS, V105, P2005, DOI 10.1007/s11192-015-1638-y; HUMMON NP, 1989, SOC NETWORKS, V11, P39, DOI 10.1016/0378-8733(89)90017-8; Jaffe AB, 2017, J ASSOC INF SCI TECH, V68, P1360, DOI 10.1002/asi.23731; Jeong HJ, 2020, INT J TECHNOL MANAGE, V82, P132; Jiang F, 2017, STROKE VASC NEUROL, V2, P230, DOI 10.1136/svn-2017-000101; Liu JS, 2019, SCIENTOMETRICS, V119, P379, DOI 10.1007/s11192-019-03034-x; Liu JS, 2012, J AM SOC INF SCI TEC, V63, P528, DOI 10.1002/asi.21692; Liu N, 2021, SCIENTOMETRICS, V126, P3153, DOI 10.1007/s11192-021-03868-4; Liu N, 2016, ENERG POLICY, V91, P220, DOI 10.1016/j.enpol.2016.01.020; Lu LYY, 2016, TECHNOL FORECAST SOC, V103, P71, DOI 10.1016/j.techfore.2015.10.018; Magistretti S, 2019, BUS HORIZONS, V62, P819, DOI 10.1016/j.bushor.2019.08.004; Martinelli A, 2012, RES POLICY, V41, P414, DOI 10.1016/j.respol.2011.10.012; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Miller T, 2019, ARTIF INTELL, V267, P1, DOI 10.1016/j.artint.2018.07.007; Mrvar A, 2016, COMPLEX ADAPT SYST M, V4, DOI 10.1186/s40294-016-0017-8; Nagaoka S, 2010, HBK ECON, V2, P1083, DOI 10.1016/S0169-7218(10)02009-5; O'Meara S, 2019, NATURE, V572, P427, DOI 10.1038/d41586-019-02360-7; OECD, 2021, POL OBS; OECD, 2009, MEAS CAP; PatentSight, EXC DAT QUAL FDN REL; Porter AL, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P587; Russell S, 2015, NATURE, V521, P415, DOI 10.1038/521415a; Shapira P, 2017, SCIENTOMETRICS, V112, P1439, DOI 10.1007/s11192-017-2452-5; Suh Y, 2019, TECHNOL FORECAST SOC, V146, P595, DOI 10.1016/j.techfore.2018.01.037; Tseng CY, 2013, INNOV-ORGAN MANAG, V15, P463, DOI 10.5172/impp.2013.15.4.463; Van Roy V., 2019, 433 GLO; Verspagen B, 2007, ADV COMPLEX SYST, V10, P93, DOI 10.1142/S0219525907000945; Vial G, 2019, J STRATEGIC INF SYST, V28, P118, DOI 10.1016/j.jsis.2019.01.003; Warner KSR, 2019, LONG RANGE PLANN, V52, P326, DOI 10.1016/j.lrp.2018.12.001; Wu F, 2020, NAT MACH INTELL, V2, P312, DOI 10.1038/s42256-020-0183-4; Xie ZQ, 2013, WORLD PAT INF, V35, P20, DOI 10.1016/j.wpi.2012.10.005	51	0	0	28	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262050	10.1371/journal.pone.0262050	http://dx.doi.org/10.1371/journal.pone.0262050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972173	Green Published, gold			2022-12-27	WOS:000773555700087
J	Mekonnen, SA; Gezehagn, A; Berju, A; Haile, B; Dejene, H; Nigatu, S; Molla, W; Jemberu, WT				Mekonnen, Sefinew Alemu; Gezehagn, Agegnehu; Berju, Adugna; Haile, Belete; Dejene, Haileyesus; Nigatu, Seleshe; Molla, Wassie; Jemberu, Wudu Temesgen			Health and economic burden of foodborne zoonotic diseases in Amhara region, Ethiopia	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; PREVALENCE; MEAT; SUSCEPTIBILITY; SALMONELLA; CATTLE	Diseases from food of animal origin are common health problems in Ethiopia. A cross-sectional study was carried out to estimate health and economic burden, and to identify demographic factors associated with community awareness of foodborne zoonotic diseases in Amhara region, Ethiopia. Data was collected from 435 households in three towns: Gondar, Lalibela and Debark. A retrospective data was also collected from health records in each town. The health burden due to zoonotic diseases was estimated at 0.2, 0.1 and 1.3 DALYs per household per year and at 73.2, 146.6 and 1,689.5 DALYs out of 100,000 populations per year in Gondar, Lalibela and Debark, respectively. The overall health burden due to foodborne zoonotic diseases (aggregated over the 435 households in the three towns) was estimated to be 89.9 DALYs per 100,000 populations per year. The economic impact of foodborne zoonotic diseases in the three towns of Amhara regional state was 278.98 Ethiopian Birr (ETB) (1ETB = 0.025 US Dollar) per household per year and 121,355.68 ETB per year. Costs of preventive measures followed by costs of patients' time made the highest contribution while costs of diagnosis made the lowest contribution to the total economic burden of foodborne zoonotic diseases. From a total of 435 respondents, 305 (70.1%) had known the presence of zoonotic diseases. Level of education, number of families in the house and income were highly associated with awareness of zoonosis. Although majority of respondents had known zoonotic diseases exists (70.1%) and disease can be acquired from animal source food (63.2%), the health and economic burden associated to foodborne zoonotic diseases are still high. Therefore, changing mindset and practical training aiming in controlling foodborne zoonotic diseases may be suggested to the community in the health improvement extension service.	[Mekonnen, Sefinew Alemu; Berju, Adugna; Haile, Belete; Dejene, Haileyesus; Nigatu, Seleshe; Molla, Wassie; Jemberu, Wudu Temesgen] Univ Gondar, Coll Vet Med & Anim Sci, Dept Vet Epidemiol & Publ Hlth, Gondar, Ethiopia; [Gezehagn, Agegnehu] Cent Gondar Zone Anim Quarantine Ctr, Gondar, Ethiopia	University of Gondar	Mekonnen, SA (corresponding author), Univ Gondar, Coll Vet Med & Anim Sci, Dept Vet Epidemiol & Publ Hlth, Gondar, Ethiopia.	asefinew@gmail.com	Dejene, Haileyesus/GLT-9623-2022; Molla, Wassie/GYD-3081-2022	Dejene, Haileyesus/0000-0002-2196-9334; Jemberu, Wudu Temesgen/0000-0002-3769-307X	University of Gondar, Ethiopia [383/10/2019]	University of Gondar, Ethiopia	This study was financially supported by University of Gondar, Ethiopia with grant Ref. number 383/10/2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe E, 2020, J TROP MED-US, V2020, DOI 10.1155/2020/4674235; Abegaz GA, 2018, 113 ETH DEV RES I ED; Aklilu Addis, 2015, BMC Res Notes, V8, P17, DOI 10.1186/s13104-014-0967-x; [Anonymous], 2010, 50833GLB WORLD BANK, V1; [Anonymous], 2012, MAPPING POVERTY LIKE; [Anonymous], 2013, POPULATION PROJECTIO; [Anonymous], 2006, CONTROL NEGLECTED ZO; [Anonymous], 1999, HUMAN POPULATION CEN; [Anonymous], 2017, WHO METHODS DATA SOU; Ashwani Kumar, 2011, Ethiopian Veterinary Journal, V15, P15; Bayleyegn Molla, 2004, Ethiopian Journal of Health Development, V18, P208; Cascio A, 2011, CLIN MICROBIOL INFEC, V17, P336, DOI 10.1111/j.1469-0691.2010.03451.x; Cleaveland S, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0168; Craig PS, 2007, LANCET INFECT DIS, V7, P385, DOI 10.1016/S1473-3099(07)70134-2; Dargatz DA, 2003, J APPL MICROBIOL, V95, P753, DOI 10.1046/j.1365-2672.2003.02034.x; Grace D, 2012, TROP ANIM HEALTH PRO, V44, pS67, DOI 10.1007/s11250-012-0209-y; Greger M, 2007, CRIT REV MICROBIOL, V33, P243, DOI 10.1080/10408410701647594; Haagsma JA, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0042-4; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hoelzer K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-34; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kemunto N, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3443-8; Leta S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-310; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Meloni D, 2009, INT J FOOD MICROBIOL, V129, P166, DOI 10.1016/j.ijfoodmicro.2008.11.014; Mengesha D, 2009, BERL MUNCH TIERARZTL, V122, P20, DOI 10.2376/0005-9366-122-20; Menghistu HT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209974; Molyneux D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-106; Narrod C, 2012, ECOHEALTH, V9, P150, DOI 10.1007/s10393-012-0747-9; Ng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072172; Pieracci EG, 2016, ONE HEALTH, V2, P131, DOI 10.1016/j.onehlt.2016.09.001; Potts KS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020354; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Seimenis A, 2012, VET ITAL, V48, P5; Seleshe S, 2014, KOREAN J FOOD SCI AN, V34, P7, DOI [10.5851/kosfa.2013.34.1.7, 10.5851/kosfa.2014.34.1.7]; Shitaye JE, 2006, VET MED-CZECH, V51, P512, DOI 10.17221/5585-VETMED; Sisay Girma, 2012, Ethiopian Veterinary Journal, V16, P15; Tadesse Getachew, 2015, BMC Res Notes, V8, P163, DOI 10.1186/s13104-015-1127-7; Tadesse G, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0270-y; Tassew H, 2010, ETHIOP J HEALTH SCI, V20, P137; Torgerson PR, 2018, ONE HEALTH-AMSTERDAM, V5, P40, DOI 10.1016/j.onehlt.2017.11.003; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	43	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262032	10.1371/journal.pone.0262032	http://dx.doi.org/10.1371/journal.pone.0262032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972156	gold, Green Published			2022-12-27	WOS:000773555700086
J	Sacchetti, S; McGlone, F; Cazzato, V; Mirams, L				Sacchetti, Sofia; McGlone, Francis; Cazzato, Valentina; Mirams, Laura			The off-line effect of affective touch on multisensory integration and tactile perceptual accuracy during the somatic signal detection task	PLOS ONE			English	Article							DYSMORPHIC CONCERN; UNMYELINATED AFFERENTS; PLEASANT TOUCH; VIBROTACTILE; STROKING; FEEL; PSYCHOPHYSICS; BRAIN	Affective touch refers to the emotional and motivational facets of tactile sensation and has been linked to the activation of a specialised system of mechanosensory afferents (the CT system), that respond optimally to slow caress-like touch. Affective touch has been shown to play an important role in the building of the bodily self: the multisensory integrated global awareness of one's own body. Here we investigated the effects of affective touch on subsequent tactile awareness and multisensory integration using the Somatic Signal Detection Task (SSDT). During the SSDT, participants were required to detect near-threshold tactile stimulation on their cheek, in the presence/absence of a concomitant light. Participants repeated the SSDT twice, before and after receiving a touch manipulation. Participants were divided into two groups: one received affective touch (CT optimal; n = 32), and the second received non-affective touch (non-CT optimal; n = 34). Levels of arousal (skin conductance levels, SCLs) and mood changes after the touch manipulation were also measured. Affective touch led to an increase in tactile accuracy, as indicated by less false reports of touch and a trend towards higher tactile sensitivity during the subsequent SSDT. Conversely, non-affective touch was found to induce a partial decrease in the correct detection of touch possibly due to a desensitization of skin mechanoreceptors. Both affective and non-affective touch induced a more positive mood and higher SCLs in participants. The increase in SCLs was greater after affective touch. We conclude that receiving affective touch enhances the sense of bodily self therefore increasing perceptual accuracy and awareness. Higher SCLs are suggested to be a possible mediator linking affective touch to a greater tactile accuracy. Clinical implications are discussed.	[Sacchetti, Sofia; McGlone, Francis; Cazzato, Valentina; Mirams, Laura] Liverpool John Moores Univ, Sch Psychol, Liverpool, Merseyside, England	Liverpool John Moores University; University of Liverpool	Sacchetti, S (corresponding author), Liverpool John Moores Univ, Sch Psychol, Liverpool, Merseyside, England.	S.V.Sacchetti@2017.ljmu.ac.uk	Cazzato, Valentina/GLV-4402-2022	Sacchetti, Sofia/0000-0002-8130-983X; Cazzato, Valentina/0000-0001-9826-7798; Mirams, Laura/0000-0002-5176-1200	Early Career Researcher PhD Studentship bursary from Liverpool John Moores University	Early Career Researcher PhD Studentship bursary from Liverpool John Moores University	This work was supported by an Early Career Researcher PhD Studentship bursary from Liverpool John Moores University.	Ackerley R, 2014, J NEUROSCI, V34, P2879, DOI 10.1523/JNEUROSCI.2847-13.2014; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Boucsein W., 2012, SPRINGER SCI BUSINES; Cabrera A, 2018, INT J METH PSYCH RES, V27, DOI 10.1002/mpr.1596; Case LK, 2016, J NEUROSCI, V36, P5850, DOI 10.1523/JNEUROSCI.1130-15.2016; Ciaunica A, 2017, EMBODIMENT, ENACTION, AND CULTURE: INVESTIGATING THE CONSTITUTION OF THE SHARED WORLD, P173; Clausen L, 2011, J PSYCHOPATHOL BEHAV, V33, P101, DOI 10.1007/s10862-010-9207-4; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Croy I, 2016, BEHAV BRAIN RES, V297, P37, DOI 10.1016/j.bbr.2015.09.038; Crucianelli L, 2018, CORTEX, V104, P180, DOI 10.1016/j.cortex.2017.04.018; Crucianelli Laura, 2013, Front Psychol, V4, P703, DOI 10.3389/fpsyg.2013.00703; Essick GK, 1999, NEUROREPORT, V10, P2083, DOI 10.1097/00001756-199907130-00017; Essick GK, 2010, NEUROSCI BIOBEHAV R, V34, P192, DOI 10.1016/j.neubiorev.2009.02.003; Fairhurst MT, 2014, PSYCHOL SCI, V25, P1124, DOI 10.1177/0956797614527114; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Garner D.M, 2004, EATING DISORDER INVE; Gazzola V, 2012, P NATL ACAD SCI USA, V109, pE1657, DOI 10.1073/pnas.1113211109; Gentsch A., 2016, AFFECTIVE TOUCH NEUR, P355; GESCHEIDER GA, 1985, J ACOUST SOC AM, V78, P534, DOI 10.1121/1.392475; Haggarty CJ, 2020, EUR J NEUROSCI, V51, P1844, DOI 10.1111/ejn.14637; Harjunen VJ, 2017, PERS INDIV DIFFER, V107, P88, DOI 10.1016/j.paid.2016.11.047; Harris JA, 2007, J NEUROSCI, V27, P7136, DOI 10.1523/JNEUROSCI.2102-07.2007; Hasson D., 2005, International Electronic Journal of Health Education, V8, P178; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Howell D. C., 2012, CENGAGE LEARNING; Jenkinson PM, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa034; Jorgensen L, 2001, AUST NZ J PSYCHIAT, V35, P124, DOI 10.1046/j.1440-1614.2001.00860.x; Katzer A, 2012, J ABNORM PSYCHOL, V121, P530, DOI 10.1037/a0026536; Krahe C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32865-6; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Lloyd DM, 2008, J PSYCHOSOM RES, V64, P21, DOI 10.1016/j.jpsychores.2007.06.004; Lloyd DM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00207; Lloyd DM, 2011, NEUROPSYCHOLOGIA, V49, P3430, DOI 10.1016/j.neuropsychologia.2011.08.018; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; Lush P, 2020, COLLABRA-PSYCHOL, V6, DOI 10.1525/collabra.325; Macmillan N. A., 2004, DETECTION THEORY USE; Mancuso SG, 2010, AUST NZ J PSYCHIAT, V44, P535, DOI 10.3109/00048671003596055; Marotta A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168489; Marshall AG, 2019, ELIFE, V8, DOI 10.7554/eLife.51642; Mayo LM, 2018, BIOL PSYCHOL, V137, P83, DOI 10.1016/j.biopsycho.2018.07.001; MCCORMACK HM, 1988, PSYCHOL MED, V18, P1007, DOI 10.1017/S0033291700009934; McGlone F, 2014, NEURON, V82, P737, DOI 10.1016/j.neuron.2014.05.001; McKenzie KJ, 2010, PERCEPTION, V39, P839, DOI 10.1068/p6401; Mehling WE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005614; Mirams L, 2017, EXP BRAIN RES, V235, P2591, DOI 10.1007/s00221-017-4998-0; Mirams L, 2012, Q J EXP PSYCHOL, V65, P926, DOI 10.1080/17470218.2011.636823; Mirams L, 2010, EXP BRAIN RES, V202, P787, DOI 10.1007/s00221-010-2185-7; Morrison I, 2016, HUM BRAIN MAPP, V37, P1308, DOI 10.1002/hbm.23103; Morrison I, 2012, CURR BIOL, V22, pR77, DOI 10.1016/j.cub.2011.11.032; Morrison I, 2010, EXP BRAIN RES, V204, P305, DOI 10.1007/s00221-009-2007-y; OHNHAUS EE, 1975, PAIN, V1, P379, DOI 10.1016/0304-3959(75)90075-5; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oosthuizen P, 1998, AUST NZ J PSYCHIAT, V32, P129, DOI 10.3109/00048679809062719; Panagiotopoulou E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13345-9; Pawling R, 2017, BIOL PSYCHOL, V129, P186, DOI 10.1016/j.biopsycho.2017.08.057; Pawling R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173457; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Porges S.W., 1993, BODY PERCEPTION QUES, V10, P2009; Ree A, 2019, BIOL PSYCHOL, V140, P55, DOI 10.1016/j.biopsycho.2018.11.006; Russo V, 2020, NEUROSCI BIOBEHAV R, V108, P445, DOI 10.1016/j.neubiorev.2019.09.037; Sacchetti S., 2021, PSYCHOL RES-PSYCH FO; Smeets MAM, 1999, J PSYCHOSOM RES, V46, P465, DOI 10.1016/S0022-3999(99)00005-7; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; Triscoli C, 2017, BIOL PSYCHOL, V128, P71, DOI 10.1016/j.biopsycho.2017.07.007; Triscoli C, 2017, PHYSIOL BEHAV, V177, P169, DOI 10.1016/j.physbeh.2017.05.006; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; van Stralen HE, 2011, PHILOS T R SOC B, V366, P3142, DOI 10.1098/rstb.2011.0163; van Stralen HE, 2014, COGNITION, V131, P147, DOI 10.1016/j.cognition.2013.11.020; VERRILLO RT, 1985, J ACOUST SOC AM, V77, P225, DOI 10.1121/1.392263; von Mohr M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13355-7; Wald A., 2004, COURIER CORPORATION; Watkins RH, 2021, J NEUROPHYSIOL, V125, P232, DOI 10.1152/jn.00587.2020; Wessberg J, 2003, J NEUROPHYSIOL, V89, P1567, DOI 10.1152/jn.00256.2002	79	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261060	10.1371/journal.pone.0261060	http://dx.doi.org/10.1371/journal.pone.0261060			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972120	Green Published, Green Accepted, gold			2022-12-27	WOS:000773555700021
J	Blanchflower, DG; Bryson, A				Blanchflower, David G.; Bryson, Alex			Further decoding the mystery of American pain: The importance of work	PLOS ONE			English	Article							UNHAPPINESS	A recent paper showed that, whereas we expect pain to rise with age due to accumulated injury, physical wear and tear, and disease, the elderly in America report less pain than those in midlife. Further exploration revealed this pattern was confined to the less educated. The authors called this the 'mystery of American pain' since pain appears to rise with age in other countries irrespective of education. Revisiting this issue with the same cross-sectional data we show that what matters in explaining pain through to age 65 is whether one is working or not. The incidence of pain across the life-course is nearly identical for workers in America and elsewhere, but it is greater for non-working Americans than it is for non-workers elsewhere. As in other countries, pain is hump-shaped in age among those Americans out of work but rises a little over the life-course for those in work. Furthermore, these patterns are apparent within educational groups. We show that, if one ascribes age-specific employment rates from other OECD countries to Americans, the age profile of pain in the United States is more similar to that found elsewhere in the OECD. This is because employment rates are lower in the United States than elsewhere between ages 30 and 60: the simulation reduces the pain contribution of these non-workers to overall pain in America, so it looks somewhat similar to pain elsewhere. We conclude that what matters in explaining pain over the life-course is whether one is working or not and once that is accounted for, the patterns are consistent across the United States and the rest of the OECD.	[Blanchflower, David G.; Bryson, Alex] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Bryson, Alex] Univ London, Inst Social Res, London, England	Dartmouth College; University of London	Bryson, A (corresponding author), Univ London, Inst Social Res, London, England.	a.bryson@ucl.ac.uk		Blanchflower, David/0000-0002-2856-7039; Bryson, Alex/0000-0003-1529-2010				Aaronson S, 2014, BROOKINGS PAP ECO AC, P197; Abraham Katharine G., 2018, 24333 NBER; Blanchflower D. G, 2021, NOT WORKING HAVE ALL; Blanchflower DG, 2020, REV BEHAV ECON, V7, P197, DOI 10.1561/105.00000120; Blanchflower DG, 2020, J ECON BEHAV ORGAN, V176, P461, DOI 10.1016/j.jebo.2020.04.022; Blanchflower DG, 2019, J ECON LIT, V57, P385, DOI 10.1257/jel.20171492; Bloom N, 2012, AM ECON REV, V102, P167, DOI 10.1257/aer.102.1.167; Case A, 2020, DEATHS OF DESPAIR AND THE FUTURE OF CAPITALISM, P1; Case A, 2020, P NATL ACAD SCI USA, V117, P24785, DOI 10.1073/pnas.2012350117; Case A, 2017, BROOKINGS PAP ECO AC, P397; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; El-Jahel L., 2020, DOES MONETARY POLCY; Feenstra RC, 2018, REV INT ECON, V26, P1053, DOI 10.1111/roie.12370; Graham C, 2021, SOC SCI MED, V270, DOI 10.1016/j.socscimed.2020.113612; Graham C, 2019, J POPUL ECON, V32, P665, DOI 10.1007/s00148-018-0687-y; Hudomiet P., 2021, J EC BEHAV ORG; Inst Med, 2011, RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH, P1; Krueger AB, 2008, LANCET, V371, P1519, DOI 10.1016/S0140-6736(08)60656-X; Krueger AB, 2017, BROOKINGS PAP ECO AC, P1, DOI 10.1353/eca.2017.0012; Nahin RL, 2015, J PAIN, V16, P769, DOI 10.1016/j.jpain.2015.05.002; Piper A., 2021, DOES PAIN LEAD JOB L, P21; Sadun Raffaella, 2016, HARVARD BUSINESS SCH, DOI 10.3386/w22327.; Winkelmann L, 1998, ECONOMICA, V65, P1, DOI 10.1111/1468-0335.00111	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261891	10.1371/journal.pone.0261891	http://dx.doi.org/10.1371/journal.pone.0261891			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025882	Green Submitted, Green Published, gold			2022-12-27	WOS:000796264200031
J	Chu, AMY; Chan, TWC; So, MKP				Chu, Amanda M. Y.; Chan, Thomas W. C.; So, Mike K. P.			Learning from work-from-home issues during the COVID-19 pandemic: Balance speaks louder than words	PLOS ONE			English	Article							SLEEP QUALITY; STRESS; FAMILY; IMPACT; PRODUCTIVITY; SATISFACTION; WORKPLACE; OUTCOMES; SUPPORT; MINDSET	During the 2019 novel coronavirus disease (COVID-19) pandemic, many employees have switched to working from home. Despite the findings of previous research that working from home can improve productivity, the scale, nature, and purpose of those studies are not the same as in the current situation with the COVID-19 pandemic. We studied the effects that three stress relievers of the work-from-home environment-company support, supervisor's trust in the subordinate, and work-life balance-had on employees' psychological well-being (stress and happiness), which in turn influenced productivity and engagement in non-work-related activities during working hours. In order to collect honest responses on sensitive questions or negative forms of behavior including stress and non-work-related activities, we adopted the randomized response technique in the survey design to minimize response bias. We collected a total of 500 valid responses and analyzed the results with structural equation modelling. We found that among the three stress relievers, work-life balance was the only significant construct that affected psychological well-being. Stress when working from home promoted non-work-related activities during working hours, whereas happiness improved productivity. Interestingly, non-work-related activities had no significant effect on productivity. The research findings provide evidence that management's maintenance of a healthy work-life balance for colleagues when they are working from home is important for supporting their psychosocial well-being and in turn upholding their work productivity.	[Chu, Amanda M. Y.] Educ Univ Hong Kong, Dept Social Sci, Tai Po, Hong Kong, Peoples R China; [Chan, Thomas W. C.; So, Mike K. P.] Hong Kong Univ Sci & Technol, Dept Informat Syst Business Stat & Operat Managem, Clear Water Bay, Hong Kong, Peoples R China	Education University of Hong Kong (EdUHK); Hong Kong University of Science & Technology	Chu, AMY (corresponding author), Educ Univ Hong Kong, Dept Social Sci, Tai Po, Hong Kong, Peoples R China.	amandachu@eduhk.hk		Chu, Amanda/0000-0002-9543-747X; Chan, Wing Chun/0000-0002-3412-4234	Hong Kong University of Science and Technology research grant "Big Data Analytics on Social Research" [CEF20BM04]	Hong Kong University of Science and Technology research grant "Big Data Analytics on Social Research"	This work was partially supported by the Hong Kong University of Science and Technology research grant "Big Data Analytics on Social Research" (grant number CEF20BM04). The funding recipient was MKPS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altena E, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.13052; Azeem S.M., 2014, INT J HUMAN RESOURCE, V4, P18; Barrero JM., 2020, SSRN ELECT J; Bayrak T, 2012, TELEMAT INFORMAT, V29, P286, DOI 10.1016/j.tele.2011.10.002; Beck MJ, 2020, TRANSPORT POLICY, V99, P95, DOI 10.1016/j.tranpol.2020.08.004; Belanger F, 2002, COMMUN ACM, V45, P64, DOI 10.1145/502269.502299; Bell A.S., 2012, E J APPL PSYCHOL, V8, P25, DOI DOI 10.7790/EJAP.V8I1.320; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bentley TA, 2016, APPL ERGON, V52, P207, DOI 10.1016/j.apergo.2015.07.019; Bialowolski P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230562; Casper A, 2017, EUR J WORK ORGAN PSY, V26, P798, DOI 10.1080/1359432X.2017.1374947; Chaiprasit K, 2011, PROCD SOC BEHV, V25, DOI 10.1016/j.sbspro.2011.10.540; Chanana N, 2021, J PUBLIC AFF, V21, DOI 10.1002/pa.2508; Chong ACY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16060970; Chu AMY, 2020, STAT METHODS MED RES, V29, P894, DOI 10.1177/0962280219847492; Chu AMY, 2015, COMMUN ASSOC INF SYS, V37, P510; Colligan TW, 2006, J WORKPLACE BEHAV HE, V21, P89, DOI 10.1300/J490v21n02_07; Cooper CD, 2002, J ORGAN BEHAV, V23, P511, DOI 10.1002/job.145; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crosbie T., 2004, SOC POLICY SOC, V3, P223, DOI DOI 10.1017/S1474746404001733; Crum AJ, 2017, ANXIETY STRESS COPIN, V30, P379, DOI 10.1080/10615806.2016.1275585; Crum AJ, 2013, J PERS SOC PSYCHOL, V104, P716, DOI 10.1037/a0031201; Delanoeije J, 2019, HUM RELAT, V72, P1843, DOI 10.1177/0018726718823071; Derks D, 2016, HUM RELAT, V69, P1045, DOI 10.1177/0018726715601890; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; dos Santos PM, 2021, COMMUN STAT-SIMUL C, DOI 10.1080/03610918.2021.1888122; Endicott J, 1997, PSYCHOPHARMACOL BULL, V33, P13; Fadinger H., 2020, COVID EC VETTED REAL; Fisher-Mcauley Gwenith, 2003, MODELING RELATIONSHI; Ford D., 2020, CBC NEWS; FORD JK, 1986, PERS PSYCHOL, V39, P291, DOI 10.1111/j.1744-6570.1986.tb00583.x; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Gefen D., 2000, COMMUN ASSOC INF SYS, V4, P7, DOI [10.17705/1CAIS.00407, 10.17705/1cais.00407, DOI 10.17705/1CAIS.00407]; Gefen D, 2005, COMMUN ASSOC INF SYS, V16, P91, DOI 10.17705/1CAIS.01605; Green N., 2020, NZ J EMPLOY RELATION, V45; Gupta R, 2020, INDIAN J PSYCHIAT, V62, P370, DOI 10.4103/psychiatry.IndianJPsychiatry_523_20; Haar JM, 2014, J VOCAT BEHAV, V85, P361, DOI 10.1016/j.jvb.2014.08.010; Halkos G, 2010, INT J PRODUCT PERFOR, V59, P415, DOI 10.1108/17410401011052869; Hill EJ, 2001, FAM RELAT, V50, P49, DOI 10.1111/j.1741-3729.2001.00049.x; Hoffman KE, 2020, INT J RADIAT ONCOL, V108, P370, DOI 10.1016/j.ijrobp.2020.06.062; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; Javed A, 2019, J ADV NURS, V75, P2820, DOI 10.1111/jan.14167; Kelliher C, 2010, HUM RELAT, V63, P83, DOI 10.1177/0018726709349199; Kjellberg A, 2010, WORK, V36, P9, DOI 10.3233/WOR-2010-1003; Knudsen HK, 2007, SOC SCI MED, V64, P1997, DOI 10.1016/j.socscimed.2007.02.020; Kossek EE., 2015, WORKPLACE FLEXIBILIT, V1, DOI [10.1093/oxfordhb/9780199337538.001.0001/oxfordhb-9780199337538-e-19, DOI 10.1093/OXFORDHB/9780199337538.001.0001/OXFORDHB-9780199337538-E-19]; Kowalski KB, 2005, BENCHMARKING, V12, P236, DOI 10.1108/14635770510600357; Kramer A., 2020, J VOCAT BEHAV, V119; Kruse K., 2012, FORBES; Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037; McBride DL, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4001; Nakrosiene A, 2019, INT J MANPOWER, V40, P87, DOI 10.1108/IJM-07-2017-0172; Oravec JA, 2002, COMMUN ACM, V45, P60, DOI 10.1145/502269.502298; Oswald AJ, 2015, J LABOR ECON, V33, P789, DOI 10.1086/681096; Pee LG, 2008, INFORM MANAGE-AMSTER, V45, P120, DOI 10.1016/j.im.2008.01.004; Petreanu V, 2013, PROCD SOC BEHV, V92, P420, DOI 10.1016/j.sbspro.2013.08.695; Robertson I, 2011, WELL-BEING: PRODUCTIVITY AND HAPPINESS AT WORK, P1, DOI 10.1057/9780230306738; Rohail I., 2020, FDN U J PSYCHOL, V4, P5; Russell JoyceE.A, 2013, WASH POST; Sgroi Daniel, 2015, SOC MARK FDN; Simpser A, 2017, SSRN ELECT J; Staples D. S., 2001, Journal of End User Computing, V13, P3, DOI 10.4018/joeuc.2001040101; Steiger JH, 1980, ANN M PSYCH SOC 1980; Sull C., 2020, MIT SLOAN MANAGE REV, V61, P1; Sundarasen S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176206; TANAKA JS, 1985, BRIT J MATH STAT PSY, V38, P197, DOI 10.1111/j.2044-8317.1985.tb00834.x; Tiwari A, 2021, INT J INFECT DIS, V103, P97, DOI 10.1016/j.ijid.2020.11.143; Toniolo-Barrios M, 2021, BUS HORIZONS, V64, P189, DOI 10.1016/j.bushor.2020.09.004; Versey HS, 2015, DEV PSYCHOL, V51, P1672, DOI 10.1037/a0039607; Vyas L, 2021, POLICY DES PRACT, V4, P59, DOI 10.1080/25741292.2020.1863560; Waizenegger L, 2020, EUR J INFORM SYST, V29, P429, DOI 10.1080/0960085X.2020.1800417; Wang J, 2001, J Occup Health Psychol, V6, P283, DOI 10.1037/1076-8998.6.4.283; West S. G., 1995, STRUCTURAL EQUATION, P56; Wong LC, 2014, RES SOCIAL WORK PRAC, V24, P356, DOI 10.1177/1049731513498622; Wright T A, 2000, J Occup Health Psychol, V5, P84, DOI 10.1037/1076-8998.5.1.84	76	7	7	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261969	10.1371/journal.pone.0261969	http://dx.doi.org/10.1371/journal.pone.0261969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025893	Green Published, gold			2022-12-27	WOS:000796264200039
J	Glatz, M; Riedl, R; Glatz, W; Schneider, M; Wedrich, A; Bolz, M; Strauss, RW				Glatz, Marlene; Riedl, Regina; Glatz, Wilfried; Schneider, Mona; Wedrich, Andreas; Bolz, Matthias; Strauss, Rupert W.			Blindness and visual impairment in Central Europe	PLOS ONE			English	Article							QUALITY-OF-LIFE; REGISTERED BLINDNESS; DIABETIC-RETINOPATHY; VISION IMPAIRMENT; ADULT-POPULATION; TRENDS; PREVALENCE; IMPACT; REGISTRATION; MORTALITY	Purpose To assess the prevalence and causes of visual impairment and blindness in a Central European country. The findings may have implications for the planning of further research and development of therapies in order to prevent blindness. Setting Department of Ophthalmology, Medical University of Graz, Austria. Design Retrospective, epidemiological study. Methods The database of the Main Confederation of Austrian Social Insurances was searched for patients with visual impairment, legal blindness or deaf-blindness. This database gathers data from patients of all insurance providers in the country who receive care due to visual impairment and blindness. To determine the prevalence of these conditions, the number of all entries recorded in February 2019 was evaluated. Additionally, all new entries between (January 1(st),) 2017, and (December 31(st),) 2018, were analysed for distinct characteristics, such as sex, the cause of blindness/visual impairment, and age. Since health care allowances can provide a considerable source of income (459.90Euro-936.90Euro per month), good coverage of practically all patients who are blind and visually impaired in the country can be assumed. Results On February 2(nd), 2019, 17,730 patients with visual impairments, blindness or deaf-blindness were registered in Austria, resulting in a prevalence of these diagnoses of 0.2% in the country. During the observational period from 2017 to 2018, 4040 persons met the inclusion criteria. Of these, 2877 were female (65.3%), and 1527 were male (34.7%). The mean age was 75.7 18.0 years (median 82). Most patients (n = 3675, 83.4%) were of retirement age, while 729 (16.6%) were working-age adults or minors. In total, an incidence of 25.0 (95% confidence limit (CL) 24.3-25.8) per 100,000 person-years was observed from 2017 to 2018. A higher incidence was observed for females (32.2, 95% CL 31.0-33.3) than for males (17.7, 95% CL 16.8-18.5). Incidences where higher for males in lower age groups (e.g. 10-14 years: rate ratio RR = 2.7, 95% CL 1.1-6.8), and higher for females in higher age groups (e.g. 70-74 years: RR = 0.6, 95% CL 0.5-0.8). In total, the most frequent diagnoses were macular degeneration (1075 persons, 24.4%), other retinal disorders (493 persons, 11.2%) and inherited retinal and choroidal diseases (IRDs) (186 persons, 4.2%). Persons with IRDs were significantly younger compared to persons with macular degeneration or retinal disorders (IRDs: median 57, range 2-96 vs 83, 5-98 and 82, 1-98 years, p<0.001). For persons of retirement age, macular degeneration, other retinal disorders and glaucoma were the three most frequent diagnoses. In contrast, among working-aged adults and children, IRDs were the leading cause of visual impairment and blindness (103 persons, 14.1%). Conclusion These data show that IRDs are the leading cause of blindness and visual impairment in working-aged persons and children in Austria. Thus, these findings suggest to draw attention to enhance further research in the fields of emerging therapies for IRDs.	[Glatz, Marlene; Glatz, Wilfried; Schneider, Mona; Wedrich, Andreas; Strauss, Rupert W.] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Riedl, Regina] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Bolz, Matthias; Strauss, Rupert W.] Kepler Univ Clin Linz, Dept Ophthalmol, Linz, Austria; [Strauss, Rupert W.] Inst Mol & Clin Ophthalmol, Basel, Switzerland; [Strauss, Rupert W.] Moorfields Eye Hosp, London, England; [Strauss, Rupert W.] UCL, Inst Ophthalmol, London, England	Medical University of Graz; Medical University of Graz; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Strauss, RW (corresponding author), Med Univ Graz, Dept Ophthalmol, Graz, Austria.; Strauss, RW (corresponding author), Kepler Univ Clin Linz, Dept Ophthalmol, Linz, Austria.; Strauss, RW (corresponding author), Inst Mol & Clin Ophthalmol, Basel, Switzerland.; Strauss, RW (corresponding author), Moorfields Eye Hosp, London, England.; Strauss, RW (corresponding author), UCL, Inst Ophthalmol, London, England.	r.strauss@medunigraz.at	Bolz, Matthias/HCI-0622-2022					Abou-Gareeb I, 2001, Ophthalmic Epidemiol, V8, P39, DOI 10.1076/opep.8.1.39.1540; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Avisar R, 2006, ISRAEL MED ASSOC J, V8, P880; Bamashmus MA, 2004, EYE, V18, P257, DOI 10.1038/sj.eye.6700606; Barry RJ, 2005, BRIT J OPHTHALMOL, V89, P995, DOI 10.1136/bjo.2004.059915; Berdeaux G, 2007, OPHTHAL EPIDEMIOL, V14, P80, DOI 10.1080/09286580600899691; Bertelsen M, 2015, ACTA OPHTHALMOL, V93, P134, DOI 10.1111/aos.12467; Bourne RRA, 2018, BRIT J OPHTHALMOL, V102, P575, DOI 10.1136/bjophthalmol-2017-311258; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Bunce C, 2008, EYE, V22, P905, DOI 10.1038/sj.eye.6702767; Chakravarthy U, 2017, OPHTHAL EPIDEMIOL, V24, P239, DOI 10.1080/09286586.2017.1281426; Chaumet-Riffaud AE, 2017, AM J OPHTHALMOL, V177, P169, DOI 10.1016/j.ajo.2017.02.016; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Crewe JM, 2013, BRIT J OPHTHALMOL, V97, P1579, DOI 10.1136/bjophthalmol-2013-303993; Crewe JM, 2011, CLIN EXP OPHTHALMOL, V39, P336, DOI 10.1111/j.1442-9071.2010.02466.x; Cruciani F, 2011, CLIN TER, V162, pE35; Cruciani F, 2010, CLIN TER, V161, pE11; Finger RP, 2011, BRIT J OPHTHALMOL, V95, P1061, DOI 10.1136/bjo.2010.194712; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Galvin O, 2020, CLIN OPHTHALMOL, V14, P707, DOI 10.2147/OPTH.S241928; Gilbert C, 2003, BMJ-BRIT MED J, V327, P760, DOI 10.1136/bmj.327.7418.760; Gruntman AM, 2018, FASEB J, V32, P1733, DOI 10.1096/fj.201700982R; Kelliher C, 2006, BRIT J OPHTHALMOL, V90, P367, DOI 10.1136/bjo.2005.075861; Kellner U, 2012, Klin Monbl Augenheilkd, V229, P171, DOI 10.1055/s-0031-1280461; Liew G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004015; Malik ANJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001496; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Munier A, 1998, BRIT J OPHTHALMOL, V82, P630, DOI 10.1136/bjo.82.6.630; Nemeth J, 2019, EUR J OPHTHALMOL, V29, P129, DOI 10.1177/1120672118819397; Quartilho A, 2016, EYE, V30, P602, DOI 10.1038/eye.2015.288; Rosenberg T, 1996, ACTA OPHTHALMOL SCAN, V74, P395; Scholl HPN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2838; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; Wong EYH, 2008, OPHTHAL EPIDEMIOL, V15, P339, DOI 10.1080/09286580802227394; Wong TY, 2018, OPHTHALMOLOGY, V125, P1608, DOI 10.1016/j.ophtha.2018.04.007; Yong VK, 2006, OPHTHAL EPIDEMIOL, V13, P35, DOI 10.1080/09286580500473779; Zatic T, 2015, BRIT J OPHTHALMOL, V99, P832, DOI 10.1136/bjophthalmol-2014-305824; Zheng Yingfeng, 2012, Indian J Ophthalmol, V60, P428, DOI 10.4103/0301-4738.100542	39	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261897	10.1371/journal.pone.0261897	http://dx.doi.org/10.1371/journal.pone.0261897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025896	gold, Green Published			2022-12-27	WOS:000796264200032
J	Peng, SK; Pan, LG; Guo, Y; Gong, B; Huang, XB; Liu, SY; Huang, JX; Pu, H; Zeng, J				Peng, Shengkun; Pan, Lingai; Guo, Yang; Gong, Bo; Huang, Xiaobo; Liu, Siyun; Huang, Jianxin; Pu, Hong; Zeng, Jie			Quantitative CT imaging features for COVID-19 evaluation: The ability to differentiate COVID-19 from non-COVID-19 (highly suspected) pneumonia patients during the epidemic period	PLOS ONE			English	Article							RADIOMICS; QUANTIFICATION; PATTERNS; NOMOGRAM	Objectives COVID-19 and Non-Covid-19 (NC) Pneumonia encountered high CT imaging overlaps during pandemic. The study aims to evaluate the effectiveness of image-based quantitative CT features in discriminating COVID-19 from NC Pneumonia. Materials and methods 145 patients with highly suspected COVID-19 were retrospectively enrolled from four centers in Sichuan Province during January 23 to March 23, 2020. 88 cases were confirmed as COVID-19, and 57 patients were NC. The dataset was randomly divided by 3:2 into training and testing sets. The quantitative CT radiomics features were extracted and screened sequentially by correlation analysis, Mann-Whitney U test, the least absolute shrinkage and selection operator (LASSO) logistic regression (LR) and backward stepwise LR with minimum AIC methods. The selected features were used to construct the LR model for differentiating COVID-19 from NC. Meanwhile, the differentiation performance of traditional quantitative CT features such as lesion volume ratio, ground glass opacity (GGO) or consolidation volume ratio were also considered and compared with Radiomics-based method. The receiver operating characteristic curve (ROC) analysis were conducted to evaluate the predicting performance. Results Compared with traditional CT quantitative features, radiomics features performed best with the highest Area Under Curve (AUC), sensitivity, specificity and accuracy in the training (0.994, 0.942, 1.0 and 0.965) and testing sets (0.977, 0.944, 0.870, 0.915) (Delong test, P < 0.001). Among CT volume-ratio based models using lesion or GGO component ratio, the model combining CT lesion score and component ratio performed better than others, with the AUC, sensitivity, specificity and accuracy of 0.84, 0.692, 0.853, 0.756 in the training set and 0.779, 0.667, 0.826, 0.729 in the testing set. The significant difference of the most selected wavelet transformed radiomics features between COVID-19 and NC might well reflect the CT signs. Conclusions The differentiation between COVID-19 and NC could be well improved by using radiomics features, compared with traditional CT quantitative values.	[Peng, Shengkun; Pu, Hong] Univ Elect Sci & Technol China, Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Dept Radiol, Chengdu, Peoples R China; [Pan, Lingai; Guo, Yang; Huang, Xiaobo] Univ Elect Sci & Technol China, Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Dept Crit Care Med, Chengdu, Peoples R China; [Gong, Bo] Univ Elect Sci & Technol China, Key Lab Human Dis Gene Study Sichuan Prov, Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Liu, Siyun] GE Healthcare China, Beijing, Peoples R China; [Huang, Jianxin] Univ Elect Sci & Technol China, Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Dept Anesthesiol, Chengdu, Peoples R China; [Zeng, Jie] Univ Elect Sci & Technol China, Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Dept Cardiol, Chengdu, Peoples R China	Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; General Electric; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China	Pu, H (corresponding author), Univ Elect Sci & Technol China, Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Dept Radiol, Chengdu, Peoples R China.	ph196797@163.com			Sichuan Province Science and Technology Support Program [2020YFS0558]; GE Healthcare	Sichuan Province Science and Technology Support Program; GE Healthcare(General ElectricGE Healthcare)	This research was supported by a grant from Sichuan Province Science and Technology Support Program to BG (Grant number: 2020YFS0558). GE Healthcare provided support in the form of salaries for author SL. The specific roles of the authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; [Anonymous], 2020, J INFECTION; [Anonymous], 2020, INVEST RADIOL; Bartholmai BJ, 2013, J THORAC IMAG, V28, P298, DOI 10.1097/RTI.0b013e3182a21969; Chinese Medical Association Chinese Medical Journals Publishing House Chinese Society of General Practice, 2019, CHIN J GEN PRACT, V18, P127; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Koo HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177379; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Li DS, 2020, KOREAN J RADIOL, V21, P505, DOI 10.3348/kjr.2020.0146; Liu Lijun, 2019, Zhonghua Yufang Yixue Zazhi, V53, P982, DOI 10.3760/cma.j.issn.0253-9624.2019.10.006; Mackin D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178524; Maldonado F, 2014, EUR RESPIR J, V43, P204, DOI 10.1183/09031936.00071812; Montague E, 2011, HUM FACTORS, V53, P502, DOI 10.1177/0018720811405986; Moulier V, 2019, BMC PSYCHOL, V7, DOI 10.1186/s40359-019-0358-0; Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370; Park SO, 2011, KOREAN J RADIOL, V12, P297, DOI 10.3348/kjr.2011.12.3.297; Scrivener M, 2016, TRANSL CANCER RES, V5, P398, DOI 10.21037/tcr.2016.06.18; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; Wang B, 2019, BMC MED IMAGING, V19, DOI 10.1186/s12880-019-0355-z; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wang H, 2020, EUR RADIOL, V30, P4910, DOI 10.1007/s00330-020-06880-z; Wang YL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50886-7; Zanfardino M, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2073-2; Zhang T, 2019, CLIN RADIOL, V74, DOI 10.1016/j.crad.2018.08.014	24	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0256194	10.1371/journal.pone.0256194	http://dx.doi.org/10.1371/journal.pone.0256194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025878	Green Published, gold			2022-12-27	WOS:000796264200003
J	de Armas, J; Ramalhinho, H; Reynal-Querol, M				de Armas, Jesica; Ramalhinho, Helena; Reynal-Querol, Marta			Improving the accessibility to public schools in urban areas of developing countries through a location model and an analytical framework	PLOS ONE			English	Article							IMPACTS; CHOICE	The location of primary public schools in urban areas of developing countries is the focus of this study. In such areas, new schools and modification of the current schools are required, and this process should be developed using rational and broad supporting tools for decision makers, such as optimization models. We propose a realistic coverage location model and a framework to analyze the location of schools. Our approach considers the existing schools and their resizing, the best locations of the new schools that may have different capacities, population coverage, walking distances and budget provisions for building and updating schools. As a case study, we assess the current primary school network in Ciudad Benito Juarez to provide managerial insights. Through the proposed framework, we analyze the current locations of schools and decisions to be made by considering future scenarios in different time periods. The proposed model is quite flexible and easy to adapt to new considerations, allowing it to be applied to regions in developing countries under similar conditions.	[de Armas, Jesica; Ramalhinho, Helena; Reynal-Querol, Marta] Univ Pompeu Fabra, Dept Econ & Business, Barcelona, Spain; [de Armas, Jesica; Ramalhinho, Helena] UPF Barcelona Sch Management, Barcelona, Spain; [de Armas, Jesica; Ramalhinho, Helena; Reynal-Querol, Marta] Barcelona Grad Sch Econ, Barcelona, Spain; [Reynal-Querol, Marta] Inst Catalana Invest & Estudios Avanzados, Barcelona, Spain; [Reynal-Querol, Marta] Inst Polit Econ & Governance, Barcelona, Spain	Pompeu Fabra University; ICREA	de Armas, J (corresponding author), Univ Pompeu Fabra, Dept Econ & Business, Barcelona, Spain.; de Armas, J (corresponding author), UPF Barcelona Sch Management, Barcelona, Spain.; de Armas, J (corresponding author), Barcelona Grad Sch Econ, Barcelona, Spain.	jesica.dearmasr@upf.edu	Lourenco, Helena Ramalhinho/C-5738-2008; de Armas, Jesica/F-1537-2014	Lourenco, Helena Ramalhinho/0000-0003-3174-3432; de Armas, Jesica/0000-0002-7619-7407	Ministerio de ciencia, innovacion y universidades [RTI2018-095197-B-I00]; Agencia de gestio d'ajuts universitaris i de recerca [017-SGR-1739]; Departament de Recerca i Universitats [2020 Pandemies 00090]; Ministerio de ciencia e innovacion [PID2020-120118GB-I00]	Ministerio de ciencia, innovacion y universidades(Spanish Government); Agencia de gestio d'ajuts universitaris i de recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Departament de Recerca i Universitats; Ministerio de ciencia e innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Ministerio de ciencia, innovacion y universidades Award Number: RTI2018-095197-B-I00 Recipient: Helena Ramalhinho, Jesica de Armas The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript Agencia de gestio d'ajuts universitaris i de recerca Award Number: 2017-SGR-1739 Recipient: Helena Ramalhinho, Jesica de Armas The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Departament de Recerca i Universitats (Generalitat de Catalunya) Award Number: 2020 Pandemies 00090. Recipient: Marta Reynal-Querol The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ministerio de ciencia e innovacion Award Number: PID2020-120118GB-I00 Recipient: Marta Reynal-Querol The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal M., 2012, J ELEMENTARY ED, V22, P23; Antunes A., 2000, SOCIO-ECON PLAN SCI, V34, P101, DOI [10.1016/S0038-0121(99)00014-2, DOI 10.1016/S0038-0121(99)00014-2, 10.1016/s0038-0121(99)00014-2]; Araya F, 2012, INT T OPER RES, V19, P695, DOI 10.1111/j.1475-3995.2012.00843.x; Bck UDK, 2016, SCAND J EDUC RES, V60, P435, DOI 10.1080/00313831.2015.1024163; Bouck Emily C., 2004, RURAL ED, V25, P38, DOI [10.35608/ruraled.v25i3.528, DOI 10.35608/RURALED.V25I3.528]; Bouzarth EL, 2018, SOCIO-ECON PLAN SCI, V64, P1, DOI 10.1016/j.seps.2017.09.001; Brau L, 1980, MANUAL DE URBANISMO; BRUNO JE, 1982, SOCIO ECON PLAN SCI, V16, P121, DOI 10.1016/0038-0121(82)90022-2; Burde D, 2013, AM ECON J-APPL ECON, V5, P27, DOI 10.1257/app.5.3.27; Castillo-Lopez I, 2015, COMPUT IND ENG, V80, P284, DOI 10.1016/j.cie.2014.12.015; Ciccone A, 2009, REV ECON STAT, V91, P66, DOI 10.1162/rest.91.1.66; CONAPO, 2020, ABOUTUS; Daskin M. S., 2011, NETWORK DISCRETE LOC; Drezner T, 2002, FACILITY LOCATION APPLICATIONS AND THEORY, P151; Duze CO., 2010, AFRICAN RES REV, V4, DOI [10.4314/afrrev.v4i4.69236, DOI 10.4314/AFRREV.V4I4.69236]; Elkhalek AMAA., 2021, INT J EC FINANCE, V13, P181, DOI [10.5539/ijef.v13n6p181, DOI 10.5539/IJEF.V13N6P181]; Farahani RZ, 2012, COMPUT IND ENG, V62, P368, DOI 10.1016/j.cie.2011.08.020; Gac I, 2009, J OPER RES SOC, V60, P895, DOI 10.1057/palgrave.jors.2602630; Haase K, 2013, OMEGA-INT J MANAGE S, V41, P847, DOI 10.1016/j.omega.2012.10.008; Handa S, 2002, J DEV ECON, V69, P103, DOI 10.1016/S0304-3878(02)00055-X; Hanushek EA, 2012, J ECON GROWTH, V17, P267, DOI 10.1007/s10887-012-9081-x; INEGI, 2020, ABOUTUS; Johnson M., 2012, COMMUNITY BASED OPER, V167; Juan AA, 2015, OPER RES PERSPECT, V2, P62, DOI 10.1016/j.orp.2015.03.001; King EM, 2011, ED WORLD FORUM; Laporte G., 2015, LOCATION SCI, V528; Lemberg DS., 2000, SOCIO-ECON PLAN SCI, V34, P159, DOI [10.1016/S0038-0121(99)00019-1, DOI 10.1016/S0038-0121(99)00019-1]; Mandujano P, 2012, TRANSPORT RES REC, P74, DOI 10.3141/2283-08; Menezes Rafael Cezar, 2014, Pesqui. Oper., V34, P301, DOI 10.1590/0101-7438.2014.034.02.0301; Midgley G, 2018, EUR J OPER RES, V268, P771, DOI 10.1016/j.ejor.2017.08.014; Moreno-Monroy AI, 2018, J TRANSP GEOGR, V67, P110, DOI 10.1016/j.jtrangeo.2017.08.012; Muller S, 2008, J TRANSP GEOGR, V16, P342, DOI 10.1016/j.jtrangeo.2007.12.004; Muller S, 2011, ERDKUNDE, V65, P401, DOI 10.3112/erdkunde.2011.04.06; Muller S, 2012, GEOGR ANAL, V44, P65, DOI 10.1111/j.1538-4632.2011.00836.x; Muller S, 2009, ENVIRON PLANN A, V41, P2929, DOI 10.1068/a40285; Murray AT, 2016, INT REGIONAL SCI REV, V39, P5, DOI 10.1177/0160017615600222; Nasir N, 2014, AIP CONF PROC, V1613, P420, DOI 10.1063/1.4894365; Ndiaye F., 2012, AM J OPERATIONS RES, V2, P253, DOI [10.4236/ajor.2012.22030, DOI 10.4236/AJOR.2012.22030]; Ozturk I., 2001, J RURAL DEV ADM, V33, P39, DOI [10.2139/ssrn.1137541, DOI 10.2139/SSRN.1137541]; PIRKUL H, 1991, MANAGE SCI, V37, P233, DOI 10.1287/mnsc.37.2.233; Pizzolato N. D., 1997, International Transactions in Operational Research, V4, P13, DOI 10.1111/j.1475-3995.1997.tb00058.x; Pizzolato N. D., 2004, International Transactions in Operational Research, V11, P667, DOI 10.1111/j.1475-3995.2004.00483.x; Plisson P., 2017, WAY SCH; Radinger A, 2019, OECD ED WORKING PAPE, V196; Schilling D. A., 1993, Location Science, V1, P25; SCHOEPFLE OB, 1991, SOCIO ECON PLAN SCI, V25, P189, DOI 10.1016/0038-0121(91)90017-L; Statista, 2020, ABOUTUS; Tayyaba S, 2012, INT J EDUC MANAG, V26, P6, DOI 10.1108/09513541211194356; Teixeira JC, 2008, EUR J OPER RES, V185, P92, DOI 10.1016/j.ejor.2006.12.027; Tewari VK., 1987, HIGH SCH LOCATION DE; United Nations, 2015, MILLENIUM DEV GOALS; Vuri D, 2008, UNDERSTANDING CHILDR; White L, 2011, EUR J OPER RES, V208, P1, DOI 10.1016/j.ejor.2010.02.015	53	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262520	10.1371/journal.pone.0262520	http://dx.doi.org/10.1371/journal.pone.0262520			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020755	Green Published, gold			2022-12-27	WOS:000834207700047
J	Kruger, D; Lahoud, N; Yako, YY; Dever, J; Smith, M				Kruger, Deirdre; Lahoud, Nicola; Yako, Yandiswa Y.; Dever, John; Smith, Martin			Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; RISK-FACTORS; PLATELET COUNT; CANCER; SURVIVAL; THROMBOCYTOSIS; MARKERS	Background/Objectives Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy associated with high metastatic risk. Prognosis remains poor even after resection. Previously our group identified biomarkers that improved diagnostic accuracy in PDAC beyond the established diagnostic tumour marker, CA19-9. Risk factors, symptoms and circulating biomarkers associated with a PDAC diagnosis may differ from those that alter disease progression and metastasis. This study aimed at assessing the risk factors, presenting symptoms and potential prognostic biomarkers in PDAC and determine their relationship with PDAC stage and/ or metastatic status. Methods Seventy-two PDAC patients with imaging available for TNM staging at presentation were enrolled following informed consent. Demographic and clinical data were captured. Blood was collected and 38 cytokines/angiogenic factors measured. Nonparametric association tests, univariate and multivariate logistic regression were performed using STATA version 14.2. A p-value <= 0.05 was considered significant and odds ratios reported for effect size. Results Most risk factors and symptoms did not differ across the stages of cancer. Although male gender and smoking are risk factors for PDAC, the majority of study patients with metastatic PDAC were non-smoking females. In addition to CA19-9, the platelet count (p<0.01), IL-15 (p = 0.02) and GM-CSF (p<0.01) were significant, independent negative predictors of metastatic PDAC. Moreover, using specific cut-off values in a combined panel, the odds in a patient with all three biomarker levels below the cut-offs is 21 times more likely to have metastatic PDAC (p<0.0001). Conclusions Platelet count, IL-15 and GM-CSF are potential prognostic indicators of metastatic disease in PDAC patients from our local South African population.	[Kruger, Deirdre; Lahoud, Nicola; Yako, Yandiswa Y.; Dever, John; Smith, Martin] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Surg, Johannesburg, South Africa; [Dever, John; Smith, Martin] Chris Hani Baragwanath Acad Hosp, Dept Gen Surg, Hepatopancreatbiliary Unit, Johannesburg, South Africa; [Yako, Yandiswa Y.] Walter Sisulu Univ, Fac Hlth Sci, Dept Human Biol, Mthatha, South Africa	University of Witwatersrand; Walter Sisulu University	Kruger, D (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Surg, Johannesburg, South Africa.	Deirdre.Kruger@wits.ac.za		Kruger, Deirdre/0000-0002-3604-7682	MS. MRC CERCP15 Pancreas South African Medical Research Council	MS. MRC CERCP15 Pancreas South African Medical Research Council	MS. MRC CERCP15 Pancreas South African Medical Research Council www.samrc.ac.za MS conceived the study design, data interpretation, critically revised the manuscript and approved the final version.	Adamska A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071338; Aktekin Ali, 2019, Ann Hepatobiliary Pancreat Surg, V23, P155, DOI 10.14701/ahbps.2019.23.2.155; Almadi MA, 2013, SAUDI J GASTROENTERO, V19, P278, DOI 10.4103/1319-3767.121036; [Anonymous], 2004, N S W Public Health Bull, V15, P107; Arnaoutakis GJ, 2011, J GASTROINTEST SURG, V15, P1611, DOI 10.1007/s11605-011-1605-8; Ballehaninna UK, 2012, J GASTROINTEST ONCOL, V3, P105, DOI 10.3978/j.issn.2078-6891.2011.021; Camara SN, 2016, J HUAZHONG U SCI-MED, V36, P295, DOI 10.1007/s11596-016-1583-x; Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; Chen S, 2018, ONCOTARGETS THER, V11, P59, DOI 10.2147/OTT.S147715; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; Decoster C, 2016, ONCOTARGET, V7, P45634, DOI 10.18632/oncotarget.9861; Dominguez I, 2008, WORLD J SURG, V32, P1051, DOI 10.1007/s00268-007-9423-6; Evans J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004215; Gomez-Olive FX, 2017, GLOB HEART, V12, P81, DOI 10.1016/j.gheart.2017.01.007; He XY, 2014, WORLD J GASTROENTERO, V20, P11241, DOI 10.3748/wjg.v20.i32.11241; Hong IS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.64; Illes D, 2016, PANCREATOLOGY, V16, P266, DOI 10.1016/j.pan.2015.12.005; Keane MG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005720; Kinney T, 2010, SURG CLIN N AM, V90, P235, DOI 10.1016/j.suc.2009.12.003; Kolodecik T, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00415; Kruger D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221169; Largillier R, 2008, ANN ONCOL, V19, P2012, DOI 10.1093/annonc/mdn424; Mann DV, 2000, EUR J SURG ONCOL, V26, P474, DOI 10.1053/ejso.1999.0925; Maraz A, 2013, ANTICANCER RES, V33, P1725; Marrelli D, 2009, AM J SURG, V198, P333, DOI 10.1016/j.amjsurg.2008.12.031; Martin HL, 2014, INTERN MED J, V44, P676, DOI 10.1111/imj.12453; Midha S, 2016, CANCER LETT, V381, P269, DOI 10.1016/j.canlet.2016.07.022; Mitsunaga S, 2016, PANCREAS, V45, P110, DOI 10.1097/MPA.0000000000000465; Miyamoto R, 2017, PANCREAS, V46, P35, DOI 10.1097/MPA.0000000000000697; Paniccia R, 2015, VASC HEALTH RISK MAN, V11, P133, DOI 10.2147/VHRM.S44469; Porta Miquel, 2005, Clin Transl Oncol, V7, P189, DOI 10.1007/BF02712816; Qi Q, 2015, PANCREATOLOGY, V15, P145, DOI 10.1016/j.pan.2014.12.004; Raptis DA, 2010, SURG-J R COLL SURG E, V8, P239, DOI 10.1016/j.surge.2010.03.001; Scarton L, 2018, CANCERS, V10, DOI 10.3390/cancers10070235; Schlesinger M, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0669-2; Schulte A, 2014, EUR J CANCER, V50, P997, DOI 10.1016/j.ejca.2013.12.014; Schwarz RE, 1999, LANCET, V353, P2158, DOI 10.1016/S0140-6736(05)75597-5; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Stravodimou A, 2013, INT J BREAST CANCER, V2013, DOI 10.1155/2013/289563; Taucher S, 2003, THROMB HAEMOSTASIS, V89, P1098; Van Hemelrijck M, 2011, EUR J CANCER, V47, P2033, DOI 10.1016/j.ejca.2011.03.010; Voutsadakis IA, 2014, WORLD J GASTRO ONCOL, V6, P34, DOI 10.4251/wjgo.v6.i2.34; Wang L, 2015, INT J CLIN EXP MED, V8, P21215; Wei EK, 2010, J CLIN ONCOL, V28, P4052, DOI 10.1200/JCO.2009.26.9324; World Health Organization, 2014, CANC FACT SHEET; Xiao YY, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6250-8; Xiao YY, 2016, CANCER MED-US, V5, P881, DOI 10.1002/cam4.644; Yako YY, 2017, PANCREATOLOGY, V17, P438, DOI 10.1016/j.pan.2017.03.003; Yuan Y, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-1139-5	49	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262439	10.1371/journal.pone.0262439	http://dx.doi.org/10.1371/journal.pone.0262439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020761	gold, Green Published			2022-12-27	WOS:000834207700041
J	Sial, MU; Mehmood, K; Saeed, S; Husain, M; Rasool, KG; Aldawood, AS				Sial, Muhammad Umair; Mehmood, Khalid; Saeed, Shafqat; Husain, Mureed; Rasool, Khawaja Ghulam; Aldawood, Abdulrahman Saad			Neonicotinoid's resistance monitoring, diagnostic mechanisms and cytochrome P450 expression in green peach aphid [Myzus persicae (Sulzer) (Hemiptera: Aphididae)]	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; INSECTICIDE RESISTANCE; HEMIPTERA APHIDIDAE; R81T MUTATION; POTATO APHID; POPULATIONS; TOBACCO	Green peach aphid [Myzus persicae (Sulzer) (Hemiptera: Aphididae)] is a significant pest with a known history of insecticide resistance. Neonicotinoids could manage this pest; however, their frequent use led to the evolution of resistance in field populations of M. persicae. Toxicity data for neonicotinoid insecticides synergized with pipernyl butoxide (PBO) in a field population (FP) were collected and compared to a laboratory susceptible clone (SC) of aphids. The enhanced expression of metabolic resistance-related cytochrome P450 gene CYP6CY3 and an arginine-threonine substitution were detected in FP, causing a single point mutation (R81T) at beta 1 subunit of nicotinic acetylcholine receptor (nAChR) within D loop. High level of resistance to imidacloprid was developed in FP with 101-fold resistance ratio and moderate resistance level (10.9-fold) to acetamiprid. The results of PBO synergized bioassay suggested that cytochrome P450 enzymes were involved in the resistance to neonicotinoids. The mRNA transcriptional level of CYP6CY3 gene was significantly higher (3.74 fold) in FP compared to SC. The R81T mutation associated with neonicotinoid resistance had 26% resistant allele frequency in FP. Both P450 enzymes and R81T mutation of nAChR were found in field-evolved neonicotinoid resistance. It is concluded that fieldevolved resistance in green peach aphid could be managed by using appropriate synergists such as PBO.	[Sial, Muhammad Umair; Mehmood, Khalid; Saeed, Shafqat] Muhammad Nawaz Shareef MNS Univ Agr Multan, Inst Plant Protect, Punjab, Pakistan; [Sial, Muhammad Umair] Chinese Acad Agr Sci, Key Lab Control Biol Hazard Factors Plant Origin, Minist Agr & Rural Affairs Peoples Republ China, Inst Plant Protect, Beijing, Peoples R China; [Husain, Mureed; Rasool, Khawaja Ghulam; Aldawood, Abdulrahman Saad] King Saud Univ, Coll Food & Agr Sci, Plant Protect Dept, Riyadh, Saudi Arabia	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs; King Saud University	Sial, MU (corresponding author), Muhammad Nawaz Shareef MNS Univ Agr Multan, Inst Plant Protect, Punjab, Pakistan.; Sial, MU (corresponding author), Chinese Acad Agr Sci, Key Lab Control Biol Hazard Factors Plant Origin, Minist Agr & Rural Affairs Peoples Republ China, Inst Plant Protect, Beijing, Peoples R China.	umair.sial@mnsuam.edu.pk	Rasool, Khawaja/GZK-3923-2022		National Key Research and Development of China [2016YFD0200500]; King Saud University [RSP-2021/107]	National Key Research and Development of China; King Saud University(King Saud University)	This study was supported financially by the National Key Research and Development of China in the form of funding to MUS [2016YFD0200500] and the Researchers Supporting Project at King Saud University in the form of funds to ASA [RSP-2021/107].	Bass C, 2015, PESTIC BIOCHEM PHYS, V121, P78, DOI 10.1016/j.pestbp.2015.04.004; Bass C, 2014, INSECT BIOCHEM MOLEC, V51, P41, DOI 10.1016/j.ibmb.2014.05.003; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Beckingham C, 2013, PESTIC BIOCHEM PHYS, V107, P293, DOI 10.1016/j.pestbp.2013.08.005; Charaabi K, 2018, PEST MANAG SCI, V74, P1297, DOI 10.1002/ps.4833; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; de Little SC, 2017, PEST MANAG SCI, V73, P1611, DOI 10.1002/ps.4495; Gao X. W., 1992, Acta Phytophylacica Sinica, V19, P365; Hirata K, 2017, PESTIC BIOCHEM PHYS, V143, P57, DOI 10.1016/j.pestbp.2017.09.009; Hulle M, 2020, ENTOMOL GEN, V40, P97, DOI 10.1127/entomologia/2019/0867; Li Y, 2016, PESTIC BIOCHEM PHYS, V132, P21, DOI 10.1016/j.pestbp.2015.11.008; Margaritopoulos JT, 2007, PEST MANAG SCI, V63, P821, DOI 10.1002/ps.1409; Mottet C, 2016, J ECON ENTOMOL, V109, P2182, DOI 10.1093/jee/tow148; Panini M, 2014, PEST MANAG SCI, V70, P931, DOI 10.1002/ps.3630; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philippou D, 2013, PEST MANAG SCI, V69, P499, DOI 10.1002/ps.3400; Philippou D, 2010, PEST MANAG SCI, V66, P390, DOI 10.1002/ps.1888; Puinean AM, 2013, PEST MANAG SCI, V69, P195, DOI 10.1002/ps.3300; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Sial MU, 2020, J PEST SCI, V93, P531, DOI 10.1007/s10340-019-01168-8; Sial MU, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35076-1; Srigiriraju L, 2010, PEST MANAG SCI, V66, P676, DOI 10.1002/ps.1929; Tang QL, 2017, PESTIC BIOCHEM PHYS, V143, P39, DOI 10.1016/j.pestbp.2017.09.013; Van Emden HF., 2017, APHIDS CROP PESTS, DOI [10.1371/journal.pone.0174182, DOI 10.1371/JOURNAL.PONE.0174182]; Voudouris CC, 2016, PEST MANAG SCI, V72, P671, DOI 10.1002/ps.4036; Wang NX, 2016, PEST MANAG SCI, V72, P1467, DOI 10.1002/ps.4220	26	1	1	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261090	10.1371/journal.pone.0261090	http://dx.doi.org/10.1371/journal.pone.0261090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020740	Green Published, gold			2022-12-27	WOS:000834207700012
J	Papaj, K; Spychalska, P; Kapica, P; Fischer, A; Nowak, J; Bzowka, M; Sellner, M; Lill, MA; Smiesko, M; Gora, A				Papaj, Katarzyna; Spychalska, Patrycja; Kapica, Patryk; Fischer, Andre; Nowak, Jakub; Bzowka, Maria; Sellner, Manuel; Lill, Markus A.; Smiesko, Martin; Gora, Artur			Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease	PLOS ONE			English	Article							CORONAVIRUS	Based on previous large-scale in silico screening several factor Xa inhibitors were proposed to potentially inhibit SARS-CoV-2 M-pro. In addition to their known anticoagulants activity this potential inhibition could have an additional therapeutic effect on patients with COVID-19 disease. In this study we examined the binding of the Apixaban, Betrixaban and Rivaroxaban to the SARS-CoV-2 M-pro with the use of the MicroScale Thermophoresis technique. Our results indicate that the experimentally measured binding affinity is weak and the therapeutic effect due to the SARS-CoV-2 M-pro inhibition is rather negligible.	[Papaj, Katarzyna; Spychalska, Patrycja; Kapica, Patryk; Bzowka, Maria; Gora, Artur] Silesian Tech Univ, Biotechnol Ctr, Tunneling Grp, Gliwice, Poland; [Fischer, Andre; Sellner, Manuel; Lill, Markus A.; Smiesko, Martin] Univ Basel, Dept Pharmaceut Sci, Computat Pharm, Basel, Switzerland; [Nowak, Jakub] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Krakow, Poland	Silesian University of Technology; University of Basel; Jagiellonian University	Gora, A (corresponding author), Silesian Tech Univ, Biotechnol Ctr, Tunneling Grp, Gliwice, Poland.	a.gora@tunnelinggroup.pl	Nowak, Jakub Stanislaw/AFZ-0547-2022; Bzówka, Maria/ABG-2897-2020; Gora, Artur/D-5041-2012	Nowak, Jakub Stanislaw/0000-0001-6536-2940; Bzówka, Maria/0000-0001-6802-8753; Gora, Artur/0000-0003-2530-6957	Plastic Omnium Auto Sp. z o.o.	Plastic Omnium Auto Sp. z o.o.	KP, PS, PK, MB, AG -Plastic Omnium Auto Sp. z o.o. for support of the experimental part of this work. AF, MS1, MAL, MS2 -NVIDIA Corporation with the donation of a Titan Xp GPU used for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani RA, 2020, AM J CARDIOVASC DRUG, V20, P525, DOI 10.1007/s40256-020-00438-6; [Anonymous], 2019, SCHRODINGER RELEASE; Augusto Chaves O., 2021, BIORXIV; Biembengut IV, 2020, MEM I OSWALDO CRUZ, V115, DOI 10.1590/0074-02760200179; Billett HH, 2020, THROMB HAEMOSTASIS, V120, P1691, DOI 10.1055/s-0040-1720978; Bosch FTM, 2021, THROMB RES, V205, P106, DOI 10.1016/j.thromres.2021.07.008; Bowers K.J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1109/SC.2006.54; Bzowka M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093099; Chan NC, 2015, VASC HEALTH RISK MAN, V11, P343, DOI 10.2147/VHRM.S63060; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Dai WH, 2020, SCIENCE, V368, P1331, DOI 10.1126/science.abb4489; Du LY, 2007, BIOCHEM BIOPH RES CO, V359, P174, DOI 10.1016/j.bbrc.2007.05.092; Fischer A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22042065; Fischer A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103626; Foerster KI, 2020, CLIN PHARMACOKINET, V59, P967, DOI 10.1007/s40262-020-00879-x; Gahlawat A, 2020, J CHEM INF MODEL, V60, P5781, DOI 10.1021/acs.jcim.0c00546; Ghosh AK, 2016, J MED CHEM, V59, P5172, DOI 10.1021/acs.jmedchem.5b01697; Gorlinger K, 2020, ANESTH ANALG, V131, P1324, DOI 10.1213/ANE.0000000000005147; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Jakowenko N, 2020, THROMB RES, V196, P276, DOI 10.1016/j.thromres.2020.09.002; Jimenez-Alberto A, 2020, COMPUT BIOL CHEM, V88, DOI 10.1016/j.compbiolchem.2020.107325; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Kabir AA, 2021, OPEN MED-WARSAW, V16, P1486, DOI 10.1515/med-2021-0354; Kanhed AM, 2021, MOL DIVERS, V25, P383, DOI 10.1007/s11030-020-10130-1; Kneller DW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16954-7; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Lee J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19662-4; Mazzini S, 2020, MOLECULES, V25, DOI 10.3390/molecules25163745; Pathak N, 2021, ACS NANO, V15, P857, DOI 10.1021/acsnano.0c07383; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shaw DE, 2014, INT CONF HIGH PERFOR, P41, DOI 10.1109/SC.2014.9; Siddiqui F, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029619847524; Tang N, 2020, J THROMB HAEMOST, V18, P1094, DOI 10.1111/jth.14817; Tungol A, 2011, J MANAGE CARE PHARM, V17, P685, DOI 10.18553/jmcp.2011.17.9.685; Ullrich S, 2020, BIOORG MED CHEM LETT, V30, DOI 10.1016/j.bmcl.2020.127377; World Health Organisation, COR DIS COVID 19 SIT; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405	37	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262482	10.1371/journal.pone.0262482	http://dx.doi.org/10.1371/journal.pone.0262482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015795	Green Published, gold			2022-12-27	WOS:000814820600027
J	Teerawattananon, Y; Anothaisintawee, T; Pheerapanyawaranun, C; Botwright, S; Akksilp, K; Sirichumroonwit, N; Budtarad, N; Isaranuwatchai, W				Teerawattananon, Yot; Anothaisintawee, Thunyarat; Pheerapanyawaranun, Chatkamol; Botwright, Siobhan; Akksilp, Katika; Sirichumroonwit, Natchalaikorn; Budtarad, Nuttakarn; Isaranuwatchai, Wanrudee			A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings	PLOS ONE			English	Review							HEALTH-CARE WORKERS; MESSENGER-RNA VACCINE; BNT162B2 VACCINE; SARS-COV-2 INFECTION; CRITICAL-APPRAISAL; READERS GUIDE; IMPACT; DEATHS; TRIALS; COHORT	Real-world effectiveness studies are important for monitoring performance of COVID-19 vaccination programmes and informing COVID-19 prevention and control policies. We aimed to synthesise methodological approaches used in COVID-19 vaccine effectiveness studies, in order to evaluate which approaches are most appropriate to implement in low-and middle-income countries (LMICs). For this rapid systematic review, we searched PubMed and Scopus for articles published from inception to July 7, 2021, without language restrictions. We included any type of peer-reviewed observational study measuring COVID-19 vaccine effectiveness, for any population. We excluded randomised control trials and modelling studies. All data used in the analysis were extracted from included papers. We used a standardised data extraction form, modified from STrengthening the Reporting of OBservational studies in Epidemiology (STROBE). Study quality was assessed using the REal Life EVidence AssessmeNt Tool (RELEVANT) tool. This study is registered with PROSPERO, CRD42021264658. Our search identified 3,327 studies, of which 42 were eligible for analysis. Most studies (97.5%) were conducted in high-income countries and the majority assessed mRNA vaccines (78% mRNA only, 17% mRNA and viral vector, 2.5% viral vector, 2.5% inactivated vaccine). Thirty-five of the studies (83%) used a cohort study design. Across studies, short follow-up time and limited assessment and mitigation of potential confounders, including previous SARS-CoV-2 infection and healthcare seeking behaviour, were major limitations. This review summarises methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines and highlights the lack of such studies in LMICs, as well as the importance of context-specific vaccine effectiveness data. Further research in LMICs will refine guidance for conducting real-world COVID-19 vaccine effectiveness studies in resource-constrained settings.	[Teerawattananon, Yot; Pheerapanyawaranun, Chatkamol; Botwright, Siobhan; Akksilp, Katika; Sirichumroonwit, Natchalaikorn; Budtarad, Nuttakarn; Isaranuwatchai, Wanrudee] Minist Publ Hlth, Hlth Intervent & Technol Assessment Program, Nonthaburi, Thailand; [Teerawattananon, Yot] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Anothaisintawee, Thunyarat] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Family Med, Bangkok, Thailand	Ministry of Public Health - Thailand; National University of Singapore; Mahidol University	Botwright, S (corresponding author), Minist Publ Hlth, Hlth Intervent & Technol Assessment Program, Nonthaburi, Thailand.	siobhan.b@hitap.net		Budtarad, Nuttakarn/0000-0002-7853-4518; Akksilp, Katika/0000-0002-7270-8820	Health Systems Research Institute [64134002RM011L0]	Health Systems Research Institute	This study was funded by the Health Systems Research Institute (https://hsri.or.th/researcher), grant number 64134002RM011L0. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Amit S, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00448-7; Angel Y, 2021, JAMA-J AM MED ASSOC, V325, P2457, DOI 10.1001/jama.2021.7152; Azamgarhi T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23927-x; Basta NE, 2019, AM J EPIDEMIOL, V188, P987, DOI 10.1093/aje/kwz043; Benenson S, 2021, NEW ENGL J MED, V384, P1775, DOI 10.1056/NEJMc2101951; Bernal JL, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1088; Blonde L, 2018, ADV THER, V35, P1763, DOI 10.1007/s12325-018-0805-y; Britton A, 2021, MMWR-MORBID MORTAL W, V70, P396, DOI 10.15585/mmwr.mm7011e3; Campbell JD, 2019, CLIN TRANSL ALLERGY, V9, DOI 10.1186/s13601-019-0256-9; Cavanaugh AM, 2021, MMWR-MORBID MORTAL W, V70, P639, DOI 10.15585/mmwr.mm7017e2; Chodick G, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.15985; Chodick G, 2022, CLIN INFECT DIS, V74, P472, DOI 10.1093/cid/ciab438; Clark A, 2020, LANCET GLOB HEALTH, V8, P1003, DOI 10.1016/S2214-109X(20)30264-3; COVAX, 2021, COVAX GLOB SUPPL FOR; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Daniel W, 2021, NEW ENGL J MED, V384, P1962, DOI 10.1056/NEJMc2102153; Domi M, 2021, J AM GERIATR SOC, V69, P2079, DOI 10.1111/jgs.17224; Fabiani M, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.17.2100420; Fathizadeh H, 2021, INT J BIOL MACROMOL, V188, P740, DOI 10.1016/j.ijbiomac.2021.08.076; Flacco ME, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060628; Garvey MI, 2021, J INFECTION, V83, P119, DOI 10.1016/j.jinf.2021.04.027; Gras-Valenti P., REV ESP SALUD PUBLIC, V95; Gupta K, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.16416; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Hall VJ, 2021, LANCET, V397, P1725, DOI 10.1016/S0140-6736(21)00790-X; Harderi T, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.28.2100563; Harris RJ, 2021, NEW ENGL J MED, V385, P759, DOI 10.1056/NEJMc2107717; International Monetary Fund, 2021, POL RESP COVID19; Jaiswal A, 2021, INDIAN J MED RES, V153, P689, DOI 10.4103/ijmr.ijmr_1671_21; Jameson AP, 2022, INFECT CONT HOSP EP, V43, P950, DOI 10.1017/ice.2021.171; Jara A, 2021, NEW ENGL J MED, V385, P875, DOI 10.1056/NEJMoa2107715; Jones NK, 2021, ELIFE, V10, DOI 10.7554/eLife.68808; Keehner J, 2021, NEW ENGL J MED, V384, P1774, DOI 10.1056/NEJMc2101927; Kissling E, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.29.2100670; Knobel P, 2021, INFECT CONT HOSP EP, V42, P1517, DOI 10.1017/ice.2021.287; Kow CS, 2021, INFLAMMOPHARMACOLOGY, V29, P1075, DOI 10.1007/s10787-021-00839-2; Kustin T, 2021, NAT MED, V27, P1379, DOI 10.1038/s41591-021-01413-7; Ledford H, 2021, NATURE, V594, P164, DOI 10.1038/d41586-021-01505-x; Lee K, 2009, GLOB INST, P1; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Martinez-Baz I, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.21.2100438; Mazagatos C, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.24.2100452; Meggiolaro A., 2021, MEDRXIV; Moore S, 2021, LANCET INFECT DIS, V21, P793, DOI 10.1016/S1473-3099(21)00143-2; Morton SC, 2016, J CLIN EPIDEMIOL, V71, P3, DOI 10.1016/j.jclinepi.2015.10.014; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Pilishvili T, 2021, MMWR-MORBID MORTAL W, V70, P753, DOI 10.15585/mmwr.mm7020e2externalicon; de Azevedo TCP, 2021, REV ASSOC MED BRAS, V67, P474, DOI 10.1590/1806-9282.20210073; Pritchard E, 2021, NAT MED, V27, P1370, DOI 10.1038/s41591-021-01410-w; Rapaka RR, 2022, CLIN INFECT DIS, V74, P352, DOI 10.1093/cid/ciab213; Rochon PA, 2005, BMJ-BRIT MED J, V330, P895, DOI 10.1136/bmj.330.7496.895; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Sansone E, 2021, J INFECTION, V83, pE17, DOI 10.1016/j.jinf.2021.04.038; Sauerbrei W, 2014, STAT MED, V33, P5413, DOI 10.1002/sim.6265; Tang L, 2021, JAMA-J AM MED ASSOC, V325, P2500, DOI 10.1001/jama.2021.6564; Tenforde MW, 2021, MMWR-MORBID MORTAL W, V70, P674, DOI 10.15585/mmwr.mm7018e1; Thompson MG, 2021, NEW ENGL J MED, V385, P320, DOI 10.1056/NEJMoa2107058; Thompson MG, 2021, MMWR-MORBID MORTAL W, V70, P495, DOI 10.15585/mmwr.mm7013e3; Tregoning JS, 2021, NAT REV IMMUNOL, V21, P626, DOI 10.1038/s41577-021-00592-1; Vasileiou E, 2021, LANCET, V397, P1646, DOI 10.1016/S0140-6736(21)00677-2; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Walsh J, 2022, IRISH J MED SCI, V191, P961, DOI 10.1007/s11845-021-02658-4; World Health Organization, 2021, STRAT ADV GROUP EXP; World Health Organization (WHO), 2021, EV COVID 19 VACC EFF; Zacay G, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab262; Zaqout A, 2021, INT J INFECT DIS, V108, P116, DOI 10.1016/j.ijid.2021.05.021	67	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0261930	10.1371/journal.pone.0261930	http://dx.doi.org/10.1371/journal.pone.0261930			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015761	Green Published, gold			2022-12-27	WOS:000814820600008
J	Abdelaleem, OO; Mohammed, SR; El Sayed, HS; Hussein, SK; Ali, DY; Abdelwahed, MY; Gaber, SN; Hemeda, NF; Abd El-Hmid, RG				Abdelaleem, Omayma O.; Mohammed, Shereen Rashad; El Sayed, Hassan S.; Hussein, Sherin Khamis; Ali, Doaa Y.; Abdelwahed, Mostafa Y.; Gaber, Sylvana N.; Hemeda, Nada F.; Abd El-Hmid, Rehab G.			Serum miR-34a-5p and miR-199a-3p as new biomarkers of neonatal sepsis	PLOS ONE			English	Article							MICRORNA-34A SUPPRESSES AUTOPHAGY; ACUTE LUNG INJURY; KAPPA-B; EPITHELIAL-CELLS; DOWN-REGULATION; PROLIFERATION; EXPRESSION; BETA; PCR	Background Neonatal sepsis is a serious condition. Recent clinical studies have indicated that micro-RNAs (miRNAs) are key players in the pathogenesis of sepsis, which could be used as bio-markers for this condition. Patients and methods A total of 90 neonates with sepsis and 90 healthy neonates were enrolled in this study. qRT-PCR was performed to measure the expression levels of serum miR-34a-5p and miR-199a-3p. Results miR-34a-5p and miR-199a-3p serum levels were significantly reduced in neonates with sepsis compared with those in healthy neonates (P = 0.006 and P = 0.001, respectively). Significant correlations of miR-34a-5p and miR-199a-3p with each of TLC, RDW, RBS, and Creactive protein (CRP) as well as SNAPII were observed, indicating their associations with the severity of neonatal sepsis. Conclusion miR-34a-5p and miR-199a-3p may be useful as novel biomarkers in neonatal sepsis and may provide a new direction for its treatment.	[Abdelaleem, Omayma O.; Mohammed, Shereen Rashad; El Sayed, Hassan S.] Fayoum Univ, Fac Med, Dept Med Biochem & Mol Biol, Al Fayyum, Egypt; [Hussein, Sherin Khamis; Abd El-Hmid, Rehab G.] Fayoum Univ, Fac Med, Dept Pediat, Al Fayyum, Egypt; [Ali, Doaa Y.] Fayoum Univ, Fac Med, Dept Clin Pathol, Al Fayyum, Egypt; [Abdelwahed, Mostafa Y.] Fayoum Univ, Fac Med, Dept Physiol, Al Fayyum, Egypt; [Gaber, Sylvana N.] Fayoum Univ, Fac Med, Dept Microbiol & Immunol, Al Fayyum, Egypt; [Hemeda, Nada F.] Fayoum Univ, Fac Agr, Dept Genet, Al Fayyum, Egypt	Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University	Abdelaleem, OO (corresponding author), Fayoum Univ, Fac Med, Dept Med Biochem & Mol Biol, Al Fayyum, Egypt.	dr.omayma@yahoo.com						Agrawal A, 2003, IMMUNOLOGY, V108, P539, DOI 10.1046/j.1365-2567.2003.01608.x; Cai ZG, 2012, CAN J PHYSIOL PHARM, V90, P37, DOI [10.1139/Y11-095, 10.1139/y11-095]; Chen M, 2021, MEDIAT INFLAMM, V2021, DOI 10.1155/2021/8874854; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chen Z, 2019, INT J BIOL SCI, V15, P2627, DOI 10.7150/ijbs.37133; Cheng DL, 2018, BIOMED PHARMACOTHER, V105, P1276, DOI 10.1016/j.biopha.2018.06.063; Chiesa C, 2004, CLIN CHEM, V50, P279, DOI 10.1373/clinchem.2003.025171; CLSI, 2020, PERFORMANCE STANDARD, V30th, DOI 10.1108/08876049410065598; Coldewey SM, 2013, DIS MODEL MECH, V6, P1031, DOI 10.1242/dmm.012435; de Prost N, 2013, CRIT CARE, V17, DOI 10.1186/cc13022; Delanghe JR, 2015, CLIN CHIM ACTA, V451, P46, DOI 10.1016/j.cca.2015.01.031; Desvignes L, 2012, J IMMUNOL, V188, P6205, DOI 10.4049/jimmunol.1200255; Di Martino MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090005; Fatmi A, 2020, MOL MED, V26, DOI 10.1186/s10020-020-00217-8; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Gantier MP, 2010, J INTERF CYTOK RES, V30, P283, DOI 10.1089/jir.2010.0037; He XB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/945169; Huang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094382; Jia XQ, 2012, CELL BIOCHEM BIOPHYS, V62, P237, DOI 10.1007/s12013-011-9263-8; Khan AA, 2013, BLOOD, V121, P4473, DOI 10.1182/blood-2012-06-435412; Lange T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183435; Liu HJ, 2017, MOL MED REP, V16, P4355, DOI 10.3892/mmr.2017.7036; Liu XJ, 2015, AM J NEPHROL, V42, P168, DOI 10.1159/000439185; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Misso G, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.47; Pang JQ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.462; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608; Satar M, 2012, TURKISH J PEDIATR, V54, P449; Shen XM, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00497-6; Solayman MHM, 2016, MOL BIOTECHNOL, V58, P179, DOI 10.1007/s12033-015-9912-z; Song AF, 2020, EUR REV MED PHARMACO, V24, P11675, DOI 10.26355/eurrev_202011_23812; Song L, 2017, INFLAMMATION, V40, P927, DOI 10.1007/s10753-017-0537-1; Szilagyi Bernadett, 2019, EJIFCC, V30, P128; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang D, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.9781; Wang LN, 2013, EXP THER MED, V5, P1101, DOI 10.3892/etm.2013.937; Wangyang YF, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180982; Xia WZ, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001293; Xie MX, 2019, J AUTOIMMUN, V102, P96, DOI 10.1016/j.jaut.2019.04.018; Xiong A, 2019, HLA, V94, P493, DOI 10.1111/tan.13677; Yin X, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01071; Yuan J, 2020, CHEM-BIOL INTERACT, V322, DOI 10.1016/j.cbi.2020.109027	44	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262339	10.1371/journal.pone.0262339	http://dx.doi.org/10.1371/journal.pone.0262339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990478	gold, Green Published			2022-12-27	WOS:000815783800028
J	Yang, L; Sun, JG; Yan, CY; Wu, JY; Wang, YY; Ren, QT; Wang, S; Ma, X; Zhao, L; Sun, JS				Yang, Lin; Sun, Jinge; Yan, Congyu; Wu, Junyi; Wang, Yaya; Ren, Qiuting; Wang, Shen; Ma, Xu; Zhao, Ling; Sun, Jinsheng			Regeneration of duckweed (Lemna turonifera) involves genetic molecular regulation and cyclohexane release	PLOS ONE			English	Article							ORGANIC-COMPOUND EMISSIONS; PLANT-REGENERATION; ROOT; INDUCTION; CELLS	Plant regeneration is important for vegetative propagation, detoxification and the obtain of transgenic plant. We found that duckweed regeneration could be enhanced by regenerating callus. However, very little is known about the molecular mechanism and the release of volatile organic compounds (VOCs). To gain a global view of genes differently expression profiles in callus and regenerating callus, genetic transcript regulation has been studied. Auxin related genes have been significantly down-regulated in regenerating callus. Cytokinin signal pathway genes have been up-regulated in regenerating callus. This result suggests the modify of auxin and cytokinin balance determines the regenerating callus. Volatile organic compounds release has been analysised by gas chromatography/ mass spectrum during the stage of plant regeneration, and 11 kinds of unique volatile organic compounds in the regenerating callus were increased. Cyclohexane treatment enhanced duckweed regeneration by initiating root. Moreover, Auxin signal pathway genes were down-regulated in callus treated by cyclohexane. All together, these results indicated that cyclohexane released by regenerating callus promoted duckweed regeneration. Our results provide novel mechanistic insights into how regenerating callus promotes regeneration.	[Yang, Lin; Sun, Jinge; Yan, Congyu; Wu, Junyi; Wang, Yaya; Ren, Qiuting; Wang, Shen; Ma, Xu; Sun, Jinsheng] Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China; [Zhao, Ling] Nankai Univ, Coll Life Sci, Dept Plant Biol & Ecol, Tianjin, Peoples R China	Tianjin Normal University; Nankai University	Sun, JS (corresponding author), Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China.	skysjs@tjnu.edu.cn		Wang, Shen/0000-0002-5113-9067; Sun, Jinsheng/0000-0002-3013-4822	National Natural Science Foundation of China [32071620]; Tianjin Natural Science Foundation of Tianjin [S20QNK618]; Postgraduate Innovative Research Projects of Tianjin [2020YJSS133]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation of Tianjin; Postgraduate Innovative Research Projects of Tianjin	Funded studies Initials of the authors who received each award: L.Yang., JG. Sun Grant numbers awarded to each author: 86185 dollars, 9276 dollars and 785 dollars The full name of each funder: Present research has been supported by National Natural Science Foundation of China (No. 32071620), Tianjin Natural Science Foundation of Tianjin (S20QNK618), The Postgraduate Innovative Research Projects of Tianjin (2020YJSS133) URL of each funder website: N/A Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript? Yes.	An D, 2019, P NATL ACAD SCI USA, V116, P18893, DOI 10.1073/pnas.1910401116; Atta R, 2009, PLANT J, V57, P626, DOI 10.1111/j.1365-313X.2008.03715.x; Azizi P, 2015, MECH DEVELOP, V135, P1, DOI 10.1016/j.mod.2014.11.001; Binglian Z., 2003, CHINESE SCI BULL, V48, P8; Cheng F, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01020; Feher A, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00536; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hao Guo., 2020, OJNS, V8, P85; Hirota A, 2007, PLANT CELL, V19, P2156, DOI 10.1105/tpc.107.050674; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Ikeuchi M, 2017, PLANT PHYSIOL, V175, P1158, DOI 10.1104/pp.17.01035; Ikeuchi M, 2016, DEVELOPMENT, V143, P1442, DOI 10.1242/dev.134668; Jud W, 2016, PLANT CELL ENVIRON, V39, P1204, DOI 10.1111/pce.12643; Karunadasa SS, 2020, NEW PHYTOL, V227, P50, DOI 10.1111/nph.16519; Lardon R, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01274-9; Li J, 2004, PLANT CELL REP, V22, P457, DOI 10.1007/s00299-003-0724-4; Liu JC, 2014, PLANT CELL, V26, P1081, DOI 10.1105/tpc.114.122887; Loreto F, 2006, PLANT CELL ENVIRON, V29, P1820, DOI 10.1111/j.1365-3040.2006.01561.x; Motte H, 2014, BIOTECHNOL ADV, V32, P107, DOI 10.1016/j.biotechadv.2013.12.002; Pi LM, 2015, DEV CELL, V33, P576, DOI 10.1016/j.devcel.2015.04.024; Raghava T., 2009, Karnataka Journal of Agricultural Sciences, V22, P1023; RAM NVR, 1984, Z PFLANZENPHYSIOL, V113, P315; Romanov GA, 2018, NEW PHYTOL, V218, P41, DOI 10.1111/nph.14991; Sagare AP, 2000, PLANT SCI, V160, P139, DOI 10.1016/S0168-9452(00)00377-0; Shim S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78324-z; Shimotohno A, 2018, GENE DEV, V32, P1085, DOI 10.1101/gad.314096.118; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; WANG Y, 1994, J PLANT PHYSIOL, V144, P710, DOI 10.1016/S0176-1617(11)80666-8; Yang L, 2020, AQUAT TOXICOL, V229, DOI 10.1016/j.aquatox.2020.105579; Yang L, 2013, PLANT CELL TISS ORG, V113, P407, DOI 10.1007/s11240-012-0280-0; Yao J, 2020, PLANT CELL TISS ORG, V143, P189, DOI 10.1007/s11240-020-01909-z; Zhang GF, 2019, NAT PLANTS, V5, P491, DOI 10.1038/s41477-019-0408-x; Zhang RM, 2012, J ARID ENVIRON, V87, P212, DOI 10.1016/j.jaridenv.2012.04.008; Zuo ZJ, 2012, BIOCHEM SYST ECOL, V40, P19, DOI 10.1016/j.bse.2011.09.007; Zuo ZJ, 2018, ECOTOX ENVIRON SAFE, V161, P214, DOI 10.1016/j.ecoenv.2018.05.095	39	0	0	8	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0254265	10.1371/journal.pone.0254265	http://dx.doi.org/10.1371/journal.pone.0254265			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990448	gold, Green Published			2022-12-27	WOS:000815783800002
J	Portnoy, S; Cohen, S; Ratzon, NZ				Portnoy, Sigal; Cohen, Shlomit; Ratzon, Navah Z.			Correlations between body postures and musculoskeletal pain in guitar players	PLOS ONE			English	Article							PROFESSIONAL ORCHESTRAL MUSICIANS; PREVALENCE; KINEMATICS; DISORDERS; INJURY	Background The guitar-playing community is the largest group at risk of developing playing related musculoskeletal disorders. A thorough investigation of the relationships between the various risk factors and players' report on musculoskeletal pain using objective and accurate means of assessment has yet to be reported. Purpose (a) to explore the correlations between demographic characteristics, anthropometric measurements, playing habits, and personal habits of guitar player and their complaints of musculoskeletal pain, (b) explore the correlations between the upper body kinematics of guitar players during playing the guitar and their complaints of musculoskeletal pain, and (c) compare the upper body kinematics of guitar players during playing the guitar while sitting versus standing. Methods Twenty-five guitar players (27.54.6 years old) filled out questionnaires regarding their guitar-playing habits, and the Standardized Nordic Questionnaires for the analysis of musculoskeletal symptoms. Kinematics of their torso and upper limbs were tracked while they played a tune twice, once while sitting and once while standing. Results We found moderate correlations between the number of painful joints in the last year and factors, such as physical comfort while playing, years of playing, and position during playing. During standing, lower back pain severity correlated with the rotation range of the torso, while during sitting, it moderately correlated with the average radial-ulnar deviation of the right wrist. During sitting, we found higher anterior and right tilt of the torso, combined with greater abduction of the right shoulder, higher flexion in the left shoulder and higher radial deviation in the left wrist. Conclusion Our results point to several risk factors, related both to playing habits but also to playing posture, which should be considered by the guitar players in order to prevent playing-related musculoskeletal disorders.	[Portnoy, Sigal; Cohen, Shlomit; Ratzon, Navah Z.] Tel Aviv Univ, Sackler Fac Med, Dept Occupat Therapy, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Portnoy, S (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Occupat Therapy, Tel Aviv, Israel.	portnoys@tauex.tau.ac.il						Ackermann B, 2012, MED PROBL PERFORM AR, V27, P181; Ackermann BJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00913; Ajidahun AT, 2019, MUZIKI, V16, P7, DOI 10.1080/18125980.2019.1606675; Brandfonbrener AG, 2003, HAND CLIN, V19, P231, DOI 10.1016/S0749-0712(02)00100-2; Brown W, 2022, INT J OCCUP SAF ERGO, V28, P536, DOI 10.1080/10803548.2020.1796039; Creech JA., 2021, SHOULDER IMPINGEMENT; Cruder C, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2440-4; Fjellman-Wiklund A, 2006, MUSCULOSKELETAL GEN; Fotiadis DG, 2013, MED PROBL PERFORM AR, V28, P91; Foxman Irina, 2006, AAOHN J, V54, P309; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gohil K., 2016, INT J THER APPL, V32, P100, DOI [10.20530/ijta_32_100-103, DOI 10.20530/IJTA_32_100]; Haj A, 2019, CLIN BIOMECH, V61, P192, DOI 10.1016/j.clinbiomech.2018.12.022; Hulshof CTJ, 2021, ENVIRON INT, V146, DOI 10.1016/j.envint.2020.106157; Kochem FB, 2018, J MANIP PHYSIOL THER, V41, P540, DOI 10.1016/j.jmpt.2018.05.001; Kok LM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191772; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Laird RA, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-229; Levanon Y, 2010, GAIT POSTURE, V32, P469, DOI 10.1016/j.gaitpost.2010.07.003; Moreira-Silva I, 2016, WORKPLACE HEALTH SAF, V64, P210, DOI 10.1177/2165079916629688; Paarup HM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-223; Paarup HM., 2011, BMC MUSCULOSKEL DIS, P12, DOI [10.1186/1471-2474-12-12, DOI 10.1186/1471-2474-12-12]; Perez-Carrillo A, 2019, FRONT COMP SCI-SWITZ, V1, DOI 10.3389/fcomp.2019.00008; Price K, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-210; Rigg JL, 2003, MED PROBL PERFORM AR, V18, P150; Silva AG, 2015, MED PROBL PERFORM AR, V30, P8, DOI 10.21091/mppa.2015.1002; Steinmetz A, 2015, CLIN RHEUMATOL, V34, P965, DOI 10.1007/s10067-013-2470-5; Steinmetz A, 2010, J MANIP PHYSIOL THER, V33, P603, DOI 10.1016/j.jmpt.2010.08.006; Storm Seneca A, 2006, Phys Med Rehabil Clin N Am, V17, P893, DOI 10.1016/j.pmr.2006.08.003; Turner-Stokes L, 1999, CLIN BIOMECH, V14, P426, DOI 10.1016/S0268-0033(98)00110-7; Woldendorp KH, 2018, INT ARCH OCC ENV HEA, V91, P215, DOI 10.1007/s00420-017-1264-5; Zuhdi N, 2020, MED PROBL PERFORM AR, V35, P167, DOI 10.21091/mppa.2020.3022	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262207	10.1371/journal.pone.0262207	http://dx.doi.org/10.1371/journal.pone.0262207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982777	Green Published, gold			2022-12-27	WOS:000834805700021
J	Galbussera, AA; Mandelli, S; Rosso, S; Zanetti, R; Rossi, M; Giacomin, A; Detoma, P; Riva, E; Tettamanti, M; Della Porta, MG; Lucca, U				Galbussera, Alessia A.; Mandelli, Sara; Rosso, Stefano; Zanetti, Roberto; Rossi, Marianna; Giacomin, Adriano; Detoma, Paolo; Riva, Emma; Tettamanti, Mauro; Della Porta, Matteo G.; Lucca, Ugo			Mild anemia and 11-to 15-year mortality risk in young-old and old-old: Results from two population-based cohort studies	PLOS ONE			English	Article							HEMOGLOBIN CONCENTRATION; PREVALENCE; COMMUNITY; HEALTH; AGE; HOSPITALIZATION; DEFINITION; ADULTS; IMPACT	Background Mild anemia is a frequent although often overlooked finding in old age. Nevertheless, in recent years anemia has been linked to several adverse outcomes in the elderly population. Objective of the study was to investigate the association of mild anemia (hemoglobin concentrations: 10.0-11.9/12.9 g/dL in women/men) with all-cause mortality over 11-15 years and the effect of change in anemia status on mortality in young-old (65-84 years) and old-old (80+ years). Methods The Health and Anemia and Monzino 80-plus are two door-to-door, prospective population-based studies that included residents aged 65-plus years in Biella municipality and 80-plus years in Varese province, Italy. No exclusion criteria were used. Results Among 4,494 young-old and 1,842 old-old, mortality risk over 15/11 years was significantly higher in individuals with mild anemia compared with those without (young-old: fully-adjusted HR: 1.35, 95%CI, 1.15-1.58; old-old: fully-adjusted HR: 1.28, 95%CI, 1.14-1.44). Results were similar in the disease-free subpopulation (age, sex, education, smoking history, and alcohol consumption adjusted HR: 1.54, 95%CI, 1.02-2.34). Both age groups showed a dose-response relationship between anemia severity and mortality (P for trend <0.0001). Mortality risk was significantly associated with chronic disease and chronic kidney disease mild anemia in both age groups, and with vitamin B-12/folate deficiency and unexplained mild anemia in young-old. In participants with two hemoglobin determinations, seven-year mortality risk was significantly higher in incident and persistent anemic cases compared to constant non-anemic individuals in both age groups. In participants without anemia at baseline also hemoglobin decline was significantly associated with an increased mortality risk over seven years in both young-old and old-old. Limited to the Monzino 80-plus study, the association remained significant also when the risk was further adjusted also for time-varying covariates and time-varying anemia status over time. Conclusions Findings from these two large prospective population-based studies consistently suggest an independent, long-term impact of mild anemia on survival at older ages.	[Galbussera, Alessia A.; Mandelli, Sara; Riva, Emma; Tettamanti, Mauro; Lucca, Ugo] Ist Ric Farmacol Mario Negri IRCCS, Lab Geriatr Neuropsychiat, Dept Neurosci, Milan, Italy; [Rosso, Stefano; Zanetti, Roberto] Ctr Epidemiol & Prevent Oncol Piedmont, Piedmont Canc Registry, Turin, Italy; [Rossi, Marianna; Della Porta, Matteo G.] Humanitas Res Hosp, Ist Ricovero & Cura Carattere Sci IRCCS, Milan, Italy; [Rossi, Marianna; Della Porta, Matteo G.] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Giacomin, Adriano] Azienda Sanitaria Locale, Epidemiol Unit, Biella, Italy; [Detoma, Paolo] Osped Inferm Biella, Lab Anal, Biella, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Fondazione IRCCS Istituto Nazionale Tumori Milan; Humanitas University	Lucca, U (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Lab Geriatr Neuropsychiat, Dept Neurosci, Milan, Italy.	lucca@marionegri.it	Galbussera, Alessia Antonella/ABG-3036-2020	Galbussera, Alessia Antonella/0000-0003-0163-1034; Della Porta, Matteo Giovanni/0000-0002-6915-5970	Cariplo Foundation, Milan, Italy [2016-0860]; Italian Ministry of Health, Italy [RF 2016-02364918]; Italo Monzino Foundation, Milano, Italy	Cariplo Foundation, Milan, Italy(Fondazione Cariplo); Italian Ministry of Health, Italy(Ministry of Health, Italy); Italo Monzino Foundation, Milano, Italy	This study was supported by Cariplo Foundation, Milan, Italy (Project #2016-0860) and Italian Ministry of Health, Italy (Ricerca Finalizzata 2016 -Project #RF 2016-02364918). The Monzino 80-plus Study is being supported by a research grant from Italo Monzino Foundation, Milano, Italy. Present and past funders of the studies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of data; preparation, review, or approval of the manuscript; or in the decision to submit the manuscript for publication.	da Silva CLA, 2013, CAD SAUDE PUBLICA, V29, P2241, DOI [10.1590/0102-311X00183712, 10.1590/0102-311x00183712]; [Anonymous], 1968, WHO TECH REP SER, V405, P5; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; BURCH GE, 1980, AM HEART J, V100, P407, DOI 10.1016/0002-8703(80)90157-X; Carmel R, 2001, BLOOD REV, V15, P9, DOI 10.1054/blre.2001.0146; Chaves PHM, 2004, J AM GERIATR SOC, V52, P1811, DOI 10.1111/j.1532-5415.2004.52502.x; Culleton BF, 2006, BLOOD, V107, P3841, DOI 10.1182/blood-2005-10-4308; DALLMAN PR, 1984, AM J CLIN NUTR, V39, P437, DOI 10.1093/ajcn/39.3.437; den Elzen WPJ, 2009, CAN MED ASSOC J, V181, P151, DOI 10.1503/cmaj.090040; Denny SD, 2006, AM J MED, V119, P327, DOI [10.1016/j.amjmed.2005.08.027, 10.1016/j.amjmed.2005.10.042]; Dong X, 2008, J GERONTOL A-BIOL, V63, P873, DOI 10.1093/gerona/63.8.873; Ershler WB, 2005, VALUE HEALTH, V8, P629, DOI 10.1111/j.1524-4733.2005.00058.x; Girelli D, 2018, HEMASPHERE, V2, DOI 10.1097/HS9.0000000000000040; Goodnough LT, 2014, AM J HEMATOL, V89, P88, DOI 10.1002/ajh.23598; Groopman JE, 1999, JNCI-J NATL CANCER I, V91, P1616, DOI 10.1093/jnci/91.19.1616; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Istituto Nazionale di Statistica, GEOD IST IT; Izaks GJ, 1999, JAMA-J AM MED ASSOC, V281, P1714, DOI 10.1001/jama.281.18.1714; Jia WP, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.613426; Lucca U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001920; Lucca U, 2015, ALZHEIMERS DEMENT, V11, P258, DOI 10.1016/j.jalz.2014.05.1750; Lucca U, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-54; Malcovati L, 2017, BLOOD, V129, P3371, DOI 10.1182/blood-2017-01-763425; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; MCLENNAN WJ, 1973, Q J MED, V42, P1; Merchant AA, 2012, BRIT J HAEMATOL, V156, P173, DOI 10.1111/j.1365-2141.2011.08920.x; Nissenson Allen R, 2005, J Manag Care Pharm, V11, P565; Nissenson AR, 2003, ARCH INTERN MED, V163, P1400, DOI 10.1001/archinte.163.12.1400; Paltiel O, 2009, CAN MED ASSOC J, V181, P129, DOI 10.1503/cmaj.091199; Patel KV, 2007, BLOOD, V109, P4663, DOI 10.1182/blood-2006-10-055384; Patel KV, 2009, BRIT J HAEMATOL, V145, P514, DOI 10.1111/j.1365-2141.2009.07659.x; Penninx BWJH, 2006, J GERONTOL A-BIOL, V61, P474, DOI 10.1093/gerona/61.5.474; Riva E, 2009, HAEMATOL-HEMATOL J, V94, P22, DOI 10.3324/haematol.13449; Robinson B, 2003, J AM GERIATR SOC, V51, pS14; Rossi M., 2021, BLOOD, V138(21):2093-2105, DOI DOI 10.1182/BLOOD.2021011320, Patent No. 20210113202021; Semba RD, 2007, AGING CLIN EXP RES, V19, P259; Shavelle RM, 2012, INT J HEMATOL, V95, P248, DOI 10.1007/s12185-012-1007-z; Stauder R, 2018, BLOOD, V131, P505, DOI 10.1182/blood-2017-07-746446; Tang WHW, 2008, J AM COLL CARDIOL, V51, P569, DOI 10.1016/j.jacc.2007.07.094; Tettamanti M, 2010, HAEMATOL-HEMATOL J, V95, P1849, DOI 10.3324/haematol.2010.023101; United Nations Department of Economic and Social Affairs Population Division, 2017, WORLD POP AG 2017 HI; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WHO, 2011, WHO TECH REP SER, V959, P1; Wilson A, 2004, AM J MED, V116, P50, DOI 10.1016/j.amjmed.2003.12.012; Wouters HJCM, 2019, HAEMATOLOGICA, V104, P468, DOI 10.3324/haematol.2018.195552; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zakai NA, 2013, AM J HEMATOL, V88, P5, DOI 10.1002/ajh.23336	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261899	10.1371/journal.pone.0261899	http://dx.doi.org/10.1371/journal.pone.0261899			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972180	gold, Green Published			2022-12-27	WOS:000773555700066
J	Sanders, ME; Kant, E; Smit, AL; Stegeman, I				Sanders, Maxime E.; Kant, Ellen; Smit, Adriana L.; Stegeman, Inge			The effect of hearing aids on cognitive function: A systematic review	PLOS ONE			English	Review							OLDER-ADULTS; IMPAIRMENT; DEMENTIA; DECLINE; HEALTH; INTERVENTION; DEPRESSION; RISK	Rationale Dementia currently affects 50 million people globally with this expected to triple by 2050. Even though hearing loss is associated with cognitive decline, the underlying mechanisms are not fully understood. Considering hearing loss is the largest modifiable risk factor for developing dementia, it is essential to study the effect of hearing aids on cognitive function. Objective To systematically review the existing literature to examine the evidence for using hearing aids intervention as a treatment for deteriorating cognitive function. Design A search of PubMed, Cochrane Library, Embase and grey literature was conducted revealing 3060 unique records between 1990-2020. Two reviewers independently selected longitudinal studies observing the effects of hearing aids on cognitive function in persons without dementia at onset of the study. Due to the heterogeneity of the data, a meta-analysis could not be performed. Outcomes are described in a summary of findings table and portrayed diagrammatically. Results We identified 17 unique studies, spanning 30 years of research and 3526 participants. The included studies made use of 50 different cognitive function tests. These tests were grouped into separate cognitive domains according to the DSM-V classification for further analysis. The most beneficial impact of hearing aids seems to be in the cognitive domain of executive function, with six studies showing improvement, two studies being inconclusive and three studies not demonstrating a significant effect. Three of five studies demonstrated significant improvement when screening for brief mental status. The least beneficial impact is seen in domain of complex attention, with eight studies showing no significant effects, compared with one demonstrating improvement with intervention. Conclusions Based on this systematic review, we conclude that there is controversy about the effects of hearing aids on cognition. Additional research through randomized clinical trials with standardized cognitive assessment and longer follow-up is warranted to further elucidate this relationship.	[Sanders, Maxime E.; Kant, Ellen; Smit, Adriana L.; Stegeman, Inge] Univ Med Ctr Utrecht, Dept Otorhinolaryngol & Head & Neck Surg, Utrecht, Netherlands; [Smit, Adriana L.; Stegeman, Inge] Univ Med Ctr Utrecht, Brain Ctr, Utrecht, Netherlands; [Stegeman, Inge] Univ Med Ctr Utrecht, Dept Ophthalmol, Utrecht, Netherlands; [Stegeman, Inge] Univ Amsterdam, Amsterdam Univ Med Ctr, Epidemiol & Data Sci, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam	Stegeman, I (corresponding author), Univ Med Ctr Utrecht, Dept Otorhinolaryngol & Head & Neck Surg, Utrecht, Netherlands.; Stegeman, I (corresponding author), Univ Med Ctr Utrecht, Brain Ctr, Utrecht, Netherlands.; Stegeman, I (corresponding author), Univ Med Ctr Utrecht, Dept Ophthalmol, Utrecht, Netherlands.; Stegeman, I (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Epidemiol & Data Sci, Amsterdam, Netherlands.	l.Stegeman@umcutrecht.nl		Kant, Ellen/0000-0002-8433-8660; Stegeman, Inge/0000-0001-5154-7178				Acar B, 2011, ARCH GERONTOL GERIAT, V52, P250, DOI 10.1016/j.archger.2010.04.013; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Amieva H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030805; Berchtold NC, 1998, NEUROBIOL AGING, V19, P173, DOI 10.1016/S0197-4580(98)00052-9; Boi R, 2012, GERIATR GERONTOL INT, V12, P440, DOI 10.1111/j.1447-0594.2011.00789.x; Brewster KK, 2020, INT J GERIATR PSYCH, V35, P842, DOI 10.1002/gps.5311; Castiglione A, 2016, AUDIOL NEURO-OTOL, V21, P21, DOI 10.1159/000448350; Chien W, 2012, ARCH INTERN MED, V172, P292, DOI 10.1001/archinternmed.2011.1408; Choi AY, 2011, CLIN EXP OTORHINOLAR, V4, P72, DOI 10.3342/ceo.2011.4.2.72; Dawes P, 2015, INT J AUDIOL, V54, P838, DOI 10.3109/14992027.2015.1059503; Deal Jennifer A, 2017, Alzheimers Dement (N Y), V3, P410, DOI 10.1016/j.trci.2017.06.003; Deal JA, 2015, AM J EPIDEMIOL, V181, P680, DOI 10.1093/aje/kwu333; Desjardins JL, 2016, AM J AUDIOL, V25, P127, DOI 10.1044/2016_AJA-15-0067; Doherty KA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00721; Golub JS, 2020, JAMA OTOLARYNGOL, V146, P57, DOI 10.1001/jamaoto.2019.3375; Griffiths TD, 2020, NEURON, V108, P401, DOI 10.1016/j.neuron.2020.08.003; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hogan A, 2009, J AGING HEALTH, V21, P1098, DOI 10.1177/0898264309347821; Huang CQ, 2010, AGEING RES REV, V9, P131, DOI 10.1016/j.arr.2009.05.005; Hugo J, 2014, CLIN GERIATR MED, V30, P421, DOI 10.1016/j.cger.2014.04.001; James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7; Johnson JCS, 2021, BRAIN, V144, P391; Karawani H, 2018, NEUROPSYCHOLOGIA, V114, P203, DOI 10.1016/j.neuropsychologia.2018.04.041; Lawrence BJ, 2020, GERONTOLOGIST, V60, pE137, DOI 10.1093/geront/gnz009; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Loughrey DG, 2018, JAMA OTOLARYNGOL, V144, P115, DOI 10.1001/jamaoto.2017.2513; Magalhaes Ruth, 2011, J Soc Bras Fonoaudiol, V23, P51; Maharani A, 2018, J AM GERIATR SOC, V66, P1130, DOI 10.1111/jgs.15363; Mamo SK, 2018, J SPEECH LANG HEAR R, V61, P2589, DOI 10.1044/2018_JSLHR-H-18-0077; McIntyre Roger S., 2014, COGNITION MAJOR DEPR; Meyer C, 2012, INT J AUDIOL, V51, P66, DOI 10.3109/14992027.2011.611178; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; MULROW CD, 1990, ANN INTERN MED, V113, P188, DOI 10.7326/0003-4819-113-3-188; Obuchi C, 2011, AUDIOL RES, V1, P40, DOI 10.4081/audiores.2011.e11; Patterson C., 2018, ALZHEIMERS DIS INT W; Peracino A, 2014, AUDIOL NEURO-OTOL, V19, P6, DOI 10.1159/000371595; Pronk M, 2013, AM J AUDIOL, V22, P316, DOI 10.1044/1059-0889(2013/12-0069); Sanchez VA, 2020, EAR HEARING, V41, P1333, DOI 10.1097/AUD.0000000000000858; Sanders M.E., 2020, PROSPERO; Sarant J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010254; Taljaard DS, 2016, CLIN OTOLARYNGOL, V41, P718, DOI 10.1111/coa.12607; TeschRomer C, 1997, J GERONTOL B-PSYCHOL, V52, pP127, DOI 10.1093/geronb/52B.3.P127; Thomson RS, 2017, LARYNGOSCOPE INVEST, V2, P69, DOI 10.1002/lio2.65; Uchida Y, 2019, AURIS NASUS LARYNX, V46, P1, DOI 10.1016/j.anl.2018.08.010; van Hooren SAH, 2005, INT J AUDIOL, V44, P265, DOI 10.1080/14992020500060370; Wayne RV, 2015, AGEING RES REV, V23, P154, DOI 10.1016/j.arr.2015.06.002; Wells G, 2000, NEWCASTLE OTTAWA SCA; World Health Organization, 2020, FACTSH DEAFN HEAR LO; Yamada Y, 2017, J COMMUN DISORD, V67, P14, DOI 10.1016/j.jcomdis.2017.05.001	52	5	5	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261207	10.1371/journal.pone.0261207	http://dx.doi.org/10.1371/journal.pone.0261207			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972121	gold, Green Published			2022-12-27	WOS:000773555700027
J	Suardi, A; Saia, S; Alfano, V; Rezaei, N; Cetera, P; Bergonzoli, S; Pari, L				Suardi, Alessandro; Saia, Sergio; Alfano, Vincenzo; Rezaei, Negar; Cetera, Paola; Bergonzoli, Simone; Pari, Luigi			Pruning harvesting with modular towed chipper: Little effect of the machine setting and configuration on performance despite strong impact on wood chip quality	PLOS ONE			English	Article							HELICAL CHIPPERS; KNIFE WEAR; RESIDUES; SYSTEM	Pruning residues can have a high quality as feedstock for energy purposes and are largely available in Europe. However, it is still an untapped resource. Such scarce use is due to the need to optimize their supply chain in term of collection machines and the associate cost of collection. A modular chipper (prototype PC50) for pruning harvest was developed. Such prototype is adaptable to various harvesting logistics and may produce a higher quality woodchip compared with the one produced by shredders available in the market. In this work, we tested the performance and quality of the product delivered by the prototype PC50 in various conditions and plant species, after a modulation of the machine settings (counter-rotating toothed rollers [CRR] speed), loading systems ([LS], either big bag or container), and knife types ([KT], either discontinuous hoe shaped knives or continuous helicoidal knives). To take into account of the covariates in the experiment (Cropping season and plant species), LSmeans were computed to have an unbiased estimate of the treatments means. The modulation of LS and KT scarcely affected the performance of the machine. In particular, the choice of the KT affected the field efficiency when the LS was a Tilting box but not a Big Bag. Whereas the continuous knife resulted in a 97% higher material capacity compared to hoe shape knives, the last of which the amount of short sized (<16 mm) fractions compared to helicoidal knives. No role of the CCR was found on the machine performance, but increasing CRR speed reduced the chip apparent bulk density and the fraction chips with a size <8 mm.	[Suardi, Alessandro; Alfano, Vincenzo; Bergonzoli, Simone; Pari, Luigi] Res Ctr Engn & Agrofood Proc CREA IT, Council Agr Res & Econ, Rome, Italy; [Saia, Sergio] Univ Pisa, Dept Vet Sci, Pisa, Italy; [Rezaei, Negar] Natl Res Council CNR Res Inst Terr Ecosyst IRET, Porano, TR, Italy; [Cetera, Paola] Univ Sassari, Dipartimento Agr, Sassari, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Pisa; University of Sassari	Saia, S (corresponding author), Univ Pisa, Dept Vet Sci, Pisa, Italy.	sergio.saia@unipi.it	Cetera, Paola/AAN-9007-2020; Cetera, Paola/GZG-8644-2022; Saia, Sergio/K-7535-2012	Cetera, Paola/0000-0002-7568-2718; Cetera, Paola/0000-0002-7568-2718; Saia, Sergio/0000-0001-5465-8500; Alfano, Vincenzo/0000-0001-6256-3931	European Horizon 2020 project Magic [727698]	European Horizon 2020 project Magic	This study has been produced with the data collected during the EuroPruning project (Development and implementation of a new and non-existent logistics chain for biomass from pruning); and the European Horizon 2020 project Magic (grant number 727698). The ideas expressed do not represent either those of the European Commission or the Italian Ministry of Agriculture (MiPAAF).	Abdallah R, 2011, BIOMASS BIOENERG, V35, P843, DOI 10.1016/j.biombioe.2010.11.009; Acampora A, 2013, RENEW ENERG, V53, P350, DOI 10.1016/j.renene.2012.12.009; [Anonymous], 2016, ISO33101; [Anonymous], 2010, 151491 EN; [Anonymous], 2015, 178282015 ISO; [Anonymous], 2009, 47741 EN, P1; Assirelli A, 2013, T ASABE, V56, P829; Assirelli A., 2012, INFORM AGRARIO, P32; Bergonzoli S, 2020, ENERGIES, V13, DOI 10.3390/en13051265; Bodria L., 2006, EDAGRICOLE; Civitarese V, 2015, CROAT J FOR ENG, V36, P101; Creutzig F, 2015, GCB BIOENERGY, V7, P916, DOI 10.1111/gcbb.12205; Dauve J J., 2015, EFF BR MINDFULNESS I, P1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; DiBlasi C, 1997, BIOMASS BIOENERG, V12, P321, DOI 10.1016/S0961-9534(96)00073-6; Dyjakon A., 2014, AGR ENG, V18, P29, DOI [10.14654/ir.2014.151.054, DOI 10.14654/IR.2014.151.054]; Eurostat, 2019, EUR GRAIN MAIZ CORN; Facello A, 2013, BIOMASS BIOENERG, V59, P468, DOI 10.1016/j.biombioe.2013.07.012; Garcia-Galindo D., 2016, EUROPEAN BIOMASS C E, DOI [10.5071/24thEUBCE2016-1BO.9.1, DOI 10.5071/24THEUBCE2016-1BO.9.1]; Kuptz D., 2015, INT J ENG TAYLOR FRA, V26, P60, DOI 10.1080/14942119.2015.1021529; Magagnotti N, 2013, BIORESOURCE TECHNOL, V128, P697, DOI 10.1016/j.biortech.2012.10.149; Palmieri N, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083466; Pari L, 2017, BIOMASS BIOENERG, V107, P398, DOI 10.1016/j.biombioe.2017.09.014; Pari L., 2018, BEST AVAILABLE TECHN; Pari L., 2019, AGR BYPRODUCTS VALOR, P60; Pari L, 2018, ENERGIES, V11, DOI 10.3390/en11071622; Pari L, 2018, ENERGIES, V11, DOI 10.3390/en11061365; Pari L, 2018, BIOMASS BIOENERG, V112, P121, DOI 10.1016/j.biombioe.2018.01.002; Pari L, 2017, BIOMASS BIOENERG, V107, P1, DOI 10.1016/j.biombioe.2017.09.007; Picchi G., 2011, 19 EUR BIOM C EXH BE, P430, DOI [10.2478/S31756-009-0109-4.6, DOI 10.2478/S31756-009-0109-4.6]; Prando D, 2014, PAPERS OF THE 22ND EUROPEAN BIOMASS CONFERENCE: SETTING THE COURSE FOR A BIOBASED ECONOMY, P655; Rackl M, 2016, BIOMASS BIOENERG, V88, P106, DOI 10.1016/j.biombioe.2016.03.011; Recchia L, 2009, BIOMASS BIOENERG, V33, P149, DOI 10.1016/j.biombioe.2008.05.003; Saia S, 2020, MYCORRHIZA, V30, P133, DOI 10.1007/s00572-019-00927-w; Santangelo E, 2015, IND CROP PROD, V75, P85, DOI 10.1016/j.indcrop.2015.07.013; Scarlat N, 2010, WASTE MANAGE, V30, P1889, DOI 10.1016/j.wasman.2010.04.016; Spinelli R, 2012, T ASABE, V55, P21; Spinelli R, 2015, SUPPLY WOOD BIOMASS, P54; Spinelli R, 2014, BIOMASS BIOENERG, V62, P117, DOI 10.1016/j.biombioe.2014.01.007; Spinelli R, 2012, SCAND J FOREST RES, V27, P393, DOI 10.1080/02827581.2011.644577; Spinelli R, 2012, APPL ENERG, V89, P374, DOI 10.1016/j.apenergy.2011.07.049; Spinelli R, 2010, BIOSYST ENG, V105, P316, DOI 10.1016/j.biosystemseng.2009.11.011; Spinelli R, 2010, BIORESOURCE TECHNOL, V101, P730, DOI 10.1016/j.biortech.2009.08.039; Suardi A, 2020, ENERGIES, V13, DOI 10.3390/en13071713; Suardi A, 2020, ENERGIES, V13, DOI 10.3390/en13071572; Suardi A, 2019, ENERGIES, V12, DOI 10.3390/en12163086; Velazquez-Marti B, 2009, BIOSYST ENG, V104, P184, DOI 10.1016/j.biosystemseng.2009.06.017; Wegener J, 2013, T ASABE, V56, P363; Wegener J, 2012, APPL ENG AGRIC, V28, P491; Wegener JK, 2014, BIOMASS BIOENERG, V66, P151, DOI 10.1016/j.biombioe.2014.01.029	49	2	2	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261810	10.1371/journal.pone.0261810	http://dx.doi.org/10.1371/journal.pone.0261810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972130	Green Published, gold			2022-12-27	WOS:000773555700056
J	Forray, A; Mele, A; Byatt, N; Londono Tobon, A; Gilstad-Hayden, K; Hunkle, K; Hong, S; Lipkind, H; Fiellin, DA; Callaghan, K; Yonkers, KA				Forray, Ariadna; Mele, Amanda; Byatt, Nancy; Londono Tobon, Amalia; Gilstad-Hayden, Kathryn; Hunkle, Karen; Hong, Suyeon; Lipkind, Heather; Fiellin, David A.; Callaghan, Katherine; Yonkers, Kimberly A.			Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics	PLOS ONE			English	Article							MEDICATION-ASSISTED TREATMENT; PRIMARY-CARE PROVIDERS; COLLABORATIVE CARE; PROJECT ECHO; METHADONE-MAINTENANCE; HEPATITIS-C; BUPRENORPHINE; MANAGEMENT; DEPRESSION; BARRIERS	Introduction The prevalence of opioid use disorder (OUD) in pregnancy increased nearly five-fold over the past decade. Despite this, obstetric providers are less likely to treat pregnant women with medication for OUD than non-obstetric providers (75% vs 91%). A major reason is many obstetricians feel unprepared to prescribe medication for opioid use disorder (MOUD). Education and support may increase prescribing and overall comfort in delivering care for pregnant women with OUD, but optimal models of education and support are yet to be determined. Methods and analysis We describe the rationale and conduct of a matched-pair cluster randomized clinical trial to compare the effectiveness of two models of support for reproductive health clinicians to provide care for pregnant and postpartum women with OUD. The primary outcomes of this trial are patient treatment engagement and retention in OUD treatment. This study compares two support models: 1) a collaborative care approach, based upon the Massachusetts Office-Based-Opioid Treatment Model, that provides practice-level training and support to providers and patients through the use of care managers, versus 2) a telesupport approach based on the Project Extension for Community Healthcare Outcomes, a remote education model that provides mentorship, guided practice, and participation in a learning community, via video conferencing. Discussion This clustered randomized clinical trial aims to test the effectiveness of two approaches to support practitioners who care for pregnant women with an OUD. The results of this trial will help determine the best model to improve the capacity of obstetrical providers to deliver treatment for OUD in prenatal clinics.	[Forray, Ariadna; Mele, Amanda; Gilstad-Hayden, Kathryn; Hunkle, Karen; Hong, Suyeon] Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Byatt, Nancy; Yonkers, Kimberly A.] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Byatt, Nancy; Callaghan, Katherine] Univ Massachusetts, Sch Med, Dept Ob Gyn, Worcester, MA USA; [Byatt, Nancy] Univ Massachusetts, Sch Med, Dept Populat & Quantitat Hlth Sci, Worcester, MA USA; [Londono Tobon, Amalia] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Lipkind, Heather] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Fiellin, David A.] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Fiellin, David A.] Yale Sch Med, Dept Emergency Med, New Haven, CT USA; [Fiellin, David A.] Yale Sch Publ Hlth, New Haven, CT USA	Yale University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Brown University; Yale University; Yale University; Yale University; Yale University	Forray, A (corresponding author), Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA.	ariadna.forray@yale.edu		Hong, Suyeon/0000-0003-0200-7479; Mele, Amanda/0000-0002-9893-3225	Patient Centered Outcomes Research Institution (PCORI) [MAT-2018C2-12891]; Andrea Brandau Program Officer Patient-Centered Outcomes Research Institute (PCORI),Washington, DC	Patient Centered Outcomes Research Institution (PCORI); Andrea Brandau Program Officer Patient-Centered Outcomes Research Institute (PCORI),Washington, DC	This work was supported by PatientCentered Outcomes Research Institution (PCORI) grant number MAT-2018C2-12891) awarded to AF and KY. PCORI had no role in the design of this study and will not have any role during its execution, analyses, interpretation of the data, or decision to submit results. LT performed this work while employed by Yale University and Lifespan/Brown University; however, she is now employed by the Division of Intramural Research, National Institute of Minority Health and Health Disparities, National Institutes of Health. The contents and views in this manuscript are those of the authors and should not be construed to represent the views of the National Institutes of Health. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder Contact: Andrea Brandau Program Officer Patient-Centered Outcomes Research Institute (PCORI) 1828 L Street, NW 9th Floor, Washington, DC 20036 Office: 202.370.9394 abrandau@pcori.orghttps://www.pcori.org/people/andrea-brandau-	Alford DP, 2011, ARCH INTERN MED, V171, P425, DOI 10.1001/archinternmed.2010.541; Andraka-Christou B, 2018, INT J DRUG POLICY, V54, P9, DOI 10.1016/j.drugpo.2017.11.021; Arora S, 2007, PUBLIC HEALTH REP, V122, P74, DOI 10.1177/00333549071220S214; Arora S, 2007, ACAD MED, V82, P154, DOI 10.1097/ACM.0b013e31802d8f68; Arora S, 2014, ACAD MED, V89, P30, DOI 10.1097/ACM.0000000000000051; Bachhuber MA, 2017, MED CARE, V55, P985, DOI 10.1097/MLR.0000000000000803; Barry DT, 2009, J GEN INTERN MED, V24, P218, DOI 10.1007/s11606-008-0881-9; Bhat A, 2017, PSYCHIAT SERV, V68, P17, DOI 10.1176/appi.ps.201600002; Brogly SB, 2018, OBSTET GYNECOL, V132, P916, DOI 10.1097/AOG.0000000000002881; Carey EP, 2016, J REHABIL RES DEV, V53, P147, DOI 10.1682/JRRD.2014.10.0247; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; CHAPPEL JN, 1985, J STUD ALCOHOL, V46, P48, DOI 10.15288/jsa.1985.46.48; Cleveland LM, 2020, ADDICTION, V115, P2079, DOI 10.1111/add.15054; Colleran K, 2012, DIABETES EDUCATOR, V38, P386, DOI 10.1177/0145721712441523; Coventry PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108114; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Cox JL, 1996, J AFFECT DISORDERS, V39, P185, DOI 10.1016/0165-0327(96)00008-0; DeFlavio JR, 2015, RURAL REMOTE HEALTH, V15; Edgington E. S., 1987, RANDOMIZATION TESTS; Falletta L, 2018, CHILD ABUSE NEGLECT, V79, P125, DOI 10.1016/j.chiabu.2018.01.026; Fals-Stewart W, 2000, J CONSULT CLIN PSYCH, V68, P134, DOI 10.1037/0022-006X.68.1.134; Fullerton CA, 2014, PSYCHIAT SERV, V65, P146, DOI 10.1176/appi.ps.201300235; Gail MH, 1996, STAT MED, V15, P1069, DOI 10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-SIM220>3.3.CO;2-H; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gordon AJ, 2011, PSYCHOL ADDICT BEHAV, V25, P215, DOI 10.1037/a0022776; Guille C, 2017, AM J PSYCHIAT, V174, P208, DOI 10.1176/appi.ajp.2016.16060710; Haight SC, 2018, MMWR-MORBID MORTAL W, V67, P845, DOI 10.15585/mmwr.mm6731a1; Hand DJ, 2017, FERTIL STERIL, V108, P222, DOI 10.1016/j.fertnstert.2017.06.011; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; Huffman JC, 2014, PSYCHOSOMATICS, V55, P109, DOI 10.1016/j.psym.2013.09.002; Huhn AS, 2017, J SUBST ABUSE TREAT, V78, P1, DOI 10.1016/j.jsat.2017.04.005; Hutchinson E, 2014, ANN FAM MED, V12, P128, DOI 10.1370/afm.1595; Jones HE, 2008, AM J ADDICTION, V17, P372, DOI 10.1080/10550490802266276; Jones HE, 2013, SUBST ABUS, V34, P89, DOI 10.1080/08897077.2012.752779; Jumah NA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011774; Kampman K, 2015, NATL PRACTICE GUIDEL; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katzman JG, 2014, J CONTIN EDUC HEALTH, V34, P68, DOI 10.1002/chp.21210; Kermack A, 2017, J SUBST ABUSE TREAT, V74, P1, DOI 10.1016/j.jsat.2016.10.005; Khatri K, 2013, J HEALTH CARE POOR U, V24, P850, DOI 10.1353/hpu.2013.0093; Kim S C, 2001, Clin Nurs Res, V10, P314; Klaman SL, 2017, J ADDICT MED, V11, P178, DOI 10.1097/ADM.0000000000000308; Komaromy M, 2017, PSYCHIAT SERV, V68, P873, DOI 10.1176/appi.ps.201600471; Komaromy M, 2016, SUBST ABUS, V37, P20, DOI 10.1080/08897077.2015.1129388; Krans EE, 2018, ADDICT BEHAV, V86, P124, DOI 10.1016/j.addbeh.2018.05.016; Kriston L, 2010, PATIENT EDUC COUNS, V80, P94, DOI 10.1016/j.pec.2009.09.034; LaBelle CT, 2016, J SUBST ABUSE TREAT, V60, P6, DOI 10.1016/j.jsat.2015.06.010; Luoma JB, 2007, ADDICT BEHAV, V32, P1331, DOI 10.1016/j.addbeh.2006.09.008; MacAfee L, 2017, DRUG ALCOHOL DEPEN, V171, pE125, DOI 10.1016/j.drugalcdep.2016.08.347; Maly RC, 1998, J AM GERIATR SOC, V46, P889, DOI 10.1111/j.1532-5415.1998.tb02725.x; Martin CE, 2015, J ADDICT MED, V9, P99, DOI 10.1097/ADM.0000000000000095; Mascola MA, 2017, OBSTET GYNECOL, V130, pE81, DOI 10.1097/AOG.0000000000002235; Mazurek MO, 2017, CLIN PEDIATR, V56, P247, DOI 10.1177/0009922816648288; McMurphy S, 2006, AM J HEALTH BEHAV, V30, P544, DOI 10.5993/AJHB.30.5.11; McRae-Clark AL, 2011, PSYCHOPHARMACOLOGY, V218, P49, DOI 10.1007/s00213-011-2376-3; Melville JL, 2014, OBSTET GYNECOL, V123, P1237, DOI 10.1097/AOG.0000000000000231; Meyer M, 2015, PREV MED, V80, P18, DOI 10.1016/j.ypmed.2015.07.015; Mittal L, 2017, SUBST ABUS, V38, P261, DOI 10.1080/08897077.2015.1129525; Moeckli J, 2017, J RURAL HEALTH, V33, P323, DOI 10.1111/jrh.12200; Patrick SW, 2019, SUBST ABUS, V40, P356, DOI 10.1080/08897077.2018.1488336; Rich KM, 2018, CURR HIV-AIDS REP, V15, P266, DOI 10.1007/s11904-018-0396-x; Saia K, 2017, ADDICT SCI CLIN PRAC, V12, DOI 10.1186/s13722-016-0070-9; Sobell LC, 1996, DRUG ALCOHOL DEPEN, V42, P49, DOI 10.1016/0376-8716(96)01263-X; Sockalingam S, 2018, ACAD PSYCHIATR, V42, P451, DOI 10.1007/s40596-017-0735-z; Substance Abuse and Mental Health Services Administration, 2016, COLLABORATIVE APPROA; Sutter MB, 2017, OBSTET GYN CLIN N AM, V44, P95, DOI 10.1016/j.ogc.2016.11.004; Suzuki Joji, 2014, J Opioid Manag, V10, P159, DOI 10.5055/jom.2014.0204; Thota AB, 2012, AM J PREV MED, V42, P525, DOI 10.1016/j.amepre.2012.01.019; Walley AY, 2008, J GEN INTERN MED, V23, P1393, DOI 10.1007/s11606-008-0686-x; Watkins KE, 2017, JAMA INTERN MED, V177, P1480, DOI 10.1001/jamainternmed.2017.3947; Wilder C, 2015, DRUG ALCOHOL DEPEN, V149, P225, DOI 10.1016/j.drugalcdep.2015.02.012; Williams ES, 1999, MED CARE, V37, P1140, DOI 10.1097/00005650-199911000-00006; Zhou C, 2016, ACAD MED, V91, P1439, DOI 10.1097/ACM.0000000000001328	74	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261751	10.1371/journal.pone.0261751	http://dx.doi.org/10.1371/journal.pone.0261751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025898	gold, Green Published			2022-12-27	WOS:000796264200027
J	Liu, WQ; Yang, QF; Xu, ZE; Hu, Y; Wang, YM; Liu, ZQ; Zhao, QQ; Wang, ZC; Wei, H; Hua, ZY				Liu, Weiqin; Yang, Qifen; Xu, Zhen-e; Hu, Ya; Wang, Yongming; Liu, Zhenqiu; Zhao, Qianqian; Wang, Zhuangcheng; Wei, Hong; Hua, Ziyu			Impact of the COVID-19 pandemic on neonatal admissions in a tertiary children's hospital in southwest China: An interrupted time-series study	PLOS ONE			English	Article								Background The unprecedented coronavirus disease 2019 (COVID-19) pandemic has caused millions of infections worldwide and represents a significant challenge facing modern health care systems. This study was conducted to investigate the impact of lockdown measures in a tertiary Children's Hospital in southwest China, which might be used to predict long-term effects related to health-seeking behavior of parents/caregivers. Methods This study included newborns enrolled over a span of 86 weeks between January 4, 2019, and August 27, 2020. We designated two time periods for analysis purposes: a stable pre-COVID period(55 weeks between January 4, 2019, and January 23, 2020) and a COVID-impacted period (31 weeks between January 24, 2020, and August 27, 2020). An interrupted time-series analysis was employed to compare changes and trends in hospital admissions and disease spectra before and after the period of nonpharmaceutical interventions (NPIs). Furthermore, this study was conducted to evaluate whether the health-seeking behavior of parents/caregivers was influenced by pandemic factors. Results Overall, 16,640 infants were admitted to the neonatology department during the pre-COVID period (n = 12,082) and the COVID-impacted period (n = 4,558). The per week neonatal admissions consistently decreased following the first days of NPIs (January 24, 2020). The average weekly admission rates of 220/week pre-COVID period and 147/week COVID-impacted period. There was an evident decrease in the volume of admissions for all disease spectra after the intervention, whereas the decrease of patients complaining about pathological jaundice-related conditions was statistically significant (p<0.05). In the COVID-impacted period, the percentage of patients who suffered from respiratory system diseases, neonatal encephalopathy, and infectious diseases decreased, while the percentage of pathological jaundice-related conditions and gastrointestinal system diseases increased. The neonatal mortality rates (NMRs) increased by 8.7% during the COVID-impacted period compared with the pre-COVID period. Conclusions In summary, there was a significant decline in neonatal admissions in a tertiary care hospital during the COVID-19 Pandemic and the associated NPIs. Additionally, this situation had a remarkable impact on disease spectra and health-seeking behavior of parents/caregivers. We, therefore, advise continuing follow-ups and monitoring the main health indicators in vulnerable populations affected by this Pandemic over time.	[Liu, Weiqin; Xu, Zhen-e; Hu, Ya; Wang, Yongming; Liu, Zhenqiu; Zhao, Qianqian; Wei, Hong; Hua, Ziyu] Chongqing Med Univ, Key Lab Child Dev & Disorders, Natl Clin Res Ctr Child Hlth & Disorders, Childrens Hosp,Minist Educ,Dept Neonatol, Chongqing, Peoples R China; [Liu, Weiqin; Xu, Zhen-e; Hu, Ya; Wang, Yongming; Liu, Zhenqiu; Zhao, Qianqian; Wei, Hong; Hua, Ziyu] Chongqing Med Univ, Childrens Hosp, Chongqing Key Lab Pediat, Chongqing, Peoples R China; [Yang, Qifen] Southwest Univ, Sch Life Sci, Chongqing, Peoples R China; [Wang, Zhuangcheng] Chongqing Univ, Engn Res Ctr, Childrens Med Big Data Intelligent Applicat, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Southwest University - China; Chongqing University	Hua, ZY (corresponding author), Chongqing Med Univ, Key Lab Child Dev & Disorders, Natl Clin Res Ctr Child Hlth & Disorders, Childrens Hosp,Minist Educ,Dept Neonatol, Chongqing, Peoples R China.; Hua, ZY (corresponding author), Chongqing Med Univ, Childrens Hosp, Chongqing Key Lab Pediat, Chongqing, Peoples R China.	h_ziyu@126.com			Clinical Research Project of Children's Hospital of Chongqing Medical University [YBXM 2019007]	Clinical Research Project of Children's Hospital of Chongqing Medical University	this study was supported by grants from the Clinical Research Project of Children's Hospital of Chongqing Medical University (YBXM 2019007), the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angoulvant F, 2021, CLIN INFECT DIS, V72, P319, DOI 10.1093/cid/ciaa710; Castagnoli R, 2020, JAMA PEDIATR, V174, P882, DOI 10.1001/jamapediatrics.2020.1467; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Ezeh OK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013350; Gazzin S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010299; Hartnett KP, 2020, MMWR-MORBID MORTAL W, V69, P699, DOI 10.15585/mmwr.mm6923e1; Hegyi T, 2019, J MATERN-FETAL NEO M, V32, P2721, DOI 10.1080/14767058.2018.1448380; Lei L, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924609; Li M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237420; Li Q., 2020, NEW ENGL J MED, V382, P1199; Liang XH, 2020, WORLD J CLIN CASES, V8, P2959, DOI 10.12998/wjcc.v8.i14.2959; Liu TC, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000102; Melnick ER, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1924; Mengistu BA, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02031-x; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Piroozi Bakhtiar, 2018, Med J Islam Repub Iran, V32, P121, DOI 10.14196/mjiri.32.121; Riordan SM, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00376; TEAM, 2014, LANG ENV STAT COMP; Tsioufis K, 2020, CLIN RES CARDIOL, V109, P1483, DOI 10.1007/s00392-020-01682-1; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Yang LL, 2020, CELL STEM CELL, V27, P125, DOI 10.1016/j.stem.2020.06.015	25	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262202	10.1371/journal.pone.0262202	http://dx.doi.org/10.1371/journal.pone.0262202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025931	Green Published, gold			2022-12-27	WOS:000796264200054
J	Parkin, ET; Hammond, JE; Owens, L; Hodges, MD				Parkin, Edward T.; Hammond, Jessica E.; Owens, Lauren; Hodges, Matthew D.			The orphan drug dichloroacetate reduces amyloid beta-peptide production whilst promoting non-amyloidogenic proteolysis of the amyloid precursor protein	PLOS ONE			English	Article							BRAIN GLUCOSE-METABOLISM; ALZHEIMERS; CLEAVAGE	The amyloid cascade hypothesis proposes that excessive accumulation of amyloid beta-peptides is the initiating event in Alzheimer's disease. These neurotoxic peptides are generated from the amyloid precursor protein via sequential cleavage by beta- and gamma-secretases in the 'amyloidogenic' proteolytic pathway. Alternatively, the amyloid precursor protein can be processed via the 'non-amyloidogenic' pathway which, through the action of the alpha-secretase a disintegrin and metalloproteinase (ADAM) 10, both precludes amyloid beta-peptide formation and has the additional benefit of generating a neuroprotective soluble amyloid precursor protein fragment, sAPP alpha. In the current study, we investigated whether the orphan drug, dichloroacetate, could alter amyloid precursor protein proteolysis. In SH-SY5Y neuroblastoma cells, dichloroacetate enhanced sAPP alpha generation whilst inhibiting beta-secretase processing of endogenous amyloid precursor protein and the subsequent generation of amyloid beta-peptides. Over-expression of the amyloid precursor protein partly ablated the effect of dichloroacetate on amyloidogenic and non-amyloidogenic processing whilst over-expression of the beta-secretase only ablated the effect on amyloidogenic processing. Similar enhancement of ADAM-mediated amyloid precursor protein processing by dichloroacetate was observed in unrelated cell lines and the effect was not exclusive to the amyloid precursor protein as an ADAM substrate, as indicated by dichloroacetate-enhanced proteolysis of the Notch ligand, Jagged1. Despite altering proteolysis of the amyloid precursor protein, dichloroacetate did not significantly affect the expression/activity of alpha-, beta- or gamma-secretases. In conclusion, dichloroacetate can inhibit amyloidogenic and promote non-amyloidogenic proteolysis of the amyloid precursor protein. Given the small size and blood-brain-barrier permeability of the drug, further research into its mechanism of action with respect to APP proteolysis may lead to the development of therapies for slowing the progression of Alzheimer's disease.	[Parkin, Edward T.; Hammond, Jessica E.; Owens, Lauren; Hodges, Matthew D.] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England	Lancaster University	Parkin, ET (corresponding author), Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England.	e.parkin@lancaster.ac.uk	Hodges, Matthew/GZB-0433-2022	Parkin, Edward/0000-0003-3270-3184; Owens, Lauren/0000-0001-9460-6609; Hammond, Jessica/0000-0002-1465-4844; Hodges, Matthew David John/0000-0002-6815-751X	Bramall Foundation	Bramall Foundation	Y EP received funding for this research from the Bramall Foundation (https://www.bramallfoundation.org) (no grant number available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEMAYOR E, 1984, J NEUROCHEM, V42, P38, DOI 10.1111/j.1471-4159.1984.tb09694.x; Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Chowdhury F, 2016, NANO LETT, V16, P3892, DOI 10.1021/acs.nanolett.6b01403; CURRY SH, 1985, CLIN PHARMACOL THER, V37, P89, DOI 10.1038/clpt.1985.17; Dai YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092962; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Findlay JA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00382; Guo L., 2016, J ALZHEIMERS DIS JAD; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harting TP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178744; He WX, 2014, J BIOL CHEM, V289, P20630, DOI 10.1074/jbc.M114.579862; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Klose K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257403; KURODA Y, 1984, PEDIATR RES, V18, P936, DOI 10.1203/00006450-198418100-00005; McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Miquel E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034776; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI [10.1007/s00259-008-1039-z, 10.1007/s00259-005-1762-7]; Mosconi L, 2009, NEUROLOGY, V72, P513, DOI 10.1212/01.wnl.0000333247.51383.43; Pajuelo-Reguera D, 2015, INT J ONCOL, V46, P2409, DOI 10.3892/ijo.2015.2953; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Parr-Sturgess CA, 2010, BIOCHEM J, V432, P283, DOI 10.1042/BJ20100321; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STACPOOLE PW, 1988, ANN INTERN MED, V108, P58, DOI 10.7326/0003-4819-108-1-58; STACPOOLE PW, 1978, NEW ENGL J MED, V298, P526, DOI 10.1056/NEJM197803092981002; Stacpoole PW, 1998, ENVIRON HEALTH PERSP, V106, P989, DOI 10.1289/ehp.98106s4989; Stapoole PW, 2008, ADV DRUG DELIVER REV, V60, P1478, DOI 10.1016/j.addr.2008.02.014; Stockwin LH, 2010, INT J CANCER, V127, P2510, DOI 10.1002/ijc.25499; Sun WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016207; Warburg O., 1923, BIOCHEM Z, V152, P319; Xu JS, 2016, BBA-MOL BASIS DIS, V1862, P1084, DOI 10.1016/j.bbadis.2016.03.001	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0255715	10.1371/journal.pone.0255715	http://dx.doi.org/10.1371/journal.pone.0255715			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025874	Green Submitted, Green Published, gold			2022-12-27	WOS:000796264200002
J	Kang, SH; Do, JY; Kim, JC				Kang, Seok Hui; Do, Jun Young; Kim, Jun Chul			Impedance-derived phase angle is associated with muscle mass, strength, quality of life, and clinical outcomes in maintenance hemodialysis patients	PLOS ONE			English	Article							HEALTH SURVEY SF-36; KIDNEY-DISEASE; VALIDITY; SARCOPENIA; PREDICTOR; SURVIVAL	Introduction We aimed to evaluate the association between the phase angle and muscle mass, muscle strength, physical performance tests, quality-of-life scales, mood scales, or patient and hospitalization-free survival rates in hemodialysis (HD) patients. Methods We included 83 HD patients. The patients were divided into tertiles based on phase angle value. The phase angle was measured using a bioimpedance analysis machine. Thigh muscle area per height squared (TMA/Ht(2)), handgrip strength (HGS), nutritional indicators, physical performance, quality-of-life, depression or anxiety status, and the presence of hospitalization or death regardless of cause were evaluated. Results In our study, no significant differences were observed in the serum albumin level and body mass index according to tertiles of phase angle. The phase angle tertiles were associated with TMA/Ht(2) and HGS. The phase angle was also associated with physical performance measurements and depression or anxiety status. Subgroup analyses according to sex, age, and diabetes mellitus showed similar trends to those of the total cohort. Furthermore, the hospitalization-free survival rate and patient survival rate were favorable in patients with high values for the phase angle. Conclusion The present study demonstrated that the phase angle is associated with muscle mass, strength, physical performance, quality-of-life scale, and hospitalization-free survival in maintenance HD patients.	[Kang, Seok Hui; Do, Jun Young] Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea; [Kim, Jun Chul] CHA Univ, CHA Gumi Med Ctr, Dept Internal Med, Div Nephrol, Gumi, Gyeongsangbuk D, South Korea	Yeungnam University; Yeungnam University Hospital; Pochon Cha University	Do, JY (corresponding author), Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea.; Kim, JC (corresponding author), CHA Univ, CHA Gumi Med Ctr, Dept Internal Med, Div Nephrol, Gumi, Gyeongsangbuk D, South Korea.	jydo@med.yu.ac.kr; truedoc1@hanmail.net			Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A2009124]	Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of Korea)	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (JYD).	Abad S, 2011, NEFROLOGIA, V31, P670, DOI 10.3265/Nefrologia.pre2011.Sep.10999; Bansal N, 2018, AM J KIDNEY DIS, V72, P662, DOI 10.1053/j.ajkd.2018.03.030; Barbosa-Silva MCG, 2005, CURR OPIN CLIN NUTR, V8, P311, DOI 10.1097/01.mco.0000165011.69943.39; Beberashvilil I, 2014, EUR J CLIN NUTR, V68, P683, DOI 10.1038/ejcn.2014.67; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chertow GM, 1997, KIDNEY INT, V52, P1617, DOI 10.1038/ki.1997.493; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Gibson AL, 2008, AM J CLIN NUTR, V87, P332, DOI 10.1093/ajcn/87.2.332; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Huang R, 2020, J RENAL NUTR, V30, P119, DOI 10.1053/j.jrn.2019.06.006; Jin DC, 2015, KIDNEY RES CLIN PRAC, V34, P132, DOI 10.1016/j.krcp.2015.08.004; Johansen KL, 2007, J AM SOC NEPHROL, V18, P2960, DOI 10.1681/ASN.2007020221; Kang SH, 2020, KIDNEY BLOOD PRESS R, V45, P419, DOI 10.1159/000506986; Kang SH, 2013, CLIN NEPHROL, V79, P261, DOI 10.5414/CN107693; Kooman JP, 2013, NEPHROL DIAL TRANSPL, V28, P48, DOI 10.1093/ndt/gfs451; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Lee JE, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7298-8; Lee K, 2019, KOREAN J RADIOL, V20, P205, DOI 10.3348/kjr.2018.0479; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539, DOI 10.1093/gerona/57.8.M539; MacFarlane DJ, 2006, AM J HUM BIOL, V18, P418, DOI 10.1002/ajhb.20503; Maggiore Q, 1996, KIDNEY INT, V50, P2103, DOI 10.1038/ki.1996.535; Markaki AG, 2019, PSYCHOL HEALTH MED, V24, P1213, DOI 10.1080/13548506.2019.1612074; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mushnick R, 2003, KIDNEY INT, V64, pS53, DOI 10.1046/j.1523-1755.64.s87.22.x; Oliveira CMC, 2010, J RENAL NUTR, V20, P314, DOI 10.1053/j.jrn.2010.01.008; Park HJ, 2007, TOHOKU J EXP MED, V211, P321, DOI 10.1620/tjem.211.321; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pupim LB, 2004, KIDNEY INT, V66, P2054, DOI 10.1111/j.1523-1755.2004.00978.x; Saitoh M, 2020, BMC NEPHROL, V21, DOI 10.1186/s12882-020-02102-2; Schubert MM, 2019, CLIN PHYSIOL FUNCT I, V39, P150, DOI 10.1111/cpf.12550; Steiber AL, 2004, J RENAL NUTR, V14, P191, DOI 10.1053/j.jrn.2004.08.004; Tan RS, 2019, J RENAL NUTR, V29, P295, DOI 10.1053/j.jrn.2018.09.001; TIETZ NW, 1992, CLIN CHEM, V38, P1167; United States renal data system, 2020, USRDS ANN DAT REP EP; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; World Health Organization, GLOBAL RECOMMENDATIO	38	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261070	10.1371/journal.pone.0261070	http://dx.doi.org/10.1371/journal.pone.0261070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020730	Green Published, gold			2022-12-27	WOS:000834207700011
J	Holden, CA; Bailey, JP; Taylor, JE; Martin, F; Beckett, P; McAinsh, M				Holden, Claire Anne; Bailey, John Paul; Taylor, Jane Elizabeth; Martin, Frank; Beckett, Paul; McAinsh, Martin			Know your enemy: Application of ATR-FTIR spectroscopy to invasive species control	PLOS ONE			English	Article							SEXUAL REPRODUCTION; FALLOPIA-JAPONICA; SPP.; EVOLUTION; L.; HYBRIDIZATION; POLYGONACEAE; POPULATIONS; DIVERSITY; TRANSPORT	1. Extreme weather and globalisation leave our climate vulnerable to invasion by alien species, which have negative impacts on the economy, biodiversity, and ecosystem services. Rapid and accurate identification is key to the control of invasive alien species. However, visually similar species hinder conservation efforts, for example hybrids within the Japanese Knotweed complex. 2. We applied the novel method of ATR-FTIR spectroscopy combined with chemometrics (mathematics applied to chemical data) to historic herbarium samples, taking 1580 spectra in total. Samples included five species from within the interbreeding Japanese Knotweed complex (including three varieties of Japanese Knotweed), six hybrids and five species from the wider Polygonaceae family. Spectral data from herbarium specimens were analysed with several chemometric techniques: support vector machines (SVM) for differentiation between plant types, supported by ploidy levels; principal component analysis loadings and spectral biomarkers to explore differences between the highly invasive Reynoutria japonica var. japonica and its non-invasive counterpart Reynoutria japonica var. compacta; hierarchical cluster analysis (HCA) to investigate the relationship between plants within the Polygonaceae family, of the Fallopia, Reynoutria, Rumex and Fagopyrum genera. 3. ATR-FTIR spectroscopy coupled with SVM successfully differentiated between plant type, leaf surface and geographical location, even in herbarium samples of varying age. Differences between Reynoutria japonica var. japonica and Reynoutria japonica var. compacta included the presence of two polysaccharides, glucomannan and xyloglucan, at higher concentrations in Reynoutria japonica var. japonica than Reynoutria japonica var. compacta. HCA analysis indicated that potential genetic linkages are sometimes masked by environmental factors; an effect that can either be reduced or encouraged by altering the input parameters. Entering the absorbance values for key wavenumbers, previously highlighted by principal component analysis loadings, favours linkages in the resultant HCA dendrogram corresponding to expected genetic relationships, whilst environmental associations are encouraged using the spectral fingerprint region. 4. The ability to distinguish between closely related interbreeding species and hybrids, based on their spectral signature, raises the possibility of using this approach for determining the origin of Japanese knotweed infestations in legal cases where the clonal nature of plants currently makes this difficult and for the targeted control of species and hybrids. These techniques also provide a new method for supporting biogeographical studies.	[Holden, Claire Anne; Taylor, Jane Elizabeth; McAinsh, Martin] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Bailey, John Paul] Univ Leicester, Dept Genet & Genome Biol, Leicester, England; [Martin, Frank] Biocel Ltd, Kingston Upon Hull, England; [Beckett, Paul] Phlorum Ltd, Brighton, England	Lancaster University; University of Leicester	Holden, CA (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, England.	c.holden6@lancaster.ac.uk		Holden, Claire/0000-0002-7831-8671; McAinsh, Martin Robert/0000-0003-4294-6470; Taylor, Jane Elizabeth/0000-0002-1467-7149				Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Bagcioglu M, 2017, METHODS ECOL EVOL, V8, P870, DOI 10.1111/2041-210X.12697; Bailey J, 2003, PLANT INVASIONS: ECOLOGICAL THREATS AND MANAGEMENT SOLUTIONS, P183; Bailey J. P., 2000, Watsonia, V23, P93; Bailey JP, 2009, BIOL INVASIONS, V11, P1189, DOI 10.1007/s10530-008-9381-4; Ben-Ari G, 2012, PLANT BIOTECHNOLOGY AND AGRICULTURE: PROSPECTS FOR THE 21ST CENTURY, P163, DOI 10.1016/B978-0-12-381466-1.00011-0; Bielczynski LW, 2017, PLANT PHYSIOL, V175, P1634, DOI 10.1104/pp.17.00904; Buitrago MF, 2016, ISPRS J PHOTOGRAMM, V111, P22, DOI 10.1016/j.isprsjprs.2015.11.003; Butler HJ, 2020, ANAL LETT, V53, P536, DOI 10.1080/00032719.2019.1658199; Butler HJ, 2018, ANALYST, V143, P6121, DOI 10.1039/c8an01384e; Butler HJ, 2017, VIB SPECTROSC, V90, P46, DOI 10.1016/j.vibspec.2017.03.004; Butler HJ, 2015, ANAL METHODS-UK, V7, P4059, DOI [10.1039/C5AY00377F, 10.1039/c5ay00377f]; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de Carvalho LC, 2016, ANAL METHODS-UK, V8, P5658, DOI [10.1039/C6AY01325B, 10.1039/c6ay01325b]; Demir P, 2015, SPECTROCHIM ACTA A, V135, P757, DOI 10.1016/j.saa.2014.07.025; DESILVA DLR, 1986, NEW PHYTOL, V104, P41, DOI 10.1111/j.1469-8137.1986.tb00632.x; Desjardins SD., 2015, EVOLUTIONARY STUDIES; Di Giambattista L, 2011, ANAL BIOANAL CHEM, V399, P2771, DOI 10.1007/s00216-011-4654-7; Du CW, 2013, SENSOR ACTUAT B-CHEM, V188, P1167, DOI 10.1016/j.snb.2013.08.023; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Euring D, 2012, TREES-STRUCT FUNCT, V26, P1933, DOI 10.1007/s00468-012-0761-0; Fennell M, 2018, PEERJ, V6, DOI 10.7717/peerj.5246; Festa G, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw1292; Gillies S, 2016, INVAS PLANT SCI MANA, V9, P71, DOI 10.1614/IPSM-D-15-00039.1; Gniwotta F, 2005, PLANT PHYSIOL, V139, P519, DOI 10.1104/pp.104.053579; Grevstad FS, 2018, BIOL BIOL CONTROL KN; Grimsby JL, 2007, AM J BOT, V94, P957, DOI 10.3732/ajb.94.6.957; Holden CA, 2021, BMC PLANT BIOL, V21, DOI 10.1186/s12870-021-03293-y; Hollingsworth ML, 1998, MOL ECOL, V7, P1681, DOI 10.1046/j.1365-294x.1998.00498.x; Hollingsworth ML, 2000, BOT J LINN SOC, V133, P463, DOI 10.1111/j.1095-8339.2000.tb01589.x; Huang YP, 2018, J FOOD ENG, V222, P185, DOI 10.1016/j.jfoodeng.2017.11.030; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Inamura A, 2000, J PLANT RES; Jones D, 2018, BIOL INVASIONS, V20, P2091, DOI 10.1007/s10530-018-1684-5; Jones IM, 2020, J APPL ENTOMOL, V144, P710, DOI 10.1111/jen.12792; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Kang SH, 2008, COLLOID SURFACE A, V318, P275, DOI 10.1016/j.colsurfa.2008.01.004; Kanter U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061518; Kim SW, 2004, PLANT CELL REP, V23, P246, DOI 10.1007/s00299-004-0811-1; Lavoie C, 2017, BIOL INVASIONS, V19, P2319, DOI 10.1007/s10530-017-1444-y; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Liu N, 2020, PLANT CELL ENVIRON, V43, P662, DOI 10.1111/pce.13691; Long F, 2021, RENEW SUST ENERG REV, V148, DOI 10.1016/j.rser.2021.111269; Mandak B, 2003, ANN BOT-LONDON, V92, P265, DOI 10.1093/aob/mcg141; Martin FL, 2010, NAT PROTOC, V5, P1748, DOI 10.1038/nprot.2010.133; McNear DH, 2010, PHYTOCHEMISTRY, V71, P188, DOI 10.1016/j.phytochem.2009.10.023; Milne RI, 2000, MOL ECOL, V9, P541, DOI 10.1046/j.1365-294x.2000.00906.x; Minnes R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04678-6; Moody ML, 2007, BIOL INVASIONS, V9, P559, DOI 10.1007/s10530-006-9058-9; Morais CLM, 2020, NAT PROTOC, V15, P2143, DOI 10.1038/s41596-020-0322-8; Morais CLM, 2019, NAT PROTOC, V14, P1546, DOI 10.1038/s41596-019-0150-x; Morais CLM, 2018, J BRAZIL CHEM SOC, V29, P472, DOI 10.21577/0103-5053.20170159; Morais CLM, 2017, ANAL METHODS-UK, V9, P2964, DOI [10.1039/c7ay00428a, 10.1039/C7AY00428A]; Mounger J, EPIGENETICS SUCCESS, DOI [10.32942/OSF.IO/69PM8, DOI 10.32942/OSF.IO/69PM8]; Nadeem MA, 2017, REV AGR ENV BIOTECHN, DOI [10.1080/13102818.2017.1400401, DOI 10.1080/13102818.2017.1400401]; Nishinari K, 2007, COMPREHENSIVE GLYCOS, P613; Ord J, 2016, ANALYST, V141, P2896, DOI [10.1039/c6an00392c, 10.1039/C6AN00392C]; Parepa M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2632; Pashley CH, 2007, CLONAL DIVERSITY BRI; Pashley CH, 2003, USE MOL MARKERS STUD; Pichancourt JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032323; Raba DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138080; Rahman MM, 2019, SPECTROCHIM ACTA A, V214, P269, DOI 10.1016/j.saa.2019.02.011; Richards CL, 2008, AM J BOT, V95, P931, DOI 10.3732/ajb.2007364; Richards CL, 2012, ECOL LETT, V15, P1016, DOI 10.1111/j.1461-0248.2012.01824.x; Ringelmann A, 2009, PLANTA, V230, P95, DOI 10.1007/s00425-009-0924-4; Santo P, 2017, J BUILD SURV APPRAIS, V6, P211; Schuster TM, 2015, TAXON, V64, P1188, DOI 10.12705/646.5; Sharma S, 2018, J APPL SPECTROSC+, V85, P771, DOI 10.1007/s10812-018-0717-2; Skolik P, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1852-5; Skolik P, 2019, PLANTA, V249, P925, DOI 10.1007/s00425-018-3060-1; Snow AA, 1999, MOL ECOL, V8, P605, DOI 10.1046/j.1365-294x.1999.00596.x; Spalding K, 2018, VIB SPECTROSC, V99, P50, DOI 10.1016/j.vibspec.2018.08.019; Taiz L., 2015, Plant physiology and development; Talari ACS, 2017, APPL SPECTROSC REV, V52, P456, DOI 10.1080/05704928.2016.1230863; Tiwari G, 2013, POSTHARVEST BIOL TEC, V86, P221, DOI 10.1016/j.postharvbio.2013.07.009; Traore M, 2018, WOOD SCI TECHNOL, V52, P487, DOI 10.1007/s00226-017-0967-9; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; Trevisan J, 2013, BIOINFORMATICS, V29, P1095, DOI 10.1093/bioinformatics/btt084; USDA Plants Database, PLANT PROF POL BOH D; Usman K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42029-9; Van den Ende W, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00247; Wang Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182161; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Williams F., 2010, VM10066 CABI; Yang Y, 2018, CURR OPIN BIOTECH, V49, P191, DOI 10.1016/j.copbio.2017.09.003; Zhang Y-Y, 2016, INVASION GENETICS, P328, DOI [10.1002/, DOI 10.1002/9781119072799.CH19]; Zika PF, 2003, RHODORA, V105, P143	88	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2022	17	1							e0261742	10.1371/journal.pone.0261742	http://dx.doi.org/10.1371/journal.pone.0261742			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6S2ZW	34995300	Green Published, gold			2022-12-27	WOS:000892861900001
J	Zhao, JZ; Zhao, Y; Ma, XW; Feng, HL; Cui, RM				Zhao, Jiazheng; Zhao, Yi; Ma, Xiaowei; Feng, Helin; Cui, Rongmin			Immunological and prognostic significance of novel ferroptosis-related genes in soft tissue sarcoma	PLOS ONE			English	Article							EXPRESSION; IMMUNOTHERAPY; SURVIVAL; REVEAL; CELLS	Background Ferroptosis has exhibited great potential in the treatment of cancer and has gained widespread attention in soft tissue sarcoma (STS). The aim was to explore the immunological and prognostic significance of novel ferroptosis-related genes in STS. Methods We identified ferroptosis-related differentially expressed genes (DEGs) in STS to construct the networks of enrichment analysis and protein-protein interaction. Subsequently, hub genes with prognostic significance were localized and a series of prognostic and immune analyses were performed. Results 40 ferroptosis-related DEGs were identified, of which HELLS, STMN1 EPAS1, CXCL2, NQO1, and IL6 were classified as hub genes and were associated with the prognosis in STS patients. In the results of the immune analysis, PDCD1, CTLA4, TIGIT, IDO1 and CD27 exhibited consistent intense correlations as immune checkpoint genes, as well as macrophage, neutrophil, cytotoxic cell, dendritic cell, interdigitating dendritic cell and plasmacytoid dendritic cell as immune cells. EPAS1 and HELLS might be independent prognostic factors for STS patients, and separate prognostic models were constructed by using them. Conclusions We recognized novel ferroptosis-related genes with prognostic value in STS. Furthermore, we searched out potential immune checkpoints and critical immune cells.	[Zhao, Jiazheng; Zhao, Yi; Ma, Xiaowei; Feng, Helin] Hebei Med Univ, Dept Orthoped, Hosp 4, Shijiazhuang, Hebei, Peoples R China; [Cui, Rongmin] Hebei Med Univ, Dept Operating Room, Hosp 4, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University	Cui, RM (corresponding author), Hebei Med Univ, Dept Operating Room, Hosp 4, Shijiazhuang, Hebei, Peoples R China.	rongmincui0311@163.com		Feng, Helin/0000-0002-7260-5485	Project of the Natural Science Foundation of Hebei Province [H2019206309]	Project of the Natural Science Foundation of Hebei Province	This work was supported by grants from the Project of the Natural Science Foundation of Hebei Province [H2019206309] for HF.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MML, 2015, INT J CLIN EXP PATHO, V8, P2795; Atherton MJ, 2020, VET COMP ONCOL, V18, P447, DOI 10.1111/vco.12595; Ayodele O, 2020, CURR ONCOL, V27, P17, DOI 10.3747/co.27.5407; Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Burugu S, 2018, SEMIN CANCER BIOL, V52, P39, DOI 10.1016/j.semcancer.2017.10.001; Callegaro D, 2017, CANCER-AM CANCER SOC, V123, P2802, DOI 10.1002/cncr.30721; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Coley W B, 1891, Ann Surg, V14, P199, DOI 10.1097/00000658-189112000-00015; Dancsok AR, 2019, MODERN PATHOL, V32, P1772, DOI 10.1038/s41379-019-0312-y; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Fanzani A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081718; Ferrari A, 2016, PROG TUMOR RES, V43, P128, DOI 10.1159/000447083; Gamboa AC, 2020, CA-CANCER J CLIN, V70, P200, DOI 10.3322/caac.21605; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hu XQ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923749; Huang WJ, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.629868; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Jafarzadeh N, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08734-3; Jiang YQ, 2017, THERANOSTICS, V7, P3293, DOI 10.7150/thno.19988; Klein S, 2019, CANCER IMMUNOL IMMUN, V68, P973, DOI 10.1007/s00262-019-02339-3; Law CT, 2019, HEPATOLOGY, V69, P2013, DOI 10.1002/hep.30414; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Lu T, 2021, MOL THER-ONCOLYTICS, V21, P134, DOI 10.1016/j.omto.2021.02.011; Miwa S, 2017, IMMUNOTHERAPY-UK, V9, P1331, DOI 10.2217/imt-2017-0101; Nabeshima A, 2015, BRIT J CANCER, V112, P547, DOI 10.1038/bjc.2014.637; Nakazawa MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10539; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Pollack SM, 2018, J CLIN ONCOL, V36, P125, DOI 10.1200/JCO.2017.75.1610; Qin S, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1091-2; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stockwell BR, 2020, TRENDS CELL BIOL, V30, P478, DOI 10.1016/j.tcb.2020.02.009; Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang R, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00946-7; Thapa D, 2014, CANCER RES, V74, P5644, DOI 10.1158/0008-5472.CAN-14-0562; Wang WM, 2019, NATURE, V569, P270, DOI 10.1038/s41586-019-1170-y; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang R, 2020, CANCER SCI, V111, P406, DOI 10.1111/cas.14262; Zhang X, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101211; Zheng BX, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0560-1; Zhou N, 2020, DATABASE-OXFORD, DOI 10.1093/database/baaa021; Zhu MMT, 2020, CANCER TREAT REV, V91, DOI 10.1016/j.ctrv.2020.102115; Zhu TY, 2021, J ADV RES, V28, P7, DOI 10.1016/j.jare.2020.06.006; Zou Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09277-9	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262234	10.1371/journal.pone.0262234	http://dx.doi.org/10.1371/journal.pone.0262234			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982796	gold, Green Published			2022-12-27	WOS:000834805700023
J	Turner, T; Elliott, J; Tendal, B; Vogel, JP; Norris, S; Tate, R; Green, S				Turner, Tari; Elliott, Julian; Tendal, Britta; Vogel, Joshua P.; Norris, Sarah; Tate, Rhiannon; Green, Sally		Natl COVID-19 Clinical Evidence	The Australian living guidelines for the clinical care of people with COVID-19: What worked, what didn't and why, a mixed methods process evaluation	PLOS ONE			English	Article								Introduction The Australian National COVID-19 Clinical Evidence Taskforce is producing living, evidence-based, national guidelines for treatment of people with COVID-19 which are updated each week. To continually improve the process and outputs of the Taskforce, and inform future living guideline development, we undertook a concurrent process evaluation examining Taskforce activities and experience of team members and stakeholders during the first 5 months of the project. Methods The mixed-methods process evaluation consisted of activity and progress audits, an online survey of all Taskforce participants; and semi-structured interviews with key contributors. Data were collected through five, prospective 4-weekly timepoints (beginning first week of May 2020) and three, fortnightly retrospective timepoints (March 23, April 6 and 20). We collected and analysed quantitative and qualitative data. Results An updated version of the guidelines was successfully published every week during the process evaluation. The Taskforce formed in March 2020, with a nominal start date of March 23. The first version of the guideline was published two weeks later and included 10 recommendations. By August 24, in the final round of the process evaluation, the team of 11 staff, working with seven guideline panels and over 200 health decision-makers, had developed 66 recommendations addressing 58 topics. The Taskforce website had received over 200,000 page views. Satisfaction with the work of the Taskforce remained very high (>90% extremely or somewhat satisfied) throughout. Several key strengths, challenges and methods questions for the work of the Taskforce were identified. Conclusions In just over 5 months of activity, the National COVID-19 Clinical Evidence Taskforce published 20 weekly updates to the evidence-based national treatment guidelines for COVID-19. This process evaluation identified several factors that enabled this achievement (e.g. an extant skill base in evidence review and convening), along with challenges that needed to be overcome (e.g. managing workloads, structure and governance) and methods questions (pace of updating, and thresholds for inclusion of evidence) which may be useful considerations for other living guidelines projects. An impact evaluation is also being conducted separately to examine awareness, acceptance and use of the guidelines.	[Turner, Tari; Elliott, Julian; Tendal, Britta; Vogel, Joshua P.; Tate, Rhiannon; Green, Sally] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Elliott, Julian] Alfred Hlth, Infect Dis Unit, Melbourne, Vic, Australia; [Vogel, Joshua P.] Burnet Inst, Maternal Child & Adolescent Hlth Program, Melbourne, Vic, Australia; [Norris, Sarah] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia	Monash University; Burnet Institute; University of Sydney	Turner, T (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	tari.turner@monash.edu	Vogel, Joshua/K-7649-2019	Vogel, Joshua/0000-0002-3214-7096; Norris, Sarah/0000-0002-4733-6906; Turner, Tari/0000-0002-7990-1623	National COVID-19 Clinical Evidence Taskforce - Australian Government Department of Health [MRF9200001]; Victorian Government Department of Health and Human Services [330251410]; Ian Potter Foundation [31110558]; Walter Cottman Endowment Fund [EQTD01]; Lord Mayors' Charitable Foundation [20/1485]	National COVID-19 Clinical Evidence Taskforce - Australian Government Department of Health; Victorian Government Department of Health and Human Services; Ian Potter Foundation; Walter Cottman Endowment Fund; Lord Mayors' Charitable Foundation	The National COVID-19 Clinical Evidence Taskforce (TT, JE, BT, JV, SN, RT, SG) is funded by the Australian Government Department of Health - www.health.gov.au (MRF9200001), the Victorian Government Department of Health and Human Services(330251410), the Ian Potter Foundation -www.ianpotter.org.au (31110558) and the Walter Cottman Endowment Fund -www.eqt.com.au (EQTD01), managed by Equity Trustees, and the Lord Mayors' Charitable Foundation -www.lmcf.org.au (20/1485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2017, J CLIN EPIDEMIOL, V91, P47, DOI 10.1016/j.jclinepi.2017.08.009; Alonso-Coello P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2016; Andrenelli E, 2020, EUR J PHYS REHAB MED, V56, P508, DOI [10.23736/S1973-9087.20.06435-7, 10.23736/S1973-9087.20.06378-9]; [Anonymous], 2020, AUSTR LIVING EVIDENC; [Anonymous], 2018, MAKING GRADE IRRESIS; Baladia E, 2020, MEDWAVE, V20, DOI 10.5867/medwave.2020.06.7978; Brooker J, 2019, GUIDANCE PRODUCTION; Chai KL, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013600.pub2, 10.1002/14651858.CD013600.pub3]; Deeks JJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013652; Elliott JH, 2017, J CLIN EPIDEMIOL, V91, P23, DOI 10.1016/j.jclinepi.2017.08.010; English C, 2019, INT J STROKE, V14, P337, DOI 10.1177/1747493019833015; Hernandez AV, 2020, ANN INTERN MED, V173, P287, DOI 10.7326/M20-2496; Khamis Assem M, 2019, F1000Res, V8, P221, DOI 10.12688/f1000research.18005.2; Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379; Salyer K, 2020, COVID 19 WHAT KNOW C; Schunemann HJ, 2020, ANN INTERN MED, V173, P204, DOI 10.7326/M20-2306; Struyf T, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013665; Tendal B, 2021, J CLIN EPIDEMIOL, V131, P11, DOI 10.1016/j.jclinepi.2020.11.005; Thombs BD, 2020, J PSYCHOSOM RES, V133, DOI 10.1016/j.jpsychores.2020.110113; Verdugo-Paiva F, 2020, MEDWAVE, V20, DOI 10.5867/medwave.2020.06.7966; Vogel JP, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001683; White H, 2020, MED J AUSTRALIA, V212, P250, DOI 10.5694/mja2.50509; Wynants, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2810	23	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2022	17	1							e0261479	10.1371/journal.pone.0261479	http://dx.doi.org/10.1371/journal.pone.0261479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4F1UM	34995312	gold, Green Published			2022-12-27	WOS:000848301200001
J	Hirakata, T; Huang, TX; Hiratsuka, Y; Yamamoto, S; Inoue, A; Murakami, A				Hirakata, Toshiaki; Huang, Tianxiang; Hiratsuka, Yoshimune; Yamamoto, Shutaro; Inoue, Akira; Murakami, Akira			Clinical patterns of rhegmatogenous retinal detachment during the first state of emergency for the COVID-19 pandemic in a Tokyo center	PLOS ONE			English	Article								The coronavirus disease 2019 (COVID-19) pandemic is disturbing and overwhelming a regular medical care in the world. We evaluated the clinical characteristics of patients with primary rhegmatogenous retinal detachment (RRD) during the state of emergency for COVID-19 pandemic in Japan. We also reviewed measures against the COVID-19 pandemic in our institute with a focus on RRD treatment. Retrospectively, patients who underwent initial RRD surgery during the state of emergency between April 7, 2020 and May 25, 2020 were included. For comparison, we recruited patients who underwent surgery for initial RRD during the same period in the last 2 years (2018 and 2019). Data related to the number of surgeries, age, gender, macular detachment, proliferative vitreoretinopathy (PVR), preoperative visual acuity, surgical techniques, the time between the onset and hospitalization and/or surgery of the 2020 cohort were analyzed and compared with those of the 2018 and 2019 cohorts. Furthermore, we reviewed measures taken against COVID-19 in our institute. The number of RRD patients during the state of emergency tended to be lower than that within the last 2 years. Relatively lesser female (vs. male) patients were observed in the 2020 cohort than in the last 2 years (P = 0.084). In contrast, among all cohorts, no significant differences were observed in the incidence of macula-off and PVR, preoperative visual acuity, and the time period between symptom onset and hospitalization and/or surgery. This is the first report to show the clinical patterns of RRD during COVID-19 pandemic in Japan. Despite the state of emergency for the COVID-19 pandemic, no delay in the patient's initial visit to the hospital and surgery was observed. Further studies, including multicenter researches, are important for investigating the influence of COVID-19 on urgent ocular diseases.	[Hirakata, Toshiaki; Huang, Tianxiang; Hiratsuka, Yoshimune; Yamamoto, Shutaro; Inoue, Akira; Murakami, Akira] Juntendo Univ, Dept Ophthalmol, Fac Med, Tokyo, Japan	Juntendo University	Hirakata, T (corresponding author), Juntendo Univ, Dept Ophthalmol, Fac Med, Tokyo, Japan.	t-hirakata@juntendo.ac.jp			MEXT/JSPS KAKENHI [19K23851, 20K18395]; Japan Agency for Medical Research and Development [20dk0310108]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by grants from MEXT/JSPS KAKENHI (19K23851 and 20K18395 to T.H.), and the Japan Agency for Medical Research and Development (20dk0310108 to Y. H.). Then, these funding helped English proofreading fee and publication fee. So, these funders had no role in study design, data collection and analysis, decision to publish, but had role in the preparation of the manuscript.	Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI DOI 10.1016/j.idm.2020.04.001; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Gao ZR, 2021, J MICROBIOL IMMUNOL, V54, P12, DOI 10.1016/j.jmii.2020.05.001; Gariano RF, 2004, AM FAM PHYSICIAN, V69, P1691; Hiroi U., 2020, J CITY PLAN INST JPN, V55, P902, DOI [10.11361/journalcpij.55.902, DOI 10.11361/JOURNALCPIJ.55.902]; Jasani KM, 2021, EUR J OPHTHALMOL, V31, P2876, DOI 10.1177/1120672120965480; Katafuchi Yuya, 2021, Econ Disaster Clim Chang, V5, P71, DOI 10.1007/s41885-020-00077-w; Kuniya T, 2020, INFECT DIS MODEL, V5, P580, DOI 10.1016/j.idm.2020.08.004; Mitry D, 2013, BRIT J OPHTHALMOL, V97, P149, DOI 10.1136/bjophthalmol-2012-302330; Ogden RS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235871; Paital B, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138914; Patel LG, 2021, OPHTHALMOLOGY, V128, P686, DOI 10.1016/j.ophtha.2020.10.009; Siddiqui MAR, 2010, ACTA OPHTHALMOL, V88, pe352, DOI 10.1111/j.1755-3768.2009.01771.x; Tirupathi Raghavendra, 2020, Infez Med, V28, P57; Vroon J, 2018, BIOMECH MODEL MECHAN, V17, P975, DOI 10.1007/s10237-018-1006-y; Wong L.E., 2020, NEJM CATAL INNOV CAR, DOI 10.1056/CAT.20.0193	16	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261779	10.1371/journal.pone.0261779	http://dx.doi.org/10.1371/journal.pone.0261779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972153	gold, Green Published			2022-12-27	WOS:000773555700053
J	Tizzani, M; Munoz-Gomez, V; De Nardi, M; Paolotti, D; Munoz, O; Ceschi, P; Viltrop, A; Capua, I				Tizzani, Michele; Munoz-Gomez, Violeta; De Nardi, Marco; Paolotti, Daniela; Munoz, Olga; Ceschi, Piera; Viltrop, Arvo; Capua, Ilaria			Integrating digital and field surveillance as complementary efforts to manage epidemic diseases of livestock: African swine fever as a case study	PLOS ONE			English	Article							INFORMATION-SEEKING; WIKIPEDIA; ATTITUDES; KNOWLEDGE	SARS-CoV-2 has clearly shown that efficient management of infectious diseases requires a top-down approach which must be complemented with a bottom-up response to be effective. Here we investigate a novel approach to surveillance for transboundary animal diseases using African Swine (ASF) fever as a model. We collected data both at a population level and at the local level on information-seeking behavior respectively through digital data and targeted questionnaire-based surveys to relevant stakeholders such as pig farmers and veterinary authorities. Our study shows how information-seeking behavior and resulting public attention during an epidemic, can be identified through novel data streams from digital platforms such as Wikipedia. Leveraging attention in a critical moment can be key to providing the correct information at the right moment, especially to an interested cohort of people. We also bring evidence on how field surveys aimed at local workers and veterinary authorities remain a crucial tool to assess more in-depth preparedness and awareness among front-line actors. We conclude that these two tools should be used in combination to maximize the outcome of surveillance and prevention activities for selected transboundary animal diseases such as ASF.	[Tizzani, Michele; Paolotti, Daniela] Inst Sci Interchange Fdn, Turin, Italy; [Munoz-Gomez, Violeta; De Nardi, Marco] SAFOSO, Liebefeld, Switzerland; [Munoz-Gomez, Violeta] Univ Zurich, Vetsuisse Fac, Sect Epidemiol, Zurich, Switzerland; [Munoz, Olga] One Hlth Ctr Excellence, Gainesville, FL USA; [Munoz, Olga; Ceschi, Piera; Capua, Ilaria] Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Viltrop, Arvo] Estonian Univ Life Sci, Tartu, Estonia	University of Zurich; Estonian University of Life Sciences	Tizzani, M (corresponding author), Inst Sci Interchange Fdn, Turin, Italy.; Munoz-Gomez, V (corresponding author), SAFOSO, Liebefeld, Switzerland.; Munoz-Gomez, V (corresponding author), Univ Zurich, Vetsuisse Fac, Sect Epidemiol, Zurich, Switzerland.	mt.tizzani@isi.it; violetamunozgomez@hotmail.com		Capua, Ilaria/0000-0002-7072-2581; Tizzani, Michele/0000-0003-3068-5111; Munoz, Violeta/0000-0001-5874-0317	Leonardo Fellowship Program; Circular Health Initiative at University of Florida; Lagrange Project of the Institute for Scientific Interchange Foundation - Fondazione CRT of Torino; Zurich Insurance Company	Leonardo Fellowship Program; Circular Health Initiative at University of Florida; Lagrange Project of the Institute for Scientific Interchange Foundation - Fondazione CRT of Torino; Zurich Insurance Company	IC acknowledges the Leonardo Fellowship Program, and the Circular Health Initiative at University of Florida (https://onehealth.ifas.ufl.edu/activities/circular-health-program/circular-health/).DP and MT acknowledge the support from the Lagrange Project of the Institute for Scientific Interchange Foundation (https://www. isi.it/en/lagrange-project/project) funded by Fondazione CRT (https://www.fondazionecrt.it/en/fondazione-crt.html) of Torino (https://www.fondazionecrt.it/).MDN and VM acknowledge the support of the Zurich Insurance Company (www.zurich.com) for funding the fieldwork in Estonia. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	Al Baghal T, 2021, EPJ DATA SCI, V10, DOI 10.1140/epjds/s13688-021-00286-7; Al Baghal T, 2020, SOC SCI COMPUT REV, V38, P517, DOI 10.1177/0894439319828011; Belgian Federal Agency for the Safety of the Food Chain (FASFC), 2019, AFRICAN SWINE FEVER; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Brigo F, 2015, EPILEPTIC DISORD, V17, P460, DOI 10.1684/epd.2015.0772; Busch F, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.637487; Castillo-Contreras R, 2018, SCI TOTAL ENVIRON, V615, P282, DOI 10.1016/j.scitotenv.2017.09.277; Chenais E, 2019, PORCINE HEALTH MANAG, V5, DOI 10.1186/s40813-018-0109-2; Choi S, 2020, SOC SCI COMPUT REV, V38, P91, DOI 10.1177/0894439318788618; Costard S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17074; Dixon LK, 2020, ANNU REV ANIM BIOSCI, V8, P221, DOI 10.1146/annurev-animal-021419-083741; E-estonia, 2020, E EST WE HAV BUILD D; Fanelli A, 2021, TRANSBOUND EMERG DIS; FAO, ASF SIT UPD AFR SWIN; FAO OIE, 2020, GLOB CONTR AFR SWIN; Galindo I, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050103; Gozzi N, 2020, J MED INTERNET RES, V22, DOI 10.2196/21597; Honnibal M, 2017, SPCY2 NATURAL LANGUA; Jabaley CS, 2019, AM J RESP CRIT CARE, V199, P531, DOI 10.1164/rccm.201809-1649LE; Jori F., 2021, UNDERSTANDING COMBAT, P197, DOI [10.3920/978-90-8686-910-7_8, DOI 10.3920/978-90-8686-910-7_8]; Krentel A, 2006, TROP MED INT HEALTH, V11, P1731, DOI 10.1111/j.1365-3156.2006.01720.x; Kristian M, 2017, WORKSH ASF MAN WILD; Leetaru Kalev, 2013, ISA ANN CONV; Lewis N., 2017, INT ENCY MEDIA EFFEC, P1, DOI [10.1002/9781118783764.wbieme0156, DOI 10.1002/9781118783764.WBIEME0156]; Liu L, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3252-8; Liu Q, 2020, J MED INTERNET RES, V22, DOI 10.2196/19118; Mason-D'Croz D, 2020, NAT FOOD, V1, DOI 10.1038/s43016-020-0057-2; Matibag Gino C., 2007, Environmental Health and Preventive Medicine, V12, P84, DOI 10.1007/BF02898154; Munoz-Gomez V, 2021, VET MED SCI, V7, P1786, DOI 10.1002/vms3.578; Nurmoja I, 2017, TRANSBOUND EMERG DIS, V64, P2034, DOI 10.1111/tbed.12614; Nurmoja I, 2020, PREV VET MED, V181, DOI 10.1016/j.prevetmed.2018.10.001; OIE, 2010, STAND GROUP EXP AFR; pandas development team, 2020, T PANDAS DEV PANDAS; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Probst C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170054; Sanchez-Cordon PJ, 2018, VET J, V233, P41, DOI 10.1016/j.tvjl.2017.12.025; Schulz K, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8020336; Seabold S., 2010, 9 PYTH SCI C, P6, DOI DOI 10.25080/MAJORA-92BF1922-011; Sidana S, 2018, IEEE T KNOWL DATA EN, V30, P1467, DOI 10.1109/TKDE.2018.2795606; Stier S, 2020, SOC SCI COMPUT REV, V38, P503, DOI 10.1177/0894439319843669; Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759; Tizzoni M., 2018, 346411 BIORXIV, DOI [10.1101/346411, DOI 10.1101/346411]; Tizzoni M, 2020, PLOS COMPUT BIOL, V16, DOI [10.1371/journal.pcbi.1007633, 10.1371/journal.pcbi.1007633.r001, 10.1371/journal.pcbi.1007633.r002, 10.1371/journal.pcbi.1007633.r003, 10.1371/journal.pcbi.1007633.r004]; USDA APHIS, USDA STAT CONF AFR S	44	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0252972	10.1371/journal.pone.0252972	http://dx.doi.org/10.1371/journal.pone.0252972			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972117	Green Published, gold, Green Accepted			2022-12-27	WOS:000773555700002
J	Rainey, A; Pierce, A; Deng, XY; Actis, LA; Smith, P; Kiss, AJ; Wilson, TJ				Rainey, Amanda; Pierce, Austin; Deng, Xiaoyun; Actis, Luis A.; Smith, Philip; Kiss, Andor J.; Wilson, Timothy J.			Validation and deployment of a direct saliva real-time RT-PCR test on pooled samples for COVID-19 surveillance testing	PLOS ONE			English	Article								A direct, real-time reverse transcriptase PCR test on pooled saliva was validated in 2,786 participants against oropharyngeal swabs. Among asymptomatic/pre-symptomatic participants, the test was found to be in 99.21% agreement and 45% more sensitive than contemporaneous oropharyngeal swabs. The test was then used for surveillance testing on 44,242 saliva samples from asymptomatic participants. Those whose saliva showed evidence of SARS-CoV-2 within 50 cycles of amplification were referred for confirmatory testing, with 87% of those tested by nasal swab within 72 hours receiving a positive diagnostic result on Abbott ID NOW or real-time PCR platforms. Median Ct values on the saliva PCR for those with a positive and negative confirmatory tests was 30.67 and 35.92 respectively, however, binary logistic regression analysis of the saliva Ct values indicates that Ct thresholds as high as 47 may be useful in a surveillance setting. Overall, data indicate that direct RT-PCR testing of pooled saliva samples is an effective method of SARS-CoV-2 surveillance.	[Rainey, Amanda; Pierce, Austin; Deng, Xiaoyun; Actis, Luis A.; Wilson, Timothy J.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Smith, Philip] Miami Univ, Dept Kinesiol Nutr & Hlth, Oxford, OH 45056 USA; [Kiss, Andor J.] Miami Univ, Ctr Bioinformat & Funct Genom, Oxford, OH 45056 USA	University System of Ohio; Miami University; University System of Ohio; Miami University; University System of Ohio; Miami University	Wilson, TJ (corresponding author), Miami Univ, Dept Microbiol, Oxford, OH 45056 USA.	tim.wilson@miamioh.edu	Kiss, Andor J/E-9863-2016	Kiss, Andor J/0000-0002-7508-0485; Wilson, Timothy/0000-0001-8403-9401				Abdalhamid B, 2020, AM J CLIN PATHOL, V153, P715, DOI [10.1093/ajcp/aqaa064, 10.1093/AJCP/AQAA064, 10.1101/2020.04.03.20050195]; B.Wilder, 2020, medRxiv, DOI 10.1101/2020.06.22.20136309; Boehme C, 2021, LANCET GLOB HEALTH, V9, pE247, DOI 10.1016/S2214-109X(21)00006-1; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; Butler-Laporte G, 2021, JAMA INTERN MED, V181, P353, DOI 10.1001/jamainternmed.2020.8876; Dahdouh E, 2021, J INFECTION, V82, P426, DOI 10.1016/j.jinf.2020.10.017; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Hasanoglu I, 2021, INFECTION, V49, P117, DOI 10.1007/s15010-020-01548-8; Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7; Khan S, 2020, EUR J PHARMACOL, V886, DOI 10.1016/j.ejphar.2020.173447; Lee RA, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02881-20; Liu L, 2011, J VIROL, V85, P4025, DOI 10.1128/JVI.02292-10; Moore NM, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00938-20; Pasomsub E, 2021, J MED VIROL, V93, P1506, DOI 10.1002/jmv.26460; Pinninti S, 2021, CLIN INFECT DIS, V72, P1253, DOI 10.1093/cid/ciaa882; Ranoa DRE, 2020, SALIVA BASED MOL TES, DOI [10.1101/2020.06.18.159434, DOI 10.1101/2020.06.18.159434]; Smithgall MC, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104428; Tom MR, 2020, CLIN INFECT DIS, V71, P2252, DOI 10.1093/cid/ciaa619; Vogels CBF, 2021, MED-CAMBRIDGE, V2, P263, DOI 10.1016/j.medj.2020.12.010; Walsh KA, 2020, J INFECTION, V81, P357, DOI 10.1016/j.jinf.2020.06.067; Wang WK, 2004, EMERG INFECT DIS, V10, P1213, DOI 10.3201/eid1007.031113; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Zhen W, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00743-20	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2021	16	12							e0261956	10.1371/journal.pone.0261956	http://dx.doi.org/10.1371/journal.pone.0261956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0C7TD	34969053	gold, Green Published			2022-12-27	WOS:000775510400024
J	Sarpong-Kumankomah, S; Knox, KB; Kelly, ME; Hunter, G; Popescu, B; Nichol, H; Kopciuk, K; Ntanda, H; Gailer, J				Sarpong-Kumankomah, Sophia; Knox, Katherine B.; Kelly, Michael E.; Hunter, Gary; Popescu, Bogdan; Nichol, Helen; Kopciuk, Karen; Ntanda, Henry; Gailer, Jurgen			Quantification of human plasma metalloproteins in multiple sclerosis, ischemic stroke and healthy controls reveals an association of haptoglobin-hemoglobin complexes with age	PLOS ONE			English	Article							ERYTHROCYTE FRAGILITY; OXIDATIVE STRESS; SERUM; IRON; DIAGNOSIS; PROTEOME; METALS; ZINC	Advanced analytical methods play an important role in quantifying serum disease biomarkers. The problem of separating thousands of proteins can be reduced by analyzing for a 'sub-proteome', such as the 'metalloproteome', defined as all proteins that contain bound metals. We employed size exclusion chromatography (SEC) coupled to an inductively coupled plasma atomic emission spectrometer (ICP-AES) to analyze plasma from multiple sclerosis (MS) participants (n = 21), acute ischemic stroke (AIS) participants (n = 17) and healthy controls (n = 21) for Fe, Cu and Zn-metalloproteins. Using ANOVA analysis to compare the mean peak areas among the groups revealed no statistically significant differences for ceruloplasmin (p = 0.31), a 2 macroglobulin (p = 0.51) and transferrin (p = 0.31). However, a statistically significant difference was observed for the haptoglobin-hemoglobin (Hp-Hb) complex (p = 0.04), being driven by the difference between the control group and AIS (p = 0.012), but not with the MS group (p = 0.13), based on Dunnes test. A linear regression model for Hp-Hb complex with the groups now adjusted for age found no statistically significant differences between the groups (p = 0.95), but was suggestive for age (p = 0.057). To measure the strength of association between the Hp-Hb complex and age without possible modifications due to disease, we calculated the Spearman rank correlation in the healthy controls. The latter revealed a positive association (r = 0.39, 95% Confidence Interval = (-0.05, 0.83), which suggests that either the removal of Hp-Hb complexes from the blood circulation slows with age or that the release of Hb from red blood cells increases with age. We also observed that the Fe-peak corresponding to the Hp-Hb complex eluted similar to 100 slater in similar to 14% of all study samples, which was not correlated with age or disease diagnosis, but is consistent with the presence of the smaller Hp (1-1) isoform in 15% of the population.	[Sarpong-Kumankomah, Sophia; Gailer, Jurgen] Univ Calgary, Dept Chem, Calgary, AB, Canada; [Knox, Katherine B.] Univ Saskatchewan, Coll Med, Dept Phys Med & Rehabil, Saskatoon, SK, Canada; [Kelly, Michael E.] Univ Saskatchewan, Coll Med, Div Neurosurg, Saskatoon, SK, Canada; [Hunter, Gary] Univ Saskatchewan, Coll Med, Div Neurol, Saskatoon, SK, Canada; [Popescu, Bogdan; Nichol, Helen] Univ Saskatchewan, Dept Anat Physiol & Pharmacol, Saskatoon, SK, Canada; [Kopciuk, Karen] Univ Calgary, Dept Math & Stat, Calgary, AB, Canada; [Kopciuk, Karen] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Kopciuk, Karen] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Kopciuk, Karen] Canc Control Alberta, Canc Epidemiol & Prevent Res, Calgary, AB, Canada; [Ntanda, Henry] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada	University of Calgary; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Gailer, J (corresponding author), Univ Calgary, Dept Chem, Calgary, AB, Canada.	jgailer@ucalgary.ca		Gailer, Juergen/0000-0002-8264-8243	Royal University Hospital Foundation [G21548]; Saskatchewan Research Chair in Clinical Stroke Research - Heart & Stroke Foundation; Saskatchewan Health Research Foundation; University of Saskatchewan's College of Medicine	Royal University Hospital Foundation; Saskatchewan Research Chair in Clinical Stroke Research - Heart & Stroke Foundation; Saskatchewan Health Research Foundation; University of Saskatchewan's College of Medicine	The project was funded by a grant from the Royal University Hospital Foundation G21548 to H. Nichol (PI) and M.E. Kelly, the Saskatchewan Research Chair in Clinical Stroke Research which is funded by the Heart & Stroke Foundation, the Saskatchewan Health Research Foundation and the University of Saskatchewan's College of Medicine.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Asleh R, 2005, CIRC RES, V96, P435, DOI 10.1161/01.RES.0000156653.05853.b9; Bale BF, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00141; BARTOSZ G, 1991, GERONTOLOGY, V37, P33, DOI 10.1159/000213251; Bredholt M, 2016, ASN NEURO, V8, DOI 10.1177/1759091416651511; Bridle TG, 2021, MOLECULES, V26, DOI 10.3390/molecules26113408; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Carelli-Alinovi C, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00276; Chaichana KL, 2007, STROKE, V38, P3266, DOI 10.1161/STROKEAHA.107.490003; Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; da Silva MAO, 2010, EXPERT REV PROTEOMIC, V7, P387, DOI [10.1586/epr.10.16, 10.1586/EPR.10.16]; di Masi A, 2020, MOL ASPECTS MED, V73, DOI 10.1016/j.mam.2020.100851; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; Doecke JD, 2012, ARCH NEUROL-CHICAGO, V69, P1318, DOI 10.1001/archneurol.2012.1282; Fagoonee S, 2005, AM J PATHOL, V166, P973, DOI 10.1016/S0002-9440(10)62319-X; Ferenci P, 2017, HAND CLINIC, V142, P171, DOI 10.1016/B978-0-444-63625-6.00014-8; Geyer PE, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20156297; Gomes FP, 2019, MASS SPECTROM REV, V38, P445, DOI 10.1002/mas.21599; Gonzalez-Dominguez R, 2014, METALLOMICS, V6, P292, DOI 10.1039/c3mt00301a; Hood L. A., 2008, PHYS BIOL ATOMS MED, P337; Kodali P, 2012, METALLOMICS, V4, P1077, DOI 10.1039/c2mt20092a; Kumar Arun, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P6, DOI 10.1016/S2221-1691(11)60058-0; Langlois MR, 1996, CLIN CHEM, V42, P1589; Manley SA, 2009, J BIOL INORG CHEM, V14, P61, DOI 10.1007/s00775-008-0424-1; Manley SA, 2009, EXPERT REV PROTEOMIC, V6, P251, DOI [10.1586/epr.09.44, 10.1586/EPR.09.44]; Melo TM, 2003, BIOL TRACE ELEM RES, V93, P1, DOI 10.1385/BTER:93:1-3:1; Miller K, 2020, J CHROMATOGR B, V1147, DOI 10.1016/j.jchromb.2020.122147; Moitra S, 2014, AM J IND MED, V57, P1064, DOI 10.1002/ajim.22336; Pan MX, 2017, AGING DIS, V8, P519, DOI 10.14336/AD.2017.0710; Pieper R, 2003, PROTEOMICS, V3, P1345, DOI 10.1002/pmic.200300449; Popescu BF, 2017, ACTA NEUROPATHOL, V134, P45, DOI 10.1007/s00401-017-1696-8; Popescu BFG, 2009, CEREBELLUM, V8, P340, DOI 10.1007/s12311-009-0102-z; Popescu BFG, 2011, CNS NEUROSCI THER, V17, P256, DOI 10.1111/j.1755-5949.2010.00149.x; Pushie MJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74698-2; Sarpong-Kumankomah S, 2019, J INORG BIOCHEM, V201, DOI 10.1016/j.jinorgbio.2019.110802; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Sussulini A, 2010, ANAL CHEM, V82, P5859, DOI 10.1021/ac101063t; Tham M, 2021, ANN NEUROL, V89, P498, DOI 10.1002/ana.25974; Vardi M, 2012, CURR DIABETES REP, V12, P274, DOI 10.1007/s11892-012-0265-8; Wang P, 2017, AGEING RES REV, V35, P265, DOI 10.1016/j.arr.2016.10.003; Zhang T, 2018, EUR NEUROL, V79, P154, DOI 10.1159/000487648; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009	45	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262160	10.1371/journal.pone.0262160	http://dx.doi.org/10.1371/journal.pone.0262160			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020753	gold, Green Published			2022-12-27	WOS:000834207700034
J	Seravalli, V; Strambi, N; D'Arienzo, A; Magni, F; Bernardi, L; Morucchio, A; Di Tommaso, M				Seravalli, Viola; Strambi, Noemi; D'Arienzo, Alessandra; Magni, Francesco; Bernardi, Ludovico; Morucchio, Anna; Di Tommaso, Mariarosaria			Patient's experience with the Arabin cervical pessary during pregnancy: A questionnaire survey	PLOS ONE			English	Article							SPONTANEOUS PRETERM BIRTH; SINGLETON PREGNANCY; TWIN PREGNANCIES; RANDOMIZED-TRIAL; WOMEN; PREVENTION; MULTICENTER; PECEP; RISK	Introduction The cervical pessary is used in women with precocious cervical ripening to prevent preterm birth. Up to now however, there have been no systematic studies on compliance and tolerance, which vary among different study cohorts. Material and methods A questionnaire was administered to 166 women treated with the Arabin cervical pessary in one center. Data were analysed about the patient's experience before insertion (adequacy of information received), during treatment (follow-up, impact on daily life, perceived discomfort, side effects) and at the time of removal (pain, if the patient's expectations had been met regarding the treatment). Results Information received before the insertion of the Arabin cervical pessary was considered adequate in 163/166 (98.2%) women. An increase in vaginal discharge was experienced by 70/ 166 (42.2%) women. Discomfort or other side effects were reported in 13.8% and 16.3% of cases, respectively. Overall, 77% of women reported an improved quality of life and 94% considered the follow-up during pregnancy adequate. Removal was moderately painful for 58/166 (35%) of women. Patient's expectations regarding the treatment were exceeded in the majority of cases (75.3%). In a final step, we compared our results to previous studies regarding the use of the pessary in singleton and twin pregnancies. Conclusion Although some trials report high rates of non-compliant patients, this could not be confirmed by our study. In contrast, most women reported having a positive experience and that they were motivated to continue the treatment when they were continuously followed by experienced clinicians.	[Seravalli, Viola; Strambi, Noemi; D'Arienzo, Alessandra; Magni, Francesco; Bernardi, Ludovico; Morucchio, Anna; Di Tommaso, Mariarosaria] Univ Florence, Dept Hlth Sci, Florence, Italy	University of Florence	Di Tommaso, M (corresponding author), Univ Florence, Dept Hlth Sci, Florence, Italy.	mariarosaria.ditommaso@unifi.it		DI TOMMASO, MARIAROSARIA/0000-0001-8248-929X				Arabin B, 2006, ULTRASOUND OBST GYN, V27, P377, DOI 10.1002/uog.2694; Arabin B, 2013, ULTRASOUND OBST GYN, V42, P390, DOI 10.1002/uog.12540; Arabin B, 2003, J PERINAT MED, V31, P122, DOI 10.1515/JPM.2003.017; Barbone AS, 2020, ULTRASOUND OBST GYN, V55, P557, DOI 10.1002/uog.20375; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Cannie MM, 2013, ULTRASOUND OBST GYN, V42, P426, DOI 10.1002/uog.12507; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Dang VQ, 2019, OBSTET GYNECOL, V133, P459, DOI 10.1097/AOG.0000000000003136; Di Renzo GC, 2017, J MATERN-FETAL NEO M, V30, P2011, DOI 10.1080/14767058.2017.1323860; Di Tommaso M, 2016, J OBSTET GYNAECOL, V36, P715, DOI 10.3109/01443615.2016.1148127; Diez-Izquierdo A, 2018, ENVIRON RES, V160, P547, DOI 10.1016/j.envres.2017.10.033; Dugoff L, 2018, ULTRASOUND OBST GYN, V51, P573, DOI 10.1002/uog.18908; Englund-Ogge L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1446; Franca MS, 2021, OBSTET GYNECOL INT J, V12, P94; Garn JV, 2015, MATERN CHILD HLTH J, V19, P811, DOI 10.1007/s10995-014-1576-y; Goya M, 2016, AM J OBSTET GYNECOL, V214, P145, DOI 10.1016/j.ajog.2015.11.012; Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0; Hoffman MK, 2020, LANCET, V395, P285, DOI 10.1016/S0140-6736(19)32973-3; Hui SYA, 2013, AM J PERINAT, V30, P283, DOI 10.1055/s-0032-1322550; Ivandic J, 2020, J MATERN-FETAL NEO M, V33, P1370, DOI 10.1080/14767058.2018.1519018; Jones KR, 2007, J REHABIL RES DEV, V44, P305, DOI 10.1682/JRRD.2006.05.0051; Kyvernitakis I, 2019, GEBURTSH FRAUENHEILK, V79, P1171, DOI 10.1055/a-1007-8613; Liem S, 2013, LANCET, V382, P1341, DOI 10.1016/S0140-6736(13)61408-7; Makrides M, 2019, NEW ENGL J MED, V381, P1035, DOI 10.1056/NEJMoa1816832; Middleton P, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003402.pub3; Nicolaides KH, 2016, NEW ENGL J MED, V374, P1044, DOI 10.1056/NEJMoa1511014; Nicolaides KH, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.08.051; Norman JE, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003506; Saccone G, 2017, JAMA-J AM MED ASSOC, V318, P2317, DOI 10.1001/jama.2017.18956; Simmonds LA, 2020, BJOG-INT J OBSTET GY, V127, P975, DOI 10.1111/1471-0528.16168; Souka AP, 2019, ULTRASOUND OBST GYN, V53, P396, DOI 10.1002/uog.19050	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261830	10.1371/journal.pone.0261830	http://dx.doi.org/10.1371/journal.pone.0261830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020768	gold, Green Published			2022-12-27	WOS:000834207700025
J	Yuan, XF; Hao, HJ; Guan, CH; Pentland, A				Yuan, Xiangfei; Hao, Haijing; Guan, Chenghua; Pentland, Alex			Which factors affect the performance of technology business incubators in China? An entrepreneurial ecosystem perspective	PLOS ONE			English	Article							SCIENCE PARK; REGIONAL GROWTH; INNOVATION; IMPACT; DIVERSITY; CAPACITY; VARIETY; SUPPORT; LINKS	To examine which factors affect the performance of technology business incubators in China, the present study proposes an entrepreneurial ecosystem framework with four key areas, i.e., people, technology, capital, and infrastructure. We then assess this framework using a three-year panel data set of 857 national-level technology business incubators in 33 major cities from 28 provinces in China, from 2015 to 2017. We utilize factor analysis to downsize dozens of characteristics of these technology business incubators into seven factors related to the four proposed areas. Panel regression model results show that four of the seven factors related to three areas of the entrepreneurial ecosystem, namely people, technology, and capital areas, have statistically significant associations with an incubator's performance when applied to the overall national data set. Further, seven factors related to all four areas have various statistically significant associations with an incubator's performance in five major regional data set. In particular, a technology related factor has a consistently statistically significant association with the performance of the incubator in both national model and the five regional models, as we expected.	[Yuan, Xiangfei] Capital Inst Sci & Technol Dev Strategy, Beijing, Peoples R China; [Yuan, Xiangfei; Hao, Haijing; Pentland, Alex] MIT, Media Lab, Cambridge, MA 02139 USA; [Hao, Haijing] Bentley Univ, Comp Informat Syst Dept, Waltham, MA 02452 USA; [Guan, Chenghua] Beijing Normal Univ, Sch Econ & Resource Management, Beijing, Peoples R China	Massachusetts Institute of Technology (MIT); Bentley University; Beijing Normal University	Hao, HJ (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.; Hao, HJ (corresponding author), Bentley Univ, Comp Informat Syst Dept, Waltham, MA 02452 USA.	hhao@bentley.edu		Hao, Haijing/0000-0003-3071-2538				Acs ZJ, 2014, RES POLICY, V43, P476, DOI 10.1016/j.respol.2013.08.016; Acs ZJ, 2009, SMALL BUS ECON, V32, P15, DOI [10.1007/s11187-008-9157-3, 10.1007/s11187-013-9505-9]; Albort-Morant G, 2016, J BUS RES, V69, P2125, DOI 10.1016/j.jbusres.2015.12.019; Albort-Morant G, 2016, J BUS RES, V69, P1775, DOI 10.1016/j.jbusres.2015.10.054; Amezcua AS, 2013, ACAD MANAGE J, V56, P1628, DOI 10.5465/amj.2011.0652; Audretsch D. B., 2016, 7 SECRETS GERMANY; Audretsch DB, 2016, J TECHNOL TRANSFER, V41, P1, DOI [10.1007/s10961-014-9381-8, 10.1007/s10961-016-9473-8]; Audretsch DB., 2019, PALGRAVE ADV EC INNO; Autio E, 2018, STRATEG ENTREP J, V12, P72, DOI 10.1002/sej.1266; Autio E, 2014, RES POLICY, V43, P1097, DOI 10.1016/j.respol.2014.01.015; Bakouros YL, 2002, TECHNOVATION, V22, P123, DOI 10.1016/S0166-4972(00)00087-0; Barro R.J., 1995, EC GROWTH; Bergek A, 2008, TECHNOVATION, V28, P20, DOI 10.1016/j.technovation.2007.07.008; Boschma R, 2009, ECON GEOGR, V85, P289, DOI 10.1111/j.1944-8287.2009.01034.x; Branstetter L, 2017, MILLENN ASIA, V8, P5, DOI 10.1177/0976399616686860; Branstetter LG, 2019, MANAGE SCI, V65, P541, DOI 10.1287/mnsc.2017.2960; Chandra Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190228; Chen JY, 2020, ENTREP REGION DEV, V32, P370, DOI 10.1080/08985626.2019.1640438; Chong SK, 2020, EPJ DATA SCI, V9, DOI 10.1140/epjds/s13688-020-00234-x; Colombo MG, 2002, RES POLICY, V31, P1103, DOI 10.1016/S0048-7333(01)00178-0; Content J, 2018, EMPIRICAL ANAL EFFEC; Dagnino GB, 2015, START UPS START UP E, P79; Davies A, 2010, GEOGR RES-AUST, V48, P223, DOI 10.1111/j.1745-5871.2009.00627.x; Fagerberg J, 2008, RES POLICY, V37, P1417, DOI 10.1016/j.respol.2008.06.003; [方创琳 Fang Chuanglin], 2017, [地理学报, Acta Geographica Sinica], V72, P179; Fealey T., 2007, ASIA PACIFIC BUSINES, V13, P79, DOI DOI 10.1080/13602380601030647; Feld B., 2012, STARTUP COMMUNITY WA, V1st; Florida R. L., 2005, CITIES CREATIVE CLAS; Florida R, 2008, J ECON GEOGR, V8, P615, DOI 10.1093/jeg/lbn023; Fritsch M, 2018, REG STUD, V52, P1360, DOI 10.1080/00343404.2017.1388914; Fukugawa N, 2018, INT ENTREP MANAG J, V14, P457, DOI 10.1007/s11365-017-0468-1; Ghio N, 2015, SMALL BUS ECON, V44, P1, DOI 10.1007/s11187-014-9588-y; Gozali L, 2020, INT J TECHNOL, V11, P155, DOI 10.14716/ijtech.v11i1.2464; Guan C., 2018, BEIJING SOCIAL SCI, V8, P107; Hackett S.M., 2004, J TECHNOL TRANSF, V29, P55, DOI [DOI 10.1023/B:JOTT.0000011181.11952.0F, 10.1023/B:JOTT.0000011181.11952.0f]; Hansen EG, 2009, INT J INNOV MANAG, V13, P683, DOI 10.1142/S1363919609002479; Haqa I., 2018, APPL ECON LETT; Harper-Anderson E, 2018, ECON DEV Q, V32, P60, DOI 10.1177/0891242417741961; Hong J, 2017, TECHNOL ANAL STRATEG, V29, P569, DOI 10.1080/09537325.2016.1216096; Isenberg DJ, 2010, HARVARD BUS REV, V88, P40; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Latham A, 2019, GEOGR COMPASS, V13, DOI 10.1111/gec3.12444; Levie J.D., 2014, WORKSH ORG HENL CTR; Li K., 2015, IMPORTANCE LEADERSHI; Li Q., 2018, SCI TECHNOLOGY MANAG, V4, P59; Lukes M, 2019, TECHNOVATION, V82-83, P25, DOI 10.1016/j.technovation.2018.07.008; Mack E, 2016, URBAN STUD, V53, P2118, DOI 10.1177/0042098015586547; Malecki EJ, 2020, INVESTOPEDIA; Marshall A., 1890, PRINCIPLES EC; Mian SA, 1996, RES POLICY, V25, P325, DOI 10.1016/0048-7333(95)00828-4; Mian SA, 1997, J BUS VENTURING, V12, P251, DOI 10.1016/S0883-9026(96)00063-8; Mian S, 2016, TECHNOVATION, V50-51, P1, DOI 10.1016/j.technovation.2016.02.005; Moore J, 1996, FORTUNE, V133, P142; Motoyama Y, 2017, ENTREP RES J, V7, DOI 10.1515/erj-2016-0011; Moya-Clemente I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238462; Obschonka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129332; Olkiewicz M, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11010173; Pan FH, 2016, GEOFORUM, V75, P148, DOI 10.1016/j.geoforum.2016.07.013; Pe'er A, 2013, J BUS VENTURING, V28, P354, DOI 10.1016/j.jbusvent.2012.03.004; Pergelova A, 2014, ENTREP REGION DEV, V26, P663, DOI 10.1080/08985626.2014.980757; Phillimore J, 1999, TECHNOVATION, V19, P673, DOI 10.1016/S0166-4972(99)00062-0; Pradhan M, 2002, WORLD BANK ECON REV, V16, P275, DOI 10.1093/wber/16.2.275; Quigley JM, 1998, J ECON PERSPECT, V12, P127, DOI 10.1257/jep.12.2.127; QUINTAS P, 1992, TECHNOVATION, V12, P161, DOI 10.1016/0166-4972(92)90033-E; Rice MP, 2002, J BUS VENTURING, V17, P163, DOI 10.1016/S0883-9026(00)00055-0; Roach M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170444; Roach M, 2013, MANAGE SCI, V59, P504, DOI 10.1287/mnsc.1120.1644; Roundy P.T., 2017, J BUS VENTURING INSI, V8, P99, DOI [10.1016/j.jbvi.2017.08.002, DOI 10.1016/J.JBVI.2017.08.002]; Roundy PT, 2018, J BUS RES, V86, P1, DOI 10.1016/j.jbusres.2018.01.032; Rubin TH, 2015, TECHNOVATION, V41-42, P11, DOI 10.1016/j.technovation.2015.03.002; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Smith K., 2006, OXFORD HDB INNOVATIO; Spigel B, 2017, ENTREP THEORY PRACT, V41, P49, DOI 10.1111/etap.12167; Stam E, 2011, HANDBOOK OF RESEARCH ON INNOVATION AND ENTREPRENEURSHIP, P421; Theodoraki Christina, 2017, International Journal of Entrepreneurship and Small Business, V31, P47; THEODORAKI C, 2020, IEEE T ENG MANAGE; Theodoraki C, 2018, SMALL BUS ECON, V51, P153, DOI 10.1007/s11187-017-9924-0; Torun M., 2018, INT J INNOVATION STU, V2, P91; Tsai HY., 2017, J ORG INNOVATION ONL, V10, P173; van Weele M, 2017, TECHNOVATION, V59, P18, DOI 10.1016/j.technovation.2016.08.004; Vanderstraeten J, 2012, TECHNOVATION, V32, P656, DOI 10.1016/j.technovation.2012.09.002; Vedovello C, 1997, TECHNOVATION, V17, P491, DOI 10.1016/S0166-4972(97)00027-8; Voisey P, 2006, J SMALL BUS ENTERP D, V13, P454, DOI 10.1108/14626000610680307; Wang J., 2016, J FINANCE EC, V5, P135; WESTHEAD P, 1995, OMEGA-INT J MANAGE S, V23, P345, DOI 10.1016/0305-0483(95)00021-F; World Economic Forum, 2013, ANN M NEW CHAMPIONS; Xiao L, 2018, ENTREP REGION DEV, V30, P29, DOI 10.1080/08985626.2017.1364789; Xiao L, 2017, J TECHNOL TRANSFER, V42, P615, DOI 10.1007/s10961-016-9493-4; Yin Q., 2009, JIANGSU SOCIAL SCI, P4228; Zacharakis AL, 2003, J BUS VENTURING, V18, P217, DOI 10.1016/S0883-9026(02)00084-8; Zhang Z., 2017, CHINA BUSINESS INCUB	91	1	1	10	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0261922	10.1371/journal.pone.0261922	http://dx.doi.org/10.1371/journal.pone.0261922			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015766	Green Published, gold			2022-12-27	WOS:000814820600007
J	Solis-Grant, MJ; Espinoza-Parcet, C; Sepulveda-Carrasco, C; Perez-Villalobos, C; Rodriguez-Nunez, I; Pincheira-Martinez, C; Gomez-Varela, JP; Aranguiz-Ibarra, D				Solis-Grant, Maria Jose; Espinoza-Parcet, Camila; Sepulveda-Carrasco, Cristobal; Perez-Villalobos, Cristhian; Rodriguez-Nunez, Ivan; Pincheira-Martinez, Cristian; Gomez-Varela, Juan Pablo; Aranguiz-Ibarra, Daniela			Inclusion at universities: Psychometric properties of an inclusive management scale as perceived by students	PLOS ONE			English	Article							HIGHER-EDUCATION; DISABLED STUDENTS; DEMANDS	Introduction During the last century, the inclusion of all kinds of diversity became a social imperative in all social spaces but above all in some institutions such as the educational ones. Among these, inclusion has been least studied in the tertiary education organizations. This communication proposes and evaluates the psychometric properties of a new instrument, named Inclusive Management in Tertiary Institutions Scale (IMTIS), to assess inclusive management in universities. Method The researchers used a quantitative research model through survey. We based on the Index for Inclusion to design the IMTIS. We first submitted it to the assessment of experts. Then we applied the resulting version in an online survey including a sample of 1557 students from two universities and 121 different undergraduate careers. A panel of experts judged the content validity of the instrument. Participants answered the IMTIS after informed consent. We used confirmatory factor analysis to assess the construct validity of the instrument. We also evaluated the reliability of the measurements. Results From a kit of 33 originally proposed items, we obtained a version of 22 items with CVR between 0.60 and 1.00, and a IVC = 0.78. The confirmatory factor analysis showed that the six-factor solution had a better adjustment than the one and three factors solutions (RMSEA = 0.059; CFI = 0.947; TLI = 0.937). The McDonald omega coefficients were between 0.864 and 0.922. Conclusion The results deliver evidence that supports the validity and reliability of the IMTIS measurements to carry out research and diagnosis of inclusive management in higher education institutions.	[Solis-Grant, Maria Jose; Rodriguez-Nunez, Ivan] Univ Concepcion, Sch Med, Dept Kinesiol, Concepcion, Chile; [Espinoza-Parcet, Camila; Perez-Villalobos, Cristhian; Pincheira-Martinez, Cristian] Univ Concepcion, Concepcion, Chile; [Sepulveda-Carrasco, Cristobal] Univ Amer, Santiago, Chile; [Gomez-Varela, Juan Pablo] Univ Santo Tomas, Santiago, Chile; [Aranguiz-Ibarra, Daniela] Univ San Sebastian, Santiago, Chile	Universidad de Concepcion; Universidad de Concepcion; Universidad de Las Americas - Chile; Universidad Santo Tomas; Universidad San Sebastian	Solis-Grant, MJ (corresponding author), Univ Concepcion, Sch Med, Dept Kinesiol, Concepcion, Chile.	mariajsolis@udec.cl		Solis-Grant, Maria-Jose/0000-0002-8467-5878; Perez-Villalobos, Cristhian/0000-0002-2049-5974; Aranguiz Ibarra, Daniela/0000-0002-6062-9674	UCO [1895]	UCO	This research was funded by UCO 1895 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERA APA NCME, 2014, STAND ED PSYCH TEST, V2014 ed.; Ahmed S., 2012, BEING INCLUDED RACIS, DOI [10.1515/9780822395324, DOI 10.1215/9780822395324]; Akpapuna M, 2020, J ORGAN BEHAV MANAGE, V40, P186, DOI 10.1080/01608061.2020.1832014; Alvarez-Castillo JL, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06450; [Anonymous], 2018, LAW 21 091 REPUBLIC; [Anonymous], 2012, LAW 20 609 REPUBLIC; [Anonymous], 2010, LAW 20 422 REPUBLIC; Antonio AL, 2012, ADV EDUC DIVERS COMM, V7, P371, DOI 10.1108/S1479-358X(2012)0000007019; Arnaiz P., 2015, REV ELECT INTERUNIV, V18, P45, DOI [10.6018/reifop.18.1.214341, DOI 10.6018/REIFOP.18.1.214341, DOI 10.6018/REIF0P.18.1.214341]; Azorin C, 2017, REV COMPLUT EDUC, V28, P1043, DOI DOI 10.5209/RCED.51343; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Blanco Rosa, 2019, Rev. latinoam. educ. inclusiva, V13, P25; Booth T., 2011, INDEX INCLUSION DEV, Vthird; Booth T, 2015, GUIDE INCLUSIVE ED D; Bowles TV, 2017, HIGH EDUC RES DEV, V36, P903, DOI 10.1080/07294360.2016.1264927; Brito Sonia, 2019, Rev. latinoam. educ. inclusiva, V13, P157; Buenestado-Fernandez M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219525; Castillo Armijo Pablo, 2020, Rev. estud. exp. educ., V19, P17, DOI 10.21703/rexe.20201941castillo1; Cerro-Santamari a G., 2020, REV EUR STUD, V21, P22, DOI DOI 10.5539/RES.V12N1P22; Chang MJ, 2002, REV HIGH EDUC, V25, P125, DOI 10.1353/rhe.2002.0003; Claeys-Kulik A.L., 2019, DIVERSITY EQUITY INC; Dalton EM, 2019, AFR J DISABIL, V8, DOI 10.4102/ajod.v8i0.519; Danforth S, 2018, HIST EDUC Q, V58, P506, DOI 10.1017/heq.2018.29; De la Herran A, 2017, REV COMPLUT EDUC, V28, P913; Deppeler J, 2004, INT J INCLUSIVE EDUC, V8, P155, DOI DOI 10.1080/1360311032000158033; dos Santos MP, 2019, REV LINE POLIT GEST, V23, P818, DOI 10.22633/rpge.v23iesp.1.13008; Buey MLD, 2010, REV ESP ORIENTAC PSI, V21, P358; Dunn TJ, 2014, BRIT J PSYCHOL, V105, P399, DOI 10.1111/bjop.12046; Echeita G, 2019, REV INT EDUC JUSTICI, V8, P7; Education World Forum, 2000, ED ALL M OUR COMM CO; Fajardo M. Stella, 2017, Rev. latinoam. educ. inclusiva, V11, P171; Fernandez-Archilla JA, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12062169; George D., 2010, SPSS WINDOWS STEP ST, V10th ed., DOI DOI 10.1080/13803395.2011.614598; Hair J.F., 2010, MULTIVARIATE DATA AN; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Martinez-Usarralde MJ, 2021, EDUC XX1, V24, P93, DOI 10.5944/educXX1.26444; Langorgen E, 2018, DISABIL SOC, V33, P598, DOI 10.1080/09687599.2018.1436041; Lawrie G, 2017, TEACH LEARN INQ, V5, DOI 10.20343/teachlearninqu.5.1.3; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Lopez-Gavira R, 2021, INNOVATION-ABINGDON, V34, P292, DOI 10.1080/13511610.2019.1578198; Lopez-Torrijo ML, 2009, P 15 HIST ED C 15 CO; Lustosa FG, 2020, REV IBERO-AM ESTUD E, V15, P1523, DOI 10.21723/riaee.v15iesp2.13825; Maldonado Eddy Paz, 2018, Rev. latinoam. educ. inclusiva, V12, P115; Marquez C, 2021, REICE-REV IBEROAM CA, V19, P33, DOI 10.15366/reice2021.19.3.003; Martinez R, 2006, PSICOMETRIA; Mato D., 2008, DIVERSIDAD CULTURAL; Matus-Betancour O, 2020, REV MED CHILE, V148, P429; Matus-Betancourt O, 2018, MEDEDPUBLISH, P7, DOI [10.15694/mep.2018.0000029.1, DOI 10.15694/MEP.2018.0000029.1., DOI 10.15694/MEP.2018.0000029.1]; Medina-Garcia M, 2021, REICE-REV IBEROAM CA, V19, P55, DOI 10.15366/reice2021.19.2.004; Ministerio de Educacion de Chile MINEDUC, 2018, ED IND CHIL 2010 201; Moreira T, 2017, DILEMAS CONTEMPORANE, V4, P1; Moshagen M, 2016, STRUCT EQU MODELING, V23, P54, DOI 10.1080/10705511.2014.950896; Moshagen M, 2012, STRUCT EQU MODELING, V19, P86, DOI 10.1080/10705511.2012.634724; Narodowski M, 2008, REICE, V6, P19; Navarro-Mateu D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225993; Oficina Regional de Educacion para America Latina y el Caribe OREALC/UNESCO Santiago, 2009, REICE, V5, P1; Perez-Castro Judith, 2016, SINECTICA REV ELECTR, P1; Perez-Jorge D, 2021, EDUC SCI, V11, DOI 10.3390/educsci11050226; Rodriguez M, SERIE AVANCES INVEST, V75; Blanco GR, 2006, REICE-REV IBEROAM CA, V4, P1; Salceda M, 2015, INTANG CAP, V11, P508; Smolentseva A, 2017, HIGH EDUC, V73, P209, DOI 10.1007/s10734-016-0009-9; The United Nations, 2006, CONVENTION RIGHTS PE, DOI DOI 10.18356/53068D8F-EN; Thomas JM, 2018, SOC CURR, V5, P140, DOI 10.1177/2329496517725335; United Nations, 1948, UN DECL HUM RIGHTS; United Nations, 2015, TRANSF OUR WORLD 203, DOI DOI 10.1163/157180910X12665776638740; United Nations Educational Scientific and Cultural Organization UNESCO, 2005, EFA GLOBAL MONITORIN; United Nations Educational Scientific and Cultural Organization UNESCO, 1994, FIN REP WORLD C SPEC; United Nations Educational Scientific and Cultural Organization UNESCO, 2020, GLOB ED MON REP 2020; West SG, 2012, HDB STRUCTURAL EQUAT	70	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2022	17	1							e0262011	10.1371/journal.pone.0262011	http://dx.doi.org/10.1371/journal.pone.0262011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6D6NK	34995314	gold, Green Published			2022-12-27	WOS:000882804600001
J	Knudsen, KS; Lehmann, S; Nielsen, R; Tangedal, S; Haaland, I; Hiemstra, PS; Eagan, TM				Knudsen, Kristel S.; Lehmann, Sverre; Nielsen, Rune; Tangedal, Solveig; Haaland, Ingvild; Hiemstra, Pieter S.; Eagan, Tomas M.			The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease	PLOS ONE			English	Article							LUNG MICROBIOME; BRONCHOALVEOLAR LAVAGE; PATHOGENESIS; PROGRESSION; BACTERIA; FLUID; SLPI	Background The lower airways microbiome and host immune response in chronic pulmonary diseases are incompletely understood. We aimed to investigate possible microbiome characteristics and key antimicrobial peptides and proteins in idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD). Methods 12 IPF patients, 12 COPD patients and 12 healthy controls were sampled with oral wash (OW), protected bronchoalveolar lavage (PBAL) and right lung protected sterile brushings (rPSB). The antimicrobial peptides and proteins (AMPs), secretory leucocyte protease inhibitor (SLPI) and human beta defensins 1 and 2 (hBD-1 & hBD-2), were measured in PBAL by enzyme linked immunosorbent assay (ELISA). The V3V4 region of the bacterial 16S rDNA gene was sequenced. Bioinformatic analyses were performed with QIIME 2. Results hBD-1 levels in PBAL for IPF were lower compared with COPD. The predominant phyla in IPF were Firmicutes, Bacteroides and Actinobacteria; Proteobacteria were among top three in COPD. Differential abundance analysis at genus level showed significant differences between study groups for less abundant, mostly oropharyngeal, microbes. Alpha diversity was lower in IPF in PBAL compared to COPD (p = 0.03) and controls (p = 0.01), as well as in rPSB compared to COPD (p = 0.02) and controls (p = 0.04). Phylogenetic beta diversity showed significantly more similarity for IPF compared with COPD and controls. There were no significant correlations between alpha diversity and AMPs. Conclusions IPF differed in microbial diversity from COPD and controls, accompanied by differences in antimicrobial peptides. Beta diversity similarity between OW and PBAL in IPF may indicate that microaspiration contributes to changes in its microbiome.	[Knudsen, Kristel S.; Lehmann, Sverre; Nielsen, Rune; Tangedal, Solveig; Haaland, Ingvild; Eagan, Tomas M.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Knudsen, Kristel S.; Lehmann, Sverre; Nielsen, Rune; Eagan, Tomas M.] Haukeland Hosp, Dept Thorac Med, Bergen, Norway; [Hiemstra, Pieter S.] Leiden Univ, Dept Pulmonol, Med Ctr, Leiden, Netherlands	University of Bergen; University of Bergen; Haukeland University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Knudsen, KS (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.; Knudsen, KS (corresponding author), Haukeland Hosp, Dept Thorac Med, Bergen, Norway.	kristelknudsen@hotmail.com	Eagan, Tomas ML/P-3554-2014	Eagan, Tomas ML/0000-0001-8725-9960; Haaland, Ingvild/0000-0002-9974-2308; Knudsen, Kristel Svalland/0000-0001-5129-3892	regional health authorities ("Helse-Vest") in 2014	regional health authorities ("Helse-Vest") in 2014	Data collection in the study was partially funded by a grant from the regional health authorities ("Helse-Vest") in 2014, to the last author, Tomas Eagan. Helse-Vest do not use grant numbers for their annual grant distribution. The funder web site is: "https://helse-vest.no/en/research-and-co-operation". Dr. Knudsen received grants from the Norwegian Thoracic Society and Boehringer Ingelheim during the study. The funders had no role in study design, data collection and analysis, descision to publish, or preparation of the manuscript.	[Anonymous], 2017, PNEUMOLOGIE, V71, P9; Ashitani J, 1999, THORAX, V54, P1015, DOI 10.1136/thx.54.11.1015; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; Dickson RP, 2017, MBIO, V8, DOI 10.1128/mBio.02287-16; Dickson RP, 2016, ANNU REV PHYSIOL, V78, P481, DOI 10.1146/annurev-physiol-021115-105238; Dickson RP, 2015, ANN AM THORAC SOC, V12, P821, DOI 10.1513/AnnalsATS.201501-029OC; Dickson RP, 2014, J CLIN MICROBIOL, V52, P3605, DOI 10.1128/JCM.01028-14; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Drengenes C, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-020-07252-z; Drengenes C, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1560-1; Eisenhofer R, 2019, TRENDS MICROBIOL, V27, P105, DOI 10.1016/j.tim.2018.11.003; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Gronseth Rune, 2017, ERJ Open Res, V3, DOI 10.1183/23120541.00019-2017; Gronseth R, 2014, EUR CLIN RESPIR J, V1, DOI 10.3402/ecrj.v1.26196; Han MK, 2014, LANCET RESP MED, V2, P548, DOI 10.1016/S2213-2600(14)70069-4; Hiemstra PS, 2016, CHEST, V149, P545, DOI 10.1378/chest.15-1353; Hoang T, 2019, 16S AMPLICON PCR V3, P1, DOI [10.17504/protocols.io.2sygefw, DOI 10.17504/PROTOCOLS.IO.2SYGEFW]; Hollander C, 2007, RESP MED, V101, P1947, DOI 10.1016/j.rmed.2007.04.010; Invernizzi R, 2021, AM J RESP CRIT CARE, V203, P339, DOI 10.1164/rccm.202002-0460OC; Invernizzi R, 2020, IMMUNOLOGY, V160, P171, DOI 10.1111/imm.13195; Invernizzi R, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01519-2019; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lederer DJ, 2018, NEW ENGL J MED, V378, P1811, DOI 10.1056/NEJMra1705751; Lee JS, 2010, AM J MED, V123, P304, DOI 10.1016/j.amjmed.2009.07.033; Leiten EO, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00168-2020; Lin H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17041-7; Molyneaux PL, 2014, AM J RESP CRIT CARE, V190, P906, DOI 10.1164/rccm.201403-0541OC; O'Dwyer DN, 2019, AM J RESP CRIT CARE, V199, P1127, DOI 10.1164/rccm.201809-1650OC; O'Dwyer DN, 2016, J IMMUNOL, V196, P4839, DOI 10.4049/jimmunol.1600279; Parameswaran GI, 2011, CHEST, V140, P611, DOI 10.1378/chest.10-2760; Patini R, 2018, EUR REV MED PHARMACO, V22, P5775, DOI 10.26355/eurrev_201809_15903; Persson LJP, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01328-2016; Pesci A, 2010, RESP MED, V104, pS70, DOI 10.1016/j.rmed.2010.03.019; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schrumpf JA, 2020, J INNATE IMMUN, V12, P74, DOI 10.1159/000497415; Shulgina L, 2013, THORAX, V68, P155, DOI 10.1136/thoraxjnl-2012-202403; Spagnolo P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225618; Sze MA, 2015, AM J RESP CRIT CARE, V192, P438, DOI 10.1164/rccm.201502-0223OC; Takahashi Y, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0736-9; van Wetering S, 2000, J INVEST MED, V48, P359	45	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262082	10.1371/journal.pone.0262082	http://dx.doi.org/10.1371/journal.pone.0262082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990493	Green Published, gold			2022-12-27	WOS:000815783800015
J	Yagoub, U; Saiyed, NS; Al Qahtani, B; Al Zahrani, AM; Birema, Y; Al Hariri, I				Yagoub, Umar; Saiyed, Nasrin S.; Al Qahtani, Bandar; Al Zahrani, Attiya Mohammed; Birema, Yassir; Al Hariri, Ibrahim			Investigating the incidence and risk factors of hypertension: A multicentre retrospective cohort study in Tabuk, Saudi Arabia	PLOS ONE			English	Article							GENDER-DIFFERENCES; ADULTS; PREVALENCE; AWARENESS	Background Hypertension is a major global health concern affecting approximately 1.13 billion people worldwide, with most of them residing in developing countries. The aim of this study was to determine the incidence of different stages of hypertension and its associated modifiable and non-modifiable risk factors among patients in military-setting hospitals in Tabuk, Saudi Arabia. Methods This retrospective cohort study was conducted at two hospitals in Tabuk, Saudi Arabia. The data were collected from hospital electronic records from 1 January 2019 to 31 December 2019. The blood pressure levels of patients from the last three separate medical visits were recorded. Descriptive statistics and multinomial logistic regression were used for the data analysis. Results The study included 884 hypertensive patients. The incidences of stage of elevated BP, stage 1, stage 2, and hypertension crisis were 60.0, 29.5, 7.0, and 3.5 cases per 1000 persons. Multivariate analysis indicated that progression from the stage of elevated blood pressure to hypertension crisis was significantly associated with advanced age (odds ratio [OR] = 3.62, 95% confidence interval [CI] = 1.99-8.42), male sex (OR = 2.84, 95% CI: 0.575.92), and a positive family history of hypertension (OR = 1.95, 95% CI: 1.23-3.09). Other key determinants of the development of stage of elevated blood pressure to hypertension crisis were current smoking status (OR = 1.74, 95% CI: 1.23-4.76), and physical inactivity (OR = 6.48, 95% CI: 2.46-9.14). Conclusion The incidence stage of elevated blood pressure was high among the patients investigated at armed forces hospitals in Tabuk, Saudi Arabia. The logistic regression model proposed in the present study can be used to predict the development of different stages of hypertension. Age, sex, marital status, family history, smoking status, and physical activity play an important role in the development of hypertension. Better strategies to improve awareness, screening, treatment, and management of hypertension are required in Saudi Arabia.	[Yagoub, Umar; Saiyed, Nasrin S.] King Salman Armed Forces Hosp, Res Dept, Tabuk, Saudi Arabia; [Al Qahtani, Bandar] King Salman Armed Forces Hosp, Acad Affairs Dept, Tabuk, Saudi Arabia; [Al Zahrani, Attiya Mohammed] King Salman Armed Forces Hosp, Surg Dept, Tabuk, Saudi Arabia; [Birema, Yassir] King Salman Armed Forces Hosp, Cardiol Dept, Tabuk, Saudi Arabia; [Al Hariri, Ibrahim] King Salman Armed Forces Hosp, Family Med Dept, Tabuk, Saudi Arabia		Yagoub, U (corresponding author), King Salman Armed Forces Hosp, Res Dept, Tabuk, Saudi Arabia.	mohammedumar2001@yahoo.com			Research Unit, Academic Affairs Department, King Salman Armed Forces Hospital Tabuk, Kingdom of Saudi Arabia [KSAFH/AFD/006]	Research Unit, Academic Affairs Department, King Salman Armed Forces Hospital Tabuk, Kingdom of Saudi Arabia	The study was fully funded by Research Unit, Academic Affairs Department, King Salman Armed Forces Hospital Tabuk, Kingdom of Saudi Arabia. Grand no. KSAFH/AFD/006, Dr Attiya Mohammed Al Zahrani.	Abraham I, 2017, J HUM HYPERTENS, V31, P373, DOI 10.1038/jhh.2017.16; Adams J, 2020, J HUM HYPERTENS, V34, P833, DOI 10.1038/s41371-020-0363-z; Ahmed AM, 2017, J SAUDI HEART ASSOC, V29, P235, DOI 10.1016/j.jsha.2017.03.004; Aldhawi MF., 2016, INT J HEALTHCARE SCI, V4, P441; Aldiab A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6216-9; Alnasir FAL., 2008, J BAHRAIN MED SOC, V20, P128; AlWabel AH, 2018, SAUDI J KIDNEY DIS T, V29, P1100, DOI 10.4103/1319-2442.243959; Andriani Putri, 2019, Journal of Physics: Conference Series, V1306, DOI 10.1088/1742-6596/1306/1/012027; Carson AP, 2011, HYPERTENSION, V57, P1101, DOI 10.1161/HYPERTENSIONAHA.110.168005; Devanaganvi AM., 2020, INDIAN J PUBLIC HLTH, V11, P46; Diederichs C, 2017, J HYPERTENS, V35, P250, DOI 10.1097/HJH.0000000000001151; Doumas M, 2013, CURR HYPERTENS REP, V15, P321, DOI 10.1007/s11906-013-0359-y; Everett B, 2015, BIODEMOGR SOC BIOL, V61, P1, DOI 10.1080/19485565.2014.929488; Geldsetzer P, 2019, LANCET, V394, P652, DOI 10.1016/S0140-6736(19)30955-9; Hu LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170238; Ibekwe RU, 2015, ANN MED HEALTH SCI R, V5, P71, DOI 10.4103/2141-9248.149793; Ishikawa Y, 2017, J EPIDEMIOL, V27, P8, DOI 10.1016/j.je.2016.08.001; Kaplan RC., 2020, AM J HYPERTENS; Khanam R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026722; Kjeldsen SE, 2018, PHARMACOL RES, V129, P95, DOI 10.1016/j.phrs.2017.11.003; Liu H, 2014, J HEALTH SOC BEHAV, V55, P403, DOI 10.1177/0022146514556893; Malekzadeh MM, 2013, J HYPERTENS, V31, P1364, DOI 10.1097/HJH.0b013e3283613053; Mohan V, 2020, J DIABETES COMPLICAT, V34, DOI 10.1016/j.jdiacomp.2020.107652; Monaghan TF, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18115669; Prabhakaran D, 2017, INDIAN HEART J, V69, P434, DOI 10.1016/j.ihj.2017.05.021; Ramezankhani A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215593; Reckelhoff JF, 2018, CURR OPIN NEPHROL HY, V27, P176, DOI 10.1097/MNH.0000000000000404; Satoh A, 2017, J HYPERTENS, V35, P401, DOI 10.1097/HJH.0000000000001169; Shahbazian H, 2020, INT J PREVENTIVE MED, V11, DOI 10.4103/ijpvm.IJPVM_474_17; Spronk I, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6820-3; Walther D, 2017, PREV MED, V97, P56, DOI 10.1016/j.ypmed.2016.12.016; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006; Wong CW, 2018, HEART, V104, P1937, DOI 10.1136/heartjnl-2018-313005; Yao FF, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8428-z; Yu ES, 2020, J HYPERTENS, V38, P1755, DOI 10.1097/HJH.0000000000002494	35	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262259	10.1371/journal.pone.0262259	http://dx.doi.org/10.1371/journal.pone.0262259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990492	Green Published, gold			2022-12-27	WOS:000815783800022
J	Feichtinger, X; Heimel, P; Tangl, S; Keibl, C; Nurnberger, S; Schanda, JE; Hercher, D; Kocijan, R; Redl, H; Grillari, J; Fialka, C; Mittermayr, R				Feichtinger, Xaver; Heimel, Patrick; Tangl, Stefan; Keibl, Claudia; Nurnberger, Sylvia; Schanda, Jakob Emanuel; Hercher, David; Kocijan, Roland; Redl, Heinz; Grillari, Johannes; Fialka, Christian; Mittermayr, Rainer			Improved biomechanics in experimental chronic rotator cuff repair after shockwaves is not reflected by bone microarchitecture	PLOS ONE			English	Article							EXTRACORPOREAL SHOCKWAVE; WAVE THERAPY; TENDON; DEGENERATION; IMAGE; PROLIFERATION; OSTEOPOROSIS; EXPRESSION; TISSUES; CELLS	Purpose The aim of this study was to investigate the effect of extracorporeal shockwave therapy (ESWT) on bone microstructure as well as the bone-tendon-interface and the musculo-tendinous transition zone to explain the previously shown improved biomechanics in a degenerative rotator cuff tear animal model. This study hypothesized that biomechanical improvements related to ESWT are a result of improved bone microstructure and muscle tendon properties. Methods In this controlled laboratory study unilateral supraspinatus (SSP) tendon detachment was performed in 48 male Sprague-Dawley rats. After a degeneration period of three weeks, SSP tendon was reconstructed transosseously. Rats were randomly assigned into three groups (n = 16 per group): control (noSW); intraoperative shockwave treatment (IntraSW); intra- and postoperative shockwave treatment (IntraPostSW). Eight weeks after SSP repair, all rats were sacrificed and underwent bone microstructure analysis as well as histological and immunohistochemical analyses. Results With exception of cortical porosity at the tendon area, bone microstructure analyses revealed no significant differences between the three study groups regarding cortical and trabecular bone parameters. Cortical Porosity at the Tendon Area was lowest in the IntraPostSW (p <= 0.05) group. Histological analyses showed well-regenerated muscle and tendon structures in all groups. Immunohistochemistry detected augmented angiogenesis at the musculo-tendinous transition zone in both shockwave groups indicated by CD31 positive stained blood vessels. Conclusion In conclusion, bone microarchitecture changes are not responsible for previously described improved biomechanical results after shockwave treatment in rotator cuff repair in rodents. Immunohistochemical analysis showed neovascularization at the musculo-tendinous transition zone within ESWT-treated animals. Further studies focusing on neovascularization at the musculo-tendinous transition zone are necessary to explain the enhanced biomechanical and functional properties observed previously.	[Feichtinger, Xaver; Heimel, Patrick; Keibl, Claudia; Nurnberger, Sylvia; Schanda, Jakob Emanuel; Hercher, David; Redl, Heinz; Grillari, Johannes; Mittermayr, Rainer] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria; [Feichtinger, Xaver; Schanda, Jakob Emanuel; Fialka, Christian; Mittermayr, Rainer] AUVA Trauma Ctr Vienna Meidling, Vienna, Austria; [Feichtinger, Xaver] Herz Jesu Krankenhaus, Dept Orthopaed Surg 2, Vienna, Austria; [Feichtinger, Xaver; Heimel, Patrick; Tangl, Stefan; Keibl, Claudia; Nurnberger, Sylvia; Schanda, Jakob Emanuel; Hercher, David; Redl, Heinz; Grillari, Johannes; Mittermayr, Rainer] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Heimel, Patrick; Tangl, Stefan] Med Univ Vienna, Univ Clin Dent, Dept Oral Surg, Karl Donath Lab Hard Tissue & Biomat Res, Vienna, Austria; [Nurnberger, Sylvia] Med Univ Vienna, Dept Orthopaed & Trauma Surg, Div Trauma Surg, Vienna, Austria; [Kocijan, Roland] Hanusch Hosp, Med Dept 1, Ludwig Boltzmann Inst Osteol, Vienna, Austria; [Kocijan, Roland; Fialka, Christian; Mittermayr, Rainer] Sigmund Freud Univ, Med Fac, Ctr Musculoskeletal Syst, Vienna, Austria	Ludwig Boltzmann Institute; Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute; WGKK - Hanusch Hospital	Feichtinger, X (corresponding author), Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.; Feichtinger, X (corresponding author), AUVA Trauma Ctr Vienna Meidling, Vienna, Austria.; Feichtinger, X (corresponding author), Herz Jesu Krankenhaus, Dept Orthopaed Surg 2, Vienna, Austria.; Feichtinger, X (corresponding author), Austrian Cluster Tissue Regenerat, Vienna, Austria.	xaver.feichtinger@gmail.com		Hercher, David/0000-0001-5928-9492; Tangl, Stefan/0000-0002-9023-4745	Medical Scientific Fund of the Mayor of the City of Vienna	Medical Scientific Fund of the Mayor of the City of Vienna	This work was supported by the Medical Scientific Fund of the Mayor of the City of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpantaki K, 2005, J BONE JOINT SURG AM, V87A, P1580, DOI 10.2106/JBJS.D.02840; BranEs J, 2012, SHOULDER ELB, V4, P163, DOI [10.1111/j.1758-5740.2012.00178.x, DOI 10.1111/J.1758-5740.2012.00178.X]; Buchmann S, 2011, ARCH ORTHOP TRAUM SU, V131, P429, DOI 10.1007/s00402-010-1246-5; Cheng JH, 2015, INT J SURG, V24, P143, DOI 10.1016/j.ijsu.2015.06.059; Cho NS, 2010, AM J SPORT MED, V38, P664, DOI 10.1177/0363546509350081; Chona DV, 2017, J SHOULDER ELB SURG, V26, P2054, DOI 10.1016/j.jse.2017.07.015; Chow DHK, 2012, AM J SPORT MED, V40, P2862, DOI 10.1177/0363546512461596; Chung SW, 2011, AM J SPORT MED, V39, P2099, DOI 10.1177/0363546511415659; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Dungel P, 2014, LASER SURG MED, V46, P773, DOI 10.1002/lsm.22299; Feichtinger X, 2021, J ORTHOP SURG RES, V16, DOI 10.1186/s13018-021-02394-6; Feichtinger X, 2019, AM J SPORT MED, V47, P2158, DOI 10.1177/0363546519854760; Feichtinger X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22844-2; FRITSCH H, 1989, STAIN TECHNOL, V64, P75, DOI 10.3109/10520298909108049; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Haffner N, 2016, INJURY, V47, P1506, DOI 10.1016/j.injury.2016.04.010; Hausdorf J, 2011, ARCH ORTHOP TRAUM SU, V131, P303, DOI 10.1007/s00402-010-1166-4; Holfeld J, 2014, INFLAMMATION, V37, P65, DOI 10.1007/s10753-013-9712-1; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Juncosa-Melvin N, 2007, TISSUE ENG, V13, P1219, DOI 10.1089/ten.2006.0339; KANNUS P, 1995, J BONE MINER RES, V10, P1263; Killian ML, 2015, AM J SPORT MED, V43, P2401, DOI 10.1177/0363546515596408; Kim HM, 2010, J BONE JOINT SURG AM, V92A, P829, DOI 10.2106/JBJS.H.01746; Kim JY, 2012, KNEE SURG SPORT TR A, V20, P2567, DOI 10.1007/s00167-012-1923-8; Kirchhoff C, 2010, AM J SPORT MED, V38, P564, DOI 10.1177/0363546509354989; Kisch T, 2016, J SURG RES, V201, P440, DOI 10.1016/j.jss.2015.11.049; Meyer DC, 2004, J SHOULDER ELB SURG, V13, P333, DOI 10.1016/j.jse.2003.12.016; Mittermayr R, 2011, ANN SURG, V253, P1024, DOI 10.1097/SLA.0b013e3182121d6e; Moya D, 2018, J BONE JOINT SURG AM, V100, P251, DOI 10.2106/JBJS.17.00661; Notarnicola A, 2018, J BIOL REG HOMEOS AG, V32, P185; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider KH, 2016, ACTA BIOMATER, V29, P125, DOI 10.1016/j.actbio.2015.09.038; Song FL, 2017, CELL PHYSIOL BIOCHEM, V41, P875, DOI 10.1159/000460005; Thomopoulos S, 2002, J ORTHOP RES, V20, P454, DOI 10.1016/S0736-0266(01)00144-9; Trantalis JN, 2008, ARTHROSCOPY, V24, P727, DOI 10.1016/j.arthro.2008.03.009; van der Jagt OP, 2011, J BONE JOINT SURG AM, V93A, P38, DOI 10.2106/JBJS.I.01535; van der Jagt OP, 2009, J ORTHOP RES, V27, P1528, DOI 10.1002/jor.20910; van der Worp H, 2013, KNEE SURG SPORT TR A, V21, P1451, DOI 10.1007/s00167-012-2009-3; Wang CJ, 2007, AM J SPORT MED, V35, P972, DOI 10.1177/0363546506298109; Weihs AM, 2014, J BIOL CHEM, V289, P27090, DOI 10.1074/jbc.M114.580936; Xu TT, 2017, MOL MED REP, V16, P8755, DOI 10.3892/mmr.2017.7735; Yu L, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1404650	46	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262294	10.1371/journal.pone.0262294	http://dx.doi.org/10.1371/journal.pone.0262294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986173	Green Published, gold			2022-12-27	WOS:000765956200036
J	Khan, M; Khan, S; Gondal, MF; Bibi, S; Khan, BT; Majid, A; Khattak, A; Khabir, MN; Anwar, M; Gul, A; Naseem, M; Attaullah, S				Khan, Majid; Khan, Sanaullah; Gondal, Mehrunnisa Fatima; Bibi, Safia; Khan, Bakht Tarin; Majid, Abdul; Khattak, Ayesha; Khabir, Muhammad Nasir; Anwar, Muhammad; Gul, Aisha; Naseem, Maryam; Attaullah, Sobia			Genetic diversity in enhancer II region of HBV genotype D and its association with advanced liver diseases	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CORE PROMOTER MUTATIONS; HEPATOCELLULAR-CARCINOMA; X-GENE; 2ND ENHANCER; TRANSCRIPTION FACTOR; BINDING-SITE; RISK; SUBGENOTYPES; REPLICATION	Background Hepatitis B Virus (HBV) is one of the most common human infectious agents, and the mutations in its genome may cause chronic hepatitis (CH), liver cirrhosis (LC), and hepatocellular carcinoma (HCC). This study was designed to characterize the enhancer-II (Enh-II) region of X gene in HBV positive patients to assess the association of such mutations with CH, LC, and HCC. Methods HBV positive samples (N = 200) with patients' demographic and clinical data were collected from different regions of Khyber Pakhtunkhwa (KP), Pakistan. The Enh-II region of the HBx gene was sequenced and zanalyzed for polymorphism associated with advanced liver disease. Univariate and logistic regression analyses were performed to evaluate potent mutations associated with a risk for LC and HCC. Results HBV Enh-II region sequences analysis revealed 25 different mutations. The highest frequency of mutations S101F (62.2%), A102V/R/G/I (56.25%), M103L/A (68.75%)were found in HCC, followed in LC and CH patients as 57.1%, 42.8%, 28.52% 16%, 15.2% and 18.4% respectively. H94 deletion in the alpha-box of the Enh-II region, associated with a high risk of HCC was found in half of the HCC patients. This deletion was present in 28.5% of LC and 6.5% of CH patients. Importantly, the high frequency of some notable mutations such as E109A/Y, A110S/K, Y111D/E, and F112L was first time reported in the entire study population. The frequencies of these mutations were high in HCC (43.75%, 37.5%, 50% and 43.75% respectively) as compared to LC (14.28%, 14.28%, 28.2% and 42.8%) and CH patients (12.8%, 15.2%, 16.8% and 16% respectively). Conclusion Mutations associated with LC and HCC are prevalent in the Enh-II region in Pakistani HBV isolates. The mutations found are alarming in CH patients as these may progress to LC and HCC in a large number of patients.	[Khan, Majid; Khan, Sanaullah; Khan, Bakht Tarin; Khattak, Ayesha; Khabir, Muhammad Nasir; Anwar, Muhammad; Gul, Aisha; Naseem, Maryam] Univ Peshawar, Dept Zool, Peshawar, Khyber Pakhtunk, Pakistan; [Gondal, Mehrunnisa Fatima; Majid, Abdul] Rural Hlth Ctr Barki, Dist Lahore, Pakistan; [Bibi, Safia] Kohat Univ Sci & Technol Kohat, Dept Zool, Kohat, Khyber Pakhtunk, Pakistan; [Khan, Bakht Tarin] Univ Buner, Dept Zool, Buner, Khyber Pakhtunk, Pakistan; [Attaullah, Sobia] Islamia Coll Peshawar Univ, Dept Zool, Peshawar, Khyber Pakhtunk, Pakistan	University of Peshawar; Kohat University of Science & Technology	Khan, S (corresponding author), Univ Peshawar, Dept Zool, Peshawar, Khyber Pakhtunk, Pakistan.	sanaullahkhan@uop.edu.pk						Al-Qahtani AA, 2017, ONCOTARGET, V8, P105115, DOI 10.18632/oncotarget.22428; De Mitri MS, 2008, GUT, V57, P12, DOI 10.1136/gut.2007.128710; Garmiri P, 2009, J GEN VIROL, V90, P2442, DOI 10.1099/vir.0.012013-0; Gededzha MP, 2018, VIRUS GENES, V54, P190, DOI 10.1007/s11262-018-1536-5; GUO WT, 1993, MOL CELL BIOL, V13, P443, DOI 10.1128/MCB.13.1.443; Hakim ST, 2008, LIBYAN J MED, V3, P66, DOI 10.4176/071123; Hamid AMuzamil., 2018, WORLD J PHARM RES, V7; Ishida H, 2000, J VIROL, V74, P1241, DOI 10.1128/JVI.74.3.1241-1251.2000; JOHNSON JL, 1995, VIROLOGY, V208, P147, DOI 10.1006/viro.1995.1138; Kim H, 2016, WORLD J GASTROENTERO, V22, P5467, DOI 10.3748/wjg.v22.i24.5467; Kyaw YY, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05269-z; Lee JH, 2011, CLIN VACCINE IMMUNOL, V18, P914, DOI 10.1128/CVI.00474-10; Li M, 1995, VIROLOGY, V214, P371, DOI 10.1006/viro.1995.0046; Li M, 1998, J BIOL CHEM, V273, P29022, DOI 10.1074/jbc.273.44.29022; Liao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038394; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Long Y, 2009, J VIRAL HEPATITIS, V16, P537, DOI 10.1111/j.1365-2893.2009.01089.x; LOPEZCABRERA M, 1991, VIROLOGY, V183, P825, DOI 10.1016/0042-6822(91)91019-D; LOPEZCABRERA M, 1990, P NATL ACAD SCI USA, V87, P5069, DOI 10.1073/pnas.87.13.5069; Naito H, 2001, J CLIN MICROBIOL, V39, P362, DOI 10.1128/JCM.39.1.362-364.2001; Noorali S, 2008, J INFECT DEV COUNTR, V2, P373; Pult I, 1997, HEPATOLOGY, V25, P1507, DOI 10.1002/hep.510250633; Qu LS, 2014, HEPATOL RES, V44, P1186, DOI 10.1111/hepr.12291; Raney AK, 1997, J VIROL, V71, P1058, DOI 10.1128/JVI.71.2.1058-1071.1997; Salarnia F, 2017, J CLIN DIAGN RES, V11, pOC31, DOI 10.7860/JCDR/2017/22570.9498; Shi HP, 2013, ASIAN PAC J CANCER P, V14, P1043, DOI 10.7314/APJCP.2013.14.2.1043; Shinkai N, 2007, J CLIN MICROBIOL, V45, P3191, DOI 10.1128/JCM.00411-07; Tanaka Y, 2006, J HEPATOL, V45, P646, DOI 10.1016/j.jhep.2006.06.018; Tong SP, 2016, J HEPATOL, V64, pS4, DOI 10.1016/j.jhep.2016.01.027; Tuteja A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091150; Utama A, 2009, WORLD J GASTROENTERO, V15, P4028, DOI 10.3748/wjg.15.4028; Wang J, 2016, J HEPATOL, V65, P700, DOI 10.1016/j.jhep.2016.05.029; Wang WX, 1998, RES VIROLOGY, V149, P99, DOI 10.1016/S0923-2516(98)80085-X; World Health Organization,, HEP B FACT SHEETS; YUH CH, 1991, MOL CELL BIOL, V11, P5044, DOI 10.1128/MCB.11.10.5044; YUH CH, 1992, J VIROL, V66, P4073, DOI 10.1128/JVI.66.7.4073-4084.1992; YUH CH, 1990, J VIROL, V64, P4281, DOI 10.1128/JVI.64.9.4281-4287.1990; ZHANG P, 1993, J VIROL, V67, P1472, DOI 10.1128/JVI.67.3.1472-1481.1993; Zhao J, 2016, J CANCER, V7, P418, DOI 10.7150/jca.13019; Zhu R, 2008, PATHOL RES PRACT, V204, P731, DOI 10.1016/j.prp.2008.05.001	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0261721	10.1371/journal.pone.0261721	http://dx.doi.org/10.1371/journal.pone.0261721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982798	gold, Green Published			2022-12-27	WOS:000834805700012
J	Slanzon, GS; Ridenhour, BJ; Moore, DA; Sischo, WM; Parrish, LM; Trombetta, SC; McConnel, CS				Slanzon, Giovana S.; Ridenhour, Benjamin J.; Moore, Dale A.; Sischo, William M.; Parrish, Lindsay M.; Trombetta, Sophie C.; McConnel, Craig S.			Fecal microbiome profiles of neonatal dairy calves with varying severities of gastrointestinal disease	PLOS ONE			English	Article							CALF DIARRHEA; BIFIDOBACTERIA; DYSBIOSIS; DIAGNOSIS	Gastrointestinal disease (GI) is the most common illness in pre-weaned dairy calves. Studies have associated the fecal microbiome composition with health status, but it remains unclear how the microbiome changes across different levels of GI disease and breeds. Our objective was to associate the clinical symptoms of GI disease with the fecal microbiome. Fecal samples were collected from calves (n = 167) of different breeds (Holstein, Jersey, Jersey-cross and beef-cross) from 4-21 d of age. Daily clinical evaluations assessed health status. Calves with loose or watery feces were diagnosed with diarrhea and classified as bright-sick (BS) or depressed-sick (DS) according to behavior. Calves with normal or semiformed feces and no clinical illness were classified as healthy (H). One hundred and three fecal samples were obtained from consistently healthy calves and 64 samples were from calves with diarrhea (n = 39 BS; n = 25 DS). The V3-V4 region of 16S rRNA gene was sequenced and analyzed. Differences were identified by a linear-mixed effects model with a negative binomial error. DS and Jersey calves had a higher relative abundance of Streptococcus gallolyticus relative to H Holstein calves. In addition, DS calves had a lower relative abundance of Bifidobacterium longum and an enrichment of Escherichia coli. Species of the genus Lactobacillus, such as an unclassified Lactobacillus, Lactobacillus reuteri, and Lactobacillus salivarius were enriched in calves with GI disease. Moreover, we created a model to predict GI disease based on the fecal microbiome composition. The presence of Eggerthella lenta, Bifidobacterium longum, and Collinsella aerofaciens were associated with a healthy clinical outcome. Although lactobacilli are often associated with beneficial probiotic properties, the presence of E. coli and Lactobacillus species had the highest coefficients positively associated with GI disease prediction. Our results indicate that there are differences in the fecal microbiome of calves associated with GI disease severity and breed specificities.	[Slanzon, Giovana S.; Moore, Dale A.; Sischo, William M.; Parrish, Lindsay M.; Trombetta, Sophie C.; McConnel, Craig S.] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Ridenhour, Benjamin J.] Univ Idaho, Coll Sci, Dept Math & Stat Sci, Moscow, ID 83843 USA	Washington State University; Idaho; University of Idaho	Slanzon, GS (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA.	giovana.slanzon@wsu.edu	Slanzon, Giovana/GQQ-7384-2022; Slanzon, Giovana/F-5136-2017	Slanzon, Giovana/0000-0002-3629-8844; Ridenhour, Benjamin/0000-0001-8271-4629	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2019-68008-29897]; USDA National Institute of Food and Agriculture; Animal Health & Disease Research Capacity Grant project [1014680]; WSU CVM Caldwell Endowment; American Jersey Cattle Association	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Animal Health & Disease Research Capacity Grant project; WSU CVM Caldwell Endowment; American Jersey Cattle Association	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2019-68008-29897 from the USDA National Institute of Food and Agriculture, the USDA National Institute of Food and Agriculture, Animal Health & Disease Research Capacity Grant project 1014680, the WSU CVM Caldwell Endowment, and the American Jersey Cattle Association.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 1995, J DAIRY SCI, V78, P2838, DOI 10.3168/jds.S0022-0302(95)76914-4; Ahl D, 2016, ACTA PHYSIOL, V217, P300, DOI 10.1111/apha.12695; Alipour MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28733-y; Allard G, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0747-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amin N, 2021, COMPUT STRUCT BIOTEC, V19, P989, DOI 10.1016/j.csbj.2021.01.035; Anderson D. C., 2003, Professional Animal Scientist, V19, P399; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Arboleya S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01204; Aust V, 2013, J ANIM PHYSIOL AN N, V97, P1091, DOI 10.1111/jpn.12019; Aw W, 2019, MICROB BIOTECHNOL, V12, P1097, DOI 10.1111/1751-7915.13460; Barden M, 2020, ANIM MICROBIOME, V2, DOI 10.1186/s42523-020-00049-1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergamaschi M, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00888-9; Bharti R, 2021, BRIEF BIOINFORM, V22, P178, DOI 10.1093/bib/bbz155; Boudry G, 2017, J DAIRY SCI, V100, P2471, DOI 10.3168/jds.2016-11890; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Castro JJ, 2016, J DAIRY SCI, V99, P9703, DOI 10.3168/jds.2016-11007; Caswell JL, 2012, VET CLIN N AM-FOOD A, V28, P419, DOI 10.1016/j.cvfa.2012.07.004; Cho YI, 2014, J VET SCI, V15, P1, DOI 10.4142/jvs.2014.15.1.1; Constable PD, 2004, J VET INTERN MED, V18, P8, DOI 10.1892/0891-6640(2004)18&lt;8:AUITTO&gt;2.0.CO;2; Constable PD, 2009, VET CLIN N AM-FOOD A, V25, P101, DOI 10.1016/j.cvfa.2008.10.012; Deelen SM, 2014, J DAIRY SCI, V97, P3838, DOI 10.3168/jds.2014-7939; DeGruttola AK, 2016, INFLAMM BOWEL DIS, V22, P1137, DOI 10.1097/MIB.0000000000000750; Dicksved J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046399; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Dou S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169851; Mokhtari EB, 2021, Arxiv, DOI arXiv:2104.01679; Fernandez S, 2020, BENEF MICROBES, V11, P477, DOI 10.3920/BM2019.0167; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fujiwara S, 1997, APPL ENVIRON MICROB, V63, P506, DOI 10.1128/AEM.63.2.506-512.1997; Gomez DE, 2017, J VET INTERN MED, V31, P928, DOI 10.1111/jvim.14695; Gomez DE, 2019, VET CLIN N AM-FOOD A, V35, P485, DOI 10.1016/j.cvfa.2019.08.002; Guzman CE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74677-7; Hagey JV, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01093; Hennessy M, 2021, J DAIRY SCI, V104, P7225, DOI 10.3168/jds.2020-19108; Hristov S., 2011, Biotechnology in Animal Husbandry, V27, P1417, DOI 10.2298/BAH1104417H; Hulbert LE, 2016, J DAIRY SCI, V99, P3199, DOI 10.3168/jds.2015-10198; Islam M, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.601061; LARSON LL, 1977, J DAIRY SCI, V60, P989, DOI 10.3168/jds.S0022-0302(77)83975-1; Lowe GL, 2019, J DAIRY SCI, V102, P5389, DOI 10.3168/jds.2018-15701; Maidak BL, 1996, NUCLEIC ACIDS RES, V24, P82, DOI 10.1093/nar/24.1.82; Malmuthuge N, 2019, APPL ENVIRON MICROB, V85, DOI [10.1128/AEM.02534-18, 10.1128/aem.02534-18]; Maynou G, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00159; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meganck V, 2015, PREV VET MED, V118, P64, DOI 10.1016/j.prevetmed.2014.11.007; National Center for Biotechnology Information (NCBI), 1988, US; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Okada S, 2018, LARGE ANIM REV, V24, P139; Oultram J, 2015, VET REC, V177, DOI 10.1136/vr.103320; Paz HA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01206; Penati M, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.650150; Pessione E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00086; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rosa F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191599; Sato H, 2010, J VET MED SCI, V72, P1551, DOI 10.1292/jvms.10-0162; Sayers RG, 2016, J DAIRY SCI, V99, P4647, DOI 10.3168/jds.2015-10600; Smith DR, 2012, VET CLIN N AM-FOOD A, V28, P465, DOI 10.1016/j.cvfa.2012.07.010; Uetake K, 2013, ANIM SCI J, V84, P101, DOI 10.1111/asj.12019; USDA, 2017, HLTH MAN PRACT US DA; Waller D.G., 2018, MED PHARM THERAPEUTI, P581, DOI [DOI 10.1016/B978-0-7020-7167-6.00046-4, 10.1016/B978-0-7020-7167-6.00051-8]; Xiao YP, 2017, ASIAN AUSTRAL J ANIM, V30, P1456, DOI 10.5713/ajas.16.0746	63	5	5	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262317	10.1371/journal.pone.0262317	http://dx.doi.org/10.1371/journal.pone.0262317			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982792	gold, Green Published			2022-12-27	WOS:000834805700030
J	Burke, RH; Nyirenda, S; Twabi, H; Nliwasa, M; Joekes, E; Walker, N; Nyirenda, R; Gupta-Wright, A; Fielding, KL; MacPherson, P; Corbett, E				Burke, Rachael H.; Nyirenda, Saulos; Twabi, Hussein; Nliwasa, Marriott; Joekes, Elizabeth; Walker, Naomi; Nyirenda, Rose; Gupta-Wright, Ankur; Fielding, Katherine L.; MacPherson, Peter; Corbett, Elizabeth			Design and protocol for a cluster randomised trial of enhanced diagnostics for tuberculosis screening among people living with HIV in hospital in Malawi (CASTLE study)	PLOS ONE			English	Article								BackgroundPeople living with HIV (PLHIV) have a high risk of death if hospitalised in low-income countries. Tuberculosis has long been the leading cause of admission and death, in part due to suboptimal diagnostics. Two promising new diagnostic tools are digital chest Xray with computer-aided diagnosis (DCXR-CAD) and urine testing with Fujifilm SILVAMP LAM (FujiLAM). Neither test has been rigorously evaluated among inpatients. Test characteristics may be complementary, with FujiLAM especially sensitive for disseminated tuberculosis and DCXR-CAD especially sensitive for pulmonary tuberculosis, making combined interventions of interest. Design and methodsAn exploratory unblinded, single site, two-arm cluster randomised controlled trial, with day of admission as the unit of randomisation. A third, smaller, integrated cohort arm (4:4:1 random allocation) contributes to understanding case-mix, but not trial outcomes. Participants are adults living with HIV not currently on TB treatment. The intervention (DCXR-CAD plus urine FujiLAM plus usual care) is compared to usual care alone. The primary outcome is proportion of participants started on tuberculosis treatment by day 56, with secondary outcomes of mortality (time to event) measured to to 56 days from enrolment, proportions with undiagnosed tuberculosis at death or hospital discharge and comparing proportions with enrolment-day tuberculosis treatment initiation. DiscussionBoth DCXR-CAD and FujiLAM have potential clinical utility and may have complementary diagnostic performance. To our knowledge, this is the first randomised trial to evaluate these tests among hospitalised PLHIV.	[Burke, Rachael H.; Gupta-Wright, Ankur; MacPherson, Peter; Corbett, Elizabeth] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Clin Res Dept, London, England; [Burke, Rachael H.; MacPherson, Peter; Corbett, Elizabeth] Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi; [Nyirenda, Saulos] Zomba Cent Hosp, Malawi Minist Hlth, Zomba, Malawi; [Twabi, Hussein; Nliwasa, Marriott] Kamuzu Univ Hlth Sci, Helse Nord TB Initiat, Blantyre, Malawi; [Joekes, Elizabeth; Walker, Naomi; MacPherson, Peter] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Nyirenda, Rose] Malawi Minist Hlth, Dept HIV AIDS, Lilongwe, Malawi; [Gupta-Wright, Ankur] UCL, Inst Global Hlth, London, England; [Fielding, Katherine L.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Infect Dis Epidemiol Dept, London, England	University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Burke, RH (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Clin Res Dept, London, England.; Burke, RH (corresponding author), Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi.	Rachael.Burke@lshtm.ac.uk	MacPherson, Peter/AHD-2477-2022	MacPherson, Peter/0000-0002-0329-9613; Corbett, Elizabeth/0000-0002-3552-3181; Burke, Rachael/0000-0002-2156-5030; Gupta-Wright, Ankur/0000-0002-5150-2970; Twabi, Hussein/0000-0003-4473-296X	Wellcome, through a Clinical PhD Fellowship [203905/Z/16/Z]	Wellcome, through a Clinical PhD Fellowship	The CASTLE study is funded by Wellcome, through a Clinical PhD Fellowship awarded to RMB (203905/Z/16/Z). The funders will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates M, 2015, LANCET INFECT DIS, V15, P544, DOI 10.1016/S1473-3099(15)70058-7; Bresges C., 2021, OPEN FORUM INFECT DI, V8, DOI [10.1093/ofid/ofab162, DOI 10.1093/OFID/OFAB162]; Broger T, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003113; Broger T, 2019, LANCET INFECT DIS, V19, P852, DOI 10.1016/S1473-3099(19)30001-5; Burke RM, 2021, AIDS, V35, P2191, DOI 10.1097/QAD.0000000000003006; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Ford N, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20714; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Gupta-Wright A, 2018, LANCET, V392, P292, DOI [10.1016/S0140-6736(18)31267-4, 10.1016/s0140-6736(18)31267-4]; Karat AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166158; Lawn SD, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0822-8; MacPherson Peter, 2018, Wellcome Open Res, V3, P61, DOI [10.12688/wellcomeopenres.14598.1, 10.12688/wellcomeopenres.14598.3]; Pande T, 2016, INT J TUBERC LUNG D, V20, P1226, DOI 10.5588/ijtld.15.0926; Peter JG, 2016, LANCET, V387, P1187, DOI 10.1016/S0140-6736(15)01092-2; Qin ZZ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51503-3; UNAIDS, COUNTR FACTSH MAL	17	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0261877	10.1371/journal.pone.0261877	http://dx.doi.org/10.1371/journal.pone.0261877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007306	Green Accepted, Green Published, gold			2022-12-27	WOS:000741060700017
J	Raab, M; Pfadenhauer, LM; Doumbouya, D; Froeschl, G				Raab, Manuel; Pfadenhauer, Lisa M.; Doumbouya, Dansira; Froeschl, Guenter			Clinical presentations, diagnostics, treatments and treatment costs of children and adults with febrile illness in a tertiary referral hospital in south-eastern Guinea: A retrospective longitudinal cohort study	PLOS ONE			English	Article							EBOLA-VIRUS DISEASE; WEST-AFRICA; SYSTEMATIC ANALYSIS; TYPHOID-FEVER; HEALTH; LEPTOSPIROSIS; PREVALENCE; RESISTANCE; CARE	BackgroundFebrile illness is frequent among patients in the tropics. It is caused by a wide variety of common diseases such as malaria or gastrointestinal infections but also by less common but highly contagious pathogens with epidemic potential. This study describes the clinical features of adult and paediatric patients with febrile illness in in the largest tertiary referral hospital in south-eastern Guinea, a region at high risk for viral haemorrhagic fever outbreaks. The study further compares their diagnostic characteristics, treatments and outcomes with non-febrile patients in order to contribute to the local epidemiology of febrile illness. MethodsWe used retrospective data collection to record demographic and clinical data of all incoming patients during a study period of three months. For the follow-up study of inpatients, we retrospectively reviewed patient charts for diagnostic characteristics, diagnoses and outcomes. ResultsOf the 4317 incoming patients during the study period, 9.5% had a febrile illness. The most used diagnostic measures to identify causative agents in febrile patients were point-of-care tests and most treatments relied on antibiotics. Most common discharge diagnoses for febrile inpatients were malaria (9.6% adults, 56.7% children), salmonella gastroenteritis/typhoid (10.6% adults, 7.8% children) and respiratory infection/pneumonia (5.3% adults, 18.7% children). Inpatient mortality for children was significantly higher in febrile than non-febrile children (18.5% vs. 5.1%, p<0.001) and considerably higher in febrile than non-febrile adults (29.8% vs. 25.0%, p = 0.404). ConclusionsMalaria, respiratory infection and gastroenteritis are considered the main causes for febrile illness. The wide reliance on rapid diagnostic tests to diagnose febrile patients not only risks to over- or under-diagnose certain diseases but also leaves the possibility of highly infectious diseases in febrile patients unexplored. Furthermore, the heavy reliance on antibiotics risks to cause antimicrobial resistance. High mortality rates in febrile patients, especially children, should be of concern to public health authorities.	[Raab, Manuel; Froeschl, Guenter] Univ Hosp LMU, Div Infect Dis & Trop Med, Munich, Germany; [Pfadenhauer, Lisa M.] Ludwig Maximilian Univ Munich, Inst Med Informat Biometry & Epidemiol, Pettenkofer Sch Publ Hlth, Munich, Germany; [Doumbouya, Dansira] Paediat Serv, Hopital Reg Nzerekore, Nzerekore, Guinea	University of Munich; University of Munich	Raab, M (corresponding author), Univ Hosp LMU, Div Infect Dis & Trop Med, Munich, Germany.	manuel.j.raab@gmail.com		Raab, Manuel/0000-0002-4247-9588	MeCuM International Scholarship by the Medical Department of the Ludwig-Maximilians-Universitat (LMU), Munich	MeCuM International Scholarship by the Medical Department of the Ludwig-Maximilians-Universitat (LMU), Munich	MR was supported financially through MeCuM International Scholarship by the Medical Department of the Ludwig-Maximilians-Universitat (LMU), Munich. The scholarship covered travel and living expenses during the research period. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhulimhen-Iyoha BI., 2012, NIGER J PAEDIAT, V39; Agence Nationale de Securite Sanitaire (ANSS), 2021, REUN HEBD INF EP; Agua-Agum J, 2016, NEW ENGL J MED, V375, P587, DOI 10.1056/NEJMsr1513109; [Anonymous], INF B EB VIR DIS OUT; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056; Bausch DG, 2001, VECTOR-BORNE ZOONOT, V1, P269, DOI 10.1089/15303660160025903; Bernabe KJ, 2017, INT J ANTIMICROB AG, V50, P629, DOI 10.1016/j.ijantimicag.2017.07.002; Berzosa P, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2481-4; Bisoffi Z, 2013, LANCET GLOB HEALTH, V1, pE11, DOI 10.1016/S2214-109X(13)70013-5; Boozary AS, 2014, JAMA-J AM MED ASSOC, V312, P1859, DOI 10.1001/jama.2014.14387; Butenko A M, 1996, Med Parazitol (Mosk), P40; Camara I., 2020, J PUBLIC HLTH EPIDEM, V12, P318, DOI DOI 10.21203/RS.3.RS-25099/V1; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Crump JA., 2017, MAJOR INFECT DIS, VThird, DOI [10.1596/978-1-4648-0524-0_ch14, DOI 10.1596/978-1-4648-0524-0_CH14]; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Crump JA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4847; de Vries SG, 2014, INT J INFECT DIS, V28, P47, DOI 10.1016/j.ijid.2014.06.013; de Wit E, 2016, EMERG INFECT DIS, V22, P323, DOI 10.3201/eid2202.151656; Endy T., 2020, HUNTERS TROPICAL MED, P325, DOI [10.1016/B978-0-323-55512-8.00036-3, DOI 10.1016/B978-0-323-55512-8.00036-3]; Fairhead J, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-005783; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; Gilson L, 2005, BMJ-BRIT MED J, V331, P762, DOI 10.1136/bmj.331.7519.762; Hartley MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005356; Jentes ES, 2010, AM J TROP MED HYG, V83, P388, DOI 10.4269/ajtmh.2010.09-0688; Kansiime C, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.84.2692; Keita M., 2014, ANN DERMATOL VENER, V141, pS356; Kerneis S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000548; Kim JY, 2013, LANCET, V382, P1060, DOI 10.1016/S0140-6736(13)61047-8; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Leach MA, 2008, SOC SCI MED, V66, P2157, DOI 10.1016/j.socscimed.2008.01.039; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Magassouba N, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12101062; Magombedze G, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3158-0; Mamady K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-436; Mawazo A, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4340-y; Maze MJ, 2018, CLIN MICROBIOL INFEC, V24, P808, DOI 10.1016/j.cmi.2018.02.011; Mfuh KO, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2711-4; Mhalu G, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4030-4; Ministry of Health Guinea., 2013, GUID THER NAT; Naidenova EV., EBOLA VIRUS DIS OUTB; Ohanu ME, 2019, MALAWI MED J, V31, P184, DOI 10.4314/mmj.v31i3.4; Okoroiwu HU, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237313; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Pierce J, 2020, INT J INFECT DIS, V96, P621, DOI 10.1016/j.ijid.2020.05.126; Pigott DM, 2017, LANCET, V390, P2662, DOI 10.1016/S0140-6736(17)32092-5; Prasad N, 2015, AM J TROP MED HYG, V93, P178, DOI 10.4269/ajtmh.14-0646; Prasad N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127962; Raab M, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009487; Raab M, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05573-8; Raab M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8433-2; Racsa LD, 2016, CLIN INFECT DIS, V62, P214, DOI 10.1093/cid/civ792; Rojek A, 2017, LANCET INFECT DIS, V17, pE280, DOI 10.1016/S1473-3099(17)30234-7; Roth E, KEY CONSIDERATIONS 2; Roth E, 2020, VIROLOGIE, V24, P61, DOI 10.1684/vir.2020.0839; Sardan J-POde., 2003, MED CINE INHOSPITALI; Stoler J, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2025-x; Tadesse BT, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2713-1; Tropenmedizin B-N-I fur, 2021, MISS MAD POSS TROTZ; Wasihun AG, 2015, INT J INFECT DIS, V35, P96, DOI 10.1016/j.ijid.2015.04.014; WHO, SENSITIVITY SPECIFIC; World Health Organization, 2016, CLIN MAN PAT VIR HAE; World Health Organization (WHO), IMAI DISTR CLIN MAN; Zimmermann S, 2007, INT J ANTIMICROB AG, V29, pS49, DOI 10.1016/S0924-8579(07)70159-0; Zunt JR, 2018, LANCET NEUROL, V17, P1061, DOI 10.1016/S1474-4422(18)30387-9	67	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262084	10.1371/journal.pone.0262084	http://dx.doi.org/10.1371/journal.pone.0262084			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007283	gold, Green Published, Green Submitted			2022-12-27	WOS:000741060700001
J	Ali, H; Din, JU; Bosso, L; Hameed, S; Kabir, M; Younas, M; Nawaz, MA				Ali, Hussain; Din, Jaffar Ud; Bosso, Luciano; Hameed, Shoaib; Kabir, Muhammad; Younas, Muhammad; Nawaz, Muhammad Ali			Expanding or shrinking? range shifts in wild ungulates under climate change in Pamir-Karakoram mountains, Pakistan	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; HINDU-KUSH; BLUE SHEEP; PSEUDOIS-NAYAUR; SNOW LEOPARD; RIVER-BASIN; DISTRIBUTIONS; CONSERVATION; HIMALAYAS; PREY	Climate change is expected to impact a large number of organisms in many ecosystems, including several threatened mammals. A better understanding of climate impacts on species can make conservation efforts more effective. The Himalayan ibex (Capra ibex sibirica) and blue sheep (Pseudois nayaur) are economically important wild ungulates in northern Pakistan because they are sought-after hunting trophies. However, both species are threatened due to several human-induced factors, and these factors are expected to aggravate under changing climate in the High Himalayas. In this study, we investigated populations of ibex and blue sheep in the Pamir-Karakoram mountains in order to (i) update and validate their geographical distributions through empirical data; (ii) understand range shifts under climate change scenarios; and (iii) predict future habitats to aid long-term conservation planning. Presence records of target species were collected through camera trapping and sightings in the field. We constructed Maximum Entropy (MaxEnt) model on presence record and six key climatic variables to predict the current and future distributions of ibex and blue sheep. Two representative concentration pathways (4.5 and 8.5) and two-time projections (2050 and 2070) were used for future range predictions. Our results indicated that ca. 37% and 9% of the total study area (Gilgit-Baltistan) was suitable under current climatic conditions for Himalayan ibex and blue sheep, respectively. Annual mean precipitation was a key determinant of suitable habitat for both ungulate species. Under changing climate scenarios, both species will lose a significant part of their habitats, particularly in the Himalayan and Hindu Kush ranges. The Pamir-Karakoram ranges will serve as climate refugia for both species. This area shall remain focus of future conservation efforts to protect Pakistan's mountain ungulates.	[Ali, Hussain; Hameed, Shoaib; Kabir, Muhammad] Quaid I Azam Univ, Dept Zool, Islamabad, Pakistan; [Din, Jaffar Ud; Younas, Muhammad] Snow Leopard Trust, Pakistan Program, Islamabad, Pakistan; [Bosso, Luciano] Univ Napoli Federico II, Dipartimento Agr, Wildlife Res Unit, Portici, Italy; [Nawaz, Muhammad Ali] Qatar Univ, Dept Biol & Environm Sci, Environm Sci Program, Doha, Qatar	Quaid I Azam University; University of Naples Federico II; Qatar University	Nawaz, MA (corresponding author), Qatar Univ, Dept Biol & Environm Sci, Environm Sci Program, Doha, Qatar.	nawazma@gmail.com	Nawaz, Muhammad Ali/GQY-8578-2022; Din, Jaffar Ud/D-7748-2017	Nawaz, Muhammad Ali/0000-0001-5632-9014; Bosso, Luciano/0000-0002-9472-3802	Snow Leopard Trust; Pakistan Snow Leopard and Ecosystem Protection Program [9231]	Snow Leopard Trust; Pakistan Snow Leopard and Ecosystem Protection Program	This study received support from the following sources: Snow Leopard Trust (awarded to MAN); and Pakistan Snow Leopard and Ecosystem Protection Program (grant number 9231, awarded to MAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellanas B, 2018, FOREST ECOL MANAG, V424, P136, DOI 10.1016/j.foreco.2018.04.050; Ahlburg DA., 2013, KO IMPACT POPULATION; Ahmad Z, 2012, ENVIRON MONIT ASSESS, V184, P5255, DOI 10.1007/s10661-011-2337-7; Akhtar M, 2008, J HYDROL, V355, P148, DOI 10.1016/j.jhydrol.2008.03.015; Ali H, 2019, ORYX, V53, P329, DOI 10.1017/S0030605317000229; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2015, READING A CAPRA SIBI; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat4858; Archis JN, 2018, PEERJ, V6, DOI 10.7717/peerj.4647; Aryal A, 2016, ECOL EVOL, V6, P4065, DOI 10.1002/ece3.2196; Ashraf A, 2012, GEOMAT NAT HAZ RISK, V3, P113, DOI 10.1080/19475705.2011.615344; Bagchi S, 2004, ANIM CONSERV, V7, P121, DOI 10.1017/S1367943003001148; Bagchi S, 2010, OECOLOGIA, V164, P1075, DOI 10.1007/s00442-010-1690-5; Balakrishnan B., 2018, ENV INFORM SYSTEMS C, P555; Bhattacharya T, 2012, MAMM STUDY, V37, P173, DOI 10.3106/041.037.0302; Bischof R, 2014, J ZOOL, V293, P40, DOI 10.1111/jzo.12100; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Bosso L, 2017, FOREST ECOL MANAG, V400, P655, DOI 10.1016/j.foreco.2017.06.044; Byeon DH, 2018, J ASIA-PAC BIODIVERS, V11, P325, DOI 10.1016/j.japb.2018.06.002; Ciach M, 2018, INT J BIOMETEOROL, V62, P2173, DOI 10.1007/s00484-018-1619-y; Dani Ahmad Hasan, 2001, HIST NO AREAS PAKIST; Dolezal J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24881; Eckstein D, 2017, J GER BONN; El-Gabbas A, 2018, ECOL EVOL, V8, P2196, DOI 10.1002/ece3.3834; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fedosenko Alexander K., 2001, Mammalian Species, V675, P1, DOI 10.1644/1545-1410(2001)675<0001:CS>2.0.CO;2; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Forsythe N, 2017, NAT CLIM CHANGE, V7, P664, DOI 10.1038/NCLIMATE3361; Gomes VHF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18927-1; Hess R., 1997, P239; Hewitt K, 2005, MT RES DEV, V25, P332, DOI 10.1659/0276-4741(2005)025[0332:TKAGEA]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Holt CDS, 2018, ECOL INFORM, V48, P97, DOI 10.1016/j.ecoinf.2018.09.005; Hu JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022873; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; IPCC, 2013, CLIMATE CHANGE 2022; Ishaq S., 2015, Journal of Mountain Area Research, V1, P53; Joshi S, 2013, ENVIRON MANAGE, V52, P639, DOI 10.1007/s00267-013-0062-4; Kabir M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187027; Khan B, 2016, J KING SAUD UNIV SCI, V28, P216, DOI 10.1016/j.jksus.2015.02.007; Khan MZ, 2014, INT J AGRIC BIOL, V16, P1050; Khan N, 2018, WATER-SUI, V10, DOI 10.3390/w10121793; Khattak RH, 2019, PAK J ZOOL; Kulkarni A, 2013, MT RES DEV, V33, P142, DOI 10.1659/MRD-JOURNAL-D-11-00131.1; Kumar P, 2015, GEOPHYS RES LETT, V42, P1818, DOI 10.1002/2015GL063392; Laws AN, 2017, CURR OPIN INSECT SCI, V23, P28, DOI 10.1016/j.cois.2017.06.010; Li J, 2016, BIOL CONSERV, V203, P188, DOI 10.1016/j.biocon.2016.09.026; Looney R, 2012, CONTEMP SOUTH ASIA, V20, P225, DOI 10.1080/09584935.2012.670203; Lu XM, 2016, ARCT ANTARCT ALP RES, V48, P461, DOI 10.1657/AAAR0015-069; Luo ZH, 2015, ECOL APPL, V25, P24, DOI 10.1890/13-1499.1; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Maurer JM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav7266; Mishra C, 2004, J APPL ECOL, V41, P344, DOI 10.1111/j.0021-8901.2004.00885.x; Mohammadi S, 2019, ECOL INFORM, V52, P7, DOI 10.1016/j.ecoinf.2019.04.003; Morelli T.L., 2017, CLIMATE CHANGE RESPO, V4, P8, DOI [10.1186/s40665-017-0036-5, DOI 10.1186/S40665-017-0036-5]; Morelli TL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159909; Murray BD, 2013, ECOLOGY, V94, P1317, DOI 10.1890/12-1582.1; Niittynen P, 2018, ECOGRAPHY, V41, P1024, DOI 10.1111/ecog.03348; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Rehman A., 2015, J EC SUSTAIN DEV, V6, P39; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Roa AL., 2003, NASSD BACKGROUND PAP; Roberts T.J, 1997, MAMMALS PAKISTAN; Salick J, 2014, J ETHNOBIOL, V34, P276, DOI 10.2993/0278-0771-34.3.276; Schaller G. B., 1977, Mountain monarchs. Wild sheep and goats of the Himalaya.; Schaller G.B., 1973, J BOMBAY NAT HIST SO, V69, P523; Schild A, 2008, MT RES DEV, V28, P328, DOI 10.1659/mrd.mp009; Schneider UA, 2011, AGR SYST, V104, P204, DOI 10.1016/j.agsy.2010.11.003; Smeraldo S, 2017, J NAT CONSERV, V37, P12, DOI 10.1016/j.jnc.2017.02.008; Sony RK, 2018, ECOL ENG, V120, P355, DOI 10.1016/j.ecoleng.2018.06.017; Tahir AA, 2015, SCI TOTAL ENVIRON, V505, P748, DOI 10.1016/j.scitotenv.2014.10.065; Tahir AA, 2011, J HYDROL, V409, P104, DOI 10.1016/j.jhydrol.2011.08.035; UHLIG H, 1978, ARCTIC ALPINE RES, V10, P519, DOI 10.2307/1550785; Virk AT., 2003, NASSD BACKGROUND PAP; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; WILSON P, 1981, BIOL CONSERV, V21, P55, DOI 10.1016/0006-3207(81)90068-9; Wiltshire AJ, 2014, CRYOSPHERE, V8, P941, DOI 10.5194/tc-8-941-2014; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; Zain O.F., 2010, PAKISTAN J SOC SCI, V30, P181	88	10	10	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0260031	10.1371/journal.pone.0260031	http://dx.doi.org/10.1371/journal.pone.0260031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972110	gold, Green Published			2022-12-27	WOS:000773555700011
J	Hagabimana, A; Omolo, J; El-Khatib, Z; Rwagasore, E; Benemariya, N; Nsekuye, O; Kabeja, A; Balisanga, H; Umutoni, A; Musafili, A; Ndagijimana, A				Hagabimana, Aphrodis; Omolo, Jared; El-Khatib, Ziad; Rwagasore, Edson; Benemariya, Noella; Nsekuye, Olivier; Kabeja, Adeline; Balisanga, Helene; Umutoni, Angela; Musafili, Aimable; Ndagijimana, Albert			Baseline knowledge and attitudes on COVID-19 among hotels' staff: A cross-sectional study in Kigali, Rwanda	PLOS ONE			English	Article								Background The World Health Organization declared coronavirus disease 2019 (COVID-19) as a global pandemic on the 11(th) of March, 2020. Hotels and other public establishments have been associated with higher transmission rates. Sensitisation of staff and strengthening of Infection Prevention and Control (IPC) practices in such settings are important interventions. This study assessed the baseline knowledge and attitudes on COVID-19 among hotels' representatives in Kigali, Rwanda. Methods A cross-sectional study was conducted among hotels' staff in Kigali in July 2020. A structured questionnaire was self-administered to 104 participants. Baseline knowledge and attitudes were assessed using a number of pre-test questions and mean scores were used to dichotomise the participants' responses as satisfactory or unsatisfactory. Results All of the 104 hotels' staff completed the self-administered questionnaires. Sixty-seven percent (n = 70) were male and 58% (n = 60) were aged between 30 and 44 years. The satisfactory rate of correct answers was 63%2.4 (n = 66) on knowledge and 68%+/- 1.7 (n = 71) on attitudes evaluation. Participants with University education were more likely to have satisfactory knowledge (AOR: 2.6, 95% C.I: 1.07-6.58) than those with secondary education or less. The staff working in the front-office (AOR: 0.05; 95% CI 0.01-0.54) and housekeeping (AOR: 0.09; 95% C.I: 0.01-0.87) were less likely to have satisfactory attitudes than those working in the administration. Conclusions Hotels' staff based in the capital of Rwanda have shown satisfactory knowledge and attitudes regarding appropriate IPC practices for preventing the COVID-19 transmission. Educational interventions are needed to improve their knowledge and attitudes for better prevention in this setting.	[Hagabimana, Aphrodis; Omolo, Jared; Benemariya, Noella; Nsekuye, Olivier; Ndagijimana, Albert] Univ Rwanda, Dept Epidemiol & Biostat, Rwanda Field Epidemiol & Lab Training Program, Kigali, Rwanda; [Hagabimana, Aphrodis] Kigeme Dist Hosp, Kirehe, Rwanda; [El-Khatib, Ziad] Univ Global Hlth Equ, Bill & Joyce Cumming Inst Global Hlth, Kigali, Rwanda; [El-Khatib, Ziad] Karolinska Inst, Dept Global Publ Hlth, Solna, Sweden; [El-Khatib, Ziad] Univ Quebec Abitibi Temiscamingue, World Hlth Programme, Rouyn Noranda, PQ, Canada; [Rwagasore, Edson; Kabeja, Adeline; Balisanga, Helene; Umutoni, Angela] Rwanda Biomed Ctr, Publ Hlth Surveillance & Epidem Response, Kigali, Rwanda; [Musafili, Aimable] Univ Rwanda, Coll Med & Hlth Sci, Sch Med & Pharm, Dept Pediat & Child Hlth, Kigali, Rwanda	University of Rwanda; Karolinska Institutet; University of Quebec; University Quebec Abitibi-Temiscamingue; Rwanda Biomedical Center; University of Rwanda	Hagabimana, A (corresponding author), Univ Rwanda, Dept Epidemiol & Biostat, Rwanda Field Epidemiol & Lab Training Program, Kigali, Rwanda.; Hagabimana, A (corresponding author), Kigeme Dist Hosp, Kirehe, Rwanda.	hagaba01@gmail.com		Nsekuye, Olivier/0000-0002-9238-4691				Adebowale OO, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248189; Ceylan Z, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138817; Ge HP, 2020, EUR J CLIN MICROBIOL, V39, P1011, DOI 10.1007/s10096-020-03874-z; Health W., 2020, OPERATIONAL CONSIDER, V2008, P1, DOI [10.1016/j.jinf.2021.06.018, DOI 10.1016/J.JINF.2021.06.018]; Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798; Krisiunas Edward, 2020, J Diabetes Sci Technol, V14, P748, DOI 10.1177/1932296820930032; Mendez-Brito A, 2021, J INFECTION, V83, P281, DOI 10.1016/j.jinf.2021.06.018; Mirowsky J, 2005, LOND REV EDUC, V3, P205, DOI 10.1080/14748460500372366; Nachega Jean B, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa695; National Institute of Statistics of Rwanda, 2014, RWAND DEM HLTH SURV; Nsanzabaganwa C., 2020, RWANDA PUBLIC HLTH B, V2, P22; Odetokun IA, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8040243; Rwanda Development Board, 2012, RWAND SKILLS SURV 20; Rwanda Development Board, 2020, GUID HOSP SECT BUS R, P1; Rwanda Ministry of Health, 2020, COV 19 CLIN MAN GUID; Rwanda Ministry of Health (MOH), RWAND PUBL HLTH B, V2, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2020, ANTIGEN DETECTION DI; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261744	10.1371/journal.pone.0261744	http://dx.doi.org/10.1371/journal.pone.0261744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972131	Green Published, gold			2022-12-27	WOS:000773555700051
J	Johnson, O; Fronterre, C; Diggle, PJ; Amoah, B; Giorgi, E				Johnson, Olatunji; Fronterre, Claudio; Diggle, Peter J.; Amoah, Benjamin; Giorgi, Emanuele			MBGapp: A Shiny application for teaching model-based geostatistics to population health scientists	PLOS ONE			English	Article								User-friendly interfaces have been increasingly used to facilitate the learning of advanced statistical methodology, especially for students with only minimal statistical training. In this paper, we illustrate the use of MBGapp for teaching geostatistical analysis to population health scientists. Using a case-study on Loa loa infections, we show how MBGapp can be used to teach the different stages of a geostatistical analysis in a more interactive fashion. For wider accessibility and usability, MBGapp is available as an R package and as a Shiny web-application that can be freely accessed on any web browser. In addition to MBGapp, we also present an auxiliary Shiny app, called VariagramApp, that can be used to aid the teaching of Gaussian processes in one and two dimensions using simulations.	[Johnson, Olatunji; Fronterre, Claudio; Diggle, Peter J.; Amoah, Benjamin; Giorgi, Emanuele] Univ Lancaster, Lancaster Med Sch, CHICAS, Lancaster, England; [Johnson, Olatunji] Univ Manchester, Dept Math, Manchester, Lancs, England	Lancaster University; University of Manchester	Johnson, O (corresponding author), Univ Lancaster, Lancaster Med Sch, CHICAS, Lancaster, England.; Johnson, O (corresponding author), Univ Manchester, Dept Math, Manchester, Lancs, England.	olatunjijohnson21111@gmail.com	Fronterre, Claudio/AGW-2090-2022	Fronterre, Claudio/0000-0001-6723-9727; Johnson, Olatunji/0000-0002-4080-0999; Giorgi, Emanuele/0000-0003-0640-181X; Diggle, Peter/0000-0003-3521-5020; Amoah, Benjamin/0000-0002-9650-2704	Coalition for Operational Research on Neglected Tropical Diseases - Bill & Melinda Gates Foundation; United States Agency for International Development through its Neglected Tropical Diseases Program; NTD Modelling Consortium by Bill and Melinda Gates Foundation [OPP1184344]; UK aid from the British people [NTD-SC ID 026.2G]	Coalition for Operational Research on Neglected Tropical Diseases - Bill & Melinda Gates Foundation; United States Agency for International Development through its Neglected Tropical Diseases Program(United States Agency for International Development (USAID)); NTD Modelling Consortium by Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK aid from the British people(CGIAR)	This work received financial support from the Coalition for Operational Research on Neglected Tropical Diseases, which is funded at The Task Force for Global Health 408 primarily by the Bill & Melinda Gates Foundation, by the United States Agency for International Development through its Neglected Tropical Diseases Program, and with UK aid from the British people (YNTD-SC ID 026.2G). This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This work was also supported by funding through the NTD Modelling Consortium (OPP1184344) by Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljraiwi SS., 2017, J ED LEARNING, V6, P132, DOI [10.5539/jel.v6n2p132, DOI 10.5539/JEL.V6N2P132]; Chang W, 2021, SHINY WEB APPL FRAME; Christensen OF, 2004, J COMPUT GRAPH STAT, V13, P702, DOI 10.1198/106186004X2525; Cleveland W., 1992, LOCAL REGRESSION MOD, P608; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Fawcett L, 2018, J STAT EDUC, V26, P2, DOI 10.1080/10691898.2018.1436999; Giorgi E, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2238-0; Giorgi E, 2017, J STAT SOFTW, V78, P1, DOI 10.18637/jss.v078.i08; Matheron G., 1955, ANNAL MINES PARIS, V12, P50; Nicholson J., 2013, TECHNOLOGY INNOVATIO, V7, DOI [10.5070/T572013906, DOI 10.5070/T572013906]; Noma M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-325; Potter G., 2016, TECHNOLOGY INNOVATIO, V9; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7	14	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262145	10.1371/journal.pone.0262145	http://dx.doi.org/10.1371/journal.pone.0262145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972193	Green Published, gold			2022-12-27	WOS:000773555700101
J	Hutajulu, SH; Prabandari, YS; Bintoro, BS; Wiranata, JA; Widiastuti, M; Suryani, ND; Saptari, RG; Taroeno-Hariadi, KW; Kurnianda, J; Purwanto, I; Hardianti, MS; Allsop, MJ				Hutajulu, Susanna Hilda; Prabandari, Yayi Suryo; Bintoro, Bagas Suryo; Wiranata, Juan Adrian; Widiastuti, Mentari; Suryani, Norma Dewi; Saptari, Rorenz Geraldi; Taroeno-Hariadi, Kartika Widayati; Kurnianda, Johan; Purwanto, Ibnu; Hardianti, Mardiah Suci; Allsop, Matthew John			Delays in the presentation and diagnosis of women with breast cancer in Yogyakarta, Indonesia: A retrospective observational study	PLOS ONE			English	Article							SELF-EXAMINATION; AWARENESS; STAGE; REASONS; IMPACT	Purpose To investigate factors associated with delays in presentation and diagnosis of women with confirmed breast cancer (BC). Methods A cross-sectional study nested in an ongoing prospective cohort study of breast cancer patients at Dr Sardjito Hospital, Yogyakarta, Indonesia, was employed. Participants (n = 150) from the main study were recruited, with secondary information on demographic, clinical, and tumor variables collected from the study database. A questionnaire was used to gather data on other socioeconomic variables, herbal consumption, number of healthcare visits, knowledge-attitude-practice of BC, and open-ended questions relating to initial presentation. Presentation delay (time between initial symptom and first consultation) was defined as >= 3 months. Diagnosis delay was defined as >= 1 month between presentation and diagnosis confirmation. Impact on disease stage and determinants of both delays were examined. A Kruskal-Wallis test was used to assess the length and distribution of delays by disease stage. A multivariable logistic regression analysis was conducted to explore the association between delays, cancer stage and factors. Results Sixty-five (43.3%) patients had a >= 3-month presentation delay and 97 (64.7%) had a diagnosis confirmation by >= 1 month. Both presentation and diagnosis delays increased the risk of being diagnosed with cancer stage III-IV (odds ratio/OR 2.21, 95% CI 0.97-5.01, p = 0.059 and OR 3.03, 95% CI 1.28-7.19, p = 0.012). Visit to providers <= 3 times was significantly attributed to a reduced diagnosis delay (OR 0.15, 95% CI 0.06-0.37, p <0.001), while having a family history of cancer was significantly associated with increased diagnosis delay (OR 2.28, 95% CI 1.03-5.04, p = 0.042). The most frequent reasons for delaying presentation were lack of awareness of the cause of symptoms (41.5%), low perceived severity (27.7%) and fear of surgery intervention (26.2%). Conclusions Almost half of BC patients in our setting had a delay in presentation and 64.7% experienced a delay in diagnosis. These delays increased the likelihood of presentation with a more advanced stage of disease. Future research is required in Indonesia to explore the feasibility of evidence-based approaches to reducing delays at both levels, including educational interventions to increase awareness of BC symptoms and reducing existing complex and convoluted referral pathways for patients suspected of having cancer.	[Hutajulu, Susanna Hilda; Taroeno-Hariadi, Kartika Widayati; Kurnianda, Johan; Purwanto, Ibnu; Hardianti, Mardiah Suci] Univ Gadjah Mada, Dr Sardjito Gen Hosp, Div Hematol & Med Oncol, Dept Internal Med,Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia; [Prabandari, Yayi Suryo; Bintoro, Bagas Suryo] Univ Gadjah Mada, Dept Hlth Behav Environm & Social Med, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia; [Prabandari, Yayi Suryo; Bintoro, Bagas Suryo; Widiastuti, Mentari] Univ Gadjah Mada, Ctr Hlth Behav & Promot, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia; [Wiranata, Juan Adrian] Univ Gadjah Mada, Med Internship Program, Acad Hosp, Yogyakarta, Indonesia; [Suryani, Norma Dewi] Dr Sardjito Hosp, Div Hematol & Med Oncol, Dept Internal Med, Yogyakarta, Indonesia; [Saptari, Rorenz Geraldi] Univ Gadjah Mada, Med Study Program, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia; [Allsop, Matthew John] Univ Leeds, Leeds Inst Hlth Sci, Sch Med, Fac Med & Hlth, Leeds, W Yorkshire, England	Gadjah Mada University; Gadjah Mada University; Gadjah Mada University; Gadjah Mada University; Central General Hospital Dr. Sardjito; Gadjah Mada University; University of Leeds	Hutajulu, SH (corresponding author), Univ Gadjah Mada, Dr Sardjito Gen Hosp, Div Hematol & Med Oncol, Dept Internal Med,Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia.	susanna.hutajulu@ugm.ac.id	Kurnianda, Johan/GOV-3648-2022; hardianti, mardiah/GOP-2427-2022; Bintoro, Bagas Suryo/GLV-5743-2022; Purwanto, Ibnu/GOV-4298-2022; Hutajulu, Susanna Hilda/GPP-6026-2022; Taroeno-Hariadi, Kartika/AHD-4364-2022	hardianti, mardiah/0000-0002-5360-6693; Widiastuti, Mentari/0000-0003-4888-5488; Allsop, Matthew/0000-0002-7399-0194	Kementrian Riset, Teknologi dan Pendidikan Tinggi Republik Indonesia; Universitas Gadjah Mada; University of Leeds	Kementrian Riset, Teknologi dan Pendidikan Tinggi Republik Indonesia; Universitas Gadjah Mada; University of Leeds	SHH received funding from Kementrian Riset, Teknologi dan Pendidikan Tinggi Republik Indonesia (ID) (2018) and Universitas Gadjah Mada (2021). MJA received funding from University of Leeds (2019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agustina R, 2019, LANCET, V393, P75, DOI 10.1016/S0140-6736(18)31647-7; Albeshan SM, 2020, CLIN BREAST CANCER, V20, P194, DOI 10.1016/j.clbc.2020.02.001; Anastasi N, 2019, J HEALTH PSYCHOL, V24, P113, DOI 10.1177/1359105317697812; Anwar SL, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4125-z; Anwar SL, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0724-3; Aryandono T, 2018, ASIAN J PHARM CLIN R, P284; Badan Penelitian dan Pengembangan Kesehatan, LAP NAS RISK 2018; Badan Pusat Statistik Provinsi D.I. Yogyakarta, JUML PEND MEN KAB KO; Bish A, 2005, J PSYCHOSOM RES, V58, P321, DOI 10.1016/j.jpsychores.2004.10.007; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Brzozowska A, 2014, GINEKOL POL, V85, P14; Cancer Research UK, 2011, BREAST MOD CANC AW M; Caplan L, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00087; Chen W, 2015, FACTORS MODIFY BREAS; Delilovic S, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4413-6; Dewi TK, 2021, PSYCHOL HEALTH, V36, P1427, DOI 10.1080/08870446.2020.1841765; Dianatinasab M, 2018, CLIN BREAST CANCER, V18, P239, DOI 10.1016/j.clbc.2017.09.005; Djatmiko A., 2013, INDONESIAN J CANC, V7, P47; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ermiah Eramah, 2012, BMC Res Notes, V5, P452, DOI 10.1186/1756-0500-5-452; Foroozani E., 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Harirchi I, 2005, PUBLIC HEALTH, V119, P885, DOI 10.1016/j.puhe.2004.11.005; Iskandarsyah A, 2014, HEALTH PSYCHOL, V33, P214, DOI 10.1037/a0031060; Jassem J, 2014, EUR J PUBLIC HEALTH, V24, P761, DOI 10.1093/eurpub/ckt131; Jogja Cancer Registry, 2020, LAP DAT REG KANK BER; Khan Ayesha, 2018, J Ayub Med Coll Abbottabad, V30, P558; Li YL, 2019, CANCER RES TREAT, V51, P1098, DOI 10.4143/crt.2018.386; Lim JNW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009863; Memon ZA, 2013, ASIAN PAC J CANCER P, V14, P7409, DOI 10.7314/APJCP.2013.14.12.7409; Norsa'adah B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-141; Norwegian Directorate of Health, 2015, NASJONAL PLAN IMPLEM; Otieno E S, 2010, East Afr Med J, V87, P147; Ozmen V, 2015, EUR J PUBLIC HEALTH, V25, P9, DOI 10.1093/eurpub/cku086; Pace LE, 2015, ONCOLOGIST, V20, P780, DOI 10.1634/theoncologist.2014-0493; Partridge AH, 2012, ONCOLOGIST, V17, P775, DOI 10.1634/theoncologist.2011-0469; Poum A, 2014, J EPIDEMIOL, V24, P102, DOI 10.2188/jea.JE20130090; Probst HB, 2012, HEALTH POLICY, V105, P65, DOI 10.1016/j.healthpol.2011.11.001; Ruddy KJ, 2014, CANCER-AM CANCER SOC, V120, P20, DOI 10.1002/cncr.28287; Scheel JR, 2020, CANCER-AM CANCER SOC, V126, P2469, DOI 10.1002/cncr.32890; Schliemann D, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4769-8; Sinaga ES, 2018, PAN AFR MED J, V31, DOI 10.11604/pamj.2018.31.163.17284; Solikhah Solikhah, 2019, Asian Pac J Cancer Prev, V20, P877, DOI 10.31557/APJCP.2019.20.3.877; Strauss J WF., 2016, RAND; Wahyuni AS, 2002, ANALISIS KETAHANAN H, DOI [10.1016/s0035-9203(02)90117-3, DOI 10.1016/S0035-9203(02)90117-3]; Wati W., 2019, Indonesian Journal of Medicine, V4, P105, DOI 10.26911/theijmed.2019.04.02.04; World Health Organization, 2018, GLOBAL CANC OBSERVAT; Yau T. K., 2010, Hong Kong Medical Journal, V16, P373	47	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262468	10.1371/journal.pone.0262468	http://dx.doi.org/10.1371/journal.pone.0262468			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025941	Green Published, gold			2022-12-27	WOS:000796264200073
J	LaCourse, SM; Seko, E; Wood, R; Bundi, W; Ouma, GS; Agaya, J; Richardson, BA; John-Stewart, G; Wandiga, S; Cangelosi, GA				LaCourse, Sylvia M.; Seko, Evans; Wood, Rachel; Bundi, Wilfred; Ouma, Gregory S.; Agaya, Janet; Richardson, Barbra A.; John-Stewart, Grace; Wandiga, Steve; Cangelosi, Gerard A.			Diagnostic performance of oral swabs for non-sputum based TB diagnosis in a TB/HIV endemic setting	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MTB/RIF ULTRA	Objective We evaluated diagnostic performance of oral swab analysis (OSA) for tuberculosis (TB) in a high HIV/TB burden setting in Kenya. Methods In this cross-sectional study, buccal swabs and sputum were collected from 100 participants with suspected TB in outpatient clinics in Kenya at enrollment and subsequent morning visits. Buccal swabs underwent IS6110-targeted qPCR analysis. Sputum was evaluated by Xpert MTB/RIF (Xpert) and culture. Diagnostic performance of OSA for TB diagnosis was evaluated relative to a combined reference of sputum Xpert and culture. Results Among 100 participants, 54% were living with HIV (PLHIV). Twenty percent (20/100) of participants had confirmed TB (19/20 [95%] culture-positive, 17/20 [85%] Xpert-positive). Overall buccal swab sensitivity was 65.0% (95% CI 40.8-84.6%) vs. sputum Xpert/culture and 76.5% (95% CI 50.1-93.2%) vs. sputum Xpert alone. Specificity was 81.3% (95% CI 71.0-89.1%) and 81.9% (95% CI 72.0-89.5%) compared to sputum Xpert/culture and Xpert alone, respectively. Sensitivity among PLHIV (n = 54) with suspected TB was 83.3% (95% CI 35.9-99.6%) vs. sputum Xpert/culture and 100% (95% CI 47.8-100.0%) vs. sputum Xpert alone. Among participants with TB, mean OSA threshold quantitation cycle (Cq) value was lower (stronger signal) at subsequent morning compared to enrolment visit (33.4 SD 3.7 vs. 35.2 SD +/- 2.9, p = 0.009). Conclusions In this pilot study, results confirm M. tuberculosis DNA is detectable in oral swabs including among PLHIV with fair diagnostic performance. Further work is needed to optimize OSA and evaluate its utility in diverse settings.	[LaCourse, Sylvia M.; John-Stewart, Grace] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [LaCourse, Sylvia M.; Richardson, Barbra A.; John-Stewart, Grace; Cangelosi, Gerard A.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Seko, Evans; Bundi, Wilfred; Ouma, Gregory S.; Agaya, Janet; Wandiga, Steve] Kenya Med Res Inst KEMRI, Kisumu, Kenya; [Wood, Rachel; Cangelosi, Gerard A.] Univ Washington, Dept Environm & Occupat Hlth, Seattle, WA 98195 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [John-Stewart, Grace; Cangelosi, Gerard A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [John-Stewart, Grace] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	LaCourse, SM (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA.; LaCourse, SM (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	sylvial2@uw.edu			National Institute of Allergy and Infectious Diseases (NIAID); University of Washington/Fred Hutch Center for AIDS Research (CFAR) [NIH/NIAID K23AI120793]; CFAR New Investigator Award [AI027757]; NIH/NIAID [R01AI139254]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington/Fred Hutch Center for AIDS Research (CFAR); CFAR New Investigator Award; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institute of Allergy and Infectious Diseases (NIAID), and the University of Washington/Fred Hutch Center for AIDS Research (CFAR) (NIH/NIAID K23AI120793 and CFAR New Investigator Award AI027757 to SML, NIH/NIAID R01AI139254 to GAC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the design, collection of data, data analysis, and interpretation or decision to submit the manuscript to this journal.	[Anonymous], 2011, GUID INT TUB CAS FIN; Datta S, 2017, LANCET GLOB HEALTH, V5, pE760, DOI 10.1016/S2214-109X(17)30201-2; Denkinger CM, 2015, J INFECT DIS, V211, pS29, DOI 10.1093/infdis/jiu821; Dorman SE, 2018, LANCET INFECT DIS, V18, P76, DOI [10.1016/S1473-3099(17)30691-6, 10.1016/s1473-3099(17)30691-6]; Horne DJ, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub4; Joint United Nations Programme on HIV/AIDS, 2015, GLOBAL REPORT UNAIDS; Kenya Ministry of Health, KEN TUB SURV 2017; Lima F, 2020, J CLIN TUBER OTH MYC, V19, DOI 10.1016/j.jctube.2020.100148; Luabeya AK, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01847-18; Modi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167685; Nicol MP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47302-5; Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803; Song YH, 2021, INFECT DRUG RESIST, V14, P89, DOI 10.2147/IDR.S284157; Wood RC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251422; Wood RC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08668; World Health Organization (WHO), 2019, TUBERCULOSIS; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262123	10.1371/journal.pone.0262123	http://dx.doi.org/10.1371/journal.pone.0262123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025930	Green Published, gold			2022-12-27	WOS:000796264200047
J	Urbina, JUM; Farias, GG; Ramirez, LLR; Gonzalez, DIR				Marquez Urbina, Jose Ulises; Gonzalez Farias, Graciela; Ramirez Ramirez, L. Leticia; Rodriguez Gonzalez, D. Ivan			A multi-source global-local model for epidemic management	PLOS ONE			English	Article								The Effective Reproduction Number R-t provides essential information for the management of an epidemic/pandemic. Projecting R-t into the future could further assist in the management process. This article proposes a methodology based on exposure scenarios to perform such a procedure. The method utilizes a compartmental model and its adequate parametrization; a way to determine suitable parameters for this model in Mexico's case is detailed. In conjunction with the compartmental model, the projection of R-t permits estimating unobserved variables, such as the size of the asymptomatic population, and projecting into the future other relevant variables, like the active hospitalizations, using scenarios. The uses of the proposed methodologies are exemplified by analyzing the pandemic in a Mexican state; the main quantities derived from the compartmental model, such as the active and total cases, are included in the analysis. This article also presents a national summary based on the methodologies to illustrate how these procedures could be further exploited. The supporting information includes an application of the proposed methods to a metropolitan area to show that it also works well at other demographic disaggregation levels. The procedures developed in this article shed light on how to develop an effective surveillance system when information is incomplete and can be applied in cases other than Mexico's.	[Marquez Urbina, Jose Ulises] CIMAT, Unidad Monterrey, Monterrey, NL, Mexico; [Marquez Urbina, Jose Ulises] Consejo Nacl Ciencia & Technol, Mexico City, DF, Mexico; [Gonzalez Farias, Graciela; Ramirez Ramirez, L. Leticia] CIMAT, Probabil & Stat, Guanajuato, Gto, Mexico; [Rodriguez Gonzalez, D. Ivan] CIMAT, Dept Technol Serv, Guanajuato, Gto, Mexico	CIMAT - Centro de Investigacion en Matematicas; CIMAT - Centro de Investigacion en Matematicas	Ramirez, LLR (corresponding author), CIMAT, Probabil & Stat, Guanajuato, Gto, Mexico.	leticia.ramirez@cimat.mx	Márquez Urbina, José Ulises/GYD-5174-2022	Gonzalez Farias, Graciela/0000-0001-7434-500X; Marquez Urbina, Jose Ulises/0000-0003-2630-7599	 [20429 INEGI]		JUMU, LLRR, GGF, DIRG All authors were awarded with the partial support of the grant: Proyecto No. 20429 INEGI.	Ali ST, 2020, SCIENCE, V369, P1106, DOI 10.1126/science.abc9004; [Anonymous], 2020, TANGLE; [Anonymous], 2020, FINANC TIMES; [Anonymous], 2020, THE ECONOMIST; [Anonymous], INFORMACION REFERENT; [Anonymous], ANUARIO MORBILIDAD 1; ARINO J., 2003, MATH POPUL STUD, V10, P175, DOI DOI 10.1080/08898480306720; Badr HS, 2021, LANCET INFECT DIS, V21, pE113, DOI 10.1016/S1473-3099(20)30861-6; Badr HS, 2020, LANCET INFECT DIS, V20, P1247, DOI 10.1016/S1473-3099(20)30553-3; Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Bichara D, 2018, J MATH BIOL, V77, P107, DOI 10.1007/s00285-017-1191-9; Bichara D, 2015, B MATH BIOL, V77, P2004, DOI 10.1007/s11538-015-0113-5; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Britton T, 2020, STAT NEERL, V74, P222, DOI 10.1111/stan.12203; Buckman SR, 2020, INFECT DIS MODEL, V5, P635, DOI 10.1016/j.idm.2020.08.007; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; CONAPO, 2020, PROYEC POBL MUN MEX; Contreras S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20699-8; Contreras S, 2020, CHAOS SOLITON FRACT, V136, DOI 10.1016/j.chaos.2020.109925; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI [10.1101/2020.02.19.20025452, 10.3201/eid2606.200357]; Dutta R, 2018, P ROY SOC A-MATH PHY, V474, DOI 10.1098/rspa.2018.0129; Espinoza B, 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0235731, 10.1371/journal.pone.0235731.r001, 10.1371/journal.pone.0235731.r002, 10.1371/journal.pone.0235731.r003, 10.1371/journal.pone.0235731.r004]; EuroMomo, 2020, EUR MORT MON; Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108; Google, 2020, COVID 19 COMM MOB RE; Graff M., 2022, COMPUT GEOSCI-UK, V159, DOI 10.1016Zj.cageo.2021.105012; INEGI, 2021, MORT; INEGI, 2021, CENS POBL VIV; Institute for Health Metrics and Evaluation (IHME), 2021, EV COVID 19 VACC EFF; Khinda J, 2021, J MED VIROL, V93, P1078, DOI 10.1002/jmv.26411; Lyra W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237627; Mexico's Secretariat of Health, 2021, SIST INF RED IRAG; Myllymaki M, 2017, J R STAT SOC B, V79, P381, DOI 10.1111/rssb.12172; Petrova T, 2020, ESTIMATION TIME DEPE; Siegenfeld AF, 2020, COMMUN PHYS-UK, V3, DOI 10.1038/s42005-020-00470-7; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Systrom K., 2020, ESTIMATING COVID 19; Tillett RL, 2021, LANCET INFECT DIS, V21, P52, DOI 10.1016/S1473-3099(20)30764-7; Wang B, 2020, PHYS REV E, V102, DOI 10.1103/PhysRevE.102.062306; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Yin Q, 2020, APPL MATH COMPUT, V386, DOI 10.1016/j.amc.2020.125517; Young BE., 2020, CLIN INFECT DIS OFFI	44	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261650	10.1371/journal.pone.0261650	http://dx.doi.org/10.1371/journal.pone.0261650			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020745	gold, Green Published			2022-12-27	WOS:000834207700020
J	Carrignon, S; Bentley, RA; Silk, M; Fefferman, NH				Carrignon, Simon; Bentley, R. Alexander; Silk, Matthew; Fefferman, Nina H.			How social learning shapes the efficacy of preventative health behaviors in an outbreak	PLOS ONE			English	Article							DISCRETE-CHOICE; BINARY CHOICE; DIFFUSION; IDENTIFICATION; PERSISTENCE; KNOWLEDGE; NETWORKS; COVID-19; INSIGHTS; MODELS	The global pandemic of COVID-19 revealed the dynamic heterogeneity in how individuals respond to infection risks, government orders, and community-specific social norms. Here we demonstrate how both individual observation and social learning are likely to shape behavioral, and therefore epidemiological, dynamics over time. Efforts to delay and reduce infections can compromise their own success, especially when disease risk and social learning interact within sub-populations, as when people observe others who are (a) infected and/or (b) socially distancing to protect themselves from infection. Simulating socially-learning agents who observe effects of a contagious virus, our modelling results are consistent with with 2020 data on mask-wearing in the U.S. and also concur with general observations of cohort induced differences in reactions to public health recommendations. We show how shifting reliance on types of learning affect the course of an outbreak, and could therefore factor into policy-based interventions incorporating age-based cohort differences in response behavior.	[Carrignon, Simon; Bentley, R. Alexander] Univ Tennessee, Dept Anthropol, Knoxville, TN 37996 USA; [Carrignon, Simon; Bentley, R. Alexander] Univ Tennessee, Ctr Dynam Social Complex DySoC, Knoxville, TN 37996 USA; [Silk, Matthew] Univ Exeter, Ctr Ecol & Conservat, Exeter, Devon, England; [Fefferman, Nina H.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Fefferman, Nina H.] Univ Tennessee, Dept Math, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Exeter; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Carrignon, S (corresponding author), Univ Tennessee, Dept Anthropol, Knoxville, TN 37996 USA.; Carrignon, S (corresponding author), Univ Tennessee, Ctr Dynam Social Complex DySoC, Knoxville, TN 37996 USA.	scarrign@utk.edu	Bentley, R Alexander/GWZ-8982-2022	Bentley, R. Alexander/0000-0001-9086-2197; Carrignon, Simon/0000-0002-4416-1389; Silk, Matthew/0000-0002-8318-5383	NSF [2028710]	NSF(National Science Foundation (NSF))	This material is based upon work supported by the NSF under award #2028710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcidiacono P, 2011, ANNU REV ECON, V3, P363, DOI 10.1146/annurev-economics-111809-125038; Banerjee A, 2013, SCIENCE, V341, P363, DOI 10.1126/science.1236498; Bansal Shweta, 2010, Journal of Biological Dynamics, V4, P478, DOI 10.1080/17513758.2010.503376; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Becker J, 2017, P NATL ACAD SCI USA, V114, pE5070, DOI 10.1073/pnas.1615978114; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Bentley A, 2011, SIMPLICITY-DES TECHN, P1; Bentley RA, 2014, BEHAV BRAIN SCI, V37, P63, DOI 10.1017/S0140525X13000289; Blume LE, 2015, J POLIT ECON, V123, P444, DOI 10.1086/679496; Brock W.A., 2001, HDB ECONOMETRICS, V5, P3297, DOI DOI 10.1016/S1573-4412(01)05007-3; Brock WA, 2001, REV ECON STUD, V68, P235, DOI 10.1111/1467-937X.00168; Brock WA, 2007, J ECONOMETRICS, V140, P52, DOI 10.1016/j.jeconom.2006.09.002; Brock WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111022; Caiado CCS, 2016, J THEOR BIOL, V405, P5, DOI 10.1016/j.jtbi.2015.12.013; Centola D, 2013, CIRCULATION, V127, P2135, DOI 10.1161/CIRCULATIONAHA.112.101816; Cheung BY, 2011, PSYCHOL SCI, V22, P147, DOI 10.1177/0956797610394661; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Donker T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000715; E.Bendavid, 2020, medRxiv, DOI 10.1101/2020.05.23.20111419; Fineberg HV, 2013, JAMA-J AM MED ASSOC, V310, P85, DOI 10.1001/jama.2013.7518; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gharzai LA, 2020, ADV RADIAT ONCOL, V5, P679, DOI 10.1016/j.adro.2020.04.009; Gibson MA, 2015, EVOL ANTHROPOL, V24, P3, DOI 10.1002/evan.21432; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Greene H., 2003, ECONOMETRIC ANAL; Greenstone M., 2020, DOES SOCIAL DISTANCI; Guiteras R, 2015, SCIENCE, V348, P903, DOI 10.1126/science.aaa0491; Hauser OP, 2014, NATURE, V511, P220, DOI 10.1038/nature13530; Henrich J, 2001, AM ANTHROPOL, V103, P992, DOI 10.1525/aa.2001.103.4.992; Hogset H, 2010, ECON DEV CULT CHANGE, V58, P563, DOI 10.1086/650424; Hoppitt W., 2013, SOCIAL LEARNING INTR, DOI DOI 10.23943/PRINCETON/9780691150703.001.0001/UPSO-9780691150703; House BR, 2013, P NATL ACAD SCI USA, V110, P14586, DOI 10.1073/pnas.1221217110; Hyndman RJ, 1996, AM STAT, V50, P120, DOI 10.2307/2684423; Inglehart RF, 2008, WEST EUR POLIT, V31, P130, DOI 10.1080/01402380701834747; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Jennings MK, 1996, PUBLIC OPIN QUART, V60, P228, DOI 10.1086/297749; Kang SJ, 2020, INFECT CHEMOTHER, V52, P154, DOI 10.3947/ic.2020.52.2.154; KEINAN G, 1987, J PERS SOC PSYCHOL, V52, P639, DOI 10.1037/0022-3514.52.3.639; Kendal RL, 2018, TRENDS COGN SCI, V22, P651, DOI 10.1016/j.tics.2018.04.003; Knoll LJ, 2017, J ADOLESCENCE, V60, P53, DOI 10.1016/j.adolescence.2017.07.002; Kronbichler A, 2020, INT J INFECT DIS, V98, P180, DOI 10.1016/j.ijid.2020.06.052; Lavela Sherri L, 2012, Top Spinal Cord Inj Rehabil, V18, P306, DOI 10.1310/sci1804-306; Lerman K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147617; Li J, 2009, J APPL ECONOMET, V24, P257, DOI 10.1002/jae.1035; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Maharaj S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-679; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Marchant R, 2020, ARXIV PREPRINT ARXIV; McAdams D, 2021, ANNU REV ECON, V13, P539, DOI 10.1146/annurev-economics-082120-122900; McKelvey R. D., 1998, Experimental Economics, V1, P9, DOI 10.1023/A:1009905800005; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Miller D., 1992, BUS HORIZONS, V35, P24, DOI 10.1016/0007-6813(92)90112-M; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; Pedro SA, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.574514; R Development Core Team, 2018, LANG ENV STAT COMP; Rendell L, 2011, PHILOS T R SOC B, V366, P1118, DOI 10.1098/rstb.2010.0376; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Rogers E.M., 1995, DIFFUSION INNOVATION, V4th; Ruck DJ, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.190725; Ruck DJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8680; Ruck DJ, 2021, EARLY WARNING VULNER; Russell Timothy W, 2020, Euro Surveill, V25, DOI 10.2807/1560-7917.ES.2020.25.12.2000256; Sanger-Katz, 2020, NEW YORK TIMES; Schrock JM, 2020, EVOL HUM BEHAV, V41, P44, DOI 10.1016/j.evolhumbehav.2019.09.002; Sears DO, 1999, J POLIT, V61, P1, DOI 10.2307/2647773; Surian D, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6045; Tizzoni M, 2020, PLOS COMPUT BIOL, V16, DOI [10.1371/journal.pcbi.1007633, 10.1371/journal.pcbi.1007633.r001, 10.1371/journal.pcbi.1007633.r002, 10.1371/journal.pcbi.1007633.r003, 10.1371/journal.pcbi.1007633.r004]; Toxvaerd F., 2020, CAMBRIDGE WORKING PA, DOI DOI 10.17863/CAM.52489; Trueblood J., 2020, TALE 2 CRISES FINANC; TULJAPURKAR S, 1991, SCIENCE, V254, P591, DOI 10.1126/science.254.5031.591; Verelst F, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0820; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Weaver JB, 2010, AM J PUBLIC HEALTH, V100, P1520, DOI 10.2105/AJPH.2009.180521; Weitz JS, 2020, P NATL ACAD SCI USA, V117, P32764, DOI 10.1073/pnas.2009911117; Weng LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02522; World Health Organization, 2020, 64 WHO; Yamey G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1643; Young HP, 2009, AM ECON REV, V99, P1899, DOI 10.1257/aer.99.5.1899; Zhang JW, 2019, ANNU REV SOCIOL, V45, P91, DOI 10.1146/annurev-soc-073117-041421	83	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262505	10.1371/journal.pone.0262505	http://dx.doi.org/10.1371/journal.pone.0262505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015794	gold, Green Published			2022-12-27	WOS:000814820600029
J	Gyorffy, Z; Bekasi, S; Dobrossy, B; Bognar, VK; Rado, N; Morva, E; Zsigri, S; Tari, P; Girasek, E				Gyorffy, Zsuzsa; Bekasi, Sandor; Dobrossy, Bence; Bognar, Virag Katalin; Rado, Nora; Morva, Emilia; Zsigri, Szabolcs; Tari, Peter; Girasek, Edmond			Exploratory attitude survey of homeless persons regarding telecare services in shelters providing mid- and long-term accommodation: The importance of trust	PLOS ONE			English	Article							HEALTH-CARE; OLDER; PEOPLE; ACCESS; SYSTEM; ADULTS	Background With the expansion of digital health, it is imperative to consider intervention techniques in order not to be the cause of even more social health inequalities in underserved populations struggling with chronic diseases. Telemedicine solutions for homeless persons might compensate for shortcomings in access to valuable health services in different settings. The main aim of our research was to examine the attitudes and openness of homeless persons regarding telecare on a Hungarian sample. Methods Quantitative survey among homeless people (n = 98) was completed in 4 shelters providing mid- and long-term accommodation in Budapest, Hungary. Attitudes regarding healthcare service accessibility and telecare were measured by a self-developed questionnaire of the research team. Telecare attitude comparison was made with data of a Hungarian weighted reference group of non-homeless persons recruited from 2 primary care units (n = 110). Results A significant fraction of homeless people with mid- or long-term residency in homeless shelters did not oppose the use of telecare via live online video consultation and there was no difference compared to the national reference group (averages of 3.09 vs. 3.15, respectively). Results of the homeless group indicate that those more satisfied with healthcare services, in general, manifest more openness to telecare. It is clearly demonstrated by the multivariate analysis that those participants in the homeless group who had problems getting health care in the last year definitely preferred in-person doctor-patient consultations. Conclusion Digital health technologies offer a potentially important new pathway for the prevention and treatment of chronic conditions among homeless persons. Based on the attitudes towards telecare, initiating an on-site telecare program for mid- and long-term residents of homeless shelters might enable better care continuity. Our results draw attention to the key factors including building trust in the implementation of such programs among underserved and other vulnerable patient groups.	[Gyorffy, Zsuzsa; Dobrossy, Bence; Bognar, Virag Katalin; Rado, Nora; Girasek, Edmond] Semmelweis Univ, Fac Med, Inst Behav Sci, Budapest, Hungary; [Bekasi, Sandor] Hungarian Char Serv Order Malta, Hlth Ctr, Budapest, Hungary; [Bekasi, Sandor] FitPuli Kft, Telemed Workgrp, Gyor, Hungary; [Morva, Emilia] Hungarian Char Serv Order Malta, Reg Directorate, Budapest, Hungary; [Zsigri, Szabolcs] Zsigri Haziorvosi Kft, Budapest, Hungary; [Tari, Peter] Ciprus 2007 Kft, Budapest, Hungary	Semmelweis University	Gyorffy, Z (corresponding author), Semmelweis Univ, Fac Med, Inst Behav Sci, Budapest, Hungary.	gyorffy.zsuzsanna@med.semmelweis-univ.hu		Dobrossy, Bence/0000-0002-1937-1528; Rado, Nora/0000-0001-8814-4487	National Research, Development and Innovation Office [OTKA-FK 134372]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	The research project was supported by the National Research, Development and Innovation Office (OTKA-FK 134372).	Adjekum A, 2018, J MED INTERNET RES, V20, DOI 10.2196/11254; [Anonymous], 2014, INT ACC HOUS IND GRE; Asan O, 2020, J MED INTERNET RES, V22, DOI 10.2196/15154; Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Baptista I, 2019, FIGHTING HOMELESSNES; Benyei Z., 2018, 6 HAJL KTALAN ADATFE; Brown RT, 2012, J GEN INTERN MED, V27, P16, DOI 10.1007/s11606-011-1848-9; Byrnes M., 2016, INT J COMMUNITCATION, V8, P45; Calvo F, 2019, COGENT PSYCHOL, V6, DOI 10.1080/23311908.2019.1631583; Calvo F, 2019, J MENT HEALTH, V28, P505, DOI 10.1080/09638237.2019.1608927; de Veer AJE, 2018, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-018-0368-3; Fajardo-Bullon F, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7380-2; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; FEANTSA, ETHOS EUR TYP HOM HO; FEANTSA, 2017, HOMELESS IN EUROPE, P1; Gabrielian S, 2013, MED CARE, V51, pS44, DOI 10.1097/MLR.0b013e31827808f6; Garibaldi B, 2005, J GEN INTERN MED, V20, P726, DOI 10.1111/j.1525-1497.2005.0142.x; Heflin KJ, 2020, J AMBUL CARE MANAG, V43, P308, DOI 10.1097/JAC.0000000000000352; Hurstak E, 2017, DRUG ALCOHOL DEPEN, V178, P562, DOI 10.1016/j.drugalcdep.2017.06.002; Koh HK, 2016, JAMA-J AM MED ASSOC, V316, P2586, DOI 10.1001/jama.2016.18760; Martins DC, 2008, PUBLIC HEALTH NURS, V25, P420, DOI 10.1111/j.1525-1446.2008.00726.x; McAuley A, 2014, PUBLIC HEALTH, V128, P1118, DOI 10.1016/j.puhe.2014.10.008; McInnes DK, 2013, AM J PUBLIC HEALTH, V103, pE11, DOI 10.2105/AJPH.2013.301623; Parker S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019192; Pribish A, 2019, J COMMUN HEALTH, V44, P249, DOI 10.1007/s10900-018-0580-3; Rakosy Z., 2018, DEMOGR FIA, V61; Reed ME, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5873; Roncero C, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113252; Shahid K, 2012, TELEMED E-HEALTH, V18, P95, DOI 10.1089/tmj.2011.0067; Stefancic A, 2013, AM J PUBLIC HEALTH, V103, pS206, DOI 10.2105/AJPH.2013.301606; Wagner J, 2014, HEALTH SOC CARE COMM, V22, P300, DOI 10.1111/hsc.12083; White BM, 2015, J PRIM CARE COMMUNIT, V6, P77, DOI 10.1177/2150131914556122; Wood SM, 2020, J ADOLESCENT HEALTH, V67, P172, DOI 10.1016/j.jadohealth.2020.05.025; World Health Organization, 2020, GLOB STRAT DIG HLTH	34	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261145	10.1371/journal.pone.0261145	http://dx.doi.org/10.1371/journal.pone.0261145			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990458	gold, Green Published			2022-12-27	WOS:000815783800006
J	Maruyama, M; Furukawa, Y; Kinoshita, M; Mukaiyama, A; Akiyama, S; Yoshimura, T				Maruyama, Michiyo; Furukawa, Yuko; Kinoshita, Masato; Mukaiyama, Atsushi; Akiyama, Shuji; Yoshimura, Takashi			Adenylate kinase 1 overexpression increases locomotor activity in medaka fish	PLOS ONE			English	Article							EXPRESSION; HEART	Maintenance of the energy balance is indispensable for cell survival and function. Adenylate kinase (Ak) is a ubiquitous enzyme highly conserved among many organisms. Ak plays an essential role in energy regulation by maintaining adenine nucleotide homeostasis in cells. However, its role at the whole organism level, especially in animal behavior, remains unclear. Here, we established a model using medaka fish (Oryzias latipes) to examine the function of Ak in environmental adaptation. Medaka overexpressing the major Ak isoform Ak1 exhibited increased locomotor activity compared to that of the wild type. Interestingly, this increase was temperature dependent. Our findings suggest that cellular energy balance can modulate locomotor activity.	[Maruyama, Michiyo; Yoshimura, Takashi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Integrat Physiol, Nagoya, Aichi, Japan; [Maruyama, Michiyo; Furukawa, Yuko; Yoshimura, Takashi] Nagoya Univ, Inst Transformat BioMol WPI ITbM, Nagoya, Aichi, Japan; [Kinoshita, Masato] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto, Japan; [Mukaiyama, Atsushi; Akiyama, Shuji] Natl Inst Nat Sci, Inst Mol Sci, Res Ctr Integrat Mol Syst CIMoS, Okazaki, Aichi, Japan; [Mukaiyama, Atsushi; Akiyama, Shuji] SOKENDAI Grad Univ Adv Studies, Dept Funct Mol Sci, Okazaki, Aichi, Japan	Nagoya University; Nagoya University; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan	Yoshimura, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Integrat Physiol, Nagoya, Aichi, Japan.; Yoshimura, T (corresponding author), Nagoya Univ, Inst Transformat BioMol WPI ITbM, Nagoya, Aichi, Japan.	takashiy@agr.nagoya-u.ac.jp		Maruyama, Michiyo/0000-0002-8821-5756; Mukaiyama, Atsushi/0000-0002-6736-631X; AKIYAMA, Shuji/0000-0002-7184-189X	JSPS KAKENHI [19H05643]; Sasakawa Scientific Research Grant from The Japan Science Society	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sasakawa Scientific Research Grant from The Japan Science Society	This work was supported by a JSPS KAKENHI "Grant-in-Aid for Scientific Research (S)" (19H05643) for T.Y. and the Sasakawa Scientific Research Grant from The Japan Science Society for M.M. There was no additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaszczyk JW., 2020, METABOLITES, P1, DOI [10.3390/metabo11010001, DOI 10.3390/METABO11010001]; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Dzeja PP, 2007, J BIOL CHEM, V282, P31366, DOI 10.1074/jbc.M705268200; Fontinha BM, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001012; Fukamachi S, 2009, GENE, V442, P81, DOI 10.1016/j.gene.2009.04.010; Horiguchi T, 2020, J MED INVESTIG, V67, P51, DOI 10.2152/jmi.67.51; Ionescu MI, 2019, PROTEIN J, V38, P120, DOI 10.1007/s10930-019-09811-0; Janssen E, 2000, EMBO J, V19, P6371, DOI 10.1093/emboj/19.23.6371; Klepinin A, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00660; Nakayama T, 2020, P NATL ACAD SCI USA, V117, P9594, DOI 10.1073/pnas.2000278117; Nakayama T, 2019, NAT ECOL EVOL, V3, P845, DOI 10.1038/s41559-019-0866-6; Olson LK, 1996, J BIOL CHEM, V271, P16544, DOI 10.1074/jbc.271.28.16544; Panayiotou C, 2014, INT J BIOCHEM CELL B, V49, P75, DOI 10.1016/j.biocel.2014.01.014; Pucar D, 2000, J BIOL CHEM, V275, P41424, DOI 10.1074/jbc.M007903200; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Schnorr SJ, 2012, BEHAV BRAIN RES, V228, P367, DOI 10.1016/j.bbr.2011.12.016; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Xie MY, 2020, BIOL REPROD, V103, P1121, DOI 10.1093/biolre/ioaa134	20	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0257967	10.1371/journal.pone.0257967	http://dx.doi.org/10.1371/journal.pone.0257967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982774	Green Submitted, gold, Green Published			2022-12-27	WOS:000834805700001
J	Young-Xu, Y; Smith, J; Nealon, J; Mahmud, SM; Van Aalst, R; Thommes, EW; Neupane, N; Lee, JKH; Chit, A				Young-Xu, Yinong; Smith, Jeremy; Nealon, Joshua; Mahmud, Salaheddin M.; Van Aalst, Robertus; Thommes, Edward W.; Neupane, Nabin; Lee, Jason K. H.; Chit, Ayman			Influenza vaccine in chronic obstructive pulmonary disease among elderly male veterans	PLOS ONE			English	Article							MORTALITY BENEFITS; PEOPLE; RISK; HOSPITALIZATIONS	Background Prior studies have established those elderly patients with chronic obstructive pulmonary disease (COPD) are at elevated risk for developing influenza-associated complications such as hospitalization, intensive-care admission, and death. This study sought to determine whether influenza vaccination could improve survival among elderly patients with COPD. Materials/Methods This study included Veterans (age >= 65 years) diagnosed with COPD that received care at the United States Veterans Health Administration (VHA) during four influenza seasons, from 2012-2013 to 2015-2016. We linked VHA electronic medical records and Medicare administrative files to Centers for Disease Control and Prevention National Death Index cause of death records as well as influenza surveillance data. A multivariable time-dependent Cox proportional hazards model was used to compare rates of mortality of recipients of influenza vaccination to those who did not have records of influenza vaccination. We estimated hazard ratios (HRs) adjusted for age, gender, race, socioeconomic status, comorbidities, and healthcare utilization. Results Over a span of four influenza seasons, we included 1,856,970 person-seasons of observation where 1,199,275 (65%) had a record of influenza vaccination and 657,695 (35%) did not have a record of influenza vaccination. After adjusting for comorbidities, demographic and socioeconomic characteristics, influenza vaccination was associated with reduced risk of death during the most severe periods of influenza seasons: 75% all-cause (HR = 0.25; 95% CI: 0.24-0.26), 76% respiratory causes (HR = 0.24; 95% CI: 0.21-0.26), and 82% pneumonia/influenza cause (HR = 0.18; 95% CI: 0.13-0.26). A significant part of the effect could be attributed to "healthy vaccinee" bias as reduced risk of mortality was also found during the periods when there was no influenza activity and before patients received vaccination: 30% all-cause (HR = 0.70; 95% CI: 0.65-0.75), 32% respiratory causes (HR = 0.68; 95% CI: 0.60-0.78), and 51% pneumonia/influenza cause (HR = 0.49; 95% CI: 0.31-0.78). However, as a falsification study, we found that influenza vaccination had no impact on hospitalization due to urinary tract infection (HR = 0.97; 95% CI: 0.80-1.18). Conclusions Among elderly patients with COPD, influenza vaccination was associated with reduced risk for all-cause and cause-specific mortality.	[Young-Xu, Yinong; Smith, Jeremy; Neupane, Nabin] Vet Affairs Med Ctr, Clin Epidemiol Program, White River Jct, VT 05009 USA; [Young-Xu, Yinong] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH 03755 USA; [Nealon, Joshua] Sanofi Pasteur, Med Evidence Generat, Lyon, France; [Mahmud, Salaheddin M.] Univ Manitoba, Coll Med, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Van Aalst, Robertus] Univ Groningen, Fac Med Sci, Groningen, Netherlands; [Van Aalst, Robertus; Thommes, Edward W.; Chit, Ayman] Sanofi Pasteur, Swiftwater, PA USA; [Thommes, Edward W.] Univ Guelph, Dept Math & Stat, Guelph, ON, Canada; [Lee, Jason K. H.; Chit, Ayman] Univ Toronto, Leslie & Sch Pharm, Toronto, ON, Canada; [Lee, Jason K. H.] Sanofi Pasteur, Toronto, ON, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); Dartmouth College; Sanofi-Aventis; Sanofi France; University of Manitoba; University of Groningen; Sanofi-Aventis; University of Guelph; University of Toronto; Sanofi-Aventis	Young-Xu, Y (corresponding author), Vet Affairs Med Ctr, Clin Epidemiol Program, White River Jct, VT 05009 USA.; Young-Xu, Y (corresponding author), Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH 03755 USA.	Yinong.Young-Xu@va.gov		Lee, Jason/0000-0001-8875-607X; van Aalst, Robertus/0000-0003-3025-7811	Sanofi Pasteur	Sanofi Pasteur	Funding Statement: YYX, JS, and NN report having received grant funds from Sanofi Pasteur that were awarded to the Veterans Education and Research Association of Northern New England Inc. The funder provided support in the form of salaries for authors JN, RVA, EWT, JKL, and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], OV INFL SURV US; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Campitelli MA, 2010, VACCINE, V29, P240, DOI 10.1016/j.vaccine.2010.10.049; cdc.gov, US; cms.gov, **DROPPED REF**; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; healthquality.va.gov, **DROPPED REF**; Huang HH, 2019, J MICROBIOL IMMUNOL, V52, P22, DOI 10.1016/j.jmii.2017.08.014; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Man William D-C, 2015, ERJ Open Res, V1; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Mulpuru S, 2019, CHEST, V155, P69, DOI 10.1016/j.chest.2018.10.044; National Center for Health Statistics, 2013, NAT DEATH IND US GUI; Olubowale OT, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004966; Petersen LA, 2010, HEALTH SERV RES, V45, P762, DOI 10.1111/j.1475-6773.2010.01107.x; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Simonsen L, 2009, VACCINE, V27, P6300, DOI 10.1016/j.vaccine.2009.07.008; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; va.gov, **DROPPED REF**; World Health Organization, 2017, VACCINES BIOL; World Health Organization, 2003, 56 WORLD HLTH ASS RE; Young-Xu Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169344	27	0	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262072	10.1371/journal.pone.0262072	http://dx.doi.org/10.1371/journal.pone.0262072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982781	gold, Green Published			2022-12-27	WOS:000834805700015
J	Zawadzka, A; Janczewska, A; Kobus-Cisowska, J; Dziedzinski, M; Siwulski, M; Czarniecka-Skubina, E; Stuper-Szablewska, K				Zawadzka, Agnieszka; Janczewska, Anna; Kobus-Cisowska, Joanna; Dziedzinski, Marcin; Siwulski, Marek; Czarniecka-Skubina, Ewa; Stuper-Szablewska, Kinga			The effect of light conditions on the content of selected active ingredients in anatomical parts of the oyster mushroom (Pleurotus ostreatus L.)	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; EDIBLE MUSHROOMS; GROWTH	This study aimed to evaluate the effect of cultivation conditions in the context of light on the retention of selected vitamins, minerals and polyphenols in the stem and cap of the oyster mushroom (Pleurotus ostreatus L.). Additionally, the effect of the retention of bioactive components on the antioxidant activity of mushroom extracts was evaluated, taking into account the morphological part. Oyster mushrooms grown in the light of 200 lux had higher riboflavin content compared to mushrooms exposed to the light of lower intensity. The thiamine content of the mushrooms dropped with decreasing light intensity during cultivation. The content of biologically active compounds was found to be equal in the stem and the cap. In the case of riboflavin, it was shown that its contents in cap fractions, irrespective of the cultivation method, was statistically significantly higher than in stems. The mineral composition of caps and stems differed from each other. No differences in Zn and Cu content between the morphological parts of the mushroom studied were found. However, it was shown that the stems, regardless of the type of light, contained less iron, magnesium and sodium. Thus, it was observed that limited light exposure caused an increase in the content of total polyphenolic compounds, which did not correlate with antioxidant activity. There was no effect of the light on the antioxidant activity of mushrooms. It was also shown that stem extracts had higher antioxidant activity compared to the extracts obtained from the caps. This findings point to the possibility and potentail of use both fraction of mushrooms in the new food products development.	[Zawadzka, Agnieszka; Janczewska, Anna; Kobus-Cisowska, Joanna; Dziedzinski, Marcin] Poznan Univ Life Sci, Dept Gastron Sci & Funct Foods, Poznan, Poland; [Siwulski, Marek] Poznan Univ Life Sci, Dept Vegetable Crops, Poznan, Poland; [Czarniecka-Skubina, Ewa] Warsaw Univ Life Sci, Dept Food Gastron & Food Hyg, Warsaw, Poland; [Stuper-Szablewska, Kinga] Poznan Univ Life Sci, Dept Chem, Poznan, Poland	Poznan University of Life Sciences; Poznan University of Life Sciences; Warsaw University of Life Sciences; Poznan University of Life Sciences	Kobus-Cisowska, J (corresponding author), Poznan Univ Life Sci, Dept Gastron Sci & Funct Foods, Poznan, Poland.	joanna.kobus-cisowska@up.poznan.pl	Dziedziński, Marcin/AAK-4211-2020; Czarniecka-Skubina, Ewa/L-8758-2019	Czarniecka-Skubina, Ewa/0000-0001-6557-5436; Dziedzinski, Marcin/0000-0003-1069-0095; Stuper-Szablewska, Kinga/0000-0002-9011-8592	Ministry of Education and Science (MEiN) [DWD/4/44/2020]; Poznan University of Life Sciences (UPP) [DWD/4/44/2020]	Ministry of Education and Science (MEiN); Poznan University of Life Sciences (UPP)	The publication was co-financed within the agreement between Ministry of Education and Science (MEiN) and Poznan University of Life Sciences (UPP), grant number DWD/4/44/2020 from 23.11.2020r. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Monem NM, 2020, BIOCHEM BIOPHYS REP, V24, DOI 10.1016/j.bbrep.2020.100852; Augustin J., 2007, BOCZNIAK OSTRYGOWATY, P170; Bernas E, 2006, ACTA SCI POLON-TECHN, V5, P5; Bolaniran Tolulope, 2021, Transactions of the Royal Society of South Africa, V76, DOI 10.1080/0035919X.2021.1947921; Cheung LM, 2003, FOOD CHEM, V81, P249, DOI 10.1016/S0308-8146(02)00419-3; Das AK, 2021, MOLECULES, V26, DOI 10.3390/molecules26092463; Espinosa-Paez E, 2021, LWT-FOOD SCI TECHNOL, V148, DOI 10.1016/j.lwt.2021.111727; Ferreira ICFR, 2009, CURR MED CHEM, V16, P1543, DOI 10.2174/092986709787909587; Fogarasi M, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10121972; Girmay Z, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0265-1; Gonzalez A, 2020, FOOD FUNCT, V11, P7400, DOI 10.1039/d0fo01746a; jun Jang myoung, 2014, [Journal of Mushrooms, 한국버섯학회지], V12, P258, DOI 10.14480/JM.2014.12.4.258; Kobus-Cisowska J, 2020, CIENC RURAL, V50, DOI 10.1590/0103-8478cr20190371; Kulczynski B, 2016, ACTA SCI POLON-TECHN, V15, P267, DOI 10.17306/J.AFS.2016.3.26; Mahari WAW, 2020, J HAZARD MATER, V400, DOI 10.1016/j.jhazmat.2020.123156; Manthou E, 2019, LWT-FOOD SCI TECHNOL, V111, P506, DOI 10.1016/j.lwt.2019.05.062; Muszynska B., 2015, MEDICINA INTERNACIA, V26, P146; Panek M, 2019, MYCOL PROG, V18, P1173, DOI 10.1007/s11557-019-01515-0; Salata A, 2018, ACTA SCI POL-HORTORU, V17, P185, DOI 10.24326/asphc.2018.2.16; Sarikurkcu C, 2008, BIORESOURCE TECHNOL, V99, P6651, DOI 10.1016/j.biortech.2007.11.062; Sarma D., 2018, J PHARMACOGN PHYTOCH, V7, P2694; Wu CY, 2016, INT J MED MUSHROOMS, V18, P589, DOI 10.1615/IntJMedMushrooms.v18.i7.40; YUSEF HM, 1967, MYCOPATH MYCOL APPL, V33, P81, DOI 10.1007/BF02053439; Zhou S, 2016, FUNGAL BIOL-UK, V120, P852, DOI 10.1016/j.funbio.2016.03.007	24	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262279	10.1371/journal.pone.0262279	http://dx.doi.org/10.1371/journal.pone.0262279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982785	Green Published, gold			2022-12-27	WOS:000834805700026
J	Rajbanshi, S; Norhayati, MN; Hazlina, NHN				Rajbanshi, Sushma; Norhayati, Mohd Noor; Hazlina, Nik Hussain Nik			Severe maternal morbidity and its associated factors: A cross-sectional study in Morang district, Nepal	PLOS ONE			English	Article							NEAR-MISS; RISK-FACTORS; PREVALENCE; PREGNANCY; MORTALITY	Background Understanding maternal morbidity and its determinants can help identify opportunities to prevent obstetric complications and improvements for maternal health. This study was conducted to determine the prevalence of severe maternal morbidity (SMM) and the associated factors. Methods A hospital-based cross-sectional study was conducted at Koshi Hospital, Nepal, from January to March 2020. All women who met the inclusion criteria of age >= 18 years of age, Morang residents of Nepalese nationality, had received routine antenatal care, and given birth at Koshi Hospital were recruited consecutively. The World Health Organization criteria were used to identify the women with SMM. A multiple logistic regression analysis was performed. Overall, 346 women were recruited. Findings The prevalence of SMM was 6.6%. Among the SMM cases, the most frequently occurring SMM conditions were hypertensive disorders (12, 56.5%), hemorrhagic disorders (6, 26.1%), and severe management indicators (8, 34.8%). Women with no or primary education (adjusted odds ratio: 0.10, 95% confidence interval: 0.01, 0.76) decreased the odds of SMM compared to secondary education. Conclusion The approximately 7% prevalence of SMM correlated with global studies. Maternal education was significantly associated with SMM. If referral hospitals were aware of the expected prevalence of potentially life-threatening maternal conditions, they could plan to avert future reproductive complications.	[Rajbanshi, Sushma; Hazlina, Nik Hussain Nik] Univ Sains Malaysia, Womens Hlth Dev Unit, Sch Med Sci, Kubang Kerian, Malaysia; [Norhayati, Mohd Noor] Univ Sains Malaysia, Sch Med Sci, Dept Family Med, Kubang Kerian, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Norhayati, MN (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Family Med, Kubang Kerian, Malaysia.	hayatikk@usm.my	Nik Hussain, Nik Hazlina/G-5453-2015; Norhayati, Mohd Noor/E-3868-2012	Nik Hussain, Nik Hazlina/0000-0002-9476-062X; Norhayati, Mohd Noor/0000-0002-6372-1476	Universiti Sains Malaysia Graduate Development Incentive Grant [311/PPSP/4404808]	Universiti Sains Malaysia Graduate Development Incentive Grant	This research was funded by the Universiti Sains Malaysia Graduate Development Incentive Grant 311/PPSP/4404808. The funder had no role in the study design, data collection, analysis, decision to publish, or manuscript preparation.	Abdollahpour S, 2019, HEALTH PROMOT PERSPE, V9, P255, DOI 10.15171/hpp.2019.35; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Al Jama FE, 2012, J REPROD MED, V57, P53; Bai J, 2002, AM J OBSTET GYNECOL, V186, P274, DOI 10.1067/mob.2002.119639; Bajagain R., 2016, JKMC, V5, P44; de Lima THB, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2381-9; Bennett L., 2008, CASTE ETHNIC REGIONA; Callaghan WM, 2014, OBSTET GYNECOL, V123, P978, DOI 10.1097/AOG.0000000000000218; Camargo RS, 2011, INT J GYNECOL OBSTET, V112, P88, DOI 10.1016/j.ijgo.2010.08.013; Pacheco AJC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-91; Dessalegn FN, 2020, J PREGNANCY, V2020, DOI 10.1155/2020/6029160; Easter SR, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.06.025; England N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233697; Fry K., 2014, MEASURING EQUITY NAT; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Geller SE, 2004, AM J OBSTET GYNECOL, V191, P939, DOI 10.1016/j.ajog.2004.05.099; Geller SE, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0527-2; Gibson Crystal, 2017, WMJ, V116, P215; Giordano JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097401; Gray KE, 2012, PAEDIATR PERINAT EP, V26, P506, DOI 10.1111/ppe.12011; Grobman WA, 2014, OBSTET GYNECOL, V123, P804, DOI 10.1097/AOG.0000000000000173; Gupta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101893; Hitti J, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.07.002; Karlsen S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-606; Kayem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029077; Galvao LPL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-25; Lima HMP, 2017, INT J GYNECOL OBSTET, V136, P337, DOI 10.1002/ijgo.12077; Liyew EF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179013; Lotufo FA, 2012, CLINICS, V67, P225, DOI 10.6061/clinics/2012(03)04; Madeiro AP, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0648-3; Mekango DE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183886; Mgaya AH, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-241; Ministry of General Affairs and General Administration, 2017, LOC GOV OP ACT 2074; Ministry of Health Nepal; New ERA; ICF, 2017, NEP DEM HLTH SURV 20; Moodley J, 2011, CARDIOVASC J AFR, V22, P31, DOI CVJ-21.026; Morais LR., 2020, MATERNAL NEAR MISS P; Morang District Health Office, 2019, 207407520172018 MIN; Mustafa R, 2009, JCPSP-J COLL PHYSICI, V19, P781, DOI 12.2009/JCPSP.781785; Naderi Tayebeh, 2015, Int J Reprod Med, V2015, P914713, DOI 10.1155/2015/914713; Nakimuli A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1001-1; Nam JY, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2820-7; Nansubuga E, 2016, INT J GYNECOL OBSTET, V135, P214, DOI 10.1016/j.ijgo.2016.05.009; Norhayati MN, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0980-2; Norhayati MN, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2895-2; Ochako R, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-1; Oliveira FC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-77; Papiernik E, 1997, J PERINAT MED, V25, P139, DOI 10.1515/jpme.1997.25.2.139; Rajbanshi S, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-04018-7; Rajbanshi S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18115801; Rana A, 2013, J NEPAL MED ASSOC, V52, P299; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Sayinzoga F, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1581-4; Shen FR, 2013, INT J GYNECOL OBSTET, V123, P64, DOI 10.1016/j.ijgo.2013.06.011; Shrestha N S, 2010, Kathmandu Univ Med J (KUMJ), V8, P222; Soma-Pillay P, 2015, SAMJ, S. Afr. med. j., V105, P578, DOI [10.7196/SAMJnew.8038, 10.7196/SAMJNEW.8038]; Souza JP, 2010, BJOG-INT J OBSTET GY, V117, P1586, DOI 10.1111/j.1471-0528.2010.02746.x; Souza JP, 2008, J CLIN EPIDEMIOL, V61, P169, DOI 10.1016/j.jclinepi.2007.04.009; Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129; Tura AK, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2225-7; Wang HY, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06854-x; WHO, MAT MORT KEY FACTS 2; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	63	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261033	10.1371/journal.pone.0261033	http://dx.doi.org/10.1371/journal.pone.0261033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34971558	gold, Green Published			2022-12-27	WOS:000773555700020
J	Knebel, A; Kampe, A; Carlson, R; Rohn, K; Tipold, A				Knebel, Anna; Kaempe, Annika; Carlson, Regina; Rohn, Karl; Tipold, Andrea			Th17 cell-mediated immune response in a subpopulation of dogs with idiopathic epilepsy	PLOS ONE			English	Article							INTERNATIONAL VETERINARY EPILEPSY; REGULATORY T-CELLS; BLOOD-BRAIN-BARRIER; INFANTILE SPASMS; INCREASED EXPRESSION; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; STATUS EPILEPTICUS; SEIZURE DISORDERS; CANINE EPILEPSY	Background Canine idiopathic epilepsy (IE) is a common neurological disease with severe impact on the owners and the dog's quality of life. A subpopulation of dogs with IE does not respond to antiseizure drugs (non-responder). Th17 cells (T helper cells) and their proinflammatory Interleukin-17 (IL-17) are part of the immune system and previous studies showed their involvement in the pathogenesis of several autoimmune diseases. Non-responder might have an abnormal immune response against structures of the central nervous system. To discover a new aetiology of canine IE and thereby optimising the therapy of intractable IE, this prospective study aimed to investigate Th17 cells and IL-17 in dogs with IE. The underlying hypothesis was that in some dogs with IE a Th17 cell-mediated immune response could be detectable. Methods 57 dogs with IE and 10 healthy dogs (control group, C) were enrolled in the study. EDTA blood was taken to measure Th17 cells by flow cytometry. IL-17 was measured in 35 cerebrospinal fluid (CSF) and 33 serum samples using an enzyme-linked immunosorbent assay (ELISA). It was investigated whether there was a significant increase of stimulated Th17 cells in blood samples or of IL-17 in serum and CSF samples of dogs with IE in comparison to C. Correlations between the amount of Th17 cells/mu L or IL-17 and different clinical parameters e.g. seizure frequency, seizure type, seizure severity or treatment response were evaluated. Additionally, Th17 cells/mu L were randomly controlled of 17 dogs with IE and were examined for changes over time and in relation to treatment response. Results Ten dogs with IE had strongly elevated stimulated Th17 cells/mu L within the blood (>100 Th17 cells/mu L). A slight positive correlation between stimulated Th17 cells/mu L and seizure severity (p = 0.046; rSpear = 0.27) was proven in these dogs. In addition, 4/10 dogs with elevated Th17 levels experienced cluster seizures and status epilepticus in comparison to 9% of the dogs with non-elevated Th17 levels (<100 Th17 cells/mu L). Dogs with IE had significantly higher IL-17 values in CSF and serum samples compared to C (p<0.001; p<0.002; respectively). Conclusion In single dogs with IE, strongly increased amounts of Th17 cells were detectable and dogs with elevated Th17 cells seemed to have a greater risk for experiencing a combination of cluster seizures and status epilepticus. Therefore, an underlying Th17-cell mediated immune response was suspected and hence anti-inflammatory drugs could be indicated in these single cases with intractable epilepsy.	[Knebel, Anna; Kaempe, Annika; Carlson, Regina; Tipold, Andrea] Univ Vet Med, Dept Small Anim Med & Surg, Hannover, Germany; [Rohn, Karl] Univ Vet Med Hannover, Dept Biometry Epidemiol & Informat Proc, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Knebel, A (corresponding author), Univ Vet Med, Dept Small Anim Med & Surg, Hannover, Germany.	anna.knebel@tiho-hannover.de			Gkf -Die Gesellschaft zur Forderung kynologischer Forschung e.V. (Society for the Support of Cynological Research e.V., Bonn, Germany); Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing	Gkf -Die Gesellschaft zur Forderung kynologischer Forschung e.V. (Society for the Support of Cynological Research e.V., Bonn, Germany); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing	The authors received financial support from the Gkf -Die Gesellschaft zur Forderung kynologischer Forschung e.V. (Society for the Support of Cynological Research e.V., Bonn, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing.	Andrea Fischer KJ., 2013, IDIOPATHISCHE EPILEP; Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684; Baram TZ, 1996, PEDIATRICS, V97, P375; BARAN H, 1994, BRAIN RES, V646, P201, DOI 10.1016/0006-8993(94)90078-7; Bateman SW, 1999, J AM VET MED ASSOC, V215, P1463; Berendt M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0461-2; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Bien CG, 2005, BRAIN, V128, P454, DOI 10.1093/brain/awh415; Brauer C, 2011, VET J, V187, P272, DOI 10.1016/j.tvjl.2009.10.023; Brenner T, 2013, EPILEPSIA, V54, P1028, DOI 10.1111/epi.12127; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; De Risio L, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0462-1; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Dhote F, 2007, TOXICOLOGY, V238, P166, DOI 10.1016/j.tox.2007.05.032; Eriksson C, 2000, J NEUROSCI RES, V60, P266, DOI 10.1002/(SICI)1097-4547(20000415)60:2<266::AID-JNR16>3.0.CO;2-P; Esendagli G, 2013, J NEUROIMMUNOL, V255, P81, DOI 10.1016/j.jneuroim.2012.10.009; Freundt-Revilla J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0784-3; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Golubovic SB, 2017, J VET EMERG CRIT CAR, V27, P288, DOI 10.1111/vec.12604; Gozubatik-Celik G, 2017, EPILEPSY RES, V135, P131, DOI 10.1016/j.eplepsyres.2017.06.008; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; He JJ, 2013, J NEUROPATH EXP NEUR, V72, P152, DOI 10.1097/NEN.0b013e318281262e; HRACHOVY RA, 1983, J PEDIATR-US, V103, P641, DOI 10.1016/S0022-3476(83)80606-4; Hu MH, 2014, CLIN EXP IMMUNOL, V175, P268, DOI 10.1111/cei.12219; Hulsmeyer VI, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0463-0; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Jamshidian A, 2013, J NEUROIMMUNOL, V262, P106, DOI 10.1016/j.jneuroim.2013.06.007; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Kawanokuchi J, 2008, J NEUROIMMUNOL, V194, P54, DOI 10.1016/j.jneuroim.2007.11.006; Kearsley-Fleet L, 2013, VET REC, V172, DOI 10.1136/vr.101133; Kim JS, 2013, CELL MOL LIFE SCI, V70, P2271, DOI 10.1007/s00018-012-1163-6; Knebel A, 2022, VET IMMUNOL IMMUNOP, V243, DOI 10.1016/j.vetimm.2021.110366; Kol A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148568; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2017, NAT REV IMMUNOL, V17, P179, DOI 10.1038/nri.2016.144; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; Mackay MT, 2004, NEUROLOGY, V62, P1668, DOI 10.1212/01.WNL.0000127773.72699.C8; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Mao LY, 2013, EPILEPSIA, V54, pe142, DOI 10.1111/epi.12337; McKnight K, 2005, NEUROLOGY, V65, P1730, DOI 10.1212/01.wnl.0000187129.66353.13; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Moynes DM, 2014, BRAIN BEHAV IMMUN, V41, P1, DOI 10.1016/j.bbi.2014.03.004; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; Ohta H, 2014, J VET MED SCI, V76, P409, DOI 10.1292/jvms.13-0008; Ong MS, 2014, JAMA NEUROL, V71, P569, DOI 10.1001/jamaneurol.2014.188; Owens T, 2008, J NEUROPATH EXP NEUR, V67, P1113, DOI 10.1097/NEN.0b013e31818f9ca8; Packer RMA, 2017, PHYSIOL BEHAV, V177, P27, DOI 10.1016/j.physbeh.2017.04.008; Packer RMA, 2015, VET REC, V176, DOI 10.1136/vr.102934; Palace J, 2000, J NEUROL NEUROSUR PS, V69, P711, DOI 10.1136/jnnp.69.6.711; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; PODELL M, 1993, J VET INTERN MED, V7, P318, DOI 10.1111/j.1939-1676.1993.tb01025.x; Potschka H, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0465-y; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; RASMUSSEN T, 1958, NEUROLOGY, V8, P435, DOI 10.1212/WNL.8.6.435; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rentzos M, 2010, ACTA NEUROL SCAND, V122, P425, DOI 10.1111/j.1600-0404.2010.01333.x; Riikonen R, 2004, J CHILD NEUROL, V19, P401, DOI 10.1177/088307380401900601; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Sallusto F, 2012, IMMUNOL REV, V248, P216, DOI 10.1111/j.1600-065X.2012.01140.x; Hernandez AS, 2009, REUMATOL CLIN, V5, P1, DOI 10.1016/j.reuma.2008.11.012; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Stadhouders R, 2018, J AUTOIMMUN, V87, P1, DOI 10.1016/j.jaut.2017.12.007; Tecellioglu M, 2018, IRISH J MED SCI, V187, P1057, DOI 10.1007/s11845-018-1777-2; Tizard I. R., 2013, VET IMMUNOLOGY; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Ueno M, 2016, BRAIN TUMOR PATHOL, V33, P89, DOI 10.1007/s10014-016-0255-7; van den Berg WB, 2013, SEMIN ARTHRITIS RHEU, V43, P158, DOI 10.1016/j.semarthrit.2013.04.006; Veiga-Parga T, 2016, VET PATHOL, V53, P737, DOI 10.1177/0300985816629719; Veiga-Parga T, 2013, IMMUNOL REV, V255, P182, DOI 10.1111/imr.12085; Vezzani A, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022699; Vezzani A, 2014, EPILEPSY CURR, V14, P3, DOI 10.5698/1535-7511-14.s2.3; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Vincent A, 2004, BRAIN, V127, P701, DOI 10.1093/brain/awh077; Vincent A, 2010, CURR OPIN NEUROL, V23, P144, DOI 10.1097/WCO.0b013e32833735fe; Volk HA, 2016, VET REC, V178, P394, DOI 10.1136/vr.i1999; Voutsinos-Porche B, 2004, NEUROBIOL DIS, V17, P385, DOI 10.1016/j.nbd.2004.07.023; Walker LSK, 2004, IMMUNOLOGY, V111, P129, DOI 10.1111/j.0019-2805.2003.01788.x; Wang Y, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0742-3; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wirrell E, 2005, CAN J NEUROL SCI, V32, P409, DOI 10.1017/S0317167100004388; Wong CK, 2008, CLIN IMMUNOL, V127, P385, DOI 10.1016/j.clim.2008.01.019; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Zambrano-Zaragoza Jose Francisco, 2014, Int J Inflam, V2014, P651503, DOI 10.1155/2014/651503; Zimmermann J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057307	91	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262285	10.1371/journal.pone.0262285	http://dx.doi.org/10.1371/journal.pone.0262285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025939	gold, Green Published			2022-12-27	WOS:000796264200056
J	Meijer, TS; Dieters, JHN; de Leede, EM; de Geus-Oei, LF; Vuijk, J; Martini, CH; van Erkel, AR; Lutjeboer, J; van der Meer, RW; Tijl, FGJ; Kapiteijn, E; Vahrmeijer, AL; Burgmans, MC				Meijer, T. Susanna; Dieters, Jan H. N.; de Leede, Eleonora M.; de Geus-Oei, Lioe-Fee; Vuijk, Jaap; Martini, Christian H.; van Erkel, Arian R.; Lutjeboer, Jacob; van der Meer, Rutger W.; Tijl, Fred G. J.; Kapiteijn, Ellen; Vahrmeijer, Alexander L.; Burgmans, Mark C.			Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer	PLOS ONE			English	Article							PHARMACOLOGICAL EVALUATION; CHEMOTHERAPY; RESECTION; INFUSION; MANAGEMENT; MELANOMA; SURVIVAL; TRENDS	Purpose Percutaneous hepatic perfusion with melphalan (M-PHP) is increasingly used in patients with liver metastases from various primary tumors, yet data on colorectal liver metastases (CRLM) are limited. The aim of this study was to prospectively evaluate the efficacy and safety of M-PHP in patients with CRLM. Materials and methods Prospective, single-center, single-arm phase II study of M-PHP with hemofiltration in patients with unresectable CRLM. Proven, extrahepatic metastatic disease was one of the exclusion criteria. Primary outcomes were overall response rate (ORR) and best overall response (BOR). Secondary outcomes were overall survival (OS), progression-free survival (PFS), hepatic PFS (hPFS), and safety. Results A total of 14 M-PHP procedures were performed in eight patients between March 2014 and December 2015. All patients (median age 56 years, ranging from 46 to 68) had received (extensive) systemic chemotherapy before entering the study. The ORR was 25.0%, with two out of eight patients showing partial response as BOR. Median OS was 17.3 months (ranging from 2.6 to 30.9) with a one-year OS of 50.0%. Median PFS and hPFS were 4.4 and 4.5 months, respectively. No serious adverse events occurred. Grade 3/4 hematologic adverse events were observed in the majority of patients, though all were transient and well-manageable. Conclusion M-PHP is a safe procedure with only limited efficacy in patients with unresectable CRLM who already showed progression of disease after receiving one or more systemic treatment regimens.	[Meijer, T. Susanna; Dieters, Jan H. N.; de Geus-Oei, Lioe-Fee; van Erkel, Arian R.; Lutjeboer, Jacob; van der Meer, Rutger W.; Burgmans, Mark C.] Leiden Univ Med Ctr, Dept Radiol, Leiden, Netherlands; [de Leede, Eleonora M.; Vahrmeijer, Alexander L.] Leiden Univ Med Ctr, Dept Surg, Leiden, Netherlands; [de Geus-Oei, Lioe-Fee] Univ Twente, Biomed Photon Imaging Grp, Enschede, Netherlands; [Martini, Christian H.] Leiden Univ Med Ctr, Dept Anesthesiol, Leiden, Netherlands; [Tijl, Fred G. J.] Leiden Univ Med Ctr, Dept Extra Corporal Circulat, Leiden, Netherlands; [Kapiteijn, Ellen] Leiden Univ Med Ctr, Dept Med Oncol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); University of Twente; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Meijer, TS (corresponding author), Leiden Univ Med Ctr, Dept Radiol, Leiden, Netherlands.	t.s.meijer@lumc.nl	Burgmans, Mark C/B-4478-2013	Burgmans, Mark C/0000-0001-5258-291X; de Geus-Oei, Lioe-Fee/0000-0003-1817-2743; Kapiteijn, Ellen/0000-0002-4814-6426	Leiden University Medical Center	Leiden University Medical Center	YES -The Leiden University Medical Center received financial support and in kind contributions from Delcath Systems Inc. for conducting studies on M-PHP. No grant number applies. The sponsor did not play any rol in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER K, 1983, RECENT RESULTS CANC, V86, P99; AUSMAN RK, 1961, NEW YORK STATE J MED, V61, P3993; Benson AB, 2017, J NATL COMPR CANC NE, V15, P370, DOI 10.6004/jnccn.2017.0036; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Burgmans MC, 2016, CARDIOVASC INTER RAD, V39, P801, DOI 10.1007/s00270-015-1276-z; Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002; de Leede EM, 2017, CARDIOVASC INTER RAD, V40, P1196, DOI 10.1007/s00270-017-1630-4; de Ridder JAM, 2016, EUR J CANCER, V59, P13, DOI 10.1016/j.ejca.2016.02.003; DEBRAUW LM, 1991, CANCER RES, V51, P1694; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hackl C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-810; HAFSTROM LR, 1994, SURG ONCOL, V3, P103, DOI 10.1016/0960-7404(94)90005-1; House MG, 2010, J AM COLL SURGEONS, V210, P744, DOI 10.1016/j.jamcollsurg.2009.12.040; Hughes MS, 2016, ANN SURG ONCOL, V23, P1309, DOI 10.1245/s10434-015-4968-3; Karydis I, 2018, J SURG ONCOL, V117, P1170, DOI 10.1002/jso.24956; Leonard GD, 2005, J CLIN ONCOL, V23, P2038, DOI 10.1200/JCO.2005.00.349; Leporrier J, 2006, BRIT J SURG, V93, P465, DOI 10.1002/bjs.5278; Mambrini A, 2006, IN VIVO, V20, P751; Marinelli A, 1998, RECENT RES CANCER, V147, P83; Marquardt S, 2019, EUR RADIOL, V29, P1882, DOI 10.1007/s00330-018-5729-z; Meijer TS, 2021, ANN SURG ONCOL, V28, P1130, DOI 10.1245/s10434-020-08741-x; Meijer TS, 2019, DIAGN INTERV RADIOL, V25, P451, DOI 10.5152/dir.2019.18138; Meijer TS, 2019, CARDIOVASC INTER RAD, V42, P841, DOI 10.1007/s00270-019-02177-x; Miao N, 2008, ANN SURG ONCOL, V15, P815, DOI 10.1245/s10434-007-9781-1; Pingpank JF, 2005, J CLIN ONCOL, V23, P3465, DOI 10.1200/JCO.2005.00.927; Rothbarth J, 2003, BRIT J SURG, V90, P1391, DOI 10.1002/bjs.4308; Savier E, 2003, ARCH SURG-CHICAGO, V138, P325, DOI 10.1001/archsurg.138.3.325; van Iersel LBJ, 2008, ANN ONCOL, V19, P1127, DOI 10.1093/annonc/mdn032; Vogl TJ, 2014, ROFO-FORTSCHR RONTG, V186, P937, DOI 10.1055/s-0034-1366081	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261939	10.1371/journal.pone.0261939	http://dx.doi.org/10.1371/journal.pone.0261939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025911	gold, Green Published			2022-12-27	WOS:000796264200036
J	Zawierucha, K; Trzebny, A; Buda, J; Bagshaw, E; Franzetti, A; Dabert, M; Ambrosini, R				Zawierucha, Krzysztof; Trzebny, Artur; Buda, Jakub; Bagshaw, Elizabeth; Franzetti, Andrea; Dabert, Miroslawa; Ambrosini, Roberto			Trophic and symbiotic links between obligate-glacier water bears (Tardigrada) and cryoconite microorganisms	PLOS ONE			English	Article							GUT MICROBIOTA; ICE WORM; SP-NOV.; COMMUNITY; HOLES; PREFERENCES; EVOLUTION; BACTERIA	Insights into biodiversity and trophic webs are important for understanding ecosystem functions. Although the surfaces of glaciers are one of the most productive and biologically diverse parts of the cryosphere, the links between top consumers, their diet and microbial communities are poorly understood. In this study, for the first time we investigated the relationships between bacteria, fungi and other microeukaryotes as they relate to tardigrades, microscopic metazoans that are top consumers in cryoconite, a biologically rich and productive biogenic sediment found on glacier surfaces. Using metabarcoding (16S rDNA for bacteria, ITS1 for fungi, and 18S rDNA for other microeukaryotes), we analyzed the microbial community structures of cryoconite and compared them with the community found in both fully fed and starved tardigrades. The community structure of each microbial group (bacteria, fungi, microeukaryotes) were similar within each host group (cryoconite, fully fed tardigrades and starved tardigrades), and differed significantly between groups, as indicated by redundancy analyses. The relative number of operational taxonomic units (ZOTUs, OTUs) and the Shannon index differed significantly between cryoconite and tardigrades. Species indicator analysis highlighted a group of microbial taxa typical of both fully fed and starved tardigrades (potential commensals), like the bacteria of the genera Staphylococcus and Stenotrophomonas, as well as a group of taxa typical of both cryoconite and fully fed tardigrades (likely part of the tardigrade diet; bacteria Flavobacterium sp., fungi Preussia sp., algae Trebouxiophyceae sp.). Tardigrades are consumers of bacteria, fungi and other microeukaryotes in cryoconite and, being hosts for diverse microbes, their presence can enrich the microbiome of glaciers.	[Zawierucha, Krzysztof; Buda, Jakub] Adam Mickiewicz Univ, Dept Anim Taxon & Ecol, Poznan, Poland; [Trzebny, Artur; Dabert, Miroslawa] Adam Mickiewicz Univ, Fac Biol, Mol Biol Tech Lab, Poznan, Poland; [Bagshaw, Elizabeth] Cardiff Univ, Sch Earth & Environm Sci, Cardiff, Wales; [Franzetti, Andrea] Univ Milano Bicocca, Earth & Environm Sci Dept, Milan, Italy; [Ambrosini, Roberto] Univ Milan, Dept Environm Sci & Policy, Milan, Italy	Adam Mickiewicz University; Adam Mickiewicz University; Cardiff University; University of Milano-Bicocca; University of Milan	Zawierucha, K (corresponding author), Adam Mickiewicz Univ, Dept Anim Taxon & Ecol, Poznan, Poland.	k.p.zawierucha@gmail.com		Zawierucha, Krzysztof/0000-0002-0754-1411; Trzebny, Artur/0000-0002-0831-7243; Dabert, Miroslawa/0000-0001-5930-3346	National Science Centre in Poland [OPUS 2018/31/B/NZ8/00198]	National Science Centre in Poland(National Science Centre, Poland)	The studies on the role and diet of microinvertebrates in cryoconite ecosystems are supported via grant OPUS 2018/31/B/NZ8/00198 financed by National Science Centre in Poland. Grant recipient: Krzysztof Zawierucha The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzoni RS, 2017, J MAPS, V13, P870, DOI 10.1080/17445647.2017.1394227; Bagshaw EA, 2013, ARCT ANTARCT ALP RES, V45, P440, DOI 10.1657/1938-4246-45.4.440; Beligala D.H., 2017, ADV MICROBIOL-IRVINE, V7, P790, DOI [10.4236/aim.2017.711063, DOI 10.4236/AIM.2017.711063]; Boesgaard TM, 2001, ZOOL ANZ, V240, P253, DOI 10.1078/0044-5231-00033; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Bryndova M, 2020, ZOOL J LINN SOC-LOND, V188, P865; Buda J, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138112; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cook J, 2016, PROG PHYS GEOG, V40, P66, DOI 10.1177/0309133315616574; Dabert M., 2015, MITT HAMB ZOOL MUS I, V17, P233; Darcy JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023742; Dastych Hieronymus, 2003, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V100, P73; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; Di Marino E, 2007, NOVA HEDWIGIA, V84, P429, DOI 10.1127/0029-5035/2007/0084-0429; Dial CR, 2012, MOL PHYLOGENET EVOL, V63, P577, DOI 10.1016/j.ympev.2012.01.008; Edgar R. C., 2018, BIORXIV389833, DOI [10.1101/389833, DOI 10.1101/389833]; Edgar R. C., 2016, BIORXIV, DOI DOI 10.1101/074252; Edgar R.C., 2017, UNBIAS ATTEMPT CORRE, DOI [10.1101/124149, DOI 10.1101/124149]; Edgar RC, 2018, PEERJ, V6, DOI 10.7717/peerj.4652; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edwards A, 2013, FUNGAL ECOL, V6, P168, DOI 10.1016/j.funeco.2012.11.001; EDWARDS JS, 1970, CAN ENTOMOL, V102, P1169, DOI 10.4039/Ent1021169-9; Ezenwa VO, 2012, SCIENCE, V338, P198, DOI 10.1126/science.1227412; Garraffoni ARS, 2019, MAR BIODIVERS, V49, P2199, DOI 10.1007/s12526-019-00983-7; Gawor J, 2016, EXTREMOPHILES, V20, P403, DOI 10.1007/s00792-016-0831-0; GERDEL R. W., 1960, TRANS AMER MICROSC SOC, V79, P256, DOI 10.2307/3223732; Glockner FO, 2017, J BIOTECHNOL, V261, P169, DOI 10.1016/j.jbiotec.2017.06.1198; Greven Hartmut, 2005, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V102, P11; Guidetti R, 2012, ZOOMORPHOLOGY, V131, P127, DOI 10.1007/s00435-012-0149-0; Guil N, 2013, SYST BIODIVERS, V11, P181, DOI 10.1080/14772000.2013.798370; Hannon GJ., 2010, FASTX TOOLKIT; Hess S, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix104; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Jaromerska TN, 2021, BIOGEOSCIENCES, V18, P1543, DOI 10.5194/bg-18-1543-2021; Kaczmarek L, 2020, MOL PHYLOGENET EVOL, V145, DOI 10.1016/j.ympev.2019.106730; Kaltenpoth M, 2020, ANNU REV ENTOMOL, V65, P145, DOI 10.1146/annurev-ento-011019-025025; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kisielewska G, 2015, EUR J PROTISTOL, V51, P138, DOI 10.1016/j.ejop.2014.12.003; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kosztyla P, 2016, ZOOL J LINN SOC-LOND, V178, P765, DOI 10.1111/zoj.12409; Lerner A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01630; Lewin GR, 2016, ANNU REV MICROBIOL, V70, P235, DOI 10.1146/annurev-micro-102215-095748; Ma Y, 2019, BIOCHEM BIOPH RES CO, V516, P120, DOI 10.1016/j.bbrc.2019.05.085; Margesin R, 2007, INT J SYST EVOL MICR, V57, P2179, DOI 10.1099/ijs.0.65111-0; Matuszewska M, 2020, TRENDS MICROBIOL, V28, P465, DOI 10.1016/j.tim.2019.12.007; McInnes SJ, 2003, POLAR BIOL, V26, P79, DOI 10.1007/s00300-002-0449-9; Murakami T, 2018, ENVIRON MICROBIOL, V20, P4170, DOI 10.1111/1462-2920.14420; Murakami T, 2017, MICROBES ENVIRON, V32, P32, DOI 10.1264/jsme2.ME16158; Murakami T, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv003; Nelson DR, 2015, ECOLOGY AND GENERAL BIOLOGY, VOL I: THORP AND COVICH'S FRESHWATER INVERTEBRATES, 4TH EDITION, P347, DOI 10.1016/B978-0-12-385026-3.00017-6; Nesvorna M, 2019, MICROB ECOL, V77, P488, DOI 10.1007/s00248-018-1224-y; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ono M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85462-5; Pantucek R, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01746-17; Perini L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00557; Pittino F, 2018, ANN GLACIOL, V59, P1, DOI 10.1017/aog.2018.16; Prochazkova L, 2019, FEMS MICROBIOL ECOL, V95, DOI 10.1093/femsec/fiz064; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2020, R LANG ENV STAT COMP; Reese AT, 2018, MBIO, V9, DOI 10.1128/mBio.01294-18; Rozwalak P, 2022, SCI TOTAL ENVIRON, V807, DOI 10.1016/j.scitotenv.2021.150874; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; Sommers P, 2019, POLAR BIOL, V42, P1973, DOI 10.1007/s00300-019-02572-7; Stibal M, 2020, NAT ECOL EVOL, V4, P686, DOI 10.1038/s41559-020-1163-0; Takeuchi N, 2001, MEM NATL I POLAR RES, V54, P495; Takeuchi N, 2014, BULL GLACIOL RES, V32, P85, DOI 10.5331/bgr.32.85; Takeuchi N, 2010, ANN GLACIOL, V51, P9, DOI 10.3189/172756411795932010; Terashima M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01481; Vecchi M, 2018, MICROB ECOL, V76, P467, DOI 10.1007/s00248-017-1134-4; Vecchi M, 2016, ZOOL J LINN SOC-LOND, V178, P846, DOI 10.1111/zoj.12446; Vonnahme TR, 2016, BIOGEOSCIENCES, V13, P659, DOI 10.5194/bg-13-659-2016; Wagg C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12798-y; Wang B, 2020, GLOBAL CHANGE BIOL, V26, P960, DOI 10.1111/gcb.14841; Waterworth SC, 2020, MBIO, V11, DOI 10.1128/mBio.02430-19; Wilson BJ, 2004, CAN J BOT, V82, P607, DOI 10.1139/B04-030; Xia JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-266; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Yoshida Y., 2019, HORIZONTAL GENE TRAN, P203; Zawierucha K, 2021, J ZOOL, V313, P18, DOI 10.1111/jzo.12832; Zawierucha K, 2019, AQUAT ECOL, V53, P543, DOI 10.1007/s10452-019-09707-2; Zawierucha K, 2018, LIMNOLOGY, V19, P141, DOI 10.1007/s10201-017-0528-9	82	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262039	10.1371/journal.pone.0262039	http://dx.doi.org/10.1371/journal.pone.0262039			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020747	Green Published, gold, Green Accepted			2022-12-27	WOS:000834207700033
J	Huy, BV; Toan, NV				Bul Vu Huy; Ngo Van Toan			Prognostic indicators associated with progresses of severe dengue	PLOS ONE			English	Article							PREDICTORS; ADULTS	Background Dengue usually progress abnormally, especially in the critical phase. The main causes of death were shock, severe bleeding and organ failure. The aim of our study was to evaluate prognostic indicators of severe dengue according to the phases of the disease progression. Methods A cross-sectional study was conducted from July to December 2017 at the National Hospital for Tropical Diseases and the Hospital for Tropical Diseases of Ho Chi Minh City. 326 patients, aged 6 years and over, including 99/326 patients with severe dengue and 227/326 patients with non-severe dengue, hospitalized in the first 3 days of illness, confirmed Dengue virus by the RT-PCR assay have been registered for the study. Clinical manifestations were monitored daily. The hematocrit, white blood cells, platelet, serum albumin, ALT, AST, bilirubin, prothrombin time (PT%, PTs), fibrinogen, aPTT, INR and creatinine were evaluated at two times: febrile phase and critical phase. Results Independent factors associated with severe dengue were identified on multivariate logistic regression models. During the first 3 days of the disease, the prognostic indicators were platelet count. 100 G/L (OR = 2.2; 95%CI: 1.2-3.9), or serum albumin < 35 g/L (OR = 3.3; 95%CI: 1.8-6.1). From day 4-6, the indicator were AST > 400 U/L (OR = 3.0; 95%CI: 1.17.9), ALT > 400 U/L (OR = 6.6; 95%CI: 1.7-24.6), albumin < 35 g/L (OR = 3.0; 95%CI: 1.55.9), and bilirubin total > 17 mu mol/ L (OR = 4.6; 95%CI: 2.0-10.4). Conclusion To predict the risk of patients with severe dengue, prognostic laboratory indicators should be indicated consistent with the progression of the disease. During the first 3 days of illness, prognostic indicators should be platelet count, or serum albumin. From the 4th - 6th day of illness, prognostic indicators should be AST, ALT, albumin, or bilirubin total.	[Bul Vu Huy] Hanoi Med Univ, Dept Infect Dis, Hanoi, Vietnam; [Bul Vu Huy] Natl Hosp Trop Dis, Dept Pediat, Hanoi, Vietnam; [Ngo Van Toan] Hanoi Med Univ, Dept Environm Hlth, Hanoi, Vietnam	Hanoi Medical University; National Hospital of Tropical Diseases; Hanoi Medical University	Huy, BV (corresponding author), Hanoi Med Univ, Dept Infect Dis, Hanoi, Vietnam.; Huy, BV (corresponding author), Natl Hosp Trop Dis, Dept Pediat, Hanoi, Vietnam.	Dr.vuhuy@yahoo.com			Research, application and development of advanced technologies for community health care and protection (Formas) [KC.10.22/16-20]	Research, application and development of advanced technologies for community health care and protection (Formas)	This study was a part of the project "Study on clinical epidemiological characteristics, the value of biomarkers in the prognosis of dengue" funded by the Research, application and development of advanced technologies for community health care and protection, http://www.vpct.gov.vn/ProjectSearch.html (Formas, grant number KC.10.22/16-20) awarded to Bui VuHuy (BVH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal VK, 2018, CASP J INTERN MED, V9, P334, DOI 10.22088/cjim.9.4.334; Huy BV, 2021, AM J TROP MED HYG, V104, P1067, DOI 10.4269/ajtmh.20-0840; de Azeredo EL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/313842; Dinh TT, 2010, AM J TROP MED HYG, V83, P774, DOI 10.4269/ajtmh.2010.10-0090; Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317; Halstead SB, 2016, J PEDIAT-BRAZIL, V92, P429, DOI 10.1016/j.jped.2016.06.004; Hsieh CC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005270; Huy Bui Vu, 2019, Biomed Res Int, V2019, P3085827, DOI 10.1155/2019/3085827; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kulasinghe S., 2016, SRI LANKA J CHILD HL, V45, P184, DOI [DOI 10.4038/SLJCH.V45I3.8031, http%3A//doi.org/10.4038/sljch.v45i3.8031]; Lim C.T.S., 2019, EMJ NEPHROL, V7, P86; Md-Sani SS, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3141-6; Tuan NM, 2017, CLIN INFECT DIS, V64, P656, DOI 10.1093/cid/ciw863; Patel ML, 2019, INDIAN J NEPHROL, V29, P15, DOI 10.4103/ijn.IJN_437_17; Samanta J, 2015, WORLD J CLIN CASES, V3, P125, DOI 10.12998/wjcc.v3.i2.125; Sani SSM, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2601-8; Teerasarntipan T, 2020, WORLD J GASTROENTERO, V26, DOI 10.3748/wjg.v26.i33.4983; Temprasertrudee S, 2018, JPN J INFECT DIS, V71, P239, DOI [10.7883/yoken.JJID.2017.457, 10.7883/yoken.jjid.2017.457]; Tewari K, 2018, MEDITERR J HEMATOL I, V10, DOI 10.4084/MJHID.2018.021; Thanachartwet V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004961; Vachvanichsanong P, 2016, ARCH VIROL, V161, P771, DOI 10.1007/s00705-015-2727-1; WHO, 2009, WHO TECH REP SER, V958, P1; WHO, FACT SHEET DENG SEV; World Health Organization, 2016, SEARO TECHN PUBL SER, V60; Yeh CY, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007817	25	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262096	10.1371/journal.pone.0262096	http://dx.doi.org/10.1371/journal.pone.0262096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986174	gold, Green Published			2022-12-27	WOS:000765956200015
J	Ovelar-Fernandez, WD; Galvez-Rodriguez, MD; Caba-Perez, C				Daniel Ovelar-Fernandez, Walter; del Mar Galvez-Rodriguez, Maria; Caba-Perez, Carmen			What determines the progress of online information access to banking corporate governance practices? The case of Paraguay	PLOS ONE			English	Article							VOLUNTARY DISCLOSURE; PERFORMANCE	This paper contributes to the lack of longitudinal studies concerning online information access to corporate governance (CG) practices in the banking sector of Latin American countries. In particular, this study aims to analyze the factors that influence information transparency, both mandatory and voluntary, related to CG practices of banks that operate in Paraguay via their websites from 2016 to 2019. Findings indicate the need to improve the level of information available on websites, with disclosure of voluntary information on CG practices being more prevalent than the disclosure of mandatory information. Likewise, banks that operate in Paraguay have made scant "progress" regarding online access to their governance information over the years analyzed. Moreover, the factors "Bank size" and "listed status" positively influence the information transparency regarding CG practices of Paraguayan banks. In contrast, "leverage," "liquidity," "size of the audit firm," and "credit risk rating" are factors that have a negative relation with the extent of CG disclosure.	[Daniel Ovelar-Fernandez, Walter] Autonoma Asuncion Univ, Econ & Business Fac, Asuncion, Paraguay; [del Mar Galvez-Rodriguez, Maria; Caba-Perez, Carmen] Univ Almeria, Econ & Business Fac, Almeria, Spain	Universidad de Almeria	Galvez-Rodriguez, MD (corresponding author), Univ Almeria, Econ & Business Fac, Almeria, Spain.	margalvez@ual.es						Al-Bassam WM, 2018, BUS SOC, V57, P335, DOI 10.1177/0007650315610611; Alali F, 2012, ADV ACCOUNT, V28, P157, DOI 10.1016/j.adiac.2012.03.009; Albitar K., 2015, INT BUSINESS RES, V8, P1, DOI DOI 10.5539/IBR.V8N3P1; Albu OB, 2019, BUS SOC, V58, P268, DOI 10.1177/0007650316659851; Allini A., 2020, CORPORATE OWNERSHIP, V17, P20; [Anonymous], 2015, INT LETT SOCIAL HUMA; Arora T.S., 2020, INDIAN J CORPORATE G, V13, P140; Baltagi B. H., 2005, ECONOMETRIC ANAL PAN; Banco Central de la Republica Argentina (BCRA), 2011, LIN GOB CORP ENT FIN; Barako D.G., 2006, RELATIONSHIP CORPORA; Basel Committee on Banking Supervision, 2015, CORP GOV-OXFORD; Basel Committee on Banking Supervision, 2006, ENH CORP GOV BANK OR; Bereskin FL, 2015, PAC-BASIN FINANC J, V35, P592, DOI 10.1016/j.pacfin.2015.10.005; Berg B.L., 2001, QUALITATIVE RES METH; Bhasin ML, 2013, INT J MANAG FINANC A, V5, P79, DOI 10.1504/IJMFA.2013.052432; Bidari G., 2020, ASIAN J ACOUNT RES, V5, P209, DOI DOI 10.1108/AJAR-03-2020-0013; Bradford W, 2019, J INT FIN MANAG ACC, V30, P113, DOI 10.1111/jifm.12094; Turrent GDB, 2015, ESTUD GERENC, V31, P275, DOI 10.1016/j.estger.2015.02.001; Cadbury A., 1992, REPORT COMMITTEE FIN; Chakib K., 2012, IUP J ACCOUNTING RES; El-Halaby S., 2017, ADV ACCOUNTING BEHAV, V20, P117; Elmagrhi MH, 2020, EUR MANAG REV, V17, P121, DOI 10.1111/emre.12329; Engel E, 2021, EXP ADV GROUP ANT TR; Forte LM, 2015, REV GEST FINANC CONT, V5, P23, DOI 10.18028/2238-5320/rgfc.v5n2p23-37; Freeman E., 1984, J MANAGE STUD; Gandia-Cabedo J, 2005, MONOGRAFIAS COMISION; Garay U, 2006, ESTUDIO IESA, V24, P1; Gonzalez M, 2021, J BUS RES, V127, P427, DOI 10.1016/j.jbusres.2019.05.014; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grassa R, 2021, J FINANC REPORT ACCO, V19, P369, DOI 10.1108/JFRA-02-2020-0036; Habbash M., 2016, INT J ACCOUNTING AUD, V12, P213; Hasan T., 2015, RES J FINANC ACCOUNT, V6, P14; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Herbert W.E., 2021, J RES EMERG MARK, V3, P14, DOI [10.30585/jrems.v3i3.674, DOI 10.30585/JREMS.V3I3.674]; Hieu P.H., 2015, J MODERN ACCOUNTING, V11, P656, DOI DOI 10.17265/1548-6583/2015.12.004; Hopt K J., 2013, ECGI WORKING PAPER S, P1; Hopt KJ, 2021, EUR BUS ORGAN LAW RE, V22, P13, DOI 10.1007/s40804-020-00201-z; Hossain M., 2008, EUR J SCI RES, V23, P659; Hsiao C, 2007, TEST-SPAIN, V16, P1, DOI 10.1007/s11749-007-0046-x; Isukul A., 2017, INT J INNOVATION EC, V3, P50; Isukul AC, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017719112; Janning F., 2020, ILLUSION TRANSPARENC, DOI 10.1007/978-3-030-35780-1; JENSEN MC, 1976, J FINANC ECON, V3, P305, DOI 10.1016/0304-405X(76)90026-X; Jizi MI, 2014, J BUS ETHICS, V125, P601, DOI 10.1007/s10551-013-1929-2; Kamal Y, 2021, ASIAN REV ACCOUNT, V29, P97, DOI 10.1108/ARA-04-2020-0052; Kang M, 2017, ECONOMIES, V5, DOI 10.3390/economies5040047; Khanifah K, 2020, J ASIAN FINANC ECON, V7, P41, DOI 10.13106/jafeb.2020.vol7.no3.41; Laeven L, 2013, ANNU REV FINANC ECON, V5, P63, DOI 10.1146/annurev-financial-021113-074421; Lan Y, 2013, CHINA J ACCOUNT RES, V6, P265, DOI 10.1016/j.cjar.2013.04.001; Lizarzaburu E. R, 2019, GLOBALIZACI6N COMPET, V13, P79; Lopes AB, 2010, INT J ACCOUNT, V45, P443, DOI 10.1016/j.intacc.2010.09.003; Mathuva D, 2020, J MONEY LAUND CONTRO, V23, P609, DOI 10.1108/JMLC-01-2020-0001; McCormick R., 2014, LAW EC YEARLY REV, V3; Munisi G, 2013, J ECON BUS, V70, P92, DOI 10.1016/j.jeconbus.2013.08.003; Murcia Fernando Dal-Ri, 2012, BAR, Braz. Adm. Rev., V9, P88; Oliveira M, 2017, CONTEXTUS REV CONT E, V15, P172; Parsons C, 2019, BUS SOC, V58, P103, DOI 10.1177/0007650317717957; Rahman M., 2014, EUR J BUS MANAGE, V6, P17; Dominguez LR, 2014, REV CONTAB, V17, P116, DOI 10.1016/j.rcsar.2013.10.002; Rose C, 2016, EUR MANAG J, V34, P202, DOI 10.1016/j.emj.2016.03.003; Sarea AM, 2020, J CENT BANK THEOR PR, V9, P183, DOI 10.2478/jcbtp-2020-0019; Sareen R., 2015, J BUSINESS THOUGHT, V5, P103; Sencal H, 2021, CORP GOV-INT J BUS S, V21, P175, DOI 10.1108/CG-01-2020-0037; Singh G., 2012, DISCLOSURE PRACTICES; Srairi S., 2015, J ISLAMIC FINANCE, V4, P1; Srairi S., 2014, J EC MANAGEMENT TRAD, V4, P523; Srairi S, 2019, BORSA ISTANB REV, V19, pS64, DOI 10.1016/j.bir.2019.02.001; Tabash MI, 2019, J ASIAN FINANC ECON, V6, P27, DOI 10.13106/jafeb.2019.vol6.no4.27; Transparency International, CORRUPTION PERCEPTIO; Tunay K. Batu, 2017, Contad. Adm, V62, P1627, DOI 10.1016/j.cya.2017.05.007; Turrent GuadalupeDelCarmenBriano., 2012, INT J DIGITAL ACCOUN, V12, P1; UNCTAD, 2006, GUID GOOD PRACT CORP; Uyar A, 2013, INTANG CAP, V9, P1080, DOI 10.3926/ic.439; Zaman R, 2018, CORP GOV-INT J BUS S, V18, P858, DOI 10.1108/CG-01-2018-0042	74	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262334	10.1371/journal.pone.0262334	http://dx.doi.org/10.1371/journal.pone.0262334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZO8DB	34986203	Green Published, gold			2022-12-27	WOS:000765956200044
J	Robbins, R; Weaver, MD; Quan, SF; Sullivan, JP; Cohen-Zion, M; Glasner, L; Qadri, S; Czeisler, CA; Barger, LK				Robbins, Rebecca; Weaver, Matthew D.; Quan, Stuart F.; Sullivan, Jason P.; Cohen-Zion, Mairav; Glasner, Laura; Qadri, Salim; Czeisler, Charles A.; Barger, Laura K.			A clinical trial to evaluate the dayzz smartphone app on employee sleep, health, and productivity at a large US employer	PLOS ONE			English	Article							MOTOR-VEHICLE CRASHES; RISK; DISORDERS	Sleep deficiency is a hidden cost of our 24-7 society, with 70% of adults in the US admitting that they routinely obtain insufficient sleep. Further, it is estimated that 50-70 million adults in the US have a sleep disorder. Undiagnosed and untreated sleep disorders are associated with diminished health for the individual and increased costs for the employer. Research has shown that adverse impacts on employees and employers can be mitigated through sleep health education and sleep disorder screening and treatment programs. Smartphone applications (app) are increasingly commonplace and represent promising, scalable modalities for such programs. The dayzz app is a personalized sleep training program that incorporates assessment of sleep disorders and offers a personalized comprehensive sleep improvement solution. Using a sample of day workers affiliated with a large institution of higher education, we will conduct a single-site, parallel-group, randomized, waitlist control trial. Participants will be randomly assigned to either use the dayzz app throughout the study or receive the dayzz app at the end of the study. We will collect data on feasibility and acceptability of the dayzz app; employee sleep, including sleep behavioral changes, sleep duration, regularity, and quality; employee presenteeism, absenteeism, and performance; employee mood; adverse and safety outcomes; and healthcare utilization on a monthly basis throughout the study, as well as collect more granular daily data from the employee during pre-specified intervals. Our results will illuminate whether a personalized smartphone app is a viable approach for improving employee sleep, health, and productivity.	[Robbins, Rebecca; Weaver, Matthew D.; Quan, Stuart F.; Sullivan, Jason P.; Qadri, Salim; Czeisler, Charles A.; Barger, Laura K.] Brigham Womens Hosp, Div Sleep & Circadian Disorders, Dept Med, Boston, MA 02115 USA; [Robbins, Rebecca; Weaver, Matthew D.; Quan, Stuart F.; Sullivan, Jason P.; Qadri, Salim; Czeisler, Charles A.; Barger, Laura K.] Brigham Womens Hosp, Div Sleep & Circadian Disorders, Dept Neurol, Boston, MA 02115 USA; [Robbins, Rebecca; Weaver, Matthew D.; Quan, Stuart F.; Czeisler, Charles A.; Barger, Laura K.] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA; [Cohen-Zion, Mairav; Glasner, Laura] Dayzz Live Well Ltd, Herzliyya, Israel; [Cohen-Zion, Mairav] Acad Coll Tel Aviv Jaffa, Tel Aviv, Israel; [Glasner, Laura] Sheba Med Ctr, Ramat Gan, Israel	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Chaim Sheba Medical Center	Robbins, R (corresponding author), Brigham Womens Hosp, Div Sleep & Circadian Disorders, Dept Med, Boston, MA 02115 USA.; Robbins, R (corresponding author), Brigham Womens Hosp, Div Sleep & Circadian Disorders, Dept Neurol, Boston, MA 02115 USA.; Robbins, R (corresponding author), Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA.	rrobbins4@bwh.harvard.edu	Quan, Stuart/J-5026-2019	Quan, Stuart/0000-0002-9474-7679; Robbins, Rebecca/0000-0003-0288-2505	dayzz Live Well, Ltd. [R01OH011773]	dayzz Live Well, Ltd.	This trial is supported by a grant from dayzz Live Well, Ltd. The funders did have a role in preparation of the manuscript. Specifically, MCZ and LG, who are employees of dayzz reviewed the manuscript and contributed to the manuscript portion describing the dayzz app. The specific roles of these authors are articulated in the `author contributions' section. Drs. Barger, Czeisler, Robbins and Weaver and Mr. Sullivan were supported, in part, by R01OH011773.	Barger LK, 2015, J CLIN SLEEP MED, V11, P233, DOI 10.5664/jcsm.4534; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Burks SV, 2016, SLEEP, V39, P967, DOI 10.5665/sleep.5734; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Centers for Disease Control and Prevention, 2009, PERC INS REST SLEEP; Davis TL, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.5659; Hafner Marco, 2017, Rand Health Q, V6, P11; Institute of Medicine (US) Committee on Sleep Medicine and Research, 2006, SLEEP DISORDERS SLEE; Kessler RC, 2004, J OCCUP ENVIRON MED, V46, pS23, DOI 10.1097/01.jom.0000126683.75201.c5; Kniffin KM, 2021, AM PSYCHOL, V76, P63, DOI 10.1037/amp0000716; Lopez-Leon S, 2020, WORK, V66, P371, DOI 10.3233/WOR-203187; Luckhaupt Sara E., 2012, Morbidity and Mortality Weekly Report, V61, P281; Lupton D, 2013, CRIT PUBLIC HEALTH, V23, P393, DOI 10.1080/09581596.2013.794931; Mitchell EJ, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04711-6; Phillips AJK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03171-4; Rajaratnam SMW, 2011, JAMA-J AM MED ASSOC, V306, P2567, DOI 10.1001/jama.2011.1851; Robbins R, 2021, AM J HEALTH PROMOT, V35, P503, DOI 10.1177/0890117120969091; Schwartz AR, 2020, SLEEP MED, V71, P66, DOI 10.1016/j.sleep.2020.03.005; Sullivan JP, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw001; W. H. Organization, 2020, 85 WHO; Weaver MD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.23256; Weaver MD, 2018, J SLEEP RES, V27, DOI 10.1111/jsr.12722	22	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0260828	10.1371/journal.pone.0260828	http://dx.doi.org/10.1371/journal.pone.0260828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986183	Green Submitted, gold, Green Published			2022-12-27	WOS:000765956200008
J	Hedlund, L; Jensen, P				Hedlund, Louise; Jensen, Per			Effects of stress during commercial hatching on growth, egg production and feather pecking in laying hens	PLOS ONE			English	Article							EARLY FEED RESTRICTION; BROILER-CHICKENS; HEAT-STRESS; CANNIBALISM; BEHAVIOR; THERMOTOLERANCE; TEMPERATURE; SELECTION; EXPOSURE	Every year, billions of egg layer chicks around the world are hatched under highly stressful, industrial circumstances. Here, it is investigated how the stressful procedure in the commercial hatchery, including incubation, hatching, processing, and transport affects the chicks with regards to traits relevant for the egg production industry. These traits were compared to those of a control group hatched in a small incubator and handled gently och quietly in a quiet room without any processing and transport. The chicks were weighed at hatch and at eight additional time points: 4 days, 1 week (w), 2 w, 3 w, 5 w, 8 w, 20 w and 25 w of age. Feather pecking was studied at 15 w of age and damages to the feathers and injuries on the comb and wattle were assessed at 25 w of age. From 19 w of age, eggs were collected on three days per week, counted and weighed. Chicks from a commercial hatchery had a lower hatch weight than control chicks (p<0.001). At 20 w of age, the weight of the commercial hatched chicks was still numerically lower, although this did not reach statistical significance. Commercially hatched chicks tended to show more feather pecking behaviour at 15 w of age compared to control chicks (p<0.1), although feather condition at 25 w of age showed the opposite pattern. Regarding production, commercially hatched chickens laid fewer (p<0.05) and smaller (p<0.05) eggs than chicks hatched and handled under calm circumstances. From this experiment, it is concluded that the stressful experience in the commercial hatchery has an overall negative effect on traits relevant for the industry.	[Hedlund, Louise; Jensen, Per] Linkoping Univ, IFM Biol, Linkoping, Sweden	Linkoping University	Jensen, P (corresponding author), Linkoping Univ, IFM Biol, Linkoping, Sweden.	per.jensen@liu.se			FORMAS [2016-01728]	FORMAS(Swedish Research Council Formas)	P.J. recieved funding from FORMAS, grant No. 2016-01728, http://formas.se.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altan O, 2000, BRIT POULTRY SCI, V41, P489, DOI 10.1080/713654965; BLOKHUIS HJ, 1984, APPL ANIM BEHAV SCI, V12, P145, DOI 10.1016/0168-1591(84)90104-7; BLOKHUIS HJ, 1992, BRIT POULTRY SCI, V33, P17, DOI 10.1080/00071669208417440; Bolhuis JE, 2009, PHYSIOL BEHAV, V97, P470, DOI 10.1016/j.physbeh.2009.03.021; Camm EJ, 2001, DEV BRAIN RES, V132, P141, DOI 10.1016/S0165-3806(01)00305-4; de Haas EN, 2013, POULTRY SCI, V92, P2259, DOI 10.3382/ps.2012-02996; Deng C, 2002, ANIM BEHAV, V63, P697, DOI 10.1006/anbe.2001.1942; Eriksen MS, 2003, BRIT POULTRY SCI, V44, P690, DOI 10.1080/00071660310001643660; FAO, FOOD AGR ORG UN; GEBHARDTHENRICH SG, 1995, POULTRY SCI, V74, P402, DOI 10.3382/ps.0740402; Giersberg MF, 2017, ANIMALS, V7, DOI 10.3390/ani7120097; Glatz PC, 2001, ASIAN AUSTRAL J ANIM, V14, P553, DOI 10.5713/ajas.2001.553; Hassan SM, 2003, POULTRY SCI, V82, P1163, DOI 10.1093/ps/82.7.1163; Hedlund L, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11041083; Hedlund L, 2021, POULTRY SCI, V100, P1, DOI 10.1016/j.psj.2020.10.015; Hedlund L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38817-y; Henriksen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023824; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; Hollemans MS, 2018, POULTRY SCI, V97, P2534, DOI 10.3382/ps/pey106; Jensen AB, 2006, APPL ANIM BEHAV SCI, V99, P287, DOI 10.1016/j.applanim.2005.10.017; Jensen P, 2014, APPL ANIM BEHAV SCI, V157, P1, DOI 10.1016/j.applanim.2014.02.009; Johnsen PF, 1998, APPL ANIM BEHAV SCI, V60, P25, DOI 10.1016/S0168-1591(98)00149-X; JOZSA R, 1979, GEN COMP ENDOCR, V39, P158, DOI 10.1016/0016-6480(79)90221-1; Kesar Alpana Goel, 2014, Int J Appl Basic Med Res, V4, P3, DOI 10.4103/2229-516X.125666; Kjaer JB, 2001, APPL ANIM BEHAV SCI, V71, P229, DOI 10.1016/S0168-1591(00)00184-2; Mashaly MM, 2004, POULTRY SCI, V83, P889, DOI 10.1093/ps/83.6.889; NORGAARDNIELSEN G, 1993, APPL ANIM BEHAV SCI, V38, P345, DOI 10.1016/0168-1591(93)90032-K; Riber AB, 2007, APPL ANIM BEHAV SCI, V106, P39, DOI 10.1016/j.applanim.2006.07.012; Riedstra B, 2004, ANIM BEHAV, V67, P1037, DOI 10.1016/j.anbehav.2003.10.009; Riedstra B, 2002, APPL ANIM BEHAV SCI, V77, P127, DOI 10.1016/S0168-1591(02)00031-X; Rodenburg TB, 2004, APPL ANIM BEHAV SCI, V86, P291, DOI 10.1016/j.applanim.2004.02.007; Shinder D, 2002, J THERM BIOL, V27, P517, DOI 10.1016/S0306-4565(02)00025-6; Tumova E, 2002, CZECH J ANIM SCI, V47, P418; Urdaneta-Rincon M, 2002, POULTRY SCI, V81, P679, DOI 10.1093/ps/81.5.679; Yahav S, 1996, POULTRY SCI, V75, P402, DOI 10.3382/ps.0750402; Zhan XA, 2007, POULTRY SCI, V86, P654, DOI 10.1093/ps/86.4.654	36	3	3	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262307	10.1371/journal.pone.0262307	http://dx.doi.org/10.1371/journal.pone.0262307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982788	Green Published, gold			2022-12-27	WOS:000834805700029
J	Wang, S; Liu, RH; Huang, CR				Wang, Shan; Liu, Ruhan; Huang, Chu-Ren			Social changes through the lens of language: A big data study of Chinese modal verbs	PLOS ONE			English	Article							FREQUENCY; EVOLUTION; TIME; WORD	Leech's corpus-based comparison of English modal verbs from 1961 to 1992 showed the steep decline of all modal verbs together, which he ascribed to continuing changes towards a more equal and less authority-driven society. This study inspired many diachronic and synchronic studies, mostly on English modal verbs and largely assuming the correlation between the use of modal verbs and power relations. Yet, there are continuing debates on sampling design and the choices of corpora. In addition, this hypothesis has not been attested in any other language with comparable corpus size or examined with longitudinal studies. This study tracks the use of Chinese modal verbs from 1901 to 2009, covering the historical events of the New Culture Movement, the establishment of the PRC, the implementation of simplified characters and the completion and finalization of simplification of the Chinese writing system. We found that the usage of modal verbs did rise and fall during the last century, and for more complex reasons. We also demonstrated that our longitudinal end-to-end approach produces convincing analysis on English modal verbs that reconciles conflicting results in the literature adopting Leech's point-to-point approach.	[Wang, Shan; Liu, Ruhan] Univ Macau, Fac Arts & Humanities, Dept Chinese Language & Literature, Zhuhai, Peoples R China; [Wang, Shan] Univ Macau, Inst Collaborat Innovat, Zhuhai, Peoples R China; [Huang, Chu-Ren] Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Hong Kong, Peoples R China; [Huang, Chu-Ren] Hong Kong Polytech Univ, Peking Univ Res Ctr Chinese Linguist, Hong Kong, Peoples R China	University of Macau; University of Macau; Hong Kong Polytechnic University; Hong Kong Polytechnic University	Wang, S (corresponding author), Univ Macau, Fac Arts & Humanities, Dept Chinese Language & Literature, Zhuhai, Peoples R China.; Wang, S (corresponding author), Univ Macau, Inst Collaborat Innovat, Zhuhai, Peoples R China.	ummacauworld@gmail.com	Huang, Chu-Ren/A-8757-2010	Huang, Chu-Ren/0000-0002-8526-5520	University of Macau [MYRG2019-00013-FAH]	University of Macau	Shan Wang is the PI who received the funded project Multi-year Research Grant by University of Macau. The project No. is: MYRG2019-00013-FAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, SEMANTICS; Barbet C, 2015, J FR LANG STUD, V25, P213, DOI 10.1017/S0959269515000113; Biber D., 1999, LONGMAN GRAMMAR SPOK; Blythe RA, 2012, LANGUAGE, V88, P269, DOI 10.1353/lan.2012.0027; Borsley RD, 2020, J LINGUIST, V56, P691, DOI 10.1017/S0022226720000213; Chen H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192545; Chen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138567; Chen Keh-Jiann, 1996, P 11 PAC AS C LANG I, P167; Cournane A, 2014, LANG ACQUIS, V21, P103, DOI 10.1080/10489223.2013.855218; Examination Center of The National Chinese Proficiency Test Committee, 2001, SYLLABUS CHINESE VOC; FILLMORE CJ, 1992, TREND LIN S, V65, P35; Francis W. N., 1979, DEP LINGUISTICS; Giannakidou A, 2018, LINGUIST PHILOS, V41, P623, DOI 10.1007/s10988-018-9235-1; Grammaticalisation SchutzlerO., 2018, ENGL LANG LINGUIST, V22, P101; Halliday M.A.K, 1989, LANGUAGE CONTEXT TEX, V2; Halliday M A K, 2013, HALLIDAYS INTRO FUNC, V4th, DOI DOI 10.4324/9780203783771; Hsieh C-L., 2005, UST WORKING PAPERS L, V1, P31; Hu Y., 1979, XIANDAI HANYU XIUDIN; Huang CR, 2021, HUM SOC SCI COMMUN, V8, DOI 10.1057/s41599-020-00682-w; Huang CR, 2017, ROUTL STUD CHIN LING, P1; Ingham R, 2020, NAT LANG LINGUIST TH, V38, P477, DOI 10.1007/s11049-019-09450-1; Janda Laura A., 2013, COGN LINGUIST; Kawalya D, 2014, INT J CORPUS LINGUIS, V19, P60, DOI 10.1075/ijcl.19.1.03kaw; Kilgarriff A, 2003, COMPUT LINGUIST, V29, P333, DOI 10.1162/089120103322711569; Kim JY, 2016, INLAND WATERS, V6, P395, DOI 10.5268/IW-6.3.849; Labov William, 1966, SOCIOL INQ, V36, P186, DOI DOI 10.1111/J.1475-682X.1966.TB00624.X; Leech G., 2003, MODALITY CONT ENGLIS; Leech G., 1992, LANGUAGE RES, V28, P1; Leech G, 2011, INT J CORPUS LINGUIS, V16, P547, DOI 10.1075/ijcl.16.4.05lee; Lei SY, 2021, LINGUA, V258, DOI 10.1016/j.lingua.2021.103095; Li J., 1951, XINZHU GUOYU WENFA; Li LX, 2020, SAGE OPEN, V10, DOI 10.1177/2158244020951272; Lieberman E, 2007, NATURE, V449, P713, DOI 10.1038/nature06137; Lin Y., 2012, P ACL 2012 SYSTEM DE, P169, DOI DOI 10.1007/978-1-4614-2311-9_8; Liu ZH, 2016, J QUANT LINGUIST, V23, P361, DOI 10.1080/09296174.2016.1226431; Lv S., 1979, HANYU YUFA FENXI WEN; Ma Q., 2005, HANYU DONGCI HE DONG; Marcus GF, 2004, NATURE, V431, P745, DOI 10.1038/431745a; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Millar N, 2009, INT J CORPUS LINGUIS, V14, P191, DOI 10.1075/ijcl.14.2.03mil; NAROLL R, 1961, PHILOS SCI, V28, P15, DOI 10.1086/287778; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; Nunberg G., 2010, HUMANITIES RES GOOGL; Pavlovic V, 2019, REV COGN LINGUIST, V17, P29, DOI 10.1075/rcl.00025/pav; Pettit M, 2016, HIST PSYCHOL, V19, P141, DOI 10.1037/hop0000023; Schutzler O., 2020, LANG SCI, P79; Thegel M, 2020, STUD NEOPHILOL, V92, P124, DOI 10.1080/00393274.2020.1724822; Twenge JM, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017723689; Wang L., 1985, ZHONGGUO XIANDAI YUF; Wang S., 2021, J CHINESE INFORM PRO; Wang S., 2021, 20 CHINA NATL C COMP; Wang XW, 2018, LECT NOTES ARTIF INT, V11173, P155, DOI 10.1007/978-3-030-04015-4_13; Westin I., 2002, LANGUAGE CHANGE ENGL; Xu Y, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01066; Zhang C, 2019, J CHINESE LINGUIST, V47, P497	55	0	0	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0260210	10.1371/journal.pone.0260210	http://dx.doi.org/10.1371/journal.pone.0260210			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982791	gold, Green Published			2022-12-27	WOS:000834805700004
J	Al Imam, MH; Jahan, I; Muhit, M; Das, MC; Power, R; Khan, A; Akbar, D; Badawi, N; Khandaker, G				Al Imam, Mahmudul Hassan; Jahan, Israt; Muhit, Mohammad; Das, Manik Chandra; Power, Rosalie; Khan, Arifuzzaman; Akbar, Delwar; Badawi, Nadia; Khandaker, Gulam			Supporting Ultra Poor People with Rehabilitation and Therapy among families of children with Cerebral Palsy in rural Bangladesh (SUPPORT CP): Protocol of a randomised controlled trial	PLOS ONE			English	Article							GROSS MOTOR FUNCTION; QUALITY-OF-LIFE; EARLY INTERVENTION; HEALTH; RELIABILITY; CLASSIFICATION; SYSTEM	Introduction Poverty is a key contributor to delayed diagnosis and limited access to early intervention and rehabilitation for children with cerebral palsy (CP) in rural Bangladesh. 97% of families of children with CP live below the poverty line in Bangladesh. Therefore, in low-and middle-income countries (LMICs), efforts to improve outcomes for children with CP (including health-related quality of life, motor function, communication, and nutritional attainments) should also include measures to improve family economic and social capital. We propose a randomised controlled trial (RCT) to evaluate the effectiveness of an integrated microfinance/livelihood and community-based rehabilitation (IMCBR) program for ultra-poor families of children with CP in rural Bangladesh. Material and methods This will be a cluster RCT comparing three arms: (a) integrated microfinance/livelihood and community-based rehabilitation (IMCBR); (b) community-based rehabilitation (CBR) alone; and (c) care-as-usual (i.e. no intervention). Seven clusters will be recruited within each arm. Each cluster will consist of 10 child-caregiver dyads totalling 21 clusters with 210 dyads. Parents recruited in the IMCBR arm will take part in a microfinance/livelihood program and Parent Training Module (PTM), their children with CP will take part in a Goal Directed Training (GDT) program. The programs will be facilitated by specially trained Community Rehabilitation Officers. The CBR arm includes the same PTM and GDT interventions excluding the microfinance/livelihood program. The care-as-usual arm will be provided with information about early intervention and rehabilitation. The assessors will be blinded to group allocation. The duration of the intervention will be 12 months; outcomes will be measured at baseline, 6 months, 12 months, and 18 months. Conclusion This will be the first RCT of an integrated microfinance/livelihood and CBR program for children with CP in LMIC settings. Evidence from the study could transform approaches to improving wellbeing of children with CP and their ultra-poor families.	[Al Imam, Mahmudul Hassan; Jahan, Israt; Muhit, Mohammad; Das, Manik Chandra; Khan, Arifuzzaman] CSF Global, Dhaka, Bangladesh; [Al Imam, Mahmudul Hassan; Jahan, Israt; Muhit, Mohammad; Das, Manik Chandra; Power, Rosalie; Khan, Arifuzzaman] Univ South Asia, Asian Inst Disabil & Dev AIDD, Dhaka, Bangladesh; [Al Imam, Mahmudul Hassan; Jahan, Israt; Khandaker, Gulam] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia; [Al Imam, Mahmudul Hassan; Khan, Arifuzzaman; Khandaker, Gulam] Cent Queensland Hosp & Hlth Serv, Cent Queensland Publ Hlth Unit, Rockhampton, Qld, Australia; [Power, Rosalie] Western Sydney Univ, Translat Hlth Res Inst THRI, Campbelltown, NSW, Australia; [Khan, Arifuzzaman] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Akbar, Delwar] Cent Queensland Univ, Sch Business & Law, Rockhampton, Qld, Australia; [Badawi, Nadia] Univ Sydney, Sydney Med Sch, Cerebral Palsy Alliance, Camperdown, NSW, Australia; [Badawi, Nadia] Sydney Childrens Hosp Network, Grace Ctr Newborn Intens Care, Westmead, NSW, Australia; [Khandaker, Gulam] Univ Sydney, Sydney Med Sch, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia	University of South Asia; Central Queensland University; University of Sydney; Western Sydney University; University of Queensland; Central Queensland University; University of Sydney; University of Sydney	Khandaker, G (corresponding author), Cent Queensland Univ, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia.; Khandaker, G (corresponding author), Cent Queensland Hosp & Hlth Serv, Cent Queensland Publ Hlth Unit, Rockhampton, Qld, Australia.; Khandaker, G (corresponding author), Univ Sydney, Sydney Med Sch, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia.	gulam.khandaker@health.qld.gov.au	Al Imam, Mahmudul Hassan/AHE-3981-2022; Al Imam, Mahmudul Hassan/AAN-6523-2020; Khan, Md Arifuzzaman/C-1117-2019	Al Imam, Mahmudul Hassan/0000-0002-1670-9060; Power, Rosalie/0000-0001-9434-3941; Khan, Md Arifuzzaman/0000-0003-4770-8308	Research Foundation of Cerebral Palsy Alliance [PG02218]; CSF Global	Research Foundation of Cerebral Palsy Alliance; CSF Global	This project is funded by the Research Foundation of Cerebral Palsy Alliance (https://cerebralpalsy.org.au/our-research/researchfoundation-and-institute/)(Steptember Project Grant PG02218) and internal funding from CSF Global (http://csf-global.org/).The funders did not and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter R, 2017, DEV MED CHILD NEUROL, V59, P538, DOI 10.1111/dmcn.13359; Al Imam MH, 2022, DISABIL REHABIL, V44, P5571, DOI 10.1080/09638288.2021.1939799; Al Imam MH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250640; Al Imam MH, 2021, DEV MED CHILD NEUROL, V63, P883, DOI 10.1111/dmcn.14861; Alim SAHM, 2014, BANGLADESH J PSYCHIA, V28, P67, DOI [28.67.10.3329/bjpsy.v28i2.32740, DOI 10.3329/BJPSY.V28I2.32740]; Australian Cerebral Palsy Register, 2018, REP AUSTR CER PALS R, P18; Avery LM, 2003, ARCH PHYS MED REHAB, V84, P697, DOI 10.1016/S0003-9993(03)04896-7; Bao XL, 1997, CHINESE MED J-PEKING, V110, P875; Benfer KA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021186; Berge LIO, 2015, J ECON BEHAV ORGAN, V118, P303, DOI 10.1016/j.jebo.2014.11.014; Boisjoly J, 2006, AM ECON REV, V96, P1890, DOI 10.1257/aer.96.5.1890; Bongo PP, 2018, JAMBA-J DISASTER RIS, V10, DOI 10.4102/jamba.v10i1.442; BRAC, 2013, END SIGHT ULTR SCAL, P1; Bunge EM, 2005, ARCH DIS CHILD, V90, P351, DOI 10.1136/adc.2003.048645; Burns J., 2015, INTERACTION PREJUDIC; Campos F, 2017, SCIENCE, V357, P1287, DOI 10.1126/science.aan5329; Coates J., 2007, HOUSEHOLD FOOD SECUR, DOI [10.1037/e576842013-001, DOI 10.1037/E576842013-001]; Dambi JM, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0301-8; Donner A., 2010, DESIGN ANAL CLUSTER; Fekkes M, 2000, QUAL LIFE RES, V9, P961, DOI 10.1023/A:1008981603178; Government of Bangladesh (GOB), 2013, ANN REP 2011 2012; Government of Bangladesh (GOB), 2016, HLTH B 2016; Hamad R, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.108399; Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106; Heckman JJ, 2012, LABOUR ECON, V19, P451, DOI 10.1016/j.labeco.2012.05.014; Hidecker MJC, 2012, DEV MED CHILD NEUROL, V54, P737, DOI 10.1111/j.1469-8749.2012.04312.x; Hidecker MJC, 2011, DEV MED CHILD NEUROL, V53, P704, DOI 10.1111/j.1469-8749.2011.03996.x; Hossain MK, 2012, INT BUSINESS RES, V5, P112, DOI DOI 10.5539/IBR.V5N4P112; Islam N, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0683-z; Jahan I, 2019, DEV MED CHILD NEUROL, V61, P1336, DOI 10.1111/dmcn.14256; Jahan I, 2019, DISABIL REHABIL, V41, P2247, DOI 10.1080/09638288.2018.1461260; Johnson K., 2007, BANGLADESH SOCIOECON; Kakooza-Mwesige A, 2017, LANCET GLOB HEALTH, V5, pE1275, DOI 10.1016/S2214-109X(17)30374-1; Karlan D, 2017, AM J TROP MED HYG, V96, P501, DOI 10.4269/ajtmh.16-0126; Khan Arifuzzaman, 2020, Infectious Disorders - Drug Targets, V20, P303, DOI 10.2174/1871526518666181001140817; Khandaker G, 2019, DEV MED CHILD NEUROL, V61, P601, DOI 10.1111/dmcn.14013; Khandaker G, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0427-9; Khandaker G, 2014, J TROP PEDIATRICS, V60, P363, DOI 10.1093/tropej/fmu031; Kreuter MW, 1999, ANN BEHAV MED, V21, P276, DOI 10.1007/BF02895958; Linnemayr Sebastian, 2017, J Int Assoc Provid AIDS Care, V16, P254, DOI 10.1177/2325957416667485; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Mahoney Gerald, 2006, Downs Syndr Res Pract, V10, P67, DOI 10.3104/reviews.307; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mastos M, 2007, CLIN REHABIL, V21, P47, DOI 10.1177/0269215506073494; May P., 2020, Infectious Disorders - Drug Targets, V20, P318, DOI 10.2174/1871526518666181024101002; Novak I, 2017, JAMA PEDIATR, V171, P897, DOI 10.1001/jamapediatrics.2017.1689; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Power R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217675; Rao G, 2019, AM ECON REV, V109, P774, DOI 10.1257/aer.20180044; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Russell DJ, 2000, PHYS THER, V80, P873, DOI 10.1093/ptj/80.9.873; Saggurti N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202562; Sakzewski L, 2014, PEDIATRICS, V133, pE175, DOI 10.1542/peds.2013-0675; Sarker D., 2015, INT J INNOV EC DEV, V1, P67; Story WT, 2015, QUAL HEALTH RES, V25, P806, DOI 10.1177/1049732315580106; Tsoi WSE, 2012, CHILD CARE HLTH DEV, V38, P21, DOI 10.1111/j.1365-2214.2011.01255.x; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Whyte B., 2016, GLASGOW HLTH CHANGIN, P17; Zuurmond M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202096	59	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261148	10.1371/journal.pone.0261148	http://dx.doi.org/10.1371/journal.pone.0261148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972100	Green Published, gold			2022-12-27	WOS:000773555700024
J	Leddy, AM; Gottert, A; Haberland, N; Hove, J; West, RL; Pettifor, A; Lippman, SA; Kahn, K; Mathebula, R; Rebombo, D; Gomez-Olive, X; Twine, R; Peacock, D; Pulerwitz, J				Leddy, Anna M.; Gottert, Ann; Haberland, Nicole; Hove, Jennifer; West, Rebecca L.; Pettifor, Audrey; Lippman, Sheri A.; Kahn, Kathleen; Mathebula, Rhandzekile; Rebombo, Dumisani; Gomez-Olive, Xavier; Twine, Rhian; Peacock, Dean; Pulerwitz, Julie			Shifting gender norms to improve HIV service uptake: Qualitative findings from a large-scale community mobilization intervention in rural South Africa	PLOS ONE			English	Article							YOUNG-ADULTS; CONDOM USE; PREVENTION; MASCULINITY; CARE; MEN; COMMUNICATION; ENGAGEMENT; ATTITUDES; VIOLENCE	Background Interventions to improve HIV service uptake are increasingly addressing inequitable and restrictive gender norms. Yet comparatively little is known about which gender norms are most salient for HIV testing and treatment and how changing these specific norms translates into HIV service uptake. To explore these questions, we implemented a qualitative study during a community mobilization trial targeting social barriers to HIV service uptake in South Africa. Methods We conducted 55 in-depth interviews in 2018, during the final months of a three-year intervention in rural Mpumalanga province. Participants included 25 intervention community members (48% women) and 30 intervention staff/community-opinion-leaders (70% women). Data were analyzed using an inductive-deductive approach. Results We identified three avenues for gender norms change which, when coupled with other strategies, were described to support HIV service uptake: (1) Challenging norms around male toughness/avoidance of help-seeking, combined with information on the health and preventive benefits of early antiretroviral therapy (ART), eased men's fears of a positive diagnosis and facilitated HIV service uptake. (2) Challenging norms about men's expected control over women, combined with communication and conflict resolution skill-building, encouraged couple support around HIV service uptake. (3) Challenging norms around women being solely responsible for the family's health, combined with information about sero-discordance and why both members of the couple should be tested, encouraged men to test for HIV rather than relying on their partner's results. Facility-level barriers such as long wait times continued to prevent some men from accessing care. Conclusions Despite continued facility-level barriers, we found that promoting critical reflection around several specific gender norms, coupled with information (e.g., benefits of ART) and skill-building (e.g., communication), were perceived to support men's and women's engagement in HIV services. There is a need to identify and tailor programming around specific gender norms that hinder HIV service uptake.	[Leddy, Anna M.; West, Rebecca L.; Lippman, Sheri A.] Univ Calif San Francisco, Dept Med, Div Prevent Sci, San Francisco, CA 94143 USA; [Gottert, Ann; Haberland, Nicole; Pulerwitz, Julie] Populat Council, Project SOAR, Washington, DC USA; [Gottert, Ann; Haberland, Nicole; Pulerwitz, Julie] Populat Council, Project SOAR, New York, NY USA; [Hove, Jennifer; Pettifor, Audrey; Lippman, Sheri A.; Kahn, Kathleen; Gomez-Olive, Xavier; Twine, Rhian] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Pettifor, Audrey] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Mathebula, Rhandzekile; Rebombo, Dumisani] Sonke Gender Justice, Johannesburg, South Africa; [Peacock, Dean] Promundo, Washington, DC USA; [Rebombo, Dumisani] Yanani Community Project, Johannesburg, South Africa	University of California System; University of California San Francisco; Population Council; Population Council; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill	Leddy, AM (corresponding author), Univ Calif San Francisco, Dept Med, Div Prevent Sci, San Francisco, CA 94143 USA.	anna.leddy@ucsf.edu		Leddy, Anna/0000-0002-1508-4193; Pettifor, Audrey/0000-0002-3387-0817	Project SOAR through the United States President's Emergency Plan for AIDS Relief (PEPFAR) [AID-OAA-A-14-00060]; United States Agency for International Development (USAID)	Project SOAR through the United States President's Emergency Plan for AIDS Relief (PEPFAR); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	The manuscript and related analyses were supported by Project SOAR (Cooperative AgreementAID-OAA-A-14-00060) (PI: NH), made possible by the generous support of the American people through the United States President's Emergency Plan for AIDS Relief (PEPFAR)and United States Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this paper are the sole responsibility of the authors and do not necessarily reflect the views of PEPFAR, USAID, or the United States Government.	Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; Antle BF, 2011, J FAM SOC WORK, V14, P387, DOI 10.1080/10522158.2011.616482; Berkowitz A. D., 2003, SOCIAL NORMS APPROAC, P259; Camlin CS, 2016, AIDS CARE, V28, P67, DOI 10.1080/09540121.2016.1164806; Colvin CJ, 2019, LANCET HIV, V6, pE191, DOI 10.1016/S2352-3018(19)30032-3; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Darbes LA, 2019, JAIDS-J ACQ IMM DEF, V80, P404, DOI [10.1097/QAI.0000000000001948, 10.1097/qai.0000000000001948]; Dovel K, 2015, AIDS, V29, P1123, DOI 10.1097/QAD.0000000000000655; Dworkin SL, 2013, AIDS BEHAV, V17, P2845, DOI 10.1007/s10461-013-0565-2; El-Bassel N, 2010, JAIDS-J ACQ IMM DEF, V55, pS98, DOI 10.1097/QAI.0b013e3181fbf407; Fleming PJ, 2016, CULT HEALTH SEX, V18, P1251, DOI 10.1080/13691058.2016.1183045; Fleming PJ, 2016, AIDS, V30, P157, DOI 10.1097/QAD.0000000000000899; Fleming PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118639; Gomez-Olive FX, 2013, AIDS CARE, V25, P1122, DOI 10.1080/09540121.2012.750710; Gottert A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237084; Gottert A, 2018, AIDS BEHAV, V22, P1858, DOI 10.1007/s10461-017-1706-9; Harichund C, 2019, AIDS CARE, V31, P186, DOI 10.1080/09540121.2018.1503638; Harichund C, 2018, AIDS BEHAV, V22, P560, DOI 10.1007/s10461-017-1848-9; Harrison A, 2006, J URBAN HEALTH, V83, P709, DOI 10.1007/s11524-006-9077-y; Heise L, 2019, LANCET, V393, P2440, DOI 10.1016/S0140-6736(19)30652-X; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Kalichman SC, 2007, AIDS CARE, V19, P20, DOI 10.1080/09540120600984003; Kaufman MR, 2008, AIDS CARE, V20, P434, DOI 10.1080/09540120701867057; Kerrigan D, 2019, JAIDS-J ACQ IMM DEF, V82, P141, DOI 10.1097/QAI.0000000000002123; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Leddy A, 2016, AIDS CARE, V28, P228, DOI 10.1080/09540121.2015.1080792; Leddy AM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7192-4; Levy JK, 2020, LANCET GLOB HEALTH, V8, pE225, DOI 10.1016/S2214-109X(19)30495-4; Lippman SA, 2020, INT AIDS SOC C SAN F; Lippman SA, 2020, JAIDS-J ACQ IMM DEF, V83, pE9, DOI 10.1097/QAI.0000000000002197; Lippman SA, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25182; Lippman SA, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-016-0541-0; Lippman SA, 2017, JAIDS-J ACQ IMM DEF, V74, pS44, DOI 10.1097/qai.0000000000001207; Lippman SA, 2016, SOC SCI MED, V157, P127, DOI 10.1016/j.socscimed.2016.04.002; Lippman SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078208; Lippman SA, 2012, SEX TRANSM DIS, V39, P209, DOI 10.1097/OLQ.0b013e31823b1937; Mburu G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1061; Minnis AM, 2015, INT J WOMENS HEALTH, V7, P517, DOI 10.2147/IJWH.S77398; Mooney AC, 2017, AIDS EDUC PREV, V29, P274, DOI 10.1521/aeap.2017.29.3.274; National Department of Health South Africa, 2018, NAT HIV SELF SCREEN; Orr N, 2017, JAIDS-J ACQ IMM DEF, V74, pS69, DOI 10.1097/qai.0000000000001204; Pettifor A, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100327; Pettifor A, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25134; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; President's Emergency Plan for ARP, 2020, MENSTAR STRAT; Pulerwitz J, 2019, AIDS BEHAV, V23, pS162, DOI 10.1007/s10461-019-02603-8; Scientific Software Development, 2018, ATLAS TI, V8; Sikweyiya YM, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24631; Sileo KM, 2019, AIDS CARE, V31, P1435, DOI 10.1080/09540121.2019.1595509; Sileo KM, 2018, AIDS BEHAV, V22, P2468, DOI 10.1007/s10461-018-2160-z; Sonke Gender Justice, 2012, BUSHB ON MAN CAN COM; Stephenson R, 2013, AIDS BEHAV, V17, P2352, DOI 10.1007/s10461-012-0223-0; Strebel A, 2006, SAHARA J, V3, P516; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; UNAIDS, 2020, UNAIDS DAT; UNAIDS, 2017, BLIND SPOT REACH MEN; van den Berg W, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001811	57	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0260425	10.1371/journal.pone.0260425	http://dx.doi.org/10.1371/journal.pone.0260425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972113	gold, Green Published			2022-12-27	WOS:000773555700014
J	Ma, XM; Liu, Q; Zhang, ZD; Zhang, ZW; Zhou, ZY; Jiang, Y; Huang, XR				Ma, Xuemei; Liu, Qiang; Zhang, Zhidong; Zhang, Zewen; Zhou, Zeyu; Jiang, Yu; Huang, Xuanrui			Effects of photosynthetic models on the calculation results of photosynthetic response parameters in young Larix principis-rupprechtii Mayr. plantation	PLOS ONE			English	Article							LIGHT-RESPONSE; CANOPY PHOTOSYNTHESIS; LEAF PHOTOSYNTHESIS; CURVES; ACCLIMATION; RESPIRATION; EFFICIENCY; EXCHANGE; CONDUCTANCE; IRRADIANCE	Accurately predicting the crown photosynthesis of trees is necessary for better understanding the C circle in terrestrial ecosystem. However, modeling crown for individual tree is still challenging with the complex crown structure and changeable environmental conditions. This study was conducted to explore model in modeling the photosynthesis light response curve of the tree crown of young Larix principis-rupprechtii Mayr. Plantation. The rectangular hyperbolic model (RHM), non-rectangular hyperbolic model (NRHM), exponential model (EM) and modified rectangular hyperbolic model (MRHM) were used to model the photosynthetic light response curves. The fitting accuracy of these models was tested by comparing determinants coefficients (R-2), mean square errors (MSE) and Akaike information criterion (AIC). The results showed that the mean value of R-2 of MRHM (R-2 = 0.9687) was the highest, whereas MSE value (MSE = 0.0748) and AIC value (AIC = -39.21) were the lowest. The order of fitting accuracy of the four models for P-n-PAR response curve was as follows: MRHM > EM > NRHM > RHM. In addition, the light saturation point (LSP) obtained by MRHM was slightly lower than the observed values, whereas the maximum net photosynthetic rates (P-max) modeled by the four models were close to the measured values. Therefore, MRHM was superior to other three models in describing the photosynthetic response curve, the accurate values were that the quantum efficiency (alpha), maximum net photosynthetic rate (P-max), light saturation point (LSP), light compensation point (LCP) and respiration rate (R-d) were 0.06, 6.06 mu mol.m(-2)s(-1), 802.68 mu mol.m(-2)s(-1), 10.76 mu mol.m(-2)s(-1) and 0.60 mu mol.m(-2)s(-1). Moreover, the photosynthetic response parameters values among different layers were also significant. Our findings have critical implications for parameter calibration of photosynthetic models and thus robust prediction of photosynthetic response in forests.	[Ma, Xuemei; Liu, Qiang; Zhang, Zhidong; Zhang, Zewen; Zhou, Zeyu; Jiang, Yu; Huang, Xuanrui] Hebei Agr Univ, Coll Forestry, Baoding, Hebei, Peoples R China; [Ma, Xuemei] Anyang Inst Technol, Anyang, Henan, Peoples R China	Hebei Agricultural University; Anyang Institute of Technology	Liu, Q; Huang, XR (corresponding author), Hebei Agr Univ, Coll Forestry, Baoding, Hebei, Peoples R China.	qiangliu2015@126.com; hxr1962@163.com			Asia-Pacific Network for Sustainable Forest Management and Rehabilitation (APFNet) project [2021SP2-CHN]; National Science Foundation of China [32071795]; Talent Special Scientific Research Fund of Hebei Agricultural University [YJ201942]	Asia-Pacific Network for Sustainable Forest Management and Rehabilitation (APFNet) project; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talent Special Scientific Research Fund of Hebei Agricultural University	This research was funded by the Asia-Pacific Network for Sustainable Forest Management and Rehabilitation (APFNet) project (No.2021SP2-CHN), the National Science Foundation of China (No.32071795) and Talent Special Scientific Research Fund of Hebei Agricultural University (YJ201942).	Akhkha A, 2001, PLANTA, V214, P135, DOI 10.1007/s004250100599; Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Atkin OK, 2006, GLOBAL CHANGE BIOL, V12, P500, DOI 10.1111/j.1365-2486.2006.01114.x; BASSMAN JH, 1991, TREE PHYSIOL, V8, P145, DOI 10.1093/treephys/8.2.145; Campbell C, 2007, NEW PHYTOL, V176, P375, DOI 10.1111/j.1469-8137.2007.02183.x; Chai SF., 2015, J GUANG 11 ACAD SCI, V31, P286, DOI [10.13657/j.cnki.gxkxyxb.20151126.001, DOI 10.13657/J.CNKI.GXKXYXB.20151126.001]; Chen Wei-Ying, 2012, Chinese Journal of Plant Ecology, V36, P1277, DOI 10.3724/SP.J.1258.2012.01277; Chen ZY, 2011, PHOTOSYNTHETICA, V49, P467, DOI 10.1007/s11099-011-0056-5; Cox PM, 1998, J HYDROL, V212, P79, DOI 10.1016/S0022-1694(98)00203-0; Di XY, 2014, BIOCHEM SYST ECOL, V54, P71, DOI 10.1016/j.bse.2013.12.035; Dias-Filho Moacyr Bernardino, 2002, Sci. agric. (Piracicaba, Braz.), V59, P65, DOI 10.1590/S0103-90162002000100009; Gardiner ES, 2001, TREE PHYSIOL, V21, P1103, DOI 10.1093/treephys/21.15.1103; HENLEY WJ, 1993, J PHYCOL, V29, P729, DOI 10.1111/j.0022-3646.1993.00729.x; Huang LiangShuai, 2017, Journal of Nanjing Forestry University (Natural Sciences Edition), V41, P193; Jin S, 2003, FOREST ECOL MANAG, V184, P125, DOI 10.1016/S0378-1127(03)00205-6; Johnson G, 2011, METHODS MOL BIOL, V775, P311, DOI 10.1007/978-1-61779-237-3_17; Kubiske ME, 1996, TREE PHYSIOL, V16, P351; Kull O, 1998, FUNCT ECOL, V12, P767, DOI 10.1046/j.1365-2435.1998.00257.x; Kyei-Boahen S, 2003, PHOTOSYNTHETICA, V41, P301, DOI 10.1023/B:PHOT.0000011967.74465.cc; Lang Y, 2013, PHOTOSYNTHETICA, V51, P370, DOI 10.1007/s11099-013-0036-z; Larocque GR, 2002, ECOL MODEL, V148, P213, DOI 10.1016/S0304-3800(01)00442-2; Liu Q, 2018, CAN J FOREST RES, V48, P1085, DOI 10.1139/cjfr-2018-0151; Liu Q, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68429-w; Liu Q, 2018, FORESTS, V9, DOI 10.3390/f9090522; Liu Qiang, 2016, Yingyong Shengtai Xuebao, V27, P2789, DOI 10.13287/j.1001-9332.201609.008; Lobo FD, 2013, PHOTOSYNTHETICA, V51, P445, DOI 10.1007/s11099-013-0045-y; Luo YQ, 2000, AGR FOREST METEOROL, V100, P35, DOI 10.1016/S0168-1923(99)00085-4; Ma YanJun, 2010, Acta Agrestia Sinica, V18, P183; MARSHALL B, 1980, J EXP BOT, V31, P29, DOI 10.1093/jxb/31.1.29; Moreno-Sotomayor A, 2002, J PLANT PHYSIOL, V159, P819, DOI 10.1078/0176-1617-00809; Peek MS, 2002, OECOLOGIA, V132, P175, DOI 10.1007/s00442-002-0954-0; Pinto H, 2016, PLANT CELL ENVIRON, V39, P514, DOI 10.1111/pce.12636; Posada JM, 2009, ANN BOT-LONDON, V103, P795, DOI 10.1093/aob/mcn265; Quan XK, 2018, FOREST ECOL MANAG, V411, P166, DOI 10.1016/j.foreco.2018.01.024; Rascher U, 2000, PLANT CELL ENVIRON, V23, P1397, DOI 10.1046/j.1365-3040.2000.00650.x; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Shang LQ., 2018, CHIN AGR SCI B, V485, P67; STEELE JH, 1962, LIMNOL OCEANOGR, V7, P137, DOI 10.4319/lo.1962.7.2.0137; Thornley J. H. M., 1976, Mathematical models in plant physiology.; [王海珍 Wang Haizhen], 2017, [生态学报, Acta Ecologica Sinica], V37, P2315; Wilson KB, 2001, PLANT CELL ENVIRON, V24, P571, DOI 10.1046/j.0016-8025.2001.00706.x; Xu ZF, 2012, EUR J FOREST RES, V131, P811, DOI 10.1007/s10342-011-0554-9; Ye ZP, 2007, PHOTOSYNTHETICA, V45, P637, DOI 10.1007/s11099-007-0110-5; Ye ZP, 2008, PHOTOSYNTHETICA, V46, P637, DOI 10.1007/s11099-008-0110-0; Ye Zi-Piao, 2008, Zhiwu Shengtai Xuebao, V32, P1356, DOI 10.3773/j.issn.1005-264x.2008.06.016; Ye ZP., 2009, J JINGGANGSHAN U SCI, V30, P9; Yuan WP, 2007, AGR FOREST METEOROL, V143, P189, DOI 10.1016/j.agrformet.2006.12.001; Zhang GY, 2006, J CHEM TECHNOL BIOT, V81, P1185, DOI 10.1002/jctb.1510; Zhang N, 2020, AGR FOREST METEOROL, V291, DOI 10.1016/j.agrformet.2020.108098; Zhang XQ, 2003, FOREST ECOL MANAG, V173, P201, DOI 10.1016/S0378-1127(02)00015-4; Zhang YunQi, 2019, Journal of Beijing Forestry University, V41, P32; Zheng T, 2017, AGR FOREST METEOROL, V236, P48, DOI 10.1016/j.agrformet.2017.01.008; Zhu SZ., 2016, J SHANXI U NAT SCI E, V39, P184, DOI [10.13451/j.cnki.shanxi.univ(nat.sci.).2016.04.028, DOI 10.13451/J.CNKI.SHANXI.UNIV(NAT.SCI.).2016.04.028]; Zu YG, 2011, PHOTOSYNTHETICA, V49, P448, DOI 10.1007/s11099-011-0057-4	54	1	1	12	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261683	10.1371/journal.pone.0261683	http://dx.doi.org/10.1371/journal.pone.0261683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972150	Green Published, gold			2022-12-27	WOS:000773555700046
J	Mohammad, HR; Gooberman-Hill, R; Delmestri, A; Broomfield, J; Patel, R; Huber, J; Garriga, C; Eccleston, C; Pinedo-Villanueva, R; Malak, TT; Arden, N; Price, A; Wylde, V; Peters, TJ; Blom, AW; Judge, A				Mohammad, Hasan Raza; Gooberman-Hill, Rachael; Delmestri, Antonella; Broomfield, John; Patel, Rita; Huber, Joerg; Garriga, Cesar; Eccleston, Christopher; Pinedo-Villanueva, Rafael; Malak, Tamer T.; Arden, Nigel; Price, Andrew; Wylde, Vikki; Peters, Tim J.; Blom, Ashley W.; Judge, Andrew			Risk factors associated with poor pain outcomes following primary knee replacement surgery: Analysis of data from the clinical practice research datalink, hospital episode statistics and patient reported outcomes as part of the STAR research programme	PLOS ONE			English	Article							PERSISTENT POSTSURGICAL PAIN; NATIONAL JOINT REGISTRY; TOTAL HIP-ARTHROPLASTY; OSTEOARTHRITIS; COHORT; SATISFACTION; PREDICTORS; COLLEGE; ENGLAND	Objective Identify risk factors for poor pain outcomes six months after primary knee replacement surgery. Methods Observational cohort study on patients receiving primary knee replacement from the UK Clinical Practice Research Datalink, Hospital Episode Statistics and Patient Reported Outcomes. A wide range of variables routinely collected in primary and secondary care were identified as potential predictors of worsening or only minor improvement in pain, based on the Oxford Knee Score pain subscale. Results are presented as relative risk ratios and adjusted risk differences (ARD) by fitting a generalized linear model with a binomial error structure and log link function. Results Information was available for 4,750 patients from 2009 to 2016, with a mean age of 69, of whom 56.1% were female. 10.4% of patients had poor pain outcomes. The strongest effects were seen for pre-operative factors: mild knee pain symptoms at the time of surgery (ARD 18.2% (95% Confidence Interval 13.6, 22.8), smoking 12.0% (95% CI:7.3, 16.6), living in the most deprived areas 5.6% (95% CI:2.3, 9.0) and obesity class II 6.3% (95% CI:3.0, 9.7). Important risk factors with more moderate effects included a history of previous knee arthroscopy surgery 4.6% (95% CI:2.5, 6.6), and use of opioids 3.4% (95% CI:1.4, 5.3) within three months after surgery. Those patients with worsening pain state change had more complications by 3 months (11.8% among those in a worse pain state vs. 2.7% with the same pain state). Conclusions We quantified the relative importance of individual risk factors including mild pre-operative pain, smoking, deprivation, obesity and opioid use in terms of the absolute proportions of patients achieving poor pain outcomes. These findings will support development of interventions to reduce the numbers of patients who have poor pain outcomes.	[Mohammad, Hasan Raza; Delmestri, Antonella; Broomfield, John; Garriga, Cesar; Pinedo-Villanueva, Rafael; Malak, Tamer T.; Arden, Nigel; Price, Andrew; Judge, Andrew] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Gooberman-Hill, Rachael; Patel, Rita; Wylde, Vikki; Blom, Ashley W.; Judge, Andrew] Univ Bristol, Bristol Med Sch, Musculoskeletal Res Unit, Translat Hlth Sci, Learning & Res Bldg, Bristol, Avon, England; [Gooberman-Hill, Rachael; Wylde, Vikki; Blom, Ashley W.; Judge, Andrew] Univ Hosp Bristol & Weston NHS Fdn Trust, Natl Inst Hlth Res, Bristol Biomed Res Ctr, Bristol, Avon, England; [Gooberman-Hill, Rachael; Wylde, Vikki; Blom, Ashley W.; Judge, Andrew] Univ Bristol, Bristol, Avon, England; [Delmestri, Antonella; Judge, Andrew] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed, Ctr Stat Med Rheumatol & Musculoskeletal Sci, Oxford, England; [Huber, Joerg] Stadtspital Triemli, Dept Orthoped, Zurich, Switzerland; [Garriga, Cesar] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Eccleston, Christopher] Univ Bath, Ctr Pain Res, Dept Hlth, Bath, Avon, England; [Peters, Tim J.] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Learning & Res Bldg, Bristol, Avon, England	Nuffield Orthopaedic Centre; University of Oxford; University of Bristol; University of Bristol; Nuffield Orthopaedic Centre; University of Oxford; Triemli Hospital; University of Oxford; University of Bath; University of Bristol	Judge, A (corresponding author), Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.; Judge, A (corresponding author), Univ Bristol, Bristol Med Sch, Musculoskeletal Res Unit, Translat Hlth Sci, Learning & Res Bldg, Bristol, Avon, England.; Judge, A (corresponding author), Univ Hosp Bristol & Weston NHS Fdn Trust, Natl Inst Hlth Res, Bristol Biomed Res Ctr, Bristol, Avon, England.; Judge, A (corresponding author), Univ Bristol, Bristol, Avon, England.; Judge, A (corresponding author), Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed, Ctr Stat Med Rheumatol & Musculoskeletal Sci, Oxford, England.	Andrew.Judge@bristol.ac.uk	Garriga, Cesar/AEV-9080-2022	Garriga, Cesar/0000-0001-7073-3611; Judge, Andrew/0000-0003-3015-0432; Wylde, Vikki/0000-0002-8460-1529; Peters, Tim/0000-0003-2881-4180; Blom, Ashley/0000-0002-9940-1095; Delmestri, Antonella/0000-0003-0388-3403; Gooberman-Hill, Rachael/0000-0003-3353-2882; Eccleston, Christopher/0000-0003-0698-1543	National Institute for Health Research (NIHR) [RP-PG-0613-20001]; NIHR Biomedical Research Centre at the University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol [ISBRC-1215-20011]	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre at the University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol	Funding This study is funded by the National Institute for Health Research (NIHR) [Programme Grant for Applied Research (Grant Reference Number RP-PG-0613-20001)]. This study was also supported by the NIHR Biomedical Research Centre at the University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol (Grant Reference number: ISBRC-1215-20011). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. Disclaimer The views expressed represent those of the authors and do not necessarily reflect those of the NHS, the National Institute for Health Research, the Programme Grants for Applied Research (PGfAR) Programme, the Department of Health and Social Care or the Healthcare Quality Improvement Partnership (HQIP) who do not vouch for how the information is presented.	Abram SGF, 2019, BONE JOINT J, V101B, P1071, DOI 10.1302/0301-620X.101B9.BJJ-2019-0335.R1; Armitage JN, 2010, BRIT J SURG, V97, P772, DOI 10.1002/bjs.6930; Baker PN, 2013, BONE JOINT J, V95B, P1359, DOI 10.1302/0301-620X.95B10.32281; Bedson J, 2019, EUR J PAIN, V23, P908, DOI 10.1002/ejp.1357; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Blagestad T, 2016, PAIN, V157, P643, DOI 10.1097/j.pain.0000000000000414; Carr AJ, 2012, LANCET, V379, P1331, DOI 10.1016/S0140-6736(11)60752-6; Collins JE, 2017, J BONE JOINT SURG AM, V99, P1812, DOI 10.2106/JBJS.17.00022; Dawson J, 1998, J BONE JOINT SURG BR, V80B, P63, DOI 10.1302/0301-620X.80B1.7859; Department for Communities and Local Government, 2011, ENGLISH INDICES DEPR; Drosos GI, 2015, WORLD J ORTHOP, V6, P528, DOI 10.5312/wjo.v6.i7.528; Harris K, 2013, QUAL LIFE RES, V22, P2561, DOI 10.1007/s11136-013-0393-x; Hawker G, 1998, J BONE JOINT SURG AM, V80A, P163, DOI 10.2106/00004623-199802000-00003; Hawker GA, 2013, ARTHRITIS RHEUM-US, V65, P1243, DOI 10.1002/art.37901; Healthcare Quality Improvement Partnership, 2019, 16 ANN REP; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Huber J, 2016, OSTEOARTHR CARTILAGE, V24, P480, DOI 10.1016/j.joca.2015.10.012; Jiang YF, 2017, J ARTHROPLASTY, V32, P92, DOI 10.1016/j.arth.2016.06.009; Judge A, 2012, J BONE JOINT SURG BR, V94B, P412, DOI 10.1302/0301-620X.94B3.27425; Judge A, 2012, RHEUMATOLOGY, V51, P1804, DOI 10.1093/rheumatology/kes075; Judge A, 2010, ARTHRIT CARE RES, V62, P480, DOI 10.1002/acr.20038; Kim SC, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8061; Kiran A, 2014, J ARTHROPLASTY, V29, P2140, DOI 10.1016/j.arth.2014.06.008; Kolasinski SL, 2020, ARTHRITIS RHEUMATOL, V72, P220, DOI [10.1002/art.41142, 10.1002/acr.24131]; Liddle AD, 2015, BONE JOINT J, V97B, P793, DOI 10.1302/0301-620X.97B6.35155; Losina E, 2012, RHEUMATOLOGY, V51, P1735, DOI 10.1093/rheumatology/kes199; Matharu GS, 2019, ACTA ORTHOP, V90, P559, DOI 10.1080/17453674.2019.1649510; Mehta SP, 2015, OSTEOARTHR CARTILAGE, V23, P1476, DOI 10.1016/j.joca.2015.05.007; Merskey H, 1986, PAIN S, V3, P1; Namba RS, 2016, ACTA ORTHOP, V87, P37, DOI 10.1080/17453674.2016.1181820; National Institute for Health and Care Excellence (NICE), 2014, OST CAR MAN CLIN GUI; Norton EC, 2013, STATA J, V13, P492, DOI 10.1177/1536867X1301300304; Padmanabhan S, 2019, EUR J EPIDEMIOL, V34, P91, DOI 10.1007/s10654-018-0442-4; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; Politzer CS, 2018, J ARTHROPLASTY, V33, pS147, DOI 10.1016/j.arth.2017.10.060; Santaguida PL, 2008, CAN J SURG, V51, P428; Sing DC, 2016, J ARTHROPLASTY, V31, pS170, DOI 10.1016/j.arth.2016.02.068; Singh JA, 2013, RHEUMATOLOGY, V52, P916, DOI 10.1093/rheumatology/kes402; Sorel JC, 2019, BONE JOINT J, V101B, P7, DOI 10.1302/0301-620X.101B1.BJJ-2018-0672.R1; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Thakur M, 2014, NAT REV RHEUMATOL, V10, P374, DOI 10.1038/nrrheum.2014.47; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Wallace G, 2014, OSTEOARTHR CARTILAGE, V22, P918, DOI 10.1016/j.joca.2014.04.013; Werner MU, 2014, BRIT J ANAESTH, V113, P1, DOI 10.1093/bja/aeu012; Whale K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029742; Williams DP, 2013, BONE JOINT J, V95B, P38, DOI 10.1302/0301-620X.95B1.28061	46	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261850	10.1371/journal.pone.0261850	http://dx.doi.org/10.1371/journal.pone.0261850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972159	Green Published, gold			2022-12-27	WOS:000773555700062
J	Humphries, H; Upfold, M; Mahlase, G; Mdladla, M; Gengiah, TN; Karim, QA				Humphries, Hilton; Upfold, Michele; Mahlase, Gethwana; Mdladla, Makhosazana; Gengiah, Tanuja N.; Karim, Quarraisha Abdool			Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision	PLOS ONE			English	Article							ACTING REVERSIBLE CONTRACEPTION; HEALTH-CARE PROVIDERS; SOUTH-AFRICA; PREEXPOSURE PROPHYLAXIS; MISCONCEPTIONS; PERSPECTIVES; MYTHS; RISK; GAPS	Preventing new HIV infections, especially amongst young women, is key to ending the HIV epidemic especially in sub-Saharan Africa. Potent antiretroviral (ARV) drugs used as pre-exposure prophylaxis (PrEP) are currently being formulated as long-acting implantable devices, or nanosuspension injectables that release drug at a sustained rate providing protection from acquiring HIV. PrEP as implants (PrEP Implants) offers an innovative and novel approach, expanding the HIV prevention toolbox. Feedback from providers and future users in the early clinical product development stages may identify modifiable characteristics which can improve acceptability and uptake of new technologies. Healthcare workers (HCWs) perspectives and lessons learned during the rollout of contraceptive implants will allow us to understand what factors may impact the roll-out of PrEP implants. We conducted eighteen interviews with HCWs (9 Nurses and 9 Community Healthcare Workers) in rural KwaZulu-Natal, South Africa. HCWs listed the long-acting nature of the contraceptive implant as a key benefit, helping to overcome healthcare system barriers like heavy workloads and understaffing. However, challenges like side effects, migration of the implant, stakeholder buy-in and inconsistent training on insertion and removal hampered the roll-out of the contraceptive implant. For PrEP implants, HCWs preferred long-acting products that were palpable and biodegradable. Our findings highlighted that the characteristics of PrEP implants that are perceived to be beneficial by HCWs may not align with that of potential users, potentially impacting the acceptability and uptake of PrEP implants. Further our data highlight the need for sustained and multi-pronged approaches to training HCWs and introducing new health technologies into communities. Finding a balance between the needs of HCWs that accommodate their heavy workloads, limited resources at points of delivery of care and the needs and preferences of potential users need to be carefully considered in the development of PrEP implants.	[Humphries, Hilton; Upfold, Michele; Mahlase, Gethwana; Mdladla, Makhosazana; Gengiah, Tanuja N.; Karim, Quarraisha Abdool] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa	University of Kwazulu Natal	Humphries, H (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.	Hilton.humphries@caprisa.org	Abdool Karim, Quarraisha/GVS-1160-2022	Abdool Karim, Quarraisha/0000-0002-0985-477X; Humphries, Hilton/0000-0001-8503-4127; Gengiah, Tanuja/0000-0002-3405-5128	South African Medical Research Council Special initiative grant [00251]; Department of Science and Innovation-National Research Foundation Centre of Excellence in HIV Prevention	South African Medical Research Council Special initiative grant; Department of Science and Innovation-National Research Foundation Centre of Excellence in HIV Prevention	Funding: Funding for the study was provided by South African Medical Research Council Special initiative grant (00251), and partial support from the Department of Science and Innovation-National Research Foundation Centre of Excellence in HIV Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Beesham I, 2021, AFR J REPROD HEALTH, V25, P41, DOI 10.29063/ajrh2021/v25i1.5; Bekker LG, 2018, LANCET HIV, V5, pE68, DOI 10.1016/S2352-3018(17)30156-X; Blackstone SR, 2017, INT Q COMMUNITY HEAL, V37, P79, DOI 10.1177/0272684X16685254; Boyatzis R., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Brown A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7312-1; Bukenya D, 2019, AIDS RES THER, V16, DOI 10.1186/s12981-018-0214-y; Dunbar MS, 2018, SEX HEALTH, V15, P513, DOI 10.1071/SH18061; Garrett CC, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0227-9; IAVI, 2021, EV ACC PATHW LONG AC; Ismail H, 2006, J FAM PLAN REPROD H, V32, P157, DOI 10.1783/147118906777888413; Karim SSAA, 2019, CAPRISA 018 PHASE 3; Kerrigan D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190487; Kharsany ABM, 2018, LANCET HIV, V5, pE427, DOI 10.1016/S2352-3018(18)30104-8; Kharsany ABM, 2015, JAIDS-J ACQ IMM DEF, V70, P289, DOI 10.1097/QAI.0000000000000761; Kriel Y, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0749-y; Krogstad EA, 2019, AIDS PATIENT CARE ST, V33, P157, DOI 10.1089/apc.2018.0177; Mansoor LE, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25381; Montgomery ET, 2019, JAIDS-J ACQ IMM DEF, V80, P542, DOI 10.1097/QAI.0000000000001960; Morrison CS, 2007, AIDS, V21, P85, DOI 10.1097/QAD.0b013e3280117c8b; Mullick S, 2017, SAMJ S AFR MED J, V107, P812, DOI [10.7196/SAMJ.2017.v107i10.12849, 10.7196/samj.2017.v107i10.12849]; Mwaisaka J, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09849-1; Nanda K, 2015, WOMENS HEALTH, V11, P729, DOI 10.2217/whe.15.84; Nel A, 2016, NEW ENGL J MED, V375, P2133, DOI 10.1056/NEJMoa1602046; Ontiri S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091543; Patel RC, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21396; Pillay D, 2017, SAMJ S AFR MED J, V107, P827, DOI [10.7196/SAMJ.2017.v107i10.12822, 10.7196/samj.2017.v107i10.12822]; Pleaner M, 2017, SAMJ S AFR MED J, V107, P933, DOI [10.7196/samj.2017.v107i11.12805, 10.7196/SAMJ.2017.v107i11.12805]; Ralph LJ, 2015, LANCET INFECT DIS, V15, P181, DOI 10.1016/S1473-3099(14)71052-7; Rees H, 2017, SAMJ S AFR MED J, V107, P939, DOI [10.7196/SAMJ.2017.v107i11.12903, 10.7196/samj.2017.v107i11.12903]; Roberts K, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0707-y; Russo JA, 2013, J ADOLESCENT HEALTH, V52, pS14, DOI 10.1016/j.jadohealth.2013.02.003; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Staveteig S., 2015, DHS ANAL STUDIES, V54; Strauss A. L, 1994, HDB QUALITATIVE RES, V1st, P273, DOI DOI 10.1007/BF00988593; Thomson KA, 2016, CURR OPIN HIV AIDS, V11, P18, DOI 10.1097/COH.0000000000000207; UNAIDS, 2019, WOM HIV SPOTL AD GIR, P120	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262043	10.1371/journal.pone.0262043	http://dx.doi.org/10.1371/journal.pone.0262043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025908	Green Published, gold			2022-12-27	WOS:000796264200041
J	Vuoskoski, JK; Zickfeld, JH; Alluri, V; Moorthigari, V; Seibt, B				Vuoskoski, Jonna K.; Zickfeld, Janis H.; Alluri, Vinoo; Moorthigari, Vishnu; Seibt, Beate			Feeling moved by music: Investigating continuous ratings and acoustic correlates	PLOS ONE			English	Article							EMOTIONAL RESPONSES; CHILLS; SAD; ANTECEDENTS; INDUCTION; STATES; SCALE	The experience often described as feeling moved, understood chiefly as a social-relational emotion with social bonding functions, has gained significant research interest in recent years. Although listening to music often evokes what people describe as feeling moved, very little is known about the appraisals or musical features contributing to the experience. In the present study, we investigated experiences of feeling moved in response to music using a continuous rating paradigm. A total of 415 US participants completed an online experiment where they listened to seven moving musical excerpts and rated their experience while listening. Each excerpt was randomly coupled with one of seven rating scales (perceived sadness, perceived joy, feeling moved or touched, sense of connection, perceived beauty, warmth [in the chest], or chills) for each participant. The results revealed that musically evoked experiences of feeling moved are associated with a similar pattern of appraisals, physiological sensations, and trait correlations as feeling moved by videos depicting social scenarios (found in previous studies). Feeling moved or touched by both sadly and joyfully moving music was associated with experiencing a sense of connection and perceiving joy in the music, while perceived sadness was associated with feeling moved or touched only in the case of sadly moving music. Acoustic features related to arousal contributed to feeling moved only in the case of joyfully moving music. Finally, trait empathic concern was positively associated with feeling moved or touched by music. These findings support the role of social cognitive and empathic processes in music listening, and highlight the social-relational aspects of feeling moved or touched by music.	[Vuoskoski, Jonna K.] Univ Oslo, RITMO Ctr Interdisciplinary Studies Rhythm Time &, Oslo, Norway; [Vuoskoski, Jonna K.; Seibt, Beate] Univ Oslo, Dept Psychol, Oslo, Norway; [Vuoskoski, Jonna K.] Univ Oslo, Dept Musicol, Oslo, Norway; [Zickfeld, Janis H.] Aarhus Univ, Dept Management, Aarhus, Denmark; [Alluri, Vinoo; Moorthigari, Vishnu] Int Inst Informat Technol, Cognit Sci Lab, Hyderabad, India	University of Oslo; University of Oslo; University of Oslo; Aarhus University; International Institute of Information Technology Hyderabad	Vuoskoski, JK (corresponding author), Univ Oslo, RITMO Ctr Interdisciplinary Studies Rhythm Time &, Oslo, Norway.; Vuoskoski, JK (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.	j.k.vuoskoski@imv.uio.no	Vuoskoski, Jonna K/B-4944-2018	Vuoskoski, Jonna K/0000-0003-0049-4373; Seibt, Beate/0000-0002-0148-0961	Research Council of Norway through its Centres of Excellence scheme [262762]	Research Council of Norway through its Centres of Excellence scheme	JKV: This work was partially supported by the Research Council of Norway through its Centres of Excellence scheme, project number 262762 https://www.forskningsradet.no/en/	Alluri V, 2012, NEUROIMAGE, V59, P3677, DOI 10.1016/j.neuroimage.2011.11.019; Alluri V, 2010, MUSIC PERCEPT, V27, P223, DOI 10.1525/mp.2010.27.3.223; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Aucouturier JJ, 2017, COGNITION, V161, P94, DOI 10.1016/j.cognition.2017.01.019; Bannister S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224974; Bannister S, 2020, PSYCHOL MUSIC, V48, P297, DOI 10.1177/0305735618798024; Barrett FS, 2010, EMOTION, V10, P390, DOI 10.1037/a0019006; Bartsch A., 2014, J MEDIA PSYCHOL-GER; Batson CD., 2010, PROSOCIAL MOTIVES EM, P15, DOI [10.1037/12061-001, DOI 10.1037/12061-001]; Beedie CJ, 2005, COGNITION EMOTION, V19, P847, DOI 10.1080/02699930541000057; Benedek M, 2011, BIOL PSYCHOL, V86, P320, DOI 10.1016/j.biopsycho.2010.12.012; Bicknell J, 2007, J CONSCIOUSNESS STUD, V14, P5; Bowling DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031942; Brattico E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00308; Brielmann AA, 2017, J VISION, V17, DOI 10.1167/17.14.9; Bringmann LF, 2018, MULTIVAR BEHAV RES, V53, P293, DOI 10.1080/00273171.2018.1439722; Coutinho E, 2017, MUSIC PERCEPT, V34, P371, DOI 10.1525/MP.2017.34.4.371; Cova F, 2014, PHILOS STUD, V169, P447, DOI 10.1007/s11098-013-0192-9; Cross I, 2014, PSYCHOL MUSIC, V42, P809, DOI 10.1177/0305735614543968; Cullhed E, 2020, EMOT REV, V12, P111, DOI 10.1177/1754073919875216; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Fleurian R, 2020, PREPRINT; Eeroia T, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01176; Eerola T, 2018, PHYS LIFE REV, V25, P100, DOI 10.1016/j.plrev.2017.11.016; Eerola T, 2011, J NEW MUSIC RES, V40, P349, DOI 10.1080/09298215.2011.602195; Eerola T, 2011, PSYCHOL MUSIC, V39, P18, DOI 10.1177/0305735610362821; Fisher R. A., 1946, Statistical methods for research workers.; Fiske A. P., 2019, KAMA MUTA DISCOVERIN; Fiske A.P., 2017, EVOL STUD IMAGINATIV, V1, P67, DOI 10.26613/esic/1.1.12; Fiske AP, 2019, EMOT REV, V11, P74, DOI 10.1177/1754073917723167; Fiske AP, 2004, RELATIONAL MODELS THEORY: CONTEMPORARY OVERVIEW, P3; Gabrielsson Alf, 2011, STRONG EXPERIENCES M; Gingras B, 2014, Q J EXP PSYCHOL, V67, P1428, DOI 10.1080/17470218.2013.863954; Gomez Gutierrez E., 2006, TONAL DESCRIPTION MU; Grewe O, 2005, ANN NY ACAD SCI, V1060, P446, DOI 10.1196/annals.1360.041; Grewe O, 2007, MUSIC PERCEPT, V24, P297, DOI 10.1525/MP.2007.24.3.297; Guhn M, 2007, MUSIC PERCEPT, V24, P473, DOI 10.1525/MP.2007.24.5.473; Hanich J, 2014, PSYCHOL AESTHET CREA, V8, P130, DOI 10.1037/a0035690; Hanser WE, 2022, MUSIC SCI, V26, P516, DOI 10.1177/1029864920981110; Harrison L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00790; Huron D, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01060; Huron D, 2016, EMPIR MUSICOL REV, V11, P261; Inagaki TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156873; Istok E, 2009, MUSIC SCI, V13, P183, DOI 10.1177/102986490901300201; Juslin PN, 2004, J NEW MUSIC RES, V33, P217, DOI 10.1080/0929821042000317813; Konecni V. J., 2005, B PSYCHOL ARTS, V5, P27; Konecni VJ, 2007, AM J PSYCHOL, V120, P619, DOI 10.2307/20445428; Konecni VJ, 2011, PHILOS TODAY, V55, P64, DOI 10.5840/philtoday201155162; Landmann H, 2021, MEDIA COMMUN-LISBON, V9, P191, DOI 10.17645/mac.v9i2.3825; Landmann H, 2019, COGNITION EMOTION, V33, P1387, DOI 10.1080/02699931.2019.1567463; Lartillot O., 2007, P INT C DIG AUD EFF, V2007, P237; Lartillot O., 2008, P 9 INT C MUS INF RE, P521; Laukka P, 2013, EMOTION, V13, P434, DOI 10.1037/a0031388; Lee CJ, 2013, J CONSUM RES, V40, P382, DOI 10.1086/670609; Levinson Jerrold, 2006, CONT DEBATES AESTHET, P192; Lokhande N. N., 2012, IJCA P INT C COMPUTA, V6, P1; Lusa L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241364; Maruskin LA, 2012, J PERS SOC PSYCHOL, V103, P135, DOI 10.1037/a0028117; McKeown GJ, 2014, PSYCHOL METHODS, V19, P155, DOI 10.1037/a0034282; Menninghaus W, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X17000309; Menninghaus W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128451; Miu AC, 2017, SEMPRE STUD PSYCHOL, P124; Mori K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46063; Nagel F, 2008, MUSIC SCI, V12, P101, DOI 10.1177/102986490801200106; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; North AC, 2004, MUSIC PERCEPT, V22, P41, DOI 10.1525/mp.2004.22.1.41; Panagiotakis C, 2005, IEEE T MULTIMEDIA, V7, P155, DOI 10.1109/TMM.2004.840604; Panksepp J, 1995, MUSIC PERCEPT, V13, P171; Peer E., 2021, BEHAV RES METHODS, DOI [10.3758/s13428-021-01694-3, DOI 10.3758/s13428-021-01694-3, 10.3758/s13428-021-01694-3.]; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Ruef A.M.., 2007, HDB EMOTION ELICITAT, P286; Savage PE, 2021, BEHAV BRAIN SCI, V44, DOI 10.1017/S0140525X20000333; Schafer T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00511; Scherer K. R., 2001, MUSIC EMOTION THEORY, DOI DOI 10.1016/j.jsams.2011.06.003; Schubert E., 2010, HDB MUSIC EMOTION TH, V2nd, P223; Schubert E., 2012, MUSICAL IMAGINATIONS, P124; Schubert TW, 2018, COGNITION EMOTION, V32, P174, DOI 10.1080/02699931.2016.1268998; Seibt B, 2018, J CROSS CULT PSYCHOL, V49, P418, DOI 10.1177/0022022117746240; Sethares WA., 1998, TUNING TIMBRE SPECTR; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Shumway RH, 2011, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4419-7865-3; Silvia PJ, 2015, PSYCHOL AESTHET CREA, V9, P376, DOI 10.1037/aca0000028; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Tanabe J, 2002, NEUROIMAGE, V15, P902, DOI 10.1006/nimg.2002.1053; Trost WJ, 2017, NEUROPSYCHOLOGIA, V96, P96, DOI 10.1016/j.neuropsychologia.2017.01.004; Van den Tol AJM, 2015, PSYCHOL MUSIC, V43, P473, DOI 10.1177/0305735613517410; Van den Tol AJM, 2013, PSYCHOL MUSIC, V41, P440, DOI 10.1177/0305735611430433; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vuoskoski JK, 2017, PSYCHOL MUSIC, V45, P584, DOI 10.1177/0305735616680289; Vuoskoski JK, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00439; Wagner V, 2021, POETICS, V85, DOI 10.1016/j.poetic.2020.101497; Wassiliwizky E, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00041; Wassiliwizky E, 2015, PSYCHOL AESTHET CREA, V9, P405, DOI 10.1037/aca0000023; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494; Zickfeld JH, 2019, EMOT REV, V11, P123, DOI 10.1177/1754073918820126; Zickfeld JH, 2019, EMOTION, V19, P402, DOI 10.1037/emo0000450; Zickfeld JH, 2018, PHYS LIFE REV, V25, P139, DOI 10.1016/j.plrev.2018.03.005; Zickfeld JH, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00723	102	3	3	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261151	10.1371/journal.pone.0261151	http://dx.doi.org/10.1371/journal.pone.0261151			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020739	gold, Green Published			2022-12-27	WOS:000834207700014
J	Kavanaugh, DW; Porrini, C; Dervyn, R; Ramarao, N				Kavanaugh, Devon W.; Porrini, Constance; Dervyn, Rozenn; Ramarao, Nalini			The pathogenic biomarker alcohol dehydrogenase protein is involved in Bacillus cereus virulence and survival against host innate defence	PLOS ONE			English	Article							NITRIC-OXIDE; BACTEREMIA; BIOFILM; STRAINS; FRANCE; HLYII; GENE	Bacillus cereus is a spore forming bacteria recognized among the leading agents responsible for foodborne outbreaks in Europe. B. cereus is also gaining notoriety as an opportunistic human pathogen inducing local and systemic infections. The real incidence of such infection is likely underestimated and information on genetic and phenotypic characteristics of the incriminated strains is generally scarce. We have recently analyzed a large strain collection of varying pathogenic potential. Screening for biomarkers to differentiate among clinical and non-clinical strains, a gene encoding an alcohol dehydrogenase-like protein was identified among the leading candidates. This family of proteins has been demonstrated to be involved in the virulence of several bacterial species. The relevant gene was knocked out to elucidate its function with regards to resistance to host innate immune response, both in vitro and in vivo. Our results demonstrate that the adhB gene plays a significant role in resistance to nitric oxide and oxidative stress in vitro, as well as its pathogenic ability with regards to in vivo toxicity. These properties may explain the pathogenic potential of strains carrying this newly identified virulence factor.	[Kavanaugh, Devon W.; Porrini, Constance; Dervyn, Rozenn; Ramarao, Nalini] Univ Paris Saclay, Micalis Inst, AgroParisTech, INRAE, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Ramarao, N (corresponding author), Univ Paris Saclay, Micalis Inst, AgroParisTech, INRAE, Jouy En Josas, France.	nalini.ramarao@inrae.fr	Rama Rao, Nalini/GRR-7800-2022	Kavanaugh, Devon/0000-0001-8831-8248				Agledal L, 2010, REDOX REP, V15, P2, DOI 10.1179/174329210X12650506623122; Callejas-Negrete OA, 2015, MICROBIOL RES, V172, P57, DOI 10.1016/j.micres.2014.11.006; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Bakker BM, 2000, J BACTERIOL, V182, P4730, DOI 10.1128/JB.182.17.4730-4737.2000; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Cadot C, 2010, J CLIN MICROBIOL, V48, P1358, DOI 10.1128/JCM.02123-09; Chin MP, 2010, CHEM RES TOXICOL, V23, P778, DOI 10.1021/tx900415k; Cormontagne D, 2021, TOXINS, V13, DOI 10.3390/toxins13020123; Darrigo C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163321; Dervyn R, 2022, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.788757; Duport C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01550; Fagerlund A, 2008, MICROBIOL-SGM, V154, P693, DOI 10.1099/mic.0.2007/014134-0; Gaur AH, 2001, CLIN INFECT DIS, V32, P1456, DOI 10.1086/320154; Glasset B, 2016, EUROSURVEILLANCE, V21, P18, DOI 10.2807/1560-7917.ES.2016.21.48.30413; Glasset B, 2021, FOOD MICROBIOL, V98, DOI 10.1016/j.fm.2021.103759; Glasset B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194346; Guillemet E, 2016, SCI REP-UK, V6, DOI 10.1038/srep29349; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x; Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002; Hagan CT, 2018, ADV CANCER RES, V139, P35, DOI 10.1016/bs.acr.2018.05.003; Haydar A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01063; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; JORNVALL H, 1987, EUR J BIOCHEM, V167, P195, DOI 10.1111/j.1432-1033.1987.tb13323.x; Kamar R, 2013, J CLIN MICROBIOL, V51, P320, DOI 10.1128/JCM.02848-12; Kavanaugh DW, 2022, CLIN MICROBIOL INFEC, V28, DOI 10.1016/j.cmi.2021.05.035; KELLY JM, 1990, MOL GEN GENET, V222, P323, DOI 10.1007/BF00633836; Leclerc M, 2021, MSYSTEMS, V6, DOI 10.1128/mSystems.00558-21; Lotte R, 2017, EMERG INFECT DIS, V23, P845, DOI 10.3201/eid2305.161788; Madeira JP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00342; Martinez-Blanch JF, 2009, INT J FOOD MICROBIOL, V135, P15, DOI 10.1016/j.ijfoodmicro.2009.07.013; Mukherjee PK, 2006, INFECT IMMUN, V74, P3804, DOI 10.1128/IAI.00161-06; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; Plapp BV, 2015, CHEM-BIOL INTERACT, V234, P85, DOI 10.1016/j.cbi.2014.12.040; Porrini C, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22105079; Porrini C, 2020, BIOL CHEM, V401, P547, DOI 10.1515/hsz-2019-0368; Ramarao N., 2015, MOL MED MICROBIOL, V2, P1041, DOI [10.1016/B978-0-12-397169-2.00059-7, DOI 10.1016/B978-0-12-397169-2.00059-7]; Ramarao N, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20092667; Ramarao N, 2012, JOVE-J VIS EXP, DOI 10.3791/4392; Ramarao N, 2014, AM J INFECT CONTROL, V42, P694, DOI 10.1016/j.ajic.2014.01.025; Rubach JK, 2003, BIOCHEMISTRY-US, V42, P2907, DOI 10.1021/bi0272656; Saliola M, 1995, MOL GEN GENET, V249, P665, DOI 10.1007/BF00418036; Tran SL, 2013, FEMS MICROBIOL LETT, V347, P1, DOI 10.1111/1574-6968.12209; SUN HW, 1992, J MOL EVOL, V34, P522, DOI 10.1007/BF00160465; Taneja B, 1999, PROTEIN ENG, V12, P815, DOI 10.1093/protein/12.10.815; THORN JM, 1995, J MOL BIOL, V249, P785, DOI 10.1006/jmbi.1995.0337; Tran SL, 2020, TOXINS, V12, DOI 10.3390/toxins12090593; Tran SL, 2013, J INVERTEBR PATHOL, V113, P205, DOI 10.1016/j.jip.2013.04.001; Tran SL, 2011, CELL MICROBIOL, V13, P92, DOI 10.1111/j.1462-5822.2010.01522.x; Tran SL, 2010, J BACTERIOL, V192, P2638, DOI 10.1128/JB.01315-09; Veysseyre F, 2015, MED MALADIES INFECT, V45, P436, DOI 10.1016/j.medmal.2015.09.011; Zaki MH, 2005, J PHARMACOL SCI, V98, P117, DOI 10.1254/jphs.CRJ05004X	53	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0259386	10.1371/journal.pone.0259386	http://dx.doi.org/10.1371/journal.pone.0259386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982789	Green Published, gold			2022-12-27	WOS:000834805700002
J	Banerjee, A; Billey, LO; Shelver, WL				Banerjee, Amrita; Billey, Lloyd O.; Shelver, Weilin L.			Uptake and toxicity of polystyrene micro/nanoplastics in gastric cells: Effects of particle size and surface functionalization	PLOS ONE			English	Article							CELLULAR UPTAKE; MICROPLASTICS; NANOPARTICLES; METABOLISM; APOPTOSIS; NANOPLASTICS; MICROBIOTA; PORATION; BAX	Toxicity of micro or nanoplastics (MP/NP) in aquatic life is well-documented, however, information about the consequences of exposure to these particles in terrestrial species is scarce. This study was used to evaluate the uptake and/or toxicity of polystyrene MP/NP in human gastric cells, comparing doses, particle sizes (50, 100, 200, 500, 1000 or 5000 nm) and surface functionalization (aminated, carboxylated or non-functionalized). In general, the uptake of 50 nm particles was significantly higher than 1000 nm particles. Among the 50 nm particles, the aminated particles were more avidly taken up by the cells and were cytotoxic at a lower concentration (>= 7.5 mu g/mL) compared to same sized carboxylated or non-functionalized particles (>= 50 mu g/mL). High toxicity of 50 nm aminated particles corresponded well with significantly high rates of apoptosis-necrosis induced by these particles in 4 h (29.2% of total cells) compared to all other particles (<= 16.8%). The trend of apoptosis-necrosis induction by aminated particles in 4 h was 50 > 5000 > 1000 > 500 > 200 > 100 nm. The 50 nm carboxylated or non-functionalized particles also induced higher levels of apoptosis-necrosis in the cells compared to 100, 1000 and 5000 nm particles with same surface functionalization but longer exposure (24 h) to 50 nm carboxylated or non-functionalized particles significantly (p<0.0001) increased apoptosis-necrosis in the cells. The study demonstrated that the toxicity of MP/NP to gastric cells was dependent on particle size, dose surface functionalization and exposure period.	[Banerjee, Amrita; Billey, Lloyd O.; Shelver, Weilin L.] ARS, USDA, Edward T Schafer Agr Res Ctr, Biosci Res Lab, Fargo, ND 58102 USA	United States Department of Agriculture (USDA)	Shelver, WL (corresponding author), ARS, USDA, Edward T Schafer Agr Res Ctr, Biosci Res Lab, Fargo, ND 58102 USA.	weilin.shelver@usda.gov			National Science Foundation [0923354]	National Science Foundation(National Science Foundation (NSF))	We thank the Department of Pharmaceutical Sciences and Coatings and Polymeric Materials at North Dakota State University, Fargo, ND for allowing us to use their Zetasizer Nano and single particle optical sizing instruments. We also thank Drs. Pawel Borowicz and Amber Chevalier Plambeck at North Dakota State University for their help with confocal microscopy imaging and flow cytometry work, respectively. In addition, we acknowledge Dr. Scott Payne and Jayma Moore at North Dakota State University Electron Microscopy Center core facility (supported by the National Science Foundation Grant No. 0923354) for help with particle imaging. The technical assistance provided by Kendra White and Amy McGarvey is also gratefully acknowledged. Statistical analysis consultation provided by Dr. Kathleen Yeater is greatly appreciated.	Alexander J, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4501; Allen S, 2019, NAT GEOSCI, V12, P339, DOI 10.1038/s41561-019-0335-5; Barboza LGA, 2020, SCI TOTAL ENVIRON, V717, DOI 10.1016/j.scitotenv.2019.134625; Behzadi S, 2017, CHEM SOC REV, V46, P4218, DOI 10.1039/c6cs00636a; Bergami E, 2017, AQUAT TOXICOL, V189, P159, DOI 10.1016/j.aquatox.2017.06.008; Bhattacharjee S, 2014, RSC ADV, V4, P19321, DOI 10.1039/c3ra46869k; Boersma AWM, 1997, CYTOMETRY, V27, P275, DOI 10.1002/(SICI)1097-0320(19970301)27:3<275::AID-CYTO10>3.0.CO;2-Q; Carbery M, 2018, ENVIRON INT, V115, P400, DOI 10.1016/j.envint.2018.03.007; Chen Y, 2021, SCI TOTAL ENVIRON, V752, DOI 10.1016/j.scitotenv.2020.141772; Araujo APD, 2021, J HAZARD MATER, V401, DOI 10.1016/j.jhazmat.2020.123263; Araujo APD, 2020, J HAZARD MATER, V386, DOI 10.1016/j.jhazmat.2019.121992; Danaei M, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10020057; Della Torre C, 2014, ENVIRON SCI TECHNOL, V48, P12302, DOI 10.1021/es502569w; Dhuriya YK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1235-0; ELIMELECH M, 1990, COLLOID SURFACE, V44, P165, DOI 10.1016/0166-6622(90)80194-9; Foroozandeh P, 2018, NANOSCALE RES LETT, V13, DOI 10.1186/s11671-018-2728-6; Forte M, 2016, TOXICOL IN VITRO, V31, P126, DOI 10.1016/j.tiv.2015.11.006; Frank D, 2019, CELL DEATH DIFFER, V26, P99, DOI 10.1038/s41418-018-0212-6; Fritsch M, 2019, NATURE, V575, P683, DOI 10.1038/s41586-019-1770-6; Frohlich E, 2012, INT J NANOMED, V7, P5577, DOI 10.2147/IJN.S36111; Frohlich E, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-26; Garg A, 2016, LANGMUIR, V32, P11837, DOI 10.1021/acs.langmuir.6b02824; Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782; Gonzalez-Fernandez C, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22137141; Greven AC, 2016, ENVIRON TOXICOL CHEM, V35, P3093, DOI 10.1002/etc.3501; Gumustas M, 2017, MULTIFUNCTIONAL SYSTEMS FOR COMBINED DELIVERY, BIOSENSING AND DIAGNOSTICS, P67, DOI 10.1016/B978-0-323-52725-5.00005-8; Hesler M, 2019, TOXICOL IN VITRO, V61, DOI 10.1016/j.tiv.2019.104610; Hirt N, 2020, PART FIBRE TOXICOL, V17, DOI 10.1186/s12989-020-00387-7; Hub SL, 2011, FOODS JOURNEY DIGEST; Inkielewicz-Stepniak I, 2018, MATERIALS, V11, DOI 10.3390/ma11050724; Jabeen K, 2018, CHEMOSPHERE, V213, P323, DOI 10.1016/j.chemosphere.2018.09.031; Jiang XE, 2011, NANOSCALE, V3, P2028, DOI 10.1039/c0nr00944j; Jin HB, 2021, J HAZARD MATER, V401, DOI 10.1016/j.jhazmat.2020.123430; Jin YX, 2019, SCI TOTAL ENVIRON, V649, P308, DOI 10.1016/j.scitotenv.2018.08.353; Joseph E, 2019, MULTIFUNCTIONAL NANO, V1, P91, DOI [10.1016/B978-0-12-816505-8.00007-2, DOI 10.1016/B978-0-12-816505-8.00007-2]; Kale J, 2018, CELL DEATH DIFFER, V25, P65, DOI 10.1038/cdd.2017.186; Kalogerakis N, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00084; Karami A, 2017, SCI REP-UK, V7, DOI [10.1038/srep46173, 10.1038/s41598-017-05828-6]; Kelpsiene E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63028-1; Laboratories B, 2016, POLYM MICROSPHERES T, V100; Li BQ, 2020, CHEMOSPHERE, V244, DOI 10.1016/j.chemosphere.2019.125492; Li S, 2013, SOFT MATTER, V9, P4969, DOI 10.1039/c3sm27578g; Li ZK, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.115025; Loos C, 2014, BEILSTEIN J NANOTECH, V5, P2403, DOI 10.3762/bjnano.5.250; Lu L, 2018, SCI TOTAL ENVIRON, V631-632, P449, DOI 10.1016/j.scitotenv.2018.03.051; Lu YF, 2016, ENVIRON SCI TECHNOL, V50, P4054, DOI 10.1021/acs.est.6b00183; Luo T, 2019, ENVIRON POLLUT, V255, DOI 10.1016/j.envpol.2019.113122; Luo T, 2019, ENVIRON SCI TECHNOL, V53, P10978, DOI 10.1021/acs.est.9b03191; Machado AAD, 2018, GLOBAL CHANGE BIOL, V24, P1405, DOI 10.1111/gcb.14020; Madell R., 2019, ARTHRTIS ARTHRALG WH; Mason SA, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00407; Mattsson K, 2015, ENVIRON SCI TECHNOL, V49, P553, DOI 10.1021/es5053655; Miller ME, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240792; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Peda C, 2016, ENVIRON POLLUT, V212, P251, DOI 10.1016/j.envpol.2016.01.083; Poma A, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9091299; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Prata JC, 2018, ENVIRON POLLUT, V234, P115, DOI 10.1016/j.envpol.2017.11.043; Rafiee M, 2018, CHEMOSPHERE, V193, P745, DOI 10.1016/j.chemosphere.2017.11.076; Ragusa A, 2021, ENVIRON INT, V146, DOI 10.1016/j.envint.2020.106274; Rainieri S, 2019, TRENDS FOOD SCI TECH, V84, P55, DOI 10.1016/j.tifs.2018.12.009; Schwabl P, 2019, ANN INTERN MED, V171, P453, DOI 10.7326/M19-0618; Sigma-Aldrich, POLYSTYRENE LATEX BE; Silva ALP, 2021, CHEM ENG J, V405, DOI 10.1016/j.cej.2020.126683; Sis H, 2009, COLLOID SURFACE A, V341, P60, DOI 10.1016/j.colsurfa.2009.03.039; Society AC., 2020, METHODS MICROPLASTIC; Sokmen TO, 2020, NEUROTOXICOLOGY, V77, P51, DOI 10.1016/j.neuro.2019.12.010; Sun QQ, 2017, BIOMATER SCI-UK, V5, P1014, DOI 10.1039/c6bm00946h; Tiseo I., 2021, GLOBAL PLASTIC PRODU; Wei JL, 2021, ENVIRON TOXICOL, V36, P935, DOI 10.1002/tox.23095; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; Wiemann JT, 2020, NANOSCALE, V12, P20326, DOI 10.1039/d0nr05355d; Wright SL, 2020, ENVIRON INT, V136, DOI 10.1016/j.envint.2019.105411; Xia T, 2008, ACS NANO, V2, P85, DOI 10.1021/nn700256c; Xia XH, 2020, SCI TOTAL ENVIRON, V716, DOI 10.1016/j.scitotenv.2019.136479; Xie XM, 2020, ECOTOX ENVIRON SAFE, V190, DOI 10.1016/j.ecoenv.2019.110133; Yacobi NR, 2010, AM J RESP CELL MOL, V42, P604, DOI 10.1165/rcmb.2009-0138OC; Yamamoto H, 1999, INT J CANCER, V84, P400, DOI 10.1002/(SICI)1097-0215(19990820)84:4<400::AID-IJC12>3.0.CO;2-S; Zhu XL, 2020, MAR ENVIRON RES, V158, DOI 10.1016/j.marenvres.2020.105005	79	8	8	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0260803	10.1371/journal.pone.0260803	http://dx.doi.org/10.1371/journal.pone.0260803			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34971556	gold, Green Published			2022-12-27	WOS:000773555700017
J	Gojanovich, GS; Jacobson, DL; Broadwell, C; Karalius, B; Kirmse, B; Geffner, ME; Jao, J; Van Dyke, RB; McFarland, EJ; Silio, M; Crain, M; Gerschenson, M				Gojanovich, Greg S.; Jacobson, Denise L.; Broadwell, Carly; Karalius, Brad; Kirmse, Brian; Geffner, Mitchell E.; Jao, Jennifer; Van Dyke, Russell B.; McFarland, Elizabeth J.; Silio, Margarita; Crain, Marilyn; Gerschenson, Mariana		Pediat HIV AIDS Cohort Study	Associations of FGF21 and GDF15 with mitochondrial dysfunction in children living with perinatally-acquired HIV: A cross-sectional evaluation of pediatric AIDS clinical trials group 219/219C	PLOS ONE			English	Article							DIFFERENTIATION FACTOR 15; INSULIN-RESISTANCE; BIOMARKER; THERAPY	Background In persons living with HIV, mitochondrial disease (MD) is difficult to diagnose, as clinical signs are non-specific with inconsistent patterns. Fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15) are mitokines elevated in MD patients without HIV, and associated with cardiometabolic comorbidities in adults living with HIV. We assessed relationships of these biomarkers with MD in children living with perinatally-acquired HIV infection (CPHIV). Setting Cross-sectional study of CPHIV from Pediatric ACTG 219/219C classified by Mitochondrial Disease Criteria (MDC) that defines scores 2-4 as "possible" MD. Methods Each case with MDC equaling 4 (MDC4; n = 23) was matched to one randomly selected control displaying no MDC (MDC0; n = 23) based on calendar date. Unmatched cases with MDC equaling 3 (MDC3; n = 71) were also assessed. Plasma samples proximal to diagnoses were assayed by ELISA. Mitokine distributions were compared using Wilcoxon tests, Spearman correlations were calculated, and associations with MD status were assessed by conditional logistic regression. Results Median FGF21 and GDF15 concentrations, respectively, were highest in MDC4 (143.9 and 1441.1 pg/mL), then MDC3 (104.0 and 726.5 pg/mL), and lowest in controls (89.4 and 484.7 pg/mL). Distributions of FGF21 (paired Wilcoxon rank sum p = 0.002) and GDF15 (paired Wilcoxon rank sum p<0.001) differed in MDC4 vs MDC0. Mitokine concentrations were correlated across all participants (r = 0.33; p<0.001). Unadjusted odds ratios of being MDC4 vs MDC0 were 5.2 [95% confidence interval (CI): 1.06-25.92] for FGF21 and 3.5 (95%CI: 1.19-10.25) for GDF15. Relationships persisted after covariate adjustments. Conclusion FGF21 and GDF15 levels may be useful biomarkers to screen for CPHIV with mitochondrial dysfunction.	[Gojanovich, Greg S.; Gerschenson, Mariana] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Jacobson, Denise L.; Broadwell, Carly; Karalius, Brad] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Kirmse, Brian] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Geffner, Mitchell E.] Keck Sch Med USC, Los Angeles, CA USA; [Jao, Jennifer] Northwestern Feinberg Sch Med, Chicago, IL USA; [Van Dyke, Russell B.; Silio, Margarita] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [McFarland, Elizabeth J.] Univ Colorado, Sch Med, Aurora, CO USA; [Crain, Marilyn] Univ Alabama Birmingham, Birmingham, AL USA	University of Hawaii System; University of Hawaii Manoa; Harvard University; Harvard T.H. Chan School of Public Health; University of Mississippi; University of Mississippi Medical Center; Northwestern University; Feinberg School of Medicine; Tulane University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Alabama System; University of Alabama Birmingham	Gerschenson, M (corresponding author), Univ Hawaii Manoa, Honolulu, HI 96822 USA.	gerschen@hawaii.edu		, Jennifer/0000-0003-1894-6040; Gojanovich, Gregory/0000-0001-5073-1686	University of Hawaii; US Department of Health and Human Services, National Institutes of Health [P20GM113134, U54MD007584]	University of Hawaii; US Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the University of Hawaii and the US Department of Health and Human Services, National Institutes of Health grants: P20GM113134 (Gerschenson, M) and U54MD007584 [Hedges, J and Mokuau, N (PI)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Payne B, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-27; Bisgaard A, 2014, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2014-7; Conte M, 2019, J GERONTOL A-BIOL, V74, P600, DOI 10.1093/gerona/gly153; Crain MJ, 2010, J INFECT DIS, V202, P291, DOI 10.1086/653497; Domingo P, 2010, CLIN INFECT DIS, V50, P1033, DOI 10.1086/651117; Elvstam O, 2019, HIV MED, V20, P571, DOI 10.1111/hiv.12756; Frigati LJ, 2020, LANCET CHILD ADOLESC, V4, P688, DOI 10.1016/S2352-4642(20)30037-7; Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006; Geffner ME, 2018, AIDS, V32, P613, DOI 10.1097/QAD.0000000000001731; Gojanovich GS, 2020, AIDS RES HUM RETROV, V36, P703, DOI [10.1089/aid.2020.0067, 10.1089/AID.2020.0067]; Hero M, 2011, CLIN ENDOCRINOL, V75, P141, DOI 10.1111/j.1365-2265.2011.03999.x; Ji XB, 2017, MOL NEUROBIOL, V54, P8110, DOI 10.1007/s12035-016-0283-7; Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374; Miller TL, 2012, HIV MED, V13, P264, DOI 10.1111/j.1468-1293.2011.00970.x; Montero R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148709; Moure R, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00029-18, 10.1128/aac.00029-18]; Praktiknjo M, 2019, LIVER INT, V39, P1514, DOI 10.1111/liv.14107; Reinehr T, 2017, HORM MOL BIOL CLIN I, V30, DOI 10.1515/hmbci-2015-0074; Rodriguez-Mora S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0203-3; Scherzer R, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004312; Sharma TS, 2013, AIDS RES HUM RETROV, V29, P1211, DOI 10.1089/aid.2012.0354; Srinivasa S, 2015, CLIN ENDOCRINOL, V82, P678, DOI 10.1111/cen.12582; Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7; Takemoto JK, 2017, AIDS, V31, P15, DOI 10.1097/QAD.0000000000001299; Tantawy AAG, 2014, BLOOD CELL MOL DIS, V53, P189, DOI 10.1016/j.bcmd.2014.07.003; Tezze C, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00419; Tsai VWW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133362; Tsygankova PG, 2019, J INHERIT METAB DIS, V42, P918, DOI 10.1002/jimd.12142; Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8; Wu L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16312-6; Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506; Yuca SA, 2017, EXP CLIN ENDOCR DIAB, V125, P86, DOI 10.1055/s-0042-114220	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261563	10.1371/journal.pone.0261563	http://dx.doi.org/10.1371/journal.pone.0261563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972147	gold, Green Published			2022-12-27	WOS:000773555700040
J	Hijikata, Y; Nakahara, M; Kusumegi, A; Morii, J; Okubo, N; Hatano, N; Takahashi, Y				Hijikata, Yasukazu; Nakahara, Masayuki; Kusumegi, Akira; Morii, Junji; Okubo, Naoki; Hatano, Nozomi; Takahashi, Yuichi			Association between occupational testicular radiation exposure and lower male sex ratio of offspring among orthopedic surgeons	PLOS ONE			English	Article							IONIZING-RADIATION; SURVIVORS; CANCER; LEVEL; RISK	Background Exposure to occupational radiation can lower the male sex ratio. However, specific radiation exposure to the testes has not been evaluated. Objective This study aimed to examine the association between testicular radiation exposure and lower male sex ratio in children. Methods A comprehensive questionnaire survey was administered to 62 full-time male doctors with children aged < 10 years at 5 hospitals. Based on the possibility of testicular radiation exposure 1 year before the child's birth, participants were assigned to 3 groups as follows: RT (orthopedic surgery), RNT (cardiology/neurosurgery), and N (others). Intergroup differences in the proportion of female children were ascertained, and the female sex ratio (number of female/total number) of each group was compared against the standard value of 0.486. Multivariate logistic regression analysis with a generalized estimating equation was used to model the effects on the probability of female birth while controlling for the correlation among the same fathers. Results The study population included 62 fathers and 109 children, 49 were female: 19/27, 11/30, and 19/52 in the RT, RNT, and N group, respectively; the RT group had the highest proportion of females (p = 0.009). The p values for comparisons with the standard sex ratio (0.486) were 0.02, 0.19, and 0.08 for the RT, RNT, and N groups, respectively. Based on the N group, the adjusted odds ratios for the child to be female were 4.40 (95% confidence interval 1.60-2.48) and 1.03 (0.40-2.61) for the RT and RNT groups, respectively. Conclusions Our results imply an association between testicular radiation exposure and low male sex ratio of offspring. Confirmatory evidence is needed from larger studies which measure the pre-conceptional doses accumulated in various temporal periods, separating out spermatogonial and spermatid effects.	[Hijikata, Yasukazu; Nakahara, Masayuki; Morii, Junji; Okubo, Naoki; Hatano, Nozomi] Kitasuma Hosp, Dept Spine & Low Back Pain Ctr, Kobe, Hyogo, Japan; [Hijikata, Yasukazu] Kyoto Univ, Sch Publ Hlth, Dept Healthcare Epidemiol, Grad Sch Med, Kyoto, Japan; [Kusumegi, Akira; Takahashi, Yuichi] Shinkomonji Hosp, Dept Spine & Spine Surg, Fukuoka, Japan	Kyoto University	Hijikata, Y (corresponding author), Kitasuma Hosp, Dept Spine & Low Back Pain Ctr, Kobe, Hyogo, Japan.; Hijikata, Y (corresponding author), Kyoto Univ, Sch Publ Hlth, Dept Healthcare Epidemiol, Grad Sch Med, Kyoto, Japan.	hiz007@hotmail.co.jp		Hijikata, Yasukazu/0000-0001-8619-5977				Amann RP, 2008, J ANDROL, V29, P469, DOI 10.2164/jandrol.107.004655; Bernier MO, 2018, RADIOLOGY, V286, P592, DOI 10.1148/radiol.2017170683; Chen TY, 2017, QJM-INT J MED, V110, P163, DOI 10.1093/qjmed/hcw140; Cheriachan D, 2016, J ORTHOP TRAUMA, V30, pE230, DOI 10.1097/BOT.0000000000000578; Dickinson HO, 1996, J EPIDEMIOL COMMUN H, V50, P645, DOI 10.1136/jech.50.6.645; Dobrzynska MM, 2014, J OCCUP HEALTH, V56, P379, DOI 10.1539/joh.13-0287-OA; Firman RC, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2019.0929; Funao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095233; Gausden EB, 2017, J BONE JOINT SURG AM, V99, P1324, DOI 10.2106/JBJS.16.01557; Hama Y, 2001, ACAD RADIOL, V8, P421, DOI 10.1016/S1076-6332(03)80550-0; Hayda RA, 2018, J AM ACAD ORTHOP SUR, V26, P268, DOI 10.5435/JAAOS-D-16-00342; Heo Y, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0144-x; JABLON S, 1971, AM J EPIDEMIOL, V93, P253, DOI 10.1093/oxfordjournals.aje.a121256; Koya PKM, 2015, RADIAT ENVIRON BIOPH, V54, P453, DOI 10.1007/s00411-015-0615-4; Little MP, 2018, EUR J EPIDEMIOL, V33, P1179, DOI 10.1007/s10654-018-0435-3; Lowery GL, 2000, EUR SPINE J, V9, pS126, DOI 10.1007/PL00008318; Mastrangelo G, 2005, OCCUP MED-OXFORD, V55, P498, DOI 10.1093/occmed/kqi048; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; Ministry of Health Labour and Welfare, 2019, SPEC REP VIT STAT; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Ozgur Burak M, 2006, Spine J, V6, P435, DOI 10.1016/j.spinee.2005.08.012; Pillarisetti Jayasree, 2013, J Atr Fibrillation, V5, P801, DOI 10.4022/jafib.801; Scherb H, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-63; Shea KM, 1997, AM J EPIDEMIOL, V145, P546, DOI 10.1093/oxfordjournals.aje.a009143; Silvestre C, 2012, ASIAN SPINE J, V6, P89, DOI 10.4184/asj.2012.6.2.89; Singer G, 2005, J AM ACAD ORTHOP SUR, V13, P69, DOI 10.5435/00124635-200501000-00009; Sumner RN, 2020, REPRODUCTION, V159, pR265, DOI 10.1530/REP-20-0042; Terrell Metrecia L, 2011, Emerg Health Threats J, V4, P7109, DOI 10.3402/ehtj.v4i0.7109; Valone LC, 2016, J BONE JOINT SURG AM, V98, P1808, DOI 10.2106/JBJS.15.01167; Zadeh HG, 1997, ANN ROY COLL SURG, V79, P214	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262089	10.1371/journal.pone.0262089	http://dx.doi.org/10.1371/journal.pone.0262089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972186	Green Published, gold			2022-12-27	WOS:000773555700095
J	Johnson, EW; McRae, SB				Johnson, Emily W.; McRae, Susan B.			Interclutch variability in egg characteristics in two species of rail: Is maternal identity encoded in eggshell patterns?	PLOS ONE			English	Article							INTRASPECIFIC BROOD PARASITISM; CONSPECIFIC NEST PARASITISM; PHOTOGRAPHIC IDENTIFICATION; MOORHENS; EVOLUTION; REJECTION; RESPONSES; BIRDS; COLOR	Maternal signatures are present in the eggs of some birds, but quantifying interclutch variability within populations remains challenging. Maternal assignment of eggs with distinctive appearances could be used to non-invasively identify renesting females, including hens returning among years, as well as to identify cases of conspecific brood parasitism. We explored whether King Rail (Rallus elegans) eggs with shared maternity could be matched based on eggshell pattern. We used NaturePatternMatch (NPM) software to match egg images taken in the field in conjunction with spatial and temporal data on nests. Since we had only a small number of marked breeders, we analyzed similar clutch images from a study of Eurasian Common Moorhens (Gallinula chloropus chloropus) with color-banded breeders for which parentage at many nests had been verified genetically to validate the method. We ran 66 King Rail clutches (n = 338 eggs) and 58 Common Moorhen clutches (n = 364 eggs) through NPM. We performed non-metric multidimensional scaling and permutational analysis of variance using the best egg match output from NPM. We also explored whether eggs could be grouped by clutch using a combination of egg dimensions and pattern data derived from NPM using linear discriminant analyses. We then scrutinized specific matches returned by NPM for King Rail eggs to determine whether multiple matches between the same clutches might reveal maternity among nests and inform our understanding of female laying behavior. To do this, we ran separate NPM analyses for clutches photographed over several years from two spatially distant parts of the site. With these narrower datasets, we were able to identify four instances where hens likely returned to breed among years, four likely cases of conspecific brood parasitism, and a within-season re-nesting attempt. Thus, the matching output was helpful in identifying congruent egg patterns among clutches when used in conjunction with spatial and temporal data, revealing previously unrecognized site fidelity, within-season movements, and reproductive interference by breeding females. Egg pattern data in combination with nest mapping can be used to inform our understanding of female reproductive effort, success, and longevity in King Rails. These methods may also be applied to other secretive birds and species of conservation concern.	[Johnson, Emily W.; McRae, Susan B.] East Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	McRae, SB (corresponding author), East Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	mcraes@ecu.edu		McRae, Susan/0000-0003-3209-4710	U.S. Fish and Wildlife Service, Refuge System Inventory and Monitoring program through a Piedmont South Atlantic Coast Cooperative Ecosystems Studies Unit [F19AC00629]; E. Alexander Bergstrom Memorial Research Award from the Association of Field Ornithologists	U.S. Fish and Wildlife Service, Refuge System Inventory and Monitoring program through a Piedmont South Atlantic Coast Cooperative Ecosystems Studies Unit; E. Alexander Bergstrom Memorial Research Award from the Association of Field Ornithologists	This study was conducted with support from the U.S. Fish and Wildlife Service, Refuge System Inventory and Monitoring program through a Piedmont South Atlantic Coast Cooperative Ecosystems Studies Unit (http://www.cesu.psu.edu/unit_portals/PSAC_portal.htm) agreement to SBM (F19AC00629), and an E. Alexander Bergstrom Memorial Research Award from the Association of Field Ornithologists (https://afonet.org/grants-awards/bergstrom/) to EWJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2001, AM NAT, V158, P599, DOI 10.1086/324113; BAERENDS G P, 1982, Behaviour, V82, P1; Birkhead T.R., 2016, MOST PERFECT THING I; BIRKHEAD TR, 1978, ANIM BEHAV, V26, P321, DOI 10.1016/0003-3472(78)90050-7; Brackett CL, 2013, CONSERV GENET RESOUR, V5, P1189, DOI 10.1007/s12686-013-9999-0; Caves EM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0598; Clauser AJ, 2016, WATERBIRDS, V39, P268; Cooper T., 2008, KING RAIL RALLUS ELE; FREEMAN S, 1988, OSTRICH, V59, P49, DOI 10.1080/00306525.1988.9633694; GASTON AJ, 1993, ANIM BEHAV, V45, P301, DOI 10.1006/anbe.1993.1034; Gomez J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248021; Gosler AG, 2005, ECOL LETT, V8, P1105, DOI 10.1111/j.1461-0248.2005.00816.x; Gosler AG, 2000, P ROY SOC B-BIOL SCI, V267, P2469, DOI 10.1098/rspb.2000.1307; Hanley D, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2592; Hoque S., 2011, INT J BIOSCI BIOTECH, V3, P45; Ishikawa S, 2010, FEBS LETT, V584, P770, DOI 10.1016/j.febslet.2009.12.041; JACKSON WM, 1992, AUK, V109, P435; Jamieson IG, 2000, AUK, V117, P250, DOI 10.1642/0004-8038(2000)117[0250:HROCBP]2.0.CO;2; KENNEDY GY, 1976, COMP BIOCHEM PHYS B, V55, P117, DOI 10.1016/0305-0491(76)90183-8; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; Kolts JR, 2017, ECOL EVOL, V7, P1101, DOI 10.1002/ece3.2761; Kolts JR, 2014, THESIS E CAROLINA U; Lahti DC, 2002, ANIM BEHAV, V63, P1135, DOI 10.1006/anbe.2002.3009; Long SL, 2017, HERPETOL CONSERV BIO, V12, P350; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Lyon BE, 2015, ANIM BEHAV, V103, P117, DOI 10.1016/j.anbehav.2015.02.010; MCRAE SB, 1995, ANIM BEHAV, V49, P1073, DOI 10.1006/anbe.1995.0136; McRae SB, 1998, BEHAV ECOL, V9, P93, DOI 10.1093/beheco/9.1.93; McRae SB, 1996, ANIM BEHAV, V52, P225, DOI 10.1006/anbe.1996.0169; McRae SB, 1997, J ANIM ECOL, V66, P143, DOI 10.2307/6017; McRae SB, 1997, IBIS, V139, P701; McRae SB, 1996, BEHAV ECOL SOCIOBIOL, V38, P115, DOI 10.1007/s002650050224; McRae SB, 2011, ECOL EVOL, V1, P317, DOI 10.1002/ece3.26; MONTEVECCHI WA, 1976, BEHAVIOUR, V58, P26, DOI 10.1163/156853976X00226; Quach L, 2021, J EXP ZOOL PART B, V336, P595, DOI 10.1002/jez.b.22945; R Core Team, 2021, R LANG ENV STAT COMP; Schroeder KM, 2018, WILSON J ORNITHOL, V130, P1036, DOI 10.1676/1559-4491.130.4.1036; Sezer M, 2009, BIOL RES, V42, P99, DOI [/S0716-97602009000100010, 10.4067/S0716-97602009000100010]; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Soto FA, 2012, COGN AFFECT BEHAV NE, V12, P220, DOI 10.3758/s13415-011-0070-x; Sparks NHC, 2011, AVIAN BIOL RES, V4, P162, DOI 10.3184/175815511X13228269481875; Speed CW, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-2; Stoddard MC, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0197; Stoddard MC, 2017, SCIENCE, V356, P1249, DOI 10.1126/science.aaj1945; Stoddard MC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5117; Stoddard MC, 2011, AVIAN BIOL RES, V4, P196, DOI 10.3184/175815511X13207484398647; Sulc M., 2020, PREPRINT; Town C, 2013, ECOL EVOL, V3, P1902, DOI 10.1002/ece3.587; TSCHANZ BEAT, 1959, BEHAVIOUR, V14, P1, DOI 10.1163/156853959X00018; Van Perlo, 1998, RAILS GUIDE RAILS CR; VICTORIA JK, 1972, IBIS, V114, P367, DOI 10.1111/j.1474-919X.1972.tb00834.x; Yom-Tov Y, 2001, IBIS, V143, P133, DOI 10.1111/j.1474-919X.2001.tb04177.x; YOMTOV Y, 1980, BIOL REV, V55, P93, DOI 10.1111/j.1469-185X.1980.tb00689.x	53	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261868	10.1371/journal.pone.0261868	http://dx.doi.org/10.1371/journal.pone.0261868			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025922	gold, Green Published			2022-12-27	WOS:000796264200030
J	Namasivayam, P; Bui, DT; Low, C; Barnett, T; Bridgman, H; Marsh, P; Lee, S				Namasivayam, Pathmavathy; Bui, Dung T.; Low, Christine; Barnett, Tony; Bridgman, Heather; Marsh, Pauline; Lee, Simone			Use of telehealth in the provision of after-hours palliative care services in rural and remote Australia: A scoping review protocol	PLOS ONE			English	Review							CAREGIVERS; SUPPORT; TOOLS	Introduction After-hours services are essential in ensuring patients with life limiting illness and their caregivers are supported to enable continuity of care. Telehealth is a valuable approach to meeting after-hours support needs of people living with life-limiting illness, their families, and caregivers in rural and remote communities. It is important to explore the provision of after-hours palliative care services using telehealth to understand the reach of these services in rural and remote Australia. A preliminary search of databases failed to reveal any scoping or systematic reviews of telehealth in after-hours palliative care services in rural or remote Australia. Aim To review and map the available evidence about the use of telehealth in providing after-hours palliative care services in Australian rural and remote communities. Methods The proposed scoping review will be conducted using the Arksey and O'Malley methodological framework and in accordance with the Joanna Briggs Institute methodology for scoping reviews. The reporting of the scoping review will be guided by the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). This review will consider research and evaluation of after-hours services using telehealth for palliative care stakeholders in rural and remote Australia. Peer reviewed studies and grey literature published in English from 2000 to May 2021 will be included. Scopus, Web of Science, CINAHL Complete, Embase via Ovid, PsycINFO via Ovid, Emcare via Ovid, Medline via Ovid, and grey literature will be searched for relevant articles. Titles and abstracts will be screened by two independent reviewers for assessment against the inclusion criteria. Data will be extracted and analysed by two reviewers using an adapted data extraction tool and thematic analysis techniques. Diagrams, tables, and summary narratives will be used to map, summarise and thematically group the characteristics of palliative care telehealth services in rural and remote Australia, including stakeholders' perceptions and benefits and challenges of the services.	[Namasivayam, Pathmavathy; Bui, Dung T.] Univ Tasmania, Sch Nursing, Hobart, Tas, Australia; [Bui, Dung T.; Low, Christine; Barnett, Tony; Bridgman, Heather; Marsh, Pauline; Lee, Simone] Univ Tasmania, Sch Hlth Sci, Ctr Rural Hlth, Newnham, Tas, Australia	University of Tasmania; University of Tasmania	Bui, DT (corresponding author), Univ Tasmania, Sch Hlth Sci, Ctr Rural Hlth, Newnham, Tas, Australia.	dungtrung.bui@utas.edu.au		Namasivayam, Pathmavathy/0000-0003-0761-223X; Bui, Trung Dung/0000-0002-9907-8240; Low, Christine/0000-0002-4247-6467				Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Armstrong K., 2016, HLTH FUTURE AUSTR; Australian Bureau of Statistics, 2017, AUSTR DEM STAT; Australian Bureau of Statistics, 2014, AUSTR HIST POP STAT; Australian Department of Health, TEL PIL PROGR; Australian Department of Health, MOD MON MOD INT; Australian Department of Health and Human Services, TASM MOD SERV DEL PA; Australian Institute of Health and Welfare, 2018, OLD AUSTR GLANC; Australian Institute of Health and Welfare, RURAL REMOTE HEALTH; Australian Institute of Health and Welfare, PALL CAR SERV AUSTR; Baird-Bower D, 2016, INT J PALLIAT NURS, V22, P286, DOI 10.12968/ijpn.2016.22.6.286; Bradford NK, 2016, RURAL REMOTE HEALTH, V16; Bradford N, 2012, J PEDIATR ONCOL NURS, V29, P141, DOI 10.1177/1043454212446023; CareSearch, RUR REM SPEC POP INT; Chi NC, 2015, J TELEMED TELECARE, V21, P37, DOI 10.1177/1357633X14562734; Chiang LC, 2012, INT J NURS STUD, V49, P1230, DOI 10.1016/j.ijnurstu.2012.04.013; Chih MY, 2013, PALLIATIVE MED, V27, P533, DOI 10.1177/0269216312457213; Ciechomski L, 2009, ASIA-PAC J HEALTH MA, V4, P57; CRANA plus, 2015, CRANA PLUS POS PAP P; Crawford M., 2017, GEN REPORT PERFORMAN; Cromwell D., 2003, CAN NATL PALLIATIVE; Demiris G, 2012, J PALLIAT MED, V15, P653, DOI 10.1089/jpm.2011.0488; Demiris G, 2007, CLIN GERONTOLOGIST, V31, P43, DOI 10.1300/J018v31n01_04; Dionne-Odom JN, 2018, J PAIN SYMPTOM MANAG, V55, P1519, DOI 10.1016/j.jpainsymman.2018.02.009; Disalvo D, 2021, PALLIATIVE MED, V35, P1385, DOI 10.1177/02692163211024451; Grindrod A, 2018, ANN PALLIAT MED, V7, pS73, DOI 10.21037/apm.2018.04.01; Johnston Bridget M, 2020, HRB Open Res, V3, P9, DOI 10.12688/hrbopenres.13006.1; McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021; National Rural Health Alliance, 2012, PALL CAR RUR REM ARE; Oliver DP, 2010, AM J HOSP PALLIAT ME, V27, P465, DOI 10.1177/1049909110362402; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Palliative Care Australia, 2018, PALL CAR SERV DEV GU; Palliative Care Australia, 2017, PALL CAR AUSTR SUBM; Palliative Care Australia, 2020, CALLS PALL CAR REF P; Palliative Care Tasmania, PALL CAR; Palliative Care team, 2012, AFT HOURS PALL CAR F; Peters M.D.J., 2017, J BRIGGS I REV MANUA, DOI DOI 10.46658/JBIMES-20-01; Phillips JL, 2008, J PAIN SYMPTOM MANAG, V36, P11, DOI 10.1016/j.jpainsymman.2007.08.017; Royal Australian Coffege of General Practitioners, 2016, GP LED PALL CAR RUR; Snoswell CL, 2020, AUST HEALTH REV, V44, P737, DOI 10.1071/AH20183; The Australian Department of Health, 2015, TEL; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850; Victoria Department of Health Human Services, 2013, HOURS PALL CAR PIL P; Wadhwa A, 2006, MED EDUC, V40, P759, DOI 10.1111/j.1365-2929.2006.02534.x; Wenham S, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp3012001; WHO, 2019, TEL WHO; Wilkes Lesley, 2004, Aust J Rural Health, V12, P95, DOI 10.1111/j.1440-1854.2004.00568.x; World Health Organization, PALL CAR; Zheng YQ, 2016, TELEMED E-HEALTH, V22, P288, DOI 10.1089/tmj.2015.0090	50	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261962	10.1371/journal.pone.0261962	http://dx.doi.org/10.1371/journal.pone.0261962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025895	Green Published, Green Accepted, gold			2022-12-27	WOS:000796264200037
J	Yang, XK; Xu, JB; Zhu, ML; Yang, YL				Yang, Xiaokang; Xu, Junbing; Zhu, Minling; Yang, Yinglong			Environmental regulation and corporate tax avoidance-Evidence from China	PLOS ONE			English	Article							CARBON; IMPACT	In this study, we used a difference-in-difference (DID) approach to analyze the effect of environmental regulation on corporate tax avoidance behavior based on China's carbon emissions trading pilot policy of 2013. Our findings were as follows: (1) Environmental regulation has led companies to adopt further tax evasion behaviors. Furthermore, the core conclusion was confirmed after a series of robust and endogenous tests, such as parallel trends and PSM-DID (propensity score matching-difference-in-difference). (2) Environmental regulations increase tax avoidance activities by reducing corporate cash flows. (3) The influence of environmental regulation on firm tax evasion is highly pronounced among non-state-owned enterprises, big-scale enterprises, and enterprises with a high degree of industry competition.	[Yang, Xiaokang; Yang, Yinglong] Xiamen Univ, Inst Financial & Accounting Studies IFAS, Xiamen, Fujian, Peoples R China; [Xu, Junbing] Xiamen Univ, Wang Yanan Inst Studies Econ WISE, Xiamen, Fujian, Peoples R China; [Zhu, Minling] Xiamen Univ, Sch Econ SOE, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Zhu, ML (corresponding author), Xiamen Univ, Inst Financial & Accounting Studies IFAS, Xiamen, Fujian, Peoples R China.; Zhu, ML (corresponding author), Xiamen Univ, Sch Econ SOE, Xiamen, Fujian, Peoples R China.	zml_dx@163.com						Berman E, 2001, J PUBLIC ECON, V79, P265, DOI 10.1016/S0047-2727(99)00101-2; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Boone JP, 2013, J AM TAX ASSOC, V35, P53, DOI 10.2308/atax-50341; Borghesi S, 2015, RES POLICY, V44, P669, DOI 10.1016/j.respol.2014.10.014; Cai HB, 2011, J LAW ECON, V54, P55, DOI 10.1086/651201; Cai HB, 2009, ECON J, V119, P764, DOI 10.1111/j.1468-0297.2009.02217.x; Chen HW, 2021, ACCOUNT REV, V96, P157, DOI 10.2308/TAR-2017-0601; Chen H, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18031316; Cheng BB, 2016, ENERG POLICY, V88, P515, DOI 10.1016/j.enpol.2015.11.006; Dong F, 2019, SCI TOTAL ENVIRON, V653, P565, DOI 10.1016/j.scitotenv.2018.10.395; Hasan I, 2017, J ACCOUNT RES, V55, P629, DOI 10.1111/1475-679X.12159; Hu YC, 2020, ENERG ECON, V85, DOI 10.1016/j.eneco.2019.104590; Huang ZH, 2020, SCI TOTAL ENVIRON, V738, DOI 10.1016/j.scitotenv.2020.139769; Law KKF, 2017, REV ACCOUNT STUD, V22, P141, DOI 10.1007/s11142-016-9373-z; Li P, 2016, J DEV ECON, V123, P18, DOI 10.1016/j.jdeveco.2016.07.002; Lv MC, 2021, FINANC RES LETT, V39, DOI 10.1016/j.frl.2020.101565; Mi ZF, 2017, J CLEAN PROD, V142, P2227, DOI 10.1016/j.jclepro.2016.11.055; Mi ZF, 2016, APPL ENERG, V184, P1073, DOI 10.1016/j.apenergy.2016.06.094; Porcano T., 1986, J AM TAX ASSOC, V7, P17; Song ML, 2018, TECHNOL FORECAST SOC, V133, P1, DOI 10.1016/j.techfore.2018.04.020; Wei CY, 2020, J CORP FINANC, V62, DOI 10.1016/j.jcorpfin.2019.101554; Wen FH, 2020, ENERG ECON, V86, DOI 10.1016/j.eneco.2019.104627; Wu L.S., 2007, J ACCOUNT PUBLIC POL, V26, P555, DOI [10.1016/j.jaccpubpol.2007.08.003, DOI 10.1016/J.JACCPUBPOL.2007.08.003]; Yang XY, 2020, ENERG POLICY, V142, DOI 10.1016/j.enpol.2020.111492; Zhang C, 2016, APPL ENERG, V182, P177, DOI 10.1016/j.apenergy.2016.08.133; Zhang WJ, 2019, TECHNOL FORECAST SOC, V141, P1, DOI 10.1016/j.techfore.2018.12.014; Zhang YJ, 2020, BUS STRATEG ENVIRON, V29, P872, DOI 10.1002/bse.2404; Zhou B, 2019, SCI TOTAL ENVIRON, V676, P514, DOI 10.1016/j.scitotenv.2019.04.303; Zhou YY, 2019, BUS STRATEG ENVIRON, V28, P567, DOI 10.1002/bse.2265	29	1	1	19	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261037	10.1371/journal.pone.0261037	http://dx.doi.org/10.1371/journal.pone.0261037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025907	Green Published, gold			2022-12-27	WOS:000796264200010
J	Rybak, B; Krawczyk, B; Furmanek-Blaszk, B; Wysocka, M; Fordon, M; Ziolkowski, P; Meissner, W; Stepniewska, K; Sikorska, K				Rybak, Bartosz; Krawczyk, Beata; Furmanek-Blaszk, Beata; Wysocka, Magdalena; Fordon, Magdalena; Ziolkowski, Pawel; Meissner, Wlodzimierz; Stepniewska, Katarzyna; Sikorska, Katarzyna			Antibiotic resistance, virulence, and phylogenetic analysis of Escherichia coli strains isolated from free-living birds in human habitats	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; HIGH-PATHOGENICITY ISLAND; MOLECULAR EPIDEMIOLOGY; CTX-M; PREVALENCE; GENES; BACTERIA; BLOOD; WATER; ENVIRONMENT	Wild birds can be colonized by bacteria, which are often resistant to antibiotics and have various virulence profiles. The aim of this study was to analyze antibiotic resistance mechanisms and virulence profiles in relation to the phylogenetic group of E. co/i strains that were isolated from the GI tract of wildfowl. Out of 241 faecal samples, presence of E. co/i resistant to a cephalosporin (ESBLIAmpC) was estimated for 33 isolates (13,7%). Based on the analysis of the coexistence of 4 genes encoding ESBLs/AmpC (bla(CTX-M), bla(TEM), bla(SHV), bla(AmpC)) and class 1 and 2 integrons genes (intl1, intl2) a subset of two resistance profiles was observed among the investigated E. coli isolates carrying bla(AmpC), bla(SHV), and bla(CTX-M), bla(TEM), class 1 and 2 integrons, respectively. The E. coli isolates were categorized into 4 phylogenetic groups A (39.4%), B2 (24.25%), D (24.25%) and B1 (12.1%). The pathogenic B2 and D groups were mainly typical for the Laridae family. Among the 28 virulence factors (Vfs) detected in pathogenic phylogenetic groups B2 and D, 7 were exclusively found in those groups (sfa, vat, tosA, tosB, h/y, usp, cm), while 4 VFs (fecA, fyuA, irp2, kspMTII) showed a statistically significant association (P <= 0.05) with phylogroups A and B1. Our results indicated that strains belonging to commensal phylogroups A/B1 possess extensive iron acquisition systems (93,9%) and autotransporters (60,6%), typical for pathogens, hence we suggest that these strains evolve towards higher levels of virulence. This study, which is a point assessment of the virulence and drug resistance potential of wild birds, confirms the importance of taking wild birds as a reservoir of strains that pose a growing threat to humans. The E. coli analyzed in our study derive from different phylogenetic groups and possess an arsenal of antibiotic resistance genes and virulence factors that contribute to their ability to cause diseases.	[Rybak, Bartosz] Med Univ Gdansk, Inst Maritime & Trop Med, Dept Environm Toxicol, Fac Hlth Sci, Gdansk, Poland; [Krawczyk, Beata; Wysocka, Magdalena; Fordon, Magdalena] Gdansk Univ Technol, Fac Chem, Dept Mol Biotechnol & Microbiol, Gdansk, Poland; [Furmanek-Blaszk, Beata; Ziolkowski, Pawel] Univ Gdansk, Fac Biol, Dept Microbiol, Gdansk, Poland; [Meissner, Wlodzimierz; Stepniewska, Katarzyna] Univ Gdansk, Dept Vertebrate Ecol & Zool, Avian Ecophysiol Unit, Gdansk, Poland; [Sikorska, Katarzyna] Med Univ Gdansk, Fac Hlth Sci, Dept Trop Med & Parasitol, Natl Ctr Trop Med,Inst Maritime & Trop Med, Gdynia, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Krawczyk, B (corresponding author), Gdansk Univ Technol, Fac Chem, Dept Mol Biotechnol & Microbiol, Gdansk, Poland.	beata.krawczyk@pg.edu.pl			Statutory Research Programme in Gdansk University of Technology [4914/E-359/M/2019 Ds-033143]	Statutory Research Programme in Gdansk University of Technology	Financial support within the framework of Statutory Research Programme in Gdansk University of Technology: 4914/E-359/M/2019 Ds-033143 for Beata Krawczyk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala L, 2016, MICROB ECOL, V72, P861, DOI 10.1007/s00248-015-0718-0; Atterby C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190380; Baraniak A, 2002, ANTIMICROB AGENTS CH, V46, P151, DOI 10.1128/AAC.46.1.151-159.2002; Binkowski LJ, 2013, ENVIRON POLLUT, V178, P336, DOI 10.1016/j.envpol.2013.03.030; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bonnedahl J, 2014, UPSALA J MED SCI, V119, P113, DOI 10.3109/03009734.2014.905663; Briongos-Figuero LS, 2012, INT J CLIN PRACT, V66, P891, DOI 10.1111/j.1742-1241.2012.02991.x; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Carattoli A, 2002, ANTIMICROB AGENTS CH, V46, P1269, DOI 10.1128/AAC.46.5.1269-1272.2002; Carniel E, 1996, J BACTERIOL, V178, P6743, DOI 10.1128/jb.178.23.6743-6751.1996; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; De Souza GM, 2019, INFECT DRUG RESIST, V12, P3595, DOI 10.2147/IDR.S228612; De Vries A, 2016, GGDENDRO CREATE DEND; Dobiasova H, 2013, FEMS MICROBIOL ECOL, V85, P604, DOI 10.1111/1574-6941.12149; Dolejska M, 2009, J APPL MICROBIOL, V106, P1941, DOI 10.1111/j.1365-2672.2009.04155.x; Dynowska M, 2013, B VET I PULAWY, V57, P323, DOI 10.2478/bvip-2013-0056; Dzidic S, 2008, FOOD TECHNOL BIOTECH, V46, P11; Edelstein M, 2003, ANTIMICROB AGENTS CH, V47, P3724, DOI 10.1128/AAC.47.12.3724-3732.2003; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; EWINS PJ, 1994, HYDROBIOLOGIA, V279, P39, DOI 10.1007/BF00027839; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Gao QQ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-143; Ge XKZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112048; Goldstein A, 2015, J COMPUT GRAPH STAT, V24, P44, DOI 10.1080/10618600.2014.907095; Gophna U, 2001, FEMS MICROBIOL LETT, V196, P57, DOI 10.1111/j.1574-6968.2001.tb10540.x; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Gordon DM, 2003, MICROBIOL-SGM, V149, P3575, DOI 10.1099/mic.0.26486-0; Gronthal T, 2018, EUROSURVEILLANCE, V23, P13, DOI 10.2807/1560-7917.ES.2018.23.27.1700497; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Guerra B, 2003, J ANTIMICROB CHEMOTH, V52, P489, DOI 10.1093/jac/dkg362; Handrova L, 2019, J ENVIRON SCI HEAL B, V54, P605, DOI 10.1080/03601234.2019.1608103; Huerta B, 2013, SCI TOTAL ENVIRON, V456, P161, DOI 10.1016/j.scitotenv.2013.03.071; Infante B, 2005, INT J ANTIMICROB AG, V25, P308, DOI 10.1016/j.ijantimicag.2004.12.004; Izdebski R, 2013, ANTIMICROB AGENTS CH, V57, P309, DOI 10.1128/AAC.01656-12; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Johnson JR, 2008, J CLIN MICROBIOL, V46, P4078, DOI 10.1128/JCM.00980-08; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Jorgensen SL, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00333-18; Kohler CD, 2011, INT J MED MICROBIOL, V301, P642, DOI 10.1016/j.ijmm.2011.09.006; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Krawczyk B, 2015, EUR J CLIN MICROBIOL, V34, P1135, DOI 10.1007/s10096-015-2331-z; Krawczyk B, 2007, J MICROBIOL METH, V71, P114, DOI 10.1016/j.mimet.2007.08.010; Krawczyk B, 2006, J CLIN MICROBIOL, V44, P2327, DOI 10.1128/JCM.00052-06; Krawczyk B, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9050318; Krawczyk B, 2017, J APPL GENET, V58, P415, DOI 10.1007/s13353-017-0393-6; Leverstein-van Hall MA, 2002, J CLIN MICROBIOL, V40, P3038, DOI 10.1128/JCM.40.8.3038-3040.2002; Literak I, 2012, MICROB DRUG RESIST, V18, P567, DOI 10.1089/mdr.2012.0075; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Liu BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073947; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Machado E, 2005, ANTIMICROB AGENTS CH, V49, P1823, DOI 10.1128/AAC.49.5.1823-1829.2005; Martinez-Martinez Luis, 2014, Enferm Infecc Microbiol Clin, V32 Suppl 4, P4, DOI 10.1016/S0213-005X(14)70168-5; Michalik M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192899; Mitchell NM, 2015, APPL ENVIRON MICROB, V81, P1177, DOI 10.1128/AEM.03524-14; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Nicolas-Chanoine MH, 2014, CLIN MICROBIOL REV, V27, P543, DOI 10.1128/CMR.00125-13; Ong CLY, 2008, J BACTERIOL, V190, P1054, DOI 10.1128/JB.01523-07; Picozzi S, 2013, UROL ANNALS, V5, P25, DOI 10.4103/0974-7796.106962; Pietsch M, 2017, VET MICROBIOL, V200, P130, DOI 10.1016/j.vetmic.2015.11.028; Radhouani H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00023; Roderova M, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02147; Sarowska J, 2019, GUT PATHOG, V11, DOI 10.1186/s13099-019-0290-0; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Schubert S, 1998, INFECT IMMUN, V66, P480, DOI 10.1128/IAI.66.2.480-485.1998; Searle LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117906; Shobrak MY, 2014, BRAZ J MICROBIOL, V45, P1199, DOI 10.1590/S1517-83822014000400010; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Skurnik D, 2005, ANTIMICROB AGENTS CH, V49, P3062, DOI 10.1128/AAC.49.7.3062-3065.2005; Sledzinska Anna, 2006, Przegl Epidemiol, V60, P27; Smith JL, 2007, FOODBORNE PATHOG DIS, V4, P134, DOI 10.1089/fpd.2007.0087; Smits JEG, 2013, COMP IMMUNOL MICROB, V36, P333, DOI 10.1016/j.cimid.2012.11.007; Smolders A, 2014, LAKE RESERV MANAGE, V30, P23, DOI 10.1080/10402381.2013.866997; Solo-Gabriele HM, 2000, APPL ENVIRON MICROB, V66, P230, DOI 10.1128/AEM.66.1.230-237.2000; Stedt J, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0166-3; Stojowska K, 2009, POL J MICROBIOL, V58, P247; The European Committee on Antimicrobial Susceptibility Testing, 2020, BREAKP TABL INT MICS; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Tsiodras S, 2008, J INFECTION, V56, P83, DOI 10.1016/j.jinf.2007.11.001; van der Westhuizen WA, 2012, AVIAN PATHOL, V41, P33, DOI 10.1080/03079457.2011.631982; Vounba P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214304; Wang S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147740; Washburn BE, 2013, CONDOR, V115, P67, DOI 10.1525/cond.2013.110185; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Yair Y, 2018, CURR TOP MICROBIOL, V416, P163, DOI 10.1007/82_2018_109	88	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262236	10.1371/journal.pone.0262236	http://dx.doi.org/10.1371/journal.pone.0262236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020771	Green Published, gold			2022-12-27	WOS:000834207700037
J	Shartaj, M; Suter, JF; Warziniack, T				Shartaj, Mostafa; Suter, Jordan F.; Warziniack, Travis			Summer crowds: An analysis of USFS campground reservations during the COVID-19 pandemic	PLOS ONE			English	Article							UNITED-STATES	During the COVID-19 pandemic, US public land managers faced the challenge of catering to large increases in camping demand, while maintaining social distancing guidelines. In this paper, we use multivariate linear regression to analyze weekly changes in reservations to US Forest Service (USFS) campgrounds between 2019 and 2020. The regression models estimate the impact of local COVID infection rates, public health restrictions, and spatial spillovers from proximity to National Parks (NPs), metropolitan areas and wildfire on camping demand. Our sample includes 1,688 individual USFS campgrounds from across the contiguous US. The results illustrate the dramatic increases in camping on USFS land that occurred in the summer of 2020 and demonstrate that increases in local infection rates led to significant increases in camping nights reserved in the summer. The results also illustrate that the increase in camping nights reserved at USFS campgrounds was particularly dramatic for campgrounds located near large metropolitan areas and near NPs that saw increases in overall recreational visits. These results point to the important role that public lands played during the pandemic and can help guide public land resource allocations for campground maintenance and operation.	[Shartaj, Mostafa; Suter, Jordan F.] Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA; [Warziniack, Travis] US Forest Serv, Rocky Mt Res Stn, Ft Collins, CO USA	Colorado State University; United States Department of Agriculture (USDA); United States Forest Service	Shartaj, M (corresponding author), Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA.	mostafa.shartaj@colostate.edu		Warziniack, Travis/0000-0002-9431-2288	US National Forest Service, National Center for Natural Resource Economics Research [19-JV-11221636-164]	US National Forest Service, National Center for Natural Resource Economics Research	Author Initials: JFS, MS Grant Number awarded: 19-JV-11221636-164 Funder: US National Forest Service, National Center for Natural Resource Economics Research The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LM, 2021, SCI TOTAL ENVIRON, V754, DOI 10.1016/j.scitotenv.2020.142396; Blahna Dale J., 2020, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P9; Craig CA, 2021, ANN TOURISM RES, V89, DOI 10.1016/j.annals.2020.103071; Department of Health and Social Care, 2020, DET METH SOURC COVID; Gellman J, 2021, WILDFIRE SMOKE OUTDO; Geng DH, 2021, J FORESTRY RES, V32, P553, DOI 10.1007/s11676-020-01249-w; Goodman-Bacon A, 2020, SURV RES METHODS-GER, V14, P153, DOI 10.18148/srm/2020.v14i2.7723; Jenkins ME, 2020, ADDRESSING MAINTENAN; Kupfer JA, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13169366; Landry CE, 2021, APPL ECON PERSPECT P, V43, P443, DOI 10.1002/aepp.13119; Moreland A, 2020, MMWR-MORBID MORTAL W, V69, P1198, DOI 10.15585/mmwr.mm6935a2; Morse JW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243697; National Interagency Fire Center, 2021, FIRE INF STAT; National Interagency Fire Center, 2021, WILDL FIR OP DAT; National Park Service, 2020, CURRENT YEAR MONTHLY; Oster AM, 2020, MMWR-MORBID MORTAL W, V69, P1127, DOI 10.15585/mmwr.mm6933e2; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Rice W.L., UNDERSTANDING DRIVER, DOI [10.31235/osf.io/97qa4, DOI 10.31235/OSF.IO/97QA4]; Romano S, 2021, RES SOC ADMIN PHARM, V17, P1876, DOI 10.1016/j.sapharm.2020.05.024; USA FACTS, 2021, US COVID 19 CAS DEAT; Volenec ZM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251799; Yi SH, 2020, MMWR-MORBID MORTAL W, V69, P1730, DOI 10.15585/mmwr.mm6946a3	22	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261833	10.1371/journal.pone.0261833	http://dx.doi.org/10.1371/journal.pone.0261833			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020759	gold, Green Published			2022-12-27	WOS:000834207700026
J	Yamagishi, T; Saito, A; Kawakami, Y				Yamagishi, Takaki; Saito, Akira; Kawakami, Yasuo			Determinants of whole-body maximal aerobic performance in young male and female athletes: The roles of lower extremity muscle size, strength and power	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; LEG EXTENSION POWER; OXYGEN-CONSUMPTION; STROKE VOLUME; VENTILATORY THRESHOLD; INCREMENTAL EXERCISE; CURVATURE CONSTANT; CYCLE ERGOMETRY; SEX-DIFFERENCES; THIGH	This study sought to determine whether lower extremity muscle size, power and strength could be a determinant of whole-body maximal aerobic performance in athletes. 20 male and 19 female young athletes (18 +/- 4 years) from various sporting disciplines participated in this study. All athletes performed a continuous ramp-incremental cycling to exhaustion for the determination of peak oxygen uptake ((V) over dotO(2peak): the highest (V) over dotO(2) over a 15-s period) and maximal power output (MPO: power output corresponding to (V) over dotO(2pe)(ak)). Axial scanning of the right leg was performed with magnetic resonance imaging, and anatomical cross-sectional areas (CSAs) of quadriceps femoris (QF) and hamstring muscles at 50% of thigh length were measured. Moreover, bilateral leg extension power and unilateral isometric knee extension and flexion torque were determined. All variables were normalised to body mass, and six independent variables ((V) over dotO(2peak), CSAs of thigh muscles, leg extension power and knee extension and flexion torque) were entered into a forward stepwise multiple regression model with MPO being dependent variable for males and females separately. In the males, (V) over dot(2)(peak), was chosen as the single predictor of MPO explaining 78% of the variance. In the females, MPO was attributed to, in the order of importance, (V) over dotO(2peak), (p < 0.001) and the CSA of QF (p = 0.011) accounting for 84% of the variance. This study suggests that while oxygen transport capacity is the main determinant of MPO regardless of sex, thigh muscle size also has a role in whole-body maximal aerobic performance in female athletes.	[Yamagishi, Takaki; Kawakami, Yasuo] Waseda Univ, Fac Sport Sci, Saitama, Japan; [Yamagishi, Takaki] Japan Inst Sport Sci, Dept Sport Sci, Tokyo, Japan; [Saito, Akira] Kyushu Sangyo Univ, Ctr Hlth & Sports Sci, Fukuoka, Japan; [Kawakami, Yasuo] Waseda Univ, Human Performance Lab, Comprehens Res Org, Tokyo, Japan	Waseda University; Waseda University	Kawakami, Y (corresponding author), Waseda Univ, Fac Sport Sci, Saitama, Japan.; Kawakami, Y (corresponding author), Waseda Univ, Human Performance Lab, Comprehens Res Org, Tokyo, Japan.	ykawa@waseda.jp	Kawakami, Yasuo/AFM-0651-2022	Kawakami, Yasuo/0000-0003-0588-4039; Yamagishi, Takaki/0000-0002-5499-8182	Go for the World! Saitama Young Athletes Development Program, Saitama prefecture; Human Performance Laboratory, Comprehensive Research Organization, Waseda University	Go for the World! Saitama Young Athletes Development Program, Saitama prefecture; Human Performance Laboratory, Comprehensive Research Organization, Waseda University	This work was supported by Go for the World! Saitama Young Athletes Development Program, Saitama prefecture; and the Human Performance Laboratory, Comprehensive Research Organization, Waseda University. One of our funders (Go for the World! Saitama Young Athletes Development Program, Saitama prefecture) played a role in participant recruitment.	Adami A, 2013, EUR J APPL PHYSIOL, V113, P2647, DOI 10.1007/s00421-013-2705-9; Akima H, 2005, INT J SPORTS MED, V26, P245, DOI 10.1055/s-2004-821000; Ansdell P, 2020, EXP PHYSIOL, V105, P2007, DOI 10.1113/EP088548; Ansdell P, 2020, J PHYSIOL-LONDON, V598, P5717, DOI 10.1113/JP280031; Ansdell P, 2019, J PHYSIOL-LONDON, V597, P5577, DOI 10.1113/JP278699; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Boone J, 2016, APPL PHYSIOL NUTR ME, V41, P55, DOI 10.1139/apnm-2015-0261; Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006; Cook DB, 1998, INT J NEUROSCI, V95, P183, DOI 10.3109/00207459809003340; di Prampero PE, 2003, EUR J APPL PHYSIOL, V90, P420, DOI 10.1007/s00421-003-0926-z; Ema R, 2014, INT J SPORTS MED, V35, P293, DOI 10.1055/s-0033-1349138; ERICSON MO, 1986, EUR J APPL PHYSIOL, V55, P229, DOI 10.1007/BF02343792; Ferretti G, 2014, EUR J APPL PHYSIOL, V114, P2007, DOI 10.1007/s00421-014-2911-0; Froyd C, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00399; GLEDHILL N, 1994, MED SCI SPORT EXER, V26, P1116; GREEN S, 1993, SPORTS MED, V15, P312, DOI 10.2165/00007256-199315050-00003; Guette M, 2005, CHRONOBIOL INT, V22, P541, DOI 10.1081/CBI-200062407; Hodgson MD, 2018, J APPL PHYSIOL, V125, P304, DOI 10.1152/japplphysiol.00722.2017; Hug F, 2006, INT J SPORTS MED, V27, P456, DOI 10.1055/s-2005-865787; Hunter SK, 2016, EXP PHYSIOL, V101, P250, DOI 10.1113/EP085370; IVY JL, 1980, J APPL PHYSIOL, V48, P523, DOI 10.1152/jappl.1980.48.3.523; Jacobs RA, 2011, J APPL PHYSIOL, V111, P1422, DOI 10.1152/japplphysiol.00625.2011; Kordi M, 2018, EUR J APPL PHYSIOL, V118, P637, DOI 10.1007/s00421-018-3807-1; Lanferdini FJ, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00979; Lavie CJ, 2004, AM J CARDIOL, V93, P588, DOI 10.1016/j.amjcard.2003.11.023; LORTIE G, 1985, EUR J APPL PHYSIOL O, V54, P471, DOI 10.1007/BF00422954; Maeo S, 2018, MED SCI SPORT EXER, V50, P1629, DOI 10.1249/MSS.0000000000001611; Marcora SM, 2010, EUR J APPL PHYSIOL, V109, P763, DOI 10.1007/s00421-010-1418-6; Mattu AT, 2020, SCAND J MED SCI SPOR, V30, P472, DOI 10.1111/sms.13590; McNulty KL, 2020, SPORTS MED, V50, P1813, DOI 10.1007/s40279-020-01319-3; Midgley AW, 2006, SPORTS MED, V36, P117, DOI 10.2165/00007256-200636020-00003; Miura A, 2002, EUR J APPL PHYSIOL, V87, P238, DOI 10.1007/s00421-002-0623-3; Morales-Alamo D, 2015, J PHYSIOL-LONDON, V593, P4631, DOI 10.1113/JP270487; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Mortensen SP, 2005, J PHYSIOL-LONDON, V566, P273, DOI 10.1113/jphysiol.2005.086025; Mortensen SP, 2008, J PHYSIOL-LONDON, V586, P2621, DOI 10.1113/jphysiol.2007.149401; Murias JM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00143; Noakes TD, 2008, BRIT J SPORT MED, V42, P551, DOI 10.1136/bjsm.2008.046821; Noakes TD, 2008, BRIT J SPORT MED, V42, P574, DOI 10.1136/bjsm.2008.046771; Noakes TD, 2004, BRIT J SPORT MED, V38, P511, DOI 10.1136/bjsm.2003.009860; Oliveira RB, 2011, CLINICS, V66, P203, DOI 10.1590/S1807-59322011000200004; Raghuveer G, 2020, CIRCULATION, V142, pE101, DOI 10.1161/CIR.0000000000000866; Roels B, 2005, BRIT J SPORT MED, V39, P965, DOI 10.1136/bjsm.2005.020404; Ronnestad BR, 2010, EUR J APPL PHYSIOL, V108, P965, DOI 10.1007/s00421-009-1307-z; Souza KM, 2015, APPL PHYSIOL NUTR ME, V40, P895, DOI 10.1139/apnm-2015-0090; Vucetic V, 2015, J STRENGTH COND RES, V29, P1057, DOI 10.1519/JSC.0000000000000725; Warburton DER, 2008, J APPL PHYSIOL, V104, P276, DOI 10.1152/japplphysiol.00595.2007a; Yamaguchi T, 2005, J STRENGTH COND RES, V19, P677; Yoshiga CC, 2003, J SPORT SCI, V21, P905, DOI 10.1080/0264041031000140437; Zhang JG, 2003, EUR J APPL PHYSIOL, V90, P109, DOI 10.1007/s00421-003-0860-0; Zhou B, 2001, MED SCI SPORT EXER, V33, P1849, DOI 10.1097/00005768-200111000-00008	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262507	10.1371/journal.pone.0262507	http://dx.doi.org/10.1371/journal.pone.0262507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020757	Green Published, gold			2022-12-27	WOS:000834207700045
J	Maharaj, AS; Parker, J; Hopkins, JP; Gournis, E; Bogoch, II; Rader, B; Astley, CM; Ivers, NM; Hawkins, JB; Lee, L; Tuite, AR; Fisman, DN; Brownstein, JS; Lapointe-Shaw, L				Maharaj, Arjuna S.; Parker, Jennifer; Hopkins, Jessica P.; Gournis, Effie; Bogoch, Isaac I.; Rader, Benjamin; Astley, Christina M.; Ivers, Noah M.; Hawkins, Jared B.; Lee, Liza; Tuite, Ashleigh R.; Fisman, David N.; Brownstein, John S.; Lapointe-Shaw, Lauren			Comparison of longitudinal trends in self-reported symptoms and COVID-19 case activity in Ontario, Canada	PLOS ONE			English	Article								Background Limitations in laboratory diagnostic capacity impact population surveillance of COVID-19. It is currently unknown whether participatory surveillance tools for COVID-19 correspond to government-reported case trends longitudinally and if it can be used as an adjunct to laboratory testing. The primary objective of this study was to determine whether self-reported COVID-19-like illness reflected laboratory-confirmed COVID-19 case trends in Ontario Canada. Methods We retrospectively analyzed longitudinal self-reported symptoms data collected using an online tool-Outbreaks Near Me (ONM)-from April 20th, 2020, to March 7th, 2021 in Ontario, Canada. We measured the correlation between COVID-like illness among respondents and the weekly number of PCR-confirmed COVID-19 cases and provincial test positivity. We explored contemporaneous changes in other respiratory viruses, as well as the demographic characteristics of respondents to provide context for our findings. Results Between 3,849-11,185 individuals responded to the symptom survey each week. No correlations were seen been self-reported CLI and either cases or test positivity. Strong positive correlations were seen between CLI and both cases and test positivity before a previously documented rise in rhinovirus/enterovirus in fall 2020. Compared to participatory surveillance respondents, a higher proportion of COVID-19 cases in Ontario consistently came from low-income, racialized and immigrant areas of the province- these groups were less well represented among survey respondents. Interpretation Although digital surveillance systems are low-cost tools that have been useful to signal the onset of viral outbreaks, in this longitudinal comparison of self-reported COVID-like illness to Ontario COVID-19 case data we did not find this to be the case. Seasonal respiratory virus transmission and population coverage may explain this discrepancy.	[Maharaj, Arjuna S.; Parker, Jennifer] Univ Toronto, Temerty Fac Med, Doctor Med Program, Toronto, ON, Canada; [Hopkins, Jessica P.] Publ Hlth Ontario, Toronto, ON, Canada; [Hopkins, Jessica P.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Hopkins, Jessica P.; Gournis, Effie; Tuite, Ashleigh R.; Fisman, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Gournis, Effie] Toronto Publ Hlth, Toronto, ON, Canada; [Bogoch, Isaac I.; Fisman, David N.; Lapointe-Shaw, Lauren] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bogoch, Isaac I.; Lapointe-Shaw, Lauren] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Rader, Benjamin; Astley, Christina M.; Hawkins, Jared B.; Brownstein, John S.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA; [Rader, Benjamin] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA; [Astley, Christina M.] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Astley, Christina M.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Ivers, Noah M.] Womens Coll Res Inst, Toronto, ON, Canada; [Ivers, Noah M.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Lee, Liza] Publ Hlth Agcy Canada, Ctr Immunizat & Resp Infect Dis, Ottawa, ON, Canada; [Brownstein, John S.] Harvard Med Sch, Dept Pediat & Biomed Informat, Boston, MA 02115 USA	University of Toronto; McMaster University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Boston Children's Hospital; Boston University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Public Health Agency of Canada; Harvard University; Harvard Medical School	Maharaj, AS (corresponding author), Univ Toronto, Temerty Fac Med, Doctor Med Program, Toronto, ON, Canada.	a.maharaj@mail.utoronto.ca		Parker, Jennifer/0000-0003-2206-4120; Maharaj, Arjuna/0000-0002-2155-7014	UofT COVID action initiative; Center for Disease Control and Prevention; Ending Pandemics; Flu Lab; Public Health Agency of Canada	UofT COVID action initiative; Center for Disease Control and Prevention; Ending Pandemics; Flu Lab; Public Health Agency of Canada	This study is funded by the UofT COVID action initiative (LL-S), URL: https://medicine.utoronto.ca/eligibility-update-toronto-covid-19-action-initiative Outbreaks Near Me is funded by the Center for Disease Control and Prevention, Ending Pandemics and Flu Lab. CDC: https://www.cdc.gov Ending Pandemics: https://endingpandemics.org Flu Lab: https://theflulab.org FluWatchers is funded by the Public Health Agency of Canada. PHAC: https://www.canada.ca/en/public-health.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FORWARD SORTATION AR; Baltrusaitis K, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3322-3; Baltrusaitis Kristin, 2017, JMIR Public Health Surveill, V3, pe18, DOI 10.2196/publichealth.7304; Brownstein John S, 2017, JMIR Public Health Surveill, V3, pe83, DOI 10.2196/publichealth.7344; Centers for Disease Control and Prevention, 2020, CORONAVIRUS DIS 2019; Chan ANT, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2016259; Desjardins MR, 2020, LANCET REG HEALTH-W, V4, DOI 10.1016/j.lanwpc.2020.100024; Guttmann A., 2020, COVID 19 IMMIGRANTS, P1; ISO, 2019, 860112019 ISO; Jernigan DB, 2011, CLIN INFECT DIS, V52, pS36, DOI 10.1093/cid/ciq020; King JA, 2021, CAN MED ASSOC J, V193, pE1, DOI 10.1503/cmaj.202065; Kretzschmar ME, 2020, LANCET PUBLIC HEALTH, V5, pE452, DOI 10.1016/S2468-2667(20)30157-2; Lapointe-Shaw L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239886; Lessler J, 2021, SCIENCE, V372, P1092, DOI 10.1126/science.abh2939; Liu M, 2020, CAN MED ASSOC J, V192, pE1540, DOI 10.1503/cmaj.201860; Luo Hongxing, 2020, JMIR Public Health Surveill, V6, pe18576, DOI 10.2196/18576; Nomura S, 2020, LANCET REG HEALTH-W, V1, DOI 10.1016/j.lanwpc.2020.100011; Patel JA, 2020, PUBLIC HEALTH, V183, P110, DOI 10.1016/j.puhe.2020.05.006; Rader B, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa076; Reses HE, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11683-y; Reses HE., 2020, MEDRXIV, DOI 10.02.20195479; Sharfstein JM, 2020, JAMA-J AM MED ASSOC, V323, P1437, DOI 10.1001/jama.2020.3864; Statistics Canada, 2016, DAT PROD 2016 CENS; Statistics Canada, 2019, STAT CANADA, DOI [10.25318/1710000501-eng%0Ahttps://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710000501, DOI 10.25318/1710000501-ENG%0AHTTPS://WWW150.STATCAN.GC.CA/T1/TBL1/EN/TV.ACTION?PID=1710000501]; Statistics Canada, 2021, CENS PROGR; Sudre Carole Helene, 2020, medRxiv, DOI 10.1101/2020.12.15.20248096; van den Wijngaard C, 2008, EMERG INFECT DIS, V14, P917, DOI 10.3201/eid1406.071467; Yoneoka D, 2020, LANCET REG HEALTH-W, V3, DOI 10.1016/j.lanwpc.2020.100016	28	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262447	10.1371/journal.pone.0262447	http://dx.doi.org/10.1371/journal.pone.0262447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015778	Green Published, gold			2022-12-27	WOS:000814820600019
J	Zhang, YH; Van Laer, AO; Baicu, CF; Neff, LS; Hoffman, S; Katz, MR; Zeigler, SM; Zile, MR; Bradshaw, AD				Zhang, Yuhua; Van Laer, An O.; Baicu, Catalin F.; Neff, Lily S.; Hoffman, Stanley; Katz, Marc R.; Zeigler, Sanford M.; Zile, Michael R.; Bradshaw, Amy D.			Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF	PLOS ONE			English	Article							HEART-FAILURE; COLLAGEN; FIBROSIS; SPARC; STIFFNESS; MATRIX	Heart failure is a leading cause of hospitalizations and mortality worldwide. Heart failure with a preserved ejection fraction (HFpEF) represents a significant clinical challenge due to the lack of available treatment modalities for patients diagnosed with HFpEF. One symptom of HFpEF is impaired diastolic function that is associated with increases in left ventricular stiffness. Increases in myocardial fibrillar collagen content is one factor contributing to increases in myocardial stiffness. Cardiac fibroblasts are the primary cell type that produce fibrillar collagen in the heart. However, relatively little is known regarding phenotypic changes in cardiac fibroblasts in HFpEF myocardium. In the current study, cardiac fibroblasts were established from left ventricular epicardial biopsies obtained from patients undergoing cardiovascular interventions and divided into three categories: Referent control, hypertension without a heart failure designation (HTN (-) HFpEF), and hypertension with heart failure (HTN (+) HFpEF). Biopsies were evaluated for cardiac myocyte cross-sectional area (CSA) and collagen volume fraction. Primary fibroblast cultures were assessed for differences in proliferation and protein expression of collagen I, Membrane Type 1-Matrix Metalloproteinase (MT1-MMP), and a smooth muscle actin (aSMA). Biopsies from HTN (-) HFpEF and HTN (+) HFpEF exhibited increases in myocyte CSA over referent control although only HTN (+) HFpEF exhibited significant increases in fibrillar collagen content. No significant changes in proliferation or aSMA was detected in HTN (-) HFpEF or HTN (+) HFpEF cultures versus referent control. Significant increases in production of collagen I was detected in HF (-) HFpEF fibroblasts, whereas significant decreases in MT1-MMP levels were measured in HTN (+) HFpEF cells. We conclude that epicardial biopsies provide a viable source for primary fibroblast cultures and that phenotypic differences are demonstrated by HTN (-) HFpEF and HTN (+) HFpEF cells versus referent control.	[Zhang, Yuhua; Van Laer, An O.; Baicu, Catalin F.; Neff, Lily S.; Zile, Michael R.; Bradshaw, Amy D.] Med Univ South Carolina, Dept Med, Div Cardiol, Charleston, SC 29425 USA; [Hoffman, Stanley] Med Univ South Carolina, Dept Med, Div Rheumatol, Charleston, SC 29425 USA; [Katz, Marc R.; Zeigler, Sanford M.] Med Univ South Carolina, Dept Surg, Charleston, SC 29425 USA; [Zile, Michael R.; Bradshaw, Amy D.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Bradshaw, AD (corresponding author), Med Univ South Carolina, Dept Med, Div Cardiol, Charleston, SC 29425 USA.; Bradshaw, AD (corresponding author), Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA.	bradshad@musc.edu			NIH [5R01-HL123478-01, T32GM132055]; National Defense Science and Engineering Graduate (NDSEG) Fellowship Program - Air Force Research Laboratory (AFRL) [FA9550-21-F-0003]; Office of Naval Research (ONR); Army Research Office (ARO); Department of Veterans Affairs [CX001608]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate (NDSEG) Fellowship Program - Air Force Research Laboratory (AFRL); Office of Naval Research (ONR)(Office of Naval Research); Army Research Office (ARO); Department of Veterans Affairs(US Department of Veterans Affairs)	YES: This work was partially supported by NIH grant 5R01-HL123478-01 to MRZ, NIH T32GM132055 and a FA9550-21-F-0003 through the National Defense Science and Engineering Graduate (NDSEG) Fellowship Program, sponsored by the Air Force Research Laboratory (AFRL), the Office of Naval Research (ONR) and the Army Research Office (ARO) to LSN and by the Department of Veterans Affairs under grants CX001608 to ADB and MRZ.	Ali SR, 2014, CIRC RES, V115, P625, DOI 10.1161/CIRCRESAHA.115.303794; Baicu CF, 2012, AM J PHYSIOL-HEART C, V303, pH1128, DOI 10.1152/ajpheart.00482.2012; Bradshaw AD, 1999, MOL BIOL CELL, V10, P1569, DOI 10.1091/mbc.10.5.1569; Bradshaw AD, 2009, CIRCULATION, V119, P269, DOI 10.1161/CIRCULATIONAHA.108.773424; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Litvinukova M, 2020, NATURE, V588, P466, DOI 10.1038/s41586-020-2797-4; McDonald LT, 2018, AM J PHYSIOL-HEART C, V315, pH92, DOI 10.1152/ajpheart.00719.2017; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Nagaraju CK, 2019, J AM COLL CARDIOL, V73, P2267, DOI 10.1016/j.jacc.2019.02.049; Pakshir P, 2018, MATRIX BIOL, V68-69, P81, DOI 10.1016/j.matbio.2018.01.019; Riley HJ, 2021, AM J PHYSIOL-HEART C, V320, pH604, DOI 10.1152/ajpheart.00552.2020; Spruill LS, 2007, AM J PHYSIOL-CELL PH, V293, pC1362, DOI 10.1152/ajpcell.00545.2006; Tallquist MD, 2017, NAT REV CARDIOL, V14, P484, DOI 10.1038/nrcardio.2017.57; Trombetta-eSilva J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079715; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451; Zile MR, 2015, CIRCULATION, V131, P1247, DOI 10.1161/CIRCULATIONAHA.114.013215; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	17	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262479	10.1371/journal.pone.0262479	http://dx.doi.org/10.1371/journal.pone.0262479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015787	Green Published, gold			2022-12-27	WOS:000814820600026
J	Emery, T; Koops, JC				Emery, Tom; Koops, Judith C.			The impact of COVID-19 on fertility behaviour and intentions in a middle income country	PLOS ONE			English	Article							GENDER SURVEY; GENERATIONS; TIME	The COVID Pandemic may affect fertility behaviour and intentions in many ways. Restrictions on service provision reduce access to family planning services and increase fertility in the short term. By contrast, the economic uncertainty brought about by the pandemic and its impact on mental health and well-being may reduce fertility. These various pathways have been explored in the context of high income countries such as the United States and Western Europe, but little is known about middle income countries. In this paper we asses the impact of the COVID pandemic on fertility intentions and behaviour in the Republic of Moldova, a middle income country in Eastern Europe, using the Generations and Gender Survey. This survey was conducted partially before and partially after the onset of the pandemic in 2020, allowing for detailed comparisons of individual circumstances. The results indicate that the pandemic reduced the used of intrauterine devices, and increased the use of male condoms, but with no overall decrease in contraceptive use. Conversely individuals interviewed after the onset of the pandemic were 34.5% less likely to be trying to conceive, although medium term fertility intentions were unchanged. Indicators therefore suggest that in the medium term fertility intentions may not be affected by the pandemic but restricted access to contraception requiring medical consultation and a decrease in short-term fertility intentions could disrupt short term family planning.	[Emery, Tom] Erasmus Univ, Dept Publ Adm, Rotterdam, Netherlands; [Koops, Judith C.] Univ Groningen, Netherlands Interdisciplinary Demog Inst NIDI KNA, Groningen, Netherlands	Erasmus University Rotterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Interdisciplinary Demographic Institute (NIDI-KNAW); University of Groningen	Emery, T (corresponding author), Erasmus Univ, Dept Publ Adm, Rotterdam, Netherlands.	tom@odissei-data.nl	Koops, Judith Christel/GOH-0134-2022; Koops, Judith Christel/GOH-0019-2022	Koops, Judith Christel/0000-0002-7449-3480; 	UNFPA Moldova; National Bureau of Statistics of the Republic of Moldova; Ministry of Health, Labour and Social Protection of the Republic of Moldova	UNFPA Moldova; National Bureau of Statistics of the Republic of Moldova; Ministry of Health, Labour and Social Protection of the Republic of Moldova	Particular thanks to the UNFPA Moldova, National Bureau of Statistics of the Republic of Moldova and the Ministry of Health, Labour and Social Protection of the Republic of Moldova for support in conducting the Gender and Generations Programme in the conduct of the study. This analysis in this paper was conducted in collaboration with the UNFPA Moldova and the Ministry of Health, Labour and Social Protection of the Republic of Moldova in response to the onset of the COVID-19 Pandemic during the fieldwork of the Moldovan GGS in 2020. Both parties reviewed and provided comments on earlier and current versions of the analysis. The contents of this publication do not necessarily reflect the views or policies of the UNFPA Moldova and the Ministry of Health, Labour and Social Protection.	Aassve A, 2020, SCIENCE, V369, P370, DOI 10.1126/science.abc9520; Alburez-Gutierrez D., 2019, DEMOGRAPHY DIGITAL E; Dasgupta Aisha, 2020, Gates Open Res, V4, P102, DOI 10.12688/gatesopenres.13148.1; Dommermuth L, 2015, ADV LIFE COURSE RES, V24, P34, DOI 10.1016/j.alcr.2015.02.001; Eeckhaut MCW, 2014, PERSPECT SEX REPRO H, V46, P149, DOI 10.1363/46e1914; Fishbein M, 2011, PREDICTING AND CHANGING BEHAVIOR: THE REASONED ACTION APPROACH, P1; Fokkema T, 2016, DEMOGR RES, V34, P498, DOI 10.4054/DemRes.2016.34.18; Gauthier A, 2018, LONGITUD LIFE COURSE, V9, P456, DOI 10.14301/llcs.v9i4.500; Ito Katsuya, 2017, International Economic Journal, V31, P462; Jacob L, 2020, J SEX MED, V17, P1229, DOI 10.1016/j.jsxm.2020.05.001; Janevic T, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-69; Lappegard T, 2020, COVID 19 COULD GENER; Lindberg L.D, 2020, CONTINUING IMPACTS C; Luppi F, 2020, DEMOGR RES, V43, P1399, DOI 10.4054/DemRes.2020.43.47; Matchan L, 2020, BOSTON GLOBE; Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8; Prodan M., 2016, IMPACT MIGRATION LAB; Settersten RA, 2020, ADV LIFE COURSE RES, V45, DOI 10.1016/j.alcr.2020.100360; Vignoli Daniele, 2020, Genus, V76, P28, DOI 10.1186/s41118-020-00094-3; Vikat A, 2007, DEMOGR RES, V17, P389, DOI 10.4054/DemRes.2007.17.14; Voicu M, 2021, EUR SOC, V23, pS199, DOI 10.1080/14616696.2020.1822537; Wilde, 2020, COVID 19 FUTURE US F; Zhu CF, 2020, INT J GYNECOL OBSTET, V151, P399, DOI 10.1002/ijgo.13366	23	1	1	11	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261509	10.1371/journal.pone.0261509	http://dx.doi.org/10.1371/journal.pone.0261509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990459	gold, Green Published			2022-12-27	WOS:000815783800008
J	Yuen, JG; Marshilok, AC; Benziger, PT; Yan, S; Cello, J; Stackhouse, CA; Kisslinger, K; Bock, DC; Takeuchi, ES; Takeuchi, KJ; Wang, L; Babu, S; Itzkowitz, G; Thanassi, D; Knopf, DA; Shroyer, KR				Yuen, John G.; Marshilok, Amy C.; Benziger, Peter Todd; Yan, Shan; Cello, Jeronimo; Stackhouse, Chavis A.; Kisslinger, Kim; Bock, David C.; Takeuchi, Esther S.; Takeuchi, Kenneth J.; Wang, Lei; Babu, Sruthi; Itzkowitz, Glen; Thanassi, David; Knopf, Daniel A.; Shroyer, Kenneth R.			Dry heat sterilization as a method to recycle N95 respirator masks: The importance of fit	PLOS ONE			English	Article							ISOTACTIC POLYPROPYLENE; FILTRATION EFFICIENCY; PERFORMANCE; DECONTAMINATION; VIRUSES; LEVEL	In times of crisis, including the current COVID-19 pandemic, the supply chain of filtering facepiece respirators, such as N95 respirators, are disrupted. To combat shortages of N95 respirators, many institutions were forced to decontaminate and reuse respirators. While several reports have evaluated the impact on filtration as a measurement of preservation of respirator function after decontamination, the equally important fact of maintaining proper fit to the users' face has been understudied. In the current study, we demonstrate the complete inactivation of SARS-CoV-2 and preservation of fit test performance of N95 respirators following treatment with dry heat. We apply scanning electron microscopy with energy dispersive X-ray spectroscopy (SEM/EDS), X-ray diffraction (XRD) measurements, Raman spectroscopy, and contact angle measurements to analyze filter material changes as a consequence of different decontamination treatments. We further compared the integrity of the respirator after autoclaving versus dry heat treatment via quantitative fit testing and found that autoclaving, but not dry heat, causes the fit of the respirator onto the users face to fail, thereby rendering the decontaminated respirator unusable. Our findings highlight the importance to account for both efficacy of disinfection and mask fit when reprocessing respirators to for clinical redeployment.	[Yuen, John G.; Babu, Sruthi; Shroyer, Kenneth R.] SUNY Stony Brook, Renaissance Sch Med, Dept Pathol, Stony Brook, NY 11794 USA; [Marshilok, Amy C.; Yan, Shan; Bock, David C.; Takeuchi, Esther S.; Takeuchi, Kenneth J.; Wang, Lei] Brookhaven Natl Lab, Interdisciplinary Sci Dept, Upton, NY 11973 USA; [Marshilok, Amy C.; Yan, Shan; Stackhouse, Chavis A.; Bock, David C.; Takeuchi, Esther S.; Takeuchi, Kenneth J.; Wang, Lei] SUNY Stony Brook, Inst Electrochem Stored Energy, Stony Brook, NY 11794 USA; [Marshilok, Amy C.; Takeuchi, Esther S.; Takeuchi, Kenneth J.] SUNY Stony Brook, Dept Mat Sci & Chem Engn, Stony Brook, NY 11794 USA; [Benziger, Peter Todd; Cello, Jeronimo; Thanassi, David] SUNY Stony Brook, Dept Microbiol & Immunol, Stony Brook, NY 11794 USA; [Cello, Jeronimo; Thanassi, David] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA; [Stackhouse, Chavis A.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Kisslinger, Kim] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Itzkowitz, Glen] SUNY Stony Brook, Off Dean, Renaissance Sch Med, Stony Brook, NY 11794 USA; [Knopf, Daniel A.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Shroyer, KR (corresponding author), SUNY Stony Brook, Renaissance Sch Med, Dept Pathol, Stony Brook, NY 11794 USA.; Knopf, DA (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	Daniel.Knopf@stonybrook.edu; Kenneth.Shroyer@stonybrookmedicine.edu	Kisslinger, Kim/F-4485-2014	Yuen, John/0000-0002-1569-3298	DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19; Coronavirus CARES Act; U.S. DOE Office of Science Facility, at Brookhaven National Laboratory [DE-SC0012704]; NIH; NIH New York Consortium for the Advancement of Postdoctoral Scholars (IRACDANYCAPS) [K12-GM102778]	DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19(United States Department of Energy (DOE)); Coronavirus CARES Act; U.S. DOE Office of Science Facility, at Brookhaven National Laboratory(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH New York Consortium for the Advancement of Postdoctoral Scholars (IRACDANYCAPS)	Contact angle, Raman spectroscopy, and electron microscopy characterization were supported by the DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19, with funding provided by the Coronavirus CARES Act (https://science.osti.gov/nvbl).Electron microscopy data were collected at Center for Functional Nanomaterials, which is a U.S. DOE Office of Science Facility, at Brookhaven National Laboratory under Contract No. DE-SC0012704 (https://www.bnl.gov).C.A.S.acknowledges support from the NIH Institutional Research and Academic Career Development Award and New York Consortium for the Advancement of Postdoctoral Scholars (IRACDANYCAPS), award K12-GM102778 (https://www.nigms.nih.gov).	3M, 2021, DEC 3M FILT FAC RESP; [Anonymous], 2013, CONTACT ANGLE WETTIN; Balazy A, 2006, AM J INFECT CONTROL, V34, P51, DOI 10.1016/j.ajic.2005.08.018; Campos RK, 2020, ACS NANO, V14, P14017, DOI 10.1021/acsnano.0c06565; CHEN CC, 1992, AM IND HYG ASSOC J, V53, P566, DOI 10.1202/0002-8894(1992)053<0566:APTFFA>2.0.CO;2; Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI [10.1016/S2666-5247(20)30003-3, 10.1016/S2666-5247(20)30095-1]; Cohen J, 2020, PREV MED, V141, DOI 10.1016/j.ypmed.2020.106263; Control CfD, PREV IMPL FILT FAC R; FDA, 2020, REC SPONS REQ EUAS D; Fischer RJ, 2020, EMERG INFECT DIS, V26, P2253, DOI 10.3201/eid2609.201524; Fisher EM, 2011, J APPL MICROBIOL, V110, P287, DOI 10.1111/j.1365-2672.2010.04881.x; Grinshpun SA, 2020, J HOSP INFECT, V105, P608, DOI 10.1016/j.jhin.2020.06.030; Guo XM, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11101698; Hager E, 2018, FORENSIC CHEM, V9, P44, DOI 10.1016/j.forc.2018.05.001; Halvorsen T., 1998, ITI062 TSI; He XJ, 2013, AEROSOL SCI TECH, V47, P1180, DOI 10.1080/02786826.2013.829209; Hiejima Y, 2017, MACROMOLECULES, V50, P5867, DOI 10.1021/acs.macromol.7b00229; Jatta M, 2021, AM J INFECT CONTROL, V49, P8, DOI 10.1016/j.ajic.2020.06.194; Jayaweera M, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109819; Kumar A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243965; Liao L, 2020, ACS NANO, V14, P6348, DOI 10.1021/acsnano.0c03597; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; Lysik D, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133199; Martin S B Jr, 2000, Appl Occup Environ Hyg, V15, P609; Mehrotra Preeti, 2020, JAMA Health Forum, V1, pe200553, DOI 10.1001/jamahealthforum.2020.0553; Meselson M, 2020, NEW ENGL J MED, V382, P2063, DOI 10.1056/NEJMc2009324; Mondelli MU, 2021, LANCET INFECT DIS, V21, pE112, DOI 10.1016/S1473-3099(20)30678-2; Nielsen AS, 2002, POLYMER, V43, P2671, DOI 10.1016/S0032-3861(02)00053-8; Qian YG, 1998, AM IND HYG ASSOC J, V59, P128, DOI 10.1080/15428119891010389; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Safety O Administration H, 2021, ADM H APPENDIX 19101; TSI, 2005, ITI041 TSI; Wang XQ, 2001, J APPL POLYM SCI, V82, P1330, DOI 10.1002/app.1968; Yim WJ, 2020, ACS APPL MATER INTER, V12, P54473, DOI 10.1021/acsami.0c17333	34	0	0	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0257963	10.1371/journal.pone.0257963	http://dx.doi.org/10.1371/journal.pone.0257963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986162	Green Published, gold, Green Submitted			2022-12-27	WOS:000765956200002
J	Gallen, CL; Anguera, JA; Gerdes, MR; Simon, AJ; Canadas, E; Marco, EJ				Gallen, Courtney L.; Anguera, Joaquin A.; Gerdes, Molly R.; Simon, Alexander J.; Canadas, Elena; Marco, Elysa J.			Enhancing neural markers of attention in children with ADHD using a digital therapeutic	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; POTENTIALS; DIAGNOSIS; SCALE; THETA	Attention deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental condition characterized by diminished attentional control. Critically, these difficulties are related to negative consequences in real-life functioning both during development and into adulthood. There is now growing evidence that modulating the underlying neural circuits related to attention can improve behavior and brain function in children with ADHD. We have previously shown that game-based digital therapeutics targeting a key neural marker of attention-midline frontal theta (MFT)-yield positive effects on attentional control in several populations. However, the effects of such digital therapeutics in children with ADHD and no other comorbidities has not been yet examined. To address this gap, we assessed a sample of 25 children with ADHD (8-12 years old) on neural, behavioral, and clinical metrics of attention before and after a 4-week at-home intervention on an iPad targeting MFT circuitry. We found that children showed enhancements on a neural measure of attention (MFT power), as well as on objective behavioral measures of attention and parent reports of clinical ADHD symptoms. Importantly, we observed relationships between the neural and behavioral cognitive improvements, demonstrating that those children who showed the largest intervention-related neural gains were also those that improved the most on the behavioral tasks indexing attention. These findings provide support for using targeted, digital therapeutics to enhance multiple features of attentional control in children with ADHD.	[Gallen, Courtney L.; Anguera, Joaquin A.; Simon, Alexander J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA; [Gallen, Courtney L.; Anguera, Joaquin A.; Simon, Alexander J.] Univ Calif San Francisco, Neuroscape Ctr, San Francisco, CA 94143 USA; [Anguera, Joaquin A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94115 USA; [Gerdes, Molly R.; Marco, Elysa J.] Cort Healthcare, Dept Neurodev Med, San Rafael, CA 94903 USA; [Canadas, Elena] Akili Interact Labs, Boston, MA USA; [Marco, Elysa J.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Anguera, JA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA.; Anguera, JA (corresponding author), Univ Calif San Francisco, Neuroscape Ctr, San Francisco, CA 94143 USA.; Anguera, JA (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94115 USA.; Marco, EJ (corresponding author), Cort Healthcare, Dept Neurodev Med, San Rafael, CA 94903 USA.; Marco, EJ (corresponding author), Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94115 USA.	joaquin.anguera@ucsf.edu; emarco@corticacare.com		Gallen, Courtney/0000-0002-4828-268X	Akili Interactive Labs	Akili Interactive Labs	Funding for this study was sponsored by Akili Interactive Labs. The funders provided input on study design and decision to publish and also assisted with manuscript preparation.	Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Anguera JA, 2021, NEUROBIOL AGING, V103, P22, DOI 10.1016/j.neurobiolaging.2021.02.023; Anguera JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172616; Anguera JA, 2015, CURR OPIN BEHAV SCI, V4, P160, DOI 10.1016/j.cobeha.2015.06.002; Baijot S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120167; Bavelier D, 2019, NEURON, V104, P147, DOI 10.1016/j.neuron.2019.09.031; Bussing R, 2003, J BEHAV HEALTH SER R, V30, P176, DOI 10.1007/BF02289806; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Clayton MS, 2015, TRENDS COGN SCI, V19, P188, DOI 10.1016/j.tics.2015.02.004; Cohen J., 1977, STATISTICAL POWER AN, P179, DOI [10.1016/b978-0-12-179060-8.50011-6, DOI 10.1016/B978-0-12-179060-8.50011]; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Connors LL, 2012, J ATTEN DISORD, V16, P60, DOI 10.1177/1087054710379734; Danielson ML, 2018, J CLIN CHILD ADOLESC, V47, P199, DOI 10.1080/15374416.2017.1417860; Duncan L, 2018, PSYCHOL ASSESSMENT, V30, P916, DOI 10.1037/pas0000541; Enriquez-Geppert S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00420; Enriquez-Geppert S, 2014, BIOL PSYCHOL, V95, P59, DOI 10.1016/j.biopsycho.2013.02.019; GREENBERG LM, 1993, J CHILD PSYCHOL PSYC, V34, P1019, DOI 10.1111/j.1469-7610.1993.tb01105.x; HEATHCOTE A, 1991, PSYCHOL BULL, V109, P340, DOI 10.1037/0033-2909.109.2.340; Hervey AS, 2006, CHILD NEUROPSYCHOL, V12, P125, DOI 10.1080/09297040500499081; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hsu WY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178579; Jurigova BG, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246449; Kobor A, 2015, DEV NEUROPSYCHOL, V40, P329, DOI 10.1080/87565641.2015.1086770; Kollins SH, 2020, LANCET DIGIT HEALTH, V2, pE168, DOI 10.1016/S2589-7500(20)30017-0; Lane SJ, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00008; Leth-Steensen C, 2000, ACTA PSYCHOL, V104, P167, DOI 10.1016/S0001-6918(00)00019-6; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; Mishra J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00218; Owens PL, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200206000-00013; Parush S, 2007, PHYSIOL BEHAV, V90, P553, DOI 10.1016/j.physbeh.2006.11.004; Paszkiel S, 2020, STUD COMPUT INTELL, V852, P3, DOI 10.1007/978-3-030-30581-9_2; Henriquez-Henriquez MP, 2015, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00197; Pelham WE, 2008, J CLIN CHILD ADOLESC, V37, P184, DOI 10.1080/15374410701818681; Peng P, 2016, LEARN INDIVID DIFFER, V45, P77, DOI 10.1016/j.lindif.2015.11.012; Pfeiffer B, 2015, PHYS OCCUP THER PEDI, V35, P1, DOI 10.3109/01942638.2014.904471; Pliszka SR, 2007, NEUROPSYCHOL REV, V17, P61, DOI 10.1007/s11065-006-9017-3; Rabiner DL, 2016, SCHOOL PSYCHOL REV, V45, P250, DOI 10.17105/SPR45-2.250-267; Rubinson M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217383; Strandburg RJ, 1996, BIOL PSYCHIAT, V40, P964, DOI 10.1016/0006-3223(95)00545-5; Wang SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178542; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Wolraich ML, 2003, J PEDIATR PSYCHOL, V28, P559, DOI 10.1093/jpepsy/jsg046; Ziegler DA, 2019, NAT HUM BEHAV, V3, P746, DOI 10.1038/s41562-019-0611-9	45	0	0	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261981	10.1371/journal.pone.0261981	http://dx.doi.org/10.1371/journal.pone.0261981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972140	Green Published, gold			2022-12-27	WOS:000773555700079
J	Saha, I; Durand-Morat, A; Nalley, LL; Alam, MJ; Nayga, R				Saha, Indrani; Durand-Morat, Alvaro; Nalley, Lawton Lanier; Alam, Mohammad Jahangir; Nayga, Rodolfo			Rice quality and its impacts on food security and sustainability in Bangladesh	PLOS ONE			English	Article							SENSORY EVALUATION; CONSUMERS; MARKET	Rice market efficiency is important for food security in countries where rice is a staple. We assess the impact of rice quality on rice prices, food security, and environmental sustainability in Bangladesh. We find that while price varies as expected for most quality attributes, it is unaffected by a broken percentage below 24.9 percent. This reveals a potential inefficiency, considering the average 5 percent broken rate observed in the market. An increase in the broken rate of milled rice within the limits supported by our findings can, ceteris paribus, increase rice rations by 4.66 million a year, or conversely, yield the current number of rice rations using 170.79 thousand fewer hectares and cutting emissions by 1.48 million metric tons of CO2 equivalent. Thus, producing rice based on quality assessment can improve food security and its sustainability.	[Saha, Indrani; Durand-Morat, Alvaro; Nalley, Lawton Lanier] Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA; [Alam, Mohammad Jahangir] Bangladesh Agr Univ, Dept Agribusiness & Mkt, Mymensingh, Bangladesh; [Nayga, Rodolfo] Texas A&M Univ, Dept Agr Econ, College Stn, TX 77843 USA	University of Arkansas System; University of Arkansas Fayetteville; Bangladesh Agricultural University (BAU); Texas A&M University System; Texas A&M University College Station	Durand-Morat, A (corresponding author), Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA.	adurand@uark.edu		Durand-Morat, Alvaro/0000-0002-8036-2217; Alam, Mohammad Jahangir/0000-0003-3412-9438	University of Arkansas Chancelor's Innovation and Collaboration Grant [IFA2019-019]	University of Arkansas Chancelor's Innovation and Collaboration Grant	DTY This study was funded by the University of Arkansas Chancelor's Innovation and Collaboration Grant #IFA2019-019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairagi S, 2017 AGR APPL EC ASS; Bangladesh Bureau of Statistics, 2021, AGR EST MAJ CROPS; Bangladesh Standards and Testing Institution, 1981, BANGL STAND SPEC GRA; Bruce RM, 2018, CEREAL CHEM, V95, P889, DOI 10.1002/cche.10107; Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; Choudhury N., 1992, CONSUMER DEMAND RICE, P117; Cuevas RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150345; Custodio MC, 2019, TRENDS FOOD SCI TECH, V92, P122, DOI 10.1016/j.tifs.2019.07.039; Custodio MC, 2016, GLOB FOOD SECUR-AGR, V9, P19, DOI 10.1016/j.gfs.2016.05.005; Custodio MC, 2016, RAPID VALUE CHAIN AS, DOI [10.13140/RG.2.2.27642.13768, DOI 10.13140/RG.2.2.27642.13768]; Dasgupta S, 2009, CLIMATIC CHANGE, V93, P379, DOI 10.1007/s10584-008-9499-5; Demont M, 2012, FOOD QUAL PREFER, V23, P63, DOI 10.1016/j.foodqual.2011.07.005; Department of Food and Public Distribution of India, UN SPEC FOOD GRAINS; Diagne M, 2017, AFR J AGRIC RESOUR E, V12, P99; Food and Agriculture Organization, FAOSTAT FOOD BAL; Giraud G, 2013, INT FOOD AGRIBUS MAN, V16, P1; Islam S., 2017, THREAT FOOD SECURITY; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Mekonnen MM, 2011, HYDROL EARTH SYST SC, V15, P1577, DOI 10.5194/hess-15-1577-2011; Meresa A, 2020, INT J FOOD SCI, V2020, DOI 10.1155/2020/8810553; Ministry of Food of Bangladesh, 2001, 28 FMRSP MIN FOOD BA; Mottaleb KA, 2016, J AGRIC APPL ECON, V48, P298, DOI 10.1017/aae.2016.18; Rahman A, 2017, 2017 2ND INTERNATIONAL CONFERENCE ON ELECTRICAL & ELECTRONIC ENGINEERING (ICEEE); Roser M., 2019, HUNGER UNDERNOURISHM; Rutsaert P, 2013, REALIZING AFRICA'S RICE PROMISE, P294, DOI 10.1079/9781845938123.0294; Sayeed K. A., 2018, RICE PRICES GROWTH P; Shew AM, 2019, ENVIRON SCI POLICY, V95, P46, DOI 10.1016/j.envsci.2019.02.004; Skorbiansky SR, 2018, RCS18L01 USDA EC RES; South Asian Network on Economic Modeling (SANEM), 2021, COVID 19 FALL POV LI; Tomlins K, 2007, J SCI FOOD AGR, V87, P1564, DOI 10.1002/jsfa.2889; Tomlins KI, 2005, FOOD QUAL PREFER, V16, P79, DOI 10.1016/j.foodqual.2004.02.002; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; United States Department of Agriculture, GLOBAL AGR INFORM NE; United States Department of Agriculture, 2020, RIC INSP HDB; USDA, PROD SUPPL DISTR; Vagsholm I, 2020, FRONT SUSTAIN FOOD S, V4, DOI 10.3389/fsufs.2020.00016; World Bank, 2019, BANGL POV ASS FAC OL, DOI [10.1596/32754, DOI 10.1596/32754]; World Bank, BANGL INT POV MAP; Yunus M., 2019, INT FOOD POLICY RES, V3, DOI [10.2499/p15738coll2.133124, DOI 10.2499/P15738COLL2.133124]; Zaman ZU., 2001, REV AGR ECON, V57, P121	41	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261118	10.1371/journal.pone.0261118	http://dx.doi.org/10.1371/journal.pone.0261118			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972112	gold, Green Published			2022-12-27	WOS:000773555700023
J	Yari, A; Khoshsabegheh, HY; Zarezadeh, Y; Ardalan, A; Boubakran, MS; Ostadtaghizadeh, A; Motlagh, ME				Yari, Arezoo; Khoshsabegheh, Homa Yousefi; Zarezadeh, Yadolah; Ardalan, Ali; Boubakran, Mohsen Soufi; Ostadtaghizadeh, Abbas; Motlagh, Mohamad Esmaeil			Behavioral, health- related and demographic risk factors of death in floods: A case-control study	PLOS ONE			English	Article							FLASH-FLOOD; FATALITIES; CIRCUMSTANCES; VULNERABILITY; FRANCE; LIFE; PREPAREDNESS; PERCEPTION; RESIDENTS; AUSTRALIA	During the first half of 2019, many provinces of Iran were affected by floods, which claimed the lives of 82 people. The present study aimed to investigate the behavioral, health related and demographic risk factors associated with deaths due to floods. We measured the odds ratio and investigated the contribution and significance of the factors in relation to mortality. This case-control study was conducted in the cities affected by flood in Iran. Data were collected on the flood victims using a questionnaire. Survivors, a member of the flood victim's family, were interviewed. In total, 77 subjects completed the survey in the case group, and 310 subjects completed the survey in the control group. The findings indicated that factors such as the age of less than 18 years, low literacy, being trapped in buildings/cars, and risky behaviors increased the risk of flood deaths. Regarding the behavioral factors, perceived/real swimming skills increased the risk of flood deaths although it may seem paradoxical. This increment is due to increased self confidence in time of flood. On the other hand, skills and abilities such as evacuation, requesting help, and escape decreased the risk of flood deaths. According to the results, the adoption of support strategies, protecting vulnerable groups, and improving the socioeconomic status of flood-prone areas could prevent and reduce the risk of flood deaths.	[Yari, Arezoo; Zarezadeh, Yadolah] Kurdistan Univ Med Sci, Social Determinants Hlth Res Ctr, Res Inst Hlth Dev, Sanandaj, Iran; [Khoshsabegheh, Homa Yousefi; Ardalan, Ali; Ostadtaghizadeh, Abbas] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Emergencies & Disasters, Tehran, Iran; [Khoshsabegheh, Homa Yousefi] Minist Hlth & Med Educ, Disaster Risk Management Off, Tehran, Iran; [Boubakran, Mohsen Soufi] Urmia Univ, Dept Mech Engn, Orumiyeh, Iran; [Motlagh, Mohamad Esmaeil] Ahvaz Jundishapur Univ Med Sci, Dept Pediat, Ahvaz, Iran	Kurdistan University of Medical Sciences; Tehran University of Medical Sciences; Ministry of Health & Medical Education (MOHME); Urmia University; Ahvaz Jundishapur University of Medical Sciences (AJUMS)	Ostadtaghizadeh, A (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Emergencies & Disasters, Tehran, Iran.; Motlagh, ME (corresponding author), Ahvaz Jundishapur Univ Med Sci, Dept Pediat, Ahvaz, Iran.	ostadtaghizadeh@gmail.com; Dr.motlagh.ms@gmail.com		Ostadtaghizadeh, Abbas/0000-0001-5260-6221	Deputy for Health at Ministry of Health and Medical Education (MOHE) in IRAN [IR.MUK.REC.1398.223]	Deputy for Health at Ministry of Health and Medical Education (MOHE) in IRAN	This study (no: IR.MUK.REC.1398.223.) was conducted with the financial support of the Deputy for Health at Ministry of Health and Medical Education (MOHE) in IRAN. The funding body did not have any other roles in the study design, collection, analysis, and interpretation of data and in writing the manuscript.	Ardalan A., 2019, NATL FLOOD REPORT RE; Ashley ST, 2008, J APPL METEOROL CLIM, V47, P805, DOI 10.1175/2007JAMC1611.1; Becker JS, 2015, WEATHER CLIM SOC, V7, P321, DOI 10.1175/WCAS-D-14-00030.1; Benadusi M, 2014, J CONTING CRISIS MAN, V22, P174, DOI 10.1111/1468-5973.12050; Brazdova M, 2014, NAT HAZARD EARTH SYS, V14, P1663, DOI 10.5194/nhess-14-1663-2014; Brons R, 2006, HANDBOOK ON DROWNING: PREVENTION, RESCUE, TREATMENT, P533; Coates L, 1999, AUST GEOGR, V30, P391, DOI 10.1080/00049189993657; Di Mauro M, 2012, NAT HAZARDS, V63, P1083, DOI 10.1007/s11069-012-0207-4; Diakakis M, 2018, INT J DISAST RISK RE, V28, P404, DOI 10.1016/j.ijdrr.2018.03.018; DUCLOS P, 1991, EUR J EPIDEMIOL, V7, P365, DOI 10.1007/BF00145001; Egli T., 2002, NONSTRUCTURAL FLOOD; FitzGerald G, 2010, EMERG MED AUSTRALAS, V22, P180, DOI 10.1111/j.1742-6723.2010.01284.x; Grothmann T, 2006, NAT HAZARDS, V38, P101, DOI 10.1007/s11069-005-8604-6; Haynes K, 2017, ENVIRON SCI POLICY, V76, P165, DOI 10.1016/j.envsci.2017.07.003; Ibrahim NF, 2017, INT J GEOMATE, V12, P107; IFRC The International Federation of Red Cross and Red Crescent Societies, 2011, WORLD DISASTERS REPO; Jackson TL., 2009, IMPACTS INCREASING R; Jongman B, 2015, P NATL ACAD SCI USA, V112, pE2271, DOI 10.1073/pnas.1414439112; Jonkman SN, 2008, J FLOOD RISK MANAG, V1, P43, DOI 10.1111/j.1753-318X.2008.00006.x; Jonkman SN, 2005, DISASTERS, V29, P75, DOI 10.1111/j.0361-3666.2005.00275.x; Jonkman SN, 2003, DC12336; Keim ME., 2009, FLOODS KOENIG SCHULT, P529; Kelman I., 2004, FLOOD RISK NET NEWSL, V1, P3; King D., 2000, J CONTING CRISIS MAN, V8, P223, DOI [10.1111/1468-5973.00143, DOI 10.1111/1468-5973.00143]; Kundzewicz ZW, 2005, EXTREME WEATHER EVENTS AND PUBLIC HEALTH RESPONSES, P197, DOI 10.1007/3-540-28862-7_19; Lee S, 2015, WATER POLICY, V17, P1045, DOI 10.2166/wp.2015.089; Lindell MK, 2000, RISK ANAL, V20, P13, DOI 10.1111/0272-4332.00002; Llewellyn M, 2006, SURG CLIN N AM, V86, P557, DOI 10.1016/j.suc.2006.02.006; Lowe D, 2013, INT J ENV RES PUB HE, V10, P7015, DOI [10.3390/ijerph10127015, 10.3390/ijerph110100030]; Lumbroso DM, 2011, NAT HAZARD EARTH SYS, V11, P2321, DOI 10.5194/nhess-11-2321-2011; Majdzadeh R., 2004, APPL RES METHODOLOGY, DOI [10.1081/clt-200042550, DOI 10.1081/CLT-200042550]; Martinez D, 2019, MEDWAVE, V19, DOI 10.5867/medwave.2019.10.7716; Miceli R, 2008, J ENVIRON PSYCHOL, V28, P164, DOI 10.1016/j.jenvp.2007.10.006; Netemeyer RG., 2003, SCALING PROCEDURES I, DOI [10.1007/BF03325000, DOI 10.1007/BF03325000]; Paul BK, 2016, NAT HAZARDS, V83, P1703, DOI 10.1007/s11069-016-2384-z; Pereira S, 2016, RISK ANAL, V36, P1188, DOI 10.1111/risa.12516; Pourhoseingholi Mohamad Amin, 2012, Gastroenterol Hepatol Bed Bench, V5, P79; Priest S., 2009, BUILDING MODEL ESTIM; Priest SJ, 2007, BUILDING MODEL ESTIM; Rae E, 2016, NONP REV RES P BUSHF; Salvati P, 2018, SCI TOTAL ENVIRON, V610, P867, DOI 10.1016/j.scitotenv.2017.08.064; Samir KC, 2013, ECOL SOC, V18, DOI 10.5751/ES-05095-180108; Shabanikiya H, 2014, NAT HAZARDS, V73, P1119, DOI 10.1007/s11069-014-1124-5; Sharif HO, 2015, NAT HAZARDS REV, V16, DOI 10.1061/(ASCE)NH.1527-6996.0000145; Sharif HO., 2010, SECURITY, V2, P325, DOI [10.1080/19439962.2010.506596, DOI 10.1080/19439962.2010.506596]; Shaw R., 2004, DISASTER PREV MANAG, V13, P39, DOI [10.1108/09653560410521689, DOI 10.1108/09653560410521689]; Terpstra T, 2008, INT J WATER RESOUR D, V24, P555, DOI 10.1080/07900620801923385; Thieken AH, 2007, HYDROLOG SCI J, V52, P1016, DOI 10.1623/hysj.52.5.1016; Vinet F, 2012, NAT HAZARDS, V61, P1179, DOI 10.1007/s11069-011-9975-5; Wallingford H., 2006, FINAL REPORT PREPARE; World Health Organization (WHO, 2002, FLOODS CLIM CHANG AD; Yadollahie M, 2019, INT J OCCUP ENV MED, V10, P54, DOI 10.15171/ijoem.2019.1681; Yari A, 2019, THESIS TEHRAN U MED; Yari A, 2020, J ENVIRON HEALTH SCI, V18, P1643, DOI 10.1007/s40201-020-00511-x; Yari A, 2019, INT J DISAST RISK RE, V40, DOI 10.1016/j.ijdrr.2019.101258	55	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262005	10.1371/journal.pone.0262005	http://dx.doi.org/10.1371/journal.pone.0262005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972162	Green Published, gold			2022-12-27	WOS:000773555700082
J	Schuler, H; Bonapersona, V; Joels, M; Sarabdjitsingh, RA				Schuler, Heike; Bonapersona, Valeria; Joels, Marian; Sarabdjitsingh, R. Angela			Effects of early life adversity on immediate early gene expression: Systematic review and 3-level meta-analysis of rodent studies	PLOS ONE			English	Review							NEONATAL MATERNAL SEPARATION; GLUCOCORTICOID-RECEPTOR EXPRESSION; CORTICOTROPIN-RELEASING-FACTOR; CHRONIC VARIABLE STRESS; PITUITARY-ADRENAL AXIS; C-FOS; SYNAPTIC PLASTICITY; COLORECTAL DISTENSION; CHILDHOOD EXPERIENCES; NEURAL ACTIVITY	Early-life adversity (ELA) causes long-lasting structural and functional changes to the brain, rendering affected individuals vulnerable to the development of psychopathologies later in life. Immediate-early genes (IEGs) provide a potential marker for the observed alterations, bridging the gap between activity-regulated transcription and long-lasting effects on brain structure and function. Several heterogeneous studies have used IEGs to identify differences in cellular activity after ELA; systematically investigating the literature is therefore crucial for comprehensive conclusions. Here, we performed a systematic review on 39 pre-clinical studies in rodents to study the effects of ELA (alteration of maternal care) on IEG expression. Females and IEGs other than cFos were investigated in only a handful of publications. We meta-analyzed publications investigating specifically cFos expression. ELA increased cFos expression after an acute stressor only if the animals (control and ELA) had experienced additional hits. At rest, ELA increased cFos expression irrespective of other life events, suggesting that ELA creates a phenotype similar to naive, acutely stressed animals. We present a conceptual theoretical framework to interpret the unexpected results. Overall, ELA likely alters IEG expression across the brain, especially in interaction with other negative life events. The present review highlights current knowledge gaps and provides guidance to aid the design of future studies.	[Schuler, Heike; Bonapersona, Valeria; Joels, Marian; Sarabdjitsingh, R. Angela] Univ Utrecht, Univ Med Ctr, Dept Translat Neurosci, Utrecht Brain Ctr, Utrecht, Netherlands; [Schuler, Heike] McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada; [Joels, Marian] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; McGill University; University of Groningen	Bonapersona, V (corresponding author), Univ Utrecht, Univ Med Ctr, Dept Translat Neurosci, Utrecht Brain Ctr, Utrecht, Netherlands.	v.bonapersona-2@umcutrecht.nl		Bonapersona, Valeria/0000-0001-8497-5152; Joels, Marian/0000-0002-4826-6209; Schuler, Heike/0000-0002-8462-5491	Netherlands Organization for Scientific Research [024.001.003]; RAS (ZoNmW program MKMD) [114024135]; Gravitation program of the Dutch Ministry of Education, Culture, and Science	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); RAS (ZoNmW program MKMD); Gravitation program of the Dutch Ministry of Education, Culture, and Science	MJ (Consortium of Individual Development, which is funded through the Gravitation program of the Dutch Ministry of Education, Culture, and Science and the Netherlands Organization for Scientific Research; grant number: 024.001.003). RAS (ZoNmW program MKMD; grant number 114024135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; Rivarola MA, 2009, INT J DEV NEUROSCI, V27, P567, DOI 10.1016/j.ijdevneu.2009.06.007; Assink M, 2016, QUANT METH PSYCHOL, V12, P154, DOI 10.20982/tqmp.12.3.p154; Auth CS, 2018, EUR NEUROPSYCHOPHARM, V28, P1270, DOI 10.1016/j.euroneuro.2018.07.103; Badr LK, 2006, J PERINAT NEONAT NUR, V20, P163, DOI 10.1097/00005237-200604000-00011; Banqueri M, 2018, NEUROBIOL LEARN MEM, V155, P30, DOI 10.1016/j.nlm.2018.06.007; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; Benekareddy M, 2010, J NEUROSCI, V30, P12138, DOI 10.1523/JNEUROSCI.3245-10.2010; Benner S, 2014, PHYSIOL BEHAV, V137, P42, DOI 10.1016/j.physbeh.2014.06.018; Blaise JH, 2008, BRAIN RES, V1193, P25, DOI 10.1016/j.brainres.2007.11.049; Bonapersona V, 2021, NAT NEUROSCI, V24, P470, DOI 10.1038/s41593-020-00792-3; Bonapersona V, 2019, NEUROSCI BIOBEHAV R, V102, P299, DOI 10.1016/j.neubiorev.2019.04.021; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Burns SB, 2018, SEMIN CELL DEV BIOL, V77, P115, DOI 10.1016/j.semcdb.2017.09.033; Chen YC, 2016, NEUROPSYCHOPHARMACOL, V41, P197, DOI 10.1038/npp.2015.181; Cheung MWL, 2014, PSYCHOL METHODS, V19, P211, DOI 10.1037/a0032968; Chung EKY, 2007, BRAIN RES, V1153, P68, DOI 10.1016/j.brainres.2007.03.047; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Clarke M, 2013, J NEUROENDOCRINOL, V25, P792, DOI 10.1111/jne.12056; COCHRAN WG, 1950, BIOMETRIKA, V37, P256, DOI 10.1093/biomet/37.3-4.256; Cohen MM, 2013, P NATL ACAD SCI USA, V110, P18274, DOI 10.1073/pnas.1310163110; Daskalakis NP, 2014, PSYCHONEUROENDOCRINO, V39, P39, DOI 10.1016/j.psyneuen.2013.09.021; Daskalakis NP, 2013, PSYCHONEUROENDOCRINO, V38, P1858, DOI 10.1016/j.psyneuen.2013.06.008; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Desbonnet L, 2008, INT J DEV NEUROSCI, V26, P259, DOI 10.1016/j.ijdevneu.2008.02.004; Felice VD, 2014, NEUROSCIENCE, V267, P252, DOI 10.1016/j.neuroscience.2014.01.064; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Gallo FT, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00079; Gardner KL, 2005, NEUROSCIENCE, V136, P181, DOI 10.1016/j.neuroscience.2005.07.042; Gaszner B, 2009, INT J DEV NEUROSCI, V27, P439, DOI 10.1016/j.ijdevneu.2009.05.006; Genest SE, 2004, J PHYSIOL-LONDON, V554, P543, DOI 10.1113/jphysiol.2003.052894; Grudniewicz A, 2019, NATURE, V576, P210, DOI 10.1038/d41586-019-03759-y; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Herzog JI, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00420; Hidaka C, 2018, NEUROPSYCH DIS TREAT, V14, P2255, DOI 10.2147/NDT.S170281; HOLM S, 1979, SCAND J STAT, V6, P65; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Hubener M, 2014, CELL, V159, P727, DOI 10.1016/j.cell.2014.10.035; James MH, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00244; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kim JY, 2015, INT J BIOL SCI, V11, P1150, DOI 10.7150/ijbs.12044; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Lang JS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243639; Vivinetto AL, 2013, BEHAV BRAIN RES, V240, P110, DOI 10.1016/j.bbr.2012.11.014; Leenaars M, 2012, LAB ANIM-UK, V46, P24, DOI 10.1258/la.2011.011087; Li Y, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00279; Lippard ETC, 2020, AM J PSYCHIAT, V177, P20, DOI 10.1176/appi.ajp.2019.19010020; Lippmann M, 2007, EUR J NEUROSCI, V25, P3091, DOI 10.1111/j.1460-9568.2007.05522.x; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Loi M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0253-17.2017; Marrocco J, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00157; Marrocco J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01014-4; Marrone DF, 2008, J NEUROSCI, V28, P1030, DOI 10.1523/JNEUROSCI.4235-07.2008; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; McGregor NW, 2018, BEHAV BRAIN RES, V341, P91, DOI 10.1016/j.bbr.2017.12.030; Menard JL, 2004, NEUROSCIENCE, V129, P297, DOI 10.1016/j.neuroscience.2004.08.009; Merrick MT, 2017, CHILD ABUSE NEGLECT, V69, P10, DOI 10.1016/j.chiabu.2017.03.016; Molet J, 2016, HIPPOCAMPUS, V26, P1618, DOI 10.1002/hipo.22661; Molet J, 2014, DEV PSYCHOBIOL, V56, P1675, DOI 10.1002/dev.21230; Navailles S, 2010, DEV NEUROSCI-BASEL, V32, P139, DOI 10.1159/000293989; Nemeroff CB, 2016, NEURON, V89, P892, DOI 10.1016/j.neuron.2016.01.019; Nestler EJ, 2015, EUR J PHARMACOL, V753, P66, DOI [10.1016/j.ejphar.2014.1.0.034, 10.1016/j.ejphar.2014.10.034]; O'Leary OF, 2014, P NATL ACAD SCI USA, V111, P15232, DOI 10.1073/pnas.1404090111; Okuno H, 2011, NEUROSCI RES, V69, P175, DOI 10.1016/j.neures.2010.12.007; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; Page MJ, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003583; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; R Core Team, 2019, R LANG ENV STAT; Ren TH, 2007, AM J PHYSIOL-GASTR L, V292, pG849, DOI 10.1152/ajpgi.00400.2006; Renard GM, 2010, DEV NEUROSCI-BASEL, V32, P71, DOI 10.1159/000280102; Rincel M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.235; Rincel M, 2019, BRAIN BEHAV IMMUN, V80, P179, DOI 10.1016/j.bbi.2019.03.006; Rivarola MA, 2008, INT J NEUROSCI, V118, P735, DOI 10.1080/00207450701750430; Rocha M, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01352-4; Rohatgi A, 2020, WEBPLOTDIGITIZER; Sandi C, 2015, NAT REV NEUROSCI, V16, P290, DOI 10.1038/nrn3918; Shansky RM, 2021, NAT NEUROSCI, V24, P457, DOI 10.1038/s41593-021-00806-8; Shin S, 2018, NEURON, V97, P195, DOI 10.1016/j.neuron.2017.11.040; Solas M, 2010, NEUROPSYCHOPHARMACOL, V35, P1664, DOI 10.1038/npp.2010.13; Tenorio-Lopes L, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12550; Troakes C, 2009, STRESS, V12, P362, DOI 10.1080/10253890802506391; Trujillo V, 2016, STRESS, V19, P91, DOI 10.3109/10253890.2015.1105958; van Bodegom M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00087; van Hasselt FN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037820; Vesterinen HM, 2014, J NEUROSCI METH, V221, P92, DOI 10.1016/j.jneumeth.2013.09.010; Vialou V, 2014, J NEUROSCI, V34, P3878, DOI 10.1523/JNEUROSCI.1787-13.2014; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Viechtbauer W, 2010, RES SYNTH METHODS, V1, P112, DOI 10.1002/jrsm.11; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wang H, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00138; Wickham H., 2017, TIDYVERSE EASILY INS; Yajima H, 2018, NEUROBIOL AGING, V64, P139, DOI 10.1016/j.neurobiolaging.2017.12.021; Yap EL, 2020, NATURE, DOI 10.1038/s41586-020-3031-0; Yap EL, 2018, NEURON, V100, P330, DOI 10.1016/j.neuron.2018.10.013; Zhang XJ, 2009, J MOL NEUROSCI, V37, P274, DOI 10.1007/s12031-008-9134-y; Zhao XP., 2013, WORLD CHINESE J DIG, V21, P3344	97	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0253406	10.1371/journal.pone.0253406	http://dx.doi.org/10.1371/journal.pone.0253406			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025862	Green Published, gold, Green Submitted			2022-12-27	WOS:000796264200001
J	Sempore, WY; Ouedraogo, N; Gandema, S; Henni, S; Ilboudo, A; Yameogo, TM; Abraham, P				Sempore, Wendsendate Yves; Ouedraogo, Nafi; Gandema, Salifou; Henni, Samir; Ilboudo, Alassane; Yameogo, Tene Marceline; Abraham, Pierre			The "Walking Estimated Limitation Stated by History" (WELSH) visual tool is applicable and accurate to determine walking capacity, even in people with low literacy level	PLOS ONE			English	Article							IMPAIRMENT QUESTIONNAIRE; VALIDATION; TRANSLATION; DISTANCES; TREADMILL	Determination of the self-reported walking capacity by interview or standardized questionnaire is important. However, the existing questionnaires require the patient to be able to read and write in a specific language. We recently proposed the WELSH (Walking Estimated Limitation Stated by History) tool to be administrable to illiterate people. The main objective was to assess the applicability of WELSH tool in the community and in a large group. We performed a prospective study in the city of Bobo-Dioulasso in Burkina Faso during June 2020. We recruited 630 interviewers among medical students. They were trained to administer the WELSH, and to conduct a 6-minute walk test. We performed a Pearson's "r" correlation between the WELSH and maximal walking distance (MWD). Of the 1723 participants available for the analysis, 757 (43.9%: 41.6-46.3) never went to school or attended only elementary school. The percentage of questionnaires with participant filling-in errors corrected by the investigator decreased with the decrease in educational level (p<0.001). The average WELSH score was 53 +/- 22 and the average MWD was 383 +/- 142 meters. The Spearman correlation coefficient between the WELSH score and the MWD was r = 0.567 (p<0.001). Correlations ranged from 0.291 to 0.576 in males and females, (all p values < 0.05) and in different levels of education, with the highest coefficients found in illiterate people. The WELSH is feasible on the community by a wide variety of interviewers. It correlates with the MWD estimated by the 6-minutes' walk test even for people with little or no schooling.	[Sempore, Wendsendate Yves; Abraham, Pierre] Inst Natl Sante Publ, Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Sempore, Wendsendate Yves; Henni, Samir; Abraham, Pierre] Ctr Hosp Univ Angers, Vasc Med Dept, Angers, France; [Sempore, Wendsendate Yves; Abraham, Pierre] Univ Angers, CNRS, Inst MitoVasc, INSERM 1083,UMR 6015, Angers, France; [Ouedraogo, Nafi] Ctr Hosp Univ Souro Sanou, Physiol, Bobo Dioulasso, Burkina Faso; [Gandema, Salifou] Ctr Hosp Univ Souro Sanou, Phys Med & Funct Rehabil Dept, Bobo Dioulasso, Burkina Faso; [Ilboudo, Alassane; Yameogo, Tene Marceline] Ctr Hosp Univ Souro Sanou, Dept Internal Med, Bobo Dioulasso, Burkina Faso	Centre Muraz; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Abraham, P (corresponding author), Ctr Hosp Univ Angers, Vasc Med Dept, Angers, France.; Abraham, P (corresponding author), Univ Angers, CNRS, Inst MitoVasc, INSERM 1083,UMR 6015, Angers, France.	piabraham@chu-angers.fr						Abraham P, 2014, EUR J VASC ENDOVASC, V47, P319, DOI 10.1016/j.ejvs.2013.11.010; Cucato GG, 2016, ARQ BRAS CARDIOL, V106, P49, DOI 10.5935/abc.20160004; Fisher R. A., 1946, Statistical methods for research workers.; Frans FA, 2013, J VASC SURG, V57, P720, DOI 10.1016/j.jvs.2012.09.044; Gernigon M., 2015, NOUVELLES APPROCHES; Lee IM, 2008, MED SCI SPORT EXER, V40, pS512, DOI 10.1249/MSS.0b013e31817c65d0; Mahe G, 2011, EUR J VASC ENDOVASC, V41, P104, DOI 10.1016/j.ejvs.2010.10.002; Manfredini F, 2004, EUR J VASC ENDOVASC, V28, P303, DOI 10.1016/j.ejvs.2004.05.005; McDermott MM, 1998, J VASC SURG, V28, P1072, DOI 10.1016/S0741-5214(98)70034-5; Myers SA, 2008, J VASC SURG, V47, P550, DOI 10.1016/j.jvs.2007.10.052; Ouedraogo N, 2013, J VASC SURG, V58, P981, DOI 10.1016/j.jvs.2013.03.039; Ouedraogo N, 2011, J VASC SURG, V54, P133, DOI 10.1016/j.jvs.2010.11.129; Ritti-Dias RM, 2009, ARQ BRAS CARDIOL, V92, P143, DOI 10.1590/S0066-782X2009000200011; Sagar SP, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/190641; Sempore WY, 2019, CARDIOVASC J AFR, V30, P341, DOI 10.5830/CVJA-2019-032; Tew GA, 2014, VASC MED, V19, P27, DOI 10.1177/1358863X14520870; Verspaget M, 2009, EUR J VASC ENDOVASC, V37, P56, DOI 10.1016/j.ejvs.2008.10.001; Yan BP, 2011, VASC MED, V16, P167, DOI 10.1177/1358863X11404934; Zhang X., 2021, BMC PUBLIC HEALTH, V21	19	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0260875	10.1371/journal.pone.0260875	http://dx.doi.org/10.1371/journal.pone.0260875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025876	gold, Green Published			2022-12-27	WOS:000796264200008
J	Woodall, CA; McGeoch, LJ; Hay, AD; Hammond, A				Woodall, Claire A.; McGeoch, Luke J.; Hay, Alastair D.; Hammond, Ashley			Respiratory tract infections and gut microbiome modifications: A systematic review	PLOS ONE			English	Review							CHAIN FATTY-ACIDS; VIRUS-INFECTION; RIBOSOMAL-RNA; INTESTINAL MICROBIOTA; BACTERIAL; COVID-19; HEALTH; AXIS; SEQUENCES; CHILDREN	Respiratory tract infections (RTIs) are extremely common and can cause gastrointestinal tract symptoms and changes to the gut microbiota, yet these effects are poorly understood. We conducted a systematic review to evaluate the reported evidence of gut microbiome alterations in patients with a RTI compared to healthy controls (PROSPERO: CRD42019138853). We systematically searched Medline, Embase, Web of Science, Cochrane and the Clinical Trial Database for studies published between January 2015 and June 2021. Studies were eligible for inclusion if they were human cohorts describing the gut microbiome in patients with an RTI compared to healthy controls and the infection was caused by a viral or bacterial pathogen. Dual data screening and extraction with narrative synthesis was performed. We identified 1,593 articles and assessed 11 full texts for inclusion. Included studies (some nested) reported gut microbiome changes in the context of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (n = 5), influenza (H1N1 and H7N9) (n = 2), Tuberculosis (TB) (n = 4), Community-Acquired Pneumonia CAP (n = 2) and recurrent RTIs (rRTI) (n = 1) infections. We found studies of patients with an RTI compared to controls reported a decrease in gut microbiome diversity (Shannon) of 1.45 units (95% CI, 0.15-2.50 [p, <0.0001]) and a lower abundance of taxa (p, 0.0086). Meta-analysis of the Shannon value showed considerable heterogeneity between studies (I-2, 94.42). Unbiased analysis displayed as a funnel plot revealed a depletion of Lachnospiraceae, Ruminococcaceae and Ruminococcus and enrichment of Enterococcus. There was an important absence in the lack of cohort studies reporting gut microbiome changes and high heterogeneity between studies may be explained by variations in microbiome methods and confounder effects. Further human cohort studies are needed to understand RTI-induced gut microbiome changes to better understand interplay between microbes and respiratory health.	[Woodall, Claire A.; Hay, Alastair D.; Hammond, Ashley] Univ Bristol, Bristol Med Sch, Ctr Acad Primary Care, Populat Hlth Sci, Bristol, Avon, England; [McGeoch, Luke J.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England	University of Bristol; University of Oxford	Woodall, CA (corresponding author), Univ Bristol, Bristol Med Sch, Ctr Acad Primary Care, Populat Hlth Sci, Bristol, Avon, England.	claire.woodall@bristol.ac.uk	Woodall, Claire/DHF-9710-2022	Woodall, Claire/0000-0002-7230-4105; Hay, Alastair/0000-0003-3012-375X; Hammond, Ashley/0000-0002-6657-1514	Medical Research Council (MCR); Wellcome Trust Institutional Strategic Support Fund [WT ISSF204813/Z/16/Z]; Elizabeth Blackwell Institute at the University of Bristol	Medical Research Council (MCR); Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Elizabeth Blackwell Institute at the University of Bristol	Medical Research Council (MCR) and Wellcome Trust Institutional Strategic Support Fund (WT ISSF204813/Z/16/Z), awarded to CAW a Daphne Jackson Trust Development Fellow in collaboration with the Elizabeth Blackwell Institute at the University of Bristol. (https://wellcome.org/what-we-do/ourwork/institutional-strategicsupport-fund).The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Abdulla MH, 2021, INT J ONCOL, V58, DOI 10.3892/ijo.2021.5197; Alghamdi HA, 2021, J PAK MED ASSOC, V71, P1221, DOI [10.47391/JPMA.1415, 10.5455/JPMA.1415]; [Anonymous], 2018, CRITICAL APPRAISAL S; [Anonymous], 2020, WHO COVID 19 DASHBOA; Antunes KH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11152-6; Appert O, 2020, ENVIRON MICROBIOL, V22, P3909, DOI 10.1111/1462-2920.15167; Ghavami SB, 2021, EXPERT REV GASTROENT, V15, P1281, DOI 10.1080/17474124.2021.1991311; Bell A, 2019, NAT MICROBIOL, V4, P2393, DOI 10.1038/s41564-019-0590-7; Beovic B, 2020, J ANTIMICROB CHEMOTH, V75, P3386, DOI 10.1093/jac/dkaa326; Boutard M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004773; Bowerman KL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19701-0; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cao JB, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2021.1887722; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caspi R, 2020, NUCLEIC ACIDS RES, V48, pD445, DOI 10.1093/nar/gkz862; Chen YF, 2022, GUT, V71, P222, DOI 10.1136/gutjnl-2021-324090; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Companys J, 2021, NUTRIENTS, V13, DOI 10.3390/nu13062032; Costea PI, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0072-8; Cultrera R, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084358; D'Amico F, 2020, CLIN GASTROENTEROL H, V18, P1663, DOI 10.1016/j.cgh.2020.04.001; Demirci M, 2019, ALLERGOL IMMUNOPATH, V47, P365, DOI 10.1016/j.aller.2018.12.009; Durazzi F, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82726-y; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elvers KT, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035677; Enaud R, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00009; Gu SL, 2020, CLIN INFECT DIS, V71, P2669, DOI 10.1093/cid/ciaa709; Hosseini Parsa, 2010, BMC Res Notes, V3, P183, DOI 10.1186/1756-0500-3-183; Hu YF, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00090; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Ismael S, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041228; Kim D, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0267-5; Kim YJ, 2021, OBESITY, V29, P636, DOI 10.1002/oby.23107; Kumar M, 2018, FUNNELR FUNNEL PLOTS; Kumbhare SV, 2019, J BIOSCIENCES, V44, DOI 10.1007/s12038-019-9860-z; Leylabadlo HE, 2020, MICROB PATHOGENESIS, V149, DOI 10.1016/j.micpath.2020.104344; Li L, 2019, MICROB PATHOGENESIS, V136, DOI 10.1016/j.micpath.2019.103709; Li WR, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1782-2; Luo M, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00822; Marotz C, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01083-0; Mazzarelli A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247041; Meier GC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236472; Myhrstad MCW, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030859; Newsome RC, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1926840; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Venegas DP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00277; Pascoal LB, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2021.1874740; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin N, 2015, SCI REP-UK, V5, DOI 10.1038/srep14771; Ren LL, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.674807; Ren XM, 2020, MICROB PATHOGENESIS, V142, DOI 10.1016/j.micpath.2020.104062; Ren ZG, 2021, GUT, V70, P1253, DOI 10.1136/gutjnl-2020-323826; Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014; Roosaare M, 2017, PEERJ, V5, DOI 10.7717/peerj.3353; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sencio V, 2021, MUCOSAL IMMUNOL, V14, P296, DOI 10.1038/s41385-020-00361-8; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Seo K, 2021, ARCH PHARM RES, V44, P325, DOI 10.1007/s12272-021-01327-5; Shi HY, 2021, EUR J NUTR, V60, P4151, DOI 10.1007/s00394-021-02519-x; Silva YP, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00025; Unger SA, 2017, J INFECTION, V74, pS84, DOI 10.1016/S0163-4453(17)30196-2; Vernocchi P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208171; Wang J, 2014, J EXP MED, V211, P2397, DOI 10.1084/jem.20140625; Xiao L, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.729346; Xu R, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01796-w; Yeoh YK, 2021, GUT, V70, P698, DOI 10.1136/gutjnl-2020-323020; Yokono M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25090-8; Zheng SY, 2021, AGEING RES REV, V69, DOI 10.1016/j.arr.2021.101347; Zhou YY, 2021, J MICROBIOL, V59, P941, DOI 10.1007/s12275-021-1206-5; Zuo T, 2021, GUT, V70, P276, DOI 10.1136/gutjnl-2020-322294; Zuo T, 2020, GASTROENTEROLOGY, V159, P944, DOI 10.1053/j.gastro.2020.05.048	74	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262057	10.1371/journal.pone.0262057	http://dx.doi.org/10.1371/journal.pone.0262057			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025938	Green Published, gold			2022-12-27	WOS:000796264200042
J	Chauhan, BS				Chauhan, Bhagirath Singh			The world's first glyphosate-resistant case of Avena fatua L. and Avena sterilis ssp. ludoviciana (Durieu) Gillet & Magne and alternative herbicide options for their control	PLOS ONE			English	Article							WILD; TRANSLOCATION	Avena fatua and A. ludoviciana (commonly known as wild oats) are the most problematic winter grass species in fallows and winter crops in the northeast region of Australia. A series of experiments were conducted to evaluate the performance of glyphosate and alternative post-emergence herbicides on A. fatua and A. ludoviciana. This study reports the world's first glyphosate-resistant (GR) biotypes of A. fatua and A. ludoviciana. The glyphosate dose required to kill 50% of the plants (LD50) and to reduce 50% of the biomass (GR(50)) for the GR biotype of A. fatua was 556 g a.e./ha and 351 g a.e./ha, respectively. These values for A. ludoviciana were 848 g a.e./ha and 289 g a.e./ha. Regardless of the growth stage (3-4 or 6-7 leaf stages), clethodim (120 g a.i./ha), haloxyfop (78 g a.i./ha), pinoxaden (20 g a.i./ha), and propaquizafop (30 g a.i./ha) were the best alternative herbicide options for the control of A. fatua and A. ludoviciana. The efficacy of butroxydim (45 g a.i./ha), clodinafop (120 g a.i./ha), imazamox + imazapyr (36 g a.i./ha), and paraquat (600 g a.i./ha) reduced at the advanced growth stage. Glufosinate (750 g a.i./ha), flamprop (225 g a.i./ha), and pyroxsulam + halauxifen (20 g a.i./ha) did not provide effective control of Avena species. This study identified alternative herbicide options to manage GR biotypes of A. fatua and A. ludoviciana.	[Chauhan, Bhagirath Singh] Univ Queensland, Ctr Crop Sci, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Qld, Australia; [Chauhan, Bhagirath Singh] Univ Queensland, Sch Agr & Food Sci SAFS, Gatton, Qld, Australia; [Chauhan, Bhagirath Singh] Chaudhary Charan Singh Haryana Agr Univ, Dept Agron, Hisar, Haryana, India	University of Queensland; University of Queensland; CCS Haryana Agricultural University	Chauhan, BS (corresponding author), Univ Queensland, Ctr Crop Sci, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Qld, Australia.; Chauhan, BS (corresponding author), Univ Queensland, Sch Agr & Food Sci SAFS, Gatton, Qld, Australia.; Chauhan, BS (corresponding author), Chaudhary Charan Singh Haryana Agr Univ, Dept Agron, Hisar, Haryana, India.	b.chauhan@uq.edu.au						Beckie HJ, 2008, WEED TECHNOL, V22, P530, DOI 10.1614/WT-07-175.1; Broster J. C., 2011, Plant Protection Quarterly, V26, P22; Chauhan BS, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208311; Desai HS, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10091266; Genstat, 2019, GENSTAT WINDOWS, V20th; HARKER KN, 1991, WEED SCI, V39, P650, DOI 10.1017/S0043174500088524; Heap I, INT SURVEY HERBICIDE; Kumaratilake AR, 2005, WEED SCI, V53, P10, DOI 10.1614/WS-03-140R; Llewellyn Rick., 2016, IMPACT WEEDS AUSTR G; Mahajan G, 2021, WEED SCI, V69, P485, DOI 10.1017/wsc.2021.25; Mahajan G, 2021, WEED SCI, V69, P362, DOI 10.1017/wsc.2021.7; Mahajan G, 2021, AGRON J, V113, P42, DOI 10.1002/agj2.20507; Nugent T, 1999, MANAGING WILD OATS; Owen MJ, 2016, CROP PASTURE SCI, V67, P520, DOI 10.1071/CP15295; Ramsey RJL, 2002, PESTIC BIOCHEM PHYS, V73, P1, DOI 10.1016/S0048-3575(02)00017-2; Sahil, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234648; Thomas G. A., 1997, Sustainable crop production in the sub-tropics: an Australian perspective., P195; VanGessel MJ, 2001, WEED SCI, V49, P703, DOI 10.1614/0043-1745(2001)049[0703:RPRHFD]2.0.CO;2; Vila-Aiub MM, 2007, WEED SCI, V55, P566, DOI 10.1614/WS-07-053.1; Webb A. A., 1997, Sustainable crop production in the sub-tropics: an Australian perspective., P8	20	1	1	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262494	10.1371/journal.pone.0262494	http://dx.doi.org/10.1371/journal.pone.0262494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020774	Green Published, gold			2022-12-27	WOS:000834207700044
J	Mumoli, N; Dentali, F; Conte, G; Colombo, A; Capra, R; Porta, C; Rotiroti, G; Zuretti, F; Cei, M; Tangianu, F; Evangelista, I; Vitale, J; Mazzone, A; Giarretta, I				Mumoli, Nicola; Dentali, Francesco; Conte, Giulia; Colombo, Alessandra; Capra, Riccardo; Porta, Cesare; Rotiroti, Giuseppe; Zuretti, Francesca; Cei, Marco; Tangianu, Flavio; Evangelista, Isabella; Vitale, Jose; Mazzone, Antonino; Giarretta, Igor			Upper extremity deep vein thrombosis in COVID-19: Incidence and correlated risk factors in a cohort of non-ICU patients	PLOS ONE			English	Article							VENOUS THROMBOSIS; PULMONARY-EMBOLISM; ANTICOAGULATION	Background Venous thromboembolism is a frequent complication of COVID-19 infection. Less than 50% of pulmonary embolism (PE) is associated with the evidence of deep venous thrombosis (DVT) of the lower extremities. DVT may also occur in the venous system of the upper limbs especially if provoking conditions are present such as continuous positive airway pressure (CPAP). The aim of this study was to evaluate the incidence of UEDVT in patients affected by moderate-severe COVID-19 infection and to identify potential associated risk factors for its occurrence. Methods We performed a retrospective analysis of all patients affected by moderate-severe COVID-19 infection admitted to our unit. In accordance with the local protocol, all patients had undergone a systematic screening for the diagnosis of UEDVT, by vein compression ultrasonography (CUS). All the patients were receiving pharmacological thromboprophylaxis according to international guidelines recommendations. Univariate and multivariate analyses were used to identify risk factors associated with UEDVT. Results 257 patients were included in the study, 28 patients were affected by UEDVT with an incidence of 10.9% (95% CI, 7.1-14.7). At univariate analysis UEDVT appeared to be significantly associated (p< 0.05) with pneumonia, ARDS, Pa02/Fi02, D-dimer value higher than the age adjusted cut off value and need for CPAP ventilation. Multivariate analysis showed a significant association between UEDVT and the need for CPAP ventilation (OR 5.95; 95% IC 1.33-26.58). Increased mortality was found in patients affected by UEDVT compared to those who were not (OR 3.71; 95% CI, 1.41-9.78). Conclusions UEDVT can occur in COVID-19 patients despite adequate prophylaxis especially in patients undergoing helmet CPAP ventilation. Further studies are needed to identify the correct strategy to prevent DVT in these patients.	[Mumoli, Nicola; Conte, Giulia; Colombo, Alessandra; Capra, Riccardo; Porta, Cesare; Rotiroti, Giuseppe; Cei, Marco; Evangelista, Isabella; Vitale, Jose; Mazzone, Antonino] ASST Ovest Milanese, Dept Internal Med, Magenta, MI, Italy; [Dentali, Francesco] Insubria Univ, Dept Med & Surg, Varese, Italy; [Zuretti, Francesca; Tangianu, Flavio; Giarretta, Igor] ASST Sette Laghi, Dept Internal Med, Varese, Italy	University of Insubria	Mumoli, N (corresponding author), ASST Ovest Milanese, Dept Internal Med, Magenta, MI, Italy.	nimumoli@tiscali.it	Mumoli, Nicola/J-4652-2019	Mumoli, Nicola/0000-0001-7166-5630				Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Ageno W, 2019, THROMB HAEMOSTASIS, V119, P1365, DOI 10.1055/s-0039-1688828; Amirfarzan H, 2021, PULMONOLOGY, V27, P413, DOI 10.1016/j.pulmoe.2021.01.008; [Anonymous], 2020, SURV STRAT COVID 19; [Anonymous], COVID 19 TREATMENT G; Arnhjort T, 2007, EUR J INTERN MED, V18, P304, DOI 10.1016/j.ejim.2006.12.005; Ashish A, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000692; Bleker SM, 2016, J THROMB HAEMOST, V14, P973, DOI 10.1111/jth.13291; Cabrini L, 2020, LANCET, V395, P685, DOI 10.1016/S0140-6736(20)30359-7; Chang H, 2021, J VASC SURG-VENOUS L, V9, P597, DOI 10.1016/j.jvsv.2020.09.010; Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830; Cuker A, 2021, BLOOD ADV, V5, P872, DOI 10.1182/bloodadvances.2020003763; Demelo-Rodriguez P, 2020, THROMB RES, V192, P23, DOI 10.1016/j.thromres.2020.05.018; Edler C, 2020, INT J LEGAL MED, V134, P1275, DOI 10.1007/s00414-020-02317-w; Flinterman LE, 2008, J THROMB HAEMOST, V6, P1262, DOI 10.1111/j.1538-7836.2008.03017.x; Gazzaruso C, 2020, NUTR METAB CARDIOVAS, V30, P1914, DOI 10.1016/j.numecd.2020.07.040; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gupta N, 2019, THROMB RES, V181, P77, DOI 10.1016/j.thromres.2019.07.013; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Ibrahim EH, 2002, CRIT CARE MED, V30, P771, DOI 10.1097/00003246-200204000-00008; Isma N, 2010, THROMB RES, V125, pE335, DOI 10.1016/j.thromres.2010.03.005; Kollias A, 2020, BRIT J HAEMATOL, V189, P846, DOI 10.1111/bjh.16727; Kucher N, 2011, NEW ENGL J MED, V364, P861, DOI 10.1056/NEJMcp1008740; Levy MM, 2011, ANN VASC SURG, V25, P442, DOI 10.1016/j.avsg.2011.01.005; Linnemann B, 2008, THROMB HAEMOSTASIS, V100, P440, DOI 10.1160/TH08-03-0196; Lippi G, 2020, THROMB HAEMOSTASIS, V120, P876, DOI 10.1055/s-0040-1709650; Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869; Lopes RD, 2021, LANCET, V397, P2253, DOI 10.1016/S0140-6736(21)01203-4; MacIntyre NR, 2019, RESP CARE, V64, P617, DOI 10.4187/respcare.06635; Marietta M, 2020, BLOOD TRANSFUS-ITALY, V18, P167, DOI 10.2450/2020.0083-20; Marinella MA, 2000, HEART LUNG, V29, P113; Marongiu F, 2020, J THROMB HAEMOST, V18, P1511, DOI 10.1111/jth.14818; Newton DH, 2017, J VASC SURG-VENOUS L, V5, P18, DOI 10.1016/j.jvsv.2016.08.002; (NICE) NIfHaCE, 2021, COVID 19 RAPID GUIDE; Owens CA, 2010, J VASC INTERV RADIOL, V21, P779, DOI 10.1016/j.jvir.2010.02.021; Porfidia A, 2020, J THROMB THROMBOLYS, V50, P355, DOI 10.1007/s11239-020-02044-4; Poston JT, 2020, JAMA-J AM MED ASSOC, V323, P1839, DOI 10.1001/jama.2020.4914; Prandoni P, 1997, ARCH INTERN MED, V157, P57, DOI 10.1001/archinte.157.1.57; Righini M, 2009, J THROMB HAEMOST, V7, P406, DOI 10.1111/j.1538-7836.2008.03264.x; Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152; Sakr Y, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00741-0; Santoliquido A, 2020, J THROMB HAEMOST, V18, P2358, DOI 10.1111/jth.14992; Sholzberg M, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2400; Smadja DM, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.747527; Spencer FA, 2007, AM J MED, V120, P678, DOI 10.1016/j.amjmed.2006.06.046; Stein PD, 2005, AM J MED, V118, P978, DOI 10.1016/j.amjmed.2005.03.012; Tadlock MD, 2015, AM J SURG, V209, P959, DOI 10.1016/j.amjsurg.2014.09.027; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Voicu S, 2021, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.608788; Zhang L, 2020, CIRCULATION, V142, P114, DOI 10.1161/CIRCULATIONAHA.120.046702	53	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262522	10.1371/journal.pone.0262522	http://dx.doi.org/10.1371/journal.pone.0262522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020777	gold, Green Published			2022-12-27	WOS:000834207700048
J	Almeda, N; Garcia-Alonso, CR; Gutierrez-Colosia, MR; Salinas-Perez, JA; Iruin-Sanz, A; Salvador-Carulla, L				Almeda, Nerea; Garcia-Alonso, Carlos R.; Gutierrez-Colosia, Mencia R.; Salinas-Perez, Jose A.; Iruin-Sanz, Alvaro; Salvador-Carulla, Luis			Modelling the balance of care: Impact of an evidence-informed policy on a mental health ecosystem	PLOS ONE			English	Article							EMERGENCY; SCHIZOPHRENIA; READMISSION; PSYCHIATRY; FUTURE	Major efforts worldwide have been made to provide balanced Mental Health (MH) care. Any integrated MH ecosystem includes hospital and community-based care, highlighting the role of outpatient care in reducing relapses and readmissions. This study aimed (i) to identify potential expert-based causal relationships between inpatient and outpatient care variables, (ii) to assess them by using statistical procedures, and finally (iii) to assess the potential impact of a specific policy enhancing the MH care balance on real ecosystem performance. Causal relationships (Bayesian network) between inpatient and outpatient care variables were defined by expert knowledge and confirmed by using multivariate linear regression (generalized least squares). Based on the Bayesian network and regression results, a decision support system that combines data envelopment analysis, Monte Carlo simulation and fuzzy inference was used to assess the potential impact of the designed policy. As expected, there were strong statistical relationships between outpatient and inpatient care variables, which preliminarily confirmed their potential and a priori causal nature. The global impact of the proposed policy on the ecosystem was positive in terms of efficiency assessment, stability and entropy. To the best of our knowledge, this is the first study that formalized expert-based causal relationships between inpatient and outpatient care variables. These relationships, structured by a Bayesian network, can be used for designing evidence-informed policies trying to balance MH care provision. By integrating causal models and statistical analysis, decision support systems are useful tools to support evidence-informed planning and decision making, as they allow us to predict the potential impact of specific policies on the ecosystem prior to its real application, reducing the risk and considering the population's needs and scientific findings.	[Almeda, Nerea; Gutierrez-Colosia, Mencia R.] Univ Loyola Andalucia, Dept Psychol, Seville, Spain; [Garcia-Alonso, Carlos R.; Salinas-Perez, Jose A.] Univ Loyola Andalucia, Dept Quantitat Methods, Seville, Spain; [Iruin-Sanz, Alvaro] Red Salud Mental Extrahospitalaria Gipuzkoa, Inst Biodonostia, Donostia San Sebastian, Spain; [Salvador-Carulla, Luis] Australian Natl Univ, ANU Coll Hlth & Med, Ctr Mental Hlth Res, Res Sch Populat Hlth, Canberra, ACT, Australia	Universidad Loyola Andalucia; Universidad Loyola Andalucia; Instituto de Investigacion Sanitaria Biodonostia; Australian National University	Salinas-Perez, JA (corresponding author), Univ Loyola Andalucia, Dept Quantitat Methods, Seville, Spain.	jsalinas@uloyola.es	Gutiérrez-Colosía, Mencía Ruiz/N-4515-2014; Almeda, Nerea/AAY-9969-2021; Salinas-Perez, Jose A./I-3930-2012; Salvador-Carulla, Luis/K-6512-2013	Gutiérrez-Colosía, Mencía Ruiz/0000-0002-2631-0205; Almeda, Nerea/0000-0002-6477-5142; Salinas-Perez, Jose A./0000-0001-8533-9342; Salvador-Carulla, Luis/0000-0002-5742-9866	Carlos III Health Institute [PI18/01521]; Regional Government of Andalusia [PY18-RE-0022]; European Union FEDER teams	Carlos III Health Institute(Instituto de Salud Carlos III); Regional Government of Andalusia(Junta de Andalucia); European Union FEDER teams	Financial support for this study was provided in part by a grant from the Carlos III Health Institute (PI18/01521), and the Regional Government of Andalusia (PY18-RE-0022), with European Union FEDER teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeda N, 2021, BMC PSYCHIATRY, V21, DOI 10.1186/s12888-020-03015-y; Almeda N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030332; BANKER RD, 1984, MANAGE SCI, V30, P1078, DOI 10.1287/mnsc.30.9.1078; Bhugra D, 2017, LANCET PSYCHIAT, V4, P775, DOI 10.1016/S2215-0366(17)30333-4; Bouras N, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040806; Costanza A, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56060295; Deslich Stacie, 2013, Perspect Health Inf Manag, V10, p1f; EU-European Union, 2017, QUAL PUBL ADM TOOLB, DOI 10.2767/879305; Fischer KE, 2013, MED DECIS MAKING, V33, P1009, DOI 10.1177/0272989X13490837; Freedman D.A., 2009, STAT MODELS THEORY P; Furst Mary Anne, 2021, BJPsych Int, V18, P23, DOI 10.1192/bji.2020.24; Garcia-Alonso CR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212179; Gibert K, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-28; Gutierrez-Colosia MR, 2019, EPIDEMIOL PSYCH SCI, V28, P210, DOI 10.1017/S2045796017000415; Hansagi H, 2001, ANN EMERG MED, V37, P561, DOI 10.1067/mem.2001.111762; Iruin A., 2012, ATLAS SALUD MENTAL G; Klir GJ, 2006, UNCERTAINTY AND INFORMATION: FOUNDATIONS OF GENERALIZED INFORMATION THEORY, P1; Lavis JN, 2009, HEALTH RES POLICY SY, V7, DOI [10.1186/1478-4505-7-S1-S1, 10.1186/1478-4505-7-S1-11, 10.1186/1478-4505-7-S1-S15, 10.1186/1478-4505-7-S1-I1]; Marcus SC, 2017, PSYCHIAT SERV, V68, P1239, DOI 10.1176/appi.ps.201600498; Montagni I, 2018, ADM POLICY MENT HLTH, V45, P342, DOI 10.1007/s10488-017-0826-x; Okumura Y, 2018, PSYCHIAT RES, V270, P490, DOI 10.1016/j.psychres.2018.10.020; Omer S, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.08.002; Rosen A, 2020, CURR OPIN PSYCHIATR, V33, P375, DOI 10.1097/YCO.0000000000000620; Salvador-Carulla L, 2015, INT J INTEGR CARE, V15; Salvador-Carulla L, 2013, IMPROVING MENTAL HEALTH CARE: THE GLOBAL CHALLENGE, P211; Salvador-Carulla L, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-218; Salvador-Carulla L, 2010, J MENT HEALTH POLICY, V13, P73; Sather EW, 2018, HEALTH SCI REP-US, V1, DOI 10.1002/hsr2.37; Shore JH, 2007, GEN HOSP PSYCHIAT, V29, P199, DOI 10.1016/j.genhosppsych.2007.01.013; Sloan PA, 2010, J PSYCHIATR PRACT, V16, P170, DOI 10.1097/01.pra.0000375713.85454.8f; Smith TE, 2020, PSYCHIAT SERV, V71, P75, DOI 10.1176/appi.ps.201900233; Thornicroft G, 2013, PSYCHOL MED, V43, P849, DOI 10.1017/S0033291712001420; Thornicroft G, 2010, WORLD PSYCHIATRY, V9, P67; Weiss AP, 2012, ANN EMERG MED, V60, P162, DOI 10.1016/j.annemergmed.2012.01.037; World Health Organisation, 2021, MENT HLTH ACT PLAN 2; World Health Organization, 2020, MENT HLTH PROJ ATL	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0261621	10.1371/journal.pone.0261621	http://dx.doi.org/10.1371/journal.pone.0261621			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015762	gold, Green Published			2022-12-27	WOS:000814820600004
J	Asim, M; Hameed, W; Saleem, S				Asim, Muhammad; Hameed, Waqas; Saleem, Sarah			Do empowered women receive better quality antenatal care in Pakistan? An analysis of demographic and health survey data	PLOS ONE			English	Article							VIOLENCE; AFRICA; AGENCY	Introduction Quality antenatal care is a window of opportunity for improving maternal and neonatal outcomes. Numerous studies have shown a positive effect of women empowerment on improved coverage of maternal and reproductive health services, including antenatal care (ANC). However, there is scarce evidence on the association between women's empowerment and improved ANC services both in terms of coverage and quality. Addressing this gap, this paper examines the relationship between multi-dimensional measures of women empowerment on utilization of quality ANC (service coverage and consultation) in Pakistan. Methods We used Pakistan Demographic and Health Survey 2017-18 (PDHS) data which comprises of 6,602 currently married women aged between 15-49 years who had a live birth in the past five years preceding the survey. Our exposure variables were three-dimensional measures of women empowerment (social independence, decision making, and attitude towards domestic violence), and our outcome variables were quality of antenatal coverage [i.e. a composite binary measure based on skilled ANC (trained professional), timeliness (1st ANC visit during first trimester), sufficiency of ANC visits (4 or more)] and quality of ANC consultation (i.e. receiving at least 7 or more essential antenatal components out of 8). Data were analysed in Stata 16.0 software. Descriptive statistics were used to describe sample characteristics and binary logistic regression was employed to assess the association between empowerment and quality of antenatal care. Results We found that 41.4% of the women received quality ANC coverage and 30.6% received quality ANC consultations during pregnancy. After controlling for a number of socio-economic and demographic factors, all three measures of women's empowerment independently showed a positive relationship with both outcomes. Women with high autonomy (i.e. strongly opposed the notion of violence) in the domain of attitude to violence are 1.66 (95% CI 1.30-2.10) and 1.45 (95% CI 1.19-1.75) and times more likely to receive antenatal coverage and quality ANC consultations respectively, compared with women who ranked low on attitude to violence. Women who enjoy high social independence had 1.87 (95% CI 1.44-2.43) and 2.78 (95% CI 2.04-3.79) higher odds of quality antenatal coverage and consultations respectively, as compared with their counterparts. Similarly, women who had high autonomy in household decision making 1.98 (95% CI 1.60-2.44) and 1.56 (95% CI 2.17-1.91) were more likely to receive quality antenatal coverage and consultation respectively, as compared to women who possess low autonomy in household decision making. Conclusion The quality of ANC coverage and consultation with service provider is considerably low in Pakistan. Women's empowerment related to social independence, gendered beliefs about violence, and decision-making have an independent positive association with the utilisation of quality antenatal care. Thus, efforts directed towards empowering women could be an effective strategy to improve utilisation of quality antenatal care in Pakistan.	[Asim, Muhammad; Hameed, Waqas; Saleem, Sarah] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	Aga Khan University	Hameed, W (corresponding author), Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan.	waqas.hameed1@gmail.com						Afulani PA, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4476-4; Agha S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0979-8; Ali PA, 2015, TRAUMA VIOLENCE ABUS, V16, P299, DOI 10.1177/1524838014526065; Ali Tazeen Saeed, 2007, JPMA Journal of the Pakistan Medical Association, V57, P27; Arsenault C, 2018, LANCET GLOB HEALTH, V6, pE1186, DOI 10.1016/S2214-109X(18)30389-9; Benova L, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000779; Bin Nisar Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-305; Carvajal-Aguirre L, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020501; Ewerling F, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020434; Freedman LP, 2014, LANCET, V384, pE42, DOI 10.1016/S0140-6736(14)60859-X; GALLOWAY R, 1994, SOC SCI MED, V39, P381, DOI 10.1016/0277-9536(94)90135-X; Ghuman SJ, 2006, SOC SCI RES, V35, P1, DOI 10.1016/j.ssresearch.2004.06.001; Gladstone M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120566; Hanmer L, 2016, FEM ECON, V22, P237, DOI 10.1080/13545701.2015.1091087; Jewkes R, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001849; Kabeer N, 1999, DEV CHANGE, V30, P435, DOI 10.1111/1467-7660.00125; Khatiwada J, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03309-9; Kishor S., 1997, EMPOWERMENT WOMEN EG; Lamiday SP., 2019, JURNAL BERKALA EPIDE, V7; Lassi Zohra S, 2019, F1000Res, V8, P200, DOI 10.12688/f1000research.17828.1; Lincetto O, 2006, ANTENATAL CARE OPPOR; Mahmud KT, 2019, J POVERTY, V23, P365, DOI 10.1080/10875549.2019.1577324; Merrell LK, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218172; Miedema SS, 2018, WORLD DEV, V110, P453, DOI 10.1016/j.worlddev.2018.05.031; Na MZ, 2015, PUBLIC HEALTH NUTR, V18, P3155, DOI 10.1017/S1368980015002621; Nadeem M, 2021, J INTERPERS VIOLENCE, V36, pNP11717, DOI 10.1177/0886260519889942; PDHS, 2018, PAK DEM HLTH SURV 20; Pratley P, 2016, SOC SCI MED, V169, P119, DOI 10.1016/j.socscimed.2016.08.001; Rowther AA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144926; Sado L, 2014, SOC SCI MED, V114, P169, DOI 10.1016/j.socscimed.2014.05.047; Sathar ZA., 1986, DELAYED MARRIAGES PA, V25, P535; Sebayang SK, 2019, WOMEN HEALTH, V59, P1155, DOI 10.1080/03630242.2019.1593282; Sharifa Begum, 2009, Bangladesh Development Studies, V32, P69; Shibre G, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0768-8; Shimamoto K, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0591-3; Tikmani SS, 2019, SEMIN PERINATOL, V43, P297, DOI 10.1053/j.semperi.2019.03.020; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; WHO, 2016, WHO TECH REP SER, V997, P1; WHO, 2015, STAT IN REPR MAT NEW; World Health Organization UNICEF UNFPA World Bank Group United Nation Population Division, 2019, TRENDS MAT MORT 2000; Zakar R, 2012, J INTERPERS VIOLENCE, V27, P3268, DOI 10.1177/0886260512441257; Zaky HHM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/403402	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262323	10.1371/journal.pone.0262323	http://dx.doi.org/10.1371/journal.pone.0262323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990479	Green Published, gold			2022-12-27	WOS:000815783800023
J	Bruggmann, D; Quinkert-Schmolke, K; Jaque, JM; Quarcoo, D; Bohlmann, MK; Klingelhofer, D; Groneberg, DA				Brueggmann, Doerthe; Quinkert-Schmolke, Kathrin; Jaque, Jenny M.; Quarcoo, David; Bohlmann, Michael K.; Klingelhoefer, Doris; Groneberg, David A.			Global cervical cancer research: A scientometric density equalizing mapping and socioeconomic analysis	PLOS ONE			English	Article							MORTALITY; SCIENCE	Cervical cancer has caused substantial morbidity and mortality for millions of women over the past decades. While enormous progress has been made in diagnosis, prevention and therapy, the disease is still fatal for many women-especially in low-income countries. Since no detailed studies are available on the worldwide research landscape, we here investigated the global scientific output related to this cancer type by an established protocol. The "New Quality and Quantity Indices in Science" platform assessed all relevant cervical cancer research published in the Web of Science since 1900. A detailed analysis was conducted including country-specific research productivity, indicators for scientific quality, and relation of research activity to socioeconomic and epidemiologic figures. Visualization of data was generated by the use of density equalizing map projections. Our approach identified 22,185 articles specifically related to cervical cancer. From a global viewpoint, the United States of America was the dominating country in absolute numbers, being followed by China and Japan. By contrast, the European countries Sweden, Austria, and Norway were positioned first when the research activity was related to the population number. When the scientific productivity was related to annual cervical cancer cases, Scandinavian countries (Finland #1, Sweden #4, Norway #5, Denmark #7), the Alpine countries Austria (#2) and Switzerland (#6), and the Netherlands (#3) were leading the field. Density equalizing mapping visualized that large parts of Africa and South America were almost invisible regarding the global participation in cervical cancer research. Our data documented that worldwide cervical cancer research activity is continuously increasing but is imbalanced from a global viewpoint. Also, the study indicated that global and public health aspects should be strengthened in cervical carcinoma research in order to empower more countries to take part in international research activities.	[Brueggmann, Doerthe; Quinkert-Schmolke, Kathrin; Quarcoo, David; Klingelhoefer, Doris; Groneberg, David A.] Goethe Univ, Dept Obstet & Gynecol, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany; [Brueggmann, Doerthe; Quinkert-Schmolke, Kathrin; Quarcoo, David; Klingelhoefer, Doris; Groneberg, David A.] Goethe Univ, Div Female Hlth & Prevent Med, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany; [Jaque, Jenny M.] Keck Sch Med USC, Dept Obstet & Gynecol, Los Angeles, CA USA; [Bohlmann, Michael K.] St Elizabeth Hosp, Dept Obstet & Gynecol, Lorrach, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Bruggmann, D (corresponding author), Goethe Univ, Dept Obstet & Gynecol, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany.; Bruggmann, D (corresponding author), Goethe Univ, Div Female Hlth & Prevent Med, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany.	prevention@uni-frankfurt.de	Klingelhoefer, Doris/AFF-8213-2022	Bruggmann, Dorthe/0000-0002-4799-3391				Bhatla N, 2018, INT J GYNECOL OBSTET, V143, P22, DOI 10.1002/ijgo.12611; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruggmann D, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02554-y; Bruggmann D, 2018, REPROD BIOMED ONLINE, V36, P227, DOI 10.1016/j.rbmo.2017.10.112; Bruggmann D, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-016-0076-2; Bruggmann D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1263-x; Bruggmann Dorthe, 2018, Oncotarget, V9, P21965, DOI 10.18632/oncotarget.25136; Canfell K, 2020, LANCET, V395, P591, DOI 10.1016/S0140-6736(20)30157-4; Carter AJR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-526; Clarivate, 2021, WEB SCI CORE COLLECT; Cohen PA, 2019, LANCET, V393, P169, DOI 10.1016/S0140-6736(18)32470-X; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; FINK DJ, 1988, CA-CANCER J CLIN, V38, P127, DOI 10.3322/canjclin.38.2.127; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Glynn RW, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2795; Groneberg DA, 2019, SCIENTOMETRICS, V121, P451, DOI 10.1007/s11192-019-03188-8; Groneberg-Kloft Beatrix, 2009, J Occup Med Toxicol, V4, P16, DOI 10.1186/1745-6673-4-16; Groneberg-Kloft B, 2009, EMBO REP, V10, DOI 10.1038/embor.2009.162; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; IARC, 2019, GLOBOCAN 2018; Nie XF, 2019, J OBSTET GYNAECOL RE, V45, P695, DOI 10.1111/jog.13849; Reid BM, 2017, CANCER BIOL MED, V14, P9, DOI 10.20892/j.issn.2095-3941.2016.0084; Samimi AJ., 2011, J ED VOCATIONAL RES, V2, P38, DOI [10.22610/jevr.v2i2.23, DOI 10.22610/JEVR.V2I2.23]; Saraiya M, 2013, PREV MED, V57, P426, DOI 10.1016/j.ypmed.2013.01.020; Small W, 2017, CANCER-AM CANCER SOC, V123, P2404, DOI 10.1002/cncr.30667; Taylor R, 2006, CANCER CAUSE CONTROL, V17, P299, DOI 10.1007/s10552-005-0515-z; UNESCO, 2021, SCI TECHNOLOGY INNOV; Vaccarella S, 2017, INT J CANCER, V141, P1997, DOI 10.1002/ijc.30901; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WHO, 2021, CERV CANC; World Health Organization, 2018, WHO DIR GEN CALLS AL; Xin SJ, 2014, INT J DERMATOL, V53, pE438, DOI 10.1111/ijd.12272; zur Hausen H, 1975, Bibl Haematol, P569; 2013, WORLD EC OUTLOOK DAT	35	3	3	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261503	10.1371/journal.pone.0261503	http://dx.doi.org/10.1371/journal.pone.0261503			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990465	gold, Green Published			2022-12-27	WOS:000815783800007
J	Radford-Smith, DE; Patel, PJ; Irvine, KM; Russell, A; Siskind, D; Anthony, DC; Powell, EE; Probert, F				Radford-Smith, Daniel E.; Patel, Preya J.; Irvine, Katharine M.; Russell, Anthony; Siskind, Dan; Anthony, Daniel C.; Powell, Elizabeth E.; Probert, Fay			Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism	PLOS ONE			English	Article							CLINICAL-PRACTICE; ASSOCIATIONS; SEVERITY; GLYCA	Non-alcoholic fatty liver disease (NAFLD) and depression are common disorders and have bidirectional contributing relationships to metabolic syndrome. We aimed to determine whether a fasting serum signature of recent, self-reported depressive symptoms could be identified in a heterogeneous NAFLD cohort using nuclear magnetic resonance (NMR)-based metabolomics integrated with clinical chemistry. Serum nuclear magnetic resonance (NMR) metabolite profiles and corresponding clinical chemistry were compared between patients with depressive symptoms in the last 12-months (n = 81) and patients without recent depressive symptoms (n = 137 controls) using multivariate statistics. Orthogonal partial least squares discriminant analysis (OPLS-DA) of the biochemical and metabolomic data identified NAFLD patients with recent depression with a cross-validated accuracy of 61.5%, independent of age, sex, medication, and other comorbidities. This led to the development of a diagnostic algorithm with AUC 0.83 for future testing in larger clinical cohorts. Serum triglycerides, VLDL cholesterol, and the inflammatory biomarker GlycA were key metabolites increased in patients with recent depressive symptoms, while serum glutamine level was reduced. Here, serum NMR metabolite analysis provides a link between disturbed lipid metabolism, inflammation, and active mental health issues in NAFLD, irrespective of disease severity.	[Radford-Smith, Daniel E.; Anthony, Daniel C.] Univ Oxford, Dept Pharmacol, Oxford, England; [Radford-Smith, Daniel E.; Probert, Fay] Univ Oxford, Dept Chem, Oxford, England; [Radford-Smith, Daniel E.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Patel, Preya J.] UCL, Inst Liver & Digest Hlth, London, England; [Patel, Preya J.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Liver Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Irvine, Katharine M.; Powell, Elizabeth E.] Univ Queensland, Ctr Liver Dis Res, Brisbane, Qld, Australia; [Irvine, Katharine M.] Univ Queensland, Mater Res, Brisbane, Qld, Australia; [Russell, Anthony] Princess Alexandra Hosp, Dept Diabet & Endocrinol, Brisbane, Qld, Australia; [Russell, Anthony] Univ Queensland, Ctr Hlth Serv Res, Brisbane, Qld, Australia; [Siskind, Dan] Univ Queensland, Sch Clin Med, Woolloongabba, Qld, Australia; [Siskind, Dan] Metro South Addict & Mental Hlth Serv, Woolloongabba, Qld, Australia; [Powell, Elizabeth E.] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia	University of Oxford; University of Oxford; University of Oxford; University of London; University College London; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Queensland; Mater Research; University of Queensland; University of Queensland; University of Queensland	Radford-Smith, DE (corresponding author), Univ Oxford, Dept Pharmacol, Oxford, England.; Radford-Smith, DE (corresponding author), Univ Oxford, Dept Chem, Oxford, England.; Radford-Smith, DE (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England.	daniel.radford-smith@pharm.ox.ac.uk	Anthony, Daniel/F-7765-2010; Russell, Anthony/A-8807-2011; Siskind, Dan/A-9812-2014	Anthony, Daniel/0000-0003-1380-6655; Russell, Anthony/0000-0001-7886-8844; Probert, Fay/0000-0002-8580-2023; Siskind, Dan/0000-0002-2072-9216	Lincoln College, University of Oxford; Oxford University Press Clarendon Scholarship; Newton Abraham Studentship, University of Oxford	Lincoln College, University of Oxford; Oxford University Press Clarendon Scholarship; Newton Abraham Studentship, University of Oxford	Lincoln College, University of Oxford (Daniel Radford-Smith): General financial support for DPhil (bursary and laboratory bench fees). Oxford University Press Clarendon Scholarship (Daniel Radford-Smith): General financial support for DPhil (bursary and laboratory bench fees). Newton Abraham Studentship, University of Oxford (Daniel Radford-Smith): General financial support for DPhil (bursary and laboratory bench fees). No other funds contributed to this study. All other authors do not declare any funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bot M, 2020, BIOL PSYCHIAT, V87, P409, DOI 10.1016/j.biopsych.2019.08.016; Brunoni AR, 2020, J AFFECT DISORDERS, V271, P39, DOI 10.1016/j.jad.2020.03.074; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Dekker RL, 2011, J CARD FAIL, V17, P755, DOI 10.1016/j.cardfail.2011.04.016; Hashimoto K, 2016, ACTA NEUROPSYCHIATR, V28, P173, DOI 10.1017/neu.2015.59; Huckvale S, 2021, J CLIN PSYCHIAT, V82, DOI 10.4088/JCP.20m13245; Jia HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23441; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kim D, 2019, ALIMENT PHARM THER, V50, P590, DOI 10.1111/apt.15395; Labenz C, 2020, HEPATOL COMMUN, V4, P1293, DOI 10.1002/hep4.1541; Liu YZ, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-106; Malhi GS, 2018, LANCET, V392, P2299, DOI 10.1016/S0140-6736(18)31948-2; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Mazidi M, 2021, AM J CLIN NUTR, V114, P1028, DOI 10.1093/ajcn/nqab132; Meessen ECE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11123000; Milaneschi Y, 2019, MOL PSYCHIATR, V24, P18, DOI 10.1038/s41380-018-0017-5; Otvos JD, 2015, CLIN CHEM, V61, P714, DOI 10.1373/clinchem.2014.232918; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Patel FJ, 2018, HEPATOL COMMUN, V2, P897, DOI 10.1002/hep4.1208; Penninx BWJH, 2018, DIALOGUES CLIN NEURO, V20, P63; Probert F, 2021, BRAIN COMMUN, V3, DOI 10.1093/braincomms/fcab084; Probert F, 2018, J CROHNS COLITIS, V12, P1326, DOI 10.1093/ecco-jcc/jjy101; Pu JC, 2021, MOL PSYCHIATR, V26, P4265, DOI 10.1038/s41380-020-0645-4; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Simon GE, 2010, GEN HOSP PSYCHIAT, V32, P583, DOI 10.1016/j.genhosppsych.2010.09.010; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; Tomeno W, 2015, J GASTROEN HEPATOL, V30, P1009, DOI 10.1111/jgh.12897; Wang L, 2007, FASEB J, V21, P1227, DOI 10.1096/fj.06-7495com; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Youssef NA, 2013, LIVER INT, V33, P1062, DOI 10.1111/liv.12165; Zimmerman M, 2006, J CLIN PSYCHIAT, V67, P1536, DOI 10.4088/JCP.v67n1007	31	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261555	10.1371/journal.pone.0261555	http://dx.doi.org/10.1371/journal.pone.0261555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990473	gold, Green Published			2022-12-27	WOS:000815783800010
J	Lia, M; Horn, LC; Sodeikat, P; Hockel, M; Aktas, B; Wolf, B				Lia, Massimiliano; Horn, Lars-Christian; Sodeikat, Paulina; Hoeckel, Michael; Aktas, Bahriye; Wolf, Benjamin			The diagnostic value of core needle biopsy in cervical cancer: A retrospective analysis	PLOS ONE			English	Article							RADICAL HYSTERECTOMY SPECIMENS; PARAMETRIAL INVOLVEMENT; STAGE-IB; CARCINOMA; IDENTIFICATION; MANAGEMENT; RESECTION; INVASION; FEATURES	Cervical carcinoma is a major cause of morbidity and mortality among women worldwide. Histological subtype, lymphovascular space invasion and tumor grade could have a prognostic and predictive value for patients' outcome and the knowledge of these histologic characteristics may influence clinical decision making. However, studies evaluating the diagnostic value of various biopsy techniques regarding these parameters of cervical cancer are scarce. We reviewed 318 cases of cervical carcinoma with available pathology reports from preoperative core needle biopsy (CNB) assessment and from final postoperative evaluation of the hysterectomy specimen. Setting the postoperative comprehensive pathological evaluation as reference, we analysed CNB assessment of histological tumor characteristics. In addition, we performed multivariable logistic regression to identify factors influencing the accuracy in identifying LVSI and tumor grade. CNB was highly accurate in discriminating histological subtype. Sensitivity and specificity were 98.8% and 89% for squamous cell carcinoma, 92.9% and 96.6% for adenocarcinoma, 33.3% and 100% in adenosquamous carcinoma respectively. Neuroendocrine carcinoma was always recognized correctly. The accuracy of the prediction of LVSI was 61.9% and was positively influenced by tumor size in preoperative magnetic resonance imaging and negatively influenced by strong peritumoral inflammation. High tumor grade (G3) was diagnosed accurately in 73.9% of cases and was influenced by histological tumor type. In conclusion, CNB is an accurate sampling technique for histological classification of cervical cancer and represents a reasonable alternative to other biopsy techniques.	[Lia, Massimiliano; Sodeikat, Paulina; Hoeckel, Michael; Aktas, Bahriye; Wolf, Benjamin] Univ Hosp Leipzig, Dept Gynecol & Obstet, Leipzig, Germany; [Horn, Lars-Christian] Univ Hosp Leipzig, Div Gynecol Breast & Perinatal Pathol, Leipzig, Germany	Leipzig University; Leipzig University	Lia, M (corresponding author), Univ Hosp Leipzig, Dept Gynecol & Obstet, Leipzig, Germany.	massimiliano.lia@medizin.uni-leipzig.de		Aktas, Bahriye/0000-0002-5474-051X				AGO, 2014, INT GERM GUIDL DIAGN; Andrade Juliano Ribeiro de, 2018, J. bras. pneumol., V44, P307, DOI [10.1590/s1806-37562017000000259, 10.1590/S1806-37562017000000259]; Bai HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep25992; Bidus MA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.02.017; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cibula D, 2018, INT J GYNECOL CANCER, V28, P641, DOI 10.1097/IGC.0000000000001216; Covens A, 2002, GYNECOL ONCOL, V84, P145, DOI 10.1006/gyno.2001.6493; Creasman WT, 2004, GYNECOL ONCOL, V92, P525, DOI 10.1016/j.ygyno.2003.11.020; DELGADO G, 1989, GYNECOL ONCOL, V35, P314, DOI 10.1016/0090-8258(89)90070-X; Eggen T, 2007, INT J GYNECOL PATHOL, V26, P447, DOI 10.1097/pgp.0b013e3180341111; Fischerova D, 2008, INT J GYNECOL CANCER, V18, P833, DOI 10.1111/j.1525-1438.2007.01015.x; Frumovitz M, 2009, OBSTET GYNECOL, V114, P93, DOI 10.1097/AOG.0b013e3181ab474d; Haesen J, 2021, GYNECOL ONCOL, V162, P539, DOI 10.1016/j.ygyno.2021.06.026; Hockel M, 2019, LANCET ONCOL, V20, P1316, DOI 10.1016/S1470-2045(19)30389-4; Hockel M, 2017, EUR J CANCER, V70, P99, DOI 10.1016/j.ejca.2016.10.016; Hockel M, 2014, LANCET ONCOL, V15, P445, DOI 10.1016/S1470-2045(14)70060-9; Hockel M, 2009, LANCET ONCOL, V10, P683, DOI 10.1016/S1470-2045(09)70100-7; Horn LC, 2019, J CANCER RES CLIN, V145, P457, DOI 10.1007/s00432-018-2793-3; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Hutchcraft ML, 2019, GYNECOL ONCOL, V153, P255, DOI 10.1016/j.ygyno.2019.01.026; Kim MK, 2012, INT J GYNECOL CANCER, V22, P1214, DOI 10.1097/IGC.0b013e31825fb63b; KINNEY WK, 1995, GYNECOL ONCOL, V57, P3, DOI 10.1006/gyno.1995.1091; Knuttel FM, 2016, BRIT J SURG, V103, P644, DOI 10.1002/bjs.10128; Koh WJ, 2019, J NATL COMPR CANC NE, V17, P64, DOI 10.6004/jnccn.2019.0001; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mascilini F, 2020, INT J GYNECOL CANCER, V30, P128, DOI 10.1136/ijgc-2019-000734; McCluggage WG, 2018, INT J GYNECOL PATHOL, V37, P205, DOI 10.1097/PGP.0000000000000412; Paja M, 2019, EUR RADIOL, V29, P4889, DOI 10.1007/s00330-019-06038-6; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Ronsini C, 2021, GYNECOL ONCOL, V162, P299, DOI 10.1016/j.ygyno.2021.06.002; Sartori E, 2007, GYNECOL ONCOL, V107, pS170, DOI 10.1016/j.ygyno.2007.07.026; Sedlis A, 1999, GYNECOL ONCOL, V73, P177, DOI 10.1006/gyno.1999.5387; Silva AL, 2005, GYNECOL OBSTET INVES, V59, P92, DOI 10.1159/000082522; Stoler M., 2014, WHO CLASSIFICATION T, V4th, P172; Tottrup M, 2020, J CLIN ULTRASOUND, V48, P134, DOI 10.1002/jcu.22769; Wagner AE, 2013, GYNECOL ONCOL, V129, P517, DOI 10.1016/j.ygyno.2013.03.008; Wenzel HHB, 2020, GYNECOL ONCOL, V158, P282, DOI 10.1016/j.ygyno.2020.04.705; Widschwendter P, 2019, ARCH GYNECOL OBSTET, V300, P1709, DOI 10.1007/s00404-019-05341-3; Wolf B, 2017, GYNECOL ONCOL, V146, P292, DOI 10.1016/j.ygyno.2017.05.007	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262257	10.1371/journal.pone.0262257	http://dx.doi.org/10.1371/journal.pone.0262257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986187	Green Published, gold, Green Submitted			2022-12-27	WOS:000765956200031
J	Park, SY; Kaneshiro, B				Park, So Yeon; Kaneshiro, Blair			User perspectives on critical factors for collaborative playlists	PLOS ONE			English	Article								Today, collaborative playlists (CPs) translate long-standing social practices around music consumption to enable people to curate and listen to music together over streaming platforms. Yet despite the critical role of CPs in digitally connecting people through music, we still understand very little about the needs and desires of real-world users, and how CPs might be designed to best serve them. To bridge this gap in knowledge, we conducted a survey with CP users, collecting open-ended text responses on what aspects of CPs they consider most important and useful, and what they viewed as missing or desired. Using thematic analysis, we derived from these responses the Codebook of Critical CP Factors, which comprises eight categories. We gained insights into which aspects of CPs are particularly useful-for instance, the ability for multiple collaborators to edit a single playlist-and which are absent and desired-such as the ability for collaborators to communicate about a CP or the music contained therein. From these findings we propose design implications to inform further design of CP functionalities and platforms, and highlight potential benefits and challenges related to their adoption in current music services.	[Park, So Yeon] Stanford Univ, Ctr Design Res, Stanford, CA 94305 USA; [Park, So Yeon; Kaneshiro, Blair] Stanford Univ, Ctr Comp Res Music & Acoust, Stanford, CA 94305 USA	Stanford University; Stanford University	Park, SY (corresponding author), Stanford Univ, Ctr Design Res, Stanford, CA 94305 USA.; Park, SY (corresponding author), Stanford Univ, Ctr Comp Res Music & Acoust, Stanford, CA 94305 USA.	syjpark@stanford.edu		Kaneshiro, Blair/0000-0003-0364-6985; Park, So Yeon/0000-0002-2508-6942				Amazon, WATCH PARTY; Anbuhl C., 2018, THESIS MALMO U; Anderson A, 2020, WEB CONFERENCE 2020: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2020), P2155, DOI 10.1145/3366423.3380281; Anthony D, 2009, RATION SOC, V21, P283, DOI 10.1177/1043463109336804; Baecker RM, 1995, READINGS HUMAN COMPU, P775; Bassoli A, 2006, COMP SUPP COMP W SER, V35, P151, DOI 10.1007/1-4020-4097-0_8; Bauer C, 2020, CHI'20: EXTENDED ABSTRACTS OF THE 2020 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, DOI 10.1145/3334480.3382942; Baym N.K., 2012, J AUDIENCE RECEPTION, V9, P286; Beierle F, 2016, 2016 IEEE INT C COMM, P1; Birnholtz Jeremy, 2012, P ACM 2012 C COMPUTE, P809, DOI [10.1145/2145204.2145325, DOI 10.1145/2145204.2145325]; Bradley R, 2015, VA QUART REV, V91, P156; Brown B, 2001, ECSCW 2001: PROCEEDINGS OF THE SEVENTH EUROPEAN CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P179; Brown B, 2006, COMP SUPP COMP W SER, V35, P37, DOI 10.1007/1-4020-4097-0_3; Bryman A., 2016, SOCIAL RES METHODS; Chang W, 2019, KRIT KULT, P260; Chao DL, 2005, P 2005 INT ACM SIGGR, P120, DOI 10.1145/1099203.1099224; Constine J., 2020, TECHCRUNCH; Crossen A., 2002, IUI 02. 2002 International Conference on Intelligent User Interfaces, P184; Cunningham Sally Jo, 2019, Information in Contemporary Society. 14th International Conference, iConference 2019. Proceedings: Lecture Notes in Computer Science (LNCS 11420), P526, DOI 10.1007/978-3-030-15742-5_50; Cunningham SJ, 2003, ACM-IEEE J CONF DIG, P5; Cunningham SJ, 2009, P 10 INT SOC MUSIC I, P747; Cunningham SJ, 2006, P 7 INT C MUSIC INFO, P240; Cunningham SJ, 2017, DIGITAL LIB DATA INF, P295; Cunningham SJ, 2014, P 15 INT SOC MUSIC I, P457; Deezer, 2021, MAKE PLAYLISTS EDIT; Dewan S, 2014, MIS QUART, V38, P101, DOI 10.25300/MISQ/2014/38.1.05; Dumford A., 2014, SURVEY PRACTICE, V7, P1, DOI [DOI 10.29115/SP-2014-0024, 10.29115/SP-2014-0024]; Erickson T., 2000, ACM Transactions on Computer-Human Interaction, V7, P59, DOI 10.1145/344949.345004; Ferwerda Bruce, 2017, 1 WORKSHOP TEMPORAL; Frank J, 2009, DNA DIGITAL REVOLUTI; Gebel M., 2019, BUSINESS INSIDER; Gilmour K, 2011, SPOTIFY DUMMIES; Gutwin C., 1998, CHI 98. Human Factors in Computing Systems. CHI 98 Conference Proceedings, P511, DOI 10.1145/274644.274713; Gutwin C, 1996, C COMPANION HUMAN FA, P208; Hagen AN, 2015, POP MUSIC SOC, V38, P625, DOI 10.1080/03007766.2015.1021174; Hakansson M, 2007, 2007 40 ANN HAWAII I, P87; Halfaker A, 2009, P 5 INT S WIKIS OPEN, P1; Hosey C, 2019, CHI 2019: PROCEEDINGS OF THE 2019 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, DOI 10.1145/3290605.3300529; Hubbles C, 2017, P ASS INFORM SCI TEC, V54, P179; Jackson KM, 2002, ORGAN RES METHODS, V5, P307, DOI 10.1177/109442802237114; Jannach D, 2016, P 2016 C US MOD AD P, P281, DOI [10.1145/2930238.2930283, DOI 10.1145/2930238.2930283]; jpfdeuce, 2019, REDDIT; Kane D, 2020, ALLIANCE REV; KARAU SJ, 1993, J PERS SOC PSYCHOL, V65, P681, DOI 10.1037/0022-3514.65.4.681; Kirk DS, 2016, DIS 2016: PROCEEDINGS OF THE 2016 ACM CONFERENCE ON DESIGNING INTERACTIVE SYSTEMS, P50, DOI 10.1145/2901790.2901874; Kittur A, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P453; Kittur A, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P37; Kou Y., 2014, P 1 ACM SIGCHI ANN S, P161; Krause AE, 2018, PSYCHOL AESTHET CREA, V12, P89, DOI 10.1037/aca0000104; Kraut R., 1992, Human-Computer Interaction, V7, P375, DOI 10.1207/s15327051hci0704_2; Kraut RE, 2011, BUILDING SUCCESSFUL ONLINE COMMUNITIES: EVIDENCE-BASED SOCIAL DESIGN, P1; LaDonna KA, 2018, ACAD MED, V93, P347, DOI [10.1097/ACM.0000000000002046, 10.1097/ACM.0000000000002088]; Laplante A, 2011, LIBR INFORM SCI RES, V33, P202, DOI 10.1016/j.lisr.2010.11.002; LATANE B, 1979, J PERS SOC PSYCHOL, V37, P822, DOI 10.1037//0022-3514.37.6.822; Lazarsfeld PF, 1944, PUBLIC OPIN QUART, V8, P38, DOI 10.1086/265666; Lee Jin H., 2015, P 16 INT SOC MUSIC I, P476; Lee JH, 2013, J INTELL INF SYST, V41, P499, DOI 10.1007/s10844-013-0259-2; Lee W., 2020, ROCK MUSIC STUDIES, V8, P36, DOI [10.1080/19401159.2020.1852772, DOI 10.1080/19401159.2020.1852772]; Lehtiniemi Arto, 2013, 2013 17th International Conference on Information Visualisation, P86, DOI 10.1109/IV.2013.10; Lehtiniemi A, 2017, INTERACT COMPUT, V29, P416; Leong T.W., 2013, P SIGCHI C HUM FACT, P951, DOI [10.1145/2470654.2466122, DOI 10.1145/2470654.2466122]; Liu KT, 2008, P 10 INT C HUMAN COM, P403, DOI [10.1145/1409240.1409299, DOI 10.1145/1409240.1409299]; McCarthy J. F., 1998, ACM 1998 Conference on Computer Supported Cooperative Work. Proceedings. CSCW 98, P363, DOI 10.1145/289444.289511; Mihaly J., 2020, BUZZFEED; Millecamp M, 2018, PROCEEDINGS OF THE 26TH CONFERENCE ON USER MODELING, ADAPTATION AND PERSONALIZATION (UMAP'18), P101, DOI 10.1145/3209219.3209223; Morris J.W., 2015, CREATIVE IND J, V8, P106, DOI [DOI 10.1080/17510694.2015.1090222, 10.1080/17510694.2015.1090222]; Murphy M, 2020, SHARE DOCUMENTS GOOG; Neuwirth CM, 2001, COMP COGNIT WORK, P535; O stergren M., 2004, INT WORKSHOP MOBILE; O'Hara K., 2004, P 5 C DES INT SYST P, P145, DOI DOI 10.1145/1013115.1013136; OKane Caitlin, 2020, CBS NEWS; Olsson T, 2009, P 4 INT C COMMUNITIE, P21; Olsson T, 2009, LECT NOTES COMPUT SC, V5621, P246, DOI 10.1007/978-3-642-02774-1_27; Park SY, 2021, CHI '21: PROCEEDINGS OF THE 2021 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, DOI 10.1145/3411764.3445353; Park So Yeon, DECODING NONVERBAL O, V2021, P61; Park SY, 2017, EXTENDED ABSTRACTS L; Park SY, 2019, P 20 INT SOC MUS INF, P723; Park SY, 2021, P 2021 ACM C COMP SU, V5; Perez S., 2020, TECHCRUNCH; Perron BE, 2011, RES SOCIAL WORK PRAC, V21, P489, DOI 10.1177/1049731510391676; Pietsch A.S., 2018, J BUSINESS ANAL, V1, P93, DOI [10.1080/2573234X.2019.1590131, DOI 10.1080/2573234X.2019.1590131]; Politico, 2020, POLITICO MAGAZINE; Posner I.R., 1992, P 25 HAWAII INT C SY, P127; Rafaeli S., 2004, Proceedings of the 37th Annual Hawaii International Conference on System Sciences; Rafaeli S, 2008, PSYCHOLOGICAL ASPECTS OF CYBERSPACE: THEORY, RESEARCH, APPLICATIONS, P243; Randles C, 2020, DAYTONA BEACH NEWS J; Rogers-Dillon RH, 2005, QUAL RES, V5, P437, DOI [10.1177/1468794105056922, DOI 10.1177/1468794105056922]; Roose K., 2020, NEW YORK TIMES; sammcc03, 2018, MY PLAYLIST IS TOO L; Santero N., 2016, THESIS U NEVADA LAS; Saucken C, 2014, KEER2014 P 5 KANESI, P1331; Schedl M, 2018, INT J MULTIMED INF R, V7, P95, DOI 10.1007/s13735-018-0154-2; Schiele K, 2013, ACR EUROPEAN ADV; Spinelli L, 2018, P 19 INT SOC MUSIC I; Spotify, WORKING PLAYLISTS; Spotify, 2020, MAKE COLLABORATIVE P; Tam J, 2006, INT J HUM-COMPUT ST, V64, P583, DOI 10.1016/j.ijhcs.2006.02.004; Teague K., 2021, CNET; Thom-Santelli J, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1481; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; VanDerHuck F, 2020, EXPLORACIONES, P1, DOI [10.18046/EUI/expl.13.2020, 10.1007/s11092-020-09331-x]; Voida A, 2005, P SIGCHI C HUMAN FAC, P191; Weng C., 2004, Computer Supported Cooperative Work Conference Proceedings, P578, DOI 10.1145/1031607.1031705; Willemsen M. C., 2010, P 4 ACM C REC SYST, P63; WILLIAMS KD, 1991, J PERS SOC PSYCHOL, V61, P570, DOI 10.1037/0022-3514.61.4.570; Zull C., 2016, OPEN ENDED QUESTIONS	106	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0260750	10.1371/journal.pone.0260750	http://dx.doi.org/10.1371/journal.pone.0260750			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZO8DB	34986153	gold, Green Published, Green Submitted			2022-12-27	WOS:000765956200006
J	Matsushima-Nishiwaki, R; Yamada, N; Hattori, Y; Hosokawa, Y; Tachi, J; Hori, T; Kozawa, O				Matsushima-Nishiwaki, Rie; Yamada, Noriko; Hattori, Yuria; Hosokawa, Yui; Tachi, Junko; Hori, Takamitsu; Kozawa, Osamu			SERMs (selective estrogen receptor modulator), acting as estrogen receptor beta agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-alpha-induced migration via specific inhibition of AKT signaling pathway	PLOS ONE			English	Article							LIGANDS; CANCER; DISCOVERY; WOMEN; RISK	Selective estrogen receptor modulator (SERM) interacts with estrogen receptors and acts as both an agonist or an antagonist, depending on the target tissue. SERM is widely used as a safer hormone replacement therapeutic medicine for postmenopausal osteoporosis. Regarding hepatocellular carcinoma (HCC), accumulating evidence indicates gender differences in the development, and that men are at higher morbidity risk than premenopausal women, suggesting that estrogen protects against HCC. However, it remains unclear whether SERM affects the HCC progression. Previously, we have shown that transforming growth factor (TGF)-alpha promotes the migration of HCC cells via p38 mitogen-activated protein kinases (MAPK), c-Jun N-terminal kinase and AKT. In the present study, we investigated whether SERM such as tamoxifen, raloxifene and bazedoxifene, affects the HCC cell migration using human HCC-derived HuH7 cells. Raloxifene and bazedoxifene but not tamoxifen, significantly suppressed the TGF-alpha-induced HuH7 cell migration. ERB041 and DPN, estrogen receptor (ER) beta agonists, inhibited the TGF-alpha-induced cell migration whereas PPT, an ER alpha agonist, did not show the suppressive effect on the cell migration. ERB041 attenuated the TGF-alpha-induced phosphorylation of AKT without affecting the phosphorylation of p38 MAPK and c-Jun N-terminal kinase. Raloxifene and bazedoxifene also inhibited the phosphorylation of AKT by TGF-alpha. Furthermore, PHTPP, an ER beta antagonist, significantly reversed the suppression by both raloxifene and bazedoxifene of the TGF-alpha-induced cell migration. Taken together, our results strongly indicate that raloxifene and bazedoxifene, SERMs, suppress the TGF-alpha-induced migration of HCC cells through ER beta-mediated inhibition of the AKT signaling pathway.	[Matsushima-Nishiwaki, Rie; Yamada, Noriko; Hattori, Yuria; Hosokawa, Yui; Tachi, Junko; Hori, Takamitsu; Kozawa, Osamu] Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan	Gifu University	Kozawa, O (corresponding author), Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan.	okkasugai@yahoo.co.jp			Japan Society for the Promotion of Science KAKENHI [JP20K08283, JP25460989]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI (https://www.jsps.go.jp/) [grant numbers; JP20K08283 to RM-N and JP25460989 to OK] form the Ministry of Education, Culture, Sports, Science and Technology of Japan The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An KC, 2016, ASIAN SPINE J, V10, P787, DOI 10.4184/asj.2016.10.4.787; Badawy AAG, 2015, APMIS, V123, P823, DOI 10.1111/apm.12431; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Cocciadiferro L, 2017, J STEROID BIOCHEM, V172, P222, DOI 10.1016/j.jsbmb.2016.05.023; Compton DR, 2004, J MED CHEM, V47, P5872, DOI 10.1021/jm049631k; Di Maio M, 2006, ANN NY ACAD SCI, V1089, P252, DOI 10.1196/annals.1386.007; Dick LR, 1996, J BIOL CHEM, V271, P7273, DOI 10.1074/jbc.271.13.7273; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Ge Y, 2020, CANCER LETT, V477, P41, DOI 10.1016/j.canlet.2020.02.003; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Hassan MM, 2017, CLIN GASTROENTEROL H, V15, P1791, DOI 10.1016/j.cgh.2017.05.036; Hernandez-Silva CD, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00544; Huang PX, 2014, J CELL MOL MED, V18, P218, DOI 10.1111/jcmm.12153; JASKIEWICZ K, 1995, ANTICANCER RES, V15, P559; Kur P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082620; Ladenheim MR, 2016, BMJ OPEN GASTROENTER, V3, DOI 10.1136/bmjgast-2016-000107; Lee TK, 2005, CARCINOGENESIS, V26, P681, DOI 10.1093/carcin/bgi002; Liu PA, 2017, ONCOTARGET, V8, P68131, DOI 10.18632/oncotarget.19245; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Long DL, 2013, ARTHRITIS RHEUM-US, V65, P1561, DOI 10.1002/art.37922; Ma HY, 2019, CANCER SCI, V110, P950, DOI 10.1111/cas.13940; Ma WJ, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6168-1; Maczis MA, 2018, J LIPID RES, V59, P2297, DOI 10.1194/jlr.M085191; Martinkovich S, 2014, CLIN INTERV AGING, V9, P1437, DOI 10.2147/CIA.S66690; Matsushima-Nishiwaki R, 2017, BBA-MOL BASIS DIS, V1863, P1629, DOI 10.1016/j.bbadis.2017.04.021; Matsushima-Nishiwaki R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151907; Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Pinkerton JV, 2014, J STEROID BIOCHEM, V142, P142, DOI 10.1016/j.jsbmb.2013.12.011; Ren JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153863; Shanle EK, 2010, ADV DRUG DELIVER REV, V62, P1265, DOI 10.1016/j.addr.2010.08.001; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Ulitzky L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145212; Villa E, 2002, ANN NY ACAD SCI, V963, P37; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Wu Eric M, 2018, Hepatoma Res, V4, DOI 10.20517/2394-5079.2018.87; Xu BB, 2017, J DIABETES COMPLICAT, V31, P773, DOI 10.1016/j.jdiacomp.2016.12.010; Yamada N, 2019, BIOMED REP, V11, P19, DOI 10.3892/br.2019.1215; Yang PC, 2016, WORLD J HEPATOL, V8, P1309, DOI 10.4254/wjh.v8.i31.1309; Zender L, 2010, J HEPATOL, V52, P921, DOI 10.1016/j.jhep.2009.12.034; Zhang Y, 2014, WORLD J GASTROENTERO, V20, P142, DOI 10.3748/wjg.v20.i1.142	44	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262485	10.1371/journal.pone.0262485	http://dx.doi.org/10.1371/journal.pone.0262485			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007301	Green Published, gold			2022-12-27	WOS:000741060700012
J	Mercier, MR; Galivanche, AR; Brand, JP; Pathak, N; Medvecky, MJ; Varthi, AG; Rubin, LE; Grauer, JN				Mercier, Michael R.; Galivanche, Anoop R.; Brand, Jordan P.; Pathak, Neil; Medvecky, Michael J.; Varthi, Arya G.; Rubin, Lee E.; Grauer, Jonathan N.			COVID-positive ankle fracture patients are at increased odds of perioperative surgical complications following open reduction internal fixation surgery	PLOS ONE			English	Article							DATABASE; OUTCOMES	Introduction Ankle fractures have continued to occur through the COVID pandemic and, regardless of patient COVID status, often need operative intervention for optimizing long-term outcomes. For healthcare optimization, patient counseling, and care planning, understanding if COVID-positive patients undergoing ankle fracture surgery are at increased risk for perioperative adverse outcomes is of interest. Methods The COVID-19 Research Database contains recent United States aggregated insurance claims. Patients who underwent ankle fracture surgery from April 1st, 2020 to June 15th, 2020 were identified. COVID status was identified by ICD coding. Demographics, comorbidities, and postoperative complications were extracted based on administrative data. COVID-positive versus negative patients were compared with univariate analyses. Propensity-score matching was done on the basis of age, sex, and comorbidities. Multivariate regression was then performed to identify risk factors independently associated with the occurrence of 30-day postoperative adverse events. Results In total, 9,835 patients undergoing ankle fracture surgery were identified, of which 57 (0.58%) were COVID-positive. COVID-positive ankle fracture patients demonstrated a higher prevalence of comorbidities, including: chronic kidney disease, diabetes, hypertension, and obesity (p<0.05 for each). After propensity matching and controlling for all preoperative variables, multivariate analysis found that COVID-positive patients were at increased risk of any adverse event (odds ratio [OR] = 3.89, p = 0.002), a serious adverse event (OR = 5.48, p = 0.002), and a minor adverse event (OR = 3.10, p = 0.021). Discussion COVID-positive patients will continue to present with ankle fractures requiring operative intervention. Even after propensity matching and controlling for patient factors, COVID-positive patients were found to be at increased risk of 30-day perioperative adverse events. Not only do treatment teams need to be protected from the transmission of COVID in such situations, but the increased incidence of perioperative adverse events needs to be considered.	[Mercier, Michael R.; Galivanche, Anoop R.; Brand, Jordan P.; Pathak, Neil; Medvecky, Michael J.; Varthi, Arya G.; Rubin, Lee E.; Grauer, Jonathan N.] Yale Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06510 USA	Yale University	Grauer, JN (corresponding author), Yale Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06510 USA.	jonathan.grauer@yale.edu		Grauer, Jonathan/0000-0002-2626-7278				Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Basques BA, 2015, CLIN ORTHOP RELAT R, V473, P1133, DOI 10.1007/s11999-014-4005-z; Blouhos K, 2020, FRONT SURG, V7, DOI 10.3389/fsurg.2020.00033; Campbell KH, 2020, JAMA-J AM MED ASSOC, V323, P2520, DOI 10.1001/jama.2020.8904; COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X; DALY PJ, 1987, ACTA ORTHOP SCAND, V58, P539, DOI 10.3109/17453678709146395; Eckerle I, 2020, LANCET, V396, P514, DOI 10.1016/S0140-6736(20)31482-3; Ellis RJ, 2018, SURGERY, V164, P173, DOI 10.1016/j.surg.2017.12.021; Fu MC., 2017, FOOT ANKLE ORTHOP, DOI [10.1177/2473011417695254, DOI 10.1177/2473011417695254]; Kadiakia AR., 2016, MILLERS REV ORTHOPAE, V7th, P483; Martinez DA, 2020, JAMA-J AM MED ASSOC, V324, P392, DOI 10.1001/jama.2020.11374; Mi BB, 2020, J BONE JOINT SURG AM, V102, P750, DOI 10.2106/JBJS.20.00390; Perfetti DC, 2015, J ARTHROPLASTY, V30, P547, DOI 10.1016/j.arth.2014.10.035; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Pugely AJ, 2015, J BONE JOINT SURG AM, V97A, P1799, DOI 10.2106/JBJS.O.00134; Pugely AJ, 2015, J BONE JOINT SURG AM, V97A, P1278, DOI 10.2106/JBJS.N.01260; Randhawa AK, 2020, JAMA-J AM MED ASSOC, V323, P2334, DOI 10.1001/jama.2020.8097; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rowe S., 2020, DATAVANT; Sivasundaram L, 2016, CURR ORTHOP PRACT, V27, P673, DOI 10.1097/BCO.0000000000000431; Sood N, 2020, JAMA-J AM MED ASSOC, V323, P2425, DOI 10.1001/jama.2020.8279; SooHoo NF, 2009, J BONE JOINT SURG AM, V91A, P1042, DOI 10.2106/JBJS.H.00653; Stringhini S, 2020, LANCET, V396, P313, DOI 10.1016/S0140-6736(20)31304-0; Suleyman G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12270; Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316; Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Xie JF, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5619; Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]	30	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262115	10.1371/journal.pone.0262115	http://dx.doi.org/10.1371/journal.pone.0262115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972190	Green Published, gold			2022-12-27	WOS:000773555700099
J	Youssouf, AS; Hasbullah, NF; Saidin, N; Habaebi, MH; Parthiban, R; Zin, MRB; Elsheikh, EAA; Suliman, FM				Youssouf, Abdouraouf Said; Hasbullah, Nurul Fadzlin; Saidin, Norazlina; Habaebi, Mohamed Hadi; Parthiban, Rajendran; Zin, Muhammad Rawi Bin Mohamed; Elsheikh, Elfatih A. A.; Suliman, F. M.			Induced electron radiation effect on the performance of inter-satellite optical wireless communication	PLOS ONE			English	Article							IRRADIATION; LINK; PHOTODIODES; RADIOS; DPSK	This paper provides the details of a study on the effects of electron radiation on the Performance of Inters-satellite Optical Wireless Communication (IsOWC). Academia and industry focus on solutions that can improve performance and reduce the cost of IsWOC systems. Spacecraft, space stations, satellites, and astronauts are exposed to an increased level of radiation when in space, so it is essential to evaluate the risks and performance effects associated with extended radiation exposures in missions and space travel in general. This investigation focuses on LEO, especially in the near-equatorial radiation environment. Radiation experiments supported with simulations have made it possible to obtain and evaluate the electron radiation impact on optoelectronics at the device level and system level performances. The electron radiation has induced a system degradation of 70%. This result demonstrates the importance of such an investigation to predict and take necessary and suitable reliable quality service for future space missions.	[Youssouf, Abdouraouf Said; Hasbullah, Nurul Fadzlin; Saidin, Norazlina; Habaebi, Mohamed Hadi] Int Islamic Univ Malaysia, Dept Elect & Comp Engn, Kuala Lumpur, Malaysia; [Parthiban, Rajendran] Monash Univ Malaysia, Sch Engn, Dept Elect & Comp Engn, Subang Jaya, Malaysia; [Zin, Muhammad Rawi Bin Mohamed] Nucl Malaysia, Radiat Proc Technol Div, Bangi, Malaysia; [Elsheikh, Elfatih A. A.; Suliman, F. M.] King Khalid Univ, Coll Engn, Dept Elect Engn, Abha, Saudi Arabia	International Islamic University Malaysia; Monash University; Monash University Sunway; King Khalid University	Hasbullah, NF (corresponding author), Int Islamic Univ Malaysia, Dept Elect & Comp Engn, Kuala Lumpur, Malaysia.	nfadzlinh@iium.edu.my	Salih, Dr. Fakher Eldin/AED-1124-2022; Parthiban, Rajendran/A-4999-2008	Salih, Dr. Fakher Eldin/0000-0002-9771-1559; Youssouf, Abdouraouf Said/0000-0003-4584-5042; Parthiban, Rajendran/0000-0003-0983-9796	King Khalid University [R.G.P.1/219/42]	King Khalid University	The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this work through Research Group Program under grant number: R.G.P.1/219/42. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyildiz IF, 2019, AD HOC NETW, V86, P166, DOI 10.1016/j.adhoc.2018.12.004; Alimenti F, 2020, IEEE ACCESS, V8, P106785, DOI 10.1109/ACCESS.2020.3000675; Arora H, 2017, J OPT COMMUN, V38, P63, DOI 10.1515/joc-2016-0017; Bourqui ML, 2008, MICROELECTRON RELIAB, V48, P1202, DOI 10.1016/j.microrel.2008.07.012; Boutillier M, 2007, IEEE T NUCL SCI, V54, P1110, DOI 10.1109/TNS.2007.894715; Boutillier M, 2006, MICROELECTRON RELIAB, V46, P1715, DOI 10.1016/j.microrel.2006.07.049; C. Systems, 2020, MASS DISTR ANT SYST, P2; Chaudhary S., 2017, EMPIRICAL EVALUATION, P1; Chaudhary S., 2012, HIGH SPEED INTERSATE; Chaudhary S, 2019, OPT QUANT ELECTRON, V51, DOI 10.1007/s11082-019-1864-2; El Nasr-Storey SS, 2013, IEEE T NUCL SCI, V60, P2518, DOI 10.1109/TNS.2013.2251356; Gregory M, 2012, OPT ENG, V51, DOI 10.1117/1.OE.51.3.031202; Heine F, 2010, IEEE MILIT COMMUN C, P1583, DOI 10.1109/MILCOM.2010.5680175; Hou R, 2013, LASER ENG, V25, P67; Hou R., 2012, 2012 S PHOT OPT SOPO; Johnston AH, 2003, IEEE T NUCL SCI, V50, P689, DOI 10.1109/TNS.2003.812926; Johnston AH, 2001, IEEE T NUCL SCI, V48, P1713, DOI 10.1109/23.960362; Johnston AH, 2013, IEEE T NUCL SCI, V60, P2054, DOI 10.1109/TNS.2013.2259504; Kaur P, 2015, PROCEDIA COMPUT SCI, V58, P572, DOI 10.1016/j.procs.2015.08.075; Kaur S, 2019, OPTO-ELECTRON REV, V27, P10, DOI 10.1016/j.opelre.2018.11.002; Kaushal H, 2017, IEEE COMMUN SURV TUT, V19, P57, DOI 10.1109/COMST.2016.2603518; Li YJ, 2018, OPT COMMUN, V407, P239, DOI 10.1016/j.optcom.2017.08.061; Lim HC, 2020, J ASTRON SPACE SCI, V37, P11, DOI 10.5140/JASS.2020.37.1.11; Lischka H, 1996, RADECS 95 - THIRD EUROPEAN CONFERENCE ON RADIATION AND ITS EFFECTS ON COMPONENTS AND SYSTEMS, P560, DOI 10.1109/RADECS.1995.509837; Liu Y, 2017, J LIGHTWAVE TECHNOL, V35, P3825, DOI 10.1109/JLT.2017.2717920; Liu Y, 2016, OPT COMMUN, V363, P97, DOI 10.1016/j.optcom.2015.10.064; Liu Y, 2015, OPTIK, V126, P2588, DOI 10.1016/j.ijleo.2015.06.032; Liu Y, 2015, OPT COMMUN, V350, P276, DOI 10.1016/j.optcom.2015.04.025; Nabila A, 2019, 2019 INTERNATIONAL CONFERENCE ON WIRELESS TECHNOLOGIES, EMBEDDED AND INTELLIGENT SYSTEMS (WITS); Olantera L, 2019, IEEE T NUCL SCI, V66, P1663, DOI 10.1109/TNS.2019.2902624; Pedroza G, 2009, J APPL PHYS, V105, DOI 10.1063/1.3072672; Phifer C. C., 2004, SAND20044725, P1; Popescu O, 2017, IEEE ACCESS, V5, P12618, DOI 10.1109/ACCESS.2017.2721948; Rinaldi F., 2020, NONTERRESTRIAL NETWO; Samsuzzaman M, 2018, IEEE ACCESS, V6, P54282, DOI 10.1109/ACCESS.2018.2871209; Sharma A, 2020, OPTIK INT J LIGHT EL; Sharma V, 2013, OPT COMMUN, V286, P99, DOI 10.1016/j.optcom.2012.08.055; Smutny B., 2006, COLLECTION TECHNICAL, V2, P1141; Specification T., 2019, 38811 3GPP TR; Su YT, 2019, IEEE WIREL COMMUN, V26, P55, DOI 10.1109/MWC.2019.1800299; Suparta W, 2018, J AEROSP TECHNOL MAN, V10, DOI 10.5028/jatm.v10.815; Suparta W, 2017, ASTROPHYS SPACE SCI, V362, DOI 10.1007/s10509-017-3082-3; You L, 2020, IEEE J SEL AREA COMM, V38, P1851, DOI 10.1109/JSAC.2020.3000803; Zhang S., COMPUT NETW, V174	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0259649	10.1371/journal.pone.0259649	http://dx.doi.org/10.1371/journal.pone.0259649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972119	Green Published, gold			2022-12-27	WOS:000773555700008
J	Asama, Y; Furutani, A; Fujioka, M; Ozawa, H; Takei, S; Shibata, S; Ogawa, K				Asama, Youji; Furutani, Akiko; Fujioka, Masato; Ozawa, Hiroyuki; Takei, Satoshi; Shibata, Shigenobu; Ogawa, Kaoru			Analysis of conductive olfactory dysfunction using computational fluid dynamics	PLOS ONE			English	Article							CHRONIC RHINOSINUSITIS; AIR-FLOW; CLEFT; OBSTRUCTION; SURGERY; ANATOMY	Conductive olfactory dysfunction (COD) is caused by an obstruction in the nasal cavity and is characterized by changeable olfaction. COD can occur even when the olfactory cleft is anatomically normal, and therefore, the cause in these cases remains unclear. Herein, we used computational fluid dynamics to examine olfactory cleft airflow with a retrospective cohort study utilizing the cone beam computed tomography scan data of COD patients. By measuring nasal-nasopharynx pressure at maximum flow, we established a cut-off value at which nasal breathing can be differentiated from combined mouth breathing in COD patients. We found that increased nasal resistance led to mouth breathing and that the velocity and flow rate in the olfactory cleft at maximum flow were significantly reduced in COD patients with nasal breathing only compared to healthy olfactory subjects. In addition, we performed a detailed analysis of common morphological abnormalities associated with concha bullosa. Our study provides novel insights into the causes of COD, and therefore, it has important implications for surgical planning of COD, sleep apnea research, assessment of adenoid hyperplasia in children, and sports respiratory physiology.	[Asama, Youji; Furutani, Akiko] Asama ENT Clin, Asama Inst, Koga, Ibaraki, Japan; [Asama, Youji; Fujioka, Masato; Ozawa, Hiroyuki; Ogawa, Kaoru] Keio Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Shinjuku Ku, Tokyo, Japan; [Asama, Youji; Furutani, Akiko; Shibata, Shigenobu] Waseda Univ, Res Org Nano & Life Innovat, Shinjyuku Ku, Tokyo, Japan; [Takei, Satoshi] Saitama City Hosp, Dept Otorhinolaryngol, Saitama, Japan	Keio University; Waseda University	Furutani, A (corresponding author), Asama ENT Clin, Asama Inst, Koga, Ibaraki, Japan.; Furutani, A (corresponding author), Waseda Univ, Res Org Nano & Life Innovat, Shinjyuku Ku, Tokyo, Japan.	a.furutani@kurenai.waseda.jp	OZAWA, HIROYUKI/AAG-4386-2021	OZAWA, HIROYUKI/0000-0002-0990-831X; Fujioka, Masato/0000-0002-5317-0885				Akkoca O, 2020, ENT-EAR NOSE THROAT, V99, P437, DOI 10.1177/0145561319881061; Alam S, 2019, AM J RHINOL ALLERGY, V33, P263, DOI 10.1177/1945892418816841; BOLGER WE, 1991, LARYNGOSCOPE, V101, P56; Bruning J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60755-3; Cherobin GB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207178; Cocuzza S, 2020, J BIOL REG HOMEOS AG, V34, P1203, DOI 10.23812/19-522-L-4; Damm M, 2002, CHEM SENSES, V27, P831, DOI 10.1093/chemse/27.9.831; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Frank-Ito DO, 2019, CLIN BIOMECH, V61, P172, DOI 10.1016/j.clinbiomech.2018.12.014; Gelardi M, 2020, ACTA CYTOL, V64, P397, DOI 10.1159/000508768; Iannella G, 2021, EUR ARCH OTO-RHINO-L, V278, P883, DOI 10.1007/s00405-020-06316-w; Jacobowitz O, 2019, LARYNGOSCOPE INVEST, V4, P211, DOI 10.1002/lio2.247; Kanowitz SJ, 2008, ENT-EAR NOSE THROAT, V87, P578, DOI 10.1177/014556130808701012; Kukwa Andrzej, 2014, Otolaryngol Pol, V68, P112, DOI 10.1016/j.otpol.2013.10.008; LEOPOLD DA, 1988, LARYNGOSCOPE, V98, P1232; Lintermann A, 2019, FLOW TURBUL COMBUST, V102, P89, DOI 10.1007/s10494-017-9876-0; Maniaci A, 2021, EUR ARCH OTO-RHINO-L, V278, P1743, DOI 10.1007/s00405-021-06724-6; Manmadhachary A, 2016, J MANUF PROCESS, V21, P46, DOI 10.1016/j.jmapro.2015.11.006; OGURA JH, 1966, ARCHIV OTOLARYNGOL, V83, P135; Pfaar O, 2006, CHEM SENSES, V31, P27, DOI 10.1093/chemse/bjj002; Rotter Nicole, 2016, GMS Curr Top Otorhinolaryngol Head Neck Surg, V15, pDoc06, DOI 10.3205/cto000133; Scadding Glenis, 2011, Clin Transl Allergy, V1, P2, DOI 10.1186/2045-7022-1-2; Schneider S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040925; Seiden AM, 2001, LARYNGOSCOPE, V111, P9, DOI 10.1097/00005537-200101000-00002; Seyed Toutounchi Seyed Javad, 2018, Iran J Otorhinolaryngol, V30, P33; Soler ZM, 2015, INT FORUM ALLERGY RH, V5, P846, DOI 10.1002/alr.21552; STAMMBERGER H, 1990, EUR ARCH OTO-RHINO-L, V247, P63; Suzuki M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231262; Tsega E.G., 2019, J BIOMED ENG TECHNOL, V7, P1, DOI [10.12691/jbet-7-1-1, DOI 10.12691/JBET-7-1-1]; Usui N., 1976, OTORHINOLARYNGOLOGY, P19; WARREN DW, 1988, AM J ORTHOD DENTOFAC, V93, P289, DOI 10.1016/0889-5406(88)90158-8; Zhao K, 2004, CHEM SENSES, V29, P365, DOI 10.1093/chemse/bjh033; Zhao K, 2014, INT FORUM ALLERGY RH, V4, P298, DOI 10.1002/alr.21272	33	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262579	10.1371/journal.pone.0262579	http://dx.doi.org/10.1371/journal.pone.0262579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020767	gold, Green Published			2022-12-27	WOS:000834207700053
J	Watanabe, Y; Nakagawa, T; Fukai, K; Honda, T; Furuya, H; Hayashi, T; Tatemichi, M				Watanabe, Yuya; Nakagawa, Toru; Fukai, Kota; Honda, Toru; Furuya, Hiroyuki; Hayashi, Takeshi; Tatemichi, Masayuki			Descriptive study of chest x-ray examination in mandatory annual health examinations at the workplace in Japan	PLOS ONE			English	Article							DOSE COMPUTED-TOMOGRAPHY; LUNG-CANCER MORTALITY; PULMONARY TUBERCULOSIS; CLASSIC SYMPTOMS; CT; SPECIFICITY; SENSITIVITY; VALIDITY	The utility of chest x-ray examination (CXR) in mandatory annual health examinations for occupational health is debatable in Japan. This study aimed to provide basic data to consider future policies for mandatory annual health examinations in the workplace. A nationwide descriptive survey was performed to determine the rate of detection of tuberculosis, lung cancer, and other diseases through CXR in organizations associated with National Federation of Industrial Health Association. The rate of finding on CXR conducted during annual health examinations in FY2016 was evaluated. Data regarding diagnosis based on follow-up examination findings were obtained and compared with the national statistics. In addition, CXR findings were compared with the results of low-dose lung computed tomography performed at the Hitachi Health Care Center. From 121 surveyed institutions, 88 institutions with 8,669,403 workers were included. For all ages, 1.0% of examinees required follow-up examination. Among 4,764,985 workers with diagnosis data, the tuberculosis detection rate was 1.8-5.3 per 100,000 persons. For Lung cancer, 3,688,396 workers were surveyed, and 334 positive cases were detected. The lung cancer detection rate using CXR was 9.1-24.4 per 100,000 persons. From 164 cases with information regarding the clinical stage, 72 (43.9%) had Stage I lung cancer. From 40,045 workers who underwent low-dose computed tomography multiple times, 31 lung cancer cases, all with Stage I disease, were detected (detection rate: 77.4 per 100,000 persons). Our findings suggest that CXR plays a little role in the detection of active tuberculosis. With regard to LC screening, the detection rate of LC by CXR was lower, approximately 50%, than the expected rate (41.0 per 100,000 persons) of LC morbidity based on the age-sex distribution of this study population. However, the role of CXR for LC screening cannot be mentioned based on this result, because assessment of mortality reduction is essential to evaluate the role.	[Watanabe, Yuya; Nakagawa, Toru; Honda, Toru; Hayashi, Takeshi] Hitachi Hlth Care Ctr, Ibaraki, Japan; [Fukai, Kota; Furuya, Hiroyuki; Tatemichi, Masayuki] Tokai Univ, Dept Prevent Med, Sch Med, Hiratsuka, Kanagawa, Japan	Tokai University	Tatemichi, M (corresponding author), Tokai Univ, Dept Prevent Med, Sch Med, Hiratsuka, Kanagawa, Japan.	tatemichi@tokai-u.jp			Ministry of Health, Labour, and Welfare of Japan through an Industrial Disease Clinical Research Grants [170301]	Ministry of Health, Labour, and Welfare of Japan through an Industrial Disease Clinical Research Grants	This study was supported by the Ministry of Health, Labour, and Welfare of Japan through an Industrial Disease Clinical Research Grants (grant no. 170301). The Hitachi Health Care Center employs Y.W., T.N., T.Ho., and T.Ha. for conducting medical examinations, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; [Anonymous], GUIDELINE LC SCREENI; [Anonymous], IND SAFETY HLTH ACT; BARNES PF, 1988, CHEST, V94, P316, DOI 10.1378/chest.94.2.316; Brawley OW, 2005, J CLIN ONCOL, V23, P293, DOI 10.1200/JCO.2005.06.107; Cancer Registry and Statistics. Cancer Information Service National Cancer Center Japan, MON CANC INC JAP MCI; Cohen R, 1996, CHEST, V109, P420, DOI 10.1378/chest.109.2.420; Dobler CC, 2016, CLINICOECONOMIC OUTC, V8, P335, DOI 10.2147/CEOR.S92244; Fu CP, 2016, CLIN RESPIR J, V10, P333, DOI 10.1111/crj.12222; Furin J, 2019, LANCET, V393, P1642, DOI 10.1016/S0140-6736(19)30308-3; Ghotbi Nader, 2005, Environmental Health and Preventive Medicine, V10, P213, DOI 10.1007/BF02897713; MacMahon H, 2017, RADIOLOGY, V284, P228, DOI 10.1148/radiol.2017161659; MARKEY AC, 1986, BRIT MED J, V292, P378, DOI 10.1136/bmj.292.6517.378; McAdams HP, 2006, RADIOLOGY, V241, P663, DOI 10.1148/radiol.2413051535; Ministry of Health Labor and Welfare, GUID HLTH ED FOC CAN; Ministry of Health Labor and Welfare, DOC 5 PURP US CHEST; Ministry of Health Labor and Welfare, DOC 6 NEC CHEST XRAY; National Cancer Center Japan, REC GRAD CANC SCREEN; Nawa T, 2002, CHEST, V122, P15, DOI 10.1378/chest.122.1.15; Nawa T, 2019, JPN J CLIN ONCOL, V49, P130, DOI 10.1093/jjco/hyy185; Nawa T, 2015, J THORAC IMAG, V30, P108, DOI 10.1097/RTI.0000000000000138; Nawa T, 2012, LUNG CANCER, V78, P225, DOI 10.1016/j.lungcan.2012.09.012; Nawa T, 2012, LUNG CANCER, V75, P197, DOI 10.1016/j.lungcan.2011.07.002; Oudkerk M, 2017, LANCET ONCOL, V18, pE754, DOI [10.1016/s1470-2045(17)30861-6, 10.1016/S1470-2045(17)30861-6]; Raffle AE, 2007, SCREENING EVIDENCE P; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; SOBUE T, 1991, JPN J CANCER RES, V82, P1069, DOI 10.1111/j.1349-7006.1991.tb01759.x; Tang X, 2019, REV ASSOC MED BRAS, V65, P1508, DOI 10.1590/1806-9282.65.12.1508; Tattevin P, 1999, CHEST, V115, P1248, DOI 10.1378/chest.115.5.1248; The Tuberculosis Research Institute, TUB SURV CTR; Toyoda Y, 2008, BRIT J CANCER, V98, P1602, DOI 10.1038/sj.bjc.6604351; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Weinrich JM, 2017, EUR RADIOL, V27, P3244, DOI 10.1007/s00330-016-4684-9; World Health Organization, GLOB STRAT TARG TUB	34	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262404	10.1371/journal.pone.0262404	http://dx.doi.org/10.1371/journal.pone.0262404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020766	gold, Green Published			2022-12-27	WOS:000834207700040
J	Irisarri-Gutierrez, MJ; Acosta, L; Parker, LA; Toledo, R; Bornay-Llinares, FJ; Esteban, JG; Munoz-Antoli, C				Jose Irisarri-Gutierrez, Maria; Acosta, Lucrecia; Anne Parker, Lucy; Toledo, Rafael; Jorge Bornay-Llinares, Fernando; Guillermo Esteban, Jose; Munoz-Antoli, Carla			Anemia and undernutrition in intestinally parasitized schoolchildren from Gakenke district, Northern Province of Rwanda	PLOS ONE			English	Article							HELMINTH INFECTIONS; GIARDIA-DUODENALIS; CHILDREN; SCHOOL; ASSOCIATION; GROWTH; ALBENDAZOLE; PREVALENCE; HOOKWORM; IMPACT	Background Rwanda is a sub-Saharan country, where intestinal parasite infections, anemia and undernutrition coexist. The purpose of this research is to study the relationship between intestinal parasite infections and undernutrition/anemia to clarify the priorities of intervention in the rural area of Gakenke district in the Northern Province of Rwanda. Materials and methods A total of 674 students from Nemba I School, participated in a cross-sectional study, in which their parasitological and nutritional status were analysed. Statistical analysis was performed by chi(2) test, univariate analysis and Odds ratios (OR). Results A total of 95.3% of children presented intestinal parasitism, most of whom (94.5%) infected by protozoa and 36.1% infected by soil-transmitted helminths (STH), with Trichuris trichiura (27.3%) being the most prevalent. Multiple infections were found to be high (83.8%), with protozoa and STH co-infections in 30.6%. STH infections were mainly of low/moderate intensity. Neither infection nor STH infection of any intensity profile, was significantly related to anemia. In addition, STH infection, regardless of the intensity profile, was not associated with stunting, underweight or thinness. There was no difference between genders nor among ages in odds of anemia and nutritional status in STH-infected schoolchildren. Conclusion Multiparasitism remains high among Rwandan schoolchildren and is likely to cause nutritional problems. This work emphasizes the importance of keeping up health programs to reduce the prevalence of infection.	[Jose Irisarri-Gutierrez, Maria; Toledo, Rafael; Guillermo Esteban, Jose; Munoz-Antoli, Carla] Univ Valencia, Fac Farm, Dept Farm & Tecnol Farmaceut & Parasitol, Area Parasitol, Valencia, Spain; [Acosta, Lucrecia; Jorge Bornay-Llinares, Fernando] Univ Miguel Hernandez Elche, Fac Farm, Dept Agroquim & Medioambiente, Area Parasitol, Alicante, Spain; [Acosta, Lucrecia] Sanatorio Fontilles, Lab Anal Clin, Alicante, Spain; [Anne Parker, Lucy] Univ Miguel Hernandez Elche, Dept Salud Publ Hist Ciencia & Ginecol, Alicante, Spain; [Anne Parker, Lucy] Ctr Invest Biomed Red CIBER Epidemiol & Salud Pub, Madrid, Spain; [Jose Irisarri-Gutierrez, Maria] Univ Europea Madrid, Fac Ciencias Biomed, Dept Ciencias Salud, Madrid, Spain	University of Valencia; Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; European University of Madrid	Munoz-Antoli, C (corresponding author), Univ Valencia, Fac Farm, Dept Farm & Tecnol Farmaceut & Parasitol, Area Parasitol, Valencia, Spain.	carla.munoz@uv.es	; Toledo, Rafael/G-6741-2016	Acosta Soto, Lucrecia/0000-0003-3989-0218; Irisarri Gutierrez, Maria Jose/0000-0001-7562-625X; Toledo, Rafael/0000-0003-2651-9794	Proyecto of Conselleria de Bienestar Social de la Generalitat Valenciana (Comunitat Valenciana, Spain) [3055/2009]; Centro de Cooperacion al Desarrollo y Voluntariado de la Universidad Miguel Hernandez de Elche (Alicante, Spain)	Proyecto of Conselleria de Bienestar Social de la Generalitat Valenciana (Comunitat Valenciana, Spain); Centro de Cooperacion al Desarrollo y Voluntariado de la Universidad Miguel Hernandez de Elche (Alicante, Spain)	This work was supported by Proyecto of Conselleria de Bienestar Social de la Generalitat Valenciana (Comunitat Valenciana, Spain) (Ref. 3055/2009) and by Centro de Cooperacion al Desarrollo y Voluntariado de la Universidad Miguel Hernandez de Elche (Alicante, Spain).	Ajjampur SSR, 2016, PARASITOL INT, V65, P772, DOI 10.1016/j.parint.2016.05.007; Al-Mekhlafi HM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002516; Ash LR., 1994, BENCH AIDS DIAGNOSIS; Butera E, 2019, PAN AFR MED J, V32, DOI 10.11604/pamj.2019.32.11.15949; Center for Infectious Diseases Control Rwanda, 2008, NAT PREV SURV SOIL T; Danquah I, 2014, TROP MED INT HEALTH, V19, P563, DOI 10.1111/tmi.12284; de Gier B, 2014, AM J CLIN NUTR, V99, P1499, DOI 10.3945/ajcn.113.069955; de Onis M, 2000, B WORLD HEALTH ORGAN, V78, P1222; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Degarege A, 2013, J INFECT PUBLIC HEAL, V6, P125, DOI 10.1016/j.jiph.2012.11.008; Demissie Fekadu, 2009, Ethiop Med J, V47, P153; Donahue Angel M, 2017, FOOD NUTR BULL, V38, P554, DOI 10.1177/0379572117723134; Dushimimana A, 2008, SITUATION NUTR INFEC; Gall S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005573; Gasana J, 2002, ENVIRON RES, V90, P76, DOI 10.1006/enrs.2002.4394; Geus D, 2019, TROP MED INT HEALTH, V24, P409, DOI 10.1111/tmi.13206; Girum Tadele, 2018, Open Nurs J, V12, P155, DOI 10.2174/1874434601812010155; Goverment of Rwanda, 2019, ENV MAN PLAN ESMP; Gulani A, 2007, BMJ-BRIT MED J, V334, P1095, DOI 10.1136/bmj.39150.510475.AE; Hailegebriel T, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3306-3; Heimer J, 2015, ACTA TROP, V145, P17, DOI 10.1016/j.actatropica.2015.01.011; HENRIKSEN SA, 1981, ACTA VET SCAND, V22, P594; Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677; Karagiannis-Voules DA, 2015, LANCET INFECT DIS, V15, P74, DOI 10.1016/S1473-3099(14)71004-7; KNIGHT WB, 1976, AM J TROP MED HYG, V25, P818, DOI 10.4269/ajtmh.1976.25.818; Krucken J, 2017, INT J PARASITOL-DRUG, V7, P262, DOI 10.1016/j.ijpddr.2017.06.001; Molla Eshetu, 2018, BMC Res Notes, V11, P585, DOI 10.1186/s13104-018-3679-9; Montresor A., 1998, WORLD HLTH ORG; Munisi DZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167122; Munoz-Antoli C, 2018, AM J TROP MED HYG, V99, P1591, DOI 10.4269/ajtmh.18-0195; Mupfasoni D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000517; Northrop-Clewes CA, 2001, AM J CLIN NUTR, V73, P53; Osazuwa F, 2011, N AM J MED SCI, V3, P30, DOI 10.4297/najms.2011.330; PRITCHARD DI, 1991, T ROY SOC TROP MED H, V85, P235, DOI 10.1016/0035-9203(91)90038-Z; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; ROBERTSON LJ, 1992, T ROY SOC TROP MED H, V86, P654, DOI 10.1016/0035-9203(92)90176-D; Ruberanziza E, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4020093; Rujeni N, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0212-z; Staudacher O, 2014, TROP MED INT HEALTH, V19, P812, DOI 10.1111/tmi.12321; Sullivan KM, 2008, TROP MED INT HEALTH, V13, P1267, DOI 10.1111/j.1365-3156.2008.02143.x; Sur D, 2005, T ROY SOC TROP MED H, V99, P261, DOI 10.1016/j.trstmh.2004.08.005; TRAC Plus (Ministry of Health) and the Access Project, 2008, REP NAT SCH PREV SUR; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organization, 2006, WHO CHILD GROWTH STA; Yap PL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002983	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262361	10.1371/journal.pone.0262361	http://dx.doi.org/10.1371/journal.pone.0262361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990483	Green Published, gold			2022-12-27	WOS:000815783800032
J	Langen, G; Lohr, C; Ueberschar, O; Behringer, M				Langen, Georg; Lohr, Christine; Ueberschaer, Olaf; Behringer, Michael			Reproducibility of knee extensor and flexor contraction velocity in healthy men and women assessed using tensiomyography: A study protocol	PLOS ONE			English	Article							GASTROCNEMIUS MEDIALIS MUSCLE; TEST-RETEST RELIABILITY; SHORTENING VELOCITY; PHYSICAL-ACTIVITY; MEASUREMENT ERROR; FATIGUE; POWER; RECOVERY	Tensiomyography measures the radial displacement of a muscle during an electrically evoked twitch contraction. The rate of muscle displacement is increasingly reported to assess contractile properties. Several formulas currently exist to calculate the rate of displacement during the contraction phase of the maximal twitch response. However, information on the reproducibility of these formulas is scarce. Further, different rest intervals ranging from 10 s to 30 s are applied between consecutive stimuli during progressive electrical stimulation until the maximum twitch response. The effect of different rest intervals on the rate of displacement has not been investigated so far. The first aim of this study is to investigate the within and between-day reliability of the most frequently used formulas to calculate the rate of displacement. The second aim is to investigate the effect of changing the inter-stimulus interval on the rate of displacement. We will determine the rectus femoris and biceps femoris rate of displacement of twenty-four healthy subjects' dominant leg on two consecutive days. The maximum displacement curve will be determined two times within three minutes on the first day and a third time 24 h later. On day two, we will also apply three blocks of ten consecutive stimuli at a constant intensity of 50 mA. Inter-stimuli intervals will be 10 s, 20 s or 30 s in each block, respectively, and three minutes between blocks. The order of inter-stimulus intervals will be randomized. This study will allow a direct comparison between the five most frequently used formulas to calculate the rate of displacement in terms of their reproducibility. Our data will also inform on the effect of different inter-stimulus intervals on the rate of displacement. These results will provide helpful information on methodical considerations to determine the rate of displacement and may thus contribute to a standardized approach.	[Langen, Georg; Behringer, Michael] Goethe Univ Frankfurt, Dept Sports Med & Performance Physiol, Frankfurt, Germany; [Langen, Georg] Inst Appl Training Sci, Dept Tech Tact Sports, Leipzig, Germany; [Ueberschaer, Olaf] Magdeburg Stendal Univ Appl Sci, Dept Engn & Ind Design, Magdeburg, Germany; [Ueberschaer, Olaf] Inst Appl Training Sci, Dept Biomech, Leipzig, Germany; [Lohr, Christine] Osteopathiepraxis, Hamburg, Germany	Goethe University Frankfurt	Langen, G (corresponding author), Goethe Univ Frankfurt, Dept Sports Med & Performance Physiol, Frankfurt, Germany.; Langen, G (corresponding author), Inst Appl Training Sci, Dept Tech Tact Sports, Leipzig, Germany.	langen@sport.uni-frankfurt.de		Langen, Georg/0000-0003-4285-5253; Ueberschar, Olaf/0000-0002-6822-5201				Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Ben-Shachar M., 2020, J OPEN SOURCE SOFTW, V5, P2815, DOI [10.21105/joss.02815, DOI 10.21105/JOSS.02815, https://doi.org/10.21105/joss.02815]; Blazevich AJ, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01359; Cheng AJ, 2010, MED SCI SPORT EXER, V42, P1651, DOI 10.1249/MSS.0b013e3181d6c5b5; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cumming G, 2017, INTRO NEW STAT ESTIM; Dahmane R, 2005, J BIOMECH, V38, P2451, DOI 10.1016/j.jbiomech.2004.10.020; Dahmane R, 2001, MED BIOL ENG COMPUT, V39, P51, DOI 10.1007/BF02345266; de Paula Simola RA., 2015, SPORTS TECHNOL, V8, P58, DOI DOI 10.1080/19346182.2015.1117475; Debold EP, 2016, MED SCI SPORT EXER, V48, P2270, DOI 10.1249/MSS.0000000000001047; Ditroilo M, 2013, J ELECTROMYOGR KINES, V23, P558, DOI 10.1016/j.jelekin.2013.01.014; Domaszewski P, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030815; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garcia-Garcia O, 2020, RES Q EXERCISE SPORT, V91, P460, DOI 10.1080/02701367.2019.1680789; Gasparini M, 2012, EUR J VASC ENDOVASC, V44, P170, DOI 10.1016/j.ejvs.2012.04.024; Hodgson M, 2005, SPORTS MED, V35, P585, DOI 10.2165/00007256-200535070-00004; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jones DA, 2006, J PHYSIOL-LONDON, V576, P913, DOI 10.1113/jphysiol.2006.116343; Kang H, 2013, KOREAN J ANESTHESIOL, V64, P402, DOI 10.4097/kjae.2013.64.5.402; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Latella C, 2019, J ELECTROMYOGR KINES, V45, P26, DOI 10.1016/j.jelekin.2019.02.002; Lohr C, 2018, EUR J APPL PHYSIOL, V118, P1349, DOI 10.1007/s00421-018-3867-2; Loturco I, 2016, J SPORT SCI MED, V15, P483; Loturco I, 2015, J STRENGTH COND RES, V29, P1723, DOI 10.1519/JSC.0000000000000803; Lucas NP, 2010, J CLIN EPIDEMIOL, V63, P854, DOI 10.1016/j.jclinepi.2009.10.002; Macgregor LJ, 2016, J SPORT REHABIL, V25, P241, DOI [10-1123/jsr.2014-0325, 10.1123/jsr.2014-0325]; Garcia-Manso JM, 2011, AM J PHYS MED REHAB, V90, P356, DOI 10.1097/PHM.0b013e31820ff352; Martin-Rodriguez S, 2017, J STRENGTH COND RES, V31, P3524, DOI 10.1519/JSC.0000000000002250; Martin-San Agustin R, 2020, PEERJ, V8, DOI 10.7717/peerj.8674; Perotto AO., 2011, ANATOMICAL GUIDE ELE; Pisot R, 2008, EUR J APPL PHYSIOL, V104, P409, DOI 10.1007/s00421-008-0698-6; Raeder C, 2016, J STRENGTH COND RES, V30, P3412, DOI 10.1519/JSC.0000000000001427; Rey E, 2012, J STRENGTH COND RES, V26, P3081, DOI 10.1519/JSC.0b013e3182470d33; Rodriguez-Ruiz D, 2013, EUR REV AGING PHYS A, V10, P127, DOI 10.1007/s11556-013-0127-7; Sanchez-Sanchez J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35345-z; Sanchez-Urena B, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00766; Simola RAD, 2015, J STRENGTH COND RES, V29, P1339, DOI 10.1519/JSC.0000000000000768; Simunic B, 2010, ANN KINESIOLOGIAE, V1, P61; Simunic B, 2019, J APPL PHYSIOL, V126, P815, DOI 10.1152/japplphysiol.00880.2018; Simunic B, 2018, J GERONTOL A-BIOL, V73, P1602, DOI 10.1093/gerona/gly069; Simunic B, 2011, MED SCI SPORT EXER, V43, P1619, DOI 10.1249/MSS.0b013e31821522d0; Suresh Kp, 2011, J Hum Reprod Sci, V4, P8, DOI 10.4103/0974-1208.82352; Tous-Fajardo J, 2010, J ELECTROMYOGR KINES, V20, P761, DOI 10.1016/j.jelekin.2010.02.008; Urbaniak G. C., RES RANDOMIZER VERSI; Valencic V, 1997, ARTIF ORGANS, V21, P240, DOI 10.1111/j.1525-1594.1997.tb04658.x; van Melick N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189876; Wagner JM, 2008, PHYS THER, V88, P652, DOI 10.2522/ptj.20070255; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Westerblad H, 1998, J PHYSIOL-LONDON, V510, P269, DOI 10.1111/j.1469-7793.1998.269bz.x; Wiewelhove T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207313; Wiewelhove T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139801; Wilson HV, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab1cef; Wilson HV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191965; Wilson MT, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01493; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zhiyong Z, 2021, WEBPOWER BASIC ADV S; Zubac D, 2017, J STRENGTH COND RES, V31, P1610, DOI 10.1519/JSC.0000000000001626	59	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262156	10.1371/journal.pone.0262156	http://dx.doi.org/10.1371/journal.pone.0262156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990494	Green Published, gold			2022-12-27	WOS:000815783800017
J	Hayat, S; Ashraf, A; Zubair, M; Aslam, B; Siddique, MH; Khurshid, M; Saqalein, M; Khan, AM; Almatroudi, A; Naeem, Z; Muzammil, S				Hayat, Sumreen; Ashraf, Asma; Zubair, Muhammad; Aslam, Bilal; Siddique, Muhammad Hussnain; Khurshid, Mohsin; Saqalein, Muhammad; Khan, Arif Muhammad; Almatroudi, Ahmad; Naeem, Zilursh; Muzammil, Saima			Biofabrication of ZnO nanoparticles using Acacia arabica leaf extract and their antibiofilm and antioxidant potential against foodborne pathogens	PLOS ONE			English	Article							ZINC-OXIDE NANOPARTICLES; SILVER NANOPARTICLES; GREEN SYNTHESIS; PSEUDOMONAS-AERUGINOSA; ANTIBACTERIAL; BIOSYNTHESIS; INHIBITION; FUNGUS	Emergence of multidrug resistant pathogens is increasing globally at an alarming rate with a need to discover novel and effective methods to cope infections due to these pathogens. Green nanoparticles have gained attention to be used as efficient therapeutic agents because of their safety and reliability. In the present study, we prepared zinc oxide nanoparticles (ZnO NPs) from aqueous leaf extract of Acacia arabica. The nanoparticles produced were characterized through UV-Visible spectroscopy, scanning electron microscopy, and X-ray diffraction. In vitro antibacterial susceptibility testing against foodborne pathogens was done by agar well diffusion, growth kinetics and broth microdilution assays. Effect of ZnO NPs on biofilm formation (both qualitatively and quantitatively) and exopolysaccharide (EPS) production was also determined. Antioxidant potential of green synthesized nanoparticles was detected by DPPH radical scavenging assay. The cytotoxicity studies of nanoparticles were also performed against HeLa cell lines. The results revealed that diameter of zones of inhibition against foodborne pathogens was found to be 16-30 nm, whereas the values of MIC and MBC ranged between 31.25-62.5 mu g/ml. Growth kinetics revealed nanoparticles bactericidal potential after 3 hours incubation at 2 x MIC for E. coli while for S. aureus and S. enterica reached after 2 hours of incubation at 2 x MIC, 4 x MIC, and 8 x MIC. 32.5-71.0% inhibition was observed for biofilm formation. Almost 50.6-65.1% (wet weight) and 44.6-57.8% (dry weight) of EPS production was decreased after treatment with sub-inhibitory concentrations of nanoparticles. Radical scavenging potential of nanoparticles increased in a dose dependent manner and value ranged from 19.25 to 73.15%. Whereas cytotoxicity studies revealed non-toxic nature of nanoparticles at the concentrations tested. The present study suggests that green synthesized ZnO NPs can substitute chemical drugs against antibiotic resistant foodborne pathogens.	[Hayat, Sumreen; Aslam, Bilal; Khurshid, Mohsin; Saqalein, Muhammad; Naeem, Zilursh; Muzammil, Saima] Govt Coll Univ, Dept Microbiol, Faisalabad, Pakistan; [Ashraf, Asma] Govt Coll Univ, Dept Zool, Faisalabad, Pakistan; [Zubair, Muhammad; Siddique, Muhammad Hussnain] Govt Coll Univ, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan; [Khan, Arif Muhammad] Univ Sargodha, Dept Biotechnol, Sargodha, Pakistan; [Almatroudi, Ahmad] Qassim Univ, Dept Med Labs, Coll Appl Med Sci, Buraydah, Saudi Arabia	Government College University Faisalabad; Government College University Faisalabad; Government College University Faisalabad; University of Sargodha; Qassim University	Muzammil, S (corresponding author), Govt Coll Univ, Dept Microbiol, Faisalabad, Pakistan.	saimamuzammil83@gmail.com	ASLAM, BILAL/AAX-6227-2020; Khurshid, Mohsin/N-8135-2013; Zubair, Muhammad/HGA-4479-2022	ASLAM, BILAL/0000-0002-5568-5049; Khurshid, Mohsin/0000-0002-3196-2857; Siddique, Muhammad Hussnain/0000-0003-3700-0509; Zubair, Muhammad/0000-0003-4534-0968	Deanship of Scientific Research, Qassim University	Deanship of Scientific Research, Qassim University	The researchers would like to thank the Deanship of Scientific Research, Qassim University for funding the publication of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe GM, 2020, INT J MICROBIOL, V2020, DOI 10.1155/2020/1705814; Agarwal H, 2019, J DRUG DELIV SCI TEC, V53, DOI 10.1016/j.jddst.2019.101212; Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1; Al-Shabib A, 2018, J NANOMATERIALS, P20181; Alekish M, 2018, VET WORLD, V11, P1428, DOI 10.14202/vetworld.2018.1428-1432; Arakha M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09578; Atkinson A, 2009, CHEM REV, V109, P4708, DOI 10.1021/cr900006y; Azam A, 2012, INT J NANOMED, V7, P6003, DOI 10.2147/IJN.S35347; Azwanida N., 2015, MED AROMAT PLANTS, V4, P2167, DOI [10.4172/2167-0412.1000196, DOI 10.4172/2167-0412.1000196]; Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; BAUMANN J, 1980, ARCH PHARM, V313, P330, DOI 10.1002/ardp.19803130409; Bharathi D, 2019, RES CHEM INTERMEDIAT, V45, P2065, DOI 10.1007/s11164-018-03717-9; Bisht Gunjan, 2016, Nanobiomedicine (Rij), V3, P9, DOI 10.5772/63437; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x; Cox SD, 2007, J APPL MICROBIOL, V103, P930, DOI 10.1111/j.1365-2672.2007.03353.x; Dalziel JM., 1956, USEFUL PLANTS W TROP, P101; Elumalai K, 2015, SPECTROCHIM ACTA A, V143, P158, DOI 10.1016/j.saa.2015.02.011; Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004; Imran M, 2021, J HAZARD MATER, V401, DOI 10.1016/j.jhazmat.2020.123338; Jacob V., 2019, ASIAN J PHARM CLIN R, V12, P200; Jadoun S, 2021, ENVIRON CHEM LETT, V19, P355, DOI 10.1007/s10311-020-01074-x; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Kahsay M.H., 2018, OPEN NANO, V3, P28, DOI [10.1016/j.onano.2018.04, DOI 10.1016/J.ONANO.2018.04.001]; Kakati M., 2014, LETT APP NANOBIOSCIE, V9, P779; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kathiresan K, 2009, COLLOID SURFACE B, V71, P133, DOI 10.1016/j.colsurfb.2009.01.016; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Kubmarawa D, 2007, AFR J BIOTECHNOL, V6, P1690; Kulshrestha S, 2016, APPL MICROBIOL BIOT, V100, P1901, DOI 10.1007/s00253-015-7154-4; Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3; Liang SJ, 2018, APPL OPTICS, V57, P5657, DOI 10.1364/AO.57.005657; Loo YY, 2012, INT J NANOMED, V7, P4263, DOI 10.2147/IJN.S33344; Lorian V., 1991, ANTIBIOTICS LAB MED, V3, P493; Mahamuni PP, 2019, BIOCHEM BIOPHYS REP, V17, P71, DOI 10.1016/j.bbrep.2018.11.007; Moghaddam AB, 2017, MOLECULES, V22, DOI 10.3390/molecules22060872; Muzammil S, 2020, BIOFOULING, P1, DOI [10.1080/08927014.2019.1708334, DOI 10.1080/08927014.2019.1708334]; Naseer M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65949-3; Nithya K., 2019, OpenNano, V4, P15, DOI 10.1016/j.onano.2018.10.001; Pallavicini P, 2017, J COLLOID INTERF SCI, V498, P271, DOI 10.1016/j.jcis.2017.03.062; Peng XH, 2011, AQUAT TOXICOL, V102, P186, DOI 10.1016/j.aquatox.2011.01.014; Pirtarighat S, 2019, J NANOSTRUCTURE CHEM, V9, P1, DOI 10.1007/s40097-018-0291-4; Prabu K, 2019, J KING SAUD UNIV SCI, V31, P724, DOI 10.1016/j.jksus.2018.04.025; Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u; Rai MK, 2012, J APPL MICROBIOL, V112, P841, DOI 10.1111/j.1365-2672.2012.05253.x; Rao TN, 2019, SAUDI J BIOL SCI, V26, P1385, DOI 10.1016/j.sjbs.2019.09.005; Rehana D, 2017, BIOPROC BIOSYST ENG, V40, P943, DOI 10.1007/s00449-017-1758-2; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Salam HA, 2014, MATER LETT, V131, P16, DOI 10.1016/j.matlet.2014.05.033; Samat NA, 2013, CERAM INT, V39, pS545, DOI 10.1016/j.ceramint.2012.10.132; Seaman SJ, 2006, AM MINERAL, V91, P12, DOI 10.2138/am.2006.1765; Selim YA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60541-1; Siddique MH, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6398165; Siddique MH, 2018, BRIT FOOD J, V120, P1358, DOI 10.1108/BFJ-09-2017-0529; Thi TUD, 2020, RSC ADV, V10, P23899, DOI 10.1039/d0ra04926c; Vanaja M, 2013, J NANOSTRUCTURE CHEM, V3, DOI 10.1186/2193-8865-3-17; World Health Organization, 2014, IN EST GLOB BURD FOO, P108; Xia L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186434; Yang FG, 2017, SOFT MATTER, V13, P638, DOI 10.1039/c6sm02174c; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yuvakkumar R, 2015, SPECTROCHIM ACTA A, V137, P250, DOI 10.1016/j.saa.2014.08.022; Zare E, 2017, J MOL STRUCT, V1146, P96, DOI 10.1016/j.molstruc.2017.05.118; Zhang XL, 2011, CHEMOSPHERE, V82, P489, DOI 10.1016/j.chemosphere.2010.10.023	62	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0259190	10.1371/journal.pone.0259190	http://dx.doi.org/10.1371/journal.pone.0259190			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986148	Green Published, gold			2022-12-27	WOS:000765956200004
J	Yan, Y; Chen, HY; Sun, LP; Zhang, W; Lu, X; Li, ZP; Xu, JL; Ren, Q				Yan, Yi; Chen, Haiyan; Sun, Leping; Zhang, Wei; Lu, Xin; Li, Zhenpeng; Xu, Jialiang; Ren, Qing			The changes of microbial diversity and flavor compounds during the fermentation of millet Huangjiu, a traditional Chinese beverage	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; RICE WINE; TORULOPSIS-GLABRATA; SYNTHETIC BIOLOGY; AROMA COMPOUNDS; ACID SYNTHESIS; WHEAT QU; SP NOV.; PYRUVATE; OPTIMIZATION	Huangjiu is a national alcoholic beverage in China. Millet has congenital advantages in development and utilization of nutrient. Brewing Huangjiu with millet can increase the value of millet. Microbial community plays crucial roles in millet Huangjiu fermentation. Flavor compounds reflect the quality and health function of Huangjiu. The flavor compounds of Huangjiu are complex and their formation is closely associated with microorganisms, but the relationship between them during fermentation has been unknown. In this research, this relationship during millet Huangjiu fermentation were deeply investigated. Totally 86 volatile compounds were detected. Bacillus, Weissella, Paenibacillus, Klebsiella, Prevotella was investigated as the dominant microbes through high-throughput sequencing. 537 correlations between major flavor compounds and microbes were established to reflect the dynamic change during millet Huangjiu fermentation. The top five dominant genus of flavor producing microbes were Chryseobacterium, Sporolactobacillus, Psychrobacter, Sphingobium and Anoxybacillus. The content of malic acid and citric acid was gradually improved all through the millet Huangjiu fermentation. Malic acid and citric acid generated from millet Huangjiu fermentation shows healthy properties as liver protection and eliminating fatigue. Our research provides essential information on microbial community succession and the flavor formation during millet Huangjiu fermentation, and beneficial for development of Huangjiu products.	[Yan, Yi; Chen, Haiyan; Sun, Leping; Xu, Jialiang; Ren, Qing] Beijing Technol & Business Univ, Sch Light Ind, Beijing, Peoples R China; [Yan, Yi; Chen, Haiyan; Sun, Leping; Xu, Jialiang; Ren, Qing] Key Lab Brewing Mol Engn China Light Ind, Beijing, Peoples R China; [Zhang, Wei] Hebei Agr Univ, Coll Food Sci & Technol, Baoding, Peoples R China; [Lu, Xin; Li, Zhenpeng] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Beijing Technology & Business University; Hebei Agricultural University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, JL; Ren, Q (corresponding author), Beijing Technol & Business Univ, Sch Light Ind, Beijing, Peoples R China.; Xu, JL; Ren, Q (corresponding author), Key Lab Brewing Mol Engn China Light Ind, Beijing, Peoples R China.	xujialiang@btbu.edu.cn; renqing@th.btbu.edu.cn	Chen, Haiyan/HGB-6216-2022; Yan, Yi/GQH-0844-2022	Sun, Leping/0000-0001-9095-1878	Fundamental Research Funding of Beijing Technology and Business University [PXM2020_014213_000017]; coarse cereals and various beans processing project of modern agricultural industrial technology system of Hebei province [HBCT2018070206]	Fundamental Research Funding of Beijing Technology and Business University; coarse cereals and various beans processing project of modern agricultural industrial technology system of Hebei province	This study was supported by Y.Y., Fundamental Research Funding of Beijing Technology and Business University (PXM2020_014213_000017) and W.Z., the coarse cereals and various beans processing project of modern agricultural industrial technology system of Hebei province (HBCT2018070206).W.Z.; Funding Acquisition; W.Z. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi S, 2019, SORGHUM AND MILLETS: CHEMISTRY, TECHNOLOGY, AND NUTRITIONAL ATTRIBUTES, 2ND EDITION, P293, DOI 10.1016/B978-0-12-811527-5.00010-1; Amadou I., 2019, FERMENTED BEVERAGES, V5, P433, DOI [10.1016/B978-0-12-815271-3.00011-7, DOI 10.1016/B978-0-12-815271-3.00011-7]; [Anonymous], 2014, LIQUOR MAKING SCI TE; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Causey TB, 2004, P NATL ACAD SCI USA, V101, P2235, DOI 10.1073/pnas.0308171100; Chandra P, 2020, MICROB CELL FACT, V19, DOI 10.1186/s12934-020-01428-8; Chen G-M, 2021, CURR OPIN FOOD SCI; Chen J., 2008, STUDY FACTORS SHAOXI; Chen S, 2018, FLAVOUR FRAG J, V33, P263, DOI 10.1002/ffj.3440; Chen T, 2020, J SCI FOOD AGR, V100, P3297, DOI 10.1002/jsfa.10343; Chen YF, 2016, J IND MICROBIOL BIOT, V43, P1261, DOI 10.1007/s10295-016-1795-x; Chethan S, 2007, FOOD CHEM, V105, P862, DOI 10.1016/j.foodchem.2007.02.012; Council CNLI, 2008, CHIN RIC WIN; Daviot L, 2019, CATALYSTS, V9, DOI 10.3390/catal9030272; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DICKINSON JR, 1993, FEBS LETT, V326, P29, DOI 10.1016/0014-5793(93)81754-N; Dong J, 2019, IRAN J BIOTECHNOL, V17, DOI 10.21859/ijb.1990; Dong Yan, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P559; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Etschmann MMW, 2002, APPL MICROBIOL BIOT, V59, P1, DOI 10.1007/s00253-002-0992-x; Fan GS, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.663744; Fan GS, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/1470543; Fang RS, 2017, THESIS ZHEJIANG U; Fang RS, 2015, J FOOD SCI, V80, pM2265, DOI 10.1111/1750-3841.13018; Fu-Rong YE, 2013, LIQUOR MAKING, V40, P80; Gao X, 2018, BREWING TECHNOL, V1, P91; Gawas SD, 2016, APPL BIOCHEM BIOTECH, V180, P1428, DOI 10.1007/s12010-016-2177-6; Ghim CM, 2010, BIOTECHNOL BIOPROC E, V15, P11, DOI 10.1007/s12257-009-3065-5; Gil JV, 1996, J FOOD SCI, V61, P1247, DOI 10.1111/j.1365-2621.1996.tb10971.x; Goldenberger D, 2014, J CLIN MICROBIOL, V52, P3180, DOI 10.1128/JCM.00792-14; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HILU KW, 1978, BIOCHEM SYST ECOL, V6, P247, DOI 10.1016/0305-1978(78)90013-3; Hong XT, 2016, SCI REP-UK, V6, DOI 10.1038/srep26621; Hu XL, 2016, APPL ENVIRON MICROB, V82, P2506, DOI 10.1128/AEM.03409-15; Hu YL, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.673670; Huang ZR, 2018, FOOD MICROBIOL, V76, P487, DOI 10.1016/j.fm.2018.07.014; Isar J, 2007, ANAEROBE, V13, P50, DOI 10.1016/j.anaerobe.2006.12.002; Ji ZW, 2018, INT J FOOD SCI TECH, V53, P1611, DOI 10.1111/ijfs.13743; Jiao JK, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.649611; Kalse S, 2016, DEV QUALITY EVALUATI, V7, P2; Karatas H, 2013, ANN MICROBIOL, V63, P45, DOI 10.1007/s13213-012-0443-6; Kariyawasam KMGMM, 2019, J DAIRY SCI, V102, P3887, DOI 10.3168/jds.2018-15360; Kawamura Y, 2015, SYST APPL MICROBIOL, V38, P104, DOI 10.1016/j.syapm.2014.11.004; Kumar MH, 2019, DRUG INVENT TODAY, V11, P2657; Li HH, 2019, FOOD CHEM, V284, P100, DOI 10.1016/j.foodchem.2019.01.102; Li LL, 2002, INT J PHARM, V237, P77, DOI 10.1016/S0378-5173(02)00029-7; Li Y, 2002, APPL MICROBIOL BIOT, V60, P101, DOI [10.1007/s0253-002-1064-y, 10.1007/s00253-002-1064-y]; Lilin S., 2021, CHINA BREWING, V40, P54; Lin H, 2020, FOOD SCI BIOTECHNOL, V29, P1037, DOI 10.1007/s10068-020-00757-z; Lin XJ, 2014, CHIN J CHROMATOGR, V32, P304, DOI 10.3724/SP.J.1123.2013.11023; Liu Jingke, 2009, Cereal & Feed Industry, P22; Liu SP, 2015, WORLD J MICROB BIOT, V31, P1907, DOI 10.1007/s11274-015-1931-1; Liu SP, 2019, INT J FOOD MICROBIOL, V303, P9, DOI 10.1016/j.ijfoodmicro.2019.05.001; Luo T, 2008, J I BREWING, V114, P172, DOI 10.1002/j.2050-0416.2008.tb00323.x; Luo W, 2016, RES IMPROVING ETHYL; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martinez-Ruiz A, 2018, BIORESOURCE TECHNOL, V265, P52, DOI 10.1016/j.biortech.2018.05.080; Miyata R, 1999, J BIOSCI BIOENG, V88, P173, DOI 10.1016/S1389-1723(99)80197-2; Ojediran J, 2021, SOME PHYS PROPERTIES, V6; Papagianni M, 2007, BIOTECHNOL ADV, V25, P244, DOI 10.1016/j.biotechadv.2007.01.002; PELEG Y, 1989, APPL MICROBIOL BIOT, V30, P176; Pines O, 1996, APPL MICROBIOL BIOT, V46, P393, DOI 10.1007/s002530050835; Rabinovitch-Deere CA, 2013, CHEM REV, V113, P4611, DOI 10.1021/cr300361t; Ran X., 2015, THESIS ZHEJIANG A F; Rayne S, 2007, J CHROMATOGR A, V1167, P195, DOI 10.1016/j.chroma.2007.08.049; Ren DQ, 2006, LIQUOR MAKING SCI TE, V144, P39; Ren Q, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40337-8; Robles A, 2019, TRAC-TREND ANAL CHEM, V120, DOI 10.1016/j.trac.2019.115630; Rong ZX, 2013, CHINA BREWING, V32, P28; Saerens SMG, 2006, J BIOL CHEM, V281, P4446, DOI 10.1074/jbc.M512028200; Shi H, 2007, STUDY NOURISHMENT HL; Song Y, SCI TECHNOLOGY FOOD, V37, P387; Song ZW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01294; Sun HL, 2020, FOOD CHEM, V317, DOI 10.1016/j.foodchem.2020.126420; Sun JX., 2012, MODERN FOOD SCI TECH, V28, P1541, DOI [10.13982/j.mfst.1673-9078.2012.11.033, DOI 10.13982/J.MFST.1673-9078.2012.11.033]; Syu MJ, 2001, APPL MICROBIOL BIOT, V55, P10, DOI 10.1007/s002530000486; Takahashi T, 2017, J BIOSCI BIOENG, V123, P707, DOI 10.1016/j.jbiosc.2017.01.014; Teng W, 2016, J FOOD SCI, V35; Tomar A, 2003, APPL MICROBIOL BIOT, V62, P76, DOI 10.1007/s00253-003-1234-6; Tong J, 2010, INT J SYST EVOL MICR, V60, P1135, DOI 10.1099/ijs.0.011783-0; van Maris AJA, 2004, APPL ENVIRON MICROB, V70, P159, DOI 10.1128/AEM.70.1.159-166.2004; Vogel H, 1987, BIOTECHNOL BIOENG, V29; Wang J, 2020, FOOD RES INT, V134, DOI 10.1016/j.foodres.2020.109238; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xiao-Yu D, 2013, J DALIAN U; Xu JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23013-1; Xu YQ, 2021, FOOD CHEM, V338, DOI 10.1016/j.foodchem.2020.128025; Yang YJ, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.580247; Yoda T, 2020, BIOMIMETICS-BASEL, V5, DOI 10.3390/biomimetics5020016; Yu HY, 2021, FOOD RES INT, V145, DOI 10.1016/j.foodres.2021.110421; Yu HY, 2015, J CHROMATOGR B, V997, P129, DOI 10.1016/j.jchromb.2015.05.037; Yu LJ, 2012, J I BREWING, V118, P114, DOI 10.1002/jib.13; Zhang Y, 2021, APPL OPTICS, V60, P5480, DOI 10.1364/AO.424015; Zhu J, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0221-9	98	4	4	29	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262353	10.1371/journal.pone.0262353	http://dx.doi.org/10.1371/journal.pone.0262353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986204	gold, Green Published			2022-12-27	WOS:000765956200046
J	Pecankova, K; Pecherkova, P; Gasova, Z; Sovova, Z; Riedel, T; Jaeger, E; Cermak, J; Majek, P				Pecankova, Klara; Pecherkova, Pavla; Gasova, Zdenka; Sovova, Zofie; Riedel, Tomas; Jaeger, Eliezer; Cermak, Jaroslav; Majek, Pavel			Proteome changes of plasma-derived extracellular vesicles in patients with myelodysplastic syndrome	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; WORLD-HEALTH-ORGANIZATION; OXIDATIVE STRESS; STROMAL CELLS; MEMBRANE-VESICLES; CLUSTERIN; EXOSOMES; MICROVESICLES; APOLIPOPROTEIN; CLASSIFICATION	BackgroundExtracellular vesicles are released into body fluids from the majority of, if not all, cell types. Because their secretion and specific cargo (e.g., proteins) varies according to pathology, extracellular vesicles may prove a rich source of biomarkers. However, their biological and pathophysiological functions are poorly understood in hematological malignancies. ObjectiveHere, we investigated proteome changes in the exosome-rich fraction of the plasma of myelodysplastic syndrome patients and healthy donors. MethodsExosome-rich fraction of the plasma was isolated using ExoQuick((TM)): proteomes were compared and statistically processed; proteins were identified by nanoLC-MS/MS and verified using the ExoCarta and QuickGO databases. Mann-Whitney and Spearman analyses were used to statistically analyze the data. 2D western blot was used to monitor clusterin proteoforms. ResultsStatistical analyses of the data highlighted clusterin alterations as the most significant. 2D western blot showed that the clusterin changes were caused by posttranslational modifications. Moreover, there was a notable increase in the clusterin proteoform in the exosome-rich fraction of plasma of patients with more severe myelodysplastic syndrome; this corresponded with a simultaneous decrease in their plasma. ConclusionsThis specific clusterin proteoform seems to be a promising biomarker for myelodysplastic syndrome progression.	[Pecankova, Klara; Pecherkova, Pavla; Gasova, Zdenka; Sovova, Zofie; Cermak, Jaroslav; Majek, Pavel] Inst Hematol & Blood Transfus, Prague, Czech Republic; [Riedel, Tomas; Jaeger, Eliezer] CAS, Inst Macromol Chem, Prague, Czech Republic	Institute of Hematology Prague; Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences	Pecankova, K (corresponding author), Inst Hematol & Blood Transfus, Prague, Czech Republic.	klara.pecankova@uhkt.cz	Riedel, Tomáš/H-6777-2014; Jäger, Eliézer/D-8924-2016	Riedel, Tomáš/0000-0002-2971-6956; Jäger, Eliézer/0000-0001-9939-2355; Majek, Pavel/0000-0002-9946-3819	Ministry of Health of the Czech Republic [00023736]; Czech Science Foundation [20-10845S]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the Ministry of Health of the Czech Republic project for the conceptual development of the research organization (Institute of Hematology and Blood Transfusion, 00023736) -KP, PP, ZG, ZS, JC, PM. This work was supported by the Czech Science Foundation (grant number 20-10845S) -KP, PP, JC, PM. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript for the infant's postnatal assessment.	Abello J, 2019, THERANOSTICS, V9, P2325, DOI 10.7150/thno.30030; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Aharon A, 2014, RAMBAM MAIMONIDES ME, V5, DOI 10.5041/RMMJ.10166; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Boyiadzis M, 2016, EXPERT REV MOL DIAGN, V16, P623, DOI 10.1080/14737159.2016.1174578; Breuza L, 2016, DATABASE-OXFORD, DOI 10.1093/database/bav120; Brunning RD., 2001, WHO CLASSIFICATION T, V1st, P61; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chevallet M, 2008, PROTEOMICS, V8, P4853, DOI 10.1002/pmic.200800321; Choi DS, 2013, PROTEOMICS, V13, P1554, DOI 10.1002/pmic.201200329; Choi DS, 2011, PROTEOMICS, V11, P2745, DOI 10.1002/pmic.201100022; Corrado C, 2014, CANCER LETT, V348, P71, DOI 10.1016/j.canlet.2014.03.009; Crescitelli R, 2021, NAT PROTOC, V16, P1548, DOI 10.1038/s41596-020-00466-1; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Ghosh AK, 2010, BLOOD, V115, P1755, DOI 10.1182/blood-2009-09-242719; Giassafaki LPN, 2021, J CELL PHYSIOL, V236, P1529, DOI 10.1002/jcp.29991; Goncalves AC, 2015, FREE RADICAL RES, V49, P1081, DOI 10.3109/10715762.2015.1035268; Halim ATA, 2016, INFLAMMATION, V39, P1277, DOI 10.1007/s10753-016-0381-8; Hrustincova A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040794; Hussein MNA, 2007, THROMB HAEMOSTASIS, V98, P1096, DOI 10.1160/TH05-04-0231; Karimi N, 2018, CELL MOL LIFE SCI, V75, P2873, DOI 10.1007/s00018-018-2773-4; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Kim JH, 2010, INVEST OPHTH VIS SCI, V51, P561, DOI 10.1167/iovs.09-3774; Kumar B, 2015, BLOOD, V126; Kumar B, 2016, BBA-MOL CELL RES, V1863, P464, DOI 10.1016/j.bbamcr.2015.09.017; Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137; Lemansky P, 1999, EXP CELL RES, V251, P147, DOI 10.1006/excr.1999.4555; Lewin S, 2020, BIOCHEM SOC T, V48, P2335, DOI 10.1042/BST20200717; Looze C, 2009, BIOCHEM BIOPH RES CO, V378, P433, DOI 10.1016/j.bbrc.2008.11.050; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; Majek P, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-56; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Matukumalli SR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41235; McLellan AD, 2009, CRIT REV IMMUNOL, V29, P203, DOI 10.1615/CritRevImmunol.v29.i3.20; Milane L, 2015, J CONTROL RELEASE, V219, P278, DOI 10.1016/j.jconrel.2015.06.029; O'Sullivan J, 2003, CELL DEATH DIFFER, V10, P914, DOI 10.1038/sj.cdd.4401254; Ogawa Y, 2008, BIOL PHARM BULL, V31, P1059, DOI 10.1248/bpb.31.1059; Onodi Z, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01479; Paggetti J, 2015, BLOOD, V126, P1106, DOI 10.1182/blood-2014-12-618025; Pandey KB, 2011, BIOMED PAP, V155, P131, DOI 10.5507/bp.2011.027; Panteleev MA, 2017, BIOCHEM MOSC SUPPL S, V11, P187, DOI 10.1134/S1990747817030060; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Poon S, 2002, FEBS LETT, V513, P259, DOI 10.1016/S0014-5793(02)02326-8; Raimondo F, 2011, PROTEOMICS, V11, P709, DOI 10.1002/pmic.201000422; Ramacciotti E, 2010, THROMB RES, V125, pE269, DOI 10.1016/j.thromres.2010.01.019; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Robert Taylor JB., 2019, J CLIN TRANSL SCI, V3, P7, DOI [10.1017/cts.2019.20, DOI 10.1017/CTS.2019.20]; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Rodriguez-Pineiro AM, 2006, MOL CELL PROTEOMICS, V5, P1647, DOI 10.1074/mcp.M600143-MCP200; Simpson RJ, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18374; Sodar BW, 2016, SCI REP-UK, V6, DOI 10.1038/srep24316; Soti C, 2005, CURR OPIN CELL BIOL, V17, P210, DOI 10.1016/j.ceb.2005.02.012; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trougakos IP, 2013, GERONTOLOGY, V59, P514, DOI 10.1159/000351207; Trougakos IP, 2009, ADV CANCER RES, V104, P171, DOI 10.1016/S0065-230X(09)04009-3; TSCHOPP J, 1993, J IMMUNOL, V151, P2159; Utleg AG, 2003, PROSTATE, V56, P150, DOI 10.1002/pros.10255; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Villarroya-Beltri C, 2014, SEMIN CANCER BIOL, V28, P3, DOI 10.1016/j.semcancer.2014.04.009; Westerman M, 2016, BLOOD CELL MOL DIS, V59, P134, DOI 10.1016/j.bcmd.2016.04.003; Wilson MR, 2017, EXPERT OPIN THER TAR, V21, P201, DOI 10.1080/14728222.2017.1267142; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; Yang CJ, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/573528; Yao Y, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-014-0082-4; Yoon YJ, 2014, BMB REP, V47, P531, DOI 10.5483/BMBRep.2014.47.10.164; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	79	3	3	9	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262484	10.1371/journal.pone.0262484	http://dx.doi.org/10.1371/journal.pone.0262484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007303	gold, Green Published			2022-12-27	WOS:000741060700010
J	Maisa, A; Lawal, AM; Islam, T; Nwankwo, C; Oluyide, B; Fotso, A; Roggeveen, H; van der Kam, S; Ariti, C; Bil, K; Lenglet, A				Maisa, Anna; Lawal, Abdulhakeem Mohammed; Islam, Tarikul; Nwankwo, Chijioke; Oluyide, Bukola; Fotso, Adolphe; Roggeveen, Harriet; van der Kam, Saskia; Ariti, Cono; Bil, Karla; Lenglet, Annick			Exploring factors influencing patient mortality and loss to follow-up in two paediatric hospital wards in Zamfara, North-West Nigeria, 2016-2018	PLOS ONE			English	Article							CHILDREN; PREDICTOR; ADMISSION; CARE	Introduction Child mortality has been linked to infectious diseases, malnutrition and lack of access to essential health services. We investigated possible predictors for death and patients lost to follow up (LTFU) for paediatric patients at the inpatient department (IPD) and inpatient therapeutic feeding centre (ITFC) of the Anka General Hospital (AGH), Zamfara State, Nigeria, to inform best practices at the hospital. Methods We conducted a retrospective cohort review study using routinely collected data of all patient admissions to the IPD and ITFC with known hospital exit status between 2016 and 2018. Unadjusted and adjusted rate ratios (aRR) and respective 95% confidence intervals (95% CI) were calculated using Poisson regression to estimate the association between the exposure variables and mortality as well as LTFU. Results The mortality rate in IPD was 22% lower in 2018 compared to 2016 (aRR 0.78; 95% CI 0.66-0.93) and 70% lower for patients coming from lead-affected villages compared to patients from other villages (aRR 0.30; 95% CI 0.19-0.48). The mortality rate for ITFC patients was 41% higher during rainy season (aRR 1.41; 95% CI 1.2-1.6). LTFU rates in ITFC increased in 2017 and 2018 when compared to 2016 (aRR 1.6; 95% CI 1.2-2.0 and aRR 1.4; 95% CI 1.1-1.8) and patients in ITFC had 2.5 times higher LTFU rates when coming from a lead-affected village. Conclusions Our data contributes clearer understanding of the situation in the paediatric wards in AGH in Nigeria, but identifying specific predictors for the multifaceted nature of mortality and LTFU is challenging. Mortality in paediatric patients in IPD of AGH improved during the study period, which is likely linked to better awareness of the hospital, but still remains high. Access to healthcare due to seasonal restrictions contributes to mortalities due to late presentation. Increased awareness of and easier access to healthcare, such as for patients living in lead-affected villages, which are still benefiting from an MSF lead poisoning intervention, decreases mortalities, but increases LTFU. We recommend targeted case audits and qualitative studies to better understand the role of health-seeking behaviour, and social and traditional factors in the use of formal healthcare in this part of Nigeria and potentially similar settings in other countries.	[Maisa, Anna] Med Sans Frontieres MSF, Sokoto, Nigeria; [Lawal, Abdulhakeem Mohammed; Islam, Tarikul] MSF, Anka, Nigeria; [Nwankwo, Chijioke] Anka Gen Hosp, Anka, Nigeria; [Oluyide, Bukola; Fotso, Adolphe] MSF, Abuja, Nigeria; [Roggeveen, Harriet; van der Kam, Saskia; Bil, Karla; Lenglet, Annick] Operat Ctr Amsterdam, MSF, Amsterdam, Netherlands; [Ariti, Cono] Cardiff Univ, Sch Med, Cardiff, Wales	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Cardiff University	Maisa, A (corresponding author), Med Sans Frontieres MSF, Sokoto, Nigeria.	anna.maisa@gmail.com	Lenglet, Annick/U-8949-2017	Lenglet, Annick/0000-0003-2013-8405; Maisa, Anna/0000-0002-8372-7525; van der Kam, Saskia/0000-0002-3608-8054				Afungchwi GM, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1719-y; Akinbami FO, 2010, ASIA PAC J CLIN NUTR, V19, P295; Bedford KJA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100038; Campbell D, 2004, J TROP PEDIATRICS, V50, P158, DOI 10.1093/tropej/50.3.158; Chloe Wurr JZ., FIELD EXCHANGE ENN, V50, P6; Clark M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041458; Das D, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1177-5; Einterz EM., 2011, RURAL REMOTE HEALTH, V11, P1; Fetzer BC, 2009, TROP MED INT HEALTH, V14, P862, DOI 10.1111/j.1365-3156.2009.02315.x; Fikrie A, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0642-x; Gordon DM, 2013, J TROP PEDIATRICS, V59, P350, DOI 10.1093/tropej/fmt031; Greig J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093716; Kampe EOI, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0818-9; Maurya M, 2014, INDIAN PEDIATR, V51, P481, DOI 10.1007/s13312-014-0432-x; McCormick NM, 2015, JAIDS-J ACQ IMM DEF, V70, pE73, DOI 10.1097/QAI.0000000000000782; Mena MB, 2018, INT J PEDIAT, V2018, DOI 10.1155/2018/8686501; Morakinyo OM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182990; Musa NA., 2021, INT J MED RES HLTH S, V10, P131; Mwangi R, 2008, T ROY SOC TROP MED H, V102, P805, DOI 10.1016/j.trstmh.2008.04.033; National Bureau of Statistisc (NBS) United Nations Children's Fund (UNICEF), 2017, MULT IND CLUST SURV, P1; Nemetchek B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023445; Nemetchek BR, 2018, AFR HEALTH SCI, V18, P1214, DOI 10.4314/ahs.v18i4.43; NIELSEN CC, 1992, TROP GEOGR MED, V44, P346; Ogbuoji Osondu, 2019, Gates Open Res, V3, P1460, DOI 10.12688/gatesopenres.12928.1; Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; Rutherford ME, 2010, TROP MED INT HEALTH, V15, P508, DOI 10.1111/j.1365-3156.2010.02497.x; Sengayi M, 2013, GLOBAL HEALTH ACTION, V6, P169, DOI 10.3402/gha.v6i0.19248; Tette EMA., 2016, PLOS ONE, V11, P2003; Thurtle N, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001739; Umuhoza Christian, 2018, Pan Afr Med J, V30, P160, DOI 10.11604/pamj.2018.30.160.15286; UNICEF, 2019, CHILDR FOOD NUTR STA; UNICEF, 2020, HUMANITARIAN ACTION; United Nations, 2015, 17 GOALS; van den Boogaard W, 2012, PUBLIC HEALTH ACTION, V2, P117, DOI 10.5588/pha.12.0038; Veirum JE, 2007, ACTA PAEDIATR, V96, P1526, DOI 10.1111/j.1651-2227.2007.00467.x; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262073	10.1371/journal.pone.0262073	http://dx.doi.org/10.1371/journal.pone.0262073			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972177	gold, Green Accepted, Green Published			2022-12-27	WOS:000773555700090
J	Nightingale, G; Laxton, M; Illian, JB				Nightingale, Glenna; Laxton, Megan; Illian, Janine B.			How does the community COVID-19 level of risk impact on that of a care home?	PLOS ONE			English	Article							MODELS	Objectives To model the risk of COVID-19 mortality in British care homes conditional on the community level risk. Methods A two stage modeling process ("doubly latent") which includes a Besag York Mollie model (BYM) and a Log Gaussian Cox Process. The BYM is adopted so as to estimate the community level risks. These are incorporated in the Log Gaussian Cox Process to estimate the impact of these risks on that in care homes. Results For an increase in the risk at the community level, the number of COVID-19 related deaths in the associated care home would be increased by exp (0.833), 2. This is based on a simulated dataset. In the context of COVID-19 related deaths, this study has illustrated the estimation of the risk to care homes in the presence of background community risk. This approach will be useful in facilitating the identification of the most vulnerable care homes and in predicting risk to new care homes. Conclusions The modeling of two latent processes have been shown to be successfully facilitated by the use of the BYM and Log Gaussian Cox Process Models. Community COVID-19 risks impact on that of the care homes embedded in these communities.	[Nightingale, Glenna] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland; [Laxton, Megan; Illian, Janine B.] Univ Glasgow, Sch Math & Stat, Glasgow, Lanark, Scotland	University of Edinburgh; University of Glasgow	Nightingale, G (corresponding author), Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland.	glenna.evans@gmail.com		Laxton, Megan/0000-0002-5017-7395; Nightingale, Glenna/0000-0002-0110-3939				Bakka H, 2018, WILEY INTERDISCIP RE, V10, DOI 10.1002/wics.1443; Brix A, 2001, J R STAT SOC B, V63, P823, DOI 10.1111/1467-9868.00315; Burton JK, 2020, LANCET HEALTH LONGEV, V1, pE21, DOI 10.1016/S2666-7568(20)30012-X; Dutey-Magni PF, 2021, AGE AGEING, V50, P1019, DOI 10.1093/ageing/afab060; Emmerson C, 2021, INFLUENZA OTHER RESP, V15, P371, DOI 10.1111/irv.12831; Grabowski DC, 2020, JAMA-J AM MED ASSOC, V324, P23, DOI 10.1001/jama.2020.8524; Illian JB, 2012, ANN APPL STAT, V6, P1499, DOI 10.1214/11-AOAS530; J C.-H.A.a.Z., 2020, MORTALITY ASS COVID; Johnson O, 2019, STAT MED, V38, P4871, DOI 10.1002/sim.8339; Lindgren F., INLA FUNCTIONS WHICH; Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x; Moraga P., 2019, GEOSPATIAL HLTH DATA; Moraga P, 2018, R J, V10, P495; Moraga P, 2012, COMPUT STAT DATA AN, V56, P1417, DOI 10.1016/j.csda.2011.11.011; NHS Services Scotland, 2020, VENTILATION WATER EN; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Salcher-Konrad M, 2020, COVID 19 RELATED MOR, DOI 10.1101/2020.06.09.20125237; Soriano-Redondo A, 2019, ECOGRAPHY, V42, P1092, DOI 10.1111/ecog.03771	18	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0260051	10.1371/journal.pone.0260051	http://dx.doi.org/10.1371/journal.pone.0260051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972103	Green Accepted, Green Published, gold			2022-12-27	WOS:000773555700012
J	Haseeb, M; Iqbal, S; Hafeez, MB; Saddiq, MS; Zahra, N; Raza, A; lbrahim, MU; Iqbal, J; Kamran, M; Ali, Q; Javed, T; Ali, HM; Siddiqui, MH				Haseeb, Muhammad; Iqbal, Shahid; Hafeez, Muhammad Bilal; Saddiq, Muhammad Sohail; Zahra, Noreen; Raza, Ali; lbrahim, Muhammad Usman; Iqbal, Javaid; Kamran, Muhammad; Ali, Qasim; Javed, Talha; Ali, Hayssam M.; Siddiqui, Manzer H.			Phytoremediation of nickel by quinoa: Morphological and physiological response	PLOS ONE			English	Article							HEAVY-METALS; CADMIUM; SOILS; CHENOPODIUM; METABOLISM; MECHANISMS; TOLERANCE; TOMATO; IMPACT; GROWTH	The amount of soil contaminated with heavy metal increases due to urbanization, industrialization, and anthropogenic activities. Quinoa is considered a useful candidate in the remediation of such soil. In this pot experiment, the phytoextraction capacity of quinoa lines (A1, A2, A7, and A9) against different nickel (Ni) concentrations (0, 50, and 100 mg kg(-1)) were investigated. Required Ni concentrations were developed in polythene bags filled with sandy loam soil using nickel nitrate salt prior to two months of sowing and kept sealed up to sowing. Results showed that translocation of Ni increased from roots to shoots with an increase in soil Ni concentration in all lines. A2 line accumulated high Ni in leaf compared to the root as depicted by translocation factor 3.09 and 3.21 when grown at soil having 50 and 100 Ni mg kg(-1), respectively. While, in the case of root, A7 accumulated high Ni followed by A9, A1, and A2, respectively. There was a 5-7% increased seed yield by 50 mg kg(-1) Ni in all except A1 compared to control. However, growth and yield declined with a further increase in Ni level. The maximum reduction in yield was noticed in A9, which was strongly linked with poor physiological performance, e.g., chlorophyll a, b, and phenolic contents. Ni concentrations in the seed of all lines were within the permissible value set (67 ppm) by FAO/WHO. The result of the present study suggests that quinoa is a better accumulator of Ni. This species can provide the scope of decontamination of heavy metal polluted soil. The screened line can be used for future quinoa breeding programs for bioremediation and phytoextraction purpose.	[Haseeb, Muhammad; Hafeez, Muhammad Bilal; lbrahim, Muhammad Usman; Kamran, Muhammad] Univ Agr Faisalabad, Dept Agron, Faisalabad, Pakistan; [Iqbal, Shahid] Univ Agr, Dept Agron, Muhammad Nawaz Shareef, Multan, Pakistan; [Saddiq, Muhammad Sohail; Iqbal, Javaid] Ghazi Univ, Dept Agron, Dera Ghazi Khan, Pakistan; [Zahra, Noreen] Univ Agr Faisalabad, Dept Bot, Faisalabad, Pakistan; [Raza, Ali] Fujian Agr & Forestry Univ, Oil Crops Res Inst, Ctr Legume Crop Genet & Syst Biol, Fujian Prov Key Lab Crop Mol & Cell Biol,Coll Agr, Fuzhou, Peoples R China; [Ali, Qasim] Univ Florida, Inst Food & Agr Sci, Gainesville, FL 32611 USA; [Javed, Talha] Fujian Agr & Forestry Univ, Coll Agr, Fuzhou, Peoples R China; [Ali, Hayssam M.; Siddiqui, Manzer H.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh, Saudi Arabia	University of Agriculture Faisalabad; University of Agriculture Faisalabad; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Fujian Agriculture & Forestry University; State University System of Florida; University of Florida; Fujian Agriculture & Forestry University; King Saud University	Saddiq, MS; Raza, A (corresponding author), Univ Agr Faisalabad, Dept Agron, Faisalabad, Pakistan.; Saddiq, MS (corresponding author), Ghazi Univ, Dept Agron, Dera Ghazi Khan, Pakistan.; Raza, A (corresponding author), Fujian Agr & Forestry Univ, Oil Crops Res Inst, Ctr Legume Crop Genet & Syst Biol, Fujian Prov Key Lab Crop Mol & Cell Biol,Coll Agr, Fuzhou, Peoples R China.	sohail1540@gmail.com; alirazamughal143@gmail.com	Siddiqui, Manzer H/Q-1519-2017	Siddiqui, Manzer H/0000-0003-2840-4608	Higher Education Comission (HEC) of Pakistan; King Saud University, Riyadh, Saudi Arabia [RSP-2021/123]	Higher Education Comission (HEC) of Pakistan; King Saud University, Riyadh, Saudi Arabia(King Saud University)	MH, SI, MSS, JI, and MK were financially supported by the Higher Education Comission (HEC) of Pakistan. HMA and MHS were financially supported by the Researchers Supporting Project number (RSP-2021/123), King Saud University, Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elwafa SF, 2019, ECOTOX ENVIRON SAFE, V173, P366, DOI 10.1016/j.ecoenv.2019.02.022; Ahmad MSA, 2007, B ENVIRON CONTAM TOX, V78, P319, DOI 10.1007/s00128-007-9182-y; Al-Whaibi MH, 2012, PROTOPLASMA, V249, P769, DOI 10.1007/s00709-011-0322-1; Ali B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123328; Ali B, 2013, ECOTOX ENVIRON SAFE, V92, P271, DOI 10.1016/j.ecoenv.2013.02.006; Amari T., 2016, J BIOREMEDIATION BIO, V7; Amari T, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9030312; Aqeel M, 2021, ENVIRON SCI POLLUT R, V28, P27376, DOI 10.1007/s11356-021-12579-5; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bai C, 2006, PLANT PHYSIOL, V140, P433, DOI 10.1104/pp.105.072983; Berni R, 2019, ENVIRON EXP BOT, V161, P98, DOI 10.1016/j.envexpbot.2018.10.017; Bhargava A, 2008, ACTA PHYSIOL PLANT, V30, P111, DOI 10.1007/s11738-007-0097-3; Chakankar M, 2016, AER ADV ENG RES, V115, P539; Colpas GJ, 2000, J BIOL CHEM, V275, P10731, DOI 10.1074/jbc.275.15.10731; Davies B. H., 1976, CHEM BIOCH PLANT PIG, V2, P38; GABBRIELLI R, 1990, PLANT SOIL, V122, P271, DOI 10.1007/BF02851985; Gad N., 2007, AUST J BASIC APPL SC, V1, P73; Guarino F, 2020, ECOTOX ENVIRON SAFE, V193, DOI 10.1016/j.ecoenv.2020.110345; Harasim P, 2015, J ELEMENTOL, V20, P525, DOI 10.5601/jelem.2014.19.3.651; Hasanuzzaman M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080681; Haseeb M, 2018, INT J AGRIC BIOL, V20, P338, DOI 10.17957/IJAB/15.0495; Hinojosa L, 2018, PLANTS-BASEL, V7, DOI 10.3390/plants7040106; Iftikhar A, 2022, ENVIRON GEOCHEM HLTH, V44, P257, DOI 10.1007/s10653-021-00937-8; Iqbal S, 2019, J AGRON CROP SCI, V205, P13, DOI 10.1111/jac.12290; Jacobsen S. E., 1993, European Journal of Agronomy, V2, P19, DOI 10.1016/S1161-0301(14)80148-2; JULKUNENTIITTO R, 1985, J AGR FOOD CHEM, V33, P213, DOI 10.1021/jf00062a013; Kamboj N., 2018, J PHARMACOGNOSY PHYT, V7, P3470; Karagiannidis N, 2002, COMMUN SOIL SCI PLAN, V33, P2247, DOI 10.1081/CSS-120005759; Khan K, 2013, FOOD CHEM TOXICOL, V58, P449, DOI 10.1016/j.fct.2013.05.014; Kumar N, 2021, EXTENDED ABSTRACTS OF THE 2021 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'21), DOI [10.1109/ICDABI53623.2021.9655928, 10.1145/3411763.3450389]; Lee CG, 2017, CHEMOSPHERE, V166, P203, DOI 10.1016/j.chemosphere.2016.09.093; Leskova A, 2020, PLANT CELL PHYSIOL, V61, P519, DOI 10.1093/pcp/pcz217; Liu WT, 2010, J HAZARD MATER, V173, P737, DOI 10.1016/j.jhazmat.2009.08.147; Malavolta E., 2007, Better Crops with Plant Food, V91, P26; Muhammad Haseeb, 2015, Agricultural Sciences, V6, P1413, DOI 10.4236/as.2015.612137; Mwamba TM, 2020, CHEMOSPHERE, V250, DOI 10.1016/j.chemosphere.2020.126308; Pandey N, 2002, PLANT SCI, V163, P753, DOI 10.1016/S0168-9452(02)00210-8; Pardo T, 2018, SCI TOTAL ENVIRON, V630, P275, DOI 10.1016/j.scitotenv.2018.02.229; Qin GW, 2021, CHEMOSPHERE, V267, DOI 10.1016/j.chemosphere.2020.129205; Rashid N, 2018, INT J AGRIC BIOL, V20, P157, DOI 10.17957/IJAB/15.0469; Raza A., 2021, APPROACHES REMEDIATI, P91, DOI DOI 10.1007/978-981-15-6221-1_6; Raza A, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9070177; Rehman F., 2011, BIOL MED, V3, P187; Sakihama Y, 2002, BIOL PLANTARUM, V45, P249, DOI 10.1023/A:1015152908241; Saleh SR, 2020, SCI TOTAL ENVIRON, V706, DOI 10.1016/j.scitotenv.2019.136013; Seregin IV, 2006, RUSS J PLANT PHYSL+, V53, P257, DOI 10.1134/S1021443706020178; Shahzad B, 2018, PLANT PHYSIOL BIOCH, V132, P641, DOI 10.1016/j.plaphy.2018.10.014; Sipos P, 2002, P 17 C CARPATHIAN BA; Sule K, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183250; Thomas EC, 2015, CAN J PLANT SCI, V95, P397, DOI [10.4141/cjps-2014-228, 10.4141/CJPS-2014-228]; Valivand M, 2021, J PLANT GROWTH REGUL, V40, P313, DOI 10.1007/s00344-020-10101-8; van der Ent A, 2013, PLANT SOIL, V362, P319, DOI 10.1007/s11104-012-1287-3; Williams S., 1984, OFFICIAL METHODS ANA; WOLF B, 1982, COMMUN SOIL SCI PLAN, V13, P1035, DOI 10.1080/00103628209367332; Yang X, 2005, J TRACE ELEM MED BIO, V18, P339, DOI 10.1016/j.jtemb.2005.02.007; Zahra N, 2021, PHYSIOL PLANTARUM, V173, P201, DOI 10.1111/ppl.13361; Zeeshan M, 2020, J CLEAN PROD, V255, DOI 10.1016/j.jclepro.2020.120318	58	5	5	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262309	10.1371/journal.pone.0262309	http://dx.doi.org/10.1371/journal.pone.0262309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025916	Green Published, gold			2022-12-27	WOS:000796264200057
J	Thavarajah, D; Lawrence, TJ; Powers, SE; Kay, J; Thavarajah, P; Shipe, E; McGee, R; Kumar, S; Boyles, R				Thavarajah, Dil; Lawrence, Tristan J.; Powers, Sarah E.; Kay, Joshua; Thavarajah, Pushparajah; Shipe, Emerson; McGee, Rebecca; Kumar, Shiv; Boyles, Rick			Organic dry pea (Pisum sativum L.) biofortification for better human health	PLOS ONE			English	Article							NITROGEN-FIXATION; WHOLE FOOD; PERFORMANCE; CULINARIS; LENTIL; IRON; ZINC	A primary criticism of organic agriculture is its lower yield and nutritional quality compared to conventional systems. Nutritionally, dry pea (Pisum sativum L.) is a rich source of low digestible carbohydrates, protein, and micronutrients. This study aimed to evaluate dry pea cultivars and advanced breeding lines using on-farm field selections to inform the development of biofortified organic cultivars with increased yield and nutritional quality. A total of 44 dry pea entries were grown in two USDA-certified organic on-farm locations in South Carolina (SC), United States of America (USA) for two years. Seed yield and protein for dry pea ranged from 61 to 3833 kg ha(-1) and 12.6 to 34.2 g/100 g, respectively, with low heritability estimates. Total prebiotic carbohydrate concentration ranged from 14.7 to 26.6 g/100 g. A 100-g serving of organic dry pea provides 73.5 to 133% of the recommended daily allowance (%RDA) of prebiotic carbohydrates. Heritability estimates for individual prebiotic carbohydrates ranged from 0.27 to 0.82. Organic dry peas are rich in minerals [iron (Fe): 1.9-26.2 mg/100 g; zinc (Zn): 1.1-7.5 mg/100 g] and have low to moderate concentrations of phytic acid (PA:18.8-516 mg/100 g). The significant cultivar, location, and year effects were evident for grain yield, thousand seed weight (1000-seed weight), and protein, but results for other nutritional traits varied with genotype, environment, and interactions. "AAC Carver," "Jetset," and "Mystique" were the best-adapted cultivars with high yield, and "CDC Striker," "Fiddle," and "Hampton" had the highest protein concentration. These cultivars are the best performing cultivars that should be incorporated into organic dry pea breeding programs to develop cultivars suitable for organic production. In conclusion, organic dry pea has potential as a winter cash crop in southern climates. Still, it will require selecting diverse genetic material and location sourcing to develop improved cultivars with a higher yield, disease resistance, and nutritional quality.	[Thavarajah, Dil; Lawrence, Tristan J.; Powers, Sarah E.; Kay, Joshua; Thavarajah, Pushparajah; Shipe, Emerson] Clemson Univ, Plant & Environm Sci, Pulse Qual & Nutr Breeding, Biosyst Res Complex, Clemson, SC 29634 USA; [McGee, Rebecca] Washington State Univ, Grain Legume Genet & Physiol Res Unit, USDA ARS, Pullman, WA USA; [Kumar, Shiv] Int Ctr Agr Res Dry Areas ICARDA, Biodivers & Crop Improvement Program, Rabat, Morocco; [Boyles, Rick] PeeDee Res & Educ Ctr, Plant & Environm Sci, Florence, SC USA	Clemson University; United States Department of Agriculture (USDA); Washington State University; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA)	Thavarajah, D (corresponding author), Clemson Univ, Plant & Environm Sci, Pulse Qual & Nutr Breeding, Biosyst Res Complex, Clemson, SC 29634 USA.	dthavar@clemson.edu		Thavarajah, Dil/0000-0002-4251-7476; Kay, Joshua/0000-0002-3639-6508; Kumar, Shiv/0000-0001-8407-3562; Powers, Sarah/0000-0001-7392-8043	Organic Agriculture Research and Extension Initiative (OREI) of the United States Department of Agriculture, National Institute of Food and Agriculture [2018-5130028431, 2018-02799]; USDA-ARS Pulse Health Initiative; Specialty Crop Block Grant Program of the U.S. Department of Agriculture [AM180100XXXXG026]; USDA National Institute of Food and Agriculture [1022664]; Good Food Institute	Organic Agriculture Research and Extension Initiative (OREI) of the United States Department of Agriculture, National Institute of Food and Agriculture; USDA-ARS Pulse Health Initiative; Specialty Crop Block Grant Program of the U.S. Department of Agriculture; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Good Food Institute	Funding support for this project was provided by the Organic Agriculture Research and Extension Initiative (OREI) (award no. 2018-5130028431/proposal no. 2018-02799) of the United States Department of Agriculture, National Institute of Food and Agriculture (DT and RB), and the USDA-ARS Pulse Health Initiative (DT); the Specialty Crop Block Grant Program of the U.S. Department of Agriculture through grant AM180100XXXXG026 (DT); the USDA National Institute of Food and Agriculture, [Hatch] project [1022664] (DT); and the Good Food Institute (DT). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the USDA.	Amarakoon D, 2015, J FOOD COMPOS ANAL, V37, P67, DOI 10.1016/j.jfca.2014.09.001; Amarakoon D, 2012, J FOOD COMPOS ANAL, V27, P8, DOI 10.1016/j.jfca.2012.05.007; Baird JM, 2009, CAN J PLANT SCI, V89, P1089, DOI 10.4141/CJPS08226; Bouis H, 2018, WORLD REV NUTR DIET, V118, P112, DOI 10.1159/000484342; Bouis HE, 2017, GLOB FOOD SECUR-AGR, V12, P49, DOI 10.1016/j.gfs.2017.01.009; Clark A., 2008, MANAGING COVER CROP; Crowder DW, 2015, P NATL ACAD SCI USA, V112, P7611, DOI 10.1073/pnas.1423674112; FAO, 2020, FAOSTAT FAOSTATS CRO; Georgieva N, 2017, BIOL AGRIC HORTIC, V33, P225, DOI 10.1080/01448765.2017.1303791; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gollner G, 2019, NUTR CYCL AGROECOSYS, V115, P391, DOI 10.1007/s10705-019-10021-4; Holdsworth WL, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.17; Jha AB, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9010073; Johnson CR, 2013, FOOD RES INT, V51, P107, DOI 10.1016/j.foodres.2012.11.025; Johnson CR., 2015, J FOOD COMPOS ANAL, V44; Johnson N, 2020, PLANTS PEOPLE PLANET, V2, P310, DOI 10.1002/ppp3.10103; Johnson N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93475-3; Kniss AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165851; Kniss AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161673; Kumar J, 2016, J AGR FOOD CHEM, V64, P6383, DOI 10.1021/acs.jafc.6b02171; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Linda MiloOhr, 2020, FOOD TECHNOLOGY MAGA, V74; Muir JG, 2009, J AGR FOOD CHEM, V57, P554, DOI 10.1021/jf802700e; Murphy KM, 2007, FIELD CROP RES, V102, P172, DOI 10.1016/j.fcr.2007.03.011; Ntatsi G, 2019, ARCH AGRON SOIL SCI, V65, P294, DOI 10.1080/03650340.2018.1501155; PEOPLES MB, 1995, PLANT SOIL, V174, P3, DOI 10.1007/BF00032239; Powers S, 2021, G3-GENES GENOM GENET, V11, DOI 10.1093/g3journal/jkab227; Powers S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75804-0; Powers SE, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01489; Powers SE., 2019, FRONT PLANT SCI, P10, DOI [10.3389/fpls.2019.00010, DOI 10.3389/FPLS.2019.00010]; Ray H, 2014, CROP SCI, V54, P1698, DOI 10.2135/cropsci2013.08.0568; Reganold JP, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.221, 10.1038/nplants.2015.221]; SAS Institute Inc, 2013, US GUID; Thavarajah D., 2015, PHENOMICS CROP PLANT, P223; Thavarajah D, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6030034; Thavarajah D, 2011, EUPHYTICA, V180, P123, DOI 10.1007/s10681-011-0365-6; Thavarajah D, 2009, J AGR FOOD CHEM, V57, P5413, DOI 10.1021/jf900786e; Thavarajah P, 2009, J AGR FOOD CHEM, V57, P9044, DOI 10.1021/jf901636p; Trewavas A, 2001, NATURE, V410, P409, DOI 10.1038/35068639; USAPulses, PROC INF TECHN MAN; USDA, 2016, USDA ORG AGR PROGR; Vandemark G, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00112; Wang N, 2009, LWT-FOOD SCI TECHNOL, V42, P842, DOI 10.1016/j.lwt.2008.10.007; Wiebe L, 2017, CAN J PLANT SCI, V97, P298, DOI 10.1139/cjps-2016-0141	45	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261109	10.1371/journal.pone.0261109	http://dx.doi.org/10.1371/journal.pone.0261109			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025919	gold, Green Published			2022-12-27	WOS:000796264200011
J	Akther, T; Nur, T				Akther, Taslima; Nur, Tasnima			A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use	PLOS ONE			English	Article							FAKE NEWS; TECHNOLOGY; BEHAVIOR; INTENTIONS; HESITANCY; PEOPLE	The aim of this study is to investigate the key factors influencing the acceptance of COVID-19 vaccines and develop a model based on the theory of reasoned action, belief in conspiracy theory, awareness, perceived usefulness, and perceived ease of use. The authors created and distributed a self-administered online questionnaire using Google Forms. Data were collected from 351 respondents ranging in age from 19 to 30 years, studying at the graduate and postgraduate levels at various public universities in Bangladesh. The Partial Least Squares Structural Equation Modeling (PLS-SEM) method was used to analyze the data. The results indicate that belief in conspiracy theory undermines COVID-19 vaccine acceptance, thereby negatively impacting the individual attitudes, subjective norms, and acceptance. Individual awareness, on the other hand, has a strong positive influence on the COVID-19 vaccine acceptance. Furthermore, the perceived usefulness of vaccination and the perceived ease of obtaining the vaccine positively impact attitude and the acceptance of immunization. Individuals' positive attitudes toward immunization and constructive subjective norms have a positive impact on vaccine acceptance. This study contributes to the literature by combining the theory of reasoned action with conspiracy theory, awareness, perceived usefulness, and perceived ease of use to understand vaccine acceptance behavior. Authorities should focus on campaigns that could reduce misinformation and conspiracy surrounding COVID-19 vaccination. The perceived usefulness of vaccination to prevent pandemics and continue normal education will lead to vaccination success. Furthermore, the ease with which people can obtain the vaccine and that it is free of cost will encourage students to get vaccinated to protect themselves, their families, and society.	[Akther, Taslima] Jagannath Univ, Fac Business Studies, Dept Accounting & Informat Syst, Dhaka, Bangladesh; [Nur, Tasnima] Inst Chartered Accountants Bangladesh, Dhaka, Bangladesh		Akther, T (corresponding author), Jagannath Univ, Fac Business Studies, Dept Accounting & Informat Syst, Dhaka, Bangladesh.	taslima@ais.jnu.ac.bd	Akther, Taslima/AAC-1670-2021	Akther, Taslima/0000-0002-8764-2692				Ajzen I, 1998, PSYCHOL HEALTH, V13, P735, DOI 10.1080/08870449808407426; Ajzen I., 1980, UNDERSTANDING ATTITU; [Anonymous], 2021, LIST U BANGLADESH WI; [Anonymous], 2021, CORONAVIRUS DIS COVI; [Anonymous], 2021, DHAKA TRIBUNE; [Anonymous], 2021, WHO DIRECTOR GEN OPE; [Anonymous], 2021, NAMING CORONAVIRUS D; [Anonymous], 2021, COVID 19 VACCINES AD; [Anonymous], 2021, BANGLADESH COVID 19; [Anonymous], 2021, ORIGIN SARS COV 2; [Anonymous], 2021, PROTHOMALO; [Anonymous], 2021, NOVEL CORONAVIRUS 20; Aylward RB, 2005, AM J PUBLIC HEALTH, V95, P773, DOI 10.2105/AJPH.2004.055897; Bertin P, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.565128; Bhattacharjee S., 2020, 1 DRAFT CASE STUDY U; Biglan A, 2000, AM J COMMUN PSYCHOL, V28, P269, DOI 10.1023/A:1005155903801; Bogart LM, 2010, JAIDS-J ACQ IMM DEF, V53, P648, DOI 10.1097/QAI.0b013e3181c57dbc; Brotherton R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00279; Carleton RA, 1996, CIRCULATION, V93, P1768, DOI 10.1161/01.CIR.93.9.1768; CARLSON M, 1988, J PERS SOC PSYCHOL, V55, P211, DOI 10.1037/0022-3514.55.2.211; Cialdini R.B., 1998, HDB SOCIAL PSYCHOL, P151; Cookson D, 2021, GROUP PROCESS INTERG, V24, P759, DOI 10.1177/1368430221993907; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Dinev T, 2007, J ASSOC INF SYST, V8, P386, DOI 10.17705/1jais.00133; Douglas KM, 2021, GROUP PROCESS INTERG, V24, P270, DOI 10.1177/1368430220982068; Douglas KM, 2019, POLIT PSYCHOL, V40, P3, DOI 10.1111/pops.12568; Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y; Eri Y, 2005, IEEE INT C MANAGEMEN; Fishbein M.A., 1975, PHILOS RHETORIC; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Freeman D, 2022, PSYCHOL MED, V52, P3127, DOI [10.1017/S0033291720005188, 10.1017/S0033291721002609]; GEISSER S, 1974, BIOMETRIKA, V61, P101, DOI 10.2307/2334290; Greene S.R., 2003, ANN M ASS STUD HIGH, P213; Hair JF, 2012, J ACAD MARKET SCI, V40, P414, DOI 10.1007/s11747-011-0261-6; Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202; Henseler J, 2016, IND MANAGE DATA SYST, V116, P2, DOI 10.1108/IMDS-09-2015-0382; Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014; HILL RJ, 1977, CONTEMP SOCIOL, V6, P244, DOI 10.2307/2065853; Hornsey MJ, 2018, HEALTH PSYCHOL, V37, P307, DOI 10.1037/hea0000586; Hussain SF, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0195-3; Islam MS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251605; Islam MS, 2021, MEDRXIV, DOI 2021.02.16.21251802; Jolley D, 2020, BRIT J SOC PSYCHOL, V59, P628, DOI 10.1111/bjso.12394; Jolley D, 2019, BRIT J SOC PSYCHOL, V58, P534, DOI 10.1111/bjso.12311; Jolley D, 2017, J APPL SOC PSYCHOL, V47, P459, DOI 10.1111/jasp.12453; Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177; Jolley D, 2014, BRIT J PSYCHOL, V105, P35, DOI 10.1111/bjop.12018; Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022; Lane S, 2018, VACCINE, V36, P3861, DOI 10.1016/j.vaccine.2018.03.063; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lavorgna L, 2018, MULT SCLER RELAT DIS, V25, P175, DOI 10.1016/j.msard.2018.07.046; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Lewandowsky S, 2013, PSYCHOL SCI, V24, P622, DOI 10.1177/0956797612457686; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Mathieson K, 1991, INFORM SYST RES, V2, P173, DOI 10.1287/isre.2.3.173; Orosz G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01525; Piaget J., 1975, EQUILIBRIUM COGNITIV; Ramayah T, 2009, COMPUT HUM BEHAV, V25, P1222, DOI 10.1016/j.chb.2009.06.007; Ramayah T., 2004, GADJAH MADA INT J BU, V6, P405, DOI DOI 10.22146/GAMAIJB.5556; Reiter PL, 2020, VACCINE, V38, P6500, DOI 10.1016/j.vaccine.2020.08.043; Reynolds, 2002, PEDAGOGY CRITICAL AP, V2, P229, DOI DOI 10.1215/15314200-2-2-229; Ringle CM, 2013, J BUS RES, V66, P1318, DOI 10.1016/j.jbusres.2012.02.031; Ritchie H., 2021, OUR WORLD DATA; Rogers E., 1962, DIFFUSION INNOVATION; Sallam M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052407; Sarstedt M., 2017, HDB MARKET RES, DOI [10.1007/978-3-319-57413-4_15, DOI 10.1007/978-3-319-05542-8_15-1]; Shammi M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04063; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Shmueli L, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10816-7; Siu-cheung Chan, 2004, Journal of Global Information Management, V12, P21, DOI 10.4018/jgim.2004070102; Snell Jr W.E, 1998, SEX MARITAL THER, V13, P191, DOI [10.1080/02674659808406559, DOI 10.1080/02674659808406559]; Stecula DA, 2020, HARV KENNEDY SCH HKS, DOI [10.37016/mr-2020-007, DOI 10.37016/MR-2020-007]; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Suresh A., 2021, PUBLIC AWARENESS ACC; Swami V, 2010, APPL COGNITIVE PSYCH, V24, P749, DOI 10.1002/acp.1583; TAYLOR S, 1995, INFORM SYST RES, V6, P144, DOI 10.1287/isre.6.2.144; Terry DJ, 1996, PERS SOC PSYCHOL B, V22, P776, DOI 10.1177/0146167296228002; Tsui L, 2000, REV HIGH EDUC, V23, P421; Waszak PM, 2018, HEALTH POLICY TECHN, V7, P115, DOI 10.1016/j.hlpt.2018.03.002; Xu FJ, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11205798	82	12	12	8	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261869	10.1371/journal.pone.0261869	http://dx.doi.org/10.1371/journal.pone.0261869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020764	gold, Green Published			2022-12-27	WOS:000834207700027
J	Dueker, ND; Beecham, A; Wang, LY; Dong, CH; Sacco, RL; Blanton, SH; Rundek, T				Dueker, Nicole D.; Beecham, Ashley; Wang, Liyong; Dong, Chuanhui; Sacco, Ralph L.; Blanton, Susan H.; Rundek, Tatjana			Rare variants in previously identified linkage regions associated with carotid plaque in Dominican Republic families	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; CORONARY-ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; ISCHEMIC-STROKE; CANDIDATE GENES; HEART-DISEASE; RISK; LOCI; ATHEROSCLEROSIS; METAANALYSIS	Carotid plaque is a subclinical measure of atherosclerosis. We have previously shown measures of carotid plaque to be heritable in a sample of 100 Dominican families and found evidence for linkage and association of common variants (CVs) on 7q36, 11p15, 14q32 and 15q23 with plaque presence. Our current study aimed to refine these regions further and identify rare variants (RVs) influencing plaque presence. Therefore, we performed targeted sequencing of the one LOD unit down region on 7q36, 11p15, 14q32 and 15q23 in 12 Dominican families with evidence for linkage to plaque presence. Gene-based RV analyses were performed using the Sequence Association Test for familial data (F-SKAT) under two filtering algorithms; 1. all exonic RVs and 2. non-synonymous RVs. Replication analyses were performed using a sample of 22 Dominican families and 556 unrelated Dominicans with Exome Array data. To identify additional non-synonymous RVs influencing plaque, we looked for co-segregation of RVs with plaque in each of the sequenced families. Our most strongly associated gene with evidence for replication was AMPD3 which showed suggestive association with plaque presence in the sequenced families (exonic RV p = 0.003, nonsynonymous RV p = 0.005) and replication families (exonic RV p = 0.04, nonsynonymous RV p = 0.02). Examination of the sequenced family pedigrees revealed two missense variants on chromosome 11 which co-segregated with plaque presence in one of our families; rs61751342 (located in DENND2B), and rs61760882 (located in RNF141). The rs61751342 missense variant is an eQTL for SCUBE2 in the atrial appendage. Notably, SCUBE2 encodes a protein which interacts with vascular endothelial growth factor (VEGF) receptor 2 to regulate VEGF-induced angiogenesis, thus providing biologic plausibility for this gene in atherosclerosis. In conclusion, using targeted sequencing of previously-identified linkage regions, we have identified suggestive evidence for the role of RVs in carotid plaque pathogenesis.	[Dueker, Nicole D.; Beecham, Ashley; Wang, Liyong; Blanton, Susan H.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL USA; [Wang, Liyong; Sacco, Ralph L.; Blanton, Susan H.] Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL USA; [Dong, Chuanhui; Sacco, Ralph L.; Rundek, Tatjana] Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL 33136 USA; [Sacco, Ralph L.; Rundek, Tatjana] Univ Miami, Dept Publ Hlth Sci, Miller Sch Med, Miami, FL 33136 USA; [Sacco, Ralph L.; Rundek, Tatjana] Univ Miami, Evelyn F McKnight Brain Inst, Dept Neurol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Rundek, T (corresponding author), Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL 33136 USA.; Rundek, T (corresponding author), Univ Miami, Dept Publ Hlth Sci, Miller Sch Med, Miami, FL 33136 USA.; Rundek, T (corresponding author), Univ Miami, Evelyn F McKnight Brain Inst, Dept Neurol, Miami, FL 33136 USA.	trundek@med.miami.edu			National Institutes of Health/National Institute for Neurological Disorders and Stroke [R01NS040807, R01NS29993]; Evelyn F. McKnight Brain Institute	National Institutes of Health/National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Evelyn F. McKnight Brain Institute	This work was supported by grants from the National Institutes of Health/National Institute for Neurological Disorders and Stroke (R01NS040807 and R01NS29993) and the Evelyn F. McKnight Brain Institute.	Abdullah MHN, 2012, J CARDIOL, V60, P192, DOI 10.1016/j.jjcc.2012.05.009; Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547; Bis JC, 2011, NAT GENET, V43, P940, DOI 10.1038/ng.920; Calabresi L, 2003, ARTERIOSCL THROM VAS, V23, P1724, DOI 10.1161/01.ATV.0000094961.74697.54; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Dong CH, 2012, ATHEROSCLEROSIS, V223, P177, DOI 10.1016/j.atherosclerosis.2012.03.025; Dong CH, 2010, STROKE, V41, P2750, DOI 10.1161/STROKEAHA.110.596981; Dueker ND, 2018, G3-GENES GENOM GENET, V8, P659, DOI 10.1534/g3.117.300358; Dueker ND, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167202; Elkind MSV, 2006, STROKE, V37, P13, DOI 10.1161/01.STR.0000195048.86810.5b; Eppinga RN, 2016, NAT GENET, V48, P1557, DOI 10.1038/ng.3708; Feng AF, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0608-0; Festa A, 1999, STROKE, V30, P1566, DOI 10.1161/01.STR.30.8.1566; Franceschini N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07340-5; Grady BJ, 2010, BIOCOMPUT-PAC SYM, P315; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hunt KJ, 2002, STROKE, V33, P2775, DOI 10.1161/01.STR.0000043827.03966.EF; Jeff JM, 2013, ANN HUM GENET, V77, P321, DOI 10.1111/ahg.12023; Johnsen Stein Harald, 2009, Curr Cardiol Rep, V11, P21; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kichaev G, 2019, AM J HUM GENET, V104, P65, DOI 10.1016/j.ajhg.2018.11.008; Kuipers AL, 2019, ATHEROSCLEROSIS, V291, P19, DOI 10.1016/j.atherosclerosis.2019.10.008; Lee CD, 2001, AM J EPIDEMIOL, V154, P758, DOI 10.1093/aje/154.8.758; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lin YC, 2017, ARTERIOSCL THROM VAS, V37, P144, DOI 10.1161/ATVBAHA.116.308546; Moskau S, 2005, STROKE, V36, P5, DOI 10.1161/01.STR.0000149936.33498.83; Pott J, 2017, ATHEROSCLEROSIS, V259, P32, DOI 10.1016/j.atherosclerosis.2017.02.018; Radicke S, 2005, J PHYSIOL-LONDON, V565, P751, DOI 10.1113/jphysiol.2005.087312; Rundek T, 2008, NEUROLOGY, V70, P1200, DOI 10.1212/01.wnl.0000303969.63165.34; Sacco RL, 2007, ETHNIC DIS, V17, P351; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Smolenski RT, 2014, CARDIOVASC DRUG THER, V28, P183, DOI 10.1007/s10557-013-6506-5; Tardif JC, 2010, EUR HEART J SUPPL, V12, pC2, DOI 10.1093/eurheartj/suq014; ten Sande JN, 2016, HEART RHYTHM, V13, P905, DOI 10.1016/j.hrthm.2015.12.006; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Toth PP, 2013, J CLIN LIPIDOL, V7, P484, DOI 10.1016/j.jacl.2013.08.001; Vergeer M, 2010, J LIPID RES, V51, P2058, DOI 10.1194/jlr.R001610; Wang LY, 2015, HUM GENET, V134, P1127, DOI 10.1007/s00439-015-1592-z; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yan Q, 2015, HUM HERED, V79, P60, DOI 10.1159/000375409	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0250799	10.1371/journal.pone.0250799	http://dx.doi.org/10.1371/journal.pone.0250799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020748	gold, Green Published			2022-12-27	WOS:000834207700003
J	Li, N; Zhou, GW; Zheng, YW; Lv, D; Zhu, XJ; Wei, P; Zheng, M; Liu, SJ; Zhou, EC; Sun, W; Zhang, L				Li, Ning; Zhou, Guowei; Zheng, Yawei; Lv, Dan; Zhu, Xiangjun; Wei, Ping; Zheng, Min; Liu, Shijia; Zhou, Enchao; Sun, Wei; Zhang, Lu			Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIORENAL SYNDROME; HEART-FAILURE; EMPAGLIFLOZIN; DAPAGLIFLOZIN; STATEMENT; MORTALITY	Introduction After stage 3 CKD, the risk of adverse cardiovascular events increased significantly. Therefore, we performed a meta-analysis to investigate the cardiovascular protective effect of SGLT2 inhibitors in patients with stage 3/4 CKD with different baseline kidney function or underlying diseases. Method To identify eligible trials, we systematically searched the Embase, PubMed, Web of Science, and Cochrane library databases from inception to April 15, 2021. The primary cardiovascular outcome was defined as a combination of cardiovascular mortality and hospitalization due to heart failure. Baseline kidney functions (stage 3a CKD: eGFR45-59mL/min per 1.73m2, stage 3b CKD: eGFR30-44mL/min per 1.73m2, stage 4 CKD: eGFR<30mL/min per 1.73m2) and underlying diseases (Type 2 diabetes, heart failure (Preserved ejection fraction or reduced ejection fraction), atherosclerotic cardiovascular disease) were used to stratify efficacy and safety outcomes. The results were subjected to a sensitivity analysis to ensure that they were reliable. Results In the present study, a total of eleven trials were included that involved a total of 27,823 patients with stage 3/4 CKD. The treatment and control groups contained 14,451 and 13,372 patients, respectively. In individuals with stage 3/4 CKD, SGLT2 inhibitors reduced the risk of primary cardiovascular outcomes by 26% (HR 0.74, [95% CI 0.69-0.80], I-2 = 0.00%), by 30% in patients with stage 3a CKD (HR 0.70, [95% CI 0.59-0.84], I-2 = 18.70%), by 23% in patients with stage 3b CKD (HR 0.77, [95% CI 0.66-0.90], I-2 = 2.12%), and by 29% in patients with stage 4 CKD (HR 0.71, [95% CI 0.53-0.96], I-2 = 0.00%). The risk of primary outcomes was reduced by 29% (HR 0.71, [95% CI 0.63-0.80], I-2 = 0.00%) in patients with type 2 diabetes, by 28% (HR 0.72, [95% CI 0.56-0.93], I-2 = 37.23%) in patients with heart failure with preserved ejection fraction, by 21% (HR 0.79, [95% CI 0.70-0.89], I-2 = 0.00%) in patients with heart failure with reduced ejection fraction, and by 25% (HR 0.75, [95% CI 0.64-0.88], I-2 = 0.00%) in patients with atherosclerotic cardiovascular disease. Conclusions For stage 3/4 CKD, SGLT2 inhibitors significantly decreased the risk of primary cardiovascular outcomes, and these benefits were consistent throughout the spectrum of different kidney functions, even in stage 4 CKD. There was no evidence of increased adverse outcomes across different baseline clinical complications, such as type 2 diabetes, heart failure, or atherosclerotic cardiovascular disease.	[Li, Ning; Zhou, Guowei; Zheng, Yawei; Lv, Dan; Zhu, Xiangjun; Wei, Ping; Zheng, Min; Liu, Shijia; Zhou, Enchao; Sun, Wei; Zhang, Lu] Nanjing Univ Chinese Med, Jiangsu Prov Hosp Chinese Med, Affilliated Hosp, Nanjing, Peoples R China	Nanjing University of Chinese Medicine	Zhang, L (corresponding author), Nanjing Univ Chinese Med, Jiangsu Prov Hosp Chinese Med, Affilliated Hosp, Nanjing, Peoples R China.	zhanglu@njucm.edu.cn		zheng, yawei/0000-0003-2497-7353	Special Project of National Clinical Research Base of Traditional Chinese Medicine	Special Project of National Clinical Research Base of Traditional Chinese Medicine	Special Project of National Clinical Research Base of Traditional Chinese Medicine.	Anker SD, 2021, NEW ENGL J MED, V385, P1451, DOI 10.1056/NEJMoa2107038; Bakris G, 2020, CLIN J AM SOC NEPHRO, V15, P1705, DOI 10.2215/CJN.10140620; Bakris GL, 2020, NEW ENGL J MED, V383, P2219, DOI 10.1056/NEJMoa2025845; Bhatt DL, 2021, NEW ENGL J MED, V384, P117, DOI 10.1056/NEJMoa2030183; Bhatt DL, 2021, NEW ENGL J MED, V384, P129, DOI 10.1056/NEJMoa2030186; Blaine J, 2012, NAT REV NEPHROL, V8, P376, DOI 10.1038/nrneph.2012.110; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Cannon CP, 2020, NEW ENGL J MED, V383, P1425, DOI 10.1056/NEJMoa2004967; Cao HY, 2021, DIABETES RES CLIN PR, V180, DOI 10.1016/j.diabres.2021.109033; Catapano Alberico L, 2017, Rev Esp Cardiol (Engl Ed), V70, P115, DOI 10.1016/j.rec.2017.01.002; Cherney DZI, 2021, DIABETES OBES METAB, V23, P2632, DOI 10.1111/dom.14513; Chertow GM, 2021, J AM SOC NEPHROL, V32, P2352, DOI 10.1681/ASN.2021020167; Chowdhury B, 2020, BIOCHEM BIOPH RES CO, V524, P50, DOI 10.1016/j.bbrc.2020.01.015; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; DeFronzo RA, 2017, NAT REV NEPHROL, V13, P11, DOI 10.1038/nrneph.2016.170; Del Vecchio L, 2021, DRUGS, V81, P1491, DOI 10.1007/s40265-021-01573-3; Egger M, 2003, Health Technol Assess, V7, P1; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Heerspink HJL, 2020, NEW ENGL J MED, V383, P1436, DOI 10.1056/NEJMoa2024816; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; House AA, 2018, AM J KIDNEY DIS, V72, P284, DOI 10.1053/j.ajkd.2017.12.006; Joubert M, 2017, DIABETES, V66, P1030, DOI 10.2337/db16-0733; Kanduri SR, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092723; Kumar N, 2018, CAN J PHYSIOL PHARM, V96, P1184, DOI 10.1139/cjpp-2018-0359; Kurth T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2392; Lu JL, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003328; Mahaffey KW, 2019, CIRCULATION, V140, P739, DOI 10.1161/CIRCULATIONAHA.119.042007; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; McMurray JJV, 2021, CIRCULATION, V143, P438, DOI 10.1161/CIRCULATIONAHA.120.051675; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Nincevic V, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235831; Packer M, 2020, NEW ENGL J MED, V383, P1413, DOI 10.1056/NEJMoa2022190; Packer M, 2020, DIABETES CARE, V43, P508, DOI 10.2337/dci19-0074; Page MJ, 2021, J CLIN EPIDEMIOL, V134, P178, DOI 10.1016/j.jclinepi.2021.03.001; Patel RB, 2021, J AM COLL CARDIOL, V78, P330, DOI 10.1016/j.jacc.2021.05.002; Perkovic V., 2019, NEW ENGL J MED, V380, P2295, DOI [10.1056/NEJMoa1811744, DOI 10.1056/NEJMOA1811744]; Rangaswami J, 2019, CIRCULATION, V139, pE840, DOI 10.1161/CIR.0000000000000664; Ronco C, 2018, ADV CHRONIC KIDNEY D, V25, P382, DOI 10.1053/j.ackd.2018.08.004; Salah HM, 2021, AM HEART J, V233, P86, DOI 10.1016/j.ahj.2020.12.007; Savira F, 2020, BRIT J PHARMACOL, V177, P2906, DOI 10.1111/bph.15065; Schefold JC, 2016, NAT REV NEPHROL, V12, P610, DOI 10.1038/nrneph.2016.113; Tyson CC, 2017, CLIN KIDNEY J, V10, P666, DOI 10.1093/ckj/sfx025; Uthman L, 2021, CARDIOVASC DRUG THER, V35, P1083, DOI 10.1007/s10557-020-07083-w; Vallon V, 2020, NAT REV NEPHROL, V16, P317, DOI 10.1038/s41581-020-0256-y; Verma S, 2019, CIRCULATION, V140, P1693, DOI 10.1161/CIRCULATIONAHA.119.042375; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Zinman B, 2016, NEW ENGL J MED, V374, P1094, DOI 10.1056/NEJMc1600827	48	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261986	10.1371/journal.pone.0261986	http://dx.doi.org/10.1371/journal.pone.0261986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020750	Green Published, gold			2022-12-27	WOS:000834207700031
J	Simes, JT; Jahn, JL				Simes, Jessica T.; Jahn, Jaquelyn L.			The consequences of Medicaid expansion under the Affordable Care Act for police arrests	PLOS ONE			English	Article							SYRINGE EXCHANGE PROGRAMS; HEALTH-INSURANCE COVERAGE; SUBSTANCE-ABUSE TREATMENT; USE DISORDERS; IMPACT; ACCESS; RATES; CRIMINALIZATION; SURVEILLANCE; ABOLITION	Background & methods National protests in the summer of 2020 drew attention to the significant presence of police in marginalized communities. Recent social movements have called for substantial police reforms, including "defunding the police," a phrase originating from a larger, historical abolition movement advocating that public investments be redirected away from the criminal justice system and into social services and health care. Although research has demonstrated the expansive role of police to respond a broad range of social problems and health emergencies, existing research has yet to fully explore the capacity for health insurance policy to influence rates of arrest in the population. To fill this gap, we examine the potential effect of Medicaid expansion under the Affordable Care Act (ACA) on arrests in 3,035 U.S. counties. We compare county-level arrests using FBI Uniform Crime Reporting (UCR) Program Data before and after Medicaid expansion in 2014-2016, relative to counties in non-expansion states. We use difference-in-differences (DID) models to estimate the change in arrests following Medicaid expansion for overall arrests, and violent, drug, and low-level arrests. Results Police arrests significantly declined following the expansion of Medicaid under the ACA. Medicaid expansion produced a 20-32% negative difference in overall arrests rates in the first three years. We observe the largest negative differences for drug arrests: we find a 25-41% negative difference in drug arrests in the three years following Medicaid expansion, compared to non-expansion counties. We observe a 19-29% negative difference in arrests for violence in the three years after Medicaid expansion, and a decrease in low-level arrests between 2428% in expansion counties compared to non-expansion counties. Our main results for drug arrests are robust to multiple sensitivity analyses, including a state-level model. Conclusions Evidence in this paper suggests that expanded Medicaid insurance reduced police arrests, particularly drug-related arrests. Combined with research showing the harmful health consequences of chronic policing in disadvantaged communities, greater insurance coverage creates new avenues for individuals to seek care, receive treatment, and avoid criminalization. As police reform is high on the agenda at the local, state, and federal level, our paper supports the perspective that broad health policy reforms can meaningfully reduce contact with the criminal justice system under historic conditions of mass criminalization.	[Simes, Jessica T.] Boston Univ, Dept Sociol, Boston, MA 02215 USA; [Jahn, Jaquelyn L.] Drexel Univ, Ubuntu Ctr Racism Global Movements & Populat Hlth, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA	Boston University; Drexel University	Simes, JT (corresponding author), Boston Univ, Dept Sociol, Boston, MA 02215 USA.	simes@bu.edu		Simes, Jessica/0000-0002-1083-600X				Abramson MF., 1972, PS, V23, P101; Adams K, 2008, CRIM JUSTICE BEHAV, V35, P913, DOI 10.1177/0093854808318624; Akbar AA, 2020, CALIF LAW REV, V108, P1781, DOI 10.15779/Z38M32NB2K; [Anonymous], 2014, STAT LOC FIN IN; [Anonymous], STAT STAT ACT MED EX; [Anonymous], 2020, ADV PUBL HLTH INT AD; [Anonymous], CRIM US 2019; Beck B, 2020, CITY COMMUNITY, V19, P245, DOI 10.1111/cico.12473; Beckett K., 2001, PUNISHMENT SOC, V3, P43, DOI DOI 10.1177/14624740122228249; Beckett K., 2010, BANISHED NEW SOCIAL; Brayne S, 2014, AM SOCIOL REV, V79, P367, DOI 10.1177/0003122414530398; Campbell KM, 2007, AM J ADDICTION, V16, P510, DOI 10.1080/10550490701641157; Cooper HLF, 2012, HEALTH PLACE, V18, P218, DOI 10.1016/j.healthplace.2011.09.005; Courtemanche C, 2017, J POLICY ANAL MANAG, V36, P178, DOI 10.1002/pam.21961; Courtemancheo C, 2020, RSF-RUS SAGE J SOC S, V6, P179, DOI 10.7758/RSF.2020.6.2.08; Creedon TB, 2016, HEALTH AFFAIR, V35, P1017, DOI 10.1377/hlthaff.2016.0098; Davis A., 2003, ARE PRISONS OBSOLETE; Davis A. Y., 2000, SOCIAL JUSTICE, V27, P212; Ettner SL, 2006, HEALTH SERV RES, V41, P192, DOI 10.1111/j.1475-6773.2005.00466.x; Feder KA, 2017, DRUG ALCOHOL DEPEN, V179, P271, DOI 10.1016/j.drugalcdep.2017.07.015; Fisher WH, 2006, ADM POLICY MENT HLTH, V33, P544, DOI 10.1007/s10488-006-0072-0; Fisher WH, 2011, PSYCHIAT SERV, V62, P67, DOI 10.1176/ps.62.1.pss6201_0067; Fry CE, 2020, RSF-RUS SAGE J SOC S, V6, P244, DOI [10.7758/rsf.2020.6.2.11, 10.7758/RSF.2020.6.2.11]; Gilbert AR, 2010, PSYCHIAT SERV, V61, P996, DOI 10.1176/ps.2010.61.10.996; Goodman L, 2017, J POLICY ANAL MANAG, V36, P211, DOI 10.1002/pam.21952; Harcourt BE., 2011, 1748796 SOC SCI RES; He QW, 2020, HEALTH ECON, V29, P261, DOI 10.1002/hec.3977; Hedegaard Holly, 2017, NCHS Data Brief, P1; Heller D., 2021, HEALTHCARE NOT HANDC; Hinton E, 2021, ANNU REV CRIMINOL, V4, P261, DOI 10.1146/annurev-criminol-060520-033306; Kaplan, 2019, JACOB KAPLANS CONCAT; Kravitz-Wirtz N, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19066; Krivo LJ, 2000, AM SOCIOL REV, V65, P547, DOI 10.2307/2657382; Lanford D, 2016, SOCIOL PERSPECT, V59, P619, DOI 10.1177/0731121415587605; Light MT, 2012, J QUANT CRIMINOL, V28, P559, DOI 10.1007/s10940-011-9162-6; Lilley DR, 2019, CRIME DELINQUENCY, V65, P352, DOI 10.1177/0011128718789856; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; Mark TL, 2016, HEALTH AFFAIR, V35, P958, DOI 10.1377/hlthaff.2016.0002; Martinez AN, 2007, J URBAN HEALTH, V84, P423, DOI 10.1007/s11524-006-9139-1; McLeod AM, 2015, UCLA LAW REV, V62, P1156; Miller S, 2017, NEW ENGL J MED, V376, P947, DOI 10.1056/NEJMsa1612890; Moriya AS, 2016, HEALTH AFFAIR, V35, P119, DOI 10.1377/hlthaff.2015.0949; Mosher C, 2001, CRIME DELINQUENCY, V47, P84, DOI 10.1177/0011128701047001004; Parker KF, 2005, CRIMINOLOGY, V43, P1111, DOI 10.1111/j.1745-9125.2005.00034.x; Perez A, 2003, CRIME DELINQUENCY, V49, P62, DOI 10.1177/0011128702239236; Rich JD, 2015, J GEN INTERN MED, V30, P503, DOI 10.1007/s11606-014-3142-0; Rich JD, 2014, HEALTH AFFAIR, V33, P462, DOI 10.1377/hlthaff.2013.1133; ROBERTS DE, 1991, HARVARD LAW REV, V104, P1419, DOI 10.2307/1341597; Roberts DE, 2019, HARVARD LAW REV, V133, P1; Rosenbaum S, 2011, PUBLIC HEALTH REP, V126, P130, DOI 10.1177/003335491112600118; Rudowitz R., 2019, 10 THINGS KNOW MEDIC; Saloner B, 2016, HEALTH AFFAIR, V35, P1058, DOI 10.1377/hlthaff.2016.0005; Sawyer W., 2020, MASS INCARCERATION W; Schwartz RP, 2017, DRUG ALCOHOL DEPEN, V180, P385, DOI 10.1016/j.drugalcdep.2017.08.025; Sewell AA, 2016, SOC SCI MED, V159, P1, DOI 10.1016/j.socscimed.2016.04.024; Sewell AA, 2020, CITY COMMUNITY, V19, P496, DOI 10.1111/cico.12517; Sharpley R., 2021, ROUTLEDGE INT HDB PE; Shepherd JP, 2017, JAMA-J AM MED ASSOC, V317, P1525, DOI 10.1001/jama.2017.1854; Shihipar A., 2020, NY TIMES 0427; Sommers BD, 2017, NEW ENGL J MED, V377, P586, DOI 10.1056/NEJMsb1706645; Teplin LA., 2000, NAT I JUSTICE J, P9, DOI [10.1037/e528652006-002, DOI 10.1037/E528652006-002]; Thomas KC, 2018, PSYCHIAT SERV, V69, P231, DOI 10.1176/appi.ps.201700044; Turney K, 2012, J HEALTH SOC BEHAV, V53, P465, DOI 10.1177/0022146512462400; Western B, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023429118; Zewde N, 2019, AM J PUBLIC HEALTH, V109, P1379, DOI 10.2105/AJPH.2019.305230	65	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261512	10.1371/journal.pone.0261512	http://dx.doi.org/10.1371/journal.pone.0261512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020737	Green Published, gold			2022-12-27	WOS:000834207700017
J	Zhu, ZL; Middleton, B; Pindilli, E; Johnson, D; Johnson, K; Covington, S				Zhu, Zhiliang; Middleton, Beth; Pindilli, Emily; Johnson, Darren; Johnson, Kurt; Covington, Scott			Conservation of carbon resources and values on public lands: A case study from the National Wildlife Refuge System	PLOS ONE			English	Article							OLD-GROWTH FORESTS; STORAGE; RATES; FIRE	Public lands in the United States are those land areas managed by federal, state, and county governments for public purposes such as preservation and recreation. Protecting carbon resources and increasing carbon sequestration capacity are compatible with public land management objectives for healthy and resilient habitats, i.e., managing habitats for the benefit of wildlife and ecosystem services can simultaneously capture and store carbon. To evaluate the effect of public land management on carbon storage and review carbon management as part of the land management objectives, we used existing data of carbon stock and net ecosystem carbon balance in a study of the National Wildlife Refuge System (NWRS), a public land management program of the U.S. Fish and Wildlife Service (Service). Total carbon storage of the 364 refuges studied was 16.6 PgC, with a mean value 42,981 gCm(-2). We used mixed modeling with Bonferroni adjustment techniques to analyze the effect of time since refuge designation on carbon storage. In general, older refuges store more carbon per unit area than younger refuges. In addition to the age factor, carbon resources are variable by regions and habitat types protected in the refuges. Mean carbon stock and the rate of sequestration are higher within refuges than outside refuges, but the statistical comparison of 364 refuges analyzed in this study was not significant. We also used the social cost of carbon to analyze the annual benefits of sequestrating carbon in these publicly managed lands in the United States, which is over $976 million per year in avoided CO2 emissions via specific conservation management actions. We examine case studies of management, particularly with respect to Service cooperation activities with The Conservation Fund (TCF) Go Zero (R) Program, Trust for Public Land (TPL) and individuals. Additional opportunities exist in improving techniques to maximize carbon resources in refuges, while continuing to meet the core purpose and need of the NWRS.	[Zhu, Zhiliang] US Geol Survey, 959 Natl Ctr, Reston, VA 22092 USA; [Middleton, Beth; Johnson, Darren] US Geol Survey, Wetland & Aquat Res Ctr, Lafayette, LA USA; [Pindilli, Emily] US Geol Survey, Sci & Decis Ctr, USGS Northeast Reg, Reston, VA USA; [Johnson, Kurt; Covington, Scott] US Fish & Wildlife Serv, Falls Church, VA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Zhu, ZL (corresponding author), US Geol Survey, 959 Natl Ctr, Reston, VA 22092 USA.	zzhu@usgs.gov	Zhu, Zhiliang/I-2686-2018	Zhu, Zhiliang/0000-0002-6860-6936				Allen ST, 2019, FOREST ECOL MANAG, V432, P345, DOI 10.1016/j.foreco.2018.09.041; Anthoff D, 2009, ENVIRON RESOUR ECON, V43, P351, DOI 10.1007/s10640-009-9269-5; Archie KM, 2012, ECOL SOC, V17, DOI 10.5751/ES-05187-170420; Ballanti L, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9111919; Burnham KP., 2004, MODEL SELECTION MULT, V2, DOI 10.1007/b97636; Cambardella CA, 2019, P 2018 2019 INT SOIL; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; Dilling L., 2013, LAND USE CARBON CYCL, P455; Drexler JZ, 2019, RESTOR ECOL, V27, P1117, DOI 10.1111/rec.12941; Drexler JZ, 2013, WETLANDS, V33, P965, DOI 10.1007/s13157-013-0456-3; Gergely KJ., 2016, GEOLOGICAL SURVEY FA; Guzman JG, 2010, J ENVIRON QUAL, V39, P136, DOI 10.2134/jeq2009.0063; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Hope C, 2008, ENERG ECON, V30, P1011, DOI 10.1016/j.eneco.2006.11.006; Ingraham MW, 2008, ECOL ECON, V67, P608, DOI 10.1016/j.ecolecon.2008.01.012; Interagency Working Group on Social Cost of Greenhouse Gases United States Government, 2016, TECHN SUPP DOC TECHN; Kroeger KD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12138-4; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; McGarvey JC, 2015, ECOLOGY, V96, P311, DOI 10.1890/14-1154.1; Merrill, 2018, US GEOLOGICAL SURVEY; Mickler RA, 2017, FIRE ECOL, V13, P34, DOI 10.4996/fireecology.1301034; Middleton B., 1999, WETLAND RESTORATION; Middleton BA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226998; Middleton Beth A., 2005, Wetlands Ecology and Management, V13, P15, DOI 10.1007/s11273-003-5024-9; Nahlik AM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13835; Parthum B, 2017, J ENVIRON MANAGE, V203, P375, DOI 10.1016/j.jenvman.2017.08.018; Pindilli E, 2018, ECOL ECON, V154, P145, DOI 10.1016/j.ecolecon.2018.08.002; Poulter B, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006455; Reddy AD, 2015, REMOTE SENS ENVIRON, V170, P306, DOI 10.1016/j.rse.2015.09.017; Richardson L., 2014, NPSNRSSEQDNRR2014880; SAS Institute Inc, 2012, SAS 9 3; Shoch DT, 2009, WETLANDS, V29, P535, DOI 10.1672/08-110.1; Sleeter BM, 2019, GLOBAL CHANGE BIOL, V25, P3334, DOI 10.1111/gcb.14677; Stackpoole S, 2011, GEOLOGICAL SURVEY FA; Stewart CE, 2009, SOIL BIOL BIOCHEM, V41, P357, DOI 10.1016/j.soilbio.2008.11.011; Stricker CA, 2019, J GEOPHYS RES-BIOGEO, V124, P2751, DOI 10.1029/2019JG005079; Tan ZX, 2015, P NATL ACAD SCI USA, V112, P12723, DOI 10.1073/pnas.1512542112; Tinling MA, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0093-4; U.S. Environmental Protection Agency (EPA), 2016, EPA FACT SHEET SOC C; U.S. Fish and Wildlife Service (USFWS), 2017, BIOL CARB SEQ ACC 20; United States Fish and Wildlife Service (USFWS), USFWS NAT CAD DAT; United States Fish and Wildlife Service (USFWS), USFWS NAT WILDL REF; US EPA, 2021, SOURC GREENH GAS EM; Vandegraff DL, 2005, GEOLOGICAL SURVEY OP; Ward S., 2015, ENV LAW I WASHINGTON, V36; Windham-Myers L, 2018, BLUE CARBON PRIMER S, DOI [10.1201/9780429435362, DOI 10.1201/9780429435362]; Zhu K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05132-5; Zhu Z., 2016, 1826 DEP INT GEOL SU, DOI [10.3133/pp1826, DOI 10.3133/PP1826]	48	0	0	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262218	10.1371/journal.pone.0262218	http://dx.doi.org/10.1371/journal.pone.0262218			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020751	gold, Green Published			2022-12-27	WOS:000834207700036
J	Druedahl, LC; Sporrong, SK; Minssen, T; Hoogland, H; De Bruin, ML; van de Weert, M; Almarsdottir, AB				Druedahl, Louise C.; Sporrong, Sofia Kalvemark; Minssen, Timo; Hoogland, Hans; De Bruin, Marie Louise; van de Weert, Marco; Almarsdottir, Anna Birna			Interchangeability of biosimilars: A study of expert views and visions regarding the science and substitution	PLOS ONE			English	Article							QUALITATIVE RESEARCH; HEALTH; CHALLENGES; MEDICINES	Healthcare systems have reached a critical point regarding the question of whether biosimilar substitution should become common practice. To move the discussion forward, the study objective was to investigate the views of experts from medicines agencies and the pharmaceutical industry on the science underpinning interchangeability of biosimilars. We conducted an empirical qualitative study using semi-structured interviews informed by a cross-disciplinary approach encompassing regulatory science, law, and pharmaceutical policy. In total 25 individuals with experience within biologics participated during September 2018-August 2019. Eight participants were EU national medicines authority regulators, and 17 had pharmaceutical industry background: five from two originator-only companies, four from two companies with both biosimilar and originator products, and eight from seven biosimilar-only companies. Two analysts independently conducted inductive content analysis, resulting in data-driven themes capturing the meaning of the data. The participants reported that interchangeability was more than a scientific question of likeness between biosimilar and reference products: it also pertained to regulatory practices and trust. Participants were overall confident in the science behind exchanging biosimilar products for the reference products via switching, i.e., with physician involvement. However, their opinions differed regarding the scientific risk associated with biosimilar substitution, i.e., without physician involvement. Almost all participants saw no need for additional scientific data to support substitution. Moreover, the participants did not believe that switching studies, as required in the US, were appropriate for obtaining scientific certainty due to their small size. It is unclear why biosimilar switching is viewed as scientifically safer than substitution; therefore, we expect greater policy debate on biosimilar substitution in the near future. We urge European and UK policymakers and regulators to clarify their visions for biosimilar substitution; the positions of these two frontrunners are likely to influence other jurisdictions on the future of biosimilar use.	[Druedahl, Louise C.; De Bruin, Marie Louise] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Ctr Regulatory Sci CORS, Dept Pharm, Copenhagen, Denmark; [Druedahl, Louise C.; Sporrong, Sofia Kalvemark; Almarsdottir, Anna Birna] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Social & Clin Pharm, Copenhagen, Denmark; [Druedahl, Louise C.; Minssen, Timo] Univ Copenhagen, Fac Law, Ctr Adv Studies Biomed Innovat Law CeBIL, Copenhagen, Denmark; [Sporrong, Sofia Kalvemark] Uppsala Univ, Fac Pharm, Dept Pharm, Social Pharm, Uppsala, Sweden; [Hoogland, Hans] LEO Pharma AS, Ballerup, Denmark; [De Bruin, Marie Louise] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [van de Weert, Marco] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Drug Delivery & Biophys Biopharmaceut, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Uppsala University; LEO Pharma; Utrecht University; University of Copenhagen	Druedahl, LC (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Ctr Regulatory Sci CORS, Dept Pharm, Copenhagen, Denmark.; Druedahl, LC (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Social & Clin Pharm, Copenhagen, Denmark.; Druedahl, LC (corresponding author), Univ Copenhagen, Fac Law, Ctr Adv Studies Biomed Innovat Law CeBIL, Copenhagen, Denmark.	louise.druedahl@jur.ku.dk	van de Weert, Marco/AGR-7726-2022; De Bruin, Marie Louise (Marieke)/O-5349-2016; Almarsdottir, Anna Birna/R-5299-2017	Hoogland, Hans/0000-0002-1508-9277; De Bruin, Marie Louise (Marieke)/0000-0001-9197-7068; Druedahl, Louise C./0000-0002-8979-8666; Minssen, Timo/0000-0002-3286-4888; Almarsdottir, Anna Birna/0000-0002-5354-2976; Kalvemark Sporrong, Sofia/0000-0001-5848-8625	LEO Pharma A/S; Collaborative Research Program for Biomedical Innovation Law, a scientifically independent research program - Novo Nordisk Foundation [NNF17SA0027784]	LEO Pharma A/S(LEO Pharma); Collaborative Research Program for Biomedical Innovation Law, a scientifically independent research program - Novo Nordisk Foundation	At the time of the study, LCD was funded by a PhD fellowship grant to the University of Copenhagen from LEO Pharma A/S, but the company has no commercial interest in the research. LEO Pharma A/S was aware of but had no decisive role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The following funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TM's work and LCD's current work is supported by the Collaborative Research Program for Biomedical Innovation Law, a scientifically independent research program supported by the Novo Nordisk Foundation (grant NNF17SA0027784).	Allens, WHIT PAP BIOL MED BI; [Anonymous], 2012, OJ C, V326, P47; [Anonymous], 2019, WHAT IS BIOS MED; Aronson JK, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3141; Ascef BD, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-00611-y; Barbier L, 2020, CLIN PHARMACOL THER, V108, P734, DOI 10.1002/cpt.1836; Chapman SR, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016730; Cohen HP, 2018, DRUGS, V78, P463, DOI 10.1007/s40265-018-0881-y; Druedahl LC, 2020, NAT BIOTECHNOL, V38, P1253, DOI 10.1038/s41587-020-0717-7; Druedahl LC, 2020, J LAW MED ETHICS, V48, P579, DOI 10.1177/1073110520958884; Druedahl LC, 2019, BASIC CLIN PHARMACOL, V124, P431, DOI 10.1111/bcpt.13147; EMA, 2019, BIOS EU INF GUID HEA; European Commission, 2020, PHARM STRAT EUR; European Medicines Agency, 2020, EMA REGULATORY SCI 2; European Medicines Agency, 2014, CHMP43704REV1 EUR ME; European Medicines Agency, 2016, EUR REG SYST MED CON; Evens R, 2015, HEALTH AFFAIR, V34, P210, DOI 10.1377/hlthaff.2014.1023; Federal Agency for Medicines and Health Products, 2020, BIOSIMILARS; Ferrario A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l5444; Glintborg B, 2019, ANN RHEUM DIS, V78, P192, DOI 10.1136/annrheumdis-2018-213474; Greene JA, 2019, CLIN PHARMACOL THER, V105, P290, DOI 10.1002/cpt.1316; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Irvine A, 2013, QUAL RES, V13, P87, DOI 10.1177/1468794112439086; Jasanoff S., 2015, DREAMSCAPES MODERNIT; Jensen TB, 2020, JAMA INTERN MED, V180, P902, DOI 10.1001/jamainternmed.2020.0338; Jensen TB, 2020, EUR J CLIN PHARMACOL, V76, P35, DOI 10.1007/s00228-019-02765-3; Kitto SC, 2008, MED J AUSTRALIA, V188, P243, DOI 10.5694/j.1326-5377.2008.tb01595.x; Kurki P, 2021, DRUGS, V81, P1881, DOI 10.1007/s40265-021-01601-2; Kurki P, 2015, EXPERT REV CLIN PHAR, V8, P649, DOI 10.1586/17512433.2015.1071188; Mack A, 2015, GABI J, V4, P90, DOI 10.5639/gabij.2015.0402.018; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Medicines for Europe, 2019, SCI CONSIDERATIONS D; Medicines & Healthcare products Regulatory Agency, CONS DOC MHRA GUID L; Meuser M, 2009, RES METHODS SER, P17; O'Callaghan J, 2019, EUR J CLIN PHARMACOL, V75, P1, DOI 10.1007/s00228-018-2542-1; O'Callaghan J, 2017, REGUL TOXICOL PHARM, V88, P252, DOI 10.1016/j.yrtph.2017.06.013; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Rathore AS, 2022, EXPERT OPIN BIOL TH, V22, P133, DOI 10.1080/14712598.2021.1889511; Regulation (EC) No 726/2004 of the European Parliament and of the Council, 2013, OFFICIAL J EUROPEAN; Reiland JB, 2017, GABI J, V6, P61, DOI 10.5639/gabij.2017.0602.014; Sarnola K, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034183; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Teeple A, 2019, CURR MED RES OPIN, V35, P611, DOI 10.1080/03007995.2019.1571296; The Cancer Vanguard Project, 2017, BIOS AD PROC TIM; The Finnish Medicines Agency, 2019, AUT SUBST BIOL MED W; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tsiftsoglou AS, 2014, BIODRUGS, V28, P479, DOI 10.1007/s40259-014-0109-y; U.S. Food and Drug Administration, 2020, BIOS; US Food and Drug Administration,, 2019, CONSIDERATIONS DEMON; van Overbeeke E, 2017, BIODRUGS, V31, P447, DOI 10.1007/s40259-017-0244-3; Vondeling GT, 2018, APPL HEALTH ECON HEA, V16, P653, DOI 10.1007/s40258-018-0406-6; Vulto AG, 2017, RHEUMATOLOGY, V56, P14, DOI 10.1093/rheumatology/kex278; Walsh G, 2018, NAT BIOTECHNOL, V36, P1136, DOI 10.1038/nbt.4305	53	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262537	10.1371/journal.pone.0262537	http://dx.doi.org/10.1371/journal.pone.0262537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015783	Green Published, gold			2022-12-27	WOS:000814820600032
J	Pamphlett, R; Bishop, DP				Pamphlett, Roger; Bishop, David P.			Mercury is present in neurons and oligodendrocytes in regions of the brain affected by Parkinson's disease and co-localises with Lewy bodies	PLOS ONE			English	Article							LOCUS-COERULEUS; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; METALS; MECHANISMS; BISMUTH; MICE; LOCALIZATION; NEUROMELANIN; FIBRILLATION	Objective Environmental toxicants are suspected to play a part in the pathogenesis of idiopathic Parkinson's disease (PD) and may underlie its increasing incidence. Mercury exposure in humans is common and is increasing due to accelerating levels of atmospheric mercury, and mercury damages cells via oxidative stress, cell membrane damage, and autoimmunity, mechanisms suspected in the pathogenesis of PD. We therefore compared the cellular distribution of mercury in the tissues of people with and without PD who had evidence of previous mercury exposure by mercury being present in their locus ceruleus neurons. Materials and methods Paraffin sections from the brain and general organs of two people with PD, two people without PD with a history of mercury exposure, and ten people without PD or known mercury exposure, were stained for inorganic mercury using autometallography, combined with immunostaining for alpha-synuclein and glial cells. All had mercury-containing neurons in locus ceruleus neurons. Laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) was used to confirm the presence of mercury and to look for other potentially toxic elements. Autometallography-stained locus ceruleus paraffin sections were examined to compare the frequency of previous mercury exposure between 20 PD and 40 non-PD individuals. Results In PD brains, autometallography-detected mercury was seen in neurons affected by the disease, such as those in the substantia nigra, motor cortex, striatum, thalamus, and cerebellum. Mercury was seen in oligodendrocytes in white and grey matter. Mercury often co-localised with Lewy bodies and neurites. A more restricted distribution of brain mercury was seen in people without PD (both with or without known mercury exposure), with no mercury present in the substantia nigra, striatum, or thalamus. The presence of autometallography-detected mercury in PD was confirmed with LA-ICP-MS, which demonstrated other potentially toxic metals in the locus ceruleus and high iron levels in white matter. Autometallography-detected mercury was found in locus ceruleus neurons in a similar proportion of PD (65%) and non-PD (63%) individuals. Conclusions In people with PD, mercury was found in neurons and oligodendrocytes in regions of the brain that are affected by the disease, and often co-localised with aggregated alpha-synuclein. Mercury in the motor cortex, thalamus and striatum could result in bradykinesia and rigidity, and mercury in the cerebellum could cause tremor. People without PD had a restricted uptake of mercury into the brain. The similar frequency of mercury in the locus ceruleus of people with and without PD suggests these two groups have had comparable previous mercury exposures but that PD brains have a greater predisposition to take up circulating mercury. While this post mortem study does not provide a direct link between mercury and idiopathic PD, it adds to the body of evidence that metal toxicants such as mercury play a role in the disease. A precautionary approach would be to reduce rising mercury levels in the atmosphere by limiting the burning of fossil fuels, which may be contributing to the increasing incidence of PD.	[Pamphlett, Roger] Univ Sydney, Brain & Mind Ctr, Sydney Med Sch, Sydney, NSW, Australia; [Pamphlett, Roger] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia; [Bishop, David P.] Univ Technol Sydney, Sch Math & Phys Sci, Elemental Bioimaging Facil, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Technology Sydney	Pamphlett, R (corresponding author), Univ Sydney, Brain & Mind Ctr, Sydney Med Sch, Sydney, NSW, Australia.; Pamphlett, R (corresponding author), Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia.	roger.pamphlett@sydney.edu.au	Bishop, David/F-2891-2019	Bishop, David/0000-0002-6533-4410				Aarsland D, 2017, NAT REV NEUROL, V13, P217, DOI 10.1038/nrneurol.2017.27; Ahmed Z, 2012, NEUROPATH APPL NEURO, V38, P4, DOI 10.1111/j.1365-2990.2011.01234.x; Ahn JS, 2018, J OCCUP HEALTH, V60, P89, DOI 10.1539/joh.16-0274-CS; Andrade V M, 2017, Adv Neurobiol, V18, P227, DOI 10.1007/978-3-319-60189-2_12; Andreoli V, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14010093; Ball N, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00218; Bloem BR, 2021, LANCET, V397, P2284, DOI 10.1016/S0140-6736(21)00218-X; Bonuccelli U, 1999, PARKINSONISM RELAT D, V5, P49, DOI 10.1016/S1353-8020(99)00010-3; Bostan AC, 2018, NAT REV NEUROSCI, V19, P338, DOI 10.1038/s41583-018-0002-7; Cai ZL, 2019, AGING CLIN EXP RES, V31, P1035, DOI 10.1007/s40520-018-1086-7; Caudle WM, 2012, NEUROTOXICOLOGY, V33, P585, DOI 10.1016/j.neuro.2012.04.011; CHANG LW, 1972, EXP NEUROL, V35, P122, DOI 10.1016/0014-4886(72)90064-7; Chen JH, 2019, NEUROEPIDEMIOLOGY, V52, P181, DOI 10.1159/000496977; Chohan H, 2021, MOVEMENT DISORD, V36, P1420, DOI 10.1002/mds.28551; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Cobbina SJ, 2015, CHEMOSPHERE, V132, P79, DOI 10.1016/j.chemosphere.2015.03.013; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Danscher G, 2000, J HISTOCHEM CYTOCHEM, V48, P1503, DOI 10.1177/002215540004801107; DANSCHER G, 1985, J HISTOCHEM CYTOCHEM, V33, P219, DOI 10.1177/33.3.2579122; DANSCHER G, 1994, NEUROPATH APPL NEURO, V20, P454, DOI 10.1111/j.1365-2990.1994.tb00996.x; DANSCHER G, 1986, HISTOCHEM J, V18, P109, DOI 10.1007/BF01675364; Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3; Dorsey ER, 2018, J PARKINSON DIS, V8, pS3, DOI 10.3233/JPD-181474; Dum RP, 2019, P NATL ACAD SCI USA, V116, P26321, DOI 10.1073/pnas.1902297116; Eraslan M, 2016, ACTA OPHTHALMOL, V94, pE68, DOI 10.1111/aos.12809; FAWER RF, 1983, BRIT J IND MED, V40, P204; Fellner L, 2013, MOL NEUROBIOL, V47, P575, DOI 10.1007/s12035-012-8340-3; Foffani G, 2018, NEURON, V99, P1116, DOI 10.1016/j.neuron.2018.07.028; Gesi M, 2000, NEUROSCI BIOBEHAV R, V24, P655, DOI 10.1016/S0149-7634(00)00028-2; Gironell A, 2018, PARKINSONS DIS-US, V2018, DOI 10.1155/2018/4327597; Goldman SM, 2014, ANNU REV PHARMACOL, V54, P141, DOI 10.1146/annurev-pharmtox-011613-135937; Gustin MS, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.139619; Hajee ME, 2009, ARCH OPHTHALMOL-CHIC, V127, P737, DOI 10.1001/archophthalmol.2009.106; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; HARGREAVES RJ, 1988, NEUROPATH APPL NEURO, V14, P443, DOI 10.1111/j.1365-2990.1988.tb01336.x; HARIK SI, 1984, ANN NEUROL, V15, P568, DOI 10.1002/ana.410150609; Hassani OK, 2020, NEUROBIOL AGING, V85, P22, DOI 10.1016/j.neurobiolaging.2019.09.014; Hou LY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00162; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Kullmann JAP, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122874; Lentini P, 2017, MOL MED REP, V15, P3413, DOI 10.3892/mmr.2017.6389; Levinthal DJ, 2012, J NEUROSCI, V32, P6726, DOI 10.1523/JNEUROSCI.0406-12.2012; Lockwood TE, 2021, ANAL CHEM, V93, P10418, DOI 10.1021/acs.analchem.1c02138; Louis ED, 2020, NAT REV NEUROL, V16, P69, DOI 10.1038/s41582-019-0302-1; Markesbery WR, 2009, J NEUROPATH EXP NEUR, V68, P816, DOI 10.1097/NEN.0b013e3181ac10a7; Martinez-Finley Ebany J, 2014, Curr Environ Health Rep, V1, P163, DOI 10.1007/s40572-014-0014-z; McGregor MM, 2019, NEURON, V101, P1042, DOI 10.1016/j.neuron.2019.03.004; Melendez-Flores JD, 2021, METAB BRAIN DIS, V36, P1, DOI 10.1007/s11011-020-00623-1; Munhoz RP, 2004, PARKINSONISM RELAT D, V10, P381, DOI 10.1016/j.parkreldis.2004.03.008; Nasrabady SE, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0515-3; Obrist D, 2018, AMBIO, V47, P116, DOI 10.1007/s13280-017-1004-9; Pamphlett R, 2000, NEUROTOXICOL TERATOL, V22, P559, DOI 10.1016/S0892-0362(00)00083-0; Pamphlett R, 1996, ACTA NEUROPATHOL, V92, P525, DOI 10.1007/s004010050556; Pamphlett R, 1998, J NEUROPATH EXP NEUR, V57, P360; Pamphlett R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96359-8; Pamphlett R, 2021, TOXICS, V9, DOI 10.3390/toxics9030067; Pamphlett R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82483-y; Pamphlett R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241054; Pamphlett R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231870; Pamphlett R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220859; Pamphlett R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203627; Paredes-Rodriguez E, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00435; Pollard KM, 2019, BBA-GEN SUBJECTS, V1863, DOI 10.1016/j.bbagen.2019.02.001; Raj K, 2021, NEUROSCI LETT, V753, DOI 10.1016/j.neulet.2021.135873; Reinert A, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0507-7; Rektor I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0187939; Robbins CB, 2021, JAMA OPHTHALMOL, V139, P182, DOI 10.1001/jamaophthalmol.2020.5730; Ross JF, 1996, BRAIN RES, V725, P137; Sanchez-Gomez A, 2021, PARKINSONISM RELAT D, V89, P22, DOI 10.1016/j.parkreldis.2021.06.002; Satue M, 2018, CURR EYE RES, V43, P109, DOI 10.1080/02713683.2017.1370116; Schartup AT, 2019, NATURE, V572, P648, DOI 10.1038/s41586-019-1468-9; SHIPLEY MT, 1985, BRAIN RES, V329, P294, DOI 10.1016/0006-8993(85)90537-2; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Streets DG, 2011, ENVIRON SCI TECHNOL, V45, P10485, DOI 10.1021/es202765m; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; VAHTER ME, 1995, TOXICOL APPL PHARM, V134, P273, DOI 10.1006/taap.1995.1193; Warfvinge K, 1996, TOXICOLOGY, V107, P189, DOI 10.1016/0300-483X(95)03257-G; Wei X, 2021, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.610962; Wen M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173731; Yamin G, 2003, J BIOL CHEM, V278, P27630, DOI 10.1074/jbc.M303302200; Zaja-Milatovic S, 2005, NEUROLOGY, V64, P545, DOI 10.1212/01.WNL.0000150591.33787.A4; Zecca L, 2002, J NEURAL TRANSM, V109, P663, DOI 10.1007/s007020200055; Zucca FA, 2006, J NEURAL TRANSM, V113, P757, DOI 10.1007/s00702-006-0453-2; Zucca FA, 2017, PROG NEUROBIOL, V155, P96, DOI 10.1016/j.pneurobio.2015.09.012	86	4	5	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262464	10.1371/journal.pone.0262464	http://dx.doi.org/10.1371/journal.pone.0262464			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015796	gold, Green Published			2022-12-27	WOS:000814820600025
J	Beczek, M; Ryzak, M; Mazur, R; Sochan, A; Polakowski, C; Bieganowski, A				Beczek, Michal; Ryzak, Magdalena; Mazur, Rafal; Sochan, Agata; Polakowski, Cezary; Bieganowski, Andrzej			Influence of slope incline on the ejection of two-phase soil splashed material	PLOS ONE			English	Article							DROP SIZE DISTRIBUTION; WATER EROSION; HEAVY-METALS; RAINFALL; DETACHMENT; WIND; IMPACT; ANGLE; INTENSITY; TRANSPORT	Soil splash is the first step in the process of water erosion, where impacting raindrops cause the detachment and transport of soil material. One of the factors that strongly influences the magnitude of soil splash is the incline of the surface (slope). The aim of this study was to investigate the effect of the slope on the course of the splash phenomenon caused by single-drop impact (one drop impact per soil sample), with respect to the mass and proportions of the ejected material, taking into account its division into solid and liquid phases i.e. soil and water. The investigation was carried out using three types of soil with different textures, in moistened (pressure head corresponding to -1.0 kPa) and air-dry (-1500 kPa) conditions. The soil samples were on three angles of slope, being 5 degrees, 15 degrees, and 30 degrees, respectively. After a single-drop impact with a diameter of 4.2 mm, the ejected material was collected using a splash cup. The following quantities of splashed material were measured: the total mass, the mass of the solid phase, and the mass of the liquid phase. Additionally, the distribution and proportions (soil/ water) of the splashed material were analysed in both the upslope and downslope directions. It was found that: (i) the change of slope had a variable influence on the measured quantities for different soils; (ii) in the case of moistened samples, the measured values were mainly influenced by the texture, while in the dry samples, by the angle of the slope; (iii) with the increase of slope, the splashed material was mostly ejected in the downslope direction (irrespective of moisture conditions); (iv) in the moistened samples, the ejected material consisted mostly of water, while in the dry samples it was soil-this occurred for material ejected both upslope and downslope. The obtained results are important for improving the physical description of the process of splash erosion. A more thorough understanding and better recognition of the mechanisms governing this phenomenon at all stages could contribute to the development of more effective methods for protecting soil against erosion.	[Beczek, Michal; Ryzak, Magdalena; Mazur, Rafal; Sochan, Agata; Polakowski, Cezary; Bieganowski, Andrzej] Polish Acad Sci, Inst Agrophys, Lublin, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences	Beczek, M (corresponding author), Polish Acad Sci, Inst Agrophys, Lublin, Poland.	m.beczek@ipan.lublin.pl	; Polakowski, Cezary/H-7294-2013	Beczek, Michal/0000-0002-8851-0982; Sochan, Agata/0000-0002-1987-0220; Polakowski, Cezary/0000-0002-1658-8334; Ryzak, Magdalena/0000-0002-6400-5375; Bieganowski, Andrzej/0000-0002-3571-3241	National Science Centre, Poland [2018/31/N/ST10/01757]; Statutory Research of Institute of Agrophysics Polish Academy of Sciences	National Science Centre, Poland(National Science Centre, Poland); Statutory Research of Institute of Agrophysics Polish Academy of Sciences	This research was partially financed by: 1) National Science Centre, Poland (https://www.ncn.gov.pl), in the frame of the project no. 2018/31/N/ST10/01757 headed by MB; 2) Statutory Research of Institute of Agrophysics Polish Academy of Sciences. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard SM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58671-7; An J, 2021, SOIL TILL RES, V209, DOI 10.1016/j.still.2021.104937; Ao C, 2020, CATENA, V189, DOI 10.1016/j.catena.2020.104473; Bai Y, 2021, ENVIRON SCI POLLUT R, V28, P21132, DOI 10.1007/s11356-020-11820-x; Banski J, 2007, PRZYRODNICZE UWARUNK, P9; Bartkowiak A, 2020, SOIL SCI ANNU, V71, P118, DOI 10.37501/soilsa/122402; Beczek M, 2021, GEODERMA, V396, DOI 10.1016/j.geoderma.2021.115087; Beczek M, 2019, GEODERMA, V347, P40, DOI 10.1016/j.geoderma.2019.03.028; Bieganowski A, 2018, ADV AGRON, V151, P215, DOI 10.1016/bs.agron.2018.04.003; Bird JC, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/6/063017; BRANDT CJ, 1989, CATENA, V16, P507, DOI 10.1016/0341-8162(89)90032-5; Brodowski R, 2013, CATENA, V105, P52, DOI 10.1016/j.catena.2013.01.006; Cerda A, 1997, CATENA, V30, P169, DOI 10.1016/S0341-8162(97)00019-2; Che ZZ, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.023032; De Ploey J, 1968, GEOMORPH NF, V12, P174; Drewnik M, 2019, SOIL SCI ANNU, V70, P225, DOI 10.2478/ssa-2019-0020; Duan J, 2021, J ENVIRON MANAGE, V278, DOI 10.1016/j.jenvman.2020.111537; EPEMA GF, 1983, CATENA, P1; Erpul G, 2008, CATENA, V72, P413, DOI 10.1016/j.catena.2007.07.008; Erpul G, 2002, CATENA, V47, P227, DOI 10.1016/S0341-8162(01)00182-5; Fernandez-Raga M, 2021, J ARID ENVIRON, V186, DOI 10.1016/j.jaridenv.2020.104419; Fernandez-Raga M, 2017, EARTH-SCI REV, V171, P463, DOI 10.1016/j.earscirev.2017.06.009; Froehlich W, 1986, Z FUER GEOMORPHOL, V60, P105; Fu SH, 2011, CATENA, V84, P29, DOI 10.1016/j.catena.2010.08.013; GARNAUT R, 1992, ECONOMIC REFORM AND INTERNATIONALISATION: CHINA AND THE PACIFIC REGION, P1; GHADIRI H, 1988, J SOIL SCI, V39, P563, DOI 10.1111/j.1365-2389.1988.tb01240.x; Ghahramani A, 2011, HYDROL PROCESS, V25, P2471, DOI 10.1002/hyp.8086; Ghahramani A, 2011, CATENA, V85, P34, DOI 10.1016/j.catena.2010.11.005; Gholami L, 2019, CATENA, V182, DOI 10.1016/j.catena.2019.104151; Giwangkara GG, 2020, J ADV CIV ENV ENG, V3, P58; Grigar J, 2020, CROP SOILS, V53, P47, DOI [10.1002/crso.20030, DOI 10.1002/CRSO.20030]; Grismer M, 2012, CALIF AGR, V66, P102, DOI 10.3733/ca.v066n03p102; Guerrero R, 2020, INT AGROPHYS, V34, P503, DOI 10.31545/intagr/131099; Hao HX, 2019, CATENA, V173, P494, DOI 10.1016/j.catena.2018.10.029; Hejduk L, 2017, J ECOL ENG, V18, P256, DOI 10.12911/22998993/67105; Hewelke E, 2016, LAND DEGRAD DEV, V27, P955, DOI 10.1002/ldr.2305; Hou TY, 2021, SOIL TILL RES, V207, DOI 10.1016/j.still.2020.104807; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6; Joniec J, 2017, INT AGROPHYS, V31, P465, DOI 10.1515/intag-2016-0078; Kukal S. S., 2011, Journal of the Indian Society of Soil Science, V59, P87; Leguedois S, 2004, EARTH SURF PROC LAND, V29, P1117, DOI 10.1002/esp.1106; Levia DF, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1225; Li HR, 2021, HYDROL PROCESS, V35, DOI 10.1002/hyp.14060; Liang GT, 2013, ACTA MECH, V224, P2993, DOI 10.1007/s00707-013-0910-6; Lima JLMR De, 1989, SOIL TECHNOL, V2, P71; Liu DD, 2015, CATENA, V128, P54, DOI 10.1016/j.catena.2015.01.022; Liu HePing, 2011, Acta Pedologica Sinica, V48, P479; Liu JF, 2021, EUR J SOIL SCI, V72, P2088, DOI 10.1111/ejss.13094; Luo J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21852-6; Marzen M, 2016, CATENA, V145, P47, DOI 10.1016/j.catena.2016.05.018; MATI BM, 1994, AGR WATER MANAGE, V26, P59, DOI 10.1016/0378-3774(94)90024-8; McFadden D, 2000, J APPL ECONOMET, V15, P447, DOI 10.1002/1099-1255(200009/10)15:5<447::AID-JAE570>3.0.CO;2-1; Meshesha DT, 2014, HYDROLOG SCI J, V59, P2203, DOI 10.1080/02626667.2013.865030; Mhaske SN, 2019, CATENA, V172, P408, DOI 10.1016/j.catena.2018.08.039; Mizugaki S, 2010, HYDROL PROCESS, V24, P576, DOI 10.1002/hyp.7552; Morgan RPC, 1981, P FLORENCE S; Nanko K, 2020, ECOL STUD-ANAL SYNTH, V240, P279, DOI 10.1007/978-3-030-26086-6_12; Nanko K, 2008, CATENA, V72, P348, DOI 10.1016/j.catena.2007.07.002; Panagos P, 2015, ENVIRON SCI POLICY, V54, P438, DOI 10.1016/j.envsci.2015.08.012; Parwada C, 2019, WATER SA, V45, P12, DOI 10.4314/wsa.v45i1.02; POESEN J, 1986, EARTH SURF PROCESSES, V11, P1, DOI 10.1002/esp.3290110103; QUANSAH C, 1981, J SOIL SCI, V32, P215, DOI 10.1111/j.1365-2389.1981.tb01701.x; Roisman IV, 2002, J FLUID MECH, V472, P373, DOI 10.1017/S0022112002002434; Roy S, 2017, RESOUR ENV, V7, P103, DOI [10.5923/j.re.20170704.03, DOI 10.5923/J.RE.20170704.03]; Ryzak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119269; Sadeghi SH, 2017, GEODERMA, V290, P100, DOI 10.1016/j.geoderma.2016.12.007; Sadeghi SH, 2013, HYDROLOG SCI J, V58, P1374, DOI 10.1080/02626667.2013.814917; SAVAT J, 1981, EARTH SURF PROC LAND, V6, P275, DOI 10.1002/esp.3290060308; Sedghi Marjan, 2019, Polish Journal of Soil Science, V52, P129, DOI [10.17951/pjss/2019.52.1.129, 10.17951/pjss.2019.52.1.129]; Seela BK, 2018, J GEOPHYS RES-ATMOS, V123, P11602, DOI 10.1029/2018JD028307; Van Dijk AIJM, 2003, HYDROL PROCESS, V17, P153, DOI 10.1002/hyp.1154; Wu J, 2016, SOIL WATER RES, V11, P83, DOI 10.17221/280/2014-SWR; Zachar D, 1982, DEV SOIL SCI, DOI [10.1016/0092-8674(82)90250-1, DOI 10.1016/0092-8674(82)90250-1]; Zambon N, 2021, CATENA, V196, DOI 10.1016/j.catena.2020.104827; Zambon N, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10124103; Zhang JQ, 2018, J SOIL SEDIMENT, V18, P1620, DOI 10.1007/s11368-017-1855-5; Zumr D, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010157	77	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2022	17	1								10.1371/journal.pone.0262203	http://dx.doi.org/10.1371/journal.pone.0262203			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6X0HY	34995324	Green Published, gold			2022-12-27	WOS:000896106100001
J	Hioki, M; Kanehira, N; Koike, T; Saito, A; Shimaoka, K; Sakakibara, H; Oshida, Y; Akima, H				Hioki, Maya; Kanehira, Nana; Koike, Teruhiko; Saito, Akira; Shimaoka, Kiyoshi; Sakakibara, Hisataka; Oshida, Yoshiharu; Akima, Hiroshi			Relationship between adiponectin and intramuscular fat content determined by ultrasonography in older adults	PLOS ONE			English	Article							INSULIN SENSITIVITY; VISCERAL ADIPOSITY; PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; PLASMA-GLUCOSE; LEPTIN; INFLAMMATION; RESISTANCE; INFILTRATION; ASSOCIATIONS	Age-associated intramuscular adipose tissue (IntraMAT) deposition induces the development of insulin resistance and metabolic syndrome. However, the relationship between IntraMAT and biochemical parameters in older adults remains unclear. The purpose of this study, therefore, was to elucidate the relationship between adiponectin and echo intensity-estimated IntraMAT using ultrasonography in normal-weight older adults (men 9, women 13) and examine biochemical parameters. Blood tests were performed to determine fasting levels of glucose, insulin, hemoglobin A1c, total cholesterol (Total-C), high-density-lipoprotein cholesterol, low-density-lipoprotein cholesterol (LDL-C), free fatty acid, triglycerides (TGs), adiponectin, leptin, high-sensitivity C-reactive protein, and high-sensitivity tumor necrosis factor, and homoeostasis model assessment index of insulin resistance (HOMA-IR). Mean gray-scale echo intensity was calculated as the IntraMAT index of the vastus lateralis. Waist circumference was measured at the level of the navel as the visceral adipose tissue (VAT) index. Echo intensity was significantly inversely correlated with adiponectin or LDL-C, and that was significantly positively correlated with TG. Adiponectin level was inversely correlated with waist circumference. Partial correlation analysis with waist circumference as the control variable revealed that adiponectin was inversely correlated with echo intensity, independent of waist circumference, whereas no such correlation was observed after controlling for LDL-C and TG levels. When biochemical parameters were grouped in the principal component analysis, among men, Total-C, insulin, and HOMA-IR or hemoglobin A1c, and high-sensitivity tumor necrosis factor-alpha were grouped with the same distribution for factors 1 and 2. Among women, glucose, insulin, HOMA-IR, and Total-C or TGs were grouped with the same distribution for factors 1 and 2. These data suggest that adiponectin level is related to IntraMAT content, independent of VAT in normal-weight older adults. The dynamics of adiponectin might not be similar to those of other circulating biochemical parameters in older men and women.	[Hioki, Maya; Sakakibara, Hisataka] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan; [Kanehira, Nana] Tokaigakuen Univ, Dept Hlth & Nutr, Nagoya, Aichi, Japan; [Koike, Teruhiko; Oshida, Yoshiharu; Akima, Hiroshi] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi, Japan; [Saito, Akira] Kyushu Sangyo Univ, Ctr Hlth & Sports Sci, Fukuoka, Fukuoka, Japan; [Shimaoka, Kiyoshi] Tokaigakuen Univ, Dept Human Wellness, Miyoshi, Aichi, Japan; [Hioki, Maya] Fac Hlth Care & Med Sports, Dept Phys Therapy, Ichihara, Chiba, Japan; [Sakakibara, Hisataka] Ichinomiya Kenshin Coll Nursing, Ichinomiya, Aichi, Japan	Nagoya University; Nagoya University	Hioki, M (corresponding author), Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan.; Hioki, M (corresponding author), Fac Hlth Care & Med Sports, Dept Phys Therapy, Ichihara, Chiba, Japan.	maya@mri.biglobe.ne.jp			Ministry of Education, Culture, Sports and Science and technology Grant [23650432]; Descente and Ishimoto Memorial Foundation for the Promotion of Sport Science	Ministry of Education, Culture, Sports and Science and technology Grant; Descente and Ishimoto Memorial Foundation for the Promotion of Sport Science	HA, Challenging Exploratory research from the Ministry of Education, Culture, Sports and Science and technology Grant(23650432), https://www.jsps.go.jp/english/index.html NO. YO, Descente and Ishimoto Memorial Foundation for the Promotion of Sport Science (grant number N/A), https://www.descente.co.jp/ishimoto/NO.	Akima H, 2007, ACTA ASTRONAUT, V60, P728, DOI 10.1016/j.actaastro.2006.10.006; Akima H, 2016, MAGN RESON IMAGING, V34, P397, DOI 10.1016/j.mri.2015.12.038; Akima H, 2015, EUR J APPL PHYSIOL, V115, P1627, DOI 10.1007/s00421-015-3148-2; Bredella MA, 2011, OBESITY, V19, P911, DOI 10.1038/oby.2010.296; Cohen AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116489; Dornbush S., 2020, PHYSIOLOGY; Fang HJ, 2018, CURR OPIN CLIN NUTR, V21, P360, DOI 10.1097/MCO.0000000000000485; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Gadekar Tukaram, 2020, Med J Armed Forces India, V76, P41, DOI 10.1016/j.mjafi.2017.12.001; Hioki M, 2021, BMC MUSCULOSKEL DIS, V22, DOI 10.1186/s12891-021-04456-6; Hioki M, 2019, EUR J APPL PHYSIOL, V119, P113, DOI 10.1007/s00421-018-4005-x; Houde AA, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0174-1; Hu XB, 2007, ACTA BIOCH BIOPH SIN, V39, P131, DOI 10.1111/j.1745-7270.2007.00255.x; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Jain SH, 2009, DIABETES CARE, V32, P903, DOI 10.2337/dc08-1733; Kanaya AM, 2004, DIABETES CARE, V27, P1375, DOI 10.2337/diacare.27.6.1375; Kantartzis K, 2006, CLIN CHEM, V52, P1934, DOI 10.1373/clinchem.2006.067397; Khabour OF, 2010, AGING MALE, V13, P188, DOI 10.3109/13685531003657800; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kizer JR, 2010, J GERONTOL A-BIOL, V65, P1208, DOI 10.1093/gerona/glq122; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Masaki T, 2003, DIABETES, V52, P2266, DOI 10.2337/diabetes.52.9.2266; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moller N, 1998, J CLIN ENDOCR METAB, V83, P931, DOI 10.1210/jc.83.3.931; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Nakamura Y, 2009, OBESITY, V17, P1269, DOI 10.1038/oby.2009.3; Rodrigo CP, 2015, NUTR HOSP, V31, P49, DOI 10.3305/nh.2015.31.sup3.8751; Perseghin G, 2002, AM J PHYSIOL-ENDOC M, V283, pE556, DOI 10.1152/ajpendo.00127.2002; Perseghin G, 2007, J CLIN ENDOCR METAB, V92, P4883, DOI 10.1210/jc.2007-0325; Pillen S, 2008, MUSCLE NERVE, V37, P679, DOI 10.1002/mus.21015; Pillen S, 2009, ULTRASOUND MED BIOL, V35, P443, DOI 10.1016/j.ultrasmedbio.2008.09.016; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Szendroedi J, 2009, CURR OPIN LIPIDOL, V20, P50, DOI 10.1097/MOL.0b013e328321b3a8; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Vella CA, 2017, MED SCI SPORT EXER, V49, P915, DOI 10.1249/MSS.0000000000001179; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; World Health Organization, 2008, WAIST CIRCUMFERENCE; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001; Zoico E, 2010, J GERONTOL A-BIOL, V65, P295, DOI 10.1093/gerona/glp155	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262271	10.1371/journal.pone.0262271	http://dx.doi.org/10.1371/journal.pone.0262271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982778	Green Published, gold			2022-12-27	WOS:000834805700025
J	Nakawuki, AW; Nekaka, R; Ssenyonga, LVN; Masifa, G; Nuwasiima, D; Nteziyaremye, J; Iramiot, JS				Nakawuki, Ashley Winfred; Nekaka, Rebecca; Ssenyonga, Lydia V. N.; Masifa, George; Nuwasiima, Dorreck; Nteziyaremye, Julius; Iramiot, Jacob Stanley			Bacterial colonization, species diversity and antimicrobial susceptibility patterns of indwelling urinary catheters from postpartum mothers attending a Tertiary Hospital in Eastern Uganda	PLOS ONE			English	Article							TRACT-INFECTIONS; RESISTANCE	BackgroundPostpartum urinary Catheter-Related Infections (CRIs) are a significant cause of maternal sepsis. Several studies done have reported the presence of mixed populations of bacteria with a significant increase in Extended-Spectrum Beta-Lactamase (ESBL) Enterobacteriaceae spps, Methicillin-Resistant Staphylococcus aureus (MRSA), Multi-Drug Resistant (MDR) bacteria in urine and blood cultures of catheterized patients despite the use of prophylactic antibiotics. This study aimed at determining the bacterial species diversity and susceptibility patterns of indwelling urinary catheters from postpartum mothers attending Mbale Regional Referral Hospital (MRRH). MethodsA cross-sectional study employing quantitative and qualitative was carried out in MRRH among postpartum mothers with urinary catheters and their care-takers. The purposive non-random sampling strategy was used to collect data using an interviewer-administered questionnaire for the quantitative data collection and in-depth interviews for qualitative data collection. All the data collection tools used were developed, pretested and validated. At the point of de-catheterization, Catheter tips from enrolled participants were cut about 2-3cm below the balloon aseptically into test-tube containing peptone water, sonication technique employed, and incubation done 24hours then cultured to ensure phenotypic identification. An antibiotic sensitivity test was performed using the disc diffusion method following Clinical and Laboratory Standards Institute (CLSI) guidelines. Quantitative data collected was entered in Microsoft Excel and then exported to STATA14 for statistical analysis. Thematic analysis was used to analyse and organise qualitative data by an inductive coding method using Nvivo 12 software. ResultsIn this study, 208 postpartum mothers participated, the majority of whom were caesarean section mothers of age range 20-24 years and 17 care-takers with a median age of 32 years. The prevalence of catheter tips bacterial colonisation was 98% despite 88.5% of the participants being on broad-spectrum antibiotics. The average duration of catheterisation was 2 days. All bacteria isolates were potential uro-pathogens with a mean occurrence of 2 bacteria species in each urinary catheter tip. The rates of MDR to commonly used antibiotics were high. The urinary catheter size of greater than F14 and duration of catheterization greater than 2 days were significantly associated with the number of bacterial species isolated from each sample. The maintenance care and knowledge of care-urinary catheter care among the care-takers was found sub-optimal. ConclusionThere was a high prevalence of catheter colonisation with bacterial spps diversity averaging 2 spps per sample despite use of broad spectrum antibiotics. The MDR rates were high, which calls for routine culture and sensitivity. Health workers practicing obstetric medicine need to pay attention to catheter sizes during catheterisation and its duration. Health education should be part of antenatal and postnatal care education.	[Nakawuki, Ashley Winfred; Ssenyonga, Lydia V. N.; Nuwasiima, Dorreck] Busitema Univ, Dept Nursing, Fac Hlth Sci, Mbale, Uganda; [Nekaka, Rebecca] Busitema Univ Sci, Fac Hlth, Dept Community & Publ Hlth, Mbale, Uganda; [Masifa, George] Mbale Clin Res Inst, Mbale, Uganda; [Nteziyaremye, Julius] Busitema Univ, Dept Obstet & Gynaecol, Fac Hlth Sci, Mbale, Uganda; [Iramiot, Jacob Stanley] Busitema Univ, Dept Microbiol & Immunol, Fac Hlth Sci, Mbale, Uganda		Iramiot, JS (corresponding author), Busitema Univ, Dept Microbiol & Immunol, Fac Hlth Sci, Mbale, Uganda.	jiramiot@gmail.com	Nekaka, Rebecca/GYQ-7546-2022	Nekaka, Rebecca/0000-0002-9199-7197; Iramiot, Jacob Stanley/0000-0002-9239-6641	Fogarty International Center of the National Institutes of Health; U.S. Department of State's Office of the U.S. Global AIDS Coordinator and Health Diplomacy (S/GAC); President's Emergency Plan for AIDS Relief (PEPFAR) [1R25TW011213]	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); U.S. Department of State's Office of the U.S. Global AIDS Coordinator and Health Diplomacy (S/GAC); President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Research reported in this publication was supported by the Fogarty International Center of the National Institutes of Health, U.S. Department of State's Office of the U.S. Global AIDS Coordinator and Health Diplomacy (S/GAC), and President's Emergency Plan for AIDS Relief (PEPFAR) under Award Number 1R25TW011213.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."	Abdallah N. M. A., 2011, International Journal for Biotechnology and Molecular Biology Research, V2, P172; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Bardoloi V, 2017, J MED MICROBIOL, V66, P927, DOI 10.1099/jmm.0.000525; Bebell LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175456; Chadha T., 2014, J BACTERIOL PARASITO, V5, P5, DOI DOI 10.4172/2155-9597.1000190; Frank DN., 2009, CULTURE INDEPENDENT, V4, P1; Fredrick B., 2019, J ADV MED MED RES, V29, P1; Gould C V., 2019, GUIDELINE PREVENTION, V61; Health Protection Surveillance Centre, 2011, S A R I GUID PREV CA; Hooton TM., 2010, CHINESE J INFECT CHE, V10, P321; Hossain MD, 2014, TZU CHI MED J, V26, P127, DOI 10.1016/j.tcmj.2014.06.003; Hussein J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087378; Knowles SJ, 2015, BJOG-INT J OBSTET GY, V122, P663, DOI 10.1111/1471-0528.12892; Letica-Kriegel AS, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022137; Lo E, 2014, INFECT CONT HOSP EP, V35, P464, DOI [10.1086/675718, 10.1017/S0899823X00193845]; Magiorakos A., EXPERT PROPOSAL STAN; Maharjan G, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/7624857; Manohar J, 2020, AM J INFECT CONTROL, V48, P178, DOI 10.1016/j.ajic.2019.08.005; Ministerio de Agricultura A. y M. A., 2013, REAL DECR 670 2013 6, P1; Musinguzi B., 2019, ADV INFECT DIS, V9, P183; Ngonzi J, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1891-1; Ngonzi J, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0986-9; Nicolle LE, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-23; Nteziyaremye J., 2020, E UGANDA, P1, DOI [10.1371/journal.pone.0230523, DOI 10.1371/JOURNAL.PONE.0230523]; Paterson DL, 2007, CLIN INFECT DIS, V45, P1179, DOI 10.1086/522287; Peerayeh SN, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.30593; Safdar N, 2016, AM J INFECT CONTROL, V44, pE23, DOI 10.1016/j.ajic.2015.10.011; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; SHAPIRO M, 1984, INFECT CONT HOSP EP, V5, P525, DOI 10.1017/S019594170006104X; Shrestha LB, 2019, INFECT DRUG RESIST, V12, P957, DOI 10.2147/IDR.S200988; Soma-Pillay P, 2016, CARDIOVASC J AFR, V27, P89, DOI 10.5830/CVJA-2016-021; Stanley IJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200093; Tambyah PA, 2000, ARCH INTERN MED, V160, P678, DOI 10.1001/archinte.160.5.678; Tolera Moti, 2018, Adv Med, V2018, P2127814, DOI 10.1155/2018/2127814; UBOS, 2016, UG DEM HLTH SURV; Wald HL, 2008, ARCH SURG-CHICAGO, V143, P551, DOI 10.1001/archsurg.143.6.551; WHO, 2011, WHO LIB CAT PUBL DAT; World Health Organization, 2015, HLTH 2015 MDGS MILL; Xu YJ, 2012, J CLIN MICROBIOL, V50, P3901, DOI 10.1128/JCM.01237-12; Zarb P, 2012, EUROSURVEILLANCE, V17, P4	40	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262414	10.1371/journal.pone.0262414	http://dx.doi.org/10.1371/journal.pone.0262414			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007300	gold, Green Published			2022-12-27	WOS:000741060700008
J	Alkhaffaf, B; Metryka, A; Blazeby, JM; Glenny, AM; Williamson, PR; Bruce, IA				Alkhaffaf, Bilal; Metryka, Aleksandra; Blazeby, Jane M.; Glenny, Anne-Marie; Williamson, Paula R.; Bruce, Iain A.		GASTROS Int Working Grp	How are trial outcomes prioritised by stakeholders from different regions? Analysis of an international Delphi survey to develop a core outcome set in gastric cancer surgery	PLOS ONE			English	Article								Background International stakeholder participation is important in the development of core outcome sets (COS). Stakeholders from varying regions may value health outcomes differently. Here, we explore how region, health income and participant characteristics influence prioritisation of outcomes during development of a COS for gastric cancer surgery trials (the GASTROS study). Methods 952 participants from 55 countries participating in a Delphi survey during COS development were eligible for inclusion. Recruits were grouped according to region (East or West), country income classification (high and low-to-middle income) and other characteristics (e.g. patients; age, sex, time since surgery, mode of treatment, surgical approach and healthcare professionals; clinical experience). Groups were compared with respect to how they categorised 56 outcomes identified as potentially important to include in the final COS ('consensus in', 'consensus out', 'no consensus'). Outcomes categorised as 'consensus in' or 'consensus out' by all 3 stakeholder groups would be automatically included in or excluded from the COS respectively. Results In total, 13 outcomes were categorised 'consensus in' (disease-free survival, disease-specific survival, surgery-related death, recurrence of cancer, completeness of tumour removal, overall quality of life, nutritional effects, all-cause complications, intraoperative complications, anaesthetic complications, anastomotic complications, multiple organ failure, and bleeding), 13 'consensus out' and 31 'no consensus'. There was little variation in prioritisation of outcomes by stakeholders from Eastern or Western countries and high or low-to-middle income countries. There was little variation in outcome prioritisation within either health professional or patient groups. Conclusion Our study suggests that there is little variation in opinion within stakeholder groups when participant region and other characteristics are considered. This finding may help COS developers when designing their Delphi surveys and recruitment strategies. Further work across other clinical fields is needed before broad recommendations can be made.	[Alkhaffaf, Bilal] Salford Royal NHS Fdn Trust, Salford Royal Hosp, Dept Oesophago Gastr Surg, Manchester, Lancs, England; [Alkhaffaf, Bilal] Univ Manchester, Fac Biol Med & Hlth, Sch Med Sci, Div Canc Sci, Manchester, Lancs, England; [Metryka, Aleksandra; Bruce, Iain A.] Manchester Univ NHS Fdn Trust, Royal Manchester Childrens Hosp, Paediat ENT Dept, Manchester, Lancs, England; [Blazeby, Jane M.] Univ Bristol, Ctr Surg Res, Bristol, Avon, England; [Blazeby, Jane M.] Univ Bristol, Bristol NIHR Biomed Res Ctr, Bristol, Avon, England; [Glenny, Anne-Marie] Univ Manchester, Div Dent, Sch Med Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Williamson, Paula R.] Univ Liverpool, MRC North West Hub Trials Methodol Res, Liverpool, Merseyside, England; [Williamson, Paula R.] Liverpool Hlth Partners, Liverpool, Merseyside, England; [Bruce, Iain A.] Univ Manchester, Div Infect Immun & Resp Med, Fac Biol Med & Hlth, Manchester, Lancs, England	Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; Royal Manchester Children's Hospital; University of Bristol; University of Bristol; University of Manchester; University of Liverpool; University of Manchester	Alkhaffaf, B (corresponding author), Salford Royal NHS Fdn Trust, Salford Royal Hosp, Dept Oesophago Gastr Surg, Manchester, Lancs, England.; Alkhaffaf, B (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Med Sci, Div Canc Sci, Manchester, Lancs, England.	bilal.alkhaffaf@srft.nhs.uk	Bodur, Muhammed Selim/GXG-1718-2022; da Costa, Paulo Matos/ABD-1573-2021; /C-4324-2009	Bodur, Muhammed Selim/0000-0002-8168-623X; da Costa, Paulo Matos/0000-0002-7550-8285; Bruce, Iain/0000-0003-0831-4760; Blazeby, Jane/0000-0002-3354-3330; Metryka, Aleksandra/0000-0001-9871-5167; Glenny, Anne-Marie/0000-0003-4037-2899; /0000-0002-6518-5806; Alkhaffaf, Bilal/0000-0001-5751-1846; O'Neill, Linda/0000-0002-0109-9650	National Institute for Health Research (NIHR) [DRF2015-08-023]; National Institute for Health Research (NIHR)	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This study is funded by the National Institute for Health Research (NIHR -www.nihr.ac.uk) Doctoral Research Fellowship Grant (DRF2015-08-023). The award was received by BA. This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhaffaf B, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034782; Alkhaffaf B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021796; Alkhaffaf B, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2100-7; Bang YJ, 2014, ASIA-PAC J CLIN ONCO, V10, P38, DOI 10.1111/ajco.12112; Chan WL, 2019, CLIN ONCOL-UK, V31, P570, DOI 10.1016/j.clon.2019.05.012; Coulman KD, 2016, OBES SURG, V26, P2738, DOI 10.1007/s11695-016-2186-0; Dodd S, 2018, J CLIN EPIDEMIOL, V96, P84, DOI 10.1016/j.jclinepi.2017.12.020; Fish R, 2020, J CLIN EPIDEMIOL, V128, P118, DOI 10.1016/j.jclinepi.2020.09.028; Gargon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099111; Kirkham JJ, 2019, J CLIN EPIDEMIOL, V115, P90, DOI 10.1016/j.jclinepi.2019.07.007; Messager M, 2016, EJSO-EUR J SURG ONC, V42, P116, DOI 10.1016/j.ejso.2015.09.017; Michalowski J., 2018, COMMISSIONED HEALTHC; Potter S, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1591-y; Remus A, 2021, BMC MED RES METHODOL, V21, DOI 10.1186/s12874-020-01197-3; Williamson PR, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1978-4; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; Yamamoto M, 2015, J GASTROINTEST ONCOL, V6, P79, DOI 10.3978/j.issn.2078-6891.2014.097	17	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261937	10.1371/journal.pone.0261937	http://dx.doi.org/10.1371/journal.pone.0261937			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972165	Green Published, Green Submitted, gold			2022-12-27	WOS:000773555700070
J	Lin, L; Liu, WQ; Mu, J; Zhan, EM; Wei, H; Hong, SQ; Hua, ZY				Lin, Lu; Liu, Weiqin; Mu, Jing; Zhan, Enmei; Wei, Hong; Hong, Siqi; Hua, Ziyu			Effect of neonatal neuronal intensive care unit on neonatal encephalopathy	PLOS ONE			English	Article							CEREBRAL-PALSY; RISK-FACTORS; MULTIPLE BIRTHS; PREGNANCY	Prophylaxis of brain injury in newborns has been a main concern since the first neonatal neuronal intensive care unit (NNICU) was established in the world in 2008. The aim of this study was to outline and evaluate the unit's development by analyzing the demographics of the patients, the services delivered, the short-term outcomes before and after the establishment of NNICU. During the two investigation periods, 384 newborns were diagnosed or suspected as "neonatal encephalopathy", among which 185 patients admitted to NNICU between 2011.03.01 and 2012.09.30 before the establishment of NNICU were enrolled in the pre-NNICU group, another 199 neonates hospitalized during 2018.03.01 to 2019.09.30 were included in the post-NNICU group. Patients in the post-NNICU group were more likely to have seizures (P = 0.001), incomplete or absent primitive reflexes (P = 0.002), therapeutic hypothermia (P<0.001) and liquid control (P<0.001) in acute phase. Meanwhile, amplitude-integrated electro encephalogram (aEEG) monitoring (P<0.001) and cranial ultrasound (P<0.001) were more often used in NNICU. Both of the follow-up rate in brain MRI and the assessment of neurodevelopment at 3 months were higher in the post-NNICU group (P<0.001). In conclusion, the NNICU focused on the neonatal neurocritical care for the babies susceptible to NE with the guidance of evidence-based medicine, the establishment of NNICU is gradually improving and standardizing the neuroprotective therapy and clinical follow-up to improve neurodevelopmental prognosis of the NE patients in CHCMU.	[Lin, Lu; Liu, Weiqin; Mu, Jing; Zhan, Enmei; Wei, Hong; Hua, Ziyu] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China; [Lin, Lu; Liu, Weiqin; Mu, Jing; Zhan, Enmei; Wei, Hong; Hong, Siqi; Hua, Ziyu] Chongqing Med Univ, Childrens Hosp, Minist Educ Key Lab Child Dev & Disorders,Chongqi, Natl Clin Res Ctr Child Hlth & Disorders,China In, Chongqing, Peoples R China; [Hong, Siqi] Chongqing Med Univ, Childrens Hosp, Dept Neurol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Hua, ZY (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China.; Hua, ZY (corresponding author), Chongqing Med Univ, Childrens Hosp, Minist Educ Key Lab Child Dev & Disorders,Chongqi, Natl Clin Res Ctr Child Hlth & Disorders,China In, Chongqing, Peoples R China.	h_ziyu@126.com			Clinical Research Project of Children's Hospital of Chongqing Medical University [YBXM 2019007]	Clinical Research Project of Children's Hospital of Chongqing Medical University	This study was supported by grants from the Clinical Research Project of Children's Hospital of Chongqing Medical University (YBXM 2019007), the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, Obstet Gynecol, V123, P896, DOI 10.1097/01.AOG.0000445580.65983.d2; [Anonymous], 2018, QUEENSLAND CLIN GUID; [Anonymous], 2019, CHINESE J PRACTICAL, V34, P126, DOI [10.19538/j.ek2019020615, DOI 10.19538/J.EK2019020615]; Badawi N, 1998, BMJ-BRIT MED J, V317, P1554, DOI 10.1136/bmj.317.7172.1554; Bonifacio SL, 2011, NAT REV NEUROL, V7, P485, DOI 10.1038/nrneurol.2011.119; Campbell SK, 2002, DEV MED CHILD NEUROL, V44, P263, DOI 10.1017/S0012162201002043; Campbell Suzann K, 2006, Pediatr Phys Ther, V18, P119, DOI 10.1097/01.pep.0000223108.03305.5d; Charon V, 2016, EUR J RADIOL, V85, P1366, DOI 10.1016/j.ejrad.2016.05.005; CLANCY RR, 1988, EPILEPSIA, V29, P256, DOI 10.1111/j.1528-1157.1988.tb03715.x; Dixon BJ, 2015, INT J MOL SCI, V16, P22368, DOI 10.3390/ijms160922368; Doyle LW, 2010, J PEDIATR-US, V156, P49, DOI 10.1016/j.jpeds.2009.07.013; Dunin-Wasowicz D, 2000, J CHILD NEUROL, V15, P417; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Ellis M, 2000, BMJ-BRIT MED J, V320, P1229, DOI 10.1136/bmj.320.7244.1229; Glass HC, 2016, CLIN PERINATOL, V43, P547, DOI 10.1016/j.clp.2016.04.011; Glass HC, 2015, ANESTH ANALG, V120, P1337, DOI 10.1213/ANE.0000000000000705; Glass HC, 2014, SEMIN PEDIATR NEUROL, V21, P241, DOI 10.1016/j.spen.2014.10.003; Glass HC, 2010, NEUROCRIT CARE, V12, P421, DOI 10.1007/s12028-009-9324-7; Hintz SR, 2015, PEDIATRICS, V135, pE32, DOI 10.1542/peds.2014-0898; Kovo M, 2016, J MATERN-FETAL NEO M, V29, P1462, DOI 10.3109/14767058.2015.1051024; Liu JM, 2000, INT J EPIDEMIOL, V29, P292, DOI 10.1093/ije/29.2.292; Liu WQ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00133; Malone A, 2009, EPILEPSIA, V50, P2097, DOI 10.1111/j.1528-1167.2009.02132.x; Mulkey SB, 2014, J CHILD NEUROL, V29, P31, DOI 10.1177/0883073812469051; Newman JE, 2012, J PEDIATR-US, V161, P1041, DOI 10.1016/j.jpeds.2012.05.048; Pascual-Castroviejo I, 2012, NEUROLOGIA, V27, P336, DOI 10.1016/j.nrl.2011.12.017; PETTERSON B, 1990, AM J MED GENET, V37, P346, DOI 10.1002/ajmg.1320370311; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Shao XM ZC., 2011, CHINESE J EVIDENCE B, V6, P327, DOI [10.3969/j.issn.1673-5501.2011.05.003, DOI 10.3969/J.ISSN.1673-5501.2011.05.003]; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Thayyil S, 2010, PEDIATRICS, V125, pE382, DOI 10.1542/peds.2009-1046; Van Meurs KP, 2018, AM J PERINAT, V35, P1197, DOI 10.1055/s-0038-1646954; Wieczorek AI, 2015, GINEKOL POL, V86, P137	33	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261837	10.1371/journal.pone.0261837	http://dx.doi.org/10.1371/journal.pone.0261837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972144	Green Published, gold			2022-12-27	WOS:000773555700060
J	Xiao, JY; Xie, BG; Zhou, KC; Shi, SN; Li, JH; Yang, MX; Liu, CC				Xiao, Jianyong; Xie, Binggeng; Zhou, Kaichun; Shi, Shana; Li, Junhan; Yang, Mingxia; Liu, ChangChang			Assessment of soil erosion in the Dongting Lake Basin, China: Patterns, drivers, and implications	PLOS ONE			English	Article							LAND-USE CHANGE; FOR-GREEN PROGRAM; LOESS PLATEAU; CLIMATE-CHANGE; USE/COVER CHANGE; WATER EROSION; CATCHMENT; IMPACTS; RUNOFF; CONSERVATION	Soil loss caused by erosion is a global problem. Therefore, the assessment of soil erosion and the its driving mechanism are of great significance to soil conservation. However, soil erosion is affected by both climate change and human activities, which have not been quantified, and few researchers studied the differences in the driving mechanisms of soil erosion depending on the land use type. Therefore, the spatiotemporal characteristics and changing trends of soil erosion in the Dongting Lake Basin were analyzed in this study. Geographic detectors were used to identify the dominant factors affecting soil erosion in different land use types. In this study, a sensitivity experiment was conducted to clarify the relative contributions of climate change and human activities to soil erosion changes. In addition, we studied the effects of different land use types and vegetation cover restoration on soil erosion. The results show that soil erosion in the Dongting Lake Basin decreased from 2000 to 2018. Human activities represented by land use types and vegetation coverage significantly contributed to the alleviation of soil erosion in the Dongting Lake Basin, whereas climate change represented by rainfall slightly aggravated soil erosion in the study area. The restoration of grassland vegetation and transfer of cultivated land to woodlands in the study area improved the soil erosion. The slope steepness is the key factor affecting the intensity of soil erosion in dry land, paddy fields, and unused land, whereas the vegetation coverage is the key factor affecting the intensity of soil erosion in woodland, garden land, and grassland. Detailed spatiotemporally mapping of soil erosion was used to determine the connections between soil erosion and potential drivers, which have important implications for vegetation restoration and the optimization of land use planning.	[Xiao, Jianyong; Xie, Binggeng; Zhou, Kaichun; Shi, Shana; Li, Junhan; Yang, Mingxia; Liu, ChangChang] Hunan Normal Univ, Sch Geog Sci, Changsha, Peoples R China	Hunan Normal University	Xie, BG (corresponding author), Hunan Normal Univ, Sch Geog Sci, Changsha, Peoples R China.	xbgyb1961@163.com			Joint Funds of the National Natural Science Foundation of China [U19A2051]	Joint Funds of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by Joint Funds of the National Natural Science Foundation of China (U19A2051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boardman J, 2006, CATENA, V68, P73, DOI 10.1016/j.catena.2006.03.007; Bochet E, 2006, EARTH SURF PROC LAND, V31, P536, DOI 10.1002/esp.1351; Cao YC., 2018, ECOLOGICAL EC, P111; Cao ZH, 2021, GEODERMA, V389, DOI 10.1016/j.geoderma.2021.114949; [陈海山 Chen Haishan], 2013, [大气科学, Chinese Journal of Atmospheric Sciences], V37, P1; [陈思旭 Chen Sixu], 2014, [资源科学, Resources Science], V36, P1288; de Almeida AQ, 2017, PESQUI AGROPECU BRAS, V52, P371, DOI [10.1590/s0100-204x2017000600001, 10.1590/S0100-204X2017000600001]; Deng C., 2021, INT SOIL WATER CONSE; Deng L, 2014, GLOBAL CHANGE BIOL, V20, P3544, DOI 10.1111/gcb.12508; Deng L, 2012, INT J SEDIMENT RES, V27, P120, DOI 10.1016/S1001-6279(12)60021-3; [邓正苗 Deng Zhengmiao], 2018, [农业现代化研究, Research of Agricultural Modernization], V39, P994; Devaty J, 2019, LAND USE POLICY, V82, P674, DOI 10.1016/j.landusepol.2018.11.058; Duan J, 2020, J HYDROL, V582, DOI 10.1016/j.jhydrol.2019.124290; Edwards BL, 2019, J SOIL WATER CONSERV, V74, P405, DOI 10.2489/jswc.74.4.405; Ferreira V, 2014, ENVIRON MANAGE, V54, P67, DOI 10.1007/s00267-014-0281-3; Gao JB, 2019, CATENA, V172, P369, DOI 10.1016/j.catena.2018.08.035; Hao HX, 2020, LAND DEGRAD DEV, V31, P1851, DOI 10.1002/ldr.3579; Haregeweyn N, 2008, CATENA, V75, P65, DOI 10.1016/j.catena.2008.04.011; Issa OM, 2006, EARTH SURF PROC LAND, V31, P929, DOI 10.1002/esp.1303; Kijowska-Strugala M, 2018, LAND DEGRAD DEV, V29, P1871, DOI 10.1002/ldr.2936; [李佳蕾 Li Jialei], 2020, [生态学报, Acta Ecologica Sinica], V40, P3473; Liang SZX, 2021, J SOIL SEDIMENT, V21, P134, DOI 10.1007/s11368-020-02756-3; Liang Y, 2020, J HYDROL, V584, DOI 10.1016/j.jhydrol.2020.124694; Liu BY, 2020, INT SOIL WATER CONSE, V8, P430, DOI 10.1016/j.iswcr.2020.07.002; Liu JB, 2018, J GEOGR SCI, V28, P59, DOI 10.1007/s11442-018-1459-z; Liu Ming, 2008, Yingyong Shengtai Xuebao, V19, P1317; Liu YS, 2014, LAND USE POLICY, V40, P6, DOI 10.1016/j.landusepol.2013.03.013; Liu Y, 2020, CLEAN-SOIL AIR WATER, V48, DOI 10.1002/clen.201900195; Luo J, 2020, FORESTS, V11, DOI 10.3390/f11030329; Luo J, 2020, CATENA, V190, DOI 10.1016/j.catena.2020.104515; Ma WM, 2016, SOIL TILL RES, V155, P69, DOI 10.1016/j.still.2015.07.007; Mancino G, 2016, ECOL INDIC, V71, P544, DOI 10.1016/j.ecolind.2016.07.040; Miller ME, 2011, INT J WILDLAND FIRE, V20, P982, DOI 10.1071/WF09142; Mohammad AG, 2010, CATENA, V81, P97, DOI 10.1016/j.catena.2010.01.008; Ndayisaba F, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020129; Ni SM, 2020, J SOIL SEDIMENT, V20, P2997, DOI 10.1007/s11368-020-02665-5; Ouyang W, 2018, SCI TOTAL ENVIRON, V613, P798, DOI 10.1016/j.scitotenv.2017.09.173; Panagos P, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12091365; Patton NR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05743-y; Anh PTQ, 2014, GEODERMA, V232, P352, DOI 10.1016/j.geoderma.2014.05.011; Phinzi K, 2019, INT SOIL WATER CONSE, V7, P27, DOI 10.1016/j.iswcr.2018.12.002; Qi JY, 2020, J HYDROL, V581, DOI 10.1016/j.jhydrol.2019.124415; Qi Y, 2020, ECOL INDIC, V117, DOI 10.1016/j.ecolind.2020.106528; [钱庆欢 Qian Qinghuan], 2018, [地理学报, Acta Geographica Sinica], V73, P2135; Renard KG., 1997, AGR HDB, DOI DOI 10.1201/9780203739358-5; Runting RK, 2017, GLOBAL CHANGE BIOL, V23, P28, DOI 10.1111/gcb.13457; Safwan M, 2021, INT J SEDIMENT RES, V36, P207, DOI 10.1016/j.ijsrc.2020.06.005; Smith P, 2016, GLOBAL CHANGE BIOL, V22, P1008, DOI 10.1111/gcb.13068; Sun WY, 2014, CATENA, V121, P151, DOI 10.1016/j.catena.2014.05.009; Swarnkar S, 2018, HYDROL EARTH SYST SC, V22, P2471, DOI 10.5194/hess-22-2471-2018; Teng MJ, 2019, SCI TOTAL ENVIRON, V697, DOI 10.1016/j.scitotenv.2019.134164; Vanwalleghem T, 2017, ANTHROPOCENE, V17, P13, DOI 10.1016/j.ancene.2017.01.002; [王国杰 WANG Guojie], 2006, [湖泊科学, Scientia Limnologica Sinica], V18, P470; Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457; Wang X, 2016, CATENA, V137, P256, DOI 10.1016/j.catena.2015.10.004; Wei YH, 2018, EARTH SURF PROC LAND, V43, P1899, DOI 10.1002/esp.4364; Wen Z, 2021, LAND DEGRAD DEV, V32, P1127, DOI 10.1002/ldr.3646; Wuepper D, 2020, NAT SUSTAIN, V3, P51, DOI 10.1038/s41893-019-0438-4; Xiao Y, 2021, GEOMAT NAT HAZ RISK, V12, P103, DOI 10.1080/19475705.2020.1861112; Xu YQ, 2011, J GEOGR SCI, V21, P1138, DOI 10.1007/s11442-011-0906-x; Yan R, 2018, INT SOIL WATER CONSE, V6, P13, DOI 10.1016/j.iswcr.2017.12.002; Yu KK, 2017, EARTH SURF PROC LAND, V42, P1238, DOI 10.1002/esp.4071; Zare M, 2017, LAND USE POLICY, V67, P558, DOI 10.1016/j.landusepol.2017.06.028; Zhang SH, 2017, SCI TOTAL ENVIRON, V574, P34, DOI 10.1016/j.scitotenv.2016.09.024; Zhang Y, 2012, J SOIL WATER CONSERV, V67, P390, DOI 10.2489/jswc.67.5.390; Zhao GJ, 2013, LAND DEGRAD DEV, V24, P499, DOI 10.1002/ldr.2246	66	3	3	21	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261842	10.1371/journal.pone.0261842	http://dx.doi.org/10.1371/journal.pone.0261842			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972138	gold, Green Published			2022-12-27	WOS:000773555700061
J	Gan, FS; Liu, L; Zhou, QZ; Huang, WL; Huang, XW; Zhao, X				Gan, Fengshan; Liu, Liu; Zhou, Qingzhu; Huang, Wenli; Huang, Xinwei; Zhao, Xian			Effects of adipose-derived stromal cells and endothelial progenitor cells on adipose transplant survival and angiogenesis	PLOS ONE			English	Article							AUTOLOGOUS FAT TRANSPLANTATION; STEM-CELLS; ASSISTED LIPOTRANSFER; MYOCARDIAL-INFARCTION; MOUSE MODEL; REGENERATION; SECRETION; EFFICACY; NECROSIS; THERAPY	Background A paracrine mechanism is thought to mediate the proangiogenic capacity of adipose-derived stromal/stem cells (ASCs). However, the precise mechanism by which ASCs promote the formation of blood vessels by endothelial progenitor cells (EPCs) is unclear. Methods The EPCs-ASCs cocultures prepared in different ratios were subjected to tube formations assay to verify whether ASCs could directly participate in the tube genesis. The supernatant from cultured ASCs was used to stimulate EPCs to evaluate the effects on the angiogenic property of EPCs, as well as capacity for migration and invasion. A coculture model with transwell chamber were used to explore the regulation of angiogenesis markers expression in EPCs by ASCs. We then mixed ASCs with EPCs and transplanted them with adipose tissue into nude mice to evaluate the effects on angiogenesis in adipose tissue grafts. Results In the EPCs-ASCs cocultures, the tube formation was significantly decreased as the relative abundance of ASCs increased, while the ASCs was found to migrate and integrated into the agglomerates formed by EPCs. The supernatant from ASCs cultures promoted the migration and invasion of EPCs and the ability to form capillary-like structures. The expression of multiple angiogenesis markers in EPCs were significantly increased when cocultured with ASCs. In vivo, ASCs combined with EPC promoted vascularization in the fat transplant. Immunofluorescence straining of Edu and CD31 indicated that the Edu labeled EPC did not directly participate in the vascularization inside the fat tissue. Conclusions ADSC can participate in the tube formation of EPC although it cannot form canonical capillary structures. Meanwhile, Soluble factors secreted by ASCs promotes the angiogenic potential of EPCs. ASCs paracrine signaling appears to promote angiogenesis by increasing the migration and invasion of EPCs and simultaneously upregulating the expression of angiogenesis markers in EPCs. The results of in vivo experiments showed that ASCs combined with EPCs significantly promote the formation of blood vessels in the fat implant. Remarkably, EPCs may promote angiogenesis by paracrine regulation of endogenous endothelial cells (ECs) rather than direct participation in the formation of blood vessels.	[Gan, Fengshan; Liu, Liu; Zhou, Qingzhu; Huang, Wenli; Zhao, Xian] Kunming Med Univ, Dept Plast Surg, Kunming, Yunnan, Peoples R China; [Huang, Xinwei] Kuming Med Coll, Affiliated Hosp 2, Key Lab, Kunming, Yunnan, Peoples R China	Kunming Medical University	Zhao, X (corresponding author), Kunming Med Univ, Dept Plast Surg, Kunming, Yunnan, Peoples R China.; Huang, XW (corresponding author), Kuming Med Coll, Affiliated Hosp 2, Key Lab, Kunming, Yunnan, Peoples R China.	24864727@qq.com; 532768282@qq.com			National Natural Science Foundation of China [81460296, 81860343]; Yunnan Provincial Reserve Talents Fundation [H2016-31]; Yunnan Provincial Science and Technology Planning Project [2017FB121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Reserve Talents Fundation; Yunnan Provincial Science and Technology Planning Project	D This study was supported by National Natural Science Foundation of China (81460296, 81860343), The Yunnan Provincial Reserve Talents Fundation (H2016-31), and The Yunnan Provincial Science and Technology Planning Project (2017FB121).	Abe Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082085; Amini AR, 2012, J ORTHOP RES, V30, P1507, DOI 10.1002/jor.22097; Cai JR, 2017, BIOCHEM BIOPH RES CO, V490, P560, DOI 10.1016/j.bbrc.2017.06.078; Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang NJ, 2013, OSTEOARTHR CARTILAGE, V21, P1613, DOI 10.1016/j.joca.2013.07.016; Chen ZZ, 2008, NEUROSCI LETT, V445, P36, DOI 10.1016/j.neulet.2008.08.039; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Coleman SR, 2001, CLIN PLAST SURG, V28, P111; Ebrahimian TG, 2009, ARTERIOSCL THROM VAS, V29, P503, DOI 10.1161/ATVBAHA.108.178962; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; Engel FB, 2016, STEM CELLS BIOL REG, P123, DOI 10.1007/978-3-319-25427-2_8; Fan WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045621; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; Heo SC, 2011, J INVEST DERMATOL, V131, P1559, DOI 10.1038/jid.2011.64; Jeon O, 2007, J BIOMED SCI, V14, P323, DOI 10.1007/s11373-007-9145-7; Kolle SFT, 2013, LANCET, V382, P1113, DOI 10.1016/S0140-6736(13)61410-5; Leobon B, 2009, CARDIOVASC RES, V83, P757, DOI 10.1093/cvr/cvp167; Li ZF, 2013, CNS NEUROSCI THER, V19, P352, DOI 10.1111/cns.12086; Liao Han-Tsung, 2014, World J Stem Cells, V6, P288, DOI 10.4252/wjsc.v6.i3.288; Lin JY, 2018, PLAST RECONSTR SURG, V142, p665E, DOI 10.1097/PRS.0000000000004898; Luo TH, 2013, J TRAUMA ACUTE CARE, V74, P508, DOI 10.1097/TA.0b013e3182703420; Mazo M, 2012, CELL TRANSPLANT, V21, P1023, DOI 10.3727/096368911X623862; Mazzola RF, 2015, CLIN PLAST SURG, V42, P147, DOI 10.1016/j.cps.2014.12.002; Moon MH, 2006, CELL PHYSIOL BIOCHEM, V17, P279, DOI 10.1159/000094140; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Nishimura T, 2000, LARYNGOSCOPE, V110, P1333, DOI 10.1097/00005537-200008000-00021; Park JB, 2015, GENES GENOM, V37, P213, DOI 10.1007/s13258-014-0239-0; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rico ADG., 2014, BRIT J ORAL MAX SURG, V52, pe60; Simonacci F, 2016, ANN MED SURG, V12, P94, DOI 10.1016/j.amsu.2016.11.012; Strassburg S, 2013, TISSUE ENG PT A, V19, P166, DOI [10.1089/ten.tea.2011.0699, 10.1089/ten.TEA.2011.0699]; Tan Shaun S, 2016, J Cutan Aesthet Surg, V9, P152; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x; Yoshimura K, 2009, REGEN MED, V4, P265, DOI 10.2217/17460751.4.2.265; Yuan Y, 2015, ARCH DERMATOL RES, V307, P693, DOI 10.1007/s00403-015-1574-y; Yuan Y, 2013, CELL BIOL INT, V37, P547, DOI 10.1002/cbin.10068; Zhao LN, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0578-2; Zhao Yan Feng., 2015, CLIN EXPERIENCE AUTO, V24, P9; Zhou YW, 2016, PLAST RECONSTR SURG, V137, p44E, DOI 10.1097/PRS.0000000000001981	43	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261498	10.1371/journal.pone.0261498	http://dx.doi.org/10.1371/journal.pone.0261498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025920	Green Published, gold, Green Submitted			2022-12-27	WOS:000796264200017
J	van Schalkwyk, MCI; Petticrew, M; Maani, N; Hawkins, B; Bonell, C; Katikireddi, SV; Knai, C				van Schalkwyk, May C., I; Petticrew, Mark; Maani, Nason; Hawkins, Ben; Bonell, Chris; Katikireddi, Srinivasa Vittal; Knai, Cecile			Distilling the curriculum: An analysis of alcohol industry-funded school-based youth education programmes	PLOS ONE			English	Article							SMOKING PREVENTION PROGRAMS; CONFLICT-OF-INTEREST; TOBACCO INDUSTRY; HEALTH-PROMOTION; FOOD; RESPONSIBILITY; MCCARTHYISM; INFORMATION; CONSUMPTION; ADDICTIONS	Background and aim For decades, corporations such as the tobacco and fossil fuel industries have used youth education programmes and schools to disseminate discourses, ideas and values favourable to their positions, and to pre-empt regulation that threatens profits. However, there is no systematic research into alcohol industry-funded youth education programmes. This article serves to address this important gap in the literature. Methods Using a discourse theoretical approach informed by poststructural discourse theory and critical discourse analysis, we analysed teaching materials from three school-based youth education initiatives which focus on alcohol consumption and health harms: Drinkaware for Education, The Smashed Project (funded by Diageo), and Talk About Alcohol (Alcohol Education Trust). These materials, some of which are disseminated internationally, are provided to schools through intermediary bodies in receipt of alcohol industry funding. Findings The analysis found that these materials drew from and presented discourses of personal responsibility, moderate alcohol consumption, and involved a narrowing of the problem definition and causes. The locus of the problem is located by the discourses within individuals including youth, with causes of youth alcohol consumption repeatedly presented as peer pressure and 'poor choices', with little or no mention of alcohol industry marketing or other practices. All programmes promoted familiarisation and normalisation of alcohol as a 'normal' adult consumer product which children must learn about and master how to use responsibly when older. The discourses constructed in these materials closely align with those of other alcohol industry corporate social responsibility discourses which employ selective presentation of harms, including misinformation about cancer, and ambiguous terms such as "responsible drinking". Furthermore, the role of alcohol price, availability and access, and the impacts of alcohol and the industry on inequities were not articulated within the discourses. The research was limited to an analysis of teaching materials and further research is needed to explore their impact on youth, teachers and wider discourses and social norms. Conclusion Alcohol industry-sponsored youth education programmes serve industry interests and promote moderate consumption while purportedly educating children about harms and influences of alcohol use. There are considerable conflicts of interest in the delivery of alcohol education programmes funded by the alcohol industry and intermediary bodies in receipt of such funding. Alcohol education materials should be developed independent from industry, including funding, and should empower children and young people to understand and think critically about alcohol, including harms and drivers of consumption, and effective interventions needed to protect them and others from alcohol-related harms. Independent organisations can use this analysis to critique their materials to strengthen alignment with meeting student and public health interests. The ongoing exposure of children and young people to such conflicted and misleading materials needs urgent attention from policymakers, practitioners, teachers and parents, and resources dependent on industry support should cease being used in schools.	[van Schalkwyk, May C., I; Petticrew, Mark; Maani, Nason; Hawkins, Ben; Bonell, Chris; Knai, Cecile] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England; [Petticrew, Mark; Maani, Nason; Knai, Cecile] SPECTRUM Consortium Shaping Publ Hlth Policies Re, London, England; [Katikireddi, Srinivasa Vittal] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	University of London; London School of Hygiene & Tropical Medicine; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	van Schalkwyk, MCI (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England.	may.vanschalkwyk@lshtm.ac.uk	; van Schalkwyk, May/Y-3687-2018	Maani, Nason/0000-0002-3398-0688; Katikireddi, Srinivasa/0000-0001-6593-9092; van Schalkwyk, May/0000-0003-2210-2289	NIHR Doctoral Fellowship [NIHR300156]; SPECTRUM Consortium - UK Prevention Research Partnership (UKRI Research Council: Medical Research Council); SPECTRUM Consortium - UK Prevention Research Partnership (UKRI Research Council: Engineering and Physical Sciences Research Council); SPECTRUM Consortium - UK Prevention Research Partnership (UKRI Research Council: Economic and Social Research Council); SPECTRUM Consortium - UK Prevention Research Partnership (UKRI Research Council: Natural Environment Research Council); SPECTRUM Consortium - UK Prevention Research Partnership (British Heart Foundation); SPECTRUM Consortium - UK Prevention Research Partnership (Cancer Research UK); SPECTRUM Consortium - UK Prevention Research Partnership (Wellcome); SPECTRUM Consortium - UK Prevention Research Partnership (Health Foundation); SPECTRUM Consortium - UK Prevention Research Partnership (Scottish Government Chief Scientist Office); SPECTRUM Consortium - UK Prevention Research Partnership (Health and Care Research Wales); SPECTRUM Consortium - UK Prevention Research Partnership (National Institute of Health Research); SPECTRUM Consortium - UK Prevention Research Partnership (Public Health Agency (NI)); NRS Senior Clinical Fellowship [SCAF/15/02]; Medical Research Council [MC_UU_00022/2]; Scottish Government Chief Scientist Office [SPHSU13]	NIHR Doctoral Fellowship; SPECTRUM Consortium - UK Prevention Research Partnership (UKRI Research Council: Medical Research Council); SPECTRUM Consortium - UK Prevention Research Partnership (UKRI Research Council: Engineering and Physical Sciences Research Council); SPECTRUM Consortium - UK Prevention Research Partnership (UKRI Research Council: Economic and Social Research Council); SPECTRUM Consortium - UK Prevention Research Partnership (UKRI Research Council: Natural Environment Research Council); SPECTRUM Consortium - UK Prevention Research Partnership (British Heart Foundation); SPECTRUM Consortium - UK Prevention Research Partnership (Cancer Research UK); SPECTRUM Consortium - UK Prevention Research Partnership (Wellcome); SPECTRUM Consortium - UK Prevention Research Partnership (Health Foundation); SPECTRUM Consortium - UK Prevention Research Partnership (Scottish Government Chief Scientist Office); SPECTRUM Consortium - UK Prevention Research Partnership (Health and Care Research Wales); SPECTRUM Consortium - UK Prevention Research Partnership (National Institute of Health Research); SPECTRUM Consortium - UK Prevention Research Partnership (Public Health Agency (NI)); NRS Senior Clinical Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Government Chief Scientist Office	MvS is funded by a NIHR Doctoral Fellowship (Ref NIHR300156, https://www.nihr.ac.uk).MP, NM and CK receive funding from the SPECTRUM Consortium which is funded by the UK Prevention Research Partnership, a consortium of UK funders (UKRI Research Councils: Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, and Natural Environment Research Council; charities: British Heart Foundation, Cancer Research UK, Wellcome, and the Health Foundation; government: Scottish Government Chief Scientist Office, Health and Care Research Wales, National Institute of Health Research, and Public Health Agency (NI) https://ukctas.net/spectrum/announcement.html).SVK acknowledges funding from a NRS Senior Clinical Fellowship (SCAF/15/02 https://www.nhsresearchscotland.org.uk), the Medical Research Council (MC_UU_00022/2 https://mrc.ukri.org) and Scottish Government Chief Scientist Office (SPHSU13 https://www.cso.scot.nhs.uk).	Alcohol Action Ireland,, ALCOHOL ED OUR SCH C; Alcohol Education Trust, IMPACT REACH; Alcohol Education Trust, TRUST REP; Alcohol Education Trust, AET RESOURCES USE SC; Alcohol Education Trust, FUNDING; Alcohol Education Trust, ALCOHOL ED TRUST; [Anonymous], 2014, RDAN M 5 NOVEMBER 20; [Anonymous], 2020, TALK ALCOHOL; [Anonymous], 2004, REDUCING UNDERAGE DR; Apollonio DE, 2010, AM J PUBLIC HEALTH, V100, P1188, DOI 10.2105/AJPH.2009.169573; Assunta M, 2004, TOB CONTROL, V13, P37, DOI 10.1136/tc.2004.007732; Ayo N, 2012, CRIT PUBLIC HEALTH, V22, P99, DOI 10.1080/09581596.2010.520692; Babor TF, 2014, ADDICTION, V109, P341, DOI 10.1111/add.12384; Ball SJ, 2012, GLOBAL EDUCATION INC: NEW POLICY NETWORKS AND THE NEO-LIBERAL IMAGINARY, P1; Ball SJ, 2016, POLICY FUTURES EDUC, V14, P1046, DOI 10.1177/1478210316664259; Baum F, 2014, SOCIOL HEALTH ILL, V36, P213, DOI 10.1111/1467-9566.12112; Boyles D., 2008, CORPORATE ASSAULT YO; Brandt AM, 2012, AM J PUBLIC HEALTH, V102, P63, DOI 10.2105/AJPH.2011.300292; Bryan CJ, 2019, NAT HUM BEHAV, V3, P596, DOI 10.1038/s41562-019-0586-6; Caluzzi G, 2021, SOCIOL HEALTH ILL, V43, P493, DOI 10.1111/1467-9566.13237; Carter SM, 2003, TOB CONTROL, V12, P71; Cathaoir KEO, 2018, NORD J HUMAN RIGHTS, V36, P109, DOI 10.1080/18918131.2018.1505090; Collingwood Learning, SMASHED PROJECT; Conibear H, 2014, ADDICTION, V109, P1382, DOI 10.1111/add.12625; Coombs J, 2011, AUSTRALAS MED J, V4, P655, DOI [10.4066/AMJ.2011.1018, 10.4066/AMJ.20111018]; Daube M., 2013, CONVERSATION; Department for Education,, GUIDANCE PLAN YOUR R; Diageo, 2018, DIAGEO SUPPORTS SMAS; Diageo,, 2018, SMASH KICKS 2018 GLO; DIFRANZA JR, 1992, J FAM PRACTICE, V34, P694; Drinkaware, DRINK ED; Drinkaware,, 2016, DRINKAWARE LAUNCHES; Eaton EM, 2020, ENVIRON EDUC RES, V26, P457, DOI 10.1080/13504622.2019.1650164; European Centre for Monitoring Alcohol Marketing, 2008, WOMENTHE NEW MARKET; European Drug Addiction Prevention, 2007, UNPLUGGED WORKBOOK P; European Drug Addiction Prevention, 2007, UNPLUGGED HDB TEACHE; EUropean Drug addiction prevention trial,, 2008, PREVENTING SUBSTANCE; Fairclough N., 2003, ANAL DISCOURSE TEXTU; Fairclough Norman, 1989, LANGUAGE POWER, V3rd; Foxcroft DR, 2012, PERSPECT PUBLIC HEAL, V132, P128, DOI 10.1177/1757913912443487; Garde A., 2018, CHILD RIGHTS BASED A; Glynos J, 2007, ROUTL INNOV POLIT TH, V26, P1; Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/S0140-6736(18)31310-2, 10.1016/s0140-6736(18)31310-2, 10.1136/bmj.l94]; Hawkes C, 2010, AM J PREV MED, V38, P457, DOI 10.1016/j.amepre.2010.01.011; Heineken, 2014, SUSTAINABILITY REPOR; Hessari NM, 2018, J PUBLIC HEALTH-UK, V40, P90, DOI 10.1093/pubmed/fdx040; Hessari NM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16050892; Hindmarsh CS, 2015, HEALTH EDUC RES, V30, P449, DOI 10.1093/her/cyv015; Howarth David, 2000, DISCOURSE; Howarth DJ., 2000, DISCOURSE THEORY POL; International Scientific Forum on Alcohol Research, FORUM MEMBERS; Jackson N, 2020, NEW ZEAL MED J, V133, P89; Jernigan DH, 2009, ADDICTION, V104, P6, DOI 10.1111/j.1360-0443.2008.02430.x; Jones SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184705; Jorgensen Marianne, 2002, DISCOURSE ANAL THEOR; Laclau E., 2014, HEGEMONY SOCIALIST S; Landman A, 2002, AM J PUBLIC HEALTH, V92, P917, DOI 10.2105/AJPH.92.6.917; Lee S, 2012, TOB CONTROL, V21, P445, DOI 10.1136/tobaccocontrol-2011-050353; Lim AWY, 2019, J STUD ALCOHOL DRUGS, V80, P524, DOI 10.15288/jsad.2019.80.524; Lima JM, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0336-y; Livesey SM., 2002, J BUS COMMUN, V39, P117, DOI [DOI 10.1177/002194360203900106, 10.1177/002194360203900106]; Mandel LL, 2006, J ADOLESCENT HEALTH, V39, P868, DOI 10.1016/j.jadohealth.2006.06.010; Marks JH., 2019, PERILS PARTNERSHIP, DOI DOI 10.1093/OSO/9780190907082.001.0001; McCambridge J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001767; McCambridge J, 2014, ADDICTION, V109, P519, DOI 10.1111/add.12356; McCloud RF, 2017, AM J PREV MED, V53, pS63, DOI 10.1016/j.amepre.2017.03.025; McClure AC, 2013, ALCOHOL CLIN EXP RES, V37, pE404, DOI 10.1111/j.1530-0277.2012.01932.x; Measham F., 2005, CRIME MEDIA CULT, V1, P262, DOI [DOI 10.1177/1741659005057641, 10.1177/1741659005057641]; Measham F, 2006, INT J DRUG POLICY, V17, P258, DOI 10.1016/j.drugpo.2006.02.013; Mialon M, 2018, EUR J PUBLIC HEALTH, V28, P664, DOI 10.1093/eurpub/cky065; Michaels D., 2020, TRIUMPH DOUBT DARK M, V1st; Michaels D, 2008, DOUBT IS THEIR PRODU, V1st; Molnar A., 2005, SCH COMMERCIALISM DE; Molnar Alex, 2005, Adolesc Med Clin, V16, P447, DOI 10.1016/j.admecli.2005.02.002; Molnar A, 2006, J EDUC POLICY, V21, P621, DOI 10.1080/02680930600866231; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Niederdeppe J, 2004, AM J PUBLIC HEALTH, V94, P255, DOI 10.2105/AJPH.94.2.255; Nixon L, 2015, AM J PUBLIC HEALTH, V105, P2228, DOI 10.2105/AJPH.2015.302819; Olajire AA, 2020, J CLEAN PROD, V256, DOI 10.1016/j.jclepro.2012.03.003; Palmedo PC, 2017, ANNU REV PUBL HEALTH, V38, P119, DOI 10.1146/annurev-publhealth-031816-044303; Petticrew M, 2020, MILBANK Q, V98, P1290, DOI 10.1111/1468-0009.12475; Petticrew M, 2018, DRUG ALCOHOL REV, V37, P293, DOI 10.1111/dar.12596; Popova S, 2009, ALCOHOL ALCOHOLISM, V44, P500, DOI 10.1093/alcalc/agp054; Powell D., 2018, GLOB STUD CHILD, V8, P379, DOI [10.1177/2043610618814840, DOI 10.1177/2043610618814840]; Powell D., 2020, SCH CORPORATIONS WAR; Powell D, 2019, J EDUC POLICY, V34, P195, DOI 10.1080/02680939.2018.1424940; Powell D, 2018, SPORT EDUC SOC, V23, P297, DOI 10.1080/13573322.2016.1192530; Powell D, 2015, DISCOURSE-ABINGDON, V36, P854, DOI 10.1080/01596306.2014.905045; Proctor RN, 2011, GOLDEN HOLOCAUST: ORIGINS OF THE CIGARETTE CATASTROPHE AND THE CASE FOR ABOLITION, P1; Remling E, 2018, CRIT DISCOURSE STUD, V15, P1, DOI 10.1080/17405904.2017.1382382; Reynolds America, YOUTH PREV; Room R, 2011, CRIT PUBLIC HEALTH, V21, P141, DOI 10.1080/09581596.2010.529424; Saltman KJ, 2014, REV EDUC PEDAGOG CUL, V36, P249, DOI 10.1080/10714413.2014.938564; Saltman Kenneth J., 2011, ED ENFORCEMENT MILIT; Schee CJV, 2010, SPORT EDUC SOC, V15, P169, DOI 10.1080/13573321003683828; Sebrie EM, 2007, AM J PUBLIC HEALTH, V97, P1357, DOI 10.2105/AJPH.2006.094128; Stockwell T, 2020, J STUD ALCOHOL DRUGS, V81, P284; Stockwell T, 2016, J STUD ALCOHOL DRUGS, V77, P839, DOI 10.15288/jsad.2016.77.839; Sukarieh M, 2009, J EDUC POLICY, V24, P769, DOI 10.1080/02680930903294636; Sussman Steve, 2002, Prev Sci, V3, P57, DOI 10.1023/A:1014623426877; Szmigin I, 2011, EUR J MARKETING, V45, P759, DOI 10.1108/03090561111120028; Talk About Alcohol, BODY WATCH; Tannock S, 2020, ENVIRON EDUC RES, V26, P474, DOI 10.1080/13504622.2020.1724891; The Brewers of Europe, 2014, 2 YEAR REP NOV 2014; Tupper KW., 2008, DISCOURSE, V29, P223, DOI [10.1080/01596300801966864, DOI 10.1080/01596300801966864]; Unicef UK,, RIGHT ED INTRO ARTIC; van Beemen O., 2019, HEINEKEN AFRICA MULT; Wine and Spirit Education Trust, CORPORATE PATRONS; World Health Organization, ALC 2018; World Health Organization, WHO ACC ACT RED HARM; World Health Organization,, 2002, SEEING SURFACE TRUTH; World Health Organization (WHO), 2010, GLOB STRAT RED HARMF; Worshipful Company of Distillers, CHARITIES WE SUPPORT; Wynne B, 2010, NATURE, V466, P441, DOI 10.1038/466441a; Zou J., 2017, OILS PIPELINE AM SCH	115	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0259560	10.1371/journal.pone.0259560	http://dx.doi.org/10.1371/journal.pone.0259560			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020741	Green Accepted, gold, Green Published			2022-12-27	WOS:000834207700007
J	Benbenishty, A; Schneiderman, J				Benbenishty, Amit; Schneiderman, Jacob			Intraarterial anti-leptin therapy via ICA protects ipsilateral CA1 neurons subjected to ischemia and reperfusion	PLOS ONE			English	Article							NF-KAPPA-B; CEREBRAL-ISCHEMIA; ACTIVATION; RECEPTOR; INJURY; DAMAGE; DEGENERATION; HIPPOCAMPUS; METABOLISM; EXPRESSION	Background Brain reperfusion following an ischemic event is essential for tissue viability, however, it also involves processes that promote neuronal cell death. We have recently shown that local expression of the hormone leptin in cardiovascular organs drives deleterious remodeling. As cerebral ischemia-reperfusion (IR) lesions derive expression of both the leptin hormone and its receptor, we hypothesized that blocking leptin activity in the injured brain area will reduce the deleterious effects of IR injury. Methods C57BL6 male mice underwent bilateral common carotid artery and external carotid artery ligation. The right hemisphere was reperfused after 12 minutes, followed by intraarterial injection of either a low-dose leptin antagonist or saline solution via the ipsilateral ICA. The left common carotid artery remained ligated. Fifteen IR/leptin antagonist-injected and fourteen IR/saline-injected mice completed the experiment. Five days after surgery brains were collected and samples of the hippocampal CA1 region were analyzed for cell viability (H&E) and apoptosis (TUNEL and caspase3), for neuroinflammation (Iba1), and for signaling pathways of pSTAT3 and pSmad2. Results The right hemisphere hippocampal CA1 region subjected to IR and saline injection exhibited increased apoptosis and necrosis of pyramidal cells. Also, increased density of activated microglia/macrophages was evident around the CA1 region. Comparatively, leptin antagonist treatment at reperfusion reduced apoptosis and necrosis of pyramidal cells, as indicated by increased number of viable cells (p < 0.01), and reduced TUNEL (p < 0.001) and caspase3-positive cells (p<0.05). Furthermore, this treatment reduced the density of activated microglia/macrophages (p < 0.001) in the CA1 region. Signaling pathway analysis revealed that while pSTAT3 and pSmad2-positive cells were found surrounding the stratum pyramidal in saline-treated animals, pSTAT3 signal was undetected and pSmad2 was greatly reduced in this territory following leptin antagonist treatment (p < 0.01). Conclusions Inhibition of leptin activity in hemispheric IR injury preserved the viability of ipsilateral hippocampal CA1 neurons, likely by preventing apoptosis and local inflammation. These results indicate that intraarterial anti-leptin therapy may have clinical potential in reducing hemispheric brain IR injury.	[Benbenishty, Amit] Tel Aviv Univ, Segol Sch Neurosci, Tel Aviv, Israel; [Schneiderman, Jacob] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Dept Vasc Surg, Tel Aviv, Israel	Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Schneiderman, J (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Dept Vasc Surg, Tel Aviv, Israel.	jschneid@post.tau.ac.il		Benbenishty, Amit/0000-0003-4559-5821				Abella V, 2017, NAT REV RHEUMATOL, V13, P100, DOI 10.1038/nrrheum.2016.209; Ambrosini G, 2002, J BIOL CHEM, V277, P34601, DOI 10.1074/jbc.M205172200; Amit B, 2017, BRAIN BEHAV IMMUN, V62, P265, DOI 10.1016/j.bbi.2017.02.012; [Anonymous], 1094539820211920424, DOI [10.1080/10945398.2021.1920424, DOI 10.1080/10945398.2021.1920424]; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BARONE FC, 1993, J CEREBR BLOOD F MET, V13, P683, DOI 10.1038/jcbfm.1993.87; Ben-Zvi D, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003474; Cheng G, 2021, ANIM BIOTECHNOL, DOI 10.1080/10495398.2021.1920424; DIAZ FG, 1985, J NEUROSURG, V63, P200, DOI 10.3171/jns.1985.63.2.0200; Donkor ES, 2018, STROKE RES TREAT, V2018, DOI 10.1155/2018/3238165; Elinav E, 2009, ENDOCRINOLOGY, V150, P3083, DOI 10.1210/en.2008-1706; Fisch S, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014761; Gao Q, 2008, AM J PHYSIOL-ENDOC M, V294, pE817, DOI 10.1152/ajpendo.00733.2007; Ghantous CM, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/534320; Giacobini E, 2018, CURR ALZHEIMER RES, V15, P1077, DOI 10.2174/1567205015666180613111504; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Hosoi T, 2000, BIOCHEM BIOPH RES CO, V273, P312, DOI 10.1006/bbrc.2000.2937; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Kadry H, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00230-3; Kain D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203902; L Lin, 2016, Biochem Pharmacol (Los Angel), V5, DOI 10.4172/2167-0501.1000213; Leyns CEG, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0192-x; Liu FF, 2015, NEURAL REGEN RES, V10, P438, DOI 10.4103/1673-5374.153693; Liu GY, 2019, NEUROL RES, V41, P125, DOI 10.1080/01616412.2018.1544399; Matsui H, 2007, LIFE SCI, V80, P672, DOI 10.1016/j.lfs.2006.10.027; Mitsushima D, 2008, ENDOCRINOLOGY, V149, P802, DOI 10.1210/en.2007-0827; Mizuma A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00467; Moon JB, 2009, J VET MED SCI, V71, P1381, DOI 10.1292/jvms.001381; Nikonenko AG, 2009, ANAT REC, V292, P1914, DOI 10.1002/ar.20969; Onken M, 2012, J NEUROSCI METH, V204, P254, DOI 10.1016/j.jneumeth.2011.11.022; Paciaroni M, 2009, EUR NEUROL, V61, P321, DOI 10.1159/000210544; Pluta R, 2018, J ALZHEIMERS DIS, V66, P429, DOI 10.3233/JAD-180772; Rininger A, 2012, J NEUROSCI METH, V207, P181, DOI 10.1016/j.jneumeth.2012.04.010; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Schneiderman J, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001727; Shpilman M, 2011, J BIOL CHEM, V286, P4429, DOI 10.1074/jbc.M110.196402; Soderberg S, 2003, CEREBROVASC DIS, V15, P63, DOI 10.1159/000067128; Tang CH, 2007, J IMMUNOL, V179, P1292, DOI 10.4049/jimmunol.179.2.1292; Tao M, 2013, ARTERIOSCL THROM VAS, V33, P311, DOI 10.1161/ATVBAHA.112.300543; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Xiong BY, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00128; Yan BC, 2011, J NEUROL SCI, V303, P100, DOI 10.1016/j.jns.2010.12.025; Zhang F, 2008, J NEUROCHEM, V107, P578, DOI 10.1111/j.1471-4159.2008.05645.x; Zhang F, 2007, STROKE, V38, P2329, DOI 10.1161/STROKEAHA.107.482786; Zhang JY, 2013, J CEREBR BLOOD F MET, V33, P567, DOI 10.1038/jcbfm.2012.202; Zhang WF, 2019, EXP THER MED, V17, P3282, DOI 10.3892/etm.2019.7377	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0261644	10.1371/journal.pone.0261644	http://dx.doi.org/10.1371/journal.pone.0261644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015765	gold, Green Published			2022-12-27	WOS:000814820600005
J	Gar, C; Thorand, B; Herder, C; Sujana, C; Heier, M; Meisinger, C; Peters, A; Koenig, W; Rathmann, W; Roden, M; Stumvoll, M; Maalmi, H; Meitinger, T; Then, H; Seissler, J; Then, C				Gar, Christina; Thorand, Barbara; Herder, Christian; Sujana, Chaterina; Heier, Margit; Meisinger, Christa; Peters, Annette; Koenig, Wolfgang; Rathmann, Wolfgang; Roden, Michael; Stumvoll, Michael; Maalmi, Haifa; Meitinger, Thomas; Then, Holger; Seissler, Jochen; Then, Cornelia			Association of circulating MR-proADM with all-cause and cardiovascular mortality in the general population: Results from the KORA F4 cohort study	PLOS ONE			English	Article							MIDREGIONAL PROADRENOMEDULLIN; SUBCLINICAL INFLAMMATION; METABOLIC SYNDROME; PROGNOSTIC VALUE; RISK-FACTORS; ADRENOMEDULLIN; PLASMA; PRO-ENDOTHELIN-1; ADIPONECTIN; DEFINITION	Background and aim Despite its vasodilatory effect, adrenomedullin and its surrogate mid-regional pro-adrenomedullin (MR-proADM) have been found to be positively associated with all-cause and cardiovascular mortality. However, the underlying mechanisms thereof remain unclear and the associations were mostly shown in geriatric cohorts or in patients with chronic diseases. Therefore, we aimed to investigate the possible involvement of abdominal obesity, selected adipokines, and biomarkers of subclinical inflammation in the association of MR-proADM with mortality in a population based study cohort. Methods Prospective analysis of the KORA F4 study; median follow-up 9.1 (8.8-9.4) years. Complete data on MR-proADM and mortality was available for 1551 participants, aged 56.9 +/- 12.9 years (mean +/- SD). Correlation and regression analyses of MR-proADM with overall (BMI) and abdominal obesity (waist circumference), selected adipokines and biomarkers of subclinical inflammation. Cox proportional hazard models on the association of MR-proADM with all-cause and cardiovascular mortality with adjustment for cardiovascular risk factors and selected biomarkers in study subgroups (n = 603-1551). Results MR-proADM associated with all-cause (HR (95%,CI): 2.37 (1.72-3.26) and 2.31 (1.67-3.20)) and cardiovascular mortality (4.28 (2.19-8.39) and 4.44 (2.25-8.76)) after adjustment for traditional cardiovascular risk factors including BMI or waist circumference, respectively. MR-proADM was further associated with four out of seven examined adipokines (leptin, retinol-binding protein-4, chemerin, and adiponectin) and with five out of eleven examined biomarkers of subclinical inflammation (high-sensitivity C-reactive protein, interleukin-6, myeloperoxidase, interleukin-22, and interleukin-1 receptor antagonist) after multivariable adjustment and correction for multiple testing. However, only IL-6 substantially attenuated the association of MR-proADM with all-cause mortality. Conclusions We found an association of MR-proADM with (abdominal) obesity, selected adipokines, and biomarkers of subclinical inflammation. However, the association of MR-proADM with mortality was independent of these parameters. Future studies should investigate the role of IL-6 and further characteristics of subclinical inflammation in the association between MR-proADM and all-cause mortality.	[Gar, Christina; Seissler, Jochen; Then, Cornelia] Ludwig Maximilians Univ Munchen, Dept Med 4, Univ Hosp, Munich, Germany; [Gar, Christina; Seissler, Jochen; Then, Cornelia] Ludwig Maximilians Univ Munchen, Clin Cooperat Grp Diabet, Munich, Germany; [Gar, Christina; Seissler, Jochen; Then, Cornelia] Helmholtz Zentrum Munchen, Munich, Germany; [Gar, Christina; Thorand, Barbara; Herder, Christian; Peters, Annette; Rathmann, Wolfgang; Roden, Michael; Maalmi, Haifa; Seissler, Jochen; Then, Cornelia] German Ctr Diabet Res DZD, Munich, Germany; [Thorand, Barbara; Sujana, Chaterina; Heier, Margit; Peters, Annette] German Res Ctr Environm Hlth GmbH, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Herder, Christian; Roden, Michael; Maalmi, Haifa] Heinrich Heine Univ Dusseldorf, German Diabet Ctr, Inst Clin Diabetol, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Herder, Christian; Roden, Michael] Heinrich Heine Univ Dusseldorf, Med Fac, Div Endocrinol & Diabetol, Dusseldorf, Germany; [Sujana, Chaterina] Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometry & Epidemiol IBE, Munich, Germany; [Heier, Margit] Univ Hosp Augsburg, KORA Study Ctr, Augsburg, Germany; [Meisinger, Christa] German Res Ctr Environm Hlth GmbH, Independent Res Grp Clin Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Meisinger, Christa] Univ Hosp Augsburg, Chair Epidemiol, Augsburg, Germany; [Peters, Annette; Koenig, Wolfgang; Meitinger, Thomas] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Koenig, Wolfgang] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Rathmann, Wolfgang] Heinrich Heine Univ Dusseldorf, German Diabet Ctr, Inst Biometr & Epidemiol, Leibniz Inst, Dusseldorf, Germany; [Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Then, Holger] Freie Waldorfschule Augsburg, Augsburg, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Centre for Cardiovascular Research; Munich Heart Alliance; Ulm University; German Heart Centre Munich; Technical University of Munich; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Leipzig University; Technical University of Munich	Gar, C (corresponding author), Ludwig Maximilians Univ Munchen, Dept Med 4, Univ Hosp, Munich, Germany.; Gar, C (corresponding author), Ludwig Maximilians Univ Munchen, Clin Cooperat Grp Diabet, Munich, Germany.; Gar, C (corresponding author), Helmholtz Zentrum Munchen, Munich, Germany.; Gar, C (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.	christina.gar@med.uni-muenchen.de	; Thorand, Barbara/B-5349-2014	Sujana, Chaterina/0000-0002-0663-2557; Thorand, Barbara/0000-0002-8416-6440; Gar, Christina/0000-0002-4218-6945; Koenig, Wolfgang/0000-0002-2064-9603	Helmholtz Zentrum Munchen German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria; Virtual Diabetes Institute (Helmholtz Zentrum Munchen); Clinical Cooperation Group Diabetes, Ludwig-Maximilians-University Munchen; Helmholtz Zentrum Munchen; German Diabetes Center; Federal Ministry of Health (Berlin, Germany); Ministry of Culture and Science of the state North Rhine Westphalia (Dusseldorf, Germany); Deutsche Diabetes Gesellschaft (DDG); German Research Foundation (DFG) [RA-45913/3-1]	Helmholtz Zentrum Munchen German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Virtual Diabetes Institute (Helmholtz Zentrum Munchen); Clinical Cooperation Group Diabetes, Ludwig-Maximilians-University Munchen; Helmholtz Zentrum Munchen(Helmholtz Association); German Diabetes Center; Federal Ministry of Health (Berlin, Germany); Ministry of Culture and Science of the state North Rhine Westphalia (Dusseldorf, Germany); Deutsche Diabetes Gesellschaft (DDG); German Research Foundation (DFG)(German Research Foundation (DFG))	The KORA study was initiated and financed by the Helmholtz Zentrum Munchen German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. The study was supported by a research grant from the Virtual Diabetes Institute (Helmholtz Zentrum Munchen) and the Clinical Cooperation Group Diabetes, Ludwig-Maximilians-University Munchen and Helmholtz Zentrum Munchen, and by the German Diabetes Center. The German Diabetes Center was supported by the Federal Ministry of Health (Berlin, Germany) and the Ministry of Culture and Science of the state North Rhine Westphalia (Dusseldorf, Germany). Further support was obtained from the Deutsche Diabetes Gesellschaft (DDG). The KORA F4 study was partly funded by a grant from the German Research Foundation (DFG) (RA-45913/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Behnes M, 2008, CLIN CHEM LAB MED, V46, P204, DOI 10.1515/CCLM.2008.040; Beltowski J, 2004, POL J PHARMACOL, V56, P5; Brouwers FP, 2012, HEART, V98, P1348, DOI 10.1136/heartjnl-2012-302390; Calabro Paolo, 2007, Subcell Biochem, V42, P63; Carstensen-Kirberg M, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0591-x; Caruhel P, 2009, CLIN BIOCHEM, V42, P725, DOI 10.1016/j.clinbiochem.2009.01.002; Castellani G, 2016, CYTOKINE, V88, P136, DOI 10.1016/j.cyto.2016.09.003; D'Elia L, 2021, HYPERTENS RES, V44, P1444, DOI 10.1038/s41440-021-00718-x; Del Ry S, 2016, EUR J NUTR, V55, P1255, DOI 10.1007/s00394-015-0938-6; Dong YL, 2018, J CLIN ENDOCR METAB, V103, P3810, DOI 10.1210/jc.2018-00905; Ebert T, 2018, J CLIN ENDOCR METAB, V103, P1015, DOI 10.1210/jc.2017-02085; Eggers KM, 2013, INT J CARDIOL, V168, P3537, DOI 10.1016/j.ijcard.2013.05.005; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Herder C, 2018, DIABETES-METAB RES, V34, DOI 10.1002/dmrr.3000; Herder C, 2017, EUR J ENDOCRINOL, V177, P277, DOI 10.1530/EJE-17-0100; Herder C, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0498-6; Herder C, 2013, DIABETES CARE, V36, P3663, DOI 10.2337/dc13-0382; Huth C, 2019, EUR J EPIDEMIOL, V34, P409, DOI 10.1007/s10654-018-0475-8; Isumi Y, 1999, FEBS LETT, V463, P110, DOI 10.1016/S0014-5793(99)01615-4; Kang KW, 2020, J OBES METAB SYNDR, V29, P248, DOI 10.7570/jomes20120; Kato J, 2005, ARTERIOSCL THROM VAS, V25, P2480, DOI 10.1161/01.ATV.0000184759.91369.f8; Kistorp Caroline, 2014, BMC Obes, V1, P24, DOI 10.1186/s40608-014-0024-2; Koyama T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113968; Lee ES, 2013, INT J EPIDEMIOL, V42, P1029, DOI 10.1093/ije/dyt087; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li Y, 2007, PEPTIDES, V28, P1129, DOI 10.1016/j.peptides.2007.03.005; Li YW, 2017, ATHEROSCLEROSIS, V259, P75, DOI 10.1016/j.atherosclerosis.2017.02.003; Lorubbio M, 2018, CLIN BIOCHEM, V53, P173, DOI 10.1016/j.clinbiochem.2018.01.003; Mandal J, 2019, PULM PHARMACOL THER, V56, P8, DOI 10.1016/j.pupt.2019.01.006; Masson S, 2010, EUR J HEART FAIL, V12, P338, DOI 10.1093/eurjhf/hfp206; Neumann JT, 2013, ATHEROSCLEROSIS, V228, P451, DOI 10.1016/j.atherosclerosis.2013.03.006; Odermatt J, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0605-3; Ohlsson T, 2019, J HYPERTENS, V37, P590, DOI 10.1097/HJH.0000000000001893; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Seissler J, 2012, EUR J ENDOCRINOL, V167, P847, DOI 10.1530/EJE-12-0472; Sinning C, 2017, CLIN RES CARDIOL, V106, P401, DOI 10.1007/s00392-016-1066-x; Unamuno X, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12997; Vila G, 2009, OBESITY, V17, P1184, DOI 10.1038/oby.2009.22; Wolf K, 2016, DIABETES, V65, P3314, DOI 10.2337/db15-1567; Wong HK, 2014, WORLD J DIABETES, V5, P364, DOI 10.4239/wjd.v5.i3.364; Wong HK, 2013, CLIN ENDOCRINOL, V79, P504, DOI 10.1111/cen.12078; Yang SL, 2002, CRIT CARE MED, V30, P2729, DOI 10.1097/00003246-200212000-00018; Yildirim NC, 2010, CLIN EXP IMMUNOL, V161, P171, DOI 10.1111/j.1365-2249.2010.04156.x; Zhou PH, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7201549; Zudaire E, 2003, REGUL PEPTIDES, V112, P121, DOI 10.1016/S0167-0115(03)00030-2	48	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262330	10.1371/journal.pone.0262330	http://dx.doi.org/10.1371/journal.pone.0262330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990470	Green Published, gold			2022-12-27	WOS:000815783800026
J	Ng' ombe, H; Simuyandi, M; Mwaba, J; Luchen, CC; Alabi, P; Chilyabanyama, ON; Mubanga, C; Hatyoka, LM; Muchimba, M; Bosomprah, S; Chilengi, R; Kwenda, G; Chisenga, CC				Ng' ombe, Harriet; Simuyandi, Michelo; Mwaba, John; Luchen, Charlie Chaluma; Alabi, Peter; Chilyabanyama, Obvious Nchimunya; Mubanga, Cynthia; Hatyoka, Luiza Miyanda; Muchimba, Mutinta; Bosomprah, Samuel; Chilengi, Roma; Kwenda, Geoffrey; Chisenga, Caroline Cleopatra			Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol (TM)) in adults residing in Lukanga Swamps of Zambia	PLOS ONE			English	Article								Introduction In cholera endemic areas, the periodicity of cholera outbreaks remains unpredictable, making it difficult to organize preventive efforts. Lack of data on duration of protection conferred by oral cholera vaccines further makes it difficult to determine when to deploy preemptive vaccination. We report on the immunogenicity and waning of immunity to Shanchol (TM) in Lukanga Swamps. Methods We enrolled a cohort of 223 participants aged between 18 and 65 years old from whom serum samples were collected at baseline, day 28 before administration of the second dose, and consecutively at 6, 12, 24, 30, 36, and 48 months. Vibriocidal antibody titres were measured and expressed as geometric mean titres. Box plots and 95% CI were computed at each visit for both Inaba and Ogawa. Seroconversion was defined as a four fold or greater increase in antibody titres compared to baseline titres. Results Overall, seroconversion against V. cholerae Inaba and Ogawa after 1st dose was 35/134 (26%) and 34/134 (25%) respectively. We observed a statistical difference in seroconversion between the two subgroups of baseline titres (low < 80 and high >= 80) for both Inaba (p = 0.02) and Ogawa (p<0.0001). From a baseline of 13.58, anti-Ogawa GMT increased to 21.95 after the first dose, but rapidly waned to 14.52, 13.13, and 12.78 at months 6, 12 and 24 respectively, and then increased to 13.21, 18.67 and 23.65 at months 30, 36 and 48 respectively. A similar trend was observed for anti-Inaba GMT across the same time points. Conclusion We found that Shanchol (TM) was immunogenic in our study population and that vibriocidal antibodies may not be a good marker for long-term immunity. The observed rise in titres after 36 months suggests natural exposure, and this may be a critical time window opening for natural transmission in an endemic areas. We recommend re-vaccination at this time point in high risk areas.	[Ng' ombe, Harriet; Simuyandi, Michelo; Mwaba, John; Luchen, Charlie Chaluma; Alabi, Peter; Chilyabanyama, Obvious Nchimunya; Mubanga, Cynthia; Hatyoka, Luiza Miyanda; Muchimba, Mutinta; Bosomprah, Samuel; Chilengi, Roma; Chisenga, Caroline Cleopatra] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Ng' ombe, Harriet; Mwaba, John; Kwenda, Geoffrey] Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia; [Bosomprah, Samuel] Univ Ghana, Sch Publ Hlth, Dept Biostat, Accra, Ghana	University of Zambia; University of Ghana	Ng' ombe, H (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.; Ng' ombe, H (corresponding author), Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia.	Harriet.Ngombe@cidrz.org	Simuyandi, Michelo/I-5598-2018; Mubanga, Cynthia/GVS-5931-2022	Simuyandi, Michelo/0000-0002-7348-2835; 	European and Developing Countries Trials Partnership (EDCTP) [TMA2016CDF-1550]; Bill & Melinda Gates Foundation through the John Hopkins University Delivery of Oral Cholera Vaccine Effectively (DOVE) project [OPP1148763]	European and Developing Countries Trials Partnership (EDCTP); Bill & Melinda Gates Foundation through the John Hopkins University Delivery of Oral Cholera Vaccine Effectively (DOVE) project	This work was funded by European and Developing Countries Trials Partnership (EDCTP) through a fellowship grant given to Dr Caroline Cleopatra Chisenga with fellowship grant number: TMA2016CDF-1550 (www.edctp.org).This work was supported in part, by the Bill & Melinda Gates Foundation [OPP1148763] through the John Hopkins University Delivery of Oral Cholera Vaccine Effectively (DOVE) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Ali M, 2011, J INFECT DIS, V204, P912, DOI 10.1093/infdis/jir416; [Anonymous], 2018, WEEKLY EPIDEMIOLOGIC; Chandralekha C, 2011, Indian J Community Med, V36, P165, DOI 10.4103/0970-0218.84142; Charles RC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002828; Deen J, 2020, VACCINE, V38, pA31, DOI 10.1016/j.vaccine.2019.07.078; Desai SN, 2017, HUM VACC IMMUNOTHER, V13, P579, DOI 10.1080/21645515.2016.1245250; Desai SN, 2016, TROP MED INT HEALTH, V21, P194, DOI 10.1111/tmi.12641; Harris JB, 2018, J INFECT DIS, V218, pS141, DOI 10.1093/infdis/jiy414; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Iyer AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep35742; Kanungo S., 2014, PLOS ONE, V9, P1; Kanungo S., 2015, OPEN LABEL NONINFERI, P1; Kanungo S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003809; Kapata N, 2018, J INFECT DIS, V218, pS181, DOI 10.1093/infdis/jiy490; Lekshmi N, 2018, INDIAN J MED RES, V147, P133, DOI [10.4103/ijmr.IJMR_280_17, 10.4103/ijmr.ijmr_280_17]; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; Murebwa-Chirambo R., 2017, ZNPHI HLTH PRESS ZAM, V1, P56; Mwaba J, 2021, VACCINE, V39, P4516, DOI 10.1016/j.vaccine.2021.06.034; Parker EPK, 2018, FUTURE MICROBIOL, V13, P97, DOI 10.2217/fmb-2017-0128; Saha A, 2011, VACCINE, V29, P8285, DOI 10.1016/j.vaccine.2011.08.108; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Sinyange N, 2018, MMWR-MORBID MORTAL W, V67, P556, DOI 10.15585/mmwr.mm6719a5; Son MS., 2011, CURRENT PROTOCOLS MI; WASSERMAN SS, 1994, VACCINE, V12, P1000, DOI 10.1016/0264-410X(94)90335-2; WHO, 2017, WEEKLY EPIDEMIOLOGIC, V1, P533	26	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262239	10.1371/journal.pone.0262239	http://dx.doi.org/10.1371/journal.pone.0262239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986195	gold, Green Published			2022-12-27	WOS:000765956200029
J	Shahjalal, M; Chakma, SK; Ahmed, T; Yasmin, I; Mahumud, RA; Hossain, A				Shahjalal, Md.; Chakma, Samar Kishor; Ahmed, Tanvir; Yasmin, Irin; Mahumud, Rashidul Alam; Hossain, Ahmed			Prevalence and determinants of using complementary and alternative medicine for the treatment of chronic illnesses: A multicenter study in Bangladesh	PLOS ONE			English	Article							PREDICTORS; PATTERNS; DISEASE	Background While conventional medicine (CM) is commonly used to treat non-communicable diseases (NCDs), complementary and alternative medicine (CAM) is gaining popularity as a health-care option in Bangladesh. We aimed to investigate the prevalence and factors associated with using CAM solely and using CAM in conjunction with CM for chronic illness treatment among NCD patients in Bangladesh. Methods A multicenter cross-sectional study was conducted, including 549 adults with a confirmed chronic illness diagnosis from three tertiary care hospitals in Dhaka city. Interviews were used to gather socio-demographic data, while medical records were used to get information on chronic illnesses. A multinomial logistic regression model was used to determine the associated factors of utilizing CAM primarily and CAM use in conjunction with CM to manage the chronic disease. Results Out of 549 NCD patients (282 women [51.4%], mean [standard deviation] age 45.4 [12.8] years), 180 (32.8%) ever used CAM for the treatment of chronic illness. Also, 15.3% of patients exclusively used CAM among the NCD patients, while 17.5% used CAM in conjunction with CM. Homeopathy medicine was the most prevalent type of treatment among CAM users (52.2%). Furthermore, 55.5% of CAM users said they used it due to its less adverse effects, and 41.6% trusted its effectiveness for chronic illness. Elderly patients (>= 60 years) preferred CAM in complementary with CM, but they did not rely only on CAM. According to the multinomial regression analysis, unmarried patients, predominantly in the younger age group, adopted CAM significantly for chronic illness treatment (Relative risk ratio, RRR = 0.29, 95% CI = 0.12-0.71, reference = Unmarried). Patients in the high-income group used CAM in conjunction with CM (RRR = 6.26, 95% CI = 1.35-18.90, reference: low-income), whereas patients in the high-income group did not rely on CAM alone (RRR = 0.99, 95% CI = 0.34-2.85). Conclusion Although CM remains the mainstream of health care in Bangladesh, CAM services play an essential role in people's health care, particularly in treating chronic illnesses. Physicians of Bangladesh should be aware that their patients may be using other services and be prepared to ask and answer questions regarding the risks and benefits of using CAM in addition to regular medical care. Thus, clinicians required to follow best-practice guidelines, which are currently not practiced in Bangladesh, when disseminating information regarding integrative techniques that combine CM and CAM approaches.	[Shahjalal, Md.; Chakma, Samar Kishor; Ahmed, Tanvir; Yasmin, Irin; Hossain, Ahmed] North South Univ, Dept Publ Hlth, Dhaka, Bangladesh; [Shahjalal, Md.; Chakma, Samar Kishor; Ahmed, Tanvir; Yasmin, Irin] Res Rats, Dhaka, Bangladesh; [Mahumud, Rashidul Alam] Univ Sydney, Fac Med & Hlth, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia; [Mahumud, Rashidul Alam] Univ Southern Queensland, Sch Business, Toowoomba, Qld, Australia; [Mahumud, Rashidul Alam] Univ Southern Queensland, Ctr Hlth Res, Toowoomba, Qld, Australia; [Hossain, Ahmed] North South Univ, Global Hlth Inst, Dhaka, Bangladesh	North South University (NSU); University of Sydney; University of Southern Queensland; University of Southern Queensland; North South University (NSU)	Hossain, A (corresponding author), North South Univ, Dept Publ Hlth, Dhaka, Bangladesh.; Hossain, A (corresponding author), North South Univ, Global Hlth Inst, Dhaka, Bangladesh.	ahmed.hossain@utoronto.ca	SHAHJALAL, MD./AAC-8316-2021; Hossain, Ahmed/H-4406-2012; Mahumud, Dr Rashidul Alam/O-2477-2018	SHAHJALAL, MD./0000-0002-2218-8433; Hossain, Ahmed/0000-0003-4575-1273; Yasmin, Irin/0000-0003-2731-0343; Chakma, Samar Kishor/0000-0002-2351-3648; Mahumud, Dr Rashidul Alam/0000-0001-9788-1868				Alam D., 2013, HLTH SYSTEMS PREPARE, P1; Althoff KN, 2016, CURR OPIN HIV AIDS, V11, P527, DOI 10.1097/COH.0000000000000305; [Anonymous], WHO FACT SHEETS 2021; [Anonymous], 2019, WHO GLOBAL REPORT TR; Barnes Patricia M, 2004, Adv Data, P1; Bodeker G, 2002, AM J PUBLIC HEALTH, V92, P1582, DOI 10.2105/AJPH.92.10.1582; Camey SA, 2014, CAD SAUDE PUBLICA, V30, P21, DOI 10.1590/0102-311X00077313; Chen FP, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-26; Chung VCH, 2021, INTEGR MED RES, V10, DOI 10.1016/j.imr.2020.100469; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ernst E, 2000, COMPLEMENT THER MED, V8, P32, DOI 10.1016/S0965-2299(00)90833-1; Habib SH, 2010, DIABETES METAB SYND, V4, P41, DOI 10.1016/j.dsx.2008.04.005; Haque MI, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2129-5; Hasan Syed Shahzad, 2009, Complement Ther Clin Pract, V15, P152, DOI 10.1016/j.ctcp.2009.02.003; Hughes GD, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/736074; Kadayat TM, 2012, J PUBLIC HEALTH-HEID, V20, P297, DOI 10.1007/s10389-011-0446-y; Lee GBW, 2004, FAM PRACT, V21, P654, DOI 10.1093/fampra/cmh613; Metcalfe A, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-58; Nailwal D, 2021, J PUBLIC HEALTH RES, V10, DOI 10.4081/jphr.2021.2109; Peltzer K, 2015, STUD ETHNO-MED, V9, P209, DOI 10.1080/09735070.2015.11905437; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Rafi MA, 2020, BMC COMPLEMENT MED, V20, DOI 10.1186/s12906-020-03021-3; Shaikh BT, 2005, EVID-BASED COMPL ALT, V2, P139, DOI 10.1093/ecam/neh088; Shorofi SA, 2017, COMPLEMENT THER CLIN, V27, P37, DOI 10.1016/j.ctcp.2017.03.001; World Health Organization, 2019, NONC DIS NCD; Xin BL, 2020, BMC COMPLEMENT MED, V20, DOI 10.1186/s12906-020-02910-x; Yamashita H, 2002, COMPLEMENT THER MED, V10, P84, DOI 10.1054/ctim.2002.0519	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262221	10.1371/journal.pone.0262221	http://dx.doi.org/10.1371/journal.pone.0262221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986159	gold, Green Published			2022-12-27	WOS:000765956200024
J	Chauhan, BS; Manalil, S				Chauhan, Bhagirath Singh; Manalil, Sudheesh			Seedbank persistence of four summer grass weed species in the northeast cropping region of Australia	PLOS ONE			English	Article							CHLORIS-TRUNCATA; GERMINATION; EMERGENCE; MANAGEMENT; SURVIVAL; BIOLOGY; ECOLOGY; DEPTH; SOIL	Summer grass weed species are a particular problem in the northeast cropping region of Australia because they are prolific seeders and favor no-till systems. Information on weed seed persistence levels can be used for the development of effective and sustainable integrated weed management programs. A field study was conducted over 42 months to evaluate the seedbank persistence of Chloris truncata, C. virgata, Dactyloctenium radulans, and Urochloa panicoides as affected by burial depth (0, 2, and 10 cm). Regardless of species, buried seeds persisted longer than surface seeds and there was no difference in seed persistence between 2 and 10 cm depths. Surface seeds of C. truncata depleted completely in 12 months and buried seeds in 24 months. Similarly, C. virgata seeds placed on the soil surface depleted in 12 months. Buried seeds of this species took 18 months to completely deplete, suggesting that C. truncata seeds persist longer than C. virgata seeds. Surface seeds of D. radulans took 36 months to completely deplete, whereas about 7% of buried seeds were still viable at 42 months. U. panicoides took 24 and 42 months to completely exhaust the surface and buried seeds, respectively. These results suggest that leaving seeds on the soil surface will result in a more rapid depletion of the seedbank. Information on seed persistence will help to manage these weeds using strategic tillage operations.	[Chauhan, Bhagirath Singh; Manalil, Sudheesh] Univ Queensland, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Qld, Australia; [Chauhan, Bhagirath Singh] Univ Queensland, Sch Agr & Food Sci SAFS, Gatton, Qld, Australia; [Manalil, Sudheesh] Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia; [Manalil, Sudheesh] Amrita Vishwa Vidyapeetham, Coimbatore, Tamil Nadu, India	University of Queensland; University of Queensland; University of Western Australia; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Coimbatore	Chauhan, BS (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Qld, Australia.; Chauhan, BS (corresponding author), Univ Queensland, Sch Agr & Food Sci SAFS, Gatton, Qld, Australia.	b.chauhan@uq.edu.au	Manalil, Sudheesh/GQR-0450-2022		Grains Research and Development Corporation (GRDC), Australia [UA00156]	Grains Research and Development Corporation (GRDC), Australia(Grains R&D Corp)	This work was supported by a grant from Grains Research and Development Corporation (GRDC), Australia, under project UA00156. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins DW, 1998, WEED RES, V38, P129, DOI 10.1046/j.1365-3180.1998.00083.x; [Anonymous], 2017, GROWNOTES, P1; Asaduzzaman M, 2019, WEED BIOL MANAG, V19, P85, DOI 10.1111/wbm.12183; BALLARE CL, 1988, ANN APPL BIOL, V112, P337, DOI 10.1111/j.1744-7348.1988.tb02070.x; Baskin CC, 2006, SEED SCI RES, V16, P165, DOI 10.1079/SSR2006247; Beckie HJ, 2018, WEED RES, V58, P177, DOI 10.1111/wre.12294; Borger CPD, 2011, CROP PASTURE SCI, V62, P678, DOI 10.1071/CP11018; Chauhan BS, 2006, WEED SCI, V54, P854, DOI 10.1614/WS-06-047R.1; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199949; Chauhan BS, 2019, WEBINAR AUSTR; Desai HS, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10091266; Douglas A., 2004, Weed management: balancing people, planet, profit. 14th Australian Weeds Conference, Wagga Wagga, New South Wales, Australia, 6-9 September 2004: papers and proceedings, P300; Fernando N, 2016, WEED SCI, V64, P605, DOI 10.1614/WS-D-15-00212.1; GenStat, 2020, GENSTAT WINDOWS, V9th ed.; Gill G., 2021, ECOLOGY MAJOR EMERGI; HATCH MD, 1988, ARCH BIOCHEM BIOPHYS, V261, P357, DOI 10.1016/0003-9861(88)90351-7; Heap I, INT SURVEY HERBICIDE; Korres NE, 2018, WEED SCI, V66, P446, DOI 10.1017/wsc.2018.27; KREMER RJ, 1993, ECOL APPL, V3, P42, DOI 10.2307/1941791; Llewellyn R, 2016, IMPACT WEEDS AUSTR G; Manalil S, 2020, CROP PASTURE SCI, V71, P916, DOI 10.1071/CP20092; Manalil S, 2017, CROP PASTURE SCI, V68, P773, DOI 10.1071/CP17116; Mohler CL, 1997, WEED RES, V37, P147, DOI 10.1046/j.1365-3180.1997.d01-21.x; Ngo TD, 2017, WEED SCI, V65, P413, DOI 10.1017/wsc.2016.33; Ngo TD, 2017, WEED SCI, V65, P395, DOI 10.1017/wsc.2017.5; Omami EN, 1999, WEED RES, V39, P345, DOI 10.1046/j.1365-3180.1999.00149.x; Taylor GB, 2005, AUST J AGR RES, V56, P645, DOI 10.1071/AR04284; Walker Steve, 2010, Plant Protection Quarterly, V25, P127	29	5	5	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262288	10.1371/journal.pone.0262288	http://dx.doi.org/10.1371/journal.pone.0262288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982794	gold, Green Published			2022-12-27	WOS:000834805700027
J	Ding, M; Pan, SY; Huang, J; Yuan, C; Zhang, Q; Zhu, XL; Cai, Y				Ding, Ming; Pan, Shi-yu; Huang, Jing; Yuan, Cheng; Zhang, Qiang; Zhu, Xiao-li; Cai, Yan			Optical coherence tomography for identification of malignant pulmonary nodules based on random forest machine learning algorithm	PLOS ONE			English	Article							LUNG-CANCER; ENDOBRONCHIAL ULTRASOUND; ATHEROSCLEROTIC PLAQUES; TRANSBRONCHIAL BIOPSY; DIAGNOSIS; CLASSIFICATION; FEATURES; TISSUES; CHINA	Objective To explore the feasibility of using random forest (RF) machine learning algorithm in assessing normal and malignant peripheral pulmonary nodules based on in vivo endobronchial optical coherence tomography (EB-OCT). Methods A total of 31 patients with pulmonary nodules were admitted to Department of Respiratory Medicine, Zhongda Hospital, Southeast University, and underwent chest CT, EB-OCT and biopsy. Attenuation coefficient and up to 56 different image features were extracted from A-line and B-scan of 1703 EB-OCT images. Attenuation coefficient and 29 image features with significant p-values were used to analyze the differences between normal and malignant samples. A RF classifier was trained using 70% images as training set, while 30% images were included in the testing set. The accuracy of the automated classification was validated by clinically proven pathological results. Results Attenuation coefficient and 29 image features were found to present different properties with significant p-values between normal and malignant EB-OCT images. The RF algorithm successfully classified the malignant pulmonary nodules with sensitivity, specificity, and accuracy of 90.41%, 77.87% and 83.51% respectively. Conclusion It is clinically practical to distinguish the nature of pulmonary nodules by integrating EB-OCT imaging with automated machine learning algorithm. Diagnosis of malignant pulmonary nodules by analyzing quantitative features from EB-OCT images could be a potentially powerful way for early detection of lung cancer.	[Ding, Ming; Huang, Jing; Yuan, Cheng; Zhang, Qiang; Zhu, Xiao-li] Southeast Univ, Zhongda Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Pan, Shi-yu; Cai, Yan] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Cai, Y (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China.	yancai@seu.edu.cn			National Nature Science Foundation of China [61821002, 11772093, 11972117, 11972118, 12072074]; Jiangsu science and technology development project [BE2017745]; Fundamental Research Funds for the Central Universities; National Demonstration Center for Experimental Biomedical Engineering Education; Funds for Young Zhishan Scholars(Southeast University, Nanjing, China)	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu science and technology development project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Demonstration Center for Experimental Biomedical Engineering Education; Funds for Young Zhishan Scholars(Southeast University, Nanjing, China)	This research is supported by the National Nature Science Foundation of China (Grant numbers 61821002, 11772093, 11972117, 11972118, 12072074), Jiangsu science and technology development project (BE2017745 Diagnosis of early lung cancer using airway optical coherence imaging technology), the Fundamental Research Funds for the Central Universities, the National Demonstration Center for Experimental Biomedical Engineering Education, and the Funds for Young Zhishan Scholars (Southeast University, Nanjing, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2017, RESPIROLOGY, V22, P443, DOI 10.1111/resp.12980; AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Bellier J, 2017, SURG ENDOSC, V31, P4705, DOI 10.1007/s00464-017-5543-8; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Butola A, 2019, APPL OPTICS, V58, pA135, DOI 10.1364/AO.58.00A135; Chakerian D., 1984, FRACTAL GEOMETRY NAT, DOI [10.1177/32.11.6386975, DOI 10.1177/32.11.6386975]; Cheddad A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110690; Chen Y, 2015, RESP MED, V109, P1446, DOI 10.1016/j.rmed.2015.09.006; Chowdhury AR, 2019, MED BIOL ENG COMPUT, V57, P193, DOI 10.1007/s11517-018-1878-0; Coxson HO, 2008, AM J RESP CRIT CARE, V177, P1201, DOI 10.1164/rccm.200712-1776OC; Ding M, 2016, CHEST, V150, P1281, DOI 10.1016/j.chest.2016.07.033; Dyer C.R., 1976, FOURIER TEXTURE FEAT; Ettinger DS, 2015, J NATL COMPR CANC NE, V13, P515, DOI 10.6004/jnccn.2015.0071; Goorsenberg A, 2020, RESPIRATION, V99, P190, DOI 10.1159/000503261; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hariri LP, 2013, JOVE-J VIS EXP, DOI 10.3791/3855; Hariri LP, 2013, CHEST, V144, P1261, DOI 10.1378/chest.13-0534; Hariri LP, 2012, ARCH PATHOL LAB MED, V136, P1492, DOI 10.5858/arpa.2012-0252-SA; Hsia DW, 2012, J BRONCHOL INTERN PU, V19, P5, DOI 10.1097/LBR.0b013e31823fcf11; Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5; KRUGER RP, 1974, IEEE T SYST MAN CYB, VSMC4, P40, DOI 10.1109/TSMC.1974.5408519; Laws K. I, P IM UND WORKSH, P47; Laws K. I, IMAGE PROCESSING MIS, P376; LENDARIS GG, 1970, PR INST ELECTR ELECT, V58, P198, DOI 10.1109/PROC.1970.7593; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Liu HC, 2021, J BIOPHOTONICS, V14, DOI 10.1002/jbio.202000364; Mandurah MM, 2015, LASER MED SCI, V30, P1189, DOI 10.1007/s10103-014-1541-4; Michel RG, 2010, CHEST, V138, P984, DOI 10.1378/chest.10-0753; Nandy S, 2016, BIOMED OPT EXPRESS, V7, P5182, DOI 10.1364/BOE.7.005182; Odermatt M, 2012, THER UMSCH, V69, P394, DOI 10.1024/0040-5930/a000305; Pahlevaninezhad H, 2015, BIOMED OPT EXPRESS, V6, P4191, DOI 10.1364/BOE.6.004191; Park S, 2020, THORAC CANCER, V11, P1639, DOI 10.1111/1759-7714.13446; PIETIKAINEN M, 1983, IEEE T SYST MAN CYB, V13, P421, DOI 10.1109/TSMC.1983.6313175; PRESS WH, 1992, NUMERICAL RECIPES; Rivera MP, 2007, CHEST, V132, p131S, DOI 10.1378/chest.07-1357; SCHMITT JM, 1993, APPL OPTICS, V32, P6032, DOI 10.1364/AO.32.006032; Shanmugavadivu P, 2012, PROCEDIA ENGINEER, V38, P2981, DOI 10.1016/j.proeng.2012.06.348; She J, 2013, CHEST, V143, P1117, DOI 10.1378/chest.11-2948; Shostak E, 2018, J BRONCHOL INTERN PU, V25, P189, DOI 10.1097/LBR.0000000000000491; Singla N, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201800255; Huynh T, 2016, IEEE T MED IMAGING, V35, P174, DOI 10.1109/TMI.2015.2461533; Tsuboi M, 2005, LUNG CANCER, V49, P387, DOI 10.1016/j.lungcan.2005.04.007; Ughi GJ, 2013, BIOMED OPT EXPRESS, V4, P1014, DOI 10.1364/BOE.4.001014; van Soest G, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3280271; Wang J, 2019, JPN J CLIN ONCOL, V49, P501, DOI 10.1093/jjco/hyz025; WESZKA JS, 1976, IEEE T SYST MAN CYB, V6, P269, DOI 10.1109/TSMC.1976.5408777; WU CM, 1992, IEEE T MED IMAGING, V11, P141, DOI 10.1109/42.141636; Zuniga PVS, 2020, CHEST, V157, P994, DOI 10.1016/j.chest.2019.10.042	48	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0260600	10.1371/journal.pone.0260600	http://dx.doi.org/10.1371/journal.pone.0260600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34971557	Green Published, gold			2022-12-27	WOS:000773555700016
J	Hiramoto, S; Asano, H; Miyamoto, T; Takegami, M; Kawabata, A				Hiramoto, Shiori; Asano, Hajime; Miyamoto, Tomoyoshi; Takegami, Manabu; Kawabata, Atsufumi			Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan	PLOS ONE			English	Article							QUALITY-OF-LIFE; PLACEBO-CONTROLLED TRIAL; DULOXETINE; BREAST; NEUROTOXICITY; GOSHAJINKIGAN; ASSOCIATION; CARBOPLATIN; IMPACT; OLDER	Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting adverse reaction in cancer patients treated with several cytotoxic anticancer agents including paclitaxel. Duloxetine, an antidepressant known as a serotonin-noradrenalin reuptake inhibitor, is the only agent that has moderate evidence for the use to treat painful CIPN. The present retrospective cohort study aimed to analyze risk factors for paclitaxel-induced peripheral neuropathy (PIPN), and investigate ongoing prescription drug use for PIPN in Japan. Female breast and gynecologic cancer patients who underwent paclitaxel-based chemotherapy at a single center in Japan between January 2016 and December 2019 were enrolled in this study. Patients' information obtained from electronic medical records were statistically analyzed to test possible risk factors on PIPN diagnosis. Patients' age, total paclitaxel dose, the history of female hormone-related diseases, hypertension and body mass index (BMI), but not additional platinum agents, were significantly associated with increased PIPN diagnosis. Drugs prescribed for PIPN included duloxetine, pregabalin, mecobalamin and Goshajinkigan, a polyherbal medicine, regardless of poor evidence for their effectiveness against CIPN, and were greatly different between breast and gynecologic cancer patients diagnosed with PIPN at the departments of Surgery and Gynecology, respectively. Thus, older age, greater total paclitaxel dose, the history of estrogen-related diseases, hypertension and BMI are considered risk factors for PIPN in paclitaxel-based chemotherapy of female cancer patients. It appears an urgent need to establish a guideline of evidence-based pharmacotherapy for PIPN.	[Hiramoto, Shiori; Miyamoto, Tomoyoshi; Kawabata, Atsufumi] Kindai Univ, Fac Pharm, Div Pharmacol & Pathophysiol, Higashiosaka, Osaka, Japan; [Hiramoto, Shiori; Asano, Hajime; Takegami, Manabu] Kindai Univ Hosp, Div Pharm, Osakasayama, Japan	Kindai University (Kinki University)	Kawabata, A (corresponding author), Kindai Univ, Fac Pharm, Div Pharmacol & Pathophysiol, Higashiosaka, Osaka, Japan.	kawabata@phar.kindai.ac.jp						Alejandro LM, 2013, AM J CLIN ONCOL-CANC, V36, P331, DOI 10.1097/COC.0b013e318246b50d; Barginear M, 2019, ONCOLOGIST, V24, P617, DOI 10.1634/theoncologist.2018-0298; Chantalat E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082815; Dolan ME, 2017, CLIN CANCER RES, V23, P5757, DOI 10.1158/1078-0432.CCR-16-3224; Domoto R, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081881; Driessen CML, 2012, SUPPORT CARE CANCER, V20, P877, DOI 10.1007/s00520-011-1336-0; Fattori V, 2020, PAIN, V161, P1321, DOI 10.1097/j.pain.0000000000001832; Ghoreishi Z, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4869-5; Greenwald MK, 2019, CANCER-AM CANCER SOC, V125, P269, DOI 10.1002/cncr.31798; Hershman DL, 2016, J CLIN ONCOL, V34, P3014, DOI 10.1200/JCO.2015.66.2346; Hertz DL, 2021, CANCER TREAT REV, V99, DOI 10.1016/j.ctrv.2021.102241; Hirayama Y, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000053; Hirayama Y, 2015, INT J CLIN ONCOL, V20, P866, DOI 10.1007/s10147-015-0810-y; Hoshino N, 2018, INT J CLIN ONCOL, V23, P434, DOI 10.1007/s10147-017-1229-4; Jordan B, 2019, BREAST CARE, V14, P79, DOI 10.1159/000499599; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kono T, 2013, CANCER CHEMOTH PHARM, V72, P1283, DOI 10.1007/s00280-013-2306-7; Kuriyama A, 2018, SUPPORT CARE CANCER, V26, P1051, DOI 10.1007/s00520-017-4028-6; Liu ZM, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00495; Loibl S, 2018, LANCET ONCOL, V19, P497, DOI 10.1016/S1470-2045(18)30111-6; Loprinzi CL, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.01399; Mielke S, 2005, CLIN CANCER RES, V11, P4843, DOI 10.1158/1078-0432.CCR-05-0298; Miyamoto T, 2021, J PHARMACOL SCI, V146, P49, DOI 10.1016/j.jphs.2021.03.001; Mols F, 2014, SUPPORT CARE CANCER, V22, P2261, DOI 10.1007/s00520-014-2255-7; Otake A, 2015, ANTICANCER RES, V35, P359; Salat K, 2020, PHARMACOL REP, V72, P486, DOI 10.1007/s43440-020-00109-y; Schloss JM, 2017, SUPPORT CARE CANCER, V25, P195, DOI 10.1007/s00520-016-3404-y; Schloss JM, 2015, SUPPORT CARE CANCER, V23, P1843, DOI 10.1007/s00520-015-2725-6; Sekiguchi F, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010367; Sekiguchi F, 2018, NEUROPHARMACOLOGY, V141, P201, DOI 10.1016/j.neuropharm.2018.08.040; Sikov WM, 2015, J CLIN ONCOL, V33, P13, DOI 10.1200/JCO.2014.57.0572; Smith EML, 2013, JAMA-J AM MED ASSOC, V309, P1359, DOI 10.1001/jama.2013.2813; Tew WP, 2014, J CLIN ONCOL, V32, P2553, DOI 10.1200/JCO.2014.55.3073; Tsubota M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1581-6; Xu JL, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6660087; Yang QW, 2016, REPROD SCI, V23, P163, DOI 10.1177/1933719115584449	36	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261473	10.1371/journal.pone.0261473	http://dx.doi.org/10.1371/journal.pone.0261473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972132	gold, Green Published			2022-12-27	WOS:000773555700036
J	Vassaur, H; Martelli, P				Vassaur, Hannah; Martelli, Peter			Inter-specialty collaboration in the formalization of a new foregut subspecialty	PLOS ONE			English	Article							AMERICAN OBSTETRICS; MEDICINE; DISEASE	Historical context and converging market conditions present a unique opportunity to study the factors contributing to the formalization of foregut, or upper gastrointestinal, surgery as a new subspecialty in United States healthcare. The aim of this study was to examine the justifications of those pursuing the formalization of a foregut subspecialty and to extract lessons for healthcare leaders on the evolving relationships between competing providers. This was a qualitative, cross-sectional study consisting of interviews, secondary survey data, and observation of society meetings between October 2018 and June 2019. Thirty interviews with healthcare professionals were conducted, transcribed, and analyzed for themes using qualitative coding software. Themes were correlated with observational field notes and archival data and compared against established social theories on professions and medical specialization. Analysis revealed that traditionally competing surgeons and gastroenterologists articulate a professional need to qualify foregut surgical expertise based on superior knowledge and outcomes, to define the allocation of certain tasks and procedures, and to foster collaboration across specialties. Converging market conditions precipitate individual and organizational decisions to pursue formal specialization. Participants in the formalization of this subspecialty should consider the history of professional competition and turf wars to achieve meaningful collaboration. Advocacy for multi-specialty societies and organizational movements could be a model for reduced conflict in other specialties as well.	[Vassaur, Hannah; Martelli, Peter] Suffolk Univ, Sawyer Business Sch, Boston, MA 02114 USA	Suffolk University	Martelli, P (corresponding author), Suffolk Univ, Sawyer Business Sch, Boston, MA 02114 USA.	pmartelli@suffolk.edu						Abbott A., 1988, SYSTEM PROFESSIONS E; American Foregut Society, 2019, OUR MISSION; Baffy G, 2017, CLIN GASTROENTEROL H, V15, P799, DOI 10.1016/j.cgh.2017.02.014; Cruess SR, 2002, MED J AUSTRALIA, V177, P208, DOI 10.5694/j.1326-5377.2002.tb04735.x; De Santis G., 1980, RES SOCIOL HLTH CARE, V1, P179; El-Serag HB, 2014, GUT, V63, P871, DOI 10.1136/gutjnl-2012-304269; European Foregut Society, 2021, 1 EFS M 2021; FREIDSON E, 1963, SOC PROBL, V11, P119, DOI 10.1525/sp.1963.11.2.03a00010; Freidson E., 1988, PROFESSIONAL POWERS; Ganz Robert A, 2016, Gastroenterol Hepatol (N Y), V12, P424; Garman AN, 2006, J ORGAN BEHAV, V27, P829, DOI 10.1002/job.394; Grams J, 2019, SAGES MANUAL FOREGUT, DOI [10.1007/978-3-319-96122-4, DOI 10.1007/978-3-319-96122-4]; Halpern R, 2010, DIGEST DIS SCI, V55, P328, DOI 10.1007/s10620-009-0927-9; Jackson HT, 2018, SURG ENDOSC, V32, P2800, DOI 10.1007/s00464-017-5983-1; Jones JW, 2005, J VASC SURG, V42, P587, DOI 10.1016/j.jvs.2005.06.025; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; LIGHT D, 1988, MILBANK Q, V66, P10, DOI 10.2307/3349912; Louie BE, 2018, THORAC SURG CLIN, V28, pXIII, DOI 10.1016/j.thorsurg.2018.08.002; MCKINLAY JB, 1985, INT J HEALTH SERV, V15, P161, DOI 10.2190/JBMN-C0W6-9WFQ-Q5A6; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Pfeffer J., 1978, EXTERNAL CONTROL ORG; Scott WR, 2008, ORGAN STUD, V29, P219, DOI 10.1177/0170840607088151; SIRCUS W, 1984, POSTGRAD MED J, V60, P725, DOI 10.1136/pgmj.60.709.725; Society of American Gastrointestinal and Endoscopic Surgeons, 2018, GUID SURG TREATM GAS; Society of American Gastrointestinal and Endoscopic Surgeons, 2019, SAGES COMM CHAIRS CO; The Fellowship Council, 2020, FOR FELL FC JOINT AN; The Foundation for Surgical Innovation and Education, 2019, AM FOR SOC IN M LAS; Timmermans S, 2010, J HEALTH SOC BEHAV, V51, pS94, DOI 10.1177/0022146510383500; Watkins JR, 2018, SURG ENDOSC, V32, P4422, DOI 10.1007/s00464-018-6184-2; Weis JJ, 2018, SURG ENDOSC, V32, P2613, DOI 10.1007/s00464-018-6020-8; Weisz G., 2006, DIVIDE CONQUER COMP; Zetka James R., 2003, SURGEONS SCOPE; Zetka JR, 2008, J HEALTH SOC BEHAV, V49, P335, DOI 10.1177/002214650804900307; Zetka JR, 2011, SOCIOL HEALTH ILL, V33, P837, DOI 10.1111/j.1467-9566.2011.01341.x	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2021	16	12							e0262019	10.1371/journal.pone.0262019	http://dx.doi.org/10.1371/journal.pone.0262019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0C7TD	34969054	Green Published, gold			2022-12-27	WOS:000775510400029
J	Zheng, SF; Masuda, T; Matsunaga, M; Noguchi, Y; Ohtsubo, Y; Yamasue, H; Ishii, K				Zheng, Shaofeng; Masuda, Takahiko; Matsunaga, Masahiro; Noguchi, Yasuki; Ohtsubo, Yohsuke; Yamasue, Hidenori; Ishii, Keiko			Cultural differences in social support seeking: The mediating role of empathic concern	PLOS ONE			English	Article							HELPING-BEHAVIOR; YOUNG ADULTHOOD; NORTH-AMERICA; LONELINESS; STRESS; COLLECTIVISM; VALIDITY; DISCRIMINATION; INDIVIDUALISM; INDEPENDENCE	Prior research has found that East Asians are less willing than Westerners to seek social support in times of need. What factors account for this cultural difference? Whereas previous research has examined the mediating effect of relational concern, we predicted that empathic concern, which refers to feeling sympathy and concern for people in need and varies by individuals from different cultures, would promote support seeking. We tested the prediction in two studies. In Study 1, European Canadians reported higher empathic concern and a higher frequency of support seeking, compared to the Japanese participants. As predicted, cultural differences in social support seeking were influenced by empathic concern. In Study 2, both empathic concern and relational concern mediated cultural differences in support seeking. Japanese with lower empathic concern but higher relational concern were more reluctant than European Americans to seek social support during stressful times. Finally, loneliness, which was more prevalent among the Japanese than among the European Americans, was partially explained by social support seeking.	[Zheng, Shaofeng; Ishii, Keiko] Nagoya Univ, Grad Sch Informat, Dept Cognit & Psychol Sci, Nagoya, Aichi, Japan; [Masuda, Takahiko] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Matsunaga, Masahiro] Aichi Med Univ, Dept Hlth & Psychosocial Med, Nagakute, Aichi, Japan; [Noguchi, Yasuki] Kobe Univ, Grad Sch Humanities, Dept Psychol, Kobe, Hyogo, Japan; [Ohtsubo, Yohsuke] Univ Tokyo, Grad Sch Humanities & Sociol, Dept Social Psychol, Bunkyo Ku, Tokyo, Japan; [Yamasue, Hidenori] Hamamatsu Univ, Dept Psychiat, Sch Med, Hamamatsu, Shizuoka, Japan	Nagoya University; University of Alberta; Aichi Medical University; Kobe University; University of Tokyo; Hamamatsu University School of Medicine	Zheng, SF (corresponding author), Nagoya Univ, Grad Sch Informat, Dept Cognit & Psychol Sci, Nagoya, Aichi, Japan.	zheng.shaofeng@i.mbox.nagoya-u.ac.jp	Ishii, Keiko/H-5607-2019	Zheng, Shaofeng/0000-0002-1834-6355	TopicSetting Program to Advance Cutting-Edge Humanities and Social Sciences Research Area Cultivation [D-4]; Japan Society for the Promotion Science	TopicSetting Program to Advance Cutting-Edge Humanities and Social Sciences Research Area Cultivation; Japan Society for the Promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The research was supported by TopicSetting Program to Advance Cutting-Edge Humanities and Social Sciences Research Area Cultivation (#D-4), the Japan Society for the Promotion Science to Keiko Ishii. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; AKERLIND I, 1992, SOC SCI MED, V34, P405, DOI 10.1016/0277-9536(92)90300-F; Anderson CA, 1999, PERS SOC PSYCHOL B, V25, P482, DOI 10.1177/0146167299025004007; Atkins D, 2014, THESIS U KENT CANTER; Atkins D, 2016, EMOTION, V16, P587, DOI 10.1037/emo0000162; Barth J, 2010, PSYCHOSOM MED, V72, P229, DOI 10.1097/PSY.0b013e3181d01611; Carlo G, 2012, PERS INDIV DIFFER, V53, P675, DOI 10.1016/j.paid.2012.05.022; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Cassels TG, 2010, J COGN CULT, V10, P309, DOI 10.1163/156853710X531203; Cheon BK, 2013, NEUROPSYCHOLOGIA, V51, P1177, DOI 10.1016/j.neuropsychologia.2013.03.018; Chiang W.-T., 2012, B ED PSYCHOL, V43, P657, DOI DOI 10.6251/BEP.20110107; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Chopik WJ, 2017, J CROSS CULT PSYCHOL, V48, P23, DOI 10.1177/0022022116673910; Chu PS, 2010, J SOC CLIN PSYCHOL, V29, P624, DOI 10.1521/jscp.2010.29.6.624; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Greck M, 2012, NEUROIMAGE, V59, P2871, DOI 10.1016/j.neuroimage.2011.09.052; DEJONGGIERVELD J, 1987, J PERS SOC PSYCHOL, V53, P119, DOI 10.1037/0022-3514.53.1.119; Demes KA, 2015, J PERS SOC PSYCHOL, V109, P316, DOI 10.1037/pspp0000046; DOVIDIO JF, 1990, J PERS SOC PSYCHOL, V59, P249, DOI 10.1037/0022-3514.59.2.249; EISENBERG N, 1994, J PERS SOC PSYCHOL, V66, P776, DOI 10.1037/0022-3514.66.4.776; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; Fiske AP, 2002, PSYCHOL BULL, V128, P78, DOI 10.1037/0033-2909.128.1.78; Foster A., 2012, PSYCHOLOGY, V3, P1142, DOI DOI 10.4236/; Goetz JL, 2019, EMOTION, V19, P320, DOI 10.1037/emo0000443; Hagerty BM, 1996, ARCH PSYCHIAT NURS, V10, P235, DOI 10.1016/S0883-9417(96)80029-X; Heine SJ, 2002, J PERS SOC PSYCHOL, V82, P903, DOI 10.1037//0022-3514.82.6.903; Himichi Toshiyuki, 2017, Shinrigaku Kenkyu, V88, P61; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Hu Y, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00024; Ishii K, 2017, J CROSS CULT PSYCHOL, V48, P1442, DOI 10.1177/0022022117731091; Ishikawa K., 2020, CULT BRAIN, P1, DOI [10. 1007/s40167-020-00091-5, DOI 10.1007/S40167-020-00091-5]; Kaelber KAY, 2014, INT J ADV COUNS, V36, P274, DOI 10.1007/s10447-013-9206-8; Kim HS, 2006, PERS SOC PSYCHOL B, V32, P1595, DOI 10.1177/0146167206291991; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Kitayama S, 2002, PSYCHOL BULL, V128, P89, DOI 10.1037/0033-2909.128.1.89; Kitayama S, 2006, J PERS SOC PSYCHOL, V91, P369, DOI 10.1037/0022-3514.91.3.369; Kitayama S, 2011, ANNU REV PSYCHOL, V62, P419, DOI 10.1146/annurev-psych-120709-145357; Kitayama S, 2009, J PERS SOC PSYCHOL, V97, P236, DOI 10.1037/a0015999; Kong F, 2013, SOC INDIC RES, V110, P271, DOI 10.1007/s11205-011-9930-6; Lachmann B, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00398; Lalwani AK, 2006, J PERS SOC PSYCHOL, V90, P165, DOI 10.1037/0022-3514.90.1.165; Larose S, 2002, PERS SOC PSYCHOL B, V28, P684, DOI 10.1177/0146167202288012; LeClair J., 2016, CULT BRAIN, V4, P21, DOI [10.1007/s40167-016-0034-7, DOI 10.1007/S40167-016-0034-7]; Markstrom CA, 2007, J ADOLESCENCE, V30, P63, DOI 10.1016/j.adolescence.2005.11.003; Markstrom CA, 2010, YOUTH SOC, V42, P59, DOI 10.1177/0044118X09333644; MARKUS HR, 1991, SELF : INTERDISCIPLINARY APPROACHES, P18; Matthews T, 2016, SOC PSYCH PSYCH EPID, V51, P339, DOI 10.1007/s00127-016-1178-7; Medin DL., 2007, HDB CULTURAL PSYCHOL, P615; Mesquita B, 2002, COGNITION EMOTION, V16, P127, DOI 10.1080/0269993014000176; Miller JG, 2020, APPL DEV SCI, V25, P1, DOI 10.1080/10888691.2020.1789348; Miller JG, 2017, J PERS SOC PSYCHOL, V113, P81, DOI 10.1037/pspi0000091; Mojaverian T, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00615; Moroi K., 1992, STUDIES HUMANITIES A, V42, P23, DOI [10.14945/00003890, DOI 10.14945/00003890]; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Oishi S, 2009, J EXP SOC PSYCHOL, V45, P913, DOI 10.1016/j.jesp.2009.04.028; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; PEARL T, 1990, PSYCHOL REP, V67, P49, DOI 10.2466/PR0.67.5.49-50; Peng KP, 1997, PSYCHOL METHODS, V2, P329, DOI 10.1037/1082-989X.2.4.329; Penner LA, 1998, J PERS SOC PSYCHOL, V74, P525, DOI 10.1037/0022-3514.74.2.525; Richman LS, 2009, PSYCHOL REV, V116, P365, DOI 10.1037/a0015250; Rokach A, 2002, EUR PSYCHOL, V7, P70, DOI 10.1027//1016-9040.7.1.70; ROOK KS, 1987, J PERS SOC PSYCHOL, V52, P1132, DOI 10.1037/0022-3514.52.6.1132; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; SCHROEDER DA, 1988, J EXP SOC PSYCHOL, V24, P333, DOI 10.1016/0022-1031(88)90024-8; Schwarzer R, 2004, HEALTH PSYCHOL, V158, P181; Stravynski A, 2001, SUICIDE LIFE-THREAT, V31, P32, DOI 10.1521/suli.31.1.32.21312; Sullivan D, 2012, J PERS SOC PSYCHOL, V103, P1023, DOI 10.1037/a0030382; Sun R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213142; Switaj P, 2015, COMPR PSYCHIAT, V59, P73, DOI 10.1016/j.comppsych.2015.02.016; Taylor SE, 2004, J PERS SOC PSYCHOL, V87, P354, DOI 10.1037/0022-3514.87.3.354; Taylor SE, 2007, PSYCHOL SCI, V18, P831, DOI 10.1111/j.1467-9280.2007.01987.x; Vignoles VL, 2016, J EXP PSYCHOL GEN, V145, DOI 10.1037/xge0000175; Wei MF, 2013, J COUNS PSYCHOL, V60, P625, DOI 10.1037/a0033413; Wilhelm MO, 2010, SOC PSYCHOL QUART, V73, P11, DOI 10.1177/0190272510361435; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009; Yuki M., 2012, RELATIONSHIP SCI INT, P137, DOI [10.1037/13489-007, DOI 10.1037/13489-007]	80	3	3	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2021	16	12							e0262001	10.1371/journal.pone.0262001	http://dx.doi.org/10.1371/journal.pone.0262001			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0C7TD	34969056	gold, Green Published			2022-12-27	WOS:000775510400027
J	Mills, MG; Bruce, E; Huang, ML; Crothers, JW; Hyrien, O; Oura, CAL; Blake, L; Brown Jordan, A; Hester, S; Wehmas, L; Mari, B; Barby, P; Lacoux, C; Fassy, J; Vial, P; Vial, C; Martinez, JRW; Oladipo, OO; Inuwa, B; Shittu, I; Meseko, CA; Chammas, R; Santos, CF; Dionisio, TJ; Garbieri, TF; Parisi, VA; Mendes-Correa, MC; de Paula, AV; Romano, CM; Goes, LGB; Minoprio, P; Campos, AC; Cunha, MP; Vilela, APP; Nyirenda, T; Mkakosya, RS; Muula, AS; Dumm, RE; Harris, RM; Mitchell, CA; Pettit, S; Botten, J; Jerome, KR				Mills, Margaret G.; Bruce, Emily; Huang, Meei-Li; Crothers, Jessica W.; Hyrien, Ollivier; Oura, Christopher A. L.; Blake, Lemar; Brown Jordan, Arianne; Hester, Susan; Wehmas, Leah; Mari, Bernard; Barby, Pascal; Lacoux, Caroline; Fassy, Julien; Vial, Pablo; Vial, Cecilia; Martinez, Jose R. W.; Oladipo, Olusola Olalekan; Inuwa, Bitrus; Shittu, Ismaila; Meseko, Clement A.; Chammas, Roger; Santos, Carlos Ferreira; Dionisio, Thiago Jose; Garbieri, Thais Francini; Parisi, Viviane Aparecida; Mendes-Correa, Maria Cassia; de Paula, Anderson V.; Romano, Camila M.; Goes, Luiz Gustavo Bentim; Minoprio, Paola; Campos, Angelica C.; Cunha, Marielton P.; Vilela, Ana Paula P.; Nyirenda, Tonney; Mkakosya, Rajhab Sawasawa; Muula, Adamson S.; Dumm, Rebekah E.; Harris, Rebecca M.; Mitchell, Constance A.; Pettit, Syril; Botten, Jason; Jerome, Keith R.			An international, interlaboratory ring trial confirms the feasibility of an extraction-less "direct" RT-qPCR method for reliable detection of SARS-CoV-2 RNA in clinical samples	PLOS ONE			English	Article								Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is used worldwide to test and trace the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). "Extraction-less" or "direct" real time-reverse transcription polymerase chain reaction (RT-PCR) is a transparent and accessible qualitative method for SARS-CoV-2 detection from nasopharyngeal or oral pharyngeal samples with the potential to generate actionable data more quickly, at a lower cost, and with fewer experimental resources than full RT-qPCR. This study engaged 10 global testing sites, including laboratories currently experiencing testing limitations due to reagent or equipment shortages, in an international interlaboratory ring trial. Participating laboratories were provided a common protocol, common reagents, aliquots of identical pooled clinical samples, and purified nucleic acids and used their existing in-house equipment. We observed 100% concordance across laboratories in the correct identification of all positive and negative samples, with highly similar cycle threshold values. The test also performed well when applied to locally collected patient nasopharyngeal samples, provided the viral transport media did not contain charcoal or guanidine, both of which appeared to potently inhibit the RT-PCR reaction. Our results suggest that direct RT-PCR assay methods can be clearly translated across sites utilizing readily available equipment and expertise and are thus a feasible option for more efficient COVID-19 coronavirus disease testing as demanded by the continuing pandemic.	[Mills, Margaret G.; Huang, Meei-Li; Jerome, Keith R.] Univ Washington, Dept Lab Med & Pathol, Div Virol, Seattle, WA 98195 USA; [Bruce, Emily; Crothers, Jessica W.; Botten, Jason] Univ Vermont, Dept Med, Robert Larner MD Coll Med, Div Immunobiol, Burlington, VT 05405 USA; [Hyrien, Ollivier; Jerome, Keith R.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Oura, Christopher A. L.; Blake, Lemar] Univ West Indies, Sch Vet Med, St Augustine, Trinidad Tobago; [Brown Jordan, Arianne] Minist Hlth, Port Of Spain, Trinidad Tobago; [Hester, Susan; Wehmas, Leah] US Environm Protect Agcy, Off Res & Dev, Res Triangle Pk, NC USA; [Mari, Bernard; Barby, Pascal; Lacoux, Caroline; Fassy, Julien] Univ Cote dAzur, CNRS, Inst Pharmacol Mol & Cellulaire, FHU OncoAge, Valbonne, France; [Vial, Pablo; Vial, Cecilia; Martinez, Jose R. W.] Clin Alemana Univ Desarrollo, Fac Med, Programa Hantavirus, Inst Ciencias & Innovac Med, Santiago, Chile; [Oladipo, Olusola Olalekan] Natl Inst Vet Res, Div Biochem, Vom, Nigeria; [Inuwa, Bitrus; Shittu, Ismaila; Meseko, Clement A.] Natl Inst Vet Res, Infect & Transboundary Anim Dis, Vom, Nigeria; [Chammas, Roger] Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Ctr Invest Translac Oncol,Inst Canc Estado Sao Pa, Sao Paulo, Brazil; [Santos, Carlos Ferreira; Dionisio, Thiago Jose; Garbieri, Thais Francini; Parisi, Viviane Aparecida] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil; [Mendes-Correa, Maria Cassia; de Paula, Anderson V.; Romano, Camila M.] Inst Trop Med Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil; [Goes, Luiz Gustavo Bentim; Minoprio, Paola; Campos, Angelica C.; Cunha, Marielton P.; Vilela, Ana Paula P.] Univ Sao Paulo, Sci Platform Pasteur USP, Sao Paulo, Brazil; [Goes, Luiz Gustavo Bentim] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [Nyirenda, Tonney; Mkakosya, Rajhab Sawasawa] Univ Malawi, Dept Pathol, Coll Med, Blantyre, Malawi; [Muula, Adamson S.] Univ Malawi, Dept Publ Hlth, Coll Med, Blantyre, Malawi; [Dumm, Rebekah E.; Harris, Rebecca M.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Pettit, Syril] Hlth & Environm Sci Inst, Washington, DC USA; [Botten, Jason] Univ Vermont, Robert Larner MD Coll Med, Dept Microbiol & Mol Genet, Burlington, VT USA	University of Washington; University of Washington Seattle; University of Vermont; Fred Hutchinson Cancer Center; University West Indies Mona Jamaica; University West Indies Saint Augustine; United States Environmental Protection Agency; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universidad del Desarrollo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Malawi; University of Malawi; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Vermont	Jerome, KR (corresponding author), Univ Washington, Dept Lab Med & Pathol, Div Virol, Seattle, WA 98195 USA.; Botten, J (corresponding author), Univ Vermont, Dept Med, Robert Larner MD Coll Med, Div Immunobiol, Burlington, VT 05405 USA.; Jerome, KR (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Pettit, S (corresponding author), Hlth & Environm Sci Inst, Washington, DC USA.; Botten, J (corresponding author), Univ Vermont, Robert Larner MD Coll Med, Dept Microbiol & Mol Genet, Burlington, VT USA.	spettit@hesiglobal.org; jason.botten@uvm.med.edu; kjerome@uw.edu	Vial, Maria Cecilia/GVS-4266-2022; Romano, Camila/ABC-2883-2020; Chammas, Roger/A-8004-2011; Pessoa Vilela, Ana Paula/Q-7538-2018; Santos, Carlos Ferreira dos/B-7676-2012; Mari, Bernard/Q-5832-2019; Almeida Campos, Angelica Cristine/Z-6089-2019	Romano, Camila/0000-0003-4550-1987; Chammas, Roger/0000-0003-0342-8726; Pessoa Vilela, Ana Paula/0000-0001-9030-0688; Harris, Rebecca/0000-0002-1944-3747; Parisi, Viviane Aparecida/0000-0002-0285-1322; Santos, Carlos Ferreira dos/0000-0002-0405-3500; Garbieri, Thais Francini/0000-0003-4507-5148; Oladipo, Olusola/0000-0001-9498-1492; Mari, Bernard/0000-0002-0422-9182; Lacoux, Caroline/0000-0002-1269-7306; Vial, Cecilia/0000-0002-0399-6144; Brown Jordan, Arianne/0000-0002-4146-3920; Almeida Campos, Angelica Cristine/0000-0003-0425-7498	Health and Environmental Sciences Institute; University of Vermont (UVM) Office of the Vice President for Research; Fondecyt [1201240]; National Institutes of Health National Institute of Allergy and Infectious Diseases [5R01AI129518, UM1AI068635]	Health and Environmental Sciences Institute; University of Vermont (UVM) Office of the Vice President for Research; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MM:A grant from the Health and Environmental Sciences Institute to the University of Washington supported preparation and shipment of Project A and B samples to Propagate partner laboratories. HESI scientific staff also served as authors on the study but were not involved in direct sample preparation or data analysis. www.hesiglobal.org JB: An award from the University of Vermont (UVM) Office of the Vice President for Research supported work in the Botten lab at UVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.uvm.edu/ovpr CV, PV: Fondecyt provided funding (grant 1201240) for the work of C. Vial and P. Vial. https://www.conicyt.cl/fondecyt/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KJ: Grants from the National Institutes of Health National Institute of Allergy and Infectious Diseases (5R01AI129518 and UM1AI068635) and a gift from the MJ Murdock Charitable Trust helped to support the work of University of Washington and Fred Hutchinson Cancer Research Center researchers. https://www.niaid.nih.gov/and https://murdocktrust.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A. M.Ribeiro-dos-Santos, 2020, medRxiv, DOI 10.1101/2020.04.15.20064931; American Society for Microbiology, 2021, EXP COVID 19 TEST FR; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Bruce Emily A, 2020, bioRxiv, DOI 10.1101/2020.03.20.001008; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Dumm RE, 2021, J APPL LAB MED, V6, P1441, DOI 10.1093/jalm/jfab079; Eshghifar N, 2021, INT J GEN MED, V14, P435, DOI 10.2147/IJGM.S297762; Graham NR, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1189; Kirkland PD, 2020, PATHOLOGY, V52, P811, DOI 10.1016/j.pathol.2020.09.013; Kuiper JWP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241740; La Scola B, 2020, EUR J CLIN MICROBIOL, V39, P1059, DOI 10.1007/s10096-020-03913-9; Millan C, 2021, TEST SCARCITY MEANS; Mina MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2025631; Pettit SD, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012634; Smyrlaki I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18611-5; Soy A, 2021, LACK COVID 19 TESTIN; U.S. Centers for Disease Control and Prevention, 2021, CDC 2019 NOV COR 201; van Kampen JJA., 2020, MEDRXIV INTERNET; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; World Health Organization, 2020, INTERIM GUIDANCE 2 M; World Health Organization, 2020, COVID 19 STRAT UPD G	21	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261853	10.1371/journal.pone.0261853	http://dx.doi.org/10.1371/journal.pone.0261853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025926	gold, Green Published			2022-12-27	WOS:000796264200029
J	van der Elst, EM; Abuna, M; Agutu, C; Ogada, F; Galole, A; Shikuku, J; Oduor, T; Graham, SM; Sanders, EJ; Operario, D				van der Elst, Elise M.; Abuna, Mitchelle; Agutu, Clara; Ogada, Fred; Galole, Aisha; Shikuku, Joyce; Oduor, Tony; Graham, Susan M.; Sanders, Eduard J.; Operario, Don			"Facilitating HIV status adjustment: Qualitative insights from the Tambua Mapema proof-of-concept study in Kenya"	PLOS ONE			English	Article							INFECTION; ADULTS	Systematic efforts are needed to prepare persons newly diagnosed with acute or chronic HIV infection to cope. We examined how patients dealt with this news, looking at how readiness to accept an HIV diagnosis impacted treatment outcomes, prevention of transmission, and HIV status disclosure. We examined vulnerability and agency over time and considered implications for policy and practice. A qualitative sub-study was embedded in the Tambua Mapema ("Discover Early") Plus (TMP) study (NCT03508908), conducted in coastal Kenya between 2017 and 2020, which was a stepped wedge trial to evaluate an opt-out HIV-1 nucleic acid testing intervention diagnosing acute and chronic HIV infections. Diagnosed participants were offered antiretroviral therapy (ART), viral load monitoring, HIV partner notification services, and provision of pre-exposure prophylaxis (PrEP) to their uninfected partners. Data were analyzed using thematic approaches. Participants included 24 individuals who completed interviews at four time points (2 weeks and 3, 6, and 9 months after diagnosis), including 18 patients (11 women and 7 men) and 6 partners (1 woman, 5 men, of whom 4 men started PrEP). Acceptance of HIV status was often a long, individualized, and complex process, whereby participants' coping strategies affected day-to-day issues and health over time. Relationship status strongly impacted coping. In some instances, couples supported each other, but in others, couples separated. Four main themes impacted participants' sense of agency: acceptance of diagnosis and commitment to ART; positive feedback after attaining viral load suppression; recognition of partner supportive role and focus on sustained healthcare support whereby religious meaning was often key to successful transition. To support patients with acute or newly diagnosed chronic HIV, healthcare and social systems must be more responsive to the needs of the individual, while also improving quality of care, strengthening continuity of care across facilities, and promoting community support.	[van der Elst, Elise M.; Agutu, Clara; Ogada, Fred; Galole, Aisha; Shikuku, Joyce; Oduor, Tony; Sanders, Eduard J.] Kenya Med Res Inst Wellcome Trust Res Programme, Dept Clin Sci, Kilifi, Kenya; [Abuna, Mitchelle; Operario, Don] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA; [Graham, Susan M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Graham, Susan M.] Univ Washington, Dept Global Hlth & Epidemiol, Seattle, WA 98195 USA; [Sanders, Eduard J.] Univ Oxford, Ctr Trop Med & Global Hlth, Headington, England	Kenya Medical Research Institute; Brown University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford	Sanders, EJ (corresponding author), Kenya Med Res Inst Wellcome Trust Res Programme, Dept Clin Sci, Kilifi, Kenya.; Sanders, EJ (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Headington, England.	esanders@kemri-wellcome.org		van der Elst, Elise/0000-0001-5106-0466; Abuna, Mitchelle/0000-0002-9431-3408; Sanders, Eduard/0000-0002-1062-8921; Agutu, Clara/0000-0003-1053-4463	National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI124968]; DELTAS Africa Initiative grant [DEL-15-006]; Wellcome Trust [107752/Z/15/Z]; Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE)	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DELTAS Africa Initiative grant; Wellcome Trust(Wellcome Trust); Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE)	The National Institute of Allergy and Infectious Diseases (NIAID) grant #R01 AI124968. The Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) and DELTAS Africa Initiative grant #DEL-15-006. The Wellcome Trust grant #107752/Z/15/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzordor P, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-01546-9; Agutu CA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246444; Agutu CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218369; COOPER DA, 1985, LANCET, V1, P537; Elliott T, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25419; Fiscus SA, 2007, J INFECT DIS, V195, P416, DOI 10.1086/510755; Graham SM, 2020, JMIR RES PROTOC, V9, DOI 10.2196/16198; Green J., 2004, QUALITATIVE METHODS; Harrison SE, 2019, AIDS, V33, pS1, DOI 10.1097/QAD.0000000000002242; Lindback S, 2000, AIDS, V14, P2333, DOI 10.1097/00002030-200010200-00014; Miles MB., 2018, QUALITATIVE DATA ANA, DOI DOI 10.1016/0149-7189(96)88232-2; Rutstein SE, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21579; Sanders EJ, 2022, HIV MED, V23, P16, DOI 10.1111/hiv.13157; Sanders EJ, 2015, AIDS, V29, pS221, DOI 10.1097/QAD.0000000000000924; Sanders EJ, 2011, AIDS, V25, P1219, DOI 10.1097/QAD.0b013e3283474ed5; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; TINDALL B, 1988, ARCH INTERN MED, V148, P945, DOI 10.1001/archinte.148.4.945; Trinh TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163594; Van der Elst EM, 2019, PSYCHOL HEALTH MED, V24, P631, DOI 10.1080/13548506.2018.1549736	19	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261255	10.1371/journal.pone.0261255	http://dx.doi.org/10.1371/journal.pone.0261255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025909	gold, Green Published			2022-12-27	WOS:000796264200014
J	Ghaddar, A; Khandaqji, S; Awad, Z; Kansoun, R				Ghaddar, Ali; Khandaqji, Sanaa; Awad, Zeinab; Kansoun, Rawad			Conspiracy beliefs and vaccination intent for COVID-19 in an infodemic	PLOS ONE			English	Article								Background The massive, free and unrestricted exchange of information on the social media during the Covid-19 pandemic has set fertile grounds for fear, uncertainty and the rise of fake news related to the virus. This "viral" spread of fake news created an "infodemic" that threatened the compliance with public health guidelines and recommendations. Objective This study aims to describe the trust in social media platforms and the exposure to fake news about COVID-19 in Lebanon and to explore their association with vaccination intent. Methods In this cross-sectional study conducted in Lebanon during July-August, 2020, a random sample of 1052 participants selected from a mobile-phone database responded to an anonymous structured questionnaire after obtaining informed consent (response rate = 40%). The questionnaire was conducted by telephone and measured socio-demographics, sources and trust in sources of information and exposure to fake news, social media activity, perceived threat and vaccination intent. Results Results indicated that the majority of participants (82%) believed that COVID-19 is a threat and 52% had intention to vaccinate. Exposure to fake/ unverified news was high (19.7% were often and 63.8% were sometimes exposed, mainly to fake news shared through Watsapp and Facebook). Trust in certain information sources (WHO, MoPH and TV) increased while trust in others (Watsapp, Facebook) reduced vaccination intent against Covid-19. Believing in the man-made theory and the business control theory significantly reduced the likelihood of vaccination intent (Beta = 0.43; p = 0.01 and Beta = -0.29; p = 0.05) respectively. Conclusion In the context of the infodemic, understanding the role of exposure to fake news and of conspiracy believes in shaping healthy behavior is important for increasing vaccination intent and planning adequate response to tackle the Covid-19 pandemic.	[Ghaddar, Ali; Khandaqji, Sanaa; Awad, Zeinab] Observ Publ Policies & Hlth, Beirut, Lebanon; [Ghaddar, Ali] Lebanese Int Univ, Dept Biomed Sci, Saida, Lebanon; [Khandaqji, Sanaa; Awad, Zeinab] Amer Univ Beirut, Dept Hlth Management & Policy, Beirut, Lebanon; [Kansoun, Rawad] Lebanese Int Univ, Dept Commun Arts, Beirut, Lebanon	American University of Beirut	Ghaddar, A (corresponding author), Observ Publ Policies & Hlth, Beirut, Lebanon.; Ghaddar, A (corresponding author), Lebanese Int Univ, Dept Biomed Sci, Saida, Lebanon.	ali.ghaddar@liu.edu.lb		Awad, Zeinab/0000-0001-5952-742X; Ghaddar, Ali/0000-0001-7261-347X				Ahmad AR, 2020, J MED INTERNET RES, V22, DOI 10.2196/19556; Ahmed W, 2020, J MED INTERNET RES, V22, DOI 10.2196/19458; Ahorsu DK, 2022, HUM VACC IMMUNOTHER, V18, DOI 10.1080/21645515.2021.1993689; Ali K, 2019, SCI COMMUN, V41, P314, DOI 10.1177/1075547019846124; Alimoradi Z, 2021, ASIAN J SOC HEAL BEH, V4, P129, DOI 10.4103/shb.shb_100_21; Alvarez-Risco A, 2020, AM J TROP MED HYG, V103, P583, DOI 10.4269/ajtmh.20-0536; Aquino F, 2017, VACCINE, V35, P4494, DOI 10.1016/j.vaccine.2017.07.029; Bin Naeem S, 2021, HEALTH INFO LIBR J, V38, P143, DOI 10.1111/hir.12320; Campbell H, 2017, VACCINE, V35, P2979, DOI 10.1016/j.vaccine.2017.03.089; Casigliani V, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2672; Centers for Disease Control and Prevention, 2020, COVID 19; Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2912; Department of Health and Social Care Department of Education, 2018, GOV RESP CONS TRANSF; Diegoli H, 2020, STROKE, V51, P2315, DOI 10.1161/STROKEAHA.120.030481; Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y; Esaiasson P, 2021, EUR J POLIT RES, V60, P748, DOI 10.1111/1475-6765.12419; Fan CW, 2021, HUM VACC IMMUNOTHER, V17, P3413, DOI 10.1080/21645515.2021.1933687; Fisher KA, 2020, ANN INTERN MED, V173, P964, DOI 10.7326/M20-3569; Fridman I, 2020, JMIR PUBLIC HLTH SUR, V6, P398, DOI 10.2196/22060; Government of Canada, 2020, FLUWATCH ANN REP 201; Greene C., 2020, EVIDENCE STUDY COVID, DOI [10.31234/osf.io/qfnm3, DOI 10.31234/OSF.IO/QFNM3]; Harrison EA, 2020, EUR J EPIDEMIOL, V35, P325, DOI 10.1007/s10654-020-00634-3; Huang PC, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9091046; Imhoff R, 2020, SOC PSYCHOL PERS SCI, V11, P1110, DOI 10.1177/1948550620934692; Ireton C., 2018, JOURNALISM FAKE NEWS; Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255; Kukreti S, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030246; Lin CY, 2020, INTERNET INTERV, V21, DOI 10.1016/j.invent.2020.100345; Melki J., 2020, MITIGATING INFODEMIC; Newton, 2020, VERGE, DOI 1263782/google-antitrust-case-attorneys-general-justice-partisan-politics.; Orso D, 2020, EUR J EMERG MED, V27, P327, DOI 10.1097/MEJ.0000000000000713; PAHO, 2020, UND INF MIS FIGHT CO; Palamenghi L, 2020, EUR J EPIDEMIOL, V35, P785, DOI 10.1007/s10654-020-00675-8; Pantaleon D, 2020, LIST N DIARIO; Patel MP, 2020, INDIAN J NEPHROL, V30, P188, DOI 10.4103/ijn.IJN_216_20; Peretti-Watel P, 2020, LANCET INFECT DIS, V20, P769, DOI 10.1016/S1473-3099(20)30426-6; Pramukti I, 2020, J MED INTERNET RES, V22, DOI 10.2196/24487; Reiter PL, 2020, VACCINE, V38, P6500, DOI 10.1016/j.vaccine.2020.08.043; Reza Zafarani, 2020, Arxiv, DOI arXiv:1812.00315; Rieger MO, 2021, ASIAN J SOC HEAL BEH, V4, P81, DOI 10.4103/shb.shb_7_21; Romer D, 2020, SOC SCI MED, V263, DOI 10.1016/j.socscimed.2020.113356; Rosen G, 2020, FACEBOOK; Rovetta A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.9884; Schaffer DeRoo S, 2020, JAMA-J AM MED ASSOC, V323, P2458, DOI 10.1001/jama.2020.8711; Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; Singh M, 2020, WHATSAPP INTRODUCES; Smallman S., 2015, J INT GLOBAL STUDIES; Spinney L., 2020, SCIENCEMAG; Statt N, 2020, VERGE; Strekalova YA, 2017, HEALTH EDUC BEHAV, V44, P332, DOI 10.1177/1090198116660310; Tangcharoensathien V, 2020, J MED INTERNET RES, V22, DOI 10.2196/19659; Tomljenovic H, 2020, PSYCHOL HEALTH, V35, P538, DOI 10.1080/08870446.2019.1673894; Trew B., 2020, INDEPENDENT; Ullah I, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.2370; UNITED NATIONS, 2020, UN TACKL INF MIS CYB; van Prooijen JW, 2018, EUR J SOC PSYCHOL, V48, P897, DOI 10.1002/ejsp.2530; Wang PW, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040380; Wang YX, 2019, SOC SCI MED, V240, DOI 10.1016/j.socscimed.2019.112552; WHO, 2020, MANAGING COVID 19 IN; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; Wong LP, 2020, HUM VACC IMMUNOTHER, V16, P2204, DOI 10.1080/21645515.2020.1790279; World Health Organization, 2020, MUN SEC C; World Health Organization (WHO), 2019, DIS OUTBREAK NE 0208; Yahaghi R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9070684; Yang LJ, 2019, EUR J EPIDEMIOL, V34, P893, DOI 10.1007/s10654-019-00574-7; Yeh YC, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030297; Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X	68	12	12	10	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261559	10.1371/journal.pone.0261559	http://dx.doi.org/10.1371/journal.pone.0261559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020721	Green Published, gold			2022-12-27	WOS:000834207700018
J	Reed, MS; Curtis, T; Gosal, A; Kendall, H; Andersen, SP; Ziv, G; Attlee, A; Fitton, RG; Hay, M; Gibson, AC; Hume, AC; Hill, D; Mansfield, JL; Martino, S; Olesen, AS; Prior, S; Rodgers, C; Rudman, H; Tanneberger, F				Reed, Mark S.; Curtis, Tom; Gosal, Arjan; Kendall, Helen; Andersen, Sarah Pyndt; Ziv, Guy; Attlee, Anais; Fitton, Richard G.; Hay, Matthew; Gibson, Alicia C.; Hume, Alex C.; Hill, David; Mansfield, Jamie L.; Martino, Simone; Olesen, Asger Strange; Prior, Stephen; Rodgers, Christopher; Rudman, Hannah; Tanneberger, Franziska			Integrating ecosystem markets to co-ordinate landscape-scale public benefits from nature	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES; PAYMENTS; GOODS	Ecosystem markets are proliferating around the world in response to increasing demand for climate change mitigation and provision of other public goods. However, this may lead to perverse outcomes, for example where public funding crowds out private investment or different schemes create trade-offs between the ecosystem services they each target. The integration of ecosystem markets could address some of these issues but to date there have been few attempts to do this, and there is limited understanding of either the opportunities or barriers to such integration. This paper reports on a comparative analysis of eleven ecosystem markets in operation or close to market in Europe, based on qualitative analysis of 25 interviews, scheme documentation and two focus groups. Our results indicate three distinct types of markets operating from the regional to national scale, with different modes of operation, funding and outcomes: regional ecosystem markets, national carbon markets and green finance. The typology provides new insights into the operation of ecosystem markets in practice, which may challenge traditionally held notions of Payment for Ecosystem Services. Regional ecosystem markets, in particular, represent a departure from traditional models, by using a risk-based funding model and aggregating both supply and demand to overcome issues of free-riding, ecosystem service trade-offs and land manager engagement. Central to all types of market were trusted intermediaries, brokers and platforms to aggregate supply and demand, build trust and lower transaction costs. The paper outlines six options for blending public and private funding for the provision of ecosystem services and proposes a framework for integrating national carbon markets and green finance with regional ecosystem markets. Such integration may significantly increase funding for regenerative agriculture and conservation across multiple habitats and services, whilst addressing issues of additionality and ecosystem service trade-offs between multiple schemes.	[Reed, Mark S.; Kendall, Helen; Rudman, Hannah] Scotlands Rural Coll SRUC, Thriving Nat Capital Challenge Ctr, Dept Rural Econ, Edinburgh, Midlothian, Scotland; [Reed, Mark S.] Newcastle Univ, Ctr Rural Econ, Newcastle Upon Tyne, Tyne & Wear, England; [Reed, Mark S.] Newcastle Univ, Sch Nat & Environm Sci, Inst Agrifood Res & Innovat, Newcastle Upon Tyne, Tyne & Wear, England; [Curtis, Tom] 3Keel LLP, Fenlock Court, Long Hanborough, England; [Gosal, Arjan; Andersen, Sarah Pyndt] Inst European Environm Policy, Brussels, Belgium; [Ziv, Guy] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Attlee, Anais] Collingwood Investments Ltd, London, England; [Attlee, Anais] Project Maya CIC, London, England; [Fitton, Richard G.; Gibson, Alicia C.; Hume, Alex C.; Mansfield, Jamie L.] FinanceEarth, London, England; [Hay, Matthew] Forest Carbon Ltd, Abbey Rd Business Ctr, Durham, England; [Hill, David] Environm Bank Ltd, The Catalyst, York, N Yorkshire, England; [Martino, Simone; Prior, Stephen] Univ York, Dept Environm & Geog, York, N Yorkshire, England; [Olesen, Asger Strange] Forest Stewardship Council, Freiburg, Germany; [Rodgers, Christopher] Newcastle Univ, Sch Law, Windsor Terrace Law Sch 21 24, Newcastle Upon Tyne, Tyne & Wear, England; [Tanneberger, Franziska] Greifswald Univ, Partner Greifswald Mire Ctr, Greifswald, Germany	Scotland's Rural College; Newcastle University - UK; Newcastle University - UK; University of Leeds; University of York - UK; Newcastle University - UK	Reed, MS (corresponding author), Scotlands Rural Coll SRUC, Thriving Nat Capital Challenge Ctr, Dept Rural Econ, Edinburgh, Midlothian, Scotland.; Reed, MS (corresponding author), Newcastle Univ, Ctr Rural Econ, Newcastle Upon Tyne, Tyne & Wear, England.; Reed, MS (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Inst Agrifood Res & Innovat, Newcastle Upon Tyne, Tyne & Wear, England.	mark.reed@sruc.ac.uk		Gosal, Arjan/0000-0001-6782-0706; Reed, Mark/0000-0002-8958-8474; Rudman, Hannah/0000-0003-4502-3583	Global Food Security's 'Resilience of the UK Food System Programme'; BBSRC; ESRC; NERC; Scottish Government, as part of the Resilient Dairy Landscapes project [BB/R005680/1]; Integrated Catchment Solutions Programme (iCASP) - UK Natural Environment Research Council's Regional Impact from Science of the Environment scheme [NE/P011160/1]; European Commission's Directorate-General for Climate Action [340201/2018/789608/ETU/CLIMA.C.3]; NatureScot [117832]; British Academy [KF5210311]	Global Food Security's 'Resilience of the UK Food System Programme'; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government, as part of the Resilient Dairy Landscapes project; Integrated Catchment Solutions Programme (iCASP) - UK Natural Environment Research Council's Regional Impact from Science of the Environment scheme; European Commission's Directorate-General for Climate Action; NatureScot; British Academy	This research was funded by the Global Food Security's 'Resilience of the UK Food System Programme' with support from BBSRC, ESRC, NERC and Scottish Government, as part of the Resilient Dairy Landscapes project (grant BB/R005680/1), the Integrated Catchment Solutions Programme (iCASP) funded by the UK Natural Environment Research Council's Regional Impact from Science of the Environment scheme (grant NE/P011160/1), European Commission's Directorate-General for Climate Action (contract 340201/2018/789608/ETU/CLIMA.C.3), NatureScot (Project No. 117832) and the British Academy (grant KF5210311). Salary support was provided by 3Keel to TC, Forest Carbon Ltd to SP, Environment Bank Ltd to DH, Institute for European Environmental Policy to AG and SPA, Collingwood Investments Ltd to SA, Project Maya CIC to SA, Forest Stewardship Council to AO, Finance Earth to RF.	Adriaens T, 2015, MANAG BIOL INVASION, V6, P215, DOI 10.3391/mbi.2015.6.2.12; Aligica PD., 2019, PUBLIC GOVERNANCE CL; Artz RRE, 2013, DECISION SUPPORT TOO; Bailey R, 2020, IMPLICATIONS BOARDS; Bateman IJ, 2018, LAND USE POLICY, V79, P293, DOI 10.1016/j.landusepol.2018.08.022; Baumeister R.F., 1997, REV GEN PSYCHOL, V1, P311, DOI [10.1037/1089-2680.1.3.311, DOI 10.1037/1089-2680.1.3.311]; Bayon R., 2012, VOLUNTARY CARBON MAR; Benessaiah K, 2012, ECOL ECON, V77, P1, DOI 10.1016/j.ecolecon.2012.02.022; Braat L., 2008, EC BIODIVERSITY ECOS; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Brown MB, 2008, MINERVA, V46, P485, DOI 10.1007/s11024-008-9106-y; Calle A, 2020, ECOSYST SERV, V42, DOI 10.1016/j.ecoser.2020.101084; CCC, 2020, LAND US POL NET ZER; COASE RH, 1960, J LAW ECON, V3, P1, DOI 10.1086/466560; Committee on Climate Change (CCC), 2019, NET ZERO UKS CONTRIB; Coyne L., 2020, LAND USE POLICY, DOI [10.1016/j.landusepol.2020.105174%3C/italic%3E%3C/underline%3E, DOI 10.1016/J.LANDUSEPOL.2020.105174%3C/ITALIC%3E%3C/UNDERLINE%3E]; Credit Suisse McKinsey, 2016, CONS FIN NICH MAINST; Crouzeilles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11666; de Lima LS, 2017, ECOSYST SERV, V27, P139, DOI 10.1016/j.ecoser.2017.09.005; de Sartre XA, 2019, ECOL SOC, V24, DOI 10.5751/ES-10711-240202; Defra, 2011, NAT CHOIC SEC VAL NA; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Environment Agency, 2020, GREEN FIN FUND ENV P; Esteves AM, 2012, IMPACT ASSESS PROJ A, V30, P34, DOI 10.1080/14615517.2012.660356; FAO, 2020, US; Gosal A., 2020, YORKSHIRE INTEGRATED, DOI [10.5518/100/48, DOI 10.5518/100/48]; Greenhalgh T, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12931; Hodge I, 2015, CONSERV BIOL, V29, P996, DOI 10.1111/cobi.12531; Johansen DF, 2020, MAR POLICY, V112, DOI 10.1016/j.marpol.2019.103783; Kendall H, UK DAIRY FARMER PERC; Kenney K, 2021, CARBON FARMING ORGAN; Lang S, 2019, CLIM POLICY, V19, P414, DOI 10.1080/14693062.2018.1556152; Martin-Ortega J, 2018, ECOL ECON, V154, P218, DOI 10.1016/j.ecolecon.2018.08.001; MARWELL G, 1979, AM J SOCIOL, V84, P1335, DOI 10.1086/226937; Mills J, 2017, AGR HUM VALUES, V34, P283, DOI 10.1007/s10460-016-9705-4; Muradian R, 2013, CONSERV LETT, V6, P274, DOI 10.1111/j.1755-263X.2012.00309.x; Nelleman C., 2010, RAPID RESPONSE ASSES; Neumann RK, 2020, THESIS NEWCASTLE U; Panks S., 2019, BIODIVERSITY METRIC; Reed MS, 2017, GLOBAL ENVIRON CHANG, V43, P92, DOI 10.1016/j.gloenvcha.2016.12.009; Reed M.S., 2020, EMERALD OPEN RES SUS, V2, P57; Reed MS, 2020, FINAL REPORT NATURAL, DOI [10.13140/RG.2.2.23295.23208, DOI 10.13140/RG.2.2.23295.23208]; Ruggiero PGC, 2019, LAND USE POLICY, V82, P283, DOI 10.1016/j.landusepol.2018.11.054; Ruto E, 2009, J ENVIRON PLANN MAN, V52, P631, DOI 10.1080/09640560902958172; Securities Industry and Financial Market Association (SIFMA), 2020, 2019 FACT BOOK; Siebert R, 2006, SOCIOL RURALIS, V46, P318, DOI 10.1111/j.1467-9523.2006.00420.x; Sommerville MM, 2009, ECOL SOC, V14; STIGLER GJ, 1989, YALE LAW J, V99, P631, DOI 10.2307/796757; Marine Mammal Action Plan, 1992, Pilot, V7, P1, DOI 10.1145/143103.143108; Vidal NG, 2010, J BUS ETHICS, V94, P553, DOI 10.1007/s10551-009-0281-z; Waylen KA, 2018, ECOSYST SERV, V29, P23, DOI 10.1016/j.ecoser.2017.11.007; WTW (Willis Towers Watson), 2020, GLOB EC RES FAC; Wunder S., 2009, Journal of Sustainable Forestry, V28, P576, DOI 10.1080/10549810902905669; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x; Wunder S, 2015, ECOL ECON, V117, P234, DOI 10.1016/j.ecolecon.2014.08.016; Young D., 2020, FINANCING UK NATURE	56	2	2	10	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0258334	10.1371/journal.pone.0258334	http://dx.doi.org/10.1371/journal.pone.0258334			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020743	gold, Green Published, Green Submitted			2022-12-27	WOS:000834207700006
J	Faisal, MR; Mishu, MP; Jahangir, F; Younes, S; Dogar, O; Siddiqi, K; Torgerson, DJ				Faisal, Mehreen Riaz; Mishu, Masuma Pervin; Jahangir, Faisal; Younes, Sabahat; Dogar, Omara; Siddiqi, Kamran; Torgerson, David J.			The effectiveness of behaviour change interventions delivered by non-dental health workers in promoting children's oral health: A systematic review and meta-analysis	PLOS ONE			English	Review							EARLY-CHILDHOOD CARIES; CLUSTER-RANDOMIZED-TRIAL; QUALITY-OF-LIFE; DENTAL-CARIES; EDUCATION-PROGRAM; YOUNG; DISEASES; PARENTS; POPULATION; MOTHERS	Objectives Dental caries is the most common preventable childhood condition. Non-dental professionals and health workers are often well placed to support parents in adopting positive oral health behaviours for their children. The aim of this study was to determine the effectiveness of behaviour change interventions and their individual component behaviour change techniques (BCTs), that were delivered by non-dental professionals and health workers. Methods A systematic search of Ovid MEDLINE, PubMed, CINAHL, Cochrane Library, Web of Science, TRoPHI and PROQUEST from inception until March 2021 was conducted. Randomised controlled trials and quasi-experimental studies for improving oral health outcomes in children were included. Quality assessment was carried out using Cochrane Risk of Bias tool and ROBINS-I tool. Publication bias was assessed using funnel plots and Egger's regression intercept. Effect sizes were estimated as standardised mean difference (SMD) and odds ratio/risk ratio for proportions. Meta-analyses were performed for studies reporting mean decayed, missing, filled surfaces (dmfs) and mean decayed, missing, filled, teeth (dmft) indices. Behaviour change technique coding was performed using behaviour change technique taxonomy v1 (BCTTv1). Results Out of the 9,101 records retrieved, 36 studies were included with 28 showing a significant effect either in clinical and/or behavioural/knowledge outcomes. Most studies (n = 21) were of poor methodological quality. The pooled SMD for caries experience showed statistically significant result for caries prevention at surface level -0.15 (95% CI -0.25, -0.04) and at the tooth level -0.24 (95% CI -0.42, -0.07). In 28 effective interventions, 27 individual BCTs were identified and the most frequently used were: "Instructions on how to perform the behaviour" and "Information about health consequences". Conclusion There is low quality of evidence suggesting non-dental professionals and health workers may help improve oral health outcomes for children. To confirm these findings, further high-quality studies incorporating a variety of BCTs in their interventions for adoption of good oral health behaviours are needed.	[Faisal, Mehreen Riaz; Mishu, Masuma Pervin; Dogar, Omara; Siddiqi, Kamran; Torgerson, David J.] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Jahangir, Faisal] Margalla Inst Hlth Sci, Dept Oral Med, Rawalpindi, Pakistan; [Younes, Sabahat] Univ Cent Lancashire, Dept Community Hlth & Wellbeing, Preston, Lancs, England; [Dogar, Omara] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland	University of York - UK; University of Central Lancashire; University of Edinburgh	Faisal, MR (corresponding author), Univ York, Dept Hlth Sci, York, N Yorkshire, England.	mehreen.faisal@york.ac.uk	Siddiqi, Kamran/AAD-8801-2021	Siddiqi, Kamran/0000-0003-1529-7778; Mishu, Masuma Pervin/0000-0002-6545-9117; dogar, omara/0000-0002-7122-8403; Faisal, Mehreen Riaz/0000-0002-2725-572X				Abanto J, 2011, COMMUNITY DENT ORAL, V39, P105, DOI 10.1111/j.1600-0528.2010.00580.x; Acs George, 1999, Pediatric Dentistry, V21, P109; Adair PM, 2013, CARIES RES, V47, P2, DOI 10.1159/000351829; Adair Pauline M, 2004, Community Dent Health, V21, P102; Albino J, 2016, J DENT RES, V95, P35, DOI 10.1177/0022034515609034; Alkarimi HA, 2014, PEDIATRICS, V133, pE616, DOI 10.1542/peds.2013-0846; [Anonymous], 2020, END CHILDH DENT CAR; Asimakopoulou K, 2015, COMMUNITY DENT ORAL, V43, P2, DOI 10.1111/cdoe.12131; Bagramian RA, 2009, AM J DENT, V22, P3; Batliner T, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-125; Bentley E M, 1993, Community Dent Health, V10, P243; Biordi DL, 2015, AM J PUBLIC HEALTH, V105, pE23, DOI 10.2105/AJPH.2014.302486; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Braun PA, 2016, J DENT RES, V95, P1237, DOI 10.1177/0022034516658612; Breitenstein SM, 2010, RES NURS HEALTH, V33, P164, DOI 10.1002/nur.20373; Brown TJ, 2019, ADDICT BEHAV, V92, P236, DOI 10.1016/j.addbeh.2018.12.031; Chaffee BW, 2013, J DENT RES, V92, pS29, DOI 10.1177/0022034513484331; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Colak Hakan, 2013, J Nat Sci Biol Med, V4, P29, DOI 10.4103/0976-9668.107257; Cooper AM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009378.pub2; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Davies GM, 2005, COMMUNITY DENT HLTH, V22, P118; De Vasconcelos S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204088; Duffy S, 2016, J MED LIBR ASSOC, V104, P309, DOI 10.3163/1536-5050.104.4.011; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El Fadl RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166760; Feldens CA, 2010, COMMUNITY DENT ORAL, V38, P324, DOI 10.1111/j.1600-0528.2010.00540.x; George A, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0862-x; Gibbs L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007321; Gomes MC, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-55; Gray-Burrows KA, 2017, BRIT DENT J, V222, P937, DOI 10.1038/sj.bdj.2017.543; Hallas D, 2015, J PEDIATR HEALTH CAR, V29, P181, DOI 10.1016/j.pedhc.2014.11.004; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Harrison RL, 2003, COMMUNITY DENT ORAL, V31, P392, DOI 10.1034/j.1600-0528.2003.00001.x; Harrison R, 2007, PEDIATR DENT, V29, P16; Heilbrunn-Lang AY, 2020, HEALTH PROMOT INT, V35, P279, DOI 10.1093/heapro/daz025; Henshaw M M, 2018, JDR Clin Trans Res, V3, P353, DOI 10.1177/2380084418794377; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoeft KS, 2016, COMMUNITY DENT ORAL, V44, P564, DOI 10.1111/cdoe.12250; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Hooley M, 2012, J DENT, V40, P873, DOI 10.1016/j.jdent.2012.07.013; IntHout J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010247; Jakobsen JC, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-34; Kassebaum NJ, 2017, J DENT RES, V96, P380, DOI 10.1177/0022034517693566; Keith RE, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-99; Kowash MB, 2000, BRIT DENT J, V188, P201, DOI 10.1038/sj.bdj.4800431a; Kressin NR, 2009, MED CARE, V47, P1121, DOI 10.1097/MLR.0b013e3181b58867; Leung C, 2015, RES SOCIAL WORK PRAC, V25, P322, DOI 10.1177/1049731514533390; Marcenes W, 2013, BRIT DENT J, V215, DOI 10.1038/sj.bdj.2013.687; Marinho V C, 2003, Cochrane Database Syst Rev, pCD002278, DOI 10.1002/14651858.CD002278; Mattheus Deborah J, 2014, Oral Health Dent Manag, V13, P316; Maupome G, 2010, ETHNIC DIS, V20, P444; Menegaz AM, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000109, 10.11606/s1518-8787.2018052000109]; Michie S., 2013, ENCY BEHAV MED, P182, DOI [10.1007/978-1-4419-1005-9_1661, DOI 10.1007/978-1-4419-1005-9_1661]; Michie S, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19990; Mirzazadeh A, 2015, J CLIN EPIDEMIOL, V68, P317, DOI 10.1016/j.jclinepi.2014.11.013; Mishu MP, 2018, COMMUNITY DENT ORAL, V46, P449, DOI 10.1111/cdoe.12412; Mohebbi SZ, 2009, CARIES RES, V43, P110, DOI 10.1159/000209343; Nair MKC, 2009, INDIAN PEDIATR, V46, pS86; Neumann AS, 2011, J PAEDIATR CHILD H, V47, P367, DOI 10.1111/j.1440-1754.2010.01988.x; O'Donovan J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021467; Petersen PE, 2010, COMMUNITY DENT HLTH, V27, P129, DOI 10.1922/CDH_2643Petersen08; Pine Cynthia M, 2004, Community Dent Health, V21, P121; Public Health England, CHILD OR HLTH APPL A; Raj S, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-67; Salzer S, 2017, J CLIN PERIODONTOL, V44, pS106, DOI 10.1111/jcpe.12673; de Sousa FSD, 2019, CARIES RES, V53, P502, DOI 10.1159/000499639; Sgan-Cohen HD, 2001, J PUBLIC HEALTH DENT, V61, P107, DOI 10.1111/j.1752-7325.2001.tb03374.x; Sheiham A, 2006, BRIT DENT J, V201, P625, DOI 10.1038/sj.bdj.4814259; Smith L, 2018, COMMUNITY DENT HLTH, V35, P211, DOI 10.1922/CDH_4293Smith06; StataCorp, 2021, STATA RELEASE 17 STA; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Tsai C, 2020, COMMUNITY DENT ORAL, V48, P549, DOI 10.1111/cdoe.12567; Turton B, 2021, COMMUNITY DENT ORAL, V49, P275, DOI 10.1111/cdoe.12599; Unkel JH, 2020, J DENT CHILD, V87, P153; Vachirarojpisan T, 2005, COMMUNITY DENT HLTH, V22, P253; Van den Branden S, 2014, EUR J PUBLIC HEALTH, V24, P893, DOI 10.1093/eurpub/ckt204; Vichayanrat T, 2012, SE ASIAN J TROP MED, V43, P526; Villaita J, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00175; Villena RS, 2019, J AM DENT ASSOC, V150, P1004, DOI 10.1016/j.adaj.2019.04.003; Watt RG, 2007, COMMUNITY DENT ORAL, V35, P1, DOI 10.1111/j.1600-0528.2007.00348.x; Whittle JG, 2008, COMMUNITY DENT HLTH, V25, P28, DOI 10.1922/CDH_2143Whittle05; Wilson LB, 2013, INT J DENT, V2013, DOI 10.1155/2013/437830; Yuan S, 2007, EUR ARCH PAEDIATR DE, V8, P55, DOI 10.1007/BF03262571; Yuan SY, 2019, DENT J-BASEL, V7, DOI 10.3390/dj7010008	85	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262118	10.1371/journal.pone.0262118	http://dx.doi.org/10.1371/journal.pone.0262118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015771	Green Accepted, Green Published, gold			2022-12-27	WOS:000814820600009
J	Velez-Paez, JL; Legua, P; Velez-Paez, P; Irigoyen, E; Andrade, H; Jara, A; Lopez, F; Perez-Galarza, J; Baldeon, L				Luis Velez-Paez, Jorge; Legua, Pedro; Velez-Paez, Pablo; Irigoyen, Estefania; Andrade, Henry; Jara, Andrea; Lopez, Fernanda; Perez-Galarza, Jorge; Baldeon, Lucy			Mean platelet volume and mean platelet volume to platelet count ratio as predictors of severity and mortality in sepsis	PLOS ONE			English	Article							MEGAKARYOCYTE	Introduction Sepsis is a public health problem due to its high prevalence and mortality. Mean platelet volume (MPV), a biomarker reported in routine blood counts, has been investigated and shows promise for determining fatal outcomes in septic patients. Objective Evaluate whether the mean platelet volume (MPV) and mean platelet volume-to-platelet count (MPV/P) ratio are predictors of clinical severity and mortality in patients with sepsis. Methods A prospective population cohort of 163 patients aged 18-97 years was recruited at the Intensive Care Unit of Pablo Arturo Hospital, Quito, Ecuador from 2017-2019 and followed up for 28 days. Patients were diagnosed with sepsis based on SEPSIS-3 septic shock criteria; in which the MPV and the MPV/P ratio were measured on days 1, 2, and 3. Sequential organ failure assessment (SOFA) score and presence of septic shock assessed clinical severity. Mortality on day 28 was considered the fatal outcome. Results The average age of the patients was 61,15 years (SD 20,94) and female sex was predominant. MPV cutoff points at days 1, 2 and 3 were >9,45fL, >8,95fL and >8, 85fL; and (MPV/P) ratio >8, 18, >4, 12 y >3, 95, respectively. MPV at days 2 (9,85fL) and 3 (8,55fL) and (MPV/ P) ratio at days 1 (4,42), 2 (4,21), and 3 (8,55), were predictors of clinical severity assessed by septic shock, which reached significance in the ROC curves. MPV and (MPV/P) ratio or were also predictors of clinical severity determined by SOFA at days 1, 2, and 3, where higher values were observed in non-survivors reaching significance in all categories. MPV and MPV/P ratio at days 1, 2 and 3 were independent predictor factors of mortality using Cox proportional hazards model (HR 2,31; 95% CI 1,36-3,94), (HR 2,11; 95% CI 1,17-3,82), (HR 2,13; 95% CI 1,07-4,21) and (HR 2,38; 95% CI 1,38-4,12), (HR 2,15; 95% CI 1,14-4,06), (HR 4,43; 95% CI, 1,72-11,37) respectively. Conclusions MPV and the MPV/P ratio are predictors of clinical severity and mortality in sepsis. The MPV and its coefficient are indicators of the biological behavior of platelets in sepsis. They should be considered as a cost-effective and rapidly available tool that guides the treatment.	[Luis Velez-Paez, Jorge; Perez-Galarza, Jorge; Baldeon, Lucy] Univ Cent Ecuador, Fac Ciencias Med, Quito, Ecuador; [Luis Velez-Paez, Jorge; Irigoyen, Estefania] Hosp Pablo Arturo Suarez, Ctr Invest Clin Med Crit, Quito, Ecuador; [Legua, Pedro] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Velez-Paez, Pablo] Ctr Invest Clin Med Crit, Quito, Ecuador; [Velez-Paez, Pablo; Andrade, Henry] Hosp Gen IESS Ibarra, Unidad Terapia Intens, Imbabura, Ecuador; [Jara, Andrea] Hosp Bas Machachi, Unidad Emergencia, Pichincha, Ecuador; [Lopez, Fernanda] Univ Cent Ecuador, Inst Posgrad Med Crit & Terapia Intens, Quito, Ecuador; [Perez-Galarza, Jorge; Baldeon, Lucy] Univ Cent Ecuador, Inst Invest Biomed, Quito, Ecuador	Universidad Central del Ecuador; Universidad Peruana Cayetano Heredia; Universidad Central del Ecuador; Universidad Central del Ecuador	Baldeon, L (corresponding author), Univ Cent Ecuador, Fac Ciencias Med, Quito, Ecuador.; Baldeon, L (corresponding author), Univ Cent Ecuador, Inst Invest Biomed, Quito, Ecuador.	lybaldeon@uce.edu.ec	Páez, Jorge Luis Vélez/AAQ-2469-2021; Baldeon, Lucy/AAE-6323-2022	Páez, Jorge Luis Vélez/0000-0002-6956-4475; Baldeon, Lucy/0000-0002-0447-0136				Ates S, 2015, SAUDI MED J, V36, P1186, DOI 10.15537/smj.2015.10.10718; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Dastjerd MS, 2006, HEMATOLOGY, V11, P317, DOI 10.1080/10245330600954163; Djordjevic Dragan, 2018, Mediators Inflamm, V2018, P3758068, DOI 10.1155/2018/3758068; Gao Yanxia, 2014, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V26, P28, DOI 10.3760/cma.j.issn.2095-4352.2014.01.006; Greco E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102200; Guclu E, 2013, AFR HEALTH SCI, V13, P333, DOI 10.4314/ahs.v13i2.19; Kitazawa T, 2013, INTERNAL MED, V52, P1487, DOI 10.2169/internalmedicine.52.9555; Machlus KR, 2014, BRIT J HAEMATOL, V165, P227, DOI 10.1111/bjh.12758; Michelson AD, 2000, METHODS, V21, P259, DOI 10.1006/meth.2000.1006; Miliotis S, 2019, MITOCHONDRION, V48, P16, DOI 10.1016/j.mito.2019.02.002; Nishimura S, 2015, J CELL BIOL, V209, P453, DOI 10.1083/jcb.201410052; Oh GH, 2017, SHOCK, V47, P323, DOI 10.1097/SHK.0000000000000718; Rocke AS, 2018, THROMB HAEMOSTASIS, V118, P63, DOI 10.1160/TH17-02-0138; Rolfes V, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107615; Santillan-Santos D.A., 2019, REV ED INVESTIG EMER, DOI [10.24875/reie.19000008, DOI 10.24875/REIE.19000008]; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tajarernmuang P, 2016, CRIT CARE RES PRACT, V2016, DOI 10.1155/2016/4370834; Thon JN, 2012, J CELL BIOL, V198, P561, DOI 10.1083/jcb.201111136; Vardon-Bounes F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223553; Vélez-Páez Jorge Luis, 2021, Infect., V25, P153, DOI 10.22354/in.v25i3.939; Vélez-Paez Jorge Luis, 2020, Infect., V24, P162, DOI 10.22354/in.v24i3.861; Yalavarthi S., 2018, ANN PATHOL LAB MED, DOI [10.21276/apalm.1717, DOI 10.21276/APALM.1717]; Yun SH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9060143; Zampieri FG, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0020-1; Zhang S, 2015, CHINESE MED J-PEKING, V128, P2012, DOI 10.4103/0366-6999.161346	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262356	10.1371/journal.pone.0262356	http://dx.doi.org/10.1371/journal.pone.0262356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990467	gold, Green Published			2022-12-27	WOS:000815783800030
J	Quaidoo, E; Ohemeng, A; Kushitor, MK; Antwi, J				Quaidoo, Esi; Ohemeng, Agartha; Kushitor, Mawuli K.; Antwi, Janet			Nutrition education incorporation into mainstream primary school curriculum in Ghana: Stakeholders' sources of nutrition information and perceived barriers	PLOS ONE			English	Article							KNOWLEDGE; TEACHERS; FOOD	Introduction Nutrition literacy has been cited as a crucial life skill. Nutrition education as a primary school subject has been treated inconsequentially when compared to other subjects. We investigated an aspect of the current state of nutrition education in Ghana by engaging stakeholders about their sources of nutrition information and the perceived barriers in implementing nutrition education in mainstream primary schools. Methods Three hundred and fifty one (351) primary school children, 121 homebased caregivers, six schoolteachers, two headteachers, two Ghana Education Service (GES) officials, and six school cooks were involved in the study. Surveys were used to collect data on nutrition information acquisition behaviors and to record perceived barriers. Key Informant Interviews were conducted among GES officials, headteachers, schoolteachers and school cooks, while Focus Group Discussions were used among homebased caregivers and children to gather qualitative information. Results Only 36.3% of the primary school children had heard about nutrition, and 71% of those got nutrition information from their family members. About 70% of homebased caregivers had heard or seen nutrition messages, and their source of nutrition information was predominantly traditional media. Schoolteachers mostly received their nutrition information from non-governmental organizations and the Internet, while most of the school cooks stated their main source of nutrition information was hospital visits. Perceived barriers included schoolteachers' knowledge insufficiency, and lack of resources to adequately deliver nutrition education. Lack of a clear policy appeared to be an additional barrier. Conclusion The barriers to the implementation of nutrition education in the mainstream curriculum at the primary school level that were identified in this study can be resolved by: providing school-teachers with learning opportunities and adequate nutrition education resources for practical delivery, having specific national policy framework, and including family members and school cooks in the nutrition education knowledge and information dissemination process.	[Quaidoo, Esi] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Nutr, Amherst, MA 01003 USA; [Ohemeng, Agartha] Univ Ghana, Dept Nutr & Food Sci, Accra, Ghana; [Kushitor, Mawuli K.] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Ho, Volta Region, Ghana; [Antwi, Janet] Prairie View A&M Univ, Dept Agr Nutr & Human Ecol, Prairie View, TX 77446 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Ghana; Texas A&M University System; Prairie View A&M University	Antwi, J (corresponding author), Prairie View A&M Univ, Dept Agr Nutr & Human Ecol, Prairie View, TX 77446 USA.	jaantwi@pvamu.edu	Ohemeng, Agartha/GWZ-8776-2022	Quaidoo, Esi/0000-0002-3903-6305	Institute of International Education (IIE) through the Carnegie African Diaspora Fellowship Program (CADFP); Cooperative Agriculture Research Center of the College of Agriculture and Human Sciences at Prairie View AM University	Institute of International Education (IIE) through the Carnegie African Diaspora Fellowship Program (CADFP); Cooperative Agriculture Research Center of the College of Agriculture and Human Sciences at Prairie View AM University	This work was supported with funding from the Institute of International Education (IIE, https://www.iie.org/) through the Carnegie African Diaspora Fellowship Program (CADFP, https://www.iie.org/en/Programs/Carnegie-AfricanDiaspora-Fellowship-Program) to JA and AO to undertake this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to thank the Cooperative Agriculture Research Center of the College of Agriculture and Human Sciences at Prairie View A&M University for supporting cost of publication of this work.	Antwi J, 2020, GLOB HEALTH PROMOT, V27, P114, DOI 10.1177/1757975920945241; Board of Studies NSW, 2007, PERS DEV HLTH PHYS E; Browne S., 2017, THESIS DUBLIN CITY U; Coccia CC, 2020, HEALTH EDUC J, V79, P974, DOI 10.1177/0017896920946061; Danquah A. O., 2012, Journal of Food Research, V1, P263; Dudley DA, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0182-8; Glasauer P., 2005, FAO, V1, P1; Golley RK, 2011, OBES REV, V12, P114, DOI 10.1111/j.1467-789X.2010.00745.x; IFPRI, 2016, 2016 GLOBAL FOOD POL, DOI DOI 10.2499/9780896295827; Jones AM, 2015, J NUTR EDUC BEHAV, V47, P162, DOI 10.1016/j.jneb.2014.06.011; Kigaru D.M.D., 2015, BMC NUTR, V1, P1, DOI [10.1186/s40795-015-0040-8, DOI 10.1186/S40795-015-0040-8]; Kirk SFL, 2010, OBES REV, V11, P109, DOI 10.1111/j.1467-789X.2009.00611.x; Kupolati MD, 2016, ECOL FOOD NUTR, V55, P279, DOI 10.1080/03670244.2016.1161615; Lakshman RR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-123; Mamba NPS, 2019, AFR J PRIM HEALTH CA, V11, DOI 10.4102/phcfm.v11i1.1846; Nyapera V., 2012, THESIS KENYATTA U; Pietinen P, 2010, PUBLIC HEALTH NUTR, V13, P901, DOI 10.1017/S1368980010001072; Rapson J, 2020, NUTRIENTS, V12, DOI 10.3390/nu12071984; Scaglioni S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060706; Scaglioni S, 2011, AM J CLIN NUTR, V94, p2006S, DOI 10.3945/ajcn.110.001685; Schmitt SA, 2019, PUBLIC HEALTH NUTR, V22, P28, DOI 10.1017/S1368980018002586; Schneider E, 2016, NUTR BULL, V41, P55, DOI 10.1111/nbu.12189; Spronk I, 2014, BRIT J NUTR, V111, P1713, DOI 10.1017/S0007114514000087; Tarabashkina L., 2014, PHD THESIS; Upper Manya Krobo, 2012, DISTRICTS UPPER MANY; Verjans-Janssen SRB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204560; Williams L, 2012, PUBLIC HEALTH NUTR, V15, P1396, DOI 10.1017/S1368980011003430; World Health Organization, 2016, REP COMM END CHILDH; World Health Organization, 2013, GLOB NUTR POL REV WH; Yeatman H, 2013, FACULTY SOCIAL SCI P, V1, P1075; Zalilah Mohd Shariff, 2008, International Electronic Journal of Health Education, V11, P119; Zarnowiecki D, 2012, PUBLIC HEALTH NUTR, V15, P1284, DOI 10.1017/S1368980011003259; Zauche LH, 2017, J PEDIATR HEALTH CAR, V31, P493, DOI 10.1016/j.pedhc.2017.01.007	33	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262359	10.1371/journal.pone.0262359	http://dx.doi.org/10.1371/journal.pone.0262359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990476	gold, Green Published			2022-12-27	WOS:000815783800031
J	Reinhart, JM; de Oliveira, GAR; Forsythe, L; Li, Z				Reinhart, Jennifer M.; de Oliveira, Gabriela A. R.; Forsythe, Lauren; Li, Zhong			Pharmacokinetics of a 503B outsourcing facility-produced theophylline in dogs	PLOS ONE			English	Article							BIOAVAILABILITY; FORMULATIONS	Theophylline is an important drug for treatment of canine chronic bronchitis and bradyarrhythmias, but new products require validation since pharmacokinetics in dogs can vary by formulation. A new, 503B outsourcing facility-produced theophylline product (OFT) is available for veterinary use. Outsourcing facilities have many advantages over traditional compounding sources including current good manufacturing practice compliance. The purpose of this study was to establish the pharmacokinetics of OFT in dogs. Eight healthy dogs received 11 mg/kg intravenous aminophylline and 10 mg/kg oral OFT followed by serial blood sampling in a two-way, randomized, crossover design with 7-day washout. Plasma theophylline concentrations were quantified by liquid chromatography-mass spectrometry. Bioavailability, maximum concentration, time to maximum concentration, half-life and area under the curve were: 97 +/- 10%, 7.13 +/- 0.71 mu g/mL, 10.50 +/- 2.07 h, 9.20 +/- 2.87 h, and 141 +/- 37.6 mu g*h/mL, respectively. Steady-state predictions supported twice daily dosing of the OFT, but specific dosage recommendations are hindered by lack of a canine-specific therapeutic range for plasma theophylline concentration. These findings suggest that the OFT is well absorbed and can likely be dosed twice daily in dogs, but future pharmacodynamic and clinical studies are needed to establish a definitive therapeutic range for theophylline in this species.	[Reinhart, Jennifer M.; de Oliveira, Gabriela A. R.; Forsythe, Lauren] Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Urbana, IL 61801 USA; [Li, Zhong] Univ Illinois, Metabol Lab, Roy J Carver Biotechnol Ctr, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Reinhart, JM (corresponding author), Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Urbana, IL 61801 USA.	jreinha2@illinois.edu		Reinhart, Jennifer/0000-0002-3021-5075	Epicur(R) Pharma	Epicur(R) Pharma	The authors declare that this study received funding from Epicur (R) Pharma (epicurpharma.com). The funder was allowed review of the manuscript prior to submission but was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.	[Anonymous], FOOD DRUG LAW J; [Anonymous], 2021, CFR SECT, V21, P210; AUBIER M, 1983, AM REV RESPIR DIS, V127, P148; Bach JF, 2004, JAVMA-J AM VET MED A, V224, P1113, DOI 10.2460/javma.2004.224.1113; Cavett CL, 2019, J VET PHARMACOL THER, V42, P593, DOI 10.1111/jvp.12813; Fox PR., 1999, TXB CANINE FELINE CA, P495; Hawkins EC., 2014, CURRENT VET THERAPY, V15th ed, P622; KORITZ GD, 1986, J VET PHARMACOL THER, V9, P293, DOI 10.1111/j.1365-2885.1986.tb00044.x; KuKanich B, 2012, J VET PHARMACOL THER, V35, P275, DOI 10.1111/j.1365-2885.2011.01316.x; Kuusela E, 2000, J VET PHARMACOL THER, V23, P15, DOI 10.1046/j.1365-2885.2000.00245.x; Martin GJW, 1999, AUST VET J, V77, P250, DOI 10.1111/j.1751-0813.1999.tb11714.x; MCKIERNAN B C, 1981, Journal of Veterinary Pharmacology and Therapeutics, V4, P103, DOI 10.1111/j.1365-2885.1981.tb00718.x; McKiernan BC, 2000, VET CLIN N AM-SMALL, V30, P1267, DOI 10.1016/S0195-5616(00)06006-X; Mengozzi G, 1998, PHARMACOL RES, V38, P481, DOI 10.1006/phrs.1998.0394; MUNSIFF IJ, 1988, J VET PHARMACOL THER, V11, P381, DOI 10.1111/j.1365-2885.1988.tb00198.x; Pharmacia & Upjohn Co, 2019, ANTISEDAN ATIPAMEZOL; Reinhart JM., 2021, J VET PHARMACOL THER, V44, P724, DOI [10.1111/jvp.12979, DOI 10.1111/JVP.12979]; Riviere J. E., 2018, VET PHARM THERAPEUTI, V10th; U.S. FDA] U.S. Food and Drug Administration, 2021, CFR SECT; WEINBERGER M, 1984, J ALLERGY CLIN IMMUN, V73, P525, DOI 10.1016/0091-6749(84)90505-0	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262336	10.1371/journal.pone.0262336	http://dx.doi.org/10.1371/journal.pone.0262336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990472	Green Published, gold			2022-12-27	WOS:000815783800027
J	Bianco, NA; Franks, PW; Hicks, JL; Delp, SL				Bianco, Nicholas A.; Franks, Patrick W.; Hicks, Jennifer L.; Delp, Scott L.			Coupled exoskeleton assistance simplifies control and maintains metabolic benefits: A simulation study	PLOS ONE			English	Article							HUMAN WALKING; ENERGETICS; MECHANICS; IDENTIFICATION; OPTIMIZATION; BIOMECHANICS; MASS	Assistive exoskeletons can reduce the metabolic cost of walking, and recent advances in exoskeleton device design and control have resulted in large metabolic savings. Most exoskeleton devices provide assistance at either the ankle or hip. Exoskeletons that assist multiple joints have the potential to provide greater metabolic savings, but can require many actuators and complicated controllers, making it difficult to design effective assistance. Coupled assistance, when two or more joints are assisted using one actuator or control signal, could reduce control dimensionality while retaining metabolic benefits. However, it is unknown which combinations of assisted joints are most promising and if there are negative consequences associated with coupled assistance. Since designing assistance with human experiments is expensive and time-consuming, we used musculoskeletal simulation to evaluate metabolic savings from multi-joint assistance and identify promising joint combinations. We generated 2D muscle-driven simulations of walking while simultaneously optimizing control strategies for simulated lower-limb exoskeleton assistive devices to minimize metabolic cost. Each device provided assistance either at a single joint or at multiple joints using massless, ideal actuators. To assess if control could be simplified for multi-joint exoskeletons, we simulated different control strategies in which the torque provided at each joint was either controlled independently or coupled between joints. We compared the predicted optimal torque profiles and changes in muscle and total metabolic power consumption across the single joint and multi-joint assistance strategies. We found multi-joint devices-whether independent or coupled-provided 50% greater metabolic savings than single joint devices. The coupled multi-joint devices were able to achieve most of the metabolic savings produced by independently-controlled multi-joint devices. Our results indicate that device designers could simplify multi-joint exoskeleton designs by reducing the number of torque control parameters through coupling, while still maintaining large reductions in metabolic cost.	[Bianco, Nicholas A.; Franks, Patrick W.; Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Hicks, Jennifer L.; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Bianco, NA (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	nbianco@stanford.edu		Hicks, Jennifer/0000-0002-2516-9334; Bianco, Nicholas/0000-0003-2229-4065; Delp, Scott/0000-0002-9643-7551	National Institutes of Health [U54 EB020405, P2C HD065690, P2C HD101913, P41 EB027060]; National Science Foundation Graduate Research Fellowship Program; Stanford Graduate Fellowship Program; U.S. Army Natick Soldier Research, Development and Engineering Center [W911QY18C0140]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Stanford Graduate Fellowship Program; U.S. Army Natick Soldier Research, Development and Engineering Center	NAB, JLH, and SLD received support from the National Institutes of Health (https://www.nih.gov) grants U54 EB020405, P2C HD065690, P2C HD101913, and P41 EB027060. NAB received support from the National Science Foundation Graduate Research Fellowship Program and the Stanford Graduate Fellowship Program (https://vpge.stanford.edu/fellowships-funding/sgf).PWF received support from the U.S. Army Natick Soldier Research, Development and Engineering Center, grant W911QY18C0140. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold EM, 2013, J EXP BIOL, V216, P2150, DOI 10.1242/jeb.075697; Arones MM, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.588925; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bretz F, 2011, MULTIPLE COMP USING, DOI DOI 10.1201/9781420010909; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Bryan GM, 2021, INT J ROBOT RES, V40, P722, DOI 10.1177/0278364920961452; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; Cornwall W, 2015, SCIENCE, V350, P270, DOI 10.1126/science.350.6258.270; De Groote F, 2016, ANN BIOMED ENG, V44, P2922, DOI 10.1007/s10439-016-1591-9; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Dembia CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180320; Ding Y, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aar5438; Ding Y, 2017, IEEE T NEUR SYS REH, V25, P119, DOI 10.1109/TNSRE.2016.2523250; Ding Y, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0196-8; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Fournier BN, 2018, IEEE T NEUR SYS REH, V26, P1596, DOI 10.1109/TNSRE.2018.2854605; Franks PW, 2020, 2020 8 IEEE RAS EMBS; Galle S, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0235-0; Gordon DFN, 2018, FRONT ROBOT AI, V5, DOI 10.3389/frobt.2018.00061; Gordon KE, 2007, J BIOMECH, V40, P2636, DOI 10.1016/j.jbiomech.2006.12.006; Grabke EP, 2019, J MED DEVICES, V13, DOI 10.1115/1.4044739; Handsfield GG, 2014, J BIOMECH, V47, P631, DOI 10.1016/j.jbiomech.2013.12.002; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jackson RW, 2017, J EXP BIOL, V220, P2082, DOI 10.1242/jeb.150011; Jackson RW, 2015, J APPL PHYSIOL, V119, P541, DOI 10.1152/japplphysiol.01133.2014; Kim J, 2019, SCIENCE, V365, P668, DOI 10.1126/science.aav7536; Koelewijn AD, 2018, COMPUT METHOD BIOMEC, V21, P521, DOI 10.1080/10255842.2018.1490954; Koller JR, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0086-5; Lee G, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aan6708; Lee S, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0410-y; Lim B, 2019, IEEE T ROBOT, V35, P1055, DOI 10.1109/TRO.2019.2913318; Malcolm P, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00069; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; Manns P, 2017, IEEE ROBOT AUTOM LET, V2, P1564, DOI 10.1109/LRA.2017.2676355; Meyer AJ, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00077; Mooney LM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-80; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Nuckols RW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60360-4; Ong CF, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006993; Panizzolo FA, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0150-9; Patterson MA, 2014, ACM T MATH SOFTWARE, V41, DOI 10.1145/2558904; Quinlivan BT, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aah4416; R Core Team, 2015, R LANGUAGE ENV STAT; Rajagopal A, 2016, IEEE T BIO-MED ENG, V63, P2068, DOI 10.1109/TBME.2016.2586891; SamualsM L, 1999, STAT LIFE SCI, V3rd; Sawicki GS, 2008, J EXP BIOL, V211, P1402, DOI 10.1242/jeb.009241; Sawicki GS, 2020, J NEUROENG REHABIL, V17, DOI 10.1186/s12984-020-00663-9; Seth A, 2007, J BIOMECH, V40, P356, DOI 10.1016/j.jbiomech.2005.12.017; Silder A, 2007, J BIOMECH, V40, P2628, DOI 10.1016/j.jbiomech.2006.12.017; Silder A, 2013, J BIOMECH, V46, P2522, DOI 10.1016/j.jbiomech.2013.06.020; Uchida TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163417; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; van Dijk W, 2011 IEEE INT C REH; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Winter D.A., 2005, BIOMECHANICS MOTOR C, V3rd ed.; Zhang JJ, 2017, SCIENCE, V356, P1280, DOI 10.1126/science.aal5054	58	1	1	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0261318	10.1371/journal.pone.0261318	http://dx.doi.org/10.1371/journal.pone.0261318			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986191	Green Published, gold, Green Submitted			2022-12-27	WOS:000765956200009
J	Sahiledengle, B; Atlaw, D; Kumie, A; Tekalegn, Y; Woldeyohannes, D; Agho, KE				Sahiledengle, Biniyam; Atlaw, Daniel; Kumie, Abera; Tekalegn, Yohannes; Woldeyohannes, Demelash; Agho, Kingsley Emwinyore			Menstrual hygiene practice among adolescent girls in Ethiopia: A systematic review and meta-analysis	PLOS ONE			English	Review							MANAGEMENT	Background Adolescent girls face several challenges relating to menstruation and its proper management. Lack of adequate sanitary products, inadequate water supply, and privacy for changing sanitary pads continue to leave adolescent girls with limited options for safe and proper menstrual hygiene in many low-income settings, including Ethiopia. These situations are also compounded by societal myths, stigmas surrounding menstruation, and discriminatory social norms. This systematic review and meta-analysis aimed to estimate the pooled proportion of safe menstrual hygiene management among adolescent girls in Ethiopia using the available studies. Methods We searched PubMed, Google Scholar, African Journal Online (AJOL), Hinari, Science Direct, ProQuest, Direct of Open Access Journals, POPLINE, and Cochrane Library database inception to May 31, 2021. Studies reporting the proportion of menstrual hygiene management among adolescent girls in Ethiopia were considered. The Cochrane Q test statistics and I-2 tests were used to assess the heterogeneity of the included studies. Since the included studies revealed considerable heterogeneity, a random effect meta-analysis model was used to estimate the pooled proportion of menstrual hygiene management (MHM). Results Of 1,045 identified articles, 22 studies were eligible for analysis (n = 12,330 participants). The pooled proportion (PP) of safe MHM in Ethiopia was 52.69% (95%CI: 44.16, 61.22). The use of commercial menstrual absorbents was common 64.63% (95%CI: 55.32, 73.93, I-2 99.2%) followed by homemade cloth 53.03% (95%CI: 22.29, 83.77, I-2 99.2%). Disposal of absorbent material into the latrine was the most common practice in Ethiopia 62.18% (95%CI: 52.87, 71.49, I-2 98.7%). One in four girls reported missing one or more school days during menstruation (PP: 32.03%, 95%CI: 22.65%, 41.40%, I-2 98.2%). Conclusion This study revealed that only half of the adolescent girls in Ethiopia had safe MHM practices. To ensure that girls in Ethiopia can manage menstruation hygienically and with dignity, strong gender-specific water, sanitation, and hygiene (WASH) facilities along with strong awareness creation activities at every level are needed.	[Sahiledengle, Biniyam; Tekalegn, Yohannes] Madda Walabu Univ, Goba Referral Hosp, Dept Publ Hlth, Bale Goba, Ethiopia; [Atlaw, Daniel] Madda Walabu Univ, Goba Referral Hosp, Sch Hlth Sci, Dept Human Anat, Bale Goba, Switzerland; [Kumie, Abera] Addis Ababa Univ, Coll Hlth Sci, Dept Community Hlth, Addis Ababa, Ethiopia; [Woldeyohannes, Demelash] Wachemo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Hossana, Ethiopia; [Agho, Kingsley Emwinyore] Western Sydney Univ, Sch Hlth Sci, Penrith, NSW, Australia	Addis Ababa University; Western Sydney University	Sahiledengle, B (corresponding author), Madda Walabu Univ, Goba Referral Hosp, Dept Publ Hlth, Bale Goba, Ethiopia.	biniyam.sahiledengle@gmail.com	Atlaw, Daniel/ACX-8977-2022; Sahiledengle, Biniyam/AAG-9457-2020	Atlaw, Daniel/0000-0002-2968-4958; Sahiledengle, Biniyam/0000-0002-1114-4849; Tekalegn, Yohannes/0000-0001-6628-8180				A. A.Felleke, 2020, medRxiv, DOI 10.1101/2020.03.16.20036913; Abay Fisseha M., 2017, COMPUT BIOL BIOINFOR, V5, P6; Abebe M., HARAR B HLTH SCI, V5, P127; Abera Y., 2004, THESIS ADDIS ABABA U; Anchebi H., 2017, J WOMENS HLTH CARE, V6, P1, DOI [DOI 10.4172/2167-0420.1000370, 10.4172/2167-0420.1000370]; [Anonymous], 2015, ASSESSMENT MENSTRUAL; [Anonymous], MENSTRUAL HYGIENE MA; [Anonymous], 2019, GUID MENSTR HLTH HYG; [Anonymous], 2019, NDTV DETTOL BANEGA S; [Anonymous], 2018, IMPORTANCE MAINTAINI; Azage M., 2018, NW ETHIOPIA ETHIOPIA, V10; Bekele F., 2018, J HLTH MEDICAL SCI, V1, P71; Belayneh Z, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7973-9; Bhavik Rana, 2015, Healthline, Journal of Indian Association of Preventive and Social Medicine, V6, P23; Birhane AD., 2020, GLOB DRUGS THER, V5, P1; Biruk E., ASSESSMENT MENSTRUAL; Boosey R, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.253.5313; Bulto GA, 2021, RISK MANAG HEALTHC P, V14, P911, DOI 10.2147/RMHP.S296670; Das P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130777; Davis J, 2018, TROP MED INT HEALTH, V23, P1350, DOI 10.1111/tmi.13159; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Gedefaw G., REV 2019 SEP; Gultie T.K., 2014, SCI J PUBLIC HLTH, V2, P189, DOI DOI 10.11648/J.SJPH.20140203.18; Kedir T., 2021, THESIS MADDA WALABU; Kitesa B., 2016, INT J IMMUNOL, V4, P52, DOI [DOI 10.11648/J.IJI.20160406.12, 10.11648/j.iji.20160406.12]; Kuhlmann AS, 2017, OBSTET GYNECOL SURV, V72, P356, DOI 10.1097/OGX.0000000000000443; Martin J., 2017, CRITICAL APPRAISAL C, P6; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; Gena HM, 2020, ADV PUBLIC HLTH, V2020, DOI 10.1155/2020/8938615; Mohammed Shamsudeen, 2020, Int J Reprod Med, V2020, P6872491, DOI 10.1155/2020/6872491; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Niguse R, 2019, THESIS MADDA WALABU; Phillips-Howard PA, 2015, J WOMENS HEALTH, V24, P801, DOI 10.1089/jwh.2014.5031; Shallo SA., 2020, MENSTRUAL HYGIENE MA; Shumie ZS, 2020, THESIS ADDIS ABABA U; Sommer M, 2013, AM J PUBLIC HEALTH, V103, P1556, DOI 10.2105/AJPH.2013.301374; Sommer M, 2010, J ADOLESCENCE, V33, P521, DOI 10.1016/j.adolescence.2009.03.008; Sudeshna Ray, 2012, National Journal of Community Medicine, V3, P294; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; Tamiru S., 2014, SNV NETHERLANDS DEV; Tegegne TK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1118; Torondel B, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3384-2; Trinies V., 2015, Waterlines, V34, P31, DOI 10.3362/1756-3488.2015.004; UNESCO, 2014, PUB ED MENSTR HYG MA; UNICEF, 2008, MAIL GUARDIAN; UNICEF-WASH, 2017, NAT BAS REP 6 REG ET; Upashe SP, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0245-7; van Eijk AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010290; WHO UNICEF JMP, 2012, CONS DRAFT LONG LIST; wvi, MENSTRUAL HYGIENE CL; Zeleke B., THESIS ADDIS ABABA U	51	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262295	10.1371/journal.pone.0262295	http://dx.doi.org/10.1371/journal.pone.0262295			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982805	Green Submitted, gold, Green Published			2022-12-27	WOS:000834805700028
J	Daemen, A; Udyavar, AR; Sandmann, T; Li, CF; Bosch, LJW; O'Gorman, W; Li, YJ; Au-Yeung, A; Takahashi, C; Kabbarah, O; Bourgon, R; Hegde, P; Bais, C; Das Thakur, M				Daemen, Anneleen; Udyavar, Akshata R.; Sandmann, Thomas; Li, Congfen; Bosch, Linda J. W.; O'Gorman, William; Li, Yijin; Au-Yeung, Amelia; Takahashi, Chikara; Kabbarah, Omar; Bourgon, Richard; Hegde, Priti; Bais, Carlos; Das Thakur, Meghna			Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B	PLOS ONE			English	Article							T-CELL EXHAUSTION; REGULARIZATION PATHS; COLON-CANCER; EXPRESSION; NK; PHENOTYPE; GENE; RECOMMENDATIONS; FLUOROURACIL; CHEMOTHERAPY	Background Colorectal cancer (CRC) is a leading cause of cancer-related deaths, with a 5% 5-year survival rate for metastatic disease, yet with limited therapeutic advancements due to insufficient understanding of and inability to accurately capture high-risk CRC patients who are most likely to recur. We aimed to improve high-risk classification by identifying biological pathways associated with outcome in adjuvant stage II/III CRC. Methods and findings We included 1062 patients with stage III or high-risk stage II colon carcinoma from the prospective three-arm randomized phase 3 AVANT trial, and performed expression profiling to identify a prognostic signature. Data from validation cohort GSE39582, The Cancer Genome Atlas, and cell lines were used to further validate the prognostic biology. Our retrospective analysis of the adjuvant AVANT trial uncovered a prognostic signature capturing three biological functions-stromal, proliferative and immune-that outperformed the Consensus Molecular Subtypes (CMS) and recurrence prediction signatures like Oncotype Dx in an independent cohort. Importantly, within the immune component, high granzyme B (GZMB) expression had a significant prognostic impact while other individual T-effector genes were less or not prognostic. In addition, we found GZMB to be endogenously expressed in CMS2 tumor cells and to be prognostic in a T cell independent fashion. A limitation of our study is that these results, although robust and derived from a large dataset, still need to be clinically validated in a prospective study. Conclusions This work furthers our understanding of the underlying biology that propagates stage II/III CRC disease progression and provides scientific rationale for future high-risk stratification and targeted treatment evaluation in biomarker defined subpopulations of resectable high-risk CRC. Our results also shed light on an alternative GZMB source with context-specific implications on the disease's unique biology.	[Daemen, Anneleen; Udyavar, Akshata R.; Sandmann, Thomas; Bourgon, Richard] Genentech Inc, Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Li, Congfen; Bosch, Linda J. W.; Li, Yijin; Au-Yeung, Amelia; Kabbarah, Omar; Hegde, Priti; Bais, Carlos; Das Thakur, Meghna] Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA; [O'Gorman, William; Takahashi, Chikara] Genentech Inc, OMNI Biomarker Dev, San Francisco, CA 94080 USA; [Daemen, Anneleen] ORIC Pharmaceut, Translat Med, San Francisco, CA 94080 USA; [Udyavar, Akshata R.] Instill Bio, Thousand Oaks, CA USA; [Sandmann, Thomas] Denali Therapeut, Discovery Genom, San Francisco, CA USA; [Bosch, Linda J. W.] Netherlands Canc Inst, Amsterdam, Netherlands; [Kabbarah, Omar] Zai Lab, Discovery Biol & Translat Med, San Francisco, CA USA; [Bourgon, Richard] Freenome, Computat Sci, San Francisco, CA USA; [Hegde, Priti] Fdn Med, Cambridge, MA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Netherlands Cancer Institute; Foundation Medicine	Daemen, A (corresponding author), Genentech Inc, Bioinformat & Computat Biol, San Francisco, CA 94080 USA.; Das Thakur, M (corresponding author), Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA.; Daemen, A (corresponding author), ORIC Pharmaceut, Translat Med, San Francisco, CA 94080 USA.	anneleen.daemen@oricpharma.com; das-thakur.meghna@gene.com		Daemen, Anneleen/0000-0001-6287-7105	Genentech Inc.; Dutch Cancer Society (KWF Kankerbestrijding (NL)) [2013-5885]	Genentech Inc.(Roche HoldingGenentech); Dutch Cancer Society (KWF Kankerbestrijding (NL))	Funding for the study was provided by Genentech Inc., a member of the Roche group. Support for these studies was also provided by the Dutch Cancer Society (KWF Kankerbestrijding (NL), Award Number 2013-5885, Recipient Linda J.W. Bosch). These funders provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Caravagna G, 2018, NAT METHODS, V15, P707, DOI 10.1038/s41592-018-0108-x; Cheng ML, 2015, SCI REP-UK, V5, DOI 10.1038/srep10752; Chtanova T, 2005, J IMMUNOL, V175, P7837, DOI 10.4049/jimmunol.175.12.7837; Clark-Langone KM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-691; Crinier A, 2018, IMMUNITY, V49, P971, DOI 10.1016/j.immuni.2018.09.009; de Gramont A, 2012, LANCET ONCOL, V13, P1225, DOI 10.1016/S1470-2045(12)70509-0; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Facchetti F, 2003, AM J SURG PATHOL, V27, P1489, DOI 10.1097/00000478-200311000-00015; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Goldstein LD, 2016, CELL REP, V16, P2605, DOI 10.1016/j.celrep.2016.08.010; Grossman WJ, 2003, CURR OPIN IMMUNOL, V15, P544, DOI 10.1016/S0952-7915(03)00099-2; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Jeong DH, 2015, ONCOTARGETS THER, V8, P3817, DOI 10.2147/OTT.S95543; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; KOIZUMI H, 1991, J EXP MED, V173, P499, DOI 10.1084/jem.173.2.499; LIU CC, 1986, J EXP MED, V164, P2061, DOI 10.1084/jem.164.6.2061; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; Mori S, 1998, INT J ONCOL, V12, P1165; Nagtegaal ID, 2012, NAT REV CLIN ONCOL, V9, P119, DOI 10.1038/nrclinonc.2011.157; Nickles D, 2020, NANOSTRINGQCPRO QUAL; Nielsen JS, 2012, CLIN CANCER RES, V18, P3281, DOI 10.1158/1078-0432.CCR-12-0234; Okita Akira, 2018, Oncotarget, V9, P18698, DOI 10.18632/oncotarget.24617; Overman MJ, 2018, J CLIN ONCOL, V36, P773, DOI 10.1200/JCO.2017.76.9901; Pages F, 2018, LANCET, V391, P2128, DOI 10.1016/S0140-6736(18)30789-X; Rissoan MC, 2002, BLOOD, V100, P3295, DOI 10.1182/blood-2002-02-0638; Roepman P, 2014, INT J CANCER, V134, P552, DOI 10.1002/ijc.28387; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Schlicker A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-66; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Simon N, 2011, J STAT SOFTW, V39, P1; Sinicrope FA, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.4_suppl.614; Sobin LH., 2009, INT UNION CANC UICC, V7, P66; Takahashi C, 2017, CYTOM PART A, V91A, P39, DOI 10.1002/cyto.a.22977; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; VELOTTI F, 1992, EUR J IMMUNOL, V22, P1049, DOI 10.1002/eji.1830220426; Victor AR, 2018, J IMMUNOL, V200, P565, DOI 10.4049/jimmunol.1701128; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Wendt K, 2006, J LEUKOCYTE BIOL, V80, P1529, DOI 10.1189/jlb.0306191; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	57	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262198	10.1371/journal.pone.0262198	http://dx.doi.org/10.1371/journal.pone.0262198			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972191	gold, Green Published			2022-12-27	WOS:000773555700106
J	Garcia-Lamont, F; Alvarado, M; Cervantes, J				Garcia-Lamont, Farid; Alvarado, Matias; Cervantes, Jair			Systematic segmentation method based on PCA of image hue features for white blood cell counting	PLOS ONE			English	Article							CLASSIFICATION; LEUKOCYTES; ALGORITHM; SMEAR	Leukocyte (white blood cell, WBC) count is an essential factor that physicians use to diagnose infections and provide adequate treatment. Currently, WBC count is determined manually or semi-automatically, which often leads to miscounting. In this paper, we propose an automated method that uses a bioinspired segmentation mimicking the human perception of color. It is based on the claim that a person can locate WBCs in a blood smear image via the high chromatic contrast. First, by applying principal component analysis over RGB, HSV, and L*a*b* spaces, with specific combinations, pixels of leukocytes present high chromatic variance; this results in increased contrast with the average hue of the other blood smear elements. Second, chromaticity is processed as a feature, without separating hue components; this is different to most of the current automation that perform mathematical operations between hue components in an intuitive way. As a result of this systematic method, WBC recognition is computationally efficient, overlapping WBCs are separated, and the final count is more precise. In experiments with the ALL-IDB benchmark, the performance of the proposed segmentation was assessed by comparing the WBC from the processed images with the ground truth. Compared with previous methods, the proposed method achieved similar results in sensitivity and precision and approximately 0.2% higher specificity and 0.3% higher accuracy for pixel classification in the segmentation stage; as well, the counting results are similar to previous works.	[Garcia-Lamont, Farid; Cervantes, Jair] Univ Autonoma Estado Mexico, Ctr Univ UAEM Texcoco, Texcoco, Estado De Mexic, Mexico; [Alvarado, Matias] IPN, Dept Comp, Ctr Invest & Estudios Avanzados, Cdmx, Mexico		Garcia-Lamont, F (corresponding author), Univ Autonoma Estado Mexico, Ctr Univ UAEM Texcoco, Texcoco, Estado De Mexic, Mexico.	fgarcial@uaemex.mx	Garcia-Lamont, Farid/B-4009-2016	Garcia-Lamont, Farid/0000-0002-9739-3802; Alvarado, Matias/0000-0003-2853-7451	National Council of Research (CONACyT in Spanish abbreviation) [A1-S-20037]	National Council of Research (CONACyT in Spanish abbreviation)	Initials: M.A. (Matias Alvarado) Grant number:A1-S-20037 Funder name: National Council of Research (CONACyT in Spanish abbreviation) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhay E, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-0912-y; Alomari YM, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/979302; Cao FL, 2019, NEURAL COMPUT APPL, V31, P6767, DOI 10.1007/s00521-018-3480-7; Cao FL, 2017, NEURAL COMPUT APPL, V28, pS503, DOI 10.1007/s00521-016-2391-8; Cao HC, 2018, BIOMED SIGNAL PROCES, V45, P10, DOI 10.1016/j.bspc.2018.05.010; Cheng HD, 2001, PATTERN RECOGN, V34, P2259, DOI 10.1016/S0031-3203(00)00149-7; Chung J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133489; Cuevas E, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/137392; Di Ruberto C, 2015, LECT NOTES COMPUT SC, V9279, P557, DOI 10.1007/978-3-319-23231-7_50; Di Ruberto C, 2015, LECT NOTES COMPUT SC, V9257, P415, DOI 10.1007/978-3-319-23117-4_36; Dorini LB, 2013, IEEE J BIOMED HEALTH, V17, P250, DOI 10.1109/TITB.2012.2207398; Garcia-Lamont F, 2018, NEUROCOMPUTING, V292, P1, DOI 10.1016/j.neucom.2018.01.091; Ghosh P, 2016, APPL SOFT COMPUT, V46, P629, DOI 10.1016/j.asoc.2015.12.038; Hegde RB, 2019, BIOCYBERN BIOMED ENG, V39, P382, DOI 10.1016/j.bbe.2019.01.005; Hegde RB, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-0962-1; Jan Z, 2018, MULTIMED TOOLS APPL, V77, P9801, DOI 10.1007/s11042-017-4495-2; Janos A., 2007, CLUSTER ANAL DATA MI; Kutlu H, 2020, MED HYPOTHESES, V135, DOI 10.1016/j.mehy.2019.109472; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu H, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1185-9; Liu YH, 2017, IEEE J BIOMED HEALTH, V21, P1644, DOI 10.1109/JBHI.2016.2623421; Lopez-Puigdollers D, 2019, EXPERT SYST APPL, V115, P695, DOI 10.1016/j.eswa.2018.08.029; Mishra S, 2019, BIOMED SIGNAL PROCES, V47, P303, DOI 10.1016/j.bspc.2018.08.012; Nazlibilek S, 2014, MEASUREMENT, V55, P58, DOI 10.1016/j.measurement.2014.04.008; Prinyakupt J, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0037-1; Ruberto Cecilia, 2016, Machine Vision and Applications, V27, P1151, DOI 10.1007/s00138-016-0812-4; Safuan SNM, 2018, MEASUREMENT, V116, P543, DOI 10.1016/j.measurement.2017.11.002; Sayed GI, 2019, NEURAL COMPUT APPL, V31, P7633, DOI 10.1007/s00521-018-3597-8; Shahzad M, 2020, COMPUT MATH METHOD M, V2020, DOI 10.1155/2020/4015323; Sudha K, 2020, BIOCYBERN BIOMED ENG, V40, P639, DOI 10.1016/j.bbe.2020.02.005; Tsai MH, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0280-9; Zhao JW, 2017, MED BIOL ENG COMPUT, V55, P1287, DOI 10.1007/s11517-016-1590-x; Zheng X, 2018, MICRON, V107, P55, DOI 10.1016/j.micron.2018.01.010	33	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261857	10.1371/journal.pone.0261857	http://dx.doi.org/10.1371/journal.pone.0261857			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972155	Green Published, gold			2022-12-27	WOS:000773555700063
J	Hansen, N; Bryant, A; McCormack, R; Johnson, H; Lindsay, T; Stelck, K; Bernards, MT				Hansen, Niko; Bryant, Adriana; McCormack, Roslyn; Johnson, Hannah; Lindsay, Travis; Stelck, Kael; Bernards, Matthew T.			Assessment of the performance of nonfouling polymer hydrogels utilizing citizen scientists	PLOS ONE			English	Article							BRUSHES; RESISTANCE; ADHESION; SCIENCE	To facilitate longer duration space travel, flight crew sickness and disease transmission amongst the crew must be eliminated. High contact surfaces within space vehicles provide an opportunity for bacterial adhesion, which can lead to biofilm formation or disease transmission. This study evaluates the performance of several nonfouling polymers using citizen science, to identify the best performing chemistry for future applications as bacteria resistant coatings. The specific polymer chemistries tested were zwitterionic sulfobetaine methacrylate (SBMA), and polyampholytes composed of [2-(acryloyloxy)ethyl] trimethylammonium chloride and 2-carboxyethyl acrylate (TMA/CAA), or TMA and 3-sulfopropyl methacrylate (TMA/SA). Each polymer chemistry is known to exhibit bacteria resistance, and this study provides a direct side-by-side comparison between the chemistries using a citizen science approach. Nearly 100 citizen scientists returned results comparing the performance of these polymers over repeat exposure to bacteria and 30 total days of growth. The results demonstrate that TMA/CAA polyampholyte hydrogels show the best long-term resistance to bacteria adhesion.	[Hansen, Niko; Bryant, Adriana; McCormack, Roslyn; Johnson, Hannah; Lindsay, Travis; Stelck, Kael; Bernards, Matthew T.] Univ Idaho, Dept Chem & Biol Engn, Moscow, ID 83843 USA	Idaho; University of Idaho	Bernards, MT (corresponding author), Univ Idaho, Dept Chem & Biol Engn, Moscow, ID 83843 USA.	mbernards@uidaho.edu		Bernards, Matthew/0000-0002-5234-1910	National Aeronautics and Space Administration (NASA) as part of the Student Payload Opportunity with Citizen Science (SPOCS) program [80NSSC17M0021]	National Aeronautics and Space Administration (NASA) as part of the Student Payload Opportunity with Citizen Science (SPOCS) program	This research was funded by the National Aeronautics and Space Administration (NASA) as part of the Student Payload Opportunity with Citizen Science (SPOCS) program under Federal Award No 80NSSC17M0021, as a subaward to the University of Idaho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves-Bueno E., 2017, B ECOL SOC AM, V98, P278, DOI DOI 10.1002/BES2.1336; Bernards M, 2014, J BIOMAT SCI-POLYM E, V25, P1479, DOI 10.1080/09205063.2014.938976; Bernards MT, 2008, MACROMOLECULES, V41, P4216, DOI 10.1021/ma800185y; Castro VA, 2004, MICROB ECOL, V47, P119, DOI 10.1007/s00248-003-1030-y; Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041; Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058; Davis JR., 2010, 22538 JSC NAT AER SP; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dobbins SC, 2012, J PHYS CHEM B, V116, P14346, DOI 10.1021/jp307588b; Grant DM, 2005, HEAT TRANSFER ENG, V26, P44, DOI 10.1080/01457630590890166; Haag SL, 2020, LANGMUIR, V36, P3292, DOI 10.1021/acs.langmuir.0c00114; Laschewsky A, 2014, POLYMERS-BASEL, V6, P1544, DOI 10.3390/polym6051544; Mi L, 2010, BIOMATERIALS, V31, P2919, DOI 10.1016/j.biomaterials.2009.12.038; Palmer J, 2007, J IND MICROBIOL BIOT, V34, P577, DOI 10.1007/s10295-007-0234-4; Schroeder ME, 2013, BIOMACROMOLECULES, V14, P3112, DOI 10.1021/bm4007369; Tah T, 2012, COLLOID SURFACE B, V93, P195, DOI 10.1016/j.colsurfb.2012.01.004; Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Wiggins A, 2019, AM J BIOETHICS, V19, P3, DOI 10.1080/15265161.2019.1619859; Wu H, 2015, INT J ORAL SCI, V7, P1, DOI 10.1038/ijos.2014.65; Yang J, 2018, METHOD MICROBIOL, V45, P3, DOI 10.1016/bs.mim.2018.07.002	22	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261817	10.1371/journal.pone.0261817	http://dx.doi.org/10.1371/journal.pone.0261817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972139	Green Published, gold			2022-12-27	WOS:000773555700057
J	Jungkunz, S; Fahey, RA; Hino, A				Jungkunz, Sebastian; Fahey, Robert A.; Hino, Airo			How populist attitudes scales fail to capture support for populists in power	PLOS ONE			English	Article							MEASUREMENT EQUIVALENCE; DISCOURSE; DEMOCRACY	Populist attitudes are generally measured in surveys through three necessary and non-compensatory elements of populism, namely anti-elitism, people-centrism, and Manicheanism. Using Comparative Study of Electoral Systems Module 5 (2016-2020) data for 30 countries, we evaluate whether this approach explains voting for populist parties across countries in Asia, Europe and the Americas. We show that the existing scales of populist attitudes effectively explain voting for populists in countries where populist leaders and parties are in opposition but fail to explain voting for populist parties in countries where they are in power. We argue that current approaches assume "the elite" to mean "politicians", thus failing to capture attitudes towards "non-political elites" often targeted by populists in office-in particular, journalists, academics/experts, bureaucrats, and corporate business leaders. The results reveal limits to the usefulness of existing survey batteries in cross-national studies of populism and emphasize the need to develop approaches that are more generalizable across political and national contexts.	[Jungkunz, Sebastian] Univ Duisburg Essen, Inst Socioecon, Duisburg, Germany; [Jungkunz, Sebastian] Univ Bamberg, Chair Polit Sociol, Bamberg, Germany; [Jungkunz, Sebastian] Zeppelin Univ, Ctr Polit Commun, Friedrichshafen, Germany; [Fahey, Robert A.] Waseda Univ, Waseda Inst Polit Econ, Tokyo, Japan; [Hino, Airo] Waseda Univ, Sch Polit Sci & Econ, Tokyo, Japan	University of Duisburg Essen; Otto Friedrich University Bamberg; Zeppelin University; Waseda University; Waseda University	Jungkunz, S (corresponding author), Univ Duisburg Essen, Inst Socioecon, Duisburg, Germany.; Jungkunz, S (corresponding author), Univ Bamberg, Chair Polit Sociol, Bamberg, Germany.; Jungkunz, S (corresponding author), Zeppelin Univ, Ctr Polit Commun, Friedrichshafen, Germany.; Fahey, RA (corresponding author), Waseda Univ, Waseda Inst Polit Econ, Tokyo, Japan.	sebastian.jungkunz@uni-due.de; robfahey@aoni.waseda.jp	Fahey, Robert A/S-6202-2019	Fahey, Robert A/0000-0002-6231-2881	Japan Society for the Promotion of Science [20KK0026]; project "The influence of socioeconomic problems on political integration" BY North Rhine-Westphalian Ministry of Culture and Science; Open Access Publication Fund of the University of Duisburg-Essen	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); project "The influence of socioeconomic problems on political integration" BY North Rhine-Westphalian Ministry of Culture and Science; Open Access Publication Fund of the University of Duisburg-Essen	AH received funding from the Kakenhi Grant 20KK0026 by the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/e-grants/). SJ would like to acknowledge funding from the project "The influence of socioeconomic problems on political integration" (PI: Paul Marx) funded by the North Rhine-Westphalian Ministry of Culture and Science. We further acknowledge support by the Open Access Publication Fund of the University of Duisburg-Essen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerman A, 2014, COMP POLIT STUD, V47, P1324, DOI 10.1177/0010414013512600; Aleman J, 2016, COMP POLIT STUD, V49, P1039, DOI 10.1177/0010414015600458; American National Election Studies, 2021, ANES 2020 TIM SER ST; Andreadis I., 2019, IDEATIONAL APPROACH, P238; Ariely G, 2011, SOC INDIC RES, V104, P271, DOI 10.1007/s11205-010-9693-5; Arima S, 2017, GEKIJYO GATA POPYURI; Bonikowski B, 2019, NATIONS NATL, V25, P58, DOI 10.1111/nana.12480; Braun M, 2013, INT J PUBLIC OPIN R, V25, P383, DOI 10.1093/ijpor/eds034; Brown T.A., 2015, CONFIRMATORY FACTOR; Castanho Silva B., 2019, IDEATIONAL APPROACH, P150; Comparative Study of Electoral Systems, 2021, CSES MOD 5 ADV REL 3; Couper M., 2003, CROSS CULTURAL SURVE, P157; Davidov E, 2014, ANNU REV SOCIOL, V40, P55, DOI 10.1146/annurev-soc-071913-043137; Elchardus M, 2016, GOV OPPOS, V51, P111, DOI 10.1017/gov.2014.27; Enyedi Z, 2018, PERSPECT POLIT, V16, P1067, DOI 10.1017/S1537592718002165; Fahey RA., 2021, OXFORD HDB JAPANESE; Goertz G, 2006, SOCIAL SCIENCE CONCEPTS: A USER'S GUIDE, P1; Goertz Gary, 2020, SOCIAL SCI CONCEPTS; Hallquist MN, 2018, STRUCT EQU MODELING, V25, P621, DOI 10.1080/10705511.2017.1402334; Hawkins K. A., 2019, IDEATIONAL APPROACH, P1, DOI DOI 10.4324/9781315196923; Hawkins KA, 2020, GOV OPPOS, V55, P283, DOI 10.1017/gov.2018.23; Hawkins KA, 2009, COMP POLIT STUD, V42, P1040, DOI 10.1177/0010414009331721; Hayduk LA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-159; Heeringa S. G., 2010, SURVEY METHODS MULTI, P251; Hobolt S., 2016, DEMOCRACY DIVIDED PE; HORN JL, 1992, EXP AGING RES, V18, P117, DOI 10.1080/03610739208253916; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jaffrelot Christophe, 2017, OXFORD HDB POPULISM, P179; Jagers J, 2007, EUR J POLIT RES, V46, P319, DOI 10.1111/j.1475-6765.2006.00690.x; Johnson TP., 2019, ADV COMP SURVEY METH; Jungkunz S, Harvard Dataverse, V2021, DOI 10.7910/DVN/IRXXMO; Kobori M, 2013, RITSUMEIKAN LAW REV, V30, P107; Kreko P, 2018, J DEMOCR, V29, P39, DOI 10.1353/jod.2018.0043; Krosnick JA, 1997, WILEY SER PROB STAT, P141; Leifeld P, 2013, J STAT SOFTW, V55, P1; LUDECKE D, 2018, J OPEN SOURCE SOFTW, V3, P772, DOI [DOI 10.21105/JOSS.00772, 10.21105/joss.00772]; Ludecke D., 2020, SJLABELLED LABELLED; Ludecke D., 2018, JOSS, V3, P754, DOI [10.21105/joss.00754, DOI 10.21105/JOSS.00754, https://doi.org/10.21105/joss.00754]; Matthijs Rooduijn, 2019, POPULIST OVERVIEW PO; Meer TWGvd, 2017, DUTCH PARLIAMENTARY; Meijers MJ, 2021, COMP POLIT STUD, V54, P372, DOI 10.1177/0010414020938081; Mudde C, 2004, GOV OPPOS, V39, P541, DOI 10.1111/j.1477-7053.2004.00135.x; Muthen L. K., 2017, MPLUS USERS GUIDE ST, V8th, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Oliver JE, 2016, ANN AM ACAD POLIT SS, V667, P189, DOI 10.1177/0002716216662639; Pappas TS, 2016, J DEMOCR, V27, P22, DOI 10.1353/jod.2016.0059; Piurko Y, 2011, POLIT PSYCHOL, V32, P537, DOI 10.1111/j.1467-9221.2011.00828.x; Poznyak D, 2014, SOC INDIC RES, V118, P741, DOI 10.1007/s11205-013-0441-5; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Schulz A, 2018, INT J PUBLIC OPIN R, V30, P316, DOI 10.1093/ijpor/edw037; Silva BC, 2019, POLIT ANAL, V27, P599, DOI 10.1017/pan.2019.24; Silva BC, 2020, POLIT RES QUART, V73, P409, DOI 10.1177/1065912919833176; Silva BC, 2019, J POLIT, V81, P1085, DOI 10.1086/703071; Stanley B, 2011, COMMUNIS POST-COMMUN, V44, P257, DOI 10.1016/j.postcomstud.2011.10.005; Stegmueller D, 2011, POLIT ANAL, V19, P471, DOI 10.1093/pan/mpr028; Taggart P, 2019, ROUTL ADV SOCIOL, P79; Taggart Paul, 2000, POPULISM; Urbinati N., 2019, ME PEOPLE POPULISM T; Urbinati Nadia, 2014, DEMOCRACY DISFIGURED; van de Vijver FJR., 2010, CROSS CULTURAL ANAL, P3; Van Hauwaert SM, 2018, EUR J POLIT RES, V57, P68, DOI 10.1111/1475-6765.12216; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Wettstein M, 2020, INT J PUBLIC OPIN R, V32, P284, DOI 10.1093/ijpor/edz018; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Wilke C.O., 2020, COWPLOT STREAMLINED; WLEZIEN C, 1995, AM J POLIT SCI, V39, P981, DOI 10.2307/2111666; Wuttke A, 2020, AM POLIT SCI REV, V114, P356, DOI 10.1017/S0003055419000807; Yamada M, 2019, COMP STUDY ELECTORAL; Yoshida T, 2020, ASIAN J COMP POLITIC, V5, P288, DOI 10.1177/2057891119844608; Yutani H, 2020, GGHIGHLIGHT HIGHLIGH	70	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261658	10.1371/journal.pone.0261658	http://dx.doi.org/10.1371/journal.pone.0261658			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972137	Green Published, gold			2022-12-27	WOS:000773555700044
J	Lin, Q; Liu, Y; Peng, SM; Liu, CJ; Lv, T; Liao, LP; Li, YH; Wang, YZ; Fan, ZY; Wu, WG; Zeng, JG; Qiu, HJ; He, X; Dai, QZ				Lin, Qian; Liu, Yang; Peng, Simin; Liu, Chunjie; Lv, Tuo; Liao, Liping; Li, Yinghui; Wang, Yanzhou; Fan, Zhiyong; Wu, Weiguo; Zeng, Jianguo; Qiu, Huajiao; He, Xi; Dai, Qiuzhong			Magnolol additive improves growth performance of Linwu ducklings by modulating antioxidative status	PLOS ONE			English	Article							HEAT-STRESS IMPAIRS; OXIDATIVE STRESS; RNA EXPRESSION; HONOKIOL; COLISTIN; SUPPLEMENTATION; SYSTEM; MITOCHONDRIAL; PATHOGENESIS; METABOLISM	Magnolol is a bioactive polyphenolic compound commonly found in Magnolia officinalis. The aim of this study is to clarify the contribution of the magnolol additive on the growth performance of Linwu ducklings aging from 7 to 28 d, comparing to the effects of antibiotic additive (colistin sulphate). A total of 325, 7-d-old ducklings were assigned to 5 groups. Each group had 5 cages with 13 ducklings in each cage. The ducklings in different groups were fed with diets supplemented with 0, 100, 200 and 300 mg/kg magnolol additive (MA) (Control, MA100, MA200 and MA300) and 30 mg/kg colistin sulphate (CS30) for 3 weeks, respectively. Parameters regarding to the growth performance, intestinal mucosal morphology, serum biochemical indices, antioxidant and peroxide biomarkers and the expression levels of antioxidant-related genes were evaluated by one way ANOVA analysis. The results showed that 30 mg/kg colistin sulphate, 200 and 300 mg/kg magnolol additive improved the average final weight (P = 0.045), average daily body weight gain (P = 0.038) and feed/gain ratios (P = 0.001) compared to the control group. 200 and 300 mg/kg magnolol additive significantly increased the villus height/crypt depth ratio of ileum, compared to the control and CS30 groups (P = 0.001). Increased serum level of glucose (P = 0.011) and total protein (P = 0.006) were found in MA200 or MA300 group. In addition, comparing to the control and CS30 groups, MA200 or MA300 significantly increased the levels of superoxide dismutase (P = 0.038), glutathione peroxidase (P = 0.048) and reduced glutathione (P = 0.039) in serum. Moreover, the serum and hepatic levels of 8-hydroxy-2'-deoxyguanosine (P = 0.043 and 0.007, respectively) were lower in all MA groups compared to those of the control and CS30 group. The hepatic mRNA expression levels of superoxide dismutase-1, catalase and nuclear factor erythroid-2-related factor 2/erythroid-derived CNC-homology factor were also increased significantly in MA200 and MA300 groups (P < 0.05). Taken together, these data demonstrated that MA was an effective feed additive enhancing the growth performance of Linwu ducklings at 7 to 28 d by improving the antioxidant and intestinal mucosal status. It suggested that MA could be a potential ingredient to replace the colistin sulphate in diets.	[Lin, Qian; Liu, Chunjie; Lv, Tuo; Liao, Liping; Wang, Yanzhou; Zeng, Jianguo; Qiu, Huajiao; Dai, Qiuzhong] Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China; [Liu, Yang; Li, Yinghui; Fan, Zhiyong; He, Xi] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Hunan, Peoples R China; [Peng, Simin; Wu, Weiguo] Hunan Agr Univ, Coll Food Sci & Technol, Changsha, Hunan, Peoples R China; [Zeng, Jianguo] Hunan Agr Univ, Coll Hort, Changsha, Hunan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS; Hunan Agricultural University; Hunan Agricultural University; Hunan Agricultural University	Qiu, HJ; Dai, QZ (corresponding author), Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China.; He, X (corresponding author), Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Hunan, Peoples R China.	qiuhuajiao@caas.cn; hexi111@126.com; daiqiuzhong@163.com		Liu, Yang/0000-0002-6579-3633	Hunan Natural Science Foundation [2019JJ50710]; National Key RD Program [2017YFD0500506]; Agricultural Science and Technology Innovation Program (ASTIP-IBFC); Modern Agricultural Technical System Foundation of China [CARS-42]	Hunan Natural Science Foundation(Natural Science Foundation of Hunan Province); National Key RD Program; Agricultural Science and Technology Innovation Program (ASTIP-IBFC); Modern Agricultural Technical System Foundation of China	QL received Hunan Natural Science Foundation (2019JJ50710) founded by China Hunan Provincial Science & Technology Department (http://kjt.hunan.gov.cn/kjt/index.html), National Key R&D Program (2017YFD0500506) founded by Chinese Academy of Science (http://www.cas.cn), the Agricultural Science and Technology Innovation Program (ASTIP-IBFC) founded by Chinese Academy of Agricultural Sciences (http://www.caas.cn), Modern Agricultural Technical System Foundation of China (CARS-42) founded by Ministry of Agriculture and Rural Affairs of the People's Republic of China (http://www.kjs.moa.gov.cn/jgzn).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorati R, 2015, J ORG CHEM, V80, P10651, DOI 10.1021/acs.joc.5b01772; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Ceriello A, 1999, DIABETES NUTR METAB, V12, P42; Chang CP, 2003, CLIN EXP PHARMACOL P, V30, P387, DOI 10.1046/j.1440-1681.2003.03847.x; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Chen F, 2021, POULTRY SCI, V100, P835, DOI 10.1016/j.psj.2020.10.047; Chen L, 2017, ANIM GENET, V48, P358, DOI 10.1111/age.12540; Chen YP, 2013, BRIT POULTRY SCI, V54, P531, DOI 10.1080/00071668.2013.809402; Chen YH, 2009, ARCH PHARM RES, V32, P221, DOI 10.1007/s12272-009-1139-8; Choi SS, 2012, BIOFACTORS, V38, P372, DOI 10.1002/biof.1029; Council NR, 1994, NUTR REQ POULTR 9 RE; Dai CS, 2016, MOL NEUROBIOL, V53, P4685, DOI 10.1007/s12035-015-9396-7; Dai CS, 2014, ANTIMICROB AGENTS CH, V58, P4075, DOI 10.1128/AAC.00070-14; Dai Q., 2019, CROP RES, V33, P461; Ezeji E. U., 2012, AM J BIOCH, V2, P21, DOI 10.5923/j.ajb.20120203.01; Fiaccadori E, 2016, AM J KIDNEY DIS, V68, P296, DOI 10.1053/j.ajkd.2016.03.421; Hohtola E, 2002, COMP BIOCHEM PHYS A, V131, P733, DOI 10.1016/S1095-6433(02)00011-9; Horosova K, 2006, FOLIA MICROBIOL, V51, P278, DOI 10.1007/BF02931812; Huang C, 2015, J ANIM SCI, V93, P2144, DOI 10.2527/jas.2014-8739; Jiang JF, 2012, ASIAN AUSTRAL J ANIM, V25, P1445, DOI 10.5713/ajas.2012.12190; Khor TO, 2011, BIOCHEM PHARMACOL, V82, P1073, DOI 10.1016/j.bcp.2011.07.065; Kim YJ, 2013, MOL NUTR FOOD RES, V57, P1988, DOI 10.1002/mnfr.201300113; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Lee YS, 2015, FOOD SCI BIOTECHNOL, V24, P1467, DOI 10.1007/s10068-015-0189-6; Li H, 2019, TOXICOL APPL PHARM, V373, P48, DOI 10.1016/j.taap.2019.04.016; Li X., 2012, INT RES J PURE APPL, V2, P68, DOI DOI 10.9734/IRJPAC/2012/628; Li YZ, 2006, J ANIM SCI, V84, P212, DOI 10.2527/jas.2006-144; Lin Q, 2017, ANIM NUTR, V3, P132, DOI 10.1016/j.aninu.2017.03.004; Lin Qian, 2015, Chinese Journal of Animal Nutrition, V27, P2466; Lin Qian, 2014, Chinese Journal of Animal Nutrition, V26, P2101; Lin YF, 2005, J NUTR, V135, P2457, DOI 10.1093/jn/135.10.2457; Liu LL, 2014, POULTRY SCI, V93, P54, DOI 10.3382/ps.2013-03423; Liu YS, 2020, BRIT POULTRY SCI, V61, P599, DOI 10.1080/00071668.2020.1774511; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LO YC, 1994, BIOCHEM PHARMACOL, V47, P549, DOI 10.1016/0006-2952(94)90187-2; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Ma XY, 2014, ANIM REPROD SCI, V145, P182, DOI 10.1016/j.anireprosci.2014.01.002; Mei C, 2016, J ZHEJIANG UNIV-SC B, V17, P413, DOI 10.1631/jzus.B1500261; Mishra B, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00060; Naghi Shokri A, 2017, ANIM SCI J, V88, P306, DOI 10.1111/asj.12629; Nation RL, 2015, LANCET INFECT DIS, V15, P225, DOI 10.1016/S1473-3099(14)70850-3; Ogata M, 1997, J AM OIL CHEM SOC, V74, P557, DOI 10.1007/s11746-997-0180-3; Qin S, 2016, MOL NUTR FOOD RES, V60, P1731, DOI 10.1002/mnfr.201501017; Rajgopal A, 2016, J ETHNOPHARMACOL, V193, P657, DOI 10.1016/j.jep.2016.10.016; Saleh AA, 2020, ANIM PROD SCI, V60, P1704, DOI 10.1071/AN19030; Saleh AA, 2014, VET MED-CZECH, V59, P536, DOI 10.17221/7818-VETMED; Saleh AA, 2018, ENVIRON SCI POLLUT R, V25, P14606, DOI 10.1007/s11356-018-1685-z; Shen JL, 2010, MOLECULES, V15, P6452, DOI 10.3390/molecules15096452; Sozer V, 2013, MINERVA MED, V104, P75; Wallace RJ, 2010, BRIT POULTRY SCI, V51, P461, DOI 10.1080/00071668.2010.506908; Wang W., 2015, INFLAMMATION, V281, P2543; Wu CL, 2014, INFLAMMATION, V37, P1957, DOI 10.1007/s10753-014-9928-8; Xia T, 2019, PHYTOTHER RES, V33, P1161, DOI 10.1002/ptr.6311; Xia XC, 2014, AFR J TRADIT COMPLEM, V11, P140, DOI 10.4314/ajtcam.v11i1.22; YASON CV, 1987, AM J VET RES, V48, P927; Yen HC, 2015, ANIM SCI J, V86, P99, DOI 10.1111/asj.12248; Yin J, 2013, FREE RADICAL RES, V47, P1027, DOI 10.3109/10715762.2013.848277; Zeng Z, 2010, J VET PHARMACOL THER, V33, P408, DOI 10.1111/j.1365-2885.2009.01136.x; Zhao C, 2011, BIOCHIMIE, V93, P1755, DOI 10.1016/j.biochi.2011.06.012	59	1	2	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0259896	10.1371/journal.pone.0259896	http://dx.doi.org/10.1371/journal.pone.0259896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972101	gold, Green Published			2022-12-27	WOS:000773555700010
J	Possamai, D; Hanafi, LA; Bellemare-Pelletier, A; Hamelin, K; Thebault, P; Hebert, MJ; Gagnon, E; Leclerc, D; Lapointe, R				Possamai, David; Hanafi, Laila-Aicha; Bellemare-Pelletier, Angelique; Hamelin, Katia; Thebault, Pamela; Hebert, Marie-Josee; Gagnon, Etienne; Leclerc, Denis; Lapointe, Rejean			MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagy	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; ENDOGENOUS VIRAL-ANTIGENS; THYMIC EPITHELIAL-CELLS; DENDRITIC CELLS; MOLECULES; MACROAUTOPHAGY; VESICLES; EPITOPES; IMMUNITY	Nanoparticles made of the coat protein of papaya mosaic virus (PapMV) and a single-strand RNA were previously shown to be an efficient antigen presentation system for the trigger of cellular immunity. Engineering of PapMV nano with a cytotoxic T lymphocyte epitope was previously shown activating specific T lymphocytes through a proteasome-independent major histocompatibility complex class I (MHC-I) cross-presentation. In this study, we provide new insights into the mechanism of the MHC-I cross-presentation mediated by PapMV nanoparticles. We demonstrate that PapMV nanoparticles do not require the transporter associated with antigen presentation (TAP), but rather depend on lysosome acidification and cathepsin S protease activity for presentation of the T cell epitope. We have also linked the induction of autophagy with this vacuolar MHC-I cross-presentation process. Interestingly, autophagy is induced in antigen-presenting cells after PapMV nanoparticles exposure and inhibition of autophagy reduce MHC-I cross-presentation. This study demonstrates that autophagy is associated with TAP- and proteasome-independent MHC-I cross-presentation. A deeper understanding of the autophagy-dependent MHC-I cross-presentation will be useful in designing vaccination platforms that aim to trigger an efficient cytotoxic T lymphocyte response.	[Possamai, David; Hanafi, Laila-Aicha; Hamelin, Katia; Thebault, Pamela; Hebert, Marie-Josee; Lapointe, Rejean] Univ Montreal, Ctr Rech, Ctr Hosp, Montreal, PQ, Canada; [Bellemare-Pelletier, Angelique; Gagnon, Etienne] Inst Rech Immunol & Cancerol, Montreal, PQ, Canada; [Bellemare-Pelletier, Angelique; Gagnon, Etienne] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Leclerc, Denis] Univ Quebec, Ctr Rech Infectiol, Ctr Hosp, Quebec City, PQ, Canada; [Leclerc, Denis] Univ Laval, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada; [Lapointe, Rejean] Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University; University of Quebec; Laval University; Universite de Montreal	Lapointe, R (corresponding author), Univ Montreal, Ctr Rech, Ctr Hosp, Montreal, PQ, Canada.; Lapointe, R (corresponding author), Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada.	rejean.lapointe@umontreal.ca		Leclerc, Denis/0000-0002-9323-1638	Canadian Institutes of Health Research [CIHR MOP 89833]; Natural Sciences and Engineering Research Council of Canada [NSERC RGPIN-2016-05376]; Fonds de la recherche du Quebec -sante (FRQ-S); Institut du cancer de Montreal	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la recherche du Quebec -sante (FRQ-S); Institut du cancer de Montreal	This work was supported by grants from the Canadian Institutes of Health Research (CIHR MOP 89833; https://cihr-irsc.gc.ca) and the Natural Sciences and Engineering Research Council of Canada (NSERC RGPIN-2016-05376; https://www.nserc-crsng.gc.ca).RL and LAH are recipients of scholarships from the Fonds de la recherche du Quebec -sante (FRQ-S; https://frq.gouv.qc.ca).DP and LAH received Canderel scholarships from the Institut du cancer de Montreal (https://www.icm.qc.ca).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichinger M, 2013, J EXP MED, V210, P287, DOI 10.1084/jem.20122149; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Basha G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003247; Bhattacharjee S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0668-9; Blander JM, 2018, ANNU REV IMMUNOL, V36, P717, DOI 10.1146/annurev-immunol-041015-055523; Budida R, 2017, EUR J IMMUNOL, V47, P1819, DOI 10.1002/eji.201646908; Carignan D, 2018, NANOMED-NANOTECHNOL, V14, P2317, DOI 10.1016/j.nano.2017.10.015; Chen LY, 2004, EUR J IMMUNOL, V34, P952, DOI 10.1002/eji.200324359; Croft NP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000490; Dasari V, 2016, IMMUNOL CELL BIOL, V94, P964, DOI 10.1038/icb.2016.59; delaSalle H, 1997, J IMMUNOL, V158, P4555; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Di Bonito P, 2009, VIROLOGY, V395, P45, DOI 10.1016/j.virol.2009.09.012; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; English L, 2009, AUTOPHAGY, V5, P1026, DOI 10.4161/auto.5.7.9163; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Fader CM, 2006, AUTOPHAGY, V2, P122, DOI 10.4161/auto.2.2.2350; Fiegl D, 2013, J IMMUNOL, V190, P2791, DOI 10.4049/jimmunol.1202741; Gromme M, 2002, MOL IMMUNOL, V39, P181, DOI 10.1016/S0161-5890(02)00101-3; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Hanafi LA, 2010, VACCINE, V28, P5617, DOI 10.1016/j.vaccine.2010.06.024; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Herb M, 2020, SEMIN CELL DEV BIOL, V101, P68, DOI 10.1016/j.semcdb.2019.04.016; Lapointe R, 2003, CANCER RES, V63, P2836; Lebel ME, 2015, VACCINES-BASEL, V3, P620, DOI 10.3390/vaccines3030620; Leclerc D, 2007, J VIROL, V81, P1319, DOI 10.1128/JVI.01720-06; Loi M, 2016, CELL REP, V15, P1076, DOI 10.1016/j.celrep.2016.04.002; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Makarkov AI, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0111-y; Matheoud D, 2013, CELL HOST MICROBE, V14, P15, DOI 10.1016/j.chom.2013.06.003; MCCOY KL, 1988, IMMUNOL REV, V106, P129, DOI 10.1111/j.1600-065X.1988.tb00777.x; Menager J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089897; Moffat JM, 2013, VACCINE, V31, P2310, DOI 10.1016/j.vaccine.2013.02.042; Mohsen MO, 2020, WIRES NANOMED NANOBI, V12, DOI 10.1002/wnan.1579; Mohsen MO, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0587-z; Mohsen MO, 2017, SEMIN IMMUNOL, V34, P123, DOI 10.1016/j.smim.2017.08.014; Munz C, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.628429; Oliveira CC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00298; Oliveira CC, 2013, MOL IMMUNOL, V55, P113, DOI 10.1016/j.molimm.2012.10.005; Pallet N, 2013, PROTEOMICS, V13, P1108, DOI 10.1002/pmic.201200531; Puleston DJ, 2014, IMMUNOLOGY, V141, P1, DOI 10.1111/imm.12165; Pushko P, 2013, INTERVIROLOGY, V56, P141, DOI 10.1159/000346773; Ressing ME, 2013, MOL IMMUNOL, V55, P139, DOI 10.1016/j.molimm.2012.10.009; Rock KL, 2010, J IMMUNOL, V184, P9, DOI 10.4049/jimmunol.0903399; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Tey SK, 2012, BLOOD, V120, P994, DOI 10.1182/blood-2012-01-402404; Van Kaer L, 2019, MOL IMMUNOL, V113, P2, DOI 10.1016/j.molimm.2017.10.021; Win SJ, 2011, IMMUNOL CELL BIOL, V89, P681, DOI 10.1038/icb.2010.161; Wu CY, 2013, AUTOPHAGY, V9, P931, DOI 10.4161/auto.24374; Zehner M, 2013, MOL IMMUNOL, V55, P146, DOI 10.1016/j.molimm.2012.10.010; Zou LY, 2009, P NATL ACAD SCI USA, V106, P15801, DOI 10.1073/pnas.0905684106	54	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261987	10.1371/journal.pone.0261987	http://dx.doi.org/10.1371/journal.pone.0261987			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972158	gold, Green Published			2022-12-27	WOS:000773555700081
J	Segreto, R; Bazafkan, H; Millinger, J; Schenk, M; Atanasova, L; Doppler, M; Buschl, C; Boeckstaens, M; Diaz, SS; Schreiner, U; Sillo, F; Balestrini, R; Schuhmacher, R; Zeilinger, S				Segreto, Rossana; Bazafkan, Hoda; Millinger, Julia; Schenk, Martina; Atanasova, Lea; Doppler, Maria; Bueschl, Christoph; Boeckstaens, Melanie; Diaz, Silvia Soto; Schreiner, Ulrike; Sillo, Fabiano; Balestrini, Raffaella; Schuhmacher, Rainer; Zeilinger, Susanne			The TOR kinase pathway is relevant for nitrogen signaling and antagonism of the mycoparasite Trichoderma atroviride	PLOS ONE			English	Article							PROTEIN S6 PHOSPHORYLATION; FISSION YEAST; AMINO-ACID; N-ACETYLGLUCOSAMINIDASE; TSC1-TSC2 COMPLEX; NPR1 KINASE; RHEB; RAPAMYCIN; GROWTH; GENE	Trichoderma atroviride (Ascomycota, Sordariomycetes) is a well-known mycoparasite applied for protecting plants against fungal pathogens. Its mycoparasitic activity involves processes shared with plant and human pathogenic fungi such as the production of cell wall degrading enzymes and secondary metabolites and is tightly regulated by environmental cues. In eukaryotes, the conserved Target of Rapamycin (TOR) kinase serves as a central regulator of cellular growth in response to nutrient availability. Here we describe how alteration of the activity of TOR1, the single and essential TOR kinase of T. atroviride, by treatment with chemical TOR inhibitors or by genetic manipulation of selected TOR pathway components affected various cellular functions. Loss of TSC1 and TSC2, that are negative regulators of TOR complex 1 (TORC1) in mammalian cells, resulted in altered nitrogen source-dependent growth of T. atroviride, reduced mycoparasitic overgrowth and, in the case of Delta tsc1, a diminished production of numerous secondary metabolites. Deletion of the gene encoding the GTPase RHE2, whose mammalian orthologue activates mTORC1, led to rapamycin hypersensitivity and altered secondary metabolism, but had an only minor effect on vegetative growth and mycoparasitic overgrowth. The latter also applied to mutants missing the npr1-1 gene that encodes a fungus-specific kinase known as TOR target in yeast. Genome-wide transcriptome analysis confirmed TOR1 as a regulatory hub that governs T. atroviride metabolism and processes associated to ribosome biogenesis, gene expression and translation. In addition, mycoparasitism-relevant genes encoding terpenoid and polyketide synthases, peptidases, glycoside hydrolases, small secreted cysteine-rich proteins, and G protein coupled receptors emerged as TOR1 targets. Our results provide the first in-depth insights into TOR signaling in a fungal mycoparasite and emphasize its importance in the regulation of processes that critically contribute to the antagonistic activity of T. atroviride.	[Segreto, Rossana; Bazafkan, Hoda; Millinger, Julia; Schenk, Martina; Schreiner, Ulrike; Zeilinger, Susanne] Univ Innsbruck, Dept Microbiol, Innsbruck, Austria; [Atanasova, Lea] Univ Nat Resources & Life Sci BOKU, Inst Food Technol, Vienna, Austria; [Doppler, Maria; Bueschl, Christoph; Schuhmacher, Rainer] Univ Nat Resources & Life Sci Vienna BOKU, Dept Agrobiotechnol IFA Tulin, Ctr Analyt Chem, Tulin, Austria; [Boeckstaens, Melanie; Diaz, Silvia Soto] Univ Libre Bruxelles, Dept Biol Mol, Lab Biol Membrane Transport, Belgium, Italy; [Sillo, Fabiano; Balestrini, Raffaella] IPSP, CNR, Turin, Italy	University of Innsbruck; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR)	Zeilinger, S (corresponding author), Univ Innsbruck, Dept Microbiol, Innsbruck, Austria.	Susanne.zeilinger@uibk.ac.at	; Sillo, Fabiano/K-5022-2016	Zeilinger, Susanne/0000-0003-3112-0948; Atanasova, Lea/0000-0002-1751-277X; Segreto, Rossana/0000-0002-2566-7042; Sillo, Fabiano/0000-0002-1218-9985; Boeckstaens, Melanie/0000-0003-1629-7403	Austrian Science Fund [P28248]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (FWF; https://www.fwf.ac.at/; grant number P28248 to SZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanasova L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-121; Atanasova L, 2010, J ZHEJIANG UNIV-SC B, V11, P151, DOI 10.1631/jzus.B1000007; Atkin J, 2014, J CELL SCI, V127, P1346, DOI 10.1242/jcs.146373; Baldin C, 2015, PROTEOMICS, V15, P2230, DOI 10.1002/pmic.201400584; Bastidas RJ, 2012, EUKARYOT CELL, V11, P270, DOI 10.1128/EC.05284-11; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; Boeckstaens M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005382; Boeckstaens M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4101; Brito AS, 2019, ISCIENCE, V20, P415, DOI 10.1016/j.isci.2019.09.025; Brunner K, 2003, CURR GENET, V43, P289, DOI 10.1007/s00294-003-0399-y; Brunner K, 2008, CURR GENET, V54, P283, DOI 10.1007/s00294-008-0217-7; Bueschl C, 2017, ANAL CHEM, V89, P9518, DOI 10.1021/acs.analchem.7b02518; Bueschl C, 2014, METABOLOMICS, V10, P754, DOI 10.1007/s11306-013-0611-0; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Ceranic A, 2020, PLANT METHODS, V16, DOI 10.1186/s13007-020-00590-9; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Chowdhury T, 2015, MOL MICROBIOL, V98, P384, DOI 10.1111/mmi.13130; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Gaubitz C, 2016, TRENDS BIOCHEM SCI, V41, P532, DOI 10.1016/j.tibs.2016.04.001; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gonzalez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120250; GRENSON M, 1983, EUR J BIOCHEM, V133, P141, DOI 10.1111/j.1432-1033.1983.tb07439.x; Hallett JEH, 2014, GENETICS, V198, P773, DOI 10.1534/genetics.114.168369; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; Karlsson M, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0016-2016; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li LX, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00501; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lopez-Berges MS, 2010, PLANT CELL, V22, P2459, DOI 10.1105/tpc.110.075937; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mach KE, 2000, GENETICS, V155, P611; MANDELS M, 1978, PROCESS BIOCHEM, V13, P6; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Matsumoto S, 2002, GENETICS, V161, P1053; Moran-Diez ME, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01120; Moreno-Ruiz D, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9100860; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; Neuman NA, 2011, EMBO MOL MED, V3, P189, DOI 10.1002/emmm.201100131; Panepinto JC, 2003, INFECT IMMUN, V71, P2819, DOI 10.1128/IAI.71.5.2819-2826.2003; Panepinto JC, 2002, FUNGAL GENET BIOL, V36, P207, DOI 10.1016/S1087-1845(02)00022-1; Pang AP., 2021, BIOTECHNOL BIOFUELS, V14; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pfannmuller A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125487; Prouteau M, 2017, NATURE, V550, P265, DOI 10.1038/nature24021; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Saikia S, 2014, INFECT IMMUN, V82, P839, DOI 10.1128/IAI.01357-13; Salas-Marina MA, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00077; Sauerschnig C, 2018, METABOLITES, V8, DOI 10.3390/metabo8010001; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Schmoll M, 2016, MICROBIOL MOL BIOL R, V80, P205, DOI 10.1128/MMBR.00040-15; Seidl V, 2006, MICROBIOL-SGM, V152, P2003, DOI 10.1099/mic.0.28897-0; Seidl V, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-567; Seo J, 2002, COMPUTER, V35, P80; Serfontein J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000803; Shertz CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-510; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takahara T, 2012, GENES CELLS, V17, P698, DOI 10.1111/j.1365-2443.2012.01618.x; Tatebe H, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7040077; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Teichert S, 2006, EUKARYOT CELL, V5, P1807, DOI 10.1128/EC.00039-06; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tisch D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-613; Tsao CC, 2009, FUNGAL GENET BIOL, V46, P126, DOI 10.1016/j.fgb.2008.11.008; Tudzynski B, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00656; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x; van Slegtenhorst M, 2004, J BIOL CHEM, V279, P12706, DOI 10.1074/jbc.M313874200; VANDENBOL M, 1990, MOL GEN GENET, V222, P393, DOI 10.1007/BF00633845; Weisman R, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.FUNK-0006-2016; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yerlikaya S, 2016, MOL BIOL CELL, V27, P397, DOI 10.1091/mbc.E15-08-0594; Yu FW, 2014, NEW PHYTOL, V203, P219, DOI 10.1111/nph.12776; Yu WJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26328-1; Zeilinger S, 2016, FUNGAL BIOL REV, V30, P74, DOI 10.1016/j.fbr.2016.05.001; Zeilinger S, 2007, GENE REGUL SYST BIO, V1, P227	98	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262180	10.1371/journal.pone.0262180	http://dx.doi.org/10.1371/journal.pone.0262180			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972198	Green Published, gold			2022-12-27	WOS:000773555700105
J	Xiao, YJ; Wang, K; Liu, WL; Peng, K; Wan, F				Xiao, Yanjun; Wang, Kuan; Liu, Weiling; Peng, Kai; Wan, Feng			Research on rapier loom fault system based on cloud-side collaboration	PLOS ONE			English	Article							DIAGNOSIS METHODS	The electrical control system of rapier weaving machines is susceptible to various disturbances during operation and is prone to failures. This will seriously affect the production and a fault diagnosis system is needed to reduce this effect. However, the existing popular fault diagnosis systems and methods need to be improved due to the limitations of rapier weaving machine process and electrical characteristics. Based on this, this paper presents an in-depth study of rapier loom fault diagnosis system and proposes a rapier loom fault diagnosis method combining edge expert system and cloud-based rough set and Bayesian network. By analyzing the process and fault characteristics of rapier loom, the electrical faults of rapier loom are classified into common faults and other faults according to the frequency of occurrence. An expert system is built in the field for edge computing based on knowledge fault diagnosis experience to diagnose common loom faults and reduce the computing pressure in the cloud. Collect loom fault data in the cloud, train loom fault diagnosis algorithms to diagnose other faults, and handle other faults diagnosed by the expert system. The effectiveness of loom fault diagnosis is verified by on-site operation and remote monitoring of the loom human-machine interaction system. Technical examples are provided for the research of loom fault diagnosis system.	[Xiao, Yanjun; Wang, Kuan; Liu, Weiling; Peng, Kai; Wan, Feng] Hebei Univ Technol, Coll Mech Engn, Tianjin, Peoples R China	Hebei University of Technology	Wan, F (corresponding author), Hebei Univ Technol, Coll Mech Engn, Tianjin, Peoples R China.	wf_hebut@163.com		Wan, Feng/0000-0002-0190-7144	fifth "333 Project" training fund project of Jiangsu Province by the Department of Human Resources and Social Security of Jiangsu Province: Research on Weaving Machine Decentralized Self-organizing Network and Remote Fault Diagnosis Expert System [BRA2020244]	fifth "333 Project" training fund project of Jiangsu Province by the Department of Human Resources and Social Security of Jiangsu Province: Research on Weaving Machine Decentralized Self-organizing Network and Remote Fault Diagnosis Expert System	This study was supported through an award from the fifth "333 Project" training fund project of Jiangsu Province issued by the Department of Human Resources and Social Security of Jiangsu Province: Research on Weaving Machine Decentralized Self-organizing Network and Remote Fault Diagnosis Expert System (Project No. BRA2020244). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, INT J ENG ADV TECHNO, V9, P1233, DOI [10.35940/ijeat.c6550.029320, DOI 10.35940/IJEAT.C6550.029320]; Asim M, 2020, IEEE TETCI, V4, P742, DOI 10.1109/TETCI.2020.3007905; Asmah AE., 2015, EUR J BASIC APPL SCI, V2, P55; Baker T, 2018, SUSTAIN COMPUT-INFOR, V19, P242, DOI 10.1016/j.suscom.2018.05.011; Deng H, 2013, ADV MATER RES-SWITZ, V605-607, P878, DOI 10.4028/www.scientific.net/AMR.605-607.878; Deng H, 2011, ADV MATER RES-SWITZ, V219-220, P709, DOI 10.4028/www.scientific.net/AMR.219-220.709; Dong D., 2011, PROC INT C CONTROL A, P1; Hazra A, 2017, J CLEAN PROD, V154, P220, DOI 10.1016/j.jclepro.2017.03.214; Javed AR, 2021, IEEE T INTELL TRANSP, V22, P4291, DOI 10.1109/TITS.2020.3025875; Lindauer Dornier GmbH., 1990, TEXT PRAX INT, V45, P931; Lu SB, 2018, RENEW SUST ENERG REV, V89, P88, DOI 10.1016/j.rser.2018.03.010; Mellit A, 2018, RENEW SUST ENERG REV, V91, P1, DOI 10.1016/j.rser.2018.03.062; Mourtzis D, 2020, FRONT MECH ENG-SWITZ, V6, DOI 10.3389/fmech.2020.578379; Mouzakitis A, 2013, MEAS CONTROL-UK, V46, P303, DOI 10.1177/0020294013510471; Nor NM, 2020, REV CHEM ENG, V36, P513, DOI 10.1515/revce-2017-0069; Pengfei Chen, 2021, Journal of Physics: Conference Series, V1750, DOI 10.1088/1742-6596/1750/1/012055; Pham MT, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20236886; Priya RMS, 2020, J PARALLEL DISTR COM, V142, P16, DOI 10.1016/j.jpdc.2020.02.010; Rupa C., 2021, Collaborative Computing: Networking, Applications and Worksharing. 16th EAI International Conference, CollaborateCom 2020. Proceedings. Lecture Notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering (LNICST 350), P550, DOI 10.1007/978-3-030-67540-0_36; Shabbir M, 2021, IEEE ACCESS, V9, P8820, DOI 10.1109/ACCESS.2021.3049564; Sheng C., 2018, J ADV OXID TECHNOL, V21, DOI [10.26802/jaots.2018.10520, DOI 10.26802/JAOTS.2018.10520]; Wang YL, 2020, IEEE ACCESS, V8, P200897, DOI 10.1109/ACCESS.2020.3034365; Xiao YJ, 2020, J INTELL FUZZY SYST, V39, P1147, DOI 10.3233/JIFS-192039; Xiao YJ, 2020, WIRELESS PERS COMMUN, V113, P2167, DOI 10.1007/s11277-020-07317-y; Yang Z, 2021, SCI PROGRAMMING-NETH, V2021, DOI 10.1155/2021/6617882; [张文龙 Zhang Wenlong], 2020, [计算机集成制造系统, Computer Integrated Manufacturing Systems], V26, P589; Zhao Y, 2019, RENEW SUST ENERG REV, V109, P85, DOI 10.1016/j.rser.2019.04.021; Zhao-min Lian, 2014, Advanced Materials Research, V912-914, P956, DOI 10.4028/www.scientific.net/AMR.912-914.956; Zhou ZX, 2020, ENERG BUILDINGS, V224, DOI 10.1016/j.enbuild.2020.110232; Zinger D.S, 2019, J ENG SCI TECHNOL RE, V12, P53, DOI 10.25103/jestr.125.07	30	0	0	7	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0260888	10.1371/journal.pone.0260888	http://dx.doi.org/10.1371/journal.pone.0260888			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972098	Green Published, gold			2022-12-27	WOS:000773555700018
J	Yang, YX; Ren, L; Du, ZH; Tong, GQ				Yang, Yuexiang; Ren, Lei; Du, Zhihui; Tong, Guanqun			Measurement and spatiotemporal analysis of high-quality development of China's industry	PLOS ONE			English	Article							ENTROPY WEIGHT	Background China's economy has been transitioning from a phase of rapid growth to high-quality development. The high-quality development of industry is the foundation of a sustainable and healthy growth of national economy, and is of great significance to improve people's living standards, and to meet people's needs for a better life. Methods We develop an evaluation index system of high-quality development of industry from the perspectives of industrial benefit, innovation ability, coordination ability, green ability, opening ability and sharing ability. Based on a panel data of 30 provinces in China during 1999-2018, we evaluate the level of high-quality development of industry using the entropy-weight method and Technique for Order Preference by Similarity to an Ideal Solution (TOPSIS) method. Meanwhile we select six specific years and adopt the Natural Breaks method to classify the provinces according to their levels. At last, Moran's I index is used to analyze the spatial correlation among the provinces. Results Opening ability and innovation ability are found to have greater impacts on industrial high-quality development than other indices, and their influence has been increasing in recent years. There are large spatial and temporal differences among different provinces. Municipalities and coastal provinces are found to be at constantly high levels. The levels in the central region dropped first and then increased, however it was the opposite in the western region. In the northeast region, the levels fluctuated greatly. Overall, the high-quality development of industry among China's provinces shows positive spatial correlation. Most provinces in China are in High-High and Low-Low clustering States. The High-High clustering type is mainly distributed in the eastern region and the Low-Low clustering type is mainly distributed in the western and central regions. Conclusion (1) Innovation ability and open ability are the most important factors. (2) Green ability has not sufficiently contributed to China's industrial development. (3) Regional and time evolution differences are significant. (4) There is a significant and stable spatial clustering effect in the high-quality development of industry among China's provinces.	[Yang, Yuexiang; Ren, Lei] China Univ Min & Technol Beijing, Sch Management, Beijing, Peoples R China; [Du, Zhihui] Univ Int Business & Econ, Sch Banking & Finance, Beijing, Peoples R China; [Tong, Guanqun] Beijing Technol & Business Univ, Canvard Coll, Beijing, Peoples R China	China University of Mining & Technology; University of International Business & Economics; Beijing Technology & Business University	Du, ZH (corresponding author), Univ Int Business & Econ, Sch Banking & Finance, Beijing, Peoples R China.	202000210048@uibe.edu.cn			Major Program of National Social Science Foundation of China [18ZDA079]	Major Program of National Social Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Major Program of National Social Science Foundation of China No.18ZDA079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayram BC, 2020, BIORESOURCES, V15, P1419, DOI 10.15376/biores.15.1.1419-1429; Chen CF, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8020153; Chen J.H., 2020, J QUANT TECH EC, V37, P108, DOI [10.13653/j.cnki.jqte.2020.12.006, DOI 10.13653/J.CNKI.JQTE.2020.12.006]; Dehdasht G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228746; [杜宇 Du Yu], 2020, [经济地理, Economic Geography], V40, P96; FARE R, 1994, AM ECON REV, V84, P66; Feng M, 2019, J SCI IND RES INDIA, V78, P827; Fu W., 2020, IND TECHNOL EC, V39, P145; Gao Y.S., 2020, J EC, V10, P65; Han H.Y., 2020, EC PROBLEMS, P1; Hou JC, 2019, RESOUR POLICY, V63, DOI 10.1016/j.resourpol.2019.101446; Hsu LC, 2013, J BUS ECON MANAG, V14, P448, DOI 10.3846/16111699.2011.633098; Hu C.P., 2020, J SUBEI, V27, P91; Huang WC, 2018, TRANSPORT RES A-POL, V111, P292, DOI 10.1016/j.tra.2018.03.025; Hwang C.L., 1981, MULTIPLE ATTRIBUTE D, DOI [10.1007/978-3-642-48318-9, DOI 10.1007/978-3-642-48318-9]; Jiang X., 2019, SHANGHAI J EC, V7, P70; Jin FJ., 2010, ECON GEOGR, V8, P1259; Jin R, 2020, J COASTAL RES, P161, DOI 10.2112/JCR-SI108-032.1; [巨虹 Ju Hong], 2020, [资源科学, Resources Science], V42, P1099; Kim AR, 2016, ASIAN J SHIPPING LOG, V32, P187, DOI 10.1016/j.ajsl.2016.12.001; Li L., 2020, ECON RES-EKON ISTRAZ, V34, P1; Li W, 2020, ECOL INDIC, V112, DOI 10.1016/j.ecolind.2019.106044; Li XS, 2021, ENVIRON SCI POLLUT R, V28, P21674, DOI [10.1007/s11356-020-12032-z, 10.1007/s11356-021-13037-y]; Li YC, 2014, SUSTAINABILITY-BASEL, V6, P4685, DOI 10.3390/su6074685; Li ZY, 2019, KOREAN CHINESE RELAT, V5, P183; [刘定惠 LIU Dinghui], 2011, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V20, P892; Liu G.X., 2020, MOD MANAG, V40, P20; Liu R., 2020, J NE U SOCIAL SCI, V22, P31; Liu YX., 2020, ECONOMIST, P69; [马茹 Ma Ru], 2019, [中国软科学, China Soft Science], P60; [欧进锋 Ou Jinfeng], 2020, [经济地理, Economic Geography], V40, P77; Shi B., 2019, SOC SCI RES, V2019, P19; Song X-N., 2019, SOFT SCI, V33, P36, DOI [10.13956/j.ss.1001-8409.2019.12.06(inChinese), DOI 10.13956/J.SS.1001-8409.2019.12.06(INCHINESE)]; Su M.Z., 2017, SHANGHAI EC RES, V4, P112; Su Y.W., 2020, EC PROBL, V9, P85; Sun LY, 2017, ECOL INDIC, V73, P554, DOI 10.1016/j.ecolind.2016.10.018; Sun XH, 2021, J ADV NURS, V77, P2929, DOI 10.1111/jan.14706; Wang Y, 2021, ECOL INDIC, V124, DOI 10.1016/j.ecolind.2021.107371; [魏敏 Wei Min], 2018, [数量经济技术经济研究, Quantitative & Technical Economics], V35, P3; YANG L., 2019, JIANGSU SOCIAL SCI, V6, P249; Yongwei S., 2019, STAT DECISION, V35, P38; [张发明 Zhang Faming], 2019, [系统科学与数学, Journal of Systems Science and Mathematical Sciences], V39, P595; Zhang LJ, 2011, RES METHODS ROBUST M, V26, P16; [张涛 Zhang Tao], 2020, [数量经济技术经济研究, Quantitative & Technical Economics], V37, P23; Zhang YS, 2021, J MANAGE, V34, P27; Zhao Li, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P235; [赵玉林 Zhao Yulin], 2018, [数量经济技术经济研究, Quantitative & Technical Economics], V35, P116	47	3	3	43	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0259845	10.1371/journal.pone.0259845	http://dx.doi.org/10.1371/journal.pone.0259845			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972118	Green Published, gold			2022-12-27	WOS:000773555700009
J	Henry, S; Thielmann, I; Booth, T; Mottus, R				Henry, Sam; Thielmann, Isabel; Booth, Tom; Mottus, Rene			Test-retest reliability of the HEXACO-100-And the value of multiple measurements for assessing reliability	PLOS ONE			English	Article							PERSONALITY; STABILITY; CONSISTENCY; ERROR; BIG	Despite the widespread use of the HEXACO model as a descriptive taxonomy of personality traits, there remains limited information on the test-retest reliability of its commonly-used inventories. Studies typically report internal consistency estimates, such as alpha or omega, but there are good reasons to believe that these do not accurately assess reliability. We report 13-day test-retest correlations of the 100- and 60-item English HEXACO Personality Inventory-Revised (HEXACO-100 and HEXACO-60) domains, facets, and items. In order to test the validity of test-retest reliability, we then compare these estimates to correlations between self- and informant-reports (i.e., cross-rater agreement), a widely-used validity criterion. Median estimates of test-retest reliability were .88, .81, and .65 (N = 416) for domains, facets, and items, respectively. Facets' and items' test-retest reliabilities were highly correlated with their cross-rater agreement estimates, whereas internal consistencies were not. Overall, the HEXACO Personality Inventory-Revised demonstrates test-retest reliability similar to other contemporary measures. We recommend that short-term retest reliability should be routinely calculated to assess reliability.	[Henry, Sam; Booth, Tom; Mottus, Rene] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Thielmann, Isabel] Univ Koblenz Landau, Dept Psychol, Koblenz, Landau, Germany; [Mottus, Rene] Univ Tartu, Inst Psychol, Tartu, Estonia	University of Edinburgh; University of Koblenz & Landau; University of Tartu	Henry, S (corresponding author), Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland.	samuel.henry@ed.ac.uk		Henry, Samuel/0000-0003-1511-2307	University of Edinburgh School of Philosophy, Psychology, and Language Sciences	University of Edinburgh School of Philosophy, Psychology, and Language Sciences	The corresponding author (SH) was supported by two Research Support Grants (grant numbers unspecified as the funds come from a common pool used by research students) from the University of Edinburgh School of Philosophy, Psychology, and Language Sciences. Information on these grants may be found at https://www.ed.ac.uk/ppls/linguistics-and-english-language/current/postgraduate/fees-and-funding/fundingphd-research.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglim J, 2020, PSYCHOL BULL, V146, P279, DOI 10.1037/bul0000226; Ashton MC, 2009, J PERS ASSESS, V91, P340, DOI 10.1080/00223890902935878; Cattell RB., 1970, HDB SIXT PERSONAL FA; Chmielewski M, 2009, J PERS SOC PSYCHOL, V97, P186, DOI 10.1037/a0015618; Condon D.M., 2020, BOTTOM CONSTRUCTION; Costa PT., 1992, REVISED NEO PERSONAL; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; de Vries RE, 2016, EUR J PERSONALITY, V30, P618, DOI 10.1002/per.2083; Dunlop PD, 2021, PERS INDIV DIFFER, V172, DOI 10.1016/j.paid.2020.110601; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; GUTTMAN L., 1945, PSYCHOMETRIKA, V10, P255; HEISE DR, 1969, AM SOCIOL REV, V34, P93, DOI 10.2307/2092790; Henry S, 2020, EUR J PERSONALITY, V34, P265, DOI 10.1002/per.2248; John O. P., 2007, HDB RES METHODS PERS, P461; Kandler C, 2019, TWIN RES HUM GENET, V22, P548, DOI 10.1017/thg.2019.62; Kosinski M, 2015, AM PSYCHOL, V70, P543, DOI 10.1037/a0039210; Lee K, 2004, MULTIVAR BEHAV RES, V39, P329, DOI 10.1207/s15327906mbr3902_8; Lee K, 2018, EUR J PERSONALITY, V32, P100, DOI 10.1002/per.2142; Lee K, 2018, ASSESSMENT, V25, P543, DOI 10.1177/1073191116659134; Lowman GH, 2018, EMOTION, V18, P896, DOI 10.1037/emo0000370; McCrae RR, 2019, CURR DIR PSYCHOL SCI, V28, P415, DOI 10.1177/0963721419849559; McCrae RR, 2015, PERS SOC PSYCHOL REV, V19, P97, DOI 10.1177/1088868314541857; McCrae RR, 2011, PERS SOC PSYCHOL REV, V15, P28, DOI 10.1177/1088868310366253; McCrae RR, 2005, J PERS ASSESS, V84, P261, DOI 10.1207/s15327752jpa8403_05; Moshagen M, 2019, Z PSYCHOL, V227, P186, DOI 10.1027/2151-2604/a000377; Moshagen M, 2014, DIAGNOSTICA, V60, P86, DOI 10.1026/0012-1924/a000112; Mottus R, 2020, EUR J PERSONALITY, V34, P1175, DOI 10.1002/per.2311; Mottus R, 2019, J PERS SOC PSYCHOL, V117, pE35, DOI 10.1037/pspp0000202; Mottus R, 2017, J PERS SOC PSYCHOL, V112, P474, DOI 10.1037/pspp0000100; R Development Core Team, 2009, R LANG ENV STAT COMP; Revelle William, 2020, CRAN; Revelle W, 2019, PSYCHOL ASSESSMENT, V31, P1395, DOI 10.1037/pas0000754; Thielmann I, 2020, J PERS ASSESS, V102, P714, DOI 10.1080/00223891.2019.1614011; Watson D, 2004, J RES PERS, V38, P319, DOI 10.1016/j.jrp.2004.03.001; Wilt J, 2015, EUR J PERSONALITY, V29, P478, DOI 10.1002/per.2002; Wood D, 2017, SOC PSYCHOL PERS SCI, V8, P454, DOI 10.1177/1948550617703168; Zettler I, 2020, PERSPECT PSYCHOL SCI, V15, P723, DOI 10.1177/1745691619895036	37	0	0	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262465	10.1371/journal.pone.0262465	http://dx.doi.org/10.1371/journal.pone.0262465			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025932	Green Submitted, Green Published, gold			2022-12-27	WOS:000796264200072
J	Ramanadhan, S; Ganapathy, K; Nukala, L; Rajagopalan, S; Camillus, JC				Ramanadhan, Shoba; Ganapathy, Krishnan; Nukala, Lovakanth; Rajagopalan, Subramaniya; Camillus, John C.			A model for sustainable, partnership-based telehealth services in rural India: An early process evaluation from Tuver village, Gujarat	PLOS ONE			English	Article							SCHEDULED TRIBES; HEALTH; IMPACT; IMPLEMENTATION; INTERVENTIONS	Background Telehealth can improve access to high-quality healthcare for rural populations in India. However, rural communities often have other needs, such as sanitation or employment, to benefit fully from telehealth offerings, highlighting a need for systems-level solutions. A Business of Humanity approach argues that innovative solutions to wicked problems like these require strategic decision-making that attends to a) humaneness, e.g., equity and safety and b) humankind, or the needs and potential of large and growing markets comprised of marginalized and low-income individuals. The approach is expected to improve economic performance and long-term value creation for partners, thus supporting sustainability. Methods A demonstration project was conducted in Tuver, a rural and tribal village in Gujarat, India. The project included seven components: a partnership that emphasized power-sharing and complementary contributions; telehealth services; health promotion; digital services; power infrastructure; water and sanitation; and agribusiness. Core partners included the academic partner, local village leadership, a local development foundation, a telehealth provider, and a design-build contractor. This early process evaluation relies on administrative data, field notes, and project documentation and was analyzed using a case study approach. Results Findings highlight the importance of taking a systems perspective and engaging inter-sectoral partners through alignment of values and goals. Additionally, the creation of a synergistic, health-promoting ecosystem offers potential to support telehealth services in the long-term. At the same time, engaging rural, tribal communities in the use of technological advances posed a challenge, though local staff and intermediaries were effective in bridging disconnects. Conclusion Overall, this early process evaluation highlights the promise and challenges of using a Business of Humanity approach for coordinated, sustainable community-level action to improve the health and well-being of marginalized communities.	[Ramanadhan, Shoba] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Ganapathy, Krishnan; Nukala, Lovakanth] Apollo Telemed Networking Fdn, Chennai, Tamil Nadu, India; [Rajagopalan, Subramaniya] Safe World Rural Serv, Chennai, Tamil Nadu, India; [Camillus, John C.] Univ Pittsburgh, Joseph M Katz Grad Sch Business, Pittsburgh, PA 15260 USA	Harvard University; Harvard T.H. Chan School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ramanadhan, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA.	sramanadhan@hsph.harvard.edu			Beall Family Foundation	Beall Family Foundation	This project is funded in part by the Beall Family Foundation (Grant awarded to JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarons GA, 2012, IMPLEMENT SCI, V7, DOI [10.1186/1748-5908-7-32, 10.1186/1748-5908-7-56]; Andrews R, 2010, J PUBL ADM RES THEOR, V20, P679, DOI 10.1093/jopart/mup045; [Anonymous], 2019, UPDATED STATEMENT PU; Babiak KM, 2009, EVAL PROGRAM PLANN, V32, P1, DOI 10.1016/j.evalprogplan.2008.09.004; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Baxter P, 2008, QUAL REP, V13, P544; Filck U., 2004, COMPANION QUALITATIV, DOI DOI 10.1007/978-3-322-97512-6; Fink L., 2019, LETT CEOS PROFIT PUR; Ganapathy K, 2015, NEUROL INDIA, V63, P142, DOI 10.4103/0028-3886.156274; Glandon D, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000970; Gopalakrishnan S., 2018, INT J COMMUN MED PUB, V5, P4, DOI [10.18203/2394-6040.ijcmph20175758, DOI 10.18203/2394-6040.IJCMPH20175758]; Gopichandran V, 2019, ASIAN BIOETHICS REV, V11, P69, DOI 10.1007/s41649-019-00083-5; Government of India, 2013, 12 5 YEAR PLAN 2012, V3; Government of IndiaMinistry of Electronics and Information Technology, COMM SERV CTR 2019; Gurney J, 2021, NEW ZEAL MED J, V134, P111; Jennett PA, 2003, J TELEMED TELECARE, V9, P311, DOI 10.1258/135763303771005207; Kruse CS, 2018, J TELEMED TELECARE, V24, P4, DOI 10.1177/1357633X16674087; Labrique AB, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0424-z; Luke DA, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130184; Macabasag R. L. A., 2016, Journal of the International Society for Telemedicine and eHealth, V4, pe24; Maity B, 2017, WORLD DEV, V96, P163, DOI 10.1016/j.worlddev.2017.03.005; McLean S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071238; Ministry of Health and Family Welfare-Government of India, 2012, M PEOPL HLTH NEEDS R; Ministry of Health and Family WelfareGovernment of India, 2019, RUR HLTH STATISTICS2; Mohindra KS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-438; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Narain JP, 2019, INDIAN J MED RES, V149, P313, DOI 10.4103/ijmr.IJMR_2079_18; Nye JS, 2008, ANN AM ACAD POLIT SS, V616, P94, DOI 10.1177/0002716207311699; Office of the Registrar General & Census Commissioner I, 2020, PRIM CENS ABSTR DAT; Ramanadhan S, 2018, CANCER CAUSE CONTROL, V29, P363, DOI 10.1007/s10552-018-1008-1; Snell-Rood C, 2021, TRANSL BEHAV MED, V11, P1617, DOI 10.1093/tbm/ibab008; Solberg KE, 2008, LANCET, V371, P17, DOI 10.1016/S0140-6736(08)60052-5; Stake R. E., 1995, ART CASE STUDY RES; Tanwar R., 2016, INT J ADV INTEGRATED, V1, P116; Trickett EJ, 2009, AM J COMMUN PSYCHOL, V43, P257, DOI 10.1007/s10464-009-9227-y; van Tulder R, 2016, J BUS ETHICS, V135, P1, DOI 10.1007/s10551-015-2756-4; World Health Organization, 2010, TEL OPP DEV MEMB STA, P8; Yunus M, 2009, GLOBAL URBAN DEV MAG, V4, P16	38	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261907	10.1371/journal.pone.0261907	http://dx.doi.org/10.1371/journal.pone.0261907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025902	Green Published, gold			2022-12-27	WOS:000796264200034
J	van Rongen, S; Handgraaf, M; Benoist, M; de Vet, E				van Rongen, Sofie; Handgraaf, Michel; Benoist, Maaike; de Vet, Emely			The effect of personal relative deprivation on food choice: An experimental approach	PLOS ONE			English	Article							SUBJECTIVE SOCIOECONOMIC-STATUS; SOCIAL-CLASS; REWARD SENSITIVITY; INCOME INEQUALITY; ENERGY-INTAKE; HEALTH; RISK; EXPERIENCE; INCREASES; CRAVINGS	Growing evidence suggests that relative disadvantage is more relevant than absolute socioeconomic factors in explaining disparities in healthfulness of diet. In a series of pre-registered experiments, we tested whether personal relative deprivation (PRD), i.e. the sense that one is unfairly deprived of a deserved outcome relative to others, results in choosing more palatable, rewarding foods. Study 1 (N = 102) demonstrated the feasibility and effectiveness of a game for inducing real-time experiences of PRD. Study 2 (N = 287) showed no main effect of PRD condition on hypothetical food choices, but an interaction between chronic PRD and condition revealed that those in the PRD condition chose more rewarding foods when feeling chronically deprived. In Study 3 (N = 260) the hypothesized main effect was found on real, non-hypothetical food choices: those in the PRD condition chose more rewarding foods, controlling for sensitivity to palatable food. Our results provide preliminary indications that the experience of being relatively deprived, rather than the objective amount or resources, may result in a higher preference for high-caloric and palatable foods. It may be suggested that efforts to reduce societal disparities in healthfulness of diet may need to focus on perceptions of injustice beyond objective inequalities.	[van Rongen, Sofie; de Vet, Emely] Wageningen Univ & Res, Consumpt & Hlth Lifestyles Grp, Wageningen, Gelderland, Netherlands; [Handgraaf, Michel] Wageningen Univ & Res, Urban Econ Grp, Wageningen, Gelderland, Netherlands; [Benoist, Maaike] Wageningen Univ & Res, Human Nutr & Hlth Grp, Wageningen, Gelderland, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	van Rongen, S (corresponding author), Wageningen Univ & Res, Consumpt & Hlth Lifestyles Grp, Wageningen, Gelderland, Netherlands.	sofie.vanrongen13@gmail.com		van Rongen, Sofie/0000-0003-3207-439X	talent scheme of the Netherlands Organization for Scientific Research (NWO) [452-14-014]	talent scheme of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	YES. The research was financially supported by a personal grant from the talent scheme of the Netherlands Organization for Scientific Research (NWO) awarded to prof. dr. EWML de Vet, grant number 452-14-014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014; [Anonymous], 2005, QUALTRICS QUALTRICS; Appelhans BM, 2012, AM J PREV MED, V42, P398, DOI 10.1016/j.amepre.2011.12.007; Appelhans BM, 2011, OBESITY, V19, P2175, DOI 10.1038/oby.2011.57; Bengers P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01932; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Beshai S, 2017, SOC SCI MED, V173, P18, DOI 10.1016/j.socscimed.2016.11.021; Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41; Blechert J, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00307; Blechert J, 2016, APPETITE, V99, P254, DOI 10.1016/j.appet.2016.01.006; Boswell RG, 2016, OBES REV, V17, P159, DOI 10.1111/obr.12354; Bratanova B, 2016, APPETITE, V100, P162, DOI 10.1016/j.appet.2016.01.028; Briers B, 2006, PSYCHOL SCI, V17, P939, DOI 10.1111/j.1467-9280.2006.01808.x; Briers B, 2013, J MARKETING RES, V50, P767, DOI 10.1509/jmr.10.0513; Caldwell AE, 2019, APPETITE, V132, P238, DOI 10.1016/j.appet.2018.07.028; Callan MJ, 2008, PERS SOC PSYCHOL B, V34, P1514, DOI 10.1177/0146167208322956; Callan MJ, 2006, PERS SOC PSYCHOL B, V32, P1646, DOI 10.1177/0146167206292236; Callan MJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01415; Callan MJ, 2011, J PERS SOC PSYCHOL, V101, P955, DOI 10.1037/a0024778; Cardel MI, 2016, PHYSIOL BEHAV, V162, P93, DOI 10.1016/j.physbeh.2016.04.024; Cheon BK, 2018, FOOD QUAL PREFER, V68, P258, DOI 10.1016/j.foodqual.2018.03.010; Cheon BK, 2017, P NATL ACAD SCI USA, V114, P72, DOI 10.1073/pnas.1607330114; Claassen MA, 2019, SOCIAL PSYCHOLOGY OF INEQUALITY, P155, DOI 10.1007/978-3-030-28856-3_10; Clary C, 2017, HEALTH PLACE, V44, P1, DOI 10.1016/j.healthplace.2016.12.005; Daly M, 2015, HEALTH PSYCHOL, V34, P222, DOI 10.1037/hea0000098; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Davillas A, 2016, SOC SCI MED, V166, P223, DOI 10.1016/j.socscimed.2016.08.032; Davis Caroline, 2006, Eat Behav, V7, P266, DOI 10.1016/j.eatbeh.2005.09.006; Davis C, 2007, ASTRON GEOPHYS, V48, P12, DOI 10.1016/j.appet.2006.05.016; de Graaf C, 2005, APPETITE, V44, P23, DOI 10.1016/j.appet.2004.08.008; Drewnowski A., 2009, FAT DETECTION TASTE, V23, P265; Dubois D, 2015, J PERS SOC PSYCHOL, V108, P436, DOI 10.1037/pspi0000008; Elgar FJ, 2016, SOC SCI MED, V152, P111, DOI 10.1016/j.socscimed.2016.01.039; Epstein LH, 2006, APPETITE, V46, P22, DOI 10.1016/j.appet.2005.04.006; Gardner MP, 2014, J CONSUM PSYCHOL, V24, P320, DOI 10.1016/j.jcps.2014.01.002; Herman C.P., 2004, HDB SELF REGULATION, P492, DOI DOI 10.1016/J.JESP.2006.05.004; Herman CP., 1980, RESTRAINED EATING; Hill SE, 2016, PSYCHOL SCI, V27, P354, DOI 10.1177/0956797615621901; Hilmers A, 2012, AM J PUBLIC HEALTH, V102, P1644, DOI 10.2105/AJPH.2012.300865; Hough G, 2015, FOOD QUAL PREFER, V40, P334, DOI 10.1016/j.foodqual.2014.05.003; Inglis V, 2009, APPETITE, V52, P273, DOI 10.1016/j.appet.2008.10.005; Jansen A, 2016, PHYSIOL BEHAV, V162, P174, DOI 10.1016/j.physbeh.2016.03.018; Kelley AE, 2005, PHYSIOL BEHAV, V86, P11, DOI 10.1016/j.physbeh.2005.06.018; Kim H, 2018, J APPL SOC PSYCHOL, V48, P519, DOI 10.1111/jasp.12531; Kraus MW, 2010, PSYCHOL SCI, V21, P1716, DOI 10.1177/0956797610387613; Kringelbach ML, 2012, PHYSIOL BEHAV, V106, P307, DOI 10.1016/j.physbeh.2012.03.023; Kruger J, 2004, AM J PREV MED, V26, P402, DOI 10.1016/j.ampere.2004.02.001; Kulendran M, 2014, INT J OBESITY, V38, P507, DOI 10.1038/ijo.2013.198; Kulendran M, 2013, LANCET, V382, P55; Laran J, 2013, PSYCHOL SCI, V24, P167, DOI 10.1177/0956797612450033; Lerner M. J., 2002, JUSTICE MOTIVE EVERY, P10; LERNER MJ, 1977, J PERS, V45, P3; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; Lowe MR, 2009, APPETITE, V53, P114, DOI 10.1016/j.appet.2009.05.016; Mellis AM, 2018, APPETITE, V129, P155, DOI 10.1016/j.appet.2018.06.032; Mercer ME, 1997, APPETITE, V29, P325, DOI 10.1006/appe.1997.0100; Mishra S, 2016, PERS INDIV DIFFER, V90, P22, DOI 10.1016/j.paid.2015.10.031; Mishra S, 2015, SOC SCI MED, V147, P144, DOI 10.1016/j.socscimed.2015.10.030; Mustonen S, 2007, APPETITE, V49, P159, DOI 10.1016/j.appet.2007.01.005; Olson James M., 1986, RELATIVE DEPRIVATION; Parra-Frutos I, 2014, BRIT J MATH STAT PSY, V67, P117, DOI 10.1111/bmsp.12011; Pavela G, 2017, CLIN OBES, V7, P316, DOI 10.1111/cob.12198; Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031; Pickett KE, 2005, J EPIDEMIOL COMMUN H, V59, P670, DOI 10.1136/jech.2004.028795; Piff PK, 2012, P NATL ACAD SCI USA, V109, P4086, DOI 10.1073/pnas.1118373109; Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277; Recio-Roman A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030639; Rollins BY, 2010, APPETITE, V55, P420, DOI 10.1016/j.appet.2010.07.014; Salmon SJ, 2014, HEALTH PSYCHOL, V33, P103, DOI 10.1037/a0031785; Sim AY, 2018, APPETITE, V121, P268, DOI 10.1016/j.appet.2017.11.100; Smith HJ, 2012, PERS SOC PSYCHOL REV, V16, P203, DOI 10.1177/1088868311430825; Su DJ, 2012, J BIOSOC SCI, V44, P417, DOI 10.1017/S002193201100071X; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Vlismas Konstantinos, 2009, Central European Journal of Public Health, V17, P55; Wilkinson RG, 2009, ANNU REV SOCIOL, V35, P493, DOI 10.1146/annurev-soc-070308-115926	77	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261317	10.1371/journal.pone.0261317	http://dx.doi.org/10.1371/journal.pone.0261317			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025897	gold, Green Published			2022-12-27	WOS:000796264200015
J	Boodram, B; Mackesy-Amiti, ME; Khanna, A; Brickman, B; Dahari, H; Ozik, J				Boodram, Basmattee; Mackesy-Amiti, Mary Ellen; Khanna, Aditya; Brickman, Bryan; Dahari, Harel; Ozik, Jonathan			People who inject drugs in metropolitan Chicago: A meta-analysis of data from 1997-2017 to inform interventions and computational modeling toward hepatitis C microelimination	PLOS ONE			English	Article							VIRUS-INFECTION; UNITED-STATES; SOCIAL NETWORKS; YOUNG; USERS; RISK; PREVALENCE; BEHAVIORS; INCREASES	Progress toward hepatitis C virus (HCV) elimination in the United States is not on track to meet targets set by the World Health Organization, as the opioid crisis continues to drive both injection drug use and increasing HCV incidence. A pragmatic approach to achieving this is using a microelimination approach of focusing on high-risk populations such as people who inject drugs (PWID). Computational models are useful in understanding the complex interplay of individual, social, and structural level factors that might alter HCV incidence, prevalence, transmission, and treatment uptake to achieve HCV microelimination. However, these models need to be informed with realistic sociodemographic, risk behavior and network estimates on PWID. We conducted a meta-analysis of research studies spanning 20 years of research and interventions with PWID in metropolitan Chicago to produce parameters for a synthetic population for realistic computational models (e.g., agent-based models). We then fit an exponential random graph model (ERGM) using the network estimates from the meta-analysis in order to develop the network component of the synthetic population.	[Boodram, Basmattee; Mackesy-Amiti, Mary Ellen] Univ Illinois, Sch Publ Hlth, Div Community Hlth Sci, Chicago, IL 60612 USA; [Khanna, Aditya] Brown Univ, Dept Behav & Social Sci, Sch Publ Hlth, Providence, RI 02912 USA; [Brickman, Bryan] Univ Chicago, Dept Med, Chicago Ctr HIV Eliminat, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Dahari, Harel] Loyola Univ Med Ctr, Div Hepatol, Dept Med, Maywood, IL 60153 USA; [Ozik, Jonathan] Argonne Natl Lab, Decis & Infrastruct Sci Div, Lemont, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Brown University; University of Chicago; Loyola University Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Mackesy-Amiti, ME (corresponding author), Univ Illinois, Sch Publ Hlth, Div Community Hlth Sci, Chicago, IL 60612 USA.	mmamiti@uic.edu	Mackesy-Amiti, Mary E/B-7208-2008	Mackesy-Amiti, Mary E/0000-0002-7238-5240; Ozik, Jonathan/0000-0002-3495-6735; Brickman, Bryan/0000-0003-0313-8227; Khanna, Aditya/0000-0003-1049-3374	National Institute of General Medical Sciences, USA [R01GM121600]; National Institute of Drug Abuse, USA [R01DA043484]	National Institute of General Medical Sciences, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Drug Abuse, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This work was supported by grants to HD, JO and BB[1] from the National Institute of General Medical Sciences, USA (https://www.nigms.nih.gov), grant number R01GM121600 and to BB[1] from the National Institute of Drug Abuse, USA (https://www.drugabuse.gov), grant number R01DA043484. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or the National Institutes of Health.	Amoako A, 2021, INT J DRUG POLICY, V96, DOI 10.1016/j.drugpo.2021.103247; Bailey SL, 2007, DRUG ALCOHOL DEPEN, V91, pS18, DOI 10.1016/j.drugalcdep.2007.02.014; Bellerose M, 2021, INT J DRUG POLICY, V88, DOI 10.1016/j.drugpo.2019.10.006; Boodram B, 2015, DRUG ALCOHOL DEPEN, V154, P229, DOI 10.1016/j.drugalcdep.2015.06.042; Boodram B, 2010, DRUG ALCOHOL DEPEN, V111, P136, DOI 10.1016/j.drugalcdep.2010.04.003; Boodram B, 2011, DRUG ALCOHOL DEPEN, V119, P166, DOI 10.1016/j.drugalcdep.2011.06.005; Booth RE, 2007, DRUG ALCOHOL DEPEN, V91, pS1, DOI 10.1016/j.drugalcdep.2007.08.010; Borenstein M, 2009, INTRO METAANALYSIS, DOI [10.1002/9780470743386, DOI 10.1002/9780470743386]; Broz D, 2008, DRUG ALCOHOL DEPEN, V94, P221, DOI 10.1016/j.drugalcdep.2007.11.020; Broz D, 2010, SUBST USE MISUSE, V45, P2000, DOI 10.3109/10826081003682875; Bruggmann P, 2013, HEPATOLOGY, V58, P1523, DOI 10.1002/hep.26539; Center for Disease Control and Prevention, 2012, HIV INF RISK PREV TE; Centers for Disease Control and Prevention, 2018, HIV SURVEILLANCE SPE; Centers for Disease Control and Prevention, 2021, PEOPLE COINFECTED HI; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P133; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; Dahari H, 2018, LANCET INFECT DIS, V18, P134, DOI 10.1016/S1473-3099(17)30678-3; De P, 2007, ADDICTION, V102, P1730, DOI 10.1111/j.1360-0443.2007.01936.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Gamkrelidze I, 2021, LIVER INT, V41, P456, DOI 10.1111/liv.14779; Goodreau Steven M, 2008, J Stat Softw, V24, P1; Gutfraind A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137993; Hagan H, 2010, J INFECT DIS, V201, P378, DOI 10.1086/649783; Handcock M.S., 2019, ERGM FIT SIMULATE DI; Hotton A, 2021, DRUG ALCOHOL DEPEN, V225, DOI 10.1016/j.drugalcdep.2021.108797; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Johnson RA, 2002, ADDICTION, V97, P1011, DOI 10.1046/j.1360-0443.2002.00165.x; Lazarus JV, 2018, SEMIN LIVER DIS, V38, P181, DOI 10.1055/s-0038-1666841; Mackesy-Amiti ME, 2018, DRUG ALCOHOL DEPEN, V187, P227, DOI 10.1016/j.drugalcdep.2018.03.016; Mackesy-Amiti ME, 2012, DRUG ALCOHOL DEPEN, V124, P70, DOI 10.1016/j.drugalcdep.2011.12.012; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; R Core Team, 2020, R LANG ENV STAT COMP; Rothenberg R, 2009, J URBAN HEALTH, V86, pS144, DOI 10.1007/s11524-009-9374-3; Sacks-Davis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047335; Schwarzer G., 2007, R NEWS, V7, P40; Snijders TAB., 2002, J SOCIAL STRUCTURE, V3(2), P1, DOI DOI 10.1016/j.socnet.2006.08.001; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Tatara E, 2019, WINT SIM C 2019 NAT; Tatara E., 2021, BIORXIV; Tempalski B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064789; Thorpe LE, 2000, J INFECT DIS, V182, P1588, DOI 10.1086/317607; Trickey A, 2019, LANCET GASTROENTEROL, V4, P435, DOI 10.1016/S2468-1253(19)30085-8; Veroniki AA, 2016, RES SYNTH METHODS, V7, P55, DOI 10.1002/jrsm.1164; Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261; WHO, 2017, WHO PUBLISHES LIST B; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0248850	10.1371/journal.pone.0248850	http://dx.doi.org/10.1371/journal.pone.0248850			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020725	gold, Green Published			2022-12-27	WOS:000834207700002
J	Hibiya, K; Iwata, H; Kinjo, T; Shinzato, A; Tateyama, M; Ueda, S; Fujita, J				Hibiya, Kenji; Iwata, Hiroyoshi; Kinjo, Takeshi; Shinzato, Akira; Tateyama, Masao; Ueda, Shinichiro; Fujita, Jiro			Incidence of common infectious diseases in Japan during the COVID-19 pandemic	PLOS ONE			English	Article							HEPATITIS-E VIRUS; TRANSMISSION; TUBERCULOSIS; INFLUENZA	Recent reports indicate that respiratory infectious diseases were suppressed during the novel coronavirus disease-2019 (COVID-19) pandemic. COVID-19 led to behavioral changes aimed to control droplet transmission or contact transmission. In this study, we examined the incidence of common infectious diseases in Japan during the COVID-19 pandemic. COVID-19 data were extracted from the national data based on the National Epidemiological Surveillance of Infectious Diseases (NESID). Common infectious diseases were selected from notifiable infectious diseases under the NESID. The epidemic activity of the diseases during 2015-2020 was evaluated based on the Infectious Disease Weekly Reports published by the National Institute of Infectious Diseases. Each disease was then categorized according to the route of transmission. Many Japanese people had adopted hygienic activities, such as wearing masks and hand washing, even before the COVID-19 pandemic. We examined the correlation between the time-series of disease counts of common infectious diseases and COVID-19 over time using cross-correlation analysis. The weekly number of cases of measles, rotavirus, and several infections transmitted by droplet spread, was negatively correlated with the weekly number of cases of COVID-19 for up to 20 weeks in the past. According to the difference-in-differences analysis, the activity of influenza and rubella was significantly lower starting from the second week in 2020 than that in 2015-2019. Only legionellosis was more frequent throughout the year than in 2015-2019. Lower activity was also observed in some contact transmitted, airborne-transmitted, and fecal-oral transmitted diseases. However, carbapenem-resistant Enterobacteriaceae, exanthema subitum, showed the same trend as that over the previous 5 years. In conclusion, our study shows that public health interventions for the COVID-19 pandemic may have effectively prevented the transmission of most droplet-transmitted diseases and those transmitted through other routes.	[Hibiya, Kenji; Kinjo, Takeshi; Shinzato, Akira; Tateyama, Masao; Fujita, Jiro] Univ Ryukyus, Grad Sch Med, Dept Infect Resp & Digest Med, Nishihara Cho, Nishihara, Okinawa, Japan; [Hibiya, Kenji] Univ Ryukyus Hosp, Dept Diagnost Pathol, Nishihara, Okinawa, Japan; [Iwata, Hiroyoshi; Ueda, Shinichiro] Univ Ryukyus, Clin Pharmacol & Therapeut, Sch Med, Nishihara, Okinawa, Japan	University of the Ryukyus; University of the Ryukyus; University of the Ryukyus	Hibiya, K (corresponding author), Univ Ryukyus, Grad Sch Med, Dept Infect Resp & Digest Med, Nishihara Cho, Nishihara, Okinawa, Japan.; Hibiya, K (corresponding author), Univ Ryukyus Hosp, Dept Diagnost Pathol, Nishihara, Okinawa, Japan.	h2139517@med.u-ryukyu.ac.jp						AIDS Trends Committee, US; [Anonymous], 2015, THE JAPAN TIMES; [Anonymous], 2020, BBC NEWS 0227; [Anonymous], 2020, SPEECH STAT PRIM MIN; [Anonymous], 2020, THE JAPAN TIMES; [Anonymous], 2020, IASR, V41, P211; [Anonymous], 2019, IASR, V40, P127; [Anonymous], 2017, IASR, V38, P191; [Anonymous], 2015, IASR, V36, P147; [Anonymous], 2019, ANN SURVEILLANCE; [Anonymous], 2020, DECL STAT EM RESP NO; Apple Maps, COVID 19 MOB TRENDS; Baker M, 2008, J EPIDEMIOL COMMUN H, V62, P715, DOI 10.1136/jech.2007.063610; Bennett JE., 2015, PRINCIPLES PRACTICE, V2; Bumpas B., 2020, COVID 19 IMPACTS FOO; CDC, 2021, NAT NOT DIS SURV SYS; Chia CC, 2021, SEX TRANSM INFECT, V97, P319, DOI 10.1136/sextrans-2020-054802; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Buckley RD, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa134; Dormitzer PR., 2015, PRINCIPLES PRACTICE, V2, P1854; Fear of catching, YOUGOV COVID 19 TRAC; Fujita J, 2021, RESPIR INVESTIG, V59, P5, DOI 10.1016/j.resinv.2020.11.002; Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117; Geme IIIJW, 2019, NELSON TXB PEDIAT, V19st, P914; Goodman Brenda, 2022, SOCIUS, DOI DOI 10.1177/2378023120948715; Harley D, 2001, Commun Dis Intell, V25, P9; Hepatitis E., 2014, IASR, V35, P1; Infectious Disease Surveillance Center, WEEKL REP; International Labour Organization [ILO], 2020, EMPL GUID WORK HOM R; Japan Student Services Organization (JASSO), 2021, RESULT ANN SURVEY IN; Komiya K, 2020, J INFECTION, V81, pE24, DOI 10.1016/j.jinf.2020.07.004; Lai CC, 2020, J INFECTION, V81, pE159, DOI 10.1016/j.jinf.2020.06.014; Latini A, 2021, SEX TRANSM INFECT, V97, P78, DOI 10.1136/sextrans-2020-054543; Li D, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4232-8; Li H, 2020, J CELL MOL MED, V24, P6558, DOI 10.1111/jcmm.15364; Lin CF, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.604089; LocationMind xPop, DECR RAT VIS EACH PR; Maqbool A., 2011, NELSON TXB PEDIAT; Ministry of Health Labour and Welfare, LIST TUB OUTBR CAS; Ministry of Health Labour and Welfare Japan, NOV COR COVID 19; MUDER RR, 1986, ARCH INTERN MED, V146, P1607, DOI 10.1001/archinte.146.8.1607; Muto K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234292; National Institute of Infectious Disease, 2016, INFECT AGENTS SURVEI, V37, P185; National Institute of Infectious Disease, 2021, IASR, V42, P177; National Institute of Infectious Diseases, 2020, INFECT AGENTS SURVEI, V41, P53; National Institute of Infectious Diseases, 2016, IASR, V37, P239; Pennanen-Iire C, 2021, SEX MED REV, V9, P3, DOI 10.1016/j.sxmr.2020.10.004; Petri WA., 2015, PRINCIPLES PRACTICE, V2, P3047; Powell DA., 2019, NELSON TXB PEDIAT, V19st, P1029; Raoult D., 2015, PRINCIPLES PRACTICE, V2, P2225; Rodriguez Islay, 2021, Public Health Pract (Oxf), V2, P100072, DOI 10.1016/j.puhip.2020.100072; Sakamoto H, 2020, JAMA-J AM MED ASSOC, V323, P1969, DOI 10.1001/jama.2020.6173; Sekizuka T., MEDRXIV, DOI [10.1128/mSphere.00786-20, DOI 10.1128/MSPHERE.00786-20]; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Subires A, 2014, INT J FOOD MICROBIOL, V168, P47, DOI 10.1016/j.ijfoodmicro.2013.10.013; Sunagawa S, 2021, RESPIR INVESTIG, V59, P149, DOI 10.1016/j.resinv.2020.10.010; Surucuoglu S, 2018, MIKROBIYOL BUL, V52, P96, DOI 10.5578/mb.66237; Takahashi M, 2014, HEPATOL RES, V44, P43, DOI 10.1111/hepr.12175; Takahashi R., 2020, THE JAPAN TIMES; Tanaka S, 2019, HEPATOL RES, V49, P705, DOI 10.1111/hepr.13314; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; The Ministry of Health Labour and Welfare, MED EXP DAT; Tominaga A, 2012, HEPATOL RES, V42, P828, DOI 10.1111/j.1872-034X.2012.00988.x; True Data, REP PURCH BEH AN NOV; Tsukada R, 2019, JPN J INFECT DIS, V72, P44, DOI 10.7883/yoken.JJID.2018.279; Tuberculosis Surveillance Center, 2020, TUB JAP ANN REP 2020; Ujiie M, 2021, EMERG INFECT DIS, V27, P2969, DOI 10.3201/eid2711.211565; Walsh SR., 2015, PRINCIPLES PRACTICE, V2, P2131; West R, 2020, NAT HUM BEHAV, V4, P451, DOI 10.1038/s41562-020-0887-9; WHO, 2020, MODES TRANSMISSION V; WHO-Worl Health Organization, 2020, CRIT REL COVID 19 PA; William L., 2007, COLOR TXB PEDIAT DER, V4st ed, P113; Yasui S., 2021, 11 ADBI OECD ILO ROU	73	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261332	10.1371/journal.pone.0261332	http://dx.doi.org/10.1371/journal.pone.0261332			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020724	Green Published, gold			2022-12-27	WOS:000834207700015
J	Liu, Y; Wang, LH; Yang, LB; Liu, XM				Liu, Yang; Wang, Li Hu; Yang, Li Bo; Liu, Xue Mei			Drought prediction based on an improved VMD-OS-QR-ELM model	PLOS ONE			English	Article							DECOMPOSITION; OPTIMIZATION; INDEX	To overcome the low accuracy, poor reliability, and delay in the current drought prediction models, we propose a new extreme learning machine (ELM) based on an improved variational mode decomposition (VMD). The model first redefines the output of the hidden layer of the ELM model with orthogonal triangular matrix decomposition (QR) to construct an orthogonal triangular ELM (QR-ELM), and then introduces an online sequence learning mechanism (OS) into the QR-ELM to construct an online sequence QR-ELM (OS-QR-ELM), which effectively improves the efficiency of the ELM model. The mutual information extension method was then used to extend both ends of the original signal to improve the VMD end effect. Finally, VMD and OS-QR-ELM were combined to construct a drought prediction method based on the VMD-OS-QR-ELM. The reliability and accuracy of the VMD-OS-QR-ELM model were improved by 86.19% and 93.20%, respectively, compared with those of the support vector regression model combined with empirical mode decomposition. Furthermore, the calculation efficiency of the OS-QR-ELM model was increased by 88.65% and 85.32% compared with that of the ELM and QR-ELM models, respectively.	[Liu, Yang; Wang, Li Hu; Yang, Li Bo; Liu, Xue Mei] North China Univ Water Resources & Elect Power, Sch Informat Engn, Zhengzhou, Henan, Peoples R China	North China University of Water Resources & Electric Power	Liu, Y (corresponding author), North China Univ Water Resources & Elect Power, Sch Informat Engn, Zhengzhou, Henan, Peoples R China.	ly_research@126.com			National Key Research and Development Project under Grant Strategic Research Projects in Key Area 16; Water Conservancy Science and Technology Research Project in Henan Province Grant [GG202042]	National Key Research and Development Project under Grant Strategic Research Projects in Key Area 16; Water Conservancy Science and Technology Research Project in Henan Province Grant	This work was supported in part by the National Key Research and Development Project under Grant Strategic Research Projects in Key Area 16 and the Water Conservancy Science and Technology Research Project in Henan Province Grant GG202042.	Afzal M, 2020, APPL WATER SCI, V10, DOI 10.1007/s13201-020-01293-1; Aghelpour P, 2021, STOCH ENV RES RISK A, V35, P2459, DOI 10.1007/s00477-021-02011-2; Aghelpour P, 2021, J HYDROL ENG, V26, DOI 10.1061/(ASCE)HE.1943-5584.0002059; Bai YL, 2021, APPL ENERG, V301, DOI 10.1016/j.apenergy.2021.117461; Basakin EE, 2021, MODEL EARTH SYST ENV, V7, P2363, DOI 10.1007/s40808-020-01010-6; Chen HL, 2020, APPL SOFT COMPUT, V86, DOI 10.1016/j.asoc.2019.105884; Cheng YJ, 2020, MULTIMED TOOLS APPL, V79, P30235, DOI 10.1007/s11042-020-09382-8; Dehghan S, 2020, J ARID LAND, V12, P318, DOI 10.1007/s40333-020-0095-5; Jimenez-Donaire MD, 2020, NAT HAZARD EARTH SYS, V20, P21, DOI [10.5194/nhess-20-21-2020,2020, 10.5194/nhess-20-21-2020]; Diao X, 2020, MECH SYST SIGNAL PR, V143, DOI 10.1016/j.ymssp.2020.106787; Feng SW, 2020, VIBROENGINEERING PRO, V35, P76, DOI [10.21595/vp.2020.21778, DOI 10.21595/VP.2020.21778]; Fung KF, 2020, J WATER CLIM CHANGE, V11, P1383, DOI 10.2166/wcc.2019.295; Hu HL, 2021, RENEW ENERG, V164, P729, DOI 10.1016/j.renene.2020.09.109; Kaur A, 2020, ECOL INFORM, V57, DOI 10.1016/j.ecoinf.2020.101067; Kaur A, 2020, J EXP THEOR ARTIF IN, V32, P273, DOI 10.1080/0952813X.2019.1647563; Khan MMH, 2020, J HYDROL, V590, DOI 10.1016/j.jhydrol.2020.125380; Khaymovich IM, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.070601; Li FH, 2019, MECH SYST SIGNAL PR, V116, P462, DOI 10.1016/j.ymssp.2018.06.055; Li GH, 2018, INFORMATION, V9, DOI 10.3390/info9070177; Li J, 2021, WATER RESOUR RES, V57, DOI 10.1029/2020WR029413; Liu C, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18051523; Liu XY, 2020, KNOWL-BASED SYST, V195, DOI 10.1016/j.knosys.2020.105653; Liu YY, 2016, SIGNAL PROCESS, V125, P349, DOI 10.1016/j.sigpro.2016.02.011; Lv L, 2020, KNOWL-BASED SYST, V195, DOI 10.1016/j.knosys.2020.105648; Malik A, 2021, METEOROL ATMOS PHYS, V133, P891, DOI 10.1007/s00703-021-00787-0; Malik A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233280; Mohamadi S, 2020, NAT HAZARDS, V104, P537, DOI 10.1007/s11069-020-04180-9; Mouatadid S, 2018, ATMOS RES, V212, P130, DOI 10.1016/j.atmosres.2018.05.012; Rao WJ, 2020, PHYS REV B, V102, DOI 10.1103/PhysRevB.102.054202; Roushangar K, 2021, HYDROL RES, V52, P1469, DOI 10.2166/nh.2021.028; Shamshirband S, 2020, ENG APPL COMP FLUID, V14, P339, DOI 10.1080/19942060.2020.1715844; Singh TP, 2021, MODEL EARTH SYST ENV, V7, P2005, DOI 10.1007/s40808-020-00947-y; Song XW, 2021, MEAS SCI TECHNOL, V32, DOI 10.1088/1361-6501/abcdc1; Tian ZD, 2020, WIND ENERGY, V23, P177, DOI 10.1002/we.2422; Wu CL, 2013, ENG APPL ARTIF INTEL, V26, P997, DOI 10.1016/j.engappai.2012.05.023; Xie T, 2019, J HYDROL, V577, DOI 10.1016/j.jhydrol.2019.123915; Xu WX, 2021, DIGIT SIGNAL PROCESS, V110, DOI 10.1016/j.dsp.2020.102936; Zhang X, 2018, MECH SYST SIGNAL PR, V108, P58, DOI 10.1016/j.ymssp.2017.11.029; Zhang YG, 2020, RENEW ENERG, V156, P1373, DOI 10.1016/j.renene.2019.12.047; Zhou Y, 2020, ENERGY, V204, DOI 10.1016/j.energy.2020.117894; Zhu Q, 2021, NAT HAZARDS, V105, P2161, DOI 10.1007/s11069-020-04394-x	41	0	0	9	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262329	10.1371/journal.pone.0262329	http://dx.doi.org/10.1371/journal.pone.0262329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990468	Green Published, gold			2022-12-27	WOS:000815783800025
J	Park, SY; Ha, HI; Lee, SM; Lee, IJ; Lim, HK				Park, Sun-Young; Ha, Hong Il; Lee, Sang Min; Lee, In Jae; Lim, Hyun Kyung			Comparison of diagnostic accuracy of 2D and 3D measurements to determine opportunistic screening of osteoporosis using the proximal femur on abdomen-pelvic CT	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ROUTINE ABDOMINAL CT; X-RAY ABSORPTIOMETRY; COMPUTED-TOMOGRAPHY; FRACTURE RISK; FEMORAL-NECK; DXA; HIP; CONTRAST; SEGMENTATION	Objectives To compare the osteoporosis-predicting ability of computed tomography (CT) indexes in abdomen-pelvic CT using the proximal femur and the reliability of measurements in two- and three-dimensional analyses. Methods Four hundred thirty female patients (age range, 50-96 years) who underwent dual-energy X-ray absorptiometry and abdominal-pelvic CT within 1 month were retrospectively selected. The volumes of interest (VOIs) from the femoral head to the lesser trochanter and the femoral neck were expressed as 3D(Femur). Round regions of interest (ROIs) of image plane drawn over the femoral neck touching the outer cortex were determined as 2D(coronal). In HU histogram analysis (HUHA), the percentages of HU histogram ranges related to the ROI or VOI were classified as HUHA(Fat) (<0 HU) and HUHA(Bone) (126 HU <=). Diagnostic performance, correlation analysis and measurement reliability were analyzed by receiver operating characteristic curves, correlation coefficient and interobserver correlation coefficient (ICC), respectively. Results AUCs of each HUHA and mean-HU measurement on 2D-ROI and 3D-VOI were 0.94 or higher (P < 0.001). Both 3D(Femur)-Mean-HU and 3D(Femur)-HUHA(Bone) showed the highest AUC (0.96). The cut-off value of 3D(Femur)-Mean-HU was 231HU or less, (sensitivity: 94.8%; specificity: 85.0%; correlation coefficient: -0.65; P<0.001) for diagnosis of osteoporosis. There was no superiority between AUCs in 2D-ROI and 3D-VOI measurements (P>0.05). Reliability of the 3D-VOI measurement showed perfect agreement (ICC >= 0.94), and 2D-ROI showed moderate to good agreement (ICC range: 0.63 similar to 0.84). Conclusions CT indexes on 3D-VOI for predicting femoral osteoporosis showed similar diagnostic accuracy with better reproducibility of measurement, compared with 2D-ROI.	[Park, Sun-Young; Ha, Hong Il; Lee, Sang Min; Lee, In Jae] Hallym Univ, Sacred Heart Hosp, Dept Radiol, Anyang Si, Gyeonggi Do, South Korea; [Lim, Hyun Kyung] Soonchunhyang Univ, Seoul Hosp, Dept Radiol, Seoul, South Korea	Hallym University; Soonchunhyang University	Ha, HI (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Radiol, Anyang Si, Gyeonggi Do, South Korea.	ha.hongil@gmail.com	Park, Sun/GSD-9620-2022	Park, Sun-Young/0000-0001-6500-3411				Alacreu E, 2017, OSTEOPOROSIS INT, V28, P983, DOI 10.1007/s00198-016-3804-3; Alberg AJ, 2004, J GEN INTERN MED, V19, P460, DOI 10.1111/j.1525-1497.2004.30091.x; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Amarnath ALD, 2015, J GEN INTERN MED, V30, P1733, DOI 10.1007/s11606-015-3349-8; Barrett-Connor E, 2005, J BONE MINER RES, V20, P185, DOI 10.1359/JBMR.041007; Buckens CF, 2015, EUR RADIOL, V25, P2074, DOI 10.1007/s00330-014-3584-0; Curtis JR, 2008, J BONE MINER RES, V23, P1061, DOI [10.1359/jbmr.080232, 10.1359/JBMR.080232]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dimai HP, 2017, BONE, V104, P39, DOI 10.1016/j.bone.2016.12.016; Fujii M, 2016, RADIOLOGY, V281, P933, DOI 10.1148/radiol.2016151657; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Jacobson JA, 2000, AM J ROENTGENOL, V174, P1699, DOI 10.2214/ajr.174.6.1741699; Jang S, 2019, RADIOLOGY, V291, P359, DOI 10.1148/radiol.2019181648; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; KOHRT WM, 1995, J BONE MINER RES, V10, P1303, DOI 10.1002/jbmr.5650100906; Lee SJ, 2016, OSTEOPOROSIS INT, V27, P1131, DOI 10.1007/s00198-015-3318-4; Lewiecki EM, 2008, BONE, V43, P1115, DOI 10.1016/j.bone.2008.08.106; Lim HK, 2019, EUR RADIOL, V29, P1831, DOI 10.1007/s00330-018-5728-0; Lindner C, 2013, IEEE T MED IMAGING, V32, P1462, DOI 10.1109/TMI.2013.2258030; Liu G, 1997, OSTEOPOROSIS INT, V7, P564, DOI 10.1007/BF02652563; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Mounach A, 2009, SEMIN ARTHRITIS RHEU, V38, P467, DOI 10.1016/j.semarthrit.2008.04.001; Pickhardt PJ, 2016, OSTEOPOROSIS INT, V27, P147, DOI 10.1007/s00198-015-3224-9; Pickhardt PJ, 2013, ANN INTERN MED, V158, P588, DOI 10.7326/0003-4819-158-8-201304160-00003; Pickhardt PJ, 2011, J BONE MINER RES, V26, P2194, DOI 10.1002/jbmr.428; Pompe E, 2015, EUR RADIOL, V25, P283, DOI 10.1007/s00330-014-3408-2; Poole KES, 2017, BONE, V94, P124, DOI 10.1016/j.bone.2016.10.020; Poole KES, 2010, J BONE MINER RES, V25, P482, DOI 10.1359/jbmr.090734; Preda L, 2007, EUR RADIOL, V17, P2096, DOI 10.1007/s00330-006-0573-y; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Sharma N, 2010, J MED PHYS, V35, P3, DOI 10.4103/0971-6203.58777; SINGH M, 1970, J BONE JOINT SURG AM, VA 52, P457, DOI 10.2106/00004623-197052030-00005; Sozen T, 2017, EUR J RHEUMATOL, V4, P46, DOI 10.5152/eurjrheum.2016.048; Thomas CDL, 2009, J BONE MINER RES, V24, P1808, DOI [10.1359/jbmr.090504, 10.1359/JBMR.090504]; Wormanns D, 2004, EUR RADIOL, V14, P86, DOI 10.1007/s00330-003-2132-0; Ziemlewicz TJ, 2016, AM J ROENTGENOL, V206, P694, DOI 10.2214/AJR.15.15128	39	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262025	10.1371/journal.pone.0262025	http://dx.doi.org/10.1371/journal.pone.0262025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982780	gold, Green Published			2022-12-27	WOS:000834805700014
J	Granot, M; Srulovici, E; Granovsky, Y; Yarnitsky, D; Kuperman, P				Granot, Michal; Srulovici, Einav; Granovsky, Yelena; Yarnitsky, David; Kuperman, Pora			Dispositional and situational personal features and acute post-collision head and neck pain: Double mediation of pain catastrophizing and pain sensitivity	PLOS ONE			English	Article							INTENSITY; STATE; MODULATION; DEPRESSION; EXPERIENCE; ANXIETY; TRAIT; MODEL; PERCEPTION; SYMPTOMS	Pain variability can be partially attributed to psycho-cognitive features involved in its processing. However, accumulating research suggests that simple linear correlation between situational and dispositional factors may not be sufficiently explanatory, with some positing a role for mediating influences. In addition, acute pain processing studies generally focus on a post-operative model with less attention provided to post-traumatic injury. As such, this study aimed to investigate a more comprehensive pain processing model that included direct and indirect associations between acute pain intensity in the head and neck, pain catastrophizing (using pain catastrophizing scale (PCS)), and pain sensitivity (using the pain sensitivity questionnaire (PSQ)), among 239 patients with post-motor vehicle collision pain. The effect of personality traits (using Ten Items Personality Inventory (TIPI)) and emotional status (using Hospital Anxiety and Depression Scale (HADS) and Perceived Stress Scale (PSS)) on that model was examined as well. To this end, three Structural Equation Modeling (SEM) analyses were conducted. Overall, the data had good fit to all the models, with only PSQ found to have a direct correlation with acute pain intensity. The SEM analyses conversely revealed several mediations. Specifically, that: first, PSQ fully mediated the relationship between PCS and pain intensity; second, PCS and PSQ together fully mediated the relationship between conscientiousness (personality trait) and pain intensity; and finally, emotional status had direct and indirect links with PSQ and pain intensity. In conclusion, these models suggest that during the acute post-collision phase, pain sensitivity intermediates between emotional states and personality traits, partially via elevated pain catastrophizing thoughts.	[Granot, Michal; Srulovici, Einav] Univ Haifa, Dept Nursing, Haifa, Israel; [Granovsky, Yelena; Yarnitsky, David] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Yarnitsky, David; Kuperman, Pora] Rambam Hlth Care Campus, Dept Neurol, Haifa, Israel	University of Haifa; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus	Granot, M (corresponding author), Univ Haifa, Dept Nursing, Haifa, Israel.	granot@research.haifa.ac.il			US Department of Defense, Health Affairs Office [W81XWH-15-1-0603]	US Department of Defense, Health Affairs Office(United States Department of Defense)	D.Y. received grant W81XWH-15-1-0603 from the US Department of Defense, Health Affairs Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Banozic A, 2018, KOREAN J PAIN, V31, P16, DOI 10.3344/kjp.2018.31.1.16; Bar-Shalita T, 2015, RES DEV DISABIL, V45-46, P157, DOI 10.1016/j.ridd.2015.07.028; Bar-Shalita T., 2019, FRONT INTEGR NEUROSC, P13, DOI [10.3389/fnint.2019.00013, DOI 10.3389/FNINT.2019.00013]; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BARRICK MR, 1991, PERS PSYCHOL, V44, P1, DOI 10.1111/j.1744-6570.1991.tb00688.x; Bowen N.K., 2011, STRUCT EQU MODELING; Campbell CM, 2010, J PAIN, V11, P443, DOI 10.1016/j.jpain.2009.08.009; Carty J, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.5652; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Conrad M, 2018, J REPROD INFANT PSYC, V36, P67, DOI 10.1080/02646838.2017.1397611; Coronado RA, 2018, MUSCULOSKEL SCI PRAC, V36, P61, DOI 10.1016/j.msksp.2018.04.009; Davis KD, 2013, J NEUROIMMUNE PHARM, V8, P518, DOI 10.1007/s11481-012-9386-8; Day MA, 2021, REHABIL PSYCHOL, V66, P39, DOI 10.1037/rep0000318; Dimitrov DM, 2010, MEAS EVAL COUNS DEV, V43, P121, DOI 10.1177/0748175610373459; Dorow M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170303; Drach-Zahavy A, 2019, J ADV NURS, V75, P368, DOI 10.1111/jan.13849; Edgley C, 2019, BRIT J ANAESTH, V123, P350, DOI 10.1016/j.bja.2019.05.030; Fairhurst M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048711; Gacs B, 2017, EUR J PAIN, V21, P1165, DOI 10.1002/ejp.1017; Gilliam WP, 2019, CLIN J PAIN, V35, P583, DOI 10.1097/AJP.0000000000000713; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Granot M, 2005, CLIN J PAIN, V21, P439, DOI 10.1097/01.ajp.0000135236.12705.2d; Grundstrom H, 2019, EUR J PAIN, V23, P1631, DOI 10.1002/ejp.1439; Hampton SN, 2019, BONE JOINT J, V101B, P800, DOI 10.1302/0301-620X.101B7.BJJ-2018-1309.R1; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hermesdorf M, 2016, J PAIN, V17, P606, DOI 10.1016/j.jpain.2016.01.474; Hovik LH, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1073-0; Hoyle R.H., 1995, STRUCTURAL EQUATION; Iezzi T, 2018, PSYCHOL INJ LAW, V11, P202, DOI 10.1007/s12207-018-9331-0; Kapoor S, 2016, PAIN MED, V17, P1069, DOI 10.1093/pm/pnv034; Kritzler S, 2020, J RES PERS, V85, DOI 10.1016/j.jrp.2020.103929; Kuperman P, 2021, INJURY, V52, P1227, DOI 10.1016/j.injury.2021.03.003; Kuperman P, 2020, PAIN REP, V5, DOI 10.1097/PR9.0000000000000821; Kuperman P, 2018, NEUROLOGY, V91, pE931, DOI 10.1212/WNL.0000000000006120; Lape EC, 2020, ARTHRIT CARE RES, V72, P1096, DOI 10.1002/acr.24000; Larsson B, 2017, CLIN J PAIN, V33, P579, DOI 10.1097/AJP.0000000000000441; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Lindberg MF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161681; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Luna IE, 2017, ACTA ANAESTH SCAND, V61, P676, DOI 10.1111/aas.12899; Nahman-Averbuch H, 2016, PAIN PRACT, V16, P38, DOI 10.1111/papr.12256; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ogino Y, 2007, CEREB CORTEX, V17, P1139, DOI 10.1093/cercor/bhl023; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Pinto PR, 2017, J PAIN RES, V10, P1087, DOI 10.2147/JPR.S126467; Pinto PR, 2012, PAIN, V153, P218, DOI 10.1016/j.pain.2011.10.020; Procento PM, 2021, J PAIN, V22, P981, DOI 10.1016/j.jpain.2021.03.138; Qazvini SJ., 2020, INT ELECT J MED, V6, P1; Ramirez-Maestre C, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-012-0312-9; Ruscheweyh R, 2012, PAIN, V153, P1210, DOI 10.1016/j.pain.2012.02.025; Ruscheweyh R, 2009, PAIN, V146, P65, DOI 10.1016/j.pain.2009.06.020; Seifert F, 2011, CURR OPIN ANESTHESIO, V24, P515, DOI 10.1097/ACO.0b013e32834a1079; Soper D.S., 2020, A PRIORI SAMPLE SIZE; Sturgeon JA, 2013, ANN BEHAV MED, V45, P69, DOI 10.1007/s12160-012-9408-z; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sullivan MJL, 2004, CLIN J PAIN, V20, P164, DOI 10.1097/00002508-200405000-00006; Suso-Ribera CS, 2018, PAIN RES MANAG, V2018, DOI 10.1155/2018/7927656; Tempelaar DT, 2007, CONTEMP EDUC PSYCHOL, V32, P105, DOI 10.1016/j.cedpsych.2006.10.004; Wade JB, 2012, CLIN J PAIN, V28, P122, DOI 10.1097/AJP.0b013e318226c3e2; Walumbwa FO, 2009, J APPL PSYCHOL, V94, P1275, DOI 10.1037/a0015848; Westland JC, 2010, ELECTRON COMMER R A, V9, P476, DOI 10.1016/j.elerap.2010.07.003; Wilt J, 2012, J PERS, V80, P1205, DOI 10.1111/j.1467-6494.2011.00756.x; Yarnitsky D, 2014, PAIN, V155, P663, DOI 10.1016/j.pain.2013.11.005; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zuroff DC, 2016, J PERS ASSESS, V98, P14, DOI 10.1080/00223891.2015.1044604	68	1	1	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262076	10.1371/journal.pone.0262076	http://dx.doi.org/10.1371/journal.pone.0262076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007302	Green Published, gold			2022-12-27	WOS:000741060700003
J	Dziwenka, M; Dolan, L; Mitchell, J				Dziwenka, Margitta; Dolan, Laurie; Mitchell, Jason			Toxicological safety of VOHO Hemp Oil; a supercritical fluid extract from the aerial parts of hemp	PLOS ONE			English	Article								VOHO Hemp Oil (Verdant Nature LLC (in collaboration with HempFusion)) is an extract of the aerial parts of hemp (Cannabis sativa L) manufactured using a supercritical CO2 extraction process. The results of four safety studies are reported here including a bacterial reverse mutation assay, an in vivo mammalian micronucleus study, a maximum tolerated dose study in rats and a 90-day repeat dose subchronic toxicity study in rats. VOHO Hemp oil can contain up to 30% phytocannabinoids and less than 0.2% is tetrahydrocannabinol (THC). VOHO Hemp Oil was found to be non-mutagenic in the bacterial reverse mutation assay and was negative for inducing micronuclei in the rat bone marrow micronucleus assay. The maximum tolerated dose in male and female Wistar rats was 2250 mg/kg bw/day. A 90-day repeat dose study was conducted in male and female Wistar rats according to OECD Guideline 408 and included a 21-day recovery period. The doses used in the study were 0, 25, 90 and 324 mg/kg bw per day in the main study, and in the recovery phase a control and 324 mg/kg bw/day group were included. One mortality was reported during the study, a high dose female, and test substance-related adverse clinical signs were reported in the high dose group. Other test substance-related changes noted in the high dose group included changes in body weights, activated partial thromboplastin time (APTT) values, and in absolute and relative organ weights. Based on the results of the study, the no observed adverse effect level (NOAEL) for VOHO Hemp Oil was determined to be 90 mg/kg bw/day in both male and female Wistar rats.	[Dziwenka, Margitta; Dolan, Laurie] GRAS Associates LLC, North Bethesda, MD 20852 USA; [Mitchell, Jason] HempFusion, Denver, CO USA		Dziwenka, M (corresponding author), GRAS Associates LLC, North Bethesda, MD 20852 USA.	dziwenka@gras-associates.com		Dziwenka, Margitta/0000-0003-4392-3473	Verdant Nature LLC; GRAS Associates LLC; Hempfusion	Verdant Nature LLC; GRAS Associates LLC; Hempfusion	Commercial companies: Verdant Nature LLC (funded study; https://verdantoasis.com/) and GRAS Associates LLC (funded 2 authors -MD and LD; http://www.nutrasource.ca/about/nutrasourcecompanies/) and Hempfusion (funded 1 author JM; https://www.hempfusion.com/).All named companies played a role in the decision to publish and Hempfusion and GRAS Associates were involved in the preparation of the manuscript.	[Anonymous], 2018, TEST 408 REP DOS 90; [Anonymous], 2009, ICH GUID M3 R2 NONCL; [Anonymous], 2001, GUIDANCE DOCUMENT AC; Bailey SA, 2004, TOXICOL PATHOL, V32, P448, DOI 10.1080/01926230490465874; Bonini SA, 2018, J ETHNOPHARMACOL, V227, P300, DOI 10.1016/j.jep.2018.09.004; Brenneisen Rudolf, 2007, P17, DOI 10.1007/978-1-59259-947-9_2; Carrier EJ, 2006, P NATL ACAD SCI USA, V103, P7895, DOI 10.1073/pnas.0511232103; Council NR, 2011, GUIDE CARE USE LAB A, VEighth; Dziwenka M, 2020, TOXICOL REP, V7, P376, DOI 10.1016/j.toxrep.2020.02.014; EU, 2008, COUNC REG EC 440 200; FDA, 2007, REDB 2000 GUID IND T; FDA, 2018, AGN RESP LETT GRAS N; Guerriero G, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00463, 10.3389/fpls.2016.00019]; Lewis RW, 2002, TOXICOL PATHOL, V30, P66, DOI 10.1080/01926230252824725; Lopez HL, 2020, J DIET SUPPL, V17, P561, DOI 10.1080/19390211.2020.1765941; Marx TK, 2018, J TOXICOL-US, V2018, DOI 10.1155/2018/8143582; OECD, 2016, TEST 474 MAMM ER MIC; OECD, 2020, TEST 471 BACT REV MU; OECD, 1997, OECD SER PRINC GOOD; Redbook, 2000, GUID TOX STUD; WHO. WHO Expert Committee on Drug Dependence Pre-Review, 2018, EXTR TINCT CANN	21	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261900	10.1371/journal.pone.0261900	http://dx.doi.org/10.1371/journal.pone.0261900			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972167	gold, Green Published			2022-12-27	WOS:000773555700067
J	Meng, WS; Zhao, CY; Gao, YH				Meng, Wenshu; Zhao, Chenyang; Gao, Youhe			Comparison of urine proteome among rat models by intraperitoneal injection with single bacteria and co-injection with two bacteria	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; INFECTIONS; BIOMARKER; LPS	Purpose To explore and compare urine proteome changes among rat models by intraperitoneal injection with single bacteria and co-injection with two bacteria. Method Escherichia coli and Staphylococcus aureus are two common human pathogens. Three rat models were established: (i) the intraperitoneal co-injection of E. coli and S. aureus model (ES model), (ii) intraperitoneal injection of E. coli model (E model), and (iii) intraperitoneal injection of S. aureus model (S model). Urinary proteomes on days 0, 1 and 2 of the three models were analyzed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Results A total of 111, 34 and 94 differential proteins were identified in the ES model, E model and S model, respectively. Among them, some differential proteins were reported to be associated with bacterial infection. Approximately 47% differential proteins in the E model overlapped with ES model, and 37% differential proteins in the S model overlapped with ES model. Compared with the E model and S model, a total of 71 unique differential proteins were identified in the ES model. Conclusion Our results indicated that (1) the urine proteome could distinguish different bacterial intraperitoneal injections models and (2) the effects of co-injection with two bacteria on the urine proteome were not simple superposition of single injection.	[Meng, Wenshu; Zhao, Chenyang; Gao, Youhe] Beijing Normal Univ, Coll Life Sci, Gene Engn Drug & Biotechnol Beijing Key Lab, Beijing, Peoples R China	Beijing Normal University	Gao, YH (corresponding author), Beijing Normal Univ, Coll Life Sci, Gene Engn Drug & Biotechnol Beijing Key Lab, Beijing, Peoples R China.	gaoyouhe@bnu.edu.cn	Gao, Youhe/F-9245-2014	Gao, Youhe/0000-0001-7159-2558	National Key Research and Development Program of China [2018YFC0910202, 2016YFC1306300]; Fundamental Research Funds for the Central Universities [2020KJZX002]; Beijing Natural Science Foundation [7172076]; Beijing cooperative construction project [110651103]; Beijing Normal University [11100704]; Peking Union Medical College Hospital [20162.27]	National Key Research and Development Program of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing cooperative construction project; Beijing Normal University; Peking Union Medical College Hospital	This work was supported by the National Key Research and Development Program of China (2018YFC0910202, 2016YFC1306300); the Fundamental Research Funds for the Central Universities (2020KJZX002); the Beijing Natural Science Foundation (7172076); the Beijing cooperative construction project (110651103); the Beijing Normal University (11100704); and the Peking Union Medical College Hospital (20162.27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocati N, 2013, INT J ENV RES PUB HE, V10, P6235, DOI 10.3390/ijerph10126235; Becker P, 2001, APPL ENVIRON MICROB, V67, P2958, DOI 10.1128/AEM.67.7.2958-2965.2001; Brosseau C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02316; Cui LL, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-021-04713-6; Curtin F, 1998, BIOL PSYCHIAT, V44, P775, DOI 10.1016/S0006-3223(98)00043-2; Gao YH, 2013, SCI CHINA LIFE SCI, V56, P1145, DOI 10.1007/s11427-013-4574-1; Armitage EG, 2015, ELECTROPHORESIS, V36, P3050, DOI 10.1002/elps.201500352; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jia LL, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00338; Jung E, 1998, AM J MED SCI, V315, P307, DOI 10.1097/00000441-199805000-00004; Langford BJ, 2020, CLIN MICROBIOL INFEC, V26, P1622, DOI 10.1016/j.cmi.2020.07.016; Le Roy D, 1999, J IMMUNOL, V162, P7454; Li RL, 2016, CLINICS, V71, P271, DOI 10.6061/clinics/2016(05)05; Loimaranta V, 2018, J LEUKOCYTE BIOL, V104, P777, DOI 10.1002/JLB.3VMR0118-036R; Ni Yanying, 2017, Sheng Wu Gong Cheng Xue Bao, V33, P1145, DOI 10.13345/j.cjb.170019; Prima V, 2011, INT IMMUNOPHARMACOL, V11, P1180, DOI 10.1016/j.intimp.2011.03.016; Pulido D, 2012, ANTIMICROB AGENTS CH, V56, P2378, DOI 10.1128/AAC.06107-11; Roine I, 2014, PEDIATR INFECT DIS J, V33, P675, DOI 10.1097/INF.0000000000000249; Soliman MM, 2015, MOL MED REP, V12, P8306, DOI 10.3892/mmr.2015.4486; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Wang CQ, 2012, CLIN BIOCHEM, V45, P215, DOI 10.1016/j.clinbiochem.2011.11.009; Wang HB, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.694928; Wiegers HMG, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4468-3; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]	24	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261488	10.1371/journal.pone.0261488	http://dx.doi.org/10.1371/journal.pone.0261488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972134	Green Published, gold			2022-12-27	WOS:000773555700038
J	Morgan, IL; Saleh, OA				Morgan, Ian L.; Saleh, Omar A.			Tweezepy: A Python package for calibrating forces in single-molecule video-tracking experiments	PLOS ONE			English	Article							OPTICAL TWEEZERS; MAGNETIC TWEEZERS; ELASTICITY; PRECISION; POSITION; NOISE; TRAP	Single-molecule force spectroscopy (SMFS) instruments (e.g., magnetic and optical tweezers) often use video tracking to measure the three-dimensional position of micron-scale beads under an applied force. The force in these experiments is calibrated by comparing the bead trajectory to a thermal motion-based model with the drag coefficient, gamma, and trap spring constant, kappa, as parameters. Estimating accurate parameters is complicated by systematic biases from spectral distortions, the camera exposure time, parasitic noise, and least-squares fitting methods. However, while robust calibration methods exist that correct for these biases, they are not always used because they can be complex to implement computationally. To address this barrier, we present Tweezepy: a Python package for calibrating forces in SMFS video-tracking experiments. Tweezepy uses maximum likelihood estimation (MLE) to estimate parameters and their uncertainties from a single bead trajectory via the power spectral density (PSD) and Allan variance (AV). It is well-documented, fast, easy to use, and accounts for most common sources of biases in SMFS video-tracking experiments. Here, we provide a comprehensive overview of Tweezepy's calibration scheme, including a review of the theory underlying thermal motion-based parameter estimates, a discussion of the PSD, AV, and MLE, and an explanation of their implementation.	[Morgan, Ian L.; Saleh, Omar A.] Univ Calif Santa Barbara, BMSE Program, Santa Barbara, CA 93106 USA; [Saleh, Omar A.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Morgan, IL; Saleh, OA (corresponding author), Univ Calif Santa Barbara, BMSE Program, Santa Barbara, CA 93106 USA.; Saleh, OA (corresponding author), Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.	ilmorgan@ucsb.edu; saleh@ucsb.edu		Morgan, Ian/0000-0001-6772-6883	National Science Foundation [1715627]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation under Grant No. 1715627. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; ALLAN DW, 1991, PROCEEDINGS OF THE 45TH ANNUAL SYMPOSIUM ON FREQUENCY CONTROL, P667, DOI 10.1109/FREQ.1991.145966; Andersson M, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/4/044020; Baydin AG, 2018, J MACH LEARN RES, V18; Beausang JF, 2007, AM J PHYS, V75, P520, DOI 10.1119/1.2710484; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; Berg-Sorensen K, 2003, J APPL PHYS, V93, P3167, DOI 10.1063/1.1554755; Bevington P. R., 2003, DATA REDUCTION ERROR, DOI 10.2307/2284752; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Bustamante CJ, 2021, NAT REV METHOD PRIME, V1, DOI 10.1038/s43586-021-00021-6; COOLEY JW, 1965, MATH COMPUT, V19, P297, DOI 10.2307/2003354; COX DR, 1968, J ROY STAT SOC B, V30, P248, DOI 10.1111/j.2517-6161.1968.tb00724.x; Czerwinski F, 2009, OPT EXPRESS, V17, P13255, DOI 10.1364/OE.17.013255; Daldrop P, 2015, BIOPHYS J, V108, P2550, DOI 10.1016/j.bpj.2015.04.011; Faxen H, 1922, ANN PHYS-BERLIN, V68, P89; FELGNER H, 1995, APPL OPTICS, V34, P977, DOI 10.1364/AO.34.000977; Florin EL, 1998, APPL PHYS A-MATER, V66, pS75, DOI 10.1007/s003390051103; Florin EL, 1997, J STRUCT BIOL, V119, P202, DOI 10.1006/jsbi.1997.3880; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Gibson GM, 2008, OPT EXPRESS, V16, P14561, DOI 10.1364/OE.16.014561; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Greenhall CA, 2003, PROC PRECISION TIME, P267; Hansen PM, 2006, COMPUT PHYS COMMUN, V175, P572, DOI 10.1016/j.cpc.2006.07.009; Harris CR, 2020, NATURE, V585, P357, DOI 10.1038/s41586-020-2649-2; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Lam S.K., 2015, P 2 WORKSHOP LLVM CO, P1, DOI [10.1145/2833157.2833162, DOI 10.1145/2833157.2833162]; Lansdorp BM, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3687431; Lukic B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.160601; Morgan I., 2021, IANLMORGANTWEEZEPY T; Neidinger RD, 2010, SIAM REV, V52, P545, DOI 10.1137/080743627; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Norrelykke SF, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3455217; Osterman N, 2010, COMPUT PHYS COMMUN, V181, P1911, DOI 10.1016/j.cpc.2010.07.024; Ostrofet E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34360-4; PERKINS TT, 1994, SCIENCE, V264, P822, DOI 10.1126/science.8171336; Ribeck N, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2981687; Riley W. J., 2004, 18th European Frequency and Time Forum (EFTF 2004), P576, DOI 10.1049/cp:20040932; Riley W. J., 2008, HDB FREQUENCY STABIL; Saleh OA, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4921348; Shen H, 2014, NATURE, V515, P151, DOI 10.1038/515151a; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Stoica P, 2005, SPECTRAL ANAL SIGNAL, V452; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Taylor CD, 2012, PROC SPIE, V8498, DOI 10.1117/12.930334; Tolic-Norrelykke IM, 2004, COMPUT PHYS COMMUN, V159, P225, DOI 10.1016/j.cpc.2004.02.012; van der Horst A, 2010, OPT EXPRESS, V18, P7670, DOI 10.1364/OE.18.007670; van Oene MM, 2018, BIOPHYS J, V114, P1970, DOI 10.1016/j.bpj.2018.02.039; Van Rossum G, 1995, PYTHON TUTORIAL, V620; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wong WP, 2006, OPT EXPRESS, V14, P12517, DOI 10.1364/OE.14.012517; Woodside MT, 2006, P NATL ACAD SCI USA, V103, P6190, DOI 10.1073/pnas.0511048103; Yu H, 2012, P NATL ACAD SCI USA, V109, P5283, DOI 10.1073/pnas.1107736109; Yu ZB, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4904148; Zhuang XW, 2003, CURR OPIN STRUC BIOL, V13, P88, DOI 10.1016/S0959-440X(03)00011-3	61	1	1	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262028	10.1371/journal.pone.0262028	http://dx.doi.org/10.1371/journal.pone.0262028			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972160	Green Published, gold			2022-12-27	WOS:000773555700084
J	Brochot, E; Souplet, V; Follet, P; Ponthieu, P; Olivier, C; Even, G; Audebert, C; Malbec, R				Brochot, Etienne; Souplet, Vianney; Follet, Pauline; Ponthieu, Pauline; Olivier, Christophe; Even, Gael; Audebert, Christophe; Malbec, Remi			A multiplex serological assay for the characterization of IgG immune response to SARS-CoV-2	PLOS ONE			English	Article							CORONAVIRUS; KINETICS; TARGETS	In the fight against SARS-COV-2, the development of serological assays based on different antigenic domains represent a versatile tool to get a comprehensive picture of the immune response or differentiate infection from vaccination beyond simple diagnosis. Here we use a combination of the Nucleoprotein (NP), the Spike 1 (S1) and Spike 2 (S2) subunits, and the receptor binding domain (RBD) and N-terminal domain (NTD) of the Spike antigens from the CoViDiag((R)) multiplex IgG assay, to follow the immune response to SARS-CoV-2 infection over a long time period and depending on disease severity. Using a panel of 209 sera collected from 61 patients up to eight months after infection, we observed that most patients develop an immune response against multiple viral epitope, but anti-S2 antibodies seemed to last longer. For all the tested IgGs, we have found higher responses for hospitalized patients than for non-hospitalized ones. Moreover the combination of the five different IgG responses increased the correlation to the neutralizing antibody titers than if considered individually. Multiplex immunoassays have the potential to improve diagnostic performances, especially for ancient infection or mild form of the disease presenting weaker antibody responses. Also the combined detection of anti-NP and anti-Spike-derived domains can be useful to differentiate vaccination from viral infection and accurately assess the antibody potential to neutralize the virus.	[Brochot, Etienne] Amiens Univ, Dept Virol, Med Ctr, Amiens, France; [Brochot, Etienne] Jules Verne Univ Picardie, Agents Infect Resistance & Chimiothe, Amiens, France; [Souplet, Vianney; Follet, Pauline; Ponthieu, Pauline; Olivier, Christophe] Innobiochips, Loos, France; [Even, Gael; Audebert, Christophe; Malbec, Remi] GD Biotech, Douai, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Brochot, E (corresponding author), Amiens Univ, Dept Virol, Med Ctr, Amiens, France.; Brochot, E (corresponding author), Jules Verne Univ Picardie, Agents Infect Resistance & Chimiothe, Amiens, France.; Souplet, V (corresponding author), Innobiochips, Loos, France.	Brochot.Etienne@chu-amiens.fr; vianney.souplet@innobiochips.fr	BROCHOT, ETIENNE/I-5318-2012	BROCHOT, ETIENNE/0000-0002-8677-6349; AUDEBERT, Christophe/0000-0002-6509-7574	GD Biotech; Innobiochips	GD Biotech; Innobiochips	EB is employee of the Amiens University Hospital. RM, GE and CA are employees of GD Biotech, while PP, PF, VS and CO are employees of Innobiochips. GD Biotech and Innobiochips provided support in the form of salaries for authors RM, GE, CA, PP, PF, VS and CO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. Innobiochips also provided the CoViDiag (R) assay kits for this study in the form research material.	Aubry A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10091815; Brochot E, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.584251; Brochot E, 2020, J CLIN VIROL, V130, DOI 10.1016/j.jcv.2020.104569; Chaudhury S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252628; Coste AT, 2021, J CLIN VIROL, V134, DOI 10.1016/j.jcv.2020.104690; de Assis RR, 2021, NAT COMMUN, V12, DOI [10.1038/s41467-020-20095-2, 10.1101/2020.04.15.043364]; Gillot C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113752; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Grossberg AN, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21040-7; Komarov A, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11010102; Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685; Lynch Kara L, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa979; Malbec R, 2020, J IMMUNOL METHODS, V483, DOI 10.1016/j.jim.2020.112808; Marien J, 2021, J VIROL METHODS, V288, DOI 10.1016/j.jviromet.2020.114025; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Sun B., 2020, NAT MED, V9, P940, DOI [https://doi.org/10.1080/22221751.2020.1762515, DOI 10.1080/22221751.2020.1762515, 10.1080/22221751.2020.1762515]; Tuaillon E, 2020, J INFECTION, V81, pE39, DOI 10.1016/j.jinf.2020.05.077; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	18	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262311	10.1371/journal.pone.0262311	http://dx.doi.org/10.1371/journal.pone.0262311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025936	Green Published, gold, Green Submitted			2022-12-27	WOS:000796264200058
J	de Oliveira, RAD; Silva, DRX; Silva, MGE				Dantas de Oliveira, Ricardo Antunes; Xavier Silva, Diego Ricardo; Goncalves e Silva, Mauricio			Geographical accessibility to the supply of antiophidic sera in Brazil: Timely access possibilities	PLOS ONE			English	Article							SUB-SAHARAN AFRICA	Snakebite accidents are considered category A neglected tropical diseases. Brazil stands out for snakebite accidents, mainly in the Amazon region. The best possible care after snakebite accidents is to obtain antiophidic sera on time. And the maximum ideal time to reach it is about 2 hours after an accident. Based on public health information and using a tool to analyze geographical accessibility, we evaluate the possibility of reaching Brazilian serum-providing health facilities from the relationship between population distribution and commuting time. In this exploratory descriptive study, the geographic accessibility of Brazilian population to health facilities that supply antiophidic serum is evaluated through a methodology that articulates several issues that influence the commuting time to health units (ACCESSMOD): population and facilities' distribution, transportation network and means, relief and land use, which were obtained in Brazilian and international sources. The relative importance of the population without the possibility of reaching a facility in two hours is highlighted for Macro-Regions, States and municipalities. About nine million people live in locations more than two hours away from serum-providing facilities, with relevant variations between regions, states, and municipalities. States like Mato Grosso, Para and MaranhAo had the most important participation of population with reaching time problems to those units. The most significant gaps are found in areas with a dispersed population and sometimes characterized by a high incidence of snakebites, such as in the North of the country, especially in the Northeastern Para state. Even using a 2010 population distribution information, because of the 2020 Census postponement, the tendencies and characteristics analyzed reveal challenging situations over the country. The growing availability of serum-providing health facilities, the enhanced possibilities of transporting accident victims, and even the availability of sera in other types of establishments are actions that would allow expanding the possibilities of access to serum supply.	[Dantas de Oliveira, Ricardo Antunes; Xavier Silva, Diego Ricardo] Oswaldo Cruz Fdn Fiocruz, Hlth Informat Lab, Inst Commun & Sci & Technol Informat Hlth Icict, Rio De Janeiro, RJ, Brazil; [Goncalves e Silva, Mauricio] Brazilian Inst Geog & Stat IBGE, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz	de Oliveira, RAD (corresponding author), Oswaldo Cruz Fdn Fiocruz, Hlth Informat Lab, Inst Commun & Sci & Technol Informat Hlth Icict, Rio De Janeiro, RJ, Brazil.	ricardo.dantas@icict.fiocruz.br	Dantas de Oliveira, Ricardo Antunes/C-2908-2019	Dantas de Oliveira, Ricardo Antunes/0000-0003-0144-7288	Inova Fiocruz Program [VPPCB-008-FIO-18-2-48]	Inova Fiocruz Program	RAD Oliveira have funding from Inova Fiocruz Program (https://portal.fiocruz.br/programa-inova-fiocruz), (Grant number: Inova Program VPPCB-008-FIO-18-2-48), a research support obtained in a selection occurred in 2018. The funds allowed the payment of scholarships to organize the datasets and the spatial information treatment, beyond the participation in congresses and seminars. The funding body had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GOOGL MAPS; Bochner R., 2014, Journal of Clinical Toxicology, V4, P194; Bochner Rosany, 2002, Cad. Saúde Pública, V18, P735, DOI [10.1590/S0102-311X2002000300022, 10.1590/S0102-311X2002000300017]; Bochner Rosany, 2003, Cad. Saúde Pública, V19, P07, DOI 10.1590/S0102-311X2003000100002; Brazil. Ministry of Health, CNESNATIONAL REG HLT; Brazil. Ministry of Health (MS), SINANN DIS INF SYST; Brazilian Institute of Geography and Statistics, 2020, POPULATION ESTIMATES; Brazilian Institute of Geography and Statistics (IBGE), 2016, 2010 DEM CENS STAT G; Brazilian Institute of Geography and Statistics (IBGE). Brazilian Digital National Atlas, 2018, THEM NOT 2018 GEOGR; Camara OF., 2020, J HUMAN GROWTH DEV, V30, P120, DOI [10.7322/jhgd.v30.9958, DOI 10.7322/JHGD.V30.9958]; Chippaux JP, 2011, TOXICON, V57, P586, DOI 10.1016/j.toxicon.2010.12.022; Citeli NQK., 2018, SINITOX NATL TOXIC P; de Oliveira RAD, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311x00120718, 10.1590/0102-311X00120718]; Dijkstra EW., 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Fiszon Judith Tiomny, 2008, Rev. bras. epidemiol., V11, P114; Google, GOOGL STREET VIEW; Hansson E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002009; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Joint Comission on Accreditation of Healthcare Organizations-JCAHO, 1993, MEAS MAND ROAD PERF; Lira-da-Silva RM., 2009, GAZETA MED BAHIA, V79, P21; Longbottom J, 2018, LANCET, V392, P673, DOI 10.1016/S0140-6736(18)31224-8; McIntyre D, 2009, HEALTH ECON POLICY L, V4, P179, DOI 10.1017/S1744133109004836; Oliveira Evangelina X. G. de, 2004, Cad. Saúde Pública, V20, P386, DOI 10.1590/S0102-311X2004000200006; OPEN STREET MAP (OSM), OPEN STREET MAP; Oswaldo Cruz Foundation (FIOCRUZ). Institute of Communication and Scientific and Technological Information in Health, 2019, SINITOXNATIONAL TOXI; Ouma PO, 2018, LANCET GLOB HEALTH, V6, pE342, DOI 10.1016/S2214-109X(17)30488-6; Ray N, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-63; Ribeiro LA, 1995, REV SAUDE PUBL, V29, P380, DOI 10.1590/S0034-89101995000500007; SRTMGL3-verso 3, 2019, EARTH DATAOPEN ACC O; Travassos Claudia, 2004, Cad. Saúde Pública, V20, pS190; Vaz Vitor Hugo da Silva, 2020, Cad. saúde colet., V28, P409, DOI 10.1590/1414-462x202028030018; Vieira DS., 2019, REV PROUNIVERSUS, V10, P8, DOI [10.21727/rpu.v10i2.1896, DOI 10.21727/RPU.V10I2.1896]; World Health Organization, 2017, 10 M WHO STRAT TECHN; World Health Organization (WHO), ACC 5	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0260326	10.1371/journal.pone.0260326	http://dx.doi.org/10.1371/journal.pone.0260326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025873	Green Published, gold			2022-12-27	WOS:000796264200006
J	Tobin, R; Crawford, G; Hallett, J; Maycock, BR; Lobo, R				Tobin, Rochelle; Crawford, Gemma; Hallett, Jonathan; Maycock, Bruce Richard; Lobo, Roanna			Critical factors that affect the functioning of a research and evaluation capacity building partnership: A causal loop diagram	PLOS ONE			English	Article							SYSTEMS THINKING; DYNAMIC CAPABILITIES; HEALTH; MODEL; ORGANIZATIONS; INTERVENTIONS; REFLECTIONS; PREVENTION; KNOWLEDGE; TOOLS	Introduction Public health policy and practice is strengthened by the application of quality evidence to decision making. However, there is limited understanding of how initiatives that support the generation and use of evidence in public health are operationalised. This study examines factors that support the internal functioning of a partnership, the Western Australian Sexual Health and Blood-borne Virus Applied Research and Evaluation Network (SiREN). SiREN aims to build research and evaluation capacity and increase evidence-informed decision making in a public health context. Methods This study was informed by systems concepts. It developed a causal loop diagram, a type of qualitative system model that illustrated the factors that influence the internal operation of SiREN. The causal loop diagram was developed through an iterative and participatory process with SiREN staff and management (n = 9) via in-depth semi-structured interviews (n = 4), workshops (n = 2), and meetings (n = 6). Results Findings identified critical factors that affected the functioning of SiREN. Central to SiREN's ability to meet its aims was its capacity to adapt within a dynamic system. Adaptation was facilitated by the flow of knowledge between SiREN and system stakeholders and the expertise of the team. SiREN demonstrated credibility and capability, supporting development of new, and strengthening existing, partnerships. This improved SiREN's ability to be awarded new funding and enhanced its sustainability and growth. SiREN actively balanced divergent stakeholder interests to increase sustainability. Conclusion The collaborative development of the diagram facilitated a shared understanding of SiREN. Adaptability was central to SiREN achieving its aims. Monitoring the ability of public health programs to adapt to the needs of the systems in which they work is important to evaluate effectiveness. The detailed analysis of the structure of SiREN and how this affects its operation provide practical insights for those interested in establishing a similar project.	[Tobin, Rochelle; Crawford, Gemma; Hallett, Jonathan; Lobo, Roanna] Curtin Univ, Sch Populat Hlth, Collaborat Evidence Res & Impact Publ Hlth, Perth, WA, Australia; [Maycock, Bruce Richard] Univ Exeter, Coll Med & Hlth, European Ctr Environm & Human Hlth, Exeter, Devon, England	Curtin University; University of Exeter	Tobin, R (corresponding author), Curtin Univ, Sch Populat Hlth, Collaborat Evidence Res & Impact Publ Hlth, Perth, WA, Australia.	Rochelle.tobin@curtin.edu.au	Lobo, Roanna C/E-4287-2013	Lobo, Roanna C/0000-0002-8335-3017; Tobin, Rochelle/0000-0003-4502-2548	Australian Government; Curtin University; Sexual Health and Blood-borne Virus Applied Research and Evaluation Network; Sexual Health and Blood-Borne Virus Program, Government of Western Australia Department of Health	Australian Government(Australian GovernmentCGIAR); Curtin University; Sexual Health and Blood-borne Virus Applied Research and Evaluation Network; Sexual Health and Blood-Borne Virus Program, Government of Western Australia Department of Health	This study was undertaken as part of RT doctoral studies. To undertake their doctoral studies RT was supported by (1) an Australian Government Research Training Program Scholarship research.curtin.edu.au, (2) a completion scholarship from the Graduate Research School at Curtin University https://www.curtin.edu.au, and (3) A scholarship from the Sexual Health and Blood-borne Virus Applied Research and Evaluation Network https://www.siren.org.au which is supported by the Sexual Health and Blood-Borne Virus Program, Government of Western Australia Department of Health https://ww2.health.wa.gov.au/Articles/S_T/Sexual-health-and-blood-borneviruses-workforcedevelopment.There are no grant numbers associated with this funding.	Asselin Marilyn E, 2003, J Nurses Staff Dev, V19, P99, DOI 10.1097/00124645-200303000-00008; BeLue R, 2012, HEALTH EDUC BEHAV, V39, P745, DOI 10.1177/1090198111430708; Bengtsson M., 2016, NURSINGPLUS OPEN, V2, P8, DOI [https://doi.org/10.1016/j.npls.2016.01.001, DOI 10.1016/J.NPLS.2016.01.001, 10.1016/j.npls.2016.01.001]; Bishai D, 2014, HEALTH RES POLICY SY, V12, DOI [10.1186/1478-4505-12-28, 10.1186/1478-4505-12-51]; Bonner Ann, 2002, Nurse Res, V9, P7; Bourgeois I, 2018, PUBLIC HEALTH, V159, P89, DOI 10.1016/j.puhe.2018.01.031; Brennan LK, 2015, J PUBLIC HEALTH MAN, V21, pS55, DOI 10.1097/PHH.0000000000000248; Brown G, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00231; Brownson RC, 2018, ANNU REV PUBL HEALTH, V39, P27, DOI 10.1146/annurev-publhealth-040617-014746; Bures V, 2017, SYSTEMS, V5, DOI 10.3390/systems5030046; Cabrera D, 2008, EVAL PROGRAM PLANN, V31, P299, DOI 10.1016/j.evalprogplan.2007.12.001; Caretta MA, 2015, SOCIOL RES ONLINE, V20, DOI 10.5153/sro.3812; Chen HT, 2016, EVAL PROGRAM PLANN, V59, P109, DOI 10.1016/j.evalprogplan.2016.05.012; Clarke B, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245535; Cooke Jo, 2005, BMC Fam Pract, V6, P44, DOI 10.1186/1471-2296-6-44; Cooke J, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0363-4; Corbin JH, 2018, HEALTH PROMOT INT, V33, P4, DOI 10.1093/heapro/daw061; DeCorby-Watson K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5591-6; Fredericks KA, 2008, AM J EVAL, V29, P251, DOI 10.1177/1098214008319446; Gagliardi AR, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0399-1; Gates EF, 2016, EVAL PROGRAM PLANN, V59, P62, DOI 10.1016/j.evalprogplan.2016.08.004; Gerritsen S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103457; Green LW, 2014, HEALTH PROMOT J AUST, V25, P25, DOI 10.1071/HE13101; Haraldsson H. V., 2000, INTRO SYSTEMS CAUSAL; Hargreaves MB., 2010, EVALUATING SYSTEM CH; Hawe P, 2009, AM J COMMUN PSYCHOL, V43, P267, DOI 10.1007/s10464-009-9229-9; Hayfield N, 2015, QUAL RES PSYCHOL, V12, P91, DOI 10.1080/14780887.2014.918224; Haynes A, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-019-0496-0; Hovland CI, 1951, PUBLIC OPIN QUART, V15, P635, DOI 10.1086/266350; Hummelbrunner R, 2011, EVALUATION-US, V17, P395, DOI 10.1177/1356389011421935; Jalali MS, 2019, SOC SCI MED, V224, P67, DOI 10.1016/j.socscimed.2018.12.021; Jull J, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0696-3; Kim H, 2012, SYST DYNAM REV, V28, P311, DOI 10.1002/sdr.1480; Kislov R, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0166-0; Labin SN, 2012, AM J EVAL, V33, P307, DOI 10.1177/1098214011434608; LaMarre A, 2020, CAN J PROGRAM EVAL, V35, P1, DOI 10.3138/cjpe.61270; LaSala M.C., 2003, J GAY LESBIAN SOC SE, V15, P15, DOI [10.1300/J041v15n01_02, DOI 10.1300/J041V15N01_02, https://doi.org/10.1300/J041v15n01_02]; Lasker RD, 2001, MILBANK Q, V79, P179, DOI 10.1111/1468-0009.00203; Lich KH, 2016, TRANSL BEHAV MED, V6, P17, DOI 10.1007/s13142-016-0390-z; Ling L, 2020, QUAL RES J, V20, P361, DOI 10.1108/QRJ-06-2020-0055; Lobo R, 2018, HEALTH PROMOT INT, V33, P468, DOI 10.1093/heapro/daw088; McGill E, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2021.113697; McGill E, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003368; Microsoft Corporation Microsoft Teams, 2020, MICR TEAMS; Murphy D, 2018, J HIGH EDUC POLICY M, V40, P321, DOI 10.1080/1360080X.2018.1482102; Murunga VI, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-019-0524-0; Nguyen T, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-0539-6; Norton S, 2016, EVAL PROGRAM PLANN, V58, P1, DOI 10.1016/j.evalprogplan.2016.04.004; Oliver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-2; Owen B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195141; Paina L, 2012, HEALTH POLICY PLANN, V27, P365, DOI 10.1093/heapol/czr054; Perry C, 2004, QUAL HEALTH RES, V14, P135, DOI 10.1177/1049732303255853; Phillippi J, 2018, QUAL HEALTH RES, V28, P381, DOI 10.1177/1049732317697102; Preskill H, 2008, AM J EVAL, V29, P443, DOI 10.1177/1098214008324182; QSR I, 2018, NVIVO 12; Renger R., 2019, EVALUATION J AUSTRAL, V19, P79, DOI [10.1177/1035719X19853660, DOI 10.1177/1035719X19853660]; RICHARDSON GP, 1995, SYST DYNAM REV, V11, P113, DOI 10.1002/sdr.4260110203; Rushmer R., 2019, KNOWLEDGE TRANSLATIO, P127; Rwashana AS, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-36; Rycroft-Malone J, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0380-z; Schulze JH, 2020, ADM SCI, V10, DOI 10.3390/admsci10030037; Teece DJ, 2014, J INT BUS STUD, V45, P8, DOI 10.1057/jibs.2013.54; Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z; Tobin R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026706; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wilkinson J, 2018, J EVAL CLIN PRACT, V24, P607, DOI 10.1111/jep.12842; Willis C, 2017, EVID POLICY, V13, P317, DOI 10.1332/174426416X14609194878495; Wye L, 2020, EVID POLICY, V16, P429, DOI 10.1332/174426419X15468577044957; Yourkavitch J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201870	70	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262125	10.1371/journal.pone.0262125	http://dx.doi.org/10.1371/journal.pone.0262125			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025924	Green Published, gold			2022-12-27	WOS:000796264200048
J	Ullah, S; Zhang, JZ; Xu, BY; Tegomo, AF; Sagada, G; Zheng, L; Wang, L; Shao, QJ				Ullah, Sami; Zhang, Jinzhi; Xu, Bingying; Tegomo, Arnaud Fabrice; Sagada, Gladstone; Zheng, Lu; Wang, Lei; Shao, Qingjun			Effect of dietary supplementation of lauric acid on growth performance, antioxidative capacity, intestinal development and gut microbiota on black sea bream (Acanthopagrus schlegelii)	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; DISEASE RESISTANCE; IMMUNE-RESPONSES; OXIDATIVE STRESS; MYRISTIC ACID; TRIGLYCERIDES; REQUIREMENT; PROTEIN; TRIACYLGLYCEROLS; DIGESTIBILITY	A feeding trial of eight weeks was conducted to examine the influence of food supplementation with lauric acid (LA) on Acanthopagrus schlegelii (juvenile black sea bream). A 24 percent fish meal baseline diet was created, while the other two diets were generated with dietary supplementation of graded points of LA at 0.1 percent and 0.8 percent, respectively. Each diet was given a triplicate tank with 20 fish weighing 6.22 +/- 0.19 g. In comparison with the control group, the weight gain rate, growth rate, as well as feed efficiency of fish fed of 0.1 percent diet of LA were considerably (P < 0.05) greater. The total body and dorsal muscle proximate compositions did not change significantly between groups (P > 0.05). Triglyceride (TG) content was considerably (P < 0.05) greater in the LA-supplemented meals eating group in comparison with the control group. In the group eating LA-supplemented meals, the height of villus and the number of goblet cells/villus were considerably (P < 0.05) larger. The microbial makeup of the gut was also studied. The differences in phyla, class, and family level were not statistically significant (P > 0.05). Firmicutes in the phylum, Betaproteobacteri, Gammaproteobacteria, and Clostridia in the class, and Clostridiaceae in the family were all substantially increased with higher levels of LA supplementation (P < 0.05). According to the findings of this study, an LA-supplemented diet improves fish development, antioxidative capability, gut microbiota and intestinal health.	[Ullah, Sami; Zhang, Jinzhi; Xu, Bingying; Sagada, Gladstone; Zheng, Lu; Wang, Lei; Shao, Qingjun] Zhejiang Univ, Coll Anim Sci, Hangzhou, Peoples R China; [Tegomo, Arnaud Fabrice] Zhejiang Univ, Ocean Coll, Zhoushan, Peoples R China; [Shao, Qingjun] Zhejiang Univ, Ocean Acad, Zhoushan, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Shao, QJ (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou, Peoples R China.; Shao, QJ (corresponding author), Zhejiang Univ, Ocean Acad, Zhoushan, Peoples R China.	qjshao@zju.edu.cn		Shao, Qingjun/0000-0002-4550-5139	Ministry of Science and Technology, China [2020YFD0900801]; Zhejiang Provincial Bureau of Science and Technology [2015C02020]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Zhejiang Provincial Bureau of Science and Technology	This work was funded by the Ministry of Science and Technology, China (Project No.: 2020YFD0900801) and the Zhejiang Provincial Bureau of Science and Technology (Project No.: 2015C02020).	Abd El Megid A, 2020, ECOTOX ENVIRON SAFE, V188, DOI 10.1016/j.ecoenv.2019.109876; Adil S., 2010, VET MED INT, V2010, P1, DOI [10.4061/2010/479485, DOI 10.4061/2010/479485, 10.4061/2010/479485.474, DOI 10.4061/2010/479485.295]; Askarian F, 2011, AQUACULT NUTR, V17, P488, DOI 10.1111/j.1365-2095.2010.00826.x; BACH AC, 1982, AM J CLIN NUTR, V36, P950, DOI 10.1093/ajcn/36.5.950; Berges JA, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1385, DOI 10.1016/B978-0-12-372522-6.00032-3; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Bruce F., 2011, SCI EVIDENCE REGARDI; Piazzon MC, 2017, MICROBIOME, V5, DOI [10.1186/S40168-017-0390-3, 10.1186/s40168-017-0390-3]; CERA KR, 1988, J ANIM SCI, V66, P574; Cerezuela R, 2012, CELL TISSUE RES, V350, P477, DOI 10.1007/s00441-012-1495-4; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chwen LT, 2013, ASIAN AUSTRAL J ANIM, V26, P700, DOI 10.5713/ajas.2012.12561; Dayrit FM, 2015, J AM OIL CHEM SOC, V92, P1, DOI 10.1007/s11746-014-2562-7; Dierick NA, 2003, ARCH ANIM NUTR, V57, P49, DOI 10.1080/0003942031000086626; Dierick NA, 2002, LIVEST PROD SCI, V76, P1, DOI 10.1016/S0301-6226(01)00331-1; Dohme F, 2001, LETT APPL MICROBIOL, V32, P47, DOI 10.1046/j.1472-765x.2001.00863.x; Duarte-Silva E, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.585857; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Estruch G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136389; FAO, 2018, STATE WORLD FISHERIE, DOI DOI 10.1093/JAPR/3.1.101; Gaber M., 2012, SCI REP-UK, V1, P1; Han D, 2011, AQUACULT NUTR, V17, pE741, DOI 10.1111/j.1365-2095.2010.00841.x; Hanczakowska E, 2011, J ANIM FEED SCI, V20, P556, DOI 10.22358/jafs/66213/2011; Hong SM, 2012, ASIAN AUSTRAL J ANIM, V25, P1003, DOI 10.5713/ajas.2011.11402; Humphrey S, 2014, MBIO, V5, DOI 10.1128/mBio.01364-14; Jiang LJ, 2018, DRUG DELIV, V25, P985, DOI 10.1080/10717544.2018.1461954; Kabara J. J., 2000, Indian Coconut Journal, V31, P2; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; Kim SK, 2012, ADV FOOD NUTR RES, V65, P353, DOI 10.1016/B978-0-12-416003-3.00023-8; Kollanoor A, 2007, AQUAC RES, V38, P1293, DOI 10.1111/j.1365-2109.2007.01799.x; Kuang Y, 2015, ANIM FEED SCI TECH, V208, P145, DOI 10.1016/j.anifeedsci.2015.07.010; Li W, 2017, AQUACULT NUTR, V23, P1035, DOI 10.1111/anu.12471; Liu HT, 2017, FISH SHELLFISH IMMUN, V60, P326, DOI 10.1016/j.fsi.2016.12.003; Martinez-Vallespin B, 2016, CYTOTECHNOLOGY, V68, P1925, DOI 10.1007/s10616-016-0003-1; McCarty MF, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000467; Messens W, 2010, VET MICROBIOL, V141, P73, DOI 10.1016/j.vetmic.2009.08.002; Nagasaki H, 2012, FEBS LETT, V586, P368, DOI 10.1016/j.febslet.2012.01.001; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Ng WK., 2011, STANDARDS ACIDIFIERS, P49; Ngandzali BO, 2011, AQUACULT NUTR, V17, P526, DOI 10.1111/j.1365-2095.2010.00835.x; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2255, DOI 10.1210/en.2004-0695; Odle J, 1997, J NUTR, V127, P1061, DOI 10.1093/jn/127.6.1061; Rimoldi S, 2018, PEERJ, V6, DOI 10.7717/peerj.5355; Rocha TM, 2011, REV BRAS ZOOTECN, V40, P2776, DOI 10.1590/S1516-35982011001200023; ROTH JA, 1982, J AM VET MED ASSOC, V180, P894; Sava S, 2005, EFFECT BACTERIAL LOA, P1; Seneviratne KN, 2008, INT J FOOD SCI TECH, V43, P597, DOI 10.1111/j.1365-2621.2006.01493.x; Silberstein Tali, 2013, Isr Med Assoc J, V15, P156; Simo-Mirabet P, 2017, PEERJ, V5, DOI 10.7717/peerj.4001; Sithara K., 2008, Current Biotica, V2, P212; Soliva CR, 2004, BRIT J NUTR, V92, P689, DOI 10.1079/BJN20041250; STUBBS RS, 1985, AM J PHYSIOL, V248, pG347, DOI 10.1152/ajpgi.1985.248.3.G347; Suckow MA, 2012, AM COLL LAB, P1; TAKASE S, 1990, J NUTR, V120, P969, DOI 10.1093/jn/120.9.969; Tang M, 1999, J ANIM SCI, V77, P3191; Tezcan F, 2009, FOOD CHEM, V115, P873, DOI 10.1016/j.foodchem.2008.12.103; Van Wymelbeke V, 1998, AM J CLIN NUTR, V68, P226, DOI 10.1093/ajcn/68.2.226; Volatiana JA, 2020, AQUACULT NUTR, V26, P15, DOI 10.1111/anu.12984; Witcher KJ, 1996, CLIN DIAGN LAB IMMUN, V3, P10, DOI 10.1128/CDLI.3.1.10-13.1996; Yu W, 2018, FISH SHELLFISH IMMUN, V74, P649, DOI 10.1016/j.fsi.2018.01.024; Zeiger K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175693; Zeitz JO, 2015, POULTRY SCI, V94, P2404, DOI 10.3382/ps/pev191; Zentek J., 2011, Animal Health Research Reviews, V12, P83, DOI 10.1017/S1466252311000089; Zhang JZ, 2010, J WORLD AQUACULT SOC, V41, P151, DOI 10.1111/j.1749-7345.2010.00356.x; Zhou F, 2011, AQUACULT NUTR, V17, P469, DOI 10.1111/j.1365-2095.2010.00823.x; Zhou F, 2010, AQUACULT NUTR, V16, P194, DOI 10.1111/j.1365-2095.2009.00651.x; Zhou F, 2010, AQUAC RES, V41, pe418, DOI 10.1111/j.1365-2109.2009.02474.x	68	3	3	12	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262427	10.1371/journal.pone.0262427	http://dx.doi.org/10.1371/journal.pone.0262427			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025934	Green Published, gold			2022-12-27	WOS:000796264200068
J	Bennett, JS				Bennett, James S.			Retrodicting the rise, spread, and fall of large-scale states in the Old World	PLOS ONE			English	Article								Understanding the rise, spread, and fall of large-scale states in the ancient world has occupied thinkers for millennia. However, no comprehensive mechanistic model of state dynamics based on their insights has emerged, leaving it difficult to evaluate empirically or quantitatively the different explanations offered. Here I present a spatially- and temporally-resolved agent-based model incorporating several hypotheses about the behavior of largescale (>200 thousand km(2)) agrarian states and steppe nomadic confederations in Afro-Eurasia between the late Bronze and the end of the Medieval era (1500 BCE to 1500 CE). The model tracks the spread of agrarian states as they expand, conquer the territory of other states or are themselves conquered, and, occasionally, collapse. To accurately retrodict the historical record, several key contingent regional technological advances in state military and agricultural efficiencies are identified. Modifying the location, scale, and timing of these contingent developments allows quantitative investigation of historically-plausible alternative trajectories of state growth, spread, and fragmentation, while demonstrating the operation and limits of the model. Under nominal assumptions, the rapid yet staggered increase of agrarian state sizes across Eurasia after 600 BCE occurs in response to intense military pressure from 'mirror' steppe nomadic confederations. Nevertheless, in spite of various technological advances throughout the period, the modeled creation and spread of new agrarian states is a fundamental consequence of state collapse and internal civil wars triggered by rising 'demographic-structural' pressures that occur when state territorial growth is checked yet (warrior elite) population growth continues. Together the model's underlying mechanisms substantially account for the number of states, their duration, location, spread rate, overall occupied area, and total population size for three thousand years.	[Bennett, James S.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Bennett, JS (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	jsb11@uw.edu		Bennett, James S./0000-0003-3051-1672				Abd al-Rahman, 1958, MUQADDIMAH; [Anonymous], 2018, HIST DYNAMICS WHY ST, DOI DOI 10.23943/PRINCETON/9780691180779.001.0001; Barfield T., 1989, PERILOUS FRONTIER NO; Bennett J., 2016, CLIODYNAMICS J QUANT, V7, P1, DOI DOI 10.21237/C7CLI07128530; Bennett JS., 2015, CLIODYNAMICS, V6, P57; Berlin I., 1954, HIST INEVITABILITY; BOSERUP E., 1965, The conditions of agricultural growth. The economics of agrarian change under population pressure.; Boulding KennethE., 1962, CONFLICT DEFENSE GEN, DOI [10.1126/science.138.3538.402, DOI 10.1126/SCIENCE.138.3538.402]; Brosseder U., 2011, XIONGNU ARCHAEOLOGY; Chase-Dunn Ch., 2010, HIST MATH PROCESSES, P64; Crawley Richard, 1996, LANDMARK THUCYDIDES, DOI 10.3201/eid0202.960220; Davis D., 2017, CLIODYNAMICS, V8, P182; Demandt A., 1984, FALL ROMS AUFL SUNG; Di Cosmo N., 2002, ANCIENT CHINA ITS EN; Gibbon E., 2003, DECLINE FALL ROMAN E; Goldstone Jack A., 1991, REVOLUTION REBELLION; Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983; Khazanov Anatoly M., 1984, NOMADS OUTSIDE WORLD; Ko CY, 2018, INT ECON REV, V59, P285, DOI 10.1111/iere.12270; Kradin N., 2002, J WORLD SYST RES, V8, P368; Kremer M, 1993, Q J ECON, V108, P681, DOI 10.2307/2118405; Martin Ged, 2004, FUTURES IMPOSSIBLE N; Mill JS., 1884, SYSTEM LOGIC, V1; Morris Ian, 2010, WHY W RULES FOR NOW; OLSON M, 1993, AM POLIT SCI REV, V87, P567, DOI 10.2307/2938736; Ortmans O., 2017, CLIODYNAMICS, V8, P113; Popper K, 1944, ECONOMICA-NEW SER, V11, P86, DOI 10.2307/2549642; Purvis A.L, 2007, LANDMARK HERODOTUS H; Renfrew C, 1997, NATURE, V386, P339, DOI 10.1038/386339a0; Rogers JD, 2005, ANTIQUITY, V79, P801, DOI 10.1017/S0003598X00114942; Rogers JD., 2010, COMPUTING STEPPES DA, P111; Scheidel W, 2019, PRINC ECON HIST W WO, P1; Scheidel W., 2014, J ROMAN ARCHAEOL, V27, P7, DOI DOI 10.1017/S1047759414001147; Tainter J., 1988, COLLAPSE COMPLEX SOC; Tilly C., 1992, COERCION CAPITAL EST; Toynbee Arnold J., 1934, STUDY HIST, VI-XII; Turchin P., 2016, CLIODYNAMICS, V7, P217; Turchin P., 2021, PLOS ONE, V16, pe0258161, DOI [10.1371/journal.pone.0258161, DOI 10.1371/JOURNAL.PONE.0258161]; Turchin P., 2009, SECULAR CYCLES; Turchin P., 2016, AGES OF DISCORD; Turchin P, 2018, P NATL ACAD SCI USA, V115, pE144, DOI 10.1073/pnas.1708800115; Turchin P, 2013, P NATL ACAD SCI USA, V110, P16384, DOI 10.1073/pnas.1308825110; Turchin P, 2009, J GLOBAL HIST, V4, P191, DOI 10.1017/S174002280900312X	43	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261816	10.1371/journal.pone.0261816	http://dx.doi.org/10.1371/journal.pone.0261816			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020723	Green Submitted, gold, Green Published			2022-12-27	WOS:000834207700024
J	Trecarichi, A; Duggett, NA; Granat, L; Lo, S; Malik, AN; Zuliani-Alvarez, L; Flatters, SJL				Trecarichi, Annalisa; Duggett, Natalie A.; Granat, Lucy; Lo, Samantha; Malik, Afshan N.; Zuliani-Alvarez, Lorena; Flatters, Sarah J. L.			Preclinical evidence for mitochondrial DNA as a potential blood biomarker for chemotherapy-induced peripheral neuropathy	PLOS ONE			English	Article							COPY NUMBER; COLORECTAL-CANCER; PACLITAXEL; RISK; NEUROTOXICITY; PLATINUM; GENOME; HEAD	Chemotherapy-induced peripheral neuropathy (CIPN) is a serious dose-limiting side effect of several first-line chemotherapeutic agents including paclitaxel, oxaliplatin and bortezomib, for which no predictive marker is currently available. We have previously shown that mitochondrial dysfunction is associated with the development and maintenance of CIPN. The aim of this study was to evaluate the potential use of mitochondrial DNA (mtDNA) levels and complex I enzyme activity as blood biomarkers for CIPN. Real-time qPCR was used to measure mtDNA levels in whole blood collected from chemotherapy- and vehicle-treated rats at three key time-points of pain-like behaviour: prior to pain development, at the peak of mechanical hypersensitivity and at resolution of pain-like behaviour. Systemic oxaliplatin significantly increased mtDNA levels in whole blood prior to pain development. Furthermore, paclitaxel- and bortezomib-treated animals displayed significantly higher levels of mtDNA at the peak of mechanical hypersensitivity. Mitochondrial complex I activity in whole blood was assessed with an ELISA-based Complex I Enzyme Activity Dipstick Assay. Complex I activity was not altered by any of the three chemotherapeutic agents, either prior to or during pain-like behaviour. These data demonstrate that blood levels of mtDNA are altered after systemic administration of chemotherapy. Oxaliplatin, in particular, is associated with higher mtDNA levels before animals show any pain-like behaviour, thus suggesting a potential role for circulating mtDNA levels as non-invasive predictive biomarker for CIPN.	[Trecarichi, Annalisa; Duggett, Natalie A.; Granat, Lucy; Lo, Samantha; Zuliani-Alvarez, Lorena; Flatters, Sarah J. L.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Wolfson Ctr Age Related Dis, London, England; [Malik, Afshan N.] Kings Coll London, Sch Life Course Sci, Dept Diabet, London, England	University of London; King's College London; University of London; King's College London	Flatters, SJL (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Wolfson Ctr Age Related Dis, London, England.	sarah.flatters@kcl.ac.uk		Duggett, Natalie/0000-0003-0660-4190	Guys and St. Thomas' charity; Wellcome Trust [WT093335AIA]; British Pharmacological Society (Integrative Pharmacology Fund); British Journal of Anaesthesia/Royal College of Anaesthetists	Guys and St. Thomas' charity; Wellcome Trust(Wellcome Trust); British Pharmacological Society (Integrative Pharmacology Fund); British Journal of Anaesthesia/Royal College of Anaesthetists	AT was supported by a PhD studentship from Guys and St. Thomas' charity. These studies were supported by project grants awarded to SJLF from the British Journal of Anaesthesia/Royal College of Anaesthetists; The Wellcome Trust (WT093335AIA) and the British Pharmacological Society (Integrative Pharmacology Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2010, CHEM REV, V110, P3212, DOI 10.1021/cr900396q; Ajaz Saima, 2015, Methods Mol Biol, V1264, P117, DOI 10.1007/978-1-4939-2257-4_12; Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Ashley N, 2009, BIOCHEM BIOPH RES CO, V378, P450, DOI 10.1016/j.bbrc.2008.11.059; Barbosa MD, 2014, CANCER RES, V74, P5955, DOI 10.1158/0008-5472.CAN-14-2060; Boyette-Davis JA, 2012, CLIN CANCER RES, V18, P3180, DOI 10.1158/1078-0432.CCR-12-0205; Cavaletti G, 2010, NAT REV NEUROL, V6, P657, DOI 10.1038/nrneurol.2010.160; Chen EI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145816; Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017; Cossarizza A, 2003, ANTIVIR THER, V8, P315; Diaz PL, 2018, BIOMARK MED, V12, P907, DOI 10.2217/bmm-2017-0427; Duggett NA, 2017, BRIT J PHARMACOL, V174, P4812, DOI 10.1111/bph.14063; Duggett NA, 2017, PAIN, V158, P1499, DOI 10.1097/j.pain.0000000000000939; Duggett NA, 2016, NEUROSCIENCE, V333, P13, DOI 10.1016/j.neuroscience.2016.06.050; Ellinger J, 2009, BJU INT, V104, P48, DOI 10.1111/j.1464-410X.2008.08289.x; Etienne-Grimaldi MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175998; Flatters SJL, 2017, BRIT J ANAESTH, V119, P737, DOI 10.1093/bja/aex229; Flatters SJL, 2015, PROG MOL BIOL TRANSL, V131, P119, DOI 10.1016/bs.pmbts.2014.12.004; Fu XA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002009; Gabriel CM, 2000, J NEUROL NEUROSUR PS, V69, P442, DOI 10.1136/jnnp.69.4.442; Girolimetti G, 2017, HUM MOL GENET, V26, P2961, DOI 10.1093/hmg/ddx186; Griffiths LA, 2018, PAIN RES MANAG, V2018, DOI 10.1155/2018/8217613; Griffiths LA, 2015, J PAIN, V16, P981, DOI 10.1016/j.jpain.2015.06.008; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045; Jiang WW, 2005, CLIN CANCER RES, V11, P2486, DOI 10.1158/1078-0432.CCR-04-2147; Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974; Lunenburg CATC, 2016, EUR J CANCER, V54, P40, DOI 10.1016/j.ejca.2015.11.008; Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002; Malik AN, 2015, DIABETES RES CLIN PR, V110, P257, DOI 10.1016/j.diabres.2015.10.006; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Malik Afshan N, 2009, Diabetes Res Clin Pract, V86, pe22, DOI 10.1016/j.diabres.2009.07.002; Marusich MF, 2009, INT J BIOCHEM CELL B, V41, P2081, DOI 10.1016/j.biocel.2009.05.009; Mehra N, 2007, CLIN CANCER RES, V13, P421, DOI 10.1158/1078-0432.CCR-06-1087; MICETICH KC, 1985, CANCER RES, V45, P4043; Oguri T, 2013, INT J CLIN PHARM TH, V51, P475, DOI 10.5414/CP201851; Podratz JL, 2011, NEUROBIOL DIS, V41, P661, DOI 10.1016/j.nbd.2010.11.017; Reddy SM, 2016, CLIN COLORECTAL CANC, V15, P37, DOI 10.1016/j.clcc.2015.07.001; Roldan CJ, 2018, PAIN PHYSICIAN, V21, pE419; Seretny M, 2014, PAIN, V155, P2461, DOI 10.1016/j.pain.2014.09.020; Serrano J, 1999, BBA-BIOENERGETICS, V1411, P201, DOI 10.1016/S0005-2728(99)00011-0; Shen J, 2010, MITOCHONDRION, V10, P62, DOI 10.1016/j.mito.2009.09.004; Shi HH, 2009, INT J GYNECOL CANCER, V19, P423, DOI 10.1111/IGC.0b013e3181a19ff0; Sunder R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164319; Terrazzino S, 2015, J PERIPHER NERV SYST, V20, P15, DOI 10.1111/jns.12110; Trecarichi A, 2019, 7 INT C NEUROPATHIC; Trecarichi A, 2019, INT REV NEUROBIOL, V145, P83, DOI 10.1016/bs.irn.2019.05.001; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; Wang XS, 2016, ONCOLOGY-BASEL, V90, P127, DOI 10.1159/000443377; Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009; Won HH, 2012, CANCER-AM CANCER SOC, V118, P2828, DOI 10.1002/cncr.26614; Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Xu FX, 2012, DIABETIC MED, V29, pE47, DOI 10.1111/j.1464-5491.2011.03565.x; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	57	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262544	10.1371/journal.pone.0262544	http://dx.doi.org/10.1371/journal.pone.0262544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015774	gold, Green Published			2022-12-27	WOS:000814820600033
J	Yang, CM; Zhuo, QQ; Chen, JY; Fang, Z; Xu, YS				Yang, Chuanming; Zhuo, Qingqing; Chen, Junyu; Fang, Zhou; Xu, Yisong			Analysis of the spatio-temporal network of air pollution in the Yangtze River Delta urban agglomeration, China	PLOS ONE			English	Article							PM2.5; POLLUTANTS; TRANSPORT; CITIES	The complex correlation between regions caused by the externality of air pollution increases the difficulty of its governance. Therefore, analysis of the spatio-temporal network of air pollution (STN-AP) holds great significance for the cross-regional coordinated governance of air pollution. Although the spatio-temporal distribution of air pollution has been analyzed, the structural characteristics of the STN-AP still need to be clarified. The STN-AP in the Yangtze River Delta urban agglomeration (YRDUA) is constructed based on the improved gravity model and is visualized by UCINET with data from 2012 to 2019. Then, its overall-individual-clustering characteristics are analyzed through social network analysis (SNA) method. The results show that the STN-AP in the YRDUA was overall stable, and the correlation level gradually improved. The centrality of every individual city is different in the STN-AP, which reveals the different state of their interactive mechanism. The STN-AP could be subdivided into the receptive block, overflow block, bidirectional block and intermediary block. Shanghai, Suzhou, Hangzhou and Wuxi could be key cities with an all above degree centrality, betweenness centrality and closeness centrality and located in the overflow block of the STN-AP. This showed that these cities had a greater impact on the STN-AP and caused a more pronounced air pollution spillovers. The influencing factors of the spatial correlation of air pollution are further determined through the quadratic assignment procedure (QAP) method. Among all factors, geographical proximity has the strongest impact and deserves to be paid attention in order to prevent the cross-regional overflow of air pollution. Furthermore, several suggestions are proposed to promote coordinated governance of air pollution in the YRDUA.	[Yang, Chuanming; Zhuo, Qingqing; Chen, Junyu; Xu, Yisong] Suzhou Univ Sci & Technol, Sch Business, Suzhou, Jiangsu, Peoples R China; [Chen, Junyu] Tianjin Univ, Coll Management & Econ, Tianjin, Peoples R China; [Fang, Zhou] Hohai Univ, Business Sch, Nanjing, Jiangsu, Peoples R China	Suzhou University of Science & Technology; Tianjin University; Hohai University	Chen, JY (corresponding author), Suzhou Univ Sci & Technol, Sch Business, Suzhou, Jiangsu, Peoples R China.; Chen, JY (corresponding author), Tianjin Univ, Coll Management & Econ, Tianjin, Peoples R China.	jychen@usts.edu.cn	Fang, Zhou/GWU-6891-2022	Fang, Zhou/0000-0002-8441-0810; Chen, Junyu/0000-0002-9004-0887	Key Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province [2018SJZDI075]; Qinglan Project of Jiangsu Province [2018JSQL028]; Jiangsu social science fund [21GLC015]	Key Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province; Qinglan Project of Jiangsu Province; Jiangsu social science fund	The Key Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province (No. 2018SJZDI075) and the Qinglan Project of Jiangsu Province (No.2018JSQL028) received by Chuanming Yang would support our work. The Jiangsu social science fund (Grant NO. 21GLC015) received by Junyu Chen would also support our work.	Chang IC, 2019, AEROSOL AIR QUAL RES, V19, P2844, DOI 10.4209/aaqr.2019.11.0554; Du MZ, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182010619; Feng HH, 2019, ECOL INDIC, V99, P251, DOI 10.1016/j.ecolind.2018.12.038; Feng YY, 2019, J ENVIRON MANAGE, V252, DOI 10.1016/j.jenvman.2019.109603; Guney S, 2019, AM J AGR ECON, V101, P541, DOI 10.1093/ajae/aay033; Jiang C, 2015, ATMOS CHEM PHYS, V15, P5803, DOI 10.5194/acp-15-5803-2015; Lasko K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196629; Lee MT, 2021, J ENERGY STORAGE, V41, DOI 10.1016/j.est.2021.102890; Li H, 2019, ENVIRON SCI POLLUT R, V26, P12136, DOI 10.1007/s11356-019-04682-5; Liu H., 2017, REV EC MANAG, V33, P57, DOI [10.13962/j.cnki.37-1486/f.2017.01.007, DOI 10.13962/J.CNKI.37-1486/F.2017.01.007]; Liu XF, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105713; Lu YL, 2019, J ENVIRON MANAGE, V249, DOI 10.1016/j.jenvman.2019.109377; Miller DJ, 2020, ENVIRON SCI TECHNOL, V54, P2133, DOI 10.1021/acs.est.9b05523; Morillas H, 2019, J CLEAN PROD, V226, P369, DOI 10.1016/j.jclepro.2019.04.063; Oetari PS, 2019, J ENVIRON MANAGE, V250, DOI 10.1016/j.jenvman.2019.109497; Pei, 2017, STAT RES, V34, P45, DOI DOI 10.19343/J.CNKI.11-1302/C.2017.03.004; Posch M, 2019, ENVIRON SCI TECHNOL, V53, P5062, DOI 10.1021/acs.est.8b06356; Saraswat A, 2016, ENVIRON SCI TECHNOL, V50, P3174, DOI 10.1021/acs.est.5b04975; Schioppo T, 2020, EPIDEMIOL PREV, V44, P228, DOI 10.19191/EP20.4.P228.052; Shan YJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237863; Shao JJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238547; Shen FZ, 2020, ENVIRON INT, V137, DOI 10.1016/j.envint.2020.105556; Squizzato S, 2018, ATMOS ENVIRON, V183, P209, DOI 10.1016/j.atmosenv.2018.03.045; Su Y, 2019, J CLEAN PROD, V213, P540, DOI 10.1016/j.jclepro.2018.12.121; Svistov PF, 2017, RUSS J GEN CHEM+, V87, P3173, DOI 10.1134/S1070363217130114; [汤放华 Tang Fanghua], 2013, [地理学报, Acta Geographica Sinica], V68, P1357; Tshehla C, 2019, S AFR J SCI, V115, DOI 10.17159/sajs.2019/6100; Wakeel M, 2017, J CLEAN PROD, V142, P3322, DOI 10.1016/j.jclepro.2016.10.138; Wang F, 2018, ENERGIES, V11, DOI 10.3390/en11102706; Wang JJ, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138134; Weaver JC, 1954, GEOGR REV, V44, P175, DOI 10.2307/212355; Wolfe AW, 1997, AM ETHNOL, V24, P219, DOI 10.1525/ae.1997.24.1.219; Xiao CC, 2020, J ENVIRON SCI, V87, P213, DOI 10.1016/j.jes.2019.05.024; Xu SC, 2019, J CLEAN PROD, V208, P340, DOI 10.1016/j.jclepro.2018.10.114; [杨传明 Yang Chuanming], 2020, [自然资源学报, Journal of Natural Resources], V35, P313; Yu XB, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020587; Yu YP, 2019, POL J ENVIRON STUD, V28, P445, DOI 10.15244/pjoes/83730; Zeng D H., 2019, RES ENV SCI, V32, P1834; Zhang LY, 2020, CHEMOSPHERE, V253, DOI 10.1016/j.chemosphere.2020.126613; Zhang YL, 2019, SCI TOTAL ENVIRON, V684, P178, DOI 10.1016/j.scitotenv.2019.05.360	40	0	0	13	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262444	10.1371/journal.pone.0262444	http://dx.doi.org/10.1371/journal.pone.0262444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015793	gold, Green Published			2022-12-27	WOS:000814820600018
J	Giri, GR; Saxena, P				Giri, Gorkha Raj; Saxena, Priti			Mycobacterial MMAR_2193 catalyzes O-methylation of diverse polyketide cores	PLOS ONE			English	Article							ADENOSYL-L-METHIONINE; CRYSTAL-STRUCTURE; ISOLIQUIRITIGENIN 2-O-METHYLTRANSFERASE; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; SUBSTRATE-SPECIFICITY; BACTERIAL BIOFILMS; STRUCTURAL BASIS; METHYLTRANSFERASE; BIOSYNTHESIS	O-methylation of small molecules is a common modification widely present in most organisms. Type III polyketides undergo O-methylation at hydroxyl end to play a wide spectrum of roles in bacteria, plants, algae, and fungi. Mycobacterium marinum harbours a distinctive genomic cluster with a type III pks gene and genes for several polyketide modifiers including a methyltransferase gene, mmar_2193. This study reports functional analyses of MMAR_2193 and reveals multi-methylating potential of the protein. Comparative sequence analyses revealed conservation of catalytically important motifs in MMAR_2193 protein. Homology-based structure-function and molecular docking studies suggested type III polyketide cores as possible substrates for MMAR_2193 catalysis. In vitro enzymatic characterization revealed the capability of MMAR_2193 protein to utilize diverse polyphenolic substrates to methylate several hydroxyl positions on a single substrate molecule. High-resolution mass spectrometric analyses identified multi-methylations of type III polyketides in cell-free reconstitution assays. Notably, our metabolomics analyses identified some of these methylated molecules in biofilms of wild type Mycobacterium marinum. This study characterizes a novel mycobacterial O-methyltransferase protein with multi-methylating enzymatic ability that could be exploited to generate a palette of structurally distinct bioactive molecules.	[Giri, Gorkha Raj; Saxena, Priti] South Asian Univ, Fac Life Sci & Biotechnol, Chem Biol Grp, New Delhi, India; [Giri, Gorkha Raj] Tribhuvan Univ, Cent Dept Biotechnol, Kathmandu, Nepal	South Asian University (SAU); Tribhuvan University	Saxena, P (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, Chem Biol Grp, New Delhi, India.	psaxena@sau.ac.in		Giri, Gorkha Raj/0000-0001-6603-0526	Innovative Young Biotechnologist Award (IYBA), Department of Biotechnology (DBT); Ministry of Science and Technology, Government of India [CRG/2018/002229]; Science and Engineering Research Board (SERB); Department of Science and Technology (DST), Government of India; Startup Grant, South Asian University SAU	Innovative Young Biotechnologist Award (IYBA), Department of Biotechnology (DBT); Ministry of Science and Technology, Government of India(Ministry of Science and Technology, Government of India); Science and Engineering Research Board (SERB); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Startup Grant, South Asian University SAU	Financial support for the study was provided to PS by Innovative Young Biotechnologist Award (IYBA), Department of Biotechnology (DBT) (https://dbtindia.gov.in), Ministry of Science and Technology, Government of India, Core Research Grant (CRG/2018/002229), Science and Engineering Research Board (SERB) (http://www.serb.gov.in/home.php), Department of Science and Technology (DST), Government of India and Startup Grant, South Asian University SAU) (http://www.sau.int/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2015, MOL CELL, V60, P637, DOI 10.1016/j.molcel.2015.10.016; Bonifacio MJ, 2002, MOL PHARMACOL, V62, P795, DOI 10.1124/mol.62.4.795; Chakraborty P, 2019, MICROB CELL, V6, P105, DOI 10.15698/mic2019.02.667; Chatterjee T, 2015, ARCH BIOCHEM BIOPHYS, V583, P140, DOI 10.1016/j.abb.2015.08.001; Cho JH, 2008, J MOL BIOL, V382, P987, DOI 10.1016/j.jmb.2008.07.080; Coiner H, 2006, PLANT J, V46, P193, DOI 10.1111/J.1365-313X.2006.02680.x; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Ferrer JL, 2005, PLANT PHYSIOL, V137, P1009, DOI 10.1104/pp.104.048751; Funa N, 2002, J BIOL CHEM, V277, P4628, DOI 10.1074/jbc.M110357200; Funabashi M, 2008, J BIOL CHEM, V283, P13983, DOI 10.1074/jbc.M710461200; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; Grocholski T, 2015, P NATL ACAD SCI USA, V112, P9866, DOI 10.1073/pnas.1501765112; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hou XW, 2007, J STRUCT BIOL, V159, P523, DOI 10.1016/j.jsb.2007.04.007; Ibdah M, 2003, J BIOL CHEM, V278, P43961, DOI 10.1074/jbc.M304932200; Ibrahim RK, 1998, PLANT MOL BIOL, V36, P1, DOI 10.1023/A:1005939803300; Joshi CP, 1998, PLANT MOL BIOL, V37, P663, DOI 10.1023/A:1006035210889; Klimasauskas S, 2007, TRENDS BIOTECHNOL, V25, P99, DOI 10.1016/j.tibtech.2007.01.006; Law BJC, 2015, CHEM SCI, V6, P2885, DOI 10.1039/c5sc00164a; Lebe KE, 2019, RSC ADV, V9, P31527, DOI 10.1039/c9ra06412e; Lee S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44592-7; Liu CJ, 2006, PLANT CELL, V18, P3656, DOI 10.1105/tpc.106.041376; Ma QH, 2008, BIOCHIMIE, V90, P515, DOI 10.1016/j.biochi.2007.09.016; MAXWELL CA, 1992, ARCH BIOCHEM BIOPHYS, V293, P158, DOI 10.1016/0003-9861(92)90379-B; MAXWELL CA, 1993, PLANT J, V4, P971, DOI 10.1046/j.1365-313X.1993.04060971.x; Morishige T, 2010, P JPN ACAD B-PHYS, V86, P757, DOI 10.2183/pjab.86.757; Noel JP, 2003, RECENT ADV PHYTOCHEM, V37, P37; Oster LM, 2006, J MOL BIOL, V358, P546, DOI 10.1016/j.jmb.2006.02.004; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Parvez A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24980-1; Perez E, 2004, J BIOL CHEM, V279, P42584, DOI 10.1074/jbc.M406134200; Petronikolou N, 2018, CHEMBIOCHEM, V19, P784, DOI 10.1002/cbic.201700679; Saxena P, 2003, J BIOL CHEM, V278, P44780, DOI 10.1074/jbc.M306714200; Scalliet G, 2008, P NATL ACAD SCI USA, V105, P5927, DOI 10.1073/pnas.0711551105; Schmidt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018184; Smith CD, 2002, PROTEIN SCI, V11, P625, DOI 10.1110/ps.37802; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wiens B, 2016, PHYTOCHEMISTRY, V132, P5, DOI 10.1016/j.phytochem.2016.10.004; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Wu SQ, 2003, J BIOSCI BIOENG, V96, P119, DOI 10.1016/S1389-1723(03)90113-7; Zheng YJ, 1997, J AM CHEM SOC, V119, P8137, DOI 10.1021/ja971019d; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029	45	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262241	10.1371/journal.pone.0262241	http://dx.doi.org/10.1371/journal.pone.0262241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986163	Green Published, gold			2022-12-27	WOS:000765956200030
J	Lo Presti, S; Mattavelli, G; Canessa, N; Gianelli, C				Lo Presti, Sara; Mattavelli, Giulia; Canessa, Nicola; Gianelli, Claudia			Risk perception and behaviour during the COVID-19 pandemic: Predicting variables of compliance with lockdown measures	PLOS ONE			English	Article							EMERGENCY DECISION-MAKING; PROSPECT-THEORY; 5-FACTOR MODEL; SOCIAL-RESPONSIBILITY; PERSONALITY-TRAITS; HARM AVOIDANCE; LOSS AVERSION; NEURAL BASIS; LOCUS; TEMPERAMENT	The COVID-19 pandemic and the measures to counteract it have highlighted the role of individual differences in evaluating and reacting to emergencies, and the challenges inherent in promoting precautionary behaviours. We aimed to explore the psychological and cognitive factors modulating behaviour and intentions during the national lockdown in Italy. We administered an online questionnaire (N = 244) that included tests for assessing personality traits (Temperament and Character Inventory; Locus of Control of Behaviour) and moral judgment (Moral Foundations Questionnaire), alongside behavioural economics tasks addressing different facets of risk attitude (loss aversion, risk aversion and delay discounting). We then assessed the extent to which individual variations in these dimensions modulated participants' compliance with the lockdown norms. When assessing their joint contribution via multiple regressions, lockdown adherence was mostly predicted by internal locus of control, psycho-economic dimensions suggestive of long-sighted and loss-averse attitudes, as well as personality traits related to cautionary behaviour, such as harm avoidance, and the authority moral concern. These findings show that a multi-domain assessment of the factors underlying personal intentions, and thus driving compliance with government measures, can help predict individuals' actions during health emergencies. This evidence points to factors that should be considered when developing interventions and communication strategies to promote precautionary behaviours.	[Lo Presti, Sara; Mattavelli, Giulia; Canessa, Nicola; Gianelli, Claudia] Scuola Univ Super IUSS, IUSS Cognit Neurosci ICON Ctr, Pavia, Italy; [Mattavelli, Giulia; Canessa, Nicola; Gianelli, Claudia] Ist Clin Sci Maugeri IRCCS, Cognit Neurosci Lab, Pavia Inst, Pavia, Italy	IUSS PAVIA	Canessa, N (corresponding author), Scuola Univ Super IUSS, IUSS Cognit Neurosci ICON Ctr, Pavia, Italy.; Canessa, N (corresponding author), Ist Clin Sci Maugeri IRCCS, Cognit Neurosci Lab, Pavia Inst, Pavia, Italy.	nicola.canessa@iusspavia.it	Mattavelli, Giulia/K-5723-2016	Mattavelli, Giulia/0000-0003-2042-8947	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This research was partially supported by the "Ricerca Corrente" funding scheme of the Italian Ministry of Health. The authors wish to thank Maria Vittoria Fronda for language editing and the Third Mission Office of the Scuola Universitaria Superiore IUSS Pavia for the valuable support in recruiting participants.	Adan A, 2009, PERS INDIV DIFFER, V46, P687, DOI 10.1016/j.paid.2009.01.023; Amanzio M, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.685180; Bartoli M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18115847; Basinska MA, 2012, INT J ENDOCRINOL MET, V10, P537, DOI 10.5812/ijem.3932; Bengtsson MM, 2012, ISME J, V6, P2188, DOI 10.1038/ismej.2012.67; Betsch C, 2020, LANCET, V395, P1255, DOI 10.1016/S0140-6736(20)30729-7; Bobbio A., 2011, GIORNALE PSICOLOGIA, V5, P7, DOI DOI 10.1037/T65368-000; Bolton GE, 2015, EUR ECON REV, V74, P109, DOI 10.1016/j.euroecorev.2014.10.002; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8, 10.1016/S0140-6736(20)30460-8.]; Brown R, 2021, J PUBLIC HEALTH-HEID, DOI 10.1007/s10389-021-01543-9; Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283; Campos-Mercade Pol, 2020, 346 U ZUR DEP EC, DOI [DOI 10.2139/SSRN.3604094, 10.2139/ssrn.3604094]; Canessa N, 2017, NEUROIMAGE, V146, P257, DOI 10.1016/j.neuroimage.2016.11.050; Canessa N, 2013, J NEUROSCI, V33, P14307, DOI 10.1523/JNEUROSCI.0497-13.2013; Chaudhry R, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100464; CHEBAT JC, 1986, J SOC PSYCHOL, V126, P559, DOI 10.1080/00224545.1986.9713626; Chua G, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18063247; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Covello VT, 2003, J HEALTH COMMUN, V8, P5, DOI 10.1080/10810730390224802; CRAIG AR, 1984, BRIT J MED PSYCHOL, V57, P173, DOI 10.1111/j.2044-8341.1984.tb01597.x; Daugherty JR, 2010, PERS INDIV DIFFER, V48, P202, DOI 10.1016/j.paid.2009.10.007; De Fruyt F, 2000, PERS INDIV DIFFER, V29, P441, DOI 10.1016/S0191-8869(99)00204-4; Diaz R, 2022, COGNITION EMOTION, V36, P120, DOI 10.1080/02699931.2021.1941783; Ding YN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237626; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Duncan LA, 2009, PERS INDIV DIFFER, V47, P541, DOI 10.1016/j.paid.2009.05.001; European Centre for Disease Prevention and Control, 2020, EUROPEAN CTR DIS PRE; Farma T, 2001, RICERCA PSICO TERAPI, V1, P1; Flesia L., 2020, STABLE PSYCHOL TRAIT, DOI [10.31234/osf. io/yb2h8., DOI 10.3390/JCM9103350, DOI 10.31234/OSF.IO/YB2H8]; Fossati A, 2007, COMPR PSYCHIAT, V48, P380, DOI 10.1016/j.comppsych.2007.02.003; Franken IHA, 2008, PSYCHIAT RES, V158, P155, DOI 10.1016/j.psychres.2007.06.002; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Gachter S, 2009, J ECON BEHAV ORGAN, V70, P443, DOI 10.1016/j.jebo.2007.11.003; Graham J., 2008, MORAL FDN QUESTIONNA; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2008, PERSPECT PSYCHOL SCI, V3, P65, DOI 10.1111/j.1745-6916.2008.00063.x; Hameleers M., 2020, SOCARXIV, DOI [10.31235/osf.io/7pykj, DOI 10.31235/OSF.IO/7PYKJ]; Henderson RK, 2021, EVOL PSYCHOL-US, V19, DOI 10.1177/14747049211021524; Hickie I, 2006, BRIT MED J, V333, P575, DOI 10.1136/bmj.38933.585764.AE; Hilbert M, 2012, PSYCHOL BULL, V138, P211, DOI 10.1037/a0025940; Iennaco D, 2018, 2018 9 IEEE INT C CO, DOI [10.1109/CogInfoCom, DOI 10.1109/COGINFOCOM]; Islam T, 2021, J RETAIL CONSUM SERV, V59, DOI 10.1016/j.jretconser.2020.102357; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kenis P, 2019, RISK HAZARDS CRISIS, V10, P275, DOI 10.1002/rhc3.12176; Kohut M, 2021, PERS INDIV DIFFER, V180, DOI 10.1016/j.paid.2021.110934; Kothari R., 2021, INT J INDIAN PSYCHOL, V9, P547; Krampe H, 2021, REVIEW, DOI [10.21203/rs.3.rs-479681/v1, DOI 10.21203/RS.3.RS-479681/V1]; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Lanciano T, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.580053; Lawless L., 2013, AGR FOOD ECON, V1, P1, DOI DOI 10.1186/2193-7532-1-17; Lee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135216; Linnemayr S, 2016, DISASTER MED PUBLIC, V10, P768, DOI 10.1017/dmp.2016.29; Linnemayr S, 2016, JAIDS-J ACQ IMM DEF, V72, pE50, DOI 10.1097/QAI.0000000000000972; Liu WJ, 2019, GRANULAR COMPUT, V4, P39, DOI 10.1007/s41066-018-0086-5; Lo Presti S, 2021, PERS INDIV DIFFER, V182, DOI 10.1016/j.paid.2021.111090; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; Misamer M, 2021, FRONT SOCIOL, V6, DOI 10.3389/fsoc.2021.705809; Mishra S., 2015, ECOPSYCHOLOGY, V7, P211, DOI [10.1089/eco.2015.0006, DOI 10.1089/ECO.2015.0006]; Mishra S, 2009, J PAC RIM PSYCHOL, V3, P11, DOI 10.1375/prp.3.1.11; Moreira D, 2019, EUR PSYCHOL, V24, P312, DOI 10.1027/1016-9040/a000360; Nafradi L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186458; Nagatsuka M, 2015, SSRN ELECT J, DOI [10.2139/ssrn.2677487, DOI 10.2139/SSRN.2677487]; O'Grady T, 2019, DATA BRIEF, V25, DOI 10.1016/j.dib.2019.104331; O'Grady T, 2019, J RES PERS, V81, P224, DOI 10.1016/j.jrp.2019.06.008; Oliver A, 2018, J RISK UNCERTAINTY, V57, P29, DOI 10.1007/s11166-018-9284-4; Oosterhoff B, 2018, J RES PERS, V77, P47, DOI 10.1016/j.jrp.2018.09.008; PARKES KR, 1984, J PERS SOC PSYCHOL, V46, P655, DOI 10.1037/0022-3514.46.3.655; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; PHELPS ES, 1968, REV ECON STUD, V35, P185, DOI 10.2307/2296547; Pud D, 2004, EUR J PAIN, V8, P31, DOI 10.1016/S1090-3801(03)00065-X; Qian K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235883; Roddenberry A, 2010, CHILD PSYCHIAT HUM D, V41, P353, DOI 10.1007/s10578-010-0173-6; Rotter J.B, 1954, SOCIAL LEARNING CLIN, DOI 10.1037/10788-000; Shi R, 2020, PERS INDIV DIFFER, V159, DOI 10.1016/j.paid.2020.109828; Sigurvinsdottir R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17196985; Slovic P, 2005, HEALTH PSYCHOL, V24, pS35, DOI 10.1037/0278-6133.24.4.S35; Smillie LD, 2019, AUST J PSYCHOL, V71, P50, DOI 10.1111/ajpy.12229; Soofi M, 2020, APPL HEALTH ECON HEA, V18, P345, DOI 10.1007/s40258-020-00595-4; Stam CH, 2022, CURR PSYCHOL, V41, P3806, DOI 10.1007/s12144-020-00899-7; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; van Baar JM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09161-6; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Yang BJ, 2006, PSYCHOL REP, V98, P21, DOI 10.2644/PRO.98.1.21-22; Yang S, 2017, AM J INFECT CONTROL, V45, pE53, DOI 10.1016/j.ajic.2017.02.013; Yoshino A, 2005, BIOL PSYCHIAT, V57, P1, DOI 10.1016/j.biopsych.2004.09.027; Zaki J, 2020, TRENDS COGN SCI, V24, P587, DOI 10.1016/j.tics.2020.05.006; Zhang H, 2016, ENCY PERSONALITY IND, P1, DOI [10.1007/978-3-319-28099-8_1252-1, DOI 10.1007/978-3-319-28099-8_1252-1]; Zhang LW, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010064; Zhang ZX, 2018, INT J DISAST RISK SC, V9, P407, DOI 10.1007/s13753-018-0173-x	98	4	4	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262319	10.1371/journal.pone.0262319	http://dx.doi.org/10.1371/journal.pone.0262319			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZO8DB	34986209	gold, Green Published			2022-12-27	WOS:000765956200041
J	Pathak, P; Moon, J; Roh, SG; Roh, C; Shim, Y; Ahn, J				Pathak, Prabhat; Moon, Jeongin; Roh, Se-Gon; Roh, Changhyun; Shim, Youngbo; Ahn, Jooeun			Application of vibration to the soles reduces minimum toe clearance variability during walking	PLOS ONE			English	Article							CUTANEOUS REFLEXES; BALANCE CONTROL; FOOT CLEARANCE; GAIT; TREADMILL; MUSCLES; INSOLES; PRESSURE; REVERSAL; PEOPLE	Minimum toe clearance (MTC) is an important indicator of the risk of tripping. Aging and neuromuscular diseases often decrease MTC height and increase its variability, leading to a higher risk of tripping. Previous studies have developed visual feedback-based gait training systems to modify MTC. However, these systems are bulky and expensive, and the effects of the training continue only for a short time. We paid attention to the efficacy of vibration in decreasing the variability of gait parameters, and hypothesized that proper vibration applied to soles can reduce the MTC variability. Using shoes embedded with active vibrating insoles, we assessed the efficacy of both sub- and supra-threshold vibration in affecting MTC distribution. Experiment results with 17 young and healthy adults showed that vibration applied throughout the walking task with constant intensity of 130% of sensory threshold significantly decreased MTC variability, whereas sub-threshold vibration yielded no significant effect. These results demonstrate that a properly designed tactile sensory input which is controlled and delivered by a simple wearable device, the active insole, can reduce the MTC variability during walking.	[Pathak, Prabhat; Moon, Jeongin; Ahn, Jooeun] Seoul Natl Univ, Dept Phys Educ, Seoul, South Korea; [Roh, Se-Gon] Samsung Elect Co Ltd, Samsung Seoul R&D Campus, Robot Ctr, Seoul, South Korea; [Roh, Changhyun] WI Robot, Suwon, Gyeonggi, South Korea; [Shim, Youngbo] T Robot, Osan, Gyeonggi, South Korea; [Ahn, Jooeun] Seoul Natl Univ, Inst Sport Sci, Seoul, South Korea	Seoul National University (SNU); Samsung; Samsung Electronics; Seoul National University (SNU)	Ahn, J (corresponding author), Seoul Natl Univ, Dept Phys Educ, Seoul, South Korea.; Ahn, J (corresponding author), Seoul Natl Univ, Inst Sport Sci, Seoul, South Korea.	ahnjooeun@snu.ac.kr		Moon, Jeongin/0000-0002-1190-8837; Pathak, Prabhat/0000-0001-8031-949X; Ahn, Jooeun/0000-0002-7964-5148	National Research Foundation of Korea (NRF) - Korean Government (MSIT) [2016R1A5A1938472]; Ministry of Trade, Industry & Energy (MOTIE, Korea) [20008912, 20007058]; Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd; Ministry of Education of the Republic of Korea	National Research Foundation of Korea (NRF) - Korean Government (MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); Ministry of Trade, Industry & Energy (MOTIE, Korea)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd(Samsung); Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea)	JA acquired all the fundings for this study, including National Research Foundation of Korea (NRF) Grants funded by the Korean Government (MSIT) (No. 2016R1A5A1938472); the Technology Innovation Program (No. 20008912) and Industrial Technology Innovation Program (No. 20007058, Development of safe and comfortable human augmentation hybrid robot suit) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea); the research Grant funded by the Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd; and the Grant funded by Ministry of Education of the Republic of Korea. One funder, Samsung Electronics Co., Ltd, provided support in the form of salaries for authors SR, CR, and YS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock L, 2016, J BIOMECH, V49, P2763, DOI 10.1016/j.jbiomech.2016.06.007; Begg R, 2007, GAIT POSTURE, V25, P191, DOI 10.1016/j.gaitpost.2006.03.008; Begg RK, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00243; Carter SC, 2020, GAIT POSTURE, V75, P14, DOI 10.1016/j.gaitpost.2019.09.025; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; De Asha AR, 2015, PROSTHET ORTHOT INT, V39, P120, DOI 10.1177/0309364613515493; DUYSENS J, 1990, EXP BRAIN RES, V82, P351; Eils E, 2002, J BIOMECH, V35, P1307, DOI 10.1016/S0021-9290(02)00168-9; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Galica AM, 2009, GAIT POSTURE, V30, P383, DOI 10.1016/j.gaitpost.2009.07.005; Harry JD, 2005, IEEE SPECTRUM, V42, P36, DOI 10.1109/MSPEC.2005.1413729; Hijmans JM, 2008, J REHABIL RES DEV, V45, P1441, DOI 10.1682/JRRD.2008.02.0023; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Inglis JT, 2002, ADV EXP MED BIOL, V508, P111; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Kitagawa N, 2016, GAIT POSTURE, V45, P110, DOI 10.1016/j.gaitpost.2016.01.014; Lipsitz LA, 2015, ARCH PHYS MED REHAB, V96, P432, DOI 10.1016/j.apmr.2014.10.004; Lirani-Silva E., 2017, LOCOMOTION POSTURE O, P307; Mackinnon CD, 2018, HAND CLINIC, V159, P3, DOI 10.1016/B978-0-444-63916-5.00001-X; Mendez-Balbuena I, 2012, J NEUROSCI, V32, P12612, DOI 10.1523/JNEUROSCI.0680-12.2012; Menz HB, 2004, ARCH PHYS MED REHAB, V85, P245, DOI 10.1016/j.apmr.2003.06.015; Meyer C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41721-0; Mildren RL, 2016, GAIT POSTURE, V43, P87, DOI 10.1016/j.gaitpost.2015.10.027; Mills PM, 2008, GAIT POSTURE, V28, P101, DOI 10.1016/j.gaitpost.2007.10.006; Moon J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58815-9; Nakajima T, 2006, EXP BRAIN RES, V175, P514, DOI 10.1007/s00221-006-0568-6; Nelson AJ, 2012, CAN J NEUROL SCI, V39, P52, DOI 10.1017/S0317167100012683; Nurse MA, 2001, CLIN BIOMECH, V16, P719, DOI 10.1016/S0268-0033(01)00090-0; Pearcey GEP, 2019, PHYSIOLOGY, V34, P354, DOI 10.1152/physiol.00008.2019; Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4; Perera CK, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.612064; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Ribot-Ciscar E, 2013, EXP BRAIN RES, V228, P503, DOI 10.1007/s00221-013-3581-6; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Schulz BW, 2011, J BIOMECH, V44, P1277, DOI 10.1016/j.jbiomech.2011.02.010; Severini G, 2018, GAIT POSTURE, V63, P27, DOI 10.1016/j.gaitpost.2018.04.031; Stephen DG, 2012, GAIT POSTURE, V36, P537, DOI 10.1016/j.gaitpost.2012.05.014; Suda EY, 2019, GAIT POSTURE, V74, P194, DOI 10.1016/j.gaitpost.2019.09.014; Taylor AJ, 2004, GAIT POSTURE, V20, P232, DOI 10.1016/j.gaitpost.2003.02.001; Tirosh O, 2013, ANN BIOMED ENG, V41, P1661, DOI 10.1007/s10439-012-0673-6; Trenado C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112782; Trenado C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00022; Trevino M, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00572; VanWezel BMH, 1997, J NEUROSCI, V17, P3804; Wing K, 2012, TOP GERIATR REHABIL, V28, P113, DOI 10.1097/TGR.0b013e31823d9cba; WINTER DA, 1992, PHYS THER, V72, P45, DOI 10.1093/ptj/72.1.45; Yamaguchi S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84247-0; YANG JF, 1990, J NEUROPHYSIOL, V63, P1109, DOI 10.1152/jn.1990.63.5.1109; Zehr EP, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-33; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	52	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0261732	10.1371/journal.pone.0261732	http://dx.doi.org/10.1371/journal.pone.0261732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982783	Green Published, gold			2022-12-27	WOS:000834805700013
J	Fuchs, AA; Balne, PK; Giuliano, EA; Sinha, NR; Mohan, RR				Fuchs, Allison A.; Balne, Praveen K.; Giuliano, Elizabeth A.; Sinha, Nishant R.; Mohan, Rajiv R.			Evaluation of a novel combination of TRAM-34 and ascorbic acid for the treatment of corneal fibrosis in vivo	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; EPIDERMAL-GROWTH-FACTOR; INTERMEDIATE-CONDUCTANCE; MITOMYCIN-C; INHIBITION; HAZE; VORINOSTAT; FIBROBLAST; APOPTOSIS; TARGET	Corneal injury and aberrant wound healing commonly result in corneal fibrosis and subsequent vision loss. Intermediate-conductance calmodulin/calcium-activated K+ channels (K(Ca)3.1) have been shown to promote fibrosis in non-ocular and ocular tissues via upregulation of transforming growth factor beta (TGF beta). TRAM-34 is a selective inhibitor of K(Ca)3.1 and reduces fibrosis by downregulation of TGF beta-induced transdifferentiation of stromal fibroblasts to myofibroblasts. Ascorbic acid has been demonstrated to be effective in promoting corneal re-epithelialization and reduction of neovascularization via anti-VEGF and anti-MMP mechanisms. This study evaluates tolerability and efficacy of a novel combination of TRAM-34 (25 mu M) and ascorbic acid (10%) topical treatment for corneal fibrosis using an established in vivo rabbit model and conducting clinical eye examinations. Markers of corneal fibrosis were evaluated in all corneas at study endpoint via histopathology, immunofluorescence, and quantitative real-time PCR. The eyedrop treated eyes showed significantly improved clinical outcomes based on modified McDonald Shadduck scores, reduction of clinical haze on Fantes scores, and reduction of central corneal thickness (CCT). At cellular and molecular levels, eyedrop treatment also significantly reduced expression of alpha smooth muscle actin (alpha-SMA) mRNA and protein, collagen III mRNA, and fibronectin mRNA compared to non-treated eyes. Our study suggests that a tested new bimodal eyedrop is well tolerated and effectively reduces corneal fibrosis/haze in rabbits in vivo.	[Fuchs, Allison A.; Balne, Praveen K.; Giuliano, Elizabeth A.; Sinha, Nishant R.; Mohan, Rajiv R.] Univ Missouri, Dept Vet Med, Coll Vet Med, Columbia, MO USA; [Fuchs, Allison A.; Balne, Praveen K.; Giuliano, Elizabeth A.; Sinha, Nishant R.; Mohan, Rajiv R.] Univ Missouri, Dept Surg, Coll Vet Med, Columbia, MO USA; [Fuchs, Allison A.; Balne, Praveen K.; Giuliano, Elizabeth A.; Sinha, Nishant R.; Mohan, Rajiv R.] Univ Missouri, Dept Biomed Sci, Coll Vet Med, Columbia, MO USA; [Balne, Praveen K.; Sinha, Nishant R.; Mohan, Rajiv R.] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Mohan, Rajiv R.] Univ Missouri, Mason Eye Inst, Sch Med, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia	Mohan, RR (corresponding author), Univ Missouri, Dept Vet Med, Coll Vet Med, Columbia, MO USA.; Mohan, RR (corresponding author), Univ Missouri, Dept Surg, Coll Vet Med, Columbia, MO USA.; Mohan, RR (corresponding author), Univ Missouri, Dept Biomed Sci, Coll Vet Med, Columbia, MO USA.; Mohan, RR (corresponding author), Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA.; Mohan, RR (corresponding author), Univ Missouri, Mason Eye Inst, Sch Med, Columbia, MO USA.	MohanR@health.missouri.edu	Balne, Praveen Kumar/X-7075-2019	Balne, Praveen Kumar/0000-0001-8365-9991; Mohan, Rajiv/0000-0002-1857-4200	University of Missouri Ruth M. Kraeuchi Endowed Chair Ophthalmology fund; American College of Veterinary Ophthalmologists Vision for Animals Foundation grant; NEI/NIH [R01EY030774, U01EY031650]; United States Department of Veterans Health Affairs [1I01BX00357, IK6BX005646]	University of Missouri Ruth M. Kraeuchi Endowed Chair Ophthalmology fund; American College of Veterinary Ophthalmologists Vision for Animals Foundation grant; NEI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); United States Department of Veterans Health Affairs	The work was mainly supported by the University of Missouri Ruth M. Kraeuchi Endowed Chair Ophthalmology fund (RRM) and the American College of Veterinary Ophthalmologists Vision for Animals Foundation grant (AAF); and partially by the NEI/NIH R01EY030774, NEI/NIH U01EY031650 and United States Department of Veterans Health Affairs 1I01BX00357 and IK6BX005646 grants (RRM).	Agarwal JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063028; Altmann S, 2010, INVEST OPHTH VIS SCI, V51, P4531, DOI 10.1167/iovs.09-5106; Anumanthan G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192145; Anumanthan G, 2018, EXP EYE RES, V167, P140, DOI 10.1016/j.exer.2017.12.003; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Berkowski WM, 2018, INVEST OPHTH VIS SCI, V59, P5509, DOI 10.1167/iovs.17-23085; Bosiack AP, 2012, VET OPHTHALMOL, V15, P291, DOI 10.1111/j.1463-5224.2011.00980.x; Bosiack AP, 2012, VET OPHTHALMOL, V15, P307, DOI 10.1111/j.1463-5224.2011.00985.x; Brown BM, 2020, ANNU REV PHARMACOL, V60, P219, DOI 10.1146/annurev-pharmtox-010919-023420; Buss DG, 2010, VET OPHTHALMOL, V13, P211, DOI 10.1111/j.1463-5224.2010.00782.x; Chen JL, 2017, STEM CELL TRANSL MED, V6, P1356, DOI 10.1002/sctm.16-0441; Choi K, 2012, MOL VIS, V18, P1010; Chowdhury S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070528; Dale E, 2016, GLIA, V64, P1733, DOI 10.1002/glia.22992; Donnelly KS, 2014, VET OPHTHALMOL, V17, P61, DOI 10.1111/vop.12129; Donnelly KS, 2014, VET OPHTHALMOL, V17, P162, DOI 10.1111/vop.12060; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; Fink MK, 2015, VET OPHTHALMOL, V18, P242, DOI 10.1111/vop.12194; Freise C, 2015, LIVER INT, V35, P1244, DOI 10.1111/liv.12681; Freise C, 2014, PHARMACOL RES, V85, P6, DOI 10.1016/j.phrs.2014.04.013; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Gronkiewicz KM, 2016, EXP EYE RES, V143, P75, DOI 10.1016/j.exer.2015.09.010; Gronkiewicz KM, 2016, VET OPHTHALMOL, V19, P480, DOI 10.1111/vop.12331; Gupta R, 2011, VET OPHTHALMOL, V14, P304, DOI 10.1111/j.1463-5224.2011.00877.x; Gupta S, 2018, INVEST OPHTH VIS SCI, V59, P1045, DOI 10.1167/iovs.17-23308; Gupta S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172928; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Kasetsuwan N, 1999, ARCH OPHTHALMOL-CHIC, V117, P649; Koc M, 2017, J OCUL PHARMACOL TH, V33, P525, DOI 10.1089/jop.2017.0025; Lee MY, 2012, CORNEA, V31, P1165, DOI 10.1097/ICO.0b013e318241433b; Lim RR, 2016, SCI REP-UK, V6, DOI 10.1038/srep20841; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Mohan RR, 2019, EXP EYE RES, V180, P200, DOI 10.1016/j.exer.2019.01.001; Mohan RR, 2011, INVEST OPHTH VIS SCI, V52, P4833, DOI 10.1167/iovs.11-7357; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; MoSller-Pedersen T., 2009, CURR EYE RES, V17, P736; Netto MV, 2006, J REFRACT SURG, V22, P562; Netto MV, 2006, EXP EYE RES, V82, P788, DOI 10.1016/j.exer.2005.09.021; PFISTER RR, 1982, INVEST OPHTH VIS SCI, V22, P382; Roach KM, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0022-0; Saika S, 2010, EYE CONTACT LENS, V36, P286, DOI 10.1097/ICL.0b013e3181eef01c; Sharma A, 2016, INVEST OPHTH VIS SCI, V57, P3381, DOI 10.1167/iovs.15-18750; Sharma A, 2009, INVEST OPHTH VIS SCI, V50, P2695, DOI 10.1167/iovs.08-2919; Tandon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066434; Tandon A, 2012, J REFRACT SURG, V28, P285, DOI 10.3928/1081597X-20120210-01; Torricelli AAM, 2016, EXP EYE RES, V142, P110, DOI 10.1016/j.exer.2014.09.012; Torricelli AAM, 2014, EXP EYE RES, V129, P151, DOI 10.1016/j.exer.2014.09.013; Wang LY, 2011, MOL VIS, V17, P2835; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Yang HK, 2013, EXP EYE RES, V110, P76, DOI 10.1016/j.exer.2013.02.015; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314	52	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262046	10.1371/journal.pone.0262046	http://dx.doi.org/10.1371/journal.pone.0262046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007294	gold, Green Published			2022-12-27	WOS:000741060700014
J	Carey, IM; Banchoff, E; Nirmalananthan, N; Harris, T; DeWilde, S; Chaudhry, UAR; Cook, DG				Carey, Iain M.; Banchoff, Emma; Nirmalananthan, Niranjanan; Harris, Tess; DeWilde, Stephen; Chaudhry, Umar A. R.; Cook, Derek G.			Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; AMYOTROPHIC-LATERAL-SCLEROSIS; DUCHENNE MUSCULAR-DYSTROPHY; MYASTHENIA-GRAVIS; INFLAMMATORY MYOPATHIES; EPIDEMIOLOGY; DISEASE; NATIONWIDE; METAANALYSIS; VALIDATION	Background In the UK, large-scale electronic primary care datasets can provide up-to-date, accurate epidemiological information on rarer diseases, where specialist diagnoses from hospital discharges and clinic letters are generally well recorded and electronically searchable. Current estimates of the number of people living with neuromuscular disease (NMD) have largely been based on secondary care data sources and lacked direct denominators. Objective To estimate trends in the recording of neuromuscular disease in UK primary care between 2000-2019. Methods The Clinical Practice Research Datalink (CPRD) database was searched electronically to estimate incidence and prevalence rates (per 100,000) for a range of NMDs in each year. To compare trends over time, rates were age standardised to the most recent CPRD population (2019). Results Approximately 13 million patients were actively registered in each year. By 2019, 28,230 active patients had ever received a NMD diagnosis (223.6), which was higher among males (239.0) than females (208.3). The most common classifications were Guillain-Barre syndrome (40.1), myasthenia gravis (33.7), muscular dystrophy (29.5), Charcot-Marie-Tooth (29.5) and inflammatory myopathies (25.0). Since 2000, overall prevalence grew by 63%, with the largest increases seen at older ages (>= 65-years). However, overall incidence remained constant, though myasthenia gravis incidence has risen steadily since 2008, while new cases of muscular dystrophy fell over the same period. Conclusions Lifetime recording of many NMDs on primary care records exceed current estimates of people living with these conditions; these are important data for health service and care planning. Temporal trends suggest this number is steadily increasing, and while this may partially be due to better recording, it cannot be simply explained by new cases, as incidence remained constant. The increase in prevalence among older ages suggests increases in life expectancy among those living with NMDs may have occurred.	[Carey, Iain M.; Banchoff, Emma; Harris, Tess; DeWilde, Stephen; Chaudhry, Umar A. R.; Cook, Derek G.] St Georges Univ London, Populat Hlth Res Inst, London, England; [Nirmalananthan, Niranjanan] St Georges Hosp NHS Trust, Dept Neurol, London, England	St Georges University London; St Georges University London	Carey, IM (corresponding author), St Georges Univ London, Populat Hlth Res Inst, London, England.	sgjd450@sgul.ac.uk	Carey, Iain/O-6973-2014	Carey, Iain/0000-0003-1099-8460; Harris, Tess/0000-0002-8671-1553; Banchoff, Emma/0000-0003-3341-4878	Muscular Dystrophy UK [19GROE-PG24-0349-2]	Muscular Dystrophy UK	The study was funded from a research grant from Muscular Dystrophy UK (Grant Ref 19GROE-PG24-0349-2) awarded to Iain Carey as principal investigator. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Hakem H, 2019, J NEUROL, V266, P440, DOI 10.1007/s00415-018-9151-x; Alkhawajah NM, 2013, MUSCLE NERVE, V48, P705, DOI 10.1002/mus.23964; All Party Parliamentary Group for Muscular Dystrophy, 2015, IMP NHS REF ACC NEUR; Barcelo MA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85395-z; Bhatt JM, 2016, NEUROL CLIN, V34, P999, DOI 10.1016/j.ncl.2016.06.017; Bragazzi NL, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02319-4; Breiner A, 2016, NEUROMUSCULAR DISORD, V26, P41, DOI 10.1016/j.nmd.2015.10.009; Carr AS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-46; Cetin H, 2012, WIEN KLIN WOCHENSCHR, V124, P763, DOI 10.1007/s00508-012-0258-2; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; Chiu ATG, 2021, EUR J NEUROL, V28, P2305, DOI 10.1111/ene.14852; Cho SK, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e55; Cole JA, 2016, PHARMACOEPIDEM DR S, V25, P103; Crisafulli S, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01430-8; de Jongh AD, 2021, NEUROLOGY, V96, pE1227, DOI 10.1212/WNL.0000000000011467; Deenen Johanna C W, 2015, J Neuromuscul Dis, V2, P73; Delannoy A, 2017, J PERIPHER NERV SYST, V22, P51, DOI 10.1111/jns.12202; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Foley C, 2012, J NEUROL NEUROSUR PS, V83, P573, DOI 10.1136/jnnp-2011-300285; Funch D, 2013, VACCINE, V31, P2075, DOI 10.1016/j.vaccine.2013.02.009; Green JD, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037909; Groft SC, 2010, ADV EXP MED BIOL, V686, P3, DOI 10.1007/978-90-481-9485-8_1; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hughes MI, 1996, NEUROMUSCULAR DISORD, V6, P69, DOI 10.1016/0960-8966(94)00017-4; Kontopantelis E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020738; Laura M, 2019, CURR OPIN NEUROL, V32, P641, DOI 10.1097/WCO.0000000000000735; Lefter S, 2017, NEUROLOGY, V88, P304, DOI 10.1212/WNL.0000000000003504; Levison LS, 2019, CLIN EPIDEMIOL, V11, P275, DOI 10.2147/CLEP.S199839; Barreto LCLS, 2016, NEUROEPIDEMIOLOGY, V46, P157, DOI 10.1159/000443706; Logroscino G, 2018, LANCET NEUROL, V17, P1083, DOI 10.1016/S1474-4422(18)30404-6; Mackenzie IS, 2014, J NEUROL NEUROSUR PS, V85, P76, DOI 10.1136/jnnp-2013-305450; Mah JK, 2016, CAN J NEUROL SCI, V43, P163, DOI 10.1017/cjn.2015.311; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; Mandall NA, 2005, BRIT DENT J, V199, P659, DOI 10.1038/sj.bdj.4812930; Marin B, 2017, INT J EPIDEMIOL, V46, P57, DOI 10.1093/ije/dyw061; McGrogan A, 2010, NEUROEPIDEMIOLOGY, V34, P171, DOI 10.1159/000279334; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; Meyer A, 2015, RHEUMATOLOGY, V54, P50, DOI 10.1093/rheumatology/keu289; Muller KI, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.1948; Muscular Dystrophy Campaign, MUSCL DIS IMP INC PR; National Institute of Neurological Disorders and Stroke, 2018, GUILLAIN BARRE SYNDR; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Ohta A, 2014, MOD RHEUMATOL, V24, P477, DOI 10.3109/14397595.2013.844308; Pallaver F, 2011, NEUROEPIDEMIOLOGY, V36, P282, DOI 10.1159/000328863; Parkinson's UK, 2017, PREVALENCE INCIDENCE; Public Health England National Neurology Intelligence network and National End of life Care Intelligence Network, 2018, DEATHS ASS NEUR COND; Rodger S, 2015, J NEUROL, V262, P629, DOI 10.1007/s00415-014-7585-3; Rose L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210574; Rudant J, 2018, NEUROLOGY, V91, pE1220, DOI 10.1212/WNL.0000000000006246; Schorling E, 2019, NEUROLOGY, V92, pE2027, DOI 10.1212/WNL.0000000000007376; Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710; Sipila JOT, 2019, J NEUROL SCI, V407, DOI 10.1016/j.jns.2019.116520; Sipila JOT, 2017, J PERIPHER NERV SYST, V22, P440, DOI 10.1111/jns.12239; Sobieszczuk E, 2021, NEUROEPIDEMIOLOGY, V55, P62, DOI 10.1159/000512973; Springate DA, 2017, BRIT J DERMATOL, V176, P650, DOI 10.1111/bjd.15021; Svensson J, 2017, RHEUMATOLOGY, V56, P802, DOI 10.1093/rheumatology/kew503; Swain S, 2020, OSTEOARTHR CARTILAGE, V28, P792, DOI 10.1016/j.joca.2020.03.004; Theadom A, 2014, NEUROEPIDEMIOLOGY, V43, P259, DOI 10.1159/000369343; Tran TN., 2014, ANN RHEUM DIS, V71; Vellozzi C, 2014, CLIN INFECT DIS, V58, P1149, DOI 10.1093/cid/ciu005; Wakap SN, 2020, EUR J HUM GENET, V28, P165, DOI 10.1038/s41431-019-0508-0; Ward MM, 2005, EPIDEMIOLOGY, V16, P270, DOI 10.1097/01.ede.0000153643.88019.92; Westerberg E, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1819; Willett DL, 2018, APPL CLIN INFORM, V9, P667, DOI 10.1055/s-0038-1668090; Wolf A, 2019, INT J EPIDEMIOL, V48, P1740, DOI 10.1093/ije/dyz034; Xu L, 2020, J NEUROL, V267, P944, DOI 10.1007/s00415-019-09652-y; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525; Zghebi SS, 2017, DIABETES OBES METAB, V19, P1537, DOI 10.1111/dom.12964	70	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261983	10.1371/journal.pone.0261983	http://dx.doi.org/10.1371/journal.pone.0261983			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972157	Green Accepted, Green Published, gold			2022-12-27	WOS:000773555700080
J	Dembelu, M; Kote, M; Gilano, G; Mohammed, T				Dembelu, Maycas; Kote, Mesfin; Gilano, Girma; Mohammed, Temesgen			Incidence and predictors of reoccurrence of opportunistic infection among adult HIV/AIDS patients attending ART clinic at public health facilities in Arba Minch town, southern Ethiopia: A retrospective cohort study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV; PREVALENCE	Background Human immunodeficiency virus (HIV) infected individuals are prone to opportunistic infections (OIs) due to HIV mediated immune suppression. When opportunistic infections occur in the form of relapse or reinfection, it is said to be reoccurrence. This study was aimed to assess Incidence and predictors of reoccurrence of opportunistic infections among adult people living with HIV (PLHIV) attending ART clinics in Arba Minch Town, Southern Ethiopia Methods This retrospective cohort study was conducted on 450 HIV/AIDS patients attending anti-retro viral therapy (ART) clinics in Arba Minch town, southern Ethiopia. Simple random sampling technique was used. Kaplan-Meier graph and log rank test were used for group wise comparison. Bivariate and multivariable Cox Proportional Hazard Regression model were used to identify independent predictors of reoccurrence of opportunistic infection. Result One hundred nineteen HIV/AIDS patient had reoccurrence of opportunistic infection. The incidence rate was 11.5 per 1000 person months. The mean time of reoccurrence was 56 months. One of the most reoccurred OIs was pulmonary tuberculosis (PTB). Predictors that were associated significantly were recent cell differentiation 4 (CD4) count, recent body mass index (BMI), recent functional status, and duration on anti-retroviral therapy (ART). Conclusion Though the incidence rate of OIs decreased from previous findings, attention should be given to HIV patients with low CD4 count, low BMI and for those bedridden patients.	[Dembelu, Maycas] Mettu Univ, Fac Hlth Sci, Dept Nursing, Mettu, Ethiopia; [Kote, Mesfin; Gilano, Girma] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Arba Minch, Ethiopia; [Mohammed, Temesgen] Arba Minch Coll Hlth Sci, Dept Publ Hlth, Arba Minch, Ethiopia	Arba Minch University	Dembelu, M (corresponding author), Mettu Univ, Fac Hlth Sci, Dept Nursing, Mettu, Ethiopia.	MaycasDembelu27@gmail.com	Toma, Temesgen Mohammed/GZK-9176-2022; Gilano, Girma/AAU-4939-2021	Toma, Temesgen Mohammed/0000-0001-8849-6722; Gilano, Girma/0000-0002-5847-1425; Dembelu, Maycas/0000-0002-6620-8547				Achenbach CJ, 2012, CLIN INFECT DIS, V54, P424, DOI 10.1093/cid/cir802; Alemu G, 2018, ETHIOP J HEALTH SCI, V28, P147, DOI 10.4314/ejhs.v28i2.6; [Anonymous], 2011, EFF HAART INC TUB HI; [Anonymous], 2009, TRUTH STUDY TB RECUR, DOI [10.2147/IDR.S150644, DOI 10.2147/IDR.S150644]; [Anonymous], 2018, PREVALENCE OPPORTUNI; [Anonymous], 2018, HIV AIDS E SO AFRICA; Buchacz K, 2016, J INFECT DIS, V214, P862, DOI 10.1093/infdis/jiw085; Debasu DGYea., 2013, BMC RES NOTES, V6; Dereje N, 2019, HIV AIDS-RES PALLIAT, V11, P229, DOI 10.2147/HIV.S218213; HIV-AIDS, 2019, WHO MYANM WORLD AIDS; Kaplan Jonathan E., GUIDELINES PREVENTIO; Krishnaraj Raja, 2014, J Int Assoc Provid AIDS Care, V13, P15, DOI 10.1177/2325957413488170; Li XL, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3991-6; Lokpo SY, 2020, AIDS RES TREAT, V2020, DOI 10.1155/2020/9247451; Maggi P, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4184-z; Mellie H., 2014, J AIDS CLIN RES, V03, DOI [10.4172/2155-6113.1000226, DOI 10.4172/2155-6113.1000226]; Naidoo K, 2018, INFECT DRUG RESIST, V11, P1413, DOI 10.2147/IDR.S150644; Nelson KCL., 2017, UGANDA COHORT STUDY, V23; Tanuma J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150781	19	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261454	10.1371/journal.pone.0261454	http://dx.doi.org/10.1371/journal.pone.0261454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972122	gold, Green Published			2022-12-27	WOS:000773555700033
J	Gilano, G; Hailegebreal, S; Seboka, BT				Gilano, Girma; Hailegebreal, Samuel; Seboka, Binyam Tariku			Geographical variation and associated factors of vitamin A supplementation among 6-59-month children in Ethiopia	PLOS ONE			English	Article							MORTALITY; COVERAGE	Introduction Vitamin A has been one of the most important micronutrients which are necessary for the health of the children. In developing countries, the supplementation of vitamins under a regular schedule had different constraints. Awareness, access, and resource limitations were usually the problem. In the current study, we analyzed the data from the demographic health survey (EDHS) 2016 to uncover the spatial distribution, predictors, and to provide additional information for policymaking and interventions. Methods In this analysis, we applied intra-community correlation to measure the random effect; global Moran's I to test the nature of variance in the null model; proportional change in variance to check the variance of null and neighborhood in subsequent models. We used STATA 15 for prediction; ArcGIS 10.7 for the spatial distribution of vitamin A supplementation; SaTscan 9.6.1 to specify location of clustering were the applied soft wares. After confirming that the traditional logistic regression cannot explore the variances, we applied multilevel logistic regression to examine predictors where p-value <0.25 was used to include variables into the model and p-value<0.05 was used to declare associations. We presented the result using means, standard deviations, numbers, and proportions or percent, and AOR with 95% CI. Result The vitamin A coverage was 4,029.22 (44.90%) in Ethiopia in 2016. The distribution followed some spatial geo-locations where Afar, Somali were severely affected (RR = 1.46, P-value < 0.001), some pockets of Addis Ababa (RR = 1.47, p-value <0.001), and the poor distribution also affected all other regions partially. Place of delivery 1.2(1-1.34), primary and secondary education 1.3 (1-1.6), media exposure 1.2(1.1-1.4), having work 1.4(1.2-1.5), and all visits of ANC were positively influenced the distribution. Conclusion The distribution of vitamin A coverage was not random as per the EDHS 2016 data. Regions like Afar, Somali, and some pocket areas in Addis inquires immediate interventions. Pastoralist, agrarian, and city administrations were all involved from severe to the lesser coverage in order. Since factors like Place of delivery, education, ANC, media exposure, and having work were showed positive associations, interventions considering awareness, access, and availability of service need more attention than ever.	[Gilano, Girma; Hailegebreal, Samuel] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Hlth Informat, Arba Minch, Ethiopia; [Seboka, Binyam Tariku] Dilla Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Hlth Informat, Dilla, Ethiopia	Arba Minch University; Dilla University	Gilano, G (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Hlth Informat, Arba Minch, Ethiopia.	gilanog@yahoo.com	Gilano, Girma/AAU-4939-2021; Seboka, Binyam Tariku/AAC-5370-2021	Gilano, Girma/0000-0002-5847-1425; Seboka, Binyam Tariku/0000-0002-8309-5986; Hailegebreal, Samuel/0000-0003-0887-7803				Adamu M. D., 2016, Annals of Nigerian Medicine, V10, P16, DOI 10.4103/0331-3131.189803; Aghaji AE., 2019, BMC PUBLIC HEALTH, V19, P1, DOI [10.1186/s12889-018-6343-3, DOI 10.1186/S12889-018-6343-3]; [Anonymous], 2021, UNICEF EV CHILD ETH, P1; Central statistical agency (CSA)[Ethiopia] and ICF, ETH DEM HLTH SURV; Chisti M. J., 2013, Food and Nutrition Sciences, V4, P150, DOI 10.4236/fns.2013.42021; Choi YJ, 2005, J HEALTH POPUL NUTR, V23, P156; Demissie T, 2010, FOOD NUTR BULL, V31, P234, DOI 10.1177/156482651003100206; ECSA, 2016, ETH DEM HLTH SURV, P161; Gatobu S, 2017, FOOD NUTR BULL, V38, P564, DOI 10.1177/0379572117708657; Gebremedhin S, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-79; Haidar J., 2016, THE MAGAZINE; Hurt L, 2013, B WORLD HEALTH ORGAN, V91, P19, DOI 10.2471/BLT.11.100412; Janmohamed A, 2017, PUBLIC HEALTH NUTR, V20, P2016, DOI 10.1017/S1368980017000684; Kassa G, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09617-1; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Muche A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82755-7; Regional O., 2012, OROMIA REGIONAL HLTH; Rodriguez G, 2003, STATA J, V3, P32, DOI 10.1177/1536867X0300300102; Ross DA, 2002, J NUTR, V132, p2902S, DOI 10.1093/jn/132.9.2902S; Semba RD, 2008, J TROP PEDIATRICS, V54, P141, DOI 10.1093/tropej/fmm095; SOMMER A, 1986, LANCET, V1, P1169; Tariku Amare, 2016, BMC Res Notes, V9, P323, DOI 10.1186/s13104-016-2134-z; WHO, 2011, GUID VIT SUPPL INF C; Wilfred N. D., 2018, Food and Nutrition Sciences, V9, P247, DOI 10.4236/fns.2018.93019; World Bank Group, 2019, ETH NUTR PROJ PERF A, P9; World Health Organization & Centers for Disease Control and Prevention (U.S, 2014, METHODOLOGICAL APPRO; Zhang XY, 2020, FOODS, V9, DOI 10.3390/foods9020232	27	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261959	10.1371/journal.pone.0261959	http://dx.doi.org/10.1371/journal.pone.0261959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972168	gold, Green Published			2022-12-27	WOS:000773555700076
J	Skov, F				Skov, Flemming			Science maps for exploration, navigation, and reflection-A graphic approach to strategic thinking	PLOS ONE			English	Article							NETWORK; VISUALIZATION; COLLECTIONS; KNOWLEDGE	The world of science is growing at an unprecedented speed with more and more scholarly papers produced each year. The scientific landscape is constantly changing as research specialties evolve, merge or become obsolete. It is difficult for researchers, research managers and the public alike to keep abreast with these changes and maintain a true and fair overview of the world of science. Such an overview is necessary to stimulate scientific progress, to maintain flexible and responsive research organizations, and to secure collaboration and knowledge exchange between different research specialties and the wider community. Although science mapping is applied to a wide range of scientific areas, examples of their practical use are sparse. This paper demonstrates how to use a topical, scientific reference maps to understand and navigate in dynamic research landscapes and how to utilize science maps to facilitate strategic thinking. In this study, the research domain of biology at Aarhus University serves as an example. All scientific papers authored by the current, permanent staff were extracted (6,830 in total). These papers were used to create a semantic cognitive map of the research field using a co-word analysis based on keywords and keyword phrases. A workflow was written in Python for easy and fast retrieval of information for topic maps (including tokens from keywords section and title) to generate intelligible research maps, and to visualize the distribution of topics (keywords), papers, journal categories, individual researchers and research groups on any scale. The resulting projections revealed new insights into the structure of the research community and made it possible to compare researchers or research groups to describe differences and similarities, to find scientific overlaps or gaps, and to understand how they relate and connect. Science mapping can be used for intended (top-down) as well as emergent (bottom-up) strategy development. The paper concludes that science maps provide alternative views of the intricate structures of science to supplement traditional bibliometric information. These insights may help strengthen strategic thinking and boost creativity and thus contribute to the progress of science.	[Skov, Flemming] Aarhus Univ, Dept Ecosci, Aarhus, Denmark	Aarhus University	Skov, F (corresponding author), Aarhus Univ, Dept Ecosci, Aarhus, Denmark.	fs@ecos.au.dk	Skov, Flemming/I-2665-2013	Skov, Flemming/0000-0002-9490-8663				ARGYRIS C, 1977, HARVARD BUS REV, V55, P115; Aria M, 2017, J INFORMETR, V11, P959, DOI 10.1016/j.joi.2017.08.007; Borner K, 2003, ANNU REV INFORM SCI, V37, P179, DOI 10.1002/aris.1440370106; Borner K, 2007, ENVIRON PLANN B, V34, P808, DOI 10.1068/b3302t; Borner K, 2018, P NATL ACAD SCI USA, V115, P12573, DOI 10.1073/pnas.1818750115; Borner K, 2018, SCIENTOMETRICS, V114, P409, DOI 10.1007/s11192-017-2596-3; Borner K, 2009, J INFORMETR, V3, P161, DOI 10.1016/j.joi.2009.03.008; Borrett SR, 2018, ECOL MODEL, V382, P63, DOI 10.1016/j.ecolmodel.2018.04.020; Borrett SR, 2014, ECOL MODEL, V293, P111, DOI 10.1016/j.ecolmodel.2014.02.019; Boyack KW, 2014, J ASSOC INF SCI TECH, V65, P670, DOI 10.1002/asi.22990; Boyack KW, 2009, SCIENTOMETRICS, V79, P27, DOI 10.1007/s11192-009-0402-6; Casey AJ, 2010, MANAGE LEARN, V41, P167, DOI 10.1177/1350507609355497; Catala-Lopez F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189091; Chandra Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190228; Chen CM, 2017, J DATA INFO SCI, V2, P1, DOI 10.1515/jdis-2017-0006; Chen CM, 2006, J AM SOC INF SCI TEC, V57, P359, DOI 10.1002/asi.20317; Cobo MJ, 2011, J AM SOC INF SCI TEC, V62, P1382, DOI 10.1002/asi.21525; Dworkin JD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216146; Dworkin JD, 2018, NEUROIMAGE, V183, P872, DOI 10.1016/j.neuroimage.2018.09.005; Fortunato S, 2018, SCIENCE, V359, DOI 10.1126/science.aao0185; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Grauwin S, 2012, J AM SOC INF SCI TEC, V63, P1327, DOI 10.1002/asi.22644; Haunschild R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160393; Heinze T, 2009, RES POLICY, V38, P610, DOI 10.1016/j.respol.2009.01.014; Heracleous L, 1998, LONG RANGE PLANN, V31, P481, DOI 10.1016/S0024-6301(98)80015-0; Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Ioana-Toroimac G, 2018, J ENVIRON MANAGE, V206, P1135, DOI 10.1016/j.jenvman.2017.11.078; Jin RY, 2019, RESOUR CONSERV RECY, V140, P175, DOI 10.1016/j.resconrec.2018.09.029; Kawamura T, 2018, SCIENTOMETRICS, V116, P941, DOI 10.1007/s11192-018-2783-x; Kim J, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8101075; Kim Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196104; Lariviere V, 2015, J ASSOC INF SCI TECH, V66, P1323, DOI 10.1002/asi.23266; Lee YN, 2015, RES POLICY, V44, P684, DOI 10.1016/j.respol.2014.10.007; Leydesdorff L, 2013, SCIENTOMETRICS, V94, P589, DOI 10.1007/s11192-012-0784-8; Leydesdorff L, 2009, J AM SOC INF SCI TEC, V60, P348, DOI 10.1002/asi.20967; Liedtka JM, 1998, LONG RANGE PLANN, V31, P120, DOI 10.1016/S0024-6301(97)00098-8; Mao A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153048; Martinez S, 2019, ECOL INDIC, V106, DOI 10.1016/j.ecolind.2019.105543; Milojevic S, 2015, J INFORMETR, V9, P962, DOI 10.1016/j.joi.2015.10.005; Mingers J, 2015, EUR J OPER RES, V246, P1, DOI 10.1016/j.ejor.2015.04.002; MINTZBERG H, 1985, ADMIN SCI QUART, V30, P160, DOI 10.2307/2393104; MINTZBERG H, 1994, HARVARD BUS REV, V72, P107; MINTZBERG H, 1994, LONG RANGE PLANN, V27, P12, DOI 10.1016/0024-6301(94)90185-6; Morris SA, 2004, P NATL ACAD SCI USA, V101, P5291, DOI 10.1073/pnas.0307604100; Morris SA, 2008, ANNU REV INFORM SCI, V42, P213; Nardi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155016; Newman D, 2010, J WEB SEMANT, V8, P169, DOI 10.1016/j.websem.2010.03.005; PETROVICH E., 2020, SCI MAPPING; Porter M.E., 1996, HARVARD BUS REV, V74, P61; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Radhakrishnan S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172778; Rafols I, 2010, J AM SOC INF SCI TEC, V61, P1871, DOI 10.1002/asi.21368; Raimbault J, 2019, SCIENTOMETRICS, V119, P617, DOI 10.1007/s11192-019-03090-3; Robinson-Garcia N, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz075; Rotolo D, 2017, J ASSOC INF SCI TECH, V68, P214, DOI 10.1002/asi.23631; Sajovic I, 2018, COLLNET J SCIENTOMET, V12, P263, DOI 10.1080/09737766.2018.1453677; Shen S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191250; Skov F, 2018, STI 2018 C P 23 INT, P8; Skupin A, 2009, J INFORMETR, V3, P233, DOI 10.1016/j.joi.2009.03.002; Small H, 2014, RES POLICY, V43, P1450, DOI 10.1016/j.respol.2014.02.005; Song M, 2015, SCIENTOMETRICS, V102, P905, DOI 10.1007/s11192-014-1372-x; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; van Eck NJ, 2009, PRO INT CONF SCI INF, V2, P886; Waltman L, 2010, J INFORMETR, V4, P629, DOI 10.1016/j.joi.2010.07.002	65	0	0	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262081	10.1371/journal.pone.0262081	http://dx.doi.org/10.1371/journal.pone.0262081			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972185	gold, Green Published			2022-12-27	WOS:000773555700091
J	Wu, MT; Aranovich, R; Filkov, V				Wu, Muting; Aranovich, Raul; Filkov, Vladimir			Evolution and differentiation of the cybersecurity communities in three social question and answer sites: A mixed-methods analysis	PLOS ONE			English	Article							STACK OVERFLOW	Cybersecurity affects us all in our daily lives. New knowledge on best practices, new vulnerabilities, and timely fixes for cybersecurity issues is growing super-linearly, and is spread across numerous, heterogeneous sources. Because of that, community contribution-based, question and answer sites have become clearinghouses for cybersecurity-related inquiries, as they have for many other topics. Historically, Stack Overflow has been the most popular platform for different kinds of technical questions, including for cybersecurity. That has been changing, however, with the advent of Security Stack Exchange, a site specifically designed for cybersecurity-related questions and answers. More recently, some cybersecurity-related subreddits of Reddit, have become hubs for cybersecurity-related questions and discussions. The availability of multiple overlapping communities has created a complex terrain to navigate for someone looking for an answer to a cybersecurity question. In this paper, we investigate how and why people choose among three prominent, overlapping, question and answer communities, for their cybersecurity knowledge needs. We aggregated data of several consecutive years of cybersecurity-related questions from Stack Overflow, Security Stack Exchange, and Reddit, and performed statistical, linguistic, and longitudinal analysis. To triangulate the results, we also conducted user surveys. We found that the user behavior across those three communities is different, in most cases. Likewise, cybersecurity-related questions asked on the three sites are different, more technical on Security Stack Exchange and Stack Overflow, and more subjective and personal on Reddit. Moreover, there appears to have been a differentiation of the communities along the same lines, accompanied by overall popularity trends suggestive of Stack Overflow's decline and Security Stack Exchange's rise within the cybersecurity community. Reddit is addressing the more subjective, discussion type needs of the lay community, and is growing rapidly.	[Wu, Muting; Filkov, Vladimir] Univ Calif Davis, Dept Comp Sci, DECAL Lab, Davis, CA 95616 USA; [Aranovich, Raul] Univ Calif Davis, Dept Linguist, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis	Wu, MT; Filkov, V (corresponding author), Univ Calif Davis, Dept Comp Sci, DECAL Lab, Davis, CA 95616 USA.	mtiwu@ucdavis.edu; vlfilkov@ucdavis.edu		Wu, Muting/0000-0001-6926-0853	Office of Advanced Cyberinfrastructure department under the NSF	Office of Advanced Cyberinfrastructure department under the NSF	The work is funded by the Office of Advanced Cyberinfrastructure department under the NSF. You can check it out through: https://www.nsf.gov/awardsearch/showAward?AWD_ID= 1840191&HistoricalAwards=false.	Abdalkareem R, 2017, INFORM SOFTWARE TECH, V88, P148, DOI 10.1016/j.infsof.2017.04.005; Alexa, 2021, TOP 500 SIT WEB; Aniche M, 2018, PROCEEDINGS 2018 IEEE/ACM 40TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE), P499, DOI 10.1145/3180155.3180180; [Anonymous], PHP IS PHP SAPI NAME; [Anonymous], 2021, REDDIT R WORLDNEWS; [Anonymous], Why do we want a timeout on a server?; [Anonymous], SHOULD LOOK JOB IND; [Anonymous], ARE THERE ENTRY LEVE; [Anonymous], 2021, GNU LIN FREE SOFTW; [Anonymous], DOES MY CODE PREVENT; [Anonymous], 2021, REDDIT R NETSEC INFO; [Anonymous], VPS RECOMMENDATIONS; [Anonymous], 2021, REDDIT R SECURITY; [Anonymous], IS CRASH ALWAYS EXPL; [Anonymous], LEARNING RECOMMENDAT; [Anonymous], 2021, REDDIT R GAMING; Answers, 2021, MOST TRUSTED PLACE A; Archive I, 2020, STACK EXCH DAT DUMP; Baltes S, 2019, EMPIR SOFTW ENG, V24, P1259, DOI 10.1007/s10664-018-9650-5; Barua A, 2014, EMPIR SOFTW ENG, V19, P619, DOI 10.1007/s10664-012-9231-y; Baumgartner J., 2020, P INT AAAI C WEB SOC, V14, P830, DOI DOI 10.5281/ZENODO.3608135; Beyer S, 2015, INT C PROGRAM COMPRE, P94, DOI 10.1109/ICPC.2015.18; Blackmore C, 2010, SOCIAL LEARNING SYSTEMS AND COMMUNITIES OF PRACTICE, P1, DOI 10.1007/978-1-84996-133-2; Bourhis A., 2005, ELECT J KNOWLEDGE MA, V3, P23; Chipidza W, 2021, INT J INFORM MANAGE, V61, DOI 10.1016/j.ijinfomgt.2021.102397; CVE, 2014, CVE20140160; CVE, 2021, CVE COMM VULN EXP; Devlin J., 2019, NAACL, P4171; Dube L, 2005, J ORGAN CHANGE MANAG, V18, P145, DOI 10.1108/09534810510589570; Duggan M., 2013, PEW INTERNET AM LIFE, V3, P1; Durumeric Z, 2014, PROCEEDINGS OF THE 2014 ACM INTERNET MEASUREMENT CONFERENCE (IMC'14), P475, DOI 10.1145/2663716.2663755; ESRI, 2021, WHAT IS GIS FRAM ORG; Exchange MS, 2021, AC PAP US STACK EXH; Exchange S., 2021, STACK EXCHANGE API; Exchange S, 2021, STACK EXCHANGE; Exchange S., 2021, STACK EXCHANGE TRAFF; Exchange SS, 2021, INFORM SECURITY STAC; Exchange US, 2021, UNIX LINUX STACK EXC; Gazan R, 2011, J AM SOC INF SCI TEC, V62, P2301, DOI 10.1002/asi.21562; Google, 2006, GOOGLE; Hamid B, 2019, 2019 13TH INTERNATIONAL CONFERENCE ON MATHEMATICS, ACTUARIAL SCIENCE, COMPUTER SCIENCE AND STATISTICS (MACS-13); Hara Noriko, 2007, Information Technology & People, V20, P235, DOI 10.1108/09593840710822859; Harper FM, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P759; Heartbleed, 2020, THE HEARTBLEED BUG; Humayun M., 2021, TURKISH J COMPUTER M, V12, P2957; Jhaver Shagun, 2019, Proceedings of the ACM on Human-Computer Interaction, V3, DOI 10.1145/3359252; Lai KW., 2006, EDUCATION; Lave J., 1991, SITUATED LEARNING LE; Leavitt A, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P317, DOI 10.1145/2675133.2675175; Li LC, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-11; Liang YY, 2017, CSCW'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, P146, DOI 10.1145/2998181.2998217; Lippman RP, 2017, WORKSH 31 AAAI C ART; Liu J, 2018, AUTOMAT SOFTW ENG, V25, P675, DOI 10.1007/s10515-018-0239-4; Lopez T, 2019, 2019 IEEE/ACM 41ST INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING: SOFTWARE ENGINEERING IN SOCIETY (ICSE-SEIS 2019), P31, DOI 10.1109/ICSE-SEIS.2019.00012; Lopez T, 2018, 2018 IEEE/ACM 1ST INTERNATIONAL WORKSHOP ON SECURITY AWARENESS FROM DESIGN TO DEPLOYMENT (SEAD), P26, DOI 10.1145/3194707.3194713; Lu Y, 2019, IEEE INTERNET THINGS, V6, P2103, DOI 10.1109/JIOT.2018.2869847; Mittal S, 2016, PROCEEDINGS OF THE 2016 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING ASONAM 2016, P860, DOI 10.1109/ASONAM.2016.7752338; Murillo E, 2008, INFORM RES, V13; October Obrst L., 2012, STIDS, P49; OpenSSL, 2014, PATCH CVE 2014 0160; OpenSSL, 2021, OPENSSL CRYPT SSL TL; Overflow S, 2021, STACK OVERFLOW WHERE; Pushshift.io, 2021, PUSHSH IO AP DOC; Reddit, 2021, HOMEPAGE REDDIT; Reddit, 2021, REDD FRONT PAG INT; Reddit, 2021, API DOC; RedditBots, 2019, AUTOWIKIBOT; Reimers N, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P3982; Silva RFG, 2018, 2018 25TH IEEE INTERNATIONAL CONFERENCE ON SOFTWARE ANALYSIS, EVOLUTION AND REENGINEERING (SANER 2018), P572; Singh P, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16 COMPANION), P699, DOI 10.1145/2872518.2890569; Squire M, 2015, 2015 IEEE/ACM 37TH IEEE INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING, VOL 2, P219, DOI 10.1109/ICSE.2015.150; Stack Exchange, 2021, STACK EXCH DAT; Stack Overflow, 2021, 2021 ANN DEV SURV; Stoddard G, 2015, WWW'15 COMPANION: PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P815, DOI 10.1145/2740908.2742470; Surowiecki James, 2004, WISDOM CROWDS; Syed Z., 2016, WORKSH 30 AAAI ART I; Taddeo M, 2019, NAT MACH INTELL, V1, P557, DOI 10.1038/s42256-019-0109-1; Triet Huynh Minh Le, 2020, MSR '20: Proceedings of the 17th International Conference on Mining Software Repositories, P350, DOI 10.1145/3379597.3387443; Vasilescu B., 2014, P 17 ACM C COMP SUPP, P342, DOI DOI 10.1145/2531602.2531659; VULDB, 2021, COMM DRIV VULN DAT; Wang JQ, 2009, PROCEEDINGS OF 2009 CONFERENCE ON SYSTEMS SCIENCE, MANAGEMENT SCIENCE & SYSTEM DYNAMICS, VOL 7, P1; Wenger E., 2002, CULTIVATING COMMUNIT; Weninger Tim, 2013, 2013 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining (ASONAM), P579; Yahoo, 2021, YAHOO; Zagalsky A, 2018, EMPIR SOFTW ENG, V23, P953, DOI 10.1007/s10664-017-9536-y; Zahedi M, 2018, PROCEEDINGS OF THE 51ST ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES (HICSS), P5504; Zhang WE, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P1221, DOI 10.1145/3038912.3052701; Zong S, 2019, P 2019 C N AM CHAPT, V1, P1380	90	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261954	10.1371/journal.pone.0261954	http://dx.doi.org/10.1371/journal.pone.0261954			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972166	Green Published, gold			2022-12-27	WOS:000773555700074
J	Harati, R; Hammad, S; Tlili, A; Mahfood, M; Mabondzo, A; Hamoudi, R				Harati, Rania; Hammad, Saba; Tlili, Abdelaziz; Mahfood, Mona; Mabondzo, Aloise; Hamoudi, Rifat			miR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability	PLOS ONE			English	Article							IN-VITRO MODEL; WNT/BETA-CATENIN; CELL-LINE; INJURY; TRANSPORTER; DISRUPTION; MICRORNAS; CLAUDIN-5; PROTEINS; HCMEC/D3	Background The brain endothelial barrier permeability is governed by tight and adherens junction protein complexes that restrict paracellular permeability at the blood-brain barrier (BBB). Dysfunction of the inter-endothelial junctions has been implicated in neurological disorders such as multiple sclerosis, stroke and Alzheimer's disease. The molecular mechanisms underlying junctional dysfunction during BBB impairment remain elusive. MicroRNAs (miRNAs) have emerged as versatile regulators of the BBB function under physiological and pathological conditions, and altered levels of BBB-associated microRNAs were demonstrated in a number of brain pathologies including neurodegeneration and neuroinflammatory diseases. Among the altered micro-RNAs, miR-27a-3p was found to be downregulated in a number of neurological diseases characterized by loss of inter-endothelial junctions and disruption of the barrier integrity. However, the relationship between miR-27a-3p and tight and adherens junctions at the brain endothelium remains unexplored. Whether miR-27a-3p is involved in regulation of the junctions at the brain endothelium remains to be determined. Methods Using a gain-and-loss of function approach, we modulated levels of miR-27a-3p in an in-vitro model of the brain endothelium, key component of the BBB, and examined the resultant effect on the barrier paracellular permeability and on the expression of essential tight and adherens junctions. The mechanisms governing the regulation of junctional proteins by miR-27a-3p were also explored. Results Our results showed that miR-27a-3p inhibitor increases the barrier permeability and causes reduction of claudin-5 and occludin, two proteins highly enriched at the tight junction, while miR-27a-3p mimic reduced the paracellular leakage and increased claudin-5 and occludin protein levels. Interestingly, we found that miR-27-3p induces expression of claudin-5 and occludin by downregulating Glycogen Synthase Kinase 3 beta (GSK3 beta) and activating Wnt/beta-catenin signaling, a key pathway required for the BBB maintenance. Conclusion For the first time, we showed that miR-27a-3p is a positive regulator of key tight junction proteins, claudin-5 and occludin, at the brain endothelium through targeting GSK3 beta gene and activating Wnt/beta-catenin signaling. Thus, miR-27a-3p may constitute a novel therapeutic target that could be exploited to prevent BBB dysfunction and preserves its integrity in neurological disorders characterized by impairment of the barrier's function.	[Harati, Rania; Hammad, Saba] Univ Sharjah, Dept Pharm Practice & Pharmacotherapeut, Coll Pharm, Sharjah, U Arab Emirates; [Harati, Rania; Hammad, Saba] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates; [Tlili, Abdelaziz; Mahfood, Mona] Univ Sharjah, Dept Appl Biol, Coll Sci, Sharjah, U Arab Emirates; [Mabondzo, Aloise] Univ Paris Saclay, Dept Med & Healthcare Technol, French Alternat Energies & Atom Energy Commiss, Gif Sur Yvette, France; [Hamoudi, Rifat] Univ Sharjah, Coll Med, Dept Clin Sci, Sharjah, U Arab Emirates; [Hamoudi, Rifat] UCL, Div Surg & Intervent Sci, London, England	University of Sharjah; University of Sharjah; University of Sharjah; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Sharjah; University of London; University College London	Harati, R (corresponding author), Univ Sharjah, Dept Pharm Practice & Pharmacotherapeut, Coll Pharm, Sharjah, U Arab Emirates.; Harati, R (corresponding author), Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates.	rharati@sharjah.ac.ae		Hammad, Saba/0000-0002-3016-495X; Harati, Rania/0000-0001-6672-2944	University of Sharjah [1701110321-P]	University of Sharjah	This work was supported by the University of Sharjah Competitive Grant (Grant no. 1701110321-P). R Harati received this funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Ban JJ, 2017, BIOCHEM BIOPH RES CO, V488, P316, DOI 10.1016/j.bbrc.2017.05.040; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bauer HC, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00392; BENSON P F, 1961, Cereb Palsy Bull, V3, P510; Bernardo-Castro S, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.594672; Cerutti C, 2017, SCI REP-UK, V7, DOI 10.1038/srep45284; Chen HJ, 2020, TECHNOL CANCER RES T, V19, DOI 10.1177/1533033820965576; Cucullo L, 2008, J CEREBR BLOOD F MET, V28, P312, DOI 10.1038/sj.jcbfm.9600525; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Enciu AM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/297512; Errede M, 2012, J NEUROPATH EXP NEUR, V71, P840, DOI 10.1097/NEN.0b013e31826ac110; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Frigerio CS, 2013, NEUROLOGY, V81, P2103, DOI 10.1212/01.wnl.0000437306.37850.22; Ortiz GG, 2014, ARCH MED RES, V45, P687, DOI 10.1016/j.arcmed.2014.11.013; Greene C, 2018, MOL PSYCHIATR, V23, P2156, DOI 10.1038/mp.2017.156; Greene C., 2019, CLAUDIN 5 GATEKEEPER, P15; Greene C, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01054-3; Harati R, 2021, BREAST CANCER RES TR, V187, P695, DOI 10.1007/s10549-021-06255-y; Harati R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239292; Harati R, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13070144; Harati R, 2013, MOL PHARMACEUT, V10, P1566, DOI 10.1021/mp300334r; Harati R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-273; Laksitorini MD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56075-w; Lee S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30875-y; Lengfeld JE, 2017, P NATL ACAD SCI USA, V114, pE1168, DOI 10.1073/pnas.1609905114; Li J, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000734; Liang T, 2020, ACTA BIOCH BIOPH SIN, V52, P363, DOI 10.1093/abbs/gmaa002; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liu LM, 2014, NEUROCHEM INT, V75, P19, DOI 10.1016/j.neuint.2014.05.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Ramirez MA, 2016, FASEB J, V30, P2662, DOI 10.1096/fj.201600435RR; Lopez-Ramirez MA, 2014, FASEB J, V28, P2551, DOI 10.1096/fj.13-248880; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Lv JJ, 2018, PROG NEUROBIOL, V161, P79, DOI 10.1016/j.pneurobio.2017.12.001; Maixner Dylan Warren, 2013, J Pharm Pharmacol (Los Angel), V1, P001; Marco S, 2006, NEUROSCI LETT, V401, P219, DOI 10.1016/j.neulet.2006.03.047; Ng L, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080826; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Paul D, 2013, MICROVASC RES, V86, P1, DOI 10.1016/j.mvr.2012.12.001; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Ramirez SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055972; Reijerkerk A, 2013, J NEUROSCI, V33, P6857, DOI 10.1523/JNEUROSCI.3965-12.2013; Roig-Carles D, 2017, PROG INFLAMM RES SER, P153, DOI 10.1007/978-3-319-45514-3_7; Rom S, 2015, J CEREBR BLOOD F MET, V35, P1957, DOI 10.1038/jcbfm.2015.154; Romanitan MO, 2010, J CELL MOL MED, V14, P1088, DOI 10.1111/j.1582-4934.2009.00999.x; Santha P, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00088; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Sun LQ, 2017, BIOCHEM BIOPH RES CO, V482, P1141, DOI 10.1016/j.bbrc.2016.12.001; Tran KA, 2016, CIRCULATION, V133, P177, DOI 10.1161/CIRCULATIONAHA.115.015982; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Watson CP, 2016, BRAIN RES, V1648, P232, DOI 10.1016/j.brainres.2016.07.026; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Wu RZ, 2020, CANCER MANAG RES, V12, P6241, DOI 10.2147/CMAR.S255419; Xi TY, 2018, J BIOL CHEM, V293, P20041, DOI 10.1074/jbc.RA118.001858; Xiao H, 2017, J NEUROCHEM, V142, P194, DOI 10.1111/jnc.14051; Yamazaki Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091965; Young JA, 2013, BLOOD, V122, P2911, DOI 10.1182/blood-2012-12-473017; Zenaro E, 2017, NEUROBIOL DIS, V107, P41, DOI 10.1016/j.nbd.2016.07.007; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	62	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262152	10.1371/journal.pone.0262152	http://dx.doi.org/10.1371/journal.pone.0262152			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025943	Green Published, gold			2022-12-27	WOS:000796264200051
J	Tanaka, J; Ishikawa, F; Jinno, T; Miyakita, M; Miyamori, H; Sasaki, T; Yokokawa, T; Goto, T; Inoue, K; Matsumura, S				Tanaka, Jin; Ishikawa, Fuka; Jinno, Tomoki; Miyakita, Motoki; Miyamori, Haruka; Sasaki, Tsutomu; Yokokawa, Takumi; Goto, Tsuyoshi; Inoue, Kazuo; Matsumura, Shigenobu			Disruption of CRTC1 and CRTC2 in Sim1 cells strongly increases high-fat diet intake in female mice but has a modest impact on male mice	PLOS ONE			English	Article							CREB COACTIVATOR TORC2; PARAVENTRICULAR NUCLEUS; FOOD-INTAKE; NEURONS; HYPOTHALAMUS; ACTIVATION; EXPRESSION; PATHWAYS; GLUCOSE; CORTICOTROPIN	cAMP responsive element binding protein (CREB)-regulated transcription coactivators (CRTCs) regulate gene transcription in response to an increase in intracellular cAMP or Ca2+ levels. To date, three isoforms of CRTC have been identified in mammals. All CRTCs are widely expressed in various regions of the brain. Numerous studies have shown the importance of CREB and CRTC in energy homeostasis. In the brain, the paraventricular nucleus of the hypothalamus (PVH) plays a critical role in energy metabolism, and CRTC1 and CRTC2 are highly expressed in PVH neuronal cells. The single-minded homolog 1 gene (Sim1) is densely expressed in PVH neurons and in some areas of the amygdala neurons. To determine the role of CRTCs in PVH on energy metabolism, we generated mice that lacked CRTC1 and CRTC2 in Sim1 cells using Sim-1 cre mice. We found that Sim1 cell-specific CRTC1 and CRTC2 double-knockout mice were sensitive to high-fat diet (HFD)-induced obesity. Sim1 cell-specific CRTC1 and CRTC2 double knockout mice showed hyperphagia specifically for the HFD, but not for the normal chow diet, increased fat mass, and no change in energy expenditure. Interestingly, these phenotypes were stronger in female mice than in male mice, and a weak phenotype was observed in the normal chow diet. The lack of CRTC1 and CRTC2 in Sim1 cells changed the mRNA levels of some neuropeptides that regulate energy metabolism in female mice fed an HFD. Taken together, our findings suggest that CRTCs in Sim1 cells regulate gene expression and suppress excessive fat intake, especially in female mice.	[Tanaka, Jin; Ishikawa, Fuka; Jinno, Tomoki; Miyakita, Motoki; Miyamori, Haruka; Yokokawa, Takumi; Goto, Tsuyoshi; Inoue, Kazuo; Matsumura, Shigenobu] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan; [Sasaki, Tsutomu] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Matsumura, Shigenobu] Osaka Prefecture Univ, Grad Sch Comprehens Rehabil, Dept Clin Nutr, Osaka, Japan	Kyoto University; Osaka University; Osaka Metropolitan University	Matsumura, S (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan.; Matsumura, S (corresponding author), Osaka Prefecture Univ, Grad Sch Comprehens Rehabil, Dept Clin Nutr, Osaka, Japan.	smatsumara@rehab.osakafu-u.ac.jp		Matsumura, Shigenobu/0000-0002-7149-1375	Takeda Life Science foundation; JSPS Kakenhi	Takeda Life Science foundation; JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Takeda Life Science foundation and JSPS Kakenhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2006, OBESITY, V14, P222; Belgacem YH, 2017, ADV EXP MED BIOL, V1015, P19, DOI 10.1007/978-3-319-62817-2_2; Butler AA, 2002, NEUROPEPTIDES, V36, P77, DOI 10.1054/npep.2002.0890; Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036; Chen M, 2012, ENDOCRINOLOGY, V153, P4256, DOI 10.1210/en.2012-1113; Chiappini F, 2011, J BIOL CHEM, V286, P8094, DOI 10.1074/jbc.M110.178186; Craig JC, 2001, J BIOL CHEM, V276, P11719, DOI 10.1074/jbc.M010263200; Elmquist JK, 2001, INT J OBESITY, V25, pS78, DOI 10.1038/sj.ijo.0801918; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Guo TT, 2020, NEUROSCI LETT, V714, DOI 10.1016/j.neulet.2019.134550; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Iwasaki-Sekino A, 2009, PSYCHONEUROENDOCRINO, V34, P226, DOI 10.1016/j.psyneuen.2008.09.003; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kwon E, 2020, FRONT NEURAL CIRCUIT, V14, DOI 10.3389/fncir.2020.595783; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Li YQ, 2016, J CLIN INVEST, V126, P40, DOI 10.1172/JCI76348; Liu Y, 2011, J NEUROENDOCRINOL, V23, P216, DOI 10.1111/j.1365-2826.2010.02101.x; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Matsumura S, 2021, ENDOCRINOLOGY, V162, DOI 10.1210/endocr/bqab076; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; Okamoto S, 2018, CELL REP, V22, P706, DOI 10.1016/j.celrep.2017.11.102; Parlato R, 2006, GENESIS, V44, P454, DOI 10.1002/dvg.20236; Pei HJ, 2014, MOL METAB, V3, P209, DOI 10.1016/j.molmet.2013.12.006; Qin C, 2018, ENDOCRINOLOGY, V159, P3458, DOI 10.1210/en.2018-00453; Ravnskjaer K, 2016, HANDB EXP PHARMACOL, V233, P29, DOI 10.1007/164_2015_32; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Sohn JW, 2015, BMB REP, V48, P229, DOI 10.5483/BMBRep.2015.48.4.272; Sutton AK, 2016, ANNU REV PHYSIOL, V78, P207, DOI 10.1146/annurev-physiol-021115-105347; Sutton AK, 2014, J NEUROSCI, V34, P15306, DOI 10.1523/JNEUROSCI.0226-14.2014; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Viau V, 2005, ENDOCRINOLOGY, V146, P137, DOI 10.1210/en.2004-0846; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Watts AG, 2011, J NEUROENDOCRINOL, V23, P754, DOI 10.1111/j.1365-2826.2011.02178.x; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045167; Xi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036453; Zhu CJ, 2020, EMBO REP, DOI 10.15252/embr.201949210	39	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262577	10.1371/journal.pone.0262577	http://dx.doi.org/10.1371/journal.pone.0262577			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020776	Green Published, gold			2022-12-27	WOS:000834207700052
J	Ward, A; Sarraju, A; Lee, D; Bhasin, K; Gad, S; Beetel, R; Chang, S; Bonafede, M; Rodriguez, F; Dash, R				Ward, Andrew; Sarraju, Ashish; Lee, Donghyun; Bhasin, Kanchan; Gad, Sanchit; Beetel, Rob; Chang, Stella; Bonafede, Mac; Rodriguez, Fatima; Dash, Rajesh			COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; VALIDATION; CODES	Introduction Infection with SARS-CoV-2 is typically compared with influenza to contextualize its health risks. SARS-CoV-2 has been linked with coagulation disturbances including arterial thrombosis, leading to considerable interest in antithrombotic therapy for Coronavirus Disease 2019 (COVID-19). However, the independent thromboembolic risk of SARS-CoV-2 infection compared with influenza remains incompletely understood. We evaluated the adjusted risks of thromboembolic events after a diagnosis of COVID-19 compared with influenza in a large retrospective cohort. Methods We used a US-based electronic health record (EHR) dataset linked with insurance claims to identify adults diagnosed with COVID-19 between April 1, 2020 and October 31, 2020. We identified influenza patients diagnosed between October 1, 2018 and April 31, 2019. Primary outcomes [venous composite of pulmonary embolism (PE) and acute deep vein thrombosis (DVT); arterial composite of ischemic stroke and myocardial infarction (MI)] and secondary outcomes were assessed 90 days post-diagnosis. Propensity scores (PS) were calculated using demographic, clinical, and medication variables. PS-adjusted hazard ratios (HRs) were calculated using Cox proportional hazards regression. Results There were 417,975 COVID-19 patients (median age 57y, 61% women), and 345,934 influenza patients (median age 47y, 66% women). Compared with influenza, patients with COVID-19 had higher venous thromboembolic risk (HR 1.53, 95% CI 1.38-1.70), but not arterial thromboembolic risk (HR 1.02, 95% CI 0.95-1.10). Secondary analyses demonstrated similar risk for ischemic stroke (HR 1.11, 95% CI 0.98-1.25) and MI (HR 0.93, 95% CI 0.85-1.03) and higher risk for DVT (HR 1.36, 95% CI 1.19-1.56) and PE (HR 1.82, 95% CI 1.57-2.10) in patients with COVID-19. Conclusion In a large retrospective US cohort, COVID-19 was independently associated with higher 90-day risk for venous thrombosis, but not arterial thrombosis, as compared with influenza. These findings may inform crucial knowledge gaps regarding the specific thromboembolic risks of COVID-19.	[Ward, Andrew; Lee, Donghyun; Bhasin, Kanchan; Gad, Sanchit; Beetel, Rob; Dash, Rajesh] HealthPals Inc, Redwood City, CA USA; [Sarraju, Ashish; Rodriguez, Fatima; Dash, Rajesh] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Sarraju, Ashish; Rodriguez, Fatima; Dash, Rajesh] Stanford Univ, Cardiovasc Inst, Stanford, CA 94305 USA; [Chang, Stella; Bonafede, Mac] Veradigm, Chicago, IL USA	Stanford University; Stanford University	Sarraju, A (corresponding author), Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA.; Sarraju, A (corresponding author), Stanford Univ, Cardiovasc Inst, Stanford, CA 94305 USA.	asarraju@stanford.edu		Ward, Andrew/0000-0002-4692-1126; Sarraju, Ashish/0000-0003-1649-2110	American Heart Association [20SFRN35360178]; National Heart, Lung, and Blood Institute, National Institutes of Health [1K01HL144607]	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	HealthPals provided support for this study in the form of salary for AW, DL, KB, SG, and RB. Veradigm provided support for this study in the form of salary for SC and MB. AS received support from the American Heart Association (20SFRN35360178). FR received support from the National Heart, Lung, and Blood Institute, National Institutes of Health (1K01HL144607). The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Samkari H, 2021, JAMA-J AM MED ASSOC, V325, P1613, DOI 10.1001/jama.2021.4295; Ammann EM, 2018, PHARMACOEPIDEM DR S, V27, P398, DOI 10.1002/pds.4398; Ammann EM, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009960; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bilaloglu S, 2020, JAMA-J AM MED ASSOC, V324, P799, DOI 10.1001/jama.2020.13372; Chan NC, 2016, CIRC RES, V118, P1409, DOI 10.1161/CIRCRESAHA.116.306925; Cheruiyot I, 2021, ANN VASC SURG, V70, P273, DOI 10.1016/j.avsg.2020.08.087; Cutrona SL, 2013, PHARMACOEPIDEM DR S, V22, P40, DOI 10.1002/pds.3310; Franklin JM, 2017, STAT MED, V36, P1946, DOI 10.1002/sim.7250; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Jevnikar M, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.00116-2021; Katherine Yih W., 2020, MASTER PROTOCOL DEV; Katsoularis I, 2021, LANCET, V398, P599, DOI 10.1016/S0140-6736(21)00896-5; Lo Re V III., 2021, SENTINEL INITIATIVE; Lo Re V III., 2021, 2 SENT IN; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Merkler AE, 2020, JAMA NEUROL, V77, P1366, DOI 10.1001/jamaneurol.2020.2730; Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001; Piroth L, 2021, LANCET RESP MED, V9, P251, DOI 10.1016/S2213-2600(20)30527-0; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152; Standl F, 2021, LANCET INFECT DIS, V21, pE77, DOI [10.1016/S1473-3099(20)30648-4, 10.1016/S1473-3099(20)30484-9]; Stewart M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248128; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924	24	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261786	10.1371/journal.pone.0261786	http://dx.doi.org/10.1371/journal.pone.0261786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020742	Green Published, Green Submitted, gold			2022-12-27	WOS:000834207700023
J	Wu, C; Xu, C; Mao, F; Xu, XL; Zhang, C				Wu, Chao; Xu, Cong; Mao, Feng; Xu, Xiaolin; Zhang, Chan			The impact of invisible-spreaders on COVID-19 transmission and work resumption	PLOS ONE			English	Article								The global impact of coronavirus disease 2019 (COVID-19) is unprecedented, and many control and prevention measures have been implemented to test for and trace COVID-19. However, invisible-spreaders, who are associated with nucleic acid detection and asymptomatic infections, have received insufficient attention in the current COVID-19 control efforts. In this paper, we analyze the time series infection data for Italy, Germany, Brazil, India and Sweden since the first wave outbreak to address the following issues through a series of experiments. We conclude that: 1) As of June 1, 2020, the proportion of invisible-spreaders is close to 0.4% in Sweden, 0.8% in early Italy and Germany, and 0.4% in the middle and late stages. However, in Brazil and India, the proportion still shows a gradual upward trend; 2) During the spread of this pandemic, even a slight increase in the proportion of invisible-spreaders could have large implications for the health of the community; and 3) On resuming work, the pandemic intervention measures will be relaxed, and invisible-spreaders will cause a new round of outbreaks.	[Wu, Chao; Xu, Cong] Zhejiang Univ, Sch Publ Affairs, Hangzhou, Peoples R China; [Wu, Chao] Imperial Coll London, Data Sci Inst, London, England; [Mao, Feng] Cardiff Univ, Sch Earth & Environm Sci, Cardiff, Wales; [Xu, Xiaolin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Biostat Bioinformat & Big Data,Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiaolin] Zhejiang Univ, Sch Med, Dept Big Data Hlth Sci, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiaolin] Natl Inst Data Sci Hlth & Med, Hangzhou, Zhejiang, Peoples R China; [Zhang, Chan] Zhejiang Univ, Coll Media & Int Culture, Hangzhou, Peoples R China	Zhejiang University; Imperial College London; Cardiff University; Zhejiang University; Zhejiang University; Zhejiang University	Wu, C (corresponding author), Zhejiang Univ, Sch Publ Affairs, Hangzhou, Peoples R China.; Wu, C (corresponding author), Imperial Coll London, Data Sci Inst, London, England.; Mao, F (corresponding author), Cardiff Univ, Sch Earth & Environm Sci, Cardiff, Wales.	chao.wu@zju.edu.cn; MaoF1@cardiff.ac.uk						[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; [Anonymous], CORONAVIRUS ITALYS P; [Anonymous], CORONAVIRUS GERMANY; Apple Google., PRIV PRES CONT TRAC; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Bailey NTJ, 1975, MATH THEORY INFECT D; BELLMAN R, 1957, J MATH MECH, V6, P679, DOI 10.1512/iumj.1957.6.56038; Benvenuto D, 2020, PATHOG GLOB HEALTH, V114, P64, DOI 10.1080/20477724.2020.1725339; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Ferguson N. M., 2020, REPORT 9 IMPACT NONP; Habib H, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2376; Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; LeCun Y, 1998, LECT NOTES COMPUT SC, V1524, P9, DOI 10.1007/3-540-49430-8_2; Liao XL, 2020, INTENS CARE MED, V46, P357, DOI 10.1007/s00134-020-05954-2; Meijering E, 2002, P IEEE, V90, P319, DOI 10.1109/5.993400; West CP, 2020, MAYO CLIN PROC, V95, P1127, DOI 10.1016/j.mayocp.2020.04.004; Winichakoon P, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00297-20; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Ye Zhen, 2020, IWEBCEE; Yun Gao, WUHAN IS SAFE 989 MI	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0252994	10.1371/journal.pone.0252994	http://dx.doi.org/10.1371/journal.pone.0252994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020722	gold, Green Published, Green Accepted			2022-12-27	WOS:000834207700004
J	Belakehal, F; Barth, SA; Menge, C; Mossadak, HT; Malek, N; Moser, I				Belakehal, Faiza; Barth, Stefanie A.; Menge, Christian; Mossadak, Hamdi T.; Malek, Naim; Moser, Irmgard			Evaluation of the discriminatory power of spoligotyping and 19-locus mycobacterial interspersed repetitive unit-variable number of tandem repeat analysis (MIRU-VNTR) of Mycobacterium bovis strains isolated from cattle in Algeria	PLOS ONE			English	Article							TUBERCULOSIS COMPLEX BACTERIA; GENETIC DIVERSITY; LIVESTOCK; WILDLIFE; DIFFERENTIATION	Bovine tuberculosis (bTB) caused by Mycobacterium (M.) bovis and M. caprae is a transmissible disease of livestock, notifiable to the World Organization for Animal Health (OIE). BTB particularly affects cattle and small ruminants and can be transmitted to humans thereby posing a significant threat to veterinary and public health worldwide. M. bovis is the principal cause of bTB in Algeria. In order to better understand the route of spreading and elaborate an eradication program, isolation and characterization of mycobacteria from Algerian cattle was performed. Sixty strains belonging to the M. tuberculosis complex were analyzed by spoligotyping, thereof 42 by 19-locus-MIRU-VNTR-typing. Spoligotyping revealed 16 distinguishable patterns (Hunter-Gaston discriminatory index [HGDI] of 0.8294), with types SB0120 (n = 20) and SB0121 (n = 13) being the most frequent patterns, representing 55% of the strains. Analyses based on 19-locus-MIRU-VNTR yielded 32 different profiles, five clusters and one orphan pattern, showing higher discriminatory power (HGDI = 0.9779) than spoligotyping. Seven VNTR-loci [VNTR 577 (alias ETR C), 2163b (QU11b), 2165 (ETR A), 2461 (ETR B), 3007 (MIRU 27), 2163a (QUB11a) and 3232 (QUB 3232)] were the most discriminative loci (HGDI > 0.50). In conclusion, 19-locus-MIRU-VNTR yielded more information than spoligotyping concerning molecular differentiation of strains and better supports the elucidation of transmission routes of M. bovis between Algerian cattle herds.	[Belakehal, Faiza; Mossadak, Hamdi T.] Lab Food Hyg & Qual Insurance Syst, High Natl Vet Sch, El Alia, Oued Smar, Algeria; [Barth, Stefanie A.; Menge, Christian; Moser, Irmgard] Friedrich Loeffler Inst Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Berlin, Germany; [Barth, Stefanie A.; Moser, Irmgard] Friedrich Loeffler & Nstitut Fed Res Inst Anim Hl, Natl Reference Lab Bovine TB, Inst Mol Pathogenesis, Berlin, Germany; [Malek, Naim] Cent Mil Hosp, Dept Microbiol, Kouba, Algeria	Ecole Nationale Superieure Veterinaire; Friedrich Loeffler Institute	Belakehal, F (corresponding author), Lab Food Hyg & Qual Insurance Syst, High Natl Vet Sch, El Alia, Oued Smar, Algeria.; Barth, SA (corresponding author), Friedrich Loeffler Inst Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Berlin, Germany.; Barth, SA (corresponding author), Friedrich Loeffler & Nstitut Fed Res Inst Anim Hl, Natl Reference Lab Bovine TB, Inst Mol Pathogenesis, Berlin, Germany.	faiza.belakehal@gmail.com; stefanie.barth@fli.de	Barth, Stefanie/K-7053-2019	Barth, Stefanie/0000-0003-4921-5056	High National Veterinary School, Algeria, (ENSV) [000592]	High National Veterinary School, Algeria, (ENSV)	Parts of this work were funded by a travel and stay grant from the High National Veterinary School, Algeria, (ENSV, www.ensv.dz) (grant no. 000592) for Faiza Belakehal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, J OFFICIEL REPUBLIQU; Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; Asebe G, 2017, J MEDICAL DIAGNOSTIC, V06, P250, DOI [10.4172/2168-9784.1000250, DOI 10.4172/2168-9784.1000250]; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Biffa D, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-28; Bolado-Martinez E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/416479; Boniotti MB, 2009, J CLIN MICROBIOL, V47, P636, DOI 10.1128/JCM.01192-08; Boschiroli M.-L., 2015, B PID MIOL SANT ANIM, V70, P2; Bouklata N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135695; Brites D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02820; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Couvin D, 2014, MISE PLACE BASES DON, V2014, P40; Cowie CE, 2016, EUR J WILDLIFE RES, V62, P51, DOI 10.1007/s10344-015-0973-x; Damene H, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008894; de la Fuente J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004232; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Djemal SE, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1314-y; Duignan A, 2012, REV SCI TECH OIE, V31, P845; Durr PA, 2000, REV SCI TECH OIE, V19, P675, DOI 10.20506/rst.19.3.1241; El Mrini M, 2016, EUR J WILDLIFE RES, V62, P479, DOI 10.1007/s10344-016-1022-0; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Ghavidel M, 2018, MICROB PATHOGENESIS, V118, P310, DOI 10.1016/j.micpath.2018.03.036; Haddad N, 2004, RES VET SCI, V76, P1, DOI 10.1016/S0034-5288(03)00078-X; Hauer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117103; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kao RR, 2016, REV SCI TECH OIE, V35, P241, DOI 10.20506/rst.35.1.2430; Katale BZ, 2017, TRANSBOUND EMERG DIS, V64, P815, DOI 10.1111/tbed.12445; Kent PT, 1985, PUBLIC HLTH MYCOBACT; Kohl TA, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01573-20; Kohl TA, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00302-18, 10.1128/jcm.00302-18]; Lamine-Khemiri H, 2014, TROP ANIM HEALTH PRO, V46, P305, DOI 10.1007/s11250-013-0488-y; Loiseau C, 2020, EVOL MED PUBLIC HLTH, P49, DOI 10.1093/emph/eoaa005; Machado A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006147; Malama Sydney, 2014, Vet Med Int, V2014, P187842, DOI 10.1155/2014/187842; Marianelli C, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007546; Matos F, 2010, VET MED-CZECH, V55, P133, DOI 10.17221/137/2009-VETMED; Matos F, 2010, J CLIN MICROBIOL, V48, P4337, DOI 10.1128/JCM.01762-10; Mekonnen GA, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.553940; Muller B, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-26; Palisson A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152578; Prodinger WM, 2005, J CLIN MICROBIOL, V43, P4984, DOI 10.1128/JCM.43.10.4984-4992.2005; Riviere J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183126; Rodriguez S, 2011, EMERG INFECT DIS, V17, P532, DOI 10.3201/eid1703.100618; Rodriguez-Campos S, 2014, RES VET SCI, V97, pS5, DOI 10.1016/j.rvsc.2014.02.009; Rodriguez-Campos S, 2013, J CLIN MICROBIOL, V51, P3658, DOI 10.1128/JCM.01271-13; Ruettger A, 2012, J CLIN MICROBIOL, V50, P2492, DOI 10.1128/JCM.00442-12; Sahraoui N, 2010, ANN BIOL CLIN-PARIS, V68, P449, DOI 10.1684/abc.2010.0459; Sahraoui N, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-4; Siala M, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007707; Skuce RA, 2002, MICROBIOL-SGM, V148, P519, DOI 10.1099/00221287-148-2-519; Smith NH, 2012, INFECT GENET EVOL, V12, P857, DOI 10.1016/j.meegid.2011.09.007; Smith NH, 2012, INFECT GENET EVOL, V12, P873, DOI 10.1016/j.meegid.2011.08.002; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tazerart F, 2021, EMERG INFECT DIS, V27, P972, DOI 10.3201/eid2703.191823; Tripathi K., 2014, INT J RECENT TRENDS, V10, P461; Yahyaoui-Azami H, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1165-6; Yang L, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0402-0	58	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262390	10.1371/journal.pone.0262390	http://dx.doi.org/10.1371/journal.pone.0262390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015775	Green Published, gold			2022-12-27	WOS:000814820600014
J	Lee, JY; Kim, M; Oh, SB; Kim, HY; Kim, C; Kim, TY; Park, YH				Lee, Ji-Yeon; Kim, Mirinae; Oh, Su Bin; Kim, Hae-Young; Kim, Chongtae; Kim, Tae-Yoon; Park, Young-Hoon			Superoxide dismutase 3 prevents early stage diabetic retinopathy in streptozotocin-induced diabetic rat model	PLOS ONE			English	Article							RETINAL METABOLISM; OXIDATIVE STRESS; EXPERIMENTAL GALACTOSEMIA; ABNORMALITIES; EXPRESSION; PROTECTION; RECOVERIN; PERICYTES; DAMAGE	Purpose To identify the effects of superoxide dismutase (SOD)3 on diabetes mellitus (DM)-induced retinal changes in a diabetic rat model. Methods Diabetic models were established by a single intraperitoneal injection of streptozotocin (STZ) in Sprague-Dawley rats. After purification of the recombinant SOD3, intravitreal injection of SOD3 was performed at the time of STZ injection, and 1 and 2 weeks following STZ injection. Scotopic and photopic electroretinography (ERG) were recorded. Immunofluorescence staining with alpha-smooth muscle actin (SMA), glial fibrillary acidic protein (GFAP), pigment epithelium-derived factor (PEDF), Flt1, recoverin, parvalbumin, extracellular superoxide dismutase (SOD3), 8-Hydroxy-2'deoxyguanosine (8-OHdG) and tumor necrosis factor-alpha (TNF-alpha) were evaluated. Results In the scotopic ERG, the diabetic group showed reduced a- and b-wave amplitudes compared with the control group. In the photopic ERG, b-wave amplitude showed significant (p < 0.0005) reduction at 8 weeks following DM induction. However, the trend of a- and b-wave reduction was not evident in the SOD3 treated group. GFAP, Flt1, 8-OHdG and TNF-alpha immunoreactivity were increased, and alpha-SMA, PEDF and SOD3 immunoreactivity were decreased in the diabetic retina. The immunoreactivity of these markers was partially recovered in the SOD3 treated group. Parvalbumin expression was not decreased in the SOD3 treated group. In the diabetic retinas, the immunoreactivity of recoverin was weakly detected in both of the inner nuclear layer and inner plexiform layer compared to the control group but not in the SOD3 treated group. Conclusions SOD3 treatment attenuated the loss of a/b-wave amplitudes in the diabetic rats, which was consistent with the immunohistochemical evaluation. We also suggest that in rod-dominant rodents, the use of blue on green photopic negative response (PhNR) is effective in measuring the inner retinal function in animal models of diabetic retinopathy. SOD3 treatment ameliorated the retinal Muller cell activation in diabetic rats and pericyte dysfunction. These results suggested that SOD3 exerted protective effects on the development of diabetic retinopathy.	[Lee, Ji-Yeon; Kim, Mirinae; Oh, Su Bin; Kim, Chongtae; Park, Young-Hoon] Catholic Univ Korea, Coll Med, Catholic Inst Visual Sci, Seoul, South Korea; [Kim, Mirinae; Park, Young-Hoon] Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Seoul St Marys Hosp, Coll Med, Seoul, South Korea; [Kim, Hae-Young; Kim, Tae-Yoon] Catholic Univ Korea, Coll Med, Dept Dermatol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Park, YH (corresponding author), Catholic Univ Korea, Coll Med, Catholic Inst Visual Sci, Seoul, South Korea.; Park, YH (corresponding author), Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Seoul St Marys Hosp, Coll Med, Seoul, South Korea.	parkyh@catholic.ac.kr			Basic Science Research Program through the National Research Foundation of Korea [NRF-2020R1F1A1074898]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	Funding This study was supported by the Basic Science Research Program through the National Research Foundation of Korea under Grant [NRF-2020R1F1A1074898]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, REDOX REP, V15, P250, DOI 10.1179/135100010X12826446921662; Altobelli GG, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00183; [Anonymous], 2004, A BRADFORD BOOK; Bagnis A, 2012, EXP EYE RES, V103, P55, DOI 10.1016/j.exer.2012.07.011; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Carmona-Rodriguez L, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000432; Cecerska-Heryc E, 2021, CLIN BIOCHEM, V93, P1, DOI 10.1016/j.clinbiochem.2021.03.008; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; Denat L, 2014, J INVEST DERMATOL, V134, P1512, DOI 10.1038/jid.2014.65; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Ferland-McCollough D, 2017, PHARMACOL THERAPEUT, V171, P30, DOI 10.1016/j.pharmthera.2016.11.008; Gong CY, 2013, INT J OPHTHALMOL-CHI, V6, P573, DOI 10.3980/j.issn.2222-3959.2013.05.03; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Ikelle L, 2019, ADV EXP MED BIOL, V1185, P335, DOI 10.1007/978-3-030-27378-1_55; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; KOWLURU R, 1994, CURR EYE RES, V13, P891, DOI 10.3109/02713689409015092; Kowluru RA, 1996, DIABETES, V45, P1233, DOI 10.2337/diabetes.45.9.1233; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; KUWABARA TOICHIRO, 1965, INVEST OPHTHALMOL, V4, P1049; Kwon MJ, 2012, J DERMATOL SCI, V67, P81, DOI 10.1016/j.jdermsci.2012.06.003; Liu YW, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/5384909; Mohammedi K, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-014-0163-2; MURAKAMI A, 1992, BIOCHEM BIOPH RES CO, V187, P234, DOI 10.1016/S0006-291X(05)81483-4; Naderi A, 2019, EXP EYE RES, V184, P213, DOI 10.1016/j.exer.2019.04.025; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Nozik-Grayck E, 2005, INT J BIOCHEM CELL B, V37, P2466, DOI 10.1016/j.biocel.2005.06.012; Ookawara T, 1998, AM J PHYSIOL-CELL PH, V275, pC840, DOI 10.1152/ajpcell.1998.275.3.C840; Park HS, 2008, ACTA NEUROPATHOL, V115, P241, DOI 10.1007/s00401-007-0314-6; Park SJ, 2018, EXP NEUROBIOL, V27, P210, DOI 10.5607/en.2018.27.3.210; Regan E, 2005, ARTHRITIS RHEUM, V52, P3479, DOI 10.1002/art.21387; Tan RJ, 2015, J AM SOC NEPHROL, V26, P2447, DOI 10.1681/ASN.2014060613; Wert KJ, 2018, FREE RADICAL BIO MED, V124, P408, DOI 10.1016/j.freeradbiomed.2018.06.024; Yamada H, 2005, DIABETOLOGIA, V48, P1663, DOI 10.1007/s00125-005-1809-0; Yoshida Y, 2009, DIABETES-METAB RES, V25, P678, DOI 10.1002/dmrr.1007; Yoshinaga A, 2021, ANTIOXID REDOX SIGN, V34, P1245, DOI 10.1089/ars.2019.8008; Yuki K, 2011, INVEST OPHTH VIS SCI, V52, P4143, DOI 10.1167/iovs.10-6294; Zhang JF, 2008, INVEST OPHTH VIS SCI, V49, P732, DOI 10.1167/iovs.07-0721; Zhao JS, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/8721379; Zhu XF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/580687	42	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262396	10.1371/journal.pone.0262396	http://dx.doi.org/10.1371/journal.pone.0262396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015779	gold, Green Published			2022-12-27	WOS:000814820600015
J	Markellos, C; Ourailidou, ME; Gavriatopoulou, M; Halvatsiotis, P; Sergentanis, TN; Psaltopoulou, T				Markellos, Christos; Ourailidou, Maria-Eleni; Gavriatopoulou, Maria; Halvatsiotis, Panagiotis; Sergentanis, Theodoros N.; Psaltopoulou, Theodora			Olive oil intake and cancer risk: A systematic review and meta-analysis	PLOS ONE			English	Review							MONOUNSATURATED FATTY-ACID; STYLE DIETARY PATTERN; OXIDATIVE DNA-DAMAGE; BREAST-CANCER; MEDITERRANEAN DIET; FOOD GROUPS; LIFE-STYLE; PHENOLIC-COMPOUNDS; COLORECTAL-CANCER; PROSTATE-CANCER	Background Research evidence has established the beneficial effects of diet in cancer prevention; various epidemiological studies have suggested that olive oil component could play a role in decreasing cancer risk. This systematic review and meta-analysis aims to investigate the association between olive oil consumption, cancer risk and prognosis. Methods A systematic search was conducted in PubMed, EMBASE and Google Scholar databases (end-of-search: May 10, 2020). Pooled relative risk (RR) and 95% confidence intervals (95% CIs) were estimated with random-effects (DerSimonian-Laird) models. Subgroup analyses, sensitivity analyses and meta-regression analysis were also performed. Results 45 studies were included in the meta-analysis; 37 were case-control (17,369 cases and 28,294 controls) and 8 were cohort studies (12,461 incident cases in a total cohort of 929,771 subjects). Highest olive oil consumption was associated with 31% lower likelihood of any cancer (pooled RR = 0.69, 95%CI: 0.62-0.77), breast (RR = 0.67, 95%CI: 0.52-0.86), gastrointestinal (RR = 0.77, 95%CI: 0.66-0.89), upper aerodigestive (RR = 0.74, 95% CI: 0.60-0.91) and urinary tract cancer (RR = 0.46, 95%CI: 0.29-0.72). Significant overall effects spanned both Mediterranean and non-Mediterranean participants, studies presenting a multivariate and a univariate analysis and all subgroups by study quality. Conclusions Olive oil consumption seems to exert beneficial actions in terms of cancer prevention. Additional prospective cohort studies on various cancer types and survivors, as well as large randomized trials, seem desirable.	[Markellos, Christos; Ourailidou, Maria-Eleni; Gavriatopoulou, Maria; Sergentanis, Theodoros N.; Psaltopoulou, Theodora] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece; [Halvatsiotis, Panagiotis] Attikon Univ Hosp, Athens Sch Med, Dept Internal Med 2, Athens, Greece	Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon	Psaltopoulou, T (corresponding author), Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece.	tpsaltop@med.uoa.gr		Sergentanis, Theodoros N./0000-0002-9355-5528				Agnoli C, 2013, INT J CANCER, V132, P1404, DOI 10.1002/ijc.27740; Al-qadasi FA, 2016, E MEDITERR HEALTH J, V22, P719, DOI 10.26719/2016.22.10.719; Alu'datt MH, 2014, J AGR FOOD CHEM, V62, P11967, DOI 10.1021/jf504557k; Anand P, 2008, PHARM RES-DORDR, V25, P2097, DOI 10.1007/s11095-008-9661-9; Arafa MA, 2011, ASIAN PAC J CANCER P, V12, P1931; Askari F., 2016, PAK J NUTR, V15, P305; Azzeh FS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4520-4; Baroudi O, 2014, TUMOR BIOL, V35, P5815, DOI 10.1007/s13277-014-1771-x; Battino M, 2019, CRIT REV FOOD SCI, V59, P893, DOI 10.1080/10408398.2018.1526165; Bauld L, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1383-9; Benetou V, 2008, BRIT J CANCER, V99, P191, DOI 10.1038/sj.bjc.6604418; Berroukche A, 2012, ONCOLOGIE, V14, P674, DOI 10.1007/s10269-012-2227-9; Bessaoud F, 2008, NUTR CANCER, V60, P177, DOI 10.1080/01635580701649651; BIDOLI E, 1992, INT J CANCER, V50, P223, DOI 10.1002/ijc.2910500211; BITTERMAN WA, 1991, UROL CLIN N AM, V18, P501; Borzi AM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010032; Bosetti C, 2002, CANCER CAUSE CONTROL, V13, P465, DOI 10.1023/A:1015760004130; Bosetti C, 2002, INT J CANCER, V100, P355, DOI 10.1002/ijc.10485; Bosetti C, 2000, INT J CANCER, V87, P289, DOI 10.1002/1097-0215(20000715)87:2&lt;289::AID-IJC22&gt;3.0.CO;2-9; Braga C, 1998, CANCER-AM CANCER SOC, V82, P448, DOI 10.1002/(SICI)1097-0142(19980201)82:3&lt;448::AID-CNCR4&gt;3.0.CO;2-L; Brinkman MT, 2011, EUR J CANCER, V47, P436, DOI 10.1016/j.ejca.2010.09.027; Buckland G, 2013, INT J CANCER, V132, P2918, DOI 10.1002/ijc.27958; Buckland G, 2015, BRIT J NUTR, V113, pS94, DOI 10.1017/S0007114514003936; Buckland G, 2012, AM J CLIN NUTR, V96, P142, DOI 10.3945/ajcn.111.024216; Buckland G, 2010, AM J CLIN NUTR, V91, P381, DOI 10.3945/ajcn.2009.28209; BUIATTI E, 1989, INT J CANCER, V44, P611, DOI 10.1002/ijc.2910440409; Cicerale S, 2009, CRIT REV FOOD SCI, V49, P218, DOI 10.1080/10408390701856223; Coccia A, 2016, ONCOL REP, V36, P3095, DOI 10.3892/or.2016.5150; Colomer Ramon, 2006, Clin Transl Oncol, V8, P15, DOI 10.1007/s12094-006-0090-0; Corona G, 2009, MOL NUTR FOOD RES, V53, P897, DOI 10.1002/mnfr.200800269; Crosignani P, 1996, INT J CANCER, V65, P308, DOI 10.1002/(SICI)1097-0215(19960126)65:3&lt;308::AID-IJC5&gt;3.0.CO;2-3; de la Lastra CA, 2001, CURR PHARM DESIGN, V7, P933; Demetriou CA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-113; Di Francesco A, 2015, J NUTR BIOCHEM, V26, P250, DOI 10.1016/j.jnutbio.2014.10.013; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Escrich E, 2014, CANCER TREAT RES, V159, P289, DOI 10.1007/978-3-642-38007-5_17; Escrich E, 2011, PUBLIC HEALTH NUTR, V14, P2323, DOI 10.1017/S1368980011002588; FRANCESCHI S, 1991, INT J CANCER, V47, P20, DOI 10.1002/ijc.2910470105; Franceschi S, 1999, BRIT J CANCER, V80, P614, DOI 10.1038/sj.bjc.6690400; Gaforio JJ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092039; Garcia-Segovia P, 2006, PUBLIC HEALTH NUTR, V9, P163, DOI 10.1079/PHN2005940; Giacosa A, 2013, EUR J CANCER PREV, V22, P90, DOI 10.1097/CEJ.0b013e328354d2d7; Gnagnarella P, 2013, ANN ONCOL, V24, P2606, DOI 10.1093/annonc/mdt302; Gorzynik-Debicka M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030686; Goulas V, 2009, MOL NUTR FOOD RES, V53, P600, DOI 10.1002/mnfr.200800204; Grosso G, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S14; Guasch-Ferre M, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-78; Hamdi HK, 2005, BIOCHEM BIOPH RES CO, V334, P769, DOI 10.1016/j.bbrc.2005.06.161; Hashim YZHY, 2014, FOOD FUNCT, V5, P1513, DOI 10.1039/c4fo00090k; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Hodge AM, 2004, CANCER CAUSE CONTROL, V15, P11, DOI 10.1023/B:CACO.0000016568.25127.10; Horton R, 2019, LANCET, V394, P1790, DOI 10.1016/S0140-6736(19)32766-7; Imran M, 2018, J FOOD SCI, V83, P1781, DOI 10.1111/1750-3841.14198; Jessri M, 2012, J AM COLL NUTR, V31, P338, DOI 10.1080/07315724.2012.10720437; Lagiou P, 2009, INT J CANCER, V124, P2671, DOI 10.1002/ijc.24246; Laouamri S, 2001, REV EPIDEMIOL SANTE, V49, P145; Launoy G, 1998, INT J CANCER, V76, P7, DOI 10.1002/(SICI)1097-0215(19980330)76:1&lt;7::AID-IJC2&gt;3.0.CO;2-4; LAVECCHIA C, 1995, CANCER CAUSE CONTROL, V6, P545, DOI 10.1007/BF00054164; LEVI F, 1993, NUTR CANCER, V19, P327, DOI 10.1080/01635589309514263; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lopez-Miranda J, 2010, NUTR METAB CARDIOVAS, V20, P284, DOI 10.1016/j.numecd.2009.12.007; Manna C, 2002, J AGR FOOD CHEM, V50, P6521, DOI 10.1021/jf020565+; MARTINMORENO JM, 1994, INT J CANCER, V58, P774, DOI 10.1002/ijc.2910580604; Menendez JA, 2006, CURR PHARM BIOTECHNO, V7, P495, DOI 10.2174/138920106779116900; Menendez JA, 2006, EUR J CANCER, V42, P2425, DOI 10.1016/j.ejca.2005.10.016; Morales Suarez-Varela M, 1998, Nutr Hosp, V13, P325; Nesic V, 2010, SRP ARK CELOK LEK, V138, P6, DOI 10.2298/SARH1002006N; Owen R W, 2000, Lancet Oncol, V1, P107, DOI 10.1016/S1470-2045(00)00015-2; Owen RW, 2004, EUR J CANCER PREV, V13, P319, DOI 10.1097/01.cej.0000130221.19480.7e; Owen RW, 2000, EUR J CANCER, V36, P1235, DOI 10.1016/S0959-8049(00)00103-9; Pei TM, 2016, ONCOTARGET, V7, P43475, DOI 10.18632/oncotarget.9782; Pelucchi C, 2011, CURR PHARM DESIGN, V17, P805, DOI 10.2174/138161211795428920; Pervaiz R, 2017, BIOMED RES THER, V4, P1171, DOI 10.15419/bmrat.v4i03.155; Piroddi M, 2017, BIOFACTORS, V43, P17, DOI 10.1002/biof.1318; Psaltopoulou T, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-127; RICHARDSON S, 1991, INT J CANCER, V48, P1; Schwingshackl L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101063; Schwingshackl L, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-154; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Soler M, 1998, EUR J CANCER PREV, V7, P455, DOI 10.1097/00008469-199812000-00005; Tayyem RF, 2016, J HUM NUTR DIET, V29, P746, DOI 10.1111/jhn.12391; Toklu H, 2018, NIGER J CLIN PRACT, V21, P1576, DOI 10.4103/njcp.njcp_238_18; Toledo E, 2015, JAMA INTERN MED, V175, P1752, DOI 10.1001/jamainternmed.2015.4838; Toric J, 2019, ACTA PHARMACEUT, V69, P461, DOI 10.2478/acph-2019-0052; Toteda G, 2017, J ENDOCRINOL INVEST, V40, P153, DOI 10.1007/s40618-016-0537-2; TRICHOPOULOU A, 1995, JNCI-J NATL CANCER I, V87, P110, DOI 10.1093/jnci/87.2.110; Trichopoulou A, 2000, CANCER EPIDEM BIOMAR, V9, P869; Trichopoulou A, 2007, MOL NUTR FOOD RES, V51, P1275, DOI 10.1002/mnfr.200700134; Tripoli E, 2005, NUTR RES REV, V18, P98, DOI 10.1079/NRR200495; Tzonou A, 1999, INT J CANCER, V80, P704, DOI 10.1002/(SICI)1097-0215(19990301)80:5&lt;704::AID-IJC13&gt;3.0.CO;2-Z; Verberne L, 2010, NUTR CANCER, V62, P860, DOI 10.1080/01635581.2010.509834; Visioli F, 1998, LIFE SCI, V62, P541, DOI 10.1016/S0024-3205(97)01150-8; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Warleta F, 2011, NUTRIENTS, V3, P839, DOI 10.3390/nu3100839; Warleta F, 2010, FOOD CHEM TOXICOL, V48, P1092, DOI 10.1016/j.fct.2010.01.031; WCRF. World Cancer Research Fund International., DIET NUTR PHYS ACT C, DOI [10.1017/S002966510800712X18452640, DOI 10.1017/S002966510800712X18452640]; Wells G.A., 2011, NEWCASTLE OTTAWA SCA; World Health Organization, US; Xin Yue, 2015, Asian Pac J Cancer Prev, V16, P5125; ZARIDZE D, 1993, ANN ONCOL, V4, P495, DOI 10.1093/oxfordjournals.annonc.a058561; Zubiri Oteiza L., 2011, 11 EUROPEAN NUTR C F	103	7	7	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0261649	10.1371/journal.pone.0261649	http://dx.doi.org/10.1371/journal.pone.0261649			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015763	gold, Green Published			2022-12-27	WOS:000814820600006
J	Bert, F; Boietti, E; Rousset, S; Pompili, E; Tibaldeo, EF; Gea, M; Scaioli, G; Siliquini, R				Bert, Fabrizio; Boietti, Edoardo; Rousset, Stefano; Pompili, Erika; Tibaldeo, Eleonora Franzini; Gea, Marta; Scaioli, Giacomo; Siliquini, Roberta			Gender sensitivity and stereotypes in medical university students: An Italian cross-sectional study	PLOS ONE			English	Article							BIAS; PHYSICIANS; AWARENESS	Gender medicine is crucial to reduce health inequalities. Knowledge about students' attitudes and beliefs regarding men, women and gender is important to improve gender medicine courses. The aim of this study is to evaluate gender stereotypes and its predictors in Italian medical students. We performed an online cross-sectional study among students from the University of Turin. We used the validated Nijmegen Gender Awareness Scale in Medicine scale to explore gender sensitivity and stereotypes. Multivariable logistic regression model was performed to explore potential predictors of gender awareness. We enrolled 430 students. Female sex, a better knowledge on gender medicine and having had a tutor aware of gender issues are associated with higher gender sensitivity. Older age, a better knowledge on gender medicine and having had a tutor sensitive to gender issues were predictors of more stereotyped opinions towards patients. Having had a tutor aware of gender medicine, male sex and older age were associated with more stereotypes towards doctors. Italian students have high gender sensitivity and low gender stereotypes. Age, higher knowledge of gender medicine and having had a tutor that considered gender were associated with higher gender stereotypes. Focusing on gender awareness in medical schools can contribute to a better care.	[Bert, Fabrizio; Boietti, Edoardo; Rousset, Stefano; Pompili, Erika; Tibaldeo, Eleonora Franzini; Gea, Marta; Scaioli, Giacomo; Siliquini, Roberta] Univ Turin, Dept Publ Hlth Sci, Turin, Italy; [Siliquini, Roberta] Univ Turin, AOU City Hlth & Sci, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin	Boietti, E (corresponding author), Univ Turin, Dept Publ Hlth Sci, Turin, Italy.	edoardo.boietti@unito.it		GEA, MARTA/0000-0002-4963-048X				Andersson J, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-3; Baggio G, 2017, G ITAL MED LAV ERGON, V39, P196; Baggio G, 2013, CLIN CHEM LAB MED, V51, P713, DOI 10.1515/cclm-2012-0849; Ben LM., 1998, DIFFERENTIAL EXPLAN, V38, P375; Celik HH, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-36; Chiaramonte GR, 2006, HEALTH PSYCHOL, V25, P255, DOI 10.1037/0278-6133.25.3.255; Danielsson U, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-56; European Institute for Gender Equality, 2021, GENDER EQUALITY INDE; European Institute for Gender Equality (EIGE), 2020, GEND EQ ACC CHANG, DOI 10.2839/850038; Fikree FF, 2004, BMJ-BRIT MED J, V328, P823, DOI 10.1136/bmj.328.7443.823; Hall JA, 2002, PATIENT EDUC COUNS, V48, P217, DOI 10.1016/S0738-3991(02)00174-X; Hamberg K, 2002, J WOMEN HEALTH GEN-B, V11, P653, DOI 10.1089/152460902760360595; Hamberg K, 2008, WOMENS HEALTH, V4, P237, DOI 10.2217/17455057.4.3.237; Morais R, 2020, ADV HEALTH SCI EDUC, V25, P457, DOI 10.1007/s10459-019-09936-y; Ragone G, 2019, MEDIOLOGIA LETTERATU; Risberg Gunilla, 2003, BMC Med Educ, V3, P8, DOI 10.1186/1472-6920-3-8; Rrustemi I, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02037-0; Salgado DM, 2002, SEX ROLES, V46, P247, DOI 10.1023/A:1020171416038; SMITH PB, 1998, SOCIAL PSYCHOL CULTU; Verdonk P, 2008, SEX ROLES, V58, P222, DOI 10.1007/s11199-007-9326-x; Verdonk P, 2009, ADV HEALTH SCI EDUC, V14, P135, DOI 10.1007/s10459-008-9100-z; Waddington I., 2010, COMUNICAZIONE SPORT, V13, P13; Westergaard D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08475-9; World Economic Forum, 2018, GLOBAL GENDER GAP RE; World Health Organisation, 1998, GEND HLTH TECHN PAP	25	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262324	10.1371/journal.pone.0262324	http://dx.doi.org/10.1371/journal.pone.0262324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990471	gold, Green Published			2022-12-27	WOS:000815783800024
J	Zhang, HW; Jiao, B; Dong, FS; Liang, XX; Zhou, S; Wang, HB				Zhang, HongWei; Jiao, Bo; Dong, FuShuang; Liang, XinXia; Zhou, Shuo; Wang, Haibo			Genome-wide identification of CCT genes in wheat (Triticum aestivum L.) and their expression analysis during vernalization	PLOS ONE			English	Article							PSEUDO-RESPONSE-REGULATOR; FLOWERING-LOCUS-T; CIRCADIAN CLOCK; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; HEADING DATE; GATA FAMILY; CONSTANS; TIME; EVOLUTION	Numerous CCT genes are known to regulate various biological processes, such as circadian rhythm regulation, flowering, light signaling, plant development, and stress resistance. The CCT gene family has been characterized in many plants but remains unknown in the major cereal wheat (Triticum aestivum L.). Extended exposure to low temperature (vernalization) is necessary for winter wheat to flower successfully. VERNALIZATION2 (VRN2), a specific CCT-containing gene, has been proved to be strongly associated with vernalization in winter wheat. Mutation of all VRN2 copies in three subgenomes results in the eliminated demands of low temperature in flowering. However, no other CCT genes have been reported to be associated with vernalization to date. The present study screened CCT genes in the whole wheat genome, and preliminarily identified the vernalization related CCT genes through expression analysis. 127 CCT genes were identified in three subgenomes of common wheat through a hidden Markov model-based method. Based on multiple alignment, these genes were grouped into 40 gene clusters, including the duplicated gene clusters TaCMF6 and TaCMF8, each tandemly arranged near the telomere. The phylogenetic analysis classified these genes into eight groups. The transcriptome analysis using leaf tissues collected before, during, and after vernalization revealed 49 upregulated and 31 downregulated CCT genes during vernalization, further validated by quantitative real-time PCR. Among the differentially expressed and well-investigated CCT gene clusters analyzed in this study, TaCMF11, TaCO18, TaPRR95, TaCMF6, and TaCO16 were induced during vernalization but decreased immediately after vernalization, while TaCO1, TaCO15, TaCO2, TaCMF8, and TaPPD1 were stably suppressed during and after vernalization. These data imply that some vernalization related CCT genes other than VRN2 may exist in wheat. This study improves our understanding of CCT genes and provides a foundation for further research on CCT genes related to vernalization in wheat.	[Zhang, HongWei; Wang, Haibo] Hebei Agr Univ, Coll Agron, Baoding, Hebei, Peoples R China; [Zhang, HongWei; Jiao, Bo; Dong, FuShuang; Liang, XinXia; Zhou, Shuo; Wang, Haibo] Hebei Acad Agr & Forestry Sci, Inst Biotechnol & Food Sci, Plant Genet Engn Ctr Hebei Prov, Shijiazhuang, Hebei, Peoples R China	Hebei Agricultural University; Hebei Academy of Agricultural & Forestry Sciences	Wang, HB (corresponding author), Hebei Agr Univ, Coll Agron, Baoding, Hebei, Peoples R China.; Zhou, S; Wang, HB (corresponding author), Hebei Acad Agr & Forestry Sci, Inst Biotechnol & Food Sci, Plant Genet Engn Ctr Hebei Prov, Shijiazhuang, Hebei, Peoples R China.	zhoushuobio@163.com; nkywanghb@163.com		zhang, hong wei/0000-0003-0460-6125	HAAFS Agriculture Science and Technology Innovation Project [2019-4-8-06]; S&T Program of Hebei [20326306D]	HAAFS Agriculture Science and Technology Innovation Project; S&T Program of Hebei	This work was supported by the HAAFS Agriculture Science and Technology Innovation Project (grant number 2019-4-8-06), and the S&T Program of Hebei (grant number 20326306D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Campoli C, 2012, PLANT J, V69, P868, DOI 10.1111/j.1365-313X.2011.04839.x; Chen A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003134; Chen CJ, 2020, MOL PLANT, V13, P1194, DOI 10.1016/j.molp.2020.06.009; [陈华夏 Chen Huaxia], 2010, [华中农业大学学报, Journal of Huazhong Agricultural University], V29, P669; Cockram J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045307; Deng WW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6882; Distelfeld A, 2009, PLANT PHYSIOL, V149, P245, DOI 10.1104/pp.108.129353; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Farre EM, 2013, CURR OPIN PLANT BIOL, V16, P621, DOI 10.1016/j.pbi.2013.06.015; Fu DL, 2007, MOL GENET GENOMICS, V277, P301, DOI 10.1007/s00438-006-0189-6; Gangappa SN, 2014, TRENDS PLANT SCI, V19, P460, DOI 10.1016/j.tplants.2014.01.010; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li CX, 2011, PLANT J, V67, P763, DOI 10.1111/j.1365-313X.2011.04630.x; Liu HY, 2020, THEOR APPL GENET, V133, P1385, DOI 10.1007/s00122-020-03554-8; Liu H, 2019, J INTEGR PLANT BIOL, V61, P359, DOI 10.1111/jipb.12720; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; Lu SN, 2020, NUCLEIC ACIDS RES, V48, pD265, DOI 10.1093/nar/gkz991; Ma L, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9040513; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Murakami M, 2004, PLANT CELL PHYSIOL, V45, P645, DOI 10.1093/pcp/pch065; Nakamichi N, 2007, PLANT CELL PHYSIOL, V48, P822, DOI 10.1093/pcp/pcm056; Nakamichi N, 2009, PLANT CELL PHYSIOL, V50, P447, DOI 10.1093/pcp/pcp004; Niinuma K, 2008, PLANT BIOTECHNOL-NAR, V25, P165, DOI 10.5511/plantbiotechnology.25.165; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Qiao LY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00770; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Shaw LM, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008812; Shaw LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079459; Shaw LM, 2012, PLANT J, V71, P71, DOI 10.1111/j.1365-313X.2012.04971.x; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Shim JS, 2017, PLANT PHYSIOL, V173, P5, DOI 10.1104/pp.16.01327; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; Woods DP, 2016, PLANT PHYSIOL, V170, P2124, DOI 10.1104/pp.15.01279; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhan HS, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100284; Zhang J, 2021, J INTEGR PLANT BIOL, V63, P913, DOI 10.1111/jipb.13013; Zhang J, 2017, J INTEGR AGR, V16, P2686, DOI 10.1016/S2095-3119(17)61724-6; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07663; Zheng XW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189333	63	1	1	13	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262147	10.1371/journal.pone.0262147	http://dx.doi.org/10.1371/journal.pone.0262147			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986172	gold, Green Published			2022-12-27	WOS:000765956200019
J	Asghar, AK; Nkabinde, TC; Naidoo, M				Asghar, Adam Konrad; Nkabinde, Thandaza Cyril; Naidoo, Mergan			An analysis of obstetric practices and outcomes in a deep rural district hospital in South Africa	PLOS ONE			English	Article							CESAREAN DELIVERY; SECTIONS	Background Internationally, there has been a focus on ensuring that Caesarean deliveries are performed only when indicated, to ensure the best outcome for mother and baby. In South Africa, despite a variety of health system interventions, maternal and perinatal mortality remain unacceptably high. Objectives To describe and compare the clinical outcomes related to the mode of delivery, for patients managed at rural primary healthcare level. Methods This retrospective cross-sectional observational analytical study was conducted at a deep rural district hospital in northern KwaZulu-Natal, South Africa. Maternity Case Records and Caesarean delivery audit tools from 2018 were reviewed. Results In total, 634 files were retrieved. The Caesarean delivery rate in the sample was 30.8% (193 of 634 deliveries), and according to the Robson classification, groups 5 and 1 were the biggest contributors to Caesarean delivery. All Caesarean deliveries were deemed to have been medically indicated. As compared to those whose delivery was normal vaginal, the odds of having post-partum haemorrhage were 25 times higher, and the odds of having any complication were three times higher, if a mother delivered by Caesarean (p<0.001). In neonates who were delivered by Caesarean, the odds of being admitted to nursery were four times higher than those delivered vaginally (p<0.001). Conclusion Showing a significantly higher risk of maternal and neonatal complications, this study validated Caesarean delivery at rural primary care as a potentially dangerous undertaking, for which adequate precautions should be taken. There is a need for interventions targeting rural healthcare in South Africa, to ensure that obstetric services are offered to patients in as safe a manner as possible in this environment.	[Asghar, Adam Konrad; Nkabinde, Thandaza Cyril; Naidoo, Mergan] Univ KwaZulu Natal, Dept Family Med, Durban, Kwazulu Natal, South Africa	University of Kwazulu Natal	Asghar, AK (corresponding author), Univ KwaZulu Natal, Dept Family Med, Durban, Kwazulu Natal, South Africa.	adam.asghar@gmail.com	Asghar, Adam/M-2171-2019	Asghar, Adam/0000-0002-3751-6196; Naidoo, Mergan/0000-0002-4287-1168	Discovery Foundation Rural Fellowship Award in the Individual category [040511]	Discovery Foundation Rural Fellowship Award in the Individual category	AKA was the recipient of a Discovery Foundation Rural Fellowship Award in the Individual category, in relation to this research (REF: 040511; https://www.discovery.co.za/marketing/discovery-foundation-site/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allanson ER, 2015, B WORLD HEALTH ORGAN, V93, P424, DOI 10.2471/BLT.14.144683; [Anonymous], 1985, LANCET, V2, P436; Aubrey-Bassler Kris, 2007, Can Fam Physician, V53, P2132; Bello OO., 2020, NIGERIAN J MED, V29, P55; Betran AP, 2018, LANCET, V392, P1358, DOI 10.1016/S0140-6736(18)31927-5; Bishop D, 2019, LANCET GLOB HEALTH, V7, pE513, DOI 10.1016/S2214-109X(19)30036-1; Boerma T, 2018, LANCET, V392, P1341, DOI 10.1016/S0140-6736(18)31928-7; Daihoum R. M., 2020, Obstetrics and Gynaecology Forum, V30, P25; Darnal Naveen, 2020, J Nepal Health Res Counc, V18, P186, DOI 10.33314/jnhrc.v18i2.2093; Gaunt CB, 2015, 34 C PRIORITIES PERI, P39; Gebhardt S., 2018, SAVING BABIES 2014 2; Govender I, 2019, S AFR FAM PRACT, V61, P246, DOI 10.1080/20786190.2019.1671655; Govender T, 2018, S AFR FAM PRACT, V60, P1, DOI 10.1080/20786190.2017.1333783; Kodan LR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244087; Lucas DN, 2000, J ROY SOC MED, V93, P346, DOI 10.1177/014107680009300703; Maaloe N, 2012, ACTA OBSTET GYN SCAN, V91, P1069, DOI 10.1111/j.1600-0412.2012.01474.x; Massyn N, 2020, DISTRICT HLTH BAROME; Massyn N, 2013, DISTRICT HLTH BAROME; Massyn N, 2015, DISTRICT HLTH BAROME; Mokaya M., 2017, THESIS U WITWATERSRA; Molina G, 2015, JAMA-J AM MED ASSOC, V314, P2263, DOI 10.1001/jama.2015.15553; Moran NF, 2011, CRITERIA REFERRAL OB; National Committee on Confidential Enquiries into Maternal Deaths, 2018, SAV MOTH 2014 2016 7; National Committee on Confidential Enquiries into Maternal Deaths in South Africa, 2015, OBSTET GYNAECOLOGY F, V25, P41; National Department of Health, 2011, HUMAN RESOURCES HLTH; National Department of Health, 2014, SAVING MOTHERS 2011; National Institute for Health and Care Excellence, 2021, CAES BIRTH NICE GUID; Padayachee N, 2013, S AFR J CHILD HEALTH, V7, P89, DOI 10.7196/SAJCH.574; Ritchie LMP, 2016, J CLIN EPIDEMIOL, V76, P229, DOI 10.1016/j.jclinepi.2016.02.017; Robson MS, 2001, FETAL MATERN MED REV, V12, P23, DOI [DOI 10.1017/S0965539501000122, 10.1017/S0965539501000122]; Royal College of Obstetricians and Gynaecologists, 2015, BIRTH PREVIOUS CAESA; Rural Health Advocacy Project, 2018, DEF RUR WHAT WE MEAN; Shah A, 2009, INT J GYNECOL OBSTET, V107, P191, DOI 10.1016/j.ijgo.2009.08.013; Tunkyi K, 2016, SAMJ, S. Afr. med. j., V106, P101, DOI [10.7196/SAMJ.2016.V106I1.9860, 10.7196/SAMJ.2016.v106i1.9860]; Versteeg M, 2013, GLOBAL HEALTH ACTION, V6, P119, DOI 10.3402/gha.v6i0.19522; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; World Health Organization, 2017, MAN COMPL PREGN CHIL	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262269	10.1371/journal.pone.0262269	http://dx.doi.org/10.1371/journal.pone.0262269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982786	Green Published, gold			2022-12-27	WOS:000834805700024
J	Sethu, S; Lawrenson, JG; Kekunnaya, R; Ali, R; Borah, RR; Suttle, C				Sethu, Sheeladevi; Lawrenson, John G.; Kekunnaya, Ramesh; Ali, Rahul; Borah, Rishi R.; Suttle, Catherine			Barriers and enablers to access childhood cataract services across India. A qualitative study using the Theoretical Domains Framework (TDF) of behaviour change	PLOS ONE			English	Article							HEALTH-CARE; DEVELOPING-COUNTRIES	Early presentation for childhood cataract surgery is an important first step in preventing related visual impairment and blindness. In the absence of neonatal eye screening programmes in developing countries, the early identification of childhood cataract remains a major challenge. The primary aim of this study was to identify potential barriers to accessing childhood cataract services from the perspective of parents and carers, as a critical step towards increasing the timely uptake of cataract surgery. In-depth interviews were conducted using a pre-designed topic guide developed for this study to seek the views of parents and carers in nine geographic locations across eight states in India regarding their perceived barriers and enablers to accessing childhood cataract services. A total of 35 in-depth interviews were conducted including 30 at the hospital premises and 5 in the participants' homes. All interviews were conducted in the local language and audio taped for further transcription and analysis. Data were organised using NVivo 11 and a thematic analysis was conducted utilising the Theoretical Domains Framework (TDF), an integrative framework of behavioural theories. The themes identified from interviews related to 11 out of 12 TDF domains. TDF domains associated with barriers included: 'Environmental context and resources', 'Beliefs about consequences' and 'Social influences'. Reported enablers were identified in three theoretical domains: 'Social influences', 'Beliefs about consequences' and 'Motivations and goals'. This comprehensive TDF approach enabled us to understand parents' perceived barriers and enablers to accessing childhood cataract services, which could be targeted in future interventions to improve timely uptake.	[Sethu, Sheeladevi; Lawrenson, John G.; Suttle, Catherine] City Univ London, Ctr Appl Vis Res, Div Optometry & Visual Sci, London, England; [Sethu, Sheeladevi; Ali, Rahul; Borah, Rishi R.] Orbis Int, Gurugram, India; [Kekunnaya, Ramesh] LV Prasad Eye Inst, Child Sight Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, India	City University London; L. V. Prasad Eye Institute	Sethu, S (corresponding author), City Univ London, Ctr Appl Vis Res, Div Optometry & Visual Sci, London, England.; Sethu, S (corresponding author), Orbis Int, Gurugram, India.	Sheeladevi.sethu@orbis.org		Sethu, Sheeladevi/0000-0001-6561-2882	School of Health Sciences, City University of London	School of Health Sciences, City University of London	This study was funded by School of Health Sciences, City University of London as a research scholarship for the primary author's PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Birch EE, 1998, INVEST OPHTH VIS SCI, V39, P1560; Birch EE, 2009, J AAPOS, V13, P67, DOI 10.1016/j.jaapos.2008.07.010; Burgess C, 2015, HEALTH EXPECT, V18, P2437, DOI 10.1111/hex.12212; Chak M, 2006, INVEST OPHTH VIS SCI, V47, P4262, DOI 10.1167/iovs.05-1160; Dyson J., 2011, Journal of Infection Prevention, V12, P17, DOI 10.1177/1757177410384300; Ebeigbe Jennifer A, 2017, J Optom, V10, P104, DOI 10.1016/j.optom.2016.06.001; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Graham-Rowe E, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0309-2; Gray-Burrows KA, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0416-4; Holloway E, 2018, DISABIL REHABIL, V40, P287, DOI 10.1080/09638288.2016.1250172; Lake AJ, 2017, J DIABETES COMPLICAT, V31, P997, DOI 10.1016/j.jdiacomp.2017.02.020; Lei L, 2017, SOC SCI MED, V179, P172, DOI 10.1016/j.socscimed.2017.02.028; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S., 2014, ABC BEHAV CHANGE THE; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Nasrin D, 2013, AM J TROP MED HYG, V89, P3, DOI 10.4269/ajtmh.12-0749; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Pillai R, 2003, SOC SCI MED, V57, P783, DOI 10.1016/S0277-9536(02)00448-3; Pokhrel S, 2004, HEALTH POLICY PLANN, V19, P218, DOI 10.1093/heapol/czh027; QSR-International, 2013, NVIVO QUAL DAT AN SO; Rimal RN, 2000, HEALTH COMMUN, V12, P219, DOI 10.1207/S15327027HC1203_01; Ritchie J., 2013, QUALITATIVE RES PRAC, V2nd; Russell S, 1996, HEALTH POLICY PLANN, V11, P219, DOI 10.1093/heapol/11.3.219; Senthilkumar D, 2013, OPTOMETRY VISION SCI, V90, P1462, DOI 10.1097/OPX.0000000000000084; Sheeladevi S, 2018, EYE, V32, P1811, DOI 10.1038/s41433-018-0176-2; Taylor David, 2001, British Journal of Ophthalmology, V85, P1120, DOI 10.1136/bjo.85.9.1120; Tipping G., 1995, HLTH CARE SEEKING BE, P89; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261308	10.1371/journal.pone.0261308	http://dx.doi.org/10.1371/journal.pone.0261308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972107	Green Published, gold, Green Accepted			2022-12-27	WOS:000773555700029
J	Yu, LX; Chen, HM; Luo, WQ; Li, C				Yu, Linxing; Chen, Huaming; Luo, Wenqi; Li, Chang			Online public opinion evaluation through the functional resonance analysis method and deep analysis	PLOS ONE			English	Article							EVOLUTION; MODEL	A conventional model of public opinion analysis is no longer suitable when the internet is the primary arena of information dissemination. Thus, a more practical approach is urgently needed to deal with this dynamic and complicated phenomenon of propagating public opinion. This paper proposes that the outbreak of internet public opinion and its negative impacts, such as the occurrence of major security incidents, are a result of coupling and the complex interaction of many factors. The Functional Resonance Analysis Method model is composed of those factors and considers the stages of network information dissemination, the unique propagation rule, and textual sentiment resonance on the internet. Moreover, it is the first public opinion governance method that simultaneously highlights the complex system, functional identification, and functional resonance. It suggests a more effective method to shorten the dissipation time of negative public opinion and is a considerable improvement over previous models for risk-prediction. Based on resonance theory and deep learning, this study establishes public opinion resonance functions, which made it possible to analyze public opinion triggers and build a simulation model to explore the patterns of public opinion development through long-term data capture. The simulation results of the Functional Resonance Analysis Method suggest that the resonance in the model is consistent with the evolution of public opinion in real situations and that the components of the resonance of public opinion can be separated into eleven subjective factors and three objective factors. In addition, managing the subjective factors can significantly accelerate the dissipation of negative opinions.	[Yu, Linxing; Chen, Huaming; Luo, Wenqi] Sichuan Univ, Coll Literature & Journalism, Chengdu, Sichuan, Peoples R China; [Li, Chang] Sichuan Normal Univ, Coll Movie & Media, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan Normal University	Li, C (corresponding author), Sichuan Normal Univ, Coll Movie & Media, Chengdu, Sichuan, Peoples R China.	changli19870918@163.com			 [SC20B076]		This study was funded in part by the Research on network rumor identification and accurate management of major epidemic situations in the form of funds to HMC (SC20B076). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Bonzom V, 2012, PHYS LETT B, V711, P88, DOI 10.1016/j.physletb.2012.03.054; Chen HM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091535; China Internet Network Information Center (CNNIC), 2020, 46 CHIN INT NETW DEV; El Alaoui I, 2018, J BIG DATA-GER, V5, DOI 10.1186/s40537-018-0120-0; Elgazzar AS, 2003, PHYSICA A, V324, P402, DOI 10.1016/S0378-4371(02)01956-8; Ergasheva MP, 2019, THEORETICAL APPL SCI, P183, DOI [10.15863/TAS.2019.10.78.33, DOI 10.15863/TAS.2019.10.78.33]; Erik H., 2017, FRAM FUNCTIONAL RESO; Falegnami A, 2020, COGN TECHNOL WORK, V22, P877, DOI 10.1007/s10111-019-00612-0; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Kermack WO, 1932, P R SOC LOND A-CONTA, V138, P55, DOI 10.1098/rspa.1932.0171; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/NPHYS1746, 10.1038/nphys1746]; Kuperman M, 2001, PHYS REV LETT, V86, P2909, DOI 10.1103/PhysRevLett.86.2909; Li ST, 2013, KNOWL-BASED SYST, V39, P23, DOI 10.1016/j.knosys.2012.10.005; Li TC, 2013, ANN PHYS-BERLIN, V525, P281, DOI 10.1002/andp.201200232; Luo QJ, 2017, TOURISM MANAGE, V62, P159, DOI 10.1016/j.tourman.2017.04.007; MCNAMARA B, 1989, PHYS REV A, V39, P4854, DOI 10.1103/PhysRevA.39.4854; Patriarca R, 2017, ENVIRON IMPACT ASSES, V63, P72, DOI 10.1016/j.eiar.2016.12.002; Pekalski A, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.057104; Riccardo P, 2018, INT J RELIAB QUAL SA, V25, DOI 10.1142/S0218539318500018; Rosa LV, 2015, COGN TECHNOL WORK, V17, P559, DOI 10.1007/s10111-015-0337-z; Suchecki K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036132; Tomassini M, 2005, COMPLEX SYST, V15, P261; Wei-dong H, 2018, INT J COMPUT COMMUN, V13, P129, DOI 10.15837/ijccc.2018.1.3176; Zhang HQ, 2016, ENG APPL ARTIF INTEL, V47, P122, DOI 10.1016/j.engappai.2015.06.007	24	2	2	11	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261009	10.1371/journal.pone.0261009	http://dx.doi.org/10.1371/journal.pone.0261009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972099	gold, Green Published			2022-12-27	WOS:000773555700019
J	De Benedictis, A; Lettieri, E; Piredda, M; Gualandi, R; De Maria, M; Tartaglini, D				De Benedictis, Anna; Lettieri, Emanuele; Piredda, Michela; Gualandi, Raffaella; De Maria, Maddalena; Tartaglini, Daniela			Development and psychometric testing of a new measure of the determinants that influence the adoption of WhatsApp in hospitals	PLOS ONE			English	Article							INFORMATION-TECHNOLOGY; USER ACCEPTANCE; PERCEIVED EASE; COMMUNICATION; SMARTPHONES; TIME; TELEMEDICINE; MEMBERS	Background Healthcare contexts are witnessing a growing use of applications to support clinical processes and to communicate between peers and with patients. An increasing number of hospital professionals use instant-messaging applications such as WhatsApp in their daily work. Previous research has mainly focused on the advantages and risks of WhatsApp usage in different clinical settings, but limited evidence is available about whether and how individual and organizational determinants can influence the use of WhatsApp in hospitals. Moreover, instruments to explore this phenomenon are lacking. A theoretical four-factor model based on the 'Technology Acceptance Model' and the Institutional Theory, guided the development of a new measure of the individual and institutional determinants of WhatsApp usage in hospitals. Aim To develop and psychometrically test the questionnaire 'Digital Innovation Adoption in Hospitals'. Method A panel of researchers and clinical experts generated an initial pool of 35 items by identifying and adapting items from existing measures. These items were assessed for content and face validity by fourteen experts. The final 28-item `Digital Innovation Adoption in Hospitals' questionnaire comprising four sections (Perceived risks, Perceived usefulness, Regulative factors and Normative factors) was administered online to nurses and physicians. Construct validity was tested through confirmatory factor analysis. Results The sample included 326 hospital nurses and physicians. The theoretical four-factors model was confirmed and the confirmatory factor analysis yielded acceptable fit indexes. The correlations between the factors were significant and ranged from -0.284 to 0.543 (p < .01). Reliability in terms of internal consistency was satisfactory with Cronbach's alpha coefficient ranging from 0.918-0.973. Conclusion This study is the first to provide a validated tool to evaluate the use of WhatsApp in hospitals. The new instrument shows reasonable psychometric properties and is a promising and widely applicable measure of factors that influence the use of WhatsApp in hospitals.	[De Benedictis, Anna; Piredda, Michela; Gualandi, Raffaella; Tartaglini, Daniela] Campus Biomed Rome Univ Hosp, Dept Healthcare Profess, Rome, Italy; [Lettieri, Emanuele] Politecn Milan, Dept Econ Management & Ind Engn, Milan, Italy; [Piredda, Michela; Tartaglini, Daniela] Campus Biomed Rome Univ, Res Unit Nursing Sci, Rome, Italy; [De Maria, Maddalena] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy	Polytechnic University of Milan; University of Rome Tor Vergata	De Benedictis, A (corresponding author), Campus Biomed Rome Univ Hosp, Dept Healthcare Profess, Rome, Italy.	a.debenedictis@unicampus.it		Gualandi, Raffaella/0000-0001-8602-5249; De Benedictis, Anna/0000-0001-8655-0895				Ammenwerth Elske, 2019, Stud Health Technol Inform, V263, P64, DOI 10.3233/SHTI190111; Astarcioglu MA, 2015, AM J EMERG MED, V33, P1382, DOI 10.1016/j.ajem.2015.07.029; Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; Barayev E, 2021, ISR J HEALTH POLICY, V10, DOI 10.1186/s13584-021-00468-8; Boulos MNK, 2016, FUTURE INTERNET, V8, DOI 10.3390/fi8030037; Brancato G, 2006, HDB RECOMMENDE PRACT; Chan WSY, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8382; Choudhari P, 2014, INT SURG J, V1, P9, DOI 10.5455/2349-2902.isj20140504; Coleman E, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1706-8; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; De Benedictis A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209873; De Vet HCW., 2011, MEASUREMENT MED PRAC, DOI [10.1017/CBO9780511996214, DOI 10.1017/CBO9780511996214]; Dhuvad JM, 2015, J CLIN DIAGN RES, V9, pZC22, DOI 10.7860/JCDR/2015/14466.6454; Dorwal P, 2016, J MED SYST, V40, DOI 10.1007/s10916-015-0384-2; Gastaldi L, 2019, INT J TECHNOL MANAGE, V80, P85, DOI 10.1504/IJTM.2019.099768; Gastaldi L, 2012, INT J ENG BUS MANAG, V4, DOI 10.5772/51643; Giansanti D, 2020, MHEALTH, V6, DOI 10.21037/mhealth.2019.11.01; Giordano V, 2017, INTERACT J MED RES, V6, DOI 10.2196/ijmr.6214; Graziano F, 2015, NEUROREPORT, V26, P602, DOI 10.1097/WNR.0000000000000393; Gulacti U, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0483-8; Jagannathan Mukund, 2013, Indian J Plast Surg, V46, P506; Johnston MJ, 2015, AM J SURG, V209, P45, DOI 10.1016/j.amjsurg.2014.08.030; Kaliyadan F, 2016, INDIAN J DERMATOL VE, V82, P67, DOI 10.4103/0378-6323.171638; Kelahmetoglu O, 2015, J CRANIOFAC SURG, V26, P1437, DOI 10.1097/SCS.0000000000001627; Khanna Vishesh, 2015, Eur J Orthop Surg Traumatol, V25, P821, DOI 10.1007/s00590-015-1600-y; Lee RS, 2008, EMERG MED J, V25, DOI 10.1136/emj.2007.051631; Machado RS, 2019, ENDOSC INT OPEN, V7, pE1027, DOI 10.1055/a-0965-6631; Martyn-Hemphill C, 2015, J UROLOGY, V193, pE169, DOI 10.1016/j.juro.2015.02.813; Migliore M, 2015, ANN ITAL CHIR, V86, P185; Mobasheri M.H., 2015, BMJ INNOV, V1, P174, DOI [DOI 10.1136/BMJINNOV-2015-000062, 10.1136/bmjinnov-2015-000062]; Moore GC, 1991, INFORM SYST RES, V2, P192, DOI 10.1287/isre.2.3.192; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; Nardo B, 2021, MINERVA SURG, V76, P146, DOI 10.23736/S2724-5691.20.08454-0; Pandian SS, 2014, J MAXILLOFAC ORAL SU, V13, P355, DOI 10.1007/s12663-013-0497-4; Patel Suha J, 2018, Mhealth, V4, P14, DOI 10.21037/mhealth.2018.04.05; Pellegrino E.D, 1979, HUMANISM PHYS, P17; Petruzzi M, 2016, OR SURG OR MED OR PA, V121, P248, DOI 10.1016/j.oooo.2015.11.005; Polit DF., 2014, ESSENTIALS NURSING R, V8th ed, Int ed.; Radaelli G, 2017, J PROD INNOVAT MANAG, V34, P450, DOI 10.1111/jpim.12385; Raiman L, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-0855-x; Scott WR, 2014, MANAGEMENT, V17, P136, DOI 10.3917/mana.172.0136; SCOTT WR, 1987, ADMIN SCI QUART, V32, P493, DOI 10.2307/2392880; Scott WR, 2003, IND CORP CHANGE, V12, P879, DOI 10.1093/icc/12.4.879; Suliman MT., 2014, J LOCAL GLOBAL HLTH, P2; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Venkatesh V, 2000, INFORM SYST RES, V11, P342, DOI 10.1287/isre.11.4.342.11872; Venkatesh V, 2011, INFORM SYST RES, V22, P523, DOI 10.1287/isre.1110.0383; Wang J, 2019, STRUCTURAL EQUATION, DOI [DOI 10.1002/9781118356258, DOI 10.1002/]; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	50	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2021	16	12							e0262003	10.1371/journal.pone.0262003	http://dx.doi.org/10.1371/journal.pone.0262003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0C7TD	34969058	gold, Green Published			2022-12-27	WOS:000775510400028
J	Berke, MS; Fensholdt, LKD; Hestehave, S; Kalliokoski, O; Abelson, KSP				Berke, Mie S.; Fensholdt, Louise K. D.; Hestehave, Sara; Kalliokoski, Otto; Abelson, Klas S. P.			Effects of buprenorphine on model development in an adjuvant-induced monoarthritis rat model	PLOS ONE			English	Article							CORTICOSTERONE LEVELS; POSTOPERATIVE PAIN; PLASMA-CORTICOSTERONE; LABORATORY RODENTS; NERVOUS-SYSTEM; GRIMACE SCALE; MELOXICAM; ANALGESIA; STRESS; HYPERALGESIA	Complete Freund's adjuvant (CFA)-induced arthritis in rats is a common animal model for studying chronic inflammatory pain. However, modelling of the disease is associated with unnecessary pain and impaired animal wellbeing, particularly in the immediate post-induction phase. Few attempts have been made to counteract these adverse effects with analgesics. The present study investigated the effect of buprenorphine on animal welfare, pain-related behaviour and model-specific parameters during the disease progression in a rat model of CFA-induced monoarthritis. The aim was to reduce or eliminate unnecessary pain in this model, in order to improve animal welfare and to avoid suffering, without compromising the quality of the model. Twenty-four male Sprague Dawley rats were injected with 20 mu l of CFA into the left tibio-tarsal joint to induce monoarthritis. Rats were treated with either buprenorphine or carprofen for 15 days during the disease development, and were compared to a saline-treated CFA-injected group or a negative control group. Measurements of welfare, pain-related behaviour and clinical model-specific parameters were collected. The study was terminated after 3 weeks, ending with a histopathologic analysis. Regardless of treatment, CFA-injected rats displayed mechanical hyperalgesia and developed severe histopathological changes associated with arthritis. However, no severe effects on general welfare were found at any time. Buprenorphine treatment reduced facial pain expression scores, improved mobility, stance and lameness scores and it did not supress the CFA-induced ankle swelling, contrary to carprofen. Although buprenorphine failed to demonstrate a robust analgesic effect on the mechanical hyperalgesia in this study, it did not interfere with the development of the intended pathology.	[Berke, Mie S.; Fensholdt, Louise K. D.; Kalliokoski, Otto; Abelson, Klas S. P.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Copenhagen, Denmark; [Hestehave, Sara] UCL, Dept Cell & Dev Biol, London, England	University of Copenhagen; University of London; University College London	Berke, MS (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Copenhagen, Denmark.	mibe@sund.ku.dk	Hestehave, Sara/AAZ-5283-2021; Kalliokoski, Otto/I-3828-2019	Hestehave, Sara/0000-0002-1837-521X; Kalliokoski, Otto/0000-0001-6531-3487; Abelson, Klas/0000-0002-4986-7882; Berke, Mie Schou/0000-0002-6197-3928	 [33010-NIFA-14-586]		KSPA received a grant from the Danish 3R-center (33010-NIFA-14-586). URL: https://en.3rcenter.dk/research/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott FV, 1997, VET REC, V140, P553, DOI 10.1136/vr.140.21.553; Abelson KSP, 2005, IN VIVO, V19, P815; Agha AM, 1999, PHARMACOL RES, V40, P385, DOI 10.1006/phrs.1999.0522; BAUMANS V, 1994, LAB ANIM-UK, V28, P97, DOI 10.1258/002367794780745308; Berke MS, 2020, SCAND J LAB ANIM SCI, V46, P39; BESSE D, 1992, EUR J PHARMACOL, V223, P123, DOI 10.1016/0014-2999(92)94830-O; Bolon B, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569068; Brennan MP, 2009, LAB ANIMAL, V38, P87, DOI 10.1038/laban0309-87; Budsberg S., 2009, HDB VET PAIN MANAGEM, VSecond Edition, P183; BUTLER SH, 1992, PAIN, V48, P73, DOI 10.1016/0304-3959(92)90133-V; COWAN A, 1977, BRIT J PHARMACOL, V60, P537, DOI 10.1111/j.1476-5381.1977.tb07532.x; Crofford LJ, 2000, ARTHRITIS RHEUM-US, V43, P4, DOI 10.1002/1529-0131(200001)43:1<4::AID-ANR2>3.0.CO;2-V; Curtin LI, 2009, COMPARATIVE MED, V59, P60; Deuis JR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00284; DONALDSON LF, 1993, J NEUROSCI METH, V49, P5, DOI 10.1016/0165-0270(93)90103-X; DOUGHERTY PM, 1992, BRAIN RES, V570, P109, DOI 10.1016/0006-8993(92)90570-Y; DUM J, 1981, EUR J PHARMACOL, V70, P293, DOI 10.1016/0014-2999(81)90163-1; Engelhardt G, 1995, INFLAMM RES, V44, P548, DOI 10.1007/BF01757360; Festing MFW., 2003, HDB LAB ANIMAL SCI V, V1, P327; Festing Michael F W, 2002, ILAR J, V43, P244; Flecknell P, 2000, PAIN MANAGEMENT ANIM; FLECKNELL PA, 1984, LAB ANIM, V18, P147, DOI 10.1258/002367784780891226; Flecknell P, 2009, LABORATORY ANIMAL ANAESTHESIA, 3RD EDITION, P109, DOI 10.1016/B978-0-12-369376-1.00004-6; Flecknell P, 2009, LABORATORY ANIMAL ANAESTHESIA, 3RD EDITION, P139, DOI 10.1016/B978-0-12-369376-1.00005-8; Gades NM, 2000, CONTEMP TOP LAB ANIM, V39, P8; Ganju P, 2001, EUR J PHARMACOL, V421, P191, DOI 10.1016/S0014-2999(01)01048-2; GARTNER J, 1980, DOC OPHTHALMOL, V49, P155; Goldkuhl R, 2008, EUR SURG RES, V41, P272, DOI 10.1159/000142372; Goldkuhl R, 2010, EUR SURG RES, V44, P117, DOI 10.1159/000264962; Goldkuhl R, 2010, LAB ANIM-UK, V44, P337, DOI 10.1258/la.2010.009115; Gomes RP, 2013, EINSTEIN-SAO PAULO, V11, P76, DOI 10.1590/S1679-45082013000100014; Grahm MJ, 1997, VET J, V153, P87, DOI 10.1016/S1090-0233(97)80013-5; Hampshire VA, 2001, LAB ANIM-UK, V35, P223, DOI 10.1258/0023677011911660; Hashmi JA, 2010, INFLAMM RES, V59, P667, DOI 10.1007/s00011-010-0179-3; Hedenqvist P., HDB LAB ANIMAL SCI, V12011; Hestehave S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188113; Jacobsen KR, 2013, COMPARATIVE MED, V63, P105; Jensen Troels S, 2014, Lancet Neurol, V13, P924, DOI 10.1016/S1474-4422(14)70102-4; Jessen L, 2007, LAB ANIM-UK, V41, P185, DOI 10.1258/002367707780378131; Kalliokoski O, 2012, IN VIVO, V26, P213; Kalliokoski O, 2010, IN VIVO, V24, P641; Kalliokoski O, 2011, VET J, V187, P251, DOI 10.1016/j.tvjl.2009.11.013; Kissin I, 1998, ANESTHESIOLOGY, V88, P224, DOI 10.1097/00000542-199801000-00031; Kyles AE, 1998, RES VET SCI, V65, P245, DOI 10.1016/S0034-5288(98)90151-5; Leach MC, 2010, LAB ANIM-UK, V44, P54, DOI 10.1258/la.2009.009029; Leung V, 2016, SCI REP-UK, V6, DOI 10.1038/srep31667; LEVINE JD, 1985, J NEUROSCI, V5, P1380; LILES JH, 1992, LAB ANIM, V26, P180, DOI 10.1258/002367792780740558; Magalhaes-Sant'Ana M, 2009, ANIM WELFARE, V18, P49; Martin LBE, 2001, COMPARATIVE MED, V51, P43; MCQUEEN DS, 1991, BRIT J PHARMACOL, V104, P178, DOI 10.1111/j.1476-5381.1991.tb12404.x; Mead R, 1988, DESIGN EXPT; Prunier A, 2005, J ANIM SCI, V83, P216; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Richardson CA, 2005, ATLA-ALTERN LAB ANIM, V33, P119, DOI 10.1177/026119290503300207; Roughan JV, 2002, LAB ANIM-UK, V36, P322, DOI 10.1258/002367702320162423; Sacerdote P, 2006, PALLIATIVE MED, V20, pS9, DOI 10.1191/0269216306pm1124oa; Shankarappa SA, 2012, P NATL ACAD SCI USA, V109, P17555, DOI 10.1073/pnas.1214634109; Shavit Y, 2005, BRAIN RES, V1047, P10, DOI 10.1016/j.brainres.2005.04.003; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Stewart LSA, 2003, CONTEMP TOP LAB ANIM, V42, P28; Stokes EL, 2009, LAB ANIM-UK, V43, P149, DOI 10.1258/la.2008.008020; Sundbom R, 2011, IN VIVO, V25, P335; Walker JS, 1996, INFLAMM RES, V45, P557, DOI 10.1007/BF02342227; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030	66	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0260356	10.1371/journal.pone.0260356	http://dx.doi.org/10.1371/journal.pone.0260356			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025864	Green Published, gold			2022-12-27	WOS:000796264200007
J	Karolak, A; Levatic, J; Supek, F				Karolak, Aleksandra; Levatic, Jurica; Supek, Fran			A framework for mutational signature analysis based on DNA shape parameters	PLOS ONE			English	Article							CANCER; PREDICTION; PATTERNS; REVEAL	The mutation risk of a DNA locus depends on its oligonucleotide context. In turn, mutability of oligonucleotides varies across individuals, due to exposure to mutagenic agents or due to variable efficiency and/or accuracy of DNA repair. Such variability is captured by mutational signatures, a mathematical construct obtained by a deconvolution of mutation frequency spectra across individuals. There is a need to enhance methods for inferring mutational signatures to make better use of sparse mutation data (e.g., resulting from exome sequencing of cancers), to facilitate insight into underlying biological mechanisms, and to provide more accurate mutation rate baselines for inferring positive and negative selection. We propose a conceptualization of mutational signatures that represents oligonucleotides via descriptors of DNA conformation: base pair, base pair step, and minor groove width parameters. We demonstrate how such DNA structural parameters can accurately predict mutation occurrence due to DNA repair failures or due to exposure to diverse mutagens such as radiation, chemical exposure, and the APOBEC cytosine deaminase enzymes. Furthermore, the mutation frequency of DNA oligomers classed by structural features can accurately capture systematic variability in mutagenesis of >1,000 tumors originating from diverse human tissues. A nonnegative matrix factorization was applied to mutation spectra stratified by DNA structural features, thereby extracting novel mutational signatures. Moreover, many of the known trinucleotide signatures were associated with an additional spectrum in the DNA structural descriptor space, which may aid interpretation and provide mechanistic insight. Overall, we suggest that the power of DNA sequence motif-based mutational signature analysis can be enhanced by drawing on DNA shape features.	[Karolak, Aleksandra; Levatic, Jurica; Supek, Fran] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Genome Data Sci, Barcelona, Spain; [Karolak, Aleksandra] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [Karolak, Aleksandra] City Hope Natl Med Ctr, Beckman Res Inst, Dept Computat & Quantitat Med, Div Math Oncol, Duarte, CA USA; [Supek, Fran] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Karolak, Aleksandra] H Lee Moffitt Canc Ctr & Res Inst, Dept Machine Learning, Div Quantitat Sci, Tampa, FL USA	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; ICREA; H Lee Moffitt Cancer Center & Research Institute	Supek, F (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Genome Data Sci, Barcelona, Spain.; Supek, F (corresponding author), Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain.	fran.supek@irbbarcelona.org	Karolak, Aleksandra/L-7386-2017	Karolak, Aleksandra/0000-0001-8430-7138	European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020), under the Marie Sklodowska-Curie PROBIST grant [754510]; European Research Council (ERC) under the European Union [757700]; ICREA Research Professor program; Severo Ochoa Centres of Excellence program of the Spanish Ministry of Economy and Competitiveness; ERDF/Spanish Ministry of Science, Innovation and Universities-Spanish Research State Agency [BFU2017-89833-P, PID2020-118795GB-I00]	European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020), under the Marie Sklodowska-Curie PROBIST grant; European Research Council (ERC) under the European Union(European Research Council (ERC)); ICREA Research Professor program; Severo Ochoa Centres of Excellence program of the Spanish Ministry of Economy and Competitiveness; ERDF/Spanish Ministry of Science, Innovation and Universities-Spanish Research State Agency	This work has received funding from the European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020), under the Marie Sklodowska-Curie PROBIST grant agreement No. 754510 (to A.K. and J.L., PROBIST co-fund fellowship of the Barcelona Institute of Science and Technology) and by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No. 757700, to F.S). F.S. is funded by the ICREA Research Professor program. A.K., J.L. and F.S. acknowledge support of the Severo Ochoa Centres of Excellence program of the Spanish Ministry of Economy and Competitiveness to the IRB Barcelona. Work in the laboratory of F.S. was supported by the ERDF/Spanish Ministry of Science, Innovation and Universities-Spanish Research State Agency/RegioMut project (grant agreement No. BFU2017-89833-P) and REPAIRSCAPE project (PID2020-118795GB-I00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2015, CELL, V161, P307, DOI 10.1016/j.cell.2015.02.008; Aggarwala V, 2016, NAT GENET, V48, P349, DOI 10.1038/ng.3511; Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Behjati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12605; Berger MF, 2018, NAT REV CLIN ONCOL, V15, P353, DOI 10.1038/s41571-018-0002-6; Buisson R, 2019, SCIENCE, V364, P1251, DOI 10.1126/science.aaw2872; Cadet J, 2018, PHOTOCH PHOTOBIO SCI, V17, P1816, DOI 10.1039/c7pp00395a; Cancer Genome Atlas N., 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Carlson J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05936-5; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chiu TP, 2016, BIOINFORMATICS, V32, P1211, DOI 10.1093/bioinformatics/btv735; Dietlein F, 2020, NAT GENET, V52, P208, DOI 10.1038/s41588-019-0572-y; Duan CR, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1525-y; Fredriksson NJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006773; Fujii S, 2007, NUCLEIC ACIDS RES, V35, P6063, DOI 10.1093/nar/gkm627; Funnell T, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006799; Georgakopoulos-Soares I, 2018, GENOME RES, V28, P1264, DOI 10.1101/gr.231688.117; Glockzin Gabriel, 2016, World J Gastrointest Pharmacol Ther, V7, P343, DOI 10.4292/wjgpt.v7.i3.343; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; Goto N, 2015, SCI REP-UK, V5, DOI 10.1038/srep11808; Gulhan DC, 2019, NAT GENET, V51, P912, DOI 10.1038/s41588-019-0390-2; Harmon Rhonda L, 2005, Int Semin Surg Oncol, V2, P3, DOI 10.1186/1477-7800-2-3; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Karolak A, 2016, J PHYS CHEM B, V120, P42, DOI 10.1021/acs.jpcb.5b09250; Karolak A, 2015, BIOPHYS CHEM, V203, P22, DOI 10.1016/j.bpc.2015.05.001; Karolak A, 2014, J COMPUT CHEM, V35, P2297, DOI 10.1002/jcc.23751; Kucab JE, 2019, CELL, V177, P821, DOI 10.1016/j.cell.2019.03.001; Lankas F, 2003, BIOPHYS J, V85, P2872, DOI 10.1016/S0006-3495(03)74710-9; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Levatic J., 2021, BIORXIV, DOI [10.1101/2021.05.19.444811, DOI 10.1101/2021.05.19.444811]; Li JS, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1145; Lim B, 2016, ONCOTARGET, V7, P8055, DOI 10.18632/oncotarget.6977; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Madakashira BP, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00076; Mao P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05064-0; Marquard AM, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0130-0; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; Martinez-Fernandez L, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.21; Mas-Ponte D, 2020, NAT GENET, V52, P958, DOI 10.1038/s41588-020-0674-6; Mathelier A, 2016, CELL SYST, V3, P278, DOI 10.1016/j.cels.2016.07.001; Matsutani T, 2019, BIOINFORMATICS, V35, P4543, DOI 10.1093/bioinformatics/btz266; McMullen JRW, 2017, ONCOTARGET, V8, P43481, DOI 10.18632/oncotarget.16480; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Nakagawa H, 2018, CANCER SCI, V109, P513, DOI 10.1111/cas.13505; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Omichessan H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221235; Petljak M, 2019, CELL, V176, P1282, DOI 10.1016/j.cell.2019.02.012; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Poon SL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0161-3; Poulos RC, 2017, NUCLEIC ACIDS RES, V45, P7786, DOI 10.1093/nar/gkx463; R Core Team, 2020, R LANG ENV STAT COMP; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Sahin IH, 2019, BRIT J CANCER, V121, P809, DOI 10.1038/s41416-019-0599-y; Salvadores M, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006953; Schrock AB, 2019, ANN ONCOL, V30, P1096, DOI 10.1093/annonc/mdz134; Seplyarskiy VB, 2021, SCIENCE, V373, P1030, DOI 10.1126/science.aba7408; Shinbrot E, 2014, GENOME RES, V24, P1740, DOI 10.1101/gr.174789.114; Shiraishi Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005657; Srivastava AK, 2015, P NATL ACAD SCI USA, V112, P4411, DOI 10.1073/pnas.1421365112; Staaf J, 2019, NAT MED, V25, P1526, DOI 10.1038/s41591-019-0582-4; Supek F, 2017, CELL, V170, P534, DOI 10.1016/j.cell.2017.07.003; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Volkova NV, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15912-7; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zhou TY, 2013, NUCLEIC ACIDS RES, V41, pW56, DOI 10.1093/nar/gkt437	69	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262495	10.1371/journal.pone.0262495	http://dx.doi.org/10.1371/journal.pone.0262495			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015788	Green Published, Green Submitted, gold			2022-12-27	WOS:000814820600028
J	Arnaout, Y; Djelouadji, Z; Robardet, E; Cappelle, J; Cliquet, F; Touzalin, F; Jimenez, G; Hurstel, S; Borel, C; Picard-Meyer, E				Arnaout, Youssef; Djelouadji, Zouheira; Robardet, Emmanuelle; Cappelle, Julien; Cliquet, Florence; Touzalin, Frederic; Jimenez, Giacomo; Hurstel, Suzel; Borel, Christophe; Picard-Meyer, Evelyne			Genetic identification of bat species for pathogen surveillance across France	PLOS ONE			English	Article							REAL-TIME PCR; MOLECULAR PHYLOGENY; CHIROPTERA VESPERTILIONIDAE; POPULATION-GENETICS; MITOCHONDRIAL; EUROPE; PHYLOGEOGRAPHY; SYSTEMATICS; AMPLIFICATION; LYSSAVIRUSES	With more than 1400 chiropteran species identified to date, bats comprise one-fifth of all mammalian species worldwide. Many studies have associated viral zoonoses with 45 different species of bats in the EU, which cluster within 5 families of bats. For example, the Serotine bats are infected by European Bat 1 Lyssavirus throughout Europe while Myotis bats are shown infected by coronavirus, herpesvirus and paramyxovirus. Correct host species identification is important to increase our knowledge of the ecology and evolutionary pattern of bat viruses in the EU. Bat species identification is commonly determined using morphological keys. Morphological determination of bat species from bat carcasses can be limited in some cases, due to the state of decomposition or nearly indistinguishable morphological features in juvenile bats and can lead to misidentifications. The overall objective of our study was to identify insectivorous bat species using molecular biology tools with the amplification of the partial cytochrome b gene of mitochondrial DNA. Two types of samples were tested in this study, bat wing punches and bat faeces. A total of 163 bat wing punches representing 22 species, and 31 faecal pellets representing 7 species were included in the study. From the 163 bat wing punches tested, a total of 159 were genetically identified from amplification of the partial cyt b gene. All 31 faecal pellets were genetically identified based on the cyt b gene. A comparison between morphological and genetic determination showed 21 misidentifications from the 163 wing punches, representing similar to 12.5% of misidentifications of morphological determination compared with the genetic method, across 11 species. In addition, genetic determination allowed the identification of 24 out of 25 morphologically non-determined bat samples. Our findings demonstrate the importance of a genetic approach as an efficient and reliable method to identify bat species precisely.	[Arnaout, Youssef; Robardet, Emmanuelle; Cliquet, Florence; Picard-Meyer, Evelyne] ANSES, WHO Collaborating Ctr Res & Management Zoonoses C, Nancy Lab Rabies & Wildlife,OIE Reference Lab Rab, European Union Reference Lab Rabies,European Unio, Malzeville, France; [Arnaout, Youssef; Djelouadji, Zouheira] VetAgro Sup Lyon Lab Leptospira, Marcy Letoile, France; [Cappelle, Julien] Univ Montpellier, UMR ASTRE, CIRAD, INRAE, Montpellier, France; [Cappelle, Julien] INRAE, VetAgro Sup, UMR EPIA, Theix, France; [Touzalin, Frederic] Univ Coll Dublin, Sci Ctr West, Sch Biol & Environm Sci, Dublin, Ireland; [Jimenez, Giacomo; Borel, Christophe] CPEPESC Lorraine, Neuves Maisons, France; [Hurstel, Suzel] GEPMA, Strasbourg, France; [Hurstel, Suzel] LPO Alsace, Rosenwiller, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire; CIRAD; INRAE; Universite de Montpellier; INRAE; VetAgro Sup; University College Dublin	Picard-Meyer, E (corresponding author), ANSES, WHO Collaborating Ctr Res & Management Zoonoses C, Nancy Lab Rabies & Wildlife,OIE Reference Lab Rab, European Union Reference Lab Rabies,European Unio, Malzeville, France.	evelyne.picard-meyer@anses.fr		Cappelle, Julien/0000-0001-7668-1971	French National Agency for Food, Environmental and Occupational Health & Safety and VetAgro Sup laboratory for Leptospira	French National Agency for Food, Environmental and Occupational Health & Safety and VetAgro Sup laboratory for Leptospira	This work was supported by the French National Agency for Food, Environmental and Occupational Health & Safety and VetAgro Sup laboratory for Leptospira.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Artyushin IV, 2009, ZOOTAXA, P40; Benda P, 2016, TURK J ZOOL, V40, P842, DOI 10.3906/zoo-1505-47; Benda Petr, 2012, Acta Societatis Zoologicae Bohemicae, V76, P163; Bogdanowicz W, 2009, ACTA CHIROPTEROL, V11, P289, DOI 10.3161/150811009X485530; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boston ESM, 2012, ACTA CHIROPTEROL, V14, P45, DOI 10.3161/150811012X654259; Chipps AS, 2020, PEERJ, V8, DOI 10.7717/peerj.10348; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; Dietz C, 2009, HDB BATS EUROPE NW A; Dool SE, 2013, MOL ECOL, V22, P4055, DOI 10.1111/mec.12373; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526; Eggerbauer E, 2017, ADV VIRUS RES, V99, P199, DOI 10.1016/bs.aivir.2017.07.004; Falcon A, 2011, ARCH VIROL, V156, P1883, DOI 10.1007/s00705-011-1057-1; Fenton MB, 2010, CURR ZOOL, V56, P454, DOI 10.1093/czoolo/56.4.454; Hassanin A, 2016, CR BIOL, V339, P517, DOI 10.1016/j.crvi.2016.09.005; Heaney LR, 2012, ACTA CHIROPTEROL, V14, P265, DOI 10.3161/150811012X661602; Hulva P, 2012, MOL ECOL, V21, P6104, DOI 10.1111/mec.12078; Jones G, 2006, ACTA CHIROPTEROL, V8, P451, DOI 10.3161/1733-5329(2006)8[451:ECWSDA]2.0.CO;2; Juste J, 2018, ACTA CHIROPTEROL, V20, P285, DOI 10.3161/15081109ACC2018.20.2.001; Kawai K, 2003, MOL PHYLOGENET EVOL, V28, P297, DOI 10.1016/S1055-7903(03)00121-0; Kawai K, 2010, ACTA CHIROPTEROL, V12, P463, DOI 10.3161/150811010X538034; Kim HS, 2008, J CLIN MICROBIOL, V46, P2992, DOI 10.1128/JCM.00027-08; Korstian JM, 2016, CONSERV GENET RESOUR, V8, P27, DOI 10.1007/s12686-015-0509-4; Lei M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27726; Lopez-Oceja A, 2016, FORENSIC SCI INT-GEN, V23, P159, DOI 10.1016/j.fsigen.2016.05.001; McElhinney LM, 2013, ZOONOSES PUBLIC HLTH, V60, P35, DOI 10.1111/zph.12003; Ministere de l'Ecologie et du Developpement Durable, 2012, ARR AUT CAPT TRANSP, V3; Moussy C, 2015, HEREDITY, V115, P83, DOI 10.1038/hdy.2015.20; Muhldorfer K, 2010, EMERG INFECT DIS, V16, P578, DOI 10.3201/eid1603.091035; Nadin-Davis SA, 2012, OPEN J ZOOLOGY S1M5, V5, P27, DOI DOI 10.2174/1874336601205010027; Nadin-Davis S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005541; Pereira MR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/639310; Puechmaille SJ, 2007, J APPL ECOL, V44, P843, DOI 10.1111/j.1365-2664.2007.01321.x; Puechmaille SJ, 2014, MAMMALIA, V78, P251, DOI 10.1515/mammalia-2013-0040; Puechmaille SJ, 2012, MAMM BIOL, V77, P224, DOI 10.1016/j.mambio.2011.11.004; Rebelo H, 2012, MOL ECOL, V21, P2761, DOI 10.1111/j.1365-294X.2012.05566.x; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Ruedi M, 2015, ZOOTAXA, V3920, P301, DOI 10.11646/zootaxa.3920.2.6; Ruedi M, 2013, MOL PHYLOGENET EVOL, V69, P437, DOI 10.1016/j.ympev.2013.08.011; Sakai T, 2003, GENES GENET SYST, V78, P179; Schlottau K, 2020, INFECT GENET EVOL, V78, DOI 10.1016/j.meegid.2019.104140; Shipley R, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4010031; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Stadelmann B, 2004, ACTA CHIROPTEROL, V6, P177, DOI 10.3161/001.006.0201; Stadelmann B, 2004, J MAMMAL, V85, P133, DOI 10.1644/1545-1542(2004)085<0133:MSOTFB>2.0.CO;2; Stuckey MJ, 2017, EMERG INFECT DIS, V23, P539, DOI 10.3201/eid2303.160934; Sylvia B., 2018, ACTION PLAN CONSERVA, V86; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tian LX, 2004, FOLIA ZOOL, V53, P303; Tobe SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014156; Troupin C, 2017, GENOME BIOL EVOL, V9, P3202, DOI 10.1093/gbe/evx236; Trujillo RG, 2009, J MAMMAL, V90, P548, DOI 10.1644/08-MAMM-A-239R2.1; Tsytsulina Katerina, 2012, Russian Journal of Theriology, V11, P1; Walker FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162342; Zhang GD, 2011, APPL ENVIRON MICROB, V77, P6495, DOI 10.1128/AEM.00520-11; Zhou ZM, 2009, J MAMMAL, V90, P57, DOI 10.1644/08-MAMM-A-048.1	61	1	1	9	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0261344	10.1371/journal.pone.0261344	http://dx.doi.org/10.1371/journal.pone.0261344			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982782	Green Published, gold			2022-12-27	WOS:000834805700008
J	Braunwarth, E; Schullian, P; Kummann, M; Reider, S; Putzer, D; Primavesi, F; Stattner, S; Ofner, D; Bale, R				Braunwarth, Eva; Schullian, Peter; Kummann, Moritz; Reider, Simon; Putzer, Daniel; Primavesi, Florian; Staettner, Stefan; Oefner, Dietmar; Bale, Reto			Aggressive local treatment for recurrent intrahepatic cholangiocarcinoma-Stereotactic radiofrequency ablation as a valuable addition to hepatic resection	PLOS ONE			English	Article							LONG-TERM SURVIVAL; THERMAL ABLATION; HEPATOCELLULAR-CARCINOMA; MICROWAVE ABLATION; SURGICAL RESECTION; LIVER-RESECTION; MANAGEMENT; OUTCOMES; GEMCITABINE; CISPLATIN	Background To evaluate the efficacy, safety and overall clinical outcome of local treatment for recurrent intrahepatic cholangiocellular carcinoma after hepatic resection. Methods Between 2007 and 2019 72 consecutive patients underwent hepatic resection for primary intrahepatic cholangiocellular carcinoma. If amenable, recurrent tumors were aggressively treated by HR or stereotactic radiofrequency ablation with local curative intent. Endpoints consisted of morbidity and mortality, locoregional and de novo recurrence, disease free survival, and overall survival. Results After a median follow-up of 28 months, recurrence of intrahepatic cholangiocellular carcinoma was observed in 43 of 72 patients undergoing hepatic resection (60.3%). 16 patients were subsequently treated by hepatic resection (n = 5) and stereotactic radiofrequency ablation (n = 11) with local curative intention. The remaining 27 patients underwent palliative treatment for first recurrence. Overall survival of patients who underwent repeated aggressive liver-directed therapy was comparable to patients without recurrence (p = 0.938) and was better as compared to patients receiving palliative treatment (p = 0.018). The 5-year overall survival rates for patients without recurrence, the repeated liver-directed treatment group and the palliative treatment group were 54.3%, 47.7% and 12.3%, respectively. By adding stereotactic radiofrequency ablation as an alternative treatment option, the rate of curative re-treatment increased from 11.9% to 37.2%. Conclusion Repeated hepatic resection is often precluded due to patient morbidity or anatomical and functional limitations. Due to the application of stereotactic radiofrequency ablation in case of recurrent intrahepatic cholangiocellular carcinoma, the number of patients treated with curative intent can be increased. This leads to favorable clinical outcome as compared to palliative treatment of intrahepatic cholangiocellular carcinoma recurrence.	[Braunwarth, Eva; Oefner, Dietmar] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, Innsbruck, Austria; [Schullian, Peter; Kummann, Moritz; Putzer, Daniel; Bale, Reto] Med Univ Innsbruck, Dept Radiol Intervent Oncol Microinvas Therapy, Innsbruck, Austria; [Reider, Simon] Med Univ Innsbruck, Dept Internal Med 1, Gastroenterol Hepatol & Endocrinol, Innsbruck, Austria; [Primavesi, Florian; Staettner, Stefan] Salzkammergut Klinikum, Dept Gen Visceral & Vasc Surg, Vocklabruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Bale, R (corresponding author), Med Univ Innsbruck, Dept Radiol Intervent Oncol Microinvas Therapy, Innsbruck, Austria.	reto.bale@i-med.ac.at	Bale, Reto/AAS-1522-2020	Bale, Reto/0000-0003-0021-5792				Amini N, 2014, J SURG ONCOL, V110, P163, DOI 10.1002/jso.23605; [Anonymous], STATISTIK AUSTRIA; Atwell TD, 2005, CARDIOVASC INTER RAD, V28, P409, DOI 10.1007/s00270-004-4082-6; Bale R, 2019, CANCERS, V11, DOI 10.3390/cancers11091341; Bale R, 2012, EUR RADIOL, V22, P930, DOI 10.1007/s00330-011-2314-0; Bale R, 2011, CARDIOVASC INTER RAD, V34, P852, DOI 10.1007/s00270-010-9966-z; Bartolini I, 2020, RADIOL ONCOL, V54, P263, DOI 10.2478/raon-2020-0045; Bartsch F, 2019, WORLD J SURG, V43, P1105, DOI 10.1007/s00268-018-04876-x; Braunwarth E, 2018, EUR SURG, V50, P100, DOI 10.1007/s10353-018-0537-x; Buettner S, 2017, J SURG ONCOL, V116, P1085, DOI 10.1002/jso.24759; Butros SR, 2014, CLIN IMAG, V38, P490, DOI 10.1016/j.clinimag.2014.01.013; Carrafiello G, 2014, RADIOL MED, V119, P75, DOI 10.1007/s11547-013-0301-z; Choi SB, 2009, ANN SURG ONCOL, V16, P3048, DOI 10.1245/s10434-009-0631-1; Chun YS, 2017, CANCER CONTROL, V24, DOI 10.1177/1073274817729241; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Crocetti L, 2008, CANCER IMAGING, V8, P19, DOI 10.1102/1470-7330.2008.0004; Doussot A, 2016, J AM COLL SURGEONS, V223, P493, DOI 10.1016/j.jamcollsurg.2016.05.019; Doussot A, 2015, J AM COLL SURGEONS, V221, P452, DOI 10.1016/j.jamcollsurg.2015.04.009; Ebata T, 2017, LIVER CANCER, V6, P59, DOI 10.1159/000449493; Eckel F, 2009, ANN ONCOL, V20, P46, DOI 10.1093/annonc/mdp125; Ercolani G, 2010, ANN SURG, V252, P107, DOI 10.1097/SLA.0b013e3181e462e6; Fu Y, 2012, J VASC INTERV RADIOL, V23, P642, DOI 10.1016/j.jvir.2012.01.081; Haidu M, 2012, CARDIOVASC INTER RAD, V35, P1074, DOI 10.1007/s00270-011-0288-6; Hu LS, 2019, ANN SURG ONCOL, V26, P2549, DOI 10.1245/s10434-019-07353-4; Hyder O, 2013, SURGERY, V153, P811, DOI 10.1016/j.surg.2012.12.005; Inoue K, 2000, SURGERY, V127, P498, DOI 10.1067/msy.2000.104673; Kim JH, 2011, AM J ROENTGENOL, V196, pW205, DOI 10.2214/AJR.10.4937; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Lang H, 2009, J AM COLL SURGEONS, V208, P218, DOI 10.1016/j.jamcollsurg.2008.10.017; Lencioni R, 2015, TECH VASC INTERV RAD, V18, P135, DOI 10.1053/j.tvir.2015.06.003; Mavros MN, 2014, JAMA SURG, V149, P565, DOI 10.1001/jamasurg.2013.5137; Mizusawa J, 2016, JPN J CLIN ONCOL, V46, P385, DOI 10.1093/jjco/hyv213; Pang Yeung Yuk, 2002, HPB (Oxford), V4, P99, DOI 10.1080/136518202760378489; Park HM, 2016, ANN SURG ONCOL, V23, P4392, DOI 10.1245/s10434-016-5454-2; Primrose JN, 2019, LANCET ONCOL, V20, P663, DOI 10.1016/S1470-2045(18)30915-X; Putzer D, 2018, EUR SURG, V50, P117, DOI 10.1007/s10353-018-0521-5; Putzer D, 2019, INT J HYPERTHER, V36, P59, DOI 10.1080/02656736.2019.1647353; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Schullian P, 2020, J VASC INTERV RADIOL, V31, P943, DOI 10.1016/j.jvir.2019.12.794; Schullian P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58383-y; Schullian P, 2019, INT J HYPERTHER, V36, P876, DOI 10.1080/02656736.2019.1648886; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Si AF, 2017, SURGERY, V161, P897, DOI 10.1016/j.surg.2016.10.024; Souche R, 2016, AM J SURG, V212, P221, DOI 10.1016/j.amjsurg.2015.07.016; Spolverato G, 2016, ANN SURG ONCOL, V23, P235, DOI 10.1245/s10434-015-4642-9; Sulpice L, 2012, BRIT J SURG, V99, P1711, DOI 10.1002/bjs.8953; Tarchi P, 2018, SURGERY, V163, P698, DOI 10.1016/j.surg.2017.09.058; Thirunavukarasu P, 2016, SURG CLIN N AM, V96, P197, DOI 10.1016/j.suc.2015.11.001; Valle JW, 2016, ANN ONCOL, V27, pv28, DOI 10.1093/annonc/mdw324; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Waisberg DR, 2018, TRANSL GASTROENT HEP, V3, DOI 10.21037/tgh.2018.08.03; Wright GP, 2018, ANN SURG ONCOL, V25, P83, DOI 10.1245/s10434-017-6110-1; Xu HX, 2012, BRIT J RADIOL, V85, P1078, DOI 10.1259/bjr/24563774; Yamashita Y, 2017, ANN GASTROENT SURG, V1, P136, DOI 10.1002/ags3.12018; Yin T, 2017, CLIN RADIOL, V72, P136, DOI 10.1016/j.crad.2016.10.022; Zhang SJ, 2013, ANN SURG ONCOL, V20, P3596, DOI 10.1245/s10434-013-3035-1; Zhang XF, 2018, BRIT J SURG, V105, P848, DOI 10.1002/bjs.10676	57	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0261136	10.1371/journal.pone.0261136	http://dx.doi.org/10.1371/journal.pone.0261136			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982804	gold, Green Published			2022-12-27	WOS:000834805700007
J	Grusser, L; Keszei, A; Coburn, M; Rossaint, R; Ziemann, S; Kowark, A				Grusser, Linda; Keszei, Andras; Coburn, Mark; Rossaint, Rolf; Ziemann, Sebastian; Kowark, Ana		ETPOS Study Grp	Intraoperative transfusion practices and perioperative outcome in the European elderly: A secondary analysis of the observational ETPOS study	PLOS ONE			English	Article							BLOOD-CELL TRANSFUSION; PREOPERATIVE ANEMIA; PRACTICE GUIDELINES; CRITICALLY-ILL; OLDER-ADULTS; MANAGEMENT; MORTALITY; STRATEGY; METAANALYSIS; ASSOCIATION	The demographic development suggests a dramatic growth in the number of elderly patients undergoing surgery in Europe. Most red blood cell transfusions (RBCT) are administered to older people, but little is known about perioperative transfusion practices in this population. In this secondary analysis of the prospective observational multicentre European Transfusion Practice and Outcome Study (ETPOS), we specifically evaluated intraoperative transfusion practices and the related outcomes of 3149 patients aged 65 years and older. Enrolled patients underwent elective surgery in 123 European hospitals, received at least one RBCT intraoperatively and were followed up for 30 days maximum. The mean haemoglobin value at the beginning of surgery was 108 (21) g/l, 84 (15) g/l before transfusion and 101 (16) g/l at the end of surgery. A median of 2 [1-2] units of RBCT were administered. Mostly, more than one transfusion trigger was present, with physiological triggers being preeminent. We revealed a descriptive association between each intraoperatively administered RBCT and mortality and discharge respectively, within the first 10 postoperative days but not thereafter. In our unadjusted model the hazard ratio (HR) for mortality was 1.11 (95% CI: 1.08-1.15) and the HR for discharge was 0.78 (95% CI: 0.74-0.83). After adjustment for several variables, such as age, preoperative haemoglobin and blood loss, the HR for mortality was 1.10 (95% CI: 1.05-1.15) and HR for discharge was 0.82 (95% CI: 0.78-0.87). Preoperative anaemia in European elderly surgical patients is undertreated. Various triggers seem to support the decision for RBCT. A closer monitoring of elderly patients receiving intraoperative RBCT for the first 10 postoperative days might be justifiable. Further research on the causal relationship between RBCT and outcomes and on optimal transfusion strategies in the elderly population is warranted. A thorough analysis of different time periods within the first 30 postoperative days is recommended.	[Grusser, Linda; Rossaint, Rolf; Ziemann, Sebastian; Kowark, Ana] Univ Hosp RWTH Aachen, Dept Anaesthesiol, Aachen, Germany; [Keszei, Andras] Rhein Westfal TH Aachen, Med Fac, Ctr Translat & Clin Res Aachen CTC A, Aachen, Germany; [Coburn, Mark] Univ Hosp Bonn, Dept Anaesthesiol & Intens Care Med, Bonn, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; University of Bonn	Grusser, L (corresponding author), Univ Hosp RWTH Aachen, Dept Anaesthesiol, Aachen, Germany.	lgruesser@ukaachen.de	Dragan, Anca/HGC-8385-2022; Gherghina, Viorel/GRY-0844-2022; Costea, Daniel Ovidiu/ABB-8101-2020; Droc, Gabriela/AAD-9980-2022; CORNECI, DAN/ABG-1803-2021; Gritsan, Alexey/M-4261-2014; Goebel, Ulrich/Q-7613-2016	Dragan, Anca/0000-0003-2944-6527; Gherghina, Viorel/0000-0002-8695-6104; Costea, Daniel Ovidiu/0000-0001-6927-0568; Droc, Gabriela/0000-0002-1042-753X; CORNECI, DAN/0000-0002-1170-0614; Schittek, Gregor Alexander/0000-0003-0976-3891; Gritsan, Alexey/0000-0002-0500-2887; Pavicic Saric, Jadranka/0000-0003-4124-8056; Goebel, Ulrich/0000-0002-9991-3226; Tasoulis, Marios Konstantinos/0000-0001-9453-1547; Ziemann, Sebastian/0000-0003-4485-6030; Jhanji, Shaman/0000-0002-1116-628X; Pacasova, Rita/0000-0002-0121-1251				Amer Soc Anesthesiologists, 2015, ANESTHESIOLOGY, V122, P241, DOI 10.1097/ALN.0000000000000463; Bailes B K, 2000, AORN J, V72, P186; Balducci L, 2003, J AM GERIATR SOC, V51, pS2; Brown CH, 2014, ANESTH ANALG, V118, P1168, DOI 10.1213/ANE.0000000000000033; Brummel-Smith K., 2007, PRIMARY CARE GERIATR, P3; Carson JL, 2008, CRIT CARE MED, V36, P2707, DOI 10.1097/CCM.0b013e3181843ee7; Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Docherty AB, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1351; Ducrocq G, 2021, JAMA-J AM MED ASSOC, V325, P552, DOI 10.1001/jama.2021.0135; Eurostat, 2019, AGEING EUROPE LOOKIN; Fominskiy E, 2015, BRIT J ANAESTH, V115, P511, DOI 10.1093/bja/aev317; Frank SM, 2012, ANESTHESIOLOGY, V117, P99, DOI 10.1097/ALN.0b013e318255e550; Glance LG, 2011, ANESTHESIOLOGY, V114, P283, DOI 10.1097/ALN.0b013e3182054d06; Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361; Goodnough LT, 2013, LANCET, V381, P1845, DOI 10.1016/S0140-6736(13)60650-9; Goodnough LT, 2012, ANESTHESIOLOGY, V116, P1367, DOI 10.1097/ALN.0b013e318254d1a3; Greinacher A, 2011, TRANSFUSION, V51, P702, DOI 10.1111/j.1537-2995.2010.02882.x; Griffiths R, 2014, ANAESTHESIA, V69, P81, DOI 10.1111/anae.12524; Gu WJ, 2018, J BONE JOINT SURG AM, V100, P686, DOI 10.2106/JBJS.17.00375; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Hamel MB, 2005, J AM GERIATR SOC, V53, P424, DOI 10.1111/j.1532-5415.2005.53159.x; Khan FA, 2008, SINGAP MED J, V49, P759; Khanna MP, 2003, TRANSFUS MED REV, V17, P110, DOI 10.1053/tmrv.2003.50008; Kozek-Langenecker SA, 2017, EUR J ANAESTH, V34, P332, DOI 10.1097/EJA.0000000000000630; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Mazer CD, 2017, NEW ENGL J MED, V377, P2133, DOI 10.1056/NEJMoa1711818; Meier J, 2016, BRIT J ANAESTH, V116, P255, DOI 10.1093/bja/aev456; Meier J, 2013, ETPOS PROTOCOL; Mueller MM, 2019, JAMA-J AM MED ASSOC, V321, P983, DOI 10.1001/jama.2019.0554; Munoz M, 2017, ANAESTHESIA, V72, P233, DOI 10.1111/anae.13773; Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612; Murphy MF, 2001, BRIT J HAEMATOL, V113, P24; Musallam KM, 2011, LANCET, V378, P1396, DOI 10.1016/S0140-6736(11)61381-0; NICE, 2015, NICE GUID NG24 BLOOD; NTCA, 2012, GAZ NOT NAT TIG CONS; Petrelli F, 2021, SURG TODAY, V51, P1535, DOI 10.1007/s00595-020-02192-3; Qian F, 2013, ANN SURG, V257, P266, DOI 10.1097/SLA.0b013e31825ffc37; Ripatti S, 2000, BIOMETRICS, V56, P1016, DOI 10.1111/j.0006-341X.2000.01016.x; Shander A, 2012, BRIT J ANAESTH, V109, P55, DOI 10.1093/bja/aes139; Silvain J, 2014, J AM COLL CARDIOL, V63, P1289, DOI 10.1016/j.jacc.2013.11.029; Simon GI, 2017, LANCET HAEMATOL, V4, pE465, DOI 10.1016/S2352-3026(17)30141-2; Stehling LC, 1996, ANESTHESIOLOGY, V84, P732; WHO, 2011, WHO TECH REP SER, V959, P1; Wu WC, 2010, ANN SURG, V252, P11, DOI 10.1097/SLA.0b013e3181e3e43f	45	1	1	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262110	10.1371/journal.pone.0262110	http://dx.doi.org/10.1371/journal.pone.0262110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982801	gold, Green Published			2022-12-27	WOS:000834805700018
J	Grandt, LM; Schweighauser, A; Kovacevic, A; Francey, T				Grandt, Lisa-Maria; Schweighauser, Ariane; Kovacevic, Alan; Francey, Thierry			The circulating renin-angiotensin-aldosterone system is down-regulated in dogs with glomerular diseases compared to other chronic kidney diseases with low-grade proteinuria	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; NEPHROTIC SYNDROME; FILTRATION-RATE; HYPOPROTEINEMIA; PRESSURE; SODIUM; EDEMA	Glomerular diseases (GD) lead to a variety of disorders of the vascular and the total body water volumes. Various pathomechanisms, including vascular underfill and overfill, have been suggested to explain these disturbances. Accordingly, the circulating renin-angiotensin-aldosterone system (cRAAS) is expected to be activated as either a cause or a result of these fluid disorders. The aim of this study was to characterize the activity of the cRAAS in dogs with GD and to evaluate its relationship with the vascular volume status. In a prospective study, we evaluated the plasma renin activity and the serum aldosterone concentration in 15 dogs with GD. Their fluid volume status was estimated with clinical variables reflecting volemia and hydration, echocardiographic volume assessment, N-terminal pro B-type natriuretic peptide, blood urea nitrogen:creatinine ratio, and the urinary fractional excretion of sodium. Ten dogs with chronic kidney disease (CKD) with matching degree of azotemia were recruited as controls. The activity of the cRAAS was low in 10 dogs, normal in 3 dogs, high in 1 dog and equivocal (high renin-low aldosterone) in 1 dog with GD. These dogs had a lower cRAAS activity than dogs with CKD (p = 0.01). The clinical evaluation showed 8 hypovolemic and 7 non-hypovolemic dogs; 3 dehydrated, 9 euhydrated and 3 overhydrated dogs. The cRAAS activity was not different between hypovolemic and non-hypovolemic dogs. The down-regulated cRAAS without obvious association with the clinical volume status of these dogs with GD, suggests different mechanisms of fluid volume dysregulation in dogs with GD than previously assumed. This finding however should be confirmed in a focused larger scale study, as it may influence the use of cRAAS blockers as part of the standard therapy of GD in dogs.	[Grandt, Lisa-Maria; Schweighauser, Ariane; Kovacevic, Alan; Francey, Thierry] Univ Bern, Small Anim Internal Med, Vetsuisse Fac, Bern, Switzerland	University of Bern	Grandt, LM (corresponding author), Univ Bern, Small Anim Internal Med, Vetsuisse Fac, Bern, Switzerland.	lisa.grandt@vetsuisse.unibe.ch	Francey, Thierry/C-2106-2014	Francey, Thierry/0000-0002-6693-5365	Specialization Commission of the Vetsuisse Faculty University of Bern	Specialization Commission of the Vetsuisse Faculty University of Bern	We acknowledge a grant from the Specialization Commission of the Vetsuisse Faculty University of Bern funding part of this project (2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno MJ, 2018, J VET INTERN MED, V32, P1803, DOI 10.1111/jvim.15331; Adin D, 2020, J VET INTERN MED, V34, P600, DOI 10.1111/jvim.15746; Ames MK, 2019, J VET INTERN MED, V33, P363, DOI 10.1111/jvim.15454; Brown N, 2015, J VET INTERN MED, V29, P28, DOI 10.1111/jvim.12518; Brown S, 2013, J VET INTERN MED, V27, pS27, DOI 10.1111/jvim.12230; Bugbee AC, 2014, J VET INTERN MED, V28, P1871, DOI 10.1111/jvim.12471; Cadnapaphornchai MA, 2014, PEDIATR NEPHROL, V29, P1159, DOI 10.1007/s00467-013-2567-8; Chen JL, 2019, AM J NEPHROL, V50, P92, DOI 10.1159/000501059; Cornell CC, 2004, J VET INTERN MED, V18, P311, DOI 10.1892/0891-6640(2004)18&lt;311:ASOMCM&gt;2.0.CO;2; Davis EM, 2015, J VET DENT, V32, P87, DOI 10.1177/089875641503200202; De Mello WC, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00016; Durkan SD., 2005, J VET EMERG CRIT CAR, V15, pS1; Ettinger SJ., 2010, TXB VET INTERNAL MED, P2021; Grauer GF, 2000, J VET INTERN MED, V14, P526, DOI 10.1892/0891-6640(2000)014&lt;0526:EOEVPA&gt;2.3.CO;2; Hokamp JA, 2018, VET CLIN PATH, V47, P425, DOI 10.1111/vcp.12648; IRIS, 2013, NOVARTIS ANIM HEAL, P1; Jiang F, 2010, NEPHROLOGY, V15, P476, DOI 10.1111/j.1440-1797.2010.01267.x; JOLES JA, 1988, AM J PHYSIOL, V254, pF887, DOI 10.1152/ajprenal.1988.254.6.F887; Keenswijk W, 2018, EUR J PEDIATR, V177, P79, DOI 10.1007/s00431-017-3029-2; Klosterman ES, 2011, J VET INTERN MED, V25, P206, DOI 10.1111/j.1939-1676.2010.0669.x; MANNING RD, 1987, AM J PHYSIOL, V252, pF91, DOI 10.1152/ajprenal.1987.252.1.F91; Miyagawa Y, 2013, VET J, V197, P445, DOI 10.1016/j.tvjl.2013.02.016; Pelander L, 2017, J VET INTERN MED, V31, P805, DOI 10.1111/jvim.14703; Riccardi A, 2013, EUR REV MED PHARMACO, V17, P1800; Rishniw M, 2000, J VET INTERN MED, V14, P429, DOI 10.1892/0891-6640(2000)014&lt;0429:EOFEMO&gt;2.3.CO;2; Rostoker G, 2000, NEPHRON, V85, P194, DOI 10.1159/000045661; Schrier RW, 1998, KIDNEY INT, V53, P1111, DOI 10.1046/j.1523-1755.1998.00864.x; Smets P, 2014, J VET INTERN MED, V28, P116, DOI 10.1111/jvim.12234; Svenningsen P, 2009, AM J PHYSIOL-REG I, V297, pR1733, DOI 10.1152/ajpregu.00321.2009; Troia R, 2018, J VET INTERN MED, V32, P1372, DOI 10.1111/jvim.15146; van den Heuvel M, 2011, J HYPERTENS, V29, P2147, DOI 10.1097/HJH.0b013e32834bbcbf; Young BC, 2014, J VET EMERG CRIT CAR, V24, P154, DOI 10.1111/vec.12154	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262121	10.1371/journal.pone.0262121	http://dx.doi.org/10.1371/journal.pone.0262121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007295	Green Published, gold			2022-12-27	WOS:000741060700011
J	Barajas, R; Hair, B; Lai, G; Rotunno, M; Shams-White, MM; Gillanders, EM; Mechanic, LE				Barajas, Rolando; Hair, Brionna; Lai, Gabriel; Rotunno, Melissa; Shams-White, Marissa M.; Gillanders, Elizabeth M.; Mechanic, Leah E.			Facilitating cancer systems epidemiology research	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TRANSDISCIPLINARY RESEARCH; HEALTH; SCIENCE; FUTURE; DISPARITIES; PREVENTION; OBESITY; IMPACT; CHALLENGES	Systems epidemiology offers a more comprehensive and holistic approach to studies of cancer in populations by considering high dimensionality measures from multiple domains, assessing the inter-relationships among risk factors, and considering changes over time. These approaches offer a framework to account for the complexity of cancer and contribute to a broader understanding of the disease. Therefore, NCI sponsored a workshop in February 2019 to facilitate discussion about the opportunities and challenges of the application of systems epidemiology approaches for cancer research. Eight key themes emerged from the discussion: transdisciplinary collaboration and a problem-based approach; methods and modeling considerations; interpretation, validation, and evaluation of models; data needs and opportunities; sharing of data and models; enhanced training practices; dissemination of systems models; and building a systems epidemiology community. This manuscript summarizes these themes, highlights opportunities for cancer systems epidemiology research, outlines ways to foster this research area, and introduces a collection of papers, "Cancer System Epidemiology Insights and Future Opportunities" that highlight findings based on systems epidemiology approaches.	[Barajas, Rolando; Lai, Gabriel; Rotunno, Melissa; Shams-White, Marissa M.; Gillanders, Elizabeth M.; Mechanic, Leah E.] NCI, Epidemiol & Genom Res Program, Div Canc Control & Populat Sci DCCPS, NIH, Bethesda, MD 20892 USA; [Hair, Brionna] NCI, DCCPS, NIH, Bethesda, MD 20892 USA; [Barajas, Rolando] Georgetown Univ, Sch Med, Washington, DC USA; [Hair, Brionna] NIH, Off Strateg Coordinat, Div Program Coordinat Planning & Strateg Initiat, Off Director, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; National Institutes of Health (NIH) - USA	Mechanic, LE (corresponding author), NCI, Epidemiol & Genom Res Program, Div Canc Control & Populat Sci DCCPS, NIH, Bethesda, MD 20892 USA.	mechanil@mail.nih.gov			Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI), National Institutes of Health (NIH)	Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI), National Institutes of Health (NIH)	This research was supported by the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI), National Institutes of Health (NIH). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Cancer Institute.	Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Alagoz O, 2018, MED DECIS MAKING, V38, p3S, DOI 10.1177/0272989X17737507; All Us Res Program Investigators, 2019, NEW ENGL J MED, V381, P668, DOI 10.1056/NEJMsr1809937; Altman N, 2018, NAT METHODS, V15, P399, DOI 10.1038/s41592-018-0019-x; Bensyl DM, 2019, AM J EPIDEMIOL, V188, P830, DOI 10.1093/aje/kwz052; Bian J, 2014, J BIOMED INFORM, V52, P130, DOI 10.1016/j.jbi.2014.01.015; Boekel J, 2015, NAT BIOTECHNOL, V33, P137, DOI 10.1038/nbt.3134; Bures RM, 2014, AM J PUBLIC HEALTH, V104, P1156, DOI 10.2105/AJPH.2014.302082; Burke TA, 2017, ENVIRON HEALTH PERSP, V125, pA43, DOI 10.1289/EHP1465; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Centers for Disease Control, 2019, 1 YEAR GEOGR FOC END; Cerda M, 2019, AM J EPIDEMIOL, V188, P862, DOI 10.1093/aje/kwy262; Chatterjee N., 2020, DATA SCI; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Colditz GA, 2012, ANNU REV PUBL HEALTH, V33, P137, DOI 10.1146/annurev-publhealth-031811-124627; Collins T, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.0fdb85e1619f313a2a5a2ec3d7a8df9e; Cornelis Marilyn C, 2013, Curr Nutr Rep, V2, DOI 10.1007/s13668-013-0052-4; Dammann O, 2014, Online J Public Health Inform, V6, pe198, DOI 10.5210/ojphi.v6i3.5571; Department of Health and Human Services, 4 NATL REP HUM EXP E; Department of Health and Human Services Administration for Children and Families Children's Bureau, 2018, CHILD MALTREATMENT; Eddy DM, 2012, VALUE HEALTH, V15, P843, DOI 10.1016/j.jval.2012.04.012; Fallah-Fini S, 2017, OBESITY, V25, P1809, DOI 10.1002/oby.21965; Frankhauser DE, 2021, WIRES MECH DIS, V13, DOI 10.1002/wsbm.1506; Franks PW, 2016, SCIENCE, V354, P69, DOI 10.1126/science.aaf5094; Gibbons MC, 2008, STUD HEALTH TECHNOL, V137, P265; Golembiewski EH, 2018, PUBLIC HEALTH REP, V133, P182, DOI 10.1177/0033354918754558; Hammond RA, 2009, PREV CHRONIC DIS, V6; Haring R, 2012, OMICS, V16, P231, DOI 10.1089/omi.2011.0108; Hiatt RA, 2014, CANCER EPIDEM BIOMAR, V23, P2078, DOI 10.1158/1055-9965.EPI-14-0403; Hu FB, 2011, CLIN CHEM, V57, P1224, DOI 10.1373/clinchem.2011.167056; Iorio A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3646-1; Jankowska MM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6501-2; Jayasekera J, 2018, JNCI-J NATL CANCER I, V110, P1370, DOI 10.1093/jnci/djy128; Jones AP, 2006, AM J PUBLIC HEALTH, V96, P488, DOI 10.2105/AJPH.2005.063529; Khurana Y., 2019, MEDIUM; Langellier BA, 2019, AM J PREV MED, V57, P273, DOI 10.1016/j.amepre.2019.03.017; Lee BY, 2018, AM J PREV MED, V54, P197, DOI 10.1016/j.amepre.2017.11.003; Lee BY, 2017, HEALTH AFFAIR, V36, P902, DOI 10.1377/hlthaff.2016.1315; Lee BY, 2017, NUTR REV, V75, P94, DOI 10.1093/nutrit/nuw049; Li Y, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150561; Lich KH, 2013, PREV SCI, V14, P279, DOI 10.1007/s11121-012-0285-2; Llewellyn N, 2020, EVAL HEALTH PROF, V43, P169, DOI 10.1177/0163278719839435; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Lund E, 2008, CANCER EPIDEM BIOMAR, V17, P2954, DOI 10.1158/1055-9965.EPI-08-0519; Mabry PL, 2008, AM J PREV MED, V35, pS211, DOI 10.1016/j.amepre.2008.05.018; Mabry PL, 2013, HEALTH EDUC BEHAV, V40, p9S, DOI 10.1177/1090198113503469; Martin DN, 2016, CANCER EPIDEM BIOMAR, V25, P573, DOI 10.1158/1055-9965.EPI-15-1297; McGuire S, 2012, ADV NUTR, V3, P708, DOI 10.3945/an.112.002733; Mechanic LE, 2012, GENET EPIDEMIOL, V36, P22, DOI 10.1002/gepi.20652; National Cancer Institute, SURVEILLANCE EPIDEMI; National Institutes of Health, 2018, NIH STRAT PLAN DAT S; Nielsen J, 2017, CELL METAB, V25, P572, DOI 10.1016/j.cmet.2017.02.002; Orr MG, 2016, J EPIDEMIOL COMMUN H, V70, P862, DOI 10.1136/jech-2015-205621; Palsson B, 2010, NAT CHEM BIOL, V6, P787, DOI 10.1038/nchembio.462; Paltoo DN, 2014, NAT GENET, V46, P934, DOI 10.1038/ng.3062; Patterson RE, 2013, CANCER CAUSE CONTROL, V24, P695, DOI 10.1007/s10552-013-0150-z; Pendergrass Sarah A, 2019, Curr Protoc Hum Genet, V100, pe80, DOI 10.1002/cphg.80; Peng B, 2019, BIOINFORMATICS, V35, P709, DOI 10.1093/bioinformatics/bty666; Pohl C., 2007, PRINCIPLES DESIGNING; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Powell-Wiley TM, 2017, OBESITY, V25, P2149, DOI 10.1002/oby.22040; Price ND, 2017, NAT BIOTECHNOL, V35, P747, DOI 10.1038/nbt.3870; Realmuto L, 2019, SSM-POPUL HLTH, V7, DOI 10.1016/j.ssmph.2019.100373; Roux AVD, 2011, AM J PUBLIC HEALTH, V101, P1627, DOI 10.2105/AJPH.2011.300149; Sanna S, 2019, NAT GENET, V51, P600, DOI 10.1038/s41588-019-0350-x; Schmitz KH, 2016, CLIN CANCER RES, V22, P1565, DOI 10.1158/1078-0432.CCR-14-1214; Shams-White MM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250061; Spratt DE, 2016, JAMA ONCOL, V2, P1070, DOI 10.1001/jamaoncol.2016.1854; Susser M, 1996, AM J PUBLIC HEALTH, V86, P668, DOI 10.2105/AJPH.86.5.668; Swerdlow AJ, 2018, CANCER EPIDEM BIOMAR, V27, P1307, DOI 10.1158/1055-9965.EPI-18-0182; Tracy M, 2018, ANNU REV PUBL HEALTH, V39, P77, DOI 10.1146/annurev-publhealth-040617-014317; Wang K, 2017, NAT GENET, V49, P1319, DOI 10.1038/ng.3931; Washington University in St. Louis, 2021, SYST SCI SOC IMP SUM; Weed DL, 1998, AM J PUBLIC HEALTH, V88, P12, DOI 10.2105/AJPH.88.1.12; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18	76	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0255328	10.1371/journal.pone.0255328	http://dx.doi.org/10.1371/journal.pone.0255328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972102	Green Published, gold			2022-12-27	WOS:000773555700004
J	Yousef, W				Yousef, Wael			An assessment of critical thinking in the Middle East: Evaluating the effectiveness of special courses interventions	PLOS ONE			English	Article							SKILLS; ENGAGEMENT; STUDENTS	Critical thinking is a requisite skill for college success, employability, and conducive active civic participation. Empirical studies have noted to the low achievement of Arab students on critical thinking assessments. Insufficient endeavors have attempted to propose effective interventions enhancing critical thinking abilities among Arab students. The current analysis provides a preliminary overview of a special course designed to improve critical thinking skills among Arab college students. Results indicated a great improvement in all areas of critical thinking including explanation of information, identification of strategies, implementing solutions, and formulating logical inferences. Students' scores on a critical thinking assessment increased from sufficient to good as a result of participating in the program. The gains are consistent after controlling for gender, major, class seniority, and nationality. Notwithstanding these promising results, this paper is limited in several respects including the choice of critical thinking assessments represented by two questions, the highly contextualized setting making it difficult to be replicated, and the convenient sampling strategy used to recruit participants. This set of limitations, however, does not discourage proactive attempts like designing special courses to enhance students' critical thinking acquisition in the Middle East.	[Yousef, Wael] Qatar Univ, Core Curriculum Program, Doha, Qatar	Qatar University	Yousef, W (corresponding author), Qatar Univ, Core Curriculum Program, Doha, Qatar.	wyousef@qu.edu.qa		Yousef, Wael/0000-0003-4297-1887				A Sharadgah T., 2020, ARAB WORLD ENGLISH J, V10; Abdullah M.K., 2019, INDIAN J FORENSIC ME, V13, P430; Abrami PC, 2015, REV EDUC RES, V85, P275, DOI 10.3102/0034654314551063; Ahrari S, 2016, THINK SKILLS CREAT, V22, P121, DOI 10.1016/j.tsc.2016.09.009; Al-Bjaidi H.G, 2014, J ED SCI, V22; Al-Hadabi D.A., 2012, ARAB J DEV EXCELLENC, V3; Al-Mahrooqi R, 2020, INT J INSTR, V13, P783, DOI 10.29333/iji.2020.13150a; Al-Otaibi K.N.R, 2012, KING SAUD U J, V24, P1454; Al-Salutt Khaled Suleiman, 2012, THESIS YARMOUK U JOR; Al-Sawwaf A. M. F. H., 2012, THESIS CAIRO U EGYPT; Al- Sharadgah T., 2020, ARAB WORLD ENGLISH J, V10; Al-Ziq A.Y, 2012, J ED PSYCHOL SCI, V13, P399; Algharaibeh S. A. S., 2020, UNIVERSAL J ED RES, V8, P3834, DOI [10.13189/ujer.2020.080906, DOI 10.13189/UJER.2020.080906]; Alkharusi HA, 2019, INT J INSTR, V12, P491, DOI 10.29333/iji.2019.12231a; Amrous N., 2016, ARAB WORLD ENGL J; Arum Richard, 2011, ACAD ADRIFT LTD LEAR; Basha S., 2016, J ED LEARNING, V5, P60; Chen MH, 2018, BRIT J EDUC TECHNOL, V49, P69, DOI 10.1111/bjet.12526; Elyas T., 2019, INDONESIAN EFL J, V5, P11; Ennis RH., 1993, THEOR PRACT, V32, P179, DOI [10.1080/00405849309543594, DOI 10.1080/00405849309543594]; Goodpasture J, 2020, ECONOMICS CULTURE, V17, P5; Heflin H, 2017, COMPUT EDUC, V107, P91, DOI 10.1016/j.compedu.2017.01.006; Karakoc B, 2022, TECHNOL KNOWL LEARN, V27, P207, DOI 10.1007/s10758-020-09471-5; Khodary Y, 2020, J COLL READING LEARN, P1; Lee J, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0761-7; Merrifield W., 2018, CULTURE CRITICAL THI; Miterianifa, 2019, AIP CONF PROC, V2194, DOI 10.1063/1.5139796; Okasha M.A.H, 2021, J RES CURRICULUM INS, V7, P141; Qian MH, 2016, COMPUT HUM BEHAV, V63, P50, DOI 10.1016/j.chb.2016.05.023; Salih M.A., 2009, J COLL BASIC ED, P545; Shaaban K.A, 2014, INT J LANGUAGE STUDI, V8; Sipiyaruk K, 2017, TECHNOL KNOWL LEARN, V22, P209, DOI 10.1007/s10758-016-9296-6; Sulaiman S, 2006, FACULTY ED ISLAMIC U, V12, P119	33	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262088	10.1371/journal.pone.0262088	http://dx.doi.org/10.1371/journal.pone.0262088			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972187	gold, Green Published			2022-12-27	WOS:000773555700094
J	Abendroth, J; Nauroth, P; Richter, T; Gollwitzer, M				Abendroth, Johanna; Nauroth, Peter; Richter, Tobias; Gollwitzer, Mario			Non-strategic detection of identity-threatening information: Epistemic validation and identity defense may share a common cognitive basis	PLOS ONE			English	Article							COMPREHENSION; MODEL	Readers use prior knowledge to evaluate the validity of statements and detect false information without effort and strategic control. The present study expands this research by exploring whether people also non-strategically detect information that threatens their social identity. Participants (N = 77) completed a task in which they had to respond to a "True" or "False" probe after reading true, false, identity-threatening, or non-threatening sentences. Replicating previous studies, participants reacted more slowly to a positive probe ("True") after reading false (vs. true) sentences. Notably, participants also reacted more slowly to a positive probe after reading identity-threatening (vs. non-threatening) sentences. These results provide first evidence that identity-threatening information, just as false information, is detected at a very early stage of information processing and lends support to the notion of a routine, non-strategic identity-defense mechanism.	[Abendroth, Johanna; Richter, Tobias] Univ Wurzburg, Dept Psychol, Wurzburg, Germany; [Nauroth, Peter] Philipps Univ Marburg, Dept Psychol, Marburg, Germany; [Gollwitzer, Mario] Ludwig Maximilians Univ Munchen, Munich, Germany	University of Wurzburg; Philipps University Marburg; University of Munich	Abendroth, J (corresponding author), Univ Wurzburg, Dept Psychol, Wurzburg, Germany.	johanna.abendroth@uni-wuerzburg.de	Richter, Tobias/C-3447-2015; Gollwitzer, Mario/AAE-6042-2020	Richter, Tobias/0000-0002-0467-9044; Gollwitzer, Mario/0000-0003-4310-4793	German Research Foundation (Deutsche Forschungsgemeinschaft) [RI 1100/5-3, GO 1674/2-2]; Open Access Publication Fund of the University of Wuerzburg	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Open Access Publication Fund of the University of Wuerzburg	This research was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) grant no. RI 1100/5-3 awarded to the third author and grant no. GO 1674/2-2 awarded to the fourth author. This publication was supported by the Open Access Publication Fund of the University of Wuerzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BORNSTEIN RF, 1994, SOC COGNITION, V12, P103, DOI 10.1521/soco.1994.12.2.103; Branscombe N.R., 1999, SOCIAL IDENTITY CONT, P35, DOI DOI 10.4135/9781446200919.N23; Brown-Schmidt S., 2011, DIALOG DISCOURSE, V2, P11, DOI DOI 10.5087/DAD.2011.102; Cohen GL, 2000, PERS SOC PSYCHOL B, V26, P1151, DOI 10.1177/01461672002611011; Cook AE, 2014, DISCOURSE PROCESS, V51, P26, DOI 10.1080/0163853X.2013.855107; Dalton AN, 2014, J CONSUM RES, V40, P1017, DOI 10.1086/674198; Demosthenes, 1980, OLYNTHIAC OTHER PUBL; Ditto PH, 1998, J PERS SOC PSYCHOL, V75, P53, DOI 10.1037/0022-3514.75.1.53; Eberhard K.M., 1996, ATTENTION PERFORM, P457; GILBERT DT, 1991, AM PSYCHOL, V46, P107, DOI 10.1037/0003-066X.46.2.107; GILBERT DT, 1990, J PERS SOC PSYCHOL, V59, P601, DOI 10.1037/0022-3514.59.4.601; Gilead M, 2019, SOC PSYCHOL PERS SCI, V10, P393, DOI 10.1177/1948550618762300; Greve W, 2004, REV GEN PSYCHOL, V8, P194, DOI 10.1037/1089-2680.8.3.194; Gross S., 1995, ATTITUDE STRENGTH AN, P215; Isberner MB, 2014, PROCESSING INACCURATE INFORMATION: THEORETICAL AND APPLIED PERSPECTIVES FROM COGNITIVE SCIENCE AND THE EDUCATIONAL SCIENCES, P245; Isberner MB, 2014, DISCOURSE PROCESS, V51, P7, DOI 10.1080/0163853X.2013.855867; Isberner MB, 2013, ACTA PSYCHOL, V142, P15, DOI 10.1016/j.actpsy.2012.10.003; Jonas E, 2014, ADV EXP SOC PSYCHOL, V49, P219, DOI 10.1016/B978-0-12-800052-6.00004-4; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Kuznetsova A., 2014, **DATA OBJECT**; Leach CW, 2008, J PERS SOC PSYCHOL, V95, P144, DOI 10.1037/0022-3514.95.1.144; Lodge M., 2000, ELEMENTS REASON COGN, P183, DOI DOI 10.1017/CBO9780511805813.009; LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Nauroth P, 2017, PUBLIC UNDERST SCI, V26, P754, DOI 10.1177/0963662516631289; Nauroth P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117476; Patil I., 2021, J OPEN SOURCE SOFTW, V6, P3167, DOI [10.21105/joss.03167, DOI 10.21105/JOSS.03167]; Piest BA, 2018, MEM COGNITION, V46, P849, DOI 10.3758/s13421-018-0807-7; Proulx T, 2012, TRENDS COGN SCI, V16, P285, DOI 10.1016/j.tics.2012.04.002; Rayner K, 2009, BIOL PSYCHOL, V80, P4, DOI 10.1016/j.biopsycho.2008.05.002; Redlawsk DP, 2002, J POLIT, V64, P1021, DOI 10.1111/1468-2508.00161; Richter T, 2018, EDUC PSYCHOL HANDB, P151; Richter T, 2017, EDUC PSYCHOL-US, V52, P148, DOI 10.1080/00461520.2017.1322968; Richter T, 2015, DISCOURSE PROCESS, V52, P337, DOI 10.1080/0163853X.2015.1025665; Richter T, 2009, J PERS SOC PSYCHOL, V96, P538, DOI 10.1037/a0014038; Schroeder S, 2008, J MEM LANG, V59, P237, DOI 10.1016/j.jml.2008.05.001; Shepherd S, 2012, J PERS SOC PSYCHOL, V102, P264, DOI 10.1037/a0026272; Singer M, 2013, CURR DIR PSYCHOL SCI, V22, P361, DOI 10.1177/0963721413495236; Sperber D, 2010, MIND LANG, V25, P359, DOI 10.1111/j.1468-0017.2010.01394.x; Steele C.M., 1988, ADV EXP SOC PSYCHOL, P261, DOI DOI 10.1016/S0065-2601(08)60229-4; Stephan W. G., 2000, REDUCING PREJUDICE D, P23; Wiswede D, 2013, SOC COGN AFFECT NEUR, V8, P647, DOI 10.1093/scan/nss042	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261535	10.1371/journal.pone.0261535	http://dx.doi.org/10.1371/journal.pone.0261535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025899	Green Published, gold			2022-12-27	WOS:000796264200019
J	Bowers, JE; Tang, HB; Burke, JM; Paterson, AH				Bowers, John E.; Tang, Haibao; Burke, John M.; Paterson, Andrew H.			GC content of plant genes is linked to past gene duplications	PLOS ONE			English	Article							DIRECTED DNA METHYLATION; TRANSPOSABLE ELEMENTS; WHOLE-GENOME; HYBRID VIGOR; ARABIDOPSIS; EVOLUTION; DIVERSITY; DEMETHYLATION; CONSEQUENCES; EXPRESSION	The frequency of G and C nucleotides in genomes varies from species to species, and sometimes even between different genes in the same genome. The monocot grasses have a bimodal distribution of genic GC content absent in dicots. We categorized plant genes from 5 dicots and 4 monocot grasses by synteny to related species and determined that syntenic genes have significantly higher GC content than non-syntenic genes at their 5'-end in the third position within codons for all 9 species. Lower GC content is correlated with gene duplication, as lack of synteny to distantly related genomes is associated with past interspersed gene duplications. Two mutation types can account for biased GC content, mutation of methylated C to T and gene conversion from A to G. Gene conversion involves non-reciprocal exchanges between homologous alleles and is not detectable when the alleles are identical or heterozygous for presence-absence variation, both likely situations for genes duplicated to new loci. Gene duplication can cause production of siRNA which can induce targeted methylation, elevating mC -> T mutations. Recently duplicated plant genes are more frequently methylated and less likely to undergo gene conversion, each of these factors synergistically creating a mutational environment favoring AT nucleotides. The syntenic genes with high GC content in the grasses compose a subset that have undergone few duplications, or for which duplicate copies were purged by selection. We propose a "biased gene duplication / biased mutation" (BDBM) model that may explain the origin and trajectory of the observed link between duplication and genic GC bias. The BDBM model is supported by empirical data based on joint analyses of 9 angiosperm species with their genes categorized by duplication status, GC content, methylation levels and functional classes.	[Bowers, John E.; Burke, John M.; Paterson, Andrew H.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Bowers, John E.; Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Tang, Haibao] Fujian Agr & Forestry Univ, Fujian Prov Key Lab Haixia Appl Plant Syst Biol, Key Lab Minist Educ Genet Breeding & Multiple Uti, Ctr Genom & Biotechnol, Fuzhou, Fujian, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Fujian Agriculture & Forestry University	Bowers, JE (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.; Bowers, JE (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	jebowers@uga.edu	Burke, John/A-3502-2013	Burke, John/0000-0002-1412-5539; Bowers, John/0000-0001-5693-2796				Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; ANTEQUERA F, 1988, EMBO J, V7, P2295, DOI 10.1002/j.1460-2075.1988.tb03072.x; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Britten RJ, 2006, P NATL ACAD SCI USA, V103, P19027, DOI 10.1073/pnas.0608796103; Buggs RJA, 2012, CURR BIOL, V22, P248, DOI 10.1016/j.cub.2011.12.027; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Caiafa P, 2005, J CELL BIOCHEM, V94, P257, DOI 10.1002/jcb.20325; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi KH, 2013, NAT GENET, V45, P1327, DOI 10.1038/ng.2766; Chu D, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6745-3; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Darracq A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4490-7; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Durand S, 2012, CURR BIOL, V22, P326, DOI 10.1016/j.cub.2011.12.054; Eichten SR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002372; Escudero M, 2020, NEW PHYTOL, V228, P805, DOI 10.1111/nph.16802; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gao L, 2019, NAT GENET, V51, P1044, DOI 10.1038/s41588-019-0410-2; Glass JL, 2007, NUCLEIC ACIDS RES, V35, P6798, DOI 10.1093/nar/gkm489; Glemin S, 2014, TRENDS GENET, V30, P263, DOI 10.1016/j.tig.2014.05.002; Gupta S, 2005, PLANT MOL BIOL, V57, P115, DOI 10.1007/s11103-004-6636-z; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hubner S, 2019, NAT PLANTS, V5, P54, DOI 10.1038/s41477-018-0329-0; Ibarra CA, 2012, SCIENCE, V337, P1360, DOI 10.1126/science.1224839; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kawakatsu T, 2016, CELL, V166, P492, DOI 10.1016/j.cell.2016.06.044; Kawanabe T, 2016, P NATL ACAD SCI USA, V113, pE6704, DOI 10.1073/pnas.1613372113; Knight RD, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-4-research0010; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Liu QP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048295; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2007, ORIGINS GENOME ARCHI; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Martinez de Alba AE, 2013, BBA-GENE REGUL MECH, V1829, P1300, DOI 10.1016/j.bbagrm.2013.10.005; Matzke MA, 2015, ANNU REV PLANT BIOL, V66, P243, DOI 10.1146/annurev-arplant-043014-114633; Mugal CF, 2015, G3-GENES GENOM GENET, V5, P441, DOI 10.1534/g3.114.015545; Muyle A, 2011, MOL BIOL EVOL, V28, P2695, DOI 10.1093/molbev/msr104; Niederhuth CE, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1059-0; Novoa EM, 2019, MOL BIOL EVOL, V36, P2328, DOI 10.1093/molbev/msz124; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Palidwor GA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013431; Park K, 2016, P NATL ACAD SCI USA, V113, P15138, DOI 10.1073/pnas.1619047114; Paterson AH, 2006, TRENDS GENET, V22, P597, DOI 10.1016/j.tig.2006.09.003; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Schultz MD, 2012, TRENDS GENET, V28, P583, DOI 10.1016/j.tig.2012.10.012; Secco D, 2015, ELIFE, V4, DOI 10.7554/eLife.09343; Serres-Giardi L, 2012, PLANT CELL, V24, P1379, DOI 10.1105/tpc.111.093674; Shen YF, 2017, PLANT J, V91, P874, DOI 10.1111/tpj.13605; Singh R, 2016, TROP PLANT BIOL, V9, P136, DOI 10.1007/s12042-016-9165-4; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tang HB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-102; Tatarinova TV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-308; Turco GM, 2017, NEW PHYTOL, V214, P1213, DOI 10.1111/nph.14448; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wijnker E, 2013, ELIFE, V2, DOI 10.7554/eLife.01426; Woodhouse MR, 2011, PLANT CELL, V23, P4241, DOI 10.1105/tpc.111.093567; Xie M, 2015, CURR GENOMICS, V16, P23, DOI 10.2174/1389202915666141128002211; Zabala G, 2005, PLANT CELL, V17, P2619, DOI 10.1105/tpc.105.033506; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zhang B, 2016, P NATL ACAD SCI USA, V113, P12580, DOI 10.1073/pnas.1613910113; Zhao ZM, 2007, MOL BIOL EVOL, V24, P23, DOI 10.1093/molbev/msl156; Zhou WD, 2020, P NATL ACAD SCI USA, V117, P19359, DOI 10.1073/pnas.1921719117; Zhou ZP, 2016, P NATL ACAD SCI USA, V113, pE6117, DOI 10.1073/pnas.1606724113; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	87	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261748	10.1371/journal.pone.0261748	http://dx.doi.org/10.1371/journal.pone.0261748			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025913	gold, Green Published			2022-12-27	WOS:000796264200026
J	Edward, A; Jung, Y; Ettyang, G; Chhorvann, C; Risko, C; Ghee, AE; Chege, J				Edward, Anbrasi; Jung, Younghee; Ettyang, Grace; Chhorvann, Chhea; Risko, Casey; Ghee, Annette E.; Chege, Jane			A comparative study of adult and adolescent maternal care continuum following community-oriented interventions in Cambodia, Guatemala, Kenya, and Zambia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MIDDLE-INCOME COUNTRIES; HEALTH-SERVICES; FACILITY DELIVERY; ANTENATAL CARE; CHILD HEALTH; SOCIAL ACCOUNTABILITY; NEWBORN HEALTH; MOTHERS; DETERMINANTS	Background The coverage for reproductive care continuum is a growing concern for communities in low- income economies. Adolescents (15-19 years) are often at higher odds of maternal morbidity and mortality due to other underlying factors including biological immaturity, social, and economic differences. The aim of the study was to examine a) differences in care-seeking and continuum of care (4 antenatal care (ANC4+), skilled birth attendance (SBA) and postnatal care (PNC) within 24h) between adult (20-49 Years) and adolescents and b) the effect of multilevel community-oriented interventions on adolescent and adult reproductive care-seeking in Cambodia, Guatemala, Kenya, and Zambia using a quasi-experimental study design. Methods In each country, communities in two districts/sub-districts received timed community health worker (CHW) household health promotion and social accountability interventions with community scorecards. Two matched districts/sub-districts were selected for comparison and received routine healthcare services. Results Results from the final evaluation showed that there were no significant differences in the care continuum for adolescents and adults except for Kenya (26.1% vs 18.8%, p<0.05). SBA was significantly higher for adolescents compared to adult women for Guatemala (64% vs 55.5%, p<0.05). Adolescents in the intervention sites showed significantly higher ANC utilization for Kenya (95.3% vs 84.8%, p<0.01) and Zambia (87% vs 72.7%, p<0.05), ANC4 for Cambodia (83.7% vs 43.2%, p<0.001) and Kenya (65.9% vs 48.1%, p<0.05), SBA for Cambodia (100% vs 88.9%, p<0.05), early PNC for Cambodia (91.8% vs 72.8%, p<0.01) and Zambia (56.5% vs 16.9%, p<0.001) compared to the comparison sites. However, the findings from Guatemala illustrated significantly lower care continuum for intervention sites (aOR:0.34, 95% CI 0.28-0.42, p<0.001). The study provides some evidence on the potential of multilevel community-oriented interventions to improve adolescent healthcare seeking in rural contexts. The predictors of care continuum varied across countries, indicating the importance of contextual factors in designing interventions.	[Edward, Anbrasi; Risko, Casey] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Jung, Younghee] World Hlth Org, Neglected Trop Dis, Dili, Timor-Leste; [Ettyang, Grace] Moi Univ, Sch Publ Hlth, Coll Hlth Sci, Kesses, Kenya; [Chhorvann, Chhea] Natl Inst Publ Hlth, Phnom Penh, Cambodia; [Ghee, Annette E.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Chege, Jane] World Vis Int, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; Moi University; University of Washington; University of Washington Seattle	Edward, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.	aedward1@jhu.edu			World Vision [113543]	World Vision	The study was conducted through a research grant #113543 to Johns Hopkins University from World Vision (www.worldvision.org).AE, YJ, CC, GE, and CR were partially funded to conduct the research study and analysis. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe E, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7854-2; [Anonymous], STATA 14 COMPUTER PR; August F, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0916-x; Banke-Thomas A, 2017, SEX REPROD HEALTHC, V12, P37, DOI 10.1016/j.srhc.2017.02.004; Banke-Thomas Oluwasola, 2016, Int J Adolesc Med Health, V30, DOI 10.1515/ijamh-2016-0042; Banke-Thomas OE, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1246-3; Bhowmik J, 2019, PUBLIC HEALTH, V170, P113, DOI 10.1016/j.puhe.2019.02.027; Blake C, 2016, INT J GYNECOL OBSTET, V135, P372, DOI 10.1016/j.ijgo.2016.10.004; Chaka EE, 2019, INT J PREVENTIVE MED, V10, DOI 10.4103/ijpvm.IJPVM_26_19; Conde-Agudelo A, 2005, AM J OBSTET GYNECOL, V192, P342, DOI 10.1016/j.ajog.2004.10.593; Demographic Health Survey, DHS OV; Edward A, 2019, J Prev Med Hyg, V60, pE93, DOI 10.15167/2421-4248/jpmh2019.60.2.1088; Edward A, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03223-0; Edward A, 2020, INT J QUAL HEALTH C, V32, P364, DOI 10.1093/intqhc/mzaa052; Edward A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0946-5; Fund UNP, 2014, MOTHERHOOD CHILDHOOD; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; George A, 2015, SOC SCI MED, V133, P159, DOI 10.1016/j.socscimed.2015.03.049; Gilmore B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-847; Global Fund, 2010, COMM SYST STRENGTH F; Hamal M, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3453-7; Hendriks S., 2015, LEAVE NO ONE; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kyei-Nimakoh M, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0503-x; Magadi MA, 2007, SOC SCI MED, V64, P1311, DOI 10.1016/j.socscimed.2006.11.004; Mayor S., 2004, BRIT MEDICAL J PUBLI; Mohan D, 2017, HEALTH POLICY PLANN, V32, P791, DOI 10.1093/heapol/czx005; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Moyer Cheryl A, 2013, Afr J Reprod Health, V17, P30; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Nove A, 2014, LANCET GLOB HEALTH, V2, pE155, DOI 10.1016/S2214-109X(13)70179-7; Perry HB, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010906; Pervin J, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-111; Reynolds HW, 2006, INT FAM PLAN PERSPEC, V32, P6, DOI 10.1363/3200606; Schaaf M, 2017, HEALTH POLICY PLANN, V32, P847, DOI 10.1093/heapol/czx024; Shibanuma A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000786; Wang WJ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0497-0; Yaya S, 2019, HEALTH EQUITY, V3, P145, DOI 10.1089/heq.2018.0082; Yeji F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142849	39	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261161	10.1371/journal.pone.0261161	http://dx.doi.org/10.1371/journal.pone.0261161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025914	Green Published, gold			2022-12-27	WOS:000796264200013
J	Craven, AJ; Pegram, C; Packer, RMA; Jarvis, S; McGreevy, PD; Warnes, C; Church, DB; Brodbelt, DC; O'Neill, DG				Craven, Annabel J.; Pegram, Camilla; Packer, Rowena M. A.; Jarvis, Susan; McGreevy, Paul D.; Warnes, Caroline; Church, David B.; Brodbelt, Dave C.; O'Neill, Dan G.			Veterinary drug therapies used for undesirable behaviours in UK dogs under primary veterinary care	PLOS ONE			English	Article							FLUOXETINE CHEWABLE TABLETS; SEPARATION ANXIETY; RISK-FACTORS; AGGRESSIVE-BEHAVIOR; TRAINING METHODS; NOISE PHOBIA; DOUBLE-BLIND; BREED; PREVALENCE; MANAGEMENT	Undesirable behaviours (UBs) in dogs are common and important issues with serious potential welfare consequences for both the dogs and their owners. This study aimed to investigate the usage of drug therapy for UBs in dogs and assess demographic risk factors for drug-prescribed UBs within the dog population under primary-care veterinary care in the UK in 2013. Dogs receiving drug therapy for UB were identified through the retrospective analysis of anonymised electronic patient records in VetCompass (TM). Risk factor analysis used multivariable logistic regression modelling. The study population comprised 103,597 dogs under veterinary care in the UK during 2013. There were 413 drug-prescribed UBs recorded among 404 dogs. The prevalence of dogs with at least one UB event treated with a drug in 2013 was 0.4%. Multivariable modelling identified 3 breeds with increased odds of drug-prescribed UB compared with crossbred dogs: Toy Poodle (OR 2.75), Tibetan Terrier (OR 2.68) and Shih-tzu (OR 1.95). Increasing age was associated with increased odds of drug-prescribed UB, with dogs >= 12 years showing 3.1 times the odds compared with dogs < 3 years. Neutered males (OR 1.82) and entire males (OR 1.50) had increased odds compared with entire females. The relatively low prevalence of dogs with at least one UB event that was treated with a drug in 2013 could suggest that opportunities for useful psychopharmaceutical intervention in UBs may be being missed in first opinion veterinary practice. While bodyweight was not a significant factor, the 3 individual breeds at higher odds of an UB treated with a behaviour modifying drug all have a relatively low average bodyweight. The current results also support previous research of a male predisposition to UBs and it is possible that this higher risk resulted in the increased likelihood of being prescribed a behaviour modifying drug, regardless of neuter status.	[Craven, Annabel J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Pegram, Camilla; Brodbelt, Dave C.; O'Neill, Dan G.] Royal Vet Coll, Pathobiol & Populat Sci, Hawkshead Lane, Hatfield, Herts, England; [Packer, Rowena M. A.; Church, David B.] Royal Vet Coll, Clin Sci & Serv, Hawkshead Lane, Hatfield, Herts, England; [Jarvis, Susan] Univ Edinburgh, Global Acad Agr & Food Secur, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [McGreevy, Paul D.] Univ New England, Sch Environm & Rural Sci, Fac Sci Agr Business & Law, Armidale, NSW, Australia	University of Edinburgh; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of Edinburgh; University of New England	Craven, AJ (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland.	annabel_craven@hotmail.com	Brodbelt, David/C-6005-2009	Brodbelt, David/0000-0001-5628-4194	Kennel Club Charitable Trust	Kennel Club Charitable Trust	This study was supported at the RVC by an award from the Kennel Club Charitable Trust. Neither the Kennel Club Charitable Trust nor the Kennel Club had any input in the design of the study, the collection, analysis and interpretation of data or in writing the manuscript.	[Anonymous], 2020, NOAH COMPENDIUM; Arhant C, 2010, APPL ANIM BEHAV SCI, V123, P131, DOI 10.1016/j.applanim.2010.01.003; Bamberger M, 2006, JAVMA-J AM VET MED A, V229, P1591, DOI 10.2460/javma.229.10.1591; Barcelos AM, 2015, VET REC, V176, P466, DOI 10.1136/vr.102823; BLACKSHAW JK, 1991, APPL ANIM BEHAV SCI, V30, P351, DOI 10.1016/0168-1591(91)90140-S; Blackwell EJ, 2013, APPL ANIM BEHAV SCI, V145, P15, DOI 10.1016/j.applanim.2012.12.004; Blackwell EJ, 2008, J VET BEHAV, V3, P207, DOI 10.1016/j.jveb.2007.10.008; BORCHELT PL, 1983, APPL ANIM ETHOL, V10, P45, DOI 10.1016/0304-3762(83)90111-6; Bowen J., 2005, BEHAV PROBLEMS SMALL; Boyd C, 2018, ANIM WELFARE, V27, P251, DOI 10.7120/09627286.27.3.251; Bradshaw JWS, 2002, VET REC, V151, P43, DOI 10.1136/vr.151.2.43; Buller K, 2020, J VET BEHAV, V37, P41, DOI 10.1016/j.jveb.2020.04.003; Christiansen FO, 2001, APPL ANIM BEHAV SCI, V72, P115, DOI 10.1016/S0168-1591(00)00202-1; Cracknell NR, 2008, VET J, V177, P80, DOI 10.1016/j.tvjl.2007.04.007; Crowell-Davis S.L., 2019, VET PSYCHOPHARMACOLO; Denenberg S, 2005, CURRENT ISSUES AND RESEARCH IN VETERINARY BEHAVIORAL MEDICINE, P56; Dinwoodie IR, 2021, J VET BEHAV, V43, P46, DOI 10.1016/j.jveb.2021.02.002; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; Egenvall A, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-42; EPI INFO 7 CDC, 2020 CDCP US INTR EP; Erath JR, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00169; Fatjo J, 2007, J VET BEHAV, V2, P158, DOI 10.1016/j.jveb.2007.07.008; Fatjo J, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10030383; Gaultier E, 2005, VET REC, V156, P533, DOI 10.1136/vr.156.17.533; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Martinez AG, 2011, J VET BEHAV, V6, P225, DOI 10.1016/j.jveb.2011.01.006; Guy NC, 2001, APPL ANIM BEHAV SCI, V74, P15, DOI 10.1016/S0168-1591(01)00153-8; Herron ME, 2008, JAVMA-J AM VET MED A, V233, P1420, DOI 10.2460/javma.233.9.1420; Hiby EF, 2004, ANIM WELFARE, V13, P63; Hobbs SL., 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Horwitz D., 2002, BSAVA MANUAL CANINE, V1; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Ibanez M, 2009, J VET BEHAV, V4, P223, DOI 10.1016/j.jveb.2009.04.001; Irion DN, 2003, J HERED, V94, P81, DOI 10.1093/jhered/esg004; Jagoe A, 1996, APPL ANIM BEHAV SCI, V47, P31, DOI 10.1016/0168-1591(95)01008-4; Jokinen TS, 2015, J VET INTERN MED, V29, P1081, DOI 10.1111/jvim.12611; Karagiannis CI, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0373-1; Katz MH., 2011, MULTIVARIABLE ANAL P, V3 ed, DOI [DOI 10.1017/CBO9780511974175, 10.1017/CBO9780511974175]; King JN, 2000, APPL ANIM BEHAV SCI, V67, P255, DOI 10.1016/S0168-1591(99)00127-6; Kirkwood B. R., 2003, MED STAT; Landsberg G., 2012, BEHAV PROBLEMS DOG C, V3rd ed; Landsberg GM, 2008, J VET BEHAV, V3, P12, DOI 10.1016/j.jveb.2007.09.001; Fagundes ALL, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00017; Lund JD, 1996, PREV VET MED, V28, P33, DOI 10.1016/0167-5877(96)01015-X; McGreevy P, 2017, VET J, V229, P1, DOI 10.1016/j.tvjl.2017.10.015; McGreevy PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080529; McLean A, 2013, P 9 INT EQUITATION S, P50; Menard S., 1995, APPL LOGISTIC REGRES; Mills DS, 2003, APPL ANIM BEHAV SCI, V81, P265, DOI 10.1016/S0168-1591(02)00286-1; Murray JK, 2015, VET REC, V177, DOI 10.1136/vr.103223; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; Myers R., 1990, CLASSICAL AND MODERN; Bosch MN, 2012, CURR ALZHEIMER RES, V9, P298; O'Neill D, 2012, J SMALL ANIM PRACT, V53, P217, DOI 10.1111/j.1748-5827.2011.01190.x; O'Neill DG, 2013, VET J, V198, P638, DOI 10.1016/j.tvjl.2013.09.020; O'Neill DG, 2013, J VET INTERN MED, V27, P814, DOI 10.1111/jvim.12090; O'Neill Dan G, 2018, Canine Genet Epidemiol, V5, P9, DOI 10.1186/s40575-018-0065-9; O'Neill DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090501; Overall K., 2013, MANUAL CLIN BEHAV ME; Overall K L, 1998, J Am Vet Med Assoc, V212, P1702; Overall KL, 2004, CLIN TECH SMALL AN P, V19, P250, DOI 10.1053/j.ctsap.2004.10.007; Overall KL, 2001, J AM VET MED ASSOC, V219, P467, DOI 10.2460/javma.2001.219.467; OVERALL KL, 1995, J AM VET MED ASSOC, V206, P629; Overall KL, 1997, CLIN BEHAV MED SMALL, V1; Packer RMA, 2018, APPL ANIM BEHAV SCI, V200, P106, DOI 10.1016/j.applanim.2017.11.008; Packer RMA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192182; Packer RMA, 2016, EPILEPSY BEHAV, V55, P62, DOI 10.1016/j.yebeh.2015.11.014; Pegram C, 2021, J SMALL ANIM PRACT, V62, P521, DOI 10.1111/jsap.13325; Pegram C, 2019, J SMALL ANIM PRACT, V60, P723, DOI 10.1111/jsap.13072; Powell L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87649-2; Radulescu SM, 2020, J VET INTERN MED, V34, P1993, DOI 10.1111/jvim.15869; Ramsey I., 2011, BSAVA SMALL ANIMAL F, V7; Ramsey I., 2014, BSAVA SMALL ANIMAL F, V8; Reisner IR, 2003, VET CLIN N AM-SMALL, V33, P303, DOI 10.1016/S0195-5616(02)00132-8; Roshier AL, 2013, VET REC, V172, DOI 10.1136/vr.101125; Salvin HE, 2010, VET J, V184, P277, DOI 10.1016/j.tvjl.2009.11.007; Scarlett J M, 1999, J Appl Anim Welf Sci, V2, P41, DOI 10.1207/s15327604jaws0201_4; Scott M, 2012, J SMALL ANIM PRACT, V53, P372, DOI 10.1111/j.1748-5827.2012.01231.x; Seksel K, 2001, AUST VET J, V79, P252, DOI 10.1111/j.1751-0813.2001.tb11976.x; Simpson BS, 2007, VET THER, V8, P18; Shihab N, 2011, EPILEPSY BEHAV, V21, P160, DOI 10.1016/j.yebeh.2011.03.018; Simpson BS, 2003, VET CLIN N AM-SMALL, V33, P365, DOI 10.1016/S0195-5616(02)00130-4; Sinn L, 2018, VET CLIN N AM-SMALL, V48, P457, DOI 10.1016/j.cvsm.2017.12.011; Stephens MJ, 2014, VET REC, V175, DOI 10.1136/vr.102431; Stone HR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149403; Storengen LM, 2014, APPL ANIM BEHAV SCI, V159, P82, DOI 10.1016/j.applanim.2014.07.006; Takeuchi Y, 2001, APPL ANIM BEHAV SCI, V70, P297, DOI 10.1016/S0168-1591(00)00156-8; Takeuchi Y, 2000, J AM VET MED ASSOC, V217, P342, DOI 10.2460/javma.2000.217.342; The Kennel Club Limited 2021, BREED STAND; The VeNom Coding Group, 2020 VENOM VET NOM V; VANDERBORG JAM, 1991, APPL ANIM BEHAV SCI, V32, P237, DOI 10.1016/S0168-1591(05)80047-4; Waite MR, 2021, LEARN MOTIV, V74, DOI 10.1016/j.lmot.2021.101726; Watson Fraje, 2020, Vet Rec, V186, P93, DOI 10.1136/vr.105222; Wells DL, 2000, APPL ANIM BEHAV SCI, V69, P55, DOI 10.1016/S0168-1591(00)00118-0; WHITE RAS, 1989, VET REC, V125, P478, DOI 10.1136/vr.125.19.478; Wilsson E, 1997, APPL ANIM BEHAV SCI, V53, P279, DOI 10.1016/S0168-1591(96)01174-4; Winter J, 2018, VET REC, V182, DOI 10.1136/vr.104603; WRIGHT JC, 1987, APPL ANIM BEHAV SCI, V19, P169, DOI 10.1016/0168-1591(87)90213-9; Yu Y, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11020493	100	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261139	10.1371/journal.pone.0261139	http://dx.doi.org/10.1371/journal.pone.0261139			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020726	Green Published, gold			2022-12-27	WOS:000834207700013
J	Ahring, KK; Dagnaes-Hansen, F; Bruel, A; Christensen, M; Jensen, E; Jensen, TG; Johannsen, M; Johansen, KS; Lund, AM; Madsen, JG; Brondum-Nielsen, K; Pedersen, M; Sorensen, LK; Kjolby, M; Moller, LB				Ahring, Kirsten K.; Dagnaes-Hansen, Frederik; Bruel, Annemarie; Christensen, Mette; Jensen, Erik; Jensen, Thomas G.; Johannsen, Mogens; Johansen, Karen S.; Lund, Allan M.; Madsen, Jesper G.; Brondum-Nielsen, Karen; Pedersen, Michael; Sorensen, Lambert K.; Kjolby, Mads; Moller, Lisbeth B.			The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model	PLOS ONE			English	Article							GENETIC MOUSE MODEL; PHENYLALANINE-HYDROXYLASE; SUPPORTS GROWTH; SPATIAL MEMORY; BARNES MAZE; BRAIN; PROTEIN; PKU; PLASMA; DIET	Introduction Management of phenylketonuria (PKU) is mainly achieved through dietary control with limited intake of phenylalanine (Phe) from food, supplemented with low protein (LP) food and a mixture of free synthetic (FS) amino acids (AA) (FSAA). Casein glycomacropeptide (CGMP) is a natural peptide released in whey during cheese making by the action of the enzyme chymosin. Because CGMP in its pure form does not contain Phe, it is nutritionally suitable as a supplement in the diet for PKU when enriched with specific AAs. Lacprodan (R) CGMP-20 (= CGMP) used in this study contained only trace amounts of Phe due to minor presence of other proteins/peptides. Objective The aims were to address the following questions in a classical PKU mouse model: Study 1, off diet: Can pure CGMP or CGMP supplemented with Large Neutral Amino Acids (LNAA) as a supplement to normal diet significantly lower the content of Phe in the brain compared to a control group on normal diet, and does supplementation of selected LNAA results in significant lower brain Phe level?. Study 2, on diet: Does a combination of CGMP, essential (non-Phe) EAAs and LP diet, provide similar plasma and brain Phe levels, growth and behavioral skills as a formula which alone consist of FSAA, with a similar composition?. Material and methods 45 female mice homozygous for the Pah(enu2 )mutation were treated for 12 weeks in five different groups; G1(N-CGMP), fed on Normal (N) casein diet (75%) in combination with CGMP (25%); G2 (N-CGMP-LNAA), fed on Normal (N) casein diet (75%) in combination with CGMP (19,7%) and selected LNAA (5,3% Leu, Tyr and Trp); G3 (N), fed on normal casein diet (100%); G4 (CGMP-EAA-LP), fed on CGMP (70,4%) in combination with essential AA (19,6%) and LP diet; G5 (FSAA-LP), fed on FSAA (100%) and LP diet. The following parameters were measured during the treatment period: Plasma AA profiles including Phe and Tyr, growth, food and water intake and number of teeth cut. At the end of the treatment period, a body scan (fat and lean body mass) and a behavioral test (Barnes Maze) were performed. Finally, the brains were examined for content of Phe, Tyr, Trp, dopamine (DA), 3,4dihydroxyphenylacetic acid (DOPAC), serotonin (5-HT) and 5-hydroxyindole-acetic acid (5HIAA), and the bone density and bone mineral content were determined by dual-energy xray absorptiometry. Results Study 1: Mice off diet supplemented with CGMP (G1 (N-CGMP)) or supplemented with CGMP in combination with LNAA (G2 (N-CGMP-LNAA)) had significantly lower Phe in plasma and in the brain compared to mice fed only casein (G3 (N)). Extra LNAA (Tyr, Trp and Leu) to CGMP did not have any significant impact on Phe levels in the plasma and brain, but an increase in serotonin was measured in the brain of G2 mice compared to G1. Study 2: PKU mice fed with mixture of CGMP and EAA as supplement to LP diet (G4 (CGMP-EAA-LP)) demonstrated lower plasma-Phe levels but similar brain- Phe levels and growth as mice fed on an almost identical combination of FSAA (G5 (FSAA-LP)). Conclusion CGMP can be a relevant supplement for the treatment of PKU.	[Ahring, Kirsten K.; Brondum-Nielsen, Karen] Copenhagen Univ Hosp, Rigshosp, Kennedy Ctr, Dept Paediat,PKU Clin, Copenhagen, Denmark; [Ahring, Kirsten K.; Brondum-Nielsen, Karen] Copenhagen Univ Hosp, Rigshosp, Kennedy Ctr, Dept Clin Genet,PKU Clin, Copenhagen, Denmark; [Dagnaes-Hansen, Frederik; Bruel, Annemarie; Jensen, Thomas G.; Johansen, Karen S.; Madsen, Jesper G.; Kjolby, Mads] Aarhus Univ, Dept Biomed, Hlth, Aarhus, Denmark; [Christensen, Mette; Lund, Allan M.] Copenhagen Univ Hosp, Rigshosp, Dept Paediat, Ctr Inherited Metab Dis, Copenhagen, Denmark; [Christensen, Mette; Lund, Allan M.] Copenhagen Univ Hosp, Rigshosp, Dept Clin Genet, Ctr Inherited Metab Dis, Copenhagen, Denmark; [Jensen, Erik] Arla Foods Ingredients Grp PS, Viby J, Denmark; [Johannsen, Mogens; Sorensen, Lambert K.] Aarhus Univ, Dept Forens Med, Aarhus, Denmark; [Pedersen, Michael] Aarhus Univ Hosp, Comparat Med Lab, Aarhus, Denmark; [Kjolby, Mads] Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark; [Kjolby, Mads] Aarhus Univ Hosp, Dept Clin Pharmacol, Aarhus, Denmark; [Moller, Lisbeth B.] Copenhagen Univ Hosp, Rigshosp, Kennedy Ctr, Dept Clin Genet, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen	Ahring, KK (corresponding author), Copenhagen Univ Hosp, Rigshosp, Kennedy Ctr, Dept Paediat,PKU Clin, Copenhagen, Denmark.; Ahring, KK (corresponding author), Copenhagen Univ Hosp, Rigshosp, Kennedy Ctr, Dept Clin Genet,PKU Clin, Copenhagen, Denmark.	kirsten.kiaer.ahring@regionh.dk		Lund, Allan/0000-0002-6091-7879; Johannsen, Mogens/0000-0002-2548-7025; Bruel, Annemarie/0000-0003-4833-0888; Dagnaes-Hansen, Frederik/0000-0002-6622-0853; Moller, Lisbeth/0000-0002-9524-4301	AFI	AFI	The research was conducted as part of an lndustrial PhD program, which in Denmark is a three-year industrially focused PhD project where a student (Kirsten Ahring) is hired by a company (Arla Foods lngredients (AFI)) and enrolled at a university (Copenhagen University) at the same time. The industrial PhD program was managed by Innovation Fund Denmark and partly funded by AFI (https://ufm.dk/en/research-and-innovation/funding-proqrammesfor-research-and-innovation/find-danish-fundingprogrammes/programmesmanaged-byinnovation-fund-denmark/industrial-phd).AFI produces and commercialize the food ingredient; Casein glycomacropeptide which was used in the research.	Ahring K., EFFECT OFFERING PHEN; Aimutis WR, 2004, J NUTR, V134, p989S, DOI 10.1093/jn/134.4.989S; BENEVENGA NJ, 1994, J NUTR, V124, P451, DOI 10.1093/jn/124.3.451; BERRY HK, 1990, AM J DIS CHILD, V144, P539, DOI 10.1001/archpedi.1990.02150290033020; Blau N, 2011, MOL GENET METAB, V104, pS2, DOI 10.1016/j.ymgme.2011.08.017; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Bruinenberg VM, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00233; Christensen R, 2005, EXP DERMATOL, V14, P535, DOI 10.1111/j.0906-6705.2005.00326.x; Demirdas S, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0232-y; Etzel MR, 2004, J NUTR, V134, p996S, DOI 10.1093/jn/134.4.996S; Giovannini M, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-7; Harding CO, 2014, J INHERIT METAB DIS, V37, P735, DOI 10.1007/s10545-013-9675-2; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; JOHANNIK K, 1994, MAGNET RESON MED, V31, P53, DOI 10.1002/mrm.1910310108; LOU HC, 1987, ACTA PAEDIATR SCAND, V76, P560, DOI 10.1111/j.1651-2227.1987.tb10521.x; LOU HC, 1985, EUR J PEDIATR, V144, P17, DOI 10.1007/BF00491918; MacDonald A, 2006, J INHERIT METAB DIS, V29, P526, DOI 10.1007/s10545-006-0234-y; Matalon R, 2007, J INHERIT METAB DIS, V30, P153, DOI 10.1007/s10545-007-0556-4; Matalon R, 2006, J INHERIT METAB DIS, V29, P732, DOI 10.1007/s10545-006-0395-8; Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141; Miller DJ, 2004, J PHYSIOL-LONDON, V555, P585, DOI 10.1113/jphysiol.2004.060731; Mitchell JJ, 2011, GENET MED, V13, P697, DOI 10.1097/GIM.0b013e3182141b48; Moats RA, 2003, PEDIATRICS, V112, P1575; Nakano T, 2002, BIOTECHNOL PROGR, V18, P409, DOI 10.1021/bp010195u; Ney DM, 2008, J NUTR, V138, P316, DOI 10.1093/jn/138.2.316; Pascucci T, 2008, BRAIN RES, V1217, P232, DOI 10.1016/j.brainres.2008.04.006; Pascucci T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084697; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; Peake RWA, 2013, CLIN CHIM ACTA, V423, P75, DOI 10.1016/j.cca.2013.03.036; Pritchett K, 2003, CONTEMP TOP LAB ANIM, V42, P53; Puglisi-Allegra S, 2000, NEUROREPORT, V11, P1361, DOI 10.1097/00001756-200004270-00042; Rocha JC, 2009, J INHERIT METAB DIS, V32, P472, DOI 10.1007/s10545-009-1132-x; Schindeler S, 2007, MOL GENET METAB, V91, P48, DOI 10.1016/j.ymgme.2007.02.002; Schuck PF, 2015, AGING DIS, V6, P390, DOI 10.14336/AD.2015.0827; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; Solverson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045165; Van Calcar SC, 2008, MOL GENET METAB, V93, P263; van Calcar SC, 2011, MOL GENET METAB, V102, P262; van Calcar SC, 2012, J ACAD NUTR DIET, V112, P1201, DOI 10.1016/j.jand.2012.05.004; van Calcar SC, 2009, AM J CLIN NUTR, V89, P1068, DOI 10.3945/ajcn.2008.27280; van Spronsen FJ, 2010, MOL GENET METAB, V99, pS90, DOI 10.1016/j.ymgme.2009.10.008; van Vliet D, 2016, AM J CLIN NUTR, V104, P1292, DOI 10.3945/ajcn.116.135996; van Vliet D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143833; van Wegberg AMJ, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0685-2; WHO, 2007, WHO TECH REP SER, V935, P1; Zaki OK, 2016, J NUTR METAB, V2016, DOI 10.1155/2016/2453027; Zimmermann M, 2012, MOL GENET METAB, V106, P264, DOI 10.1016/j.ymgme.2012.04.016	47	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0261150	10.1371/journal.pone.0261150	http://dx.doi.org/10.1371/journal.pone.0261150			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015767	gold, Green Published			2022-12-27	WOS:000814820600002
J	Mascia, F; Mazo, I; Alterovitz, WL; Karagiannis, K; Wu, WW; Shen, RF; Beaver, JA; Rao, VA				Mascia, Francesca; Mazo, Ilya; Alterovitz, Wei-Lun; Karagiannis, Konstantinos; Wu, Wells W.; Shen, Rong-Fong; Beaver, Julia A.; Rao, V. Ashutosh			In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines	PLOS ONE			English	Article							MAMMALIAN AUTOPHAGY; GENES	Autophagy drives drug resistance and drug-induced cancer cell cytotoxicity. Targeting the autophagy process could greatly improve chemotherapy outcomes. The discovery of specific inhibitors or activators has been hindered by challenges with reliably measuring autophagy levels in a clinical setting. We investigated drug-induced autophagy in breast cancer cell lines with differing ER/PR/Her2 receptor status by exposing them to known but divergent autophagy inducers each with a unique molecular target, tamoxifen, trastuzumab, bortezomib or rapamycin. Differential gene expression analysis from total RNA extracted during the earliest sign of autophagy flux showed both cell- and drug-specific changes. We analyzed the list of differentially expressed genes to find a common, cell- and drug-agnostic autophagy signature. Twelve mRNAs were significantly modulated by all the drugs and 11 were orthogonally verified with Q-RT-PCR (Klh124, Hbp1, Crebrf, Ypel2, Fbxo32, Gdf15, Cdc25a, Ddit4, Psat1, Cd22, Ypel3). The drug agnostic mRNA signature was similarly induced by a mitochondrially targeted agent, MitoQ. In-silico analysis on the KM-plotter cancer database showed that the levels of these mRNAs are detectable in human samples and associated with breast cancer prognosis outcomes of Relapse-Free Survival in all patients (RSF), Overall Survival in all patients (OS), and Relapse-Free Survival in ER+ Patients (RSF ER+). High levels of Klh124, Hbpl, Crebrf, YpeIl2, CD22 and Ypel3 were correlated with better outcomes, whereas lower levels of Gdf15, Cdc25a, Ddit4 and Psat1 were associated with better prognosis in breast cancer patients. This gene signature uncovers candidate autophagy biomarkers that could be tested during preclinical and clinical studies to monitor the autophagy process.	[Mascia, Francesca; Rao, V. Ashutosh] US FDA, Lab Appl Biochem, Div Biotechnol Review & Res 3, CDER, Silver Spring, MD 20993 USA; [Mazo, Ilya; Alterovitz, Wei-Lun; Karagiannis, Konstantinos] US FDA, HIVE Bioinformat Grp, Off Biostat & Epidemiol, CBER, Silver Spring, MD USA; [Wu, Wells W.; Shen, Rong-Fong] US FDA, Facil Biotechnol Resource, CBER, Silver Spring, MD USA; [Beaver, Julia A.] US FDA, Oncol Ctr Excellence, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Rao, VA (corresponding author), US FDA, Lab Appl Biochem, Div Biotechnol Review & Res 3, CDER, Silver Spring, MD 20993 USA.	ashutosh.rao@fda.hhs.gov		Karagiannis, Konstantinos/0000-0002-4776-5137				Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556; Biel TG, 2018, ONCOTARGET, V9, P995, DOI 10.18632/oncotarget.23171; Chen XX, 2020, DNA CELL BIOL, V39, P1595, DOI 10.1089/dna.2020.5667; Das CK, 2018, CANCER METAST REV, V37, P749, DOI 10.1007/s10555-018-9727-z; Fulda S, 2015, ONCOGENE, V34, P5105, DOI 10.1038/onc.2014.458; Fullgrabe J, 2016, J CELL SCI, V129, P3059, DOI 10.1242/jcs.188920; Go Ma JY., 2021, AGEING, V13, P13684; Gonzalez Y, 2014, ONCOTARGET, V5, P1526, DOI 10.18632/oncotarget.1715; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Jegga AG, 2011, AUTOPHAGY, V7, P477, DOI 10.4161/auto.7.5.14811; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klionsky DJ, 2011, AUTOPHAGY, V7, P1, DOI 10.4161/auto.7.1.14130; Lai JG, 2020, J CELL MOL MED, V24, P9145, DOI 10.1111/jcmm.15551; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Li XP, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.569318; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Pinto JA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01207-3; Rosenbluth JM, 2008, MOL CELL BIOL, V28, P5951, DOI 10.1128/MCB.00305-08; Santana-Quintero L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099033; Simonyan V, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw022; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wu TZ, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100141; Wu WW, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4677-y; Zhou J, 2017, GENE, V627, P549, DOI 10.1016/j.gene.2017.06.053	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262134	10.1371/journal.pone.0262134	http://dx.doi.org/10.1371/journal.pone.0262134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990474	Green Published, gold			2022-12-27	WOS:000815783800016
J	Tabatabaei-Malazy, O; Moghaddam, SS; Masinaei, M; Rezaei, N; Fateh, SM; Dilmaghani-Marand, A; Abdolhamidi, E; Razi, F; Khashayar, P; Mahdavihezaveh, A; Samiee, SM; Larijani, B; Farzadfar, F				Tabatabaei-Malazy, Ozra; Moghaddam, Sahar Saeedi; Masinaei, Masoud; Rezaei, Nazila; Fateh, Sahar Mohammadi; Dilmaghani-Marand, Arezou; Abdolhamidi, Elham; Razi, Farideh; Khashayar, Patricia; Mahdavihezaveh, Alireza; Samiee, Siamak Mirab; Larijani, Bagher; Farzadfar, Farshad			Association between being metabolically healthy/unhealthy and metabolic syndrome in Iranian adults	PLOS ONE			English	Article							BODY-MASS INDEX; OBESE INDIVIDUALS; NORMAL-WEIGHT; HEALTHY; MORTALITY; RISK; PREVALENCE; PHENOTYPES; OVERWEIGHT	Introduction The prevalence of metabolically healthy obesity (MHO) varies based on different criteria. We assessed the prevalence of MHO and metabolic unhealthiness based on body mass index (BMI) and their association with metabolic syndrome (MetS) in a nation-wide study. Methods Data were taken from the STEPs 2016 study, from 18,459 Iranians aged >= 25 years. Demographic, metabolic, and anthropometric data were collected. Subjects were stratified by BMI, metabolic unhealthiness, and having MetS. The latter was defined based on National Cholesterol Education Program Adult Treatment Panel III 2004 (NCEP ATP III), was then assessed. Results The prevalence of MHO and metabolic unhealthiness in obese subjects was 7.5% (about 3.6 million) and 18.3% (about 8.9 million), respectively. Most of the metabolic unhealthy individuals were female (53.5%) or urban residents (72.9%). Low physical activity was significantly and positively associated (Odds Ratio: 1.18, 95% CI: 1.04-1.35) with metabolic unhealthiness, while being a rural residence (0.83, 0.74-0.93), and having higher education (0.47, 0.39-0.58) significantly but negatively affected it. Dyslipidemia was the most frequent MetS component with a prevalence rate of 46.6% (42.1-51.1), 62.2% (60.8-63.6), 76.3% (75.1-77.5), and 83.4% (82.1-84.6) among underweight, normal weight, overweight and obese phenotypes, respectively. Conclusion BMI aside, an additional set of criteria such as metabolic markers should be taken into account to identify normal weight but metabolically unhealthy individuals. Given the highest prevalence of dyslipidemia among obese subjects, further interventions are required to raise public awareness, promote healthy lifestyles and establish lipid clinics.	[Tabatabaei-Malazy, Ozra; Moghaddam, Sahar Saeedi; Masinaei, Masoud; Rezaei, Nazila; Fateh, Sahar Mohammadi; Dilmaghani-Marand, Arezou; Abdolhamidi, Elham; Farzadfar, Farshad] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran; [Tabatabaei-Malazy, Ozra; Fateh, Sahar Mohammadi; Larijani, Bagher; Farzadfar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Masinaei, Masoud] Univ Tehran Med Sci, Dept Epidemiol, Tehran, Iran; [Masinaei, Masoud] Univ Tehran Med Sci, Dept Biostat, Tehran, Iran; [Razi, Farideh] Univ Tehran Med Sci, Diabet Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Khashayar, Patricia] Univ Tehran Med Sci, Osteoporosis Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Khashayar, Patricia] Univ Ghent Belgium, Ctr Microsyst Technol, Imec & Ghent, Ghent, Belgium; [Mahdavihezaveh, Alireza] Minist Hlth & Med Educ, Hlth, Tehran, Iran; [Samiee, Siamak Mirab] Minist Hlth & Med Educ, Reference Hlth Lab, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Ghent University; IMEC; Ministry of Health & Medical Education (MOHME); Ministry of Health & Medical Education (MOHME)	Farzadfar, F (corresponding author), Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran.; Farzadfar, F (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran.	f-farzadfar@tums.ac.ir	Masinaei, Masoud/AAE-2481-2022; Khashayar, Patricia/C-2738-2009; tabatabaei, ozra/E-3634-2013	Masinaei, Masoud/0000-0002-0145-7526; Khashayar, Patricia/0000-0001-7525-8418; Larijani, Bagher/0000-0001-5386-7597; tabatabaei, ozra/0000-0003-0188-9721	National Institute for Medical Research Development (NIMAD), Tehran, Iran; National Institute of Health Research	National Institute for Medical Research Development (NIMAD), Tehran, Iran; National Institute of Health Research(National Institute for Health Research (NIHR))	This work was supported by National Institute for Medical Research Development (NIMAD), Tehran, Iran and National Institute of Health Research.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Aryan Z, 2018, J CLIN LIPIDOL, V12, P1471, DOI 10.1016/j.jacl.2018.08.001; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Djalalinia S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00042; Djalalinia S, 2017, ARCH IRAN MED, V20, P608, DOI 0172009/AIM.009; Djalalinia S, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.169075; Goncalves CG, 2016, NUTRITION, V32, P14, DOI 10.1016/j.nut.2015.07.010; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Gutierrez-Repiso C, 2014, NUTR METAB CARDIOVAS, V24, P947, DOI 10.1016/j.numecd.2014.04.019; Hwang YC, 2015, INT J OBESITY, V39, P1365, DOI 10.1038/ijo.2015.75; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Karelis A, 2004, DIABETES METAB, V30, P569, DOI 10.1016/S1262-3636(07)70156-8; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kaur A, 2016, EUR J ENDOCRINOL, V175, P133, DOI 10.1530/EJE-16-0095; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Lee K, 2009, ASIA PAC J CLIN NUTR, V18, P280; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Marques-Vidal P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-330; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Messier V, 2010, OBESITY, V18, P911, DOI 10.1038/oby.2009.364; Mohebi F, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7592-5; Nematy M., 2014, J MOL GENET MED, VS1, P019, DOI [10.4172/1747-0862.S1-019, DOI 10.4172/1747-0862.S1-019]; Panagiotakos DB, 2004, AM HEART J, V147, P106, DOI 10.1016/S0002-8703(03)00442-3; Qorbani M, 2015, CLIN LIPIDOL, V10, P449, DOI 10.2217/clp.15.30; ROBERTS WC, 1988, AM J CARDIOL, V62, P345, DOI 10.1016/0002-9149(88)90248-2; Schroder H, 2014, EUR J NUTR, V53, P1345, DOI 10.1007/s00394-013-0635-2; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Soriguer F, 2004, EUR J EPIDEMIOL, V19, P33, DOI 10.1023/B:EJEP.0000013254.93980.97; Soriguer F, 2013, J CLIN ENDOCR METAB, V98, P2318, DOI 10.1210/jc.2012-4253; Tabatabaei-Malazy O, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0241926; Tomiyama AJ, 2016, INT J OBESITY, V40, P883, DOI 10.1038/ijo.2016.17; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; who, STEPS MANUAL; WHO, NONCOMMUNICABLE DIS; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262246	10.1371/journal.pone.0262246	http://dx.doi.org/10.1371/journal.pone.0262246			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990491	Green Published, gold			2022-12-27	WOS:000815783800021
J	Patel, SM; Shaik-Dasthagirisaheb, YB; Congdon, M; Young, RR; Patel, MZ; Mazhani, T; Boiditswe, S; Leburu, T; Lechiile, K; Arscott-Mills, T; Steenhoff, AP; Feemster, KA; Shah, SS; Cunningham, CK; Pelton, SI; Kelly, MS				Patel, Sweta M.; Shaik-Dasthagirisaheb, Yazdani B.; Congdon, Morgan; Young, Rebecca R.; Patel, Mohamed Z.; Mazhani, Tiny; Boiditswe, Sefelani; Leburu, Tirayaone; Lechiile, Kwana; Arscott-Mills, Tonya; Steenhoff, Andrew P.; Feemster, Kristen A.; Shah, Samir S.; Cunningham, Coleen K.; Pelton, Stephen I.; Kelly, Matthew S.			Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine	PLOS ONE			English	Article							CARRIAGE; CHILDREN	Pneumococcal conjugate vaccines reduce the burden of invasive pneumococcal disease, but the sustained effect of these vaccines can be diminished by an increase in disease caused by non-vaccine serotypes. To describe pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine (PCV-13) in July 2012, we performed molecular serotyping of 268 pneumococcal strains isolated from 221 children between 2012 and 2017. The median (interquartile range) age of the children included in this analysis was 6 (3,12) months. Fifty-nine percent of the children had received at least one dose of PCV-13 and 35% were fully vaccinated with PCV-13. While colonization by vaccine serotypes steadily declined following PCV-13 introduction, 25% of strains isolated more than 3 years after vaccine introduction were PCV-13 serotypes. We also observed an increase in colonization by non-vaccine serotypes 21 and 23B, which have been associated with invasive pneumococcal disease and antibiotic resistance in other settings.	[Patel, Sweta M.] Duke Univ, Div Pulm Allergy & Crit Care Med, Durham, NC 27708 USA; [Patel, Sweta M.; Kelly, Matthew S.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Shaik-Dasthagirisaheb, Yazdani B.; Pelton, Stephen I.] Boston Univ, Sch Med, Div Pediat Infect Dis, Boston, MA 02118 USA; [Congdon, Morgan; Arscott-Mills, Tonya; Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; [Young, Rebecca R.; Kelly, Matthew S.] Duke Univ, Div Pediat Infect Dis, Durham, NC USA; [Patel, Mohamed Z.; Mazhani, Tiny; Arscott-Mills, Tonya; Steenhoff, Andrew P.] Univ Botswana, Fac Med, Dept Paediat & Adolescent Hlth, Gaborone, Botswana; [Boiditswe, Sefelani; Leburu, Tirayaone; Lechiile, Kwana; Arscott-Mills, Tonya] Botswana Univ Pennsylvania Partnership, Gaborone, Botswana; [Steenhoff, Andrew P.; Feemster, Kristen A.] Childrens Hosp Philadelphia, Div Pediat Infect Dis, Philadelphia, PA USA; [Steenhoff, Andrew P.; Feemster, Kristen A.] Childrens Hosp Philadelphia, Dept Pediat, Global Hlth Ctr, Philadelphia, PA 19104 USA; [Shah, Samir S.] Cincinnati Childrens Med Ctr, Div Hosp Med, Cincinnati, OH USA; [Shah, Samir S.] Cincinnati Childrens Med Ctr, Div Infect Dis, Cincinnati, OH USA; [Cunningham, Coleen K.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA	Duke University; Duke University; Boston University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Duke University; University of Botswana; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of California System; University of California Irvine	Patel, SM (corresponding author), Duke Univ, Div Pulm Allergy & Crit Care Med, Durham, NC 27708 USA.; Patel, SM (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	sweta.patel@duke.edu		Patel, Sweta M./0000-0001-7867-7706	Merck Investigator Studies Program Grant (MISP) [59310]; VECD Global Health Fellowship - Office of AIDS Research (OAR); Fogarty International Center (FIC) of the National Institutes of Health (NIH) [D43 TW009337]; Early Career Award from the Thrasher Research Fund; Burroughs Wellcome/American Society of Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases; NIH Career Development Award [K23AI135090]; CIPHER grant from the International AIDS Society - ViiV Healthcare; NIH through the Duke Center for AIDS Research [P30-AI064518]; Children's Hospital of Philadelphia; Penn Center for AIDS Research, an NIH-funded program [P30AI045008]	Merck Investigator Studies Program Grant (MISP); VECD Global Health Fellowship - Office of AIDS Research (OAR); Fogarty International Center (FIC) of the National Institutes of Health (NIH); Early Career Award from the Thrasher Research Fund; Burroughs Wellcome/American Society of Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases; NIH Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIPHER grant from the International AIDS Society - ViiV Healthcare; NIH through the Duke Center for AIDS Research; Children's Hospital of Philadelphia; Penn Center for AIDS Research, an NIH-funded program	This research was supported by a Merck Investigator Studies Program Grant (MISP #59310 to M.S.K; URL: https://engagezone.msd.com/misp.php).S.M.P.was supported by a VECD Global Health Fellowship, funded by the Office of AIDS Research (OAR) and the Fogarty International Center (FIC) of the National Institutes of Health (NIH; D43 TW009337; URL: https://www.vumc.org/vecd/home).M.S.K.was supported by an Early Career Award from the Thrasher Research Fund (URL: https://www.thrasherresearch.org/earlycareer-award?lang=eng), a Burroughs Wellcome/American Society of Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases (URL: https://www.astmh.org/awardsfellowships-medals/awards-and-fellowships/burroughs-wellcome-fund-astmh-postdoctoralfellows), an NIH Career Development Award (K23AI135090; URL: https://www.niaid.nih.gov/grantscontracts/mentored-patient-oriented-research-career-development-award-k23), and a CIPHER grant from the International AIDS Society, supported by ViiV Healthcare (URL: https://www.iasociety.org/HIV-Programmes/Programmes/Paediatrics-CIPHER/CIPHER-Grant-Programme).The views expressed in this publication do not necessarily reflect the official policies of the International AIDS Society or ViiV Healthcare. M.S. K. and C.K.C. received financial support from the NIH through the Duke Center for AIDS Research (P30-AI064518; URL: https://cfar.duke.edu/).A.P.S and K.A.F received support from the Children's Hospital of Philadelphia and A.P.S. and T.A-M. through core services from the Penn Center for AIDS Research, an NIH-funded program (P30AI045008; URL https://www.med.upenn.edu/cfar/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bliss SJ, 2008, LANCET INFECT DIS, V8, P67, DOI 10.1016/S1473-3099(07)70242-6; Centers for Disease Control and Prevention, 2014, LIST OL PRIM US 41 C; CongdonM HH, 2020, CLIN INFECT DIS; Dube FS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30345-5; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Heinsbroek E, 2018, VACCINE, V36, P7369, DOI 10.1016/j.vaccine.2018.10.021; Kaplan SL, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0567; Kelly MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126593; Madhi SA, 2020, VACCINE, V38, P2350, DOI 10.1016/j.vaccine.2020.01.062; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Rodenburg GD, 2010, EMERG INFECT DIS, V16, P816, DOI 10.3201/eid1605.091223; Swarthout TD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15786-9; Turner P, 2020, CLIN INFECT DIS, V70, P1580, DOI 10.1093/cid/ciz481; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Voysey M, 2018, CLIN INFECT DIS, V66, P913, DOI 10.1093/cid/cix895; Weinberger DM, 2013, AM J EPIDEMIOL, V178, P1488, DOI 10.1093/aje/kwt156; Whelan Fiona J, 2014, Ann Am Thorac Soc, V11, P513, DOI 10.1513/AnnalsATS.201310-351OC; World Health Organization, 2020, UN REP TANZ MEASL VA; Wouters I, 2019, VACCINE, V37, P1080, DOI 10.1016/j.vaccine.2018.12.068	19	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262225	10.1371/journal.pone.0262225	http://dx.doi.org/10.1371/journal.pone.0262225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986196	gold, Green Published			2022-12-27	WOS:000765956200026
J	Mogaka, JN; Sharma, M; Temu, T; Masyuko, S; Kinuthia, J; Osoti, A; Zifodya, J; Nakanjako, D; Njoroge, A; Otedo, A; Page, S; Farquhar, C				Mogaka, Jerusha Nyabiage; Sharma, Monisha; Temu, Tecla; Masyuko, Sarah; Kinuthia, John; Osoti, Alfred; Zifodya, Jerry; Nakanjako, Damalie; Njoroge, Anne; Otedo, Amos; Page, Stephanie; Farquhar, Carey			Prevalence and factors associated with hypertension among adults with and without HIV in Western Kenya	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; BLOOD-PRESSURE; GUIDELINES; RISK	IntroductionThe burden of cardiovascular disease (CVD) is increasing in sub-Saharan Africa with untreated hypertension being a major contributing factor. Understanding the magnitude of the problem and risk factors associated with HIV and long-term antiretroviral therapy (ART) is critically important for designing effective programs for diagnosing and treating hypertension in Kenya. MethodsIn this cross-sectional study, we enrolled 300 persons with HIV (PWH) on long term ART (>= 6 months) and 298 HIV-negative adults seeking care at the Kisumu County Hospital between September 2017 and May 2018. Hypertension was defined as blood pressure of >= 140/90mmHg or a previous hypertension diagnosis. Multivariate regression was used to assess the association between hypertension and HIV adjusting for age, sex, and known CVD risk factors. ResultsOverall prevalence of hypertension was 22%. PWH had a lower prevalence of hypertension than HIV-negative persons (16% vs 27% respectively; p<0.002). In multivariate analyses, persons with HIV were 37% less likely to have hypertension compared to HIV-negative individuals (adjusted prevalence ratio 0.63; 95% confidence interval: 0.46-0.86). Other factors that were associated with hypertension in all participants included older age >40 years, body mass index (BMI) >25 kg/m(2) and low-density lipoproteins >= 130mg/dL. Among PWH, being older than 40 years and higher BMI >30 kg/m(2) were associated with hypertension. ConclusionPrevalence of hypertension was high, affecting nearly one in every 4 adults, and associated with older age, higher BMI and high low-density lipoproteins. PWH on long-term ART had significantly lower prevalence of hypertension compared to HIV-negative individuals, potentially due to increased access to healthcare services and interaction with prevention messaging. Interventions to increase screening for and prevention of hypertension in the community for all adults are warranted.	[Mogaka, Jerusha Nyabiage; Sharma, Monisha; Temu, Tecla; Masyuko, Sarah; Njoroge, Anne; Page, Stephanie; Farquhar, Carey] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Mogaka, Jerusha Nyabiage; Kinuthia, John] Kenyatta Natl Hosp, Dept Res & Programs, Nairobi, Kenya; [Masyuko, Sarah; Otedo, Amos] Minist Hlth, Nairobi, Kenya; [Osoti, Alfred] Univ Nairobi, Dept Obstet & Gynecol, Nairobi, Kenya; [Osoti, Alfred] Univ Nairobi, Coll Hlth Sci, Dept Clin Med & Therapeut, Nairobi, Kenya; [Zifodya, Jerry] Tulane Univ, Sect Pulm Crit Care & Environm Med, Dept Med, New Orleans, LA USA; [Nakanjako, Damalie] Makerere Univ, Sch Med, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Page, Stephanie; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Kenyatta National Hospital; University of Nairobi; University of Nairobi; Tulane University; Makerere University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mogaka, JN (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Mogaka, JN (corresponding author), Kenyatta Natl Hosp, Dept Res & Programs, Nairobi, Kenya.	jerunyags@gmail.com		Nakanjako, Damalie/0000-0002-0935-2112; Mogaka, Jerusha/0000-0001-9913-9034; Temu, Tecla/0000-0002-0056-4143; Zifodya, Jerry/0000-0003-2742-5976; Sharma, Monisha/0000-0002-7599-1561	US National Institutes of Health (NIH) [R21 TW010459]; Fogarty International Center (FIC) [D43 TW009580]; NIMH [K01MH115789]	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by US National Institutes of Health (NIH), R21 TW010459 and the Fogarty International Center (FIC) D43 TW009580. Monisha Sharma received support from NIMH K01MH115789. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaney T, 2018, LANCET GLOB HEALTH, V6, pE736, DOI 10.1016/S2214-109X(18)30259-6; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Bull FC, 2020, BRIT J SPORT MED, V54, P1451, DOI 10.1136/bjsports-2020-102955; Chepchirchir A., 2018, INT J CYTOKINE EXPRE, DOI [10.1080/09540121.2017.1384533, DOI 10.1080/09540121.2017.1384533]; Dhungana RR, 2016, INT J HYPERTENS, V2016, P1, DOI 10.1155/2016/1656938; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Gebrie A, 2018, SAGE OPEN MED, V6, DOI [10.1177/2050312118756663, 10.1177/2050312118774142]; Guwatudde D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2546-z; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Ibekwe RU, 2015, ANN MED HEALTH SCI R, V5, P71, DOI 10.4103/2141-9248.149793; IHME, 2020, GBD COMP VIZ HUB; Joshi MD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1177; Kwarisiima D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156309; Lubega G, 2021, PAN AFR MED J, V38, DOI 10.11604/pamj.2021.38.216.28034; Masenga SK, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0956-5; Masyuko SJ, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020845; Ministry of Health; Kenyan National Bureau of Statistics; World Health Organization, 2015, PUBLIC HEALTH, V5, P8, DOI [10.1007/s11605-008-0794-2, DOI 10.1007/S11605-008-0794-2]; MoH-Kenya, 2018, KEN NAT GUID CARD DI; Mosha NR, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1321279; Nahimana MR, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4536-9; NASCOP K, KEN ARV GUID 2018 FI; Nduka CU, 2016, J HUM HYPERTENS, V30, P355, DOI 10.1038/jhh.2015.97; Ngatchou W, 2013, BLOOD PRESS MONIT, V18, P247, DOI 10.1097/MBP.0b013e328363ee43; Olack B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2610-8; Peck RN, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0125-2; Ploth DW, 2018, KIDNEY INT REP, V3, P905, DOI 10.1016/j.ekir.2018.04.006; Pustil R., 2016, AIDS S4, V17, pS3, DOI 10.1073/pnas.86.15.5781; Trickey A, 2017, LANCET HIV, V4, pE349, DOI 10.1016/S2352-3018(17)30066-8; Whelton PK, 2018, JAMA-J AM MED ASSOC, V320, P1749, DOI 10.1001/jama.2018.16755; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2003, WHOCDSWHOPESGCDPP200, P43; World Health O, 2008, WAIST CIRCUMFERENCE, P8, DOI [10.1038/ejcn.2009.139, DOI 10.1038/EJCN.2009.139]; Yoruk A, 2018, AM J HYPERTENS, V31, P387, DOI 10.1093/ajh/hpx196	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262400	10.1371/journal.pone.0262400	http://dx.doi.org/10.1371/journal.pone.0262400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007291	gold, Green Published			2022-12-27	WOS:000741060700005
J	Boothe, MAS; Baltazar, CS; Sathane, I; Raymond, HF; Fazito, E; Temmerman, M; Luchters, S				Boothe, Makini A. S.; Baltazar, Cynthia Sema; Sathane, Isabel; Raymond, Henry F.; Fazito, Erika; Temmerman, Marleen; Luchters, Stanley			Young key populations left behind: The necessity for a targeted response in Mozambique	PLOS ONE			English	Article							RISK BEHAVIORS; HIV-INFECTION; SEX WORKERS; MEN; PEOPLE; DRUGS	Introduction The first exposure to high-risk sexual and drug use behaviors often occurs during the period of youth (15-24 years old). These behaviors increase the risk of HIV infection, especially among young key populations (KP)-men how have sex with men (MSM), female sex workers (FSW), and people who inject drugs (PWID). We describe the characteristics of young KP participants in the first Biobehavioral Surveillance (BBS) surveys conducted in Mozambique and examine their risk behaviors compared to adult KP. Methods Respondent-driven sampling (RDS) methodology was used to recruit KP in three major urban areas in Mozambique. RDS-weighted pooled estimates were calculated to estimate the proportion of young KP residing in each survey city. Unweighted pooled estimates of risk behaviors were calculated for each key population group and chi-square analysis assessed differences in proportions between youth (aged less than 24 years old) and older adult KP for each population group. Results The majority of MSM and FSW participants were young 80.7% (95% CI: 71.5-89.9%) and 71.9% (95% CI: 71.9-79.5%), respectively, although not among PWID (18.2%, 95% CI: 13.2-23.2%). Young KP were single or never married, had a secondary education level or higher, and low employment rates. They reported lower perception of HIV risk (MSM: 72.3% vs 56.7%, p<0.001, FSW: 45.3% vs 24.4%, p<0.001), lower HIV testing uptake (MSM: 67.5% vs 72.3%, p<0.001; FSW: 63.2% vs 80.6%; p<0.001, PWID: 53.3% vs 31.2%; p = 0.001), greater underage sexual debut (MSM: 9.6% vs 4.8%, p<0.001; FSW: 35.2% vs 22.9%, p<0.001), and greater underage initiation of injection drug use (PWID: 31.9% vs 7.0%, p<0.001). Young KP also had lower HIV prevalence compared to older KP: MSM: 3.3% vs 27.0%, p<0.001; FSW: 17.2% vs 53.7%, p<0.001; and PWID: 6.0% vs 55.0%, p<0.001. There was no significant difference in condom use across the populations. Conclusion There is an immediate need for a targeted HIV response for young KP in Mozambique so that they are not left behind. Youth must be engaged in the design and implementation of interventions to ensure that low risk behaviors are sustained as they get older to prevent HIV infection.	[Boothe, Makini A. S.; Baltazar, Cynthia Sema; Temmerman, Marleen; Luchters, Stanley] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth & Primary Care, Ghent, Belgium; [Baltazar, Cynthia Sema] Natl Inst Hlth, Maputo, Mozambique; [Sathane, Isabel] Natl Directorate Publ Hlth, Natl STI HIV AIDS Control Program, Maputo, Mozambique; [Raymond, Henry F.] Rutgers State Univ, Sch Publ Hlth, Piscataway, NJ USA; [Fazito, Erika] Columbia Univ, ICAP, Pretoria, South Africa; [Temmerman, Marleen] Aga Khan Univ, Dept Obstet & Gynecol, Nairobi, Kenya; [Luchters, Stanley] Aga Khan Univ, Dept Populat Hlth, Nairobi, Kenya; [Luchters, Stanley] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia	Ghent University; Ghent University Hospital; Rutgers State University New Brunswick; Aga Khan University; Aga Khan University; Monash University	Boothe, MAS (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth & Primary Care, Ghent, Belgium.	Makini.boothe@ugent.be		Luchters, Stanley/0000-0001-5235-5629; , Makini/0000-0002-5362-5106	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [U2GPS001468]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	"This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of the Cooperative Agreement #U2GPS001468. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the CDC."The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], Adolescents and Youth Dashboard; Augusto AD, 2016, AIDS BEHAV, V20, P799, DOI 10.1007/s10461-015-1140-9; Baltazar CS, 2020, HARM REDUCT J, V17, DOI 10.1186/s12954-020-00363-6; Baltazar CS, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4655-2; Bekker LG, 2015, J INT AIDS SOC, V18, P1, DOI 10.7448/IAS.18.2.20027; Busza J, 2014, HEALTH PLACE, V28, P85, DOI 10.1016/j.healthplace.2014.04.002; Coetzee J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196759; Delany-Moretlwe S, 2015, J INT AIDS SOC, V18, P29, DOI 10.7448/IAS.18.2.19833; Demissie M, 2018, AJAR-AFR J AIDS RES, V17, P259, DOI 10.2989/16085906.2018.1511604; Fast-Track Cities, 2015, PLAN ESTR NAC RESP H; Harper GW, 2015, AIDS, V29, pS261, DOI 10.1097/QAD.0000000000000905; HIV/AIDS/STI UWG on G, 2012, STRAT LAB METH STREN; Instituto Nacional de Estatistica, POPULATION PROJECTIO; Instituto Nacional de Saude Centers for Disease Control and Prevention University of California San Francisco Pathfinder International and I-TECH, 2012, INT BIOL BEH SURV ME; Kim EJ, 2016, SEX TRANSM INFECT, V92, P240, DOI 10.1136/sextrans-2015-052034; Kounta CH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212245; Kurth AE, 2015, JAIDS-J ACQ IMM DEF, V70, P420, DOI 10.1097/QAI.0000000000000769; Lancaster KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147662; Mavedzenge SN, 2011, J ADOLESCENT HEALTH, V49, P559, DOI 10.1016/j.jadohealth.2011.02.012; Milne J, 2020, AIDS BEHAV, V24, P2307, DOI 10.1007/s10461-020-02790-9; Ministerio da Saude, 2018, BREV CONS REL ESTR N; Ministerio da Saude, 2016, DIR INT SERV PREV C; Ministerio da Saude and Instituto Nacional de Saude, 2017, MOZ INT BIOL BEH SUR; Ministerio da Saude (MISAU) Instituto Nacional de Estatistica (INE) Com a Assistencia Tecnica de ICF., 2018, INQ IND IM MAL HIV S; Mmbaga EJ, 2020, ARCH SEX BEHAV, V49, P2045, DOI 10.1007/s10508-019-01529-5; Musyoki H, 2015, AIDS BEHAV, V19, pS46, DOI 10.1007/s10461-014-0919-4; Muzyamba C, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0067-6; Nala R, 2015, AIDS BEHAV, V19, P393, DOI 10.1007/s10461-014-0895-8; Needle R, 2008, SOC SCI MED, V67, P1447, DOI 10.1016/j.socscimed.2008.06.031; Okoboi S, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25269; Pantelic M, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001285; Pettifor A, 2015, J INT AIDS SOC, V18, P8, DOI 10.7448/IAS.18.2.19434; Rotheram-Borus MJ, 2018, CURR OPIN PEDIATR, V30, P131, DOI 10.1097/MOP.0000000000000580; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Tsang EYH, 2019, AM J MENS HEALTH, V13, DOI 10.1177/1557988318823883; Tun W, 2015, AIDS BEHAV, V19, pS24, DOI 10.1007/s10461-014-0936-3; UNAIDS, 2018, YOUTH BULG HIV; UNAIDS, 2016, END AIDS EP AD AD, P32, DOI [10.1080/09540121.2016.1139043, DOI 10.1080/09540121.2016.1139043]; UNAIDS, 2018, YOUTH HIV MAINSTR 3; United Nations, 2018, WORLD YOUTH REP YOUT, DOI [10.1186/s12884-018-1763-8, DOI 10.1186/S12884-018-1763-8]; United Nations General Assembly, 1996, ARES5081 UN GEN ASS; Vandepitte J, 2014, HIV OTHER SEXUALLY T, P17; Wirtz AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18742; World Health Organization, 2015, HIV YOUNG MEN WHO HA; World Health Organization, 2014, CONS GUID HIV PREV D; World Health Organization, 2015, TECHN BRIEF HIV YOUN	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261943	10.1371/journal.pone.0261943	http://dx.doi.org/10.1371/journal.pone.0261943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972172	Green Published, gold			2022-12-27	WOS:000773555700071
J	Fahmy, S; Kan, PF; Lewon, JW				Fahmy, Sarah; Kan, Pui-Fong; Lewon, Jen Walentas			The effects of theatre-based vocal empowerment on young Egyptian women's vocal and language characteristics	PLOS ONE			English	Article							FUNDAMENTAL-FREQUENCY; SPEECH PRACTICE; ENGLISH	This study investigates the impact of a theatre-based vocal empowerment program on the vocal and language characteristics and the self-perceptions of young bilingual Egyptian women. The program used applied theatre, a dramatic practice that promotes civic action by utilizing improvisational techniques to engage participants in exploring solutions to self-identified community concerns. These techniques supported participants' pursuit of vocal empowerment: the ability to comfortably express their intended content with a clear audible voice, accompanied by the belief that what they had to say was worthwhile. The program was implemented in Alexandria and Aswan, two Egyptian cities in different regions of the country, with distinct socio-economic profiles. Thirty-six young women from Aswan and nineteen from Alexandria participated. The program was facilitated in Arabic, for 90 minutes per day over twelve consecutive days in 2018. Participants in both groups spoke Arabic as a home language and studied English in school settings but differed in their educational experiences and English proficiency. The vocal and language characteristics of each participant were tested in Arabic and English pre- and post- program using a spontaneous speech task and a reading aloud task. Their self-perceptions were evaluated through a vocal self-perception survey. Results indicated that participants responded differently in each city. In Alexandria, participants showed significant improvement in language skills (e.g., mean length of utterance). In contrast, participants in Aswan showed a significant change in fundamental frequency. Overall, the self-surveys indicated that all participants experienced an increased sense of confidence, a stronger belief in self-authorship, and an increased desire to voice their opinions clearly in public; however, there were subtle differences between the groups. In analyzing these results, we conclude that to design effective vocal empowerment outreach programs internationally, it is necessary to consider participants' cultural backgrounds, language diversity, and socio-economic status.	[Fahmy, Sarah] Univ Colorado, Dept Theatre & Dance, Boulder, CO 80309 USA; [Kan, Pui-Fong; Lewon, Jen Walentas] Univ Colorado, Dept Speech Language & Hearing Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Fahmy, S (corresponding author), Univ Colorado, Dept Theatre & Dance, Boulder, CO 80309 USA.	sarah.fahmy@colorado.edu	Kan, Pui Fong/AAL-7650-2020; Fahmy, Sarah/CAG-8336-2022	Kan, Pui Fong/0000-0001-8671-7755; Fahmy, Sarah/0000-0002-6702-9145	University of Colorado Boulder Office of Outreach and Engagement	University of Colorado Boulder Office of Outreach and Engagement	SF $2000 The University of Colorado Boulder Office of Outreach and Engagement https://www.colorado.edu/outreach/ooe/microgrants The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Hamid A., 2005, J READ LIT, V50, P15; Aboulfetouh M.., 2014, PARENTSATTITUDES THE; Abu-Al-Makarem A, 2007, PERCEPT MOTOR SKILL, V105, P572, DOI 10.2466/PMS.105.2.572-580; Altenberg EP, 2006, J VOICE, V20, P89, DOI 10.1016/j.jvoice.2005.01.005; Aravanis M.., 2020, EGYPTIAN STREETS; Aung T, 2020, CURR OPIN PSYCHOL, V33, P154, DOI 10.1016/j.copsyc.2019.07.028; Bassiouney R.., 2020, ARABIC SOCIOLINGUIST, VSecond; Boal A., 2002, AUGUSTO BOAL GAMES A; Boersma P., 2012, VERSION 6037; Borkowska B, 2011, ANIM BEHAV, V82, P55, DOI 10.1016/j.anbehav.2011.03.024; Cantor-Cutiva LC, 2021, J VOICE, V35, P194, DOI 10.1016/j.jvoice.2019.08.009; Chakraborty R, 2008, J SPEECH LANG HEAR R, V51, P321, DOI 10.1044/1092-4388(2008/024); El Shimi R., 2013, AHRAM ONLINE 16 FEB; Elsirgany S., 2017, AHRAM ONLINE 5 NOV; Fahmy S., 2019, VOCAL EMPOWERMENT YO; Goy H, 2013, J VOICE, V27, P545, DOI 10.1016/j.jvoice.2013.03.002; Index Mundi, 2019, EGYPT DEMOGRAPHICS P; Jones BC, 2010, ANIM BEHAV, V79, P57, DOI 10.1016/j.anbehav.2009.10.003; Kan PF, 2015, SEMIN SPEECH LANG, V36, P109, DOI 10.1055/s-0035-1549106; Kan PF, 2014, J SPEECH LANG HEAR R, V57, P929, DOI 10.1044/2013_JSLHR-L-13-0045; Kandil Y., 2015, Applied Theatre Research, V3, P237, DOI 10.1386/atr.3.3.237_1; Khattab M, 2016, COMP FEM STUD SER, P127, DOI 10.1057/978-1-137-50675-7_9; Kleinow J, 2006, DEV PSYCHOBIOL, V48, P275, DOI 10.1002/dev.20141; Lee B, 2017, SPEECH LANG HEARING, V20, P174, DOI 10.1080/2050571X.2016.1273572; Lev-Ari S, 2020, COGNITIVE SCI, V44, DOI 10.1111/cogs.12836; Linklater Kristin., 2018, VOICE SPEECH REV, V12, P211, DOI [10.1080/23268263.2018.1444558, DOI 10.1080/23268263.2018.1444558]; Mahrholz G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204991; Mattei A, 2019, EUR ANN OTORHINOLARY, V136, P151, DOI 10.1016/j.anorl.2019.02.010; MENA OECD, 2018, WOMENS POLITICAL PAR, P1; Miller J.F., 2017, SYSTEMATIC ANAL LANG; Nader N., 2017, N AFRICAN WOMEN ARAB, P211, DOI [10.1007/978-3-319-49926-0_11, DOI 10.1007/978-3-319-49926-0_11]; O'Connor P, 2009, RIDE-J APPL THEATRE, V14, P471, DOI 10.1080/13569780903285966; Osnes B., 2017, SPEAK; Osnes B, 2019, THEATR DANCE PERFORM, V10, P313, DOI 10.1080/19443927.2019.1637371; Pahwa S, 2019, TEXT PERFORM Q, V39, P56, DOI 10.1080/10462937.2018.1544375; Peterson M. A., 2011, CONNECTED CAIRO GROW; Sabbah SS, 2015, ARAB WORLD ENGL J, V6, P54, DOI 10.24093/awej/vol6no2.4; Shalaby M, 2016, COMP FEM STUD SER, P171, DOI 10.1057/978-1-137-55747-6_8; Siupsinskiene N, 2011, J VOICE, V25, pE177, DOI 10.1016/j.jvoice.2010.03.010; Smith A, 2006, J COMMUN DISORD, V39, P331, DOI 10.1016/j.jcomdis.2006.06.017; SUSSMAN JE, 1994, J VOICE, V8, P145, DOI 10.1016/S0892-1997(05)80306-6; Tahan S, 2011, READ WRIT, V24, P1061, DOI 10.1007/s11145-011-9301-3; Tower Jacob I, 2019, OTO Open, V3, p2473974X19866384, DOI 10.1177/2473974X19866384; Voniati L, 2016, J GREEK LINGUIST, V16, P117, DOI 10.1163/15699846-01601002; Waaramaa T, 2021, J VOICE, V35, DOI 10.1016/j.jvoice.2019.09.003; Worldometer, 2020, EGYPT POPULATION LIV	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261294	10.1371/journal.pone.0261294	http://dx.doi.org/10.1371/journal.pone.0261294			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972115	gold, Green Published			2022-12-27	WOS:000773555700028
J	Kim, H; Park, J; Choung, YH; Jang, JH; Ko, J				Kim, Hantai; Park, JaeYeon; Choung, Yun-Hoon; Jang, Jeong Hun; Ko, JeongGil			Predicting speech discrimination scores from pure-tone thresholds-A machine learning-based approach using data from 12,697 subjects	PLOS ONE			English	Article							HEMISPHERIC ASYMMETRIES; TEMPORAL RESOLUTION	Diagnostic tests for hearing impairment not only determines the presence (or absence) of hearing loss, but also evaluates its degree and type, and provides physicians with essential data for future treatment and rehabilitation. Therefore, accurately measuring hearing loss conditions is very important for proper patient understanding and treatment. In current-day practice, to quantify the level of hearing loss, physicians exploit specialized test scores such as the pure-tone audiometry (PTA) thresholds and speech discrimination scores (SDS) as quantitative metrics in examining a patient's auditory function. However, given that these metrics can be easily affected by various human factors, which includes intentional (or accidental) patient intervention, there are needs to cross validate the accuracy of each metric. By understanding a "normal" relationship between the SDS and PTA, physicians can reveal the need for re-testing, additional testing in different dimensions, and also potential malingering cases. For this purpose, in this work, we propose a prediction model for estimating the SDS of a patient by using PTA thresholds via a Random Forest-based machine learning approach to overcome the limitations of the conventional statistical (or even manual) methods. For designing and evaluating the Random Forest-based prediction model, we collected a large-scale dataset from 12,697 subjects, and report a SDS level prediction accuracy of 95.05% and 96.64% for the left and right ears, respectively. We also present comparisons with other widely-used machine learning algorithms (e.g., Support Vector Machine, Multi-layer Perceptron) to show the effectiveness of our proposed Random Forest-based approach. Results obtained from this study provides implications and potential feasibility in providing a practically-applicable screening tool for identifying patient-intended malingering in hearing loss-related tests.	[Kim, Hantai; Choung, Yun-Hoon; Jang, Jeong Hun] Ajou Univ Hosp, Suwon, South Korea; [Kim, Hantai; Choung, Yun-Hoon; Jang, Jeong Hun] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon, South Korea; [Park, JaeYeon; Ko, JeongGil] Yonsei Univ, Coll Engn, Sch Integrated Technol, Seoul, South Korea	Ajou University; Ajou University Hospital; Ajou University; Yonsei University	Jang, JH (corresponding author), Ajou Univ Hosp, Suwon, South Korea.; Jang, JH (corresponding author), Ajou Univ, Sch Med, Dept Otolaryngol, Suwon, South Korea.; Ko, J (corresponding author), Yonsei Univ, Coll Engn, Sch Integrated Technol, Seoul, South Korea.	jhj@ajou.ac.kr; jeonggil.ko@yonsei.ac.kr	Ko, JeongGil/CAF-8134-2022	Kim, Hantai/0000-0002-5020-7814	National Research Foundation of Korea (NRF) - Korean Government (MSIT) [2021R1A2C4002380, ERC: 2015R1A5A1037668, KMDFPR202105270007202102]; Institute for Information and Communications Technology Planning and Evaluation [IITP-2020-2020-0-01461]	National Research Foundation of Korea (NRF) - Korean Government (MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); Institute for Information and Communications Technology Planning and Evaluation	This study was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIT) in the form of funds to JGK [Basic Science Research Program:2021R1A2C4002380; ERC: 2015R1A5A1037668] and HK, YHC, and JHJ [KMDFPR202105270007202102]. This study was also supported by the Institute for Information and Communications Technology Planning and Evaluation to JGK [IITP-2020-2020-0-01461].	Adhikari Surabhi, 2020, 2020 International Conference on Electronics and Sustainable Communication Systems (ICESC). Proceedings, P975, DOI 10.1109/ICESC48915.2020.9155833; Ahn J, 2021, AD HOC NETW, V113, DOI 10.1016/j.adhoc.2020.102360; Ahn J, 2018, COMPUTER, V51, P68, DOI 10.1109/MC.2018.2381116; Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Breiman L., 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bressler S, 2017, HEARING RES, V349, P98, DOI 10.1016/j.heares.2016.10.018; Brown S, 1997, PERCEPT PSYCHOPHYS, V59, P442, DOI 10.3758/BF03211910; Brown SD, 2009, COMPREHENSIVE CHEMOMETRICS: CHEMICAL AND BIOCHEMICAL DATA ANALYSIS, VOLS 1-4, P1; Mondelli MFCG, 2020, CODAS, V32, DOI 10.1590/2317-1782/20192018202; Crowson MG, 2020, LARYNGOSCOPE, V130, P45, DOI 10.1002/lary.27850; Cruz JA, 2006, CANCER INFORM, V2, P59; Dillon H., 2008, HEARING AIDS; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; FLETCHER H, 1950, Acta Otolaryngol Suppl, V90, P26; Flint PW., 2014, CUMMINGS OTOLARYNGOL; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gislason PO, 2006, PATTERN RECOGN LETT, V27, P294, DOI 10.1016/j.patrec.2005.08.011; Guan HY, 2013, INT J REMOTE SENS, V34, P5166, DOI 10.1080/01431161.2013.788261; He H, 2013, IMBALANCED LEARNING: FOUNDATIONS, ALGORITHMS, AND APPLICATIONS, P1, DOI 10.1002/9781118646106; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hodgson W., 1986, HEARING AID ASSESSME; Hong Seong Ah L., 2002, KOREAN J AUDIOL, V6, P128; HyeonJung Park, 2021, Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, V5, DOI 10.1145/3463498; Jaeyeon Park, 2020, Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, V4, DOI 10.1145/3411843; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Kaga K, 2016, AURIS NASUS LARYNX, V43, P10, DOI 10.1016/j.anl.2015.06.008; Kim H, 2021, DYES PIGMENTS, V193, DOI 10.1016/j.dyepig.2021.109492; Kim H, 2021, SENSOR ACTUAT B-CHEM, V329, DOI 10.1016/j.snb.2020.129248; Levene H., 1961, CONTRIBUTIONS PROBAB, P279; Liden G, 1969, J Laryngol Otol, V83, P507, DOI 10.1017/S0022215100070651; MARSHALL L, 1981, EAR HEARING, V2, P148, DOI 10.1097/00003446-198107000-00003; Menze BH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-213; Moturu ST, 2007, IEEE INT C BIOINFORM, P202, DOI 10.1109/BIBM.2007.54; MULLINS C J, 1957, Acta Otolaryngol, V47, P149, DOI 10.3109/00016485709130328; PAL SK, 1992, IEEE T NEURAL NETWOR, V3, P683, DOI 10.1109/72.159058; Park J, 2017, PROCEEDINGS OF THE 15TH ACM CONFERENCE ON EMBEDDED NETWORKED SENSOR SYSTEMS (SENSYS'17), DOI 10.1145/3131672.3131690; PAULER M, 1986, ARCH OTO-RHINO-LARYN, V243, P200, DOI 10.1007/BF00470622; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; RAFFIN MJM, 1980, J SPEECH HEAR RES, V23, P5, DOI 10.1044/jshr.2301.05; Royston P, 1992, STAT COMPUT, V2, P117, DOI [DOI 10.1007/BF01891203, 10.1007/BF01891203]; Shibata T, 2004, ACTA OTO-LARYNGOL, V124, P30, DOI 10.1080/03655230410018417; Sulakhe N, 2003, BRAIN COGNITION, V53, P372, DOI 10.1016/S0278-2626(03)00146-5; Tan Aik Choon, 2003, Appl Bioinformatics, V2, pS75; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; Van Dijk JE, 2000, ACTA OTO-LARYNGOL, V120, P627, DOI 10.1080/000164800750000450; Wilcoxon F., 1992, SPRINGER SERIES STAT, V1, P196, DOI DOI 10.2307/3001968; Yoon HJ, 2017, ACM T SENSOR NETWORK, V13, DOI 10.1145/3079764; YOSHIOKA P, 1980, J SPEECH HEAR RES, V23, P814, DOI 10.1044/jshr.2304.814; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	50	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261433	10.1371/journal.pone.0261433	http://dx.doi.org/10.1371/journal.pone.0261433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972151	Green Published, gold			2022-12-27	WOS:000773555700032
J	Kim, J; Cho, S; Park, Y; Lee, J; Park, J				Kim, Jiyoon; Cho, Siwoo; Park, Yonghyun; Lee, Jiyoul; Park, Jaesung			Evaluation of micro-RNA in extracellular vesicles from blood of patients with prostate cancer	PLOS ONE			English	Article							PCR DATA; CIRCULATING MICRORNAS; BIOMARKERS; SERUM; DIAGNOSIS; MIRNAS; NORMALIZATION; EXPRESSION; EXOSOMES; GENES	Extracellular vesicles (EVs) contain various types of molecules including micro-RNAs, so isolating EVs can be an effective way to analyze and diagnose diseases. A lot of micro-RNAs have been known in relation to prostate cancer (PCa), and we evaluate miR-21, miR-141, and miR-221 in EVs and compare them with prostate-specific antigen (PSA). EVs were isolated from plasma of 38 patients with prostate cancer and 8 patients with benign prostatic hyperplasia (BPH), using a method that showed the highest recovery of RNA. Isolation of EVs concentrated micro-RNAs, reducing the cycle threshold (Ct) value of RT-qPCR amplification of micro-RNA such as miR-16 by 5.12 and miR-191 by 4.65, compared to the values before EV isolation. Normalization of target micro-RNAs was done using miR-191. For miR-221, the mean expression level of patients with localized PCa was significantly higher than that of the control group, having 33.45 times higher expression than the control group (p < 0.01). Area under curve (AUC) between BPH and PCa for miR-221 was 0.98 (p < 0.0001), which was better than AUC for prostate-specific antigen (PSA) level in serum for the same patients. The levels of miR-21 and miR-141 in EVs did not show significant changes in patients with PCa compared to the control group in this study. This study suggests isolating EVs can be a helpful approach in analyzing micro-RNAs with regard to disease.	[Kim, Jiyoon; Park, Jaesung] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeong Buk, South Korea; [Cho, Siwoo; Park, Jaesung] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang, Gyeong Buk, South Korea; [Park, Yonghyun; Lee, Jiyoul] Catholic Univ Korea, Coll Med, Dept Urol, Seoul St Marys Hosp, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Catholic University of Korea; Seoul St. Mary's Hospital	Park, J (corresponding author), Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeong Buk, South Korea.; Park, J (corresponding author), Pohang Univ Sci & Technol, Dept Mech Engn, Pohang, Gyeong Buk, South Korea.	jpark@posteach.ac.kr		Kim, Ji Yoon/0000-0003-0975-9171	Korea Medical Device Development Fund - Korea government (the Ministry of Science and ICT) [1711137918, KMDF_PR_20200901_0018]; Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy) [1711137918, KMDF_PR_20200901_0018]; Korea Medical Device Development Fund - Korea government (Ministry of Health Welfare) [1711137918, KMDF_PR_20200901_0018]; Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety) [1711137918, KMDF_PR_20200901_0018]	Korea Medical Device Development Fund - Korea government (the Ministry of Science and ICT); Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy); Korea Medical Device Development Fund - Korea government (Ministry of Health Welfare); Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety)	The author who received the fund: JP -Grant number: 1711137918, KMDF_PR_20200901_0018 -Full name of funder: Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety) -URL: https://www.kmdf.org/-The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abak A, 2018, EUR REV MED PHARMACO, V22, P3094, DOI 10.26355/eurrev_201805_15069; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Castanares MA, 2016, PROSTATE, V76, P215, DOI 10.1002/pros.23115; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; El-Hefnawy T, 2004, CLIN CHEM, V50, P564, DOI 10.1373/clinchem.2003.028506; Fabris L, 2016, EUR UROL, V70, P312, DOI 10.1016/j.eururo.2015.12.054; Fernandez-Mercado M, 2015, J CELL MOL MED, V19, P2307, DOI 10.1111/jcmm.12625; Filella X, 2017, CLIN CHEM LAB MED, V55, P715, DOI 10.1515/cclm-2015-1073; Gharbi S, 2015, CELL J, V17, P494; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Keck B, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10061315; Khanlou KM, 2012, PLANTA, V236, P1381, DOI 10.1007/s00425-012-1682-2; Kim J, 2017, J DENT RES, V96, P938, DOI 10.1177/0022034517702100; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kotb S, 2014, TUMOR BIOL, V35, P12613, DOI 10.1007/s13277-014-2584-7; Latham GJ, 2010, METHODS MOL BIOL, V667, P19, DOI 10.1007/978-1-60761-811-9_2; Li P, 2017, THERANOSTICS, V7, P789, DOI 10.7150/thno.18133; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logozzi M, 2020, J ENZYM INHIB MED CH, V35, P280, DOI 10.1080/14756366.2019.1697249; Luu HN, 2017, BMC UROL, V17, DOI 10.1186/s12894-017-0206-6; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Neuhaus J, 2018, DIAGNOSTICS, V8, DOI 10.3390/diagnostics8040068; Ryan D, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0948-z; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen J, 2013, CANCER LETT, V329, P125, DOI 10.1016/j.canlet.2012.11.001; Shin H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13103; Sun Z, 2018, J CELL MOL MED, V22, P3719, DOI 10.1111/jcmm.13676; Tamada T, 2011, AM J ROENTGENOL, V197, P664, DOI 10.2214/AJR.10.5923; Taylor MA, 2015, BIOMEDICINES, V3, DOI 10.3390/biomedicines3040270; Wang WT, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0086-0; Whiteside TL, 2016, ADV CLIN CHEM, V74, P103, DOI 10.1016/bs.acc.2015.12.005; Zedan AH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57101-7; Zheng C, 2012, MED ONCOL, V29, P815, DOI 10.1007/s12032-011-9934-8	35	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262017	10.1371/journal.pone.0262017	http://dx.doi.org/10.1371/journal.pone.0262017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972164	Green Published, gold			2022-12-27	WOS:000773555700083
J	Wood, CL; Leslie, KL; Greene, A; Lam, LS; Basnett, B; Hamilton, SL; Samhouri, JF				Wood, Chelsea L.; Leslie, Katie L.; Greene, Alanna; Lam, Laurel S.; Basnett, Bonnie; Hamilton, Scott L.; Samhouri, Jameal F.			The weaker sex: Male lingcod (Ophiodon elongatus) with blue color polymorphism are more burdened by parasites than are other sex-color combinations	PLOS ONE			English	Article							FISH; INFECTIONS; NUTRITION; SELECTION; PIGMENTS; SCULPIN; HEALTH; WILD	The unusual blue color polymorphism of lingcod (Ophiodon elongatus) is the subject of much speculation but little empirical research; similar to 20% of lingcod individuals exhibit this striking blue color morph, which is discrete from and found within the same populations as the more common brown morph. In other species, color polymorphisms are intimately linked with host-parasite interactions, which led us to ask whether blue coloration in lingcod might be associated with parasitism, either as cause or effect. To test how color and parasitism are related in this host species, we performed parasitological dissection of 89 lingcod individuals collected across more than 26 degrees of latitude from Alaska, Washington, and California, USA. We found that male lingcod carried 1.89 times more parasites if they were blue than if they were brown, whereas there was no difference in parasite burden between blue and brown female lingcod. Blue individuals of both sexes had lower hepatosomatic index (i.e., relative liver weight) values than did brown individuals, indicating that blueness is associated with poor body condition. The immune systems of male vertebrates are typically less effective than those of females, due to the immunocompromising properties of male sex hormones; this might explain why blueness is associated with elevated parasite burdens in males but not in females. What remains to be determined is whether parasites induce physiological damage that produces blueness or if both blue coloration and parasite burden are driven by some unmeasured variable, such as starvation. Although our study cannot discriminate between these possibilities, our data suggest that the immune system could be involved in the blue color polymorphism-an exciting jumping-off point for future research to definitively identify the cause of lingcod blueness and a hint that immunocompetence and parasitism may play a role in lingcod population dynamics.	[Wood, Chelsea L.; Leslie, Katie L.; Greene, Alanna] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Greene, Alanna] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA; [Lam, Laurel S.] NOAA, Pacific States Marine Fisheries Commiss, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Basnett, Bonnie; Hamilton, Scott L.] San Jose State Univ, Moss Landing Marine Labs, Moss Landing, CA USA; [Samhouri, Jameal F.] NOAA, Conservat Biol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; California State University System; San Jose State University; Moss Landing Marine Laboratories; National Oceanic Atmospheric Admin (NOAA) - USA	Wood, CL (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	chelwood@uw.edu		Basnett, Bonnie/0000-0001-9019-7270; Wood, Chelsea/0000-0003-2738-3139	NOAA NMFS Habitat Assessment Improvement Plan (HAIP) [NA15-NMF4550353]; National Science Foundation [OCE-1829509]; Sloan Research Fellowship from the Alfred P. Sloan Foundation; UW Innovation Award; UW Royalty Research Fund	NOAA NMFS Habitat Assessment Improvement Plan (HAIP); National Science Foundation(National Science Foundation (NSF)); Sloan Research Fellowship from the Alfred P. Sloan Foundation; UW Innovation Award; UW Royalty Research Fund	Funding for lingcod collections was provided by NOAA NMFS Habitat Assessment Improvement Plan (HAIP; #NA15-NMF4550353; https://www.st.nmfs.noaa.gov/Assets/science_ program/ecosystem-program-review/Habitat/HAIP_ES.pdf) to JFS and SLH. CLW was supported by a grant from the National Science Foundation (OCE-1829509; https://www.nsf.gov/geo/oce/programs/biores.jsp), a Sloan Research Fellowship from the Alfred P. Sloan Foundation (https://sloan.org/fellowships/), a UW Innovation Award (https://www.washington.edu/research/resources/fundingopportunities/the-university-of-washington-innovation-awards/), and the UW Royalty Research Fund (https://www.washington.edu/research/or/royalty-research-fund-rrf/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZPELLITERO P, 1993, J FISH BIOL, V42, P889, DOI 10.1111/j.1095-8649.1993.tb00398.x; Andrews KS, 2018, CONSERV GENET, V19, P865, DOI 10.1007/s10592-018-1060-0; Armitage SAO, 2005, HEREDITY, V94, P650, DOI 10.1038/sj.hdy.6800675; BADA JL, 1970, EXPERIENTIA, V26, P251, DOI 10.1007/BF01900075; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BOLGER T, 1989, J FISH BIOL, V34, P171, DOI 10.1111/j.1095-8649.1989.tb03300.x; Brunner FS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0128; Coop RL, 1999, VET PARASITOL, V84, P187, DOI 10.1016/S0304-4017(99)00070-9; Cornet S, 2014, J ANIM ECOL, V83, P256, DOI 10.1111/1365-2656.12113; Cote J, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0285; Ezenwa VO, 2004, INT J PARASITOL, V34, P535, DOI 10.1016/j.ijpara.2003.11.012; FANG LS, 1987, COMP BIOCHEM PHYS B, V88, P667; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Foo YZ, 2017, BIOL REV, V92, P551, DOI 10.1111/brv.12243; Galeotti P, 2003, J ZOOL, V261, P91, DOI 10.1017/S0952836903003960; Galloway AWE, 2021, MAR BIOL, V168, DOI 10.1007/s00227-021-03936-6; Gangoso L, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0839; Getty T, 2002, AM NAT, V159, P363, DOI 10.1086/338992; Hair F., 1995, MULTIVARIATE DATA AN, V4th; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hamilton WJ, 1997, BEHAVIOUR, V134, P299, DOI 10.1163/156853997X00485; Huntington B.E., 2014, OREGON MARINE RESERV; KETTLEWELL H. B. D., 1955, HEREDITY, V9, P323, DOI 10.1038/hdy.1955.36; King JR, 2005, MOL ECOL, V14, P653, DOI 10.1111/j.1365-294X.2005.02438.x; Love M.S., 2011, CERTAINLY MORE YOU W; LOW PS, 1974, COMP BIOCHEM PHYSIOL, V47, P411, DOI 10.1016/0300-9629(74)90003-6; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; LUDECKE D, 2018, J OPEN SOURCE SOFTW, V3, P772, DOI [DOI 10.21105/JOSS.00772, 10.21105/joss.00772]; Majerus Michael E.N., 2009, Evolution Education and Outreach, V2, P63, DOI 10.1007/s12052-008-0107-y; Manniste M, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00004; Mikkola K, 2010, BIOL J LINN SOC, V99, P831, DOI 10.1111/j.1095-8312.2010.01398.x; Miller D.J., 1973, FISH B-NOAA, V158; Oksanen J., 2022, R PACKAGE VERSION; Ponton F, 2013, J INSECT PHYSIOL, V59, P130, DOI 10.1016/j.jinsphys.2012.10.011; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Retschnig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085261; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Rust M.B., 2003, FISH NUTR, P367; Sugimoto M, 2002, MICROSC RES TECHNIQ, V58, P496, DOI 10.1002/jemt.10168; Venesky MD, 2015, J ZOOL, V295, P279, DOI 10.1111/jzo.12208; Wendt DE, 2009, MAR COAST FISH, V1, P315, DOI 10.1577/C08-054.1; WILLEY CH, 1957, J PARASITOL, V43, P324, DOI 10.2307/3274359; Wood CL, 2014, ECOLOGY, V95, P1929, DOI 10.1890/13-1270.1; YAMAGUCHI K, 1976, COMP BIOCHEM PHYS B, V55, P85, DOI 10.1016/0305-0491(76)90177-2; Zuk M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000267	46	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261202	10.1371/journal.pone.0261202	http://dx.doi.org/10.1371/journal.pone.0261202			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972116	gold, Green Published			2022-12-27	WOS:000773555700026
J	Otaki, Y; Fujishiro, N; Oyama, Y; Hata, N; Kato, D; Kawachi, S				Otaki, Yasuhiro; Fujishiro, Naofumi; Oyama, Yasuaki; Hata, Naoko; Kato, Daisuke; Kawachi, Shoji			The risk of fatal bleeding complications in jugular catheterization in patients with coagulopathy: A retrospective analysis of death cases in closed claims and the Medical Accident Investigating System in Japan	PLOS ONE			English	Article							MALPRACTICE CLAIMS; GUIDELINES; MANAGEMENT; ARTHRITIS; ERRORS	Background To prevent recurrence of medical accidents, the Medical Accident Investigating System was implemented in October 2015 by the Japan Medical Safety Research Organization (Medsafe Japan) to target deaths from medical care that were unforeseen by the administrator. Medsafe Japan analyzed the 10 cases of central venous catheterization-related deaths reported in the system and published recommendations in March 2017. However, the particular emphasis for the prevention of central venous catheterization-related deaths is unclear. Methods This study aimed to identify the recommendation points that should be emphasized to prevent recurrence of central venous catheterization-related deaths. We assessed central venous catheterization in 8530 closed-claim cases between January 2002 and December 2016 covered by the medical insurer Sompo-Japan. Moreover, we compared central venous catheterization-related death in closed-claim cases with death in reported cases. Results The background, error type, anatomic insertion site, and fatal complication data were evaluated for 37 closed-claim cases, of which 12 (32.4%) were death cases. Of the 12 closed-claim cases and 10 reported cases, 9 (75.0%) closed-claim cases and 9 (90.0%) reported cases were related to vascular access. Among these, 5 closed-claim cases (41.7%) and 7 reported cases (77.8%) were related to internal jugular vein catheterization (p = 0.28). Coagulopathy was observed in 3 (60.0%) of 5 closed-claim cases and 6 (85.7%) of 7 reported cases. Conclusions The risk of internal jugular catheterization in patients with coagulopathy must be carefully considered.	[Otaki, Yasuhiro; Fujishiro, Naofumi; Hata, Naoko; Kato, Daisuke; Kawachi, Shoji] Teikyo Univ, Gen Med Educ & Res Ctr, Tokyo, Japan; [Otaki, Yasuhiro; Kawachi, Shoji] Teikyo Univ Hosp, Safety Control Dept, Tokyo, Japan; [Oyama, Yasuaki] Sompo Japan Insurance Inc, Specialty Claims Dept, Tokyo, Japan	Teikyo University; Teikyo University	Otaki, Y (corresponding author), Teikyo Univ, Gen Med Educ & Res Ctr, Tokyo, Japan.; Otaki, Y (corresponding author), Teikyo Univ Hosp, Safety Control Dept, Tokyo, Japan.	y-otaki@med.teikyo-u.ac.jp		Otaki, Yasuhiro/0000-0002-8617-1120; Fujishiro, Naofumi/0000-0001-6573-9613	Japan Society for the Promotion of Science (JSPS) KAKENHI [18KT0099, 19K10542]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	YO received the funding for this work from the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant number 18KT0099 and 19K10542, available from https://nrid.nii.ac.jp/ja/nrid/1000060464004/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Soc Anesthesiologists, 2012, ANESTHESIOLOGY, V116, P539, DOI 10.1097/ALN.0b013e31823c9569; Ares G, 2017, CURR OPIN PEDIATR, V29, P340, DOI 10.1097/MOP.0000000000000485; Domino KB, 2004, ANESTHESIOLOGY, V100, P1411, DOI 10.1097/00000542-200406000-00013; Frykholm P, 2014, ACTA ANAESTH SCAND, V58, P508, DOI 10.1111/aas.12295; Ibeas Jose, 2017, Nefrologia, V37 Suppl 1, P1, DOI 10.1016/j.nefro.2017.11.004; Jaffray J, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00005; Japan Medical Safety Research Organization, RES QUEST REC CVC IN; Japan Medical Safety Research Organization, SEC MED SAF MED ACC; Joffe AM, 2019, ANESTHESIOLOGY, V131, P818, DOI 10.1097/ALN.0000000000002815; Lamperti M, 2012, INTENS CARE MED, V38, P1105, DOI 10.1007/s00134-012-2597-x; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Medical Accident Investigation and Support Center Japan Medical Safety Research Organization, 2017, AN DEATHS REL COMPL; Miki Tamotsu, 2011, Masui, V60 Suppl, pS25; Ministry of Health Labor and Welfare, MED ACC INV SYST; Mirski MA, 2007, ANESTHESIOLOGY, V106, P164, DOI 10.1097/00000542-200701000-00026; Morley M, 2020, OPHTHALMOLOGY, V127, P852, DOI 10.1016/j.ophtha.2019.12.019; Nishiwaki K, 2020, J ANESTH, V34, P167, DOI 10.1007/s00540-019-02702-9; Norris LB, 2017, INT J ANTIMICROB AG, V50, P308, DOI 10.1016/j.ijantimicag.2017.06.013; Otaki Y, 2018, J CHIN MED ASSOC, V81, P236, DOI 10.1016/j.jcma.2017.06.023; Otaki Y, 2017, CHINESE MED J-PEKING, V130, P1454, DOI 10.4103/0366-6999.207479; Parienti JJ, 2015, NEW ENGL J MED, V373, P1220, DOI 10.1056/NEJMoa1500964; Schummer W, 2014, BRIT J ANAESTH, V113, P122, DOI 10.1093/bja/aeu049; Singh H, 2007, ARCH INTERN MED, V167, P2030, DOI 10.1001/archinte.167.19.2030; Stephens R, 2001, BRIT J ANAESTH, V87, P306, DOI 10.1093/bja/87.2.306; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Troianos CA, 2012, ANESTH ANALG, V114, P46, DOI 10.1213/ANE.0b013e3182407cd8; Vincent C, 2006, J EVAL CLIN PRACT, V12, P665, DOI 10.1111/j.1365-2753.2006.00634.x; Zengerink I, 2016, J ARTHROPLASTY, V31, P1890, DOI 10.1016/j.arth.2016.02.055	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261636	10.1371/journal.pone.0261636	http://dx.doi.org/10.1371/journal.pone.0261636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025900	Green Published, gold			2022-12-27	WOS:000796264200022
J	Shahdadi, A; von Wyschetzki, K; Liu, HC; Chu, KH; Schubart, CD				Shahdadi, Adnan; von Wyschetzki, Katharina; Liu, Hung-Chang; Chu, Ka Hou; Schubart, Christoph D.			Molecular phylogeography reveals multiple Pleistocene divergence events in estuarine crabs from the tropical West Pacific	PLOS ONE			English	Article							INDO-PACIFIC; MANGROVE CRAB; GENETIC DIFFERENTIATION; BIODIVERSITY HOTSPOTS; BRACHYURA SESARMIDAE; POPULATION-GROWTH; EAST-ASIA; DIVERSITY; SPECIATION; CONSERVATION	Due to the lack of visible barriers to gene flow, it was a long-standing assumption that marine coastal species are widely distributed, until molecular studies revealed geographically structured intraspecific genetic differentiation in many taxa. Historical events of sea level changes during glacial periods are known to have triggered sequential disjunctions and genetic divergences among populations, especially of coastal organisms. The Parasesarma bidens species complex so far includes three named plus potentially cryptic species of estuarine brachyuran crabs, distributed along East to Southeast Asia. The aim of the present study is to address phylogeography and uncover real and hidden biological diversity within this complex, by revealing the underlying genetic structure of populations and species throughout their distribution ranges from Japan to West Papua, with a comparison of mitochondrial COX1 and 16S rRNA gene sequences. Our results reveal that the P. bidens species complex consists of at least five distinct clades, resulting from four main cladogenesis events during the mid to late Pleistocene. Among those clades, P. cricotum and P. sanguimanus are recovered as monophyletic taxa. Geographically restricted endemic clades are encountered in southeastern Indonesia, Japan and China respectively, whereas the Philippines and Taiwan share two clades. As individuals of the Japanese clade can also be found in Taiwan, we provide evidence of a third lineage and the occurrence of a potential cryptic species on this island. Ocean level retreats during Pleistocene ice ages and present oceanic currents appear to be the main triggers for the divergences of the five clades that are here addressed as the P. bidens complex. Secondary range expansions converted Taiwan into the point of maximal overlap, sharing populations with Japan and the Philippines, but not with mainland China.	[Shahdadi, Adnan; Schubart, Christoph D.] Univ Hormozgan, Fac Marine Sci & Technol, Dept Marine Biol, Bandar Abbas, Iran; [von Wyschetzki, Katharina] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge, England; [Liu, Hung-Chang] Land Crab Ecol Res Lab, Jhubei City, Hsinchu County, Taiwan; [Chu, Ka Hou] Chinese Univ Hong Kong, Sch Life Sci, Simon FS Marine Sci Lab, Shatin, Hong Kong, Peoples R China; [Chu, Ka Hou] Hong Kong Univ Sci & Technol, Hong Kong Branch Southern Marine Sci & Technol, Guangdong Lab Guangzhou, Clear Water Bay, Hong Kong, Peoples R China; [Schubart, Christoph D.] Univ Regensburg, Zool & Evolut, Regensburg, Germany	University of Hormozgan; Wellcome Trust Sanger Institute; Chinese University of Hong Kong; Hong Kong University of Science & Technology; University of Regensburg	Schubart, CD (corresponding author), Univ Regensburg, Zool & Evolut, Regensburg, Germany.	Christoph.Schubart@biologie.uni-regensburg.de	Chu, Ka Hou/B-8010-2011	Chu, Ka Hou/0000-0001-8107-5415; Shahdadi, Adnan/0000-0001-5131-7700	Germany/Hong Kong Joint Research Scheme of the German Academic Exchange Service (DAAD); Research Grants Council (RGC), Hong Kong [50022239/G_HK008/08, 54385238/G-H022/11]; German Academic Exchange Service (DAAD); Research Grants Council (RGC); University of Regensburg, Dept. Zoology Evolution; Hong Kong Research Institute of Textiles and Apparel [HK008/08]	Germany/Hong Kong Joint Research Scheme of the German Academic Exchange Service (DAAD); Research Grants Council (RGC), Hong Kong(Hong Kong Research Grants Council); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Research Grants Council (RGC)(Hong Kong Research Grants Council); University of Regensburg, Dept. Zoology Evolution; Hong Kong Research Institute of Textiles and Apparel	Two travel grants under the Germany/Hong Kong Joint Research Scheme of the German Academic Exchange Service (DAAD) and Research Grants Council (RGC), Hong Kong in 2009-2010 (ID 50022239/G_HK008/08) and in 2012-2013 (ID 54385238/G-H022/11). The travel grants [German Academic Exchange Service (DAAD) and Research Grants Council (RGC)] were solely used to support travel expenses between universities and collection sites. Laboratory expenses were supported by departmental funds of: -University of Regensburg, Dept. Zoology & Evolution, chair: Prof. Ju<spacing diaeresis>rgen Heinze -Hong Kong Research Institute of Textiles and Apparel (HK), HK008/08, chair: Prof. Ka Hou Chu. From those funding organizations, only Prof. KH Chu had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PH, 2006, EVOLUTION, V60, P1825; Barber PH, 2005, MOL PHYLOGENET EVOL, V35, P235, DOI 10.1016/j.ympev.2004.10.004; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Beck SV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179557; Benzie J. A. H., 1998, P197; Benzie JAH, 2002, MOL ECOL, V11, P2553, DOI 10.1046/j.1365-294X.2002.01638.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Borsa P, 2016, ACTA OECOL, V72, P72, DOI 10.1016/j.actao.2015.10.009; Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650; Bowen BW, 2016, P NATL ACAD SCI USA, V113, P7962, DOI 10.1073/pnas.1602404113; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Briggs JC, 2005, J BIOGEOGR, V32, P1517, DOI 10.1111/j.1365-2699.2005.01266.x; Briggs JC, 2000, J BIOGEOGR, V27, P1183, DOI 10.1046/j.1365-2699.2000.00459.x; Carlberg C., 2014, STAT ANAL MICROSOFT; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Carpenter KE., 2011, J MAR BIOL, P2011; Chan BKK, 2007, ZOOL SCR, V36, P79, DOI 10.1111/j.1463-6409.2007.00260.x; Chang YW, 2017, MAR ECOL-EVOL PERSP, V38, DOI 10.1111/maec.12422; Cheang CC, 2008, J PHYCOL, V44, P855, DOI 10.1111/j.1529-8817.2008.00532.x; Chen W, 2015, ENVIRON BIOL FISH, V98, P845, DOI 10.1007/s10641-014-0320-1; Cheng J, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1477-1; Copilas-Ciocianu D, 2015, MOL ECOL, V24, P3980, DOI 10.1111/mec.13286; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dai A., 1991, P1; Davie Peter J. F., 1994, Memoirs of the Queensland Museum, V36, P55; Dawson MN, 2011, J BIOGEOGR, V38, P1600, DOI 10.1111/j.1365-2699.2011.02499.x; De Grave S, 2009, RAFFLES B ZOOL, P1; Dong YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036178; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Guerao G, 2004, J PLANKTON RES, V26, P1389, DOI 10.1093/plankt/fbh127; Guo X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129715; Haan HMD., FAUNA JAPONICA SIVE; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hongjamrassilp W., 2020, ZOOL STUD, P59; Horne JB, 2008, MOL PHYLOGENET EVOL, V49, P629, DOI 10.1016/j.ympev.2008.08.023; Kim So Yeon, 2020, Animal Systematics Evolution and Diversity, V36, P159, DOI 10.5635/ASED.2020.36.2.056; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Kojima S, 2004, MAR ECOL PROG SER, V276, P161, DOI 10.3354/meps276161; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kwok P-W, 1995, ECOLOGY 2 SESARMINE; Lai JCY, 2010, RAFFLES B ZOOL, V58, P199; Laurenzano C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166518; Lee SY, 1998, MAR FRESHWATER RES, V49, P335, DOI 10.1071/MF97179; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Li JJ, 2019, ZOOL STUD, V58, DOI 10.6620/ZS.2019.58-40; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ma KY, 2018, J BIOGEOGR, V45, P2658, DOI 10.1111/jbi.13443; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; Ng Peter K.L., 2017, Journal of the National Taiwan Museum, V70, P1; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Poettinger T, 2014, HYDROBIOLOGIA, V739, P73, DOI 10.1007/s10750-013-1643-1; PORTER SC, 1989, QUATERNARY RES, V32, P245, DOI 10.1016/0033-5894(89)90092-6; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Puckridge M, 2013, ECOL EVOL, V3, P217, DOI 10.1002/ece3.448; Ragionieri L, 2012, RAFFLES B ZOOL, V60, P71; Ragionieri L, 2009, MOL PHYLOGENET EVOL, V52, P825, DOI 10.1016/j.ympev.2009.04.008; Rahayu DL, 2002, CRUSTACEANA, V75, P597, DOI 10.1163/156854002760095624; RICHMOND GM, 1986, QUATERNARY SCI REV, V5, P183; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rocha LA, 2003, J BIOGEOGR, V30, P1161, DOI 10.1046/j.1365-2699.2003.00900.x; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Schubart CD, 1998, NATURE, V393, P363, DOI 10.1038/30724; Shahdadi A, 2021, INVERTEBR SYST, V35, P542, DOI 10.1071/IS20046; Shahdadi A, 2020, ZOOL J LINN SOC-LOND, V190, P1123, DOI 10.1093/zoolinnean/zlaa025; Shahdadi A, 2020, ZOOTAXA, V4803, P397, DOI 10.11646/zootaxa.4803.2.12; Shahdadi A, 2018, ZOOL J LINN SOC-LOND, V182, P517, DOI 10.1093/zoolinnean/zlx032; Shahdadi A, 2018, INVERTEBR SYST, V32, P196, DOI 10.1071/IS17040; Shandadi A, 2020, CRUSTACEANA, V93, P793, DOI 10.1163/15685403-bja10039; Shih HT, 2019, ZOOKEYS, P1, DOI 10.3897/zookeys.877.38300; Shih HT, 2009, HYDROBIOLOGIA, V635, P373, DOI 10.1007/s10750-009-9930-6; Shin J, 2019, GENES GENOM, V41, P1127, DOI 10.1007/s13258-019-00831-9; Shokita S., 2000, BANGLADESH J FISHERI, V4, P43; Silva IC, 2010, BIOL J LINN SOC, V99, P28, DOI 10.1111/j.1095-8312.2009.01338.x; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; SPRINGER VG, 1990, B MAR SCI, V47, P631; TAN CGS, 1994, HYDROBIOLOGIA, V285, P75, DOI 10.1007/BF00005655; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thurman CL, 2021, ZOOL STUD, V60, DOI 10.6620/ZS.2021.60-19; Tsang LM, 2008, MAR ECOL PROG SER, V364, P107, DOI 10.3354/meps07476; Tsang LM, 2008, MOL ECOL, V17, P4151, DOI 10.1111/j.1365-294X.2008.03907.x; Tsang LM, 2013, MAR ECOL PROG SER, V488, P187, DOI 10.3354/meps10385; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wafar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014613; Wang J, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0387-0; Wong KJH, 2010, ZOOTAXA, P43; Woodruff DS, 2010, BIODIVERS CONSERV, V19, P919, DOI 10.1007/s10531-010-9783-3; Wu TH, 2015, MAR ECOL-EVOL PERSP, V36, P368, DOI 10.1111/maec.12146; Xu JW, 2009, MOL PHYLOGENET EVOL, V52, P45, DOI 10.1016/j.ympev.2009.02.007; Xu SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01742-z; Yednock BK, 2011, CRUSTACEAN ISS, V19, P57; Zhou HL, 2016, MITOCHONDRIAL DNA A, V27, P3255, DOI 10.3109/19401736.2015.1015002	101	1	1	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262122	10.1371/journal.pone.0262122	http://dx.doi.org/10.1371/journal.pone.0262122			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025933	Green Published, gold			2022-12-27	WOS:000796264200046
J	Thompson, JLM; West, DWD; Doering, TM; Budiono, BP; Lessard, SJ; Koch, LG; Britton, SL; Byrne, NM; Brown, MA; Ashton, KJ; Coffey, VG				Thompson, Jamie-Lee M.; West, Daniel W. D.; Doering, Thomas M.; Budiono, Boris P.; Lessard, Sarah J.; Koch, Lauren G.; Britton, Steven L.; Byrne, Nuala M.; Brown, Matthew A.; Ashton, Kevin J.; Coffey, Vernon G.			Effect of short-term hindlimb immobilization on skeletal muscle atrophy and the transcriptome in a low compared with high responder to endurance training model	PLOS ONE			English	Article							REGULATORY T-CELLS; TIME-COURSE; EXERCISE; RESISTANCE; DISUSE; ADAPTATIONS; EXPRESSION; RECOVERY; REPAIR	Skeletal muscle atrophy is a physiological response to disuse, aging, and disease. We compared changes in muscle mass and the transcriptome profile after short-term immobilization in a divergent model of high and low responders to endurance training to identify biological processes associated with the early atrophy response. Female rats selectively bred for high response to endurance training (HRT) and low response to endurance training (LRT; n = 6/group; generation 19) underwent 3 day hindlimb cast immobilization to compare atrophy of plantaris and soleus muscles with line-matched controls (n = 6/group). RNA sequencing was utilized to identify Gene Ontology Biological Processes with differential gene set enrichment. Aerobic training performed prior to the intervention showed HRT improved running distance (+60.6 +/- 29.6%), while LRT were unchanged (-0.3 +/- 13.3%). Soleus atrophy was greater in LRT vs. HRT (-9.0 +/- 8.8 vs. 6.2 +/- 8.2%; P<0.05) and there was a similar trend in plantaris (-16.4 +/- 5.6% vs. -8.5 +/- 7.4%; P = 0.064). A total of 140 and 118 biological processes were differentially enriched in plantaris and soleus muscles, respectively. Soleus muscle exhibited divergent LRT and HRT responses in processes including autophagy and immune response. In plantaris, processes associated with protein ubiquitination, as well as the atrogenes (Trim63 and Fbxo32), were more positively enriched in LRT. Overall, LRT demonstrate exacerbated atrophy compared to HRT, associated with differential gene enrichments of biological processes. This indicates that genetic factors that result in divergent adaptations to endurance exercise, may also regulate biological processes associated with short-term muscle unloading.	[Thompson, Jamie-Lee M.; Doering, Thomas M.; Ashton, Kevin J.; Coffey, Vernon G.] Bond Univ, Fac Hlth Sci & Med, Robina, Australia; [West, Daniel W. D.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [West, Daniel W. D.] Toronto Rehabil Inst, Toronto, ON, Canada; [West, Daniel W. D.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Doering, Thomas M.] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia; [Budiono, Boris P.] Charles Sturt Univ, Sch Community Hlth, Bathurst, NSW, Australia; [Lessard, Sarah J.] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Lessard, Sarah J.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Lessard, Sarah J.] Harvard Med Sch, Boston, MA 02115 USA; [Koch, Lauren G.] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Britton, Steven L.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Byrne, Nuala M.] Univ Tasmania, Sch Hlth Sci, Hobart, Tas, Australia; [Brown, Matthew A.] Kings Coll London, Natl Inst Hlth Res, Guys & St Thomas Biomed Res Ctr, London, England	Bond University; University of California System; University of California Davis; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; Central Queensland University; Charles Sturt University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University System of Ohio; University of Toledo; University of Michigan System; University of Michigan; University of Tasmania; University of London; King's College London	Coffey, VG (corresponding author), Bond Univ, Fac Hlth Sci & Med, Robina, Australia.	vcoffey@bond.edu.au	Doering, Thomas/GXZ-8161-2022; Ashton, Kevin/R-2147-2016	Ashton, Kevin/0000-0001-6106-3425; Thompson, Jamie-Lee/0000-0003-3015-0854; Doering, Thomas Michael/0000-0002-6427-1067	Collaborative Research Network for Advancing Exercise and Sport Science - Department of Education and Training, Australia [CRN-AESS -201202]; Institute of Biomedical Innovation Collaborative Research Development scheme by Queensland University of Technology, Australia; National Institutes of Health [P40ODO21331]	Collaborative Research Network for Advancing Exercise and Sport Science - Department of Education and Training, Australia; Institute of Biomedical Innovation Collaborative Research Development scheme by Queensland University of Technology, Australia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the Collaborative Research Network for Advancing Exercise and Sport Science (CRN-AESS -201202) scheme awarded by the Department of Education and Training, Australia, and the Institute of Biomedical Innovation Collaborative Research Development scheme by Queensland University of Technology, Australia. The LRT-HRT rat model is funded by the Office of Infrastructure Programs grant P40ODO21331 (to L.G.K and S.L.B) from the National Institutes of Health. These rat models for low and high exercise response to training are maintained as an international resource with support from the Department of Physiology & Pharmacology, The University of Toledo College of Medicine, Toledo, OH. Contact L.G.K(Lauren.Koch2@UToledo.edu) or S.L.B (brittons@umich.edu) for information on the rat models. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006518; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Baehr LM, 2017, J APPL PHYSIOL, V122, P1336, DOI 10.1152/japplphysiol.00703.2016; Baehr LM, 2016, AGING-US, V8, P127, DOI 10.18632/aging.100879; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brocca L, 2012, J PHYSIOL-LONDON, V590, P5211, DOI 10.1113/jphysiol.2012.240267; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Camera DM, 2010, MED SCI SPORT EXER, V42, P1843, DOI 10.1249/MSS.0b013e3181d964e4; Chun Y, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120278; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Conesa A., MASIGPRO SIGNIFICANT; Edwards SJ, 2020, AM J CLIN NUTR, V112, P1368, DOI 10.1093/ajcn/nqaa229; Figueiredo VC, 2021, J CACHEXIA SARCOPENI, V12, P130, DOI 10.1002/jcsm.12636; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Howard EE, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00087; Kelleher AR, 2015, AM J PHYSIOL-ENDOC M, V308, pE122, DOI 10.1152/ajpendo.00341.2014; Koch LG, 2013, PHYSIOL GENOMICS, V45, P606, DOI 10.1152/physiolgenomics.00021.2013; Krawiec BJ, 2005, AM J PHYSIOL-ENDOC M, V289, pE969, DOI 10.1152/ajpendo.00126.2005; Kucera Mike, 2016, F1000Res, V5, P1717; Kuo IY, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a006023; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Lawrence MM, 2020, ACTA PHYSIOL, V229, DOI 10.1111/apha.13460; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lessard SJ, 2013, DIABETES, V62, P2717, DOI 10.2337/db13-0062; Li JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00585; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Neubauer O, 2014, J APPL PHYSIOL, V116, P274, DOI 10.1152/japplphysiol.00909.2013; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Phillips BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003389; Phillips SM, 2014, J PHYSIOL-LONDON, V592, P5341, DOI 10.1113/jphysiol.2014.273615; Reid MB, 2014, J PHYSIOL-LONDON, V592, P5345, DOI 10.1113/jphysiol.2014.279406; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rudrappa SS, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00361; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schiaffino S, 2017, FEBS J, V284, P517, DOI 10.1111/febs.13827; Stokes T, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107980; Taillandier D, 2019, BIOCHIMIE, V166, P251, DOI 10.1016/j.biochi.2019.07.014; Timmons JA, 2011, J APPL PHYSIOL, V110, P846, DOI 10.1152/japplphysiol.00934.2010; Vellers HL, 2018, MAMM GENOME, V29, P48, DOI 10.1007/s00335-017-9732-5; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; West DWD, 2021, EXP PHYSIOL, V106, P714, DOI 10.1113/EP089301; West DWD, 2016, J PHYSIOL-LONDON, V594, P453, DOI 10.1113/JP271365; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	46	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261723	10.1371/journal.pone.0261723	http://dx.doi.org/10.1371/journal.pone.0261723			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025912	Green Accepted, gold, Green Published			2022-12-27	WOS:000796264200024
J	Zhu, D; Wei, YY; Huang, HN; Xie, T				Zhu, Dan; Wei, Yaoyao; Huang, Hainan; Xie, Tian			Parallel simulation and optimization framework of supplies production processes for unconventional emergencies	PLOS ONE			English	Article							DECISION; MODEL	The outbreak of unconventional emergencies leads to a surge in demand for emergency supplies. How to effectively arrange emergency production processes and improve production efficiency is significant. The emergency manufacturing systems are typically complex systems, which are difficult to be analyzed by using physical experiments. Based on the theory of Random Service System (RSS) and Parallel Emergency Management System (PeMS), a parallel simulation and optimization framework of production processes for surging demand of emergency supplies is constructed. Under this novel framework, an artificial system model paralleling with the real scenarios is established and optimized by the parallel implementation processes. Furthermore, a concrete example of mask shortage, which occurred at Huoshenshan Hospital in the COVID-19 pandemic, verifies the feasibility of this method.	[Zhu, Dan; Wei, Yaoyao; Huang, Hainan; Xie, Tian] Univ South China, Sch Econ, Management & Law, Hengyang, Hunan, Peoples R China; [Zhu, Dan] Nanjing Normal Univ, Sch Publ Adm, Nanjing, Jiangsu, Peoples R China; [Wei, Yaoyao] Cent China Normal Univ, Sch Educ, Wuhan, Hubei, Peoples R China	University of South China; Nanjing Normal University; Central China Normal University	Wei, YY (corresponding author), Univ South China, Sch Econ, Management & Law, Hengyang, Hunan, Peoples R China.; Wei, YY (corresponding author), Cent China Normal Univ, Sch Educ, Wuhan, Hubei, Peoples R China.	24359048@qq.com		zhu, dan/0000-0003-3195-6614	Philosophy and Social Science Foundation Youth Project of Hunan Province of China [19YBQ093]; Scientific research project of Education Department [20C1625]; Special Funds for Student Innovation and Entrepreneurship Training Program [S202010555083]; Natural Science Foundation of Hunan Province of China [2018JJ2336]; Philosophy and Social Science Foundation of Hunan Province of China [18YBQ105]; Youth talents support program of Hunan Province of China [2018HXQ03]; Key scientific research project of Education Department [20A443]; Social Science Key Breeding Project of USC [2018XZX16]; Doctoral scientific research foundation of USC [2013XQD27]	Philosophy and Social Science Foundation Youth Project of Hunan Province of China; Scientific research project of Education Department; Special Funds for Student Innovation and Entrepreneurship Training Program; Natural Science Foundation of Hunan Province of China(Natural Science Foundation of Hunan Province); Philosophy and Social Science Foundation of Hunan Province of China; Youth talents support program of Hunan Province of China; Key scientific research project of Education Department; Social Science Key Breeding Project of USC; Doctoral scientific research foundation of USC	This paper is supported by Philosophy and Social Science Foundation Youth Project of Hunan Province of China (http://113.246.250.84:8080/, 19YBQ093), Scientific research project of Education Department (http://www.cutech.edu.cn/, No. 20C1625), the Special Funds for Student Innovation and Entrepreneurship Training Program (http://gjcxcy.bjtu.edu.cn/, S202010555083), Natural Science Foundation of Hunan Province of China (http://kjt.hunan.gov.cn/zxgz/zkjj/, No. 2018JJ2336), Philosophy and Social Science Foundation of Hunan Province of China (http://113.246.250.84:8080/, 18YBQ105), Youth talents support program of Hunan Province of China (http://www.hunan.gov.cn/, 2018HXQ03), Key scientific research project of Education Department (http://www.cutech.edu.cn/, No. 20A443), Social Science Key Breeding Project of USC (https://jgxy.usc.edu.cn/, 2018XZX16), Doctoral scientific research foundation of USC (https://www.usc.edu.cn/, No. 2013XQD27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedrabboh K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246110; Adan I., 2002, QUEUEING THEORY; [Anonymous], 2020, UN LAUNCH COVID 19 P; Bhaskar V., 2009, APPL MATH MODEL, V34; Cao CJ, 2021, INT J PROD ECON, V235, DOI 10.1016/j.ijpe.2021.108081; Cao CJ, 2018, J CLEAN PROD, V174, P1422, DOI 10.1016/j.jclepro.2017.11.037; [邓守城 Deng Shoucheng], 2014, [中国安全科学学报, China Safety Science Journal（CSSJ）], V24, P79; Greer AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067253; Hong YX, 2019, J ENVIRON PSYCHOL, V63, P82, DOI 10.1016/j.jenvp.2019.04.005; [胡晓伟 Hu Xiaowei], 2020, [中国公路学报, China Journal of Highway and Transport], V33, P55; Huang HN, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084245; Jin RD, 2021, IEEE ACCESS, V9, P9903, DOI 10.1109/ACCESS.2021.3050607; Lee HR, 2018, FLEX SERV MANUF J, V30, P98, DOI 10.1007/s10696-017-9276-8; Leonard K., 1975, QUEUEING SYST, V1; National Health Commission of the Peoples Republic of China, 2020, NEWS; Qiu Xiaogang, 2014, Journal of System Simulation, V26, P2239; [唐伟勤 TANG Wei-qin], 2009, [中国安全科学学报, China Safety Science Journal], V19, P33; Wang F.-Y., 2004, COMPLEX SYST COMPLEX, V1, P25; Wang Fei-yue, 2004, Control and Decision, V19, P485; [王飞跃 Wang Feiyue], 2012, [复杂系统与复杂性科学, Complex Systems and Complexity Science], V9, P1; Wang FY., 2007, CHINA EMERGENCY MANA, P22; Xie T, 2020, EUR J OPER RES, V287, P1131, DOI 10.1016/j.ejor.2020.05.025; Xie T, 2019, DISASTER MED PUBLIC, V13, P1017, DOI 10.1017/dmp.2019.30; Xie T, 2016, SAFETY SCI, V85, P99, DOI 10.1016/j.ssci.2016.01.005; Xintaiming Intelligent Equipment Co, N95 MASK PROD MACH E; Zeng B., 2015, CHINESE J MANAGEMENT, V23, P84; Zhang JM., 2021, REFRIGERATION AIR CO, V21, P18; Zhang YX., 2012, CHINESE J SYSTEMS SC, V20, P75; Zhang Zi-li, 2009, Computer Integrated Manufacturing Systems, V15, P1349; Zhu L., 2017, SYSTEMS ENG, V35, P105	30	0	0	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261771	10.1371/journal.pone.0261771	http://dx.doi.org/10.1371/journal.pone.0261771			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025918	gold, Green Published			2022-12-27	WOS:000796264200028
J	Turban, JL; King, D; Kobe, J; Reisner, SL; Keuroghlian, AS				Turban, Jack L.; King, Dana; Kobe, Julia; Reisner, Sari L.; Keuroghlian, Alex S.			Access to gender-affirming hormones during adolescence and mental health outcomes among transgender adults	PLOS ONE			English	Article							MINORITY STRESS; SUBSTANCE USE; VICTIMIZATION; POPULATIONS; YOUTH; CARE	Objective To examine associations between recalled access to gender-affirming hormones (GAH) during adolescence and mental health outcomes among transgender adults in the U.S. Methods We conducted a secondary analysis of the 2015 U.S. Transgender Survey, a cross-sectional non-probability sample of 27,715 transgender adults in the U.S. Using multivariable logistic regression adjusting for potential confounders, we examined associations between access to GAH during early adolescence (age 14-15), late adolescence (age 16-17), or adulthood (age >= 18) and adult mental health outcomes, with participants who desired but never accessed GAH as the reference group. Results 21,598 participants (77.9%) reported ever desiring GAH. Of these, 8,860 (41.0%) never accessed GAH, 119 (0.6%) accessed GAH in early adolescence, 362 (1.7%) accessed GAH in late adolescence, and 12,257 (56.8%) accessed GAH in adulthood. After adjusting for potential confounders, accessing GAH during early adolescence (aOR = 0.4, 95% CI = 0.2-0.6, p < .0001), late adolescence (aOR = 0.5, 95% CI = 0.4-0.7, p < .0001), or adulthood (aOR = 0.8, 95% CI = 0.7-0.8, p < .0001) was associated with lower odds of past-year suicidal ideation when compared to desiring but never accessing GAH. In post hoc analyses, access to GAH during adolescence (ages 14-17) was associated with lower odds of past-year suicidal ideation (aOR = 0.7, 95% CI = 0.6-0.9, p = .0007) when compared to accessing GAH during adulthood. Conclusion Access to GAH during adolescence and adulthood is associated with favorable mental health outcomes compared to desiring but not accessing GAH.	[Turban, Jack L.] Stanford Univ, Sch Med, Div Child & Adolescent Psychiat, Stanford, CA 94305 USA; [King, Dana; Kobe, Julia; Reisner, Sari L.; Keuroghlian, Alex S.] Fenway Inst, Boston, MA USA; [Reisner, Sari L.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 75 Francis St, Boston, MA 02115 USA; [Reisner, Sari L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Reisner, Sari L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Keuroghlian, Alex S.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Keuroghlian, Alex S.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	Stanford University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Turban, JL (corresponding author), Stanford Univ, Sch Med, Div Child & Adolescent Psychiat, Stanford, CA 94305 USA.	jturban@stanford.edu		Keuroghlian, Alex/0000-0002-6624-8354	Arbor; Pfizer; National Institute of Mental Health [MH094612]; Sorensen Foundation; Health Resources and Services Administration Bureau of Primary Health Care [U30CS22742]	Arbor; Pfizer(Pfizer); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sorensen Foundation; Health Resources and Services Administration Bureau of Primary Health Care	JLT received a pilot research award for general psychiatry residents from The American Academy of Child & Adolescent Psychiatry, supported by Industry Sponsors (Arbor and Pfizer), an award from the National Institute of Mental Health (MH094612), and a fellowship from The Sorensen Foundation. ASK received a grant from Health Resources and Services Administration Bureau of Primary Health Care (U30CS22742). The sponsors of this research did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AACAP:https://www.aacap.org/AACAP/Press/Press_Releases/2019/Jack_Turban_Receives_AACAP_Pilot_ Research_Award_for_General_Psychiatry_ Residents_Supported_b.aspx#:~:text=Washington %2C%20DC%2C%20September%2030% 2C,2019%20Pilot%20Research%20Award%20for NIMH: nimh.nih.gov Sorensen Foundation: https://sorensenfellowship.org/Health Resources and Services Administration Bureau of Primary Health Care: https://bphc.hrsa.gov/	Achille C, 2020, INT J PEDIATR ENDOCR, V2020, DOI 10.1186/s13633-020-00078-2; Allen LR, 2019, CLIN PRACT PEDIAT PS, V7, P302, DOI 10.1037/cpp0000288; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Bennett DA, 2001, AUST NZ J PUBL HEAL, V25, P464, DOI 10.1111/j.1467-842X.2001.tb00294.x; Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873; de Vries ALC, 2014, PEDIATRICS, V134, P696, DOI 10.1542/peds.2013-2958; Gilbert PA, 2018, DRUG ALCOHOL DEPEN, V186, P138, DOI 10.1016/j.drugalcdep.2018.01.016; Gill-Peterson J., 2018, HIST TRANSGENDER CHI; Hatchel T, 2019, J CHILD FAM STUD, V28, P2467, DOI 10.1007/s10826-018-1168-3; Hembree W. C., 2017, J CLIN ENDOCRINOL; Hembree WC, 2009, J CLIN ENDOCR METAB, V94, P3132, DOI 10.1210/jc.2009-0345; Hendricks ML, 2012, PROF PSYCHOL-RES PR, V43, P460, DOI 10.1037/a0029597; Hughes LD, 2022, ANN BEHAV MED, V56, P592, DOI 10.1093/abm/kaab063; James SE., 2016, REPORT 2015 US TRANS; Johns MM, 2019, MMWR-MORBID MORTAL W, V68, P67, DOI 10.15585/mmwr.mm6803a3; Kaltiala R, 2020, NORD J PSYCHIAT, V74, P213, DOI 10.1080/08039488.2019.1691260; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Keuroghlian AS, 2015, DRUG ALCOHOL DEPEN, V152, P139, DOI 10.1016/j.drugalcdep.2015.04.008; Kidd KM, 2021, J ADOLESCENT HEALTH, V68, P1082, DOI 10.1016/j.jadohealth.2020.09.010; Klein A, 2016, LGBT HEALTH, V3, P193, DOI 10.1089/lgbt.2015.0111; Kuper LE, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-3006; de Lara DL, 2020, AN PEDIATR, V93, P41, DOI 10.1016/j.anpedi.2020.01.019; Mehringer JE, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-013300; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Olson-Kennedy J, 2018, JAMA PEDIATR, V172, P431, DOI 10.1001/jamapediatrics.2017.5440; Reisner SL, 2016, LANCET, V388, P412, DOI 10.1016/S0140-6736(16)00684-X; Turban JL, 2021, J ADOLESCENT HEALTH, V69, P991, DOI 10.1016/j.jadohealth.2021.06.001; Turban JL, 2021, JAMA-J AM MED ASSOC, V325, P2251, DOI 10.1001/jama.2021.7764; Turban JL, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-1725; Turban JL, 2020, JAMA PSYCHIAT, V77, P68, DOI 10.1001/jamapsychiatry.2019.2285; Turban JL, 2019, AM J PUBLIC HEALTH, V109, P1452, DOI 10.2105/AJPH.2019.305237; Turban JL, 2018, J CHILD PSYCHOL PSYC, V59, P1228, DOI 10.1111/jcpp.12833; Wiepjes CM, 2018, J SEX MED, V15, P582, DOI 10.1016/j.jsxm.2018.01.016	33	12	12	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261039	10.1371/journal.pone.0261039	http://dx.doi.org/10.1371/journal.pone.0261039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020719	gold, Green Published			2022-12-27	WOS:000834207700010
J	Jiangid, XF; Qin, JX; Gao, JG; Gossage, MG				Jiangid, Xiufang; Qin, Jianxiong; Gao, Jianguo; Gossage, Mollie G.			The mediation of perceived risk's impact on destination image and travel intention: An empirical study of Chengdu, China during COVID-19	PLOS ONE			English	Article							BEHAVIORAL INTENTION; TOURISM; PERCEPTIONS; RESIDENTS	Perceived risk clearly impacts travel behavior, including destination selection and satisfaction, but it is unclear how or why its effect is only significant in certain cases. This is because existing studies have undervalued the mediating factors of risk aversion, government initiatives, and media influence as well as the multiple forms or dimensions of risk that can mask its direct effect. This study constructs a structural equation model of perceived risk's impact on destination image and travel intention for a more nuanced model of the perceived risk mechanism in tourism, based on 413 e-questionnaires regarding travel to Chengdu, China during the COVID-19 pandemic, using the Bootstrap method to analyze suppressing effect. It finds that while perceived risk has a significant negative impact on destination image and travel intention, this is complexly mediated so as to appear insignificant. Furthermore, different mediating factors and dimensions of perceived risk operate differently according to their varied combinations in actual circumstances. This study is significant because it provides a theoretical interpretation of tourism risk, elucidates the mechanisms or paths by which perceived risk affects travel intention, and expands a framework for research on destination image and travel intention into the realms of psychology, political, and communication science. It additionally encourages people to pay greater attention to the negative impact of crises and focuses on the important role of internal and external responses in crisis management, which can help improve the effectiveness of crisis management and promote the sustainable development of the tourism industry.	[Jiangid, Xiufang] Southwest Minzu Univ, Coll Econ, Chengdu, Peoples R China; [Qin, Jianxiong] Southwest Minzu Univ, Coll Hist Culture & Tourism, Chengdu, Peoples R China; [Gao, Jianguo] Chengdu Univ Technol, Coll Earth Sci, Chengdu, Peoples R China; [Gossage, Mollie G.] Univ Wisconsin Madison, Dept Anthropol, Madison, WI USA	Southwest Minzu University; Southwest Minzu University; Chengdu University of Technology; University of Wisconsin System; University of Wisconsin Madison	Jiangid, XF (corresponding author), Southwest Minzu Univ, Coll Econ, Chengdu, Peoples R China.; Qin, JX (corresponding author), Southwest Minzu Univ, Coll Hist Culture & Tourism, Chengdu, Peoples R China.	15203656667@163.com; jx-qin@vip.163.com		Jiang, xiufang/0000-0002-8280-8606	Research project of the Key Research Base of Humanities and Social Sciences in Universities of Sichuan Province [GJGY2019-ZD002]; Innovative research project of Southwest Minzu University [CX2020BS20]	Research project of the Key Research Base of Humanities and Social Sciences in Universities of Sichuan Province; Innovative research project of Southwest Minzu University	This research was funded by Research project of the Key Research Base of Humanities and Social Sciences in Universities of Sichuan Province, grant number GJGY2019-ZD002(Q received the award); and was supported by "the Innovative research project of Southwest Minzu University", grant number CX2020BS20(J received the award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], QUESTIONNAIRE STAR; Bai K., 2009, TOURISM SCI, V23, P9, DOI [10.16323/j.cnki.lykx.2009.02.004, DOI 10.16323/J.CNKI.LYKX.2009.02.004]; Baloglu S., 1999, Journal of Travel Research, V38, P144, DOI 10.1177/004728759903800207; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bauer RA., 1960, DYNAMIC MARKETING CH, P389, DOI DOI 10.4018/978-1-4666-7357-1.CH101; Bhatnagar Amit, CHEMOSPHERE, V157, P277, DOI [10.1016/j.cej.2010.01.007, DOI 10.1016/J.CHEMOSPHERE.2003.10.039, 10.1016/j.neubiorev.2012.11.002, DOI 10.1016/J.NEUBIOREV.2012.11.002]; Boksberger PE, 2007, J AIR TRANSP MANAG, V13, P90, DOI 10.1016/j.jairtraman.2006.10.003; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Cai LPA, 2002, ANN TOURISM RES, V29, P720, DOI 10.1016/S0160-7383(01)00080-9; Carr N, 2001, TOURISM MANAGE, V22, P565, DOI 10.1016/S0261-5177(01)00014-0; Cevik S, 2022, OPEN ECON REV, V33, P141, DOI 10.1007/s11079-021-09619-5; Chai SS, 2011, J OCEAN U CHINA SOCI, P55; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Chew EYT, 2014, TOURISM MANAGE, V40, P382, DOI 10.1016/j.tourman.2013.07.008; Chi CGQ, 2008, TOURISM MANAGE, V29, P624, DOI 10.1016/j.tourman.2007.06.007; Cohen E, 2012, ANN TOURISM RES, V39, P2177, DOI 10.1016/j.annals.2012.07.009; Cui XJ, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11010210; Edgell D., 2013, TOURISM POLICY PLANN, V2nd; Eisinga R, 2013, INT J PUBLIC HEALTH, V58, P637, DOI 10.1007/s00038-012-0416-3; Enright M. J., 2005, Journal of Travel Research, V43, P339, DOI 10.1177/0047287505274647; EVERITT BS, 1975, BRIT J PSYCHIAT, V126, P237, DOI 10.1192/bjp.126.3.237; Fang Z, 2007, REFORM EC SYSTEM, P173; FISCHER GW, 1991, RISK ANAL, V11, P303, DOI 10.1111/j.1539-6924.1991.tb00606.x; Fu H, 2016, TOURISM MANAGE, V55, P37, DOI 10.1016/j.tourman.2016.01.009; Fuchs G, 2011, TOURISM MANAGE, V32, P266, DOI 10.1016/j.tourman.2010.01.012; Gartner W. C., 1993, Journal of Travel & Tourism Marketing, V2, P191; Gibson H, 2002, ANN TOURISM RES, V29, P358, DOI 10.1016/S0160-7383(01)00037-8; Gunn CA, 1988, VACATIONSCAPE DESIGN; Hainan Provincial Bureau of Statistics, 2014, HAIN STAT YB; Hardeep Chahal, 2017, International Journal of Leisure and Tourism Marketing, V5, P100, DOI 10.1504/IJLTM.2017.084618; Heath R, 1998, SAFETY SCI, V30, P139, DOI 10.1016/S0925-7535(98)00042-3; Hsi-Tien Chen, 2012, Information Technology Journal, V11, P1357, DOI 10.3923/itj.2012.1357.1368; Huang YH, 2018, RESOURCE DEV MARKET, V34, P1327; Ivanov S, 2017, J POLICY RES TOUR LE, V9, P100, DOI 10.1080/19407963.2016.1209677; Jalilvand MR, 2012, J ISLAMIC MARK, V3, P175, DOI 10.1108/17590831211232573; JUDD CM, 1981, EVALUATION REV, V5, P602, DOI 10.1177/0193841X8100500502; Kapuscinski G, 2016, TOURISM MANAGE, V57, P234, DOI 10.1016/j.tourman.2016.06.017; Kenny DA, 2003, PSYCHOL METHODS, V8, P115, DOI 10.1037/1082-989X.8.2.115; Krajnak T, 2021, TOURISM ECON, V27, P1736, DOI 10.1177/1354816620938900; Laing JH, 2009, TOUR ANAL, V14, P187, DOI 10.3727/108354209789116547; Lee TH, 2018, J TRAVEL RES, V57, P792, DOI 10.1177/0047287517717350; Li S.R., 2021, P ENTER 2021 ET C CH, P490, DOI DOI 10.1007/978-3-030-65785-7_47; Li ZY, 2020, J DESTIN MARK MANAGE, V18, DOI 10.1016/j.jdmm.2020.100502; Liang XH, 2020, WORLD J CLIN CASES, V8, P2959, DOI 10.12998/wjcc.v8.i14.2959; Liu LL, 2013, JAFMS, V8, P23; Lo AS, 2011, J TRAVEL TOUR MARK, V28, P240, DOI 10.1080/10548408.2011.562851; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MacKinnon DP, 2009, CURR DIR PSYCHOL SCI, V18, P16, DOI 10.1111/j.1467-8721.2009.01598.x; Mercille J, 2005, ANN TOURISM RES, V32, P1039, DOI 10.1016/j.annals.2005.02.001; Merrilees B, 2013, J BUS RES, V66, P37, DOI 10.1016/j.jbusres.2011.07.021; Mohseni S, 2018, CURR ISSUES TOUR, V21, P616, DOI 10.1080/13683500.2016.1200539; Neuburger L, 2021, CURR ISSUES TOUR, V24, P1003, DOI 10.1080/13683500.2020.1803807; Noh J, 2013, CURR ISSUES TOUR, V16, P455, DOI 10.1080/13683500.2012.741576; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Pan B, 2011, ANN TOURISM RES, V38, P132, DOI 10.1016/j.annals.2010.06.004; Parrey SH, 2019, INT J TOUR CITIES, V5, P90, DOI 10.1108/IJTC-02-2018-0019; Parrey Shakir Hussain, INT J TOUR CITIES, V5, P90, DOI [10.1108/IJTC-02-2018-0019, DOI 10.1108/IJTC-02-2018-0019]; Phillips W, 2017, AMBIVALENT INTERNET, DOI 10.1177/875697280603700102; Qi XueQing [Qi X. Q. C.], 2009, Journal of Sport Tourism, V14, P43, DOI 10.1080/14775080902847439; Rasoolimanesh SM, 2021, J DESTIN MARK MANAGE, V21, DOI 10.1016/j.jdmm.2021.100620; Rittichainuwat BN, 2009, TOURISM MANAGE, V30, P410, DOI 10.1016/j.tourman.2008.08.001; Roehl W. S., 1992, Journal of Travel Research, V30, P17, DOI 10.1177/004728759203000403; Rossello J, 2020, TOURISM MANAGE, V79, DOI 10.1016/j.tourman.2020.104080; Senbeto DL, 2020, CURR ISSUES TOUR, V23, P740, DOI 10.1080/13683500.2018.1546674; Sharma GD, 2021, TOUR MANAG PERSPECT, V37, DOI 10.1016/j.tmp.2020.100786; Sohn HK, 2016, J TRAVEL TOUR MARK, V33, P28, DOI 10.1080/10548408.2015.1024912; SPENCE HE, 1970, J MARKETING RES, V7, P364, DOI 10.2307/3150296; SPSSAU, FREQUENTLY ASKED QUE; Stepchenkova S, 2013, TOURISM MANAGE, V36, P590, DOI 10.1016/j.tourman.2012.08.006; Tavitiyaman P, 2021, J HOSP TOUR MANAG, V46, P476, DOI 10.1016/j.jhtm.2021.02.003; Tessitore T, 2014, TOURISM MANAGE, V42, P3, DOI 10.1016/j.tourman.2013.10.001; The National Congress of the People's Republic of China, 2007, EM RESP LAW PEOPL RE; U SC, 2020, TOUR MANAG PERSPECT, V33, DOI 10.1016/j.tmp.2019.100628; United Nations World Tourism Organization, 2021, WORST YEAR TOUR HIST; United Nations World Tourism Organization, 2003, BMC PLANT BIOL; Uriely N, 2006, ANN TOURISM RES, V33, P339, DOI 10.1016/j.annals.2005.10.009; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; WHHLY. SHANDONG. GOV. CN, 2018, SHANDONG STAT YB; Woosnam KM, 2015, TOURISM MANAGE, V46, P263, DOI 10.1016/j.tourman.2014.06.022; Wu M L, 2009, WENJUAN TONGJI FENXI; Xiang Z, 2010, TOURISM MANAGE, V31, P179, DOI 10.1016/j.tourman.2009.02.016; Zeng BX, 2014, TOUR MANAG PERSPECT, V10, P27, DOI 10.1016/j.tmp.2014.01.001; Zhang TF, 2006, MODERN COMMUNICATION, P12; Zhang Wen, 2005, Current Issues in Tourism, V8, P22, DOI 10.1080/13683500508668203; Zhao SR, 2010, CHINESE PUBLIC ADM, P119; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257; Zhu H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103514	87	2	2	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2022	17	1							e0261851	10.1371/journal.pone.0261851	http://dx.doi.org/10.1371/journal.pone.0261851			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6E4LQ	34995317	Green Published, gold			2022-12-27	WOS:000883352700001
J	Alghamdi, AG; El-Saeid, MH; Alzahrani, AJ; Ibrahim, HM				Alghamdi, Abdulaziz G.; El-Saeid, Mohamed H.; Alzahrani, Abdulhakim J.; Ibrahim, Hesham M.			Heavy metal pollution and associated health risk assessment of urban dust in Riyadh, Saudi Arabia	PLOS ONE			English	Article							ROAD DUST; MULTIVARIATE-ANALYSIS; TOXIC ELEMENTS; POULTRY MANURE; CONTAMINATION; CITY; ENRICHMENT; SEDIMENTS; ACCUMULATION; ADSORPTION	Depending on their particle size and concentration, heavy metals in urban dust pose a health hazard to humans. This study investigated the total concentration, health risk, integrated pollution load index (IPI), and enrichment factor (EF) of various heavy metals in urban dust at different locations in Riyadh City. Surface dust samples were collected from 50 different residential yards in the north, south, west, east, and central corners of the city and analyzed for cadmium (Cd), chromium (Cr), copper (Cu), manganese (Mn), nickel (Ni), lead (Pb), and zinc (Zn). With respect to concentrations heavy metals were in the following order Zn > Cu > Mn > Cr > Ni > Pb > Cd. The EF trends exposed repeated anthropogenic activities were responsible for Mn, Cr, and Ni, while Pb, Zn, and Cu appeared to come from Earth's crust. Since the heavy metal concentrations were lower than the threshold values, children and adults are exposed to lower health risk in investigated area. Also, there are no pollution of heavy metals in the dust with respect to IPI which is less than the critical limit (<1) with the exception of a sampling location in north side of the city with higher IPI showed unhealthy respiration conditions in particular areas. It was concluded that rapid industrialization and urbanization and their concentrations in dust may cause health problems in near future in north side as well as other sides of Riyadh City.	[Alghamdi, Abdulaziz G.; El-Saeid, Mohamed H.; Alzahrani, Abdulhakim J.; Ibrahim, Hesham M.] King Saud Univ, Coll Food & Agr Sci, Dept Soil Sci, Riyadh, Saudi Arabia; [Ibrahim, Hesham M.] Suez Canal Univ, Fac Agr, Dept Soils & Water, Ismailia, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Suez Canal University	Alghamdi, AG (corresponding author), King Saud Univ, Coll Food & Agr Sci, Dept Soil Sci, Riyadh, Saudi Arabia.	agghamdi@ksu.edu.sa		Ibrahim, Hesham/0000-0002-0320-0943	Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia [RGP1440-050]	Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia	This article was supported by Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia, research group no. RGP1440-050.	Adriano D.C., 2001, TRACE ELEMENTS TERRE, DOI 10.1007/978-0-387-21510-5; Aiman U, 2016, CHEMOSPHERE, V144, P2229, DOI 10.1016/j.chemosphere.2015.10.077; Al-Tayeb NT, 1993, P INDUSTERIAL AIR PO, P66; Alharbi BH, 2020, ENVIRON SCI POLLUT R, V27, P18475, DOI 10.1007/s11356-020-08362-7; Ali MU, 2017, CHEMOSPHERE, V181, P111, DOI 10.1016/j.chemosphere.2017.04.061; AlRajhi MA, 1996, ENVIRON INT, V22, P315, DOI 10.1016/0160-4120(96)00017-7; Batool S, 2020, ENVIRON RES, V181, DOI 10.1016/j.envres.2019.108955; Batool S, 2017, CHEM PHYS LETT, V689, P190, DOI 10.1016/j.cplett.2017.10.016; Castellanos D, 2014, POWDER TECHNOL, V254, P331, DOI 10.1016/j.powtec.2013.11.028; Chang CC, 2006, J TOXICOL ENV HEAL A, V69, P229, DOI 10.1080/15287390500227415; [陈丽旋 Chen Lixuan], 2005, [环境科学学报, Acta Scientiae Circumstantiae], V25, P409; Cheng VWS, 2018, JMIR MENT HEALTH, V5, DOI 10.2196/11068; Duong TTT, 2011, J ENVIRON MANAGE, V92, P554, DOI 10.1016/j.jenvman.2010.09.010; [方凤满 Fang Fengman], 2010, [地理研究, Geographical Research], V29, P1193; Forstner U, 1990, SEDIMENTS ENV GEOCHE, P311, DOI DOI 10.1007/978-3-642-75097-7_18; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Han Q, 2020, ECOTOX ENVIRON SAFE, V191, DOI 10.1016/j.ecoenv.2019.110157; Han YM, 2006, SCI TOTAL ENVIRON, V355, P176, DOI 10.1016/j.scitotenv.2005.02.026; Harikumar PS, 2009, INT J ENVIRON SCI TE, V6, P225; Hjortenkrans D, 2006, ENVIRON MONIT ASSESS, V117, P85, DOI 10.1007/s10661-006-7706-2; Ho HH, 2010, GEOL BELG, V13, P37; Idrees M, 2018, J MOL LIQ, V266, P373, DOI 10.1016/j.molliq.2018.06.049; Idrees M, 2016, SEP SCI TECHNOL, V51, P2307, DOI 10.1080/01496395.2016.1205093; Kamani H, 2015, B ENVIRON CONTAM TOX, V94, P382, DOI 10.1007/s00128-014-1453-9; Loska K, 2005, COMMUN SOIL SCI PLAN, V36, P1117, DOI 10.1081/CSS-200056880; MADANY IM, 1994, ENVIRON INT, V20, P483, DOI 10.1016/0160-4120(94)90197-X; Trujillo-Gonzalez JM, 2016, SCI TOTAL ENVIRON, V553, P636, DOI 10.1016/j.scitotenv.2016.02.101; Modaihsh AS, 2013, APCBEE PROC, V5, P50, DOI 10.1016/j.apcbee.2013.05.010; Muller G., 1969, GEO J, V2, P108, DOI DOI 10.1055/S-2007-1023171; OSKARSSON A, 1995, ANALYST, V120, P765, DOI 10.1039/an9952000765; Rasmussen PE, 2001, SCI TOTAL ENVIRON, V267, P125, DOI 10.1016/S0048-9697(00)00775-0; Saw HY., 2013, CHEMECA CHALLENGING, V299; Shabbaj II, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010036; Shi GT, 2011, ATMOS ENVIRON, V45, P764, DOI 10.1016/j.atmosenv.2010.08.039; Soares HMVM, 1999, ENVIRON POLLUT, V105, P311, DOI 10.1016/S0269-7491(99)00048-2; Statistics Center of Iran, 2016, GEN POPULATION HOUSI; Sutherland RA, 2000, ARCH ENVIRON CON TOX, V38, P428, DOI 10.1007/s002449910057; USEPA, 2002, GUID DEV SOIL SCRE S; Van Pelt RS, 2007, ENVIRON MONIT ASSESS, V130, P3, DOI 10.1007/s10661-006-9446-8; WHO, 2000, WHO EUR SER; Wu QH, 2015, SCI TOTAL ENVIRON, V506, P217, DOI 10.1016/j.scitotenv.2014.10.121; Xing WQ, 2019, ECOTOX ENVIRON SAFE, V175, P192, DOI 10.1016/j.ecoenv.2019.03.062; Yang ZP, 2011, J GEOCHEM EXPLOR, V108, P27, DOI 10.1016/j.gexplo.2010.09.006; Zhao HJ, 2021, SCI TOTAL ENVIRON, V763, DOI 10.1016/j.scitotenv.2020.142979; Zheng N, 2010, SCI TOTAL ENVIRON, V408, P726, DOI 10.1016/j.scitotenv.2009.10.075	45	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261957	10.1371/journal.pone.0261957	http://dx.doi.org/10.1371/journal.pone.0261957			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990460	gold, Green Published			2022-12-27	WOS:000815783800014
J	Boguszewicz-Kreft, M; Kuczamer-Klopotowska, S; Kozlowski, A				Boguszewicz-Kreft, Monika; Kuczamer-Klopotowska, Sylwia; Kozlowski, Arkadiusz			The role and importance of perceived risk in medical tourism. Applying the theory of planned behaviour	PLOS ONE			English	Article							COUNTRY-OF-ORIGIN; DESTINATION CHOICE; CULTURAL-DIFFERENCES; TRAVEL DESTINATION; EASTERN-EUROPE; PAST BEHAVIOR; INTENTION; CONSUMERS; SERVICES; PERCEPTION	The main aim of the study was to investigate the role and importance of perceived risk in medical tourism (MT). The research demonstrates that the country of origin and an assessment of the respondents' own health condition significantly moderates the impact of their attitudes on behavioral intention. The research shows a strong correlation between the risk perceived by the respondents and their attitudes towards MT services. This relationship is significantly moderated by risk awareness, aversion to risk and gender. Additionally, an important factor in the model is the level of satisfaction with medical services in their own country. The survey using a fully structured questionnaire was conducted among young consumers from Jordan, Poland and Turkey. To verify the hypotheses, a multiple regression model with interactions was used.	[Boguszewicz-Kreft, Monika] WSB Univ Gdansk, Fac Finance & Management, Dept Mkt, Gdansk, Poland; [Kuczamer-Klopotowska, Sylwia] Univ Gdansk, Fac Management, Dept Mkt, Sopot, Poland; [Kozlowski, Arkadiusz] Univ Gdansk, Fac Management, Dept Stat, Sopot, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Boguszewicz-Kreft, M (corresponding author), WSB Univ Gdansk, Fac Finance & Management, Dept Mkt, Gdansk, Poland.	mboguszewicz@wsb.gda.pl		Boguszewicz-Kreft, Monika/0000-0002-9294-7175				Abubakar AM, 2016, J DESTIN MARK MANAGE, V5, P192, DOI 10.1016/j.jdmm.2015.12.005; Adam I, 2015, TOURISM MANAGE, V49, P99, DOI 10.1016/j.tourman.2015.02.016; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 2000, EUR REV SOC PSYCHOL, V11, P1, DOI [10.1080/14792779943000116, DOI 10.1080/14792779943000116]; Ajzen I, 2011, PSYCHOL HEALTH, V26, P1113, DOI 10.1080/08870446.2011.613995; Amaro S, 2015, TOURISM MANAGE, V46, P64, DOI 10.1016/j.tourman.2014.06.006; An M, 2010, SERV BUS, V4, P155, DOI 10.1007/s11628-010-0094-2; [Anonymous], 2007, SERVICE MANAGEMENT M; Artuger Savas, 2015, EUR J BUS MANAG, V7, P36; Bamberg S, 2003, BASIC APPL SOC PSYCH, V25, P175, DOI 10.1207/S15324834BASP2503_01; Banevicius S, 2020, SOC TYRIM, V43, P26; Bao YQ, 2003, PSYCHOL MARKET, V20, P733, DOI 10.1002/mar.10094; Bauer R.A., 1960, DYNAMIC MARKETING CH, P389; Bloom PN., 1984, HARV BUS REV, V62; Boguszewicz-Kreft M, 2017, MARK RYNEK, V9, P21; Boguszewicz-Kreft M, 2019, J E EUR MANAG STUD, V24, P466, DOI 10.5771/0949-6181-2019-3-466; Booms B. H., 1981, MARKETING SERVICES, P172; Bruning E, 2013, J GLOB MARK, V26, P41; Campbell MC, 2001, J CONSUM RES, V28, P439, DOI 10.1086/323731; Carter S, 1998, TOURISM MANAGE, V19, P349, DOI 10.1016/S0261-5177(98)00032-6; Cetinsoz BC, 2013, ANATOLIA, V24, P173, DOI 10.1080/13032917.2012.743921; Chan K, 2011, J CONSUM MARK, V28, P354; Chelliah S, 2021, INT J PHARM HEALTHC, V15, P43, DOI 10.1108/IJPHM-07-2018-0039; Cheng S., 2006, J HOSP TOUR RES, V30, P95, DOI [10.1177/1096348005284269, DOI 10.1177/1096348005284269]; Chew EYT, 2014, TOURISM MANAGE, V40, P382, DOI 10.1016/j.tourman.2013.07.008; Crooks Valorie A, 2017, BMC Proc, V11, P6, DOI 10.1186/s12919-017-0075-8; Cui FN, 2016, NAT HAZARDS, V82, P643, DOI 10.1007/s11069-016-2208-1; Dash A, 2020, J HOSP TOUR INSIGHTS, DOI 10.1108/JHTI-03-2020-0037; Dholakia U.M., 2001, EUR J MARKETING, V35, P1340, DOI [DOI 10.1108/EUM0000000006479, 10.1108/EUM0000000006479]; Doran R, 2016, INT J TOUR RES, V18, P159, DOI 10.1002/jtr.2042; Drwal R, KULTUROWA ADAPTACJA; Fahrmeir L., 2013, REGRESSION MODELS ME, DOI [10.1515/ijb-2012-0035, DOI 10.1515/IJB-2012-0035]; Farrukh M, 2022, INT J HEALTHCARE MAN, V15, P28, DOI 10.1080/20479700.2020.1836733; Faulkner B, 2001, TOURISM MANAGE, V22, P331, DOI 10.1016/S0261-5177(00)00069-8; Floyd M. F., 2003, Journal of Travel & Tourism Marketing, V15, P19; Fuchs G, 2011, TOURISM MANAGE, V32, P266, DOI 10.1016/j.tourman.2010.01.012; Grewal D, 2007, J ACAD MARKET SCI, V35, P250, DOI 10.1007/s11747-007-0044-2; Gurhan-Canli Z, 2000, J MARKETING RES, V37, P309, DOI 10.1509/jmkr.37.3.309.18778; Gursoy D, 2003, ANN TOURISM RES, V30, P906, DOI 10.1016/S0160-7383(03)00059-8; Guy BS, 2015, INT J HEALTHCARE MAN, V8, P68, DOI 10.1179/2047971914Y.0000000076; Habibi A, 2019, ANATOLIA, V30, P35, DOI 10.1080/13032917.2018.1496122; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Harrison-Walker LJ., 1995, J SERV MARK, DOI [10.1108/08876049510079880, DOI 10.1108/08876049510079880]; Hasan MK, 2017, COGENT BUS MANAG, V4, DOI 10.1080/23311975.2017.1412874; Hassandra M, 2011, PSYCHOL HEALTH, V26, P1241, DOI 10.1080/08870446.2011.605137; Henson JN, 2015, INT J HEALTHCARE MAN, V8, P4, DOI 10.1179/2047971914Y.0000000083; Hofstede G, COMPARE COUNTRIES; Hofstede G., 1980, CULTURES CONSEQUENCE, DOI DOI 10.1016/S0005-7967(02)00184-5; Holliday R, 2015, GENDER PLACE CULT, V22, P90, DOI 10.1080/0966369X.2013.832655; Hu H, 2019, SCI TOTAL ENVIRON, V657, P1127, DOI 10.1016/j.scitotenv.2018.12.114; Huan TC, 2004, ANN TOURISM RES, V31, P255, DOI 10.1016/j.annals.2003.10.003; Huang JH, 2008, ANN TOURISM RES, V35, P1074, DOI 10.1016/j.annals.2008.06.007; Huang JH, 2002, TOURISM MANAGE, V23, P145, DOI 10.1016/S0261-5177(01)00051-6; Irvine W., 2006, Tourism, security and safety: from theory to practice, P169, DOI 10.1016/B978-0-7506-7898-8.50016-3; Jacoby J., 1972, P 3 ANN C ASS CONS R, P382; Jalilvand MR, 2012, INTERNET RES, V22, P591, DOI 10.1108/10662241211271563; Javalgi R.G., 2001, J SERV MARK, V15, P565; Kaplan S, 2015, TOURISM MANAGE, V47, P34, DOI 10.1016/j.tourman.2014.08.017; Karl M, 2018, EUR J TOUR RES, V18, P160; Karl M, 2017, TOURISM, V65, P138; Kemp E, 2015, INT J ADVERT, V34, P621, DOI 10.1080/02650487.2015.1024385; Khan Mohammad J, 2017, Sultan Qaboos Univ Med J, V17, pe11, DOI 10.18295/squmj.2016.17.01.003; Khan MJ, 2017, INT J HEALTHCARE MAN, V10, P115, DOI 10.1080/20479700.2017.1304345; Khan MJ, 2016, INT J HEALTHCARE MAN, V9, P134, DOI 10.1080/20479700.2016.1142046; Kim SM, 2016, ASIA PAC J TOUR RES, V21, P1020, DOI 10.1080/10941665.2015.1093515; Kor K, 2011, PSYCHOL HEALTH, V26, P1208, DOI 10.1080/08870446.2010.551210; Kozak M., 2007, International Journal of Tourism Research, V9, P233, DOI 10.1002/jtr.607; Lam T, 2006, TOURISM MANAGE, V27, P589, DOI 10.1016/j.tourman.2005.02.003; Laroche M., 2003, J SERV MARK, V17, P122, DOI [10.1108/08876040310467907, DOI 10.1108/08876040310467907]; Lautier M, 2014, HEALTH POLICY, V118, P105, DOI 10.1016/j.healthpol.2014.07.004; Law R., 2006, International Journal of Tourism Research, V8, P289, DOI 10.1002/jtr.576; Lee JJ., 2016, J MARK THOUGHT, V3, P11; Lee JA, 2007, INT MARKET REV, V24, P330, DOI 10.1108/02651330710755320; Lee M, 2012, J TRAVEL TOUR MARK, V29, P69, DOI 10.1080/10548408.2012.638564; Li J, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183387; Liang LJ, 2019, INT J TOUR RES, V21, P772, DOI 10.1002/jtr.2303; Lubowiecki-Vikuk A, 2019, ALMATOURISM, V10, P25, DOI 10.6092/issn.2036-5195/8199; Lubowiecki-Vikuk A, 2019, ECON RES-EKON ISTRAZ, V32, P1256, DOI 10.1080/1331677X.2019.1627892; Mandrik CA, 2005, ADV CONSUM RES, V32, P531; Mansfeld Y., 2006, Tourism, security and safety: from theory to practice, P271, DOI 10.1016/B978-0-7506-7898-8.50022-9; Martin DS, 2011, TOUR REV, V66, P45, DOI 10.1108/16605371111127233; Maser B., 1998, Journal of Travel & Tourism Marketing, V7, P107, DOI 10.1300/J073v07n04_06; Maslow A.H., 1954, MOTIVATION PERSONALI; McEachan RRC, 2011, HEALTH PSYCHOL REV, V5, P97, DOI 10.1080/17437199.2010.521684; Menvielle L, 2014, QUAL MARK RES, V17, P264, DOI 10.1108/QMR-10-2012-0044; Mirzaei N, 2019, PSYCHOL RES BEHAV MA, V12, P901, DOI 10.2147/PRBM.S196417; Mitchell V. W., 1997, Journal of Euro-Marketing, V6, P47, DOI 10.1300/J037v06n03_03; Mitra K., 1999, J SERV MARK, V13, P208, DOI [10.1108/08876049910273763, DOI 10.1108/08876049910273763]; Morakabati Y, 2016, INT J TOUR RES, V18, P506, DOI 10.1002/jtr.2068; Na SA, 2016, PROCD SOC BEHV, V224, P546, DOI 10.1016/j.sbspro.2016.05.434; NAGASHIMA A, 1970, J MARKETING, V34, P68, DOI 10.2307/1250298; NARAYANA CL, 1981, COLUMBIA J WORLD BUS, V16, P31; Nobre L.H.N., 2015, J FINANCIAL SERVICE, V69, P18; Oh KM, 2014, J COMMUN HEALTH, V39, P221, DOI 10.1007/s10900-013-9800-z; PARASURAMAN A, 1985, J MARKETING, V49, P41, DOI 10.2307/1251430; Park J, 2017, J HEALTHC MANAG, V62, P405, DOI 10.1097/JHM-D-16-00016; Ponsignon F, 2015, J SERV MANAGE, V26, P460, DOI 10.1108/JOSM-10-2014-0265; Quintal VA, 2010, ASIA PAC J MARKET LO, V22, P554, DOI 10.1108/13555851011090565; Quintal VA, 2010, TOURISM MANAGE, V31, P797, DOI 10.1016/j.tourman.2009.08.006; Rab-Przybylowicz J, 2016, STUDIA PERIEGETICA, V2, P99; Ramamonjiarivelo Zo, 2015, Health Mark Q, V32, P165, DOI 10.1080/07359683.2015.1033934; Reddy SG, 2010, INT J TOUR RES, V12, P510, DOI 10.1002/jtr.769; Reisinger Y., 2006, Journal of Travel & Tourism Marketing, V20, P13, DOI 10.1300/J073v20n01_02; Rittichainuwat BN, 2009, TOURISM MANAGE, V30, P410, DOI 10.1016/j.tourman.2008.08.001; Scheinfeld E, 2019, HEALTH BEHAV POLICY, V6, P115, DOI [10.14485/hbpr.6.2.1, 10.14485/HBPR.6.2.1]; Seow AN, 2017, INT J TOUR RES, V19, P383, DOI 10.1002/jtr.2120; Sharma P, 2011, J INT CONSUM MARK, V23, P344, DOI 10.1080/08961530.2011.602952; Siegel S, 2018, PSYCHOL RES BEHAV MA, V11, P243, DOI 10.2147/PRBM.S158876; Snyder J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-445; Sonmez S. F., 1998, Journal of Travel Research, V37, P171, DOI 10.1177/004728759803700209; Sonmez SF, 1998, ANN TOURISM RES, V25, P112, DOI 10.1016/S0160-7383(97)00072-8; Sparks B, 2007, TOURISM MANAGE, V28, P1180, DOI 10.1016/j.tourman.2006.11.003; Sparks B, 2009, TOURISM MANAGE, V30, P483, DOI 10.1016/j.tourman.2008.10.014; Suki AA, 2015, THEORY AND PRACTICE IN HOSPITALITY AND TOURISM RESEARCH, P519; Suki AA, 2017, PERTANIKA J SOC SCI, V25, P203; Teitler-Regev S, 2018, ISR AFF, V24, P467, DOI 10.1080/13537121.2018.1454003; Um S., 1992, Journal of Travel Research, V30, P18, DOI 10.1177/004728759203000303; Wang C, 2019, J ENVIRON MANAGE, V231, P804, DOI 10.1016/j.jenvman.2018.10.089; Wang HY, 2012, MANAG SERV QUAL, V22, P465, DOI 10.1108/09604521211281387; Williams AM, 2013, TOURISM MANAGE, V35, P209, DOI 10.1016/j.tourman.2012.07.006; Wong JY, 2009, ANN TOURISM RES, V36, P6, DOI 10.1016/j.annals.2008.09.005; Yang CL, 2014, PROCD SOC BEHV, V144, P322, DOI 10.1016/j.sbspro.2014.07.302; Yang ChiaoLing [Yang C. L. E. ], 2014, Asia-Pacific Journal of Innovation in Hospitality and Tourism, V3, P239; Yuzhanin S, 2016, TOUR REV, V71, P135, DOI 10.1108/TR-11-2015-0055; Zeithaml VA, 1981, SERVICES MARKETING	125	1	1	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262137	10.1371/journal.pone.0262137	http://dx.doi.org/10.1371/journal.pone.0262137			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZO8DB	34986182	Green Published, gold			2022-12-27	WOS:000765956200018
J	Imran, N; Naz, F; Sharif, MI; Liaqat, S; Riaz, M; Khawar, A; Azeem, MW				Imran, Nazish; Naz, Fauzia; Sharif, Muhammad Imran; Liaqat, Sumbul; Riaz, Musarrat; Khawar, Abida; Azeem, Muhammad Waqar			Multidimensional impacts of coronavirus pandemic in adolescents in Pakistan: A cross sectional research	PLOS ONE			English	Article							MENTAL-HEALTH; CHILDREN	Background COVID-19 has posed unique challenges for adolescents in different dimensions of their life including education, home and social life, mental and physical health. Whether the impact is positive or negative, its significance on the overall shaping of adolescents' lives cannot be overlooked. The aim of the present study was to explore impacts of the pandemic on the adolescents' everyday lives in Pakistan. Methods Following ethical approval, this cross-sectional study was conducted through September to December, 2020 via an online survey on 842 adolescents with the mean age of 17.14 +/- SD 1.48. Socio-demographic data and Epidemic Pandemic Impact Inventory-Adolescent Adaptation (EPII-A) was used to assess the multi-dimensional effects of the pandemic. Results Among the 842 participants, 84% were girls. Education emerged as the most negatively affected Pandemic domain (41.6-64.3%). Most of the adolescents (62.0-65.8%) had reported changes in responsibilities at home including increased time spent in helping family members. Besides, increase in workload of participants and their parents was prominent (41.8% & 47.6%). Social activities were mostly halted for approximately half (41-51%) of the participants. Increased screen time, decreased physical activity and sedentary lifestyle were reported by 52.7%, 46.3% and 40.7% respectively. 22.2-62.4% of the adolescents had a direct experience with quarantine, while 15.7% experienced death of a close friend or relative. Positive changes in their lives were endorsed by 30.5-62.4% respondents. Being male and older adolescents had significant association with negative impact across most domains (p<0.05). Conclusions Results have shown that COVID-19 exert significant multidimensional impacts on the physical, psycho-social, and home related domains of adolescents that are certainly more than what the previous researches has suggested.	[Imran, Nazish; Sharif, Muhammad Imran; Liaqat, Sumbul] King Edward Med Univ, Dept Child & Family Psychiat, Mayo Hosp, Lahore, Pakistan; [Naz, Fauzia] Govt Islamia Grad Coll, Lahore, Pakistan; [Riaz, Musarrat] Baqai Med Univ, Baqai Inst Diabetol & Endocrinol, Karachi, Pakistan; [Khawar, Abida] ZA Sch Syst, Lahore, Pakistan; [Azeem, Muhammad Waqar] Weill Cornell Med, Dept Psychiat, Sidra Med, Doha, Qatar	Baqai Medical University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Sidra Medical & Research Center	Imran, N (corresponding author), King Edward Med Univ, Dept Child & Family Psychiat, Mayo Hosp, Lahore, Pakistan.	nazishimrandr@gmail.com		Liaqat, Sumbul/0000-0001-7112-4471				Bates LC, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7090138; Bodla Z, 2020, ESCULAPIO, V16, P22; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8, 10.1016/S0140-6736(20)30460-8.]; Cardenas MC, 2020, ACTA PAEDIATR, V109, P2187, DOI 10.1111/apa.15536; de Miranda DM, 2020, INT J DISAST RISK RE, V51, DOI 10.1016/j.ijdrr.2020.101845; Duan L, 2020, J AFFECT DISORDERS, V275, P112, DOI 10.1016/j.jad.2020.06.029; Ellis WE, 2020, CAN J BEHAV SCI, V52, P177, DOI 10.1037/cbs0000215; Fegert JM, 2020, CHILD ADOL PSYCH MEN, V14, DOI 10.1186/s13034-020-00329-3; Glabska D, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092640; Golberstein E, 2019, HEALTH ECON, V28, P955, DOI 10.1002/hec.3885; Grasso DJ., 2020, EPIDEMIC PANDEMIC IM; Imran N, 2020, PAK J MED SCI, V36, P1106, DOI 10.12669/pjms.36.5.3088; Imran N, 2020, PAK J MED SCI, V36, pS67, DOI 10.12669/pjms.36.COVID19-S4.2759; Khan KS, 2022, INT J MENT HEALTH AD, V20, P380, DOI 10.1007/s11469-020-00367-0; Laar RA, 2019, RELIGIONS, V10, DOI 10.3390/rel10110617; Saurabh K, 2020, INDIAN J PEDIATR, V87, P532, DOI 10.1007/s12098-020-03347-3; Zhang XX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207666; Zhou J, POSITIVE NEGATIVE PS; Zhu N, 2020, CHILD ADOL MENT H-UK, V25, P173, DOI 10.1111/camh.12408	19	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262325	10.1371/journal.pone.0262325	http://dx.doi.org/10.1371/journal.pone.0262325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZO8DB	34986208	gold, Green Published			2022-12-27	WOS:000765956200042
J	Roggero, CM; Esser, V; Duan, LL; Rice, AM; Ma, SH; Raj, GV; Rosen, MK; Liu, ZP; Rizoi, J				Roggero, Carlos M.; Esser, Victoria; Duan, Lingling; Rice, Allyson M.; Ma, Shihong; Raj, Ganesh V.; Rosen, Michael K.; Liu, Zhi-Ping; Rizoi, Josep			Poly-glutamine-dependent self-association as a potential mechanism for regulation of androgen receptor activity	PLOS ONE			English	Article							PROSTATE-CANCER; TRANSACTIVATION DOMAIN; PHASE-TRANSITION; ACTIVATION; CONFORMATION; DEPRIVATION; RESISTANCE; BEHAVIOR; REPEATS; LENGTH	The androgen receptor (AR) plays a central role in prostate cancer. Development of castration resistant prostate cancer (CRPC) requires androgen-independent activation of AR, which involves its large N-terminal domain (NTD) and entails extensive epigenetic changes depending in part on histone lysine demethylases (KDMs) that interact with AR. The AR-NTD is rich in low-complexity sequences, including a polyQ repeat. Longer polyQ sequences were reported to decrease transcriptional activity and to protect against prostate cancer, although they can lead to muscular atrophy. However, the molecular mechanisms underlying these observations are unclear. Using NMR spectroscopy, here we identify weak interactions between the AR-NTD and the KDM4A catalytic domain, and between the AR ligand-binding domain and a central KDM4A region that also contains low-complexity sequences. We also show that the AR-NTD can undergo liquid-liquid phase separation in vitro, with longer polyQ sequences phase separating more readily. Moreover, longer polyQ sequences hinder nuclear localization in the absence of hormone and increase the propensity for formation of AR-containing puncta in the nucleus of cells treated with dihydrotestosterone. These results lead us to hypothesize that polyQ-dependent liquid-liquid phase separation may provide a mechanism to decrease the transcriptional activity of AR, potentially opening new opportunities to design effective therapies against CRPC and muscular atrophy.	[Roggero, Carlos M.; Esser, Victoria; Rice, Allyson M.; Rosen, Michael K.; Rizoi, Josep] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Roggero, Carlos M.; Esser, Victoria; Rizoi, Josep] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Roggero, Carlos M.; Esser, Victoria; Rizoi, Josep] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Duan, Lingling; Liu, Zhi-Ping] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Ma, Shihong; Raj, Ganesh V.] Univ Texas Southwestern Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Rosen, Michael K.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Liu, Zhi-Ping] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Roggero, CM; Rizoi, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Roggero, CM; Rizoi, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.; Roggero, CM; Rizoi, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	Carlos.Roggero@UTSouthwestern.edu; Jose.Rizo-Rey@UTSouthwestern.edu			Cancer Prevention and Research Institute of Texas (CPRIT) [RP120717-P3, RP120717-AC, RP120717-P1]; Welch Foundation [I-1304]; NIH [RO1 CA215063]	Cancer Prevention and Research Institute of Texas (CPRIT); Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.R. RP120717-P3 Cancer Prevention and Research Institute of Texas (CPRIT) https://www.cprit.state.tx.us/J.R.I-1304 Welch Foundation https://welch1.org/Z.P.L.RP120717-AC and RP120717-P1 Cancer Prevention and Research Institute of Texas (CPRIT) https://www.cprit.state.tx.us/Z.P.L.RO1 CA215063 NIH https://www.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, Lancet, V346, P265; Attard G, 2009, CANCER CELL, V16, P458, DOI 10.1016/j.ccr.2009.11.006; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Bouchard JJ, 2018, MOL CELL, V72, P19, DOI 10.1016/j.molcel.2018.08.027; Cao SB, 2016, ENDOCR-RELAT CANCER, V23, pT199, DOI 10.1530/ERC-16-0298; Case LB, 2019, SCIENCE, V363, P1093, DOI 10.1126/science.aau6313; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Charbonnier S, 2006, PROTEIN EXPRES PURIF, V50, P89, DOI 10.1016/j.pep.2006.06.010; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Davies P, 2008, J MOL ENDOCRINOL, V41, P301, DOI 10.1677/JME-08-0042; De Mol E, 2018, STRUCTURE, V26, P145, DOI 10.1016/j.str.2017.11.007; De Mol E, 2016, ACS CHEM BIOL, V11, P2499, DOI 10.1021/acschembio.6b00182; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doesburg P, 1997, BIOCHEMISTRY-US, V36, P1052, DOI 10.1021/bi961775g; Duan LL, 2019, NUCLEIC ACIDS RES, V47, P11623, DOI 10.1093/nar/gkz1004; Eftekharzadeh B, 2016, BIOPHYS J, V110, P2361, DOI 10.1016/j.bpj.2016.04.022; Eisenberger MA, 1999, NEW ENGL J MED, V341, P1837, DOI 10.1056/NEJM199912093412409; Escobedo A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09923-2; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Huang WYC, 2019, SCIENCE, V363, P1098, DOI 10.1126/science.aau5721; Irvine RA, 2000, HUM MOL GENET, V9, P267, DOI 10.1093/hmg/9.2.267; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jochum T, 2012, BBA-MOL BASIS DIS, V1822, P1070, DOI 10.1016/j.bbadis.2012.02.006; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kumar R, 2011, LIFE SCI, V88, P565, DOI 10.1016/j.lfs.2011.01.021; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lavery DN, 2008, BIOCHEMISTRY-US, V47, P3360, DOI 10.1021/bi702221e; Lee DH, 2020, FASEB J, V34, P3461, DOI 10.1096/fj.201902584R; Lyon AS, 2021, NAT REV MOL CELL BIO, V22, P215, DOI 10.1038/s41580-020-00303-z; Martin EW, 2020, SCIENCE, V367, P694, DOI 10.1126/science.aaw8653; McEwan IJ, 2012, MOL BIOSYST, V8, P82, DOI 10.1039/c1mb05249g; Myung JK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.017413; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Oppong E, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7020044; Peeples W, 2021, NAT CHEM BIOL, V17, P693, DOI 10.1038/s41589-021-00801-x; Peng Y, 2019, STRUCTURE, V27, P229, DOI 10.1016/j.str.2018.10.026; Perry AS, 2010, NAT REV UROL, V7, P668, DOI 10.1038/nrurol.2010.185; Peskett TR, 2018, MOL CELL, V70, P588, DOI 10.1016/j.molcel.2018.04.007; Quayle SN, 2007, P NATL ACAD SCI USA, V104, P1331, DOI 10.1073/pnas.0606718104; Rizo J, 2012, J MOL CELL BIOL, V4, P270, DOI 10.1093/jmcb/mjs036; Roggero CM, 2021, ONCOGENE, V40, P1106, DOI 10.1038/s41388-020-01585-5; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shao C, 2019, LIFE SCI, V234, DOI 10.1016/j.lfs.2019.116768; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Stanford JL, 1997, CANCER RES, V57, P1194; Tan MHE, 2015, ACTA PHARMACOL SIN, V36, P3, DOI 10.1038/aps.2014.18; Tibble RW, 2021, NAT CHEM BIOL, V17, P615, DOI 10.1038/s41589-021-00774-x; Tut TG, 1997, J CLIN ENDOCR METAB, V82, P3777, DOI 10.1210/jc.82.11.3777; Wilson EM, 2011, METHODS MOL BIOL, V776, P113, DOI 10.1007/978-1-61779-243-4_8; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yegnasubramanian S, 2004, CANCER RES, V64, P1975, DOI 10.1158/0008-5472.CAN-03-3972	58	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0258876	10.1371/journal.pone.0258876	http://dx.doi.org/10.1371/journal.pone.0258876			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986150	gold, Green Submitted, Green Published			2022-12-27	WOS:000765956200003
J	Stumpf, RP; Li, YZ; Kirkpatrick, B; Litaker, RW; Hubbard, KA; Currier, RD; Harrison, KK; Tomlinson, MC				Stumpf, Richard P.; Li, Yizhen; Kirkpatrick, Barbara; Litaker, R. Wayne; Hubbard, Katherine A.; Currier, Robert D.; Harrison, Katherine Kohler; Tomlinson, Michelle C.			Quantifying Karenia brevis bloom severity and respiratory irritation impact along the shoreline of Southwest Florida	PLOS ONE			English	Article							GULF-OF-MEXICO; HARMFUL ALGAL BLOOMS; RED-TIDE TOXINS; REMOTE-SENSING TECHNIQUES; WESTERN LAKE-ERIE; HUMAN HEALTH; CYANOBACTERIAL BLOOM; PSEUDO-NITZSCHIA; DOMOIC ACID; SHELF	Nearly all annual blooms of the toxic dinoflagellate Karenia brevis (K. brevis) pose a serious threat to coastal Southwest Florida. These blooms discolor water, kill fish and marine mammals, contaminate shellfish, cause mild to severe respiratory irritation, and discourage tourism and recreational activities, leading to significant health and economic impacts in affected communities. Despite these issues, we still lack standard measures suitable for assessing bloom severity or for evaluating the efficacy of modeling efforts simulating bloom initiation and intensity. In this study, historical cell count observations along the southwest Florida shoreline from 1953 to 2019 were used to develop monthly and annual bloom severity indices (BSI). Similarly, respiratory irritation observations routinely reported in Sarasota and Manatee Counties from 2006 to 2019 were used to construct a respiratory irritation index (RI). Both BSI and RI consider spatial extent and temporal evolution of the bloom, and can be updated routinely and used as objective criteria to aid future socioeconomic and scientific studies of K. brevis. These indices can also be used to help managers and decision makers both evaluate the risks along the coast during events and design systems to better respond to and mitigate bloom impacts. Before 1995, sampling was done largely in response to reports of discolored water, fish kills, or respiratory irritation. During this time-frame, lack of sampling during the fall, when blooms typically occur, generally coincided with periods of more frequent-than-usual offshore winds. Consequently, some blooms may have been undetected or under-sampled. As a result, the BSIs before 1995 were likely underestimated and cannot be viewed as accurately as those after 1995. Anomalies in the frequency of onshore wind can also largely account for the discrepancies between BSI and RI during the period from 2006 to 2019. These findings highlighted the importance of onshore wind anomalies when predicting respiratory irritation impacts along beaches.	[Stumpf, Richard P.; Tomlinson, Michelle C.] Natl Ocean Serv, NOAA, Natl Ctr Coastal Ocean Sci, Silver Spring, MD 20910 USA; [Li, Yizhen; Litaker, R. Wayne] Natl Ocean Serv, CSS Inc, NOAA, Natl Ctr Coastal Ocean Sci, Silver Spring, MD USA; [Kirkpatrick, Barbara; Currier, Robert D.; Harrison, Katherine Kohler] Texas A&M Univ, Gulf Mexico Coastal Ocean Observing Syst Reg Asso, Dept Oceanog, College Stn, TX USA; [Hubbard, Katherine A.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); Texas A&M University System; Texas A&M University College Station; Florida Fish & Wildlife Conservation Commission	Stumpf, RP (corresponding author), Natl Ocean Serv, NOAA, Natl Ctr Coastal Ocean Sci, Silver Spring, MD 20910 USA.	Richard.stumpf@noaa.gov	Litaker, Richard Wayne/AAH-2036-2021	Litaker, Richard Wayne/0000-0001-6293-8000; Stumpf, Richard/0000-0001-5531-6860	National Aeronautics and Space Administration, Applied Sciences, ROSES Award [NNH16AC891, NN13ZDA001]; Center for Sponsored Coastal Ocean Research, the National Oceanic and Atmospheric Administration [NA20NOS4780194]	National Aeronautics and Space Administration, Applied Sciences, ROSES Award; Center for Sponsored Coastal Ocean Research, the National Oceanic and Atmospheric Administration	BK received funding from National Aeronautics and Space Administration, Applied Sciences, ROSES Award Number NN13ZDA001, https://appliedsciences.nasa.gov/what-we-do/health-air-quality.RS received funding from National Aeronautics and Space Administration, Applied Sciences, ROSES Award Number NNH16AC891, https://appliedsciences.nasa.gov/what-we-do/health-air-quality.BK received funding from Center for Sponsored Coastal Ocean Research, the National Oceanic and Atmospheric Administration, Award Number, NA20NOS4780194, https://coastalscience.noaa.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2015, IEEE GEOSCI REMOTE S, V12, P2080, DOI 10.1109/LGRS.2015.2448453; Amin R, 2009, OPT EXPRESS, V17, P9126, DOI 10.1364/OE.17.009126; Bossart GD, 1998, TOXICOL PATHOL, V26, P276, DOI 10.1177/019262339802600214; Brand LE, 2007, HARMFUL ALGAE, V6, P232, DOI 10.1016/j.hal.2006.08.005; Cannizzaro JP, 2013, J COASTAL RES, V29, P1257, DOI 10.2112/JCOASTRES-D-12-00223.1; Carvalho GA, 2011, REMOTE SENS ENVIRON, V115, P1, DOI 10.1016/j.rse.2010.07.007; Chew F., 1955, EOS WASHINGTON DC, V36, P963; Clark S, 2019, HARMFUL ALGAE, V88, DOI 10.1016/j.hal.2019.101656; DAVIS CC, 1948, BOT GAZ, V109, P358, DOI 10.1086/335488; DiLeone AMG, 2019, ECOL MODEL, V392, P250, DOI 10.1016/j.ecolmodel.2018.11.022; Dixon LK, 2004, HARMFUL ALGAE 2002, P29; Duan HT, 2009, ENVIRON SCI TECHNOL, V43, P3522, DOI 10.1021/es8031852; Eberhart BTL, 2012, HARMFUL ALGAE, V19, P39, DOI 10.1016/j.hal.2012.05.005; ECOHAB. Ecology and oceanography of harmful algal blooms (ECOHAB), 2003, FIN REP ECOHAB FLOR; El-Habashi A, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8050377; Feinstein A., 1955, U MIAMI MARINE LAB R, P55; Feinstein A., 1956, B MAR SCI, V6, P209; FFWCC. Florida Fish and Wildlife Conservation Commission, 2021, KAR BREV ARCH STAT M; FFWCC. Florida Fish and Wildlife Conservation Commission (FFWCC), 100 YEARS RED TID OF, P2; Fire SE, 2015, MAR ECOL PROG SER, V526, P241, DOI 10.3354/meps11225; Fisher KM, 2005, 047 NOS COOPS NAT OC; Flaherty KE, 2011, ESTUAR COAST, V34, P417, DOI 10.1007/s12237-010-9350-x; Fleming LE, 2006, MAR POLLUT BULL, V53, P545, DOI 10.1016/j.marpolbul.2006.08.012; Fleming LE, 2005, ENVIRON HEALTH PERSP, V113, P650, DOI 10.1289/ehp.7500; Fleming LE, 2005, ENVIRON HEALTH PERSP, V113, P618, DOI 10.1289/ehp.7501; Fleming LE, 2007, CHEST, V131, P187, DOI 10.1378/chest.06-1830; Fleming LE, 2011, HARMFUL ALGAE, V10, P224, DOI 10.1016/j.hal.2010.08.006; Fleming LE, 2009, ENVIRON HEALTH PERSP, V117, P1095, DOI 10.1289/ehp.0900673; Florida Fish and Wildlife Conservation Commission, 2020, HAB MON DAT; Friedman MA, 2005, J INT NEUROPSYCH SOC, V11, P331, DOI 10.1017/S1355617705050381; Gilbes F, 2002, CONT SHELF RES, V22, P2479, DOI 10.1016/S0278-4343(02)00102-4; Gilbes F, 1996, CONT SHELF RES, V16, P1201, DOI 10.1016/0278-4343(95)00065-8; Hardison DR, 2012, J PHYCOL, V48, P844, DOI 10.1111/j.1529-8817.2012.01186.x; Hardison DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058545; Haywood AJ, 2004, J PHYCOL, V40, P165, DOI 10.1111/j.0022-3646.2004.02-149.x; Heil CA, 2014, HARMFUL ALGAE, V38, P127, DOI 10.1016/j.hal.2014.07.016; Heil CA, 2014, HARMFUL ALGAE, V38, P3, DOI 10.1016/j.hal.2014.07.015; Hoagland P, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00538; Hoagland P, 2009, ENVIRON HEALTH PERSP, V117, P1239, DOI 10.1289/ehp.0900645; Hu CM, 2015, SENSORS-BASEL, V15, P2873, DOI 10.3390/s150202873; Huang CC, 2014, ENVIRON EARTH SCI, V71, P3705, DOI 10.1007/s12665-013-2764-6; Kahru M, 2007, MAR ECOL PROG SER, V343, P15, DOI 10.3354/meps06943; Kahru M, 2014, BIOGEOSCIENCES, V11, P3619, DOI 10.5194/bg-11-3619-2014; Kirkpatrick B, 2004, HARMFUL ALGAE, V3, P99, DOI 10.1016/j.hal.2003.08.005; Kirkpatrick B, 2008, SCI TOTAL ENVIRON, V402, P1, DOI 10.1016/j.scitotenv.2008.03.032; Kirkpatrick B, 2011, HARMFUL ALGAE, V10, P138, DOI 10.1016/j.hal.2010.08.005; Kirkpatrick B, 2010, HARMFUL ALGAE, V9, P186, DOI 10.1016/j.hal.2009.09.003; Kleindinst JL, 2014, DEEP-SEA RES PT II, V103, P277, DOI 10.1016/j.dsr2.2013.03.027; Kusek Kristen M., 1999, Contributions in Marine Science, V34, P1; Landsberg JH, 2009, HARMFUL ALGAE, V8, P598, DOI 10.1016/j.hal.2008.11.010; Lewitus AJ, 2012, HARMFUL ALGAE, V19, P133, DOI 10.1016/j.hal.2012.06.009; Liu YG, 2016, J GEOPHYS RES-OCEANS, V121, P5501, DOI 10.1002/2016JC011938; Magana HA, 2003, HARMFUL ALGAE, V2, P163, DOI 10.1016/S1568-9883(03)00026-X; Matthews MW, 2015, S AFR J SCI, V111, P77; Matthews MW, 2014, REMOTE SENS ENVIRON, V155, P161, DOI 10.1016/j.rse.2014.08.010; Maze G, 2015, HARMFUL ALGAE, V50, P1, DOI 10.1016/j.hal.2015.10.003; McKibben SM, 2015, HARMFUL ALGAE, V50, P32, DOI 10.1016/j.hal.2015.10.004; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Morgan KL, 2009, HARMFUL ALGAE, V8, P212, DOI 10.1016/j.hal.2008.05.002; NOAA. National Oceanographic and Atmospheric Administration, OCEANREPORTS OC BIOP; OSHEA TJ, 1991, MAR MAMMAL SCI, V7, P165, DOI 10.1111/j.1748-7692.1991.tb00563.x; Pierce RH, 2008, ECOTOXICOLOGY, V17, P623, DOI 10.1007/s10646-008-0241-x; Pierce RH, 2005, HARMFUL ALGAE, V4, P965, DOI 10.1016/j.hal.2004.11.004; Reich A, 2015, HARMFUL ALGAE, V43, P13, DOI 10.1016/j.hal.2014.12.003; Rounsefell GA, 1966, 535 US FISH WILDL SE; Sagarese SR, 2017, ECOL MODEL, V345, P75, DOI 10.1016/j.ecolmodel.2016.11.001; Sayers MJ, 2019, J GREAT LAKES RES, V45, P508, DOI 10.1016/j.jglr.2019.01.005; Smith J, 2018, HARMFUL ALGAE, V79, P87, DOI 10.1016/j.hal.2018.07.007; Soto IM, 2015, REMOTE SENS ENVIRON, V170, P239, DOI 10.1016/j.rse.2015.09.026; Steidinger KA, 2009, HARMFUL ALGAE, V8, P549, DOI 10.1016/j.hal.2008.11.009; Stumpf RP, 2008, CONT SHELF RES, V28, P189, DOI 10.1016/j.csr.2007.04.017; Stumpf RP, 2016, J GREAT LAKES RES, V42, P1174, DOI 10.1016/j.jglr.2016.08.006; Stumpf RP, 2016, HARMFUL ALGAE, V54, P160, DOI 10.1016/j.hal.2016.01.005; Stumpf RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042444; Stumpf RP, 2009, J MARINE SYST, V76, P151, DOI 10.1016/j.jmarsys.2008.05.016; Stumpf RP, 2003, HARMFUL ALGAE, V2, P147, DOI 10.1016/S1568-9883(02)00083-5; Stumpf RP, 2001, HUM ECOL RISK ASSESS, V7, P1363, DOI 10.1080/20018091095050; TBRPC, 2019, EC RIPPL EFF FLOR RE; Tester PA, 1997, LIMNOL OCEANOGR, V42, P1039, DOI 10.4319/lo.1997.42.5_part_2.1039; Tomlinson MC, 2009, REMOTE SENS ENVIRON, V113, P598, DOI 10.1016/j.rse.2008.11.003; Tomlinson MC, 2004, REMOTE SENS ENVIRON, V91, P293, DOI 10.1016/j.rse.2004.02.014; Trainer VL, 2009, LIMNOL OCEANOGR, V54, P289, DOI 10.4319/lo.2009.54.1.0289; VARGO GA, 1987, LIMNOL OCEANOGR, V32, P762, DOI 10.4319/lo.1987.32.3.0762; Vargo GA, 2008, CONT SHELF RES, V28, P73, DOI 10.1016/j.csr.2007.04.008; Walsh JJ, 2001, J GEOPHYS RES-OCEANS, V106, P11597, DOI 10.1029/1999JC000123; Wynne TT, 2015, TOXINS, V7, P1649, DOI 10.3390/toxins7051649; Wynne TT, 2010, LIMNOL OCEANOGR, V55, P2025, DOI 10.4319/lo.2010.55.5.2025; Wynne TT, 2005, HARMFUL ALGAE, V4, P992, DOI 10.1016/j.hal.2005.02.004	88	4	4	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0260755	10.1371/journal.pone.0260755	http://dx.doi.org/10.1371/journal.pone.0260755			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986155	gold, Green Published			2022-12-27	WOS:000765956200007
J	Ashour, A; Phipps, DL; Ashcroft, DM				Ashour, Ahmed; Phipps, Denham L.; Ashcroft, Darren M.			Predicting dispensing errors in community pharmacies: An application of the Systematic Human Error Reduction and Prediction Approach (SHERPA)	PLOS ONE			English	Article							FAILURE MODE; RISK ANALYSIS; HEALTH-CARE; MEDICATION	Introduction The objective of this study was to use a prospective error analysis method to examine the process of dispensing medication in community pharmacy settings and identify remedial solutions to avoid potential errors, categorising them as strong, intermediate, or weak based on an established patient safety action hierarchy tool. Method Focus group discussions and non-participant observations were undertaken to develop a Hierarchical Task Analysis (HTA), and subsequent focus group discussions applied the Systematic Human Error Reduction and Prediction Approach (SHERPA) focusing on the task of dispensing medication in community pharmacies. Remedial measures identified through the SHERPA analysis were then categorised as strong, intermediate, or weak based on the Veteran Affairs National Centre for Patient Safety action hierarchy. Non-participant observations were conducted at 3 pharmacies, totalling 12 hours, based in England. Additionally, 7 community pharmacists, with experience ranging from 8 to 38 years, participated in a total of 4 focus groups, each lasting between 57 to 85 minutes, with one focus group discussing the HTA and three applying SHERPA. A HTA was produced consisting of 10 sub-tasks, with further levels of sub-tasks within each of them. Results Overall, 88 potential errors were identified, with a total of 35 remedial solutions proposed to avoid these errors in practice. Sixteen (46%) of these remedial measures were categorised as weak, 14 (40%) as intermediate and 5 (14%) as strong according to the Veteran Affairs National Centre for Patient Safety action hierarchy. Sub-tasks with the most potential errors were identified, which included 'producing medication labels' and 'final checking of medicines'. The most common type of error determined from the SHERPA analysis related to omitting a check during the dispensing process which accounted for 19 potential errors. Discussion This work applies both HTA and SHERPA for the first time to the task of dispensing medication in community pharmacies, detailing the complexity of the task and highlighting potential errors and remedial measures specific to this task. Future research should examine the effectiveness of the proposed remedial solutions to improve patient safety.	[Ashour, Ahmed; Phipps, Denham L.; Ashcroft, Darren M.] Univ Manchester, Fac Biol Med & Hlth, Ctr Pharmacoepidemiol & Drug Safety, Sch Hlth Sci,Div Pharm & Optometry, Manchester, Lancs, England; [Ashour, Ahmed; Ashcroft, Darren M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Greater Manchester Patient Safety Translat R, Manchester, Lancs, England; [Ashcroft, Darren M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Sch Primary Care Res, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Ashour, A (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Ctr Pharmacoepidemiol & Drug Safety, Sch Hlth Sci,Div Pharm & Optometry, Manchester, Lancs, England.; Ashour, A (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Greater Manchester Patient Safety Translat R, Manchester, Lancs, England.	ahmed.ashour@postgrad.manchester.ac.uk		Ashour, Ahmed/0000-0003-1645-1810	National Institute for Health Research (NIHR) through the Greater Manchester Patient Safety Translational Research Centre [PSTRC-2016-003]	National Institute for Health Research (NIHR) through the Greater Manchester Patient Safety Translational Research Centre(National Institute for Health Research (NIHR))	This work was funded by the National Institute for Health Research (NIHR) through the Greater Manchester Patient Safety Translational Research Centre (award number: PSTRC-2016-003). The views expressed are those of the author (s) and not necessarily those of the NIHR or the Department of Health and Social Care.	Annett J., 2004, HDB HUMAN FACTORS ER, P355; Ashley Laura, 2010, J Patient Saf, V6, P210, DOI 10.1097/PTS.0b013e3181fc98d7; Ashley L, 2010, JT COMM J QUAL PATIE, V36, P351, DOI 10.1016/S1553-7250(10)36053-3; Ashour A, 2021, APPL ERGON, V93, DOI 10.1016/j.apergo.2021.103372; Aspden P., 2006, I MED, P26; Bowie P, 2016, EDUC PRIM CARE, V27, P86, DOI 10.1080/14739879.2016.1152658; CIEHF, 2016, HUM FACT BARR MAN; Donaldson LJ, 2017, LANCET, V389, P1680, DOI 10.1016/S0140-6736(17)31047-4; Elliott RA, 2021, BMJ QUAL SAF, V30, P96, DOI 10.1136/bmjqs-2019-010206; Embrey D., 2014, PROC INT S HUM FACTO, V3, P246; Embrey DE., 1986, SHERPA SYSTEMATIC HU; Greenall J., 2007, CAN PHARM J REV PHAR, V140, P191, DOI [10.1177/171516350714000324, DOI 10.1177/171516350714000324]; Habraken MMP, 2009, ERGONOMICS, V52, P809, DOI 10.1080/00140130802578563; Harris D, 2005, AEROSP SCI TECHNOL, V9, P525, DOI 10.1016/j.ast.2005.04.002; Harvey J, 2015, RES SOC ADMIN PHARM, V11, P216, DOI 10.1016/j.sapharm.2014.06.005; Kessels-Habraken M, 2009, INT J QUAL HEALTH C, V21, P427, DOI 10.1093/intqhc/mzp043; Knudsen P, 2007, QUAL SAF HEALTH CARE, V16, P285, DOI 10.1136/qshc.2006.022053; Li YF, 2020, QUAL RELIAB ENG INT, V36, P1657, DOI 10.1002/qre.2652; Mandal S, 2015, EXPERT SYST APPL, V42, P7195, DOI 10.1016/j.eswa.2015.05.033; McLeod RW, 2017, PROCESS SAF ENVIRON, V110, P31, DOI 10.1016/j.psep.2017.01.012; Napier P, 2018, RES SOC ADMIN PHARM, V14, P382, DOI 10.1016/j.sapharm.2017.05.002; National Patient Safety Foundation, 2016, RCA2 IMPR ROOT CAUS; NHS Digital, 2019, GEN PHARM SERV ENGL; Panagioti M, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4185; Phipps D, 2008, BRIT J ANAESTH, V100, P333, DOI 10.1093/bja/aem392; Phipps DL, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-158; Raduma-Tomas MA, 2012, BMJ QUAL SAF, V21, P211, DOI 10.1136/bmjqs-2011-000220; Roberts Alison S, 2005, Res Social Adm Pharm, V1, P546, DOI 10.1016/j.sapharm.2005.09.003; Shebl NA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-150; Shebl Nada Atef, 2009, J Patient Saf, V5, P86, DOI 10.1097/PTS.0b013e3181a6f040; Sheikh A, 2017, B WORLD HEALTH ORGAN, V95, P546, DOI 10.2471/BLT.17.198002; Stanton N.A., 2013, HUMAN FACTORS METHOD; Stojkovic T, 2021, J PATIENT SAF, V17, pe515, DOI 10.1097/PTS.0000000000000403; Stojkovic T, 2018, INT J HEALTH PLAN M, V33, pE320, DOI 10.1002/hpm.2479; Stojkovic T, 2017, RES SOC ADMIN PHARM, V13, P1159, DOI 10.1016/j.sapharm.2016.11.009; Sujan MA, 2020, RELIAB ENG SYST SAFE, V194, DOI 10.1016/j.ress.2018.06.017; Vosper Helen, 2018, Am J Pharm Educ, V82, P6184, DOI 10.5688/ajpe6184; Weir NM, 2020, RES SOC ADMIN PHARM, V16, P637, DOI 10.1016/j.sapharm.2019.08.029; Wetterneck TB, 2006, AM J HEALTH-SYST PH, V63, P1528, DOI 10.2146/ajhp050515; Wood LJ, 2020, INT J QUAL HEALTH C, V32, P438, DOI 10.1093/intqhc/mzaa068	40	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0261672	10.1371/journal.pone.0261672	http://dx.doi.org/10.1371/journal.pone.0261672			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982776	Green Published, gold			2022-12-27	WOS:000834805700011
J	Hendley, SA; Bhargava, A; Holland, CK; Wool, GD; Ahmed, O; Paul, JD; Bader, KB				Hendley, Samuel A.; Bhargava, Aarushi; Holland, Christy K.; Wool, Geoffrey D.; Ahmed, Osman; Paul, Jonathan D.; Bader, Kenneth B.			(More than) doubling down: Effective fibrinolysis at a reduced rt-PA dose for catheter-directed thrombolysis combined with histotripsy	PLOS ONE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; PULSED FOCUSED ULTRASOUND; DEEP VENOUS THROMBOSIS; IN-VITRO; VEIN THROMBOSIS; HIGH-INTENSITY; CAVITATION; THERAPY; DEGRADATION; MECHANISMS	Deep vein thrombosis is a major source of morbidity and mortality worldwide. For acute proximal deep vein thrombosis, catheter-directed thrombolytic therapy is an accepted method for vessel recanalization. Thrombolytic therapy is not without risk, including the potential for hemorrhagic bleeding that increases with lytic dose. Histotripsy is a focused ultrasound therapy that generates bubble clouds spontaneously in tissue at depth. The mechanical activity of histotripsy increases the efficacy of thrombolytic therapy at doses consistent with current pharmacomechanical treatments for venous thrombosis. The objective of this study was to determine the influence of lytic dose on histotripsy-enhanced fibrinolysis. Human whole blood clots formed in vitro were exposed to histotripsy and a thrombolytic agent (recombinant tissue plasminogen activator, rt-PA) in a venous flow model perfused with plasma. Lytic was administered into the clot via an infusion catheter at concentrations ranging from 0 (control) to 4.54 mu g/mL (a common clinical dose for catheter-directed thrombolysis). Following treatment, perfusate samples were assayed for markers of fibrinolysis, hemolysis, and intact red blood cells and platelets. Fibrinolysis was equivalent between the common clinical dose of rt-PA (4.54 mu g/mL) and rt-PA at a reduction to one-twentieth of the common clinical dose (0.23 mu g/mL) when combined with histotripsy. Minimal changes were observed in hemolysis for treatment arms with or without histotripsy, potentially due to clot damage from insertion of the infusion catheter. Likewise, histotripsy did not increase the concentration of red blood cells or platelets in the perfusate following treatment compared to rt-PA alone. At the highest lytic dose, a refined histotripsy exposure scheme was implemented to cover larger areas of the clot. The updated exposure scheme improved clot mass loss and fibrinolysis relative to administration of lytic alone. Overall, the data collected in this study indicate the rt-PA dose can be reduced by more than a factor of ten and still promote fibrinolysis when combined with histotripsy.	[Hendley, Samuel A.; Bader, Kenneth B.] Univ Chicago, Comm Med Phys, Chicago, IL 60637 USA; [Bhargava, Aarushi; Ahmed, Osman; Bader, Kenneth B.] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; [Holland, Christy K.] Univ Cincinnati, Dept Internal Med, Cincinnati, OH USA; [Holland, Christy K.] Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH USA; [Wool, Geoffrey D.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Paul, Jonathan D.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Chicago; University of Chicago	Bader, KB (corresponding author), Univ Chicago, Comm Med Phys, Chicago, IL 60637 USA.; Bader, KB (corresponding author), Univ Chicago, Dept Radiol, Chicago, IL 60637 USA.	baderk@uchicago.edu			National Heart, Lung, and Blood Institute [R01 HL133334]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov/), Grant Number R01 HL133334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia C, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816750; Bader KB, 2021, IEEE T BIO-MED ENG, V68, P1220, DOI 10.1109/TBME.2020.3023630; Bader KB, 2019, ULTRASOUND MED BIOL, V45, P1056, DOI 10.1016/j.ultrasmedbio.2018.10.035; Bader KB, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aab79b; Bader KB, 2016, PHYS MED BIOL, V61, P5253, DOI 10.1088/0031-9155/61/14/5253; Bader KB, 2016, ULTRASOUND MED BIOL, V42, P1701, DOI 10.1016/j.ultrasmedbio.2016.02.010; Bader KB, 2016, ADV EXP MED BIOL, V880, P339, DOI 10.1007/978-3-319-22536-4_19; Bader KB, 2015, ULTRASOUND MED BIOL, V41, P187, DOI 10.1016/j.ultrasmedbio.2014.08.018; Bajd Franci, 2012, Microcirculation, V19, P632, DOI 10.1111/j.1549-8719.2012.00198.x; Bajd F, 2010, THROMB RES, V126, P137, DOI 10.1016/j.thromres.2010.04.012; Bollen T, 2020, ULTRASOUND MED BIOL, V46, P336, DOI 10.1016/j.ultrasmedbio.2019.10.009; BRENNER B, 1990, CIRCULATION, V81, P1818, DOI 10.1161/01.CIR.81.6.1818; Chen JX, 2016, RADIOGRAPHICS, V36, P1565, DOI 10.1148/rg.2016150138; Coviello C, 2015, J ACOUST SOC AM, V137, P2573, DOI 10.1121/1.4916694; Czaplicki C, 2017, CARDIOVASC DIAGN THE, V7, pS186, DOI 10.21037/cdt.2017.11.05; Duck F.A., 1990, MED PHYS, V18; Go AS, 2013, CIRCULATION, V127, pE841, DOI 10.1161/CIR.0b013e31829ae08c; Goel L, 2021, ULTRASOUND MED BIOL, V47, P3231, DOI 10.1016/j.ultrasmedbio.2021.07.018; Goel L, 2021, MICROSYST NANOENG, V7, DOI 10.1038/s41378-020-00228-9; Graham SM, 2014, J CONTROL RELEASE, V178, P101, DOI 10.1016/j.jconrel.2013.12.016; Haworth KJ, 2017, IEEE T ULTRASON FERR, V64, P177, DOI 10.1109/TUFFC.2016.2620492; Haynes W., 2013, ENCY SYSTEMBIOL, P2354, DOI [10.1007/978-1-4419-9863-7_1185, DOI 10.1007/978-1-4419-9863-7_1185]; Hendley SA, 2021, IEEE T ULTRASON FERR, V68, P2942, DOI 10.1109/TUFFC.2021.3052393; Hilleman DE, 2008, J VASC INTERV RADIOL, V19, P377, DOI 10.1016/j.jvir.2007.10.027; Hitchcock KE, 2011, ULTRASOUND MED BIOL, V37, P1240, DOI 10.1016/j.ultrasmedbio.2011.05.011; Holland CK, 2008, THROMB RES, V121, P663, DOI 10.1016/j.thromres.2007.07.006; Jensen CT, 2017, J ULTRAS MED, V36, P1867, DOI 10.1002/jum.14220; Khokhlova VA, 2015, INT J HYPERTHER, V31, P145, DOI 10.3109/02656736.2015.1007538; Kieran K, 2007, J UROLOGY, V178, P672, DOI 10.1016/j.juro.2007.03.093; Kleven RT, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83442-3; Kolbel T, 2008, J ENDOVASC THER, V15, P605, DOI 10.1583/08-2462.1; Lafond M, 2021, ULTRASOUND MED BIOL, V47, P693, DOI 10.1016/j.ultrasmedbio.2020.10.010; Li T, 2015, CANCER RES, V75, P3738, DOI 10.1158/0008-5472.CAN-15-0296; Lin KW, 2014, IEEE T ULTRASON FERR, V61, P1123, DOI 10.1109/TUFFC.2014.3012; Maxwell AD, 2022, IEEE T ULTRASON FERR, V69, P156, DOI 10.1109/TUFFC.2021.3113635; Maxwell AD, 2017, IEEE T ULTRASON FERR, V64, P1542, DOI 10.1109/TUFFC.2017.2739649; Maxwell AD, 2014, PHYS MED BIOL, V59, P4927, DOI 10.1088/0031-9155/59/17/4927; Maxwell AD, 2013, ULTRASOUND MED BIOL, V39, P449, DOI 10.1016/j.ultrasmedbio.2012.09.004; Maxwell AD, 2011, J ACOUST SOC AM, V130, P1888, DOI 10.1121/1.3625239; Maxwell AD, 2011, J VASC INTERV RADIOL, V22, P369, DOI 10.1016/j.jvir.2010.10.007; Mercado-Shekhar KP, 2018, ULTRASOUND MED BIOL, V44, P2710, DOI 10.1016/j.ultrasmedbio.2018.08.005; Mewissen MW, 1999, RADIOLOGY, V211, P39, DOI 10.1148/radiology.211.1.r99ap4739; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Nyamekye I, 2012, PHLEBOLOGY, V27, P61, DOI 10.1258/phleb.2012.012S37; Rathbun S, 2009, CIRCULATION, V119, pE480, DOI 10.1161/CIRCULATIONAHA.108.841403; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Sharafuddin MJA, 1998, J VASC INTERV RADIOL, V9, P15, DOI 10.1016/S1051-0443(98)70477-4; Shaw George J, 2009, BMC Res Notes, V2, P117, DOI 10.1186/1756-0500-2-117; Spencer FA, 2006, J GEN INTERN MED, V21, P722, DOI 10.1111/j.1525-1497.2006.00458.x; TURI ZG, 1993, AM J CARDIOL, V71, P1009, DOI 10.1016/0002-9149(93)90564-S; Vedantham S, 2017, NEW ENGL J MED, V377, P2240, DOI 10.1056/NEJMoa1615066; Vedantham S, 2016, J THROMB THROMBOLYS, V41, P68, DOI 10.1007/s11239-015-1318-z; Virani SS, 2021, CIRCULATION, V143, pe254, DOI 10.1161/CIR.0000000000000950; Vlaisavljevich E, 2016, ULTRASOUND MED BIOL, V42, P931, DOI 10.1016/j.ultrasmedbio.2015.11.027; Vlaisavljevich E, 2014, PHYS MED BIOL, V59, P253, DOI 10.1088/0031-9155/59/2/253; Waheed SM., 2021, DEEP VEIN THROMBOSIS; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; Wang TY, 2012, ULTRASOUND MED BIOL, V38, P753, DOI 10.1016/j.ultrasmedbio.2012.01.013; Wolf MF, 2021, J BIOMED MATER RES B, V109, P358, DOI 10.1002/jbm.b.34705; Wright CC, 2012, IEEE T BIO-MED ENG, V59, P842, DOI 10.1109/TBME.2011.2180904; Xu Z, 2021, INT J HYPERTHER, V38, P561, DOI 10.1080/02656736.2021.1905189; Zhang X, 2017, ULTRASOUND MED BIOL, V43, P1378, DOI 10.1016/j.ultrasmedbio.2017.01.028; Zhang X, 2015, IEEE T ULTRASON FERR, V62, P1342, DOI 10.1109/TUFFC.2015.007016	63	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0261567	10.1371/journal.pone.0261567	http://dx.doi.org/10.1371/journal.pone.0261567			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982784	gold, Green Published			2022-12-27	WOS:000834805700010
J	Al-Sawalha, NA; Almomani, BA; Mokhemer, E; Al-Shatnawi, SF; Bdeir, R				Al-Sawalha, Nour A.; Almomani, Basima A.; Mokhemer, Enas; Al-Shatnawi, Samah F.; Bdeir, Roba			E-cigarettes use among university students in Jordan: Perception and related knowledge	PLOS ONE			English	Article							ELECTRONIC CIGARETTE; UNITED-STATES; PRODUCT USE; TOBACCO; SMOKING; ADULTS; INFORMATION; EXPOSURE; BELIEFS; MESSAGE	The use of e-cigarettes has been increasing in popularity among people, especially young adults. Assessing young individuals' perceptions of e-cigarettes can help to identify factors that may influence their decision to use e-cigarettes. To examine prevalence, perceptions, and knowledge of e-cigarettes among university students in Jordan, an observational cross-sectional study using an online self-administered questionnaire was conducted among students from public and private universities between October 2020 and January 2021. A total of 1259 university students completed the questionnaire. Approximately, 11% of participants reported e-cigarettes use. Among users, 26.5% used it for the purpose of smoking cessation, while 22% of them used it out of curiosity, and 20.5% used it as they believed it is less harmful than other tobacco products. Multivariate analysis showed that conventional cigarette smokers were independently associated with a better knowledge about e-cigarettes (OR = 1.496, 95CI% = 1.018-2.197, p-value = 0.040). In addition, medical students showed a significantly better knowledge compared to non-medical students (OR = 1.710, 95CI% = 1.326-2.204, p-value = <0.001). In Jordan, e-cigarettes use is less popular compared to other countries. Nonetheless, educational interventions are needed to correct misconceptions about e-cigarettes among young adults.	[Al-Sawalha, Nour A.; Almomani, Basima A.; Al-Shatnawi, Samah F.] Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan; [Mokhemer, Enas; Bdeir, Roba] Jadara Univ, Fac Pharm, Irbid, Jordan	Jordan University of Science & Technology	Al-Sawalha, NA (corresponding author), Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan.	nasawalha@just.edu.jo		Alshatnawi, Samah/0000-0001-8863-0258	Deanship of Research at Jordan University of Science and Technology [20200501]	Deanship of Research at Jordan University of Science and Technology	The work was supported by Deanship of Research at Jordan University of Science and Technology (grant number 20200501) to NAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Qader DH, 2021, J COMMUN HEALTH, V46, P577, DOI 10.1007/s10900-020-00896-8; Aghar H, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8381-x; Al-Balas H, 2021, J COMMUN HEALTH, V46, P803, DOI 10.1007/s10900-020-00953-2; Al-Balas HI, 2021, J COMMUN HEALTH, V46, P587, DOI 10.1007/s10900-020-00904-x; Almutham A, 2019, J FAM MED PRIM CARE, V8, P2921, DOI 10.4103/jfmpc.jfmpc_567_19; Antoniewicz L, 2019, CARDIOVASC TOXICOL, V19, P441, DOI 10.1007/s12012-019-09516-x; Bao W, 2018, JAMA-J AM MED ASSOC, V319, P2039, DOI 10.1001/jama.2018.4658; Bekki K, 2014, INT J ENV RES PUB HE, V11, P11192, DOI 10.3390/ijerph111111192; Brown J, 2014, ADDICT BEHAV, V39, P1120, DOI 10.1016/j.addbeh.2014.03.009; Brozek G, 2017, ADV RESPIR MED, V85, P8, DOI 10.5603/ARM.2017.0003; Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417; Chudech S, 2021, J PUBLIC HEALTH RES, V10, DOI 10.4081/jphr.2021.1912; Coleman BN, 2017, TOB CONTROL, V26, pe117, DOI 10.1136/tobaccocontrol-2016-053462; Collins L, 2019, NICOTINE TOB RES, V21, P14, DOI 10.1093/ntr/ntx284; Cooper M, 2017, J AM COLL HEALTH, V65, P103, DOI 10.1080/07448481.2016.1254638; Corrigan JR, 2020, ADDICT BEHAV, V105, DOI 10.1016/j.addbeh.2020.106324; Dawkins L, 2013, ADDICTION, V108, P1115, DOI 10.1111/add.12150; Emery SL, 2014, TOB CONTROL, V23, P17, DOI 10.1136/tobaccocontrol-2014-051648; Evans ME, 2020, MMWR-MORBID MORTAL W, V68, P1189, DOI 10.15585/mmwr.mm685152e2; Farajat M, 2011, J DEV ORIG HLTH DIS, V2, P152, DOI 10.1017/S2040174411000122; Farrelly MC, 2015, AM J PREV MED, V49, P686, DOI 10.1016/j.amepre.2015.05.010; Franks AM, 2017, CURR PHARM TEACH LEA, V9, P1003, DOI 10.1016/j.cptl.2017.07.023; Gee RE, 2021, AM J PUBLIC HEALTH, V111, P224, DOI 10.2105/AJPH.2020.306072; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Gotts JE, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5275; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Gupta V, 2020, OPEN MED-WARSAW, V15, P796, DOI 10.1515/med-2020-0224; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; Jankowski M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16132279; Jiang N, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7464-z; Kalkhoran S, 2016, LANCET RESP MED, V4, P116, DOI 10.1016/S2213-2600(15)00521-4; Kanyadan V, 2019, CUREUS, V11, DOI 10.7759/cureus.5234; Khabour OF, 2012, INT J TUBERC LUNG D, V16, P986, DOI 10.5588/ijtld.11.0764; Mantey DS, 2016, J ADOLESCENT HEALTH, V58, P686, DOI 10.1016/j.jadohealth.2016.03.003; Morean ME, 2016, DRUG ALCOHOL DEPEN, V167, P224, DOI 10.1016/j.drugalcdep.2016.06.031; Ndunda PM., 2019, STROKE, V50, pA9, DOI [10.1161/str.50.suppl_1.9, DOI 10.1161/STR.50.SUPPL_1.9]; Ogunwale MA, 2017, ACS OMEGA, V2, P1207, DOI 10.1021/acsomega.6b00489; Padon Alisa A, 2017, Tob Regul Sci, V3, P95, DOI 10.18001/TRS.3.1.9; Paek HJ, 2014, J HEALTH COMMUN, V19, P545, DOI 10.1080/10810730.2013.821560; Pepper JK, 2015, J BEHAV MED, V38, P318, DOI 10.1007/s10865-014-9605-2; Puteh SEW, 2018, TOB INDUC DIS, V16, DOI 10.18332/tid/99539; Qanash S, 2019, ANN THORAC MED, V14, P56, DOI 10.4103/atm.ATM_76_18; Ralho A, 2019, J EVID-BASED DENT PR, V19, DOI 10.1016/j.jebdp.2019.04.002; Snider SE, 2017, DRUG ALCOHOL DEPEN, V177, P14, DOI 10.1016/j.drugalcdep.2017.03.017; Soneji S, 2017, JAMA PEDIATR, V171, P788, DOI 10.1001/jamapediatrics.2017.1488; Stoklosa M, 2016, NICOTINE TOB RES, V18, P1973, DOI 10.1093/ntr/ntw109; van der Tempel J, 2016, INT J PUBLIC HEALTH, V61, P249, DOI 10.1007/s00038-016-0791-2; Villarroel Maria A, 2020, NCHS Data Brief, P1; Vogel EA, 2020, TOB CONTROL, V29, P258, DOI 10.1136/tobaccocontrol-2018-054900; Wang TW, 2018, MMWR-MORBID MORTAL W, V67, P1225, DOI 10.15585/mmwr.mm6744a2; Zawertailo L, 2017, NICOTINE TOB RES, V19, P183, DOI 10.1093/ntr/ntw218; Zhan YC, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.5780; Zhou S, 2015, ACAD MED, V90, P1713, DOI 10.1097/ACM.0000000000000873	53	3	3	26	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262090	10.1371/journal.pone.0262090	http://dx.doi.org/10.1371/journal.pone.0262090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972196	Green Published, gold			2022-12-27	WOS:000773555700096
J	Campagna, S; Borraccino, A; Politano, G; Dalmasso, M; Ravaglia, A; Dimonte, V; Gianino, MM				Campagna, Sara; Borraccino, Alberto; Politano, Gianfranco; Dalmasso, Marco; Ravaglia, Aldo; Dimonte, Valerio; Gianino, Maria Michela			Emergency-department accesses in home care paediatric patients: Occurrence and risks of use in a six-year retrospective investigation in Northern Italy	PLOS ONE			English	Article							CHRONIC RESPIRATORY-FAILURE; WELL-CHILD CARE; HEALTH-CARE; FEASIBILITY; MANAGEMENT; SERVICES; QUALITY	Objective To assess the determinants of ED use in paediatric patients enrolled in an Integrated Paediatric Home Care (IPHC) program. Methods A retrospective study was conducted using administrative databases on a cohort of patients enrolled in an IPHC program between January 1st, 2012, and December 31st, 2017, in Northern Italy. ED visits that occurred during the IPHC program were considered. Data were collected considering sociodemographic, clinical and organizational variables. A multivariable stepwise logistic regression analysis was performed. The dependent variable to identify possible associations was ED visit. Results A total of 463 ED visits occurred in 465 children, with an incidence rate of 1. The risk of ED visits significantly increased among children involved in the IPHC program after hospital discharge (OR 1.94). Additionally, the risk of ED visits increased significantly as the duration of IPHC increased (OR 5.80 between 101 and 200 days, to OR 7.84 between 201 and 300 days, OR 12.54 between 301 and 400 days and OR 18.67 to more than 400 days). Conclusion The overall results represent a practical perspective to contribute improving both the service quality of IPHC and reducing low acuity and improper ED use.	[Campagna, Sara; Borraccino, Alberto; Dimonte, Valerio; Gianino, Maria Michela] Univ Torino, Dept Publ Hlth & Paediat, Turin, Italy; [Politano, Gianfranco] Politecn Torino, Dept Control & Comp Engn, Turin, Italy; [Dalmasso, Marco] Local Hlth Unit T03, Epidemiol Unit, Piedmont Region, Italy; [Ravaglia, Aldo] Local Hlth Unit T03, Piedmont Region, Italy	University of Turin; Polytechnic University of Turin	Borraccino, A (corresponding author), Univ Torino, Dept Publ Hlth & Paediat, Turin, Italy.	alberto.borraccino@unito.it	Borraccino, Alberto/C-9013-2012	Borraccino, Alberto/0000-0001-8235-8775; Campagna, Sara/0000-0003-2722-1818				Appierto L, 2002, PAEDIATR ANAESTH, V12, P345, DOI 10.1046/j.1460-9592.2002.00856.x; Brousseau DC, 2007, PEDIATRICS, V119, P1131, DOI 10.1542/peds.2006-3518; Campagna S., 2020, INT J HEALTH POLICY; Casavant DW, 2014, J TELEMED TELECARE, V20, P441, DOI 10.1177/1357633X14555620; Castor C, 2017, J CLIN NURS, V26, P2784, DOI 10.1111/jocn.13821; Corsello G, 2016, J PEDIATR-US, V177, pS116, DOI 10.1016/j.jpeds.2016.04.048; Davis T, 2018, J AM BOARD FAM MED, V31, P550, DOI 10.3122/jabfm.2018.04.170474; Deliberazione della Giunta Regionale, 2020, LIN GUID ATT SERV CU, P22; Dipartimento per lo Sviluppo e la Coesione Economica, 2012, AR INT QUAL TERR PAR; Farion KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128927; Foster CC, 2019, HEALTH AFFAIR, V38, P987, DOI 10.1377/hlthaff.2018.05531; Frierdich Sharon, 2003, J Pediatr Oncol Nurs, V20, P252, DOI 10.1177/1043454203254052; Graham RJ, 2017, HEALTHCARE-J DEL SCI, V5, P23, DOI 10.1016/j.hjdsi.2016.04.002; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; ISTAT Istituto Nazionale di Statistica, 2019, 9788845820038 ISTAT; Jha AK, 2006, JAMA-J AM MED ASSOC, V296, P95, DOI 10.1001/jama.296.1.95; Johnson EK, 2013, J UROLOGY, V190, P17, DOI 10.1016/j.juro.2013.04.048; Kirk S, 2004, CHILD CARE HLTH DEV, V30, P209, DOI 10.1111/j.1365-2214.2004.00393.x; Miano M, 2002, HAEMATOLOGICA, V87, P637; Ministero della Salute del Lavoro e delle Politiche Sociali, 2009, GAZZETTA UFFICIALE, V6, P30; Nunes MS, 2016, EPIR TOOLS ANAL EPID; Page B, 2019, ARCH DIS CHILD, V104, P1174, DOI 10.1136/archdischild-2019-317090; Parab CS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004383.pub3; Parker G, 2002, Health Technol Assess, V6, piii; Peetoom KKB, 2017, ARCH DIS CHILD, V102, P261, DOI 10.1136/archdischild-2016-311042; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Sanghavi DM, 2005, ARCH PEDIAT ADOL MED, V159, P482, DOI 10.1001/archpedi.159.5.482; Sartain SA, 2001, HEALTH SOC CARE COMM, V9, P108, DOI 10.1046/j.1365-2524.2001.00287.x; Tie SW, 2009, ARCH DIS CHILD, V94, P641, DOI 10.1136/adc.2008.144709; Vincent C, 2016, SAFER HEALTHCARE STR; Wang KWK, 2004, J ADV NURS, V45, P36, DOI 10.1046/j.1365-2648.2003.02858.x; Whiting M, 2019, J CHILD HEALTH CARE, V23, P35, DOI 10.1177/1367493518777149; World Health Organization,, 2019, WHO MORT DAT; Yoffe SJ, 2011, FAM MED, V43, P106	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262085	10.1371/journal.pone.0262085	http://dx.doi.org/10.1371/journal.pone.0262085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972170	Green Published, gold			2022-12-27	WOS:000773555700093
J	Mozersky, J; McIntosh, T; Walsh, HA; Parsons, MV; Goodman, M; DuBois, JM				Mozersky, Jessica; McIntosh, Tristan; Walsh, Heidi A.; Parsons, Meredith, V; Goodman, Melody; DuBois, James M.			Barriers and facilitators to qualitative data sharing in the United States: A survey of qualitative researchers	PLOS ONE			English	Article							HEALTH RESEARCH; ETHICAL-ISSUES	Qualitative health data are rarely shared in the United States (U.S.). This is unfortunate because gathering qualitative data is labor and time-intensive, and data sharing enables secondary research, training, and transparency. A new U.S. federal policy mandates data sharing by 2023, and is agnostic to data type. We surveyed U.S. qualitative researchers (N = 425) on the barriers and facilitators of sharing qualitative health or sensitive research data. Most researchers (96%) have never shared qualitative data in a repository. Primary concerns were lack of participant permission to share data, data sensitivity, and breaching trust. Researcher willingness to share would increase if participants agreed and if sharing increased the societal impact of their research. Key resources to increase willingness to share were funding, guidance, and de-identification assistance. Public health and biomedical researchers were most willing to share. Qualitative researchers need to prepare for this new reality as sharing qualitative data requires unique considerations.	[Mozersky, Jessica; McIntosh, Tristan; Walsh, Heidi A.; Parsons, Meredith, V; DuBois, James M.] Washington Univ, Sch Med, Div Gen Med Sci, Bioeth Res Ctr, St Louis, MO 63110 USA; [Goodman, Melody] NYU, Sch Global Publ Hlth, New York, NY USA	Washington University (WUSTL); New York University	Mozersky, J (corresponding author), Washington Univ, Sch Med, Div Gen Med Sci, Bioeth Res Ctr, St Louis, MO 63110 USA.	jmozersky@wustl.edu	Goodman, Melody S./H-2887-2019	Goodman, Melody S./0000-0001-8932-624X; Mozersky, Jessica/0000-0002-4942-4571; Walsh, Heidi/0000-0001-9447-6496	National Human Genome Research Institute (NHGRI) [R01HG009351]; National Center for Advancing Translational Sciences [UL1TR002345]	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project is funded by the National Human Genome Research Institute (NHGRI https://www.genome.gov) R01HG009351 (PI DuBois) (JM, TM, HW, MP, MG, JD) and the National Center for Advancing Translational Sciences (UL1TR002345 https://ncats.nih.gov) (JM, TM, MP, JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Barbour RS, 2000, J EVAL CLIN PRACT, V6, P155; Bishop L, 2017, SAGE OPEN, V7, DOI 10.1177/2158244016685136; Broom A, 2009, SOCIOLOGY, V43, P1163, DOI 10.1177/0038038509345704; Brownson RC., 2012, DISSEMINATION IMPLEM, V23; CONRAD P, 1985, SOC SCI MED, V20, P29, DOI 10.1016/0277-9536(85)90308-9; Corti L., 2016, SAGE OPEN, V6, DOI [10.1177/2158244016679211, DOI 10.1177/2158244016679211]; Corti L., 2014, MANAGING SHARING RES, V2014; Corti L., 2004, QUALITATIVE RES PRAC, P297; Corti L, 2015, INT J SOC RES METHOD, V18, P545, DOI 10.1080/13645579.2015.1062627; DuBois James M, 2018, Qual Psychol, V5, P380, DOI 10.1037/qup0000076; DuBois JM, 2011, CURR OPIN PSYCHIATR, V24, P208, DOI 10.1097/YCO.0b013e3283459422; Gibson G, 2004, AGE AGEING, V33, P422, DOI 10.1093/ageing/afh136; Greener I., 2011, DESIGNING SOCIAL RES, DOI [10.4135/9781446287934, DOI 10.4135/9781446287934]; Grypdonck MHE, 2006, QUAL HEALTH RES, V16, P1371, DOI 10.1177/1049732306294089; Guishard M. A., 2018, QUALITATIVE PSYCHOL, V5, P402, DOI [https://doi.org/10.1037/qup0000085, DOI 10.1037/QUP0000085, 10.1037/qup0000085]; Gupta A, 2021, JAMIA OPEN, V4, DOI 10.1093/jamiaopen/ooab069; Hammersley M, 2010, SOCIOL RES ONLINE, V15, DOI 10.5153/sro.2076; Kuula A., 2011, IASSIST Q, V34, P12; Mannheimer S, 2019, AM BEHAV SCI, V63, P643, DOI 10.1177/0002764218784991; Mozersky Jessica, 2020, Ethics Hum Res, V42, P13, DOI 10.1002/eahr.500044; Mozersky Jessica, 2020, IASSIST Q, V43, DOI 10.29173/iq952; National Institutes of Health, 2020, NIH DAT SHAR POL IMP; National Institutes of Health, NIH DAT SHAR POL IMP; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Power R, 1998, AIDS, V12, P687, DOI 10.1097/00002030-199807000-00004; Ruggiano N, 2019, QUAL SOC WORK, V18, P81, DOI 10.1177/1473325017700701; Scharff DP, 2010, J HEALTH CARE POOR U, V21, P879, DOI 10.1353/hpu.0.0323; Toye F, 2013, HLTH SERV DELIV RES, V12, DOI DOI 10.3310/HSDR01120; Tsai AC, 2016, SOC SCI MED, V169, P191, DOI 10.1016/j.socscimed.2016.08.004; Walsh D, 2005, J ADV NURS, V50, P204, DOI 10.1111/j.1365-2648.2005.03380.x; Walters P, 2009, AUST J SOC ISSUES, V44, P309, DOI 10.1002/j.1839-4655.2009.tb00148.x; Yardley SJ, 2014, QUAL HEALTH RES, V24, P102, DOI 10.1177/1049732313518373; Yoon A., 2014, P AM SOC INFORM SCI, V51, P1, DOI [10.1002/meet.2014.14505101140, DOI 10.1002/MEET.2014.14505101140]	35	2	2	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261719	10.1371/journal.pone.0261719	http://dx.doi.org/10.1371/journal.pone.0261719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972126	Green Published, gold			2022-12-27	WOS:000773555700049
J	Pedler, MG; Petrash, JM; Subramanian, PS				Pedler, Michelle G.; Petrash, J. Mark; Subramanian, Prem S.			Prostaglandin analog effects on cerebrospinal fluid reabsorption via nasal mucosa	PLOS ONE			English	Article							RAT; LYMPHATICS; TRANSPORT	Introduction Cerebrospinal fluid (CSF) outflow has been demonstrated along nasal lymphatics via olfactory nerve projections; flow may be increased by stimulating lymphatic contractility using agents such as noradrenaline and the thromboxane A2 analog U46619. Lymphatics elsewhere in the body show increased contractility upon exposure to the prostaglandin F2alpha analog isoprostane-8-epi-prostaglandin. We investigated the ability of ophthalmic prostaglandin F2alpha analogs to increase CSF outflow when applied to the nasal mucosa by inhalation. Methods Latanoprost (0.1, 0.5, or 1mg/ml), bimatoprost (0.3 or 3mg/ml), travoprost (0.04 or 0.4mg/ml), latanoprostene bunod (0.24 or 2.4mg/ml), tafluprost (0.25 or 2.5mg/ml), or control vehicle (10% DMSO) was administered to awake adult C57B/6 mice by nasal inhalation of 2 mu l droplets. Multiday dosing (daily for 3 days) of latanoprost also was evaluated. A total of 81 animals were studied including controls. General anesthesia was induced by injection, and fluorescent tracer (AlexaFluor647-labelled ovalbumin) was injected under stereotaxic guidance into the right lateral ventricle. Nasal turbinate tissue was harvested and homogenized after 1 hour for tracer detection by ELISA and fluorometric analysis. Results Inhalation of latanoprost 0.5mg/ml and 1mg/ml led to a 11.5-fold increase in tracer recovery from nasal turbinate tissues compared to controls (3312 pg/ml vs 288 pg/ml, p<0.001 for 0.5mg/ml; 3355 pg/ml vs 288 pg/ml, p<0.001 for 1mg/ml), while latanoprost 0.1 mg/ml enhanced recovery 6-fold (1713 pg/ml vs 288 pg/ml, p<0.01). Tafluprost 0.25mg/ml and bimatoprost 0.3mg/ml showed a modest (1.4x, p<0.05) effect, and the remaining agents showed no significant effect on tracer recovery. After 3 days of daily latanoprost treatment and several hours after the last dose, a persistently increased recovery of tracer was found. Conclusions Prostaglandin F2alpha analogs delivered by nasal inhalation resulted in increased nasal recovery of a CSF fluorescent tracer, implying increased CSF outflow via the nasal lymphatics. The greatest effect, partially dose-dependent, was observed using latanoprost. Further studies are needed to determine the efficacy of these agents in reducing ICP in short and long-term applications.	[Pedler, Michelle G.; Petrash, J. Mark; Subramanian, Prem S.] Univ Colorado, Sch Med, Dept Ophthalmol, Aurora, CO 80045 USA; [Subramanian, Prem S.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO 80045 USA; [Subramanian, Prem S.] Univ Colorado, Sch Med, Dept Neurosurg, Aurora, CO 80045 USA; [Subramanian, Prem S.] Uniformed Serv Univ Hlth Sci, Div Ophthalmol, Bethesda, MD 20814 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Uniformed Services University of the Health Sciences - USA	Subramanian, PS (corresponding author), Univ Colorado, Sch Med, Dept Ophthalmol, Aurora, CO 80045 USA.; Subramanian, PS (corresponding author), Univ Colorado, Sch Med, Dept Neurol, Aurora, CO 80045 USA.; Subramanian, PS (corresponding author), Univ Colorado, Sch Med, Dept Neurosurg, Aurora, CO 80045 USA.; Subramanian, PS (corresponding author), Uniformed Serv Univ Hlth Sci, Div Ophthalmol, Bethesda, MD 20814 USA.	prem.subramanian@cuanschutz.edu		Subramanian, Prem/0000-0001-5824-8322; Petrash, Mark/0000-0002-6900-4240	Research to Prevent Blindness, Inc.	Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB))	This work was supported in part by an unrestricted grant to the University of Colorado Department of Ophthalmology from Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2019, NATURE, V572, P62, DOI 10.1038/s41586-019-1419-5; Bothwell SW, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0129-6; Boulton M, 1996, NEUROPATH APPL NEURO, V22, P325, DOI 10.1111/j.1365-2990.1996.tb01111.x; Boulton M., 1997, American Journal of Physiology, V272, pR1613; Boulton M, 1999, AM J PHYSIOL-REG I, V276, pR818, DOI 10.1152/ajpregu.1999.276.3.R818; Dave SB, 2014, INDIAN J OPHTHALMOL, V62, P996, DOI 10.4103/0301-4738.145991; DeVos SL, 2013, JOVE-J VIS EXP, DOI 10.3791/50326; Di Staso S, 2018, IN VIVO, V32, P211, DOI 10.21873/invivo.11227; Hanson LR, 2013, JOVE-J VIS EXP, DOI 10.3791/4440; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kim H, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-4; Kim YK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169683; Koh L, 2007, J VASC RES, V44, P423, DOI 10.1159/000104255; Nagra G, 2008, AM J PHYSIOL-REG I, V294, pR1752, DOI 10.1152/ajpregu.00748.2007; Pahlavian SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091888; Sinzinger H, 1997, LYMPHOLOGY, V30, P155; Tam ALC, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.5.3; Tsutsumi S, 2014, AM J NEURORADIOL, V35, P1735, DOI 10.3174/ajnr.A4007; Vysniauskiene I, 2006, INVEST OPHTH VIS SCI, V47, P295, DOI 10.1167/iovs.05-0760	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0248545	10.1371/journal.pone.0248545	http://dx.doi.org/10.1371/journal.pone.0248545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34971554	Green Submitted, gold, Green Published			2022-12-27	WOS:000773555700001
J	Sukhai, A; Govender, R; van Niekerk, A				Sukhai, Anesh; Govender, Rajen; van Niekerk, Ashley			Fatality risk and issues of inequity among vulnerable road users in South Africa	PLOS ONE			English	Article							TRAFFIC INJURIES; EXPOSURE; HEALTH; SAFETY	Background Contextual effects from the physical and social environment contribute to inequitable protection for a large proportion of road users, especially in low- and middle-income countries like South Africa where distorted urban planning and socio-spatial disparities from the apartheid era prevail. Objectives This paper examines the differentiated risk of road traffic crashes and injuries to vulnerable road users in South Africa, including pedestrians, females and users of some modes of public transport, in relation to characteristics of the crashes that proxy a range of contextual influences such as rurality and socio-economic deprivation. Methods The study is based on a descriptive analysis of 33 659 fatal crashes that occurred in South Africa over a three-year period from 2016-2018. Measures of simple proportion, population-based fatality rate, "impact factor" and crash severity are compared between disaggregated groups using Chi-Square analysis, with the Cramer's V statistic used to assess effect size. Results and significance Key findings show a higher pedestrian risk in relation to public transport vehicles and area-level influences such as the nature of roads or extent of urbanity; higher passenger risk in relation to public transport vehicles and rurality; and higher risk for female road users in relation to public transport vehicles. The findings have implications for prioritising a range of deprivation-related structural effects. In addition, we present a "User-System-Context" conceptual framework that allows for a holistic approach to addressing vulnerability in the transport system. The findings provide an important avenue for addressing the persistently large burden of road traffic crashes and injuries in the country.	[Sukhai, Anesh; Govender, Rajen; van Niekerk, Ashley] Univ South Africa, Inst Social & Hlth Sci, Johannesburg, South Africa; [Sukhai, Anesh; Govender, Rajen; van Niekerk, Ashley] Univ South Africa, Masculin & Hlth Res Unit, Cape Town, South Africa; [Sukhai, Anesh; Govender, Rajen; van Niekerk, Ashley] South African Med Res Council, Cape Town, South Africa	University of South Africa; University of South Africa; South African Medical Research Council	Sukhai, A (corresponding author), Univ South Africa, Inst Social & Hlth Sci, Johannesburg, South Africa.; Sukhai, A (corresponding author), Univ South Africa, Masculin & Hlth Res Unit, Cape Town, South Africa.; Sukhai, A (corresponding author), South African Med Res Council, Cape Town, South Africa.	anesh.sukhai@gmail.com		Sukhai, Anesh/0000-0002-9739-782X	Road Traffic Management Corporation(RTMC)	Road Traffic Management Corporation(RTMC)	This research was funded by the Road Traffic Management Corporation (RTMC) through an award received by AVN. The RTMC is the lead agency for road safety in the country and hosts the national database on fatal crashes from which the data was sourced for this research. The funder had no role in the study design, data analysis, decision to publish, or preparation of the manuscript.	Aldred R, 2021, INJURY PREV, V27, P71, DOI 10.1136/injuryprev-2019-043534; Allen H., 2016, SAFE SOUND INT RES W; Allen H., 2018, APPROACHES GENDER RE, V2nd ed; Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Azetsop J, 2010, PUBLIC HEALTH ETH-UK, V3, P115, DOI 10.1093/phe/phq013; Chapman R, 1973, ACCIDENT ANAL PREV, V5, P95, DOI [10.1016/0001-4575(73)90018-3, DOI 10.1016/0001-4575(73)90018-3]; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Dean AG, OPENEPI OPEN SOURCE; Department of Health, 2015, ETH HLTH RES PRINC; Gignac GE, 2016, PERS INDIV DIFFER, V102, P74, DOI 10.1016/j.paid.2016.06.069; Govender R., 2020, DRIVER INTOXICATION; Heydari S, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11226249; Institute for Road Safety Research, 2012, VULN ROAD US; Khayesi M, 2020, FRONT SUSTAIN CITIES, V2, DOI 10.3389/frsc.2020.00025; Mabunda MM, 2008, ACCIDENT ANAL PREV, V40, P586, DOI 10.1016/j.aap.2007.08.019; Macpherson A, 1998, AM J PUBLIC HEALTH, V88, P1840, DOI 10.2105/AJPH.88.12.1840; Mangiafico SS., 2016, SUMMARY ANAL EXTENSI; Molino JA, 2009, TRANSPORT RES REC, P145, DOI 10.3141/2140-16; Nantulya Vinand M, 2003, Inj Control Saf Promot, V10, P13, DOI 10.1076/icsp.10.1.13.14116; Ravallion M., 2007, WORLD BANK RES DIGES, V1, P1; RISK A, 1982, ACCIDENT ANAL PREV, V14, P353, DOI 10.1016/0001-4575(82)90013-6; Road Traffic Management Corporation, 2019, STAT ROAD SAF REP CA; Scheiner J, 2011, ACCIDENT ANAL PREV, V43, P307, DOI 10.1016/j.aap.2010.08.029; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Sinclair MR., 2015, P 34 ANN SO AFR TRAN; Solar O., 2010, CONCEPTUAL FRAMEWORK, DOI DOI 10.13016/17CR-AQB9; Sonkin B, 2006, J ROY SOC MED, V99, P402, DOI 10.1258/jrsm.99.8.402; Spoerri A, 2011, ACCIDENT ANAL PREV, V43, P40, DOI 10.1016/j.aap.2010.06.009; Starkey P., 2016, INT C TRANSP ROAD RE; Statistics South Africa, 2016, GEND SER; Statistics South Africa, 2021, NAT HOUS TRAV SURV 2; Stoker P, 2015, J PLAN LIT, V30, P377, DOI 10.1177/0885412215595438; Sukhai A, 2013, S AFR GEOGR J, V95, P187, DOI 10.1080/03736245.2013.847802; Sukhai A., 2014, J INJURY VIOLENCE PR, V12, P10; Sukhai A, 2009, S AFR GEOGR J, V91, P4, DOI 10.1080/03736245.2009.9725325; United Nations, 2015, TRANSF OUR WORLD 203; United Nations, 2019, UN HIGH LEV M HLM 23; Vanderschuren MJWA, 2019, TRANSPORT RES REC, V2673, P616, DOI 10.1177/0361198119854087; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; WHO, 2018, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248; World Bank, 2021, S AFR COUNTR DAT; World Health Organization, 2002, GEND HLTH INF SHEET; World Health Organization, 2021, EQ; World Health Organization and World Bank, 2004, WORLD REPORT ROAD TR	44	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261182	10.1371/journal.pone.0261182	http://dx.doi.org/10.1371/journal.pone.0261182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972108	gold, Green Published			2022-12-27	WOS:000773555700025
J	Tokumitsu, K; Norio, YF; Adachi, N; Kubota, Y; Watanabe, Y; Miki, K; Azekawa, T; Edagawa, K; Katsumoto, E; Hongo, S; Goto, E; Ueda, H; Kato, M; Nakagawa, A; Kikuchi, T; Tsuboi, T; Watanabe, K; Shimoda, K; Yoshimura, R				Tokumitsu, Keita; Norio, Yasui-Furukori; Adachi, Naoto; Kubota, Yukihisa; Watanabe, Yoichiro; Miki, Kazuhira; Azekawa, Takaharu; Edagawa, Koji; Katsumoto, Eiichi; Hongo, Seiji; Goto, Eiichiro; Ueda, Hitoshi; Kato, Masaki; Nakagawa, Atsuo; Kikuchi, Toshiaki; Tsuboi, Takashi; Watanabe, Koichiro; Shimoda, Kazutaka; Yoshimura, Reiji			Real-world clinical predictors of manic/hypomanic episodes among outpatients with bipolar disorder	PLOS ONE			English	Article							MULTICENTER TREATMENT SURVEY; WEEKLY SYMPTOMATIC STATUS; PERSONALITY-DISORDERS; NATURAL-HISTORY; MANIA; COMORBIDITY; PREVALENCE; ANTIDEPRESSANT; DEPRESSION; EFFICACY	Background Bipolar disorder is a mental illness in which manic and depressive states are repeated, causing psychosocial dysfunction. Manic/hypomanic episodes cause problems with interpersonal, social and financial activities, but there is limited evidence regarding the predictors of manic/hypomanic episodes in real-world clinical practice. Methods The multicenter treatment survey on bipolar disorder (MUSUBI) in Japanese psychiatric clinics was administered in an observational study that was conducted to accumulate evidence regarding bipolar disorder in real-world clinical practice. Psychiatrists were asked to complete a questionnaire about patients with bipolar disorder who visited 176 member clinics of the Japanese Association of Neuro-Psychiatric Clinics by conducting a retrospective medical record survey. Our study extracted baseline patient characteristics from September to October 2016, including comorbidities, mental status, duration of treatment, Global Assessment of Functioning (GAF) score, and pharmacological treatment details. We investigated the presence or absence of manic/hypomanic episodes over the course of one year from baseline to September-October 2017. Results In total, 2231 participants were included in our study, 29.1% of whom had manic/hypomanic episodes over the course of one year from baseline. Binomial logistic regression analysis revealed that the presence of manic/hypomanic episodes was correlated with lower baseline GAF scores, rapid cycling, personality disorder, bipolar I disorder, and a mood state with manic or mixed features. Substance abuse was also a risk factor for manic episodes. There was no significant association between a baseline antidepressant prescription and manic/hypomanic episodes. Conclusions In Japan, 29.1% of outpatients with bipolar disorder had manic/hypomanic episodes over the course of one year. Our study suggested that a low GAF score, rapid cycling, personality disorder, bipolar I disorder, substance abuse, and baseline mood state could be predictors of manic/hypomanic episodes. Based on our findings, an antidepressant prescription is not a predictor of manic/hypomanic episodes.	[Tokumitsu, Keita; Norio, Yasui-Furukori; Shimoda, Kazutaka] Dokkyo Med Univ, Dept Psychiat, Sch Med, Mibu, Tochigi, Japan; [Norio, Yasui-Furukori; Kato, Masaki; Nakagawa, Atsuo; Kikuchi, Toshiaki; Tsuboi, Takashi; Watanabe, Koichiro; Yoshimura, Reiji] Japanese Soc Clin Neuropsychopharmacol, Tokyo, Japan; [Adachi, Naoto; Kubota, Yukihisa; Watanabe, Yoichiro; Miki, Kazuhira; Azekawa, Takaharu; Edagawa, Koji; Katsumoto, Eiichi; Hongo, Seiji; Goto, Eiichiro; Ueda, Hitoshi] Japanese Assoc Neuropsychiat Clin, Tokyo, Japan; [Kato, Masaki] Kansai Med Univ, Dept Neuropsychiat, Osaka, Japan; [Nakagawa, Atsuo; Kikuchi, Toshiaki] Keio Univ, Dept Neuropsychiat, Sch Med, Tokyo, Japan; [Tsuboi, Takashi; Watanabe, Koichiro] Kyorin Univ, Dept Neuropsychiat, Sch Med, Tokyo, Japan; [Yoshimura, Reiji] Univ Occupat & Environm Hlth, Dept Psychiat, Fukuoka, Japan	Dokkyo Medical University; Kansai Medical University; Keio University; Kyorin University; University of Occupational & Environmental Health - Japan	Norio, YF (corresponding author), Dokkyo Med Univ, Dept Psychiat, Sch Med, Mibu, Tochigi, Japan.; Norio, YF (corresponding author), Japanese Soc Clin Neuropsychopharmacol, Tokyo, Japan.	furukori@dokkyomed.ac.jp	Tokumitsu, Keita/AHC-1832-2022	TOKUMITSU, KEITA/0000-0001-6747-4348	Ken Tanaka memorial research grant [2016-2, 2017-4, 2019-3]	Ken Tanaka memorial research grant	This study was supported by a Ken Tanaka memorial research grant (grant numbers: 2016-2, 2017-4 and 2019-3). The funder had no role in the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	Adachi N, 2021, HUM PSYCHOPHARM CLIN, V36, DOI 10.1002/hup.2764; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, V5th, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Anderson IM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8508; Bahji A, 2020, J AFFECT DISORDERS, V269, P154, DOI 10.1016/j.jad.2020.03.030; Calabrese JR, 2004, BIOL PSYCHIAT, V56, P957, DOI 10.1016/j.biopsych.2004.09.022; Carvalho AF, 2020, NEW ENGL J MED, V383, P58, DOI 10.1056/NEJMra1906193; Carvalho AF, 2014, J CLIN PSYCHIAT, V75, pE578, DOI 10.4088/JCP.13r08905; Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383; Fan AH, 2008, J CLIN PSYCHIAT, V69, P1794, DOI 10.4088/JCP.v69n1115; Fornaro M, 2016, J AFFECT DISORDERS, V195, P105, DOI 10.1016/j.jad.2016.01.040; Fornaro M, 2018, BIPOLAR DISORD, V20, P195, DOI 10.1111/bdi.12612; Fornaro M, 2018, J AFFECT DISORDERS, V234, P131, DOI 10.1016/j.jad.2018.02.085; Fornaro M, 2016, NEUROPSYCH DIS TREAT, V12, P719, DOI 10.2147/NDT.S100846; Friborg O, 2014, J AFFECT DISORDERS, V152, P1, DOI 10.1016/j.jad.2013.08.023; George EL, 2003, BIPOLAR DISORD, V5, P115, DOI 10.1034/j.1399-5618.2003.00028.x; Ghouse AA, 2013, SCI WORLD J, DOI 10.1155/2013/297087; Gitlin MJ, 2018, INT J BIPOLAR DISORD, V6, DOI 10.1186/s40345-018-0133-9; Gordon-Smith K, 2020, BIPOLAR DISORD, V22, P731, DOI 10.1111/bdi.12905; Howland RH, 1996, J CLIN PSYCHOPHARM, V16, P425, DOI 10.1097/00004714-199612000-00003; Judd LL, 2002, ARCH GEN PSYCHIAT, V59, P530, DOI 10.1001/archpsyc.59.6.530; Judd LL, 2003, ARCH GEN PSYCHIAT, V60, P261, DOI 10.1001/archpsyc.60.3.261; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kato M, 2020, J PSYCHIATR RES, V131, P228, DOI 10.1016/j.jpsychires.2020.09.030; Kenneson A, 2013, DRUG ALCOHOL DEPEN, V133, P338, DOI 10.1016/j.drugalcdep.2013.06.011; Kessing LV, 2016, BIPOLAR DISORD, V18, P174, DOI 10.1111/bdi.12371; Krishnan KRR, 2005, PSYCHOSOM MED, V67, P1, DOI 10.1097/01.psy.0000151489.36347.18; Lima IMM, 2018, CLIN PSYCHOL REV, V59, P126, DOI 10.1016/j.cpr.2017.11.006; Liu BS, 2017, J AFFECT DISORDERS, V223, P41, DOI 10.1016/j.jad.2017.07.023; Lyall LM, 2019, BRIT J PSYCHIAT, V215, P415, DOI 10.1192/bjp.2019.16; Martinez-Aran A, 2004, AM J PSYCHIAT, V161, P262, DOI 10.1176/appi.ajp.161.2.262; Martino DJ, 2018, J AFFECT DISORDERS, V225, P250, DOI 10.1016/j.jad.2017.08.011; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Mousavi Z, 2018, J AFFECT DISORDERS, V236, P136, DOI 10.1016/j.jad.2018.04.097; Niitsu T, 2015, J PSYCHIATR RES, V66-67, P45, DOI 10.1016/j.jpsychires.2015.04.014; Okasha A, 1996, COMPR PSYCHIAT, V37, P95, DOI 10.1016/S0010-440X(96)90568-4; Rhee TG, 2020, AM J PSYCHIAT, V177, P706, DOI 10.1176/appi.ajp.2020.19091000; Ruggero CJ, 2010, J PSYCHIATR RES, V44, P405, DOI 10.1016/j.jpsychires.2009.09.011; Schneck CD, 2008, AM J PSYCHIAT, V165, P370, DOI 10.1176/appi.ajp.2007.05081484; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Simon GE, 2007, J CLIN PSYCHIAT, V68, P1237, DOI 10.4088/JCP.v68n0811; Swartz HA, 2005, BIPOLAR DISORD, V7, P192, DOI 10.1111/j.1399-5618.2005.00179.x; Tokumitsu K, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02967-5; Tsuboi T, 2020, NEUROPSYCH DIS TREAT, V16, P881, DOI 10.2147/NDT.S246136; Vieta E, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.8; Viktorin A, 2014, AM J PSYCHIAT, V171, P1067, DOI 10.1176/appi.ajp.2014.13111501; World Health Organization, 1992, INT STAT CLASS DIS R; Yasui-Furukori N, 2020, CLIN PSYCHOPHARM NEU, V18, P599, DOI 10.9758/cpn.2020.18.4.599; Yatham LN, 2018, BIPOLAR DISORD, V20, P97, DOI 10.1111/bdi.12609; Zimmerman M, 2008, J CLIN PSYCHIAT, V69, P935, DOI 10.4088/JCP.v69n0608	49	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262129	10.1371/journal.pone.0262129	http://dx.doi.org/10.1371/journal.pone.0262129			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972188	gold, Green Published			2022-12-27	WOS:000773555700100
J	Watts, BD; Smith, FM; Hines, C; Duval, L; Hamilton, DJ; Keyes, T; Paquet, J; Pirie-Dominix, L; Rausch, J; Truitt, B; Winn, B; Woodard, P				Watts, Bryan D.; Smith, Fletcher M.; Hines, Chance; Duval, Laura; Hamilton, Diana J.; Keyes, Tim; Paquet, Julie; Pirie-Dominix, Lisa; Rausch, Jennie; Truitt, Barry; Winn, Brad; Woodard, Paul			The annual cycle for whimbrel populations using the Western Atlantic Flyway	PLOS ONE			English	Article							KNOTS CALIDRIS-CANUTUS; RED KNOTS; NUMENIUS-PHAEOPUS; MIGRATORY BIRDS; SHOREBIRDS; HABITAT; DECLINE; ARRIVAL; RATES; SANDPIPERS	Many long-distance migratory birds use habitats that are scattered across continents and confront hazards throughout the annual cycle that may be population-limiting. Identifying where and when populations spend their time is fundamental to effective management. We tracked 34 adult whimbrels (Numenius phaeopus) from two breeding populations (Mackenzie Delta and Hudson Bay) with satellite transmitters to document the structure of their annual cycles. The two populations differed in their use of migratory pathways and their seasonal schedules. Mackenzie Delta whimbrels made long (22,800 km) loop migrations with different autumn and spring routes. Hudson Bay whimbrels made shorter (17,500 km) and more direct migrations along the same route during autumn and spring. The two populations overlap on the winter grounds and within one spring staging area. Mackenzie Delta whimbrels left the breeding ground, arrived on winter grounds, left winter grounds and arrived on spring staging areas earlier compared to whimbrels from Hudson Bay. For both populations, migration speed was significantly higher during spring compared to autumn migration. Faster migration was achieved by having fewer and shorter stopovers en route. We identified five migratory staging areas including four that were used during autumn and two that were used during spring. Whimbrels tracked for multiple years had high (98%) fidelity to staging areas. We documented dozens of locations where birds stopped for short periods along nearly all migration routes. The consistent use of very few staging areas suggests that these areas are integral to the annual cycle of both populations and have high conservation value.	[Watts, Bryan D.; Smith, Fletcher M.; Hines, Chance; Duval, Laura] William & Mary, Ctr Conservat Biol, Williamsburg, VA 23185 USA; [Smith, Fletcher M.; Keyes, Tim] Georgia Dept Nat Resources, Wildlife Resources Div, Nongame Conservat Sect, Brunswick, GA USA; [Hamilton, Diana J.] Mt Allison Univ, Sackville, NB, Canada; [Paquet, Julie] Environm & Climate Change Canada, Canadian Wildlife Serv, Sackville, NB, Canada; [Pirie-Dominix, Lisa] Environm & Climate Change Canada, Canadian Wildlife Serv, Igaluit, NU, Canada; [Rausch, Jennie; Woodard, Paul] Environm & Climate Change Canada, Canadian Wildlife Serv, Yellowknife, NT, Canada; [Truitt, Barry] Nat Conservancys, Volgenau Virginia Coast Reserve, Nassawadox, VA USA; [Winn, Brad] Manoment Inc, Manomet, MA USA	Mount Allison University; Environment & Climate Change Canada; Canadian Wildlife Service; Environment & Climate Change Canada; Canadian Wildlife Service; Environment & Climate Change Canada; Canadian Wildlife Service; Nature Conservancy	Watts, BD (corresponding author), William & Mary, Ctr Conservat Biol, Williamsburg, VA 23185 USA.	bdwatt@wm.edu		Watts, Bryan/0000-0001-8244-6951; Smith, Fletcher/0000-0002-7617-8142	US Fish and Wildlife Service; National Fish and Wildlife Foundation's Atlantic Flyway Shorebird Initiative; The Nature Conservancy; Environmental Resources Network, (T.E.R.N.); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant; New Brunswick Wildlife Trust Fund; Polar Continental Shelf Program; Cumulative Impacts Monitoring Program; Virginia Coastal Zone Management Program at the Department of Environmental Quality; Georgia Department of Natural Resources Non-game Section; Manomet Inc.	US Fish and Wildlife Service(US Fish & Wildlife Service); National Fish and Wildlife Foundation's Atlantic Flyway Shorebird Initiative; The Nature Conservancy; Environmental Resources Network, (T.E.R.N.); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); New Brunswick Wildlife Trust Fund; Polar Continental Shelf Program; Cumulative Impacts Monitoring Program; Virginia Coastal Zone Management Program at the Department of Environmental Quality; Georgia Department of Natural Resources Non-game Section; Manomet Inc.	This study and publication were completed with logistical support and/or funding provided by the US Fish and Wildlife Service, Environment and Climate Change Canada, the National Fish and Wildlife Foundation's Atlantic Flyway Shorebird Initiative, The Nature Conservancy, The Georgia Department of Natural Resources Non-game Section, Manomet Inc., the Environmental Resources Network, (T.E.R.N.), a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant, the New Brunswick Wildlife Trust Fund, the Polar Continental Shelf Program, the Cumulative Impacts Monitoring Program, and the Virginia Coastal Zone Management Program at the Department of Environmental Quality. No funders had any influence on the content of the submitted or published manuscript. No funders require approval of the final manuscript to be published.	Alves JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38154; Andres Brad A., 2012, Wader Study Group Bulletin, V119, P178; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Bent AC, 1929, US NATURAL MUSEUM B, V74; Burger J, 2007, J COASTAL RES, V23, P1159, DOI 10.2112/04-0393.1; Drent R, 2003, OIKOS, V103, P274, DOI 10.1034/j.1600-0706.2003.12274.x; Duijns S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45862-0; Escudero G, 2012, AUSTRAL ECOL, V37, P355, DOI 10.1111/j.1442-9993.2011.02283.x; Fancy SG., 1998, US FISH WILDLIFE SER, V172; Finch T, 2014, BIODIVERS CONSERV, V23, P2427, DOI 10.1007/s10531-014-0731-5; Gates HR, 2013, AUK, V130, P372, DOI 10.1525/auk.2013.12052; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Hijmans RJ., 2017, SPHERICAL TRIGONOMET, V1, P7; International Wader Study Group, 2003, WADER STUDY GROUP B, V101/102, P8; Johnson AS, 2016, J FIELD ORNITHOL, V87, P371, DOI 10.1111/jofo.12173; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Johnson DS, 2018, Zenodo, DOI 10.5281/zenodo.569569; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; La Sorte FA, 2017, J ANIM ECOL, V86, P273, DOI 10.1111/1365-2656.12624; Lank DB, 2003, J AVIAN BIOL, V34, P225, DOI 10.1034/j.1600-048X.2003.03250.x; Lindstrom A, 2019, NAT CLIM CHANGE, V9, P288, DOI 10.1038/s41558-019-0443-7; Mallory E.P., 1982, Wader Study Group Bulletin, P37; MCNEIL R, 1995, IBIS, V137, P169, DOI 10.1111/j.1474-919X.1995.tb03236.x; Morrison RIG, 2007, J AVIAN BIOL, V38, P479, DOI 10.1111/j.2007.0908-8857.03934.x; Morrison RIG, 2012, WATERBIRDS, V35, P120, DOI 10.1675/063.035.0112; Myers J.P., 1983, American Birds, V37, P23; Nagy-Macarthur A, 2016, THESIS MOUNT ALLISON; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Norris DR, 2007, CONDOR, V109, P535; Prater A.J, 1977, GUIDE IDENTIFICATION; Pyle P, 2008, IDENTIFICATION GUIDE; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Reed ET, 2018, CONDOR, V120, P357, DOI 10.1650/CONDOR-17-127.1; Rosenberg KV, 2019, SCIENCE, V366, P120, DOI 10.1126/science.aaw1313; Sanzenbacher Peter M., 2000, Wader Study Group Bulletin, V91, P16; Schroder J., 2010, THESIS U GRONINGEN G; Skeel M. A., 2020, BIRDS OF THE WORLD, DOI [10.2173/bow.whimbr.01, DOI 10.2173/BOW.WHIMBR.01]; Smith PA, 2010, J AVIAN BIOL, V41, P292, DOI 10.1111/j.1600-048X.2009.04815.x; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; STODDARD PK, 1983, ANIM BEHAV, V31, P173, DOI 10.1016/S0003-3472(83)80186-9; Swift RJ, 2017, POLAR BIOL, V40, P1777, DOI 10.1007/s00300-017-2101-8; Taverner P. A., 1942, Wilson Bulletin, V54, P1; van Gils JA, 2006, ECOLOGY, V87, P1189, DOI 10.1890/0012-9658(2006)87[1189:FIATSE]2.0.CO;2; Warnock N, 2010, J AVIAN BIOL, V41, P621, DOI 10.1111/j.1600-048X.2010.05155.x; Watts BD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92429-z; Watts BD, 2021, J AVIAN BIOL, V52, DOI 10.1111/jav.02629; Watts BD, 2019, CONDOR, V121, DOI 10.1093/condor/duy001; Watts Bryan D., 2015, Wader Study, V122, P37; Watts BD, 2011, WATERBIRDS, V34, P347, DOI 10.1675/063.034.0308; Watts Bryan D., 2008, Wader Study Group Bulletin, V115, P119; Wauchope HS, 2017, GLOBAL CHANGE BIOL, V23, P1085, DOI 10.1111/gcb.13404; Wetlands International, 2019, WATERBIRD POPULATION; WILLIAMS T C, 1977, American Birds, V31, P251; Yasue M, 2005, J ETHOL, V23, P199, DOI 10.1007/s10164-005-0152-8; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713; Ydenberg RC, 2017, OECOLOGIA, V183, P1101, DOI 10.1007/s00442-017-3835-2; ZWARTS L, 1990, ARDEA, V78, P257	58	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0260339	10.1371/journal.pone.0260339	http://dx.doi.org/10.1371/journal.pone.0260339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972114	Green Published, gold			2022-12-27	WOS:000773555700013
J	Arana, C; Liang, CY; Brock, M; Zhang, B; Zhou, JC; Chen, L; Cantarel, B; SoRelle, J; Hooper, LV; Raj, P				Arana, Carlos; Liang, Chaoying; Brock, Matthew; Zhang, Bo; Zhou, Jinchun; Chen, Li; Cantarel, Brandi; SoRelle, Jeffrey; Hooper, Lora V.; Raj, Prithvi			A short plus long-amplicon based sequencing approach improves genomic coverage and variant detection in the SARS-CoV-2 genome	PLOS ONE			English	Article							MUTATIONS; EPIDEMIOLOGY; EVOLUTION; SPREAD	High viral transmission in the COVID-19 pandemic has enabled SARS-CoV-2 to acquire new mutations that may impact genome sequencing methods. The ARTIC.v3 primer pool that amplifies short amplicons in a multiplex-PCR reaction is one of the most widely used methods for sequencing the SARS-CoV-2 genome. We observed that some genomic intervals are poorly captured with ARTIC primers. To improve the genomic coverage and variant detection across these intervals, we designed long amplicon primers and evaluated the performance of a short (ARTIC) plus long amplicon (MRL) sequencing approach. Sequencing assays were optimized on VR-1986D-ATCC RNA followed by sequencing of nasopharyngeal swab specimens from fifteen COVID-19 positive patients. ARTIC data covered 94.47% of the virus genome fraction in the positive control and patient samples. Variant analysis in the ARTIC data detected 217 mutations, including 209 single nucleotide variants (SNVs) and eight insertions & deletions. On the other hand, long-amplicon data detected 156 mutations, of which 80% were concordant with ARTIC data. Combined analysis of ARTIC + MRL data improved the genomic coverage to 97.03% and identified 214 high confidence mutations. The combined final set of 214 mutations included 203 SNVs, 8 deletions and 3 insertions. Analysis showed 26 SARS-CoV-2 lineage defining mutations including 4 known variants of concern K417N, E484K, N501Y, P618H in spike gene. Hybrid analysis identified 7 nonsynonymous and 5 synonymous mutations across the genome that were either ambiguous or not called in ARTIC data. For example, G172V mutation in the ORF3a protein and A2A mutation in Membrane protein were missed by the ARTIC assay. Thus, we show that while the short amplicon (ARTIC) assay provides good genomic coverage with high throughput, complementation of poorly captured intervals with long amplicon data can significantly improve SARS-CoV-2 genomic coverage and variant detection.	[Arana, Carlos; Liang, Chaoying; Brock, Matthew; Zhang, Bo; Zhou, Jinchun; Hooper, Lora V.; Raj, Prithvi] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Arana, Carlos; Liang, Chaoying; Brock, Matthew; Zhou, Jinchun; Raj, Prithvi] Univ Texas Southwestern Med Ctr Dallas, Microbiome & Genom Core, Dallas, TX 75390 USA; [Chen, Li; SoRelle, Jeffrey] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA; [Cantarel, Brandi] Univ Texas Southwestern Med Ctr Dallas, Dept Bioinformat, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Raj, P (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.; Raj, P (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Microbiome & Genom Core, Dallas, TX 75390 USA.	prithvi.raj@utsouthwestern.edu			Microbiome Research Laboratory at UT Southwestern Medical Center	Microbiome Research Laboratory at UT Southwestern Medical Center	Present study was supported by Microbiome Research Laboratory at UT Southwestern Medical Center.	Aleem A, 2021, STATPEARLS; Alteri C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20688-x; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Artesi M, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01598-20; Ascoli CA, 2021, NAT BIOTECHNOL, V39, P274, DOI 10.1038/s41587-021-00845-3; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Charre C, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa075; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Chen ZG, 2021, J VIROL METHODS, V289, DOI 10.1016/j.jviromet.2020.114032; Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; De Coster W, 2018, BIOINFORMATICS, V34, P2666, DOI 10.1093/bioinformatics/bty149; Di Tommaso P, 2017, NAT BIOTECHNOL, V35, P316, DOI 10.1038/nbt.3820; Ewels PA, 2020, NAT BIOTECHNOL, V38, P276, DOI 10.1038/s41587-020-0439-x; Forni D, 2017, TRENDS MICROBIOL, V25, P35, DOI 10.1016/j.tim.2016.09.001; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Gohl DM, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-07283-6; Hasan MR, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.03278-20; Hodcroft EB, 2021, NATURE, V595, P707, DOI [10.1038/s41586-021-03677-y, 10.1101/2020.10.25.20219063]; Itokawa K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239403; Kandeel M, 2020, J MED VIROL, V92, P660, DOI 10.1002/jmv.25754; Kurtzer GM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177459; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Maurano MT, 2020, GENOME RES, V30, DOI 10.1101/gr.266676.120; McNamara RP, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108352; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Nasir JA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12080895; Munnink BOB, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0997-y; Shah SA, 2021, LANCET DIGIT HEALTH, V3, pE539, DOI 10.1016/S2589-7500(21)00175-8; Singh D, 2021, EXP MOL MED, V53, P537, DOI 10.1038/s12276-021-00604-z; Tahan S, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00075-21; Tang JLW, 2021, J INFECTION, V82, pE27, DOI 10.1016/j.jinf.2020.12.024; Tyson JR., 2020, BIORXIV; Wang R, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01754-6; Washington Nicole L, 2021, medRxiv, DOI 10.1101/2021.02.06.21251159; Weber S, 2020, VIRUS RES, V289, DOI 10.1016/j.virusres.2020.198170; Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0; Xiao MF, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00751-4	41	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261014	10.1371/journal.pone.0261014	http://dx.doi.org/10.1371/journal.pone.0261014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025877	Green Published, gold, Green Submitted			2022-12-27	WOS:000796264200009
J	AbdelGhaffar, MM; Omran, D; Elgebaly, A; Bahbah, EI; Afify, S; AlSoda, M; El-Shiekh, M; ElSayed, ES; Shaaban, SS; AbdelHafez, S; Elkelany, K; Eltayar, AA; Ali, OS; Kamal, L; Heiba, AM; El Askary, A; Shousha, HI				AbdelGhaffar, Muhammad M.; Omran, Dalia; Elgebaly, Ahmed; Bahbah, Eshak, I; Afify, Shimaa; AlSoda, Mohamed; El-Shiekh, Mohamed; ElSayed, Enass S.; Shaaban, Soha S.; AbdelHafez, Samah; Elkelany, Khaled; Eltayar, Ayman A.; Ali, Omnia S.; Kamal, Lamiaa; Heiba, Ahmed M.; El Askary, Ahmad; Shousha, Hend Ibrahim			Prediction of mortality in hospitalized Egyptian patients with Coronavirus disease-2019: A multicenter retrospective study	PLOS ONE			English	Article							COVID-19; ANTICOAGULATION	We aimed to assess the epidemiological, clinical, and laboratory characteristics associated with mortality among hospitalized Egyptian patients with COVID-19. A multicenter, retrospective study was conducted on all polymerase chain reaction (PCR)-confirmed COVID-19 cases admitted through the period from April to July 2020. A generalized linear model was reconstructed with covariates based on predictor's statistical significance and clinically relevance. The odds ratio (OR) was calculated by using stepwise logistic regression modeling. A total of 3712 hospitalized patients were included; of them, 900 deaths were recorded (24.2%). Compared to survived patients, non-survived patients were more likely to be older than 60 years (65.7%), males (53.6%) diabetic (37.6%), hypertensive (37.2%), and had chronic renal insufficiency (9%). Non-survived patients were less likely to receive azithromycin (p <0.001), anticoagulants (p <0.001), and steroids (p <0.001). We found that age >= 60 years old (OR = 2.82, 95% CI 2.05-3.86; p <0.0001), diabetes mellitus (OR = 1.58, 95% CI 1.14-2.19; p = 0.006), hypertension (OR = 1.69, 95% CI 1.22-2.36; p = 0.002), chronic renal insufficiency (OR = 3.15, 95% CI 1.84-5.38; p <0.0001), tachycardia (OR = 1.65, 95% CI 1.22-2.23; p <0.001), hypoxemia (OR = 5.69, 95% CI 4.05-7.98; p <0.0001), GCS <13 (OR 515.2, 95% CI 148.5-1786.9; p <0.0001), the use of therapeutic dose of anticoagulation (OR = 0.4, 95% CI 0.22-0.74, p = 0.003) and azithromycin (OR = 0.16, 95% CI 0.09-0.26; p <0.0001) were independent negative predictors of mortality. In conclusion, age >60 years, comorbidities, tachycardia, hypoxemia, and altered consciousness level are independent predictors of mortality among Egyptian hospitalized patients with COVID-19. On the other hand, the use of anticoagulants and azithromycin is associated with reduced mortality.	[AbdelGhaffar, Muhammad M.; AbdelHafez, Samah; Heiba, Ahmed M.] Ahmed Maher Teaching Hosp, Gastroenterol & Infect Dis Dept, Cairo, Egypt; [AbdelGhaffar, Muhammad M.; Omran, Dalia; AlSoda, Mohamed] Gen Org Teaching Hosp & Inst GOTHI, Cairo, Egypt; [Omran, Dalia; Shousha, Hend Ibrahim] Cairo Univ, Fac Med, Endem Med Dept, Cairo, Egypt; [Elgebaly, Ahmed; Bahbah, Eshak, I] Al Azhar Univ, Fac Med, Cairo, Egypt; [Afify, Shimaa] Natl Hepatol & Trop Med Res Inst, Gastroenterol Dept, Cairo, Egypt; [El-Shiekh, Mohamed] Matareya Teaching Hosp, Chest Unit, Cairo, Egypt; [ElSayed, Enass S.] Ahmed Maher Teaching Hosp, Nephrol Dept, Cairo, Egypt; [Shaaban, Soha S.] El Matareya Educ Hosp, Rheumatol Dept, Cairo, Egypt; [Elkelany, Khaled] Shebin Elkom Teaching Hosp, Pediat Dept, Shibin Al Kawm, Egypt; [Eltayar, Ayman A.] Damanhour Teaching Hosp, Intens Care Dept, Damanhour, Egypt; [Ali, Omnia S.] Ahmed Maher Teaching Hosp, Clin & Chem Pathol Dept, Cairo, Egypt; [Kamal, Lamiaa] Sahel Gen Hosp, Clin & Chem Pathol Dept, Cairo, Egypt; [Heiba, Ahmed M.] Natl Res Ctr, Internal Med Dept, Cairo, Egypt; [El Askary, Ahmad] Taif Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Taif, Saudi Arabia	Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); National Hepatology & Tropical Medicine Research Institute (NHTMRI); Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Egyptian Knowledge Bank (EKB); Damanhour University; General Organization of Teaching Hospitals & Institutes (GOTHI); Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Taif University	Shousha, HI (corresponding author), Cairo Univ, Fac Med, Endem Med Dept, Cairo, Egypt.	hendshousha@yahoo.com	Bahbah, Eshak I/I-4504-2019; heiba, ahmed/GQI-1599-2022; Afify, Shimaa/AAB-6018-2021	Bahbah, Eshak I/0000-0002-6168-9134; Afify, Shimaa/0000-0001-5937-4240; Omran, Dalia/0000-0002-5513-6955; Heiba, Ahmed/0000-0002-5200-5458; Shousha, Hend Ibrahim/0000-0002-0928-4738; Elgebaly, Ahmed/0000-0002-8324-0960	Taif University, Taif, Saudi Arabia [TURSP-2020/82]	Taif University, Taif, Saudi Arabia	The authors acknowledge the support of Taif University Researchers Supporting Project number (TURSP-2020/82), Taif University, Taif, Saudi Arabia.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2020, EP UPD MONK MULT OUT; [Anonymous], 2020, US; [Anonymous], 2013, KIDNEY INT SUPPL, V3, P5, DOI [10.1038/kisup.2012.77, DOI 10.1038/KISUP.2012.77]; Boettler T, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100169; Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Chen Y., 2020, PREPRINT, DOI [10.20944/preprints202002.0258.v2, DOI 10.20944/PREPRINTS202002.0258.V2]; Chen YY, 2021, AGEING RES REV, V65, DOI 10.1016/j.arr.2020.101205; Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003; Cuker A., 2020, UPTODATE; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Fung SY, 2020, EMERG MICROBES INFEC, V9, P558, DOI 10.1080/22221751.2020.1736644; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Griesbeck M, 2015, J IMMUNOL, V195, P5327, DOI 10.4049/jimmunol.1501684; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harrison SL, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003321; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096; Klein S, 2020, J CLIN INVEST, V130, P6141, DOI 10.1172/JCI142004; Kragholm K, 2021, CLIN INFECT DIS, V73, pE4025, DOI 10.1093/cid/ciaa924; Lee K, 2009, GLOB INST, P1; Lim S, 2021, NAT REV ENDOCRINOL, V17, P11, DOI 10.1038/s41574-020-00435-4; McBane RD, 2020, MAYO CLIN PROC, V95, P2467, DOI 10.1016/j.mayocp.2020.08.030; Middleton PM, 2012, AUSTRALAS EMERG NURS, V15, P170, DOI 10.1016/j.aenj.2012.06.002; Ministry of Health and Population, 2020, EG MAN PROT COVID 19; Nasiri MJ, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00459; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Pawelec G, 2018, EXP GERONTOL, V105, P4, DOI 10.1016/j.exger.2017.10.024; Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Singh S, 2020, GASTROENTEROLOGY, V159, P768, DOI 10.1053/j.gastro.2020.04.064; Tiwari NR, 2020, J CRIT CARE MED, V6, P217, DOI 10.2478/jccm-2020-0033; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Walker JL, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10427-2; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xie P, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00189; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Zhang BC, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00157; Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954	45	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262348	10.1371/journal.pone.0262348	http://dx.doi.org/10.1371/journal.pone.0262348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015782	Green Published, gold			2022-12-27	WOS:000814820600012
J	Hamal, PK; Yadav, RK; Malla, P				Hamal, Pawan Kumar; Yadav, Rupesh Kumar; Malla, Pragya			Performance of custom made videolaryngoscope for endotracheal intubation: A systematic review	PLOS ONE			English	Review							LOW-COST VIDEOLARYNGOSCOPE; MACINTOSH LARYNGOSCOPE; TRACHEAL INTUBATION; VIDEO LARYNGOSCOPE; BLADE; SMARTPHONE	Introduction Videolaryngoscope is regarded as the standard of care for airway management in well-resourced setups however the technology is largely inaccessible and costly in middle and low-income countries. An improvised and cost-effective form of customized videolaryngoscope was proposed and studied for patient care in underprivileged areas however there were no distinct conclusions on its performances. Method The study follows PRISMA guidelines for systematic review and the protocol in International Prospective Register for Systematic Reviews. The primary aim was to assess the first attempt success of customized videolaryngoscope for endotracheal intubation. The secondary objective was to evaluate the number of attempts, laryngoscopic view in terms of Cormack Lehane score and Percentage of glottic opening, use of external laryngeal maneuver and stylet and, the airway injuries after the endotracheal intubation. Result Five studies were analyzed for risk of bias using the National Institute of Health Quality Assessment Tool for cross-sectional studies. Most of the studies had a poor to a fair level of evidence with only one study with a good level of evidence. Certainty of evidence was "very low" for all eligible studies when graded using the Grading of Recommendation, Assessment, Development and Evaluation approach for systematic review. Conclusions The certainty of the evidence regarding performance of custom-made videolaryngoscope compared to conventional laryngoscope was very low and the study was performed in small numbers with fair to the poor risk of bias. It was difficult to establish and do further analysis regarding whether the customized form of videolaryngoscope will improve the first attempt success rate for tracheal intubation, reduce the number of attempts, improve the laryngoscopic view, require fewer external aids and reduce the incidences of airway injury with the given low-grade evidence. Some properly conducted randomised clinical trials will be required to further analyze the outcome and make the strong recommendations.	[Hamal, Pawan Kumar; Yadav, Rupesh Kumar] Natl Acad Med Sci, Natl Trauma Ctr, Dept Anaesthesiol & Intens Care, Kathmandu, Nepal; [Malla, Pragya] Nepal Med Coll, Dept Biochem, Kathmandu, Nepal; [Malla, Pragya] Teaching Hosp, Kathmandu, Nepal		Hamal, PK (corresponding author), Natl Acad Med Sci, Natl Trauma Ctr, Dept Anaesthesiol & Intens Care, Kathmandu, Nepal.	nawaph@gmail.com		Hamal, Pawan Kumar/0000-0003-4887-3487				Almarakbi WA, 2012, SAUDI MED J, V33, P617; [Anonymous], QUALITY ASSESSMENT T; [Anonymous], SELF ASSEMBLED MODIF; Cohen Y, 2016, ANESTH ANALG, V123, P680, DOI 10.1213/01.ane.0000492919.95559.72; Elfeky M, 2014, EGYPT J ANAESTH, V30, P365, DOI 10.1016/j.egja.2014.05.004; Gaszynska E, 2014, CENT EUR J MED, V9, P768, DOI 10.2478/s11536-013-0319-6; Guerra-Hernandez M, 2020, ELECTRONICS-SWITZ, V9, DOI 10.3390/electronics9101629; Hamal PK, 2020, LANCET GLOB HEALTH, V8, pE893, DOI 10.1016/S2214-109X(20)30259-X; Hasija N, 2018, KOREAN J ANESTHESIOL, V71, P486, DOI 10.4097/kja.d.18.00093; Karippacheril JG, 2016, INDIAN J ANAESTH, V60, P143, DOI 10.4103/0019-5049.176288; Karippacheril JG, 2014, J CLIN MONIT COMPUT, V28, P261, DOI 10.1007/s10877-013-9522-x; Lambert CT, 2020, EUR J ANAESTH, V37, P992, DOI 10.1097/EJA.0000000000001264; Lewis SR, 2017, BRIT J ANAESTH, V119, P369, DOI 10.1093/bja/aex228; LuqmanMuhamed M., IOSR J DENT MEDICAL, V16, P45; Narayan AK, 2018, J ANAESTH CLIN PHARM, V34, P552, DOI 10.4103/joacp.JOACP_337_17; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n160; Pappu A, 2020, INDIAN J ANAESTH, V64, P186, DOI 10.4103/ija.IJA_313_20; Park SO, 2013, EMERG MED J, V30, P270, DOI 10.1136/emermed-2011-200899; Peirovifar Ali, 2014, J Anaesthesiol Clin Pharmacol, V30, P488, DOI 10.4103/0970-9185.142810; Rendeki S, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0362-y; Saoraya J, 2020, WEST J EMERG MED, V21, P817, DOI 10.5811/westjem.2020.5.47831; Schauer S.G., US ARMY I SURG RES J; Schauer SG, 2020, MIL MED; Sgalambro F, 2013, ACTA MEDICA MEDITERR, V29, P437; Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008; Shruthi AH, 2020, INDIAN J ANAESTH, V64, P855, DOI 10.4103/ija.IJA_211_20; Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Triantopoulos A., 2020, TRENDS ANAESTH CRIT, V30, pe184; Trivedi JN, 2014, INDIAN J ANAESTH, V58, P394, DOI 10.4103/0019-5049.138967; Vadhanan P, 2017, ANAESTH PAIN INTENSI, V21, P406; Wang PK, 2013, AM J EMERG MED, V31, P330, DOI 10.1016/j.ajem.2012.08.026; Zaouter C, 2015, BRIT J ANAESTH, V114, P181, DOI 10.1093/bja/aeu266	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261863	10.1371/journal.pone.0261863	http://dx.doi.org/10.1371/journal.pone.0261863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990475	gold, Green Published			2022-12-27	WOS:000815783800012
J	Sirshar, M; Paracha, MFK; Akram, MU; Alghamdi, NS; Zaidi, SZY; Fatima, T				Sirshar, Mehreen; Paracha, Muhammad Faheem Khalil; Akram, Muhammad Usman; Alghamdi, Norah Saleh; Zaidi, Syeda Zainab Yousuf; Fatima, Tatheer			Attention based automated radiology report generation using CNN and LSTM	PLOS ONE			English	Article								The automated generation of radiology reports provides X-rays and has tremendous potential to enhance the clinical diagnosis of diseases in patients. A new research direction is gaining increasing attention that involves the use of hybrid approaches based on natural language processing and computer vision techniques to create auto medical report generation systems. The auto report generator, producing radiology reports, will significantly reduce the burden on doctors and assist them in writing manual reports. Because the sensitivity of chest X-ray (CXR) findings provided by existing techniques not adequately accurate, producing comprehensive explanations for medical photographs remains a difficult task. A novel approach to address this issue was proposed, based on the continuous integration of convolutional neural networks and long short-term memory for detecting diseases, followed by the attention mechanism for sequence generation based on these diseases. Experimental results obtained by using the Indiana University CXR and MIMIC-CXR datasets showed that the proposed model attained the current state-of-the-art efficiency as opposed to other solutions of the baseline. BLEU-1, BLEU-2, BLEU-3, and BLEU-4 were used as the evaluation metrics.	[Sirshar, Mehreen; Paracha, Muhammad Faheem Khalil; Akram, Muhammad Usman] Natl Univ Sci & Technol, Coll Elect & Mech, Dept Comp & Software Engn, Islamabad, Pakistan; [Alghamdi, Norah Saleh] Princess Nourah Bint Abdulrahman Univ, Coll Comp & Informat Sci, Riyadh, Saudi Arabia; [Zaidi, Syeda Zainab Yousuf] Bahria Univ, Dept Comp Sci, Islamabad, Pakistan; [Fatima, Tatheer] Pakistan Inst Med Sci, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan; Princess Nourah bint Abdulrahman University; Pakistan Institute of Medical Sciences	Paracha, MFK (corresponding author), Natl Univ Sci & Technol, Coll Elect & Mech, Dept Comp & Software Engn, Islamabad, Pakistan.	faheem.paracha18@ce.ceme.edu.pk		Khalil Paracha, Muhammad Faheem/0000-0002-6279-6193; , Norah/0000-0001-6421-6001	Deanship of Scientific Research, Princess Nourah bint Abdulrahman University, through the "Program of Research Project Funding After Publication" [42-PRFA-P-53]	Deanship of Scientific Research, Princess Nourah bint Abdulrahman University, through the "Program of Research Project Funding After Publication"(Princess Nourah bint Abdulrahman University)	This research project was funded by the Deanship of Scientific Research, Princess Nourah bint Abdulrahman University, through the "Program of Research Project Funding After Publication, grant No (42-PRFA-P-53)". https://www.pnu.edu.sa/en/Pages/home.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarghaly Omar, 2021, Informatics in Medicine Unlocked, V24, DOI 10.1016/j.imu.2021.100557; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2018, LARGE SCALE AUTOMATE; Brady Adrian, 2012, Ulster Med J, V81, P3; Bustos A, 2020, MED IMAGE ANAL, V66, DOI 10.1016/j.media.2020.101797; Chen Z., 2020, ARXIV PREPRINT ARXIV; Chung J., 2014, EMPIRICAL EVALUATION, DOI 10.3115/v1/w14-4012; Delrue L., 2011, COMP INTERPRETATION, P27; Demner-Fushman D, 2016, J AM MED INFORM ASSN, V23, P304, DOI 10.1093/jamia/ocv080; Donahue J, 2014, PR MACH LEARN RES, V32; Donahue J, 2017, IEEE T PATTERN ANAL, V39, P677, DOI 10.1109/TPAMI.2016.2599174; Dzmitry Bahdanau, 2016, Arxiv, DOI arXiv:1409.0473; Farhadi A, 2010, LECT NOTES COMPUT SC, V6314, P15, DOI 10.1007/978-3-642-15561-1_2; Gale W., 2018, ARXIV PREPRINT ARXIV; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Graves Alex, 2013, ARXIV13080850; Hsu T.M.H., 2018, ARXIV PREPRINT ARXIV; IOFFE S, 2015, ARXIV 1502 03167, V1502, P3167, DOI DOI 10.1007/S13398-014-0173-7.2; Irvin J, 2019, AAAI CONF ARTIF INTE, P590; Jing B., 2017, ARXIV171108195; Kar C, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-1134-8; Kingma D.P., 2014, ARXIV, DOI DOI 10.48550/ARXIV.1412.6980; Krause J, 2017, PROC CVPR IEEE, P3337, DOI 10.1109/CVPR.2017.356; Kulkarni G, 2013, IEEE T PATTERN ANAL, V35, P2891, DOI 10.1109/TPAMI.2012.162; Li Yuan, 2018, ADV NEURAL INFORM PR, P1530; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Liu Guanxiong, 2019, ARXIV PREPRINT ARXIV, P249; Miura Y., 2020, ARXIV PREPRINT ARXIV; Moradi M, 2018, LECT NOTES COMPUT SC, V11070, P449, DOI 10.1007/978-3-030-00928-1_51; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Papineni K, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P311, DOI 10.3115/1073083.1073135; Schlegl Thomas, 2015, Inf Process Med Imaging, V24, P437, DOI 10.1007/978-3-319-19992-4_34; Schuster M, 1997, IEEE T SIGNAL PROCES, V45, P2673, DOI 10.1109/78.650093; Shin HC, 2015, PROC CVPR IEEE, P1090, DOI 10.1109/CVPR.2015.7298712; Sutskever I., 2014, NEURAL INFORM PROCES, P3104; Tanti M., 2019, ARXIV PREPRINT ARXIV; Vedantam R, 2015, PROC CVPR IEEE, P4566, DOI 10.1109/CVPR.2015.7299087; Wang X, 2016, ARXIV PREPRINT ARXIV; Wang XS, 2018, PROC CVPR IEEE, P9049, DOI 10.1109/CVPR.2018.00943; Wang YB, 2017, PROC CVPR IEEE, P2097, DOI 10.1109/CVPR.2017.226; Xu K, 2015, PR MACH LEARN RES, V37, P2048	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262209	10.1371/journal.pone.0262209	http://dx.doi.org/10.1371/journal.pone.0262209			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990477	gold, Green Published			2022-12-27	WOS:000815783800020
J	Ito, T; Kubiura-Ichimaru, M; Murakami, Y; Bogutz, AB; Lefebvre, L; Suetake, I; Tajima, S; Tada, M				Ito, Takamasa; Kubiura-Ichimaru, Musashi; Murakami, Yuri; Bogutz, Aaron B.; Lefebvre, Louis; Suetake, Isao; Tajima, Shoji; Tada, Masako			DNMT1 regulates the timing of DNA methylation by DNMT3 in an enzymatic activity-dependent manner in mouse embryonic stem cells	PLOS ONE			English	Article							DE-NOVO METHYLATION; METHYLTRANSFERASE DNMT1; SELF-RENEWAL; MAINTENANCE; LSH; TET; DEMETHYLATION; TRANSCRIPTION; ACTIVATION; BINDING	DNA methylation (DNAme; 5-methylcytosine, 5mC) plays an essential role in mammalian development, and the 5mC profile is regulated by a balance of opposing enzymatic activities: DNA methyltransferases (DNMTs) and Ten-eleven translocation dioxygenases (TETs). In mouse embryonic stem cells (ESCs), de novo DNAme by DNMT3 family enzymes, demethylation by the TET-mediated conversion of 5mC to 5-hydroxymethylation (5hmC), and maintenance of the remaining DNAme by DNMT1 are actively repeated throughout cell cycles, dynamically forming a constant 5mC profile. Nevertheless, the detailed mechanism and physiological significance of this active cyclic DNA modification in mouse ESCs remain unclear. Here by visualizing the localization of DNA modifications on metaphase chromosomes and comparing whole-genome methylation profiles before and after the mid-S phase in ESCs lacking Dnmt1 (1KO ESCs), we demonstrated that in 1KO ESCs, DNMT3-mediated remethylation was interrupted during and after DNA replication. This results in a marked asymmetry in the distribution of 5hmC between sister chromatids at mitosis, with one chromatid being almost no 5hmC. When introduced in 1KO ESCs, the catalytically inactive form of DNMT1 (DNMT1CI) induced an increase in DNAme in pericentric heterochromatin and the DNAme-independent repression of IAPEz, a retrotransposon family, in 1KO ESCs. However, DNMT1CI could not restore the ability of DNMT3 to methylate unmodified dsDNA de novo in S phase in 1KO ESCs. Furthermore, during in vitro differentiation into epiblasts, 1KO ESCs expressing DNMT1CI showed an even stronger tendency to differentiate into the primitive endoderm than 1KO ESCs and were readily reprogrammed into the primitive streak via an epiblast-like cell state, reconfirming the importance of DNMT1 enzymatic activity at the onset of epiblast differentiation. These results indicate a novel function of DNMT1, in which DNMT1 actively regulates the timing and genomic targets of de novo methylation by DNMT3 in an enzymatic activity-dependent and independent manner, respectively.	[Ito, Takamasa; Kubiura-Ichimaru, Musashi; Murakami, Yuri; Tada, Masako] Toho Univ, Fac Sci, Dept Biol, Stem Cells & Reprogramming Lab, Funabashi, Chiba, Japan; [Bogutz, Aaron B.; Lefebvre, Louis] Univ British Columbia, Life Sci Inst, Dept Med Genet, Vancouver, BC, Canada; [Suetake, Isao] Nakamura Gakuen Univ, Grad Sch Nutr Sci, Dept Nutr Sci, Fukuoka, Japan; [Suetake, Isao; Tajima, Shoji] Osaka Univ, Inst Prot Res, Lab Epigenet, Suita, Osaka, Japan	Toho University; University of British Columbia; Osaka University	Tada, M (corresponding author), Toho Univ, Fac Sci, Dept Biol, Stem Cells & Reprogramming Lab, Funabashi, Chiba, Japan.	masako.tada@sci.toho-u.ac.jp	; Lefebvre, Louis/O-9309-2016	Ito, Takamasa/0000-0003-4220-3861; Tada, Masako/0000-0003-3641-3520; Lefebvre, Louis/0000-0001-5664-9480	JSPS [24613004, 2610904]; CIHR [PJT-165992]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CIHR(Canadian Institutes of Health Research (CIHR))	Funds from the JSPS supported this work to MT (Grant 24613004) and MK (DC1, 2610904) https://www-shinsei.jsps.go.jp/kaken/english/index.html; and from the CIHR (PJT-165992) to LL, https://cihr-irsc.gc.ca/e/37788.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barau J, 2016, SCIENCE, V354, P909, DOI 10.1126/science.aah5143; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Berkyurek AC, 2014, J BIOL CHEM, V289, P379, DOI 10.1074/jbc.M113.523209; Berrens RV, 2017, CELL STEM CELL, V21, P694, DOI 10.1016/j.stem.2017.10.004; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chronis C, 2017, CELL, V168, P442, DOI 10.1016/j.cell.2016.12.016; Dai HQ, 2016, NATURE, V538, P528, DOI 10.1038/nature20095; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Duymich CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11453; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fatemi M, 2002, EUR J BIOCHEM, V269, P4981, DOI 10.1046/j.1432-1033.2002.03198.x; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Ferry L, 2017, MOL CELL, V67, P550, DOI 10.1016/j.molcel.2017.07.012; Garvilles RG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137509; Gu TP, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1464-7; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Haggerty C, 2021, NAT STRUCT MOL BIOL, V28, P594, DOI 10.1038/s41594-021-00603-8; Hagihara Y, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009646; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Hata K, 2002, DEVELOPMENT, V129, P1983; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hervouet E, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0450-y; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jia YH, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.7; Karg E, 2017, J MOL BIOL, V429, P3814, DOI 10.1016/j.jmb.2017.10.014; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Kubiura M, 2012, CHROMOSOME RES, V20, P837, DOI 10.1007/s10577-012-9317-9; Kubiura-Ichimaru M, 2021, CHROMOSOME RES, V29, P145, DOI 10.1007/s10577-020-09645-y; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li T, 2018, NUCLEIC ACIDS RES, V46, P3218, DOI 10.1093/nar/gky104; Li YF, 2018, NATURE, V564, P136, DOI 10.1038/s41586-018-0751-5; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Ming X, 2020, CELL RES, V30, P980, DOI 10.1038/s41422-020-0359-9; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Nishiyama A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15006-4; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Nozawa RS, 2013, NAT STRUCT MOL BIOL, V20, P566, DOI 10.1038/nsmb.2532; Oda M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003574; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Otani J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082961; Pennisi E, 2012, SCIENCE, V337, P1159, DOI 10.1126/science.337.6099.1159; Price FD, 2013, STEM CELLS, V31, P752, DOI 10.1002/stem.1321; Qin WH, 2015, CELL RES, V25, P911, DOI 10.1038/cr.2015.72; Qin WH, 2011, NUCLEUS-PHILA, V2, P392, DOI 10.4161/nucl.2.5.17928; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ren JK, 2015, NUCLEIC ACIDS RES, V43, P1444, DOI 10.1093/nar/gku1371; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sakaue M, 2010, CURR BIOL, V20, P1452, DOI 10.1016/j.cub.2010.06.050; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shirane K, 2020, NAT GENET, V52, P1088, DOI 10.1038/s41588-020-0689-z; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Takebayashi S, 2007, MOL CELL BIOL, V27, P8243, DOI 10.1128/MCB.00899-07; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang QJ, 2020, NAT GENET, V52, P828, DOI 10.1038/s41588-020-0661-y; Weinberg DN, 2019, NATURE, V573, P281, DOI 10.1038/s41586-019-1534-3; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Xu QH, 2019, NAT GENET, V51, P844, DOI 10.1038/s41588-019-0398-7; Yamaguchi S, 2013, CELL RES, V23, P329, DOI 10.1038/cr.2013.22; Yan QS, 2003, MOL CELL BIOL, V23, P8416, DOI 10.1128/MCB.23.23.8416-8428.2003; Zeng Y, 2020, GENE DEV, V34, P1546, DOI 10.1101/gad.341925.120; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	84	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262277	10.1371/journal.pone.0262277	http://dx.doi.org/10.1371/journal.pone.0262277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986190	Green Published, gold			2022-12-27	WOS:000765956200034
J	Kumari, MV; Amarasiri, L; Rajindrajith, S; Devanarayana, NM				Kumari, Manori Vijaya; Amarasiri, Lakmali; Rajindrajith, Shaman; Devanarayana, Niranga Manjuri			Gastric motility and pulmonary function in children with functional abdominal pain disorders and asthma: A pathophysiological study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GASTROESOPHAGEAL-REFLUX; ANTRAL MOTILITY; ULTRASONOGRAPHIC MEASUREMENT; GASTROINTESTINAL DISORDERS; MAST-CELLS; PREVALENCE; ASSOCIATION; KNOWLEDGE; INGESTION	Background An association has been shown between functional abdominal pain disorders (FAPDs) and asthma. However, the exact reason for this association is obscured. The main objective of this study is to identify the possible underlying pathophysiological mechanisms for the association between FAPDs and asthma using gastric motility and lung function tests. Methods This was a cross-sectional comparative study that consisted of four study groups. Twenty-four children (age 7-12 years) each were recruited for four study groups; asthma only, FAPDs only, both asthma and FAPDs, and healthy controls. Asthma was diagnosed using the history and bronchodilator reversibility test. The diagnosis of FAPDs was made using Rome IV criteria. All subjects underwent ultrasound assessment of gastric motility and pulmonary function assessment by spirometry, using validated techniques. Results All gastric motility parameters, gastric emptying rate, amplitude of antral contraction, and antral motility index, were significantly impaired in children with FAPDs only, children with asthma only, and children with both asthma & FAPDs, compared to controls (p<0.05). Pulmonary function parameters indicating airway obstruction (FEV1/FVC ratio, peak expiratory flow rate, FEF25-75%) were not impaired in children with FAPDs only compared to controls (p>0.05), but significantly impaired in children with asthma and children with both disorders. Antral motility index correlated with the FEV1/FVC ratio (r = 0.60, p = 0.002) and FEF25%-75% (r = 0.49, p = 0.01) in children with both asthma and FAPDs. Conclusions Gastric motor functions were significantly impaired in children with asthma, children with FAPDs, and children with both disorders. Motility index, measuring overall gastric motor activity, showed a significant positive correlation with lung function parameters that measure airflow limitation. Therefore, these diseases might arise as a result of primary disturbance of smooth muscle activity in the airways and gastrointestinal wall, which could be a possible pathophysiological mechanism for this association between asthma and FAPDs.	[Kumari, Manori Vijaya] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Physiol, Anuradhapura, North Central P, Sri Lanka; [Amarasiri, Lakmali] Univ Colombo, Fac Med, Dept Physiol, Colombo, Western Provinc, Sri Lanka; [Rajindrajith, Shaman] Univ Colombo, Fac Med, Dept Pediat, Colombo, Western Provinc, Sri Lanka; [Devanarayana, Niranga Manjuri] Univ Kelaniya, Fac Med, Dept Physiol, Ragama, Western Provinc, Sri Lanka	Rajarata University of Sri Lanka; University of Colombo; University of Colombo; University Kelaniya	Devanarayana, NM (corresponding author), Univ Kelaniya, Fac Med, Dept Physiol, Ragama, Western Provinc, Sri Lanka.	niranga@kln.ac.lk						Amarasiri WADL, 2013, J NEUROGASTROENTEROL, V19, P355, DOI 10.5056/jnm.2013.19.3.355; Amra Babak, 2006, Indian J Gastroenterol, V25, P185; Criee CP, 2010, MED KLIN, V105, P652, DOI 10.1007/s00063-010-1106-7; Darwiche G, 2003, J ULTRAS MED, V22, P459, DOI 10.7863/jum.2003.22.5.459; Devanarayana NM, 2012, NEUROGASTROENT MOTIL, V24, P420, DOI 10.1111/j.1365-2982.2011.01871.x; Devanarayana NM, 2013, J PEDIATR GASTR NUTR, V56, P443, DOI 10.1097/MPG.0b013e31827f7a3d; Devanarayana NM, 2018, WORLD J GASTROENTERO, V24, P2211, DOI 10.3748/wjg.v24.i21.2211; Devanarayana NM, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0435-2; Devanarayana NM, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-150; Devanarayana NM, 2013, J GASTROEN HEPATOL, V28, P1161, DOI 10.1111/jgh.12205; Ekici A, 2005, DIGEST LIVER DIS, V37, P773, DOI 10.1016/j.dld.2005.05.006; El-Serag HB, 2001, GASTROENTEROLOGY, V121, P1294, DOI 10.1053/gast.2001.29545; GIBSON PG, 1995, ARCH DIS CHILD, V73, P321, DOI 10.1136/adc.73.4.321; Gourcerol G, 2013, NEUROGASTROENT MOTIL, V25, P800, DOI 10.1111/nmo.12181; Hoekman DR, 2015, J PEDIATR-US, V167, P1103, DOI 10.1016/j.jpeds.2015.07.058; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Hyams Jeffrey S, 2016, Gastroenterology, DOI 10.1053/j.gastro.2016.02.015; IRVINE EJ, 1993, DIGEST DIS SCI, V38, P803, DOI 10.1007/BF01295904; Karunanayake A, 2019, WORLD J GASTROENTERO, V25, P95, DOI 10.3748/wjg.v25.i1.95; Karunanayake A, 2018, J PEDIATR GASTR NUTR, V66, P725, DOI 10.1097/MPG.0000000000001819; Korterink JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126982; Kumari MV, 2021, EXPERT REV GASTROENT, V15, P9, DOI 10.1080/17474124.2020.1821652; Kumari MV, 2018, WORLD J CLIN CASES, V6, P944, DOI 10.12998/wjcc.v6.i15.944; Kusunoki H, 2000, J GASTROEN HEPATOL, V15, P1022, DOI 10.1046/j.1440-1746.2000.02251.x; Lai CKW, 2009, THORAX, V64, P476, DOI 10.1136/thx.2008.106609; Lee EH, 2016, J NEUROGASTROENTEROL, V22, P459, DOI 10.5056/jnm15174; Marotta A, 2003, J ALLERGY CLIN IMMUN, V112, P317, DOI 10.1067/mai.2003.1627; NNIfHE, ASTHM DIAGN MON CHRO; Ozier Annaig, 2011, J Allergy (Cairo), V2011, P742710, DOI 10.1155/2011/742710; Pires GV, 2004, ALLERGY ASTHMA PROC, V25, P253; Rajindrajith S, 2018, EXPERT REV GASTROENT, V12, P369, DOI 10.1080/17474124.2018.1438188; Roussos A, 2003, RESP MED, V97, P75, DOI 10.1053/rmed.2001.1409; Steutel NF, 2020, J PEDIATR-US, V221, P107, DOI 10.1016/j.jpeds.2020.02.076; Thakkar K, 2010, PEDIATRICS, V125, pE925, DOI 10.1542/peds.2009-2382; Walker Marjorie M, 2011, Curr Gastroenterol Rep, V13, P323, DOI 10.1007/s11894-011-0197-5; WHITE AM, 1991, GASTROENTEROLOGY, V100, P68, DOI 10.1016/0016-5085(91)90584-8; Wouters MM, 2016, GUT, V65, P155, DOI 10.1136/gutjnl-2015-309151; Yamauchi K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071733; Zhang L, 2016, J NEUROGASTROENTEROL, V22, P181, DOI 10.5056/jnm15137	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262086	10.1371/journal.pone.0262086	http://dx.doi.org/10.1371/journal.pone.0262086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982797	gold, Green Published			2022-12-27	WOS:000834805700016
J	Mwangi, FW; Suybeng, B; Gardiner, CP; Kinobe, RT; Charmley, E; Malau-Aduli, BS; Malau-Aduli, AEO				Mwangi, Felista W.; Suybeng, Benedicte; Gardiner, Christopher P.; Kinobe, Robert T.; Charmley, Edward; Malau-Aduli, Bunmi S.; Malau-Aduli, Aduli E. O.			Effect of incremental proportions of Desmanthus spp. in isonitrogenous forage diets on growth performance, rumen fermentation and plasma metabolites of pen-fed growing Brahman, Charbray and Droughtmaster crossbred beef steers	PLOS ONE			English	Article							VOLATILE FATTY-ACIDS; NEUTRAL DETERGENT FIBER; LEGUME-BASED PASTURES; RUMINAL FERMENTATION; METHANE PRODUCTION; ANIMAL PRODUCTION; FEEDING-BEHAVIOR; TROPICAL GRASS; DAIRY-COWS; DIGESTIBILITY	Desmanthus (Desmanthus spp.), a tropically adapted pasture legume, is highly productive and has the potential to reduce methane emissions in beef cattle. However, liveweight gain response to desmanthus supplementation has been inconclusive in ruminants. This study aimed to evaluate weight gain, rumen fermentation and plasma metabolites of Australian tropical beef cattle in response to supplementation with incremental levels of desmanthus forage legume in isonitrogenous diets. Forty-eight Brahman, Charbray and Droughtmaster crossbred beef steers were pen-housed and fed a basal diet of Rhodes grass (Chloris gayana) hay supplemented with 0, 15, 30 or 45% freshly chopped desmanthus forage on dry matter basis, for 140 days. Varying levels of lucerne (Medicago sativa) hay were added in the 0, 15 and 30% diets to ensure that all diets were isonitrogenous with the 45% desmanthus diet. Data were analyzed using the Mixed Model procedures of SAS software. Results showed that the proportion of desmanthus in the diet had no significant effect on steer liveweight, rumen volatile fatty acids molar proportions and plasma metabolites (P >= 0.067). Total bilirubin ranged between 3.0 and 3.6 mu mol/L for all the diet treatments (P = 0.67). All plasma metabolites measured were within the expected normal range reported for beef cattle. Rumen ammonia nitrogen content was above the 10 mg/dl threshold required to maintain effective rumen microbial activity and maximize voluntary feed intake in cattle fed low-quality tropical forages. The average daily weight gains averaged 0.5 to 0.6 kg/day (P = 0.13) and were within the range required to meet the target slaughter weight for prime beef markets within 2.5 years of age. These results indicate that desmanthus alone or mixed with other high-quality legume forages can be used to supplement grass-based diets to improve tropical beef cattle production in northern Australia with no adverse effect on cattle health.	[Mwangi, Felista W.; Suybeng, Benedicte; Gardiner, Christopher P.; Kinobe, Robert T.; Malau-Aduli, Aduli E. O.] James Cook Univ, Anim Genet & Nutr, Div Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci,Vet Sci Discipline, Townsville, Qld, Australia; [Charmley, Edward] James Cook Univ, CSIRO Agr & Food, Private Mail Bag Aitkenvale, Australian Trop Sci & Innovat Precinct, Townsville, Qld, Australia; [Malau-Aduli, Bunmi S.] James Cook Univ, Div Trop Hlth & Med, Coll Med & Dent, Townsville, Qld, Australia	James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University; James Cook University	Malau-Aduli, AEO (corresponding author), James Cook Univ, Anim Genet & Nutr, Div Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci,Vet Sci Discipline, Townsville, Qld, Australia.	aduli.malauaduli@jcu.edu.au	Malau-Aduli, Aduli Enoch Othniel/C-2419-2014; Malau-Aduli, Bunmi/J-9388-2014	Malau-Aduli, Aduli Enoch Othniel/0000-0002-3660-7862; Mwangi, Felista/0000-0002-4095-3098; Malau-Aduli, Bunmi/0000-0001-6054-8498; Kinobe, Robert/0000-0003-1166-0947	CRC-Projects; Meat & Livestock Australia	CRC-Projects; Meat & Livestock Australia(Meat and Livestock Australia)	The study reported herein received financial support from the CRC-Projects and Meat & Livestock Australia, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agle M, 2010, J DAIRY SCI, V93, P4211, DOI 10.3168/jds.2009-2977; Archer JA, 2000, LIVEST PROD SCI, V65, P47, DOI 10.1016/S0301-6226(99)00181-5; ARMENTANO LE, 1992, J NUTR, V122, P838, DOI 10.1093/jn/122.suppl_3.838; Asano K, 2017, ANIM SCI J, V88, P468, DOI 10.1111/asj.12665; AUFRERE J, 1988, ANIM FEED SCI TECH, V20, P203, DOI 10.1016/0377-8401(88)90044-2; Australian Government Bureau of Meteorology,, WOOLSH WEATH; Baloyi J. J., 2008, Tropical and Subtropical Agroecosystems, V8, P81; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Brandao RKC, 2018, TROP ANIM HEALTH PRO, V50, P105, DOI 10.1007/s11250-017-1408-3; Brandao VLN, 2019, TRANSL ANIM SCI, V3, P1064, DOI 10.1093/tas/txz019; Braun JP, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P485, DOI 10.1016/B978-0-12-370491-7.00016-7; CHANEY AL, 1962, CLIN CHEM, V8, P130; Cholongitas E, 2007, LIVER TRANSPLANT, V13, P523, DOI 10.1002/lt.20994; Coates DB, 1997, TROP GRASSLANDS, V31, P494; COCHRAN RC, 1994, FORAGE QUALITY, EVALUATION, AND UTILIZATION, P613; Commonwealth Scientific and Industrial Research Organization (CSIRO), 2007, NUTR REQUIREMENTS DO; Cook B., 1993, 17 INT GRASSL C ROCK, P2148; Molina-Botero IC, 2019, ANIM FEED SCI TECH, V251, P1, DOI 10.1016/j.anifeedsci.2019.01.011; Dal Pizzol JG, 2017, ANIM FEED SCI TECH, V228, P178, DOI 10.1016/j.anifeedsci.2017.04.020; Detmann E, 2009, LIVEST SCI, V126, P136, DOI 10.1016/j.livsci.2009.06.013; DIJKSTRA J, 1994, LIVEST PROD SCI, V39, P61, DOI 10.1016/0301-6226(94)90154-6; Dixon RM., 2005, RECENT ADV ANIM NUTR, V15, P65; Du WC, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9110983; Durmic Z, 2017, J SCI FOOD AGR, V97, P4075, DOI 10.1002/jsfa.8274; F. The Food and Agriculture Organization of the United Nations, 2020, FAOSTAT; Gagen EJ, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0314-3; Gardiner C., 2012, 2 AUSTR NZ SOC ANIMA; Gardiner C, 2013, TROP GRASSL-FORRAJES, V1, P78, DOI 10.17138/TGFT(1)78-80; Gebregiorgis F, 2012, TROP ANIM HEALTH PRO, V44, P511, DOI 10.1007/s11250-011-9927-9; Gemeda BS., 2018, APPROACHES POULTRY D, V2, P154, DOI [10.31031/APDV.2018.02.000538, DOI 10.31031/APDV.2018.02.000538]; Greenwood PL, 2018, ASIAN AUSTRAL J ANIM, V31, P992, DOI 10.5713/ajas.18.0090; Grev AM, 2020, AGRON J, V112, P406, DOI 10.1002/agj2.20011; Grunwaldt EG, 2005, TROP ANIM HEALTH PRO, V37, P527, DOI 10.1007/s11250-005-2474-5; Hart KJ, 2009, J ANIM SCI, V87, P3342, DOI 10.2527/jas.2009-1786; Hill JO, 2009, ANIM PROD SCI, V49, P983, DOI 10.1071/EA06331; IVORY DA, 1978, AUST J PLANT PHYSIOL, V5, P149, DOI 10.1071/PP9780149; Jancik F, 2008, CZECH J ANIM SCI, V53, P128, DOI 10.17221/2716-CJAS; Jones RJ, 2003, TROP GRASSLANDS, V37, P129; Kanani J, 2006, SMALL RUMINANT RES, V65, P1, DOI 10.1016/j.smallrumres.2005.04.028; Kaneko J. J., 1997, Clinical biochemistry of domestic animals., P45, DOI 10.1016/B978-012396305-5/50004-X; Kennedy PC, 2018, J AGR SCI-CAMBRIDGE, V156, P1005, DOI 10.1017/S0021859618000837; Kiro R., 2017, J DAIRY VET SCI, V2, P555588, DOI [10.19080/jdvs.2017.02.555588, DOI 10.19080/JDVS.2017.02.555588, 10.19080/JDVS.2017.02.555588]; Kurihara M, 1999, BRIT J NUTR, V81, P227, DOI 10.1017/S0007114599000422; LENG R A, 1990, Nutrition Research Reviews, V3, P277, DOI 10.1079/NRR19900016; Maasdorp BV, 1999, ANIM FEED SCI TECH, V77, P49, DOI 10.1016/S0377-8401(98)00232-6; Marsetyo DR., 2017, J AGR SCI TECH-IRAN, V7, P117, DOI [10.17265/2161-6256/2017.02.006, DOI 10.17265/2161-6256/2017.02.006]; McLennan S, 2015, NUTRIENT REQUIREMENT; McPherson R.A., 2016, HENRYS CLIN DIAGNOSI; Meat & Livestock Australia (MLA),, 2020, STAT IND REP; MILLER CP, 1991, TROP GRASSLANDS, V25, P98; Mwangi FW, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11082355; Ndlovu T, 2007, AFR J BIOTECHNOL, V6, P2727; NHMRC, 2013, AUSTR COD PRACT CAR; Norman HC, 2020, ANIM PROD SCI, V60, P1111, DOI 10.1071/AN19310; Ortiz-Rubio MA, 2007, ANIM FEED SCI TECH, V139, P143, DOI 10.1016/j.anifeedsci.2007.01.016; Otto F., 2000, ISR J VET MED, V55, P1; PARK KK, 1994, J ANIM SCI, V72, P478, DOI 10.2527/1994.722478x; Pearson RA, 2006, BRIT J NUTR, V95, P88, DOI 10.1079/BJN20051617; Pengelly BC, 2000, TROP GRASSLANDS, V34, P162; Popp JD, 2000, CAN J PLANT SCI, V80, P513, DOI 10.4141/P99-049; Poppi DP, 2018, REV BRAS ZOOTECN, V47, DOI 10.1590/rbz4720160419; Ramirez-Restrepo CA, 2005, ANIM FEED SCI TECH, V120, P179, DOI 10.1016/j.anifeedsci.2005.01.015; Rinne M, 2002, J ANIM SCI, V80, P1986; Rottman LW, 2015, J DAIRY SCI, V98, P4673, DOI 10.3168/jds.2014-8859; Sacks DB, 2002, CLIN CHEM, V48, P436; Sampaio CB, 2010, TROP ANIM HEALTH PRO, V42, P1471, DOI 10.1007/s11250-010-9581-7; Seymour WM, 2005, ANIM FEED SCI TECH, V119, P155, DOI 10.1016/j.anifeedsci.2004.10.001; SHIMIZU S, 1980, ANAL BIOCHEM, V107, P193, DOI 10.1016/0003-2697(80)90511-4; Suybeng B, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10112097; THOMAS RJ, 1995, PLANT SOIL, V174, P103, DOI 10.1007/BF00032243; THOMAS RJ, 1992, GRASS FORAGE SCI, V47, P133, DOI 10.1111/j.1365-2494.1992.tb02256.x; tMannetje L, 1997, TROP GRASSLANDS, V31, P81; Tomkins NW, 2015, ANIM FEED SCI TECH, V200, P25, DOI 10.1016/j.anifeedsci.2014.11.013; Vandermeulen S, 2018, CROP PASTURE SCI, V69, P797, DOI 10.1071/CP17279; Zanton GI., 2009, PROF ANIM SCI, V25, P393, DOI [10.15232/S1080-7446(15)30740-3, DOI 10.15232/S1080-7446(15)30740-3]	75	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0260918	10.1371/journal.pone.0260918	http://dx.doi.org/10.1371/journal.pone.0260918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982779	gold, Green Published, Green Accepted			2022-12-27	WOS:000834805700005
J	Shu, Y; Liang, DH				Shu, Yan; Liang, Donghui			Effect of tetracycline on nitrogen removal in Moving Bed Biofilm Reactor (MBBR) System	PLOS ONE			English	Article							WASTE-WATER TREATMENT; MICROBIAL COMMUNITY STRUCTURE; ANTIBIOTIC-RESISTANCE GENES; TREATMENT PLANTS; PERFORMANCE; SLUDGE; CARBON; DENITRIFICATION; NITRIFICATION; ENVIRONMENT	The effect of tetracycline (TC) on nitrogen removal in wastewater treatment plants has become a new problem. This study investigated the effects of TC on nitrogen removal using a Moving Bed Biofilm Reactor system. The results showed that there was no significant effect on nitrogen removal performance when the concentration of TC was 5 mg/L, and that the total nitrogen (TN) removal efficiency could reach 75-77%. However, when the concentration of TC increased to 10 mg/L, the denitrification performance was affected and the TN removal efficiency decreased to 58%. The abundance of denitrifying bacteria such as those in the genus Thauera decreased, and TC-resistant bacteria gradually became dominant. At a TC concentration of 10 mg/L, there were also increases and decreases, respectively, in the abundance of resistance and denitrification functional genes. The inhibitory effect of TC on denitrification was achieved mainly by the inhibition of nitrite-reducing bacteria.	[Shu, Yan; Liang, Donghui] South China Univ Technol, Guangzhou Higher Educ Mega Ctr, Sch Environm & Energy, Guangzhou, Peoples R China; [Shu, Yan; Liang, Donghui] South China Univ Technol, Guangzhou Higher Educ Mega Ctr, Key Lab Pollut Control & Ecosyst Restorat Ind Clu, Minist Educ, Guangzhou, Peoples R China	South China University of Technology; South China University of Technology	Shu, Y (corresponding author), South China Univ Technol, Guangzhou Higher Educ Mega Ctr, Sch Environm & Energy, Guangzhou, Peoples R China.; Shu, Y (corresponding author), South China Univ Technol, Guangzhou Higher Educ Mega Ctr, Key Lab Pollut Control & Ecosyst Restorat Ind Clu, Minist Educ, Guangzhou, Peoples R China.	scutshuyan@163.com						Adam M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-52; Bernier SP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00020; Beyersmann PG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00784-7; Chen JF, 2018, BIORESOURCE TECHNOL, V270, P482, DOI 10.1016/j.biortech.2018.09.060; Chettri B, 2019, BIORESOURCE TECHNOL, V294, DOI 10.1016/j.biortech.2019.122190; Dai HT, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.573302; Fan ZZ, 2022, CHEMOSPHERE, V291, DOI 10.1016/j.chemosphere.2021.132681; Gao Y, 2012, J COLLOID INTERF SCI, V368, P540, DOI 10.1016/j.jcis.2011.11.015; Ge SJ, 2015, CHEMOSPHERE, V140, P85, DOI 10.1016/j.chemosphere.2015.02.004; Grabert R, 2018, BIORESOURCE TECHNOL, V267, P265, DOI 10.1016/j.biortech.2018.07.061; Guo HX, 2020, BIORESOURCE TECHNOL, V305, DOI 10.1016/j.biortech.2020.123073; He Y, 2020, NPJ CLEAN WATER, V3, DOI 10.1038/s41545-020-0051-0; Hou GY, 2016, BIORESOURCE TECHNOL, V212, P20, DOI 10.1016/j.biortech.2016.03.156; Hou J, 2016, ENVIRON SCI POLLUT R, V23, P1722, DOI 10.1007/s11356-015-5431-5; Huang MH, 2014, J ENVIRON SCI HEAL A, V49, P940, DOI 10.1080/10934529.2014.893794; Islam GM, 2019, J HAZARD MATER, V371, P130, DOI 10.1016/j.jhazmat.2019.02.032; Jia YT, 2020, CHEM ENG J, V400, DOI 10.1016/j.cej.2020.125905; Jia YT, 2019, BIORESOURCE TECHNOL, V294, DOI 10.1016/j.biortech.2019.122114; Kummerer K, 2009, CHEMOSPHERE, V75, P435, DOI 10.1016/j.chemosphere.2008.12.006; Li TT, 2020, J TAIWAN INST CHEM E, V106, P99, DOI 10.1016/j.jtice.2019.10.004; Liao Q, 2021, SCI TOTAL ENVIRON, V757, DOI 10.1016/j.scitotenv.2020.143981; Liu H, 2018, BIORESOURCE TECHNOL, V256, P414, DOI 10.1016/j.biortech.2018.02.051; Meng FG, 2015, CHEM ENG J, V280, P448, DOI 10.1016/j.cej.2015.06.025; Meng YB, 2019, SCI TOTAL ENVIRON, V668, P379, DOI 10.1016/j.scitotenv.2019.02.389; Michael I, 2013, WATER RES, V47, P957, DOI 10.1016/j.watres.2012.11.027; Nzoughet JK, 2011, TOXICON, V58, P619, DOI 10.1016/j.toxicon.2011.09.012; Razavi M, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00418-20; Shu DT, 2015, BIORESOURCE TECHNOL, V186, P163, DOI 10.1016/j.biortech.2015.03.072; Sperfeld M, 2018, WATER RES, V132, P146, DOI 10.1016/j.watres.2017.12.040; Wan K, 2021, WATER RES, V190, DOI 10.1016/j.watres.2020.116744; Wan R, 2015, APPL MICROBIOL BIOT, V99, P2839, DOI 10.1007/s00253-014-6155-z; Wang LX, 2017, J ENVIRON MANAGE, V204, P152, DOI 10.1016/j.jenvman.2017.08.027; Wang QK, 2020, WATER RES, V185, DOI 10.1016/j.watres.2020.116300; Xu ZS, 2018, SCI TOTAL ENVIRON, V634, P195, DOI 10.1016/j.scitotenv.2018.03.348; Yang XH, 2020, AQUACULTURE, V529, DOI 10.1016/j.aquaculture.2020.735665; Yim G, 2006, INT J MED MICROBIOL, V296, P163, DOI 10.1016/j.ijmm.2006.01.039; Zhang JY, 2016, WATER RES, V91, P339, DOI 10.1016/j.watres.2016.01.010; Zhang YP, 2021, WATER RES, V207, DOI 10.1016/j.watres.2021.117834; Zhao RX, 2019, WATER RES, V151, P388, DOI 10.1016/j.watres.2018.12.034	39	3	3	8	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0261306	10.1371/journal.pone.0261306	http://dx.doi.org/10.1371/journal.pone.0261306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007308	gold, Green Published			2022-12-27	WOS:000741060700015
J	Chen, TY; Li, XY; Goobie, GC; Hung, CH; Hung, TK; Hamilton, K; Bahudhanapati, H; Tan, JN; Kass, DJ; Zhang, YZ				Chen, Ting-Yun; Li, Xiaoyun; Goobie, Gillian C.; Hung, Ching-Hsia; Hung, Tin-Kan; Hamilton, Kyle; Bahudhanapati, Harinath; Tan, Jiangning; Kass, Daniel J.; Zhang, Yingze			Identification of a distal RXFP1 gene enhancer with differential activity in fibrotic lung fibroblasts involving AP-1	PLOS ONE			English	Article							PULMONARY-FIBROSIS; TRANSCRIPTION FACTORS; SYSTEMIC-SCLEROSIS; RELAXIN; EXPRESSION; RECEPTOR; PEPTIDE; PATHWAY	Relaxin/insulin-like family peptide receptor 1 (RXFP1) mediates relaxin's antifibrotic effects and has reduced expression in the lung and skin of patients with fibrotic interstitial lung disease (fILD) including idiopathic pulmonary fibrosis (IPF) and systemic sclerosis (SSc). This may explain the failure of relaxin-based anti-fibrotic treatments in SSc, but the regulatory mechanisms controlling RXFP1 expression remain largely unknown. This study aimed to identify regulatory elements of RXFP1 that may function differentially in fibrotic fibroblasts. We identified and evaluated a distal regulatory region of RXFP1 in lung fibroblasts using a luciferase reporter system. Using serial deletions, an enhancer upregulating pGL3-promoter activity was localized to the distal region between -584 to -242bp from the distal transcription start site (TSS). This enhancer exhibited reduced activity in IPF and SSc lung fibroblasts. Bioinformatic analysis identified two clusters of activator protein 1 (AP-1) transcription factor binding sites within the enhancer. Site-directed mutagenesis of the binding sites confirmed that only one cluster reduced activity (-358 to -353 relative to distal TSS). Co-expression of FOS in lung fibroblasts further increased enhancer activity. In vitro complex formation with a labeled probe spanning the functional AP-1 site using nuclear proteins isolated from lung fibroblasts confirmed a specific DNA/protein complex formation. Application of antibodies against JUN and FOS resulted in the complex alteration, while antibodies to JUNB and FOSL1 did not. Analysis of AP-1 binding in 5 pairs of control and IPF lung fibroblasts detected positive binding more frequently in control fibroblasts. Expression of JUN and FOS was reduced and correlated positively with RXFP1 expression in IPF lungs. In conclusion, we identified a distal enhancer of RXFP1 with differential activity in fibrotic lung fibroblasts involving AP-1 transcription factors. Our study provides insight into RXFP1 downregulation in fILD and may support efforts to reevaluate relaxin-based therapeutics alongside upregulation of RXFP1 transcription.	[Chen, Ting-Yun; Li, Xiaoyun; Goobie, Gillian C.; Hamilton, Kyle; Bahudhanapati, Harinath; Tan, Jiangning; Kass, Daniel J.; Zhang, Yingze] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Chen, Ting-Yun; Li, Xiaoyun; Goobie, Gillian C.; Hamilton, Kyle; Bahudhanapati, Harinath; Tan, Jiangning; Kass, Daniel J.; Zhang, Yingze] Univ Pittsburgh, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA 15260 USA; [Chen, Ting-Yun; Hung, Ching-Hsia] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Tainan, Taiwan; [Goobie, Gillian C.] Univ British Columbia, Dept Med, Clinician Investigator Program, Vancouver, BC, Canada; [Goobie, Gillian C.; Zhang, Yingze] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Hung, Tin-Kan; Zhang, Yingze] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Cheng Kung University; University of British Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, YZ (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.; Zhang, YZ (corresponding author), Univ Pittsburgh, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA 15260 USA.; Zhang, YZ (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.; Zhang, YZ (corresponding author), Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15260 USA.	zhangyx@upmc.edu		Zhang, Yingze/0000-0001-6947-2901	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R21AR076024-01, 5P50AR060780-08]; Ministry of Science and Technology in Taiwan (MOST) [108IPFA0900005]	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Ministry of Science and Technology in Taiwan (MOST)	Funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R21AR076024-01 (YZ) and pilot grant from 5P50AR060780-08 (YZ); Ministry of Science and Technology in Taiwan (MOST) 108IPFA0900005 (TYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2012, MOL CELL ENDOCRINOL, V363, P46, DOI 10.1016/j.mce.2012.07.006; Bahudhanapati H, 2019, J BIOL CHEM, V294, P5008, DOI 10.1074/jbc.RA118.004910; Bathgate RAD, 2018, PHARMACOL THERAPEUT, V187, P114, DOI 10.1016/j.pharmthera.2018.02.008; Bejjani F, 2019, BBA-REV CANCER, V1872, P11, DOI 10.1016/j.bbcan.2019.04.003; Chen TY, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1194; Chiariello AM, 2022, FEBS J, V289, P1180, DOI 10.1111/febs.15762; Chow BSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042714; Corallo Claudio, 2019, Clin Exp Rheumatol, V37 Suppl 119, P69; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 2008, P NATL ACAD SCI USA, V105, P10525, DOI 10.1073/pnas.0801414105; Giordano N, 2012, SCAND J RHEUMATOL, V41, P391, DOI 10.3109/03009742.2012.669496; James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7; Kamat AA, 2004, ENDOCRINOLOGY, V145, P4712, DOI 10.1210/en.2004-0515; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Khanna D, 2009, ARTHRITIS RHEUM-US, V60, P1102, DOI 10.1002/art.24380; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kusko RL, 2016, AM J RESP CRIT CARE, V194, P948, DOI 10.1164/rccm.201510-2026OC; Lam M, 2018, PHARMACOL THERAPEUT, V187, P61, DOI 10.1016/j.pharmthera.2018.02.004; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; McVicker BL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00318; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mortimer KM, 2020, RESPIRATION, V99, P108, DOI 10.1159/000504630; Ng HH, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00501; Pini A, 2010, J PHARMACOL EXP THER, V335, P589, DOI 10.1124/jpet.110.170977; Rajasekaran S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041611; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Samuel CS, 2017, BRIT J PHARMACOL, V174, P962, DOI 10.1111/bph.13529; Samuel CS, 2005, CLIN MED RES, V3, P241, DOI 10.3121/cmr.3.4.241; Samuel CS, 2005, ANN NY ACAD SCI, V1041, P173, DOI 10.1196/annals.1282.025; Sasser JM, 2013, AM J PHYSIOL-REG I, V305, pR559, DOI 10.1152/ajpregu.00528.2012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Tan JN, 2016, AM J RESP CRIT CARE, V194, P1392, DOI 10.1164/rccm.201509-1865OC; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; Ucero AC, 2019, J CLIN INVEST, V129, P3293, DOI 10.1172/JCI125366; Vierbuchen T, 2017, MOL CELL, V68, P1067, DOI 10.1016/j.molcel.2017.11.026; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; Yu SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163277; Yu SB, 2013, BONE, V56, P234, DOI 10.1016/j.bone.2013.06.019; Zent J, 2018, CELL PHYSIOL BIOCHEM, V49, P848, DOI 10.1159/000493217; Zhang YZ, 2021, THORAX, V76, P335, DOI 10.1136/thoraxjnl-2020-215356	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0254466	10.1371/journal.pone.0254466	http://dx.doi.org/10.1371/journal.pone.0254466			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972106	gold, Green Submitted, Green Published			2022-12-27	WOS:000773555700003
J	Lopez, M; Miron-Gonzalez, R; Castro, MJ; Jimenez, JM				Lopez, Maria; Miron-Gonzalez, Ruben; Castro, Maria-Jose; Jimenez, Jose-Maria			Training of volunteer nurses during the Spanish Civil War (1936-1939): A historical study	PLOS ONE			English	Article							MILITARY NURSES; NURSING-CARE; EXPERIENCES; IDENTITY	Background The Spanish Civil War (1936-1939) is an example of a historic event involving nurses, with the participation of professional and volunteer nurses from Spain and other countries. In this context, nurses were trained over short periods of time and recruited to work at hospitals serving the two warring camps. Objectives To identify the characteristics of the training received by volunteer nurses on both sides in the Spanish Civil War and compare it with previous experiences in the history. Design Historical research. Methods Heuristic and hermeneutical analysis of nurse training manuals and news articles from 1936 to 1939. Spanish primary sources were consulted at the Red Cross Documentation Centre Archive in Madrid, the General Military Archive in avila, the Municipal Newspaper Archive in Madrid, and the archives of Spanish daily newspapers ABC and La Vanguardia. The following variables were analysed: duration, entry requirements, and theoretical content of the training courses. Consolidated Criteria for Reporting Qualitative Research (COREQ) has been used. Findings Both sides in the conflict offered a varied training programme, which was supported by official institutions and private initiatives. The courses lasted between one week and two months. Entry requirements were influenced by education level, age, moral conduct, health status, and social and political background. Training content focused on the techniques needed in conflict settings and covered specific moral values. Conclusions Despite the different social and political characteristics of the two warring factions, the variety of training programmes on offer, the entry requirements, and the theoretical content of volunteer nurse training were similar on both sides. At the end of the Spanish Civil War, volunteer nurses on the Republican side suffered reprisals or had to go into exile. We now know that some countries involved in World War II provided training courses for volunteer nurses. It would therefore be interesting to ascertain whether Spanish volunteer nurses contributed their experience to these courses.	[Lopez, Maria; Castro, Maria-Jose; Jimenez, Jose-Maria] Univ Valladolid, Fac Nursing, Valladolid, Spain; [Miron-Gonzalez, Ruben] Univ Alcala, Fac Med & Hlth Sci, Madrid, Spain	Universidad de Valladolid; Universidad de Alcala	Miron-Gonzalez, R (corresponding author), Univ Alcala, Fac Med & Hlth Sci, Madrid, Spain.	ruben.miron@uah.es	Jiménez, Ph.D. José María/AAQ-4921-2021; Mirón-González, Rubén/T-1506-2019; CASTRO ALIJA, MARIA JOSE/ABD-7316-2020	Jiménez, Ph.D. José María/0000-0003-4264-6582; Mirón-González, Rubén/0000-0003-4788-6083; CASTRO ALIJA, MARIA JOSE/0000-0002-1852-4318; Lopez Vallecillo, Maria/0000-0002-8972-2151	Spanish State Agency for Research [PID2019-104581GB-I00]	Spanish State Agency for Research	Initials of the authors who received each award: RMG. -Grant numbers awarded to each author: ML (0), RMG (1), MJC (0) and JMJ (0). The full name of each funder: Project "Translational Humanitarian Medicine and Technological Innovation in Spaces of Confinement, 1870-1950"[TRANSHUMED; PID2019-104581GB-I00], funded by the Spanish State Agency for Research.	[Anonymous], 1937, ABC SEVILLA, P12; [Anonymous], 1938, ABC SEVILLA, P19; [Anonymous], 1936, ABC SEVILLA, P11; [Anonymous], 1936, ABC SEVILLA, P18; [Anonymous], 1937, ABC SEVILLA, P17; [Anonymous], 1936, VANGUARDIA, P3; [Anonymous], 1937, ABC SEVILLA, P4; Anton-Solanas I, 2019, JPN J NURS SCI, V16, P103, DOI 10.1111/jjns.12218; Bernalte Marti V., 2015, ENFERMER A GLOBAL; Blanco Rodriguez JA., 2007, HISP NOVA; Boletin de Auxilio de Invierno, 1937, B AUXILIO INVIERNO, P10; Buckingham S, 2010, CAN BULL MED HIST, V27, P185, DOI 10.3138/cbmh.27.1.185; Calvo Fontan., 1936, CONTESTACIONES PROGR; Cardillo A, 2019, ASSIST INFERM RIC, V38, P15, DOI 10.1702/3129.31104; Connolly CJD, 2018, HEC FORUM, V30, P133, DOI 10.1007/s10730-018-9348-5; Davis M, 2005, HUM RIGHTS QUART, V27, P858, DOI 10.1353/hrq.2005.0034; De Caro W., 2014, SOINS, V59, P109, DOI [10.1016/j.soin.2014.04.013, DOI 10.1016/J.SOIN.2014.04.013]; Dominguez Isabel P., 2019, CUID, DOI [10.14198/cuid.2019.53.08, DOI 10.14198/CUID.2019.53.08]; Duarte J, 2016, INT J NURS STUD, V60, P1, DOI 10.1016/j.ijnurstu.2016.02.015; Duran Escribano M., 2020, PENSAMIENTO QUE PERD; Elliott B, 2015, J ADV NURS, V71, P1066, DOI 10.1111/jan.12588; Elomaa-Krapu M, 2020, NURS INQ, V27, DOI 10.1111/nin.12334; Evans J, 2004, J ADV NURS, V47, P321, DOI 10.1111/j.1365-2648.2004.03096.x; Finnegan A, 2016, NURS OUTLOOK, V64, P450, DOI 10.1016/j.outlook.2016.05.005; Finnegan A, 2016, NURS EDUC TODAY, V36, P86, DOI 10.1016/j.nedt.2015.07.030; Finnegan A, 2015, NURS EDUC TODAY, V35, P104, DOI 10.1016/j.nedt.2014.07.008; Firouzkouhi M, 2017, CHIN J TRAUMATOL, V20, P288, DOI 10.1016/j.cjtee.2017.07.002; Fletcher A, 2011, MED HIST, V55, P419, DOI 10.1017/S0025727300005500; Francesa Cruz Roja., 1937, MANUAL ENFERMERA HOS; Francis K., 2013, HIST RES QUALITATIVE; Ferrandis XG, 2019, ASCLEPIO, V71, DOI 10.3989/asclepio.2019.05; Garcia Tornel L., 1938, QUINTA; Grant S, 2014, NURS HIST REV, V22, P13, DOI 10.1891/1062-8061.22.13; Hallett C., 2008, CAPTURING NURSING HI, P149; Hallett CE, 2014, ENDEAVOUR, V38, P101, DOI 10.1016/j.endeavour.2014.05.001; Huguet M., 2016, J FEMINIST, P31, DOI [10.15366/jfgws2016.3, DOI 10.15366/JFGWS2016.3]; Jackson A., 2010, MUJERES BRIT NICAS G; Keeling A., 2015, NURSES DISASTERS GLO; Kneodler TDS, 2017, REV BRAS ENFERM, V70, P407, DOI 10.1590/0034-7167-2016-0440; Latva-Aijo Annika, 2004, LOTTA SVARDIN SYNTY; Legido-Quigley H, 2020, LANCET PUBLIC HEALTH, V5, pE251, DOI 10.1016/S2468-2667(20)30060-8; Lewenson SB., 2008, CAPTURING NURSING HI, P25; Lopez Vallecillo M., 2016, MEMORIA CIVILIZACI N, V19, P419, DOI [10.15581/001.19.419-439, DOI 10.15581/001.19.419]; Maben J, 2020, J CLIN NURS, V29, P2742, DOI 10.1111/jocn.15307; Martin-Espinosa N, 2018, C NAC HIST ENF, P703; Martin-Llorente MJ., 2020, EGLE, V7; Melchior F, 2004, WESTERN J NURS RES, V26, P340, DOI 10.1177/0193945903261030; Ministerio de Instruccion Publica y Bellas Artes [Ministry of Public Instruction and Fine Arts], 1937, GACETA REPUBLIC 0401, P10; Miro M, 2012, NURS INQ, V19, P270, DOI 10.1111/j.1440-1800.2011.00565.x; Miro-Bonet M, 2008, ENFERM CLIN, V18, P26, DOI 10.1016/S1130-8621(08)70690-9; Miron-Gonzalez R, 2020, DYNAMIS, V40, P49, DOI 10.30827/dynamis.v40i1.15658; Moruno DM, 2009, J WAR CULT STUD, V2, P305, DOI 10.1386/jwcs.2.3.305/1; Nelson S, 2020, NURS HIST REV, V28, P63, DOI 10.1891/1062-8061.28.63; Nolla M.Mila, 1938, ARCH GEN MILITAR AVI; Nolla M.Mila, 1939, ARCH GEN MILITAR AVI; Nolla MMila, 1937, ARCH GEN MILITAR AVI; Ohara R., 2015, NURSES DISASTERS, V1st, DOI [10.1891/9780826126733.0007, DOI 10.1891/9780826126733.0007]; Patai F, 1995, Nurs Hist Rev, V3, P79; Perez I., 1939, JORNADA ENFERMERA; Piga A., 1936, TERAPEUTICA GASEADOS; Ramio A., 2015, ENFERMERAS GUERRA PR; Bernardes MMR, 2019, REV BRAS ENFERM, V72, P111, DOI 10.1590/0034-7167-2018-0414; Romo Aldana E., 1937, MANUAL ENFERMERA ADA; Scott-Ellis P., 1996, DIARIO GUERRA ESPANA; Serrano-Fuentes N, 2021, NURS INQ, V28, DOI 10.1111/nin.12392; Stievano A, 2019, INT NURS REV, V66, P17, DOI 10.1111/inr.12449; Swift A, 2020, J CLIN NURS, V29, P3111, DOI 10.1111/jocn.15298; Telford JC, 2010, CAN BULL MED HIST, V27, P85, DOI 10.3138/cbmh.27.1.85; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Usandizaga M., 1936, NORMAS ELEMENTALES P; Vanguardia La., 1937, VANGUARDIA, V2; Wildman S, 2009, INT J NURS STUD, V46, P1650, DOI 10.1016/j.ijnurstu.2009.06.008	72	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261787	10.1371/journal.pone.0261787	http://dx.doi.org/10.1371/journal.pone.0261787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972142	Green Published, gold			2022-12-27	WOS:000773555700055
J	Tongununui, P; Kuriya, Y; Murata, M; Sawada, H; Araki, M; Nomura, M; Morioka, K; Ichie, T; Ikejima, K; Adachi, K				Tongununui, Prasert; Kuriya, Yuki; Murata, Masahiro; Sawada, Hideki; Araki, Michihiro; Nomura, Mika; Morioka, Katsuji; Ichie, Tomoaki; Ikejima, Kou; Adachi, Kohsuke			Mangrove crab intestine and habitat sediment microbiomes cooperatively work on carbon and nitrogen cycling	PLOS ONE			English	Article							EATING SESARMID CRABS; ORGANIC-MATTER; GUT MICROBIOTA; LEAF-LITTER; PHYLOGENETIC DIVERSITY; FEEDING ECOLOGY; FIXATION GENES; FOOD-INTAKE; SP NOV.; BACTERIA	Mangrove ecosystems, where litter and organic components are degraded and converted into detrital materials, support rich coastal fisheries resources. Sesarmid (Grapsidae) crabs, which feed on mangrove litter, play a crucial role in material flow in carbon-rich and nitrogen-limited mangrove ecosystems; however, the process of assimilation and conversion into detritus has not been well studied. In this study, we performed microbiome analyses of intestinal bacteria from three species of mangrove crab and five sediment positions in the mud lobster mounds, including the crab burrow wall, to study the interactive roles of crabs and sediment in metabolism. Metagenome analysis revealed species-dependent intestinal profiles, especially in Neosarmatium smithi, while the sediment microbiome was similar in all positions, albeit with some regional dependency. The microbiome profiles of crab intestines and sediments were significantly different in the MDS analysis based on OTU similarity; however, 579 OTUs (about 70% of reads in the crab intestinal microbiome) were identical between the intestinal and sediment bacteria. In the phenotype prediction, cellulose degradation was observed in the crab intestine. Cellulase activity was detected in both crab intestine and sediment. This could be mainly ascribed to Demequinaceae, which was predominantly found in the crab intestines and burrow walls. Nitrogen fixation was also enriched in both the crab intestines and sediments, and was supported by the nitrogenase assay. Similar to earlier reports, sulfur-related families were highly enriched in the sediment, presumably degrading organic compounds as terminal electron acceptors under anaerobic conditions. These results suggest that mangrove crabs and habitat sediment both contribute to carbon and nitrogen cycling in the mangrove ecosystem via these two key reactions.	[Tongununui, Prasert] Rajamangala Univ Technol Srivijaya, Fac Sci & Fisheries Technol, Dept Marine Sci & Environm, Amphur Sikao, Trang, Thailand; [Kuriya, Yuki; Murata, Masahiro; Araki, Michihiro] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Sawada, Hideki] Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Kyoto, Japan; [Araki, Michihiro] Natl Inst Biomed Innovat Hlth & Nutr, Tokyo, Japan; [Nomura, Mika] Kagawa Univ, Fac Agr, Miki, Kagawa, Japan; [Morioka, Katsuji; Ichie, Tomoaki; Ikejima, Kou; Adachi, Kohsuke] Kochi Univ, Fac Agr & Marine Sci, Nankoku, Kochi, Japan	Rajamangala University of Technology Srivijaya; Kyoto University; Kyoto University; Kagawa University; Kochi University	Adachi, K (corresponding author), Kochi Univ, Fac Agr & Marine Sci, Nankoku, Kochi, Japan.	kohsukeadachi@kochi-u.ac.jp		Ichie, Tomoaki/0000-0002-1979-5806; Ikejima, Kou/0000-0003-3935-8475	JSPS KAKENHI [26520308]; Research Institute of Marine Invertebrate	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Institute of Marine Invertebrate	This work was partly supported by JSPS KAKENHI (Grant Number 26520308) and the Research Institute of Marine Invertebrate. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2012, FISHERIES SCI, V78, P1309, DOI 10.1007/s12562-012-0547-8; Adame MF, 2011, HYDROBIOLOGIA, V663, P23, DOI 10.1007/s10750-010-0554-7; Alfaro-Espinoza G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00445; Alongi D., CYCLING GLOBAL FLUXE; Alongi DM., 2020, NITROGEN, V1, P167, DOI [DOI 10.3390/NITROGEN1020014, 10.3390/nitrogen1020014]; Alongi DM, 2009, ENERGETICS MANGROVE; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andreote FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038600; Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497; Banba M, 2001, MOL PLANT MICROBE IN, V14, P173, DOI 10.1094/MPMI.2001.14.2.173; Barzkar N, 2020, APPL MICROBIOL BIOT, V104, P6873, DOI 10.1007/s00253-020-10692-y; Bertrand M, 2015, AGRON SUSTAIN DEV, V35, P553, DOI 10.1007/s13593-014-0269-7; Bomble YJ, 2017, CURR OPIN CHEM BIOL, V41, P61, DOI 10.1016/j.cbpa.2017.10.013; Booth JM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40315-0; Borges AV, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017143; Bouillon S, 2008, J SEA RES, V59, P44, DOI 10.1016/j.seares.2007.05.001; Bouillon S, 2002, OECOLOGIA, V130, P441, DOI 10.1007/s004420100814; Brauman A, 2000, EUR J SOIL BIOL, V36, P117, DOI 10.1016/S1164-5563(00)01058-X; Breznak JA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P209; Brune A, 2015, ANNU REV MICROBIOL, V69, P145, DOI 10.1146/annurev-micro-092412-155715; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Bui THH, 2015, COMP BIOCHEM PHYS B, V179, P27, DOI 10.1016/j.cbpb.2014.09.004; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ceja-Navarro JA, 2014, ISME J, V8, P6, DOI 10.1038/ismej.2013.134; Chen GC, 2010, MAR ECOL PROG SER, V419, P137, DOI 10.3354/meps08859; Cuellar-Gempeler C, 2018, ISME J, V12, P825, DOI 10.1038/s41396-017-0014-8; DENG SP, 1994, SOIL BIOL BIOCHEM, V26, P473, DOI 10.1016/0038-0717(94)90179-1; Dittmar T, 2001, MAR CHEM, V73, P253, DOI 10.1016/S0304-4203(00)00110-9; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/NGEO1123, 10.1038/ngeo1123]; Douglas GM, 2020, NAT BIOTECHNOL, V38, P685, DOI 10.1038/s41587-020-0548-6; DUCKLOW HW, 1992, ADV MICROB ECOL, V12, P113; EMMERSON WD, 1992, J EXP MAR BIOL ECOL, V157, P41, DOI 10.1016/0022-0981(92)90073-J; GARDNER WS, 1987, LIMNOL OCEANOGR, V32, P1226, DOI 10.4319/lo.1987.32.6.1226; GIDDINS RL, 1986, MAR ECOL PROG SER, V33, P147, DOI 10.3354/meps033147; Gong X, 2018, SOIL BIOL BIOCHEM, V121, P120, DOI 10.1016/j.soilbio.2018.03.011; Goodenough AE, 2017, J ORNITHOL, V158, P233, DOI 10.1007/s10336-016-1371-1; Harada Y, 2016, ESTUAR COAST SHELF S, V174, P41, DOI 10.1016/j.ecss.2016.03.017; HOLGUIN G, 1992, FEMS MICROBIOL ECOL, V101, P207; Holguin G, 2001, BIOL FERT SOILS, V33, P265, DOI 10.1007/s003740000319; Hongoh Y, 2005, APPL ENVIRON MICROB, V71, P6590, DOI 10.1128/AEM.71.11.6590-6599.2005; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Hongoh Y, 2006, APPL ENVIRON MICROB, V72, P6780, DOI 10.1128/AEM.00891-06; Igai K, 2016, SCI REP-UK, V6, DOI 10.1038/srep31942; Ikejima K, 2003, ESTUAR COAST SHELF S, V56, P447, DOI 10.1016/S0272-7714(02)00194-4; Kawaida S, 2021, FOOD WEBS, V26, DOI 10.1016/j.fooweb.2020.e00180; Kawaida S, 2019, ESTUAR COAST SHELF S, V222, P43, DOI 10.1016/j.ecss.2019.04.004; Kawaida S, 2017, FISHERIES SCI, V83, P1007, DOI 10.1007/s12562-017-1139-4; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Klemm D., 1998, COMPREHENSIVE CELLUL, VVolume 1, DOI DOI 10.1002/3527601929; Kristensen DK, 2010, ESTUAR COAST SHELF S, V87, P583, DOI 10.1016/j.ecss.2010.02.016; Kristensen E, 2001, BEL BAR LIB, P369; Kristensen E, 2008, J SEA RES, V59, P30, DOI 10.1016/j.seares.2007.05.004; Kristensen E, 2017, LIMNOL OCEANOGR, V62, P2097, DOI 10.1002/lno.10553; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Lee SY, 2008, J SEA RES, V59, P16, DOI 10.1016/j.seares.2007.05.002; Lee SG, 2017, MAT SCI ENG A-STRUCT, V697, P55, DOI 10.1016/j.msea.2017.04.115; Lee SY, 1997, MAR ECOL PROG SER, V159, P275, DOI 10.3354/meps159275; LEE SY, 1995, HYDROBIOLOGIA, V295, P203, DOI 10.1007/BF00029127; Lesser MP, 2007, MAR ECOL PROG SER, V346, P143, DOI 10.3354/meps07008; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Lin XL, 2019, MICROB ECOL, V78, P57, DOI 10.1007/s00248-018-1261-6; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lucey KS, 2014, MOL ECOL, V23, P1531, DOI 10.1111/mec.12598; Maher DT, 2013, LIMNOL OCEANOGR, V58, P475, DOI 10.4319/lo.2013.58.2.0475; MALLEY DF, 1978, MAR BIOL, V49, P377, DOI 10.1007/BF00455032; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Tue NT, 2012, J SEA RES, V72, P14, DOI 10.1016/j.seares.2012.05.006; Nordhaus I, 2006, ESTUAR COAST SHELF S, V67, P239, DOI 10.1016/j.ecss.2005.11.022; Nordhaus I, 2011, J SEA RES, V65, P414, DOI 10.1016/j.seares.2011.03.006; Oakes JM, 2010, LIMNOL OCEANOGR, V55, P393, DOI 10.4319/lo.2010.55.1.0393; Odum WE, 1983, BASIC ECOLOGY; Odum WE, 1975, ESTUARINE RES, P265; Otani S, 2016, MICROB ECOL, V71, P207, DOI 10.1007/s00248-015-0692-6; PRESTWICH GD, 1980, OECOLOGIA, V46, P397, DOI 10.1007/BF00346270; Rahman NA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0067-8; Ravikumar S, 2004, J EXP MAR BIOL ECOL, V312, P5, DOI 10.1016/j.jembe.2004.05.020; ROBERTSON AI, 1989, OECOLOGIA, V78, P191, DOI 10.1007/BF00377155; Sarker SK, 2019, BIOL CONSERV, V236, P79, DOI 10.1016/j.biocon.2019.05.011; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; SENGUPTA A, 1991, OECOLOGIA, V87, P560, DOI 10.1007/BF00320420; Skov MW, 2002, OECOLOGIA, V131, P1, DOI 10.1007/s00442-001-0847-7; Tai V, 2015, APPL ENVIRON MICROB, V81, P1059, DOI 10.1128/AEM.02945-14; Tanimura A, 2013, FISHERIES SCI, V79, P1, DOI 10.1007/s12562-012-0559-4; TAYASU I, 1994, NATURWISSENSCHAFTEN, V81, P229, DOI 10.1007/s001140050063; Bui THH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089074; Thompson B. M., 2013, COMMUNITY ECOLOGY SI; Thongtham N, 2005, ESTUAR COAST SHELF S, V65, P213, DOI 10.1016/j.ecss.2005.05.014; Thongtham N, 2008, ESTUAR COAST SHELF S, V80, P573, DOI 10.1016/j.ecss.2008.09.017; TOLEDO G, 1995, CAN J MICROBIOL, V41, P1012, DOI 10.1139/m95-140; TRANVIK LJ, 1992, HYDROBIOLOGIA, V229, P107, DOI 10.1007/BF00006994; Twilley R.R., 2017, MANGROVE ECOSYSTEMS, P113, DOI DOI 10.1007/978-3-319-62206-4_5; Ue H, 2011, INT J SYST EVOL MICR, V61, P1322, DOI 10.1099/ijs.0.024299-0; Varon-Lopez M, 2014, ENVIRON MICROBIOL, V16, P845, DOI 10.1111/1462-2920.12237; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Weidenbach K, 2014, FEBS J, V281, P3507, DOI 10.1111/febs.12876; Werry J, 2005, MAR ECOL PROG SER, V293, P165, DOI 10.3354/meps293165; Yamada A, 2007, MOL ECOL, V16, P3768, DOI 10.1111/j.1365-294X.2007.03326.x; Yew WC, 2018, POLAR BIOL, V41, P269, DOI 10.1007/s00300-017-2189-x; Yi H, 2007, INT J SYST EVOL MICR, V57, P151, DOI 10.1099/ijs.0.64525-0; Zhang XY, 2018, SCI TOTAL ENVIRON, V633, P518, DOI 10.1016/j.scitotenv.2018.03.158; Zhu P, 2018, APPL SOIL ECOL, V130, P159, DOI 10.1016/j.apsoil.2018.06.003; Zilius M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70834-0	108	2	2	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261654	10.1371/journal.pone.0261654	http://dx.doi.org/10.1371/journal.pone.0261654			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972143	Green Published, gold			2022-12-27	WOS:000773555700043
J	Vetsch, R; Garrett, HE; Stout, CL; Wladis, AR; Thompson, M; Lombardi, JV				Vetsch, Raymond; Garrett, Harvey E.; Stout, Christopher L.; Wladis, Alan R.; Thompson, Matt; Lombardi, Joseph, V			Midterm outcomes of 455 patients receiving the AFX2 endovascular graft for the treatment of abdominal aortic aneurysm: A retrospective multi-center analysis	PLOS ONE			English	Article							POWERLINK BIFURCATED SYSTEM; VASCULAR-SURGERY; ENDOLOGIX AFX; REPAIR; TRIAL; CARE; SURVEILLANCE; METAANALYSIS; ENDOLEAKS	Since being introduced into clinical practice the AFX family of endografts has undergone labelling updates, design and manufacturing changes to address a Type III failure mode. The published literature on the performance of the current endograft-AFX2 -is limited to small series with limited follow up. The present study reports the largest series of patients implanted with AFX2 for the treatment of abdominal aortic aneurysms. The study was a retrospective, 5 center study of patients receiving an AFX2 endograft from January 2016 until Dec 2020. Electronic case report forms were provided to four of the centers, with one additional site providing relevant outcomes in an independent dataset. Relevant outcomes were reported via Kaplan-Meier analysis and included all-cause mortality, aneurysm-related mortality, post EVAR aortic rupture, open conversion, device related reinterventions and endoleaks. Among a cohort of 460 patients, 405 underwent elective repair of an AAA, 50 were treated for a ruptured AAA, and 5 were aorto-iliac occlusive disease cases. For the elective cohort (mean age 73.7y, 77% male, mean AAA diameter 5.4cm), the peri-operative mortality was 1.7%. Freedom from aneurysm-related mortality was 98.2% at 1,2,3 and 4 years post-operatively, there were no post-operative aortic ruptures, and 2 patients required open conversion. Freedom from Type Ia endoleaks was 99.4% at 1, 2, 3 and 4 years. Freedom from Type IIIa and Type IIIb endoleaks were 100% and 100% (year 1), 100% and 99.6% (year 2), 99.4% and 99.6% (year 3), 99.4% and 99.6% (year 4) respectively. Freedom from all device-related reintervention (including Type II endoleaks) at 4 y was 86.8%. The AFX2 endograft appears to perform to a satisfactory standard in terms of patient centric outcomes in mid-term follow up. The Type Ia and Type III endoleaks rates at 4y appear to be within acceptable limits. Further follow up studies are warranted.	[Vetsch, Raymond] Freeman Heart & Vasc Inst, Joplin, MO USA; [Garrett, Harvey E.] Univ Tennessee, Hlth Sci Ctr, Dept Vasc Surg, Memphis, TN USA; [Stout, Christopher L.] Ozark Reg Vein & Artery Ctr, Rogers, AR USA; [Wladis, Alan R.] Advent Hlth Med Grp, Orlando, FL USA; [Thompson, Matt] Cleveland Clin Fdn, Heart & Vasc Inst, Dept Vasc Surg, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Lombardi, Joseph, V] Cooper Univ Healthcare, Camden, NJ USA; [Thompson, Matt] Endologix LLC, Irvine, CA 92618 USA	University of Tennessee System; University of Tennessee Health Science Center; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando; Cleveland Clinic Foundation	Thompson, M (corresponding author), Cleveland Clin Fdn, Heart & Vasc Inst, Dept Vasc Surg, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Thompson, M (corresponding author), Endologix LLC, Irvine, CA 92618 USA.	thompsm31@ccf.org		Lombardi, Joseph/0000-0002-2665-8084	Endologix LLC	Endologix LLC	This study was sponsored by Endologix LLC (www.endologix.com).Sites received compensation for contributing data to the study. The sponsor (Endologix LLC) played a role in data assimilation, data analysis and preparation of the manuscript. Dr Thompson is the Chief Medical Officer of Endologix LLC and is also a contract Staff Surgeon in the Heart, Vascular and Thoracic Institute at Main Campus, Cleveland Clinic Foundation. Dr Thompson receives a salary and equity from Endologix LLC and payment from the Cleveland Clinic Foundation. Payments were made to the institutions that were involved in the study to reimburse time and resources utilized to collect and collate clinical information. No authors at the clinical sites received an award or grant, rather payment was made to sites.	Bahia SS, 2015, EUR J VASC ENDOVASC, V50, P320, DOI 10.1016/j.ejvs.2015.05.004; Buck DB, 2018, ANN VASC SURG, V47, P31, DOI 10.1016/j.avsg.2017.08.021; Burns PB, 2011, PLAST RECONSTR SURG, V128, P305, DOI 10.1097/PRS.0b013e318219c171; Carpenter JP, 2010, J ENDOVASC THER, V17, P153, DOI 10.1583/09-2977.1; Carpenter JP, 2004, J VASC SURG, V40, P849, DOI 10.1016/j.jvs.2004.08.051; Carpenter JP, 2002, J VASC SURG, V36, P1129, DOI 10.1067/mva.2002.129641; Chaikof EL, 2002, J VASC SURG, V35, P1048, DOI 10.1067/mva.2002.123763; Chaikof EL, 2018, J VASC SURG, V67, P2, DOI 10.1016/j.jvs.2017.10.044; Chang RW, 2021, J VASC SURG, V73, P856, DOI 10.1016/j.jvs.2020.06.048; Columbo JA, 2021, ANN SURG, V274, P179, DOI 10.1097/SLA.0000000000003446; Franks SC, 2007, EUR J VASC ENDOVASC, V33, P154, DOI 10.1016/j.ejvs.2006.10.017; Grima MJ, 2019, EUR J VASC ENDOVASC, V57, P521, DOI 10.1016/j.ejvs.2018.10.032; Grima MJ, 2018, EUR J VASC ENDOVASC, V55, P492, DOI 10.1016/j.ejvs.2017.11.030; Hinchliffe RJ, 2009, J VASC SURG, V49, P1077, DOI 10.1016/j.jvs.2009.02.005; Hobo R, 2006, J VASC SURG, V43, P896, DOI 10.1016/j.jvs.2006.01.010; Jo EunAh, 2019, Vasc Specialist Int, V35, P209, DOI 10.5758/vsi.2019.35.4.209; Karthikesalingam A, 2016, NEW ENGL J MED, V375, P2051, DOI 10.1056/NEJMoa1600931; Karthikesalingam A, 2010, J ENDOVASC THER, V17, P356, DOI 10.1583/10-3035.1; Lal BK, 2015, J VASC SURG, V62, P1394, DOI 10.1016/j.jvs.2015.02.003; Lemmon G, 2019, J VASC SURG CASES IN, V5, P51, DOI 10.1016/j.jvscit.2018.10.006; Lemmon GW, 2016, J VASC SURG, V64, P571, DOI 10.1016/j.jvs.2016.03.416; Machin M, 2021, EUR J VASC ENDOVASC, V61, P909, DOI 10.1016/j.ejvs.2021.02.009; Maldonado TS, 2016, EUR J VASC ENDOVASC, V52, P64, DOI 10.1016/j.ejvs.2016.04.003; Martinelli O, 2020, ANN VASC SURG, V63, P155, DOI 10.1016/j.avsg.2019.08.095; Montross BC, 2020, J VASC SURG, V72, P1347, DOI 10.1016/j.jvs.2020.01.048; Powell JT, 2018, EUR J VASC ENDOVASC, V55, P625, DOI 10.1016/j.ejvs.2018.01.028; Powell JT, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7661; Schwarze ML, 2009, J VASC SURG, V50, P722, DOI 10.1016/j.jvs.2009.05.010; Silingardi R, 2020, JMIR RES PROTOC, V9, DOI 10.2196/16959; Sirignano P, 2020, FUTUR CARDIOL, V17, P793, DOI 10.2217/fca-2020-0119; Skibba AA, 2015, J VASC SURG, V62, P868, DOI 10.1016/j.jvs.2015.04.454; Starnes BW, 2015, J VASC SURG, V61, p66S, DOI 10.1016/j.jvs.2015.04.125; Starnes BW, 2010, J VASC SURG, V51, P9, DOI 10.1016/j.jvs.2009.08.038; Wanhainen A, 2019, EUR J VASC ENDOVASC, V57, P8, DOI 10.1016/j.ejvs.2018.09.020; Welborn MB, 2014, J VASC SURG, V60, P876, DOI 10.1016/j.jvs.2014.04.017	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261623	10.1371/journal.pone.0261623	http://dx.doi.org/10.1371/journal.pone.0261623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972133	gold, Green Published			2022-12-27	WOS:000773555700042
J	Lee, C; Holroyd, TA; Gur-Arie, R; Sauer, M; Zavala, E; Paul, AM; Shattuck, D; Karron, RA; Limaye, RJ				Lee, Clarice; Holroyd, Taylor A.; Gur-Arie, Rachel; Sauer, Molly; Zavala, Eleonor; Paul, Alicia M.; Shattuck, Dominick; Karron, Ruth A.; Limaye, Rupali J.			COVID-19 vaccine acceptance among Bangladeshi adults: Understanding predictors of vaccine intention to inform vaccine policy	PLOS ONE			English	Article								Objectives The purpose of this study was to identify predictors of COVID-19 vaccine intention among Bangladeshi adults. Methods Secondary data from the COVID-19 Beliefs, Behaviors & Norms Survey conducted by the Massachusetts Institute of Technology (MIT) and Facebook were analyzed. Data were collected from 2,669 adult Facebook users in Bangladesh and was collected between February 15 and February 28, 2021. Binomial logistic regression examined the relationship between COVID-19 vaccination intent and demographic variables, risk perception, preventive behaviors, COVID-19 knowledge, and likelihood of future actions. Results Seventy-nine percent of respondents reported intent to get the COVID-19 vaccine when it becomes available. Intent to get vaccinated was highest among females, adults aged 71-80, individuals with college or graduate-level degrees, city dwellers, and individuals who perceived that they were in excellent health. Results of the binomial logistic regression indicated that predictors of vaccination intent include age (OR = 1.39), high risk perception of COVID-19 (OR = 1.47), and intent to practice social distancing (OR = 1.22). Discussion Findings suggest that age, perceived COVID-19 risk, and non-pharmaceutical COVID-19 interventions may predict COVID-19 vaccination intent among Bangladeshi adults. Findings can be used to create targeted messaging to increase demand for and uptake of COVID-19 vaccines in Bangladesh.	[Lee, Clarice; Holroyd, Taylor A.; Sauer, Molly; Zavala, Eleonor; Paul, Alicia M.; Karron, Ruth A.; Limaye, Rupali J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Lee, Clarice; Holroyd, Taylor A.; Sauer, Molly; Paul, Alicia M.; Limaye, Rupali J.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Baltimore, MD 21205 USA; [Gur-Arie, Rachel] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA; [Gur-Arie, Rachel] Oxford Johns Hopkins Global Infect Dis Ethics Col, Oxford, England; [Paul, Alicia M.; Limaye, Rupali J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA; [Shattuck, Dominick] Johns Hopkins Univ, Ctr Commun Programs, JHU CCP, Baltimore, MD USA; [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD USA; [Limaye, Rupali J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Limaye, RJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.; Limaye, RJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Baltimore, MD 21205 USA.; Limaye, RJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA.; Limaye, RJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	rlimaye@jhu.edu		Shattuck, Dominick/0000-0002-8524-8149; Gur-Arie, Rachel/0000-0002-0868-7682; Sauer, Molly/0000-0002-5837-6997	Bill & Melinda Gates Foundation, Seattle, WA [INV016877]	Bill & Melinda Gates Foundation, Seattle, WA(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, Seattle, WA [INV016877]. https://www.gatesfoundation.org/The funder played no role in study design; in collection, analysis and interpretation of data; in writing of the report; or in the decision to submit the article for publication.	Abedin M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250495; AJMC Staff, 2021, TIM COVID 19 DEV 202; Al-Bari MAA, 2021, WORLD J RADIOL, V13, DOI 10.4329/wjr.v13.i1.1; Ali M., 2021, BMJ OPEN, DOI [10.1136/bmjopen-2021-050303, DOI 10.1136/BMJOPEN-2021-050303]; [Anonymous], 2021, BUSINESS STANDARD; [Anonymous], 2021, TIMES INDIA; Bangladesh Ministry of Health and Family Welfare, 2021, COVID 19 VACC DASHB; Barkay N, 2020, WEIGHTS METHODOLOGY; Berkley S., 2020, COVAX EXPLAINED; Center for Systems Science and Engineering at Johns Hopkins University, 2021, NIG CDC COVID 19 DAS; Collis C., 2020, GLOBAL SURVEY COVID; de Figueiredo A, 2020, LANCET, V396, P898, DOI 10.1016/S0140-6736(20)31558-0; Government of India M of EA, 2021, COVID 19 UPD VACC SU; Hasan K., 2021, DHAKA TRIBUNE; Holder J, 2021, NEW YORK TIMES; Holman N, 2020, LANCET DIABETES ENDO, V8, P823, DOI 10.1016/S2213-8587(20)30271-0; Institute of Epidemiology DC and R, 2021, COV 19 STAT BANGL; Kabir R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050416; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Mahmud S., 2021, ACCEPTANCE COVID 19; Mamun S., 2021, DHAKA TRIBUNE 0421; Moehring A.V., 2021, SURFACING NORMS INCR, DOI 10.31234/osf.io/srv6t; Molla MAM, 2021, DAILY STAR; Molla MMA, 2021, INT J HEALTH PLAN M, V36, P1014, DOI 10.1002/hpm.3156; National Institute of Population Research and Training (NIPORT) ICF, 2020, 2017 18 BANGL DEM HL; Opu MH, 2021, DHAKA TRIBUNE 0604; Our World in Data, 2021, OUR WORLD DAT; Paul, 2021, REUTERS; Saha S., 2021, COVID 19 RISE BANGLA; Sakib SN., 2021, BANGLADESH EXPORT LO; Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160; UNICEF, 2021, COVAX WORK GLOB EQ A; Wang W, 2015, INT J FORECASTING, V31, P980, DOI 10.1016/j.ijforecast.2014.06.001; Yeung MPS., 2016, FACTORS ASS UPTAKE S	34	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261929	10.1371/journal.pone.0261929	http://dx.doi.org/10.1371/journal.pone.0261929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025903	gold, Green Published			2022-12-27	WOS:000796264200035
J	Natalia, F; Young, JC; Afriliana, N; Meidia, H; Yunus, RE; Sudirman, S				Natalia, Friska; Young, Julio Christian; Afriliana, Nunik; Meidia, Hira; Yunus, Reyhan Eddy; Sudirman, Sud			Automated selection of mid-height intervertebral disc slice in traverse lumbar spine MRI using a combination of deep learning feature and machine learning classifier	PLOS ONE			English	Article							BOUNDARY DELINEATION; SEGMENTATION	Abnormalities and defects that can cause lumbar spinal stenosis often occur in the Intervertebral Disc (IVD) of the patient's lumbar spine. Their automatic detection and classification require an application of an image analysis algorithm on suitable images, such as mid-sagittal images or traverse mid-height intervertebral disc slices, as inputs. Hence the process of selecting and separating these images from other medical images in the patient's set of scans is necessary. However, the technological progress in making this process automated is still lagging behind other areas in medical image classification research. In this paper, we report the result of our investigation on the suitability and performance of different approaches of machine learning to automatically select the best traverse plane that cuts closest to the half-height of an IVD from a database of lumbar spine MRI images. This study considers images features extracted using eleven different pre-trained Deep Convolution Neural Network (DCNN) models. We investigate the effectiveness of three dimensionality-reduction techniques and three feature-selection techniques on the classification performance. We also investigate the performance of five different Machine Learning (ML) algorithms and three Fully Connected (FC) neural network learning optimizers which are used to train an image classifier with hyperparameter optimization using a wide range of hyperparameter options and values. The different combinations of methods are tested on a publicly available lumbar spine MRI dataset consisting of MRI studies of 515 patients with symptomatic back pain. Our experiment shows that applying the Support Vector Machine algorithm with a short Gaussian kernel on full-length image features extracted using a pre-trained DenseNet201 model is the best approach to use. This approach gives the minimum per-class classification performance of around 0.88 when measured using the precision and recall metrics. The median performance measured using the precision metric ranges from 0.95 to 0.99 whereas that using the recall metric ranges from 0.93 to 1.0. When only considering the L3/L4, L4/L5, and L5/S1 classes, the minimum F1-Scores range between 0.93 to 0.95, whereas the median F1-Scores range between 0.97 to 0.99.	[Natalia, Friska; Young, Julio Christian; Afriliana, Nunik; Meidia, Hira; Sudirman, Sud] Univ Multimedia Nusantara, Fac Engn & Informat, Serpong, Indonesia; [Yunus, Reyhan Eddy] Dr Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Sudirman, Sud] Liverpool John Moores Univ, Sch Comp Sci & Math, Liverpool, Merseyside, England	Multimedia Nusantara University; University of Indonesia; Liverpool John Moores University	Sudirman, S (corresponding author), Liverpool John Moores Univ, Sch Comp Sci & Math, Liverpool, Merseyside, England.	s.sudirman@ljmu.ac.uk		Sudirman, Sud/0000-0003-4083-0810; Afriliana, Nunik/0000-0001-6314-6128	Indonesian Ministry of Research, Technology and Higher Education [9/E1/KPT/2020]	Indonesian Ministry of Research, Technology and Higher Education(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	Grant Holder: FN Grant Number: 9/E1/KPT/2020 Funder: The Indonesian Ministry of Research, Technology and Higher Education. Funder URL: https://www.ristekbrin.go.id/The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kafri AS, 2019, IEEE ACCESS, V7, P43487, DOI 10.1109/ACCESS.2019.2908002; Alomari RS., 2015, SPINAL IMAGING IMAGE, P193; Alomari RS, 2014, COMPUTATIONAL METHOD, P87, DOI DOI 10.1007/978-3-319-07269-2_8; Anthony G, 2007, ARXIV PREPR ARXIV071; Ardekani BA, 1997, IEEE T MED IMAGING, V16, P947, DOI 10.1109/42.650892; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Bagley Carlos, 2019, F1000Res, V8, DOI 10.12688/f1000research.16082.1; Baloch SH, 2007, IEEE T IMAGE PROCESS, V16, P317, DOI 10.1109/TIP.2006.888348; Barros RC, 2012, IEEE T SYST MAN CY C, V42, P291, DOI 10.1109/TSMCC.2011.2157494; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/BF00058655; Bull AD, 2011, J MACH LEARN RES, V12, P2879; Chollet F., 2015, US, DOI DOI 10.1038/NATURE083580; Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195; Cournapeau D, SCIKIT LEARN; Davarpanah SH, 2017, INT J FUZZY SYST, V19, P591, DOI 10.1007/s40815-016-0247-0; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Fordellone M, 2019, STAT ANAL COMPLEX DA; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Ghosh S, 2014, COMPUT MED IMAG GRAP, V38, P639, DOI 10.1016/j.compmedimag.2014.03.005; Girshick R, 2014, PROC CVPR IEEE, P580, DOI 10.1109/CVPR.2014.81; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hartman J, 2019, CUREUS, V11, DOI 10.7759/cureus.4268; He K, 2017, P IEEE INT C COMPUTE, P29619; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; He XX, 2017, MED IMAGE ANAL, V36, P22, DOI 10.1016/j.media.2016.10.009; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Huang GL, 2017, IEEE ICC; Huang JW, 2020, SPINE J, V20, P590, DOI 10.1016/j.spinee.2019.11.010; Hussain N, 2020, MULTIMED TOOLS APPL, DOI 10.1007/s11042-020-08852-3; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jones DR, 1998, J GLOBAL OPTIM, V13, P455, DOI 10.1023/A:1008306431147; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jovic A, 2015, 2015 8TH INTERNATIONAL CONVENTION ON INFORMATION AND COMMUNICATION TECHNOLOGY, ELECTRONICS AND MICROELECTRONICS (MIPRO), P1200, DOI 10.1109/MIPRO.2015.7160458; Khan MA, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11050811; Khan MA, 2021, CMC-COMPUT MATER CON, V68, P1041, DOI 10.32604/cmc.2021.016307; Khan MA, 2021, PATTERN RECOGN LETT, V143, P58, DOI 10.1016/j.patrec.2020.12.015; Khan MA, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10080565; Kingma D.P., 2014, ARXIV, DOI DOI 10.48550/ARXIV.1412.6980; Koh J, 2010, PROC SPIE, V7624, DOI 10.1117/12.844386; Koitka S, 2016, CLEF WORKING NOTES, P30417; Kornblith S, 2019, P IEEECVF C COMPUTER; Krizhevsky A., P 25 INT C NEUR INF, P1097; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; LeCun Y, 1990, ADV NEURAL INFORM PR; Ma J, 2019, J VIS COMMUN IMAGE R, V63, DOI 10.1016/j.jvcir.2019.102578; Mattes D, 2003, IEEE T MED IMAGING, V22, P120, DOI 10.1109/TMI.2003.809072; Morid MA, 2021, COMPUT BIOL MED, V128, DOI 10.1016/j.compbiomed.2020.104115; Natalia F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241309; Natalia F, 2018, IEEE 20TH INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS / IEEE 16TH INTERNATIONAL CONFERENCE ON SMART CITY / IEEE 4TH INTERNATIONAL CONFERENCE ON DATA SCIENCE AND SYSTEMS (HPCC/SMARTCITY/DSS), P1449, DOI 10.1109/HPCC/SmartCity/DSS.2018.00239; No U, 2018, ARXIV PREPR ARXIV180; Paul CPL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191442; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Ruder S., 2016, ABS16090 CORR; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; Seiffert C, 2010, IEEE T SYST MAN CY A, V40, P185, DOI 10.1109/TSMCA.2009.2029559; Simonyan K., 2015, PROC 3 INT C LEARN R; Song Y, 2013, IEEE T MED IMAGING, V32, P797, DOI 10.1109/TMI.2013.2241448; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Sudirman S, 2019, LUMBAR SPINE MRI DAT; Sudirman S, MENDELEY DATA, V2021; Szegedy C, 2016, ARXIV PREPR ARXIV160; Szegedy C, 2016, P IEEE C COMPUTER VI; Yang W, 2012, J COMPUT, V7, P161, DOI 10.4304/jcp.7.1.161-168; Zhang JP, 2019, MED IMAGE ANAL, V54, P10, DOI 10.1016/j.media.2019.02.010; Zhang Q, 2017, INT C INFORM PROCESS, P21022; Zou F, 2019, P IEEECVF C COMPUTER	68	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261659	10.1371/journal.pone.0261659	http://dx.doi.org/10.1371/journal.pone.0261659			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025904	Green Published, gold, Green Accepted			2022-12-27	WOS:000796264200023
J	Raisman, JC; Fiore, MA; Tomin, L; Adjei, JKO; Aswad, VX; Chu, J; Domondon, CJ; Donahue, BA; Masciotti, CA; McGrath, CG; Melita, J; Podbielski, PA; Schreiner, MR; Trumpore, LJ; Wengert, PC; Wrightstone, EA; Hudson, AO; Wadsworth, CB				Raisman, Jordan C.; Fiore, Michael A.; Tomin, Lucille; Adjei, Joseph K. O.; Aswad, Virginia X.; Chu, Jonathan; Domondon, Christina J.; Donahue, Ben A.; Masciotti, Claudia A.; McGrath, Connor G.; Melita, Jo; Podbielski, Paul A.; Schreiner, Madelyn R.; Trumpore, Lauren J.; Wengert, Peter C.; Wrightstone, Emalee A.; Hudson, Andre O.; Wadsworth, Crista B.			Evolutionary paths to macrolide resistance in a Neisseria commensal converge on ribosomal genes through short sequence duplications	PLOS ONE			English	Article							GENOMIC EPIDEMIOLOGY; GONORRHOEAE; MENINGITIDIS; AZITHROMYCIN; MUTATION; PROTEIN; SUSCEPTIBILITY; TRANSFORMATION; MECHANISMS; DIVERSITY	Neisseria commensals are an indisputable source of resistance for their pathogenic relatives. However, the evolutionary paths commensal species take to reduced susceptibility in this genus have been relatively underexplored. Here, we leverage in vitro selection as a powerful screen to identify the genetic adaptations that produce azithromycin resistance (>= 2 mu g/mL) in the Neisseria commensal, N. elongata. Across multiple lineages (n = 7/16), we find mutations that reduce susceptibility to azithromycin converge on the locus encoding the 50S ribosomal L34 protein (rpmH) and the intergenic region proximal to the 30S ribosomal S3 protein (rpsC) through short tandem duplication events. Interestingly, one of the laboratory evolved mutations in rpmH is identical (7LKRTYQ12), and two nearly identical, to those recently reported to contribute to high-level azithromycin resistance in N. gonorrhoeae. Transformations into the ancestral N. elongata lineage confirmed the causality of both rpmH and rpsC mutations. Though most lineages inheriting duplications suffered in vitro fitness costs, one variant showed no growth defect, suggesting the possibility that it may be sustained in natural populations. Ultimately, studies like this will be critical for predicting commensal alleles that could rapidly disseminate into pathogen populations via allelic exchange across recombinogenic microbial genera.	[Raisman, Jordan C.; Fiore, Michael A.; Tomin, Lucille; Adjei, Joseph K. O.; Aswad, Virginia X.; Chu, Jonathan; Domondon, Christina J.; Donahue, Ben A.; Masciotti, Claudia A.; McGrath, Connor G.; Melita, Jo; Podbielski, Paul A.; Schreiner, Madelyn R.; Trumpore, Lauren J.; Wengert, Peter C.; Wrightstone, Emalee A.; Hudson, Andre O.; Wadsworth, Crista B.] Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA	Rochester Institute of Technology	Wadsworth, CB (corresponding author), Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA.	cbwsbi@rit.edu			RIT College of Science	RIT College of Science	The authors would like to acknowledge the generous support provided by the RIT College of Science for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma G, 2014, J BACTERIOL, V196, P3820, DOI 10.1128/JB.01896-14; Andrews S., 2010, FASTQC QUALITY CONTR; Arnold B, 2020, MOL BIOL EVOL, V37, P417, DOI 10.1093/molbev/msz225; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Castillo-Ramirez S, 2021, ENVIRON MICROBIOL, V23, P7271, DOI 10.1111/1462-2920.15841; Chamorro G, 2019, J MED MICROBIOL, V68, P1793, DOI 10.1099/jmm.0.001097; Chen ML, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01494-19; Chisholm SA, 2010, ANTIMICROB AGENTS CH, V54, P3812, DOI 10.1128/AAC.00309-10; Clinical and Laboratory Standards Institute, 2019, PERFORMANCE STANDARD, P1, DOI [10.1108/08876049410065598, DOI 10.1108/08876049410065598]; Corander J, 2012, J R SOC INTERFACE, V9, P1208, DOI 10.1098/rsif.2011.0601; de Block T, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10030384; Demczuk W, 2016, J CLIN MICROBIOL, V54, P1304, DOI 10.1128/JCM.03195-15; Diallo K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50203-2; Diallo K, 2016, J INFECTION, V72, P667, DOI 10.1016/j.jinf.2016.03.010; Dong HV, 2020, CLIN INFECT DIS, V70, P1169, DOI 10.1093/cid/ciz365; FEAVERS IM, 1992, MOL MICROBIOL, V6, P489, DOI 10.1111/j.1365-2958.1992.tb01493.x; Fifer H, 2020, INT J STD AIDS, V31, P4, DOI 10.1177/0956462419886775; Fiore MA, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9100656; Frye SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003458; Fussenegger M, 1997, GENE, V192, P125, DOI 10.1016/S0378-1119(97)00038-3; Gong ZJ, 2016, ANTIMICROB AGENTS CH, V60, P2043, DOI 10.1128/AAC.00149-15; Goytia M, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10050538; Grad YH, 2016, J INFECT DIS, V214, P1579, DOI 10.1093/infdis/jiw420; HAGMAN KE, 1995, J BACTERIOL, V177, P4162, DOI 10.1128/jb.177.14.4162-4165.1995; HALTER R, 1989, EMBO J, V8, P2737, DOI 10.1002/j.1460-2075.1989.tb08415.x; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Harcourt BH, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv117; Jansen G, 2013, DRUG RESIST UPDATE, V16, P96, DOI 10.1016/j.drup.2014.02.002; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kim WJ, 2019, CELL HOST MICROBE, V26, P228, DOI 10.1016/j.chom.2019.07.003; Krone M, 2020, J ANTIMICROB CHEMOTH, V75, P984, DOI 10.1093/jac/dkz535; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laumen JGE, 2021, J ANTIMICROB CHEMOTH, V76, P1752, DOI 10.1093/jac/dkab084; Liu GY, 2015, MICROBIOL-SGM, V161, P1297, DOI 10.1099/mic.0.000086; Ma KC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19250-6; Ng LK, 2002, ANTIMICROB AGENTS CH, V46, P3020, DOI 10.1128/AAC.46.9.3020-3025.2002; Nji E, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82693-4; Ohneck EA, 2011, MBIO, V2, DOI 10.1128/mBio.00187-11; Pallecchi L, 2007, ANTIMICROB AGENTS CH, V51, P2720, DOI 10.1128/AAC.00026-07; Papp JR, 2018, J MED MICROBIOL, V67, P68, DOI 10.1099/jmm.0.000651; R Development Core Team, 2009, R LANG ENV STAT COMP; Retchless AC, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4560-x; Rouquette-Loughlin CE, 2018, MBIO, V9, DOI 10.1128/mBio.02281-18; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shoji S, 2011, J MOL BIOL, V413, P751, DOI 10.1016/j.jmb.2011.09.004; So M, 2019, MICROB CELL, V6, P544, DOI 10.15698/mic2019.12.701; SPRATT BG, 1992, J MOL EVOL, V34, P115; St Cyr S, 2020, MMWR-MORBID MORTAL W, V69, P1911, DOI 10.15585/mmwr.mm6950a6; Sukhum KV, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.01699-20; Unemo M, 2011, CLIN MICROBIOL REV, V24, P447, DOI 10.1128/CMR.00040-10; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; Vincent LR, 2018, MBIO, V9, DOI 10.1128/mBio.01905-17; von Wintersdorff CJH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00173; Wadsworth CB, 2018, MBIO, V9, DOI 10.1128/mBio.01419-18; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wu HM, 2009, NEW ENGL J MED, V360, P886, DOI 10.1056/NEJMoa0806414; Zarantonelli L, 2001, J ANTIMICROB CHEMOTH, V47, P651, DOI 10.1093/jac/47.5.651; ZHOU JJ, 1992, MOL MICROBIOL, V6, P2135, DOI 10.1111/j.1365-2958.1992.tb01387.x	59	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262370	10.1371/journal.pone.0262370	http://dx.doi.org/10.1371/journal.pone.0262370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025928	Green Published, gold			2022-12-27	WOS:000796264200064
J	Zhong, KY				Zhong, Kaiyang			Does the digital finance revolution validate the Environmental Kuznets Curve? Empirical findings from China	PLOS ONE			English	Article							CO2 EMISSIONS; INCOME INEQUALITY; ENERGY-CONSUMPTION; ECONOMIC-GROWTH; INTERNET PENETRATION; TRADE; HYPOTHESIS; ICT; POLLUTION; QUALITY	In recent years, digital finance has become a crucial part of the financial system and reshaped the mode of green finance in China. Digital finance has brought certain impact on economic growth, industrial structure, and resident income, which may affect pollution. The nexus of digital finance and environment in China is thus worth exploring. By revising the traditional Environmental Kuznets Curve model with income inequality variable, this paper decomposes the environmental effects of economic activities into income growth effect, industrial structure effect and income inequality effect, and use panel data of China's provinces to conduct an empirical analysis. The results reveal the following: (1) the Environmental Kuznets Curve is still valid in sample, and digital finance can reduce air and water pollution (as measured through SO2 and COD emission) directly; (2) in the influence mechanism, digital finance can alleviate income inequality and promote green industrial structure, thus reducing pollution indirectly, but the scale effect of income growth outweighs the technological effect, which increases pollution indirectly; and (3) digital finance has a threshold effect on improving the environment, then an acceleration effect appears after a certain threshold value. From the regional perspective, digital finance development in eastern regions is generally ahead of central and western regions, and the effects of environmental improvement in the eastern regions are greater. According to the study, this paper suggest that digital finance can be an effective way to promote social sustainability by alleviating income inequality and environmental sustainability by reducing pollution.	[Zhong, Kaiyang] Southwestern Univ Finance & Econ, Sch Econ Informat Engn, Chengdu, Peoples R China	Southwestern University of Finance & Economics - China	Zhong, KY (corresponding author), Southwestern Univ Finance & Econ, Sch Econ Informat Engn, Chengdu, Peoples R China.	zhongky0626@163.com		zhong, kaiyang/0000-0002-5575-0306				Akbostanci E, 2009, ENERG POLICY, V37, P861, DOI 10.1016/j.enpol.2008.09.088; Anand S., 2013, MANAG LABOUR STUD, V38, P103, DOI 10.1177/0258042X13498009; Higon DA, 2017, TELEMAT INFORM, V34, P85, DOI 10.1016/j.tele.2017.01.001; Antweiler W, 2001, AM ECON REV, V91, P877, DOI 10.1257/aer.91.4.877; Armeanu D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195708; Avom D, 2020, TECHNOL FORECAST SOC, V155, DOI 10.1016/j.techfore.2020.120028; Baek J, 2013, ENERG POLICY, V62, P1434, DOI 10.1016/j.enpol.2013.07.097; Beck T, 2018, J DEV ECON, V133, P162, DOI 10.1016/j.jdeveco.2018.01.005; Bittencourt M, 2010, ECON CHANG RESTRUCT, V43, P113, DOI 10.1007/s10644-009-9080-x; BOYCE JK, 1994, ECOL ECON, V11, P169, DOI 10.1016/0921-8009(94)90198-8; Chakravarty SR, 2013, J POLICY MODEL, V35, P813, DOI 10.1016/j.jpolmod.2012.12.007; Chen JD, 2020, J ENVIRON MANAGE, V271, DOI 10.1016/j.jenvman.2020.110987; Chen JL, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11174747; Chen X., 2018, COMMERCIAL RES, V8, P167; Cheng CY, 2021, ECON MODEL, V94, P662, DOI 10.1016/j.econmod.2020.02.008; Cole MA, 2003, J ENVIRON ECON MANAG, V46, P363, DOI 10.1016/S0095-0696(03)00021-4; Corrado G, 2017, CURR OPIN ENV SUST, V24, P19, DOI 10.1016/j.cosust.2017.01.013; Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011; Dong XY, 2018, ENERGY, V142, P215, DOI 10.1016/j.energy.2017.10.027; Du Y, 2017, ENVIRON PROG SUSTAIN, V36, P1290, DOI 10.1002/ep.12598; Farhani S, 2015, ENVIRON SCI POLLUT R, V22, P15663, DOI 10.1007/s11356-015-4767-1; Friedl B, 2003, ECOL ECON, V45, P133, DOI 10.1016/S0921-8009(03)00008-9; Golley J, 2012, ENERG ECON, V34, P1864, DOI 10.1016/j.eneco.2012.07.025; Gomber P, 2017, J BUSINESS ECO NOMIC, V67, P537, DOI [10.1007/s11573-017-0852-x, DOI 10.1007/S11573-017-0852-X]; Gonel F, 2018, WORLD J SCI TECHNOL, V15, P2, DOI 10.1108/WJSTSD-03-2017-0007; Gong XM, 2020, J CLEAN PROD, V256, DOI 10.1016/j.jclepro.2020.120725; Grossman G. M., 1991, Working Paper Series - National Bureau of Economic Research (Massachusetts); Halkos GE, 2013, J ENVIRON PLANN MAN, V56, P159, DOI 10.1080/09640568.2012.657756; Harbaugh WT, 2002, REV ECON STAT, V84, P541, DOI 10.1162/003465302320259538; Heidari H, 2015, INT J ELEC POWER, V64, P785, DOI 10.1016/j.ijepes.2014.07.081; Hsu A, 2020, J ENVIRON PLANN MAN, V63, P14, DOI 10.1080/09640568.2019.1661228; Huang Y.P., 2018, CHINA EC Q, V17, P1489, DOI DOI 10.13821/J.CNKI.CEQ.2018.03.09; Jayanthakumaran K, 2012, ENERG POLICY, V42, P450, DOI 10.1016/j.enpol.2011.12.010; Kar AK., 2011, J SMALL BUSINESS ENT, V24, P427, DOI [10.1080/08276331.2011.10593547, DOI 10.1080/08276331.2011.10593547]; Kong YS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209532; Kuznets S, 1955, AM ECON REV, V45, P1; Lange S, 2020, ECOL ECON, V176, DOI 10.1016/j.ecolecon.2020.106760; Lee S, 2015, CHINA ECON REV, V36, P73, DOI 10.1016/j.chieco.2015.08.009; Li J, 2020, ECON MODEL, V86, P317, DOI 10.1016/j.econmod.2019.09.027; Liang SL., 2018, IND EC REV, V2, P130; Lim JH, 2012, J ENVIRON PLANN MAN, V55, P271, DOI 10.1080/09640568.2011.597588; Liu JQ., 2019, RES EC MANAGEMENT, V4, P37; Lu Lerong., 2018, BANKING FINANCE LAW, V33, P317; Ma XW, 2020, ENVIRON SCI POLLUT R, V27, P36231, DOI 10.1007/s11356-020-09403-x; Manyika J., 2016, DIGITAL FINANCE ALL; Marsiliani L, 2000, 36 FEEM; Mushtaq R, 2019, TECHNOL SOC, V59, DOI 10.1016/j.techsoc.2019.101154; Ozili PK, 2018, BORSA ISTANB REV, V18, P329, DOI 10.1016/j.bir.2017.12.003; Panayatou T, 1993, 238 WORLD EMPL PROGR; Pata UK, 2018, ENERGY, V160, P1115, DOI 10.1016/j.energy.2018.07.095; Salahuddin M, 2016, RENEW SUST ENERG REV, V62, P1226, DOI 10.1016/j.rser.2016.04.018; Sebri M, 2016, J ENVIRON PLANN MAN, V59, P1933, DOI 10.1080/09640568.2015.1100983; Shaw ES., 1973, FINANCIAL DEEPING EC; Sicular T, 2008, STUD DEV ECON POLICY, P30; Song XL., 2017, FINANCE EC, V6, P20; Tchamyou VS, 2019, TECHNOL FORECAST SOC, V139, P169, DOI 10.1016/j.techfore.2018.11.004; Torras M, 1998, ECOL ECON, V25, P147, DOI 10.1016/S0921-8009(97)00177-8; Uzar U, 2019, J CLEAN PROD, V227, P149, DOI 10.1016/j.jclepro.2019.04.169; Wang Y, 2018, SUSTAIN PROD CONSUMP, V16, P237, DOI 10.1016/j.spc.2018.08.011; Yang HS, 2015, ECOL ECON, V109, P41, DOI 10.1016/j.ecolecon.2014.10.023; Zeng M, 2003, CALIF MANAGE REV, V45, P107, DOI 10.2307/41166168; Zhang GX, 2020, COMPUT IND ENG, V148, DOI 10.1016/j.cie.2020.106748; Zhang JP, 2019, J CLEAN PROD, V212, P1025, DOI 10.1016/j.jclepro.2018.12.100; Zhang ZB, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11051358; Zhong M, 2013, EC JINGWEI, V30, P125; Zhong WQ, 2021, FINANC RES LETT, V40, DOI 10.1016/j.frl.2020.101731	66	15	15	60	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0257498	10.1371/journal.pone.0257498	http://dx.doi.org/10.1371/journal.pone.0257498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025871	Green Published, gold			2022-12-27	WOS:000796264200004
J	Yoshihara, K; Takahashi, K				Yoshihara, Keisuke; Takahashi, Kei			A simple method for unsupervised anomaly detection: An application to Web time series data	PLOS ONE			English	Article							OUTLIER DETECTION	We propose a simple anomaly detection method that is applicable to unlabeled time series data and is sufficiently tractable, even for non-technical entities, by using the density ratio estimation based on the state space model. Our detection rule is based on the ratio of log-likelihoods estimated by the dynamic linear model, i.e. the ratio of log-likelihood in our model to that in an over-dispersed model that we will call the NULL model. Using the Yahoo S5 data set and the Numenta Anomaly Benchmark data set, publicly available and commonly used benchmark data sets, we find that our method achieves better or comparable performance compared to the existing methods. The result implies that it is essential in time series anomaly detection to incorporate the specific information on time series data into the model. In addition, we apply the proposed method to unlabeled Web time series data, specifically, daily page view and average session duration data on an electronic commerce site that deals in insurance goods to show the applicability of our method to unlabeled real-world data. We find that the increase in page view caused by e-mail newsletter deliveries is less likely to contribute to completing an insurance contract. The result also suggests the importance of the simultaneous monitoring of more than one time series.	[Yoshihara, Keisuke] Gunma Univ, Ctr Math & Data Sci, Maebashi, Gumma, Japan; [Takahashi, Kei] Fukuoka Inst Technol, Fac Informat Engn, Fukuoka, Japan; [Takahashi, Kei] Inst Stat Math, Sch Stat Thinking, Tokyo, Japan	Gunma University; Fukuoka Institute of Technology; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan	Yoshihara, K (corresponding author), Gunma Univ, Ctr Math & Data Sci, Maebashi, Gumma, Japan.	ksk0110@gmail.com		Yoshihara, Keisuke/0000-0002-3365-9755				Ahmad S, 2017, NEUROCOMPUTING, V262, P134, DOI 10.1016/j.neucom.2017.04.070; Amarbayasgalan T, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12081251; [Anonymous], YAHOO WEBSCOPE DATAS; Baragona R, 2007, NEURAL COMPUT, V19, P1962, DOI 10.1162/neco.2007.19.7.1962; Bozbura M., 2019, NEURAL NETWORKS, P217; Braei M., 2020, ANOMALY DETECTION UN; Daubener S., 2019, ICDM; FOX AJ, 1972, J ROY STAT SOC B, V34, P350; Galeano P, 2006, J AM STAT ASSOC, V101, P654, DOI 10.1198/016214505000001131; Hill DJ, 2010, ENVIRON MODELL SOFTW, V25, P1014, DOI 10.1016/j.envsoft.2009.08.010; Hundman K, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P387, DOI 10.1145/3219819.3219845; Lavin A, 2015, 2015 IEEE 14TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA), P38, DOI 10.1109/ICMLA.2015.141; Lu H, 2018, IEEE ACCESS, V6, P53593, DOI 10.1109/ACCESS.2018.2870151; Maciag PS, 2021, NEURAL NETWORKS, V139, P118, DOI 10.1016/j.neunet.2021.02.017; Manandhar K, 2014, IEEE T CONTROL NETW, V1, P370, DOI 10.1109/TCNS.2014.2357531; Munir M, 2019, IEEE ACCESS, V7, P1991, DOI 10.1109/ACCESS.2018.2886457; Nakano M, 2017, EXPERT SYST APPL, V73, P187, DOI 10.1016/j.eswa.2016.12.034; Papadimitriou Spiros, 2005, P 31 INT C VER LARG, P697; Petris G, 2009, USE R, P31, DOI 10.1007/b135794_2; Prasad NR, 2009, CMC-COMPUT MATER CON, V14, P1, DOI 10.1145/1541880.1541882; Shahriar MS, 2016, COMPUT ELECTRON AGR, V128, P20, DOI 10.1016/j.compag.2016.08.009; Soule A., 2005, Performance Evaluation Review, V33, P362, DOI 10.1145/1071690.1064259; Suh S, 2016, IEEE IJCNN, P1015, DOI 10.1109/IJCNN.2016.7727309; Thill M, 2017, 2017 EVOLVING ADAPTI, P1; Zhang Y, 2012, INT J GEOGR INF SCI, V26, P1373, DOI 10.1080/13658816.2012.654493; Zhou YS, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082628; Zhou YX, 2016, IEEE DECIS CONTR P, P6335, DOI 10.1109/CDC.2016.7799244	28	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262463	10.1371/journal.pone.0262463	http://dx.doi.org/10.1371/journal.pone.0262463			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015791	Green Published, gold			2022-12-27	WOS:000814820600024
J	Brzozowicz, M; Krawczyk, M				Brzozowicz, Magdalena; Krawczyk, Michal			Anchors on prices of consumer goods only hold when decisions are hypothetical	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; CONTINGENT VALUATION; BIAS; MECHANISMS; UNCERTAINTY; ROBUSTNESS; AUCTIONS; THINKING; UTILITY; POINT	We elicit willingness to pay for different types of consumption goods, systematically manipulating irrelevant anchors (high vs. low) and incentives to provide true valuations (hypothetical questions vs. Becker-DeGroot-Marschak mechanism). On top of a strong hypothetical bias, we find that anchors only make a substantial, significant difference in the case of hypothetical data, the first experiments to directly document such an interaction. This finding suggests that hypothetical market research methods may deliver lower quality data. Moreover, it contributes to the discussion examining the mechanism underlying the anchoring effect, suggesting it could partly be caused by insufficient conscious effort to drift away from the anchor.	[Brzozowicz, Magdalena; Krawczyk, Michal] Univ Warsaw, Fac Econ Sci, Warsaw, Poland	University of Warsaw	Brzozowicz, M (corresponding author), Univ Warsaw, Fac Econ Sci, Warsaw, Poland.	mbrzozowicz@wne.uw.edu.pl		Krawczyk, Michal/0000-0001-6795-1175; Brzozowicz, Magdalena/0000-0001-9000-1178	National Science Centre, Poland [UMO2017/27/N/HS4/02116]	National Science Centre, Poland(National Science Centre, Poland)	Brzozowicz M., grant number: UMO2017/27/N/HS4/02116, National Science Centre, Poland, https://www.ncn.gov.pl/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 2004, PERS SOC PSYCHOL B, V30, P1108, DOI 10.1177/0146167204264079; Alevy JE, 2015, ECON INQ, V53, P1522, DOI 10.1111/ecin.12201; [Anonymous], 2006, J SOCIO-ECON, DOI DOI 10.1016/J.SOCEC.2005.11.045; [Anonymous], 2011, J SOCIO-ECON, DOI DOI 10.1016/J.SOCEC.2010.10.008; Ariely D, 2003, Q J ECON, V118, P73, DOI 10.1162/00335530360535153; Bahnik S, 2017, COGNITIVE ILLUSIONS: INTRIGUING PHENOMENA IN THINKING, JUDGEMENT AND MEMORY, P223; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Bergman O, 2010, ECON LETT, V107, P66, DOI 10.1016/j.econlet.2009.12.028; Blamey RK, 1999, LAND ECON, V75, P126, DOI 10.2307/3146997; Blumenschein K, 1998, SOUTHERN ECON J, V65, P169, DOI 10.2307/1061360; Bohm P, 1997, ECON J, V107, P1079, DOI 10.1111/1468-0297.00207; Boyce RR, 1989, P JOINT M W COMM BEN, P305; Carson RT, 2007, ENVIRON RESOUR ECON, V37, P181, DOI 10.1007/s10640-007-9124-5; CHAIKEN S, 1989, P212; Champ PA, 1997, J ENVIRON ECON MANAG, V33, P151, DOI 10.1006/jeem.1997.0988; Chang JB, 2009, AM J AGR ECON, V91, P518, DOI 10.1111/j.1467-8276.2008.01242.x; CHAPMAN GB, 1994, J BEHAV DECIS MAKING, V7, P223, DOI 10.1002/bdm.3960070402; Cvitanic J, 2019, AM ECON REV INSIGHTS, V1, P179, DOI 10.1257/aeri.20180227; Doyon M., 2015, THEORETICAL EC LETT, V5, P749, DOI DOI 10.4236/TEL.2015.56087; Englich B, 2001, J APPL SOC PSYCHOL, V31, P1535; Enke B., 2020, CESIFO WORKING PAPER, P8168; Epley N, 2005, J BEHAV DECIS MAKING, V18, P199, DOI 10.1002/bdm.495; Flachaire E, 2006, LAND ECON, V82, P103, DOI 10.3368/le.82.1.103; Foster H., 2017, CONTINGENT VALUATION, DOI 10.4337/9781786434692.00016; Fudenberg D, 2012, AM ECON J-MICROECON, V4, P131, DOI 10.1257/mic.4.2.131; GILBERT DT, 1988, J PERS SOC PSYCHOL, V54, P733, DOI 10.1037/0022-3514.54.5.733; Green D, 1998, RESOUR ENERGY ECON, V20, P85, DOI 10.1016/S0928-7655(97)00031-6; Harrison GW, 2004, J ECON LIT, V42, P1009, DOI 10.1257/0022051043004577; Ioannidis K, 2020, J ECON SCI ASSOC-JES, V6, P77, DOI 10.1007/s40881-020-00094-1; JOHNSON EJ, 1989, MANAGE SCI, V35, P406, DOI 10.1287/mnsc.35.4.406; Jung MH, 2016, J MARKETING RES, V53, P354, DOI 10.1509/jmr.14.0238; Kahneman D., 2002, HEURISTICS BIASES PS, P120, DOI DOI 10.1017/CBO9780511808098.008; Kocas C, 2014, MARKET LETT, V25, P139, DOI 10.1007/s11002-013-9235-4; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P221, DOI 10.1037/0022-3514.77.2.221; Li LZ, 2021, J BEHAV EXP ECON, V90, DOI 10.1016/j.socec.2020.101629; List JA, 2001, AM ECON REV, V91, P1498, DOI 10.1257/aer.91.5.1498; List JA, 2003, J REGUL ECON, V23, P193, DOI 10.1023/A:1022259014448; List JA, 2001, ENVIRON RESOUR ECON, V20, P241, DOI 10.1023/A:1012791822804; Loomis J, 1996, LAND ECON, V72, P450, DOI 10.2307/3146908; Loomis JB, 2014, J AGR RESOUR ECON, V39, P34; Lusk JL, 2009, LAND ECON, V85, P500; Maniadis Z, 2014, AM ECON REV, V104, P277, DOI 10.1257/aer.104.1.277; Miller KM, 2011, J MARKETING RES, V48, P172, DOI 10.1509/jmkr.48.1.172; Moser R, 2014, EUR REV AGRIC ECON, V41, P25, DOI 10.1093/erae/jbt016; Murphy J. J., 2004, Agricultural and Resource Economics Review, V33, P182; Murphy JJ, 2005, ENVIRON RESOUR ECON, V30, P313, DOI 10.1007/s10640-004-3332-z; Mussweiler T, 1999, J EXP SOC PSYCHOL, V35, P136, DOI 10.1006/jesp.1998.1364; Mussweiler T, 2000, PERS SOC PSYCHOL B, V26, P1142, DOI 10.1177/01461672002611010; Penn JM, 2018, AM J AGR ECON, V100, P1186, DOI 10.1093/ajae/aay021; PLOUS S, 1989, J APPL SOC PSYCHOL, V19, P67, DOI 10.1111/j.1559-1816.1989.tb01221.x; Shogren JF, 2006, ENVIRON RESOUR ECON, V34, P163, DOI 10.1007/s10640-005-3785-8; Simmons JP, 2010, J PERS SOC PSYCHOL, V99, P917, DOI 10.1037/a0021540; Simonson I, 2004, J CONSUM RES, V31, P681, DOI 10.1086/425103; Strack F, 1997, J PERS SOC PSYCHOL, V73, P437, DOI 10.1037/0022-3514.73.3.437; Sugden R, 2013, J ECON PSYCHOL, V39, P21, DOI 10.1016/j.joep.2013.06.008; Tufano F, 2010, EXP ECON, V13, P1, DOI 10.1007/s10683-009-9226-8; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wertenbroch K, 2002, J MARKETING RES, V39, P228, DOI 10.1509/jmkr.39.2.228.19086; Wilson TD, 1996, J EXP PSYCHOL GEN, V125, P387, DOI 10.1037/0096-3445.125.4.387; Yoon S, 2019, JUDGM DECIS MAK, V14, P470; Zhang L., 2018, ANCHORING PROJECT DU, P88456	61	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262130	10.1371/journal.pone.0262130	http://dx.doi.org/10.1371/journal.pone.0262130			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZO8DB	34986164	Green Published, gold			2022-12-27	WOS:000765956200017
J	Fitriana, N; Hutagalung, FD; Awang, Z; Zaid, SM				Fitriana, Nina; Hutagalung, Fonny Dameaty; Awang, Zainudin; Zaid, Sumaia Mohammed			Happiness at work: A cross-cultural validation of happiness at work scale	PLOS ONE			English	Article							CONTENT VALIDITY	The idea of Happiness at Work is drawn from psychology and economic studies. It is often considered as a synonym with 'wellbeing' and defined as a state characterized by a high level of life satisfaction, a high level of positive emotions, and less negative emotions. This research aims to validate the Happiness at Work scale in the Indonesian context. In this study, the researchers conducted cross-cultural adaptation for the Happiness at Work scale following systematic procedures to produce the Scale of Happiness at Work in the Indonesian language. Afterward, the researchers evaluated the content validity with the help of professional judgment and measured the Content Validity Index at the item level and the scale level. Further, to examine the psychometric properties of the Happiness at Work scale, the researchers administer the questionnaire to a sample of 105 (35 male and 70 female) lecturers to conduct exploratory factor analysis to formulate the new dimensionality of the Happiness at Work scale. The results of Exploratory Factor Analysis indicated that Happiness at Work in the Indonesian context could be measured using four dimensions. To confirm that the extracted dimensions measure a single construct, the researchers administered the produced version to a sample of 370 (147 male and 223 female). Afterward, researchers conducted confirmatory factor analysis to evaluate the validity and reliability of the measurement model. This research found out that the Indonesian version of Happiness at Work measurement is reliable and valid. Thus, this study may contribute to the happiness at work literature of non-western context. In conclusion, the Indonesian-Happiness at Work scale shows robust psychometric properties that can be used for further research.	[Fitriana, Nina; Hutagalung, Fonny Dameaty; Zaid, Sumaia Mohammed] Univ Malaya, Educ Psychol & Counselling Dept, Fac Educ, Kuala Lumpur, Malaysia; [Fitriana, Nina] Univ Mercu Buana Yogyakarta, Fac Psychol, Dept Psychol, Yogyakarta, Indonesia; [Awang, Zainudin] Univ Sultan Zainal Abidin, Fac Econ & Management Sci, Terengganu, Malaysia; [Zaid, Sumaia Mohammed] Sanaa Univ, Dept Psychol, Sanaa, Yemen	Universiti Malaya; Universiti Sultan Zainal Abidin	Hutagalung, FD (corresponding author), Univ Malaya, Educ Psychol & Counselling Dept, Fac Educ, Kuala Lumpur, Malaysia.	fonny@um.edu.my	Hutagalung, Fonny/E-1443-2019; Zaid, Sumaia/AAU-2393-2021	Hutagalung, Fonny/0000-0001-9097-720X; Zaid, Sumaia/0000-0002-8330-387X; Fitriana, Nina/0000-0002-9906-1043				Afthanorhan A., 2018, MANAGEMENT SCI LETT, V8, P1421, DOI [10.5267/j.msl.2018.10.004, DOI 10.5267/J.MSL.2018.10.004]; Afthanorhan A., 2019, MANAGEMENT SCI LETT, V9, P13, DOI DOI 10.5267/J.MSL.2018.11.004; Aimran AN, 2017, AIP C P; Alias N., 2019, IIUM J ED STUDIES, V7, P22; Argyle M., 2013, PSYCHOL HAPPINESS, DOI [10.4324/9781315812212, DOI 10.4324/9781315812212]; Awang Z., 2015, SEM MADE SIMPLE GENT; Bakker A.B., 2008, CAREER DEV INT, V13, P209, DOI [DOI 10.1108/13620430810870476, 10.1108/13620430810870476]; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Davis L.L., 1992, APPL NURS RES, V5, P194, DOI [10.1016/S0897-1897(05)80008-4, DOI 10.1016/S0897-1897(05)80008-4]; Diener E, 2009, SOC INDIC RES SER, V38, P43, DOI 10.1007/978-90-481-2352-0_3; Ehido A., 2020, INT J SOCIAL SCI PER, V7, P58; Felber C, 2015, EC COMMON GOOD; Fisher CD, 2014, WORK WELLBEING WELLB; Fisher CD, 2010, INT J MANAG REV, V12, P384, DOI 10.1111/j.1468-2370.2009.00270.x; Hair J.F., 2019, MULTIVARIATE DATA AN, V8th; Khan AS, 2015, GLOBAL J MANAGEMENT, V15, P16; Lu L, 2006, ASIAN J SOC PSYCHOL, V9, P36, DOI 10.1111/j.1467-839X.2006.00183.x; Mohamad M., 2017, INT J APPL BUSINESS, V15, P91, DOI [10.1016/j.visres.2016.06.012, DOI 10.1016/J.VISRES.2016.06.012]; Parker GB, 2011, J NERV MENT DIS, V199, P394, DOI 10.1097/NMD.0b013e31821cd3b9; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Pryce-Jones J., 2011, HAPPINESS WORK MAXIM; Rahlin N.A., 2019, INT J INNOV CREAT CH, V7, P351; Ramirez-Garcia C, 2019, RAE-REV ADMIN EMPRES, V59, P327, DOI [10.1590/s0034-759020190503, 10.1590/S0034-759020190503]; Salas-Vallina A, 2021, J MANAGE ORGAN, V27, P460, DOI 10.1017/jmo.2018.24; Salas-Vallina A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00456; Salas-Vallina A, 2017, INT J MANPOWER, V38, P470, DOI 10.1108/IJM-10-2015-0163; Salas-Vallina A, 2017, PERS REV, V46, P314, DOI 10.1108/PR-06-2015-0186; Shkeer A. S., 2019, INT REV MANAGEMENT M, V9, P87, DOI DOI 10.32479/IRMM.8622; Singh S, 2018, J HAPPINESS STUD, V19, P1439, DOI 10.1007/s10902-017-9882-x; Tabachnick BG., 2007, USING MULTIVARIATE S, V5, P481; Yusoff M.S.B., 2019, RESOURCE, V11, P49, DOI [10.21315/eimj2019.11.2.6, DOI 10.21315/EIMJ2019.11.2.6]	32	3	3	12	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0261617	10.1371/journal.pone.0261617	http://dx.doi.org/10.1371/journal.pone.0261617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZO8DB	34986180	gold, Green Published			2022-12-27	WOS:000765956200012
J	Hendriksen, RB; van der Gaag, EJ				Hendriksen, Rosanne Barbra; van der Gaag, Ellen Jose			Effect of a dietary intervention including minimal and unprocessed foods, high in natural saturated fats, on the lipid profile of children, pooled evidence from randomized controlled trials and a cohort study	PLOS ONE			English	Article							TRANS-PALMITOLEIC ACID; CALCIUM INTAKE; ATHEROSCLEROSIS; METAANALYSIS; ASSOCIATION; OVERWEIGHT; OBESITY; ADULTS; MILK	Aim To study the possible effects of a dietary intervention with minimal and unprocessed foods, high in natural saturated fats on the lipid profile and body mass index of children. Method This study combines three intervention studies; one non-randomized retrospective cohort study and two randomized controlled trials, to a pooled analysis. The intervention group received a dietary intervention of minimal and unprocessed foods for three to six months, consisting of five times per week green vegetables, three times per week beef, daily 200300 mL whole cow's milk (3.4% fat) and whole dairy butter (80% fat) on each slice of bread. The control group continued their usual dietary habits. Raw data of the three intervention studies where combined into one single dataset for data analysis, using mixed effects analysis of covariance to test the effects of the dietary advice on the main study outcomes, which are measurements of the lipid profile. Results In total, 267 children aged 1 to 16 years were followed. 135 children were included in the intervention group and 139 children in the control group. Characteristics (age, gender and follow-up period) were equally distributed between the groups at baseline. In the intervention group HDL-cholesterol increased significantly from 1.22 mmol/L, 95% confidence interval (CI) 1.14-1.32 to 1.42 mmol/L 95% CI 1.30-1.65 (p = 0.007). The increase over time in HDL cholesterol in the intervention group was significantly different compared to the increase in the control group (from 1.26 mmol/L, 95% CI 1.19-1.35, to 1.30 mmol/L, 95% CI 1.26-1.37) (p = 0.04). Due to the increased HDL concentration in the intervention group, the total cholesterol/HDL cholesterol ratio decreased significantly from 3.70 mmol/L, 95% CI 3.38-3.87, to 3.25 mmol/L, 95% CI 2.96-3.31 (p = 0.05). Conclusion Consumption of minimal and unprocessed foods (high in natural saturated fats) has favourable effects on HDL cholesterol in children. Therefore, this dietary advice can safely be recommended to children.	[Hendriksen, Rosanne Barbra] Wageningen Univ & Res WUR, MSc Nutr & Hlth, Wageningen, Netherlands; [van der Gaag, Ellen Jose] Hosp Grp Twente ZGT, Dept Pediat, Hengelo, Netherlands	Wageningen University & Research	Hendriksen, RB (corresponding author), Wageningen Univ & Res WUR, MSc Nutr & Hlth, Wageningen, Netherlands.	rosannebh@gmail.com						Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Bhateja PK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/572013; Silverio RNC, 2019, DIABETES RES CLIN PR, V154, P9, DOI 10.1016/j.diabres.2019.06.005; Cornwell B, 2018, PUBLIC HEALTH NUTR, V21, P142, DOI 10.1017/S1368980017000891; Costa CS, 2019, NUTR METAB CARDIOVAS, V29, P177, DOI 10.1016/j.numecd.2018.11.003; Davies KM, 2000, J CLIN ENDOCR METAB, V85, P4635, DOI 10.1210/jc.85.12.4635; Engel S, 2018, EUR J CLIN NUTR, V72, P249, DOI 10.1038/s41430-017-0042-5; Fredriks AM, 2005, ACTA PAEDIATR, V94, P496, DOI [10.1080/08035250410024240, 10.1111/j.1651-2227.2005.tb01923.x]; Gillman MW, 1997, JAMA-J AM MED ASSOC, V278, P2145, DOI 10.1001/jama.278.24.2145; Kohnke R, 2009, SCAND J GASTROENTERO, V44, P712, DOI 10.1080/00365520902803499; Kratz M, 2013, EUR J NUTR, V52, P1, DOI 10.1007/s00394-012-0418-1; Lee AK, 2014, CONSUMPTION LESS 10; Lewis K, 2010, INFLAMM BOWEL DIS, V16, P1138, DOI 10.1002/ibd.21177; Liu XR, 2013, BRIT J NUTR, V109, P1695, DOI 10.1017/S0007114513000196; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mozaffarian D, 2004, AM J CLIN NUTR, V80, P1175, DOI 10.1093/ajcn/80.5.1175; Mozaffarian D, 2013, AM J CLIN NUTR, V97, P854, DOI 10.3945/ajcn.112.045468; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; Ohlsson L, 2010, EUR J CLIN NUTR, V64, P1344, DOI 10.1038/ejcn.2010.164; Rauber F, 2015, NUTR METAB CARDIOVAS, V25, P116, DOI 10.1016/j.numecd.2014.08.001; Roberts JL, 2016, FOOD FUNCT, V7, P3337, DOI [10.1039/C6FO00051G, 10.1039/c6fo00051g]; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; SHRAPNEL WS, 1992, MED J AUSTRALIA, V156, pS9; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Skinner JD, 2003, J AM DIET ASSOC, V103, P1626, DOI 10.1016/j.jada.2003.09.020; UNICEF, VERL NAAR GEZ 2020; van der Gaag E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103689; van der Gaag E, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010272; van der Gaag EJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050518; Vanderhout SM, 2020, AM J CLIN NUTR, V111, P266, DOI 10.1093/ajcn/nqz276; Vandevijvere S, 2019, EUR J NUTR, V58, P3267, DOI 10.1007/s00394-018-1870-3; Wang HF, 2011, OBESITY, V19, P2404, DOI 10.1038/oby.2011.234; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; World Health Organization, OB OV 2020; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0261446	10.1371/journal.pone.0261446	http://dx.doi.org/10.1371/journal.pone.0261446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986194	gold, Green Published			2022-12-27	WOS:000765956200010
J	Kumar, A; Siddharth, V; Singh, SI; Narang, R				Kumar, Atul; Siddharth, Vijaydeep; Singh, Soubam Iboyaima; Narang, Rajiv			Cost analysis of treating cardiovascular diseases in a super-specialty hospital	PLOS ONE			English	Article							MEDICAL-CARE COSTS	Cardiovascular care is expensive; hence, economic evaluation is required to estimate resources being consumed and to ensure their optimal utilization. There is dearth of data regarding cost analysis of treating various diseases including cardiac diseases from developing countries. The study aimed to analyze resource consumption in treating cardio-vascular disease patients in a super-specialty hospital. An observational and descriptive study was carried out from April 2017 to June 2018 in the Department of Cardiology, Cardio-Thoracic (CT) Centre of All India Institute of Medical Sciences, New Delhi, India. As per World Health Organization, common cardiovascular diseases i.e. Coronary Artery Disease (CAD), Rheumatic Heart Disease (RHD), Cardiomyopathy, Congenital heart diseases, Cardiac Arrhythmias etc. were considered for cost analysis. Medical records of 100 admitted patients (Ward & Cardiac Care Unit) of cardiovascular diseases were studied till discharge and number of patient records for a particular CVD was identified using prevalence-based ratio of admitted CVD patient data. Traditional Costing and Time Driven Activity Based Costing (TDABC) methods were used for cost computation. Per bed per day cost incurred by the hospital for admitted patients in Cardiac Care Unit, adult and pediatric cardiology ward was calculated to be Indian Rupee (INR) 28,144 (US$ 434), INR 22,210 (US$ 342) and INR 18,774 (US$ 289), respectively. Inpatient cost constituted almost 70% of the total cost and equipment cost accounted for more than 50% of the inpatient cost followed by human resource cost (28%). Per patient cost of treating any CVD was computed to be INR 2,47,822 (US $ 3842). Cost of treating Rheumatic Heart Disease was the highest among all CVDs followed by Cardiomyopathy and other CVDs. Cost of treating cardiovascular diseases in India is less than what has been reported in developed countries. Findings of this study would aid policy makers considering recent radical changes and massive policy reforms ushered in by the Government of India in healthcare delivery.	[Kumar, Atul; Siddharth, Vijaydeep; Singh, Soubam Iboyaima] All India Inst Med Sci AIIMS, Dept Hosp Adm, New Delhi, India; [Narang, Rajiv] AIIMS, Cardiothorac Ctr, Dept Cardiol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Siddharth, V (corresponding author), All India Inst Med Sci AIIMS, Dept Hosp Adm, New Delhi, India.	dr.siddharthmamc@gmail.com	Kumar, Dr. Atul/H-2076-2018	Kumar, Dr. Atul/0000-0002-2813-3951; Siddharth, Vijaydeep/0000-0002-4703-9733				American Heart Association, 2017, CARD DIS COSTL BURD, P7; Celermajer DS, 2012, J AM COLL CARDIOL, V60, P1207, DOI 10.1016/j.jacc.2012.03.074; Deloitte, 2011, INT HEART PROT SUMM, P1; Ding JM, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009341; Drummond Michael F., 2015, METHODS EC EVALUATIO, VFourth, P464; Edbrooke DL, 1997, INTENS CARE MED, V23, P645, DOI 10.1007/s001340050388; Emamgholipour S, 2018, INT CARDIOVASC RES J, V12, P1; Gajuryal SH, 2017, INDIAN J NUCL MED, V32, P1, DOI 10.4103/0972-3919.198438; Gheorghe A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5806-x; Horngren CT, 2012, COST ACCOUNTING MANA, DOI [10.1097/IAE.0b013-318248e6ba, DOI 10.1097/IAE.0B013-318248E6BA]; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Imani A, 2016, JUNDISHAPUR J HLTH S, V8; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Kastor A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196106; Kausar M, 2021, INDIAN J PUBLIC HLTH, V65, P45, DOI 10.4103/ijph.IJPH_431_20; Khan M, 2017, J BIOEQUIV BIOAVAILA, V09, P353; Kumar P, 2014, GSTF J NURS HEALTHC, V1, P6; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Nichols GA, 2002, DIABETES CARE, V25, P482, DOI 10.2337/diacare.25.3.482; Nichols GA, 2010, AM J MANAG CARE, V16, pE86; Parissis J, 2015, INT J CARDIOL, V180, P46, DOI 10.1016/j.ijcard.2014.11.123; Prabhakaran D, 2018, LANCET GLOB HEALTH, V6, pE1339, DOI 10.1016/S2214-109X(18)30407-8; Prabhakaran D, 2018, J AM COLL CARDIOL, V72, P79, DOI 10.1016/j.jacc.2018.04.042; Rahman MM, 2017, JAMA INTERN MED, V177, P1297, DOI 10.1001/jamainternmed.2017.3133; Siddharth V, 2015, INDIAN J SURG, V77, pS530, DOI 10.1007/s12262-013-0908-2; Silva MP, 2016, INT ARCH MED, P1; Singh Sheetal, 2016, J Emerg Trauma Shock, V9, P133, DOI 10.4103/0974-2700.193347; Wang SN, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000837; WHO, 2018, CARDIOVASCULAR DIS C, P1; World Health Organization, 2014, NONCOMMUNICABLE DIS, P1, DOI [10.1111/jgs.12171, DOI 10.1111/JGS.12171]; World Health Organization, 2017, CARD DIS CVDS	31	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262190	10.1371/journal.pone.0262190	http://dx.doi.org/10.1371/journal.pone.0262190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986193	Green Submitted, Green Published, gold			2022-12-27	WOS:000765956200022
J	Alem, AZ; Yeshaw, Y; Liyew, AM; Tesema, GA; Alamneh, TS; Worku, MG; Teshale, AB; Tessema, ZT				Alem, Adugnaw Zeleke; Yeshaw, Yigizie; Liyew, Alemneh Mekuriaw; Tesema, Getayeneh Antehunegn; Alamneh, Tesfa Sewunet; Worku, Misganaw Gabrie; Teshale, Achamyeleh Birhanu; Tessema, Zemenu Tadesse			Timely initiation of antenatal care and its associated factors among pregnant women in sub-Saharan Africa: A multicountry analysis of Demographic and Health Surveys	PLOS ONE			English	Article							GLOBAL LEVELS; MORTALITY; TRENDS	BackgroundTimely initiation of antenatal care (ANC) is an important component of ANC services that improve the health of the mother and the newborn. Mothers who begin attending ANC in a timely manner, can fully benefit from preventive and curative services. However, evidence in sub-Saharan Africa (sSA) indicated that the majority of pregnant mothers did not start their first visit timely. As our search concerned, there is no study that incorporates a large number of sub-Saharan Africa countries. Thus, the objective of this study was to assess the prevalence of timely initiation of ANC and its associated factors in 36 sSA countries. MethodsThe Demographic and Health Survey (DHS) of 36 sSA countries were used for the analysis. The total weighted sample of 233,349 women aged 15-49 years who gave birth in the five years preceding the survey and who had ANC visit for their last child were included. A multi-level logistic regression model was used to examine the individual and community-level factors that influence the timely initiation of ANC. Results were presented using adjusted odds ratio (AOR) with 95% confidence interval (CI). ResultsIn this study, overall timely initiation of ANC visit was 38.0% (95% CI: 37.8-38.2), ranging from 14.5% in Mozambique to 68.6% in Liberia. In the final multilevel logistic regression model:- women with secondary education (AOR = 1.08; 95% CI: 1.06, 1.11), higher education (AOR = 1.43; 95% CI: 1.36, 1.51), women aged 25-34 years (AOR = 1.20; 95% CI: 1.17, 1.23), >= 35 years (AOR = 1.30; 95% CI: 1.26, 1.35), women from richest household (AOR = 1.19; 95% CI: 1.14, 1.22), women perceiving distance from the health facility as not a big problem (AOR = 1.05; 95%CI: 1.03, 1.07), women exposed to media (AOR = 1.29; 95%CI: 1.26, 1.32), women living in communities with medium percentage of literacy (AOR = 1.51; 95%CI: 1.40, 1.63), and women living in communities with high percentage of literacy (AOR = 1.56; 95%CI: 1.38, 1.76) were more likely to initiate ANC timely. However, women who wanted their pregnancy later (AOR = 0.84; 95%CI: 0.82, 0.86), wanted no more pregnancy (AOR = 0.80; 95%CI: 0.77, 0.83), and women residing in the rural area (AOR = 0.90; 95%CI: 0.87, 0.92) were less likely to initiate ANC timely. ConclusionEven though the WHO recommends all women initiate ANC within 12 weeks of gestation, sSA recorded a low overall prevalence of timely initiation of ANC. Maternal education, pregnancy intention, residence, age, wealth status, media exposure, distance from health facility, and community-level literacy were significantly associated with timely initiation of ANC. Therefore, intervention efforts should focus on the identified factors in order to improve timely initiation of ANC in sSA. This can be done through the providing information and education to the community on the timing and importance of attending antenatal care and family planning to prevent unwanted pregnancy, especially in rural settings.	[Alem, Adugnaw Zeleke; Yeshaw, Yigizie; Liyew, Alemneh Mekuriaw; Tesema, Getayeneh Antehunegn; Alamneh, Tesfa Sewunet; Teshale, Achamyeleh Birhanu; Tessema, Zemenu Tadesse] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Yeshaw, Yigizie] Univ Gondar, Sch Med, Dept Physiol, Coll Med & Hlth Sci, Gondar, Ethiopia; [Worku, Misganaw Gabrie] Univ Gondar, Sch Med, Dept Human Anat, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Alem, AZ (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia.	aduzeleke2201@gmail.com	Teshale, Achamyeleh/HHN-8416-2022	Alemneh, Tesfa Sewunet/0000-0002-4830-931X; Yeshaw, Yigizie/0000-0003-4587-7925				Akhtar F, 2018, CUREUS, V10, DOI 10.7759/cureus.2078; Alemu Y, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0646-9; Aliyu Alhaji Abubakar, 2017, Pan Afr Med J, V26, P124, DOI 10.11604/pamj.2017.26.124.9861; Aung TZ., 2017, INT J COMMUNITY MED, V3, P900; Austin PC, 2017, STAT MED, V36, P3257, DOI 10.1002/sim.7336; Banda I., 2012, MED J AUSTRALIA, V39, P29; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P137, DOI 10.4314/ejhs.v24i0.12S; Blackstone SR, 2019, WOMEN HEALTH, V59, P1141, DOI 10.1080/03630242.2019.1590496; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Branum AM, 2017, MATERN CHILD HLTH J, V21, P715, DOI 10.1007/s10995-016-2155-1; Chewe M. M., 2016, African Journal of Midwifery and Women's Health, V10, P169; Ejeta E, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.184.10926; Ekholuenetale M, 2020, J EGYPT PUBLIC HEAL, V95, DOI 10.1186/s42506-020-00041-2; Emiru AA, 2020, INT J WOMENS HEALTH, V12, P463, DOI 10.2147/IJWH.S250832; Ethiopian Central Statistics Agency (ECSA), 2016, ETH DEM HLTH SURV ED; Ewunetie AA, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1748-7; Exavery A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-35; Gebrekidan K, 2017, PRAGMAT OBS RES, V8, P223, DOI 10.2147/POR.S140733; Gebresilassie B, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2490-5; Geta M. B., 2017, Advances in Public Health, V2017, P1624245, DOI 10.1155/2017/1624245; Gidey G, 2018, ASIAN J PHARM CLIN R, V11; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Gong E, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4369-6; Gross K, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-16; Gudayu TW, 2015, AFR J REPROD HEALTH, V19, P94; Haftu Abera, 2018, BMC Res Notes, V11, P872, DOI 10.1186/s13104-018-3987-0; Hanna G, TIMING 1 ANTENATAL C; Hug L, 2019, LANCET GLOB HEALTH, V7, pE710, DOI 10.1016/S2214-109X(19)30163-9; Institut National de la Statistique, 2011, ENQ DEM SANT IND MUL; Isawumi A, 2018, ONLINE J HLTH ALLIED, V7, P4; Jiwani SS, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010502; Kenya National Bureau of Statistics, 2014, KEN DEM HLTH SURV; Kisuule I, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-121; Leshabari LK., 2020, EC GYNAECOL, V93, P01; Luginaah IN, 2016, SOC SCI MED, V160, P75, DOI 10.1016/j.socscimed.2016.05.019; Manyeh AK, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2738-0; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Mgata S, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2576-0; Moller AB, 2017, LANCET GLOB HEALTH, V5, pE977, DOI 10.1016/S2214-109X(17)30325-X; Moore N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171136; Nigeria, 2014, NIG DEM HLTH SURV 20; Njiku F., 2017, PREVALENCE FACTORS A, V19, P1; Nwagwu AM, 2011, ANN LIBR INF STUD, V58, P270; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Ochako R, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0168-2; Pena-Rosas JP., 2017, COCHRANE DB SYST REV, V7; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Service AC., 2018, BMC PREGNANCY CHILDB, V19; Sinyange Nyambe, 2016, Pan Afr Med J, V25, P109, DOI 10.11604/pamj.2016.25.109.6873; Smith C, 2019, OBSTET GYNECOL, V134, P1234, DOI 10.1097/AOG.0000000000003557; Starbird E, 2016, GLOB HEALTH-SCI PRAC, V4, P191, DOI 10.9745/GHSP-D-15-00374; Tekelab T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222566; Tesfaye G, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0412-4; Teshale AB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235538; Tessema ZT, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03669-w; Tolefac Paul Nkemtendong, 2017, Matern Health Neonatol Perinatol, V3, P29, DOI 10.1186/s40748-017-0067-8; Tolossa T, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-01449-9; Turyasiima M, 2015, E AFR MED J, V91, P317; Weldearegawi GG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4789-8; WHO, 2016, WHO TECH REP SER, V997, P1; Wondemagegn AT, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0110-y; World Health Organization, 2002, ANT CAR RAND TRIAL M; World Health Organization, 2019, MAT DEATHS DECL SLOW; World Health Organization (WHO),S.a.r. health,, 2018, MOR WOM WORLDW REC E; WP. M, 2013, CAN J LIBR INF PR RE, V7, P19; Yeji F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142849; Zamawe COF, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0816-0; Zhao Qi, 2009, BMC Womens Health, V9, P5, DOI 10.1186/1472-6874-9-5	69	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262411	10.1371/journal.pone.0262411	http://dx.doi.org/10.1371/journal.pone.0262411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007296	Green Published, gold			2022-12-27	WOS:000741060700004
J	Chen, L; Zhang, ZX; Long, Y				Chen, Long; Zhang, Zhaoxi; Long, Ying			Association between leisure-time physical activity and the built environment in China: Empirical evidence from an accelerometer and GPS-based fitness app	PLOS ONE			English	Article							NEIGHBORHOOD ENVIRONMENTS; WALKING; ADULTS; DESIGN	To reexamine the relationship between leisure-time physical activity (LTPA) and the built environment (BE), this paper takes advantage of the massive amount of data collected by an accelerometer and GPS-based fitness mobile app. Massive LTPA data from more than 3 million users were recorded by Codoon in 500m by 500m grid cells and aggregated to 742 natural cities in mainland China. Six BE indicators were quantified using GIS at the city scale. Robust regression analysis was used to estimate the correlation between LTPA and BE. Five of six BE indicators-connectivity, road density, land use mix, points of interest density, and density of parks and squares-were significantly, positively, independently, and linearly related to LTPA in the regression analysis. The study obtains findings that are consistent with the previous literature but also provides novel insights into the important role of POI density in encouraging LTPA, as well as how the relationship between LTPA and BE varies by time of day. The study also sheds light on the embrace of new technology and new data in public health and urban studies.	[Chen, Long; Long, Ying] Tsinghua Univ, Sch Architecture, Beijing, Peoples R China; [Zhang, Zhaoxi] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Zhang, Zhaoxi] Aarhus Univ, Danish Big Data Ctr Environm & Hlth BERTHA, Aarhus, Denmark; [Long, Ying] Tsinghua Univ, Hang Lung Ctr Real Estate, Beijing, Peoples R China; [Long, Ying] Minist Educ, Key Lab Eco Planning & Green Bldg, Beijing, Peoples R China	Tsinghua University; Aarhus University; Aarhus University; Tsinghua University	Long, Y (corresponding author), Tsinghua Univ, Sch Architecture, Beijing, Peoples R China.; Long, Y (corresponding author), Tsinghua Univ, Hang Lung Ctr Real Estate, Beijing, Peoples R China.; Long, Y (corresponding author), Minist Educ, Key Lab Eco Planning & Green Bldg, Beijing, Peoples R China.	ylong@tsinghua.edu.cn		Chen, Long/0000-0002-0972-449X; zhang, zhaoxi/0000-0002-6694-6670; Long, Ying/0000-0002-8657-6988	Beijing Outstanding Young Scientist Program [JJWZYJH01201910003010]; Beijing Nova Programme Interdisciplinary Cooperation Project [Z191100001119017]	Beijing Outstanding Young Scientist Program; Beijing Nova Programme Interdisciplinary Cooperation Project	Supported by a grant from Beijing Outstanding Young Scientist Program (Grant No. JJWZYJH01201910003010), this funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (2) Supported by Beijing Nova Programme Interdisciplinary Cooperation Project (Grant No. Z191100001119017), this funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almanza E, 2012, HEALTH PLACE, V18, P46, DOI 10.1016/j.healthplace.2011.09.003; Amin A., 2008, CITY ANAL URBAN TREN, V12, P5; Barnett DW, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0558-z; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Van Cauwenberg J, 2011, HEALTH PLACE, V17, P458, DOI 10.1016/j.healthplace.2010.11.010; Cerin E, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0471-5; Cerin E, 2013, PREV MED, V56, P86, DOI 10.1016/j.ypmed.2012.10.024; Cervero R, 1997, TRANSPORT RES D-TR E, V2, P199, DOI 10.1016/S1361-9209(97)00009-6; Consolvo S., 2006, PROC SIGCHI C HUMAN, P457, DOI DOI 10.1145/1124772.1124840; Forsyth A, 2008, URBAN STUD, V45, P1973, DOI 10.1177/0042098008093386; Gunner Kathy B, 2005, J Pediatr Health Care, V19, P253, DOI 10.1016/j.pedhc.2005.05.002; Hallal PC, 2010, J PHYS ACT HEALTH, V7, pS213, DOI 10.1123/jpah.7.s2.s213; Handy S, 2006, J AM PLANN ASSOC, V72, P55, DOI 10.1080/01944360608976724; Hillsdon M, 2007, AM J PREV MED, V32, P506, DOI 10.1016/j.amepre.2007.02.018; Hinckson E, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0597-5; Hino AAF, 2011, PREV MED, V52, P419, DOI 10.1016/j.ypmed.2011.03.019; Hou NQ, 2010, HEALTH PLACE, V16, P1206, DOI 10.1016/j.healthplace.2010.08.005; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Jacobs Jane, 1961, DEATH LIFE GREAT AM; Karmeniemi M, 2018, ANN BEHAV MED, V52, P239, DOI 10.1093/abm/kax043; King AC, 2011, SOC SCI MED, V73, P1525, DOI 10.1016/j.socscimed.2011.08.032; Lindsey Greg, 2006, J Phys Act Health, V3, pS139, DOI 10.1123/jpah.3.s1.s139; Liu JP, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12030541; McCormack GR, 2010, HEALTH PLACE, V16, P712, DOI 10.1016/j.healthplace.2010.03.003; Mohr DJ., 2006, PHYS EDUC, V63; Norman Gregory J, 2006, J Phys Act Health, V3, pS118, DOI 10.1123/jpah.3.s1.s118; Perez LG, 2018, J PHYS ACT HEALTH, V15, P22, DOI 10.1123/jpah.2017-0163; Rodriguez DA, 2004, TRANSPORT RES D-TR E, V9, P151, DOI 10.1016/j.trd.2003.11.001; Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2; Song YZ, 2018, INT J GEOGR INF SCI, V32, P2447, DOI 10.1080/13658816.2018.1511793; Tsunoda K, 2012, PREV MED, V55, P113, DOI 10.1016/j.ypmed.2012.05.013; Wang ZX, 2019, BMC UROL, V19, DOI 10.1186/s12894-019-0443-y; Welk GJ, 2004, MED SCI SPORT EXER, V36, P1637, DOI 10.1249/01.MSS.0000074670.03001.98; Xu Q, 2010, NEUROLOGY, V75, P341, DOI 10.1212/WNL.0b013e3181ea1597; Yue Y, 2017, INT J GEOGR INF SCI, V31, P658, DOI 10.1080/13658816.2016.1220561; Zhang R, 2019, J SPORT HEALTH SCI, V8, P412, DOI 10.1016/j.jshs.2018.11.002	38	0	0	15	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0260570	10.1371/journal.pone.0260570	http://dx.doi.org/10.1371/journal.pone.0260570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34971553	Green Published, gold			2022-12-27	WOS:000773555700015
J	Raza, M; Naveed, K; Akram, A; Salem, N; Afaq, A; Madni, HA; Khan, MAU; Mui-zzud-din				Raza, Mohsin; Naveed, Khuram; Akram, Awais; Salem, Nema; Afaq, Amir; Madni, Hussain Ahmad; Khan, Mohammad A. U.; Mui-zzud-din			DAVS-NET: Dense Aggregation Vessel Segmentation Network for retinal vasculature detection in fundus images	PLOS ONE			English	Article							BLOOD-VESSELS; DIABETIC-RETINOPATHY; SENSITIVITY	In this era, deep learning-based medical image analysis has become a reliable source in assisting medical practitioners for various retinal disease diagnosis like hypertension, diabetic retinopathy (DR), arteriosclerosis glaucoma, and macular edema etc. Among these retinal diseases, DR can lead to vision detachment in diabetic patients which cause swelling of these retinal blood vessels or even can create new vessels. This creation or the new vessels and swelling can be analyzed as biomarker for screening and analysis of DR. Deep learning-based semantic segmentation of these vessels can be an effective tool to detect changes in retinal vasculature for diagnostic purposes. This segmentation task becomes challenging because of the low-quality retinal images with different image acquisition conditions, and intensity variations. Existing retinal blood vessels segmentation methods require a large number of trainable parameters for training of their networks. This paper introduces a novel Dense Aggregation Vessel Segmentation Network (DAVS-Net), which can achieve high segmentation performance with only a few trainable parameters. For faster convergence, this network uses an encoder-decoder framework in which edge information is transferred from the first layers of the encoder to the last layer of the decoder. Performance of the proposed network is evaluated on publicly available retinal blood vessels datasets of DRIVE, CHASE_DB1, and STARE. Proposed method achieved state-of-the-art segmentation accuracy using a few number of trainable parameters.	[Raza, Mohsin] Bahria Univ, Dept Comp Sci, Islamabad, Pakistan; [Naveed, Khuram; Madni, Hussain Ahmad] COMSATS Univ Islamabad CUI, Dept Elect & Comp Engn, Islamabad, Pakistan; [Akram, Awais] Dept Primary & Secondary Healthcare, Lahore, Pakistan; [Salem, Nema; Khan, Mohammad A. U.] Effat Univ, Elect & Comp Engn Dept, Effat Coll Engn, Jeddah, Saudi Arabia; [Afaq, Amir] RMIT Univ, RF & Antenna Res Grp, Melbourne, Vic, Australia; [Khan, Mohammad A. U.] Namal Inst Mianwali, Dept Elect Engn, Mianwali, Pakistan; [Mui-zzud-din] Khwaja Fareed Univ Engn & Informat Technol, Dept Comp Sci, Rahim Yar Khan, Pakistan	COMSATS University Islamabad (CUI); Effat University; Royal Melbourne Institute of Technology (RMIT); Khwaja Fareed University of Engineering & Information Technology, Pakistan	Naveed, K (corresponding author), COMSATS Univ Islamabad CUI, Dept Elect & Comp Engn, Islamabad, Pakistan.	khurram.naveed@comsats.edu.pk	Raza, Mohsin/HDM-2483-2022; Salem, Nema/GRO-2185-2022	Salem, Nema/0000-0002-8440-4111; Naveed, Khuram/0000-0001-8286-6139				Arsalan M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091446; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Chen LCE, 2018, LECT NOTES COMPUT SC, V11211, P833, DOI 10.1007/978-3-030-01234-2_49; Cherukuri V, 2020, IEEE T IMAGE PROCESS, V29, P2552, DOI 10.1109/TIP.2019.2946078; Cheung CYL, 2011, OPHTHALMOLOGY, V118, P812, DOI 10.1016/j.ophtha.2010.08.045; Demissie B, 2016, 2016 19TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION), P1; Fan Z, 2019, IEEE T IMAGE PROCESS, V28, P2367, DOI 10.1109/TIP.2018.2885495; Franklin SW, 2014, BIOCYBERN BIOMED ENG, V34, P117, DOI 10.1016/j.bbe.2014.01.004; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P600, DOI 10.1016/j.cmpb.2011.08.009; Gu ZW, 2019, IEEE T MED IMAGING, V38, P2281, DOI 10.1109/TMI.2019.2903562; Guan S, 2020, IEEE J BIOMED HEALTH, V24, P568, DOI 10.1109/JBHI.2019.2912935; Guo S, 2019, INT J MED INFORM, V126, P105, DOI 10.1016/j.ijmedinf.2019.03.015; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Huang GL, 2017, IEEE ICC; Imtiaz R, 2021, COMPUT ELECTR ENG, V91, DOI 10.1016/j.compeleceng.2021.107036; Irshad S, 2014, CAIRO INT BIOM ENG, P133, DOI 10.1109/CIBEC.2014.7020937; Jin QG, 2019, KNOWL-BASED SYST, V178, P149, DOI 10.1016/j.knosys.2019.04.025; Khan M, 2019, PEDIATR NEUROSURG, V54, P319, DOI 10.1159/000502360; Khan MAU, 2019, SIGNAL IMAGE VIDEO P, V13, P1667, DOI 10.1007/s11760-019-01515-3; Khan MAU, 2019, PATTERN ANAL APPL, V22, P1177, DOI 10.1007/s10044-018-0696-1; Khan MAU, 2019, PATTERN ANAL APPL, V22, P583, DOI 10.1007/s10044-017-0661-4; Khan Tariq M., 2021, Structural, Syntactic, and Statistical Pattern Recognition. Joint IAPR International Workshops, S+SSPR 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12644), P324, DOI 10.1007/978-3-030-73973-7_31; Khan T. M., 2020, NEURAL INFORM PROCES, P159; Khan TM, 2022, BIOMED SIGNAL PROCES, V71, DOI 10.1016/j.bspc.2021.103169; Khan TM, 2020, IEEE ACCESS, V8, P219275, DOI 10.1109/ACCESS.2020.3041719; Khan TM, 2017, IEEE T IMAGE PROCESS, V26, P2116, DOI 10.1109/TIP.2017.2671781; Khawaja A, 2019, IEEE ACCESS, V7, P164344, DOI 10.1109/ACCESS.2019.2953259; Khawaja A, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19224949; Li QL, 2016, IEEE T MED IMAGING, V35, P109, DOI 10.1109/TMI.2015.2457891; Liskowski P, 2016, IEEE T MED IMAGING, V35, P2369, DOI 10.1109/TMI.2016.2546227; Ma W, 2019, MED IMAGE COMPUTING; MAUKTMKMPNM Toufique Soomro, 2016, IEEE INT C DIG IM CO, P1; Mehmood M., 2019, PROCEDIA COMPUTER SC, V163, P370, DOI [10.1016/j.procs.2019.12.119, DOI 10.1016/J.PROCS.2019.12.119]; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Naveed K, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11010114; Niemeijer M, 2004, PROC SPIE, V5370, P648, DOI 10.1117/12.535349; Rayudu M, 2012, I CONF SENS TECHNOL, P320, DOI 10.1109/ICSensT.2012.6461695; Ronneberger O., 2015, U NET CONVOLUTIONAL, P234; Simonyan K., 2015, PROC 3 INT C LEARN R; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Soomro TA., 2016, PROCEEDING INT C DIG, P1; Soomro TA, 2018, IEEE ACCESS, V6, P3524, DOI 10.1109/ACCESS.2018.2794463; Soomro TA, 2017, PATTERN ANAL APPL, V20, P927, DOI 10.1007/s10044-017-0630-y; Soomro T, 2017, SIGNAL IMAGE VIDEO P, V11, P1509, DOI 10.1007/s11760-017-1114-7; Srinidhi CL, 2017, J MED SYST, V41, DOI 10.1007/s10916-017-0719-2; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Tuba E., 2017, 27 INT C RADIOELEKTR, P1; Wang B, 2019, MED IMAGE COMPUTING; Wang DY, 2020, IEEE J BIOMED HEALTH, V24, P3384, DOI 10.1109/JBHI.2020.3002985; Wisaeng K., 2013, Applied Medical Informatics, V32, P33; Wu Y, 2019, VESSEL NET RETINAL V; Yin PS, 2020, IEEE ACCESS, V8, P116106, DOI 10.1109/ACCESS.2020.3002835; Zhang J, 2016, IEEE T MED IMAGING, V35, P2631, DOI 10.1109/TMI.2016.2587062	54	2	2	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261698	10.1371/journal.pone.0261698	http://dx.doi.org/10.1371/journal.pone.0261698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972109	gold, Green Published			2022-12-27	WOS:000773555700047
J	Sinchaisri, WP; Jensen, ST				Sinchaisri, Wichinpong Park; Jensen, Shane T.			Community vibrancy and its relationship with safety in Philadelphia	PLOS ONE			English	Article							SOCIAL DISORGANIZATION THEORY; PROPENSITY SCORE; CRIME; COHESION; HEALTH; IMPACT	To what extent can the strength of a local urban community impact neighborhood safety? We construct measures of community vibrancy based on a unique dataset of block party permit approvals from the City of Philadelphia. Our first measure captures the overall volume of block party events in a neighborhood whereas our second measure captures differences in the type (regular versus spontaneous) of block party activities. We use both regression modeling and propensity score matching to control for the economic, demographic and land use characteristics of the surrounding neighborhood when examining the relationship between crime and our two measures of community vibrancy. We conduct our analysis on aggregate levels of crime and community vibrancy from 2006 to 2015 as well as the trends in community vibrancy and crime over this time period. We find that neighborhoods with a higher number of block parties have a significantly higher crime rate, while those holding a greater proportion of spontaneous block party events have a significantly lower crime rate. We also find that neighborhoods which have an increase in the proportion of spontaneous block parties over time are significantly more likely to have a decreasing trend in total crime incidence over that same time period.	[Sinchaisri, Wichinpong Park] Univ Penn, Wharton Sch, Dept Operat Informat & Decis, Philadelphia, PA 19104 USA; [Jensen, Shane T.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Jensen, ST (corresponding author), Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA.	stjensen@wharton.upenn.edu	Sinchaisri, Wichinpong Park/CAF-4811-2022					Bellair PE, 1997, CRIMINOLOGY, V35, P677, DOI 10.1111/j.1745-9125.1997.tb01235.x; Branas CC, 2011, AM J EPIDEMIOL, V174, P1296, DOI 10.1093/aje/kwr273; Clarke R. V., 1995, CRIME JUSTICE, V19, P91, DOI 10.1086/449230; CRUTCHFIELD RD, 1982, CRIMINOLOGY, V20, P467, DOI 10.1111/j.1745-9125.1982.tb00472.x; Dean LT, 2015, SOC SCI MED, V138, P201, DOI 10.1016/j.socscimed.2015.06.019; Geeting J, 2016, PLAN PHILLY; Hipp JR., 2015, INT ENCY SOCIAL BEHA, V4; Humphrey C, 2020, ENVIRON PLAN B-URBAN, V47, P1573, DOI 10.1177/2399808319830403; Kelling G.L., 1982, ATLANTIC, V249, P29, DOI DOI 10.4135/9781412959193.n281; Loukaitou-Sideris A, 2002, J PLAN EDUC RES, V22, P135, DOI 10.1177/0739456X02238443; Loukaitou-Sideris A, 2001, ENVIRON PLANN B, V28, P255, DOI 10.1068/b2642r; MacDonald J, 2015, CRIME JUSTICE, V44, P333, DOI 10.1086/681558; Markowitz FE, 2001, CRIMINOLOGY, V39, P293, DOI 10.1111/j.1745-9125.2001.tb00924.x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; SAMPSON RJ, 1989, AM J SOCIOL, V94, P774, DOI 10.1086/229068; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Shaw CR., 1942, JUVENILE DELINQUENCY; Steenbeek W, 2011, CRIMINOLOGY, V49, P833, DOI 10.1111/j.1745-9125.2011.00241.x; Taylor R.B., 1988, HUMAN TERRITORIAL FU; Wickes R, 2013, AM J COMMUN PSYCHOL, V52, P115, DOI 10.1007/s10464-013-9582-6; Wilcox P, 2018, ANNU REV CRIMINOL, V1, P123, DOI 10.1146/annurev-criminol-032317-092421; Wu JY, 2018, CITIES, V74, P100, DOI 10.1016/j.cities.2017.11.008; Zhang WJ, 2016, URBAN STUD, V53, P3007, DOI 10.1177/0042098015605222	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0257530	10.1371/journal.pone.0257530	http://dx.doi.org/10.1371/journal.pone.0257530			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972104	Green Published, Green Submitted, gold			2022-12-27	WOS:000773555700006
J	Mokhayeri, Y; Nazemipour, M; Mansournia, MA; Naimi, AI; Kaufman, JS				Mokhayeri, Yaser; Nazemipour, Maryam; Mansournia, Mohammad Ali; Naimi, Ashley I.; Kaufman, Jay S.			Does weight mediate the effect of smoking on coronary heart disease? Parametric mediational g-formula analysis	PLOS ONE			English	Article							TIME-VARYING EXPOSURES; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; RISK; ATHEROSCLEROSIS; CESSATION; BIASES	Background In settings in which there are time-varying confounders affected by previous exposure and a time-varying mediator, natural direct and indirect effects cannot generally be estimated unbiasedly. In the present study, we estimate interventional direct effect and interventional indirect effect of cigarette smoking as a time-varying exposure on coronary heart disease while considering body weight as a time-varying mediator. Methods To address this problem, the parametric mediational g-formula was proposed to estimate interventional direct effect and interventional indirect effect. We used data from the Multi-Ethnic Study of Atherosclerosis to estimate effect of cigarette smoking on coronary heart disease, considering body weight as time-varying mediator. Results Over a 11-years period, smoking 20 cigarettes per day compared to no smoking directly (not through weight) increased risk of coronary heart disease by an absolute difference of 1.91% (95% CI: 0.49%, 4.14%), and indirectly decreased coronary heart disease risk by -0.02% (95% CI: -0.05%, 0.04%) via change in weight. The total effect was estimated as an absolute 1.89% increase (95% CI: 0.49%, 4.13%). Conclusion The overall absolute impact of smoking to incident coronary heart disease is modest, and we did not discern any important contribution to this effect relayed through changes to bodyweight. In fact, changes in weight because of smoking have no meaningful mediating effect on CHD risk.	[Mokhayeri, Yaser] Lorestan Univ Med Sci, Shahid Rahimi Hosp, Cardiovasc Res Ctr, Khorramabad, Iran; [Nazemipour, Maryam] Univ Tehran Med Sci, Osteoporosis Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Mansournia, Mohammad Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Naimi, Ashley I.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Kaufman, Jay S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Fac Med, Montreal, PQ, Canada	Lorestan University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Emory University; McGill University	Mansournia, MA (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran.	mansournia_ma@yahoo.com		Mansournia, Mohammad Ali/0000-0003-3343-2718	National Heart, Lung, and Blood Institute (NHLBI) [V02 1d20120806]	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This manuscript was prepared using MESA Research Materials obtained from the National Heart, Lung, and Blood Institute (NHLBI); Research Materials Distribution Agreement (RMDA) V02 1d20120806. We would like to extend our thanks to the staff and coordinators of BioLINCC.	Aryaie M., 2020, AM J EPIDEMIOL; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Chen A, 2005, INT JOINT C ARTIFICI; Chen SM, 2021, NICOTINE TOB RES, V23, P85, DOI 10.1093/ntr/ntz165; Clair C, 2013, JAMA-J AM MED ASSOC, V309, P1014, DOI 10.1001/jama.2013.1644; DOYLE JT, 1959, NEW ENGL J MED, V261, P1096, DOI 10.1056/NEJM195911262612202; Etminan M, 2021, AM HEART J, V237, P62, DOI 10.1016/j.ahj.2021.03.008; Etminan M, 2021, GASTROENTEROLOGY, V160, P1443, DOI 10.1053/j.gastro.2020.11.053; Etminan M, 2020, CHEST, V158, pS21, DOI 10.1016/j.chest.2020.03.011; Feodoroff M, 2018, DIABETOLOGIA, V61, P2580, DOI 10.1007/s00125-018-4725-9; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Freathy RM, 2011, INT J EPIDEMIOL, V40, P1617, DOI 10.1093/ije/dyr077; Lin SH, 2017, EPIDEMIOLOGY, V28, P266, DOI [10.1097/EDE.0000000000000609, 10.1097/ede.0000000000000609]; Luo JH, 2013, JAMA-J AM MED ASSOC, V310, P94, DOI 10.1001/jama.2013.6871; Mansournia MA, 2013, INT J EPIDEMIOL, V42, P860, DOI 10.1093/ije/dyt083; Mansournia MA, 2021, INT J EPIDEMIOL, V50, P1405, DOI 10.1093/ije/dyab157; Mansournia MA, 2021, BRIT J SPORT MED, V55, P1009, DOI 10.1136/bjsports-2020-103652; Mansournia MA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4587; Mansournia MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i189; Mansournia MA, 2017, EPIDEMIOLOGY, V28, P54, DOI 10.1097/EDE.0000000000000564; Mansournia MA, 2012, EPIDEMIOLOGY, V23, P631, DOI 10.1097/EDE.0b013e31824cc1c3; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Mokhayeri Y, 2019, STROKE, V50, P3286, DOI 10.1161/STROKEAHA.119.025749; Mucha Lisa, 2006, Gend Med, V3, P279, DOI 10.1016/S1550-8579(06)80216-0; Munafo MR, 2009, NICOTINE TOB RES, V11, P765, DOI 10.1093/ntr/ntp062; Naimi AI, 2017, INT J EPIDEMIOL, V46, P756, DOI 10.1093/ije/dyw323; Nettleton JA, 2008, AM J CLIN NUTR, V88, P185, DOI 10.1093/ajcn/88.1.185; Pearl J, 2012, PREV SCI, V13, P426, DOI 10.1007/s11121-011-0270-1; Price JF, 1999, EUR HEART J, V20, P344, DOI 10.1053/euhj.1998.1194; ROBINS J, 1986, MATH MODELLING, V7, P1393, DOI 10.1016/0270-0255(86)90088-6; Robins JM, 1999, J AM STAT ASSOC, V94, P687, DOI 10.2307/2669978; Robins JM., 1997, P 13 C UNCERTAINTY A; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Schomaker M, 2018, STAT MED, V37, P2252, DOI 10.1002/sim.7654; Shakiba M, 2017, AM J EPIDEMIOL; Sneve M, 2008, SCAND J PUBLIC HEALT, V36, P397, DOI 10.1177/1403494807088453; Tamura U, 2010, J ATHEROSCLER THROMB, V17, P12, DOI 10.5551/jat.1800; VanderWeele TJ, 2017, J R STAT SOC B, V79, P917, DOI 10.1111/rssb.12194; Vansteelandt S, 2009, EPIDEMIOLOGY, V20, P851, DOI 10.1097/EDE.0b013e3181b6f4c9; WARNER KE, 1978, J AM STAT ASSOC, V73, P314, DOI 10.2307/2286658; Woodward M, 1999, J Epidemiol Biostat, V4, P285	42	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262403	10.1371/journal.pone.0262403	http://dx.doi.org/10.1371/journal.pone.0262403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025942	Green Published, gold			2022-12-27	WOS:000796264200066
J	Zauner, J; Plischke, H; Strasburger, H				Zauner, Johannes; Plischke, Herbert; Strasburger, Hans			Spectral dependency of the human pupillary light reflex. Influences of pre-adaptation and chronotype	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; MONOCHROMATIC LIGHT; MELANOPSIN; ILLUMINATION; CONE; SENSITIVITY; RESPONSES; ROD; COLOR; WAKE	Non-visual photoreceptors (ipRGCs) and rods both exert a strong influence on the human pupil, yet pupil models regularly use cone-derived sensitivity as their basis. This inconsistency is further exacerbated by the fact that circadian effects can modulate the wavelength sensitivity. We assessed the pupillary reaction to narrowband light stimuli in the mesopic range. Pupil size for eighty-three healthy participants with normal color vision was measured in nine experimental protocols with varying series of continuous or discontinuous light stimuli under Ganzfeld conditions, presented after 90 seconds of dark adaptation. One hundred and fifty series of stimulation were conducted across three experiments, and were analyzed for wavelength-dependency on the normalized pupillary constriction (nPC), conditional on experimental settings and individual traits. Traits were surveyed by questionnaire; color vision was tested by Ishihara plates or the Lanthony D15test. Data were analyzed with generalized additive mixed models (GAMM). The normalized pupillary constriction response is consistent with L+M-cone derived sensitivity when the series of light stimuli is continuous, i.e., is not interrupted by periods of darkness, but not otherwise. The results also show that a mesopic illuminance weighing led to an overall best prediction of pupillary constriction compared to other types of illuminance measures. IpRGC influence on nPC is not readily apparent from the results. When we explored the interaction of chronotype and time of day on the wavelength dependency, differences consistent with ipRGC influence became apparent. The models indicate that subjects of differing chronotype show a heightened or lowered sensitivity to short wavelengths, depending on their time of preference. IpRGC influence is also seen in the post-illumination pupil reflex if the prior light-stimulus duration is one second. However, shorter wavelengths than expected become more important if the light-stimulus duration is fifteen or thirty seconds. The influence of sex on nPC was present, but showed no interaction with wavelength. Our results help to define the conditions, under which the different wavelength sensitivities in the literature hold up for narrowband light settings. The chronotype effect might signify a mechanism for strengthening the individual's chronotype. It could also be the result of the participant's prior exposure to light (light history). Our explorative findings for this effect demand replication in a controlled study.	[Zauner, Johannes; Plischke, Herbert] Munich Univ Appl Sci, Munich, Germany; [Strasburger, Hans] Ludwig Maximilians Univ Munchen, Inst Med Psychol, Munich, Germany	University of Munich; University of Munich	Zauner, J (corresponding author), Munich Univ Appl Sci, Munich, Germany.	zauner@me.com		Strasburger, Hans/0000-0001-7156-5111; Zauner, Johannes/0000-0003-2171-4566; Plischke, Herbert/0000-0002-2132-6267	Hochschule Munchen University of Applied Sciences (MUAS); German Research Foundation (DFG)	Hochschule Munchen University of Applied Sciences (MUAS); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was financially supported by the Hochschule Munchen University of Applied Sciences (MUAS) and the German Research Foundation (DFG) through the "Open Access Publishing" program.	Adhikari P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33373; Adhikari P, 2015, SCI REP-UK, V5, DOI 10.1038/srep17610; Adhikari P, 2015, INVEST OPHTH VIS SCI, V56, P3838, DOI 10.1167/iovs.14-16233; Adrian Werner, 2003, Clin Exp Optom, V86, P235; ALPERN M, 1962, J PHYSIOL-LONDON, V164, P478, DOI 10.1113/jphysiol.1962.sp007033; Bonmati-Carrion MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162476; [Anonymous], 2021, SUPPORTING INFORM TH; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BESHARSE JC, 1983, SCIENCE, V219, P1341, DOI 10.1126/science.6828862; BOUMA H, 1962, NATURE, V193, P690, DOI 10.1038/193690a0; Brown TM, 2021, J PINEAL RES, V71, DOI 10.1111/jpi.12719; Chellappa SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13973-1; CIE, 2018, COS026E2018 CIE; CIE, 2005, 1652005 CIE; CIE, 2019, 1166412019E ISO CIE; CIE, 2004, ISO 235392005 E CO S; CIE, 2016, COTN0042016 CIE; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Daneault V, 2012, J BIOL RHYTHM, V27, P257, DOI 10.1177/0748730412441172; Danilenko KV, 2011, CHRONOBIOL INT, V28, P407, DOI 10.3109/07420528.2011.567425; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; DIN, 1982, 50313198203 DIN; DIN, 1982, 50312198203 DIN; EPEE, 2016, STRENGTH IND ENV QUA; Facer-Childs E, 2015, CURR BIOL, V25, P518, DOI 10.1016/j.cub.2014.12.036; Feigl B, 2012, ACTA OPHTHALMOL, V90, pe230, DOI 10.1111/j.1755-3768.2011.02226.x; Fischer D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178782; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Goldstein D, 2007, PERS INDIV DIFFER, V42, P431, DOI 10.1016/j.paid.2006.07.008; Gooley JJ, 2012, J NEUROSCI, V32, P14242, DOI 10.1523/JNEUROSCI.1321-12.2012; Griefahn B., 2001, SOMNOLOGIE, V5, P71, DOI [10.1046/j.1439-054X.2001.01149.x, DOI 10.1046/J.1439-054X.2001.01149.X]; Guido ME, 2022, CELL MOL NEUROBIOL, V42, P59, DOI 10.1007/s10571-020-00997-x; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Hastie TJ., 2017, GEN ADDITIVE MODELS; Iadanza E, 2020, IEEE ACCESS, V8, P34949, DOI 10.1109/ACCESS.2020.2973747; Ishihara S, 1972, ISHIHARAS TESTS COLO; Joyce DS, 2016, INVEST OPHTH VIS SCI, V57, P5672, DOI 10.1167/iovs.16-19934; Kelbsch C, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00129; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; LANTHONY P, 1978, DOC OPHTHALMOL, V46, P185; Lee SK, 2019, CELL REP, V29, P3349, DOI 10.1016/j.celrep.2019.11.024; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; Lund D., 2012, COMPUTERIZED APPROAC; Martinez-Lozano N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73297-5; McDougal DH, 2015, COMPR PHYSIOL, V5, P439, DOI 10.1002/cphy.c140014; McDougal DH, 2010, VISION RES, V50, P72, DOI 10.1016/j.visres.2009.10.012; McHill AW, 2021, J PINEAL RES, V70, DOI 10.1111/jpi.12720; Morad Y, 2000, CURR EYE RES, V21, P535, DOI 10.1076/0271-3683(200007)21:1;1-Z;FT535; Mouland JW, 2019, CURR BIOL, V29, P4260, DOI 10.1016/j.cub.2019.10.028; Munch M, 2012, INVEST OPHTH VIS SCI, V53, P4546, DOI 10.1167/iovs.12-9494; Mure LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005991; Okimura K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81540-w; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; Pedersen EJ, 2019, PEERJ, V7, DOI 10.7717/peerj.6876; Prayag AS, 2019, CLOCKS SLEEP, V1, P193, DOI 10.3390/clockssleep1010017; Prigge CL, 2016, J NEUROSCI, V36, P7184, DOI 10.1523/JNEUROSCI.3500-15.2016; R Development Core Team, 2017, R LANG STAT COMP; Rao F, 2017, VISION RES, V137, P24, DOI 10.1016/j.visres.2017.02.010; Ringer RVC, 2021, I PERCEPTION; Roenneberg T, 2007, COLD SPRING HARB SYM, V72, P293, DOI 10.1101/sqb.2007.72.043; Roenneberg T, 2015, J BIOL RHYTHM, V30, P487, DOI 10.1177/0748730415603835; Roenneberg T, 2012, SLEEP BIOL RHYTHMS, V10, P75, DOI 10.1111/j.1479-8425.2012.00541.x; Rufiange M, 2007, J BIOL RHYTHM, V22, P454, DOI 10.1177/0748730407305375; Rukmini AV, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00076; Rukmini AV, 2017, SCI REP-UK, V7, DOI 10.1038/srep43832; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simpson GL, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00149; Soskuthy M, 2017, ARXIV; Spitschan M, 2019, CURR BIOL, V29, pR1297, DOI 10.1016/j.cub.2019.11.031; Spitschan M, 2019, J VISION, V19, DOI 10.1167/19.9.5; Spitschan M, 2014, P NATL ACAD SCI USA, V111, P15568, DOI 10.1073/pnas.1400942111; Stone RA, 2013, EXP EYE RES, V114, P35, DOI 10.1016/j.exer.2013.01.001; Szabadi E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01069; Veitch JA, 2020, 0112020 CIE TN; Wagman IH, 1942, AM J PHYSIOL, V137, P0769, DOI 10.1152/ajplegacy.1942.137.4.769; Watson AB, 2012, J VISION, V12, DOI 10.1167/12.10.12; Webler FS, 2019, CURR OPIN BEHAV SCI, V30, P80, DOI 10.1016/j.cobeha.2019.06.006; Welbourne LE, 2015, CURR BIOL, V25, pR646, DOI 10.1016/j.cub.2015.06.030; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; Wood SN, 2016, J AM STAT ASSOC, V111, P1548, DOI 10.1080/01621459.2016.1180986; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zandi B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67593-3; Zauner J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239553; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860	92	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							0253030	10.1371/journal.pone.0253030	http://dx.doi.org/10.1371/journal.pone.0253030			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020744	gold, Green Submitted, Green Published			2022-12-27	WOS:000834207700005
J	Robinson, G; Lee, E; Leckning, B; Silburn, S; Nagel, T; Midford, R				Robinson, Gary; Lee, Eunro; Leckning, Bernard; Silburn, Sven; Nagel, Tricia; Midford, Richard			Validity and reliability of resiliency measures trialled for the evaluation of a preventative Resilience-promoting social-emotional curriculum for remote Aboriginal school students	PLOS ONE			English	Article							CONNOR-DAVIDSON RESILIENCE; SCALE; ADOLESCENTS; VALIDATION; COMMUNITY; CONSTRUCT; DISASTER; MODEL; YOUTH; FIT	Purpose We aimed to test the reliability and validity of two brief measures of resilience adopted for the evaluation of a preventative social-emotional curriculum implemented for Aboriginal middle school students from socially disadvantaged remote communities in Australia's Northern Territory. The questionnaires chosen were intended to measure psychological resilience and socio-cultural resilience as complementary dimensions of the capacity to cope in circumstances of significant life stress and risk of self-harm. Methods Confirmatory factor analysis (CFA) was conducted to assess construct validity of the 10-item Connor-Davidson Resilience Scale (CD-RISC-10), a measure of psychological resilience, and the 12-item Child and Youth Resilience Measure (CYRM-12), a measure of socio-cultural resilience, with a sample of 520 students. Associations between resilience and psychological distress and emotional and behavioural difficulty were analysed in relation to life stressors to assess criterion validity of the scales. Results CFA provided support for the validity of the respective constructs. There was good fit for both scales. However, assessment of criterion validity of the scales suggested that the adapted measure of socio-cultural resilience (CYRM-12NT) showed higher reliability and a CFA clearer indication of predictive validity than the measure of psychological resilience (CD-RISC-10). Conclusions The CYRM-12NT appears to be a more useful measure of resilience among Aboriginal youth exposed to significant life stress and disadvantage. However, both measures may require further development to enhance their validity and utility among potentially at-risk adolescents in socially, culturally and linguistically diverse remote Aboriginal communities.	[Robinson, Gary; Leckning, Bernard; Silburn, Sven; Midford, Richard] Charles Darwin Univ, Ctr Child Dev & Educ, Menzies Sch Hlth Res, Casuarina, Australia; [Lee, Eunro] RMIT Univ, Coll STEM, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia; [Nagel, Tricia] Charles Darwin Univ, Menzies Sch Hlth Res, Wellbeing & Preventable Chron Dis Div, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research; Royal Melbourne Institute of Technology (RMIT); Charles Darwin University; Menzies School of Health Research	Robinson, G (corresponding author), Charles Darwin Univ, Ctr Child Dev & Educ, Menzies Sch Hlth Res, Casuarina, Australia.	gary.robinson@menzies.edu.au	Leckning, Bernard/AHD-3810-2022	Leckning, Bernard/0000-0001-5901-4579; Robinson, Gary/0000-0002-9665-2817	National Health and Medical Research Council [App 1076817]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	GR, SS, RM & TN were named investigators on National Health and Medical Research Council Grant no App 1076817 https://www.nhmrc.gov.au/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, DEATHS SUIC REM AR S; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Bonanno GA, 2013, J CHILD PSYCHOL PSYC, V54, P378, DOI 10.1111/jcpp.12021; Byrne B, 2011, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Campbell-Sills L, 2009, J PSYCHIATR RES, V43, P1007, DOI 10.1016/j.jpsychires.2009.01.013; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cutuli JJ, 2013, INT J EMOT EDUC, V5, P67; Durish CL, 2018, BRAIN INJURY, V32, P1525, DOI 10.1080/02699052.2018.1502471; Gorman E, 2021, AUST PSYCHOL, V56, P25, DOI 10.1080/00050067.2020.1829453; Green JG, 2010, INT J METH PSYCH RES, V19, P23, DOI 10.1002/mpr.314; Greenberg MT, 2017, FUTURE CHILD, V27, P13, DOI 10.1353/foc.2017.0001; Hanson T.L., 2007, MEASURING RESILIENCE, P1; Holtge J, 2021, J ADOLESCENT HEALTH, V68, P580, DOI 10.1016/j.jadohealth.2020.07.010; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hunter E, 1993, ABORIGINAL HLTH HIST; Jew CL, 1999, MEAS EVAL COUNS DEV, V32, P75, DOI 10.1080/07481756.1999.12068973; Johnson J, 2010, BEHAV RES THER, V48, P179, DOI 10.1016/j.brat.2009.10.007; Johnson J, 2011, CLIN PSYCHOL REV, V31, P563, DOI 10.1016/j.cpr.2010.12.007; Jongen C, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00194; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Kobau Rosemarie, 2011, Am J Public Health, V101, pe1, DOI 10.2105/AJPH.2010.300083; Kukihara H, 2014, PSYCHIAT CLIN NEUROS, V68, P524, DOI 10.1111/pcn.12159; Langham E, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00299; Leckning B, 2021, CHILD ABUSE NEGLECT, V113, DOI 10.1016/j.chiabu.2021.104931; Liebenberg L, 2013, CAN J PUBLIC HEALTH, V104, pE131, DOI 10.1007/BF03405676; Liu DWY, 2014, ARCH SUICIDE RES, V18, P453, DOI 10.1080/13811118.2013.833881; Luthar S.S., 2014, HDB DEV PSYCHOPATHOL, P125; LUTHAR SS, 1993, DEV PSYCHOPATHOL, V5, P703, DOI 10.1017/S0954579400006246; McCalman J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2762-1; Merrell KW, 2008, J APPL SCH PSYCHOL, V24, P209, DOI 10.1080/15377900802089981; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Olsson CA, 2003, J ADOLESCENCE, V26, P1, DOI 10.1016/S0140-1971(02)00118-5; Panter-Brick C, 2018, CHILD DEV, V89, P1803, DOI 10.1111/cdev.12868; Prochaska JJ, 2012, INT J METH PSYCH RES, V21, P88, DOI 10.1002/mpr.1349; Renbarger RL, 2020, J RES ADOLESCENCE, V30, P896, DOI 10.1111/jora.12569; ROBINSON G, 1995, OCEANIA, V65, P323, DOI 10.1002/j.1834-4461.1995.tb02519.x; Robinson G., 2012, SUICIDE CHILDREN YOU, P52; Robinson G, 2016, HEALTH EDUC, V116, P510, DOI 10.1108/HE-09-2015-0026; Robinson GW, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.552878; Roy A, 2011, J AFFECT DISORDERS, V133, P591, DOI 10.1016/j.jad.2011.05.006; Sass DA, 2014, STRUCT EQU MODELING, V21, P167, DOI 10.1080/10705511.2014.882658; Sher L, 2019, ACTA PSYCHIAT SCAND, V140, P169, DOI 10.1111/acps.13059; Shilton AL., 2019, COGNITION BRAIN BEHA, V23, P155; Silburn S., 2018, EARLY PATHWAYS SCH L, V156; Strauss ME, 2009, ANNU REV CLIN PSYCHO, V5, P1, DOI 10.1146/annurev.clinpsy.032408.153639; Tomyn AJ, 2018, AUST PSYCHOL, V53, P68, DOI 10.1111/ap.12251; Ungar M, 2015, J CHILD PSYCHOL PSYC, V56, P4, DOI 10.1111/jcpp.12306; Ungar M, 2013, SCHOOL PSYCHOL INT, V34, P514, DOI 10.1177/0143034312472761; Ungar M, 2013, J CHILD PSYCHOL PSYC, V54, P348, DOI 10.1111/jcpp.12025; Ungar M, 2011, CHILD YOUTH SERV REV, V33, P1742, DOI 10.1016/j.childyouth.2011.04.027; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Xia Y, 2019, BEHAV RES METHODS, V51, P409, DOI 10.3758/s13428-018-1055-2	53	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262406	10.1371/journal.pone.0262406	http://dx.doi.org/10.1371/journal.pone.0262406			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015776	gold, Green Published			2022-12-27	WOS:000814820600016
J	Wolna, A; Durlik, J; Wodniecka, Z				Wolna, Agata; Durlik, Joanna; Wodniecka, Zofia			Pronominal anaphora resolution in Polish: Investigating online sentence interpretation using eye-tracking	PLOS ONE			English	Article							PRONOUN RESOLUTION; IMPLICIT-CAUSALITY; DISCOURSE; FOCUS; COHERENCE; SPEAKERS; SPANISH; NULL	The mechanism of anaphora resolution is subject to large cross-linguistic differences. The most likely reason for this is the different sensitivity of pronouns to the range of factors that determine their reference. In the current study, we explored the mechanism of anaphora resolution in Polish. First, we explored preferences in the interpretation of null and overt pronouns in ambiguous sentences. More specifically, we investigated whether Polish speakers prefer to relate overt pronouns to subject or object antecedents. Subsequently, we tested the consequences of violating this bias when tracing the online sentence-interpretation process using eye-tracking. Our results show that Polish speakers have a strong preference for interpreting null pronouns as referring to subject antecedents and interpreting overt pronouns as referring to object antecedents. However, in online sentence interpretation, only overt pronouns showed sensitivity to a violation of the speaker's preference for a pronoun-antecedent match. This suggests that null pronoun resolution is more flexible than overt pronoun resolution. Our results indicate that it is much easier for Polish speakers to shift the reference of a null pronoun than an overt one whenever a pronoun is forced to refer to a less-preferred antecedent. These results are supported by naturalness ratings, which showed that null pronouns are considered equally natural regardless of their reference, while overt pronouns referring to subject antecedents are rated as considerably less natural than those referring to object antecedents. To explain this effect, we propose that the interpretation of null and overt pronouns is sensitive to different factors which determine their reference.	[Wolna, Agata; Durlik, Joanna; Wodniecka, Zofia] Jagiellonian Univ, Inst Psychol, Psychol Language & Bilingualism Lab, Krakow, Poland	Jagiellonian University	Wolna, A (corresponding author), Jagiellonian Univ, Inst Psychol, Psychol Language & Bilingualism Lab, Krakow, Poland.	agata.wolna@doctoral.uj.edu.pl		Wolna, Agata/0000-0001-5822-104X	National Science Center Poland [2015/18/E/HS6/00428]; Polish National Science Centre [2018/28/T/HS6/00277]	National Science Center Poland(National Science Centre, Poland); Polish National Science Centre	This research was possible thanks to the grant SONATA BIS grant no 2015/18/E/HS6/00428 awarded to ZW by the National Science Center Poland (https://ncn.gov.pl/).During writing the paper JD was supported by Etiuda scholarship no 2018/28/T/HS6/00277 awarded by the Polish National Science Centre (https://ncn.gov.pl/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almor A, 1999, PSYCHOL REV, V106, P748, DOI 10.1037/0033-295X.106.4.748; Almor A., 2000, ARCHITECTURES MECH L, P341, DOI 10.3758/bf03209354; Alonso-Ovalle L., 2002, ITAL J LINGUIST, V14, P151; Arnold J.E., 1998, THESIS STANFORD U; Badecker W, 2002, J EXP PSYCHOL LEARN, V28, P748, DOI 10.1037//0278-7393.28.4.748; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Burkner PC, 2018, R J, V10, P395; CARMINATI M. N., 2002, THESIS U MASSACHUSET; Chamorro G, 2016, BILING-LANG COGN, V19, P520, DOI 10.1017/S1366728915000152; Chomsky N, 1982, SOME CONCEPTS CONSEQ; Clifton Charles Jr., 2007, P341, DOI 10.1016/B978-008044980-7/50017-3; Colonna S, 2015, LANG COGN NEUROSCI, V30, P1306, DOI 10.1080/23273798.2015.1066510; Colonna S, 2012, LINGUISTICS, V50, P991, DOI 10.1515/ling-2012-0031; Conklin K., 2018, EYE TRACKING GUIDE A, DOI [10.1017/9781108233279, DOI 10.1017/9781108233279]; Cowles HW, 2007, TOPOI-INT REV PHILOS, V26, P3, DOI 10.1007/s11245-006-9004-6; CRAWLEY RA, 1990, J PSYCHOLINGUIST RES, V19, P245, DOI 10.1007/BF01077259; de la Fuente I., 2016, EMPIRICAL PERSPECTIV, P11; Featherstone CR, 2010, Q J EXP PSYCHOL, V63, P3, DOI 10.1080/17470210903134344; Fernandes EG, 2018, J EXP PSYCHOL LEARN, V44, P1986, DOI 10.1037/xlm0000569; Filiaci F, 2014, LANG COGN NEUROSCI, V29, P825, DOI 10.1080/01690965.2013.801502; GERNSBACHER MA, 1988, J MEM LANG, V27, P699, DOI 10.1016/0749-596X(88)90016-2; GROSZ BJ, 1995, COMPUT LINGUIST, V21, P203; Hemforth B, 2010, COGNITION IN FLUX, P2218; Hobbs J. R., 1979, COGNITIVE SCI, V3, P67, DOI [10.1207/s15516709cog0301_4, DOI 10.1207/S15516709COG0301_4]; Hung YC, 2012, NEUROSCI LETT, V511, P59, DOI 10.1016/j.neulet.2012.01.013; Jarvikivi J, 2005, PSYCHOL SCI, V16, P260, DOI 10.1111/j.0956-7976.2005.01525.x; Kaiser E, 2008, LANG COGNITIVE PROC, V23, P709, DOI 10.1080/01690960701771220; Kaiser E, 2011, LANG COGNITIVE PROC, V26, P1625, DOI 10.1080/01690965.2010.523082; Kehler A., 2008, REFERENCE INTERDISCI; Kehler A, 2013, THEOR LINGUIST, V39, P1, DOI 10.1515/tl-2013-0001; Kehler A, 2008, J SEMANT, V25, P1, DOI 10.1093/jos/ffm018; Kleiman E., 2017, R PACKAGE VERSION 0; Koornneef AW, 2006, J MEM LANG, V54, P445, DOI 10.1016/j.jml.2005.12.003; Kwon N, 2013, LANG COGNITIVE PROC, V28, P377, DOI 10.1080/01690965.2011.645314; MATTHEWS A, 1988, J MEM LANG, V27, P245, DOI 10.1016/0749-596X(88)90053-8; MAZUKA R, 1991, J PSYCHOLINGUIST RES, V20, P215, DOI 10.1007/BF01067216; Patterson C., 2020, INFORM STRUCTURING D, P56; Patterson C, 2019, J PSYCHOLINGUIST RES, V48, P453, DOI 10.1007/s10936-018-9613-4; R Core Team, 2021, R LANG ENV STAT COMP; RAYNER K, 1986, MEM COGNITION, V14, P191, DOI 10.3758/BF03197692; Reinders-Machowska E., 1991, LONG DISTANCE ANAPHO, P137; Roberts L, 2008, STUD SECOND LANG ACQ, V30, P333, DOI 10.1017/S0272263108080480; Sanford AJ, 2007, Q J EXP PSYCHOL, V60, P171, DOI 10.1080/17470210600973390; Schumacher PB, 2017, LINGUA, V185, P25, DOI 10.1016/j.lingua.2016.07.004; Schumacher PB, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01746; Sorace A, 2006, SECOND LANG RES, V22, P339, DOI 10.1191/0267658306sr271oa; Venditti JJ., 2001, RUCCSTR68, P1; Verissimo J., 2021, BILING-LANG COGN, P1	50	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262459	10.1371/journal.pone.0262459	http://dx.doi.org/10.1371/journal.pone.0262459			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015772	Green Published, Green Submitted, gold			2022-12-27	WOS:000814820600022
J	Rawal, LB; Sun, YW; Dahal, PK; Baral, SC; Khanal, S; Arjyal, A; Manandhar, S; Abdullah, A				Rawal, Lal B.; Sun, Yuewen; Dahal, Padam K.; Baral, Sushil C.; Khanal, Sudeepa; Arjyal, Abriti; Manandhar, Shraddha; Abdullah, Abu S.			Engaging Female Community Health Volunteers (FCHVs) for cardiovascular diseases risk screening in Nepal	PLOS ONE			English	Article							PREVENTION; INTERVENTION; BURDEN; INCOME; CARE	Introduction Non-Communicable Diseases (NCDs) have become the leading public health problems worldwide and the cardiovascular diseases (CVDs) is one of the major NCDs. Female Community Health Volunteers (FCHVs) in Nepal are the key drivers to implementing frontline health services. We explored the potential for engaging FCHVs for CVD risk screening at the community level in Nepal. Methods We used multiple approaches (quantitative and qualitative) for data collection. The trained FCHVs administered CVD risk screening questionnaire among 491 adults in rural and urban areas and calculated the CVD risk scores. To maintain consistency and quality, a registered medical doctor also, using the same risk scoring chart, independently calculated the CVD risk scores. Kappa statistics and concordance coefficient were used to compare these two sets of risk screening results. Sensitivity and specificity analyses were conducted. Two focus group discussions among the FCHVs were conducted to determine their experiences with CVD risk screening and willingness to engage with CVD prevention and control efforts. Results The mean level of agreement between two sets of risk screening results was 94.5% (Kappa = 0.77, P<0.05). Sensitivity of FCHV screening was 90.3% (95% CI: 0.801-0.964); and the specificity was 97% (95% CI: 0.948, 0.984). FCHVs who participated in the FGDs expressed a strong enthusiasm and readiness to using the CVD risk screening tools. Despite their busy workload, all FCHVs showed high level of motivation and willingness in using CVD risk screening tools and contribute to the prevention and control efforts of NCDs. The FCHVs recommended needs for providing additional training and capacity building opportunities. Conclusion We conclude that there is a potential for engaging FCHVs to use simple CVD risk screening tools at the community level. The findings are promising, however, further studies engaging larger number of FCHVs and larger population would warrant feasibility of such tools within the existing healthcare systems in Nepal.	[Rawal, Lal B.; Dahal, Padam K.] Cent Queensland Univ, Coll Sci & Sustainabil, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia; [Rawal, Lal B.] Cent Queensland Univ, Appleton Inst, Phys Act Res Grp, Rockhampton, Qld, Australia; [Rawal, Lal B.] Western Sydney Univ, Translat Hlth Res Inst, Penrith, NSW, Australia; [Rawal, Lal B.] Western Sydney Univ, Sch Social Sci, Penrith, NSW, Australia; [Sun, Yuewen; Abdullah, Abu S.] Duke Kunshan Univ, Global Hlth Inst, Suzhou, Jiangsu, Peoples R China; [Baral, Sushil C.; Khanal, Sudeepa; Arjyal, Abriti; Manandhar, Shraddha] HERD Int, Kathmandu, Nepal; [Khanal, Sudeepa] Bielefeld Univ, Sch Publ Hlth, Bielefeld, Germany; [Abdullah, Abu S.] Duke Univ, Durban, NC 27708 USA; [Abdullah, Abu S.] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA	Central Queensland University; Central Queensland University; Western Sydney University; Western Sydney University; Duke Kunshan University; University of Bielefeld; Duke University; Boston Medical Center; Boston University	Rawal, LB (corresponding author), Cent Queensland Univ, Coll Sci & Sustainabil, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia.; Rawal, LB (corresponding author), Cent Queensland Univ, Appleton Inst, Phys Act Res Grp, Rockhampton, Qld, Australia.; Rawal, LB (corresponding author), Western Sydney Univ, Translat Hlth Res Inst, Penrith, NSW, Australia.; Rawal, LB (corresponding author), Western Sydney Univ, Sch Social Sci, Penrith, NSW, Australia.; Abdullah, A (corresponding author), Duke Kunshan Univ, Global Hlth Inst, Suzhou, Jiangsu, Peoples R China.; Abdullah, A (corresponding author), Duke Univ, Durban, NC 27708 USA.; Abdullah, A (corresponding author), Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA.	L.rawal@cqu.edu.au; abu.abdullah@duke.edu	Dahal, Padam/AAL-9920-2020; Manandhar, Shraddha/GZL-6574-2022	Dahal, Padam/0000-0002-5978-3762; Rawal, Lal/0000-0003-1106-0108				Abdullah A., 2019, WHO REG OFF SE NEW D; Advancing Partners & Communities, 2015, FEMALE COMMUNITY HLT; [Anonymous], 2016, WHO METHODS DATA SOU; Biswas T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167140; Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466; Chicago Department of Public Health, 2019, HIV EPIDEMIOLOGY ANN; Crossan C, 2017, BRIT J GEN PRACT, V67, pE67, DOI 10.3399/bjgp16X687973; Dahal PK, 2019, AUST J PRIM HEALTH, V25, P526, DOI 10.1071/PY19007; Dhimal Meghnath, 2019, J Nepal Health Res Counc, V17, P394, DOI 10.33314/jnhrc.v17i3.2327; Dhital S. M., 2013, Regional Health Forum, V17, P44; Dhungana RR, 2016, INT J HYPERTENS, V2016, P1, DOI 10.1155/2016/1656938; Di Angelantonio E, 2019, LANCET GLOB HEALTH, V7, pE1332, DOI 10.1016/S2214-109X(19)30318-3; Eggleston K, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01850-0; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Gauchan B, 2018, HUM RESOUR HEALTH, V16, DOI 10.1186/s12960-018-0287-7; Gautam, 2013, HLTH PROSPECT, V11; Gaziano TA, 2015, LANCET GLOB HEALTH, V3, pE556, DOI 10.1016/S2214-109X(15)00143-6; Global Burden of Disease Collaborative Network, 2017, GLOB BURD DIS STUD 2; Government of Nepal, 2014, MULT ACT PLAN PREV C; Institute for Health Metrics and Evaluation (IHME), 2018, FIND GLOB BURD DIS S; Khatri RB, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00181; Koniak-Griffin D, 2015, INT J NURS STUD, V52, P75, DOI 10.1016/j.ijnurstu.2014.09.005; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Mehata S, 2018, J HYPERTENS, V36, P1680, DOI [10.1097/HJH.0000000000001745, 10.1097/01.hjh.0000549242.70622.3e]; Meherali Salima, 2020, Health Lit Res Pract, V4, pe251, DOI 10.3928/24748307-20201118-01; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; Mirelman AJ, 2016, HEALTH POLICY PLANN, V31, P785, DOI 10.1093/heapol/czv134; Mishra SR, 2016, LANCET DIABETES ENDO, V4, P979, DOI 10.1016/S2213-8587(16)30331-X; Neupane D, 2018, LANCET GLOB HEALTH, V6, pE66, DOI [10.1016/S2214-109X(17)30411-4, 10.1016/s2214-109x(17)30411-4]; Neupane D, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.28254; Organization WH, 2018, NONCOMMUNICABLE DIS; Panday S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2567-7; Rawal LB, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040350; Rawal LB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205912; Rawal LB, 2012, INT J BEHAV MED, V19, P121, DOI 10.1007/s12529-011-9162-9; Rossello X, 2019, EUR J PREV CARDIOL, V26, P1534, DOI 10.1177/2047487319846715; Roth GA, 2020, J AM COLL CARDIOL, V76, P2982, DOI 10.1016/j.jacc.2020.11.010; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; UNDP (United Nations Popul. Div.), 2017, AD YOUTH; Vaidya Abhinav, 2012, Indian Heart J, V64, P128, DOI 10.1016/S0019-4832(12)60045-5; van Schaik TM, 2017, NETH HEART J, V25, P446, DOI 10.1007/s12471-017-0963-6; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2010, PACK ESS NONC PEN DI; Xavier D, 2016, LANCET DIABETES ENDO, V4, P244, DOI 10.1016/S2213-8587(15)00480-5	45	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261518	10.1371/journal.pone.0261518	http://dx.doi.org/10.1371/journal.pone.0261518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990481	gold, Green Published			2022-12-27	WOS:000815783800009
J	Mishica, C; Kyrolalnen, H; Hynynen, E; NummelaID, A; Holmberg, HC; Linnamo, V				Mishica, Christina; Kyrolalnen, Heikki; Hynynen, Esa; NummelaID, Ari; Holmberg, Hans-Christer; Linnamo, Vesa			Evaluation of nocturnal vs. morning measures of heart rate indices in young athletes	PLOS ONE			English	Article							RATE-VARIABILITY; TRAINING LOAD; PERFORMANCE; EXERCISE; MONITOR; SLEEP; NIGHT	Purpose The purpose of this study was to compare heart rate (HR) and heart rate variability in young endurance athletes during nocturnal sleep and in the morning; and to assess whether changes in these values are associated with changes in submaximal running (SRT) and counter-movement jump (CMJ) performance. Methods During a three-week period of similar training, eleven athletes (16 +/- 1 years) determined daily HR and heart rate variability (RMSSD) during sleep utilizing a ballistocardiographic device (Emfit QS), as well as in the morning with a HR monitor (Polar V800). Aerobic fitness and power production were assessed employing SRT and CMJ test. Results Comparison of the average values for week 1 and week 3 revealed no significant differences with respect to nocturnal RMSSD (6.8%, P = 0.344), morning RMSSD (13.4%, P = 0.151), morning HR (-3.9 bpm, P = 0.063), SRT HR (-0.7 bpm, P = 0.447), SRT blood lactate (4.9%, P = 0.781), CMJ (-4.2%, P = 0.122) or training volume (16%, P = 0.499). There was a strong correlation between morning and nocturnal HRs during week 1 (r = 0.800, P = 0.003) and week 3 (r = 0.815, P = 0.002), as well as between morning and nocturnal RMSSD values (for week 1, r = 0.895, P<0.001 and week 3, r = 0.878, P = 0.001). Conclusion This study concluded that HR and RMSSD obtained during nocturnal sleep and in the morning did not differ significantly. In addition, weekly changes in training and performance were small indicating that fitness was similar throughout the 3-week period of observation. Consequently, daily measurement of HR indices during nocturnal sleep provide a potential tool for long-term monitoring of young endurance athletes.	[Mishica, Christina; Kyrolalnen, Heikki; Linnamo, Vesa] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland; [Hynynen, Esa; NummelaID, Ari] KIHU Res Inst Olymp Sports, Jyvaskyla, Finland; [Holmberg, Hans-Christer] Lulea Univ Technol, Dept Hlth Sci, Lulea, Sweden	University of Jyvaskyla; Lulea University of Technology	Mishica, C (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland.	christina.m.mishica@jyu.fi		Nummela, Ari/0000-0002-7965-3092; Kyrolainen, Heikki/0000-0003-3822-1733; Mishica, Christina/0000-0002-7232-5600	Amer Cultural Foundation of Finland	Amer Cultural Foundation of Finland	CM received funding for this work. The Amer Cultural Foundation of Finland supported funding for this project. The funder website is found at https://amerinkulttuurisaatio.emmi.fi/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Balsalobre-Fernandez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106066; BOSCO C, 1983, EUR J APPL PHYSIOL O, V51, P357, DOI 10.1007/BF00429072; Bosquet L, 2008, BRIT J SPORT MED, V42, P709, DOI 10.1136/bjsm.2007.042200; Bourdillon N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00456; Buchheit M, 2004, AM J PHYSIOL-HEART C, V287, pH2813, DOI 10.1152/ajpheart.00490.2004; Buchheit M, 2012, EUR J APPL PHYSIOL, V112, P711, DOI 10.1007/s00421-011-2014-0; Buchheit M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00073; Camm AJ, 1996, EUR HEART J, V17, P354; Dupuy O, 2013, APPL PHYSIOL NUTR ME, V38, P200, DOI 10.1139/apnm-2012-0203; Fatisson J, 2016, HEART INT, V11, pE32, DOI 10.5301/heartint.5000232; Garrett JM, 2020, INT J SPORT PHYSIOL, V15, P68, DOI 10.1123/ijspp.2019-0150; Giles D, 2016, EUR J APPL PHYSIOL, V116, P563, DOI 10.1007/s00421-015-3303-9; Hamlin MJ, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00034; Hautala AJ, 2009, NEUROSCI BIOBEHAV R, V33, P107, DOI 10.1016/j.neubiorev.2008.04.009; Hedelin R, 2000, SCAND J MED SCI SPOR, V10, P298, DOI 10.1034/j.1600-0838.2000.010005298.x; Hynynen E, 2006, MED SCI SPORT EXER, V38, P313, DOI 10.1249/01.mss.0000184631.27641.b5; Hynynen E, 2011, EUR J APPL PHYSIOL, V111, P733, DOI 10.1007/s00421-010-1698-x; JEUKENDRUP AE, 1992, INT J SPORTS MED, V13, P534, DOI 10.1055/s-2007-1021312; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kuipers H., 1996, RES Q EXERC SPORT, V67, pS, DOI [10.1080/02701367.1996.10608855, DOI 10.1080/02701367.1996.10608855]; Lamberts RP, 2004, J STRENGTH COND RES, V18, P641, DOI 10.1519/00124278-200408000-00044; Le Meur Y, 2013, MED SCI SPORT EXER, V45, P2061, DOI 10.1249/MSS.0b013e3182980125; Nummela A, 2010, INT J SPORTS MED, V31, P154, DOI 10.1055/s-0029-1243221; Ohtonen O, 2015, 3 INT C SCI NORDIC S; Pichot V, 2000, MED SCI SPORT EXER, V32, P1729, DOI 10.1097/00005768-200010000-00011; Pinheiro Eduardo, 2010, Open Biomed Eng J, V4, P201, DOI 10.2174/1874120701004010201; Plews DJ, 2017, INT J SPORT PHYSIOL, V12, P1324, DOI 10.1123/ijspp.2016-0668; Plews DJ, 2012, EUR J APPL PHYSIOL, V112, P3729, DOI 10.1007/s00421-012-2354-4; Schafer D, 2015, EUR J APPL PHYSIOL, V115, P2107, DOI 10.1007/s00421-015-3190-0; Schmitt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071588; Stanley J, 2013, SPORTS MED, V43, P1259, DOI 10.1007/s40279-013-0083-4; Taylor K., 2012, J AUST STRENGTH COND, V20, P12; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Vesterinen V., 2020, JMIR BIOMED ENG, V5, pe16620, DOI [10.2196/16620, DOI 10.2196/16620]; Waldeck Miriam R, 2003, J Sports Sci Med, V2, P133	36	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262333	10.1371/journal.pone.0262333	http://dx.doi.org/10.1371/journal.pone.0262333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986202	Green Published, gold			2022-12-27	WOS:000765956200043
J	Al-Haifi, AR; Al-Awadhi, BA; Al-Dashti, YA; Aljazzaf, BH; Allafi, AR; Al-Mannai, MA; Al-Hazzaa, HM				Al-Haifi, Ahmad R.; Al-Awadhi, Balqees A.; Al-Dashti, Yousef A.; Aljazzaf, Badriyah H.; Allafi, Ahmad R.; Al-Mannai, Mariam A.; Al-Hazzaa, Hazzaa M.			Prevalence of overweight and obesity among Kuwaiti adolescents and the perception of body weight by parents or friends	PLOS ONE			English	Article							MASS INDEX; DIVERSE SAMPLE; ASSOCIATION; COUNTRIES; HEALTH; TRENDS; DECADE; LIFE	Objective Recently, the State of Kuwait has witnessed a steady rise in the prevalence of obesity among children and adolescents. The present study aims to provide an update on the rate of overweight or obesity among Kuwaiti adolescents and examines the associations between adolescents' overweight/obesity levels and their perception of body weight as seen by parents or friends. Methods A cross-sectional study was conducted in Kuwaiti secondary schools and included adolescents between the ages of 15 and 18 years, using a multistage stratified random sampling method. Body weight and height were measured. A specifically designed self-report questionnaire was used to assess parents' and friends' perceptions of an adolescent's body weight. Results A total of 706 adolescents were included the study. The prevalence of overweight or obesity among Kuwaiti adolescents reached nearly 50%, with males (54.3%) having a significantly higher overweight or obesity percentage than females (44.6%). No significant difference in the prevalence of obesity relative to age, from 15 to 18 years, was found. In addition, logistic regression analysis, adjusted for age and gender, revealed that adolescents perceived their parents (p = 0.011 and p < 0.001) or friends (p = 0.002 and p < 0.001) as more likely to classify their weight as overweight or obese, respectively. Conclusion Overweight or obesity levels appear to be high among Kuwaiti adolescents, and appears to have reached a plateau recently. Efforts to combat obesity and promote physical activity and healthy nutrition are needed. Future studies should seek to identify important moderators of parental and social underestimation/overestimation of children's overweight or obesity.	[Al-Haifi, Ahmad R.; Al-Awadhi, Balqees A.; Al-Dashti, Yousef A.; Aljazzaf, Badriyah H.] PAAET, Dept Food & Nutr Sci, Coll Hlth Sci, Showaikh, Kuwait; [Allafi, Ahmad R.] Univ Kuwait, Coll Life Sci, Dept Food Sci & Nutr, Kuwait, Kuwait; [Al-Mannai, Mariam A.] Univ Bahrain, Dept Math, Sakheer, Bahrain; [Al-Hazzaa, Hazzaa M.] Princess Nourah Bint Abdulrahman Univ, Lifestyle & Hlth Res Ctr, Hlth Sci Res Ctr, Riyadh, Saudi Arabia	Public Authority for Applied Education & Training (PAAET) - Kuwait; Kuwait University; University of Bahrain; Princess Nourah bint Abdulrahman University	Al-Hazzaa, HM (corresponding author), Princess Nourah Bint Abdulrahman Univ, Lifestyle & Hlth Res Ctr, Hlth Sci Res Ctr, Riyadh, Saudi Arabia.	halhazzaa@hotmail.com	Al-Hazzaa, Hazzaa/R-6909-2019	Al-Hazzaa, Hazzaa/0000-0002-3099-0389	Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University through the Fast-track Research Funding Program	Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University through the Fast-track Research Funding Program(Princess Nourah bint Abdulrahman University)	For your information the corresponding author, Professor Hazzaa M. Al-Hazzaa's research has been funded by the Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University through the Fast-track Research Funding Program.	Al Hammadi Hanouf, 2019, BMC Obes, V6, P3, DOI 10.1186/s40608-018-0221-5; Al-Haifi Ahmad A, 2015, Glob J Health Sci, V8, P107, DOI 10.5539/gjhs.v8n1p107; Al-Hazzaa HM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-140; Al-Hazzaa HM., 2018, OBES OPEN ACCESS, V4, DOI [10.16966/2380-5528.136, DOI 10.16966/2380-5528.136]; Al-Hussaini A, 2019, SAUDI J GASTROENTERO, V25, P229, DOI 10.4103/sjg.SJG_617_18; Al-Isa AN, 2004, EUR J CLIN NUTR, V58, P1273, DOI 10.1038/sj.ejcn.1601961; Azar KMJ, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02038-4; Balantekin KN, 2014, APPETITE, V80, P190, DOI 10.1016/j.appet.2014.05.016; Bandura A., 1977, SOCIAL LEARNING THEO, V1; Bauer KW, 2017, CHILD OBES, V13, P470, DOI 10.1089/chi.2017.0067; Bauer KW, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-45; Berge JM, 2015, BODY IMAGE, V15, P8, DOI 10.1016/j.bodyim.2015.04.006; Brechwald WA, 2011, J RES ADOLESCENCE, V21, P166, DOI 10.1111/j.1532-7795.2010.00721.x; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Eisenberg Marla, 2008, Int J Adolesc Med Health, V20, P155; Eisenberg ME, 2011, BODY IMAGE, V8, P12, DOI 10.1016/j.bodyim.2010.11.002; Gordon-Larsen P, 2010, OBESITY, V18, P1801, DOI 10.1038/oby.2009.451; Haines J, 2008, OBESITY, V16, pS18, DOI 10.1038/oby.2008.447; Hebebrand J, 2017, OBESITY FACTS, V10, P284, DOI 10.1159/000479208; Howe CJ, 2017, J PEDIATR NURS, V37, P57, DOI 10.1016/j.pedn.2017.06.005; Ievers-Landis CE, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091540; Kerkadi A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224428; Lissau I, 2004, ARCH PEDIAT ADOL MED, V158, P27, DOI 10.1001/archpedi.158.1.27; Lundahl A, 2014, PEDIATRICS, V133, pE689, DOI 10.1542/peds.2013-2690; Marks J, 2019, J RES ADOLESCENCE, V29, P710, DOI 10.1111/jora.12407; McCormack LA, 2011, J AM DIET ASSOC, V111, P431, DOI 10.1016/j.jada.2010.11.021; Moonesar IA., 2017, ADV OBES WEIGHT MANA, V6, P00150, DOI [10.15406/aowmc.2017.06.00150, DOI 10.15406/AOWMC.2017.06.00150]; Musaiger A. O., 2003, Nutrition & Food Science, V33, P145, DOI 10.1108/00346650310488480; Musaiger AO, 2014, J BIOSOC SCI, V46, P240, DOI 10.1017/S0021932013000278; Musaiger AO, 2014, APPETITE, V73, P197, DOI 10.1016/j.appet.2013.11.002; Musaiger AO, 2011, J OBES, V2011, DOI 10.1155/2011/407237; Neumark-Sztainer D, 2002, INT J OBESITY, V26, P123, DOI 10.1038/sj.ijo.0801853; Oen G, 2018, INT J QUAL STUD HEAL, V13, DOI 10.1080/17482631.2018.1479581; Philippi ST, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00029817, 10.1590/0102-311X00029817]; Puhl RM, 2012, J YOUTH ADOLESCENCE, V41, P27, DOI 10.1007/s10964-011-9713-z; Pulgaron ER, 2013, CLIN THER, V35, pA18, DOI 10.1016/j.clinthera.2012.12.014; Rey-Lopez JP, 2019, MINERVA PEDIATR, V71, P326, DOI 10.23736/S0026-4946.18.04911-3; Sirico F, 2020, HIGH BLOOD PRESS CAR, V27, P29, DOI 10.1007/s40292-019-00352-2; Steinberg L, 2001, ANNU REV PSYCHOL, V52, P83, DOI 10.1146/annurev.psych.52.1.83; Sweeting HN, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-1; Sweeting HN, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-32; Tantawy SA, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019950; Valois DD, 2019, BODY IMAGE, V29, P65, DOI 10.1016/j.bodyim.2019.02.009; van Geel M, 2014, INT J OBESITY, V38, P1263, DOI 10.1038/ijo.2014.117; Waly I.M., 2017, EC NUTR, V7, P3; World Health Organization, 2016, FACT SHEET OB OV; Yoon HK, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145126	47	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262101	10.1371/journal.pone.0262101	http://dx.doi.org/10.1371/journal.pone.0262101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982787	gold, Green Published			2022-12-27	WOS:000834805700017
J	Kober, C; Manni, S; Wolff, S; Barnes, T; Mukherjee, S; Vogel, T; Hoenig, L; Vogel, P; Hahn, A; Gerlach, M; Vey, M; Widmer, E; Keiner, B; Schuetz, P; Roth, N; Kalina, U				Kober, Christina; Manni, Sandro; Wolff, Svenja; Barnes, Thomas; Mukherjee, Shatanik; Vogel, Thomas; Hoenig, Lea; Vogel, Peter; Hahn, Aaron; Gerlach, Michaela; Vey, Martin; Widmer, Eleonora; Keiner, Bjorn; Schuetz, Patrick; Roth, Nathan; Kalina, Uwe			IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools	PLOS ONE			English	Article								Analysis of convalescent plasma derived from individuals has shown that IgG3 has the most important role in binding to SARS-CoV-2 antigens; however, this has not yet been confirmed in large studies, and the link between binding and neutralization has not been confirmed. By analyzing plasma pools consisting of 247-567 individual convalescent donors, we demonstrated the binding of IgG3 and IgM to Spike-1 protein and the receptor-binding domain correlates strongly with viral neutralization in vitro. Furthermore, despite accounting for only approximately 12% of total immunoglobulin mass, collectively IgG3 and IgM account for approximately 80% of the total neutralization. This may have important implications for the development of potent therapies for COVID-19, as it indicates that hyperimmune globulins or convalescent plasma donations with high IgG3 concentrations may be a highly efficacious therapy.	[Kober, Christina; Wolff, Svenja; Mukherjee, Shatanik; Vogel, Thomas; Vogel, Peter; Hahn, Aaron; Gerlach, Michaela; Vey, Martin; Keiner, Bjorn; Kalina, Uwe] CSL Behring Innovat GmbH, Res & Dev, Marburg, Germany; [Manni, Sandro; Barnes, Thomas; Hoenig, Lea; Widmer, Eleonora; Schuetz, Patrick; Roth, Nathan] CSL Behring, Res & Dev, Bern, Switzerland	CSL	Kalina, U (corresponding author), CSL Behring Innovat GmbH, Res & Dev, Marburg, Germany.	Uwe.Kalina@cslbehring.com			CSL Behring GmbH	CSL Behring GmbH	The study was funded by CSL Behring GmbH. The funder provided support in the form of salaries for authors [Christina Kober, Sandro Manni, Svenja Wolff, Thomas Barnes, Shatanik Mukherjee, Thomas Vogel, Lea Hoenig, Peter Vogel, Aaron Hahn, Michaela Gerlach, Martin Vey, Eleonora Widmer, Bjorn Keiner, Patrick Schuetz, Nathan Roth, Uwe Kalina], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	A.Nadas, 2020, medRxiv, DOI 10.1101/2020.08.18.20177303; A. S.Buzzanco, 2020, medRxiv, DOI 10.1101/2020.05.15.20103341; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Bavli I, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4074; Chen YX, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008796; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Collins AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00235; Damelang T, 2019, TRENDS IMMUNOL, V40, P197, DOI 10.1016/j.it.2019.01.005; Gasser R, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108790; Goh YS, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100193; Huang AT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18450-4; J. D. Herman, 2021, medRxiv, DOI 10.1101/2021.03.08.21253157; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kallolimath S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2107249118; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; Khatri I, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.570018; Klasse PJ, 2020, ELIFE, V9, DOI 10.7554/eLife.57877; Liu XM, 2020, EMERG MICROBES INFEC, V9, P1269, DOI 10.1080/22221751.2020.1773324; Luo HL, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.632814; Maor Y, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100525; Mazzini L, 2021, J IMMUNOL METHODS, V489, DOI 10.1016/j.jim.2020.112937; MILES J, 1994, ANN CLIN BIOCHEM, V31, P245, DOI 10.1177/000456329403100305; Moura AD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95045-z; Muller L, 2021, EUR J CLIN MICROBIOL, V40, P1063, DOI 10.1007/s10096-021-04169-7; Munitz A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83019-0; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Prevost J, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100126; Rowntree LC, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1258; Sakoulas George, 2020, Crit Care Explor, V2, pe0280, DOI 10.1097/CCE.0000000000000280; Scharf O, 2001, J VIROL, V75, P6558, DOI 10.1128/JVI.75.14.6558-6565.2001; Schwaiger J, 2020, J INFECT DIS, V222, P1960, DOI 10.1093/infdis/jiaa593; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Suthar MS, 2020, CELL REP MED, V1, DOI [10.1016/j.xcrm.2020.100040, 10.1101/2020.05.03.20084442]; Suthar MS., 2020, PREPRINT, DOI [10.1101/2020.05.03.20084442, DOI 10.1101/2020.05.03.20084442]; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Whitcombe AL, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1261; Yates JL, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100329; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	41	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262162	10.1371/journal.pone.0262162	http://dx.doi.org/10.1371/journal.pone.0262162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982806	gold, Green Published			2022-12-27	WOS:000834805700019
J	Schuetz, A; Kurz, K; Busch, G				Schuetz, Aurelia; Kurz, Katharina; Busch, Gesa			Virtual farm tours-Virtual reality glasses and tablets are suitable tools to provide insights into pig husbandry	PLOS ONE			English	Article							ANIMAL-WELFARE; PERCEPTION	Apart from improving husbandry conditions and animal welfare, there is a clear public demand to increase transparency in agricultural activities. Personal farm tours have shown to be appreciated by citizens but are limited in their impact because of hygiene requirements and accessibility. Virtual farm tours are a promising approach to overcome these limitations but evidence on their perceptions is missing. This study analyzes how a virtual farm tour is perceived by showing participants (n = 17) a 360-degree video of a conventional pig fattening pen on a tablet and via virtual reality (VR) glasses. Semi-structured in-depth interviews were conducted to analyze perceptions and level of immersion and to elicit differences between media devices. Participants' perception of the pig fattening pen was rather poor and depended on the recording perspective as well as on the media device. However, housing conditions were perceived more positively compared to the image participants had in mind prior to the study, and thus the stable was considered as a rather positive example. Participants described virtual farm tours as suitable tool to improve transparency and information transfer and to gain insights into husbandry conditions. They appreciated the comfortable and entertaining character of both media devices and named various possibilities for implementation. However, VR glasses were favored regarding the higher realistic and entertaining value, while the tablet was considered beneficial in terms of usability. The presentation of video sequences without additional explanations about the farm or the housing conditions were claimed insufficient to give an adequate understanding of the seen content.	[Schuetz, Aurelia; Kurz, Katharina; Busch, Gesa] Univ Goettingen, Dept Agr Econ & Rural Dev, Gottingen, Lower Saxony, Germany	University of Gottingen	Schuetz, A (corresponding author), Univ Goettingen, Dept Agr Econ & Rural Dev, Gottingen, Lower Saxony, Germany.	aurelia.schuetz@uni-goettingen.de		Schutz, Aurelia/0000-0003-2084-0296	Open Access Publication Funds of the Gottingen University	Open Access Publication Funds of the Gottingen University	We acknowledge support by the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the Manuscript. Apart from the publication funding, the authors received no further funding for the study presented herein.	Ahn SJG, 2016, J COMPUT-MEDIAT COMM, V21, P399, DOI 10.1111/jcc4.12173; [Anonymous], 2019, VIRTUAL AUGMENTED RE, DOI [10.1007/978-3-662-58861-1, DOI 10.1007/978-3-662-58861-1]; Asani Emmanuel Oluwatobi, 2019, International Journal of Interactive Mobile Technologies, V13, P110, DOI 10.3991/ijim.v13i05.9119; Bailey J., 2012, P INT SOC PRES RES A, P24; Blokhuis HJ, 2003, ANIM WELFARE, V12, P445; Boogaard BK, 2011, LIVEST SCI, V140, P189, DOI 10.1016/j.livsci.2011.03.028; Busch G, 2015, SCHRIFTENREIHE RENTE, V31, P67; Busch G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211256; Busch G, 2017, GER J AGR ECON, V66, P65; Caracciolo F, 2016, J CLEAN PROD, V112, P121, DOI 10.1016/j.jclepro.2015.06.045; Crouch M, 2006, SOC SCI INFORM, V45, P483, DOI 10.1177/0539018406069584; Durnell Linda A, 2018, THESIS FIELDING GRAD; Ermann M., 2017, SCHRIFTEN GESELLSCHA, P45; European Commission, 2015, ATT EUR AN WELF SPEC; Fossey E, 2002, AUST NZ J PSYCHIAT, V36, P717, DOI 10.1046/j.1440-1614.2002.01100.x; Gauly S., 2017, Diskussionspapiere - Department fur Agrarokonomie und Rurale Entwicklung, Universitat Gottingen; i.m.a.-Informationen.Medien-Agrar, 2003, IM DTSCH LANDW SICHT; Kisker J, 2021, PSYCHOL RES-PSYCH FO, V85, P68, DOI 10.1007/s00426-019-01244-9; Kletschke T, 2019, LIVE STREAM STALL SU; Krystallis A, 2009, LIVEST SCI, V126, P46, DOI 10.1016/j.livsci.2009.05.016; Lebensmittel Praxis, 2018, FLEISCH STAR 18; Liagkou V, 2019, PROC CIRP, V79, P712, DOI 10.1016/j.procir.2019.02.025; Markowitz DM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02364; Mayring P, 2010, QUALITATIVE INHALTSA, DOI DOI 10.1007/978-3-531-92052-8_42; Meehan M, 2002, ACM T GRAPHIC, V21, P645, DOI 10.1145/566570.566630; Mkwanazi MV, 2019, ASIAN AUSTRAL J ANIM, V32, P1, DOI 10.5713/ajas.17.0138; MOSTL A., 2016, KOMMUNIKATION LANDWI; Pasanen K, 2019, INFORMATION AND COMMUNICATION TECHNOLOGIES IN TOURISM 2019, P120, DOI 10.1007/978-3-030-05940-8_10; Radianti J, 2020, COMPUT EDUC, V147, DOI 10.1016/j.compedu.2019.103778; Ritchie J., 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.4135/9781452230108; Rizzo A, 2011, J CLIN PSYCHOL MED S, V18, P176, DOI 10.1007/s10880-011-9247-2; Rizzo A, 2017, NEUROPSYCHOLOGY, V31, P877, DOI 10.1037/neu0000405; Roche K, 2019, J NEUROLOGY PSYCHIAT; Schone B, 2019, CURR PSYCHOL, V38, P715, DOI 10.1007/s12144-017-9648-y; Spiller A., 2013, DLG MITTEILUNGEN, V1, P26; STEUER J, 1992, J COMMUN, V42, P73, DOI 10.1111/j.1460-2466.1992.tb00812.x; Stohlmann LK, 2019, THESIS OHIO STATE U; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; van Herpen E, 2016, APPETITE, V107, P196, DOI 10.1016/j.appet.2016.07.033; Vanhonacker F, 2008, LIVEST SCI, V116, P126, DOI 10.1016/j.livsci.2007.09.017; Ventura BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154733; Veres P., 2020, J ENG RES REPORTS, DOI [10.9734/jerr/2020/v13i217107, DOI 10.9734/JERR/2020/V13I217107]; Vierboom C., 2015, SCHRIFTENREIHE RENTE, V31, P67; Weible D, 2016, BRIT FOOD J, V118, P1994, DOI 10.1108/BFJ-12-2015-0458; Wells KT, 2019, THESIS LOWA STATE U; Wernsmann A, 2018, GER J AGR ECON, V67, P246; WILDRAUT C, 2015, MULTIMETHODISCHE BEW, V36; Wille SC, 2017, GER J AGR ECON, V66, P1; Zander K., 2013, ERWARTUNGEN GESELLSC	49	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0261248	10.1371/journal.pone.0261248	http://dx.doi.org/10.1371/journal.pone.0261248			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007299	gold, Green Published			2022-12-27	WOS:000741060700009
J	Zhao, JL; Li, YF; Li, JM; Li, JX				Zhao, Jianlong; Li, Yanfeng; Li, Junmei; Li, Jiaxin			A study on the temperature profile of bifurcation tunnel fire under natural ventilation	PLOS ONE			English	Article							SMOKE TEMPERATURE; METRO TUNNEL; MOVEMENT; AREA; ROAD	This study simulated a series of bifurcation tunnel fire scenarios using the numerical code to investigate the temperature profile of bifurcation tunnel fire under natural ventilation. The bifurcation tunnel fire scenarios considered three bifurcation angles (30 degrees, 45 degrees, and 60 degrees) and six heat release rates (HRRs) (5, 10, 15, 20, 25, and 30 MW). According to the simulation results, the temperature profile with various HRRs and bifurcation angles was described. Furthermore, the effects of bifurcation angles and HRRs on the maximum temperature under the bifurcation tunnel ceiling and the temperature decay along the longitudinal direction of the branch were investigated. According to the theoretical analysis, two prediction models were proposed. These models can predict a bifurcation tunnel fire's maximum temperature and longitudinal temperature decay in the branch. The results of this study could be valuable for modelling a bifurcation tunnel fire and benefit the fire engineering design of bifurcation tunnels.	[Zhao, Jianlong; Li, Yanfeng; Li, Junmei; Li, Jiaxin] Beijing Univ Technol, Beijing Key Lab Green Built Environm & Energy Eff, Beijing, Peoples R China	Beijing University of Technology	Li, YF (corresponding author), Beijing Univ Technol, Beijing Key Lab Green Built Environm & Energy Eff, Beijing, Peoples R China.	liyanfeng@bjut.edu.cn		Zhao, Jianlong/0000-0003-1098-7868				ALPERT RL, 1975, COMBUST SCI TECHNOL, V11, P197, DOI 10.1080/00102207508946699; Chen CK, 2020, TUNN UNDERGR SP TECH, V104, DOI 10.1016/j.tust.2020.103522; Chen CK, 2020, TUNN UNDERGR SP TECH, V98, DOI 10.1016/j.tust.2019.103275; Chen CK, 2021, COMBUST SCI TECHNOL, V193, P2194, DOI 10.1080/00102202.2020.1732362; Chen LF, 2020, TUNN UNDERGR SP TECH, V98, DOI 10.1016/j.tust.2020.103295; Evers E., 1978, BUILD RES ESTABL FIR; Fan CG, 2016, APPL THERM ENG, V93, P405, DOI 10.1016/j.applthermaleng.2015.09.048; Feng S, 2020, TUNN UNDERGR SP TECH, V97, DOI 10.1016/j.tust.2019.103234; Gao Y, 2017, PROCEDIA ENGINEER, V205, P1850, DOI 10.1016/j.proeng.2017.10.260; Gao YJ, 2019, ADV STRUCT ENG, V22, P2089, DOI 10.1177/1369433219831485; Gong L, 2016, INT J THERM SCI, V102, P319, DOI 10.1016/j.ijthermalsci.2015.12.006; Haddad RK, 2020, J APPL FLUID MECH, V13, P1289, DOI 10.36884/jafm.13.04.30876; Hu LH, 2005, TUNN UNDERGR SP TECH, V20, P223, DOI 10.1016/j.tust.2004.08.007; Huang YB, 2020, TUNN UNDERGR SP TECH, V99, DOI 10.1016/j.tust.2020.103388; Huang YB, 2019, INT J THERM SCI, V145, DOI 10.1016/j.ijthermalsci.2019.105997; Huang YB, 2018, TUNN UNDERGR SP TECH, V72, P120, DOI 10.1016/j.tust.2017.11.021; Ingason H, 2010, FIRE SAFETY J, V45, P371, DOI 10.1016/j.firesaf.2010.07.004; Ji J, 2017, APPL THERM ENG, V118, P663, DOI 10.1016/j.applthermaleng.2017.03.026; Khoury G.A., 2000, PROG STRUCT ENG MAT, P429, DOI [10.1002/pse.51, 10.1002/pse.51.URL, DOI 10.1002/PSE.51]; Kurioka H, 2003, FIRE SAFETY J, V38, P319, DOI 10.1016/S0379-7112(02)00089-9; Lei P, 2021, INT J THERM SCI, V159, DOI 10.1016/j.ijthermalsci.2020.106631; Li JM, 2017, PROCEDIA ENGINEER, V205, P1858, DOI 10.1016/j.proeng.2017.10.262; Li YZ, 2018, TUNN UNDERGR SP TECH, V81, P568, DOI 10.1016/j.tust.2018.08.013; Li YZ, 2018, FIRE SAFETY J, V97, P85, DOI 10.1016/j.firesaf.2018.03.006; Li YS, 2021, TUNN UNDERGR SP TECH, V113, DOI 10.1016/j.tust.2021.103953; Li ZS, 2021, TUNN UNDERGR SP TECH, V112, DOI 10.1016/j.tust.2021.103893; Liu C, 2020, TUNN UNDERGR SP TECH, V97, DOI 10.1016/j.tust.2020.103296; Liu C, 2019, INT J THERM SCI, V138, P84, DOI 10.1016/j.ijthermalsci.2018.12.037; Liu C, 2017, APPL THERM ENG, V110, P382, DOI 10.1016/j.applthermaleng.2016.08.147; Lou B, 2017, J APPL FLUID MECH, V10, P1139, DOI 10.18869/acadpub.jafm.73.241.26529; Ma X, 2021, TUNN UNDERGR SP TECH, V107, DOI 10.1016/j.tust.2020.103674; McGrattan K., 2019, NIST SPEC PUBL, V1019; Tang F, 2020, INT J THERM SCI, V152, DOI 10.1016/j.ijthermalsci.2020.106294; Tomar MS, 2019, TUNN UNDERGR SP TECH, V85, P149, DOI 10.1016/j.tust.2018.12.018; Wang YF, 2016, APPL THERM ENG, V109, P344, DOI 10.1016/j.applthermaleng.2016.08.081; Wang ZY, 2020, INT J THERM SCI, V152, DOI 10.1016/j.ijthermalsci.2020.106272; Wang ZH, 2021, TUNN UNDERGR SP TECH, V109, DOI 10.1016/j.tust.2020.103752; Xu T, 2021, INDOOR BUILT ENVIRON, DOI 10.1177/1420326X211013080; Yan GF, 2020, INDOOR BUILT ENVIRON, V29, P1017, DOI 10.1177/1420326X19870313; Yang D, 2017, TUNN UNDERGR SP TECH, V61, P189, DOI 10.1016/j.tust.2016.10.009; Yao YZ, 2021, TUNN UNDERGR SP TECH, V108, DOI 10.1016/j.tust.2020.103672; Yao YZ, 2019, INDOOR BUILT ENVIRON, V28, P77, DOI 10.1177/1420326X17734906; Ye K, 2019, INT J THERM SCI, V142, P434, DOI 10.1016/j.ijthermalsci.2019.04.023; Yu L, 2021, TUNN UNDERGR SP TECH, V108, DOI 10.1016/j.tust.2020.103715; Zhang XL, 2021, TUNN UNDERGR SP TECH, V107, DOI 10.1016/j.tust.2020.103661; Zhao SZ, 2018, TUNN UNDERGR SP TECH, V73, P187, DOI 10.1016/j.tust.2017.12.002	46	0	0	15	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262546	10.1371/journal.pone.0262546	http://dx.doi.org/10.1371/journal.pone.0262546			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007305	gold, Green Published			2022-12-27	WOS:000741060700007
J	AlQudah, AA; Al-Emran, M; Shaalan, K				AlQudah, Adi A.; Al-Emran, Mostafa; Shaalan, Khaled			Medical data integration using HL7 standards for patient's early identification	PLOS ONE			English	Article							WAITING TIME; EMERGENCY; CARE	Integration between information systems is critical, especially in the healthcare domain, since interoperability requirements are related to patients' data confidentiality, safety, and satisfaction. The goal of this study is to propose a solution based on the integration between queue management solution (QMS) and the electronic medical records (EMR), using Health Level Seven (HL7) protocols and Extensible Markup Language (XML). The proposed solution facilitates the patient's self-check-in within a healthcare organization in UAE. The solution aims to help in minimizing the waiting times within the outpatient department through early identification of patients who hold the Emirates national ID cards, i.e., whether an Emirati or expatriates. The integration components, solution design, and the custom-designed XML and HL7 messages were clarified in this paper. In addition, the study includes a simulation experiment through control and intervention weeks with 517 valid appointments. The experiment goal was to evaluate the patient's total journey and each related clinical stage by comparing the "routine-based identification" with the "patient's self-check-in" processes in case of booked appointments. As a key finding, the proposed solution is efficient and could reduce the "patient's journey time" by more than 14 minutes and "time to identify" patients by 10 minutes. There was also a significant drop in the waiting time to triage and the time to finish the triage process. In conclusion, the proposed solution is considered innovative and can provide a positive added value for the patient's whole journey.	[AlQudah, Adi A.; Al-Emran, Mostafa; Shaalan, Khaled] British Univ Dubai, Fac Engn & IT, Dubai, U Arab Emirates		AlQudah, AA (corresponding author), British Univ Dubai, Fac Engn & IT, Dubai, U Arab Emirates.	adi.qudah@gmail.com	Al-Emran, Mostafa/W-4466-2018; Shaalan, Khaled/E-7377-2016	Al-Emran, Mostafa/0000-0002-5269-5380; Shaalan, Khaled/0000-0003-0823-8390; AlQudah, Adi/0000-0003-3942-5869				Aburayya A., 2020, MANAGEMENT SCI LETT, V10, P1265; Abusair M, 2021, 2021 7TH INTERNATIONAL CONFERENCE ON INFORMATION MANAGEMENT (ICIM 2021), P167, DOI 10.1109/ICIM52229.2021.9417043; AlHammadi H., 2019, THESIS UAEU; ANSI. American National Standards Institute, 2021, ANSI WEBSITE; Ben-Assuli O, 2015, HEALTH POLICY, V119, P287, DOI 10.1016/j.healthpol.2014.11.014; Bogdan O., 2010, NEW ADV TECHNOLOGIES; Boos J, 2017, AM J ROENTGENOL, V208, P577, DOI 10.2214/AJR.16.16974; Cerner Corporation, 2021, HOM CERN; Choi YF, 2006, EMERG MED J, V23, P262, DOI 10.1136/emj.2005.025254; Costa Bezerra Carlos Andrew, 2020, 17th International Conference on Information Technology-New Generations (ITNG 2020). Advances in Intelligent Systems and Computing (AISC 1134), P461, DOI 10.1007/978-3-030-43020-7_61; Coyle N, 2019, CAN J EMERG MED, V21, P789, DOI 10.1017/cem.2019.349; Davis M. M., 1994, International Journal of Operations & Production Management, V14, P21, DOI 10.1108/01443579410056777; Ghazal Mohammed, 2016, International Journal of Computing and Digital Systems, V5, P305, DOI 10.12785/ijcds/050402; Ghazal M, 2015, PR INT CONF ELEARN, P257, DOI 10.1109/ECONF.2015.69; Handayani DP., 2020, KINET GAME TECHNOL I, V5, P45; HL7 International, 2021, HL7 STAND PROD BRIEF; Ieraci S, 2008, EMERG MED AUSTRALAS, V20, P241, DOI 10.1111/j.1742-6723.2008.01087.x; Kuiper A, 2021, DECISION SCI, DOI 10.1111/deci.12517; Kuiper A, 2021, OMEGA-INT J MANAGE S, V98, DOI 10.1016/j.omega.2019.102122; Kwa P, 2008, EMERG MED AUSTRALAS, V20, P10, DOI 10.1111/j.1742-6723.2007.01021.x; Lopez DM, 2010, METHOD INFORM MED, V49, P196, DOI 10.3414/ME09-02-0012; Marusteri M, 2010, BIOCHEM MEDICA, V20, P15; McGinn T, 2016, JMIR MED INF, V4, P74, DOI 10.2196/medinform.4553; Morgan R, 2007, J EMERG NURS, V33, P530, DOI 10.1016/j.jen.2007.04.011; Oemig F., 2016, HEALTHCARE INTEROPER, DOI [10.1007/978-3-319-44839-8.pdf, DOI 10.1007/978-3-319-44839-8.PDF]; Sadi BA, 2021, INT J HEALTHCARE MAN, V14, P756, DOI 10.1080/20479700.2019.1692768; Safdar KA, 2020, INT J HEALTH CARE Q, V33, P477, DOI 10.1108/IJHCQA-03-2020-0052; Scalia P, 2021, J MED INTERNET RES, V23, DOI 10.2196/22766; Snelick R, 2013, P INT C SOFTW ENG RE; Spaite DW, 2002, ANN EMERG MED, V39, P168, DOI 10.1067/mem.2002.121215; SPSS&REG;, 2017, STAT 25 0 OV; Tantitharanukul Nasi, 2018, 2018 International Conference on Digital Arts, Media and Technology (ICDAMT), P207, DOI 10.1109/ICDAMT.2018.8376525; Xie S, 2013, 2013 THIRD INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEM DESIGN AND ENGINEERING APPLICATIONS (ISDEA), P1549, DOI 10.1109/ISDEA.2012.372	33	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262067	10.1371/journal.pone.0262067	http://dx.doi.org/10.1371/journal.pone.0262067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972171	gold, Green Published			2022-12-27	WOS:000773555700089
J	Harlan, B; Park, HG; Spektor, R; Cummings, B; Brenna, JT; Soloway, PD				Harlan, Blaine; Park, Hui Gyu; Spektor, Roman; Cummings, Bethany; Brenna, J. Thomas; Soloway, Paul D.			Single-cell chromatin accessibility and lipid profiling reveals SCD1-dependent metabolic shift in adipocytes induced by bariatric surgery	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; VERTICAL SLEEVE GASTRECTOMY; HUMAN ADIPOSE-TISSUE; THERMOGENIC PROGRAM; GASTRIC BYPASS; PROTECTS MICE; FAT; DEFICIENCY; EXPRESSION; BROWN	Obesity promotes type 2 diabetes and cardiometabolic pathologies. Vertical sleeve gastrectomy (VSG) is used to treat obesity resulting in long-term weight loss and health improvements that precede weight loss; however, the mechanisms underlying the immediate benefits remain incompletely understood. Because adipose plays a crucial role in energy homeostasis and utilization, we hypothesized that VSG exerts its influences, in part, by modulating adipose functional states. We applied single-cell ATAC sequencing and lipid profiling to inguinal and epididymal adipose depots from mice that received sham surgery or VSG. We observed depot-specific cellular composition and chromatin accessibility patterns that were altered by VSG. Specifically, accessibility at Scd1, a fatty acid desaturase, was substantially reduced after VSG in mature adipocytes of inguinal but not epididymal depots. This was accompanied by reduced accumulation of SCD1-produced unsaturated fatty acids. Given these findings and reports that reductions in Scd1 attenuate obesity and insulin resistance our results suggest VSG exerts its beneficial effects through an inguinal depot-specific reduction of SCD1 activity.	[Harlan, Blaine; Spektor, Roman; Soloway, Paul D.] Cornell Univ, Dept Mol Biol & Genet, Field Genet Genom & Dev, Ithaca, NY 14850 USA; [Park, Hui Gyu; Brenna, J. Thomas] Univ Texas Austin, Dell Pediat Res Inst, Dept Pediat, Austin, TX USA; [Cummings, Bethany] Univ Calif Davis, Sch Med, Dept Surg, Sacramento, CA USA; [Cummings, Bethany; Soloway, Paul D.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14850 USA; [Brenna, J. Thomas; Soloway, Paul D.] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14850 USA	Cornell University; University of Texas System; University of Texas Austin; University of California System; University of California Davis; Cornell University; Cornell University	Soloway, PD (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Field Genet Genom & Dev, Ithaca, NY 14850 USA.; Soloway, PD (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14850 USA.; Soloway, PD (corresponding author), Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14850 USA.	soloway@cornell.edu						Akama T, 2018, J BIOL CHEM, V293, P6603, DOI 10.1074/jbc.RA117.000456; Backdahl J, 2021, CELL METAB, V33, P1869, DOI 10.1016/j.cmet.2021.07.018; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Cereijo R, 2018, CELL METAB, V28, P750, DOI 10.1016/j.cmet.2018.07.015; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Chi JY, 2018, CELL METAB, V27, P226, DOI 10.1016/j.cmet.2017.12.011; Cho DS, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900561; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Coulter AA, 2006, BIOCHEM BIOPH RES CO, V344, P1342, DOI 10.1016/j.bbrc.2006.04.071; Cummings BP, 2012, ENDOCRINOLOGY, V153, P3620, DOI 10.1210/en.2012-1131; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Ejarque M, 2019, INT J OBESITY, V43, P1256, DOI 10.1038/s41366-018-0219-6; Galanakis CG, 2015, WORLD J SURG, V39, P417, DOI 10.1007/s00268-014-2826-2; GARCES R, 1993, ANAL BIOCHEM, V211, P139, DOI 10.1006/abio.1993.1244; Garibay D, 2018, CELL REP, V23, P967, DOI 10.1016/j.celrep.2018.03.120; Gealekman O, 2011, CIRCULATION, V123, P186, DOI 10.1161/CIRCULATIONAHA.110.970145; Gleeson PA, 2014, SEMIN CELL DEV BIOL, V31, P64, DOI 10.1016/j.semcdb.2014.03.002; Granja JM, 2021, NAT GENET, V53, P403, DOI 10.1038/s41588-021-00790-6; Harris DA, 2020, AM J PHYSIOL-ENDOC M, V318, pE678, DOI 10.1152/ajpendo.00441.2019; Hartmann IB, 2016, SURG OBES RELAT DIS, V12, P1554, DOI 10.1016/j.soard.2016.04.016; Ikeda K, 2017, NAT MED, V23, P1454, DOI 10.1038/nm.4429; Jahansouz C, 2018, INT J OBESITY, V42, P139, DOI 10.1038/ijo.2017.197; Jiang YW, 2017, ELIFE, V6, DOI 10.7554/eLife.30329; Kelly AS, 2016, INT J OBESITY, V40, P275, DOI 10.1038/ijo.2015.174; Kwok KHM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.5; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Liu TY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16148-1; Liu WH, 2020, CELL CYCLE, V19, P895, DOI 10.1080/15384101.2020.1731644; Liu X, 2009, LOSS STEAROYL COA DE; McGavigan AK, 2017, DIS MODEL MECH, V10, P235, DOI 10.1242/dmm.027474; McGavigan AK, 2017, GUT, V66, P226, DOI 10.1136/gutjnl-2015-309871; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Miyazaki M, 2009, BIOCHEM BIOPH RES CO, V380, P818, DOI 10.1016/j.bbrc.2009.01.183; Mori M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001314; Ng Y, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.144; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Preissl S, 2018, NAT NEUROSCI, V21, P432, DOI 10.1038/s41593-018-0079-3; Rahman SM, 2003, P NATL ACAD SCI USA, V100, P11110, DOI 10.1073/pnas.1934571100; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Ralston JC, 2014, INT J OBESITY, V38, P1449, DOI 10.1038/ijo.2014.35; Rinaldi VD, 2020, ELIFE, V9, DOI 10.7554/eLife.55474; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sanchez-Gurmaches J, 2015, STEM CELL REP, V4, P541, DOI 10.1016/j.stemcr.2015.02.008; Savu MK, 2009, SURG OBES RELAT DIS, V5, P172, DOI 10.1016/j.soard.2008.08.013; Schupp JC, 2020, BIORXIV; Schweitzer P., 2014, J BIOMOL TECH, V25, pS15; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sjogren P, 2008, DIABETOLOGIA, V51, P328, DOI 10.1007/s00125-007-0876-9; Sowers James R, 2008, Clin Cornerstone, V9, P32, DOI 10.1016/S1098-3597(08)60026-5; Spektor R, 2019, BIORXIV; Stine RR, 2016, MOL METAB, V5, P57, DOI 10.1016/j.molmet.2015.11.001; Sun W, 2019, MOL METAB, V28, P48, DOI 10.1016/j.molmet.2019.07.004; Toro-Ramos T, 2015, OBESITY, V23, P62, DOI 10.1002/oby.20932; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Velazquez-Villegas LA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02068-0; Vijay J, 2020, NAT METAB, V2, P97, DOI 10.1038/s42255-019-0152-6; Wang WS, 2014, P NATL ACAD SCI USA, V111, P14466, DOI 10.1073/pnas.1412685111; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoon DY, 2007, ANZ J SURG, V77, P121, DOI 10.1111/j.1445-2197.2006.03990.x; Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188; Zhang Y, 2014, OBES SURG, V24, P1617, DOI 10.1007/s11695-014-1258-2; Zhao Peng, 2013, JAKSTAT, V2, pe23092, DOI 10.4161/jkst.23092	66	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261783	10.1371/journal.pone.0261783	http://dx.doi.org/10.1371/journal.pone.0261783			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972124	Green Published, gold			2022-12-27	WOS:000773555700054
J	Jennings, S; Lumpkin, D; Warnock, N; Condeso, TE; Kelly, JP				Jennings, Scott; Lumpkin, David; Warnock, Nils; Condeso, T. Emiko; Kelly, John P.			Great egret (Ardea alba) habitat selection and foraging behavior in a temperate estuary: Comparing natural wetlands to areas with shellfish aquaculture	PLOS ONE			English	Article							WADING BIRDS; EELGRASS; ACCELERATION; AVAILABILITY; ENERGETICS; MOVEMENT; ANIMALS; HERONS; BAY	Movement by animals to obtain resources and avoid predation often depends on natural cycles, and human alteration of the landscape may disrupt or enhance the utility of different habitats or resources to animals through the phases of these cycles. We studied habitat selection by GPS/accelerometer-tagged great egrets (Ardea alba) foraging in areas with shellfish aquaculture infrastructure and adjacent natural wetlands, while accounting for tide-based changes in water depth. We used integrated step selection analysis to test the prediction that egrets would express stronger selection for natural wetlands (eelgrass, tidal marsh, and other tidal wetlands) than for shellfish aquaculture areas. We also evaluated differences in foraging behavior among shellfish aquaculture areas and natural wetlands by comparing speed travelled (estimated from distance between GPS locations) and energy expended (Overall Dynamic Body Acceleration) while foraging. We found evidence for stronger overall habitat selection for eelgrass than for shellfish aquaculture areas, with results conditional on water depth: egrets used shellfish aquaculture areas, but only within a much narrower range of water depths than they used eelgrass and other natural wetlands. We found only slight differences in our metrics of foraging behavior among shellfish aquaculture areas and natural wetlands. Our results suggest that although great egrets appear to perceive or experience shellfish aquaculture areas as suitable foraging habitat during some conditions, those areas provide less foraging opportunity throughout tidal cycles than natural wetlands. Thus, expanding the footprint of shellfish aquaculture into additional intertidal areas may reduce foraging opportunities for great egrets across the range of tidal cycles. Over longer time scales, the ways in which natural wetlands and shellfish aquaculture areas adapt to rising sea levels (either through passive processes or active management) may change the ratios of these wetland types and consequently change the overall value of Tomales Bay to foraging great egrets.	[Jennings, Scott; Lumpkin, David; Warnock, Nils; Condeso, T. Emiko; Kelly, John P.] Audubon Canyon Ranch, Cypress Grove Res Ctr, Marshall, CA 94940 USA		Jennings, S (corresponding author), Audubon Canyon Ranch, Cypress Grove Res Ctr, Marshall, CA 94940 USA.	scott.jennings@egret.org		Jennings, Scott/0000-0002-4922-9661				Allen AM, 2016, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00155; Avgar T, 2016, METHODS ECOL EVOL, V7, P619, DOI 10.1111/2041-210X.12528; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beerens JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128182; Botson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158864; Brzorad JN, 2004, J FIELD ORNITHOL, V75, P266, DOI 10.1648/0273-8570-75.3.266; Brzorad JN, 2014, WATERBIRDS, V37, P335, DOI 10.1675/063.037.0312; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Burr PC, 2020, CONDOR, V122, DOI 10.1093/condor/duaa036; California Department of Fish and Wildlife, TOM BAY SHELLF UNPUB; Calle L, 2018, ECOL MONOGR, V88, P600, DOI 10.1002/ecm.1305; Calle L, 2016, AUK, V133, P378, DOI 10.1642/AUK-15-234.1; Cruz SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056889; CUSTER TW, 1978, AUK, V95, P733; Doherty TS, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2272; Dumbauld BR, 2009, AQUACULTURE, V290, P196, DOI 10.1016/j.aquaculture.2009.02.033; ESRI, 2021, ARCGIS PRO; Fair J., 2010, ORNITHOLOGICAL COUNC; Fieberg J., 2020, HOW TO GUIDE INTERPR, DOI [10.1101/2020.11.12.379834, DOI 10.1101/2020.11.12.379834]; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Gorenzel WP., 1994, HDB PREV CONTROL WIL, V57; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; Huang AC, 2015, OIKOS, V124, P1492, DOI 10.1111/oik.01988; Hughes BB., 2014, NURSERY FUNCTIONS US, P168; Hughes BB, 2013, P NATL ACAD SCI USA, V110, P15313, DOI 10.1073/pnas.1302805110; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kelley D., 2020, **DATA OBJECT**; Kelly JP, 2008, WETLANDS, V28, P257, DOI 10.1672/07-152.1; Kelly JP, 1996, CALIF FISH GAME, V82, P160; Lantz SM, 2011, WATERBIRDS, V34, P439, DOI 10.1675/063.034.0406; Maccarone AD, 2002, WATERBIRDS, V25, P1, DOI 10.1675/1524-4695(2002)025[0001:FPOBEA]2.0.CO;2; Maccarone AD, 2007, J FIELD ORNITHOL, V78, P411, DOI 10.1111/j.1557-9263.2007.00133.x; Manly B.F.J., 2002, RESOURCE SELECTION A; Marin County, 2018, MAR MAP LIDAR DEM VE; Marin County, 2018, MAR COUNT ORTH IM; McCrimmon DAJ., 2020, BIRDS WORLD; Muff S, 2020, J ANIM ECOL, V89, P80, DOI 10.1111/1365-2656.13087; National Centers for Environmental Information N, 2018, NOAA NOS EST BATH TO; National Oceanic and Atmospheric Association, 2014, W COAST REG CAL EELG; Noonan MJ, 2019, MOV ECOL, V7, DOI 10.1186/s40462-019-0177-1; Norevik G, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000456; Paton RS, 2016, ECOLOGY, V97, P1113, DOI 10.1890/14-2241.1; Plummer ML, 2013, ECOSYSTEMS, V16, P237, DOI 10.1007/s10021-012-9609-0; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Ranacher P, 2016, INT J GEOGR INF SCI, V30, P316, DOI 10.1080/13658816.2015.1086924; Rohr ME, 2018, GLOBAL BIOGEOCHEM CY, V32, P1457, DOI 10.1029/2018GB005941; San Francisco Estuary Institute, 2017, CAL AQ RES INV CARI; San Francisco Estuary Institute, 2017, EELGR SURV GIS DAT V; Signer J, 2019, ECOL EVOL, V9, P880, DOI 10.1002/ece3.4823; Stolen ED, 2012, CONDOR, V114, P744, DOI 10.1525/cond.2012.110159; Teitelbaum CS, 2020, MOV ECOL, V8, DOI 10.1186/s40462-020-00233-7; Tucker MA, 2018, SCIENCE, V359, P466, DOI 10.1126/science.aam9712; Van Moorter B, 2016, J ANIM ECOL, V85, P21, DOI 10.1111/1365-2656.12394; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Zarnoch CB, 2017, MAR POLLUT BULL, V124, P376, DOI 10.1016/j.marpolbul.2017.07.061; Zuur Alain F., 2009, P1	57	0	0	8	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261963	10.1371/journal.pone.0261963	http://dx.doi.org/10.1371/journal.pone.0261963			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972178	Green Published, gold			2022-12-27	WOS:000773555700077
J	Lee, JW; Sohn, SY				Lee, Jong Wook; Sohn, So Young			Evaluating borrowers' default risk with a spatial probit model reflecting the distance in their relational network	PLOS ONE			English	Article							CREDIT RISK; SOFT INFORMATION; SCORING MODEL; REGRESSION; PREDICTION; TEXT	Potential relationship among loan applicants can provide valuable information for evaluating default risk. However, most of the existing credit scoring models either ignore this relationship or consider a simple connection information. This study assesses the applicants' relation in terms of their distance estimated based on their characteristics. This information is then utilized in a proposed spatial probit model to reflect the different degree of borrowers' relation on the default prediction of loan applicant. We apply this method to peer-to-peer Lending Club Loan data. Empirical results show that the consideration of information on the spatial autocorrelation among loan applicants can provide high predictive power for defaults.	[Lee, Jong Wook; Sohn, So Young] Yonsei Univ, Dept Informat & Ind Engn, Seoul, South Korea	Yonsei University	Sohn, SY (corresponding author), Yonsei Univ, Dept Informat & Ind Engn, Seoul, South Korea.	sohns@yonsei.ac.kr		Sohn, So Young/0000-0002-3958-2269	National Research Foundation of Korea (NRF) - Korea government (MSIT) [2020R1A2C2005026]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2020R1A2C2005026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou HA, 2011, INTELL SYST ACCOUNT, V18, P59, DOI 10.1002/isaf.325; Agosto A, 2019, FRONT ARTIF INTELL, V2, DOI 10.3389/frai.2019.00006; Ahmad A, 2007, DATA KNOWL ENG, V63, P503, DOI 10.1016/j.datak.2007.03.016; Angilella S, 2015, EUR J OPER RES, V244, P540, DOI 10.1016/j.ejor.2015.01.033; ANSELIN L, 1988, GEOGR ANAL, V20, P1, DOI 10.1111/j.1538-4632.1988.tb00159.x; Calabrese R, 2017, J OPER RES SOC, V68, P1503, DOI 10.1057/s41274-017-0189-4; Calabrese R, 2014, J REGIONAL SCI, V54, P664, DOI 10.1111/jors.12116; Crook JN, 2007, EUR J OPER RES, V183, P1447, DOI 10.1016/j.ejor.2006.09.100; Dorfleitner G, 2016, J BANK FINANC, V64, P169, DOI 10.1016/j.jbankfin.2015.11.009; Emekter R, 2015, APPL ECON, V47, P54, DOI 10.1080/00036846.2014.962222; Harris T, 2013, EXPERT SYST APPL, V40, P4404, DOI 10.1016/j.eswa.2013.01.044; Jeon HJ, 2008, J OPER RES SOC, V59, P1624, DOI 10.1057/palgrave.jors.2602506; Jiang CQ, 2018, ANN OPER RES, V266, P511, DOI 10.1007/s10479-017-2668-z; Ju Y, 2015, J OPER RES SOC, V66, P463, DOI 10.1057/jors.2014.10; Kelejian HH, 1998, J REAL ESTATE FINANC, V17, P99, DOI 10.1023/A:1007707430416; Kim Y, 2007, J OPER RES SOC, V58, P1341, DOI 10.1057/palgrave.jors.2602306; Klier T, 2008, J BUS ECON STAT, V26, P460, DOI 10.1198/073500107000000188; Kotsiantis S., 2003, ANN MATH COMPUT TELE, V1, P46; Kruppa J, 2012, HUM GENET, V131, P1639, DOI 10.1007/s00439-012-1194-y; Li W, 2018, IEEE ACCESS, V6, P54396, DOI 10.1109/ACCESS.2018.2810864; Li ZY, 2017, EXPERT SYST APPL, V74, P105, DOI 10.1016/j.eswa.2017.01.011; Lin XC, 2017, APPL ECON, V49, P3538, DOI 10.1080/00036846.2016.1262526; Longadge Rushi, 2013, INT J COMPUT SCI NET; Ma ZW, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255216; Malekipirbazari M, 2015, EXPERT SYST APPL, V42, P4621, DOI 10.1016/j.eswa.2015.02.001; Oskarsdottir M, 2019, APPL SOFT COMPUT, V74, P26, DOI 10.1016/j.asoc.2018.10.004; Paul S, 2014, MARGIN, V8, P59, DOI 10.1177/0973801013506401; Pinkse J, 1998, J ECONOMETRICS, V85, P125, DOI 10.1016/S0304-4076(97)00097-3; Serrano-Cinca C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139427; Sohn SY, 2012, J OPER RES SOC, V63, P1051, DOI 10.1057/jors.2011.105; Szwabe A, 2018, COMM COM INF SC, V928, P207, DOI 10.1007/978-3-319-99987-6_16; Verbeek M., 2008, GUIDE MODERN ECONOME, V3rd ed.; Wei Y, 2016, MARKET SCI, V35, P234, DOI 10.1287/mksc.2015.0949; Yao X, 2015, EUR J OPER RES, V240, P528, DOI 10.1016/j.ejor.2014.06.043; Zeng XX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184242	36	0	0	8	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261737	10.1371/journal.pone.0261737	http://dx.doi.org/10.1371/journal.pone.0261737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972129	Green Published, gold			2022-12-27	WOS:000773555700050
J	Midthassel, TC; Hansen, AH				Midthassel, Tiki Celine; Hansen, Anne Helen			Are lifestyle changes from online information associated with discussing the information with a doctor? A cross -sectional study	PLOS ONE			English	Article							NUTRITION THERAPY; PHYSICAL-ACTIVITY; RISK-FACTOR; MORTALITY; ADULTS; INTERVENTIONS; PREDICTORS; TYPE-1	Background The prevalence of diabetes and the use of electronic health (eHealth) are increasing. Lifestyle changes in a positive direction may reduce morbidity and mortality in patients with diabetes. The main objective of this study was to test the association between lifestyle changes based on online information seeking and discussing the information with a doctor. Methods In this cross-sectional study we used e-mail survey data from 1250 members of The Norwegian Diabetes Association, collected in 2018. Included in the analyses were 847 men and women aged 18 to 89 years diagnosed with diabetes and who reported use of eHealth within the previous year. We used descriptive statistics to estimate lifestyle changes based on information from the internet. Logistic regressions were used to estimate the associations between lifestyle changes after online information seeking and discussing the information with a doctor. Analyses were adjusted for gender, age, education, and self-rated health. Results Lifestyle changes accomplished after online information seeking was reported by 46.9% (397/847) of the participants. The odds of changing lifestyle were more than doubled for those who had discussed information from the internet with a doctor (odds ratio 2.54, confidence interval 1.90-3.40). The odds of lifestyle changes were lower in the age groups 30-39 years and 60 years and over, compared to those aged 18-29 years (the reference group). Lifestyle changes were not associated with gender, education, or self-rated health. Conclusions Our findings indicate that health-care professionals can play an important role in lifestyle changes additional to health-advice found on the internet. This study underlines the importance of easily accessible high-quality online information, as well as the importance of making room for discussing lifestyle in the clinical encounter.	[Midthassel, Tiki Celine; Hansen, Anne Helen] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Hansen, Anne Helen] Univ Hosp North Norway, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Hansen, AH (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway.; Hansen, AH (corresponding author), Univ Hosp North Norway, Tromso, Norway.	anne.h.hansen@uit.no		Hansen, Anne Helen/0000-0002-2731-6916				Afshin A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003058; Alvarez-Galvez J, 2020, INT J PUBLIC HEALTH, V65, P325, DOI 10.1007/s00038-020-01363-w; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS38, DOI 10.2337/dc18-S004; Andreassen HK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-53; [Anonymous], 2018, DIABETES CARE, V41, pS1, DOI [10.2337/dc18-Sint01, 10.2337/dc18-SINT01]; Beck F, 2014, J MED INTERNET RES, V16, P193, DOI 10.2196/jmir.2934; Brandt CJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017466; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Chimen M, 2012, DIABETOLOGIA, V55, P542, DOI 10.1007/s00125-011-2403-2; Church TS, 2005, ARCH INTERN MED, V165, P2114, DOI 10.1001/archinte.165.18.2114; Civljak M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub4; Cooper John G, 2013, Tidsskr Nor Laegeforen, V133, P2257, DOI 10.4045/tidsskr.13.0153; Department of Information Science and Media Studies University of Bergen, MED NORW FACTS FIG N; Dutton GR, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0442-0; Evert AB, 2013, DIABETES CARE, V36, P3821, DOI 10.2337/dc13-2042; Fox Susannah, 2013, PEW RES INTERNET PRO; Franz MJ, 2010, J AM DIET ASSOC, V110, P1852, DOI 10.1016/j.jada.2010.09.014; Gregg EW, 2003, ARCH INTERN MED, V163, P1440, DOI 10.1001/archinte.163.12.1440; Hallan SI, 2011, KIDNEY INT, V80, P516, DOI 10.1038/ki.2011.157; Hansen AH, 2019, J MED INTERNET RES, V21, DOI 10.2196/13615; Hansen AH, 2018, J MED INTERNET RES, V20, DOI 10.2196/11322; Hong YA, 2017, J GERONTOL B-PSYCHOL, V72, P856, DOI 10.1093/geronb/gbw100; Hu G, 2005, DIABETES CARE, V28, P799, DOI 10.2337/diacare.28.4.799; International Diabetes Federation, 2019, IDF DIABETES ATLAS, V9th ed.; Jenssen TG, 2008, DIABETES RES CLIN PR, V80, P314, DOI 10.1016/j.diabres.2007.12.025; Joiner KL, 2017, PREV MED, V100, P194, DOI 10.1016/j.ypmed.2017.04.033; Kennedy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058861; Komkova Anastasija, 2019, JMIR Diabetes, V4, pe12140, DOI 10.2196/12140; Kontos Emily, 2014, J Med Internet Res, V16, pe172, DOI 10.2196/jmir.3117; Kummervold PE, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1023; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Li JH, 2016, HEALTH INFORM J, V22, P804, DOI 10.1177/1460458215595851; McCully SN, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2612; Medlock S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3749; Mouland G., 2014, DIABETES FASTLEGEPRA, V134, DOI [10.4045/tidsskr.13.0375, DOI 10.4045/TIDSSKR.13.0375]; Nolke L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1423-0; Norwegian Diabetes Association, 2018, VEIV GOD EG DIAB; Norwegian Directorate of Health, 2018, NASJONAL FAGLIG RETN; Norwegian Institute of Public Health, 2019, NORW PRESCR DAT; Norwegian Institute of Public Health, 2018, PUBL HLTH REP HLTH S; Norwegian Institute of Public Health, 2017, BURD DIS NORW 2015; Pinchevsky Y, 2015, CARDIOVASC J AFR, V26, P188, DOI 10.5830/CVJA-2015-050; Sandahl K, 2017, DIABETIC MED, V34, P380, DOI 10.1111/dme.13124; Sorensen T., 2014, PROSJEKTRAPPORT E HE; Statistics Norway, ICT US HOUS 2017; Statistics Norway, ED LEV POL 2020; Strom H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-520; Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347; Tang J, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2857; The Norwegian Diabetes Association, 2018, ARSB 2017; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; van den Berg MH, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e26; Wangberg SC., 2015, USING INTERNET SUPPO, pe3; Wangberg S, 2009, SCAND J CARING SCI, V23, P691, DOI 10.1111/j.1471-6712.2008.00662.x; Wantland DJ, 2004, J MED INTERNET RES, V6, P67; Webb TL, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1376; World Health Organization, EHEALTH WHO; YUDKIN JS, 1993, BMJ-BRIT MED J, V306, P1313, DOI 10.1136/bmj.306.6888.1313	59	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261471	10.1371/journal.pone.0261471	http://dx.doi.org/10.1371/journal.pone.0261471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972136	gold, Green Published			2022-12-27	WOS:000773555700035
J	Nightingale, GF; Williams, AJ; Hunter, RF; Woodcock, J; Turner, K; Cleland, CL; Baker, G; Kelly, M; Cope, A; Kee, F; Milton, K; Foster, C; Jepson, R; Kelly, P				Nightingale, Glenna F.; Williams, Andrew James; Hunter, Ruth F.; Woodcock, James; Turner, Kieran; Cleland, Claire L.; Baker, Graham; Kelly, Michael; Cope, Andy; Kee, Frank; Milton, Karen; Foster, Charlie; Jepson, Ruth; Kelly, Paul			Evaluating the citywide Edinburgh 20mph speed limit intervention effects on traffic speed and volume: A pre-post observational evaluation	PLOS ONE			English	Article							20 MPH	Objectives Traffic speed is important to public health as it is a major contributory factor to collision risk and casualty severity. 20mph (32km/h) speed limit interventions are an increasingly common approach to address this transport and health challenge, but a more developed evidence base is needed to understand their effects. This study describes the changes in traffic speed and traffic volume in the City of Edinburgh, pre- and 12 months post-implementation of phased city-wide 20mph speed limits from 2016-2018. Methods The City of Edinburgh Council collected speed and volume data across one full week (24 hours a day) pre- and post-20mph speed limits for 66 streets. The pre- and post-speed limit intervention data were compared using measures of central tendency, dispersion, and basic t-tests. The changes were assessed at different aggregations and evaluated for statistical significance (alpha = 0.05). A mixed effects model was used to model speed reduction, in the presence of key variables such as baseline traffic speed and time of day. Results City-wide, a statistically significant reduction in mean speed of 1.34mph (95% CI 0.95 to 1.72) was observed at 12 months post-implementation, representing a 5.7% reduction. Reductions in speed were observed throughout the day and across the week, and larger reductions in speed were observed on roads with higher initial speeds. Mean 7-day volume of traffic was found to be lower by 86 vehicles (95% CI: -112 to 286) representing a reduction of 2.4% across the city of Edinburgh (p = 0.39) but with the direction of effect uncertain. Conclusions The implementation of the city-wide 20mph speed limit intervention was associated with meaningful reductions in traffic speeds but not volume. The reduction observed in road traffic speed may act as a mechanism to lessen the frequency and severity of collisions and casualties, increase road safety, and improve liveability.	[Nightingale, Glenna F.; Turner, Kieran; Jepson, Ruth] Univ Edinburgh, Sch Hlth Social Sci, Scottish Collaborat Publ Hlth Res SCPHRP, Edinburgh, Midlothian, Scotland; [Williams, Andrew James] Univ St Andrews, Populat & Behav Sci, Sch Med, St Andrews, Fife, Scotland; [Hunter, Ruth F.; Cleland, Claire L.; Kee, Frank] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Woodcock, James; Kelly, Michael] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Turner, Kieran; Baker, Graham; Kelly, Paul] Univ Edinburgh, Inst Sport Phys Educ & Hlth Sci, Phys Act Hlth Res Ctr PAHRC, Edinburgh, Midlothian, Scotland; [Cope, Andy] Sustrans, Cathedral Sq, Bristol, Avon, England; [Milton, Karen] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Foster, Charlie] Univ Bristol, Bristol, Avon, England	University of Edinburgh; University of St Andrews; Queens University Belfast; University of Cambridge; University of Edinburgh; University of East Anglia; University of Bristol	Nightingale, GF (corresponding author), Univ Edinburgh, Sch Hlth Social Sci, Scottish Collaborat Publ Hlth Res SCPHRP, Edinburgh, Midlothian, Scotland.	glenna.evans@gmail.com		Foster, Charlie/0000-0002-5041-0601; Baker, Graham/0000-0002-9547-6778; Nightingale, Glenna/0000-0002-0110-3939; Cope, Andy/0000-0001-8506-5054	National Institute for Health Research (NIHR) Public Health Research (PHR) [15/82/12]; National Institute for Health Research (NIHR)	National Institute for Health Research (NIHR) Public Health Research (PHR); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	The 'Is 20 plenty for health?' project is funded by a National Institute for Health Research (NIHR) Public Health Research (PHR) grant 15/82/12. This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health and Social Care. The funding was awarded to: Professor Ruth Jepson (PI) of Edinburgh University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, BRISTOL 20 MILES PER; Atkins, 2010, INTERIM EVALUATION I; Atkins Maher M, 2018, 20MPH RES STUDY PROC; Bornioli A, 2018, J TRANSP HEALTH, V11, P47, DOI 10.1016/j.jth.2018.09.009; Cairns J, 2015, J PUBLIC HEALTH-UK, V37, P515, DOI 10.1093/pubmed/fdu067; Cleland C., 2019, J TRANSPORT HLTH; Cleland CL., 2021, HEALTH PLACE, V70, DOI [10.1016/j.healthplace.2021.102627, DOI 10.1016/J.HEALTHPLACE.2021.102627]; Edinburgh City Council, 2014, DEL LOC TRANSP STRAT; Edinburgh City Council, 2019, EV 20MPH SPEED LIM R; Edinburgh City Council, 2016, OBJ TRAFF REG ORD TR; Edinburgh City Council, 2015, DEL LOC TRANSP STRAT; Elvik R, 2019, ACCIDENT ANAL PREV, V125, P63, DOI 10.1016/j.aap.2019.01.033; European Commission, SPEED INJ RISK DIFF; GBD Compare, 2021, VIZ HUB; Manchester City Council, 2017, REP RES EV PHAS 1 2; Milton K, 2021, J TRANSP HEALTH, V22, DOI 10.1016/j.jth.2021.101141; National Institute for Health and Care Excellence, 2017, AIR POLL OUTD AIR QU; National Institute for Health Research, 2017, IS 20 PLENT HLTH EV; Popov V, 2021, ENVIRON PLAN B-URBAN, V48, P2590, DOI 10.1177/2399808320985524; Scottish Government, 2020, RIAGH ALB; Tapp A, 2016, TRANSPORT RES A-POL, V91, P195, DOI 10.1016/j.tra.2016.06.007; Tapp A, 2015, TRANSPORT RES F-TRAF, V31, P36, DOI 10.1016/j.trf.2015.03.002; Taylor M.C., 2000, EFFECTS DRIVERS SPEE; Toy S, 2014, J TRANSP HEALTH, V1, P165, DOI 10.1016/j.jth.2014.05.003; Turner K, 2018, J TRANSP HEALTH, V10, P92, DOI 10.1016/j.jth.2018.08.004; VIS AA, 1992, ACCIDENT ANAL PREV, V24, P75, DOI 10.1016/0001-4575(92)90074-S; Webster DC, 1996, REV TRAFFIC CALMING; WHO, 2009, EUROPEAN HEALTH REPORT 2009: HEALTH AND HEALTH SYSTEMS, P1; WHO, 2018, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248; Williams AJ, 2021, PUBLIC ATTITUDES PER	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261383	10.1371/journal.pone.0261383	http://dx.doi.org/10.1371/journal.pone.0261383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972123	gold, Green Published, Green Accepted			2022-12-27	WOS:000773555700031
J	Ong, CE; Ahmad, R; Goh, YK; Azizan, KA; Baharum, SN; Goh, KJ				Ong, Cu Ean; Ahmad, Rafidah; Goh, You Keng; Azizan, Kamalrul Azlan; Baharum, Syarul Nataqain; Goh, Kah Joo			Growth modulation and metabolic responses of Ganoderma boninense to salicylic acid stress	PLOS ONE			English	Article							BASAL STEM ROT; PALM ELAEIS-GUINEENSIS; OIL PALM; ROOT INFECTION; CAUSAL AGENT; BIOSYNTHESIS; PATHWAYS; FUNGAL; DEGRADATION; VIRULENCE	Various phenolic compounds have been screened against Ganoderma boninense, the fungal pathogen causing basal stem rot in oil palms. In this study, we focused on the effects of salicylic acid (SA) on the growth of three G. boninense isolates with different levels of aggressiveness. In addition, study on untargeted metabolite profiling was conducted to investigate the metabolomic responses of G. boninense towards salicylic acid. The inhibitory effects of salicylic acid were both concentration- (P < 0.001) and isolate-dependent (P < 0.001). Also, growth-promoting effect was observed in one of the isolates at low concentrations of salicylic acid where it could have been utilized by G. boninense as a source of carbon and energy. Besides, adaptation towards salicylic acid treatment was evident in this study for all isolates, particularly at high concentrations. In other words, inhibitory effect of salicylic acid treatment on the fungal growth declined over time. In terms of metabolomics response to salicylic acid treatment, G. boninense produced several metabolites such as coumarin and azatyrosine, which suggests that salicylic acid modulates the developmental switch in G. boninense towards the defense mode for its survival. Furthermore, the liquid chromatography time-of-flight mass spectrometry (LC-TOF-MS) analysis showed that the growth of G. boninense on potato dextrose agar involved at least four metabolic pathways: amino acid metabolism, lipid pathway, tryptophan pathway and phenylalanine pathway. Overall, there were 17 metabolites that contributed to treatment separation, each with P<0.005. The release of several antimicrobial metabolites such as eudistomin I may enhance G. boninense's competitiveness against other microorganisms during colonisation. Our findings demonstrated the metabolic versatility of G. boninense towards changes in carbon sources and stress factors. G. boninense was shown to be capable of responding to salicylic acid treatment by switching its developmental stage.	[Ong, Cu Ean; Goh, You Keng; Goh, Kah Joo] Adv Agriecol Res Sdn Bhd, Petaling Jaya, Selangor, Malaysia; [Ahmad, Rafidah; Azizan, Kamalrul Azlan; Baharum, Syarul Nataqain] Univ Kebangsaan Malaysia, Inst Syst Biol INBIOSIS, Metabol Res Lab, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Ong, CE (corresponding author), Adv Agriecol Res Sdn Bhd, Petaling Jaya, Selangor, Malaysia.; Baharum, SN (corresponding author), Univ Kebangsaan Malaysia, Inst Syst Biol INBIOSIS, Metabol Res Lab, Bangi, Selangor, Malaysia.	ongce@aarsb.com.my; nataqain@ukm.edu.my		Ong, Cu Ean/0000-0003-2154-7139	Centre for Research and Instrumentation Management (CRIM), UKM; AAR [RB-2015-002]	Centre for Research and Instrumentation Management (CRIM), UKM; AAR	We acknowledge the Centre for Research and Instrumentation Management (CRIM), UKM for the Research Instrumentation Development Grants awarded in 2010 and 2013 (PIP-CRIM). The authors are grateful to AAR Principals, Boustead Plantations Berhad and Kuala Lumpur Kepong Berhad, for funding this research under the grant number RB-2015-002, and for their permission to publish the data presented in this paper.	Ahmad R., 2016, INT J PHARMACOGN PHY, V8, P1986; Ahmad R, 2020, MOLECULES, V25, DOI 10.3390/molecules25245965; Ahmed W, 2016, APPL ENVIRON MICROB, V82, P1316, DOI 10.1128/AEM.03765-15; Akone SH, 2016, TETRAHEDRON, V72, P6340, DOI 10.1016/j.tet.2016.08.022; Arasimowicz-Jelonek M, 2014, MOL PLANT PATHOL, V15, P406, DOI 10.1111/mpp.12095; Badawy AAB, 2017, INT J TRYPTOPHAN RES, V10, DOI 10.1177/1178646917691938; Beals KA, 2019, AM J POTATO RES, V96, P102, DOI 10.1007/s12230-018-09705-4; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; Bivi M. R., 2012, African Journal of Biotechnology, V11, P13477; Bivi MSHR, 2016, PLANT PATHOLOGY J, V32, P396, DOI 10.5423/PPJ.OA.03.2016.0052; Bomprezzi R, 2015, THER ADV NEUROL DISO, V8, P20, DOI 10.1177/1756285614564152; Bubols GB, 2013, MINI-REV MED CHEM, V13, P318; Cheemanapalli S, 2018, BIOMED PHARMACOTHER, V108, P547, DOI 10.1016/j.biopha.2018.09.069; Chong K., 2010, ROLE PHENOLICS INTER; Chong KP, 2012, PLANT PATHOL, V61, P953, DOI 10.1111/j.1365-3059.2011.02577.x; Cooper R. M., 2011, Planter, V87, P515; Cooper RM, 1984, PLANT DIS INFECT DAM, P13; Corley RHV, 2016, WORLD AGRIC SER, P399; Costa TM, 2016, APPL MICROBIOL BIOT, V100, P6571, DOI 10.1007/s00253-016-7660-z; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Feys BJ, 2000, TRENDS GENET, V16, P449, DOI 10.1016/S0168-9525(00)02107-7; Fiskesund R, 2010, PLANTA MED, V76, P1635, DOI 10.1055/s-0030-1250120; Garbe E, 2019, CURR CLIN MICROBIOL, V6, P108, DOI 10.1007/s40588-019-00124-5; Garzon CD, 2011, PLANT DIS, V95, P1233, DOI 10.1094/PDIS-09-10-0693; Georgiou CD, 2000, MYCOLOGIA, V92, P825, DOI 10.2307/3761577; Gnonlonfin GJB, 2012, CRIT REV PLANT SCI, V31, P47, DOI 10.1080/07352689.2011.616039; Goto K, 2018, BIOORGAN MED CHEM, V26, P3763, DOI 10.1016/j.bmc.2017.11.041; Haniff M. H., 2005, Asian Journal of Plant Sciences, V4, P438; Harborne J.B., 1984, PHYTOCHEMICAL METHOD, DOI [10.1007/978-94-009-5570-7_2, DOI 10.1007/978-94-009-5570-7_2]; Hyun Min Woo, 2011, Mycobiology, V39, P257, DOI 10.5941/MYCO.2011.39.4.257; INOUYE S, 1975, CHEM PHARM BULL, V23, P2669; IZAWA M, 1992, CANCER RES, V52, P1628; Jayawickrama GS, 2015, CURR MED CHEM, V22, P2902, DOI 10.2174/0929867322666150608094054; Jiang N., 2021, FRONT MICROBIOL, V12, P1; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Knabe N, 2013, EUKARYOT CELL, V12, P941, DOI 10.1128/EC.00355-12; Kok SM, 2013, MALAYS J MICROBIOL, V9, P33, DOI 10.21161/mjm.45212; Kues U, 2000, APPL MICROBIOL BIOT, V54, P141, DOI 10.1007/s002530000396; Kunkel BN, 2018, J EXP BOT, V69, P245, DOI 10.1093/jxb/erx447; Laila Naher, 2013, Australian Journal of Crop Science, V7, P1723; Leung GSW, 2000, MOL GEN GENET, V262, P977, DOI 10.1007/PL00008666; Li E, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw198; Li X, 2015, J FLOW CHEM, V5, P82, DOI 10.1556/1846.2014.00043; Lim CK, 2018, SAINS MALAYS, V47, P3061, DOI 10.17576/jsm-2018-4712-16; Liu R, 2018, REDOX BIOL, V16, P388, DOI 10.1016/j.redox.2018.03.018; Lu X, 2015, NEW PHYTOL, V206, P295, DOI 10.1111/nph.13187; Miles E., 1987, BIOCH VITAMIN B6, P73; MISHRA AK, 1994, APPL ENVIRON MICROB, V60, P1101, DOI 10.1128/AEM.60.4.1101-1105.1994; Ntushelo Khayalethu, 2017, Pak J Biol Sci, V20, P278, DOI 10.3923/pjbs.2017.278.288; Ong Cu Ean, 2018, Archives of Phytopathology and Plant Protection, V51, P122, DOI 10.1080/03235408.2018.1439870; Paterson RRM, 2007, CROP PROT, V26, P1369, DOI 10.1016/j.cropro.2006.11.009; Patten CL, 2013, CRIT REV MICROBIOL, V39, P395, DOI 10.3109/1040841X.2012.716819; Perkin W. H. VI., 1868, J CHEM SOC, V21, P53, DOI [10.1039/JS8682100053, DOI 10.1039/JS8682100053]; Phillips AJ, 2006, P NATL ACAD SCI USA, V103, P726, DOI 10.1073/pnas.0506405103; Qi G, 2018, MOL PLANT, V11, P1427, DOI 10.1016/j.molp.2018.10.002; Qi PF, 2012, FUNGAL BIOL-UK, V116, P413, DOI 10.1016/j.funbio.2012.01.001; Rabe F, 2013, MOL MICROBIOL, V89, P179, DOI 10.1111/mmi.12269; Ramzi AB, 2019, PEERJ, V7, DOI 10.7717/peerj.8065; Rees RW, 2007, PLANT PATHOL, V56, P862, DOI 10.1111/j.1365-3059.2007.01621.x; Rees RW, 2009, PLANT PATHOL, V58, P982, DOI 10.1111/j.1365-3059.2009.02100.x; RINEHART KL, 1987, J AM CHEM SOC, V109, P3378, DOI 10.1021/ja00245a031; Saito K, 2000, BIOSCI BIOTECH BIOCH, V64, P1321, DOI 10.1271/bbb.64.1321; Schulz H., 1888, PFLUGERS ARCH GES PH, V42, P517, DOI DOI 10.1007/BF01669373; Schulz H., 1887, VIRCHOWS ARCH, V108, P423, DOI [DOI 10.1007/BF02281473, 10.1515/9783112369043-025, DOI 10.1515/9783112369043-025]; SHINDOOKADA N, 1989, MOL CARCINOGEN, V2, P159, DOI 10.1002/mc.2940020309; SKIDMORE AM, 1976, T BRIT MYCOL SOC, V66, P57, DOI 10.1016/S0007-1536(76)80092-7; Southam CM, 1943, PHYTOPATHOLOGY, V33, P517; Surendran A, 2018, IND CROP PROD, V122, P358, DOI 10.1016/j.indcrop.2018.06.005; Sy-Cordero AA, 2012, J ANTIBIOT, V65, P541, DOI 10.1038/ja.2012.71; THOMPSON DP, 1989, MYCOLOGIA, V81, P151, DOI 10.2307/3759462; Tohge T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00062; Tomas-Gallardo L, 2014, MICROB BIOTECHNOL, V7, P100, DOI 10.1111/1751-7915.12096; Turner, 1981, OIL PALM DIS DISORDE; Tzin V, 2010, MOL PLANT, V3, P956, DOI 10.1093/mp/ssq048; Umetrics M., 2002, USER GUIDE TO SIMCA, DOI [10.1023/a:1022450725545, DOI 10.1023/A:1022450725545]; Veeramohan R, 2018, DATA BRIEF, V18, P1212, DOI 10.1016/j.dib.2018.04.001; VILAMBI NRK, 1987, J ELECTROCHEM SOC, V134, P3074, DOI 10.1149/1.2100342; Wachtel-Galor S., 2011, HERBAL MED BIOMOLECU, V2nd; Ward G., 2004, Fungal biotechnology in agricultural, food, and environmental applications, P393; Weingart H, 2001, PHYTOPATHOLOGY, V91, P511, DOI 10.1094/PHYTO.2001.91.5.511; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wichrowska D, 2009, POL J ENVIRON STUD, V18, P487; Xiao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29026; Yamamoto T, 1999, J BIOCHEM-TOKYO, V126, P799, DOI 10.1093/oxfordjournals.jbchem.a022519; Ye LY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196287; Yeoh HockHin, 1996, Tropical Science, V36, P243; You BJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00281-x; You BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053616	88	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262029	10.1371/journal.pone.0262029	http://dx.doi.org/10.1371/journal.pone.0262029			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972183	gold, Green Published			2022-12-27	WOS:000773555700085
J	Sahile, Z; Perimal-Lewis, L; Arbon, P; Maeder, AJ				Sahile, Zekariyas; Perimal-Lewis, Lua; Arbon, Paul; Maeder, Anthony John			Protocol of a parallel group Randomized Control Trial (RCT) for Mobile-assisted Medication Adherence Support (Ma-MAS) intervention among Tuberculosis patients	PLOS ONE			English	Article							ANTITUBERCULOSIS TREATMENT; ANTIRETROVIRAL THERAPY; TREATMENT NONADHERENCE; VALIDATION; MODEL	Background Non-adherence to Tuberculosis (TB) medication is a serious threat to TB prevention and control programs, especially in resource-limited settings. The growth of the popularity of mobile phones provides opportunities to address non-adherence, by facilitating direct communication more frequently between healthcare providers and patients through SMS texts and voice phone calls. However, the existing evidence is inconsistent about the effect of SMS interventions on TB treatment adherence. Such interventions are also seldom developed based on appropriate theoretical foundations. Therefore, there is a reason to approach this problem more rigorously, by developing the intervention systematically with evidence-based theory and conducting the trial with strong measurement methods. Methods This study is a single-blind parallel-group design individual randomized control trial. A total of 186 participants (93 per group) will be individually randomized into one of the two groups with a 1:1 allocation ratio by a computer-generated algorithm. Group one (intervention) participants will receive daily SMS texts and weekly phone calls concerning their daily medication intake and medication refill clinic visit reminder and group two (control) participants will receive the same routine standard treatment care as the intervention group, but no SMS text and phone calls. All participants will be followed for two months of home-based self-administered medication during the continuation phases of the standard treatment period. Urine test for the presence of isoniazid (INH) drug metabolites in urine will be undertaken at the random point at the fourth and eighth weeks of intervention to measure medication adherence. Medication adherence will also be assessed by self-report measurements using the AIDS Clinical Trial Group adherence (ACTG) and Visual Analogue Scales (VAS) questionnaires, and clinic appointment attendance registration. Multivariable regression model analysis will be employed to assess the effect of the Ma-MAS intervention at a significance level of P-value < 0.05 with a 95% confidence interval. Discussion For this trial, a mobile-assisted medication adherence intervention will first be developed systematically based on the Medical Research Council framework using appropriate behavioural theory and evidence. The trial will then evaluate the effect of SMS texts and phone calls on TB medication adherence. Evidence generated from this trial will be highly valuable for policymakers, program managers, and healthcare providers working in Ethiopia and beyond.	[Sahile, Zekariyas] Ambo Univ, Dept Publ Hlth, Ambo, Ethiopia; [Sahile, Zekariyas; Maeder, Anthony John] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Flinders Digital Hlth Res Ctr, Adelaide, SA, Australia; [Perimal-Lewis, Lua] Flinders Univ S Australia, Coll Sci & Engn, Flinders Digital Hlth Res Ctr, Adelaide, SA, Australia; [Arbon, Paul] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Adelaide, SA, Australia	Ambo University; Flinders University South Australia; Flinders University South Australia; Flinders University South Australia	Sahile, Z (corresponding author), Ambo Univ, Dept Publ Hlth, Ambo, Ethiopia.; Sahile, Z (corresponding author), Flinders Univ S Australia, Coll Nursing & Hlth Sci, Flinders Digital Hlth Res Ctr, Adelaide, SA, Australia.	zekariyas.nezenega@flinders.edu.au		Sahile, Zekariyas/0000-0002-7215-9489; Arbon, Paul/0000-0002-5914-3300	Flinders University	Flinders University	This trial protocol is partially funded by Flinders University. The funder and sponsor had no role in trial design, and will not have a role in the trial implementation, analysis, and interpretation of the findings. All trial information is the responsibility of the authors.	Adane AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078791; Alipanah N, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002595; Barclay E, 2009, LANCET, V373, P15, DOI 10.1016/S0140-6736(08)61938-8; Barkman C, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1337356; Bediang G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5502-x; Bleijenberg N, 2018, INT J NURS STUD, V79, P86, DOI 10.1016/j.ijnurstu.2017.12.001; Broomhead S, 2012, TELEMED E-HEALTH, V18, P24, DOI 10.1089/tmj.2011.0143; Central Statistical Agency, 2012, ETH DEM GRAPH HLTH S; Central statistical agency-CSA/Ethiopia ICF, 2017, ETH DEM HLTH SURV 20; Chen SQ, 2015, LANCET, V386, pS29, DOI 10.1016/S0140-6736(15)00867-3; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Davey Sanjeev, 2014, Indian J Community Med, V39, P178, DOI 10.4103/0970-0218.137160; Eticha T., 2014, ETHIOPIA, V6, P61; Fang XH, 2017, MED SCI MONITOR, V23, P2465, DOI 10.12659/MSM.904957; Fiseha D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1142-2; Fisher JD, 2006, HEALTH PSYCHOL, V25, P462, DOI 10.1037/0278-6133.25.4.462; Gashu KD, 2019, BMJ HEALTH CARE INFO, V26, DOI 10.1136/bmjhci-2019-100050; Goel S, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2688; Habteyes Hailu T., 2015, TUBERCULOSIS TREATME, V44, P1; Horne R., 2005, CONCORDANCE ADHERENC, V2005, P40; Kalichman Seth C, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P367, DOI 10.1177/1545109709352884; Kamath-Rayne BD, 2018, GLOB HEALTH-SCI PRAC, V6, P538, DOI 10.9745/GHSP-D-18-00147; Kanters S, 2017, LANCET HIV, V4, pE31, DOI 10.1016/S2352-3018(16)30206-5; Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4; Kebede A, 2012, N AM J MED SCI, V4, P67, DOI 10.4103/1947-2714.93376; Kunawararak P, 2011, SE ASIAN J TROP MED, V42, P1444; Lester R, 2019, J CLIN TUBER OTH MYC, V16, DOI 10.1016/j.jctube.2019.100108; Liu Q, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006594.pub3; Liu XQ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001876; Mckay B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217219; Mekonnen Habtamu Sewunet, 2018, BMC Res Notes, V11, P691, DOI 10.1186/s13104-018-3789-4; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Mkopi A, 2014, INT J TUBERC LUNG D, V18, P804, DOI 10.5588/ijtld.13.0675; Mohammed H, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00753-9; Mohammed S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162944; Nezenega ZS, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155626; Nglazi MD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-566; Ogundele OA., 2015, P 2015 ANN RES C S A; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Sagbakken M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-11; Soobratty MR, 2014, EUR RESPIR J, V43, P1519, DOI 10.1183/09031936.00132613; Strathdee SA, 2012, ANN EPIDEMIOL, V22, P426, DOI 10.1016/j.annepidem.2012.04.002; Subbaraman R, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001018; Tegegne T, 2011, IS MHEALTH VIABLE ET; Tesfahuneygn Gebrehiwet, 2015, BMC Res Notes, V8, P503, DOI 10.1186/s13104-015-1452-x; The Federal Ministry of Health, 2018, NAT GUID TB DR TB LE; Tola HH, 2019, INT J TUBERC LUNG D, V23, P741, DOI 10.5588/ijtld.18.0672; Tola HH, 2017, ETHIOP J HEALTH SCI, V27, P447, DOI 10.4314/ejhs.v27i5.2; Tola HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155147; Valencia S, 2017, EXPERT REV ANTI-INFE, V15, P157, DOI 10.1080/14787210.2017.1264270; van den Boogaard J, 2011, B WORLD HEALTH ORGAN, V89, P632, DOI 10.2471/BLT.11.086462; WHO, 2017, GUIDELINES TREATMENT; World Hlth Org, 2002, INT J TUBERC LUNG D, V6, P378; Yew WW, 1999, CHEMOTHERAPY, V45, P26, DOI 10.1159/000048479; Zegeye A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210422	56	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261758	10.1371/journal.pone.0261758	http://dx.doi.org/10.1371/journal.pone.0261758			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972128	Green Published, gold			2022-12-27	WOS:000773555700052
J	Maciuszek, J; Polak, M; Stasiuk, K; Dolinski, D				Maciuszek, Jozef; Polak, Mateusz; Stasiuk, Katarzyna; Dolinski, Dariusz			Active pro-vaccine and anti-vaccine groups: Their group identities and attitudes toward science	PLOS ONE			English	Article							IDENTIFICATION; SKEPTICISM; BEHAVIOR; REFUSAL; IMPACT	Vaccine rejection is a problem severely impacting the global society, especially considering the COVID-19 outbreak. The need to understand the psychological mechanisms underlying the active involvement of the pro-vaccine and anti-vaccine movements is therefore very important both from a theoretical and practical perspective. This paper investigates the group identities of people with positive and negative attitudes towards vaccination, and their attitudes toward general science. A targeted sample study of 192 pro-vaccine and 156 anti-vaccine group members showed that the group identity of pro-vaccine individuals is higher than of anti-vaccine individuals. and that both pro-vaccine and anti-vaccine individuals had a positive attitude toward science. Results are discussed in context of the heterogeneity of motivations causing vaccine rejection and the relation between active involvement in online discussion and group identity.	[Maciuszek, Jozef; Polak, Mateusz; Stasiuk, Katarzyna] Jagiellonian Univ, Fac Management & Social Commun, Inst Appl Psychol, Krakow, Poland; [Dolinski, Dariusz] SWPS Univ Social Sci & Humanities, Fac Psychol Wroclaw, Inst Psychol, Wroclaw, Poland	Jagiellonian University; SWPS University of Social Sciences & Humanities	Polak, M (corresponding author), Jagiellonian Univ, Fac Management & Social Commun, Inst Appl Psychol, Krakow, Poland.	mateusz.polak@uj.edu.pl		Dolinski, Dariusz/0000-0002-4225-4258	Priority Research Area Society of the Future under the program "Excellence Initiative - Research University" at the Jagiellonian University in Krakow	Priority Research Area Society of the Future under the program "Excellence Initiative - Research University" at the Jagiellonian University in Krakow	The publication was funded by the Priority Research Area Society of the Future under the program "Excellence Initiative - Research University" at the Jagiellonian University in Krakow. https://id.uj.edu.pl/en_GB/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; ALLISON ST, 1988, PERS SOC PSYCHOL B, V14, P231, DOI 10.1177/0146167288142002; Attwell K, 2018, VACCINE, V36, P1621, DOI 10.1016/j.vaccine.2018.01.076; Attwell K, 2017, INT J HEALTH GOV, V22, P183, DOI 10.1108/IJHG-03-2017-0008; Bliuc AM, 2007, EUR J SOC PSYCHOL, V37, P19, DOI 10.1002/ejsp.334; Borczyk B., 2010, EVOLUTION N Y, V4, P614; Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212; Dunlap RE, 2013, AM BEHAV SCI, V57, P691, DOI 10.1177/0002764213477097; Engels A, 2013, GLOBAL ENVIRON CHANG, V23, P1018, DOI 10.1016/j.gloenvcha.2013.05.008; European Centre for Disease Prevention and Control, COVID19 VACC TRACK; Faasse K, 2016, VACCINE, V34, P5808, DOI 10.1016/j.vaccine.2016.09.029; Falomir-Pichastor JM, 2009, APPL PSYCHOL-INT REV, V58, P42, DOI 10.1111/j.1464-0597.2008.00381.x; Farias M, 2013, J EXP SOC PSYCHOL, V49, P1210, DOI 10.1016/j.jesp.2013.05.008; Fisher WA, 2013, J SEX MED, V10, P2455, DOI 10.1111/jsm.12211; Hogg M. A., 1992, SOCIAL PSYCHOL GROUP; Holton Gerald J., 1993, SCI ANTISCIENCE; Hornsey MJ, 2018, HEALTH PSYCHOL, V37, P307, DOI 10.1037/hea0000586; Hornsey MJ, 2017, AM PSYCHOL, V72, P459, DOI 10.1037/a0040437; Hotez PJ, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000683; Kahan D. M, 2014, CCP RISK PERCEPTION, V17; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022; Lickel B, 2001, PERS SOC PSYCHOL REV, V5, P129, DOI 10.1207/S15327957PSPR0502_4; Matzke NJ., 2010, EVOL EDUC OUTREACH, V3, P145, DOI 10.1007/s12052-010-0233-1; McKee Chephra, 2016, J Pediatr Pharmacol Ther, V21, P104, DOI 10.5863/1551-6776-21.2.104; Moreland RL, 1993, UNDERSTANDING SMALL; Morgan M., 2018, SOCIAL SCI, V7, P64, DOI [10.3390/socsci7040064, DOI 10.3390/SOCSCI7040064]; Motta M, 2018, SOC SCI MED, V211, P274, DOI 10.1016/j.socscimed.2018.06.032; Nichols T., 2017, DEATH EXPERTISE CAMP; Petrocelli JV, 2007, J PERS SOC PSYCHOL, V92, P30, DOI 10.1037/0022-3514.92.1.30; Phalet K, 1997, EUR J SOC PSYCHOL, V27, P703; Reich JA, 2014, GENDER SOC, V28, P679, DOI 10.1177/0891243214532711; Roccas S, 2008, PERS SOC PSYCHOL REV, V12, P280, DOI 10.1177/1088868308319225; Ross L., 1995, ADV EXPT SOCIAL PSYC, V27, P255, DOI DOI 10.1016/S0065-2601(08)60407-4; Rutjens BT, 2020, PUBLIC UNDERST SCI, V29, P335, DOI 10.1177/0963662520908534; Rutjens BT, 2018, PERS SOC PSYCHOL B, V44, P384, DOI 10.1177/0146167217741314; Smith TC, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx146; Sniehotta FF, 2009, BRIT J HEALTH PSYCH, V14, P261, DOI 10.1348/135910708X389042; Tajfel H., 1986, DIFFERENTIATION SOCI, V5, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Visser PS, 2004, J PERS SOC PSYCHOL, V87, P779, DOI 10.1037/0022-3514.87.6.779; Voinson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142990; WEISS RF, 1982, B PSYCHONOMIC SOC, V20, P21	43	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2021	16	12							e0261648	10.1371/journal.pone.0261648	http://dx.doi.org/10.1371/journal.pone.0261648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0C7TD	34969055	Green Published, gold			2022-12-27	WOS:000775510400013
J	Bin Helayel, H; Ahmed, A; Ahmed, SK; Ahmad, A; Khan, R; Al-Swailem, SA				Bin Helayel, Halah; Ahmed, Anwar; Ahmed, Syed Khabir; Ahmad, Abeer; Khan, Ruhi; Al-Swailem, Samar A.			Quarantine-related traumatic stress, views, and experiences during the first wave of Coronavirus pandemic: A mixed-methods study among adults in Saudi Arabia	PLOS ONE			English	Article							HEALTH-CARE WORKERS; EAST RESPIRATORY SYNDROME; PSYCHOLOGICAL IMPACT; SARS; COVID-19; PERCEPTIONS; EPIDEMIC; OUTBREAK; TORONTO; EBOLA	Purpose Mental health is a significant problem following exposure to a traumatic event. This study aimed to examine quarantine-related experiences, traumatic stress, and coping strategies among adults quarantined in Saudi Arabia due to coronavirus disease 2019 (COVID-19) exposure or travel history. Methods Individuals aged >= 18 years who were quarantined in Saudi Arabia due to COVID-19 exposure or travel history were included. We used a sequential mixed methods design, using an online survey followed by in-depth individual telephonic interviews. The Impact of Event Scale-Revised (IES-R) was used to measure post-traumatic stress disorder (PTSD) symptoms after the quarantine. To identify factors associated with significant symptoms (IES-R score >= 33), prevalence ratios (PR) with 95% confidence intervals were computed using Poisson regression with robust error variance. In the next phase, a subset of the participants (n = 26) were interviewed to elicit their quarantine-related experiences and coping responses. Major themes and subthemes were identified. Results Of the 111 adults who completed the survey, 32 (28.8% [95% CI, 21.1-38.0%]) had significant PTSD symptoms (IES-R score >= 33) and 27 (24.3% [95% CI, 17.2-33.3%]) had severe symptoms (IES-R score > 37). Marital status was the only variable that was significantly associated with significant PTSD symptoms (P = 0.028). Significant symptoms were twice as prevalent in married adults than among other marital groups (PR 2.00, 95% CI, 1.08-3.72). Participants reported negative emotions such as overwhelming fear, helplessness, anxiety, and disgust. Participants utilized both problem-centered coping (e.g., use of social support) and emotion-centered coping (e.g., use of positive diversionary activities) during the quarantine period. Conclusion PTSD symptoms were present in one out of every four quarantined persons. The quarantine experience is viewed negatively. These findings highlight the need for increased awareness about stress-related disorders among quarantined individuals. Efforts are needed to detect and manage these symptoms early while making the quarantine experience more satisfying for the involved individuals and groups.	[Bin Helayel, Halah; Ahmed, Anwar; Ahmed, Syed Khabir; Ahmad, Abeer; Khan, Ruhi; Al-Swailem, Samar A.] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia	King Khaled Eye Specialist Hospital	Ahmed, A (corresponding author), King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia.	Anwarahmed991@gmail.com		Ahmed, Anwar/0000-0002-4797-8423; Ahmad, Khabir/0000-0002-1569-0628; HELAYEL, HALAH/0000-0003-2522-9234; Al-Swailem, Samar/0000-0002-1070-7232				Alkhamees AA, 2020, COMPR PSYCHIAT, V102, DOI 10.1016/j.comppsych.2020.152192; AlNajjar N S, 2017, East Mediterr Health J, V22, P817; Alshehri FS, 2020, SAUDI PHARM J, V28, P1666, DOI 10.1016/j.jsps.2020.10.013; Alsubaie S, 2019, J INFECT DEV COUNTR, V13, P920, DOI 10.3855/jidc.11753; Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055; Beck JG, 2008, J ANXIETY DISORD, V22, P187, DOI 10.1016/j.janxdis.2007.02.007; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8; Caleo G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5158-6; Cava MA, 2005, PUBLIC HEALTH NURS, V22, P398, DOI 10.1111/j.0737-1209.2005.220504.x; cdc, QUARANTINE ISOLATION; Chong MY, 2004, BRIT J PSYCHIAT, V185, P127, DOI 10.1192/bjp.185.2.127; Desclaux A, 2017, SOC SCI MED, V178, P38, DOI 10.1016/j.socscimed.2017.02.009; DiGiovanni C, 2004, BIOSECUR BIOTERROR, V2, P265, DOI 10.1089/bsp.2004.2.265; Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0; Fawaz M, 2020, INT J SOC PSYCHIATR, V66, P666, DOI 10.1177/0020764020932207; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Ifthikar Z, 2021, MIDDLE EAST CURR PSY, V28, DOI 10.1186/s43045-021-00127-3; Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048; Kim EY, 2016, AM J INFECT CONTROL, V44, P1414, DOI 10.1016/j.ajic.2016.03.014; Kim HC, 2018, PSYCHIAT INVEST, V15, P355, DOI 10.30773/pi.2017.10.25.1; Lee Dong-Hun, 2016, [Korean Journal of Psychology: General, 한국심리학회지:일반], V35, P355, DOI 10.22257/kjp.2016.06.35.2.355; Lee S, 2005, SOC SCI MED, V61, P2038, DOI 10.1016/j.socscimed.2005.04.010; Lee SM, 2018, COMPR PSYCHIAT, V87, P123, DOI 10.1016/j.comppsych.2018.10.003; Mihashi M, 2009, HEALTH PSYCHOL, V28, P91, DOI 10.1037/a0013674; Nickell LA, 2004, CAN MED ASSOC J, V170, P793, DOI 10.1503/cmaj.1031077; North Carol S, 2004, Ann Clin Psychiatry, V16, P209, DOI 10.1080/10401230490522034; North CS, 2004, J NERV MENT DIS, V192, P823, DOI 10.1097/01.nmd.0000146911.52616.22; Rattray J, 2007, J CLIN NURS, V16, P234, DOI 10.1111/j.1365-2702.2006.01573.x; Robertson E, 2004, CAN J PSYCHIAT, V49, P403; Taylor MR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-347; Temsah MH, 2020, J INFECT PUBLIC HEAL, V13, P877, DOI [10.1016/j.jiph.2020.05.021, 10.1016/j.ijph.2020.05.021]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wang YG, 2011, GEN HOSP PSYCHIAT, V33, P75, DOI 10.1016/j.genhosppsych.2010.11.001; Wester M, 2019, SCAND J PUBLIC HEALT, V47, P99, DOI 10.1177/1403494817753450; Wu P, 2009, CAN J PSYCHIAT, V54, P302, DOI 10.1177/070674370905400504; Xin MQ, 2020, AM PSYCHOL, V75, P607, DOI 10.1037/amp0000692	37	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261967	10.1371/journal.pone.0261967	http://dx.doi.org/10.1371/journal.pone.0261967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025910	Green Published, gold			2022-12-27	WOS:000796264200038
J	D'Ambrosi, F; Cesano, N; Iurlaro, E; Ronchi, A; Ramezzana, IG; Di Maso, M; Pietrasanta, C; Ronchi, A; Pugni, L; Ferrazzi, E				D'Ambrosi, Francesco; Cesano, Nicola; Iurlaro, Enrico; Ronchi, Alice; Ramezzana, Ilaria Giuditta; Di Maso, Matteo; Pietrasanta, Carlo; Ronchi, Andrea; Pugni, Lorenza; Ferrazzi, Enrico			Prelabor rupture of membranes at term: A possible hematological triage in addition to vagino-rectal beta-hemolytic streptococcus screening for early labor induction	PLOS ONE			English	Article							EXPECTANT MANAGEMENT; GUIDELINES; CHORIOAMNIONITIS; DIAGNOSIS	Introduction A potential complication of term prelabor rupture of membranes (term PROM) is chorioamnionitis with an increased burden on neonatal outcomes of chronic lung disease and cerebral palsy. The purpose of the study was to analyze the efficacy of a standing clinical protocol designed to identify women with term PROM at low risk for chorioamnionitis, who may benefit from expectant management, and those at a higher risk for chorioamnionitis, who may benefit from early induction. Material and methods This retrospective study enrolled all consecutive singleton pregnant women with term PROM. Subjects included women with at least one of the following factors: white blood cell count >= 15x100/mu L, C-reactive protein >= 1.5 mg/dL, or positive vaginal swab for beta-hemolytic streptococcus. These women comprised the high risk (HR) group and underwent immediate induction of labor by the administration of intravaginal dinoprostone. Women with none of the above factors and those with a low risk for chorioamnionitis waited for up to 24 hours for spontaneous onset of labor and comprised the low-risk (LR) group. Results Of the 884 consecutive patients recruited, 65 fulfilled the criteria for HR chorioamnionitis and underwent immediate induction, while 819 were admitted for expectant management. Chorioamnionitis and Cesarean section rates were not significantly different between the HR and LR groups. However, the prevalence of maternal fever (7.7% vs. 2.9%; p = 0.04) and meconium-stained amniotic fluid was significantly higher in the HR group than in LR group (6.1% vs. 2.2%; p = 0.04). This study found an overall incidence of 4.2% for chorioamnionitis, 10.9% for Cesarean section, 0.5% for umbilical artery blood pH < 7.10, and 1.9% for admission to the neonatal intensive care unit. Furthermore, no confirmed cases of neonatal sepsis were encountered. Conclusions A clinical protocol designed to manage, by immediate induction, only those women with term PROM who presented with High Risk factors for infection/inflammation achieved similar maternal and perinatal outcomes between such women and women without any risks who received expectant management. This reduced the need for universal induction of term PROM patients, thereby reducing the incidence of maternal and fetal complications without increasing the rate of Cesarean sections.	[D'Ambrosi, Francesco; Cesano, Nicola; Iurlaro, Enrico; Ronchi, Alice; Ramezzana, Ilaria Giuditta; Ferrazzi, Enrico] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Woman Child & Neonate, Obstert Unit, Milan, Italy; [Di Maso, Matteo] Univ Milan, Branch Med Stat Biometry & Epidemiol GA Maccacaro, Dept Clin Sci & Community Hlth, Milan, Italy; [Pietrasanta, Carlo; Ronchi, Andrea; Pugni, Lorenza] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neonatal Intens Care Unit, Milan, Italy; [Ferrazzi, Enrico] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	D'Ambrosi, F (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Woman Child & Neonate, Obstert Unit, Milan, Italy.	dambrosifr@gmail.com	Di Maso, Matteo/AAC-4816-2022	Di Maso, Matteo/0000-0002-6481-990X				[Anonymous], 2020, OBSTET GYNECOL, V135, pE80, DOI 10.1097/AOG.0000000000003700; Benitz WE, 2015, J PEDIATR-US, V166, P1070, DOI 10.1016/j.jpeds.2014.12.023; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Cahill AG, 2009, OBSTET GYNECOL, V114, P124, DOI [10.1097/AOG.0b013e3181a99def, 10.1097/AOG.0b013e3181aef106]; Cotten CM, 2015, CLIN PERINATOL, V42, P195, DOI 10.1016/j.clp.2014.10.007; Davey MA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0869-0; Duff P, 1998, CLIN OBSTET GYNECOL, V41, P883, DOI 10.1097/00003081-199812000-00012; Hannah ME, 1996, NEW ENGL J MED, V334, P1005, DOI 10.1056/NEJM199604183341601; Higgins RD, 2016, OBSTET GYNECOL, V127, P426, DOI 10.1097/AOG.0000000000001246; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Krupa FD, 2005, BJOG-INT J OBSTET GY, V112, P1284, DOI 10.1111/j.1471-0528.2005.00700.x; Maqbool S., PAKISTAN J; MIDDLETON P, 2017, COCHRANE DB SYST REV; Ocviyanti D, 2018, J PREGNANCY, V2018, DOI 10.1155/2018/4823404; Polin RA, 2012, PEDIATRICS, V129, P1006, DOI 10.1542/peds.2012-0541; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Romero R, 2019, J PERINAT MED, V47, P915, DOI 10.1515/jpm-2019-0297; Saccone G, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.034; SIGO, 2016, INDUZIONE TRAVAGLIO; Term Prelabour Rupture of Membranes (Term PROM), 2020, RANZCOG GUIDELINES; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003	21	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261906	10.1371/journal.pone.0261906	http://dx.doi.org/10.1371/journal.pone.0261906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025890	gold, Green Published			2022-12-27	WOS:000796264200033
J	Beraud, G; Timsit, JF; Leleu, H				Beraud, Guillaume; Timsit, Jean-Francois; Leleu, Henri			Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact	PLOS ONE			English	Article							FRANCE	Remdesivir and dexamethasone are the only drugs providing reductions in the lengths of hospital stays for COVID-19 patients. We assessed the impacts of remdesivir on hospital-bed resources and budgets affected by the COVID-19 outbreak. A stochastic agent-based model was combined with epidemiological data available on the COVID-19 outbreak in France and data from two randomized control trials. Strategies involving treating with remdesivir only patients with low-flow oxygen and patients with low-flow and high-flow oxygen were examined. Treating all eligible low-flow oxygen patients during the entirety of the second wave would have decreased hospital-bed occupancy in conventional wards by 4% [2%; 7%] and intensive care unit (ICU)-bed occupancy by 9% [6%; 13%]. Extending remdesivir use to high-flow-oxygen patients would have amplified reductions in ICU-bed occupancy by up to 14% [18%; 11%]. A minimum remdesivir uptake of 20% was required to observe decreases in bed occupancy. Dexamethasone had effects of similar amplitude. Depending on the treatment strategy, using remdesivir would, in most cases, generate savings (up to 722(sic)) or at least be cost neutral (an extra cost of 34(sic)). Treating eligible patients could significantly limit the saturation of hospital capacities, particularly in ICUs. The generated savings would exceed the costs of medications.	[Beraud, Guillaume] Univ Hosp Poitiers, Infect Dis Dept, Poitiers, France; [Timsit, Jean-Francois] Hop Xavier Bichat, APHP, Med & Infect Dis Intens Care Unit, Paris, France; [Timsit, Jean-Francois] Univ Paris Paris Diderot, IAME, UMR 1137, Paris, France; [Leleu, Henri] Publ Hlth Expertise, Paris, France	CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Beraud, G (corresponding author), Univ Hosp Poitiers, Infect Dis Dept, Poitiers, France.	beraudguillaume@gmail.com	Beraud, Guillaume/O-6062-2017	Beraud, Guillaume/0000-0002-4705-0916	GILEAD	GILEAD(Gilead Sciences)	HL is an employee of Public Health Expertise, which received funding from GILEAD for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence Technique de l'Information sur l'Hospitalisation, 2010, ET NAT COUTS; [Anonymous], REMDESIVIR COVID 19; Assurance Maladie, 2019, PERSONNES PRISES CHA; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bardet A., ESMO 2020 MIN OR SES; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Bonaldi C, 2011, DIABETIC MED, V28, P583, DOI 10.1111/j.1464-5491.2011.03250.x; Chang R, 2020, MEDRXIV; Courtejoie N., 2020, DREES, P67; Efron B, 1998, INTRO BOOTSTRAP; Ferre A, 2012, RESP MED, V106, P467, DOI 10.1016/j.rmed.2011.12.002; FHF, 2 MILL EUR SUPPL ALL; GEODES, NUMB PERS HOSP COVID; Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301; GRENE-LEROUGE Nathalie, 2020, INSTRUCTION N DGSCOR; HAS, 2020, AV COMM TRANSP REMD; Hoertel N, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1001-6; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Insee, 2020, POPULATION TOTALE SE; INSERM, 2020, EPICOV; Keogh-Brown MR, 2010, EUR J HEALTH ECON, V11, P543, DOI 10.1007/s10198-009-0210-1; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Kluge Stefan., 2020, AWMF; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Marijon E, 2020, LANCET PUBLIC HEALTH, V5, pE437, DOI 10.1016/S2468-2667(20)30117-1; NEULAT-ISARD Sabine, 2020, APM NEWS 0414; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; Sante Publique France, 2020, COVIPREV; Sante Publique France, 2020, COVID 19 POINT EP HE; Schmidt M, 2021, INTENS CARE MED, V47, P60, DOI 10.1007/s00134-020-06294-x; Sprung CL, 2020, CRIT CARE MED, V48, P1196, DOI 10.1097/CCM.0000000000004410; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262462	10.1371/journal.pone.0262462	http://dx.doi.org/10.1371/journal.pone.0262462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020746	gold, Green Published, Green Submitted			2022-12-27	WOS:000834207700042
J	Doria, N; Numer, M				Doria, Nicole; Numer, Matthew			Dancing in a culture of disordered eating: A feminist poststructural analysis of body and body image among young girls in the world of dance	PLOS ONE			English	Article							OBJECTIFICATION THEORY; ADOLESCENT GIRLS; SELF-ESTEEM; SOCIOCULTURAL INFLUENCES; FEMALE ADOLESCENTS; RISK; BALLET; DISSATISFACTION; PERFECTIONISM; ANOREXIA	Eating disorders among adolescent girls are a public health concern. Adolescent girls that participate in aesthetic sport, such as dance, are of particular concern as they experience the highest rates of clinical eating disorders. The purpose of this study is to explore the experiences of young girls in the world of competitive dance and examine how these experiences shape their relationship with the body; feminist poststructural discourse analysis was employed to critically explore this relationship. Interviews were conducted across Canada with twelve young girls in competitive dance (14-18 years of age) to better understand how the dominant discourses in the world of competitive dance constitute the beliefs, values and practices about body and body image. Environment, parents, coaches, and peers emerged as the largest influencers in shaping the young dancers' relationship with their body. These influencers were found to generate and perpetuate body image discourses that reinforce the ideal dancer's body and negative body image.	[Doria, Nicole; Numer, Matthew] Dalhousie Univ, Sch Hlth & Human Performance, Stairs House, Halifax, NS, Canada	Dalhousie University	Doria, N (corresponding author), Dalhousie Univ, Sch Hlth & Human Performance, Stairs House, Halifax, NS, Canada.	Nicole.doria@dal.ca		Doria, Nicole/0000-0003-4786-997X	Canada Graduate Scholarship, Canadian Institutes of Health Research; Nova Scotia Health Research Foundation	Canada Graduate Scholarship, Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation	ND - Canada Graduate Scholarship, Canadian Institutes of Health Research ND - Scotia Scholars, Nova Scotia Health Research Foundation.	Adelson Leslie., 1993, MAKING BODIES MAKING; Al-sheyab NA, 2018, J OBES, V2018, DOI 10.1155/2018/7309878; Alfoukha MM, 2019, J SCH NURS, V35, P169, DOI 10.1177/1059840517737140; Annus A, 2009, EUR EAT DISORD REV, V17, P50, DOI 10.1002/erv.899; [Anonymous], 2016, CREAT ED; Anshel M. H., 2004, J SPORT BEHAV, V27, P115; ARCHINARD M, 1995, EUR EAT DISORD REV, V3, P111, DOI 10.1002/erv.2400030207; Aston M, 2014, NURS REP, V4, P12, DOI 10.4081/nursrep.2014.3290; Aston M, 2012, J ADV NURS, V68, P1187, DOI 10.1111/j.1365-2648.2011.05866.x; Bail C.A., 2021, BREAKING SOCIAL MEDI, DOI DOI 10.2307/J.CTV18ZHDHG; Basow SA, 2008, SEX ROLES, V59, P290, DOI 10.1007/s11199-008-9396-4; Berg B.L, 2007, QUALITATIVE RES METH; Blowers Lucy C, 2003, Eat Behav, V4, P229, DOI 10.1016/S1471-0153(03)00018-7; Bordo S., 2009, Critical feminist approaches to eating dis/orders, P46; Bordo S., 1994, B HIST MED, V68, P754; Bordo Susan, 2004, UNBEARABLE WEIGHT FE; Brochu JP, 2018, EAT DISORD, V26, P388, DOI 10.1080/10640266.2018.1454806; Busanich R, 2010, QUEST, V62, P385, DOI 10.1080/00336297.2010.10483656; BUTLER J, 1989, J PHILOS, V86, P601, DOI 10.5840/jphil198986117; Butler J., 1993, BODIES MATTER DISCUR; Butler Judith, 1992, FEMINISTS THEORIZE P, P3; Cash TF, 2004, J CONSULT CLIN PSYCH, V72, P1081, DOI 10.1037/0022-006X.72.6.1081; Cassidy C, 2016, J CLIN NURS, V25, P2378, DOI 10.1111/jocn.13354; Cerniglia L, 2017, PSYCHOL RES BEHAV MA, V10, P305, DOI 10.2147/PRBM.S145463; Cheek J., 2000, POSTMODERN POSTSTRUC; Chernin K., 1981, OBSESSION REFLECTION, V1st ed; Cortes-Garcia L, 2019, INT J EAT DISORDER, V52, P924, DOI 10.1002/eat.23086; Crespo C, 2010, J YOUTH ADOLESCENCE, V39, P1392, DOI 10.1007/s10964-009-9433-9; Creswell J.W., 2015, RES DESIGN QUANTITAT; de Bruin AP, 2007, PSYCHOL SPORT EXERC, V8, P507, DOI 10.1016/j.psychsport.2006.10.002; de Bruin AP, 2009, PSYCHOL SPORT EXERC, V10, P72, DOI 10.1016/j.psychsport.2008.07.002; Dohnt H, 2006, DEV PSYCHOL, V42, P929, DOI 10.1037/0012-1649.42.5.929; Dosil J., 2008, EATING DISORDERS ATH, P41; Downing L, 2008, CAMBRIDGE INTRO M FO; Dunkley TL, 2001, ADOLESCENCE, V36, P265; Egan SJ, 2011, CLIN PSYCHOL REV, V31, P203, DOI 10.1016/j.cpr.2010.04.009; Fallon P., 1996, FEMINIST PERSPECTIVE; Filaire E, 2008, SCI SPORT, V23, P49, DOI 10.1016/j.scispo.2007.10.009; FOUCAULT M, 1982, CRIT INQUIRY, V8, P777, DOI 10.1086/448181; Foucault M., 1977, DISCIPLINE PUNISH; Foucault Michel., 1978, HIST SEXUALITY INTRO; Foucault Michel, 1983, M FOUCAULT STRUCTURA, V2nd, P208; Francisco R, 2012, SPAN J PSYCHOL, V15, P265, DOI 10.5209/rev_SJOP.2012.v15.n1.37333; Franko DL, 2007, INT J EAT DISORDER, V40, P156, DOI 10.1002/eat.20341; Fredrickson BL, 1997, PSYCHOL WOMEN QUART, V21, P173, DOI 10.1111/j.1471-6402.1997.tb00108.x; Frost L., 2001, YOUNG WOMEN BODY FEM; Gee J.P., 2005, INTRO DISCOURSE ANAL; Gilbert N, 2005, INT J EAT DISORDER, V37, P307, DOI 10.1002/eat.20105; Giles SM, 2007, COMMUN STUD, V58, P395, DOI 10.1080/10510970701648608; Goodwin H, 2014, EUR EAT DISORD REV, V22, P346, DOI 10.1002/erv.2282; Groesz LM, 2002, INT J EAT DISORDER, V31, P1, DOI 10.1002/eat.10005; Grosz Elizabeth, 1994, VOLATILE BODIES CORP; Gvion L, 2008, YOUNG, V16, P67, DOI 10.1177/110330880701600105; Haines Jess, 2010, Eat Disord, V18, P10, DOI 10.1080/10640260903439516; Harper D.J., 1995, J MENTAL HLTH, V4, P347, DOI [10.1080/09638239550037406, DOI 10.1080/09638239550037406]; Herbrich L, 2011, J SPORT SCI, V29, P1115, DOI 10.1080/02640414.2011.578147; Hesse-Biber S. N., 2007, CULT THINNESS; Hincapie CA, 2010, ARCH PHYS MED REHAB, V91, P1777, DOI 10.1016/j.apmr.2010.07.230; Holland G, 2016, BODY IMAGE, V17, P100, DOI 10.1016/j.bodyim.2016.02.008; Kim J.H., 2007, CLOTH TEXT RES J, V25, P3, DOI 10.1177/0887302X06296873; Kirsch AC, 2016, EAT BEHAV, V22, P175, DOI 10.1016/j.eatbeh.2016.06.018; Kleposki Raymond W, 2002, J Am Acad Nurse Pract, V14, P26; KRISTEVA J, 1981, SIGNS, V7, P13, DOI 10.1086/493855; Lattimore PJJ, 2003, BRIT J HEALTH PSYCH, V8, P451, DOI 10.1348/135910703770238301; Latzer Y, 2015, INT J ADOLESC YOUTH, V20, P375, DOI 10.1080/02673843.2015.1014925; Lenhart A., 2010, SOCIAL MEDIA MOBILE; Lewis S, 2015, HEALTH PROMOT PRACT, V16, P473, DOI 10.1177/1524839915580941; Lindberg SM, 2006, PSYCHOL WOMEN QUART, V30, P65, DOI 10.1111/j.1471-6402.2006.00263.x; Loth K, 2015, INT J EAT DISORDER, V48, P100, DOI 10.1002/eat.22339; Martinsen M, 2010, BRIT J SPORT MED, V44, P70, DOI 10.1136/bjsm.2009.068668; McEwen K, 2011, QUAL RES SPORT EXERC, V3, P152, DOI 10.1080/2159676X.2011.572181; Merriam S. B., 2016, QUAL RES, V4th; Mooney E, 2004, INT J CONSUM STUD, V28, P347, DOI DOI 10.1111/j.1470-6431.2004.00392.x; Morrison CM, 2010, PSYCHOPATHOLOGY, V43, P121, DOI 10.1159/000277001; National Eating Disorder Information Centre, 2018, STATISTICS-ABINGDON; Neumarker KJ, 1998, EUR CHILD ADOLES PSY, V7, P19, DOI 10.1007/s007870050040; Nordin-Bates Sanna M, 2011, Eat Disord, V19, P211, DOI 10.1080/10640266.2011.564976; O'dea J, 2007, EVERYBODYS DIFFERENT; Oliver W., 2005, DANCE RES J, V37, P38; Orbach S., 1982, FAT IS FEMINIST ISSU; Orbach S., 1978, FAT IS FEMINIST ISSU; Ortner Sherry, 1974, WOMEN CULTURE SOC; Piran N., 2005, PREVENTING DANCE INJ, P201; Powers P, 2001, METHODOLOGY DISCOURS; Resch M, 2007, HUNGARIAN MEDICAL J, V1, P449; Ricciardelli LA, 2001, SEX ROLES, V44, P189, DOI 10.1023/A:1010955120359; Ringham R, 2006, INT J EAT DISORDER, V39, P503, DOI 10.1002/eat.20299; Roberts SJ, 2001, J HUM NUTR DIET, V14, P103, DOI 10.1046/j.1365-277X.2001.00278.x; Rojo-Moreno L, 2013, EAT DISORD, V21, P53, DOI 10.1080/10640266.2013.741988; Ruggiero GM, 2003, INT J EAT DISORDER, V34, P220, DOI 10.1002/eat.10191; Sassaroli S, 2005, INT J EAT DISORDER, V37, P135, DOI 10.1002/eat.20079; Schneider S, 2013, EUR J PEDIATR, V172, P373, DOI 10.1007/s00431-012-1897-z; Schnitz S, 2010, INT J EAT DISORDER, V43, P393, DOI 10.1002/eat.20704; Schutz HK, 2007, BRIT J CLIN PSYCHOL, V46, P67, DOI 10.1348/014466506X115993; Scott Joan., 1992, FEMINISTS THEORIZE P; Seid R., 1994, FEMINIST PERSPECTIVE, P3; Shenton A. K., 2004, ED INFORM, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Slater A, 2002, SEX ROLES, V46, P343, DOI 10.1023/A:1020232714705; Slater JM, 2001, J ADOLESCENT HEALTH, V28, P443, DOI 10.1016/S1054-139X(00)00207-X; Smolak L, 2000, INT J EAT DISORDER, V27, P371, DOI 10.1002/(SICI)1098-108X(200005)27:4&lt;371::AID-EAT1&gt;3.0.CO;2-Y; Stice E, 2002, PSYCHOL BULL, V128, P825, DOI 10.1037//0033-2909.128.5.825; Sundgot-Borgen J, 2004, SCAND J MED SCI SPOR, V14, P205, DOI 10.1111/j.1600-0838.2004.00412.x; Sundgot-Borgen J, 2004, CLIN J SPORT MED, V14, P25, DOI 10.1097/00042752-200401000-00005; Sundgot-Borgen J, 2002, SCAND J MED SCI SPOR, V12, P259; Sundgot-Borgen J, 1999, BRIT J SPORT MED, V33, P434, DOI 10.1136/bjsm.33.6.434; Sundgot-Borgen J., 2003, HDB EATING DISORDERS, P385; Tafa M, 2017, J CHILD FAM STUD, V26, P28, DOI 10.1007/s10826-016-0531-5; Thomas JJ, 2005, INT J EAT DISORDER, V38, P263, DOI 10.1002/eat.20185; Thompson J. K, 2009, BODY IMAGE EATING DI; Thompson JK, 2001, CURR DIR PSYCHOL SCI, V10, P181, DOI 10.1111/1467-8721.00144; Tiggemann M, 2001, PSYCHOL WOMEN QUART, V25, P57, DOI 10.1111/1471-6402.00007; Tolman Deborah L., 1994, FEMINIST PERSPECTIVE, P301; Toro J, 2005, INT J SPORTS MED, V26, P693, DOI 10.1055/s-2004-830378; Van Durme K, 2012, EAT BEHAV, V13, P119, DOI 10.1016/j.eatbeh.2011.11.002; Weedon C., 1987, FEMINIST PRACTICE PO; Wykes M., 2005, MEDIA BODY IMAGE LOO; Young Robert J. C., 2004, WHITE MYTHOLOGIES WR; Zoletic E, 2009, PSYCHIAT DANUB, V21, P302	118	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0247651	10.1371/journal.pone.0247651	http://dx.doi.org/10.1371/journal.pone.0247651			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020720	gold, Green Published			2022-12-27	WOS:000834207700001
J	Horita, R; Nishio, A; Yamamoto, M				Horita, Ryo; Nishio, Akihiro; Yamamoto, Mayumi			Lingering effects of COVID-19 on the mental health of first-year university students in Japan	PLOS ONE			English	Article								Background The coronavirus disease 2019 (COVID-19) pandemic is continuing unabated in Japan, as of October 2021. We aimed to compare first-year university students' psychological distress before the pandemic in 2019, during the pandemic in 2020, and one year after the onset of the pandemic, in 2021. Methods The study conducted online surveys over three years from April to May each year. Participants were 400 first-year students in 2019, 766 in 2020, and 738 in 2021. We examined differences in scores on the Counseling Center Assessment of Psychological Symptoms- Japanese version (CCAPS-Japanese) between the three years using a one-way analysis of variance, and differences in the CCAPS-Japanese critical items using chi-squared test and residual analysis. Results The average scores on the Depression and Generalized Anxiety subscale in 2021 were significantly higher than those in 2020, but remained the same as in 2019. The Academic Distress subscale score in 2020 was the worst compared to 2019 and 2021. Meanwhile, the number of students who experienced severe suicidal ideation increased year by year from 2019 to 2021. Conclusion The mean mental health of first-year university students worsened after the onset of the COVID-19 pandemic, and recovered to the pre-pandemic level over the next two years. However, the number of high-risk students with suicidal ideation continued to increase. A system is required for early detection and support for students at high risk of mental health issues.	[Horita, Ryo; Nishio, Akihiro; Yamamoto, Mayumi] Gifu Univ, Hlth Adm Ctr, Gifu, Japan; [Horita, Ryo; Nishio, Akihiro; Yamamoto, Mayumi] Gifu Univ Hosp, Gifu, Japan; [Yamamoto, Mayumi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan	Gifu University; Gifu University; Gifu University	Horita, R (corresponding author), Gifu Univ, Hlth Adm Ctr, Gifu, Japan.; Horita, R (corresponding author), Gifu Univ Hosp, Gifu, Japan.	horita@gifu-u.ac.jp		Horita, Ryo/0000-0002-2922-9277	Japan Society for the Promotion of Science KAKENHI [JP19K14446]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant [grant number JP19K14446]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorsu DK, 2021, PSYCHOL RES BEHAV MA, V14, P1857, DOI 10.2147/PRBM.S333226; Arima M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-043728; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Feng Y, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00587-y; Fruehwirth JC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247999; Fuse-Nagase Y, 2021, PSYCHIAT CLIN NEUROS, V75, P351, DOI 10.1111/pcn.13293; Fushimi M, 2021, PSYCHOL MED, DOI 10.1017/S0033291721001240; Hatabu A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244350; Horita R, 2021, JPN PSYCHOL RES, DOI 10.1111/jpr.12345; Horita R, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113561; Horita R, 2020, CLIN PSYCHOL PSYCHOT, V27, P97, DOI 10.1002/cpp.2412; Japan's National Police Agency, 2021, NUMB SUIC VICT 2020; Lai AYK, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.584240; Locke BD, 2011, J COUNS PSYCHOL, V58, P97, DOI 10.1037/a0021282; Marashi MY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0239244; Marutani T, 2021, ASIAN J PSYCHIATR, V65, DOI 10.1016/j.ajp.2021.102803; Nishimura Y, 2021, J MED INTERNET RES, V23, DOI 10.2196/25232; Nomura K, 2021, ENVIRON HEALTH PREV, V26, DOI 10.1186/s12199-021-00953-1; Pirkis J, 2021, LANCET PSYCHIAT, V8, P579, DOI 10.1016/S2215-0366(21)00091-2; Pramukti I, 2020, J MED INTERNET RES, V22, DOI 10.2196/24487; Sharma R, 2021, ASIAN J SOC HEAL BEH, V4, P98, DOI 10.4103/shb.shb_9_21; Son C, 2020, J MED INTERNET RES, V22, DOI 10.2196/21279; Tahara M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18147245; Ueda M, 2022, J PUBLIC HEALTH-UK, V44, P541, DOI 10.1093/pubmed/fdab113; Villani L, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00680-w; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010	26	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262550	10.1371/journal.pone.0262550	http://dx.doi.org/10.1371/journal.pone.0262550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020752	Green Published, gold			2022-12-27	WOS:000834207700050
J	Tigabu, A; Beyene, Y; Getaneh, T; Chekole, B; Gebremaryam, T; Chanie, ES; Selomom, N; Alene, T; Aragie, G; Legas, G; Dessie, G				Tigabu, Agimasie; Beyene, Yeshiwork; Getaneh, Temesgen; Chekole, Bogale; Gebremaryam, Tigist; Chanie, Ermias Sisay; Selomom, Nigusie; Alene, Tamiru; Aragie, Getachew; Legas, Getasew; Dessie, Getnet			Incidence and predictors of anemia among adults on HIV care at South Gondar Zone Public General Hospital Northwest Ethiopia, 2020; retrospective cohort study	PLOS ONE			English	Article							PREVALENCE	Background Anemia is a major public health problem worldwide which accounts 24.8% of the population. Subsequently, anemia is a leading killer of people living with human immunodeficiency virus and many of these deaths occur in developing countries including Ethiopia. Cross sectional studies have done on anemia and human immunodeficiency virus. However, there is limited study on incidence of anemia and its predictors among adults on HIV care, especially no survival study has been conducted in the study area. Objective To assess incidence and predictors of anemia among adults on Human immunodeficiency virus care. Methods An institution-based retrospective cohort study was conducted among 434 adults on HIV care from January 1st 2015 to December 30th 2019 at Debre Tabor Referral Hospital. A computer-generated simple random sampling technique was employed to select the study participants. Ethical clearance was obtained from the Institutional Review Board of Bahir Dar University, and also, we got implied consent to review charts from the concerned bodies in the hospital. Data were entered using Epi-data version 3.1 and analyzed by using STATA version 14.0. A Kaplan Meier survival curve was utilized to estimate anemia free survival time. Bivariable and Multivariable Cox proportional hazards model were fitted to identify predictors of anemia. Results The overall incidence density rate of anemia was 6.27 (95% CI: 0.051, 0.077) per 100 person years. Clinical stage III/IV (AHR = 1.04; 95% CI = 1.02, 1.06), Body Mass Index less than 18.5 kg/m2 (AHR = 3.11; 95% CI = 1.56, 6.22), serum creatinine greater than 1.1 IU/L (AHR = 2.07; 95% CI = 1.12, 3.81) and fair/poor level of adherence(AHR = 1.05; 95% CI = 1.03, 1.07) were statistically significant predictors of anemia while increased anti-retroviral treatment duration (AHR = 0.98; 95% CI = 0.97, 0.99) decrease the risk of anemia at 95% confidence level. Conclusion The overall incidence density rate of anemia was high. Patients with clinical stage III/IV, body mass index < 18.5 kg/m(2), serum creatinine greater than 1.1 IU/L and fair/poor level of adherence were significant predictors of anemia while increased antiretroviral treatment duration had decreased the risk of anemia. Recommendation Even if the overall incidence rate of anemia was lower as compared to previous studies in Ethiopia, still the incidence of anemia was high. So, prevention measures should be taken beside with HIV care especially within 6-months ART initiation.	[Tigabu, Agimasie] Debre Tabor Univ, Coll Med & Hlth Sci, Dept Adult Hlth Nursing, Nursing, Debre Tabor, Ethiopia; [Beyene, Yeshiwork; Dessie, Getnet] Bahir Dar Univ, Dept Adult Hlth Nursing, Sch Hlth Sci, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Getaneh, Temesgen] Debre Markos Univ, Dept Clin Midwife, Coll Med & Hlth Sci, Debre Markos, Ethiopia; [Chekole, Bogale] Wolkite Univ, Dept Pediat Nursing, Coll Med & Hlth Sci, Wolkite, Ethiopia; [Gebremaryam, Tigist] Debre Markos Univ, Dept Pediat Nursing, Coll Med & Hlth Sci, Debre Markos, Ethiopia; [Chanie, Ermias Sisay; Selomom, Nigusie; Aragie, Getachew] Debre Tabor Univ, Coll Med & Hlth Sci, Dept Pediat Nursing, Debre Tabor, Ethiopia; [Alene, Tamiru] Wolaita Sodo Univ, Dept Pediat Nursing, Coll Med & Hlth Sci, Sodo, Ethiopia; [Legas, Getasew] Debre Tabor Univ, Dept Psychiat Nursing, Coll Med & Hlth Sci, Debre Tabor, Ethiopia	Bahir Dar University	Tigabu, A (corresponding author), Debre Tabor Univ, Coll Med & Hlth Sci, Dept Adult Hlth Nursing, Nursing, Debre Tabor, Ethiopia.	ethiomom23@gmail.com	Tibebu, Nigusie Selomon/AAH-6157-2021	Tibebu, Nigusie Selomon/0000-0002-5511-5812; Dessie, Getenet/0000-0001-7276-0891; Gebremaryam, Tigist/0000-0002-2191-435X; Tigabu, Agimasie/0000-0001-9085-9625; Legas, Getasew/0000-0002-1230-3952				Adamu AL, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0128-2; Ageru TA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221853; Akilimali PZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140240; [Anonymous], 2011, BMC INFECT DIS, V11, P190; Assefa Muluken, 2015, BMC Hematol, V15, P6, DOI 10.1186/s12878-015-0024-6; Bhattad Dhiraj, 2013, J Assoc Physicians India, V61, P673; Brentlinger PE, 2016, AIDS RES HUM RETROV, V32, P12, DOI [10.1089/aid.2015.0030, 10.1089/AID.2015.0030]; De Benoist B, WORLDWIDE PREVALENCE; Denue Ballah Akawu, 2013, Infect Dis (Auckl), V6, P25, DOI 10.4137/IDRT.S10477; Federal Ministry of Health, 2017, NATL GUIDELINES COMP; Gebremedhin Ketema Bizuwork, 2019, Adv Hematol, V2019, P9614205, DOI 10.1155/2019/9614205; Gebreweld Angesom, 2018, Adv Hematol, V2018, P3942301, DOI 10.1155/2018/3942301; Gibellini Davide, 2013, World J Virol, V2, P91, DOI 10.5501/wjv.v2.i2.91; Gunda DW, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.26.8268; Ikunaiye N Y, 2018, Ann Ib Postgrad Med, V16, P115; Johannessen A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-190; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Llibre JM, 2015, AIDS REV, V17, P56; Manaye Y, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7901241; Martin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116263; Mata-Marin JA., 2017, NATL GUIDELINES COMP; Mata-Marin JA., 2016, WHO REVISED GUIDELIN; Mata-Marin Jose A, 2010, BMC Res Notes, V3, P230, DOI 10.1186/1756-0500-3-230; McClellan WM, 2005, EUR J CLIN INVEST, V35, P58, DOI 10.1111/j.1365-2362.2005.01532.x; Melese H, 2017, HIV AIDS-RES PALLIAT, V9, P25, DOI 10.2147/HIV.S121021; Mengesha Misganaw Birhaneselassie, 2019, BMC Hematol, V19, P1, DOI 10.1186/s12878-018-0133-0; Milkias H., 2013, J HIVAIDS INFECT DIS; Nabitaka VM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232419; Negesse Ayenew, 2018, BMC Hematol, V18, P32, DOI 10.1186/s12878-018-0127-y; Panwar Ajay., STUDY ANEMIA HUMAN I; Petraro P, 2016, AM J TROP MED HYG, V94, P384, DOI 10.4269/ajtmh.15-0587; Semba RD, 2002, CLIN INFECT DIS, V34, P260, DOI 10.1086/338151; Ssali F., 2006, PREVALENCE INCIDENCE; Sullivan P, 2002, J INFECT DIS, V185, pS138, DOI 10.1086/340203; Tadesse S, J TROPICAL DIS; Takuva S, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/162950; Tamir Z, 2018, ETHIOP J HEALTH SCI, V28, P73, DOI 10.4314/ejhs.v28i1.9; Thai ACS, 2019, ANAEMIA ASSESSMENT C; who, DOLUTEGRAVIR DTG FIX; WHO, 2013, CONSOLIDATED GUIDELI; WHO, HEMOGLOBIN CONCENTRA; World Health Organisation (WHO), 2016, ANTIRETROVIRAL MED L; World Health Organization, 2016, GLOBAL HLTH SECTOR S; Yesuf T, 2019, HIV AIDS-RES PALLIAT, V11, P211, DOI 10.2147/HIV.S209446; Zhou J., 2012, J INT AIDS SOC	45	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0259944	10.1371/journal.pone.0259944	http://dx.doi.org/10.1371/journal.pone.0259944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020736	gold, Green Published			2022-12-27	WOS:000834207700008
J	Hashemi, NS; Skogen, JC; Sevic, A; Thorrisen, MM; Rimstad, SL; Sagvaag, H; Riper, H; Aas, RW				Hashemi, Neda S.; Skogen, Jens Christoffer; Sevic, Aleksandra; Thorrisen, Mikkel Magnus; Rimstad, Silje Lill; Sagvaag, Hildegunn; Riper, Heleen; Aas, Randi Wago			A systematic review and meta-analysis uncovering the relationship between alcohol consumption and sickness absence. When type of design, data, and sickness absence make a difference	PLOS ONE			English	Review							YOUNG EMPLOYEES; SOCIOECONOMIC DIFFERENCES; WORKPLACE ABSENTEEISM; LONGITUDINAL COHORT; DISABILITY PENSION; HEALTH-STATUS; RISK-FACTORS; JOB STRAIN; DRUG-USE; WORK	Aim Earlier research has revealed a strong relationship between alcohol use and sickness absence. The aim of this review was to explore and uncover this relationship by looking at differences in type of design (cross-sectional vs. longitudinal), type of data (self-reported vs. registered data), and type of sickness absence (long-term vs. short term). Method Six databases were searched through June 2020. Observational and experimental studies from 1980 to 2020, in English or Scandinavian languages reporting the results of the association between alcohol consumption and sickness absence among working population were included. Quality assessment, and statistical analysis focusing on differences in the likelihood of sickness absence on subgroup levels were performed on each association, not on each study. Differences in the likelihood of sickness absence were analyzed by means of meta-analysis. PROSPERO registration number: CRD42018112078. Results Fifty-nine studies (58% longitudinal) including 439,209 employees (min. 43, max. 77,746) from 15 countries were included. Most associations indicating positive and statistically significant results were based on longitudinal data (70%) and confirmed the strong/causal relationship between alcohol use and sickness absence. The meta-analysis included eight studies (ten samples). The increased risk for sickness absence was likely to be found in cross-sectional studies (OR: 8.28, 95% CI: 6.33-10.81), studies using self-reported absence data (OR: 5.16, 95% CI: 3.16-8.45), and those reporting short-term sickness absence (OR: 4.84, 95% CI: 2.73-8.60). Conclusion This review supports, but also challenges earlier evidence on the association between alcohol use and sickness absence. Certain types of design, data, and types of sickness absence may produce large effects. Hence, to investigate the actual association between alcohol and sickness absence, research should produce and review longitudinal designed studies using registry data and do subgroup analyses that cover and explain variability of this association.	[Hashemi, Neda S.; Skogen, Jens Christoffer; Sevic, Aleksandra; Thorrisen, Mikkel Magnus; Rimstad, Silje Lill; Sagvaag, Hildegunn; Aas, Randi Wago] Univ Stavanger, Fac Hlth Sci, Dept Publ Hlth, Stavanger, Norway; [Skogen, Jens Christoffer] Norwegian Inst Publ Hlth, Dept Hlth Promot, Bergen, Norway; [Skogen, Jens Christoffer] Stavanger Univ Hosp, Alcohol & Drug Res Western Norway, Stavanger, Norway; [Thorrisen, Mikkel Magnus; Aas, Randi Wago] OsloMet Oslo Metropolitan Univ, Fac Hlth Sci, Dept Occupat Therapy Prosthet & Orthot, Oslo, Norway; [Rimstad, Silje Lill] West Norway Competence Ctr KoRus Stavanger Rogala, Stavanger, Norway; [Riper, Heleen] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Clin Neuro & Dev Psychol, Amsterdam, Netherlands; [Riper, Heleen] Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Psychiat, Amsterdam, Netherlands; [Riper, Heleen] Univ Southern Denmark, Dept Clin Res, Res Unit Telepsychiat & Mental Hlth, Odense, Denmark; [Riper, Heleen] Univ Turku, Res Ctr Child Psychiat, Turku, Finland	Universitetet i Stavanger; Norwegian Institute of Public Health (NIPH); Stavanger University Hospital; Oslo Metropolitan University (OsloMet); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Southern Denmark; University of Turku	Hashemi, NS; Aas, RW (corresponding author), Univ Stavanger, Fac Hlth Sci, Dept Publ Hlth, Stavanger, Norway.; Aas, RW (corresponding author), OsloMet Oslo Metropolitan Univ, Fac Hlth Sci, Dept Occupat Therapy Prosthet & Orthot, Oslo, Norway.	neda.hashemi@uis.no; randi.aas@uis.no		S. Hashemi, Neda/0000-0002-6614-407X; Riper, Heleen/0000-0002-8144-8901	Norwegian Directorate of Health; Research Council of Norway [260640]	Norwegian Directorate of Health; Research Council of Norway(Research Council of Norway)	The WIRUS project is funded by the Norwegian Directorate of Health, the Research Council of Norway. Grant number: 260640. https://www.forskningsradet.no/en/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacharach SB, 2010, J APPL PSYCHOL, V95, P334, DOI 10.1037/a0018018; Balsa AI, 2010, HEALTH ECON, V19, P833, DOI 10.1002/hec.1520; Bendtsen P, 2003, ADDICT BEHAV, V28, P777, DOI 10.1016/S0306-4603(01)00294-5; BLUM TC, 1993, J STUD ALCOHOL, V54, P61, DOI 10.15288/jsa.1993.54.61; Boniface S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170892; Buvik K, 2020, DRUG-EDUC PREV POLIC, V27, P86, DOI 10.1080/09687637.2019.1570082; Buvik K, 2018, INT J DRUG POLICY, V58, P71, DOI 10.1016/j.drugpo.2018.05.005; Araujo MYC, 2017, J OCCUP ENVIRON MED, V59, P313, DOI [10.1097/JOM.0000000000000951, 10.1097/jom.0000000000000951]; Cercarelli R, REDUCING ALCOHOL REL; Chakraborty Suhash, 2013, Ind Psychiatry J, V22, P17, DOI 10.4103/0972-6748.123589; Chien PFW, 2012, BJOG-INT J OBSTET GY, V119, P903, DOI 10.1111/j.1471-0528.2011.03242.x; Christensen KB, 2007, IND HEALTH, V45, P348, DOI 10.2486/indhealth.45.348; CONIGRAVE KM, 1995, ADDICTION, V90, P1479, DOI 10.1111/j.1360-0443.1995.tb02810.x; Cunradi CB, 2005, J URBAN HEALTH, V82, P43, DOI 10.1093/jurban/jti007; da Silva JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115885; Dale-Olsen H., 2010, S KELYS P ARBEIDSLIV, V27, P105; Dawson DA, 2011, ALCOHOL RES HEALTH, V34, P144; De Clercq B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141608; Drummond C, 2021, EUR ADDICT RES, V27, P227, DOI 10.1159/000512112; Edvardsen HME, 2015, J OCCUP MED TOXICOL, V10, DOI 10.1186/s12995-015-0087-0; Ervasti J, 2018, ADDICTION, V113, P1633, DOI 10.1111/add.14249; Ervasti J, 2018, ALCOHOL ALCOHOLISM, V53, P95, DOI 10.1093/alcalc/agx079; Ervasti J, 2018, J EPIDEMIOL COMMUN H, V72, P61, DOI 10.1136/jech-2017-209777; European Foundation for the Improvement of Living and Working Conditions (Eurofound), 2002, TELEWORK EUROPEAN UN; Floderus B, 2005, J REHABIL MED, V37, P291, DOI 10.1080/16501970510034422; Folger J., CAUSES COSTS ABSENTE; FRENCH MT, 1995, PUBLIC HEALTH REP, V110, P593; Gordon R, 2012, PUBLIC HEALTH, V126, P3, DOI 10.1016/j.puhe.2011.09.014; Grimsmo A., 1997, SIFA RAPPORT; Hammer T., 1999, NOVA RAPPORT; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; HARRIS MM, 1992, J MANAGE, V18, P239, DOI 10.1177/014920639201800203; Hauge KE, 2017, IZA J LABOR POLICY, V6, DOI 10.1186/s40173-017-0088-y; HAYS RD, 1995, BEHAV RES METH INSTR, V27, P277, DOI 10.3758/BF03204745; Heeb JL, 2003, ADDICTION, V98, P1433, DOI 10.1046/j.1360-0443.2003.00461.x; Hensing G, 2011, ALCOHOL ALCOHOLISM, V46, P471, DOI 10.1093/alcalc/agr033; Hermansson U, 2002, ALCOHOL CLIN EXP RES, V26, P28, DOI 10.1111/j.1530-0277.2002.tb02428.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hjollund NH, 2007, SCAND J PUBLIC HEALT, V35, P497, DOI 10.1080/14034940701271882; HOLDER HD, 1991, J OCCUP ENVIRON MED, V33, P453; International Alliance for Responsible Drinking, 2019, TRENDS REP UND DRINK; JENKINS R, 1986, BRIT J ADDICT, V81, P525; Johansson E, 2009, EUR J PUBLIC HEALTH, V19, P19, DOI 10.1093/eurpub/ckn116; Johansson G., 2005, DIS FLEXIBILITY MODE; Jorgensen MB, 2019, EUR J EPIDEMIOL, V34, P397, DOI 10.1007/s10654-018-0476-7; Jorgensen MB, 2017, ADDICTION, V112, P1754, DOI 10.1111/add.13875; Jourdain G, 2014, EUR J WORK ORGAN PSY, V23, P483, DOI 10.1080/1359432X.2012.754573; Kaila-Kangas L, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5059-8; Kausto J., 2015, SICKNESS ABSENCE NOR; Kirkham HS, 2015, POPUL HEALTH MANAG, V18, P30, DOI 10.1089/pop.2014.0033; Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364; Kivimaki M, 2002, PSYCHOSOM MED, V64, P817, DOI 10.1097/01.PSY.0000031576.42041.B1; KIVLAHAN DR, 1990, J CONSULT CLIN PSYCH, V58, P805, DOI 10.1037/0022-006X.58.6.805; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Kondo K, 2006, INT ARCH OCC ENV HEA, V79, P213, DOI 10.1007/s00420-005-0027-x; Kujala V, 2006, SCAND J WORK ENV HEA, V32, P75, DOI 10.5271/sjweh.979; Laaksonen M, 2009, OCCUP ENVIRON MED, V66, P840, DOI 10.1136/oem.2008.039248; LABBE KA, 1987, ANN INTERN MED, V107, P224, DOI 10.7326/0003-4819-107-2-224; LANDAU JC, 1994, J ORGAN BEHAV MANAGE, V14, pU104; Landberg J, 2020, EUR ADDICT RES, V26, P40, DOI 10.1159/000504437; Lidwall U, 2011, INT J SOC WELF, V20, P167, DOI 10.1111/j.1468-2397.2010.00744.x; Lund I, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6891-1; Makela P, 2008, ADDICTION, V103, P181, DOI 10.1111/j.1360-0443.2007.02049.x; Mangione TW, 1999, J STUD ALCOHOL, V60, P261, DOI 10.15288/jsa.1999.60.261; Marchand A, 2011, INT J ENV RES PUB HE, V8, P2692, DOI 10.3390/ijerph8072692; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; MARMOT MG, 1993, ADDICTION, V88, P369, DOI 10.1111/j.1360-0443.1993.tb00824.x; Marzan M, 2022, ALCOHOL ALCOHOLISM, V57, P47, DOI 10.1093/alcalc/agab008; McFarlin SK, 2002, PSYCHOL ADDICT BEHAV, V16, P17, DOI 10.1037//0893-164X.16.1.17; Mekonnen TH, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4223-2; Moan IS, 2020, SUBST USE MISUSE, V55, P2305, DOI 10.1080/10826084.2020.1801744; Moan IS, 2021, ADDICTION, V116, P771, DOI 10.1111/add.15202; Modesti PA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147601; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moore S, 2000, J SUBST ABUSE, V11, P183, DOI 10.1016/S0899-3289(00)00020-1; Morikawa Y, 2004, EUR J PUBLIC HEALTH, V14, P413, DOI 10.1093/eurpub/14.4.413; Morois S, 2017, EUR J PUBLIC HEALTH, V27, P482, DOI 10.1093/eurpub/ckx012; Nielsen MB, 2018, SUBST USE MISUSE, V53, P574, DOI 10.1080/10826084.2017.1349797; Norstrom T, 2006, ADDICTION, V101, P1421, DOI 10.1111/j.1360-0443.2006.01446.x; Norstrom T, 2009, EUR J PUBLIC HEALTH, V19, P383, DOI 10.1093/eurpub/ckp044; NORTH F, 1993, BRIT MED J, V306, P361, DOI 10.1136/bmj.306.6874.361; Odlaug BL, 2016, ALCOHOL ALCOHOLISM, V51, P201, DOI 10.1093/alcalc/agv088; Ostby KA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3502-2; Ovuga Emilio, 2006, Afr Health Sci, V6, P14; PERSSON J, 1989, Scandinavian Journal of Primary Health Care, V7, P211, DOI 10.3109/02813438909088666; Pidd KJ, 2006, MED J AUSTRALIA, V185, P637, DOI 10.5694/j.1326-5377.2006.tb00738.x; Ragland D R, 1998, J Occup Health Psychol, V3, P172, DOI 10.1037/1076-8998.3.2.172; Richmond MK, 2016, J OCCUP ENVIRON MED, V58, P641, DOI 10.1097/JOM.0000000000000744; Richmond RL, 1999, ADDICTION, V94, P1509, DOI 10.1046/j.1360-0443.1999.941015097.x; Roche AM, 2008, ADDICTION, V103, P738, DOI 10.1111/j.1360-0443.2008.02154.x; Ruhle SA, 2020, J BUS PSYCHOL, V35, P241, DOI 10.1007/s10869-019-09615-0; Sagvaag H, 2019, J PUBLIC HEALTH RES, V8, P75, DOI 10.4081/jphr.2019.1585; Salonsalmi A, 2015, SCAND J PUBLIC HEALT, V43, P364, DOI 10.1177/1403494815574154; Salonsalmi A, 2009, SCAND J PUBLIC HEALT, V37, P846, DOI 10.1177/1403494809350519; Scheil-Adlung X., 2010, 9 WHO; Schou L, 2016, DRUG ALCOHOL REV, V35, P158, DOI 10.1111/dar.12278; Schou L, 2015, NORD STUD ALCOHOL DR, V32, P411, DOI 10.1515/nsad-2015-0040; Schou LA, 2014, EUR J PUBLIC HEALTH, V24, P480, DOI 10.1093/eurpub/cku035; Schunemann H, 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184.ch11, DOI 10.1002/9780470712184.CH11]; Skogen JC, 2019, DRUG ALCOHOL DEPEN, V202, P87, DOI 10.1016/j.drugalcdep.2019.06.002; Spak F, 1998, SOC PSYCH PSYCH EPID, V33, P613, DOI 10.1007/s001270050101; Stapelfeldt CM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-661; StataCorp, 2021, STATA STAT SOFTWARE; Suominen S, 2007, J OCCUP ENVIRON MED, V49, P990, DOI 10.1097/JOM.0b013e3181343e2b; Thorrisen MM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029184; Thorrisen MM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5660-x; Torvik FA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3427-9; Udo T, 2015, DRUG ALCOHOL DEPEN, V157, P68, DOI 10.1016/j.drugalcdep.2015.10.008; Upmark M, 1999, ADDICTION, V94, P507, DOI 10.1046/j.1360-0443.1999.9445076.x; Upmark M, 1999, J EPIDEMIOL COMMUN H, V53, P223, DOI 10.1136/jech.53.4.223; Vahtera J, 2004, J EPIDEMIOL COMMUN H, V58, P321, DOI 10.1136/jech.2003.011817; Vahtera J, 2002, AM J EPIDEMIOL, V156, P969, DOI 10.1093/aje/kwf138; Vasse RM, 1998, ADDICTION, V93, P231, DOI 10.1046/j.1360-0443.1998.9322317.x; Voss M, 2004, J OCCUP ENVIRON MED, V46, P1134, DOI 10.1097/01.jom.0000145433.65697.8d; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007; Wang YM, 2015, DIGEST DIS SCI, V60, P1889, DOI 10.1007/s10620-014-3518-3; Wells G., NEWCASTLE OTTAWA SCA; Whitaker SC, 2001, OCCUP ENVIRON MED, V58, P420, DOI 10.1136/oem.58.6.420; World Health Organization, 2018, AIR POLL CHILD HLTH; World Health Organization, 2012, ALCOHOL EUROPEAN UNI	122	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262458	10.1371/journal.pone.0262458	http://dx.doi.org/10.1371/journal.pone.0262458			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015789	Green Published, gold			2022-12-27	WOS:000814820600021
J	Lupei, MI; Li, D; Ingraham, NE; Baum, KD; Benson, B; Puskarich, M; Milbrandt, D; Melton, GB; Scheppmann, D; Usher, MG; Tignanelli, CJ				Lupei, Monica I.; Li, Danni; Ingraham, Nicholas E.; Baum, Karyn D.; Benson, Bradley; Puskarich, Michael; Milbrandt, David; Melton, Genevieve B.; Scheppmann, Daren; Usher, Michael G.; Tignanelli, Christopher J.			A 12-hospital prospective evaluation of a clinical decision support prognostic algorithm based on logistic regression as a form of machine learning to facilitate decision making for patients with suspected COVID-19	PLOS ONE			English	Article							PREDICTION; VALIDATION; COHORT; SCORES	Objective To prospectively evaluate a logistic regression-based machine learning (ML) prognostic algorithm implemented in real-time as a clinical decision support (CDS) system for symptomatic persons under investigation (PUI) for Coronavirus disease 2019 (COVID-19) in the emergency department (ED). Methods We developed in a 12-hospital system a model using training and validation followed by a real-time assessment. The LASSO guided feature selection included demographics, comorbidities, home medications, vital signs. We constructed a logistic regression-based ML algorithm to predict "severe" COVID-19, defined as patients requiring intensive care unit (ICU) admission, invasive mechanical ventilation, or died in or out-of-hospital. Training data included 1,469 adult patients who tested positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) within 14 days of acute care. We performed: 1) temporal validation in 414 SARS-CoV-2 positive patients, 2) validation in a PUI set of 13,271 patients with symptomatic SARS-CoV-2 test during an acute care visit, and 3) real-time validation in 2,174 ED patients with PUI test or positive SARS-CoV-2 result. Subgroup analysis was conducted across race and gender to ensure equity in performance. Results The algorithm performed well on pre-implementation validations for predicting COVID-19 severity: 1) the temporal validation had an area under the receiver operating characteristic (AUROC) of 0.87 (95%-CI: 0.83, 0.91); 2) validation in the PUI population had an AUROC of 0.82 (95%-CI: 0.81, 0.83). The ED CDS system performed well in real-time with an AUROC of 0.85 (95%-CI, 0.83, 0.87). Zero patients in the lowest quintile developed "severe" COVID-19. Patients in the highest quintile developed "severe" COVID-19 in 33.2% of cases. The models performed without significant differences between genders and among race/ethnicities (all p-values > 0.05). Conclusion A logistic regression model-based ML-enabled CDS can be developed, validated, and implemented with high performance across multiple hospitals while being equitable and maintaining performance in real-time validation.	[Lupei, Monica I.] Univ Minnesota, Sch Med, Dept Anesthesiol, Div Crit Care, Minneapolis, MN 55455 USA; [Li, Danni] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Ingraham, Nicholas E.] Univ Minnesota, Sch Med, Dept Med, Div Pulm & Crit Care, Minneapolis, MN 55455 USA; [Baum, Karyn D.; Benson, Bradley; Usher, Michael G.] Univ Minnesota, Sch Med, Dept Med, Div Gen Internal Med,Sect Hosp Med, Minneapolis, MN 55455 USA; [Puskarich, Michael; Milbrandt, David] Univ Minnesota, Sch Med, Dept Emergency Med, Minneapolis, MN 55455 USA; [Melton, Genevieve B.; Tignanelli, Christopher J.] Univ Minnesota, Sch Med, Dept Surg, Minneapolis, MN 55455 USA; [Melton, Genevieve B.; Scheppmann, Daren; Tignanelli, Christopher J.] Univ Minnesota, Inst Hlth Informat, Minneapolis, MN USA; [Tignanelli, Christopher J.] Univ Minnesota, Sch Med, Dept Surg, Div Crit Care & Acute Care Surg, Minneapolis, MN 55455 USA; [Lupei, Monica I.] Univ Minnesota, Sch Med, Dept Anesthesiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lupei, MI (corresponding author), Univ Minnesota, Sch Med, Dept Anesthesiol, Div Crit Care, Minneapolis, MN 55455 USA.; Lupei, MI (corresponding author), Univ Minnesota, Sch Med, Dept Anesthesiol, Minneapolis, MN 55455 USA.	lupei001@umn.edu	Issanov, Alpamys/AAD-2792-2020; Puskarich, Michael/N-7849-2014	Issanov, Alpamys/0000-0002-8968-2655; Ingraham, Nicholas/0000-0002-0292-0594; Melton-Meaux, Genevieve/0000-0001-5193-1663; Lupei, Monica/0000-0002-8513-4061; Tignanelli, Christopher/0000-0002-8079-5565; Puskarich, Michael/0000-0001-6358-4670; Li, Danni/0000-0002-0608-2831	Gates Foundation; MN Department of Health; Agency for Healthcare Research	Gates Foundation(Bill & Melinda Gates Foundation); MN Department of Health; Agency for Healthcare Research	CJT: Funding received through Agency for Healthcare Research and the Gates Foundation KDB: Supported on 2 grants from the MN Department of Health to oversee statewide placement of patients as part of COVID response. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta AM, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.30479; Asch DA, 2021, JAMA INTERN MED, V181, P471, DOI 10.1001/jamainternmed.2020.8193; Auld SC, 2020, CRIT CARE MED, V48, pE799, DOI 10.1097/CCM.0000000000004457; Bramante Carolyn, 2020, medRxiv, DOI 10.1101/2020.09.01.20185850; Bramante CT, 2021, J MED VIROL, V93, P4273, DOI 10.1002/jmv.26873; Bramante CT, 2021, LANCET HEALTH LONGEV, V2, pE34, DOI 10.1016/S2666-7568(20)30033-7; Castro VM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.23934; Chung HS, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e189; Ciceri F, 2020, CLIN IMMUNOL, V217, DOI 10.1016/j.clim.2020.108509; Clift AK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3731; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Dutta N, 2021, J PRIM CARE COMMUNIT, V12, DOI 10.1177/2150132721996283; Elliott J, 2021, EUR J EPIDEMIOL, V36, P299, DOI 10.1007/s10654-021-00722-y; Grasselli G, 2020, JAMA INTERN MED, V180, P1345, DOI 10.1001/jamainternmed.2020.3539; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Gupta RK, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.03498-2020; Haimovich AD, 2020, ANN EMERG MED, V76, P442, DOI 10.1016/j.annemergmed.2020.07.022; Hao BR, 2020, ELIFE, V9, DOI 10.7554/eLife.60519; Harrison Raquel F, 2021, Crit Care Explor, V3, pe0324, DOI 10.1097/CCE.0000000000000324; Hu H, 2020, ACAD EMERG MED, V27, P461, DOI 10.1111/acem.13992; Hufner A, 2020, MED KLIN-INTENSIVMED, V115, P132, DOI 10.1007/s00063-020-00754-4; Ingraham NE, 2021, J GEN INTERN MED, V36, P3462, DOI 10.1007/s11606-021-06790-w; Ingraham NE, 2020, LANCET RESP MED, V8, P544, DOI 10.1016/S2213-2600(20)30226-5; Ingraham Nicholas E, 2020, Crit Care Explor, V2, pe0108, DOI 10.1097/CCE.0000000000000108; Ingraham NE, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00912-2020; Ioannou GN, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22310; Jaffe E, 2020, ISR MED ASSOC J, V22, P410; Ji D, 2020, CLIN INFECT DIS, V71, P1393, DOI 10.1093/cid/ciaa414; Kline JA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248438; Knight SR, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3339; Kristinsson B, 2020, CRIT CARE MED, V48, pE1102, DOI 10.1097/CCM.0000000000004582; Levy Y, 2020, ISR MED ASSOC J, V22, P404; Lusczek ER, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248956; Mackey K, 2021, ANN INTERN MED, V174, P362, DOI 10.7326/M20-6306; Mahdavi M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252384; Nelson SJ, 2011, J AM MED INFORM ASSN, V18, P441, DOI 10.1136/amiajnl-2011-000116; O'Reilly GM, 2020, EMERG MED AUSTRALAS, V32, P511, DOI 10.1111/1742-6723.13513; Obi AT, 2021, J VASC SURG-VENOUS L, V9, P23, DOI 10.1016/j.jvsv.2020.08.030; Ogedegbe G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.26881; Paranjape N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248891; Paulus JK, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0304-9; Penverne Y, 2020, SCAND J TRAUMA RESUS, V28, DOI 10.1186/s13049-020-00775-0; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Rada G, 2020, MEDWAVE, V20, DOI 10.5867/medwave.2020.03.7867; Rentsch Christopher T, 2020, medRxiv, DOI [10.1101/2020.05.12.20099135, 10.1101/2020.04.09.20059964]; Singh K, 2021, ANN AM THORAC SOC, V18, P1129, DOI [10.1513/AnnalsATS.202006-698OC, 10.17660/ActaHortic.2020.1297.1, 10.1101/2020.04.24.20079012]; Sun YXH, 2020, CLIN INFECT DIS, V71, P786, DOI 10.1093/cid/ciaa322; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tillin T, 2014, HEART, V100, P60, DOI 10.1136/heartjnl-2013-304474; Wallace DW, 2020, JACEP OPEN, V1, P1374, DOI 10.1002/emp2.12210; Wang AZ, 2021, ACAD EMERG MED, V28, P511, DOI 10.1111/acem.14245; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328	54	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262193	10.1371/journal.pone.0262193	http://dx.doi.org/10.1371/journal.pone.0262193			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986168	gold, Green Published			2022-12-27	WOS:000765956200023
J	Przybyl, J; Spans, L; Ganjoo, K; Bui, N; Mohler, D; Norton, J; Poultsides, G; Debiec-Rychter, M; van de Rijn, M				Przybyl, Joanna; Spans, Lien; Ganjoo, Kristen; Bui, Nam; Mohler, David; Norton, Jeffrey; Poultsides, George; Debiec-Rychter, Maria; van de Rijn, Matt			Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma	PLOS ONE			English	Article								High-level amplification of MDM2 and other genes in the 12q13-15 locus is a hallmark genetic feature of well-differentiated and dedifferentiated liposarcomas (WDLPS and DDLPS, respectively). Detection of this genomic aberration in plasma cell-free DNA may be a clinically useful assay for non-invasive distinction between these liposarcomas and other retroperitoneal tumors in differential diagnosis, and might be useful for the early detection of disease recurrence. In this study, we performed shallow whole genome sequencing of cell-free DNA extracted from 10 plasma samples from 3 patients with DDLPS and 1 patient with WDLPS. In addition, we studied 31 plasma samples from 11 patients with other types of soft tissue tumors. We detected MDM2 amplification in cell-free DNA of 2 of 3 patients with DDLPS. By applying a genome-wide approach to the analysis of cell-free DNA, we also detected amplification of other genes that are known to be recurrently affected in DDLPS. Based on the analysis of one patient with DDLPS with longitudinal plasma samples available, we show that tracking MDM2 amplification in cell-free DNA may be potentially useful for evaluation of response to treatment. The patient with WDLPS and patients with other soft tissue tumors in differential diagnosis were negative for the MDM2 amplification in cell-free DNA. In summary, we demonstrate the feasibility of detecting amplification of MDM2 and other DDLPS-associated genes in plasma cell-free DNA using technology that is already routinely applied for other clinical indications. Our results may have clinical implications for improved diagnosis and surveillance of patients with retroperitoneal tumors.	[Przybyl, Joanna] McGill Univ, Dept Surg, Montreal, PQ, Canada; [Przybyl, Joanna] McGill Univ Hlth Ctr, Res Inst, Canc Res Program, Montreal, PQ, Canada; [Spans, Lien; Debiec-Rychter, Maria] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium; [Spans, Lien; Debiec-Rychter, Maria] Univ Hosp Leuven, Leuven, Belgium; [Ganjoo, Kristen; Bui, Nam] Stanford Univ, Dept Med, Div Med Oncol, Stanford, CA 94305 USA; [Mohler, David] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Norton, Jeffrey; Poultsides, George] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [van de Rijn, Matt] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	McGill University; McGill University; KU Leuven; KU Leuven; University Hospital Leuven; Stanford University; Stanford University; Stanford University; Stanford University	Przybyl, J (corresponding author), McGill Univ, Dept Surg, Montreal, PQ, Canada.; Przybyl, J (corresponding author), McGill Univ Hlth Ctr, Res Inst, Canc Res Program, Montreal, PQ, Canada.	joanna.przybyl@mcgill.ca		van de Rijn, Matt/0000-0002-1909-9739; Przybyl, Joanna/0000-0002-8162-5226				Amant F, 2015, JAMA ONCOL, V1, P814, DOI 10.1001/jamaoncol.2015.1883; Bayindir B, 2015, EUR J HUM GENET, V23, P1286, DOI 10.1038/ejhg.2014.282; Binh MBN, 2007, AM J SURG PATHOL, V31, P1557, DOI 10.1097/PAS.0b013e31804b4109; Braig D, 2019, INT J CANCER, V145, P1148, DOI 10.1002/ijc.32216; Casadei L, 2019, CANCER RES, V79, P4911, DOI 10.1158/0008-5472.CAN-19-0203; Castriota G, 2007, CELL BIOL INT, V31, P586, DOI 10.1016/j.cellbi.2006.11.033; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Chibon F, 2004, GENE CHROMOSOME CANC, V40, P32, DOI 10.1002/gcc.20012; Coindre JM, 2010, VIRCHOWS ARCH, V456, P167, DOI 10.1007/s00428-009-0815-x; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Hemming ML, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.18.00235; Lazar AJ, 2017, CELL, V171, P950, DOI 10.1016/j.cell.2017.10.014; Lee ATJ, 2018, J CLIN ONCOL, V36, P151, DOI 10.1200/JCO.2017.74.9598; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Matthyssens LE, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00004; Przybyl J, 2019, JCO PRECIS ONCOL, V3, DOI [10.1200/PO.18.00409, 10.1200/po.18.00409]; Przybyl J, 2018, CLIN CANCER RES, V24, P2688, DOI 10.1158/1078-0432.CCR-17-3704; Somaiah Neeta, 2018, Oncotarget, V9, P19891, DOI 10.18632/oncotarget.24924; Vandenberghe P, 2015, LANCET HAEMATOL, V2, pE55, DOI 10.1016/S2352-3026(14)00039-8	20	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262272	10.1371/journal.pone.0262272	http://dx.doi.org/10.1371/journal.pone.0262272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986184	gold, Green Published			2022-12-27	WOS:000765956200033
J	Sidhoum, AA; Dakpo, KH; Latruffe, L				Ait Sidhoum, Amer; Dakpo, K. Herve; Latruffe, Laure			Trade-offs between economic, environmental and social sustainability on farms using a latent class frontier efficiency model: Evidence for Spanish crop farms	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; TECHNICAL EFFICIENCY; DAIRY FARMS; CHEAP TALK; AGRICULTURE; IMPACT; TECHNOLOGY; BEHAVIOR; LEVEL; INEFFICIENCIES	This article studies trade-offs of farms in terms of economic sustainability (proxied here by technical efficiency), environmental sustainability (proxied here by farmers' commitment towards the environment) and social sustainability (proxied here by farmers' contribution to on farm well-being and communities' well-being). We use the latent class stochastic frontier model and create classes based on three separating variables, representing farms' environmental sustainability and social sustainability. The application to a sample of Spanish crop farms shows that more environmentally sustainable farms are likely to have lower levels of technical efficiency. However, improvements in social concerns, both towards own farm and the larger community, may lead to improved technical efficiency levels. In general, our study provides evidence of trade-offs for farms between economic sustainability and environmental sustainability, but also between environmental sustainability and social sustainability.	[Ait Sidhoum, Amer] Tech Univ Munich, Dept Agr Prod & Resource Econ, Freising Weihenstephan, Germany; [Ait Sidhoum, Amer] Nat Resources Inst Finland Luke, Business Econ, Helsinki, Finland; [Dakpo, K. Herve] Univ Paris Saclay, INRAE, AgroParisTech, Economie Publ, Thiverval Grignon, France; [Dakpo, K. Herve] Swiss Fed Inst Technol, Agr Econ & Policy Grp, Zurich, Switzerland; [Latruffe, Laure] Univ Bordeaux, INRAE, GREThA, Bordeaux, France	Technical University of Munich; Natural Resources Institute Finland (Luke); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite de Bordeaux	Sidhoum, AA (corresponding author), Tech Univ Munich, Dept Agr Prod & Resource Econ, Freising Weihenstephan, Germany.; Sidhoum, AA (corresponding author), Nat Resources Inst Finland Luke, Business Econ, Helsinki, Finland.	amer.ait-sidhoum@luke.fi		AITSIDHOUM, Amer/0000-0001-7089-6242	Instituto Nacional de Investigaciones Agricolas (INIA) in Spain; European Regional Development Fund (ERDF), Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I + D + i) [RTA2012-00002-00-00]; Technical University of Munich (TUM)	Instituto Nacional de Investigaciones Agricolas (INIA) in Spain(Instituto de Investigacion Agropecuaria (INIA)); European Regional Development Fund (ERDF), Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I + D + i); Technical University of Munich (TUM)	The authors gratefully acknowledge financial support for data collection from Instituto Nacional de Investigaciones Agricolas (INIA) in Spain and from the European Regional Development Fund (ERDF), Plan Nacional de Investigacion Cienti ' fica, Desarrollo e Innovacion Tecnologica (I + D + i), Project Reference Number RTA2012-00002-00-00. This work is also supported by the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv A, 2006, EUR REV AGRIC ECON, V33, P49, DOI 10.1093/erae/jbi035; Aigner D., 1977, J EC, V6, P21; Allen P., 1991, American Journal of Alternative Agriculture, V6, P34, DOI 10.1017/S0889189300003787; Alvarez A, 2008, J DAIRY SCI, V91, P3693, DOI 10.3168/jds.2008-1123; Alvarez A, 2010, EUR REV AGRIC ECON, V37, P231, DOI 10.1093/erae/jbq015; [Anonymous], 2010, SUSTAINABLE AGR SYST, DOI DOI 10.17226/12832; BANKER RD, 1984, MANAGE SCI, V30, P1078, DOI 10.1287/mnsc.30.9.1078; Battese G. E., 1995, EMPIR ECON, V20, P325, DOI DOI 10.1007/BF01205442; BATTESE GE, 1977, AUST J AGR ECON, V21, P169, DOI 10.1111/j.1467-8489.1977.tb00204.x; BATTESE GE, 1988, J ECONOMETRICS, V38, P387, DOI 10.1016/0304-4076(88)90053-X; Berre D, 2014, J ENVIRON MANAGE, V146, P235, DOI 10.1016/j.jenvman.2014.07.008; Bogetoft P, 2003, J PROD ANAL, V20, P243, DOI 10.1023/A:1027347616038; Bojnec S, 2008, IND MANAGE DATA SYST, V108, P258, DOI 10.1108/02635570810847617; Bostrom M, 2012, INT J SUST DEV WORLD, V19, P3, DOI 10.1080/13504509.2011.582891; BRAVOURETA BE, 1994, AGR ECON, V10, P27, DOI 10.1016/0169-5150(94)90037-X; Burton RJF, 2014, J ENVIRON MANAGE, V135, P19, DOI 10.1016/j.jenvman.2013.12.005; Chambers RG, 2018, EMPIR ECON, V54, P189, DOI 10.1007/s00181-016-1135-z; Chang HH, 2010, EUR REV AGRIC ECON, V37, P523, DOI 10.1093/erae/jbq032; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Chen Z, 2009, CHINA ECON REV, V20, P153, DOI 10.1016/j.chieco.2009.03.002; Chopin P, 2015, AGR SYST, V140, P26, DOI 10.1016/j.agsy.2015.08.006; Cillero MM, 2019, EUR REV AGRIC ECON, V46, P193, DOI 10.1093/erae/jby028; Cuesta RA, 2000, J PROD ANAL, V13, P139, DOI 10.1023/A:1017297831646; Cummings RG, 1999, AM ECON REV, V89, P649, DOI 10.1257/aer.89.3.649; Dakpo KH, 2021, J AGR ECON, V72, P760, DOI 10.1111/1477-9552.12422; Dempsey N, 2011, SUSTAIN DEV, V19, P289, DOI 10.1002/sd.417; Diazabakana A., REV FARM LEVEL INDIC; Dillard J., 2008, UNDERSTANDING SOCIAL; Duke JM, 2012, ECOL ECON, V74, P95, DOI 10.1016/j.ecolecon.2011.12.002; Edum-Fotwe FT, 2009, INT J PROJ MANAG, V27, P313, DOI 10.1016/j.ijproman.2008.04.003; Fare R., 1985, MEASUREMENT EFFICIEN, P1, DOI [10.1007/978-94-015-7721-2_1, DOI 10.1007/978-94-015-7721-2_1]; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; Florax RJGM, 2005, EUR REV AGRIC ECON, V32, P441, DOI 10.1093/erae/jbi025; Garmendia E, 2010, ECOL ECON, V69, P1712, DOI 10.1016/j.ecolecon.2010.03.027; Govindan K, 2018, INT J PROD ECON, V200, P353, DOI 10.1016/j.ijpe.2016.09.003; Greene, 2002, ALTERNATIVE PANEL DA; Greene W, 2005, J ECONOMETRICS, V126, P269, DOI 10.1016/j.jeconom.2004.05.003; Guan ZF, 2006, AM J AGR ECON, V88, P644, DOI 10.1111/j.1467-8276.2006.00885.x; Guesmi B, 2012, SPAN J AGRIC RES, V10, P552, DOI 10.5424/sjar/2012103-462-11; Hagenaars J., 2002, APPL LATENT CLASS AN, DOI DOI 10.1017/CBO9780511499531; Haggar J, 2017, ECOL INDIC, V79, P330, DOI 10.1016/j.ecolind.2017.04.023; Hansson H, 2020, EUR REV AGRIC ECON, V47, P1, DOI 10.1093/erae/jby042; Hensher DA, 2015, APPLIED CHOICE ANALYSIS, 2ND EDITION, P1, DOI 10.1017/CBO9781316136232; Huang HC, 2004, J PROD ANAL, V21, P277, DOI 10.1023/B:PROD.0000022094.39915.cf; Huijps K, 2010, EUR REV AGRIC ECON, V37, P553, DOI 10.1093/erae/jbq036; JONDROW J, 1982, J ECONOMETRICS, V19, P233, DOI 10.1016/0304-4076(82)90004-5; KALIRAJAN KP, 1994, OXFORD B ECON STAT, V56, P87; KALIRAJAN KP, 1990, J APPL ECONOM, V5, P75, DOI 10.1002/jae.3950050106; Kumbhakar, 2004, EMPIR ECON, V29, P169, DOI [10.1007/s00181-003-0184-2, DOI 10.1007/S00181-003-0184-2]; Lansink AO, 2002, EUR REV AGRIC ECON, V29, P51, DOI 10.1093/erae/29.1.51; Latruffe L, 2004, APPL ECON, V36, P1255, DOI 10.1080/0003684042000176793; Latruffe L., 2016, EU FP7 FLINT FARM LE, P1; Lebacq T, 2013, AGRON SUSTAIN DEV, V33, P311, DOI 10.1007/s13593-012-0121-x; Lusk JL, 2003, AM J AGR ECON, V85, P840, DOI 10.1111/1467-8276.00492; Manjunatha AV, 2013, LAND USE POLICY, V31, P397, DOI 10.1016/j.landusepol.2012.08.005; Mathijs E, 2001, REV ECON STAT, V83, P100, DOI 10.1162/003465301750160072; Mayen CD, 2010, AM J AGR ECON, V92, P181, DOI 10.1093/ajae/aap018; MEEUSEN W, 1977, INT ECON REV, V18, P435, DOI 10.2307/2525757; Mercade L., 2012, PRACTIQUES FERTILITZ; Michalos A.C., 2014, ENCY QUALITY LIFE RE; Murphy K., 2012, SCI PRACT POLICY, V8; Nielsen H.B., 2016, PACKAGE UCMINF; Phelan A, 2017, ECOL ECON, V131, P300, DOI 10.1016/j.ecolecon.2016.09.010; Pineiro V, 2020, NAT SUSTAIN, V3, P809, DOI 10.1038/s41893-020-00617-y; Rahman S, 2003, J ENVIRON MANAGE, V68, P183, DOI 10.1016/S0301-4797(03)00066-5; Roibas D, 2010, J DAIRY SCI, V93, P4366, DOI 10.3168/jds.2010-3135; Rosa-Schleich J, 2019, ECOL ECON, V160, P251, DOI 10.1016/j.ecolecon.2019.03.002; Sabiha NE, 2016, J ENVIRON MANAGE, V166, P84, DOI 10.1016/j.jenvman.2015.10.003; Sauer J., 2020, OECD FOOD AGR FISHER; Sauer J, 2013, APPL ECON, V45, P1461, DOI 10.1080/00036846.2011.617704; Seager T.P., 2008, BUS STRATEG ENVIRON, V17, P444, DOI [10.1002/bse.632, DOI 10.1002/BSE.632]; Serra T, 2009, J PROD ANAL, V31, P113, DOI 10.1007/s11123-008-0124-4; Sidhoum AA, 2020, EUR REV AGRIC ECON, V47, P200, DOI 10.1093/erae/jbz015; Spanish Ministry of Agriculture, 2010, BAL NITR AGR ESP AN; Ssebunya BR, 2019, ECOL ECON, V156, P35, DOI 10.1016/j.ecolecon.2018.09.004; Sydorovych O, 2009, RENEW AGR FOOD SYST, V24, P234, DOI 10.1017/S174217050999010X; Testa R, 2015, ECOL ENG, V83, P227, DOI 10.1016/j.ecoleng.2015.06.021; Upton M., 1987, European Review of Agricultural Economics, V14, P351, DOI 10.1093/erae/14.4.351; van Calker KJ, 2007, AGR SYST, V94, P205, DOI 10.1016/j.agsy.2006.08.006; Van Cauwenbergh N, 2007, AGR ECOSYST ENVIRON, V120, P229, DOI 10.1016/j.agee.2006.09.006; Vermeir I, 2008, ECOL ECON, V64, P542, DOI 10.1016/j.ecolecon.2007.03.007; Villalba D, 2019, AGR SYST, V173, P107, DOI 10.1016/j.agsy.2019.01.011; Yigitcanlar Tan, 2010, Sustainability, V2, P321, DOI 10.3390/su2010321; Zahm F, 2008, SUSTAIN DEV, V16, P271, DOI 10.1002/sd.380	84	2	2	8	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0261190	10.1371/journal.pone.0261190	http://dx.doi.org/10.1371/journal.pone.0261190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007293	gold, Green Published			2022-12-27	WOS:000741060700002
J	Huang, K; Wang, CTRE; Vagts, C; Raguveer, V; Finn, PW; Perkins, DL				Huang, Kai; Wang, Catherine; Vagts, Christen; Raguveer, Vanitha; Finn, Patricia W.; Perkins, David L.			Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION; INFLAMMASOMES; INFLAMMATION; PYROPTOSIS; REGULATORS	Hyperactive and damaging inflammation is a hallmark of severe rather than mild Coronavirus disease 2019 (COVID-19). To uncover key inflammatory differentiators between severe and mild COVID-19, we applied an unbiased single-cell transcriptomic analysis. We integrated two single-cell RNA-seq datasets with COVID-19 patient samples, one that sequenced bronchoalveolar lavage (BAL) cells and one that sequenced peripheral blood mononuclear cells (PBMCs). The combined cell population was then analyzed with a focus on genes associated with disease severity. The immunomodulatory long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 were highly differentially expressed between mild and severe patients in multiple cell types. Within those same cell types, the concurrent detection of other severity-associated genes involved in cellular stress response and apoptosis regulation suggests that the pro-inflammatory functions of these lncRNAs may foster cell stress and damage. Thus, NEAT1 and MALAT1 are potential components of immune dysregulation in COVID-19 that may provide targets for severity related diagnostic measures or therapy.	[Huang, Kai; Vagts, Christen; Finn, Patricia W.] Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Dept Med, Chicago, IL USA; [Huang, Kai; Finn, Patricia W.; Perkins, David L.] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Wang, Catherine; Raguveer, Vanitha] Univ Illinois, Coll Med, Chicago, IL USA; [Finn, Patricia W.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Perkins, David L.] Univ Illinois, Div Nephrol, Dept Med, Chicago, IL USA; [Perkins, David L.] Univ Illinois, Dept Surg, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Finn, PW (corresponding author), Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Dept Med, Chicago, IL USA.; Finn, PW (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL USA.; Finn, PW (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA.	pwfinn@uic.edu		Finn, Patricia/0000-0001-6936-103X; Huang, Kai/0000-0003-2445-2696	National Heart, Lung, and Blood Institute [F30HL151182, T32HL144909, R01HL138628]; National Institute of Allergy and Infectious Diseases [U01AI132898]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Heart, Lung, and Blood Institute F30HL151182 (Kai Huang), T32HL144909 (Christen Vagts), R01HL138628 (Patricia W. Finn and David L. Perkins), and the National Institute of Allergy and Infectious Diseases U01AI132898 (David L. Perkins). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A., 2021, TOPGO ENRICHMENT ANA; Ali S, 2013, J IMMUNOL, V190, P3949, DOI 10.4049/jimmunol.1201015; Amodio N, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0606-4; Baller A, 2020, WHO2019NCOVCLINICAL2; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Biswas S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24907-w; Bittmann Stefan, 2020, J Clin Med Res, V12, P320, DOI 10.14740/jocmr4161; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cai LJ, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00656-8; Camper N, 2016, MUCOSAL IMMUNOL, V9, P669, DOI 10.1038/mi.2015.90; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Chang MY, 2017, AM J PHYSIOL-LUNG C, V313, pL1069, DOI 10.1152/ajplung.00353.2017; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Collin M, 2018, IMMUNOLOGY, V154, P3, DOI 10.1111/imm.12888; Cui HC, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124522; Du CX, 2016, INT J NANOMED, V11, P5871, DOI 10.2147/IJN.S114838; Evavold CL, 2018, J MOL BIOL, V430, P217, DOI 10.1016/j.jmb.2017.09.019; Farag NS, 2020, INT J BIOCHEM CELL B, V122, DOI 10.1016/j.biocel.2020.105738; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Franzen O, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz046; Freeman TL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01518; Garcia LF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01441; Gavin AL, 2018, NAT IMMUNOL, V19, P942, DOI 10.1038/s41590-018-0179-y; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hirano T, 2020, IMMUNITY, V52, P731, DOI 10.1016/j.immuni.2020.04.003; Kapellos TS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02035; Laha S, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06395; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Li YH, 2020, OPEN MED-WARSAW, V15, P38, DOI 10.1515/med-2020-0007; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liu R, 2018, INT J MOL MED, V42, P2903, DOI 10.3892/ijmm.2018.3829; Masoumi F, 2019, J NEUROIMMUNOL, V328, P50, DOI 10.1016/j.jneuroim.2018.11.013; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; McInnes L., 2018, J OPEN SOURCE SOFTW, V3, P861, DOI [10.21105/joss.00861, DOI 10.21105/JOSS.00861]; Menon MP, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.569524; Meydan C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.590870; Mohr A, 2018, CLIN TRANSL IMMUNOL, V7, DOI 10.1002/cti2.1005; Monaco G, 2019, CELL REP, V26, P1627, DOI 10.1016/j.celrep.2019.01.041; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Plowman T, 2021, NON-CODING RNA, V7, DOI 10.3390/ncrna7030054; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Rodrigues AC, 2021, MOL ORAL MICROBIOL, V36, P291, DOI 10.1111/omi.12351; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Santofimia-Castano P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35020-3; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Soneson C, 2018, NAT METHODS, V15, P255, DOI [10.1038/nmeth.4612, 10.1038/NMETH.4612]; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tang H, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.200; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Palomino DCT, 2015, EINSTEIN-SAO PAULO, V13, P469, DOI 10.1590/S1679-45082015RB3438; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van den Berg DF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01580; Vetter P, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m627; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Wang F, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02423-8; Wang L, 2019, J CELL PHYSIOL, V234, P5319, DOI 10.1002/jcp.27340; Wang L, 2019, CAN RESPIR J, V2019, DOI 10.1155/2019/1871394; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Wei L, 2019, MOL THER-NUCL ACIDS, V18, P285, DOI 10.1016/j.omtn.2019.05.009; Wei SB, 2019, INT J CLIN EXP PATHO, V12, P3311; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Yang QZ, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.700184; Yap JKY, 2020, J IMMUNOL, V205, P307, DOI 10.4049/jimmunol.2000513; Yu SY, 2018, INT J CARDIOL, V254, P50, DOI 10.1016/j.ijcard.2017.10.071; Yue Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0917-y; Zaim S, 2020, CURR PROB CARDIOLOGY, V45, DOI 10.1016/j.cpcardiol.2020.100618; Zhan JF, 2020, KIDNEY BLOOD PRESS R, V45, P589, DOI 10.1159/000508372; Zhang JY, 2020, NAT IMMUNOL, V21, P1107, DOI 10.1038/s41590-020-0762-x; Zhang PF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09482-6; Zhang XX, 2019, NUCLEIC ACIDS RES, V47, pD721, DOI 10.1093/nar/gky900; Zhao G, 2016, FEBS LETT, V590, P2884, DOI 10.1002/1873-3468.12315; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zhou Q, 2020, CYTOGENET GENOME RES, V160, P565, DOI 10.1159/000509811; Zietkiewicz E, 2019, AM J RESP CELL MOL, V61, P440, DOI 10.1165/rcmb.2018-0260OC; Zmijewski JW, 2020, ANESTH ANALG, V131, P989, DOI 10.1213/ANE.0000000000005140	86	8	8	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0261242	10.1371/journal.pone.0261242	http://dx.doi.org/10.1371/journal.pone.0261242			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007307	Green Published, gold, Green Submitted			2022-12-27	WOS:000741060700006
J	Berendam, SJ; Morgan-Asiedu, PK; Mangan, RJ; Li, SH; Heimsath, H; Luo, K; Curtis, AD; Eudailey, JA; Fox, CB; Tomai, MA; Phillips, B; Itell, HL; Kunz, E; Hudgens, M; Cronin, K; Wiehe, K; Alam, SM; Van Rompay, KKA; De Paris, K; Permar, SR; Moody, MA; Fouda, GG				Berendam, Stella J.; Morgan-Asiedu, Papa K.; Mangan, Riley J.; Li, Shuk Hang; Heimsath, Holly; Luo, Kan; Curtis, Alan D., II; Eudailey, Joshua A.; Fox, Christopher B.; Tomai, Mark A.; Phillips, Bonnie; Itell, Hannah L.; Kunz, Erika; Hudgens, Michael; Cronin, Kenneth; Wiehe, Kevin; Alam, S. Munir; Van Rompay, Koen K. A.; De Paris, Kristina; Permar, Sallie R.; Moody, M. Anthony; Fouda, Genevieve G.			Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS SIV; NEUTRALIZING ANTIBODIES; ANTIRETROVIRAL THERAPY; INFLUENZA VACCINE; ORAL CHALLENGE; IMMUNOGENICITY; SAFETY; WOMEN; TRIAL; ALVAC	Different HIV vaccine regimens elicit distinct plasma antibody responses in both human and nonhuman primate models. Previous studies in human and non-human primate infants showed that adjuvants influenced the quality of plasma antibody responses induced by pediatric HIV envelope vaccine regimens. We recently reported that use of the 3M052-SE adjuvant and longer intervals between vaccinations are associated with higher magnitude of antibody responses in infant rhesus macaques. However, the impact of different adjuvants in HIV vaccine regimens on the developing infant B cell receptor (BCR) repertoire has not been studied. This study evaluated whether pediatric HIV envelope vaccine regimens with different adjuvants induced distinct antigen-specific memory B cell repertoires and whether specific immunoglobulin (Ig) immunogenetic characteristics are associated with higher magnitude of plasma antibody responses in vaccinated infant rhesus macaques. We utilized archived preclinical pediatric HIV vaccine studies PBMCs and tissue samples from 19 infant rhesus macaques immunized either with (i) HIV Env protein with a squalene adjuvant, (ii) MVA-HIV and Env protein co-administered using a 3-week interval, (iii) MVA-HIV prime/protein boost with an extended 6-week interval between immunizations, or (iv) with HIV Env administered with 3M-052-SE adjuvant. Frequencies of vaccine-elicited HIV Env-specific memory B cells from PBMCs and tissues were similar across vaccination groups (frequency range of 0.06-1.72%). There was no association between vaccine-elicited antigen-specific memory B cell frequencies and plasma antibody titer or avidity. Moreover, the epitope specificity and Ig immunogenetic features of vaccine-elicited monoclonal antibodies did not differ between the different vaccine regimens. These data suggest that pediatric HIV envelope vaccine candidates with different adjuvants that previously induced higher magnitude and quality of plasma antibody responses in infant rhesus macaques were not driven by distinct antigen-specific memory BCR repertoires.	[Berendam, Stella J.; Morgan-Asiedu, Papa K.; Mangan, Riley J.; Li, Shuk Hang; Heimsath, Holly; Luo, Kan; Eudailey, Joshua A.; Itell, Hannah L.; Kunz, Erika; Cronin, Kenneth; Wiehe, Kevin; Alam, S. Munir; Permar, Sallie R.; Moody, M. Anthony; Fouda, Genevieve G.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Curtis, Alan D., II; Phillips, Bonnie; De Paris, Kristina] Univ N Carolina, Sch Med, Childrens Res Inst, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Curtis, Alan D., II; Phillips, Bonnie; De Paris, Kristina] Univ N Carolina, Sch Med, Ctr AIDS Res, Chapel Hill, NC 27515 USA; [Eudailey, Joshua A.; Permar, Sallie R.] Weill Cornell Coll Med, Dept Pediat, New York, NY USA; [Fox, Christopher B.] Infect Dis Res Inst IDRI, Seattle, WA USA; [Fox, Christopher B.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Tomai, Mark A.] 3 M Drug Delivery Syst, 3M Ctr, St Paul, MN USA; [Hudgens, Michael] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA; [Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Washington; University of Washington Seattle; 3M; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Davis	Fouda, GG (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA.	genevieve.fouda@duke.edu		Morgan-Asiedu, Papa Kwadwo/0000-0001-5622-524X	National Institute of Allergy and Infectious Diseases (NIAID) [P01 AI117915]; Office of Research Infrastructure Program, Office of The Director, NIH [P51OD011107]; Interdisciplinary Research and Training Program in AIDS from NIAID [5T32AI007392-32]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Research Infrastructure Program, Office of The Director, NIH; Interdisciplinary Research and Training Program in AIDS from NIAID	This work was supported by grant P01 AI117915 from the National Institute of Allergy and Infectious Diseases (NIAID) to KDP and SRP, and P51OD011107 (Office of Research Infrastructure Program, Office of The Director, NIH) to California National Primate Research Center (CNPRC). SJB is supported by the Interdisciplinary Research and Training Program in AIDS (5T32AI007392-32) to Duke University from NIAID.	[Anonymous], 2014, GLOB UPD HLTH SECT R; Belshe RB, 2001, J INFECT DIS, V183, P1343, DOI 10.1086/319863; Bernat NV, 2021, IMMUNITY, V54, P355, DOI 10.1016/j.immuni.2020.12.018; Brochu HN, 2020, J IMMUNOL, V204, P3434, DOI 10.4049/jimmunol.1901256; Cirelli KM, 2019, CELL, V177, P1153, DOI 10.1016/j.cell.2019.04.012; Dai KF, 2015, MBIO, V6, DOI 10.1128/mBio.01375-15; DOLIN R, 1991, ANN INTERN MED, V114, P119, DOI 10.7326/0003-4819-114-2-119; Dowling DJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91020; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Fouda GG, 2015, J INFECT DIS, V211, P508, DOI 10.1093/infdis/jiu444; Gao Y, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040167; Goo L, 2014, NAT MED, V20, P655, DOI 10.1038/nm.3565; Haas AD, 2016, CLIN INFECT DIS, V63, P1227, DOI 10.1093/cid/ciw500; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Holbrook BC, 2018, IMMUNOLOGY, V153, P357, DOI 10.1111/imm.12845; Holbrook BC, 2017, VACCINE, V35, P6137, DOI 10.1016/j.vaccine.2017.09.054; Holbrook BC, 2016, J IMMUNOL, V197, P555, DOI 10.4049/jimmunol.1600497; Johnson DC, 2005, J INFECT DIS, V192, P2129, DOI 10.1086/498163; Kaleebu P, 2014, JAIDS-J ACQ IMM DEF, V65, P268, DOI 10.1097/01.qai.0000435600.65845.31; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Kintu K, 2013, JAIDS-J ACQ IMM DEF, V63, P1, DOI 10.1097/QAI.0b013e31827f1c2d; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; Luo K, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88522; McFarland EJ, 2006, AIDS, V20, P1481, DOI 10.1097/01.aids.0000237363.33994.45; NIoHN, 2020, EXP HIV VACC REG IN; Organization WH, HIV AIDS 2019; Phillips B, 2018, J VIROL, V92, DOI 10.1128/JVI.01051-18; Phillips B, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00231-17; Ramesh A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01407; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Siberry GK, 2014, PEDIATR REV, V35, P268, DOI 10.1542/pir.35-7-268; Simonich CA, 2016, CELL, V166, P77, DOI 10.1016/j.cell.2016.05.055; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; UNAIS, 2016, PREV GAP REP; Van Rompay KKA, 2005, JAIDS-J ACQ IMM DEF, V38, P124, DOI 10.1097/00126334-200502010-00002; Van Rompay KKA, 2003, J VIROL, V77, P179, DOI 10.1128/JVI.77.1.179-190.2003; Vigdorovich V, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.42; Wiehe K, 2014, IMMUNITY, V41, P909, DOI 10.1016/j.immuni.2014.11.014; Wright PF, 1999, J INFECT DIS, V180, P1080, DOI 10.1086/314985; Zhang W, 2019, J IMMUNOL, V202, P1612, DOI 10.4049/jimmunol.1800342	43	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0256885	10.1371/journal.pone.0256885	http://dx.doi.org/10.1371/journal.pone.0256885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972105	gold, Green Submitted, Green Published			2022-12-27	WOS:000773555700005
J	Petschner, P; Baksa, D; Hullam, G; Torok, D; Millinghoffer, A; Deakin, JFW; Bagdy, G; Juhasz, G				Petschner, Peter; Baksa, Daniel; Hullam, Gabor; Torok, Dora; Millinghoffer, Andras; Deakin, J. F. William; Bagdy, Gyorgy; Juhasz, Gabriella			A replication study separates polymorphisms behind migraine with and without depression	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; VASCULAR DEPRESSION; COMMON MIGRAINE; GENE; VARIANTS; PRDM16; NEUROTICISM; EXPRESSION; BIOMARKERS	The largest migraine genome-wide association study identified 38 candidate loci. In this study we assessed whether these results replicate on a gene level in our European cohort and whether effects are altered by lifetime depression. We tested SNPs of the loci and their vicinity with or without interaction with depression in regression models. Advanced analysis methods such as Bayesian relevance analysis and a neural network based classifier were used to confirm findings. Main effects were found for rs2455107 of PRDM16 (OR = 1.304, p = 0.007) and five intergenic polymorphisms in 1p31.1 region: two of them showed risk effect (OR = 1.277, p = 0.003 for both rs11209657 and rs6686879), while the other three variants were protective factors (OR = 0.4956, p = 0.006 for both rs12090642 and rs72948266; OR = 0.4756, p = 0.005 for rs77864828). Additionally, 26 polymorphisms within ADGRL2, 2 in REST, 1 in HPSE2 and 33 mostly intergenic SNPs from 1p31.1 showed interaction effects. Among clumped results representing these significant regions, only rs11163394 of ADGRL2 showed a protective effect (OR = 0.607, p = 0.002), all other variants were risk factors (rs1043215 of REST with the strongest effect: OR = 6.596, p = 0.003). Bayesian relevance analysis confirmed the relevance of intergenic rs6660757 and rs12128399 (p31.1), rs1043215 (REST), rs1889974 (HPSE2) and rs11163394 (ADGRL2) from depression interaction results, and the moderate relevance of rs77864828 and rs2455107 of PRDM16 from main effect analysis. Both main and interaction effect SNPs could enhance predictive power with the neural network based classifier. In summary, we replicated p31.1, PRDM16, REST, HPSE2 and ADGRL2 genes with classic genetic and advanced analysis methods. While the p31.1 region and PRDM16 are worthy of further investigations in migraine in general, REST, HPSE2 and ADGRL2 may be prime candidates behind migraine pathophysiology in patients with comorbid depression.	[Petschner, Peter] Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Uji, Kyoto, Japan; [Petschner, Peter; Baksa, Daniel; Torok, Dora; Bagdy, Gyorgy; Juhasz, Gabriella] Semmelweis Univ, Fac Pharm, Dept Pharmacodynam, Budapest, Hungary; [Petschner, Peter; Millinghoffer, Andras; Bagdy, Gyorgy; Juhasz, Gabriella] Semmelweis Univ, Hungarian Acad Sci, MTA SE Neuropsychopharmacol & Neurochem Res Grp, Budapest, Hungary; [Baksa, Daniel; Juhasz, Gabriella] Semmelweis Univ, Hungarian Brain Res Program, SE NAP2 Genet Brain Imaging Migraine Res Grp, Budapest, Hungary; [Hullam, Gabor; Millinghoffer, Andras] Budapest Univ Technol & Econ, Dept Measurement & Informat Syst, Budapest, Hungary; [Millinghoffer, Andras; Bagdy, Gyorgy] Semmelweis Univ, Nap 2 SE New Antidepresst Target Res Grp, Budapest, Hungary; [Deakin, J. F. William] Univ Manchester, Div Neurosci & Expt Psychol, Neurosci & Psychiat Unit, Manchester, Lancs, England; [Deakin, J. F. William] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	Kyoto University; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Budapest University of Technology & Economics; Semmelweis University; University of Manchester; University of Manchester	Petschner, P (corresponding author), Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Uji, Kyoto, Japan.; Petschner, P (corresponding author), Semmelweis Univ, Fac Pharm, Dept Pharmacodynam, Budapest, Hungary.; Petschner, P (corresponding author), Semmelweis Univ, Hungarian Acad Sci, MTA SE Neuropsychopharmacol & Neurochem Res Grp, Budapest, Hungary.	petschnerp@yahoo.com	Baksa, Daniel/O-1142-2017	Baksa, Daniel/0000-0002-7826-9179	European Union; Hungarian Brain Research Program [KTIA_13_NAP-A-II/14, 20171.2.1-NKP-2017-00002]; National Development Agency [KTIA_NAP_13-1-20130001]; Sixth Framework Program of the European Union, NewMood [LSHM-CT2004-503474]; Hungarian Academy of Sciences; Hungarian Brain Research Program (MTA-SE-NAP B Genetic Brain Imaging Migraine Research Group) [KTIA_NAP_13-2-2015-0001]; National Institute for Health Research Manchester Biomedical Research Centre; Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group); National Research, Development and Innovation Office, Hungary [2019-2.1.7-ERA-NET-2020-00005, ERAPERMED2019-108]; New National Excellence Program of Ministry of Human Capacities [UNKP-17-4-I-SE-8, UNKP-194-BME-344]; New National Excellence Program of the Ministry for Innovation and Technology from the National Research, Development and Innovation Fund [UNKP-20-3-II-SE-51, UNKP-20-5-BME-92, UNKP21-5-BME-362, UNKP-21-4-I-SE-15]; BMEBiotechnology FIKP grant of EMMI (BME FIKPBIO); Thematic Excellence Programme (Temateruleti Kivalosagi Program)of the Ministry for Innovation and Technology in Hungary, [2020-4.1.1.TKP2020]; OTKA [119866]; NRDI Fund (BME NC TKP2020,BME IE-BIO TKP2020, Artificial Intelligence National Laboratory Programme); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; Japan Society for the Promotion of Science [P20809]; Semmelweis University	European Union(European Commission); Hungarian Brain Research Program; National Development Agency; Sixth Framework Program of the European Union, NewMood; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Brain Research Program (MTA-SE-NAP B Genetic Brain Imaging Migraine Research Group); National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group); National Research, Development and Innovation Office, Hungary(National Research, Development & Innovation Office (NRDIO) - Hungary); New National Excellence Program of Ministry of Human Capacities; New National Excellence Program of the Ministry for Innovation and Technology from the National Research, Development and Innovation Fund; BMEBiotechnology FIKP grant of EMMI (BME FIKPBIO); Thematic Excellence Programme (Temateruleti Kivalosagi Program)of the Ministry for Innovation and Technology in Hungary,; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NRDI Fund (BME NC TKP2020,BME IE-BIO TKP2020, Artificial Intelligence National Laboratory Programme); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Semmelweis University	Our study was part of NewMood (New Molecules in Mood Disorders, 2004-2009) research program funded by the European Union and was supported by the Hungarian Brain Research Program (KTIA_13_NAP-A-II/14, 20171.2.1-NKP-2017-00002); by the National Development Agency (KTIA_NAP_13-1-20130001); by the Sixth Framework Program of the European Union, NewMood (Grant No. LSHM-CT2004-503474); by the Hungarian Academy of Sciences, Semmelweis University and the Hungarian Brain Research Program (MTA-SE-NAP B Genetic Brain Imaging Migraine Research Group, Grant KTIA_NAP_13-2-2015-0001); by the National Institute for Health Research Manchester Biomedical Research Centre; by the Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group); by the National Research, Development and Innovation Office, Hungary (2019-2.1.7-ERA-NET-2020-00005), under the frame of ERA PerMed (ERAPERMED2019-108); by the New National Excellence Program of Ministry of Human Capacities (UNKP-17-4-I-SE-8, UNKP-194-BME-344); by the New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund (U ' NKP-20-3-II-SE-51, U ' NKP-20-5-BME-92, U ' NKP21-5-BME-362, U ' NKP-21-4-I-SE-15); by the BMEBiotechnology FIKP grant of EMMI (BME FIKPBIO); by the Thematic Excellence Programme (Te ' materuleti Kiva ' lo ' sa ' gi Program, 2020-4.1.1.TKP2020) of the Ministry for Innovation and Technology in Hungary, within the framework of the Neurology and Translational Biotechnology thematic programmes of the Semmelweis University; by OTKA 119866; and by the NRDI Fund (BME NC TKP2020, BME IE-BIO TKP2020, Artificial Intelligence National Laboratory Programme) based on the charter of bolster issued by the NRDI Office under the auspices of the Ministry for Innovation and Technology. GH is a recipient of the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. PP is an international research fellow of Japan Society for the Promotion of Science (Postdoctoral Fellowships for Research in Japan, standard program, P20809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M, 2016, ACM SIGPLAN NOTICES, V51, P1, DOI [10.1145/2951913.2976746, 10.1145/3022670.2976746]; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; An XK, 2013, HEADACHE, V53, P1595, DOI 10.1111/head.12212; Antal P., 2008, P C WORKSH J MACH LE, P74; Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; Baker M, 2016, NATURE, V531, P151, DOI 10.1038/nature.2016.19503; Bloudek LM, 2012, J HEADACHE PAIN, V13, P361, DOI 10.1007/s10194-012-0460-7; Breslau N, 2003, NEUROLOGY, V60, P1308, DOI 10.1212/01.WNL.0000058907.41080.54; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; Chen MH, 2021, J AFFECT DISORDERS, V279, P687, DOI 10.1016/j.jad.2020.10.056; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Chen ZS, 2021, G3-GENES GENOM GENET, V11, DOI 10.1093/g3journal/jkaa056; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Christensen AF, 2016, CEPHALALGIA, V36, P624, DOI 10.1177/0333102415610874; Coleman JRI, 2016, BRIEF FUNCT GENOMICS, V15, P298, DOI 10.1093/bfgp/elv037; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Csepany E, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0938-z; de Boer I, 2019, CURR OPIN NEUROL, V32, P413, DOI 10.1097/WCO.0000000000000687; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Eszlari N, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0454-1; Fan XP, 2014, HEADACHE, V54, P709, DOI 10.1111/head.12329; Fenzl A, 2014, HORM MOL BIOL CLIN I, V19, P25, DOI 10.1515/hmbci-2014-0022; Foster SA, 2020, J MED ECON, V23, P1356, DOI 10.1080/13696998.2020.1814790; Friedman N, 2003, MACH LEARN, V50, P95, DOI 10.1023/A:1020249912095; Gargus JJ, 2009, ANN NY ACAD SCI, V1151, P133, DOI 10.1111/j.1749-6632.2008.03572.x; Ghosh J, 2013, HEADACHE, V53, P1583, DOI 10.1111/head.12240; Giral H, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00181; Gonda X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22221-z; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Hare DL, 2021, CURR OPIN LIPIDOL, V32, P167, DOI 10.1097/MOL.0000000000000749; Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Horvath C, 2014, MED HYPOTHESES, V82, P529, DOI 10.1016/j.mehy.2014.02.004; Howard DM, 2019, NAT NEUROSCI, V22, P343, DOI 10.1038/s41593-018-0326-7; Hullam G., 2017, 2017 IEEE C COMP INT; Hullam G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46001-5; Irimia P, 2020, EUR J NEUROL, V27, P2616, DOI 10.1111/ene.14431; Juhasz G, 2003, J NEUROGENET, V17, P231, DOI 10.1080/01677060390249079; Juhasz G, 2003, NEUROSCI LETT, V350, P56, DOI 10.1016/S0304-3940(03)00834-6; Juhasz G, 2018, THESIS SEMMELWEIS U; Juhasz Gabriella, 2012, Neuropsychopharmacol Hung, V14, P259; Juhasz G, 2011, BIOL PSYCHIAT, V69, P762, DOI 10.1016/j.biopsych.2010.11.019; Juhasz G, 2009, NEUROSCI LETT, V461, P116, DOI 10.1016/j.neulet.2009.06.021; Juhasz G, 2009, NEUROPSYCHOPHARMACOL, V34, P2019, DOI 10.1038/npp.2009.19; Kaur S, 2019, MOL BIOL REP, V46, P1247, DOI 10.1007/s11033-019-04593-1; Kingma D.P., 2014, ARXIV, DOI DOI 10.48550/ARXIV.1412.6980; Kondratieva N, 2016, J NEUROL SCI, V369, P63, DOI 10.1016/j.jns.2016.08.008; Lee HH, 2020, HEADACHE, V60, P71, DOI 10.1111/head.13670; Levey DF, 2020, AM J PSYCHIAT, V177, P223, DOI 10.1176/appi.ajp.2019.19030256; Levy-Adam F, 2010, J BIOL CHEM, V285, P28010, DOI 10.1074/jbc.M110.116384; Ligthart L, 2014, HUM GENET, V133, P173, DOI 10.1007/s00439-013-1370-8; Ligthart L, 2010, HEADACHE, V50, P1549, DOI 10.1111/j.1526-4610.2010.01705.x; Lipton RB, 2003, NEUROLOGY, V61, P375, DOI 10.1212/01.WNL.0000078940.53438.83; Lipton RB, 2020, HEADACHE, V60, P1683, DOI 10.1111/head.13914; Liu WP, 2020, NEUROPSYCHOPHARMACOL, V45, P1196, DOI 10.1038/s41386-020-0659-2; Maggioni F, 2012, NEUROL SCI, V33, P1447, DOI 10.1007/s10072-011-0926-4; Marx P, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005487; Matsushita H, 1999, FEBS LETT, V443, P348, DOI 10.1016/S0014-5793(99)00005-8; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; McKenzie E, 2000, BIOCHEM BIOPH RES CO, V276, P1170, DOI 10.1006/bbrc.2000.3586; Meza-Aguilar Diana G., 2014, BioMolecular Concepts, V5, P457, DOI 10.1515/bmc-2014-0032; Minen MT, 2016, J NEUROL NEUROSUR PS, V87, P741, DOI 10.1136/jnnp-2015-312233; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Ordas CM, 2013, PAIN MED, V14, P1260, DOI 10.1111/pme.12145; Osumili B, 2018, HEADACHE, V58, P287, DOI 10.1111/head.13210; Otsuki K, 2010, J PSYCHIATR RES, V44, P378, DOI 10.1016/j.jpsychires.2009.09.009; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Rajan R, 2014, CLIN APPL THROMB-HEM, V20, P851, DOI 10.1177/1076029613486538; Rajput DS, 2021, J AMB INTEL HUM COMP, DOI 10.1007/s12652-021-03154-4; Ran C, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-38; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roqueiro D, 2015, BIOINFORMATICS, V31, P303, DOI 10.1093/bioinformatics/btv254; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schur EA, 2009, HEADACHE, V49, P1493, DOI 10.1111/j.1526-4610.2009.01425.x; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shimada IS, 2017, GENE DEV, V31, P1134, DOI 10.1101/gad.291773.116; Singh-Taylor A, 2018, MOL PSYCHIATR, V23, P648, DOI 10.1038/mp.2016.240; Sintas C, 2015, CEPHALALGIA, V35, P776, DOI 10.1177/0333102414557841; Tamasi V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113662; Taylor WD, 2013, MOL PSYCHIATR, V18, P963, DOI 10.1038/mp.2013.20; Tietjen GE, 2015, CEPHALALGIA, V35, P95, DOI 10.1177/0333102414544976; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; van den Oord EJCG, 2008, AM J MED GENET B, V147B, P637, DOI 10.1002/ajmg.b.30650; van Dongen RM, 2017, CEPHALALGIA, V37, P49, DOI 10.1177/0333102415625614; Warburton A, 2015, THESIS U LIVERPOOL; Woelfle R, 2016, TRANSL NEUROSCI, V7, P17, DOI 10.1515/tnsci-2016-0004; Woelfle R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00146, 10.3389/fnins.2015.00146]; World Health Organization, 2011, ATLAS HEADACHE DISOR; Wray NR, 2018, NAT GENET, V50, P668, DOI 10.1038/s41588-018-0090-3; Yang YH, 2018, EUR J HUM GENET, V26, P1202, DOI 10.1038/s41431-018-0150-2; Zafar R, 2021, SAUDI J BIOL SCI, V28, P5793, DOI 10.1016/j.sjbs.2021.06.028; Zullo JM, 2019, NATURE, V574, P359, DOI 10.1038/s41586-019-1647-8	95	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261477	10.1371/journal.pone.0261477	http://dx.doi.org/10.1371/journal.pone.0261477			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972135	gold, Green Published, Green Accepted			2022-12-27	WOS:000773555700037
J	Zoccolotti, JD; Cavalheiro, AJ; Tasso, CO; Ribas, BR; Ferrisse, TM; Jorge, JH				Zoccolotti, Jacqueline de Oliveira; Cavalheiro, Alberto Jose; Tasso, Camilla Olga; Ribas, Beatriz Ribeiro; Ferrisse, Tulio Morandin; Jorge, Janaina Habib			Antimicrobial efficacy and biocompatibility of extracts from Cryptocarya species	PLOS ONE			English	Article							DENTURE STOMATITIS; FLAVONOID GLYCOSIDES; ALKALOIDS; BIOFILMS; MANAGEMENT; ETIOLOGY; SUSCEPTIBILITY; STYRYLPYRONES; COLONIZATION; EPIDEMIOLOGY	This study evaluated the efficacy of Cryptocarya spp extracts on biofilm of Candida albicans and its biocompatibility. Mature biofilm of C. albicans was formed on denture base acrylic resin samples and the fungicidal effect of the extracts was evaluated by Alamar Blue (R) assay, counting colony-forming units (CFU/mL) and confocal laser scanning microscopy (CLSM). Cytotoxicity of extracts from Cryptocarya species was evaluated by AlamarBlue (R) assay, using normal oral keratinocytes (NOK) cells. In additional, Analysis of plant extracts by ultra-high-performance liquid chromatography-diode array detector-tandem mass spectrometry (UPLC-DAD-MS) was performed. The results showed significant reduction in the cellular metabolism and in the number of CFU/mL of C. albicans (p<0.05). The concentration of 0.045 g/mL completely inhibited the number of CFU/mL. Regarding cytotoxicity, all extracts decreased cell viability compared to the control group. CLSM analysis showed predominance of live cells, but with a great difference between the groups. Antimicrobial activity of extracts from Cryptocarya on C. albicans biofilm was confirmed. However, all extracts showed toxicity on NOK cells.	[Zoccolotti, Jacqueline de Oliveira; Tasso, Camilla Olga; Ribas, Beatriz Ribeiro; Ferrisse, Tulio Morandin; Jorge, Janaina Habib] Sao Paulo State Univ Unesp, Sch Dent, Dept Dent Mat & Prosthodont, Araraquara, SP, Brazil; [Cavalheiro, Alberto Jose] Sao Paulo State Univ Unesp, Inst Chem, Dept Biochem & Organ Chem, Araraquara, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Jorge, JH (corresponding author), Sao Paulo State Univ Unesp, Sch Dent, Dept Dent Mat & Prosthodont, Araraquara, SP, Brazil.	habib.jorge@unesp.br	Jorge, Janaina Habib/Q-2197-2019; Ferrisse, Túlio Morandin/ABB-5885-2020	Jorge, Janaina Habib/0000-0002-9135-3455; Ferrisse, Túlio Morandin/0000-0002-9933-2819; Ribas, Beatriz/0000-0001-6763-7258	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) [88887.513643/2020-00]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The author Jacqueline de Oliveira Zoccolotti received a doctoral scholarship by the Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior -Brasil (CAPES) -Finance Code 88887.513643/2020-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior -Brasil (CAPES) -Finance Code 88887.513643/2020-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awang K, 2008, FITOTERAPIA, V79, P308, DOI 10.1016/j.fitote.2007.11.025; Bandeira KF, 2009, CHROMATOGRAPHIA, V70, P1455, DOI 10.1365/s10337-009-1338-y; Belazi M, 2004, ORAL MICROBIOL IMMUN, V19, P347, DOI 10.1111/j.1399-302x.2004.00165.x; Calcaterra R, 2013, INT J IMMUNOPATH PH, V26, P239, DOI 10.1177/039463201302600125; Sugio CYC, 2020, J FUNGI, V6, DOI 10.3390/jof6020070; Cavalheiro AJ, 2000, PHYTOCHEMISTRY, V53, P811, DOI 10.1016/S0031-9422(99)00532-4; Chang HS, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1073-5; Chang WT, 1998, PHYTOCHEMISTRY, V48, P119, DOI 10.1016/S0031-9422(97)01102-3; De Andrade PM, 2018, AN ACAD BRAS CIENC, V90, P2671, DOI 10.1590/0001-3765201820170332; Panariello BHD, 2016, AM J DENT, V29, P154; Dongari-Bagtzoglou A, 2009, ORAL MICROBIOL IMMUN, V24, P249, DOI 10.1111/j.1399-302X.2009.00505.x; DorockaBobkowska B, 1996, J ORAL PATHOL MED, V25, P411, DOI 10.1111/j.1600-0714.1996.tb00288.x; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Feng R, 2013, PHYTOCHEMISTRY, V90, P147, DOI 10.1016/j.phytochem.2013.01.009; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Gendreau L, 2011, J PROSTHODONT, V20, P251, DOI 10.1111/j.1532-849X.2011.00698.x; Giocondo M. P., 2009, Revista de Ciencias Farmaceuticas Basica e Aplicada, V30, P315; Gulati M, 2016, MICROBES INFECT, V18, P310, DOI 10.1016/j.micinf.2016.01.002; Hannah Victoria Elizabeth, 2017, Prim Dent J, V6, P46, DOI 10.1308/205016817822230175; Hellstein JW, 2019, HEAD NECK PATHOL, V13, P25, DOI 10.1007/s12105-019-01004-6; Hertiani T, 2019, PAK J PHARM SCI, V32, P1519; Hilgert JB, 2016, J AM GERIATR SOC, V64, P2539, DOI 10.1111/jgs.14399; Huang Hurng-Wern, 2014, ScientificWorldJournal, V2014, P180462, DOI 10.1155/2014/180462; Huang W, 2014, PLANTA MED, V80, P925, DOI 10.1055/s-0034-1368613; Kathiravan MK, 2012, BIOORGAN MED CHEM, V20, P5678, DOI 10.1016/j.bmc.2012.04.045; Lamfon H, 2005, FEMS MICROBIOL LETT, V242, P345, DOI 10.1016/j.femsle.2004.11.032; Lin FW, 2002, CHEM PHARM BULL, V50, P157, DOI 10.1248/cpb.50.157; Lin FW, 2001, CHEM PHARM BULL, V49, P1292, DOI 10.1248/cpb.49.1292; Maciel AJ, 2019, CHEM BIODIVERS, V16, DOI 10.1002/cbdv.201900204; Makarasen A, 2011, PLANTA MED, V77, P1519, DOI 10.1055/s-0030-1270743; Nasrullah AA, 2013, MOLECULES, V18, P8009, DOI 10.3390/molecules18078009; Nehme CJ, 2005, PHYTOCHEM ANALYSIS, V16, P93, DOI 10.1002/pca.818; Nehme CJ, 2008, BIOCHEM SYST ECOL, V36, P602, DOI 10.1016/j.bse.2008.05.001; Perlin DS, 2017, LANCET INFECT DIS, V17, pE383, DOI 10.1016/S1473-3099(17)30316-X; Queiroz MMF, 2014, PHYTOCHEM LETT, V10, pLXXXVIII, DOI 10.1016/j.phytol.2014.08.013; Reddy DK, 2010, EUR J MED CHEM, V45, P4657, DOI 10.1016/j.ejmech.2010.07.036; Ricardo MAG, 2004, ARKIVOC, P127, DOI 10.3998/ark.5550190.0005.616; Silva S, 2010, CURR MICROBIOL, V61, P534, DOI 10.1007/s00284-010-9649-7; Silva S, 2009, MED MYCOL, V47, P681, DOI 10.3109/13693780802549594; Toribio A, 2006, ORG LETT, V8, P3825, DOI 10.1021/ol061435f; Webb BC, 1998, AUST DENT J, V43, P160, DOI 10.1111/j.1834-7819.1998.tb00157.x; Webb BC, 1998, AUST DENT J, V43, P45, DOI 10.1111/j.1834-7819.1998.tb00152.x; Wu TS, 2001, J NAT PROD, V64, P1404, DOI 10.1021/np010258i; Xiong RQ, 2021, NAT PROD RES, V35, P1019, DOI 10.1080/14786419.2019.1611808; Zonaro VA., 2016, THESIS U ESTADUAL PA	45	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261884	10.1371/journal.pone.0261884	http://dx.doi.org/10.1371/journal.pone.0261884			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972152	Green Published, gold			2022-12-27	WOS:000773555700065
J	Sanchez-Tocino, ML; Miranda-Serrano, B; Gracia-Iguacel, C; de-Alba-Penaranda, AM; Mas-Fontao, S; Lopez-Gonzalez, A; Villoria-Gonzalez, S; Pereira-Garcia, M; Ortiz, A; Gonzalez-Parra, E				Luz Sanchez-Tocino, M.; Miranda-Serrano, Blanca; Gracia-Iguacel, Carolina; Maria de-Alba-Penaranda, Ana; Mas-Fontao, Sebastian; Lopez-Gonzalez, Antonio; Villoria-Gonzalez, Silvia; Pereira-Garcia, Monica; Ortiz, Alberto; Gonzalez-Parra, Emilio			Sarcopenia assessed by 4-step EWGSOP2 in elderly hemodialysis patients: Feasibility and limitations	PLOS ONE			English	Article							MORTALITY; ASSOCIATION; PREVALENCE; PREDICTOR; CONSENSUS; DIALYSIS; FRAILTY; AGE	Background In 2019, EWGSOP2 proposed 4 steps to diagnose and assess sarcopenia. We aimed to quantify the prevalence of sarcopenia according to the EWGSOP2 diagnostic algorithm and to assess its applicability in elderly patients on hemodialysis. Methods Prospective study of 60 outpatients on chronic hemodialysis aged 75- to 95-years, sarcopenia was assessed according to the 4-step EWGSOP2: Find: Strength, Assistance walking, Rise from a chair, Climb stairs, and Falls (SARC-F); Assess: grip strength by dynamometry (GSD) and sit to stand to sit 5 (STS5); Confirm: appendicular skeletal muscle mass (ASM) by bioimpedance; Severity: gait speed (GS), Timed-Up and Go (TUG), and Short Physical Performance Battery (SPPB). Results The sequential four steps resulted in a prevalence of confirmed or severe sarcopenia of 20%. Most (97%) patients fulfilled at least one criterion for probable sarcopenia. The sensitivity of SARC-F for confirmed sarcopenia was low (46%). Skipping the SARC-F step increased the prevalence of confirmed and severe sarcopenia to 40% and 37%, respectively. However, 78% of all patients had evidence of dynapenia consistent with severe sarcopenia. Muscle mass (ASM) was normal in 60% of patients, while only 25% had normal muscle strength values (GSD). Conclusions According to the 4-step EWGSOP2, the prevalence of confirmed or severe sarcopenia was low in elderly hemodialysis patients. The diagnosis of confirmed sarcopenia underestimated the prevalence of dynapenia consistent with severe sarcopenia. Future studies should address whether a 2-step EWGSOP2 assessment (Assess-Severity) is simpler to apply and may provide better prognostic information than 4-step EWGSOP2 in elderly persons on hemodialysis.	[Luz Sanchez-Tocino, M.; Miranda-Serrano, Blanca; Villoria-Gonzalez, Silvia; Gonzalez-Parra, Emilio] Fdn Renal Inigo Aivarez de Toledo, Salamanca, Spain; [Gracia-Iguacel, Carolina; Ortiz, Alberto; Gonzalez-Parra, Emilio] IIS FJD UAM, Fdn Jimenez Diaz, Serv Nefrol & Hipertens, Madrid, Spain; [Maria de-Alba-Penaranda, Ana; Pereira-Garcia, Monica] Fdn Renal Inigo Alvarez de Toledo, Madrid, Spain; [Mas-Fontao, Sebastian] IIS Fdn Jimenez Diaz UAM, CIBERDEM, Madrid, Spain; [Lopez-Gonzalez, Antonio] Complejo Hosp Univ A Coruna, La Coruna, Spain	Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Fundacion Jimenez Diaz; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna	Gonzalez-Parra, E (corresponding author), IIS FJD UAM, Fdn Jimenez Diaz, Serv Nefrol & Hipertens, Madrid, Spain.	egparra@fjd.es	; Ortiz Arduan, Alberto/Y-7582-2018	de Alba, Ana Maria/0000-0001-8262-2847; Mas, Sebastian/0000-0001-6604-3327; Sanchez-Tocino, M. Luz/0000-0002-2730-3242; Ortiz Arduan, Alberto/0000-0002-9805-9523	Ministerio de Economia, Industria y competitividad: FIS/Fondos FEDER [PI16/01298, PI17/00257, PI18/01386, PI19/00588, PI19/00815, PI20/00487, PI21/01430, KIDNEY ATTACK AC18/00064, PERSTIGAN AC18/00071, ISCIII-RETIC REDinREN RD016/0009]; Sociedad Espanola de Nefrologia, Comunidad de Madrid en Biomedicina [B2017/BMD-3686 CIFRA2-CM]; Fundacion Renal Inigo Alvarez de Toledo (FRIAT)	Ministerio de Economia, Industria y competitividad: FIS/Fondos FEDER; Sociedad Espanola de Nefrologia, Comunidad de Madrid en Biomedicina; Fundacion Renal Inigo Alvarez de Toledo (FRIAT)(Fonds de la Recherche Scientifique - FNRS)	This research received no external funding. EGP, SM and AO research groups are funded by Ministerio de Economia, Industria y competitividad: FIS/Fondos FEDER (PI16/01298, PI17/00257, PI18/01386, PI19/00588, PI19/00815, PI20/00487, PI21/01430, ERA-PerMed-JTC2018 (KIDNEY ATTACK AC18/00064 and PERSTIGAN AC18/00071, ISCIII-RETIC REDinREN RD016/0009), and Sociedad Espanola de Nefrologi ' a, Comunidad de Madrid en Biomedicina B2017/BMD-3686 CIFRA2-CM. All authors want to thank Fundacio ' n RenalI ' nigoA ' lvarez de Toledo (FRIAT) for it support to renal research in Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahat G, 2018, J NUTR HEALTH AGING, V22, P898, DOI 10.1007/s12603-018-1067-8; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bischoff HA, 2003, AGE AGEING, V32, P315, DOI 10.1093/ageing/32.3.315; Carrero JJ, 2016, KIDNEY INT, V90, P53, DOI 10.1016/j.kint.2016.02.025; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clark BC, 2012, NUTRITION, V28, P495, DOI 10.1016/j.nut.2011.12.002; Conley KE, 2013, EXP PHYSIOL, V98, P768, DOI 10.1113/expphysiol.2012.067314; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Davenport A, 2010, NEPHRON CLIN PRACT, V114, pC60, DOI 10.1159/000245070; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; El-Kateb S, 2016, NUTR CLIN PRACT, V31, P375, DOI 10.1177/0884533615621549; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gracia-Iguacel C, 2013, NEFROLOGIA, V33, P495, DOI 10.3265/Nefrologia.pre2013.Apr.11979; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hobbelen PHF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099366, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0103480, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0095422, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0095536]; Isoyama N, 2014, CLIN J AM SOC NEPHRO, V9, P1720, DOI 10.2215/CJN.10261013; Jassal SV, 2009, NEW ENGL J MED, V361, P1612, DOI 10.1056/NEJMc0905289; Kalantar-Zadeh K, 2004, NEPHROL DIAL TRANSPL, V19, P1507, DOI 10.1093/ndt/gfh143; Kramer A, 2020, CLIN KIDNEY J, V13, P693, DOI 10.1093/ckj/sfaa048; Malmstrom TK, 2016, J CACHEXIA SARCOPENI, V7, P28, DOI 10.1002/jcsm.12048; McAdams-DeMarco MA, 2013, J AM GERIATR SOC, V61, P896, DOI 10.1111/jgs.12266; Moreno-Gonzalez R., 2020, BMC GERIATR, P20, DOI [10.1186/s12877-020-1421-7, DOI 10.1186/S12877-020-1421-7]; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Pavasini R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0763-7; Pereira RA, 2015, NEPHROL DIAL TRANSPL, V30, P1718, DOI 10.1093/ndt/gfv133; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Souweine J-S., 2020, NEPHROL DIAL TRANSPL; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; Thompson S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211032; Zhu F, 2004, INT J ARTIF ORGANS, V27, P104, DOI 10.1177/039139880402700205	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261459	10.1371/journal.pone.0261459	http://dx.doi.org/10.1371/journal.pone.0261459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025892	Green Published, gold			2022-12-27	WOS:000796264200016
J	Rasheduzzaman, M; al-Mamun, F; Hosen, I; Akter, T; Hossain, M; Griffiths, MD; Mamun, MA				Rasheduzzaman, M.; al-Mamun, Firoj; Hosen, Ismail; Akter, Tahmina; Hossain, Moazzem; Griffiths, Mark D.; Mamun, Mohammed A.			Suicidal behaviors among Bangladeshi university students: Prevalence and risk factors	PLOS ONE			English	Article							FAMILY-HISTORY; DEPRESSION; IDEATION; ASSOCIATION; DISORDER; REASONS	Background Bangladeshi university students are considered to be highly suicide-prone compared to other populations and cohorts. However, no prior epidemiological studies have assessed the suicidality (i.e., past-year suicidal ideation [SI], lifetime suicide plan [SP], and lifetime suicide attempt [SA]) among Bangladeshi students, including the variables such as past-year stressful life events and family mental health history. This is arguably a major knowledge gap in the country. Therefore, the present study investigated the prevalence and associated risk factors for suicidal behaviors among Bangladeshi university students. Methods A cross-sectional study was conducted utilizing a convenience sampling method among a total of 1844 university students between October and November 2019. Data were collected based on the information related to socio-demographics, perceived health-related questions, past-year stressful life events, family mental health history, and suicidal behaviors (i.e., SI, SP, and SA). Chi-square tests and binary logistic regressions were used to analyze the data utilizing SPSS statistical software. Results The prevalence of past-year suicidal ideation, lifetime suicide plans, and suicide attempts were 13.4%, 6.0%, and 4.4%, respectively. Females reported significantly higher suicidal behavior than males (i.e., 20.6% vs.10.2% SI; 9% vs. 4.6% SP; and 6.4% vs.3.6% SA). Risk factors for SI were being female, year of academic study, residing in an urban area, using psychoactive substances, experiencing both past year physical and mental illness, experiencing any type of stressful past-year life events, experiencing campus ragging (i.e., senior students abusing, humiliating and/or harassing freshers or more junior students), experiencing family mental illness history, and having family suicide attempt history. SP was associated with several factors including being female, year of academic study, using psychoactive substance, experiencing both past-year physical and mental illness, and experiencing any type of stressful past-year life events. Risk factors for SA were being female, year of academic study, using psychoactive substances, experiencing past-year mental illness, experiencing any type of stressful past-year life events, and having family suicide attempt history. Conclusions University students appear to be a vulnerable group for experiencing suicidal behaviors. The present findings warrant rigorous action and early intervention programs such as counseling and other mental health professional services by university authorities. Longitudinal studies are highly recommended involving countrywide representative samples.	[Rasheduzzaman, M.; al-Mamun, Firoj; Hosen, Ismail; Akter, Tahmina; Mamun, Mohammed A.] CHINTA Res Bangladesh, Dhaka, Bangladesh; [Rasheduzzaman, M.] Univ Dhaka, Inst Social Welf & Res, Dhaka, Bangladesh; [al-Mamun, Firoj; Hosen, Ismail; Mamun, Mohammed A.] Jahangirnagar Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh; [Akter, Tahmina] Bangladesh Univ Hlth Sci, Dept Epidemiol, Dhaka, Bangladesh; [Hossain, Moazzem] Inst Allergy & Clin Immunol Bangladesh, Dhaka, Bangladesh; [Griffiths, Mark D.] Nottingham Trent Univ, Dept Psychol, Nottingham, England	University of Dhaka; Jahangirnagar University; Bangladesh University of Health Sciences (BUHS); Nottingham Trent University	Mamun, MA (corresponding author), CHINTA Res Bangladesh, Dhaka, Bangladesh.; Mamun, MA (corresponding author), Jahangirnagar Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh.; Griffiths, MD (corresponding author), Nottingham Trent Univ, Dept Psychol, Nottingham, England.	mark.griffiths@ntu.ac.uk; mamunphi46@gmail.com	Al Mamun, Firoj/AAX-8208-2021; Hosen, Ismail/GLR-7097-2022	Al Mamun, Firoj/0000-0003-4611-9624; Hosen, Ismail/0000-0001-6406-7325; Mamun, Mohammed/0000-0002-1728-8966				Ahmad M, 2010, J AFMC BANGLADESH, V6, P37, DOI [DOI 10.3329/JAFMC.V6I2.7273, 10.3329/jafmc.v6i2.7273]; Arafat SMY, 2019, ASIAN J PSYCHIATR, V39, P84, DOI 10.1016/j.ajp.2018.12.014; Arafat SMY, 2018, ASIAN J PSYCHIATR, V34, P44, DOI 10.1016/j.ajp.2018.04.020; Asante KO, 2017, SSM-POPUL HLTH, V3, P427, DOI 10.1016/j.ssmph.2017.05.005; Belik SL, 2007, J NERV MENT DIS, V195, P342, DOI 10.1097/01.nmd.0b013e318060a869; Bhuiyan MAH, 2020, ASIAN J PSYCHIATR, V50, DOI 10.1016/j.ajp.2020.101944; Breet E, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5425-6; Carballo JJ, 2008, J AFFECT DISORDERS, V109, P57, DOI 10.1016/j.jad.2007.12.225; Castle K., 2007, PEDIAT CLIN ADVISOR, VSecond, P544, DOI [10.1016/B978-032303506-4.10315-3, DOI 10.1016/B978-032303506-4.10315]; Faruk MO, 2021, INT J MENT HEALTH AD, DOI 10.1007/s11469-021-00603-1; Fegg M, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0088-5; Feroz A. H. M., 2012, Journal of Medicine, V13, P3, DOI 10.3329/jom.v13i1.10042; Goodwin RD, 2004, PSYCHIAT RES, V126, P159, DOI 10.1016/j.psychres.2004.02.010; Hossain S, 2020, J AFFECT DISORDERS, V263, P282, DOI 10.1016/j.jad.2019.11.153; Hubers AAM, 2018, EPIDEMIOL PSYCH SCI, V27, P186, DOI 10.1017/S2045796016001049; Jahan S, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.101994; Juurlink DN, 2004, ARCH INTERN MED, V164, P1179, DOI 10.1001/archinte.164.11.1179; MacLean J, 2011, J AFFECT DISORDERS, V130, P245, DOI 10.1016/j.jad.2010.10.028; Mamun MA, 2022, PERSPECT PSYCHIATR C, V58, P278, DOI 10.1111/ppc.12783; Mamun MA, 2022, INT J MENT HEALTH AD, V20, P1438, DOI 10.1007/s11469-020-00267-3; Mamun MA, 2020, ASIAN J PSYCHIATR, V49, DOI 10.1016/j.ajp.2020.101951; Mamun MA, 2020, ASIAN J PSYCHIATR, V48, DOI 10.1016/j.ajp.2019.101905; Mamun MA, 2022, INT J MENT HEALTH AD, V20, P657, DOI 10.1007/s11469-019-00144-8; Mamun MA, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2019.112645; Mashreky SR, 2013, ARCH SUICIDE RES, V17, P387, DOI 10.1080/13811118.2013.801809; McKinnon B, 2016, B WORLD HEALTH ORGAN, V94, P340, DOI 10.2471/BLT.15.163295; Mendez-Bustos P, 2013, SCI WORLD J, DOI 10.1155/2013/485851; Milner A, 2018, OCCUP ENVIRON MED, V75, P245, DOI 10.1136/oemed-2017-104531; Mortier P, 2018, PSYCHOL MED, V48, P554, DOI 10.1017/S0033291717002215; Mortier P, 2018, J AM ACAD CHILD PSY, V57, P263, DOI 10.1016/j.jaac.2018.01.018; Oner S, 2007, EUR PSYCHIAT, V22, P223, DOI 10.1016/j.eurpsy.2007.01.002; Oner S, 2015, J INT MED RES, V43, P483, DOI 10.1177/0300060514562056; Panagioti M, 2012, COMPR PSYCHIAT, V53, P915, DOI 10.1016/j.comppsych.2012.02.009; Panagioti M, 2009, CLIN PSYCHOL REV, V29, P471, DOI 10.1016/j.cpr.2009.05.001; Rafi MA, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00578; Rasheduzzaman M, 2021, PERSPECT PSYCHIATR C, V57, P1585, DOI 10.1111/ppc.12722; Sakib N, 2021, PERSPECT PSYCHIATR C, V57, P1150, DOI 10.1111/ppc.12670; Scott KM, 2010, PSYCHOSOM MED, V72, P712, DOI 10.1097/PSY.0b013e3181e3333d; Shah Md Mohsin Ali, 2017, Psychiatry J, V2017, P3047025, DOI 10.1155/2017/3047025; Shah MMA, 2018, ASIAN J PSYCHIATR, V35, P4, DOI 10.1016/j.ajp.2018.04.035; Wagner BM, 2003, AM BEHAV SCI, V46, P1171, DOI 10.1177/0002764202250661; Wang YG, 2017, J PSYCHIATR RES, V90, P21, DOI 10.1016/j.jpsychires.2017.02.006; World Health Organization, 2019, SUIC FACTS; Yozwiak JA., 2012, INT J DISABIL HUM DE, V11, P185, DOI [10.1515/ijdhd-2012-0042, DOI 10.1515/IJDHD-2012-0042]	44	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262006	10.1371/journal.pone.0262006	http://dx.doi.org/10.1371/journal.pone.0262006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025905	Green Published, gold, Green Accepted			2022-12-27	WOS:000796264200040
J	Rose, LJ; Houston, H; Martinez-Smith, M; Lyons, AK; Whitworth, C; Reddy, SC; Noble-Wang, J				Rose, Laura J.; Houston, Hollis; Martinez-Smith, Marla; Lyons, Amanda K.; Whitworth, Carrie; Reddy, Sujan C.; Noble-Wang, Judith			Factors influencing environmental sampling recovery of healthcare pathogens from non-porous surfaces with cellulose sponges	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BLOOD-STREAM INFECTIONS; GRAM-NEGATIVE BACTERIA; ACINETOBACTER-BAUMANNII; CLOSTRIDIUM-DIFFICILE; VANCOMYCIN-RESISTANT; BIOFILM FORMATION; STAINLESS-STEEL; CELL-SURFACE; NOSOCOMIAL PATHOGENS	Results from sampling healthcare surfaces for pathogens are difficult to interpret without understanding the factors that influence pathogen detection. We investigated the recovery of four healthcare-associated pathogens from three common surface materials, and how a body fluid simulant (artificial test soil, ATS), deposition method, and contamination levels influence the percent of organisms recovered (%R). Known quantities of carbapenemase-producing KPC+ Klebsiella pneumoniae (KPC), Acinetobacter baumannii, vancomycin-resistant Enterococcus faecalis, and Clostridioides difficile spores (CD) were suspended in Butterfield's buffer or ATS, deposited on 323 cm(2) steel, plastic, and laminate surfaces, allowed to dry 1h, then sampled with a cellulose sponge wipe. Bacteria were eluted, cultured, CFU counted and %R determined relative to the inoculum. The %R varied by organism, from <1% (KPC) to almost 60% (CD) and was more dependent upon the organism's characteristics and presence of ATS than on surface type. KPC persistence as determined by culture also declined by >1 log(10) within the 60 min drying time. For all organisms, the %R was significantly greater if suspended in ATS than if suspended in Butterfield's buffer (p<0.05), and for most organisms the %R was not significantly different when sampled from any of the three surfaces. Organisms deposited in multiple droplets were recovered at equal or higher %R than if spread evenly on the surface. This work assists in interpreting data collected while investigating a healthcare infection outbreak or while conducting infection intervention studies.	[Rose, Laura J.; Houston, Hollis; Martinez-Smith, Marla; Lyons, Amanda K.; Whitworth, Carrie; Reddy, Sujan C.; Noble-Wang, Judith] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Emerging & Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Noble-Wang, J (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Emerging & Infect Dis, Atlanta, GA 30333 USA.	cux2@cdc.gov		Lyons, Amanda/0000-0003-4312-2481; Noble-Wang, Judith/0000-0001-5090-5025				ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90, DOI 10.1128/AEM.46.1.90-97.1983; Al-Nassir WN., 2008, COMP CLIN MICROBIOLO, V47, P62, DOI [10.1086/588293, DOI 10.1086/588293]; Allison DG, 2003, BIOFOULING, V19, P139, DOI 10.1038/nrmicro2415; Arnold JW, 2000, POULTRY SCI, V79, P1839, DOI 10.1093/ps/79.12.1839; Barnes LM, 1999, APPL ENVIRON MICROB, V65, P4543; BENDINGER B, 1993, APPL ENVIRON MICROB, V59, P3973, DOI 10.1128/AEM.59.11.3973-3977.1993; Blanco N, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00790-17, 10.1128/aac.00790-17]; Bond WW., 2004, MICROBIOLOGICAL ASSA, P13; Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622; Boyce JM, 2014, AM J INFECT CONTROL, V42, P326, DOI 10.1016/j.ajic.2013.09.009; BUGGY BP, 1983, J CLIN MICROBIOL, V18, P348, DOI 10.1128/JCM.18.2.348-352.1983; BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980, DOI 10.1128/AEM.48.5.980-983.1984; Casey AL, 2010, J HOSP INFECT, V74, P72, DOI 10.1016/j.jhin.2009.08.018; Centers for Disease Control and Prevention, SURF SAMPL PROC BAC; Chai C, 2015, J MICROBIOL METH, V109, P20, DOI 10.1016/j.mimet.2014.12.001; Chowdhary D., 2018, J HOSP INFECT; Da Silva SM, 2011, APPL ENVIRON MICROB, V77, P2374, DOI 10.1128/AEM.01932-10; Denton M, 2004, J HOSP INFECT, V56, P106, DOI 10.1016/j.jhin.2003.10.017; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; Dobbs TE, 2014, AM J INFECT CONTROL, V42, P731, DOI 10.1016/j.ajic.2014.03.007; Dolan A, 2011, J HOSP INFECT, V79, P227, DOI 10.1016/j.jhin.2011.05.011; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donskey CJ, 2000, J INFECT DIS, V181, P1830, DOI 10.1086/315428; Donskey CJ, 2013, AM J INFECT CONTROL, V41, pS12, DOI 10.1016/j.ajic.2012.12.010; EICKHOFF TC, 1974, HEALTH LAB SCI, V11, P73; Eijkelkamp BA, 2011, FEMS MICROBIOL LETT, V323, P44, DOI 10.1111/j.1574-6968.2011.02362.x; Evancho G., 2001, MICROBIOLOGICAL MONI, V4th ed, P25, DOI [10.1115/1.1389461, DOI 10.1115/1.1389461]; Fijan S, 2005, J HOSP INFECT, V61, P30, DOI 10.1016/j.jhin.2005.02.005; FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67, DOI 10.1128/AEM.37.1.67-72.1979; Fletcher M., 1996, BACTERIAL ADHESION M; Fletcher M., 1980, BACTERIAL ADHERENCE, P345; Gilchrist M., 1992, CLIN MICROBIOLOGY PR, P11; Greene C, 2015, AM J INFECT CONTROL, V43, P928, DOI 10.1016/j.ajic.2015.05.008; Griffith CJ, 2007, J HOSP INFECT, V66, P352, DOI 10.1016/j.jhin.2007.05.016; Hacek DM, 2000, J CLIN MICROBIOL, V38, P4646, DOI 10.1128/JCM.38.12.4646-4648.2000; Hasan JA, 2011, J AOAC INT, V94, P259; Havill NL, 2014, INFECT CONT HOSP EP, V35, P445, DOI 10.1086/675606; Head CB., 1982, COMP STUDY SELECTIVE, V16, P615, DOI [10.1128/jcm.16.4.615-621.19827153309, DOI 10.1128/JCM.16.4.615-621.19827153309]; Hilbert LR, 2003, INT BIODETER BIODEGR, V52, P175, DOI 10.1016/S0964-8305(03)00104-5; Hogan PG., 2015, ANN PUBLIC HLTH RES, V2; Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945; HUSMARK U, 1990, J APPL BACTERIOL, V69, P557, DOI 10.1111/j.1365-2672.1990.tb01548.x; Jawad A, 1996, J CLIN MICROBIOL, V34, P2881, DOI 10.1128/JCM.34.12.2881-2887.1996; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Krauter PA, 2012, APPL ENVIRON MICROB, V78, P846, DOI 10.1128/AEM.07403-11; LARSSON K, 1981, ACTA ODONTOL SCAND, V39, P79, DOI 10.3109/00016358109162263; Lemmen SW, 2001, INT J HYG ENVIR HEAL, V203, P245, DOI 10.1078/S1438-4639(04)70035-8; Li L., 2014, IMPORTANCE VIABLE NO, V5, P258; Lyons A., 2017, SURVIVAL HEALTHCARE; Lyons A RL., 2018, PERSISTENCE ANTIMICR; McDonald LC, 1998, PEDIATR INFECT DIS J, V17, P716, DOI 10.1097/00006454-199808000-00011; MCFETERS GA, 1995, J MICROBIOL METH, V21, P1, DOI 10.1016/0167-7012(94)00027-5; Michael K, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw236; Morgan DJ, 2012, CRIT CARE MED, V40, P1045, DOI 10.1097/CCM.0b013e31823bc7c8; Neely AN., 2000, SURVIVAL ENTEROCOCCI, V38, P724, DOI [10.1128/JCM.38.2.724-726.200010655374, DOI 10.1128/JCM.38.2.724-726.200010655374]; OHara LM., 2019, OPTIMIZING CONTACT P, V69, pS171, DOI [10.1093/cid/ciz621, DOI 10.1093/CID/CIZ621]; Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363; Park GW, 2015, APPL ENVIRON MICROB, V81, P5987, DOI 10.1128/AEM.01657-15; Pembrey RS, 1999, APPL ENVIRON MICROB, V65, P2877; Perry KA., 2013, BIOSAFETY, V2013, DOI [10.4172/2167-0331.S1-002, DOI 10.4172/2167-0331.S1-002]; Peterson AE, 2013, AM J INFECT CONTROL, V41, P1298, DOI 10.1016/j.ajic.2013.05.015; Prevention CfDCa, 2020, RED RISK SURF; Ramamurthy T., 2014, CURRENT PERSPECTIVES, V2, P103, DOI [10.3389/fpubh.2014.00103, DOI 10.3389/FPUBH.2014.00103]; Rawlinson S, 2019, J HOSP INFECT, V103, P363, DOI 10.1016/j.jhin.2019.07.015; ROLLINS DM, 1986, APPL ENVIRON MICROB, V52, P531, DOI 10.1128/AEM.52.3.531-538.1986; Rose L, 2004, EMERG INFECT DIS, V10, P1023, DOI 10.3201/eid1006.030716; Rose LJ, 2011, APPL ENVIRON MICROB, V77, P8355, DOI 10.1128/AEM.05377-11; Rose LJ N-WJ., 2014, ASM MANUAL MICROBIOL, V4th; ROSZAK DB, 1987, APPL ENVIRON MICROB, V53, P2889, DOI 10.1128/AEM.53.12.2889-2893.1987; Rutala WA, 2016, AM J INFECT CONTROL, V44, pE69, DOI 10.1016/j.ajic.2015.10.039; Seahulster LM RL., 2012, HOSP EPIDEMIOLOGY IN, V4th ed, P1059; Sehulster L, 2003, MORBID MORTAL WKLY R, V52, P1; Shams AM, 2016, INFECT CONT HOSP EP, V37, P1426, DOI 10.1017/ice.2016.198; Shams AM., 2017, ASM MICROBE 0603; Suleyman G, 2018, CURR INFECT DIS REP, V20, DOI 10.1007/s11908-018-0620-2; USP, 2012, USP35 US PHAMACOPEIA; USP, 2015, USP 797 PHARM COMP S; van Loosdrecht M C, 1990, J Biomater Appl, V5, P91, DOI 10.1177/088532829000500202; van Merode AEJ, 2006, J BACTERIOL, V188, P2421, DOI 10.1128/JB.188.7.2421-2426.2006; VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75, DOI 10.1128/MMBR.54.1.75-87.1990; Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7; Watson SP, 1998, J BACTERIOL, V180, P1750, DOI 10.1128/JB.180.7.1750-1758.1998; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; Wendt C, 1998, J CLIN MICROBIOL, V36, P3734, DOI 10.1128/JCM.36.12.3734-3736.1998; West-Deadwyler RM, 2020, INFECT CONT HOSP EP, V41, P226, DOI 10.1017/ice.2019.264; Wilson APR, 2016, J HOSP INFECT, V92, pS1, DOI 10.1016/j.jhin.2015.08.007	90	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261588	10.1371/journal.pone.0261588	http://dx.doi.org/10.1371/journal.pone.0261588			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025906	gold, Green Published			2022-12-27	WOS:000796264200020
J	Logeson, ZS; MacLennan, RJ; Abad, GKB; Methven, JM; Gradl, MR; Pinto, MD; Pinto, RS; Stock, MS				Logeson, Zachary S.; MacLennan, Rob J.; Abad, Gerard-Kyle B.; Methven, Johnathon M.; Gradl, Molly R.; Pinto, Matheus D.; Pinto, Ronei S.; Stock, Matt S.			The impact of skeletal muscle disuse on distinct echo intensity bands: A retrospective analysis	PLOS ONE			English	Article							BODY-COMPOSITION; ADAPTATIONS; FAT	Echo intensity (EI) is a novel tool for assessing muscle quality. El has traditionally been reported as the mean of the pixel histogram, with 0 and 255 arbitrary units (A.U.) representing excellent and poor muscle quality, respectively. Recent work conducted in youth and younger and older adults suggested that analyzing specific El bands, rather than the mean, may provide unique insights into the effectiveness of exercise and rehabilitation interventions. As our previous work showed deterioration of muscle quality after knee joint immobilization, we sought to investigate whether the increase in El following disuse was limited to specific El bands. Thirteen females (age = 21 yrs) underwent two weeks of left knee immobilization and ambulated via crutches. B-mode ultrasonography was utilized to obtain images of the immobilized vastus lateralis. The percentage of the total number of pixels within bands of 0-50, 51-100, 101-150, 151-200, and 201-255 A.U. was examined before and after immobilization. We also sought to determine if further subdividing the histogram into 25 A.U. bands (i.e., 0-25, 26-50, etc.) would be a more sensitive methodological approach. Immobilization resulted in a decrease in the percentage of pixels within the 0-50 A.U. band (-3.11 +/- 3.98%), but an increase in the 101-150 A.U. (2.94 +/- 2.64%) and 151-200 A.U. (0.93 +/- 1.42%) bands. Analyses of variance on the change scores indicated that these differences were large and significant ( %EI0-50VS. %EI101-150: p< .001, d= 1.243); %EI0-50 vs. %EI151-200: P = .043, d = 0.831). The effect size for the %EI51-100 versus %EI(101-150)comparison was medium/large (d= 0.762), but not statistically significant (p = .085). Further analysis of the 25 A.U. bands indicated that the percentage of pixels within the 25-50 A.U. band decreased (-2.97 +/- 3.64%), whereas the 101-125 (1.62 +/- 1.47%) and 126-150 A.U. (1.18 +/- 1.07%) bands increased. Comparison of the 50 A.U. and 25 A.U. band methods found that 25 A.U. bands offer little additional insight. Though studies are needed to ascertain the factors that may influence specific bands, changes in El during muscle disuse are not homogeneous across the pixel histogram. We encourage investigators to think critically about the robustness of data obtained from El histograms, rather than simply reporting the El(mean) value, in muscle quality research.	[Logeson, Zachary S.; Abad, Gerard-Kyle B.; Methven, Johnathon M.; Gradl, Molly R.; Stock, Matt S.] Univ Cent Florida, Inst Exercise Physiol & Rehabil Sci, Neuromuscular Plast Lab, Orlando, FL 32816 USA; [MacLennan, Rob J.] Oklahoma State Univ, Appl Neuromuscular Physiol Lab, Stillwater, OK 74078 USA; [Pinto, Matheus D.] Edith Cowan Univ, Ctr Exercise & Sport Sci Res CESSR, Sch Med & Hlth Sci, Joondalup, Australia; [Pinto, Ronei S.] Univ Fed Rio Grande do Sul, Phys Educ Physiotherapy & Dance Sch, Exercise Res Lab, Porto Alegre, RS, Brazil	State University System of Florida; University of Central Florida; Oklahoma State University System; Oklahoma State University - Stillwater; Edith Cowan University; Universidade Federal do Rio Grande do Sul	Stock, MS (corresponding author), Univ Cent Florida, Inst Exercise Physiol & Rehabil Sci, Neuromuscular Plast Lab, Orlando, FL 32816 USA.	matt.stock@ucf.edu	Stock, Matt S./G-8308-2018	Stock, Matt S./0000-0003-1156-1084; Daros Pinto, Matheus/0000-0002-2616-2492	De Luca Foundation; University of Central Florida's Office of Research; UCF College of Graduate Studies Open Access Publishing Fund	De Luca Foundation; University of Central Florida's Office of Research; UCF College of Graduate Studies Open Access Publishing Fund	Funding support for this project was provided to RJM by the De Luca Foundation and the University of Central Florida's Office of Research to MSS. Article processing charges were provided to ZSL in part by the UCF College of Graduate Studies Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akima H, 2016, MAGN RESON IMAGING, V34, P397, DOI 10.1016/j.mri.2015.12.038; Arts IMP, 2012, MUSCLE NERVE, V45, P449, DOI 10.1002/mus.22254; Bali AU, 2020, EXP GERONTOL, V139, DOI 10.1016/j.exger.2020.111047; Burton AM, 2018, CLIN PHYSIOL FUNCT I, V38, P1062, DOI 10.1111/cpf.12532; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Deschenes MR, 2008, MED SCI SPORT EXER, V40, P856, DOI 10.1249/MSS.0b013e318164f4b6; Deschenes MR, 2009, EUR J APPL PHYSIOL, V105, P889, DOI 10.1007/s00421-008-0974-5; Giuliani HK, 2021, PHYSIOL MEAS, V42, DOI 10.1088/1361-6579/abea24; Hackney KJ, 2012, EUR J APPL PHYSIOL, V112, P9, DOI 10.1007/s00421-011-1971-7; Hioki M, 2020, EXP GERONTOL, V132, DOI 10.1016/j.exger.2020.110834; Komforti D, 2021, AGING CLIN EXP RES, V33, P921, DOI 10.1007/s40520-020-01596-y; Lopez P, 2019, ULTRASOUND MED BIOL, V45, P612, DOI 10.1016/j.ultrasmedbio.2018.10.010; Lopez P, 2017, MUSCLE NERVE, V55, P9, DOI 10.1002/mus.25168; MacLennan RJ, 2020, PEERJ, V8, DOI 10.7717/peerj.8224; Mota JA, 2018, AGING CLIN EXP RES, V30, P861, DOI 10.1007/s40520-017-0829-1; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Pillen S, 2009, ULTRASOUND MED BIOL, V35, P443, DOI 10.1016/j.ultrasmedbio.2008.09.016; Pinto RS, 2021, EXP GERONTOL, V145, DOI 10.1016/j.exger.2020.111179; Ruby L, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000023576; Ryan ED, 2016, APPL PHYSIOL NUTR ME, V41, P1104, DOI 10.1139/apnm-2016-0238; Schulze K, 2002, MED SCI SPORT EXER, V34, P303, DOI 10.1097/00005768-200202000-00019; Stevens J. P., 2012, APPL MULTIVARIATE ST; Stock MS, 2021, EUR J APPL PHYSIOL, V121, P369, DOI 10.1007/s00421-020-04556-6; Stokes T, 2021, PHYSIOL REP, V9, DOI 10.14814/phy2.14683; Tesch PA, 2004, J APPL PHYSIOL, V96, P1451, DOI 10.1152/japplphysiol.01051.2003; Tesch PA, 2016, J APPL PHYSIOL, V120, P1207, DOI 10.1152/japplphysiol.01052.2015; Wong V, 2020, J ULTRASOUND, V23, P457, DOI 10.1007/s40477-019-00424-y; Young HJ, 2015, MUSCLE NERVE, V52, P963, DOI 10.1002/mus.24656	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262553	10.1371/journal.pone.0262553	http://dx.doi.org/10.1371/journal.pone.0262553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015790	Green Published, gold, Green Submitted			2022-12-27	WOS:000814820600034
J	Siewe, N; Friedman, A				Siewe, Nourridine; Friedman, Avner			Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; DENDRITIC CELLS; SIPULEUCEL-T; ANDROGEN DEPRIVATION; CASTRATION; CTLA-4; IMMUNOTHERAPY; RECEPTOR; SURVIVAL; CD8(+)	Metastatic castration resistant prostate cancer (mCRPC) is commonly treated by androgen deprivation therapy (ADT) in combination with chemotherapy. Immune therapy by checkpoint inhibitors, has become a powerful new tool in the treatment of melanoma and lung cancer, and it is currently being used in clinical trials in other cancers, including mCRPC. However, so far, clinical trials with PD-1 and CTLA-4 inhibitors have been disappointing. In the present paper we develop a mathematical model to assess the efficacy of any combination of ADT with cancer vaccine, PD-1 inhibitor, and CTLA-4 inhibitor. The model is represented by a system of partial differential equations (PDEs) for cells, cytokines and drugs whose density/concentration evolves in time within the tumor. Efficacy of treatment is determined by the reduction in tumor volume at the endpoint of treatment. In mice experiments with ADT and various combinations of PD-1 and CTLA-4 inhibitors, tumor volume at day 30 was always larger than the initial tumor. Our model, however, shows that we can decrease tumor volume with large enough dose; for example, with 10 fold increase in the dose of anti-PD-1, initial tumor volume will decrease by 60%. Although the treatment with ADT in combination with PD-1 inhibitor or CTLA-4 inhibitor has been disappointing in clinical trials, our simulations suggest that, disregarding negative effects, combinations of ADT with checkpoint inhibitors can be effective in reducing tumor volume if larger doses are used. This points to the need for determining the optimal combination and amounts of dose for individual patients.	[Siewe, Nourridine] Rochester Inst Technol, Sch Math Sci, Coll Sci, Rochester, NY 14623 USA; [Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA	Rochester Institute of Technology; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Siewe, N (corresponding author), Rochester Inst Technol, Sch Math Sci, Coll Sci, Rochester, NY 14623 USA.	nourridine@aims.ac.za		Siewe, Nourridine/0000-0002-3005-8508	College of Science [15874]; Rochester Institute of Technology [16067]; Mathematical Biosciences Institute of The Ohio State University	College of Science; Rochester Institute of Technology; Mathematical Biosciences Institute of The Ohio State University	This research was supported by the Dean's Research Initiative Grant #15874 of the 390 College of Science, and the SEED Grant #16067, at Rochester Institute of Technology. 391 This work was also supported by the Mathematical Biosciences Institute of The Ohio 392 State University. There was no additional external funding received for this study.	Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; Anassi Enock, 2011, P T, V36, P197; Ardiani A, 2013, CLIN CANCER RES, V19, P6205, DOI 10.1158/1078-0432.CCR-13-1026; Barnes MJ, 2013, MUCOSAL IMMUNOL, V6, P324, DOI 10.1038/mi.2012.75; Beer TM, 2017, J CLIN ONCOL, V35, P40, DOI 10.1200/JCO.2016.69.1584; Blank CU, 2015, INT IMMUNOL, V27, P3, DOI 10.1093/intimm/dxu076; Boettcher AN, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00884; Brady-Nicholls R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15424-4; Buchbinder EI, 2016, AM J CLIN ONCOL-CANC, V39, P98, DOI 10.1097/COC.0000000000000239; Cai JJ, 2019, ONCOTARGETS THER, V12, P8437, DOI 10.2147/OTT.S221340; Cancer org, SURV RAT PROST CANC; Cancer org, KEY STAT PROST CANC; Cheng XX, 2013, J BIOL CHEM, V288, P11771, DOI 10.1074/jbc.M112.448126; Davis ID, 2019, NEW ENGL J MED, V381, P121, DOI 10.1056/NEJMoa1903835; de Almeida Daniel Vargas P, 2020, Am Soc Clin Oncol Educ Book, V40, P1, DOI 10.1200/EDBK_278853; Dennis KL, 2013, CURR OPIN ONCOL, V25, P637, DOI 10.1097/CCO.0000000000000006; Doersch KM, 2016, EXP BIOL MED, V241, P1900, DOI 10.1177/1535370216660212; Drake CG, 2005, CANCER CELL, V7, P239, DOI 10.1016/j.ccr.2005.01.027; DrugBank, NIV P T DRUG CREAT F; Du XX, 2018, CELL RES, V28, P416, DOI 10.1038/s41422-018-0011-0; Eikenberry SE, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-24; Erlandsson A, 2019, PROSTATE, V79, P363, DOI 10.1002/pros.23742; Fay AP, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.01.37; Fellner Chris, 2012, P T, V37, P503; Feng Q, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00858; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Fijak M, 2015, AM J REPROD IMMUNOL, V74, P12, DOI 10.1111/aji.12363; Friedman A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192449; Friedman A, 2013, MATH BIOSCI ENG, V10, P591, DOI 10.3934/mbe.2013.10.591; Friedmen A, 2014, J MATH ANAL APPL, V412, P776, DOI 10.1016/j.jmaa.2013.11.017; Funt SA, 2014, ONCOLOGY-NY, V28, P6; Gamat M, 2017, ENDOCR-RELAT CANCER, V24, pT297, DOI 10.1530/ERC-17-0145; Gong JL, 2000, P NATL ACAD SCI USA, V97, P2715, DOI 10.1073/pnas.050587197; Graff JN, 2015, CORE EVID, V10, P1, DOI 10.2147/CE.S54712; Gupta R, 2010, DISCOV MED, V10, P52; Ha D, 2019, P NATL ACAD SCI USA, V116, P609, DOI 10.1073/pnas.1812186116; Haabeth OAW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00174; He JB, 2015, SCI REP-UK, V5, DOI 10.1038/srep13110; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hirata Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20788-1; Inc FP, 2008, TRADENAME DEG INJ LA; Jain HV, 2011, P NATL ACAD SCI USA, V108, P19701, DOI 10.1073/pnas.1115750108; Janco JMT, 2015, J IMMUNOL, V194, P2985, DOI 10.4049/jimmunol.1403134; Ji HH, 2019, CLIN DRUG INVEST, V39, P319, DOI 10.1007/s40261-018-0735-0; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kaufman HL, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-11; Kim TJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155484; Kissick HT, 2014, P NATL ACAD SCI USA, V111, P9887, DOI 10.1073/pnas.1402468111; Koh YT, 2009, PROSTATE, V69, P571, DOI 10.1002/pros.20906; Lai XL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231499; Lai XL, 2018, P NATL ACAD SCI USA, V115, P5534, DOI 10.1073/pnas.1721559115; Lai XL, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0446-9; Lai XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178479; Lamberti MJ, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12030256; Li CX, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01234-1; Liechtenstein T., 2012, J CLIN CELL IMMUNO S, VS12, P006, DOI 10.4172/2155-9899.S12-006; Lin D, 2016, ASIAN J UROL, V3, P195, DOI 10.1016/j.ajur.2016.08.002; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; Ma Y, 2013, J CANCER, V4, P36, DOI 10.7150/jca.5046; Mailliard RB, 2002, J EXP MED, V195, P473, DOI 10.1084/jem.20011662; Maute RL, 2015, P NATL ACAD SCI USA, V112, pE6506, DOI 10.1073/pnas.1519623112; Mirlekar B, 2021, CANCERS, V13, DOI 10.3390/cancers13020167; Modena A, 2016, ONCOL REV, V10, DOI 10.4081/oncol.2016.293; Morse MD, 2010, HUM IMMUNOL, V71, P496, DOI 10.1016/j.humimm.2010.02.007; Muppidi M.R., 2015, J TARGET THER CANC, V4, P47; National Cancer Institute, 2021, NCI FACT SHEET; Ostroumov D, 2018, CELL MOL LIFE SCI, V75, P689, DOI 10.1007/s00018-017-2686-7; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Phan T, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10082721; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Recine F, 2015, TRANSL ANDROL UROL, V4, P355, DOI 10.3978/j.issn.2223-4683.2015.04.11; Rudd CE, 2009, EUR J IMMUNOL, V39, P687, DOI 10.1002/eji.200939261; Saenz R, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-211; Saraon Punit, 2014, EJIFCC, V25, P42; SB, 2021, PD L1 PROT REC; Schalken J, 2016, BJU INT, V117, P215, DOI 10.1111/bju.13123; Sheikh NA, 2013, CANCER IMMUNOL IMMUN, V62, P137, DOI 10.1007/s00262-012-1317-2; Shen YC, 2018, PROSTATE CANCER P D, V21, P113, DOI 10.1038/s41391-017-0013-x; Shi L, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-74; Siewe N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252620; Simmons AD, 2007, CANCER IMMUNOL IMMUN, V56, P1653, DOI 10.1007/s00262-007-0315-2; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sun C, 2006, ONCOGENE, V25, P3905, DOI 10.1038/sj.onc.1209424; Sun GJ, 2019, FUTURE ONCOL, V15, P1167, DOI 10.2217/fon-2018-0619; Taghizadeh H, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1644109; Tang S, 2012, CANCER RES, V72, P1975, DOI 10.1158/0008-5472.CAN-11-2499; Tsukumo S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00101; US Food and Drug Administration, 2012, XTANDI C 12A005 ENZ; van der Burg SH, 2016, NAT REV CANCER, V16, P219, DOI 10.1038/nrc.2016.16; Vaz CV, 2016, J CANCER RES CLIN, V142, P5, DOI 10.1007/s00432-015-1992-4; Wang SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24249	91	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262453	10.1371/journal.pone.0262453	http://dx.doi.org/10.1371/journal.pone.0262453			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015785	gold, Green Published			2022-12-27	WOS:000814820600020
J	Li, J; Nie, JW; Ye, J				Li, Jia; Nie, Jin-Wei; Ye, Jing			Evaluation of virtual tour in an online museum: Exhibition of Architecture of the Forbidden City	PLOS ONE			English	Article							DESIGN	Online virtual museum tours combine museum authority and an academic approach with the diversity and interactivity of online resources; such tours have become an essential resource for online scientific research and education. Many important museums around the world are developing this type of online service. Comprehensive evaluation of such tours is, however, urgently needed to ensure effectiveness. This paper establishes a heuristic evaluation scale based on the literature. Taking the online virtual tour of the Exhibition of Architecture of the Forbidden City as a case study, confirmatory factor analysis was then carried out to improve the scale. Interviews were conducted to discuss and analyze the research results. The developed evaluation scale has four dimensions: authenticity, interaction, navigation, and learning. The results from the case study showed, first, that the exhibition had visual authenticity, but the behavioral authenticity was insufficient; second, the exhibition was generally interactive, but this aspect could be improved by enriching the links; third, the lack of effective navigation design for the exhibit was the main factor affecting experience quality. Fourth, the exhibition was informative and supported learning, but needs further improvement to the quantity and quality of information provided. Finally, the interviews revealed that the online exhibition did not entirely support people of different ages and abilities, so it needs further improvement to be wholly inclusive.	[Li, Jia] Chung Yuan Christian Univ, PhD Program Design, Taoyuan, Taiwan; [Nie, Jin-Wei] Chung Yuan Christian Univ, Sch Design, Dept Interior Design, Taoyuan, Taiwan; [Ye, Jing] Chang Gung Univ, Grad Inst Management, Taoyuan, Taiwan	Chung Yuan Christian University; Chung Yuan Christian University; Chang Gung University	Li, J (corresponding author), Chung Yuan Christian Univ, PhD Program Design, Taoyuan, Taiwan.	519061889@qq.com		Ye, Jing/0000-0002-3971-2780; li, jia/0000-0001-5911-7789				Barbieri L, 2017, J CULT HERIT, V26, P101, DOI 10.1016/j.culher.2017.02.005; Barneche-Naya V., 2020, COMP STUDY USER GEST, P1; Bastanlar Y, 2007, ITI, P221; Bessa M., 2016, P 17 INT C HUMAN COM; Cachia Amanda, 2013, DISABILITY STUDIES Q, V33, P3; Vi CT, 2017, INT J HUM-COMPUT ST, V108, P1, DOI 10.1016/j.ijhcs.2017.06.004; Clarkson PJ, 2015, APPL ERGON, V46, P235, DOI 10.1016/j.apergo.2013.03.002; Coleman R., 2016, DESIGN INCLUSIVITY P; Cunliffe D., 2001, MUS MANAGE CURATOR, V19, P229; Cushing AL, 2017, J DOC, V73, P917, DOI 10.1108/JD-03-2017-0031; Donghai S, 1988, CHINESE MUSEUM, P10; Foo S, 2008, DESIDOC J LIB INF TE, V28, P22, DOI 10.14429/djlit.28.4.194; Hammady R, 2020, MULTIMED TOOLS APPL, V79, P3465, DOI 10.1007/s11042-019-08026-w; Hu QW, 2017, INFORM VISUAL, V16, P126, DOI 10.1177/1473871616655467; Kabassi K, 2019, INFORMATION, V10, DOI 10.3390/info10110351; Ke G, 2019, CONCURR COMP-PRACT E, V31, DOI 10.1002/cpe.4680; Leinhardt G, 2002, PERSPECTIVES ON OBJECT-CENTERED LEARNING IN MUSEUMS, P301; Lifeng S., 1999, J IMAGE GRAPHICS, V4, P507; Lin ACH, 2012, DECIS SUPPORT SYST, V53, P846, DOI 10.1016/j.dss.2012.05.020; MacDonald C., 2015, MW2015 MUSEUMS WEB 2; Montagud M, 2020, PERS UBIQUIT COMPUT, V24, P887, DOI 10.1007/s00779-019-01357-3; Navarrete T, 2019, WORLD LEISURE J, V61, P200, DOI 10.1080/16078055.2019.1639920; Noreikis M, 2019, IEEE ACCESS, V7, P148108, DOI 10.1109/ACCESS.2019.2945819; Pagano A, 2017, EDULEARN PROC, P3373; Pagano A, 2015, 2015 DIGITAL HERITAGE INTERNATIONAL CONGRESS, VOL 1: DIGITIZATION & ACQUISITION, COMPUTER GRAPHICS & INTERACTION, P373, DOI 10.1109/DigitalHeritage.2015.7413905; Parker E, 2020, CONVERGENCE-US, V26, P1159, DOI 10.1177/1354856519897251; Pescarin S., 2012, 2012 18th International Conference on Virtual Systems and Multimedia (VSMM 2012). Proceedings, P25, DOI 10.1109/VSMM.2012.6365903; Rodrigues JMF, 2019, IEEE ACCESS, V7, P163022, DOI 10.1109/ACCESS.2019.2953003; Roussou M., 2018, MULTIMODAL TECHNOL I, V2, P1, DOI [DOI 10.3390/mti2020032, DOI 10.3390/MTI2020032]; Schweibenz W., 2004, MUSEUM NEWS, V57, P3; Sutcliffe A, 2004, INTERACT COMPUT, V16, P831, DOI 10.1016/j.intcom.2004.05.001; Sylaiou S, 2009, J CULT HERIT, V10, P520, DOI 10.1016/j.culher.2009.03.003; The Audio Description Project, AUD DESCR PROJ; Tian J, 2015, INT CONF MEAS, P683, DOI 10.1109/ICMTMA.2015.170; Yaneva A, 2009, PUBLIC UNDERST SCI, V18, P79, DOI 10.1177/0963662507077512	35	0	0	22	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261607	10.1371/journal.pone.0261607	http://dx.doi.org/10.1371/journal.pone.0261607			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990488	gold, Green Published			2022-12-27	WOS:000815783800011
J	Mahbub, M; Srinivasan, S; Danciu, I; Peluso, A; Begoli, E; Tamang, S; Peterson, GD				Mahbub, Maria; Srinivasan, Sudarshan; Danciu, Ioana; Peluso, Alina; Begoli, Edmon; Tamang, Suzanne; Peterson, Gregory D.			Unstructured clinical notes within the 24 hours since admission predict short, mid & long-term mortality in adult ICU patients	PLOS ONE			English	Article							HOSPITAL MORTALITY	Mortality prediction for intensive care unit (ICU) patients is crucial for improving outcomes and efficient utilization of resources. Accessibility of electronic health records (EHR) has enabled data-driven predictive modeling using machine learning. However, very few studies rely solely on unstructured clinical notes from the EHR for mortality prediction. In this work, we propose a framework to predict short, mid, and long-term mortality in adult ICU patients using unstructured clinical notes from the MIMIC III database, natural language processing (NLP), and machine learning (ML) models. Depending on the statistical description of the patients' length of stay, we define the short-term as 48-hour and 4-day period, the mid-term as 7-day and 10-day period, and the long-term as 15-day and 30-day period after admission. We found that by only using clinical notes within the 24 hours of admission, our framework can achieve a high area under the receiver operating characteristics (AU-ROC) score for short, mid and long-term mortality prediction tasks. The test AU-ROC scores are 0.87, 0.83, 0.83, 0.82, 0.82, and 0.82 for 48-hour, 4-day, 7-day, 10-day, 15-day, and 30-day period mortality prediction, respectively. We also provide a comparative study among three types of feature extraction techniques from NLP: frequency-based technique, fixed embedding-based technique, and dynamic embedding-based technique. Lastly, we provide an interpretation of the NLP-based predictive models using feature-importance scores.	[Mahbub, Maria; Srinivasan, Sudarshan; Begoli, Edmon] Oak Ridge Natl Lab, Cyber Resilience & Intelligence Div, Oak Ridge, TN 37830 USA; [Danciu, Ioana; Peluso, Alina] Oak Ridge Natl Lab, Computat Sci & Engn Div, Oak Ridge, TN USA; [Tamang, Suzanne] Stanford Univ, Ctr Populat Hlth Sci, Palo Alto, CA 94304 USA; [Mahbub, Maria; Peterson, Gregory D.] Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN 37996 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Stanford University; University of Tennessee System; University of Tennessee Knoxville	Mahbub, M (corresponding author), Oak Ridge Natl Lab, Cyber Resilience & Intelligence Div, Oak Ridge, TN 37830 USA.; Mahbub, M (corresponding author), Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN 37996 USA.	mmahbub@vols.utk.edu		Mahbub, Maria/0000-0002-3422-9650; Tamang, Suzanne/0000-0003-2077-4620	Office of Science of the U.S. Department of Energy [DE-AC05-00OR22725]; Department of Veterans Affairs Office of Information Technology Inter-Agency; Department of Energy [VA118-16-M-1062]; U.S. Department of Energy [DE-AC05-00OR22725]	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Department of Veterans Affairs Office of Information Technology Inter-Agency(US Department of Veterans Affairs); Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This research used resources of the Knowledge Discovery Infrastructure at the Oak Ridge National Laboratory, which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC05-00OR22725 and the Department of Veterans Affairs Office of Information Technology Inter-Agency Agreement with the Department of Energy under IAA No. VA118-16-M-1062. This manuscript has been in part co-authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a nonexclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the `author contributions' section.	Alsentzer E., 2019, PUBLICLY AVAILABLE C, P72; Anand Rajsavi S, 2018, AMIA Jt Summits Transl Sci Proc, V2017, P310; Auslander B, 2020, IEEE GLOBE WORK, DOI 10.1109/GCWkshps50303.2020.9367547; Awad A, 2017, INT J MED INFORM, V108, P185, DOI 10.1016/j.ijmedinf.2017.10.002; Bai ZX, 2021, COMPUT MATH METHOD M, V2021, DOI 10.1155/2021/7252280; Barlas G., 2020, IFIP INT C ART INT A, P255; Beaulieu-Jones BK, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00426-3; Biswas E, 2020, PROC IEEE INT CONF S, P162, DOI 10.1109/ICSME46990.2020.00025; Bojanowski P., 2017, T ASSOC COMPUT LING, V5, P135, DOI [https://doi.org/10.1162/tacl_a_00051, 10.1162/tacl_a_00051]; Breiman L., 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Caicedo-Torres W, 2019, J BIOMED INFORM, V98, DOI 10.1016/j.jbi.2019.103269; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Cramer J.S, 2002, 20021194 TINB I, DOI [10.2139/ssrn.360300, DOI 10.2139/SSRN.360300]; Deschepper M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235117; Devlin Jacob, 2019, P ANN C N AM CHAPTER, V1, P4171; Ding N, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6638919; Doig G S, 1993, Proc Annu Symp Comput Appl Med Care, P361; Dybowski R, 1996, LANCET, V347, P1146, DOI 10.1016/S0140-6736(96)90609-1; Feng JY, 2020, PROCEEDINGS OF THE 2020 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING (EMNLP), P1478; FERYLEMONNIER E, 1995, INTENS CARE MED, V21, P356, DOI 10.1007/BF01705416; Ghassemi M, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P75, DOI 10.1145/2623330.2623742; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Haniffa R, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1930-8; Hashir M, 2020, J BIOMED INFORM, V108, DOI 10.1016/j.jbi.2020.103489; Hernandez-Boussard T, 2019, J AM MED INFORM ASSN, V26, P1189, DOI 10.1093/jamia/ocz119; Hou NZ, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02620-5; Johnson Alistair E W, 2017, AMIA Annu Symp Proc, V2017, P994; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Ke GL, 2017, ADV NEUR IN, V30; Kefi Z, 2019, INT J ADV COMPUT SC, V10, P583; Kingma D. P., 2014, P INT C LEARN REPR, P1, DOI DOI 10.1007/S11390-017-1754-7; Kocbek P, 2017, P SIKDD 2017 C DATA, V29, P31; Kong GL, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01271-2; Kong HJ, 2019, HEALTHC INFORM RES, V25, P1, DOI 10.4258/hir.2019.25.1.1; Krishnan GS, 2018, LECT NOTES COMPUT SC, V10859, P126, DOI 10.1007/978-3-319-91947-8_13; Lee J, 2020, BIOINFORMATICS, V36, P1234, DOI 10.1093/bioinformatics/btz682; Lin K, 2019, INT J MED INFORM, V125, P55, DOI 10.1016/j.ijmedinf.2019.02.002; Liu EQ, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/5948636; Lu ZQ, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.661710; Mahdavi M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252384; Mikolov T, 2013, P WORKSHOP ICLR, P1; Parikh RB, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.15997; Paszke A, 2019, ADV NEUR IN, V32; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peng YF, 2019, SIGBIOMED WORKSHOP ON BIOMEDICAL NATURAL LANGUAGE PROCESSING (BIONLP 2019), P58; Radhachandran A, 2021, BIODATA MIN, V14, DOI 10.1186/s13040-021-00255-w; Sadeghi Reza, 2018, Smart Health (Amst), V9-10, P265, DOI 10.1016/j.smhl.2018.07.001; Sammut C., 2010, ENCY MACHINE LEARNIN, P986, DOI [10.1007/978-0-387-30164-8_832, DOI 10.1007/978-0-387-30164-8_832]; Sandfort V, 2019, J INTENSIVE CARE MED, V34, P622, DOI 10.1177/0885066618756828; Sazli MH., 2006, COMMUNICATIONS FACUL, V50; Tang CL, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0984-8; Tenney I, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P4593; Teo K, 2020, J MED IMAG HEALTH IN, V10, P2869, DOI 10.1166/jmihi.2020.3291; Theis J, 2022, IEEE J BIOMED HEALTH, V26, P388, DOI 10.1109/JBHI.2021.3092969; van Aken B, 2021, 16TH CONFERENCE OF THE EUROPEAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (EACL 2021), P881; Vaswani A., 2017, ADV NEURAL INFORM PR, P5998; Wolf T, 2020, PROCEEDINGS OF THE 2020 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING: SYSTEM DEMONSTRATIONS, P38; Wu Y., 2016, ARXIV PREPRINT ARXIV; Ye JC, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01318-4; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yu Gu, 2022, ACM Transactions on Computing and Healthcare, V3, DOI 10.1145/3458754; Yu K, 2020, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2020, P103; Yu Y, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-2614; Zahid MAH., 2018, 2018 IEEE EMBS INT C, P226, DOI DOI 10.1109/BHI.2018.8333410; Zhu YB, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.662340	67	3	3	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262182	10.1371/journal.pone.0262182	http://dx.doi.org/10.1371/journal.pone.0262182			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990485	Green Published, gold, Green Submitted			2022-12-27	WOS:000815783800018
J	Nguyen, JL; Benigno, M; Malhotra, D; Khan, F; Angulo, FJ; Hammond, J; Swerdlow, DL; Reimbaeva, M; Emir, B; McLaughlin, JM				Nguyen, Jennifer L.; Benigno, Michael; Malhotra, Deepa; Khan, Farid; Angulo, Frederick J.; Hammond, Jennifer; Swerdlow, David L.; Reimbaeva, Maya; Emir, Birol; McLaughlin, John M.			Pandemic-related declines in hospitalization for non-COVID-19-related illness in the United States from January through July 2020	PLOS ONE			English	Article							COVID-19; ADMISSIONS; TRENDS; IMPACT	Background The COVID-19 pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has substantially impacted healthcare utilization worldwide. The objective of this retrospective analysis of a large hospital discharge database was to compare all-cause and cause-specific hospitalizations during the first six months of the pandemic in the United States with the same months in the previous four years. Methods Data were collected from all hospitals in the Premier Healthcare Database (PHD) and PHD Special Release reporting hospitalizations from January through July for each year from 2016 through 2020. Hospitalization trends were analyzed stratified by age group, major diagnostic categories (MDCs), and geographic region. Results The analysis included 286 hospitals from all 9 US Census divisions. The number of allcause hospitalizations per month was relatively stable from 2016 through 2019 and then fell by 21% (57,281 fewer hospitalizations) between March and April 2020, particularly in hospitalizations for non-respiratory illnesses. From April onward there was a rise in the number of monthly hospitalizations per month. Hospitalizations per month, nationally and in each Census division, decreased for 20 of 25 MDCs between March and April 2020. There was also a decrease in hospitalizations per month for all age groups between March and April 2020 with the greatest decreases in hospitalizations observed for patients 50-64 and >= 65 years of age. Conclusions Rates of hospitalization declined substantially during the first months of the COVID-19 pandemic, suggesting delayed routine, elective, and emergency care in the United States. These lapses in care for illnesses not related to COVID-19 may lead to increases in morbidity and mortality for other conditions. Thus, in the current stage of the pandemic, clinicians and public-health officials should work, not only to prevent SARS-CoV-2 transmission, but also to ensure that care for non-COVID-19 conditions is not delayed.	[Nguyen, Jennifer L.; Benigno, Michael; Malhotra, Deepa] Pfizer Inc, Real World Evidence Ctr Excellence, New York, NY 10017 USA; [Nguyen, Jennifer L.; Khan, Farid; Angulo, Frederick J.; Swerdlow, David L.; McLaughlin, John M.] Pfizer Inc, Pfizer Vaccines, Med Dev & Sci Clin Affairs, Collegeville, PA 19426 USA; [Hammond, Jennifer] Pfizer Inc, Clin Dev Internal Med & Hosp, Pfizer Global Prod Dev, Collegeville, PA USA; [Reimbaeva, Maya] Pfizer Inc, Global Biometr & Data Management, Pfizer Global Prod Dev, Groton, CT 06340 USA; [Emir, Birol] Pfizer Inc, Pfizer Global Prod Dev, Global Biometr & Data Management, New York, NY USA	Pfizer; Pfizer; Pfizer; Pfizer; Pfizer	Nguyen, JL (corresponding author), Pfizer Inc, Real World Evidence Ctr Excellence, New York, NY 10017 USA.; Nguyen, JL (corresponding author), Pfizer Inc, Pfizer Vaccines, Med Dev & Sci Clin Affairs, Collegeville, PA 19426 USA.	Jennifer.Nguyen2@pfizer.com	Nguyen, Jennifer/GVS-4347-2022		Pfizer Inc.	Pfizer Inc.(Pfizer)	This work and the article processing charges were sponsored by Pfizer Inc. The funder provided support in the form of salaries for authors F.A, M.B, B.E, J.H, F.K, D.M, J.M, J.L.N, M.R, and D.L.S, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Argenziano MG, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1996; Birkmeyer JD, 2020, HEALTH AFFAIR, V39, P2010, DOI 10.1377/hlthaff.2020.00980; Center for Systems Science and Engineering at Johns Hopkins University, COVID 19 DASHB 2020; Centers for Disease Control and Prevention, CDC COVID DATA TRACK, DOI [10.2196/1939932788148, DOI 10.2196/1939932788148]; Centers for Disease Control and Prevention, FRAM HEALTHC SYST PR; Centers for Disease Control and Prevention, EST DIS BURD COVID 1; Centers for Disease Control and Prevention, ICD 10 CM OFF COD RE; Centers for Medicare and Medicaid Services, ICD 10 CM PCS MS DRG; Centers for Medicare and Medicaid Services, 2020, ICD 10 MS DRGS VERS; Cowling BJ, 2020, J INFECT DIS, V221, P1749, DOI 10.1093/infdis/jiaa123; Cox C., 2020, HAVE HEALTHCARE UTIL; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1250, DOI 10.15585/mmwr.mm6936a4; de Pablo GS, 2020, J AFFECT DISORDERS, V275, P48, DOI 10.1016/j.jad.2020.06.022; De Rosa S, 2020, EUR HEART J, V41, P2083, DOI 10.1093/eurheartj/ehaa409; Ettman CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19686; Federal Government of the United States of America, 2020, PROCLAMATION DECLARI; Gallaway MS, 2020, MMWR-MORBID MORTAL W, V69, P1460, DOI 10.15585/mmwr.mm6940e3; Hartnett KP, 2020, MMWR-MORBID MORTAL W, V69, P699, DOI 10.15585/mmwr.mm6923e1; Hutchins HJ, 2020, MMWR-MORBID MORTAL W, V69, P1584, DOI 10.15585/mmwr.mm6943e4; Jewell JS, 2020, JMIR FORM RES, V4, DOI 10.2196/22043; Kadri SS, 2020, JAMA-J AM MED ASSOC, V324, P2553, DOI 10.1001/jama.2020.20323; Kim HS, 2020, ACAD EMERG MED, V27, P910, DOI 10.1111/acem.14099; Lai PH, 2020, JAMA CARDIOL, V5, P1154, DOI 10.1001/jamacardio.2020.2488; Mafham MM, 2020, LANCET, V396, P381, DOI 10.1016/S0140-6736(20)31356-8; Moreland A, 2020, MMWR-MORBID MORTAL W, V69, P1198, DOI 10.15585/mmwr.mm6935a2; Olsen SJ, 2020, MMWR-MORBID MORTAL W, V69, P1305, DOI 10.15585/mmwr.mm6937a6; Oseran AS, 2020, AM J MANAG CARE, V26, P327, DOI 10.37765/ajmc.2020.43837; Oster AM, 2020, MMWR-MORBID MORTAL W, V69, P1127, DOI 10.15585/mmwr.mm6933e2; Pollard MS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22942; Premier Applied Sciences PI, 2020, PREM HEALTHC DAT COV; Prevention CfDCa, CDC COVID DAT TRACK; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI [10.15585/mmwr.mm6930e1, 10.15585/mmwr.mm6930e1externalicon]; Thompson CN, 2020, MMWR-MORBID MORTAL W, V69, P1725, DOI 10.15585/mmwr.mm6946a2; United Van Lines, 2020, ANN 2020 UN LIN NAT; US Census Bureau, CENS REG DIV US 2010; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013	37	9	9	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262347	10.1371/journal.pone.0262347	http://dx.doi.org/10.1371/journal.pone.0262347			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990489	Green Published, gold			2022-12-27	WOS:000815783800029
J	Bouassa, RSM; Tonen-Wolyec, S; Veyer, D; Pere, H; Belec, L				Bouassa, Ralph-Sydney Mboumba; Tonen-Wolyec, Serge; Veyer, David; Pere, Helene; Belec, Laurent			Analytical performances of the AMPLIQUICK (R) Respiratory Triplex assay for simultaneous detection and differentiation of SARS-CoV-2, influenza A/B and respiratory syncytial viruses in respiratory specimens	PLOS ONE			English	Article							AGREEMENT; COVID-19; COINFECTION	Although patients infected with severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), influenza A, influenza B and respiratory syncytial virus (RSV) show comparable or very similar manifestations, the therapeutic approaches of these respiratory viral infections are different, which requires an accurate diagnosis. Recently, the novel multiplex real-time reverse transcription-polymerase chain reaction assay AMPLIQUICK (R) Respiratory Triplex (BioSynex SA, Illkirch-Graffenstaden, France) allows simultaneous detection and differentiation of SARS-CoV-2, influenza A, influenza B, and RSV in respiratory tract samples. We herein evaluated the performance of the AMPLIQUICK (R) Respiratory Triplex for the detection of the four viruses in respiratory specimens, using AllplexT Respiratory Panel 1 and 2019-nCoV assays (Seegene, Seoul, Korea) as reference comparator assays. A total of 359 archived predetermined respiratory samples, including 83, 145, 19 and 95 positive specimens for SARS-CoV-2, influenza A, influenza B and RSV respectively, were included. The AMPLIQUICK (R) Respiratory Triplex showed high concordance with the reference assays, with an overall agreement for SARS-CoV-2, influenza A, influenza B, and RSV at 97.6%, 98.8%, 98.3% and 100.0%, respectively, and high. values ranging from 0.93 to 1.00, indicating an almost perfect agreement between assays. Furthermore, high correlations of cycle threshold (Ct) values were observed for positive samples of the four viruses between the AMPLIQUICK (R) Respiratory Triplex and comparator assays, with an overall high agreement between Ct values assessed by Bland-Altman analyses. In conclusion, these observations demonstrate that the multiplex AMPLIQUICK (R) Respiratory Triplex is a reliable assay for the qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and RSV in respiratory specimens, which may prove useful for streamlining diagnostics during the winter influenza-seasons.	[Bouassa, Ralph-Sydney Mboumba; Tonen-Wolyec, Serge] Ecole Doctorale Infectiol Trop, Franceville, Gabon; [Bouassa, Ralph-Sydney Mboumba; Veyer, David; Pere, Helene; Belec, Laurent] Hop Europeen Georges Pompidou, AP HP, Lab Virol, Paris, France; [Tonen-Wolyec, Serge] Univ Kisangani, Fac Med & Pharm, Kisangani, DEM REP CONGO; [Pere, Helene; Belec, Laurent] Univ Paris, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Belec, L (corresponding author), Hop Europeen Georges Pompidou, AP HP, Lab Virol, Paris, France.; Belec, L (corresponding author), Univ Paris, Sorbonne Paris Cite, Paris, France.	laurent.belec@aphp.fr	Tonen-Wolyec, Serge/ADM-2951-2022	Tonen-Wolyec, Serge/0000-0002-7734-7729				Azekawa S, 2020, IDCASES, V20, DOI 10.1016/j.idcr.2020.e00775; Benezit F, 2020, INFECTION, V48, P489, DOI 10.1007/s15010-019-01388-1; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brendish NJ, 2020, LANCET RESP MED, V8, P1192, DOI 10.1016/S2213-2600(20)30454-9; Brukner I, 2020, J INFECT PUBLIC HEAL, V13, P991, DOI 10.1016/j.jiph.2020.01.307; Centers for Disease Control and Prevention, 2020, COMM INV PROT INV SU; Centers for Disease Control and Prevention, 2020, RES USE ONLY CDC INF; Centers for Disease Control and Prevention, 2020, COVID 19 CDC GUID EX; Chung HY, 2021, EMERG MICROBES INFEC, V10, P161, DOI 10.1080/22221751.2021.1873073; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Creager HM, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104538; Cuadrado-Payan E, 2020, LANCET, V395, pE84, DOI 10.1016/S0140-6736(20)31052-7; Farfour E, 2020, EUR J CLIN MICROBIOL, V39, P1997, DOI 10.1007/s10096-020-03930-8; Gimferrer L, 2018, J CLIN VIROL, V105, P31, DOI 10.1016/j.jcv.2018.05.006; Hashemi SA, 2020, J MED VIROL, V92, P2319, DOI 10.1002/jmv.26014; Hirotsu Y, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104543; Huang BR, 2021, J MICROBIOL IMMUNOL, V54, P336, DOI 10.1016/j.jmii.2020.06.011; Jefferson T, 2021, CLIN INFECT DIS, V73, pe3884, DOI [10.1093/cid/ciaa1764, DOI 10.1093/CID/CIAA1764]; Kim D, 2020, JAMA-J AM MED ASSOC, V323, P2085, DOI 10.1001/jama.2020.6266; Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P505, DOI 10.1016/j.jmii.2020.05.013; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lansbury L, 2020, J INFECTION, V81, P266, DOI 10.1016/j.jinf.2020.05.046; Leung ECM, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02965-20; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Mancini F, 2020, J INFECT DIS; Mostafa HH, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02955-20; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ni MJ, 2021, INT J INFECT DIS, V103, P517, DOI 10.1016/j.ijid.2020.12.027; Norz D, 2021, J MED MICROBIOL, V70, DOI 10.1099/jmm.0.001295; Nowak MD, 2020, J MED VIROL, V92, P1699, DOI 10.1002/jmv.25953; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Solomon DA, 2020, JAMA-J AM MED ASSOC, V324, P1342, DOI 10.1001/jama.2020.14661; Standl F, 2021, LANCET INFECT DIS, V21, pE77, DOI [10.1016/S1473-3099(20)30648-4, 10.1016/S1473-3099(20)30484-9]; Tang YW, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00512-20; Uyeki TM, 2019, CLIN INFECT DIS, V68, pE1, DOI [10.1093/cid/ciy866, 10.1093/cid/ciy874]; Visseaux B, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00630-20; Wu D, 2020, PEDIATR INFECT DIS J, V39, pE79, DOI 10.1097/INF.0000000000002688; Wu XJ, 2020, EMERG INFECT DIS, V26, P1324, DOI 10.3201/eid2606.200299; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yu FT, 2020, CLIN INFECT DIS, V71, P793, DOI 10.1093/cid/ciaa345; Yu KK, 2017, CELL TISSUE BANK, V18, P433, DOI 10.1007/s10561-016-9600-7; Zheng X, 2020, J INFECTION, V81, pE128, DOI 10.1016/j.jinf.2020.05.041; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262258	10.1371/journal.pone.0262258	http://dx.doi.org/10.1371/journal.pone.0262258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986156	Green Published, gold			2022-12-27	WOS:000765956200032
J	Molla, M; Sisay, W; Andargie, Y; Kefale, B; Singh, P				Molla, Mulugeta; Sisay, Woretaw; Andargie, Yared; Kefale, Belayneh; Singh, Pradeep			Patients' satisfaction with outpatient pharmacy services and associated factors in Debre Tabor comprehensive specialized hospital, Northwest Ethiopia: A cross-sectional study	PLOS ONE			English	Article							CARE; EXPECTATION; PERCEPTION	Introduction By measuring patients' satisfaction, providers can gain insight into several elements of health care services, including the effectiveness of their care and the level of empathy they exhibit. The aim of this study was to assess patient satisfaction with pharmaceutical services and associated factors in public hospitals located in Northwestern Ethiopia. Methods An institution-based quantitative cross-sectional study was used. The study was carried out in an outpatient pharmacy from January 1-June 30, 2021. Participants were selected by a systematic sampling technique. The IBM SPSS statistical package (version 23) was used to enter and analyze the collected data. The findings were presented using descriptive statistical methods. To find factors linked to satisfaction, binary logistic regression was used. Results The final analysis included a total of 401 samples. More than half of the participants (229, or 55.1%) were female. The overall mean score of satisfaction was 30.6 out of a maximum of 100 scores. By taking this mean score as a cut-off point, 204 (50.9%) of the study participants had satisfaction with the outpatient pharmacists' service. Participants' responses scored on the uncomfortable and inconvenient waiting areas [AOR = 0.31; 95%CI, (0.13, 0.49)] were found to be negatively associated with the level of patients' satisfaction. Also, the unavailability of medications [AOR = 0.12; 95%CI, (0.02, 0.37)] was negatively associated with the respondent satisfaction. Uncomfortable and inconvenient private counseling areas [AOR = 1.37; 95%CI, (0.79, 4.42)] showed a negative association with their satisfaction. Conclusion Patients' satisfaction levels with pharmacy service were found to be greater than 50%. The socio-demographic characteristics of patients have no association with their level of satisfaction, but their perception of uncomfortable private counseling areas and waiting areas was negatively associated with their satisfaction.	[Molla, Mulugeta; Sisay, Woretaw; Andargie, Yared] Debre Tabor Univ, Coll Hlth Sci, Dept Pharm, Pharmacol & Toxicol Unit, Debre Tabor, Ethiopia; [Kefale, Belayneh] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Pharm, Clin Pharm Unit, Bahir Dar, Ethiopia; [Singh, Pradeep] Debre Tabor Univ, Coll Hlth Sci, Dept Pharm, Pharmaceut Chem Unit, Debre Tabor, Ethiopia	Bahir Dar University	Molla, M (corresponding author), Debre Tabor Univ, Coll Hlth Sci, Dept Pharm, Pharmacol & Toxicol Unit, Debre Tabor, Ethiopia.	mulugetamolla112@gmail.com	Sisay, Woretaw/ABD-3163-2021; Kefale, Belayneh/AAK-7367-2020; Molla, Mulugeta/ABB-8714-2021; Singh, Pradeep/J-2853-2013	Sisay, Woretaw/0000-0003-2616-4014; Molla, Mulugeta/0000-0001-7904-5823; Singh, Pradeep/0000-0003-2908-2823	Debre Tabor University and Pharmacy unit of Debre Tabor comprehensive specialized hospital	Debre Tabor University and Pharmacy unit of Debre Tabor comprehensive specialized hospital	Sources of funding (material support): Debre Tabor University and Pharmacy unit of Debre Tabor comprehensive specialized hospital. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." "The authors received no specific funding for this work."	Abebe TB, 2016, PATIENT PREFER ADHER, V10, P2073, DOI 10.2147/PPA.S114720; Adamu H., 2014, British Journal of Medicine and Medical Research, V4, P2181; Adane MD, 2019, HLTH SYSTEMS POLICY, V6, P1; Ahmad I, 2011, GOMAL J MED SCI, V9, P183; Al-Abri Rashid, 2014, Oman Med J, V29, P3, DOI 10.5001/omj.2014.02; Ambelie YA., 2014, SCI J PUBLIC HLTH, V2, P417, DOI [10.11648/j.sjph.20140205.17, DOI 10.11648/J.SJPH.20140205.17]; Anteneh Asefa, 2014, Journal of Public Health and Epidemiology, V6, P101; Ayalew MB, 2017, J RES PHARM PRACT, V6, P21, DOI 10.4103/2279-042X.200995; Ayele Y, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312120922659; Berehe Tirhas T, 2018, BMC Res Notes, V11, P507, DOI 10.1186/s13104-018-3603-3; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; El-Sharif SI, 2017, ARCH PHARM PRACT, V8, P22, DOI 10.4103/2045-080X.199615; Eshetie G, 2020, ADV PUBLIC HLTH, V2020, DOI 10.1155/2020/6102938; FDRE M, 2017, ETH HOSP MAN IN PHAR; Gamo Sagaro G, 2015, SCI J CLIN MED, V4, P109, DOI [10.11648/j.sjcm.20150405.16, DOI 10.11648/J.SJCM.20150405.16]; Hailu T, 2014, AUDITABLE PHARM T SE; IBM, 2015, IBM SPSS STAT WID, V23; Kebede H, 2021, PATIENT PREFER ADHER, V15, P87, DOI 10.2147/PPA.S287948; Kefale AT, 2016, INTEGR PHARM RES PRA, V5, P85, DOI 10.2147/IPRP.S118657; Lee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142269; Marquez-Peiro J F, 2008, Farm Hosp, V32, P71; Molugulu N, 2012, INT RES J PHARM, V3, P141; Nigussie S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01132; Park K, 2016, HEALTH POLICY, V120, P621, DOI 10.1016/j.healthpol.2016.01.017; Semegn S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224400; Surur AS, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0900-6; Tesfu M, 2016, J NURSING CARE, V05, DOI [10.4172/2167-1168.1000334, DOI 10.4172/2167-1168.1000334]; Wirth F, 2010, J PHARM HEALTH SERV, V1, P189, DOI 10.1111/j.1759-8893.2010.00034.x; Yirgu AN, 2020, INT J FAMILY COMMUNI, V4, P153	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262300	10.1371/journal.pone.0262300	http://dx.doi.org/10.1371/journal.pone.0262300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986179	gold, Green Published			2022-12-27	WOS:000765956200038
J	Gallego-Pinazo, R; Pina-Marin, B; Comellas, M; Aceituno, S; Gomez-Baldo, L; Blanch, C				Gallego-Pinazo, Roberto; Pina-Marin, Begona; Comellas, Marta; Aceituno, Susana; Gomez-Baldo, Laia; Blanch, Carles		AMD-Manage Investigators	Patient and retina specialists' preferences in neovascular age-related macular degeneration treatment. A discrete choice experiment	PLOS ONE			English	Article							GLAUCOMA PATIENTS; MANAGEMENT; GUIDELINES; VIEWS	Introduction and objective Neovascular age-related macular degeneration (nAMD) leads to severe and permanent visual impairment, significantly impacting patients' quality of life and functional independence. Although treatment with anti-vascular endothelial growth factor (VEGF) prevents and, in some cases, reverses visual damage, the need for frequent monitoring visits and intravitreal injections represents a significant burden on patients, caregivers and retina specialists. Objective To elicit preferences for nAMD treatment characteristics from the perspectives of patients and retina specialists. Method A discrete choice experiment was conducted. Participants (patients > 50 years with nAMD receiving anti-VEGF drugs for at least 2 years and without previous experience with anti-VEGF and retina specialists working in the Spanish National Healthcare System) were asked to select one of two hypothetical treatments resulting from the combination of five attributes (effects on visual function, effects on retinal fluid, treatment regimen, monitoring frequency, and cost); their levels were identified by reviewing the literature and two focus groups. The relative importance (RI) given to each attribute was estimated using a mixed logit model. The marginal rates of substitution (MRS) were calculated taking cost as the risk attribute. Results A total of 110 patients (P) [aged 79.0 (SD:7.4) years; 57.3% women; 2.3 (SD:0.7) years with nAMD; 2.1 years (SD:0.1) in treatment] and 66 retina specialists (RS) participated in the study. Participants gave greater RI to improvements in their visual function [60.0% (P); 52.7% (RS)], lower monitoring frequency [20.2% (P); 27.1% (RS)] and reduction in retinal fluid [9.8% (P); 13.0%(RS)]. Patients and retina specialists would agree to an increase in cost by 65.0% and 56.5%, respectively, in exchange for improvements of visual function; and 25.5% and 43.3% on delaying monitoring frequency by one month. Conclusions Efficacy of treatment, in terms of visual function improvements, is the main driver for treatment election for both patients and retina specialists. Treatment monitoring requirements are also considered, mainly from the retina specialist's perspective. These results suggest that the use of more efficacious anti-VEGF agents with a longer duration of action may contribute to aligning treatment characteristics with patients/specialists' preferences. A better alignment would facilitate better disease management, fulfilling the unmet needs of patients and retina specialists.	[Gallego-Pinazo, Roberto] Oftalvist Clin, Unit Macula, Barcelona, Spain; [Pina-Marin, Begona] Hosp Maig, Dept Ophthalmol, Barcelona, Spain; [Comellas, Marta; Aceituno, Susana] Outcomes 10, Castellon De La Plana, Spain; [Gomez-Baldo, Laia] Novartis Farmaceut SA, Med Dept, Barcelona, Spain; [Blanch, Carles] Novartis Farmaceut SA, Hlth Econ & Market Access, Barcelona, Spain	Novartis; Novartis	Blanch, C (corresponding author), Novartis Farmaceut SA, Hlth Econ & Market Access, Barcelona, Spain.	carles.blanch@novartis.com						Androudi S, 2016, ADV THER, V33, P715, DOI 10.1007/s12325-016-0332-7; Arroyo J., 2020, AGE RELATED MACULAR; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Baxter JM, 2016, EYE, V30, P698, DOI 10.1038/eye.2016.18; Bhagat D, 2020, CLIN OPHTHALMOL, V14, P2975, DOI 10.2147/OPTH.S273564; Bhargava JS, 2008, BRIT J OPHTHALMOL, V92, P1601, DOI 10.1136/bjo.2008.140483; Bhargava JS, 2006, INVEST OPHTH VIS SCI, V47, P2885, DOI 10.1167/iovs.05-1244; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Chakravarthy U, 2020, JAMA-J AM MED ASSOC, V324, P794, DOI 10.1001/jama.2020.5576; Colijn JM, 2017, OPHTHALMOLOGY, V124, P1753, DOI 10.1016/j.ophtha.2017.05.035; Danner M, 2017, VALUE HEALTH, V20, P1166, DOI 10.1016/j.jval.2017.04.022; Finger R, 2012, BRIT J OPHTHALMOL, V96, P997, DOI 10.1136/bjophthalmol-2011-301201; Garcia-Layana A, 2019, J OPHTHALMOL, V2019, DOI 10.1155/2019/9821509; Garcia-Layana A, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/595132; Gohil R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129361; Hauber AB, 2013, OSTEOARTHR CARTILAGE, V21, P289, DOI 10.1016/j.joca.2012.11.007; Heinemann M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222045; Jackson Y, 2019, EXPERT REV PHARM OUT, V19, P383, DOI 10.1080/14737167.2019.1612242; Jaffe DH, 2018, J COMP EFFECT RES, V7, P1125, DOI 10.2217/cer-2018-0058; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; Joko T, 2020, PATIENT PREFER ADHER, V14, P553, DOI 10.2147/PPA.S228890; Mitchell P, 2018, LANCET, V392, P1147, DOI 10.1016/S0140-6736(18)31550-2; Mott DJ, 2020, VALUE HEALTH, V23, P979, DOI 10.1016/j.jval.2020.04.1831; Mueller S, 2016, OPHTHALMOLOGY, V123, P876, DOI 10.1016/j.ophtha.2015.12.001; Orme B.K., 2006, GETTING STARTED CONJ; Marin BP, 2022, EUR J OPHTHALMOL, V32, P385, DOI 10.1177/11206721211001716; Nguyen QD, 2020, OPHTHALMOLOGY, V127, P963, DOI 10.1016/j.ophtha.2019.12.031; Ruiz-Moreno J., 2014, SOC ESPANOLA RETIN V; Schmidt-Erfurth U, 2014, BRIT J OPHTHALMOL, V98, P1144, DOI 10.1136/bjophthalmol-2014-305702; StataCorp, 2015, STAT STAT SOFTW REL; van Overbeeke E, 2019, DRUG DISCOV TODAY, V24, P57, DOI 10.1016/j.drudis.2018.09.015; Varano M, 2016, CLIN OPHTHALMOL, V10, P257, DOI 10.2147/OPTH.S92616; Varano M, 2015, CLIN OPHTHALMOL, V9, P2243, DOI 10.2147/OPTH.S92548; Vennedey V, 2016, PATIENT PREFER ADHER, V10, P993, DOI 10.2147/PPA.S101584; Wykoff CC, 2018, J MANAG CARE SPEC PH, V24, pS3, DOI 10.18553/jmcp.2018.24.2-a.s3; Yonekawa Y, 2015, J CLIN MED, V4, P343, DOI 10.3390/jcm4020343	36	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261955	10.1371/journal.pone.0261955	http://dx.doi.org/10.1371/journal.pone.0261955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972174	gold, Green Published			2022-12-27	WOS:000773555700075
J	Haines, TP; Botti, M; Brusco, N; O'Brien, L; Redley, B; Bowles, KA; Hutchinson, A; Mitchell, D; Jellett, J; Steen, K; Boyd, L; Webb-St Mart, M; Raymond, M; Hunter, P; Russo, P; Bonnici, R; Pu, D; Sevenhuysen, S; Davies, V; Shorr, R				Haines, Terry P.; Botti, Mari; Brusco, Natasha; O'Brien, Lisa; Redley, Bernice; Bowles, Kelly-Ann; Hutchinson, Alison; Mitchell, Debra; Jellett, Joanna; Steen, Kate; Boyd, Leanne; Webb-St Mart, Melinda; Raymond, Melissa; Hunter, Peter; Russo, Phillip; Bonnici, Rachel; Pu, Dai; Sevenhuysen, Samantha; Davies, Vicki; Shorr, Ronald			Disinvestment in the presence of uncertainty: Description of a novel, multi-group, disinvestment trial design and protocol for an application to reduce or cease use of mobilisation alarms for preventing falls in hospitals	PLOS ONE			English	Article							COST-EFFECTIVENESS; HEALTH; CARE; INTERRUPTIONS; INTERVENTION; RESOURCES; BED	Disinvestment is the removal or reduction of previously provided practices or services, and has typically been undertaken where a practice or service has been clearly shown to be ineffective, inefficient and/or harmful. However, practices and services that have uncertain evidence of effectiveness, efficiency and safety can also be considered as candidates for disinvestment. Disinvestment from these practices and services is risky as they may yet prove to be beneficial if further evidence becomes available. A novel research approach has previously been described for this situation, allowing disinvestment to take place while simultaneously generating evidence previously missing from consideration. In this paper, we describe how this approach can be expanded to situations where three or more conditions are of relevance, and describe the protocol for a trial examining the reduction and elimination of use of mobilisation alarms on hospital wards to prevent patient falls. Our approach utilises a 3-group, concurrent, non-inferiority, stepped wedge, randomised design with an embedded parallel, cluster randomised design. Eighteen hospital wards with high rates of alarm use (.3%) will be paired within their health service and randomly allocated to a calendar month when they will transition to a "Reduced" (<3%) or "Eliminated" (0%) mobilisation alarm condition. Dynamic randomisation will be used to determine which ward in each pair will be allocated to either the reduced or eliminated condition to promote equivalence between wards for the embedded parallel, cluster randomised component of the design. A project governance committee will set non-inferiority margins. The primary outcome will be rates of falls. Secondary clinical, process, safety, and economic outcomes will be collected and a concurrent economic evaluation undertaken.	[Haines, Terry P.; Bonnici, Rachel; Pu, Dai] Monash Univ, Sch Primary & Allied Hlth Care, Frankston, Australia; [Botti, Mari] Deakin Univ, Sch Nursing & Midwifery, Geelong, Vic, Australia; [Brusco, Natasha] Monash Univ, Rehabil Ageing & Independent Living RAIL Res Ctr, Sch Primary & Allied Hlth Care, Melbourne, Vic, Australia; [O'Brien, Lisa] Monash Univ, Dept Occupat Therapy, Melbourne, Vic, Australia; [Redley, Bernice; Hutchinson, Alison] Ctr Qual & Patient Safety Res Monash Hlth Partner, Melbourne, Vic, Australia; [Redley, Bernice; Hutchinson, Alison] Deakin Univ, Fac Hlth, Sch Nursing & Midwifery, Geelong, Vic, Australia; [Bowles, Kelly-Ann] Monash Univ, Dept Paramed, Melbourne, Vic, Australia; [Mitchell, Debra] Monash Hlth, Allied Hlth Workforce Innovat Strategy Educ & Res, Clayton, Vic, Australia; [Jellett, Joanna] Peninsula Hlth, Falls Prevent Serv, Mornington Ctr, Frankston, Vic, Australia; [Steen, Kate] Epworth HealthCare, Richmond, Australia; [Boyd, Leanne] Eastern Hlth, Learning & Teaching, Richmond, Australia; [Webb-St Mart, Melinda] Eastern Hlth, Richmond, Australia; [Raymond, Melissa] Alfred Hlth, Physiotherapy Dept, Melbourne, Vic, Australia; [Raymond, Melissa] La Trobe Univ, Coll Sci Hlth & Engn, Melbourne, Vic, Australia; [Hunter, Peter] Alfred Hlth, Geriatr Med, Melbourne, Vic, Australia; [Russo, Phillip] Monash Univ, Sch Nursing & Midwifery, Melbourne, Vic, Australia; [Russo, Phillip] Cabrini Inst, Dept Nursing Res, Malvern, Australia; [Sevenhuysen, Samantha; Davies, Vicki] Peninsula Hlth, Frankston, Australia; [Shorr, Ronald] Malcolm Randall Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Gainesville, FL USA; [Shorr, Ronald] Univ Florida, Dept Epidemiol, Gainesville, FL USA	Monash University; Deakin University; Monash University; Monash University; Deakin University; Monash University; La Trobe University; Monash University; Geriatric Research Education & Clinical Center; State University System of Florida; University of Florida	Haines, TP (corresponding author), Monash Univ, Sch Primary & Allied Hlth Care, Frankston, Australia.	Terry.Haines@monash.edu	Brusco, Tash/HGE-5496-2022; Pu, Debbie/W-5064-2019; Bowles, Kelly-Ann/I-2226-2014; Haines, Terry/E-9372-2015	Pu, Debbie/0000-0002-6268-4378; Bowles, Kelly-Ann/0000-0002-5965-5971; Haines, Terry/0000-0003-3150-6154	National Health and Medical Research Council; Australian Government [APP1186185]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR)	Trial funding: National Health and Medical Research Council, Australian Government. Grant number: APP1186185.	[Anonymous], 2017, STATA STAT SOFTWARE; Barker AL, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6781; Brusco NK, 2021, INT J NURS STUD, V117, DOI 10.1016/j.ijnurstu.2020.103769; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Cumming RG, 2008, BMJ-BRIT MED J, V336, P758, DOI 10.1136/bmj.39499.546030.BE; Draper M, 2001, INT J QUAL HEALTH C, V13, P463, DOI 10.1093/intqhc/13.6.463; Elshaug Adam G, 2007, Aust New Zealand Health Policy, V4, P23, DOI 10.1186/1743-8462-4-23; Frane JW, 1998, DRUG INF J, V32, P423, DOI 10.1177/009286159803200213; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Hackett A, 2018, NURSE RES, V26, P8, DOI 10.7748/nr.2018.e1580; Haines T, 2014, J CLIN EPIDEMIOL, V67, P144, DOI 10.1016/j.jclinepi.2013.08.014; Haines TP, 2018, J PHYSIOTHER, V64, P63, DOI 10.1016/j.jphys.2017.11.008; Haines TP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002412; Haines TP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-135; Harris C, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2269-1; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Hill AM, 2010, J AM GERIATR SOC, V58, P1347, DOI 10.1111/j.1532-5415.2010.02856.x; Inouye SK, 2009, NEW ENGL J MED, V360, P2390, DOI 10.1056/NEJMp0900963; Jellett J, 2020, J CLIN NURS, V29, P4505, DOI 10.1111/jocn.15471; Joshi NP., 2009, REASSESSMENT HLTH TE; King B, 2021, GERIATR NURS, V42, P225, DOI 10.1016/j.gerinurse.2020.08.005; King B, 2018, GERONTOLOGIST, V58, P331, DOI 10.1093/geront/gnw156; Lach HW, 2016, J GERONTOL NURS, V42, P17, DOI 10.3928/00989134-20160113-04; Lyons VH, 2017, J CLIN EPIDEMIOL, V86, P160, DOI 10.1016/j.jclinepi.2017.04.004; Mihaylova B, 2011, HEALTH ECON, V20, P897, DOI 10.1002/hec.1653; Mitchel D, 2019, INT J HEALTH POLICY, V8, P403, DOI 10.15171/ijhpm.2019.20; Mitchell D, 2021, HEALTH CARE MANAGE R, V46, P44, DOI 10.1097/HMR.0000000000000239; Mitchell D, 2018, INT J NURS STUD, V86, P52, DOI 10.1016/j.ijnurstu.2018.06.002; Niven DJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0488-z; Nixon RM, 2010, HEALTH ECON, V19, P316, DOI 10.1002/hec.1477; Prasad V, MAYO CLIN P; Sahota O, 2014, AGE AGEING, V43, P247, DOI 10.1093/ageing/aft155; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sarkies MN, 2015, APPL CLIN INFORM, V6, P96, DOI 10.4338/ACI-2014-10-RA-0097; Shorr RI, 2012, ANN INTERN MED, V157, P692, DOI 10.7326/0003-4819-157-10-201211200-00005; Snapinn Steven M, 2000, Curr Control Trials Cardiovasc Med, V1, P19, DOI 10.1186/CVM-1-1-019; Visvanathan R, 2021, J GERONTOL A, DOI [10.1093/gerona/glab174, DOI 10.1093/GERONA/GLAB174]; Wennberg JE, 2002, BRIT MED J, V325, P961, DOI 10.1136/bmj.325.7370.961; Westbrook JI, 2010, QUAL SAF HEALTH CARE, V19, P284, DOI 10.1136/qshc.2009.039255; Westbrook JI, 2010, ARCH INTERN MED, V170, P683, DOI 10.1001/archinternmed.2010.65; WHITE KL, 1995, LANCET, V346, P837, DOI 10.1016/S0140-6736(95)91651-2; Xie H, 2009, CRIT CARE, V13, DOI 10.1186/cc7154	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2021	16	12							e0261793	10.1371/journal.pone.0261793	http://dx.doi.org/10.1371/journal.pone.0261793			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0C7TD	34969050	Green Published, gold			2022-12-27	WOS:000775510400018
J	Vendramini, THA; Olivindo, RFG; Zafalon, RVA; Rentas, MF; Zanini, LD; Amaral, AR; Pedrinelli, V; de Oliveira, VV; Risolia, LW; Teixeira, FA; Brunetto, MA				Annibale Vendramini, Thiago Henrique; Gomes Olivindo, Rodrigo Fernando; Amorim Zafalon, Rafael Vessecchi; Rentas, Mariana Fragoso; Zanini, Lucca Denuci; Amaral, Andressa Rodrigues; Pedrinelli, Vivian; de Oliveira, Vinicius Vasques; Risolia, Larissa Wunsche; Teixeira, Fabio Alves; Brunetto, Marcio Antonio			Profile qualitative variables on the dynamics of weight loss programs in dogs	PLOS ONE			English	Article							LIMITED FOOD-CONSUMPTION; OWNER-PERCEIVED OBESITY; RISK-FACTORS; VETERINARY PRACTICES; LEPTIN CONCENTRATIONS; PREVALENCE; OSTEOARTHRITIS; ASSOCIATION; NUTRITION; CATS	Obesity is the most common nutritional disorder in dogs and it is associated with many comorbidities. Some obesity risk factors have already been established, however, the evaluation of the effect of different individual variables on weight loss induced by calorie restriction, although very important, is still poorly explored. The weight loss protocol can be updated and improved by more precise and adjusted equations throughout the weight loss program in the clinical routine practice. Therefore, the objective of this study was to analyze weight loss program dynamics in groups according to reproductive status, age, body size, and breed, as well as to define more accurately the amount of calories per target metabolic weight throughout the program. Data of 1,053 cases, presented between 2012 and 2019 at the Veterinary Hospital of the School of Veterinary Medicine and Animal Science of the University of Sao Paulo (FMVZ-USP) were retrospectively analyzed. A total of 77 obese dogs (body condition scores 8/9 or 9/9) of different ages, breeds, sizes, and reproductive status were selected. These dogs did not have any concomitant illnesses and successfully completed the weight loss program. Statistical analysis was performed and values of p <= 0.05 were considered significant. The proposed weight loss program was based on an energy restriction protocol where daily energy intake (in kcal) was estimated as 70 kcal x target weight(0.)(75). The target weight (TW) was defined as 80% of the animal's current weight. The average calorie intake for weight loss (calories x target weight(0.75)) was lower for spayed females (62.36), differing from intact males (66.14) and neutered males (65.41), while intact females (63.66) showed intermediate values without differing between groups (p = 0.015). There were no differences between weight loss calories according to age (p = 0.473) or body size (p = 0.084), allowing the use of the same mathematical equation for intact and neutered dogs; for dogs older than 1 year and of different body sizes. Regarding the breed, the average calorie intake was lower (p = 0.002) in mixed breed dogs (61.54xTW(0.)(75)) when compared to obesity-prone purebred dogs (64.17xTW(0.)(75)) and other purebreds (65.27xTW(0.)(75)). It was concluded that spayed females and mixed breed dogs have greater difficulty in losing weight, that is, they need fewer calories per metabolic body weight for the weight loss program to succeed. A more accurate equation for energy requirement for weight loss can improve chances of success, therefore improving compliance and helping clinical management of obesity in dogs.	[Annibale Vendramini, Thiago Henrique; Amorim Zafalon, Rafael Vessecchi; Rentas, Mariana Fragoso; Zanini, Lucca Denuci; Risolia, Larissa Wunsche; Brunetto, Marcio Antonio] Univ Sao Paulo, Pet Nutrol Res Ctr, Nutr & Prod Dept, Sch Vet Med & Anim Sci, Pirassununga, Brazil; [Gomes Olivindo, Rodrigo Fernando; Amaral, Andressa Rodrigues; Pedrinelli, Vivian; de Oliveira, Vinicius Vasques; Teixeira, Fabio Alves; Brunetto, Marcio Antonio] Univ Sao Paulo, Vet Teaching Hosp, Sch Vet Med & Anim Sci, Vet Nutrol Serv, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Brunetto, MA (corresponding author), Univ Sao Paulo, Pet Nutrol Res Ctr, Nutr & Prod Dept, Sch Vet Med & Anim Sci, Pirassununga, Brazil.; Brunetto, MA (corresponding author), Univ Sao Paulo, Vet Teaching Hosp, Sch Vet Med & Anim Sci, Vet Nutrol Serv, Sao Paulo, Brazil.	mabrunetto@usp.br		Vendramini, Thiago/0000-0003-4457-8392	Grandfood Ind. Ltd.	Grandfood Ind. Ltd.	We would like to thank Grandfood Ind. Ltd. team for maintaining the Pet Nutrology Research Center and supporting the Veterinary Nutrology Service.	Montoya-Alonso JA, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00059; Vendramini THA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238638; Bach JF, 2007, AM J VET RES, V68, P670, DOI 10.2460/ajvr.68.6.670; Brooks D, 2014, J AM ANIM HOSP ASSOC, V50, P1, DOI 10.5326/JAAHA-MS-6331; Brown DC, 1996, VET COMP ORTHOPAED, V9, P75; Brunetto MA, 2011, BRIT J NUTR, V106, pS194, DOI 10.1017/S0007114511000870; Brunetto MA, 2011, CIENC RURAL, V41, P266, DOI 10.1590/S0103-84782011005000004; Carciofi Aulus Cavalieri, 2005, Cienc. Rural, V35, P1331, DOI 10.1590/S0103-84782005000600016; CHIKAMUNE T, 1995, J VET MED SCI, V57, P595, DOI 10.1292/jvms.57.595; Colliard L, 2006, J NUTR, V136, p1951S, DOI 10.1093/jn/136.7.1951S; Corbee RJ, 2013, J ANIM PHYSIOL AN N, V97, P904, DOI 10.1111/j.1439-0396.2012.01336.x; Couillard C, 1997, DIABETOLOGIA, V40, P1178, DOI 10.1007/s001250050804; Courcier EA, 2010, J SMALL ANIM PRACT, V51, P362, DOI 10.1111/j.1748-5827.2010.00933.x; CUNNINGHAM JJ, 1991, AM J CLIN NUTR, V54, P963, DOI 10.1093/ajcn/54.6.963; Devito FC, 2020, VET ANIM SCI, V10, DOI 10.1016/j.vas.2020.100131; EDNEY ATB, 1986, VET REC, V118, P391, DOI 10.1136/vr.118.14.391; Flanagan J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184199; Freeman LM, 2012, J VET INTERN MED, V26, P3, DOI 10.1111/j.1939-1676.2011.00838.x; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; GARLAND T, 1991, EVOLUTION, V45, P1969, DOI 10.1111/j.1558-5646.1991.tb02703.x; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; German AJ, 2017, J NUTR SCI, V6, DOI 10.1017/jns.2017.6; German AJ, 2011, BRIT J NUTR, V106, pS93, DOI 10.1017/S0007114511000584; Porsani MYH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70937-8; Hayek MG., 1998, J ANTI-AGING MED, V1, P117, DOI [10.1089/rej.1.1998.1.117, DOI 10.1089/REJ.1.1998.1.117]; HENDRICKS JC, 1992, VET CLIN N AM-SMALL, V22, P1145, DOI 10.1016/S0195-5616(92)50306-0; Hosgood G, 2007, J VET EMERG CRIT CAR, V8, P222, DOI DOI 10.1111/J.1476-4431.1998.TB00128.X; Jeusette IC, 2005, RES VET SCI, V79, P169, DOI 10.1016/j.rvsc.2004.11.012; Kealy RD, 2000, J AM VET MED ASSOC, V217, P1678, DOI 10.2460/javma.2000.217.1678; Kealy RD, 1997, J AM VET MED ASSOC, V210, P222; Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315; Laflamme D, 1997, CANINE PRACT, V22, P10; Laflamme D, 2014, VET CLIN N AM-SMALL, V44, P761, DOI 10.1016/j.cvsm.2014.03.001; Larsen JA, 2014, VET CLIN N AM-SMALL, V44, P741, DOI 10.1016/j.cvsm.2014.03.003; Lund E. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P177; Mao JF, 2013, PREV VET MED, V112, P438, DOI 10.1016/j.prevetmed.2013.08.012; Mawby DI, 2004, J AM ANIM HOSP ASSOC, V40, P109, DOI 10.5326/0400109; McGreevy PD, 2005, VET REC, V156, P695, DOI 10.1136/vr.156.22.695; National Research Council, 2006, NUTR REQ DOGS CATS, V10th; Neto GBP, 2010, PESQUI VET BRASIL, V30, P167, DOI 10.1590/S0100-736X2010000200012; NRC, 2006, NUTR REQ DOGS CATS, DOI [10.17226/10668, DOI 10.17226/10668]; O'Neill DG, 2014, VET J, V202, P286, DOI 10.1016/j.tvjl.2014.08.004; Park HJ, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-113; Pereira-Neto GB, 2018, J ANIM PHYSIOL AN N, V102, P1743, DOI 10.1111/jpn.12963; Pereira-Neto GB, 2014, PESQUI VET BRASIL, V34, P87, DOI 10.1590/S0100-736X2014001300016; Pianka ER, 2000, EVOL ECOL, V6th, DOI [10.2307/4645, DOI 10.2307/4645]; Piantedosi D, 2016, VET J, V216, P72, DOI 10.1016/j.tvjl.2016.07.002; Raffan E, 2016, CELL METAB, V23, P893, DOI 10.1016/j.cmet.2016.04.012; Robertson ID, 2003, PREV VET MED, V58, P75, DOI 10.1016/S0167-5877(03)00009-6; Sallander M, 2010, PREV VET MED, V96, P132, DOI 10.1016/j.prevetmed.2010.05.004; SANTEN RJ, 1980, AM J PHYSIOL, V239, pE109, DOI 10.1152/ajpendo.1980.239.2.E109; Schauf S, 2016, J ANIM SCI, V94, P4239, DOI 10.2527/jas.2015-0109; Tropf M, 2017, J VET INTERN MED, V31, P1000, DOI 10.1111/jvim.14775; Usui S, 2016, ASIAN PAC J TROP BIO, V6, P338, DOI 10.1016/j.apjtb.2016.01.011; Vendramini THA, 2020, NUTR RES REV, V33, P134, DOI 10.1017/S0954422419000271; Zoran DL, 2010, VET CLIN N AM-SMALL, V40, P221, DOI 10.1016/j.cvsm.2009.10.009	56	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261946	10.1371/journal.pone.0261946	http://dx.doi.org/10.1371/journal.pone.0261946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020762	gold, Green Published			2022-12-27	WOS:000834207700030
J	Lee, G; Yoon, SE; Shin, K				Lee, Geon; Yoon, Se-eun; Shin, Kijung			Simple epidemic models with segmentation can be better than complex ones	PLOS ONE			English	Article								Given a sequence of epidemic events, can a single epidemic model capture its dynamics during the entire period? How should we divide the sequence into segments to better capture the dynamics? Throughout human history, infectious diseases (e.g., the Black Death and COVID-19) have been serious threats. Consequently, understanding and forecasting the evolving patterns of epidemic events are critical for prevention and decision making. To this end, epidemic models based on ordinary differential equations (ODEs), which effectively describe dynamic systems in many fields, have been employed. However, a single epidemic model is not enough to capture long-term dynamics of epidemic events especially when the dynamics heavily depend on external factors (e.g., lockdown and the capability to perform tests). In this work, we demonstrate that properly dividing the event sequence regarding COVID-19 (specifically, the numbers of active cases, recoveries, and deaths) into multiple segments and fitting a simple epidemic model to each segment leads to a better fit with fewer parameters than fitting a complex model to the entire sequence. Moreover, we propose a methodology for balancing the number of segments and the complexity of epidemic models, based on the Minimum Description Length principle. Our methodology is (a) Automatic: not requiring any user-defined parameters, (b) Model-agnostic: applicable to any ODE-based epidemic models, and (c) Effective: effectively describing and forecasting the spread of COVID-19 in 70 countries.	[Lee, Geon; Shin, Kijung] Korea Adv Inst Sci & Technol, Kim Jaechul Grad Sch AI, Daejeon, South Korea; [Yoon, Se-eun; Shin, Kijung] Korea Adv Inst Sci & Technol, Sch Elect Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Shin, K (corresponding author), Korea Adv Inst Sci & Technol, Kim Jaechul Grad Sch AI, Daejeon, South Korea.; Shin, K (corresponding author), Korea Adv Inst Sci & Technol, Sch Elect Engn, Daejeon, South Korea.	kijungs@kaist.ac.kr			Disaster-Safety Platform Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [2019M3D7A1094364]; Institute of Information & Communications Technology Planning & Evaluation (IITP) - Korea government (MSIT) [2019-0-00075]	Disaster-Safety Platform Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science and ICT(National Research Foundation of Korea); Institute of Information & Communications Technology Planning & Evaluation (IITP) - Korea government (MSIT)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This research was supported by Disaster-Safety Platform Technology Development Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (No. 2019M3D7A1094364), and Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korea government (MSIT) (No. 2019-0-00075, Artificial Intelligence Graduate School Program (KAIST)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antulov-Fantulin N, 2013, INFORM SCIENCES, V239, P226, DOI 10.1016/j.ins.2013.03.036; Baranowski R, 2019, J R STAT SOC B, V81, P649, DOI 10.1111/rssb.12322; Bohm C., 2007, ACM T KNOWL DISCOV D, V1, P10, DOI [DOI 10.1145/1297332.1297334, 10.1145/1297332.1297334]; Chen RTQ., 2018, NEURAL ORDINARY DIFF; Dandekar R., 2020, MEDRXIV; Davidson I, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P194; Fang HP, 2005, P ANN INT IEEE EMBS, P7470; George Em Karniadakis, 2017, Arxiv, DOI arXiv:1703.10230; Guo WJ, 2018, INFORM SCIENCES, V467, P670, DOI 10.1016/j.ins.2018.03.054; Hethcote H.W., 1981, DIFFER EQUATIONS APP, P65; Hooi B, 2017, LECT NOTES ARTIF INT, V10535, P3, DOI 10.1007/978-3-319-71246-8_1; Jiang FY, 2021, J R STAT SOC B, DOI 10.1111/rssb.12453; Jiang Feiyu, 2023, J Econom, V232, P1, DOI 10.1016/j.jeconom.2020.07.039; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Mathioudakis M., 2010, WSDM; Matsubara Y., 2012, P 18 ACM SIGKDD INT, P6, DOI 10.1145/2339530.2339537; Matsubara Y, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P458, DOI 10.1145/3292500.3330947; Matsubara Y, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1045, DOI 10.1145/2939672.2939755; Matsubara Y, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P721, DOI 10.1145/2736277.2741092; Matsubara Y, 2014, SIGMOD'14: PROCEEDINGS OF THE 2014 ACM SIGMOD INTERNATIONAL CONFERENCE ON MANAGEMENT OF DATA, P193, DOI 10.1145/2588555.2588556; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Osemwinyen A, 2015, APPL COMPUT MATH, V4, P313, DOI [10.11648/j.acm.20150404.19, DOI 10.11648/j.acm.20150404.19]; Papadimitriou S., 2005, P 31 INT C VER LARG; Papadimitriou Spiros, 2006, P 2006 ACM SIGMOD IN; Raissi M, 2018, J COMPUT PHYS, V357, P125, DOI 10.1016/j.jcp.2017.11.039; Rajkumar S., 2020, DAY LEVEL INFORM COV; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Schober M, 2014, ADV NEUR IN, V27; SCOTT AJ, 1974, BIOMETRICS, V30, P507, DOI 10.2307/2529204; TULJAPURKAR S, 1991, SCIENCE, V254, P591, DOI 10.1126/science.254.5031.591; Yang F, 2018, PROC INT CONF DATA, P65, DOI 10.1109/ICDE.2018.00016	31	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262244	10.1371/journal.pone.0262244	http://dx.doi.org/10.1371/journal.pone.0262244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020775	gold, Green Published			2022-12-27	WOS:000834207700038
J	Weir, S; Kessler, SE				Weir, Sarah; Kessler, Sharon E.			The making of a (dog) movie star: The effect of the portrayal of dogs in movies on breed registrations in the United States	PLOS ONE			English	Article							CHILDRENS; ANIMALS; STORIES; FILM	The media is a powerful force that can affect the welfare of the domiciled dog population. Dogs have long been in human stories and their depictions can create demand for the breeds shown. While previous research has found that this effect can last for up to ten years after the release of a movie, how this phenomenon occurs is unknown. This paper examines if how a dog is portrayed in a movie is associated with a subsequent change in American Kennel Club breed registrations for that breed. Following a systematic literature review, four key themes were identified in how dogs are portrayed in the media; dogs portrayed as heroes, as anthropomorphised, as embodying the ideals of Western societies (Whiteness and heteronormativity) and as boundaries between wilderness and human society. Forty movies from between 1930 to 2004 were analysed, resulting in 95 dog characters scored, and hierarchical multiple linear regression was run. Movies with dogs portrayed as heroes were followed by significant increases in the number of American Kennel Club breed registrations for the breed shown, while anthropomorphised dogs were followed by significant decreases in the number of dogs registered for up to five years after a movie's release. These results indicate that how dogs are portrayed may be an important driver of demand for breeds. Future work should investigate whether these portrayals may have negative welfare implications for real dogs by leading to owners having unrealistic expectations for dogs or increasing demand for dogs with in-breeding related disorders.	[Weir, Sarah; Kessler, Sharon E.] Univ Stirling, Fac Nat Sci, Dept Psychol, Stirling, Scotland	University of Stirling	Weir, S (corresponding author), Univ Stirling, Fac Nat Sci, Dept Psychol, Stirling, Scotland.	s.a.weir@stir.ac.uk		, Sarah/0000-0002-1885-3330				Alexander KJ, 2001, SOC DEV, V10, P374, DOI 10.1111/1467-9507.00171; Anderson MV, 2005, SOC ANIM, V13, P297, DOI 10.1163/156853005774653645; Armbruster K, 2002, PAP LANG LIT, V38, P351; Armbruster K., 2012, SPEAKING ANIMALS, P27; Armbruster K, 2018, TYDSKR LETT, V55, P6, DOI 10.17159/2309-9070/tvl.v.55i3.5514; Burt Jonathan, 2002, ANIMALS FILM; Chodosh C, 2018, MOMENTUM, V5, P4; Coren S., 1994, INTELLIGENCE DOGS CA; Doble J, 2020, HIST WORKSHOP J, P68, DOI 10.1093/hwj/dbaa003; Field A., 2012, DISCOVERING STAT USI; Frank JM, 2007, ECOL ECON, V62, P740, DOI 10.1016/j.ecolecon.2006.09.011; Fuller-Seeley K., 2014, CINEMATIC CANINES DO, P54; Ghirlanda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106565; Ghirlanda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074770; Gregersdotter Katarina., 2016, ANIMAL HORROR CINEMA; Grier KC., 2010, PETS AM HIST; Hannon K., 2011, DAMN GOOD DOGS REAL; Herzog HA, 2004, P ROY SOC B-BIOL SCI, V271, pS353, DOI 10.1098/rsbl.2004.0185; King R., 2008, FUN FACTORY KEYSTONE; Lawrence M, 2015, SCREEN, V56, P115, DOI 10.1093/screen/hjv009; Leane E., 2014, CINEMATIC CANINES DO, P181; Lewis D, 2015, JUDY DOG MILLION RUN; MARKOWSKY JK, 1975, ELEM ENGL, V52, P460; McHugh Susan, 2004, DOG; McLean AL., 2014, CINEMATIC CANINES DO, P235; McLean AL, 2014, INTRO WONDER DOGS CI, P1; Megias DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182368; Nijman V, 2017, GLOB ECOL CONSERV, V11, P84, DOI 10.1016/j.gecco.2017.04.004; Nurik C, 2018, COMMUN CULT CRIT, V11, P530, DOI 10.1093/ccc/tcy024; Olver F.W.J., 2020, NIST DIGITAL LIB MAT; OSWALD LJ, 1995, CHILD LIT EDUC, V26, P135, DOI 10.1007/BF02535736; Oswald R.F., 2005, SOURCEBOOK FAMILY TH, P143; Painter D., 2008, HOLLYWOODS TOP DOGS; Quinn EJ, 2016, SOC ANIM, V24, P507, DOI 10.1163/15685306-12341424; Rapf JE., 2014, CINEMATIC CANINES DO, P33; Redmalm D, 2014, INT J CULTURAL STUD, V17, P93, DOI 10.1177/1367877912464539; Riffe D., 2019, ANAL MEDIA MESSAGES; Ritvo Harriet, 1987, ANIMAL ESTATE ENGLIS; Rosenberg M, 2011, MAKING ANIMAL MEANIN, P113; Ross S., 2014, CINEMATIC CANINES DO, P78; Salman M. D., 2000, Journal of Applied Animal Welfare Science, V3, P93, DOI 10.1207/S15327604JAWS0302_2; Sheen E, 2005, WORLDVIEWS, V9, P236, DOI 10.1163/1568535054615385; Sherman BL, 2008, VET CLIN N AM-SMALL, V38, P1081, DOI 10.1016/j.cvsm.2008.04.012; Simpson BS, 2000, COMP CONT EDUC PRACT, V22, P328; Skabelund A., 2011, EMPIRE DOGS; Stockton Kathryn Bond, 2009, QUEER CHILD GROWING, P89; Tang PC, 2017, EARLY POPUL VIS CULT, V15, P44, DOI 10.1080/17460654.2016.1232203; The Bradshaw Foundation, 2017, RED LAD; Towbin MA., 2004, J FEM FAM THER, V15, P19, DOI [10.1300/J086v15n04_02, DOI 10.1300/J086V15N04_02]; Vallely Anne, 2012, ANIMALS HUMAN IMAGIN, P174; Wiersma BA, 2000, GENDERED WORLD DISNE; Wolf K., 2014, CINEMATIC CANINES DO, P104; Wynne CD., 2019, DOG IS LOVE WHY YOUR	54	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261916	10.1371/journal.pone.0261916	http://dx.doi.org/10.1371/journal.pone.0261916			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020738	Green Published, gold			2022-12-27	WOS:000834207700029
J	Suzuki, Y; Iijima, H; Nakamura, M; Aoyama, T				Suzuki, Yusuke; Iijima, Hirotaka; Nakamura, Masatoshi; Aoyama, Tomoki			Rate of force development in the quadriceps of individuals with severe knee osteoarthritis: A preliminary cross-sectional study	PLOS ONE			English	Article							MUSCLE STRENGTH; RISK; WEAKNESS; DISEASE; PAIN; HIP	Knee osteoarthritis (KOA) is a leading cause of knee pain and disability due to irreversible cartilage degeneration. Previous studies have not identified modifiable risk factors for KOA. In this preliminary cross-sectional study, we aimed to test the following hypotheses: individuals with severe KOA would have a significantly lower quadriceps rate of force development (RFD) than individuals with early KOA, and the decrease in quadriceps RFD would be greater than the decrease in maximum quadriceps strength in individuals with severe KOA. The maximum isometric strength of the quadriceps was assessed in individuals with mild (Kellgren and Lawrence [K&L]grade 1-2) and severe KOA (K&L grade 3-4) using a handheld dynamometer. The RFD was analyzed at 200 ms from torque onset and normalized to the body mass and maximum voluntary isometric contraction torque. To test whether the quadriceps RFD was lowered and whether the lower in the quadriceps RFD was greater than the lower in maximum quadriceps strength in individuals with severe knee OA, the Mann-Whitney U-test and analysis of covariance were performed, respectively. The effect size (ES) based on Hedges' g with a 95% confidence interval (CI) was calculated for the quadriceps RFD and maximum quadriceps strength. Sixty-six participants were analyzed. Individuals with severe KOA displayed significantly lower quadriceps RFD (p = 0.009), the lower being greater than the lower in maximum quadriceps strength (between-group difference, ES: 0.88, -1.07 vs. 0.06, -0.22). Our results suggest that a decreased quadriceps RFD is a modifiable risk factor for progressive KOA. Our finding could help in the early detection and prevention of severe KOA.	[Suzuki, Yusuke; Nakamura, Masatoshi] Niigata Univ Hlth & Welf, Fac Rehabil, Dept Phys Therapy, Niigata, Japan; [Iijima, Hirotaka; Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Dept Phys Therapy, Human Hlth Sci, Kyoto, Japan; [Iijima, Hirotaka] Keio Univ, Fac Sci & Technol, Dept Syst Design Engn, Yokohama, Kanagawa, Japan	Niigata University; Kyoto University; Keio University	Suzuki, Y (corresponding author), Niigata Univ Hlth & Welf, Fac Rehabil, Dept Phys Therapy, Niigata, Japan.	yusuke-suzuki@nuhw.ac.jp		Suzuki, Yusuke/0000-0001-9595-2191	JSPS KAKENHI [20K19356]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI with grant number 20K19356 (Yusuke Suzuki). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Amin S, 2009, ARTHRITIS RHEUM-US, V60, P189, DOI 10.1002/art.24182; Andersen LL, 2006, EUR J APPL PHYSIOL, V96, P46, DOI 10.1007/s00421-005-0070-z; Ando R, 2019, HUM MOVEMENT SCI, V66, P285, DOI 10.1016/j.humov.2019.05.002; Andriacchi TP, 2004, ANN BIOMED ENG, V32, P447, DOI 10.1023/B:ABME.0000017541.82498.37; Bierma-Zeinstra SMA, 2007, NAT CLIN PRACT RHEUM, V3, P78, DOI 10.1038/ncprheum0423; Callahan DM, 2015, EXP GERONTOL, V72, P16, DOI 10.1016/j.exger.2015.08.016; Callahan DM, 2014, J APPL PHYSIOL, V116, P1582, DOI 10.1152/japplphysiol.01362.2013; Culvenor AG, 2017, ARTHRIT CARE RES, V69, P649, DOI 10.1002/acr.23005; Fukutani N, 2016, CLIN RHEUMATOL, V35, P2307, DOI 10.1007/s10067-016-3251-8; Henriksen M, 2012, KNEE, V19, P392, DOI 10.1016/j.knee.2011.07.003; Hu B, 2018, ARCH PHYS MED REHAB, V99, P1352, DOI 10.1016/j.apmr.2017.12.027; Hurley MV, 1999, RHEUM DIS CLIN N AM, V25, P283, DOI 10.1016/S0889-857X(05)70068-5; Iijima Hirotaka, 2018, BMC Psychol, V6, P19, DOI 10.1186/s40359-018-0234-3; Jefferson R J, 1990, Proc Inst Mech Eng H, V204, P21, DOI 10.1243/PIME_PROC_1990_204_224_02; Kamo T, 2019, GAIT POSTURE, V72, P28, DOI 10.1016/j.gaitpost.2019.05.019; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; LaRoche DP, 2010, J ELECTROMYOGR KINES, V20, P482, DOI 10.1016/j.jelekin.2009.08.004; Mirkov DM, 2004, EUR J APPL PHYSIOL, V91, P147, DOI 10.1007/s00421-003-0946-8; Oiestad BE, 2015, OSTEOARTHR CARTILAGE, V23, P171, DOI 10.1016/j.joca.2014.10.008; Petterson SC, 2008, MED SCI SPORT EXER, V40, P422, DOI [10.1249/mss.0b013e31815ef285, 10.1249/MSS.0b013e31815ef285]; Suetta C, 2007, J APPL PHYSIOL, V102, P942, DOI 10.1152/japplphysiol.00067.2006; Suetta C, 2004, J APPL PHYSIOL, V97, P1954, DOI 10.1152/japplphysiol.01307.2003; van Leeuwen DLM, 2013, AGING CLIN EXP RES, V25, P561, DOI 10.1007/s40520-013-0110-1; Ventura A, 2019, J ELECTROMYOGR KINES, V44, P94, DOI 10.1016/j.jelekin.2018.11.010; Vickers Andrew J, 2006, J Soc Integr Oncol, V4, P194, DOI 10.2310/7200.2006.023; Vos T., 2012, LANCET, V380, P2163, DOI [10.1016/S0140-6736(12)61729-2, DOI 10.1016/S0140-6736(12)61729-2, 10.1016/S0140-6736(12)61729-2.Erratumin]; Wang CY, 2002, ARCH PHYS MED REHAB, V83, P811, DOI 10.1053/apmr.2002.32743; Winters JD, 2014, EUR J APPL PHYSIOL, V114, P273, DOI 10.1007/s00421-013-2759-8	29	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262508	10.1371/journal.pone.0262508	http://dx.doi.org/10.1371/journal.pone.0262508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015797	gold, Green Published, Green Submitted			2022-12-27	WOS:000814820600031
J	Woods, M; Koon, W; Brander, RW				Woods, Mark; Koon, William; Brander, Robert W.			Identifying risk factors and implications for beach drowning prevention amongst an Australian multicultural community	PLOS ONE			English	Article							CURRENT HAZARD; RIP CURRENTS; SAFETY; KNOWLEDGE; PERCEPTIONS; EDUCATION; STUDENTS; ABILITY	Multicultural communities in Australia are recognised as a priority area for drowning prevention, but no evidence-based study has addressed their knowledge of beach safety. This study used an online survey tool to identify and examine risk factors relating to swimming ability, beach visitation characteristics and behaviour, and beach safety knowledge of the Australian Southern Asian community to assist in the development of future beach safety interventions. Data was obtained through 249 online and in-person surveys of people aged > 18 years. Most respondents reported poor swimming ability (80%), often swam in in the absence of lifeguards (77%), did not understand the rip current hazard (58%), but reported that they entered the water (76%) when visiting beaches. Close to one-quarter (28%) had not heard, or didn't know the purpose, of the red and yellow beach flags, which identify lifeguard supervised areas on Australian beaches. Length of time living in Australia is an important beach safety consideration for this community, with minimal differences in terms of gender and age. Those who have lived < 10 years in Australia visit beaches more frequently and are less likely to have participated in swimming lessons, be able to swim, heard of the flags or swim between them, understand rip currents, or have participated in a beach safety program. Very few (3%) respondents received beach safety information from within their own community. The importance of beach safety education and swimming lessons within the Southern Asian community should be prioritised for new and recent migrants to Australia.	[Woods, Mark; Koon, William; Brander, Robert W.] UNSW Sydney, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Woods, Mark; Koon, William; Brander, Robert W.] UNSW Sydney, UNSW Beach Safety Res Grp, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Brander, RW (corresponding author), UNSW Sydney, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.; Brander, RW (corresponding author), UNSW Sydney, UNSW Beach Safety Res Grp, Sydney, NSW, Australia.	rbrander@unsw.edu.cn	Brander, Robert/GZH-3081-2022	Koon, William/0000-0003-4708-4347; Brander, Robert/0000-0002-7268-2587				Acharya M, 2018, SBS; Australian Bureau of Statistics (ABS), 2021, MIGRATION; Australian Bureau of Statistics (ABS), CENS 2016 COUNTR BIR; Australian Bureau of Statistics (ABS), CENS 2016 ANC BIRTHP; Australian Water Safety Council, 2021, AUSTR WAT SAF STRAT; Ballantyne R, 2005, TOURISM MANAGE, V26, P617, DOI 10.1016/j.tourman.2004.02.016; Batra R, 2016, ADV DEV HUM RESOUR, V18, P88, DOI 10.1177/1523422316630651; Beale-Tawfeeq A. K., 2018, International Journal of Aquatic Research and Education, V11, P8, DOI 10.25035/ijare.11.01.08; Beasley Intercultural, 2018, CULTR DIV DROWN PREV; Brander R, 2013, NAT HAZARD EARTH SYS, V13, P1687, DOI 10.5194/nhess-13-1687-2013; Brander RW., 2015, RIP CURRENTS, P335; Brannstrom C, 2015, APPL GEOGR, V56, P61, DOI 10.1016/j.apgeog.2014.10.011; Brannstrom C, 2014, NAT HAZARDS, V72, P1123, DOI 10.1007/s11069-014-1061-3; Brighton B, 2013, NAT HAZARD EARTH SYS, V13, P1069, DOI 10.5194/nhess-13-1069-2013; Caldwell N, 2013, NAT HAZARDS, V68, P1041, DOI 10.1007/s11069-013-0673-3; Castelle B, 2016, EARTH-SCI REV, V163, P1, DOI 10.1016/j.earscirev.2016.09.008; Clifford KM, 2018, TOURISM MANAGE, V69, P487, DOI 10.1016/j.tourman.2018.06.032; Cooney N., 2020, COASTAL SAFETY BRIEF; Della Bona M, 2019, INT J PUBLIC HEALTH, V64, P755, DOI 10.1007/s00038-018-1197-0; FAO, 2015, FISH AQ COUNTR PROF; Farmer N., 2016, ESTABLISHING BEACH S, P161; Golob M. I., 2013, International Journal of Aquatic Research and Education, V7, P39; Hatfield J, 2012, ACCIDENT ANAL PREV, V46, P45, DOI 10.1016/j.aap.2011.10.003; Houser C, 2017, NAT HAZARD EARTH SYS, V17, P1003, DOI 10.5194/nhess-17-1003-2017; Irwin CC., 2009, INT J AQUATIC RES ED, V3, P10, DOI [10.25035/ijare.03.01.03, DOI 10.25035/IJARE.03.01.03]; Kamstra P, 2020, INT J DISAST RISK RE, V47, DOI 10.1016/j.ijdrr.2020.101558; Koon W, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246034; Lawes JC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256202; Lawes JC, 2021, INJURY PREV, V27, P442, DOI 10.1136/injuryprev-2020-043969; Lawes JC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238317; Mackellar KM., 2015, INT J AQUATIC RES ED, V9, P348, DOI [10.25035/ijare.09.03.10, DOI 10.25035/IJARE.09.03.10]; Matthews B., 2012, INJURY PREV, V18, DOI [10.1136/injuryprev-2012-040590h.14, DOI 10.1136/INJURYPREV-2012-040590H.14]; Matthews B, 2014, SAFETY SCI, V62, P312, DOI 10.1016/j.ssci.2013.09.003; Metwally Y., 2018, SBS; Mitchell R., 2004, HEALTH PROMOT J AUST, V15, P38, DOI [10.1071/he04038, DOI 10.1071/HE04038]; Moran K., 2013, International Journal of Aquatic Research and Education, V7, P136; Multicultural NSW, PROF ENGL; Pasta DJ, 2009, LEARNING BE DISCRETE; Pitman SJ, 2021, NAT HAZARD EARTH SYS, V21, P115, DOI 10.5194/nhess-21-115-2021; Robitzsch A, 2020, FRONT EDUC, V5, DOI 10.3389/feduc.2020.589965; Savage M. A., 2015, International Journal of Aquatic Research and Education, V9, P241; Scarr J, 2019, ADDRESSING DROWNING; SES Multicultural Water Safety Committee (SESMWSC), 2018, S E SYDN WAT SAF DIR; Sherker S, 2008, J SCI MED SPORT, V11, P81, DOI 10.1016/j.jsams.2006.08.007; Sherker S, 2010, ACCIDENT ANAL PREV, V42, P1785, DOI 10.1016/j.aap.2010.04.020; Short A., 2007, BEACHES NEW S WALES; Siano CJ, 2010, ARCH PEDIAT ADOL MED, V164, P299, DOI 10.1001/archpediatrics.2009.296; Stanley T., 2018, J ED HUMAN DEV, V7, P82, DOI [10.1186/s13054-018-2052-7, DOI 10.1186/S13054-018-2052-7]; Stevenson L, 2021, AUST J FORENSIC SCI, V53, P535, DOI 10.1080/00450618.2020.1759686; Surf Life Saving Australia, 2020, NAT COAST SAF REP 20; White KM, 2010, ACCIDENT ANAL PREV, V42, P1831, DOI 10.1016/j.aap.2010.05.004; Wilks J, 2017, INT J INJ CONTROL SA, V24, P283, DOI 10.1080/17457300.2016.1170043; Willcox-Pidgeon S, 2021, AUST NZ J PUBL HEAL, V45, P255, DOI 10.1111/1753-6405.13102; Willcox-Pidgeon SM, 2021, HEALTH PROMOT J AUST, V32, P49, DOI 10.1002/hpja.407; Willcox-Pidgeon SM, 2020, INJURY PREV, V26, P279, DOI 10.1136/injuryprev-2019-043432; Williamson A, 2012, AUST NZ J PUBL HEAL, V36, P385, DOI 10.1111/j.1753-6405.2012.00888.x; Woodward E, 2013, J COASTAL RES, P850, DOI 10.2112/SI65-144.1	57	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262175	10.1371/journal.pone.0262175	http://dx.doi.org/10.1371/journal.pone.0262175			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015768	Green Published, gold			2022-12-27	WOS:000814820600010
J	Rasouli-Dogaheh, S; Komarek, J; Chatchawan, T; Hauer, T				Rasouli-Dogaheh, Somayeh; Komarek, Jiri; Chatchawan, Thomrat; Hauer, Tomas			Thainema gen. nov. (Leptolyngbyaceae, Synechococcales): A new genus of simple trichal cyanobacteria isolated from a solar saltern environment in Thailand	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; SPECIES DELIMITATION; SP.-NOV.; MOLECULAR CHARACTERIZATION; PHYLOGENETIC-RELATIONSHIPS; SECONDARY STRUCTURE; DIVERSITY; SEQUENCE; GENERA; EVOLUTIONARY	Simple trichal types constitute a group of cyanobacteria with an abundance of novel, often cryptic taxa. Here, we investigated material collected from wet surface-soil in a saline environment in Petchaburi Province, central Thailand. A morphological comparison of the isolated strain with similar known species, as well as its phylogenetic and species delimitation analyses based on the combined datasets of other related organisms, especially simple trichal cyanobacteria, revealed that the material of this study represented an independent taxon. Using a multifaceted method, we propose that this material represents a new genus, Thainema gen. nov., belonging to the family Leptolyngbyaceae, with the type species Thainema salinarum sp. nov. This novel taxon shares similar ecological habitats with strains previously placed in the same lineage.	[Rasouli-Dogaheh, Somayeh; Komarek, Jiri; Hauer, Tomas] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Chatchawan, Thomrat] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai, Thailand; [Komarek, Jiri] Acad Sci Czech Republ, Inst Bot, Trebon, Czech Republic	University of South Bohemia Ceske Budejovice; Chiang Mai University; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Rasouli-Dogaheh, S (corresponding author), Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic.	somaye.rasooli1990@gmail.com	Hauer, Tomas/F-5089-2010	Hauer, Tomas/0000-0002-8005-5874	Ministry of Education of the CR [LTAUSA 180088]; TRF/BIOTEC Special Program for Biodiversity Research and Training Grant [BRT T_149014]; Ministry of Education [GACR 206/08/0318]	Ministry of Education of the CR(Ministry of Education, Youth & Sports - Czech Republic); TRF/BIOTEC Special Program for Biodiversity Research and Training Grant(Thailand Research Fund (TRF)); Ministry of Education	TH, TC, JK. -1.Ministry of Education of the CR project No. LTAUSA 180088 (TH) 2.TRF/BIOTEC Special Program for Biodiversity Research and Training Grant BRT T_149014 (TC) 3.GACR 206/08/0318 (JK) -Ministry of Education of the CR -https://www.msmt.cz/-NO: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed RMM, 2002, ARCH MICROBIOL, V177, P361, DOI 10.1007/s00203-001-0390-2; Adeolu M, 2013, ANTON LEEUW INT J G, V104, P1, DOI 10.1007/s10482-013-9920-6; Akagham SC, 2019, FOTTEA, V19, P1, DOI 10.5507/fot.2018.012; Becerra-Absalon I, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00937; Blank CE, 2016, ALGAL RES, V15, P152, DOI 10.1016/j.algal.2016.02.014; Bohunicka M, 2015, PHYTOTAXA, V197, P84, DOI 10.11646/phytotaxa.197.2.2; Bornet E, 1888, REVISION NOSTOCACEES; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Brito A, 2017, MOL PHYLOGENET EVOL, V111, P18, DOI 10.1016/j.ympev.2017.03.006; Caires TA, 2018, MOL PHYLOGENET EVOL, V120, P196, DOI 10.1016/j.ympev.2017.12.009; Casamatta DA, 2006, HYDROBIOLOGIA, V561, P13, DOI 10.1007/s10750-005-1602-6; CASTENHOLZ RW, 1992, J PHYCOL, V28, P737, DOI 10.1111/j.0022-3646.1992.00737.x; Castenholz RW, 2001, PHYLUM BX CYANOBACTE; Chakraborty S, 2019, PHYTOTAXA, V422, P58, DOI 10.11646/phytotaxa.422.1.4; Chatchawan T, 2011, FOTTEA, V11, P203, DOI 10.5507/fot.2011.019; DasSarma S., 2001, ELS, P1, DOI DOI 10.1038/NPG.ELS.0000394; Dennis PP, 1997, MICROBIOL MOL BIOL R, V61, P90, DOI 10.1128/.61.1.90-104.1997; Derkarabetian S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104982; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dvorak P, 2017, MODERN TOPICS PHOTOT, P3, DOI [10.1007/978-3-319-46261-5, DOI 10.1007/978-3-319-46261-5]; Dvorak P, 2018, FOTTEA, V18, P130, DOI 10.5507/fot.2017.023; Dvorak P, 2015, BIODIVERS CONSERV, V24, P739, DOI 10.1007/s10531-015-0888-6; Eckert Ester M., 2015, Life-Basel, V5, P50, DOI 10.3390/life5010050; Erwin PM, 2008, MOL ECOL, V17, P2937, DOI 10.1111/j.1365-294X.2008.03808.x; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Fontaneto D, 2015, MAR BIODIVERS, V45, P433, DOI 10.1007/s12526-015-0319-7; Fourcans A, 2006, FEMS MICROBIOL ECOL, V57, P367, DOI 10.1111/j.1574-6941.2006.00124.x; Fucikova K, 2014, J PHYCOL, V50, P14, DOI 10.1111/jpy.12118; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gevers D, 2006, PHILOS T R SOC B, V361, P1911, DOI 10.1098/rstb.2006.1915; Giarla TC, 2014, MOL PHYLOGENET EVOL, V70, P137, DOI 10.1016/j.ympev.2013.09.019; GIOVANNONI SJ, 1988, J BACTERIOL, V170, P3584, DOI 10.1128/jb.170.8.3584-3592.1988; Gonzalez-Resendiz L, 2019, J PHYCOL, V55, P898, DOI 10.1111/jpy.12867; Gupta RS, 2015, INT J SYST EVOL MICR, V65, P1050, DOI 10.1099/ijs.0.070136-0; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Johansen J. R., 2005, ALGOLOGICAL STUDIES, V116, P71, DOI [DOI 10.1127/1864-1318/2005/0117-0071, 10.1127/1864-1318/2005/0117-0071]; Johansen JR, 2011, NOVA HEDWIGIA, V92, P283, DOI 10.1127/0029-5035/2011/0092-0283; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; Kilgore C, 2018, FOTTEA, V18, P150, DOI 10.5507/fot.2018.002; Komarek J, 2021, WORLD WIDE ELECT PUB; Komarek J., 2005, CYANOPROKARYOTA 2, V19; Komarek J, 1999, CYANOPROKARYOTA TEIL, V19; Komarek Jiri, 2006, Algae, V21, P349; Komarek J, 2014, PRESLIA, V86, P295; Komarkova J, 2013, FOTTEA, V13, P227, DOI 10.5507/fot.2013.018; Kosuthova A, 2020, BMC EVOL BIOL, V20, DOI 10.1186/s12862-020-01681-w; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Lemes-Da-Silva NM, 2012, BRAZ J BOT, V35, P169, DOI 10.1590/S1806-99592012000200006; Li XC, 2016, PHYCOLOGIA, V55, P478, DOI 10.2216/15-149.1; Loren JG, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00770; Mai T, 2018, PHYTOTAXA, V365, P1, DOI 10.11646/phytotaxa.365.1.1; Malavasi V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151137; Vaz MGMV, 2015, INT J SYST EVOL MICR, V65, P298, DOI 10.1099/ijs.0.070110-0; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller SR, 2000, APPL ENVIRON MICROB, V66, P4222, DOI 10.1128/AEM.66.10.4222-4229.2000; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Miscoe Laura H., 2016, V120, P75; Mishler BD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P44; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Osorio-Santos K, 2014, EUR J PHYCOL, V49, P450, DOI 10.1080/09670262.2014.976843; Palinska KA, 2014, HYDROBIOLOGIA, V740, P1, DOI 10.1007/s10750-014-1971-9; Parker CT, 2019, INT J SYST EVOL MICR, V69, pS7, DOI 10.1099/ijsem.0.000778; Perkerson RB, 2011, J PHYCOL, V47, P1397, DOI 10.1111/j.1529-8817.2011.01077.x; Pietrasiak N, 2019, J PHYCOL, V55, P976, DOI 10.1111/jpy.12897; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Rambaut A, FIGTREE VERSION 1 4; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rehakova K, 2007, PHYCOLOGIA, V46, P481, DOI 10.2216/06-92.1; Rehakova K, 2014, FOTTEA, V14, P161, DOI 10.5507/fot.2014.013; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Rudi K, 1998, J BACTERIOL, V180, P3453, DOI 10.1128/JB.180.13.3453-3461.1998; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; Satyanarayana T, 2005, CURR SCI INDIA, V89, P78; Sawana A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00429; Schirrmeister BE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-45; Seo PS, 2003, J GEN APPL MICROBIOL, V49, P191, DOI 10.2323/jgam.49.191; Sherwood AR, 2014, PHYCOLOGIA, V53, P579, DOI 10.2216/14-059.1; Siegesmund MA, 2008, J PHYCOL, V44, P1572, DOI 10.1111/j.1529-8817.2008.00604.x; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; Staley JT, 2006, PHILOS T R SOC B, V361, P1899, DOI 10.1098/rstb.2006.1914; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang CQ, 2014, EVOLUTION, V68, P2901, DOI 10.1111/evo.12483; Taton A, 2011, POLAR BIOL, V34, P181, DOI 10.1007/s00300-010-0868-y; Taton A, 2003, APPL ENVIRON MICROB, V69, P5157, DOI 10.1128/AEM.69.9.5157-5169.2003; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Turland NJ, 2018, REGNUM VEG, V159, P1; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Turner S, 1997, PLANT SYST EVOL, P13; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; Wilmotte A, 2001, BERGEYS MAN SYST BAC, P487; Xu X, 2017, ZOOL J LINN SOC-LOND, V181, P867, DOI 10.1093/zoolinnean/zlx024; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Zammit G, 2018, PHYCOLOGIA, V57, P481, DOI 10.2216/17-125.1; Zammit G, 2012, EUR J PHYCOL, V47, P341, DOI 10.1080/09670262.2012.717106; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zimba PV, 2017, J PHYCOL, V53, P188, DOI 10.1111/jpy.12490	104	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2022	17	1							e0261682	10.1371/journal.pone.0261682	http://dx.doi.org/10.1371/journal.pone.0261682			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5Z7IO	34995289	Green Published, gold			2022-12-27	WOS:000880142700001
J	Arif, B; Arif, Z; Ahmad, J; Perveen, K; Bukhari, NA; Ashraf, JM; Moinuddin; Alam, K				Arif, Binish; Arif, Zarina; Ahmad, Jamal; Perveen, Kahkashan; Bukhari, Najat A.; Ashraf, Jalaluddin M.; Moinuddin; Alam, Khursheed			Attenuation of hyperglycemia and amadori products by aminoguanidine in alloxan-diabetic rabbits occurs via enhancement in antioxidant defenses and control of stress	PLOS ONE			English	Article							NONENZYMATIC GLYCOSYLATION; LIPID-PEROXIDATION; OXIDATIVE STRESS; MECHANISM; GLYCATION; PROTEINS; MELLITUS; COMPLICATIONS; ALBUMIN; TYPE-1	The micro- and macro-complications in diabetes mellitus (DM) mainly arise from the damage induced by Amadori and advanced glycation end products, as well as the released free radicals. The primary goal of DM treatment is to reduce the risk of micro- and macro-complications. In this study, we looked at the efficacy of aminoguanidine (AG) to prevent the production of early glycation products in alloxan-diabetic rabbits. Type1 DM was induced in rabbits by a single intravenous injection of alloxan (90 mg/kg body weight). Another group of rabbits was pre-treated with AG (100 mg/kg body weight) prior to alloxan injection; this was followed by weekly treatment with 100 mg/kg of AG for eight weeks. Glucose, insulin, and early glycation products (HbA1C and fructosamine) were measured in control, diabetic and AG treated diabetic rabbits. The effects of hyperglycemia on superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (Gpx), reduced glutathione (rGSH), nitric oxide, lipid peroxides, and protein carbonyl were investigated. Alloxan-diabetic rabbits had lower levels of SOD, CAT, Gpx, and rGSH than control rabbits. Nitric oxide levels were considerably greater. AG administration restored the activities of SOD, CAT, Gpx enzymes up to 70-80% and ameliorated the nitric oxide production. HbA1c and fructosamine levels were considerably lower in AG-treated diabetic rabbits. The observed control of hyperglycemia and amadori adducts in alloxan-diabetic rabbits by AG may be attributed to decrease of stress and restoration of antioxidant defenses.	[Arif, Binish] Sherikashmir Inst Med Sci, Dept Clin Biochem, Srinagar, J&K, India; [Arif, Zarina; Moinuddin; Alam, Khursheed] Aligarh Muslim Univ, Fac Med, JN Med Coll, Dept Biochem, Aligarh, UP, India; [Ahmad, Jamal] Aligarh Muslim Univ, Fac Med, JN Med Coll, Rajiv Gandhi Ctr Diabet & Endocrinol, Aligarh, UP, India; [Perveen, Kahkashan; Bukhari, Najat A.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia; [Ashraf, Jalaluddin M.] Jazan Univ, Fac Appl Med Sci, Dept Clin Biochem, Jazan, Saudi Arabia	Sher-i-Kashmir Institute of Medical Sciences; Aligarh Muslim University; Aligarh Muslim University; King Saud University; Jazan University	Alam, K (corresponding author), Aligarh Muslim Univ, Fac Med, JN Med Coll, Dept Biochem, Aligarh, UP, India.	kalam786@rediffmail.com	Perveen, Kahkashan/N-1679-2014; Ashraf, Dr. Jalaluddin M/P-5391-2014	Perveen, Kahkashan/0000-0002-9618-5876; Ashraf, Dr. Jalaluddin M/0000-0001-7885-2551; Alam, Khursheed/0000-0001-9729-9966	Deanship of Scientific Research at King Saud University [RGP-066]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors would like to extend their sincere appreciations to the Deanship of Scientific Research at King Saud University for funding to the Research Group No. RGP-066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; ARAI K, 1987, BIOCHIM BIOPHYS ACTA, V924, P292, DOI 10.1016/0304-4165(87)90025-0; Assmann TS, 2016, NITRIC OXIDE-BIOL CH, V61, P1, DOI 10.1016/j.niox.2016.09.009; BUCALA R, 1994, DRUG DEVELOP RES, V32, P77, DOI 10.1002/ddr.430320204; Ceriello A, 2000, METABOLISM, V49, P27, DOI 10.1016/S0026-0495(00)80082-7; Chaturvedi N, 2002, DIABETES CARE, V25, P2320, DOI 10.2337/diacare.25.12.2320; CHEN HJC, 1993, J CARBOHYD CHEM, V12, P731; Cohen MP, 2006, J LAB CLIN MED, V147, P211, DOI 10.1016/j.lab.2005.12.006; Csonka C, 2015, BRIT J PHARMACOL, V172, P1620, DOI 10.1111/bph.12832; CURTISS LK, 1983, J CLIN INVEST, V72, P1427, DOI 10.1172/JCI111099; Dunn JS, 1943, LANCET, V1, P484; El-Mahmoudy A, 2005, INT IMMUNOPHARMACOL, V5, P195, DOI 10.1016/j.intimp.2004.09.001; El-Missiry MA, 2000, ANN NUTR METAB, V44, P97, DOI 10.1159/000012829; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; GALLOU G, 1993, CLIN CHIM ACTA, V214, P227, DOI 10.1016/0009-8981(93)90114-J; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; Harding JL, 2019, DIABETOLOGIA, V62, P3, DOI 10.1007/s00125-018-4711-2; Hattori Y, 2002, HYPERTENSION, V39, P22, DOI 10.1161/hy1201.097300; HIRSCH J, 1995, CARBOHYD RES, V267, P17, DOI 10.1016/0008-6215(94)00285-N; Ighodaro OM, 2017, MEDICINA-LITHUANIA, V53, P365, DOI 10.1016/j.medici.2018.02.001; JAIN SK, 1989, DIABETES, V38, P1539, DOI 10.2337/diabetes.38.12.1539; Jakus V, 2000, Bratisl Lek Listy, V101, P541; Jaleel A, 2005, DIABETES CARE, V28, P645, DOI 10.2337/diacare.28.3.645; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; Kedziora-Kornatowska KZ, 1998, CLIN CHEM LAB MED, V36, P771; KENNEDY L, 1984, DIABETOLOGIA, V26, P93; KHATAMI M, 1988, LIFE SCI, V43, P1725, DOI 10.1016/0024-3205(88)90484-5; KIRSCHENBAUM DM, 1984, PEDIATR CLIN N AM, V31, P611; KURAHASHI M, 1993, DIABETES RES CLIN PR, V19, P39, DOI 10.1016/0168-8227(93)90143-S; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LEWIS BS, 1990, EXP EYE RES, V50, P463, DOI 10.1016/0014-4835(90)90033-Q; Magdaleno F, 2019, EXP THER MED, V18, P3125, DOI 10.3892/etm.2019.7921; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mironova R, 2005, MOL MICROBIOL, V55, P1801, DOI 10.1111/j.1365-2958.2005.04504.x; MULLARKEY CJ, 1990, BIOCHEM BIOPH RES CO, V173, P932, DOI 10.1016/S0006-291X(05)80875-7; Nagai R, 2012, DIABETES, V61, P549, DOI 10.2337/db11-1120; Natarajan R, 2021, DIABETES, V70, P328, DOI 10.2337/dbi20-0030; Lima TFO, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1036360; Ozturk A, 2012, EXP DIABETES RES, DOI 10.1155/2012/721256; Pageon H, 2010, PATHOL BIOL, V58, P226, DOI 10.1016/j.patbio.2009.09.009; Parlakpinar H, 2004, UROL RES, V32, P278, DOI 10.1007/s00240-004-0399-5; Rabbani N, 2020, OXIDATIVE STRESS: EUSTRESS AND DISTRESS, P759, DOI 10.1016/B978-0-12-818606-0.00036-5; Schalkwijk CG, 1999, DIABETES, V48, P2446, DOI 10.2337/diabetes.48.12.2446; Sliman SM, 2010, MOL CELL BIOCHEM, V333, P9, DOI 10.1007/s11010-009-0199-x; STOCKS J, 1971, BRIT J HAEMATOL, V20, P95, DOI 10.1111/j.1365-2141.1971.tb00790.x; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Valeri C, 2004, DIABETES-METAB RES, V20, pS1, DOI 10.1002/dmrr.512; VELAZQUEZ E, 1991, DIABETIC MED, V8, P752, DOI 10.1111/j.1464-5491.1991.tb01695.x; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; YOSHIOKA T, 1979, AM J OBSTET GYNECOL, V135, P372, DOI 10.1016/0002-9378(79)90708-7	53	2	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262233	10.1371/journal.pone.0262233	http://dx.doi.org/10.1371/journal.pone.0262233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986201	gold, Green Published			2022-12-27	WOS:000765956200028
J	Helou, RI; Waltmans-den Breejen, CM; Severin, JA; Hulscher, MEJL; Verbon, A				Helou, R. I.; Waltmans-den Breejen, C. M.; Severin, J. A.; Hulscher, M. E. J. L.; Verbon, A.			Use of a smartphone app to inform healthcare workers of hospital policy during a pandemic such as COVID-19: A mixed methods observational study	PLOS ONE			English	Article							IMPACT	Objective To evaluate the use of a COVID-19 app containing relevant information for healthcare workers (HCWs) in hospitals and to determine user experience. Methods A smartphone app (Firstline) was adapted to exclusively contain local COVID-19 policy documents and treatment protocols. This COVID-19 app was offered to all HCWs of a 900-bed tertiary care hospital. App use was evaluated with user analytics and user experience in an online questionnaire. Results A total number of 1168 HCWs subscribed to the COVID-19 app which was used 3903 times with an average of 1 minute and 20 seconds per session during a three-month period. The number of active users peaked in April 2020 with 1017 users. Users included medical specialists (22.3%), residents (16.5%), nurses (22.2%), management (6.2%) and other (26.5%). Information for HCWs such as when to test for SARS-CoV-2 (1214), latest updates (1181), the COVID-19 telephone list (418) and the SARS-CoV-2 / COVID-19 guideline (280) were the most frequently accessed advice. Seventy-one users with a mean age of 46.1 years from 19 different departments completed the questionnaire. Respondents considered the COVID-19 app clear (54/59; 92%), easy-to-use (46/55; 84%), fast (46/52; 88%), useful (52/56; 93%), and had faith in the information (58/70; 83%). The COVID-19 app was used to quickly look up something (43/68; 63%), when no computer was available (15/68; 22%), look up / dial COVID-related phone numbers (15/68; 22%) or when walking from A to B (11/68; 16%). Few respondents felt app use cost time (5/68; 7%). Conclusions Our COVID-19 app proved to be a relatively simple yet innovative tool that was used by HCWs from all disciplines involved in taking care of COVID-19 patients. The up-to-date app was used for different topics and had high user satisfaction amongst questionnaire respondents. An app with local hospital policy could be an invaluable tool during a pandemic.	[Helou, R. I.; Waltmans-den Breejen, C. M.; Severin, J. A.; Verbon, A.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Hulscher, M. E. J. L.] Radboud Univ Nijmegen Med Ctr, Sci Ctr Qual Healthcare IQ Healthcare, Radboud Inst Hlth Sci, Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	Verbon, A (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	A.Verbon@umcutrecht.nl	Hulscher, Marlies/B-1229-2014	Hulscher, Marlies/0000-0002-2160-4810	Joint Programming Initiative on Antimicrobial Resistance [JPIAMR2017-045]	Joint Programming Initiative on Antimicrobial Resistance	This work has been made possible by a grant from Joint Programming Initiative on Antimicrobial Resistance (JPIAMR2017-045) https://www.jpiamr.eu/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belfroid E, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2293-0; Belfroid E, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0896-x; Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160; Bruun M, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0482-3; Charanil E, 2013, J ANTIMICROB CHEMOTH, V68, P960, DOI 10.1093/jac/dks492; Costantini E, 2016, INTERN EMERG MED, V11, P929, DOI 10.1007/s11739-016-1445-3; Currie DJ, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp3022009; Dondo TB, 2017, EUR HEART J-ACUTE CA, V6, P412, DOI 10.1177/2048872616647705; Faezipour M, 2020, TELEMED E-HEALTH, V26, P1202, DOI 10.1089/tmj.2020.0114; Flottorp SA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-35; Helou RI, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-033640; Hoff Brian M, 2018, J Pathol Inform, V9, P10, DOI 10.4103/jpi.jpi_77_17; Kang HS, 2018, INT J NURS PRACT, V24, DOI 10.1111/ijn.12664; Kharbanda EO, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2954; Li HOY, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002604; Liu Y, 2020, J MED INTERNET RES, V22, DOI 10.2196/19786; McRae MP, 2020, LAB CHIP, V20, P2075, DOI 10.1039/d0lc00373e; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; National Institute for Public Health and the Environment, COVID 19 DEV GRAPHS; Panesar P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154202; Payne KFB, 2014, HEALTH INFORM J, V20, P59, DOI 10.1177/1460458213478812; Reeves JJ, 2020, J AM MED INFORM ASSN, V27, P853, DOI 10.1093/jamia/ocaa037; Rittmann B, 2019, CURR INFECT DIS REP, V21, DOI 10.1007/s11908-019-0683-8; Ros M, 2020, NURS EDUC TODAY, V91, DOI 10.1016/j.nedt.2020.104479; Sadat-Ali M, 2010, AM J INFECT CONTROL, V38, P404, DOI 10.1016/j.ajic.2009.08.007; Shenouda JEA, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1279-y; Sutton RT, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0221-y; Timmers T, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/19822; Wang SX, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/19457; Windisch O, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/20025; Yoon CH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211157; Young HL, 2018, INFECT CONT HOSP EP, V39, P986, DOI 10.1017/ice.2018.135; Zamberg I, 2020, JMIR PUBLIC HLTH SUR, V6, P206, DOI 10.2196/18668	33	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262105	10.1371/journal.pone.0262105	http://dx.doi.org/10.1371/journal.pone.0262105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986171	Green Published, gold			2022-12-27	WOS:000765956200016
J	Kairys, P; Frese, T; Voigt, P; Horn, J; Girndt, M; Mikolajczyk, R				Kairys, Paul; Frese, Thomas; Voigt, Paul; Horn, Johannes; Girndt, Matthias; Mikolajczyk, Rafael			Development of the simulation-based German albuminuria screening model (S-GASM) for estimating the cost-effectiveness of albuminuria screening in Germany	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; CHRONIC KIDNEY-DISEASE; TYPE-2 DIABETES-MELLITUS; RECEPTOR ANTAGONISTS; RENAL OUTCOMES; PREVALENCE; HYPERTENSION; POPULATION; MORTALITY; ADULTS	Background Chronic kidney disease is often asymptomatic in its early stages but constitutes a severe burden for patients and causes major healthcare systems costs worldwide. While models for assessing the cost-effectiveness of screening were proposed in the past, they often presented only a limited view. This study aimed to develop a simulation-based German Albuminuria Screening Model (S-GASM) and present some initial applications. Methods The model consists of an individual-based simulation of disease progression, considering age, gender, body mass index, systolic blood pressure, diabetes, albuminuria, glomerular filtration rate, and quality of life, furthermore, costs of testing, therapy, and renal replacement therapy with parameters based on published evidence. Selected screening scenarios were compared in a cost-effectiveness analysis. Results Compared to no testing, a simulation of 10 million individuals with a current age distribution of the adult German population and a follow-up until death or the age of 90 shows that a testing of all individuals with diabetes every two years leads to a reduction of the lifetime prevalence of renal replacement therapy from 2.5% to 2.3%. The undiscounted costs of this intervention would be 1164.10(sic)/QALY (quality-adjusted life year). Considering saved costs for renal replacement therapy, the overall undiscounted costs would be-12581.95(sic)/QALY. Testing all individuals with diabetes or hypertension and screening the general population reduced the lifetime prevalence even further (to 2.2% and 1.8%, respectively). Both scenarios were cost-saving (undiscounted, - 7127.10(sic)/QALY and-5439.23(sci)/QALY). Conclusions The S-GASM can be used for the comparison of various albuminuria testing strategies. The exemplary analysis demonstrates cost savings through albuminuria testing for individuals with diabetes, diabetes or hypertension, and for population-wide screening.	[Kairys, Paul; Frese, Thomas; Voigt, Paul] Martin Luther Univ Halle Wittenberg, Med Fac, Inst Gen Practice & Family Med, Halle, Germany; [Horn, Johannes; Mikolajczyk, Rafael] Martin Luther Univ Halle Wittenberg, Med Fac, Inst Med Epidemiol Biometry & Informat IMEBI, Halle, Germany; [Girndt, Matthias] Martin Luther Univ Halle Wittenberg, Med Fac, Dept Internal Med 2, Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Kairys, P (corresponding author), Martin Luther Univ Halle Wittenberg, Med Fac, Inst Gen Practice & Family Med, Halle, Germany.	paul.kairys@student.uni-halle.de		Kairys, Paul/0000-0002-6111-1885; Mikolajczyk, Rafael/0000-0003-1271-7204; Girndt, Matthias/0000-0003-2823-0847				Adarkwah CC, 2011, EXPERT REV PHARM OUT, V11, P215, DOI [10.1586/erp.11.18, 10.1586/ERP.11.8]; Adarkwah CC, 2010, INT J TECHNOL ASSESS, V26, P62, DOI 10.1017/S0266462309990584; Adler C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2023-8; Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Alagoz O, 2010, MED DECIS MAKING, V30, P474, DOI 10.1177/0272989X09353194; [Anonymous], 2015, VERBAND PRIVATARZTLI; Balijepalli C, 2014, J HUM HYPERTENS, V28, P193, DOI 10.1038/jhh.2013.85; Bundesamt Statistisches, 2017, KRANKH GES BUND; Bundesamt Statistisches, 2019, STERB 2015 2017 PER; Centalus Media GmbH, PREISV RAM 100 ST 08; Chen TT, 2018, MED J AUSTRALIA, V209, P275, DOI 10.5694/mja18.00297; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; da Silva GB, 2018, REV ASSOC MED BRAS, V64, P1108, DOI 10.1590/1806-9282.64.12.1108; de Vries EF, 2016, NEPHRON, V133, P89, DOI 10.1159/000446548; DEGAM e.V, 2019, VERS PAT CHRON NICHT; Excellence N.I. f.H.a.C, 2020, CHTE METH REV DISC; Gandjour A, 2015, EXPERT REV PHARM OUT, V15, P341, DOI 10.1586/14737167.2015.972375; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Gemeinsamer Bundesausschuss (GBA), 2020, DMP DIAB MELL TYP 1; Girndt M, 2016, DTSCH ARZTEBL INT, V113, P85, DOI 10.3238/arztebl.2016.0085; Go DS, 2019, NEPHROLOGY, V24, P56, DOI 10.1111/nep.13203; Gozzoli V, 2000, DEUT MED WOCHENSCHR, V125, P1154, DOI 10.1055/s-2000-7670; Gracchi V, 2016, NEPHROL DIAL TRANSPL, V31, P1686, DOI 10.1093/ndt/gfv407; Grams ME, 2017, AM J KIDNEY DIS, V70, P337, DOI 10.1053/j.ajkd.2017.01.050; Heerspink HJL, 2015, CLIN J AM SOC NEPHRO, V10, P1079, DOI 10.2215/CJN.11511114; Hemmelmann C, 2010, DEUT MED WOCHENSCHR, V135, P848, DOI 10.1055/s-0030-1253666; Icks A, 2011, NEPHROL DIAL TRANSPL, V26, P264, DOI 10.1093/ndt/gfq398; Icks A, 2010, NEPHROL DIAL TRANSPL, V25, P1647, DOI 10.1093/ndt/gfp672; Ku E, 2018, CLIN J AM SOC NEPHRO, V13, P693, DOI 10.2215/CJN.10360917; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Lozano R, 2013, LANCET, V381, P991, DOI 10.1016/S0140-6736(13)60704-7; Palmer AJ, 2006, DEUT MED WOCHENSCHR, V131, P1721, DOI 10.1055/s-2006-947822; Palmer AJ, 2004, DIABETES CARE, V27, P1897, DOI 10.2337/diacare.27.8.1897; Pereira BD, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0646-4; Postma MJ, 2008, NEPHROL DIAL TRANSPL, V23, P1103, DOI 10.1093/ndt/gfl756; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Rathmann W, 2010, DIABETOLOGE, V6, P170, DOI 10.1007/s11428-009-0496-8; Sarganas G, 2016, AM J HYPERTENS, V29, P104, DOI 10.1093/ajh/hpv067; Schweitzer RD, 2007, J CARDIOVASC NURS, V22, P76, DOI 10.1097/00005082-200701000-00012; Squires David A, 2011, Issue Brief (Commonw Fund), V16, P1; Statistisches Bundesamt, 2019, BEV ERW 2016 BEV GRU; Strippoli GFM, 2004, BMJ-BRIT MED J, V329, P828, DOI 10.1136/bmj.38237.585000.7C; Sugrue DM, 2019, PHARMACOECONOMICS, V37, P1451, DOI 10.1007/s40273-019-00835-z; Tajima R, 2010, CLIN EXP NEPHROL, V14, P340, DOI 10.1007/s10157-010-0304-1; Wen CP, 2014, KIDNEY INT, V86, P819, DOI 10.1038/ki.2013.553; Wilke T, 2013, DEUT MED WOCHENSCHR, V138, P69, DOI 10.1055/s-0032-1327394; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wu HY, 2014, JAMA INTERN MED, V174, P1108, DOI 10.1001/jamainternmed.2014.1363; Wyld M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001307; Xie XF, 2016, AM J KIDNEY DIS, V67, P728, DOI 10.1053/j.ajkd.2015.10.011; Yarnoff BO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205530; Yarnoff BO, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0497-6; Zhuo M, 2020, KIDNEY INT REP, V5, P475, DOI 10.1016/j.ekir.2019.12.011	53	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262227	10.1371/journal.pone.0262227	http://dx.doi.org/10.1371/journal.pone.0262227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986199	gold, Green Published			2022-12-27	WOS:000765956200027
J	Sveinsdottir, HS; Decker, A; Christensen, C; Lucena, PB; Porsteinsson, H; Richert, E; Maier, VH; Cornell, R; Karlsson, K&AElig;				Sveinsdottir, Hildur Soley; Decker, Amanda; Christensen, Christian; Lucena, Pablo Botella; Porsteinsson, Haraldur; Richert, Elena; Maier, Valerie Helene; Cornell, Robert; Karlsson, Karl Aegir			Motility phenotype in a zebrafish vmat2 mutant	PLOS ONE			English	Article							PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; CELL-DEATH; EXPRESSION; SLEEP; BRAIN; SYSTEM; MODEL; MPTP	In the present study, we characterize a novel zebrafish mutant of solute carrier 18A2 (slc18a2), also known as vesicular monoamine transporter 2 (vmat2), that exhibits a behavioural phenotype partially consistent with human Parkinson's disease. At six days-post-fertilization, behaviour was analysed and demonstrated that vmat2 homozygous mutant larvae, relative to wild types, show changes in motility in a photomotor assay, altered sleep parameters, and reduced dopamine cell number. Following an abrupt lights-off stimulus mutant larvae initiate larger movements but subsequently inhibit them to a lesser extent in comparison to wild-type larvae. Conversely, during a lights-on period, the mutant larvae are hypomotile. Thigmotaxis, a preference to avoid the centre of a behavioural arena, was increased in homozygotes over heterozygotes and wild types, as was daytime sleep ratio. Furthermore, incubating mutant larvae in pramipexole or L-Dopa partially rescued the motor phenotypes, as did injecting glial cell-derived neurotrophic factor (GDNF) into their brains. This novel vmat2 model represents a tool for high throughput pharmaceutical screens for novel therapeutics, in particular those that increase monoamine transport, and for studies of the function of monoamine transporters.	[Sveinsdottir, Hildur Soley; Christensen, Christian; Porsteinsson, Haraldur; Karlsson, Karl Aegir] 3Z, Reykjavik, Iceland; [Decker, Amanda; Cornell, Robert] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA USA; [Lucena, Pablo Botella; Richert, Elena; Karlsson, Karl Aegir] Reykjavik Univ, Sch Sci & Engn, Reykjavik, Iceland; [Richert, Elena] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Oldenburg, Germany; [Maier, Valerie Helene; Karlsson, Karl Aegir] Univ Iceland, Biomed Ctr, Reykjavik, Iceland; [Lucena, Pablo Botella] Hasselt Univ, Biomed Res Inst, Dept Neurosci, Hasselt, Belgium	University of Iowa; Reykjavik University; Carl von Ossietzky Universitat Oldenburg; University of Iceland; Hasselt University	Karlsson, K&AElig; (corresponding author), 3Z, Reykjavik, Iceland.; Karlsson, K&AElig; (corresponding author), Reykjavik Univ, Sch Sci & Engn, Reykjavik, Iceland.; Karlsson, K&AElig; (corresponding author), Univ Iceland, Biomed Ctr, Reykjavik, Iceland.	karlsson@ru.is		Karlsson, Karl/0000-0002-5931-8422; Richert, Elena/0000-0003-0919-4879	National Institutes of Health [GM067841, AR062547]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is funded in part by grants from the National Institutes of Health GM067841 (RAC) and AR062547 (RAC). NO The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Barnhill LM, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8070197; Baronio D, 2022, ACTA PHYSIOL, V234, DOI 10.1111/apha.13725; Basnet RM, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7010023; Bohn MC, 2000, NOVART FDN SYMP, V231, P70, DOI 10.1002/0470870834.ch5; Bonito-Oliva A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00290; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Brunk I, 2006, J BIOL CHEM, V281, P33373, DOI 10.1074/jbc.M603204200; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chen MK, 2008, J NEUROCHEM, V105, P78, DOI 10.1111/j.1471-4159.2007.05108.x; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; Christensen C, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.623924; De Lazzari F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123911; Decker AR, 2015, TRPM7 FUNCTION ZEBRA; Drinkut A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.263; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gasnier B, 2000, BIOCHIMIE, V82, P327, DOI 10.1016/S0300-9084(00)00221-2; Harrington KA, 1996, MOL BRAIN RES, V36, P157, DOI 10.1016/0169-328X(95)00278-Z; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Ichise M, 2010, J NUCL MED, V51, P1001, DOI 10.2967/jnumed.109.068999; Jiang S, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00356; Kvernmo T, 2006, CLIN THER, V28, P1065, DOI 10.1016/j.clinthera.2006.08.004; Leung LC, 2019, NATURE, V571, P198, DOI 10.1038/s41586-019-1336-7; Levitas-Djerbi T, 2017, CURR OPIN NEUROBIOL, V44, P89, DOI 10.1016/j.conb.2017.02.017; Lohr KM, 2016, TOXICOL SCI, V153, P79, DOI 10.1093/toxsci/kfw106; Lohr KM, 2014, EXPERT REV NEUROTHER, V14, P1115, DOI 10.1586/14737175.2014.960399; Lohr KM, 2014, P NATL ACAD SCI USA, V111, P9977, DOI 10.1073/pnas.1402134111; Lulla A, 2016, ENVIRON HEALTH PERSP, V124, P1766, DOI 10.1289/EHP141; Ma K, 2019, BIOCHEM BIOPH RES CO, V513, P306, DOI 10.1016/j.bbrc.2019.03.159; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; Mooslehner KA, 2001, MOL CELL BIOL, V21, P5321, DOI 10.1128/MCB.21.16.5321-5331.2001; Oo TF, 2003, J NEUROSCI, V23, P5141; Panula P, 2010, NEUROBIOL DIS, V40, P46, DOI 10.1016/j.nbd.2010.05.010; Panula P, 2006, ZEBRAFISH, V3, P235, DOI 10.1089/zeb.2006.3.235; PETER D, 1995, J NEUROSCI, V15, P6179; Pontone GM, 2019, NPJ PARKINSON DIS, V5, DOI 10.1038/s41531-019-0102-8; Rilstone JJ, 2013, NEW ENGL J MED, V368, P543, DOI 10.1056/NEJMoa1207281; Rink E, 2002, BRAIN RES BULL, V57, P385, DOI 10.1016/S0361-9230(01)00696-7; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Sallinen V, 2009, J NEUROCHEM, V109, P403, DOI 10.1111/j.1471-4159.2009.05986.x; Schafer MKH, 2013, ADV PHARMACOL, V68, P319, DOI 10.1016/B978-0-12-411512-5.00015-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schnorr SJ, 2012, BEHAV BRAIN RES, V228, P367, DOI 10.1016/j.bbr.2011.12.016; Semenova SA, 2014, HISTOCHEM CELL BIOL, V142, P619, DOI 10.1007/s00418-014-1240-z; Shen Y, 2018, CHINESE MED J-PEKING, V131, P974, DOI 10.4103/0366-6999.229889; Sheng DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000914; Sigurgeirsson B, 2013, BEHAV BRAIN RES, V256, P377, DOI 10.1016/j.bbr.2013.08.032; Sorribes A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00178; Taylor TN, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/124165; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Unal I, 2019, J CLIN NEUROSCI, V62, P1, DOI 10.1016/j.jocn.2019.01.015; Wang YL, 2016, BIOCHEM BIOPH RES CO, V470, P792, DOI 10.1016/j.bbrc.2016.01.079; Wen L, 2008, DEV BIOL, V314, P84, DOI 10.1016/j.ydbio.2007.11.012; Whone AL, 2019, J PARKINSON DIS, V9, P301, DOI 10.3233/JPD-191576; Wulliman MF, 1986, NEUROANATOMY ZEBRAFI; Xi YW, 2010, EUR J NEUROSCI, V31, P623, DOI 10.1111/j.1460-9568.2010.07091.x; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277; Zalsman G, 2011, J NEURAL TRANSM, V118, P1383, DOI 10.1007/s00702-011-0643-4	62	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0259753	10.1371/journal.pone.0259753	http://dx.doi.org/10.1371/journal.pone.0259753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986152	gold, Green Published			2022-12-27	WOS:000765956200005
J	Rivelli, A; Fitzpatrick, V; Blair, C; Copeland, K; Richards, J				Rivelli, Anne; Fitzpatrick, Veronica; Blair, Christopher; Copeland, Kenneth; Richards, Jon			Incidence of COVID-19 reinfection among Midwestern healthcare employees	PLOS ONE			English	Article							IMMUNITY	Given the overwhelming worldwide rate of infection and the disappointing pace of vaccination, addressing reinfection is critical. Understanding reinfection, including longevity after natural infection, will allow us to better know the prospect of herd immunity, which hinges on the assumption that natural infection generates sufficient, protective immunity. The primary objective of this observational cohort study is to establish the incidence of reinfection of COVID-19 among healthcare employees who experienced a prior COVID-19 infection over a 10-month period. Of 2,625 participants who experienced at least one COVID-19 infection during the 10-month study period, 156 (5.94%) experienced reinfection and 540 (20.57%) experienced recurrence after prior infection. Median days were 126.50 (105.50-171.00) to reinfection and 31.50 (10.00-72.00) to recurrence. Incidence rate of COVID-19 reinfection was 0.35 cases per 1,000 person-days, with participants working in COVID-clinical and clinical units experiencing 3.77 and 3.57 times, respectively, greater risk of reinfection relative to those working in non-clinical units. Incidence rate of COVID-19 recurrence was 1.47 cases per 1,000 person-days. This study supports the consensus that COVID-19 reinfection, defined as subsequent infection >= 90 days after prior infection, is rare, even among a sample of healthcare workers with frequent exposure.	[Rivelli, Anne; Fitzpatrick, Veronica; Blair, Christopher; Copeland, Kenneth; Richards, Jon] Advocate Aurora Hlth, Downers Grove, IL 60515 USA; [Rivelli, Anne; Fitzpatrick, Veronica; Blair, Christopher] Advocate Aurora Res Inst, Downers Grove, IL 60515 USA; [Copeland, Kenneth] ACL Labs, Downers Grove, IL USA		Rivelli, A (corresponding author), Advocate Aurora Hlth, Downers Grove, IL 60515 USA.; Rivelli, A (corresponding author), Advocate Aurora Res Inst, Downers Grove, IL 60515 USA.	Anne.rivelli@aah.org		Richards, Jon/0000-0003-2788-5649; Rivelli, Anne/0000-0001-8676-5546	Advocate Aurora Health (AAH)	Advocate Aurora Health (AAH)	This study was funded by Advocate Aurora Health (AAH). AAH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are all employees of AAH and receive salary from funding source. The authors, however, received no specific funding for this work.	Altmann DM, 2021, SCIENCE, V371, P1103, DOI 10.1126/science.abg7404; Alwan NA, 2020, LANCET, V396, pE71, DOI 10.1016/S0140-6736(20)32153-X; Andrenelli E, 2020, EUR J PHYS REHAB MED, V56, P508, DOI [10.23736/S1973-9087.20.06435-7, 10.23736/S1973-9087.20.06378-9]; [Anonymous], 2021, LANCET, DOI [10.1016/, DOI 10.1016/]; Bryan A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00941-20; cdc.gov, INT GUID END IS PREC; Cevik M, 2021, LANCET MICROBE, V2, pE13, DOI 10.1016/S2666-5247(20)30172-5; Curci C, 2021, EUR J PHYS REHAB MED, V57, P443, DOI 10.23736/S1973-9087.20.06660-5; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Elsayed SM, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.10264; Falahi S, 2020, NEW MICROB NEW INFEC, V38, DOI 10.1016/j.nmni.2020.100812; Fari G, 2022, J MED VIROL, V94, P110, DOI 10.1002/jmv.27272; Ferraro F, 2021, J MED VIROL, V93, P1896, DOI 10.1002/jmv.26717; Fitzpatrick V, 2021, PUBLIC HEALTH REP, V136, P361, DOI 10.1177/0033354921999168; Gousseff M, 2020, J INFECTION, V81, P821, DOI 10.1016/j.jinf.2020.06.073; Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9; Iddir M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061562; Johns Hopkins University & Medicine, COR CUM CAS; Joseph A., 2021, STAT-US; Kirkcaldy RD, 2020, JAMA-J AM MED ASSOC, V323, P2245, DOI 10.1001/jama.2020.7869; Ledford H, 2021, NATURE, V594, P164, DOI 10.1038/d41586-021-01505-x; Lieberman JA, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00821-20; Liu WD, 2020, J INFECTION, V81, P329, DOI 10.1016/j.jinf.2020.03.063; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n597; Molina LP, 2020, OBSTET GYNECOL, V136, P838, DOI 10.1097/AOG.0000000000004086; Peltan ID, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251214; Randolph HE, 2020, IMMUNITY, V52, P737, DOI 10.1016/j.immuni.2020.04.012; U.S Food & Drug Administration, SARS COV 2 IGG US AR; U.S. Food & Drug Administration, COR DIS 2019 COVID 1; Veronica F, 2021, ANN EPIDEMIOL, V60, P8, DOI 10.1016/j.annepidem.2021.04.005; Xiao AT, 2020, CLIN INFECT DIS, V71, P2249, DOI 10.1093/cid/ciaa460; Yahav D, 2021, CLIN MICROBIOL INFEC, V27, P315, DOI 10.1016/j.cmi.2020.11.028	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262164	10.1371/journal.pone.0262164	http://dx.doi.org/10.1371/journal.pone.0262164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982800	gold, Green Published, Green Submitted			2022-12-27	WOS:000834805700020
J	Bizuayew, H; Abebe, H; Mullu, G; Bewuket, L; Tsega, D; Alemye, T				Bizuayew, Hulubante; Abebe, Haimanot; Mullu, Getachew; Bewuket, Likinaw; Tsega, Daniel; Alemye, Tsegaw			Post-cesarean section surgical site infection and associated factors in East Gojjam zone primary hospitals, Amhara region, North West Ethiopia, 2020	PLOS ONE			English	Article							CESAREAN-SECTION; RISK-FACTORS; MORBIDITY; DELIVERY	Purpose Maternal surgical site infection after cesarean delivery is a clinical problem which contributes to significant morbidity and mortality. In Ethiopia admissions following cesarean section due to surgical site infection have been routine activities of health care institutions but there is limited scientific evidence on both the magnitude of the problem and factors associated with it making prevention mechanisms less effective. Therefore, this study aimed to assess magnitude and risk factors of post-cesarean section surgical site infection at primary hospitals of East Gojjam Zone, Northwest Ethiopia. Methods Institution-based cross sectional study with retrospective chart review was conducted from September 10-30 /2020 at 3 randomly selected primary hospitals of east Gojjam zone. The data were entered in Epi data version 3.1 and exported to Statistical Package for Social Science Software version 26. Post-cesarean section surgical site infection was measured based on disease classification and definition of the term by Center for Disease Control and Prevention. After checking for presence of multicollinarity, presence and degree of association of factors with outcome variable were computed through logistic regression analysis. Factors with P value <= 0.2 in bi-variable logistic regression analysis were included in the multivariable logistic regression analysis and those variables with P-value of <0.05 in multivariable analysis were considered statistically significant. Result From 622 medical records of women who underwent cesarean section, 77 (12.4%) of them developed surgical site infection. Rural residence [(AOR = 2.30, 95%CI: (1.29, 4.09)], duration of labor greater than 24hrs [(AOR = 3.48, 95%CI: (1.49, 8.09)], rupture of membrane>12hrs[(AOR = 4.61,95%CI:(2.34,9.09)], hypertension[(AOR = 3.14,95%CI:(1.29,7.59)] and preoperative Hematocrit <= 30%[(AOR = 3.22,95%CI:(1.25,8.31)] were factors significantly associated with post-cesarean section surgical site infections. Conclusion Magnitude of post-cesarean section surgical site infection was a significant problem in primary hospitals. Minimizing prolonged labor; minimize early rupture of membrane, properly managing patients with comorbidities like hypertension, strengthen prophylaxis and treatment for anemia during antenatal care and raising awareness for rural residents can reduce the problem. Zonal police makers should give emphasis to reduce its burden.	[Bizuayew, Hulubante; Alemye, Tsegaw] Mizan Aman Hlth Sci Coll, Dept Midwifery, Mizan, Ethiopia; [Abebe, Haimanot] Wolkite Univ, Dept Nursing, Wolkite, Ethiopia; [Mullu, Getachew; Bewuket, Likinaw] Debre Markos Univ, Dept Midwifery, Debre Markos, Ethiopia; [Tsega, Daniel] Wolkite Univ, Dept Midwifery, Wolkite, Ethiopia		Bizuayew, H (corresponding author), Mizan Aman Hlth Sci Coll, Dept Midwifery, Mizan, Ethiopia.	hbizuayew@gmail.com	Abebe, Haimanot Geletie/AGD-2238-2022	Kassa, Getachew Mullu/0000-0002-8095-7376				Adane F, 2019, PATIENT SAF SURG, V13, DOI 10.1186/s13037-019-0212-6; Alfouzan W., 2019, EPIDEMIOLOGY INFECT, V147; Allegranzi Benedetta, 2016, Lancet Infect Dis, V16, pe276, DOI 10.1016/S1473-3099(16)30398-X; Amenu D, 2011, ETHIOP J HEALTH SCI, V21, P91; Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]; [Anonymous], 2015, J PREG CHILD HLTH, DOI DOI 10.4172/2376-127X.1000169; Ansar A., 2013, PAK J SURG, V18, P2; Azeze GG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4325-x; Betran AP, 2016, BJOG-INT J OBSTET GY, V123, P667, DOI 10.1111/1471-0528.13526; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Bizimana JK., 2016, INT J CURRENT MICROB, V5, P631; Busarira M., 2011, J HIGH I PUBLIC HLTH, V41, P359; del Monte MCC, 2010, AM J INFECT CONTROL, V38, P467, DOI 10.1016/j.ajic.2009.10.008; Central Statistical Agency, 2007, STAT ABSTR; Chu K, 2015, WORLD J SURG, V39, P350, DOI 10.1007/s00268-014-2840-4; Dacho AM, 2018, J NURS CARE, V7, P1168; Daniel A, 2008, THESIS, V23; De Nardo P, 2016, J HOSP INFECT, V93, P355, DOI 10.1016/j.jhin.2016.02.021; Gong SP, 2012, J OBSTET GYNAECOL RE, V38, P509, DOI 10.1111/j.1447-0756.2011.01746.x; Gordillo GM, 2003, AM J SURG, V186, P259, DOI 10.1016/S0002-9610(03)00211-3; Grayi A., 2018, HLTH POLICY LEGISLAT, V21; Haque M, 2018, INFECT DRUG RESIST, V11, P2321, DOI 10.2147/IDR.S177247; Harrison Margo S, 2016, Matern Health Neonatol Perinatol, V2, P6, DOI 10.1186/s40748-016-0033-x; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Jabbar S, 2016, ANN ABBASI SHAHEED H, V21, P233; Jido TA, 2012, ANN MED HEALTH SCI R, V2, P33, DOI 10.4103/2141-9248.96934; Krieger Y, 2017, J MATERN-FETAL NEO M, V30, P8, DOI 10.3109/14767058.2016.1163540; Lijaemiro H, 2020, OBSTET GYNECOL INT, V2020, DOI 10.1155/2020/9714640; Mamo T, 2017, PATIENT SAF SURG, V11, DOI 10.1186/s13037-017-0138-9; Molla M, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2442-0; Mpogoro FJ, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-25; Mulu W., 2013, NW ETHIOPIA, V2, P140; Ojiyi E. C., 2013, Orient Journal of Medicine, V25, P8; Onsrud M, 2011, INT J GYNECOL OBSTET, V114, P10, DOI 10.1016/j.ijgo.2011.01.018; Onyegbule O. A., 2015, British Journal of Medicine and Medical Research, V5, P767, DOI 10.9734/BJMMR/2015/10297; Organization WH., 2016, GLOB GUID PREV SURG; Saeed KBM, 2019, EUR J OBSTET GYN R B, V240, P256, DOI 10.1016/j.ejogrb.2019.07.020; Schneid-Kofman N, 2005, INT J GYNECOL OBSTET, V90, P10, DOI 10.1016/j.ijgo.2005.03.020; Shrestha S, 2016, Kathmandu Univ Med J (KUMJ), V14, P107; Smaill FM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007482.pub3; Solomokin J., 2017, SWITZERLAND LANCET I, V17, P262, DOI [10.1016/S1473-3099(17)30081-6, DOI 10.1016/S1473-3099(17)30081-6]; Tran TS, 2000, OBSTET GYNECOL, V95, P367, DOI 10.1016/S0029-7844(99)00540-2; Vijayan CP, 2016, INT J SCI STUDY, V3, P97, DOI 10.17354/ijss/2016/129; WAGER GP, 1980, AM J OBSTET GYNECOL, V138, P1028, DOI 10.1016/0002-9378(80)91102-3; Wendmagegn TA, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2075-8; Wodajo S, 2017, ETHIOP J HEALTH SCI, V27, P283, DOI 10.4314/ejhs.v27i3.10; Worku M., 2018, ETHIOPIAN J REPROD H, V10	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261951	10.1371/journal.pone.0261951	http://dx.doi.org/10.1371/journal.pone.0261951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972176	Green Submitted, Green Published, gold			2022-12-27	WOS:000773555700072
J	Heikkila, K; Pulakka, A; Metsala, J; Alenius, S; Hovi, P; Gissler, M; Sandin, S; Kajantie, E				Heikkila, Katriina; Pulakka, Anna; Metsala, Johanna; Alenius, Suvi; Hovi, Petteri; Gissler, Mika; Sandin, Sven; Kajantie, Eero			Preterm birth and the risk of chronic disease multimorbidity in adolescence and early adulthood: A population-based cohort study	PLOS ONE			English	Article							BORN PRETERM; YOUNG-ADULTS; SURVIVAL; METAANALYSIS; DEFINITION; REGISTER; QUALITY; MODELS; ASTHMA	Background People who were born prematurely have high risks of many individual diseases and conditions in the early part of the life course. However, our knowledge of the burden of multiple diseases (multimorbidity) among prematurely born individuals is limited. We aimed to investigate the risk and patterns of chronic disease multimorbidity in adolescence and early adulthood among individuals born across the spectrum of gestational ages, comparing preterm and full-term born individuals. Methods and findings We used individual-level data from linked nationwide registers to examine the associations of gestational age at birth with specialised healthcare records of >= 2 chronic diseases (multimorbidity) in adolescence (age 10-17 years) and early adulthood (age 18-30 years). Our study population comprised 951,116 individuals (50.2% females) born alive in Finland between 1(st) January 1987 and 31(st) December 2006, inclusive. All individuals were followed from age 10 years to the onset of multimorbidity, emigration, death, or 31 December 2016 (up to age 30 years). We estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for multimorbidity using flexible parametric survival models. During 6,417,903 person-years at risk (median follow-up: 7.9 years), 11,919 individuals (1.3%) had multimorbidity in adolescence (18.6 per 10,000 person-years). During 3,967,419 person-years at risk (median follow-up: 6.2 years), 15,664 individuals (1.7%) had multimorbidity in early adulthood (39.5 per 10,000 person-years). Adjusted HRs for adolescent multimorbidity, comparing preterm to full-term born individuals, were 1.29 (95% CI: 1.22 to 1.36) and 1.26 (95% CI: 1.18 to 1.35) in females and males, respectively. The associations of preterm birth with early adult multimorbidity were less marked, with the adjusted HRs indicating 1.18-fold risk in females (95% CI: 1.12 to 1.24) and 1.10-fold risk in males (95% CI: 1.04 to 1.17). We observed a consistent dose-response relationship between earlier gestational age at birth and increasing risks of both multimorbidity outcomes. Compared to full-term born males, those born at 37-38 weeks (early term) had a 1.06-fold risk of multimorbidity in adolescence (95% CI: 0.98 to 1.14) and this risk increased in a graded manner up to 6.85-fold (95% CI: 5.39 to 8.71) in those born at 23-27 weeks (extremely premature), independently of covariates. Among females, the same risks ranged from 1.16-fold (95% CI: 1.09 to 1.23) among those born at 37-38 weeks to 5.65-fold (95% CI: 4.45 to 7.18) among those born at 23-27 weeks. The corresponding risks of early adult multimorbidity were similar in direction but less marked in magnitude, with little difference in risks between males and females born at 36-37 weeks but up to 3-fold risks observed among those born at 23-27 weeks. Conclusions Our findings indicate that an earlier gestational age at birth is associated with increased risks of chronic disease multimorbidity in the early part of the life course. There are currently no clinical guidelines for follow-up of prematurely born individuals beyond childhood, but these observations suggest that information on gestational age would be a useful characteristic to include in a medical history when assessing the risk of multiple chronic diseases in adolescent and young adult patients.	[Heikkila, Katriina; Pulakka, Anna; Metsala, Johanna; Alenius, Suvi; Hovi, Petteri; Kajantie, Eero] Finnish Inst Hlth & Welf, Populat Hlth Unit, Helsinki, Finland; [Alenius, Suvi] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Alenius, Suvi] Helsinki Univ Hosp, Helsinki, Finland; [Gissler, Mika] Finnish Inst Hlth & Welf, Informat Serv Dept, Helsinki, Finland; [Gissler, Mika] Acad Primary Hlth Care Ctr, Reg Stockholm, Stockholm, Sweden; [Gissler, Mika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Sandin, Sven] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Sandin, Sven] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Sandin, Sven] Seaver Autism Ctr Res & Treatment Mt Sinai, New York, NY USA; [Kajantie, Eero] Oulu Univ Hosp, PEDEGO Res Unit, MRC Oulu, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Kajantie, Eero] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; University of Oulu; University of Oulu; Norwegian University of Science & Technology (NTNU)	Heikkila, K (corresponding author), Finnish Inst Hlth & Welf, Populat Hlth Unit, Helsinki, Finland.	katriina.heikkila@thl.fi	Sandin, Sven/L-5357-2015	Sandin, Sven/0000-0001-6994-4884	European Union Horizon 2020 [733280]; Academy of Finland [315690]; Foundation for Pediatric Research; Sigrid Juse' lius Foundation	European Union Horizon 2020; Academy of Finland(Academy of Finland); Foundation for Pediatric Research; Sigrid Juse' lius Foundation(Sigrid Juselius Foundation)	EK, SS and MG: European Union Horizon 2020 (grant no. 733280: RECAP: "Research on Children and Adults Born Preterm"), https://ec.europa.eu/programmes/horizon2020/en/home; Academy of Finland (grant no. 315690), https:// www.aka.fi/en.EK: Foundation for Pediatric Research, https://www.lastentautientutkimussaatio.fi; and Sigrid Juse ' lius Foundation https://www.sigridjuselius.fi/en/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilsteen JF, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6085; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bramham K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2301; Breeman LD, 2015, PEDIATRICS, V136, P415, DOI 10.1542/peds.2015-0608; Brylka A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041735; Buurman BM, 2016, EUR J INTERN MED, V27, P68, DOI 10.1016/j.ejim.2015.09.021; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Cornish RP, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-66; Crump C, 2019, JAMA-J AM MED ASSOC, V322, P1580, DOI 10.1001/jama.2019.15040; Crump C, 2019, JAMA PEDIATR, V173, P736, DOI 10.1001/jamapediatrics.2019.1327; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; Doyle LW, 2019, LANCET RESP MED, V7, P677, DOI 10.1016/S2213-2600(18)30530-7; Ekeus C, 2010, PEDIATRICS, V125, pE67, DOI 10.1542/peds.2008-3329; Eves R, 2021, JAMA PEDIATR, V175, DOI 10.1001/jamapediatrics.2021.1058; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Gill JV, 2017, ARCH DIS CHILD, V102, P194, DOI 10.1136/archdischild-2015-309584; Gissler M, 2003, J EPIDEMIOL COMMUN H, V57, P433, DOI 10.1136/jech.57.6.433; GISSLER M, 1995, SCAND J SOC MED, V23, P75, DOI 10.1177/140349489502300113; Heo JS, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18062951; Hovi P, 2016, HYPERTENSION, V68, P880, DOI 10.1161/HYPERTENSIONAHA.116.08167; Howson CP, 2012, BORN TOO SOON GLOBAL; Jani BD, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1305-x; Johnson S, 2011, PEDIATR RES, V69, p11R, DOI 10.1203/PDR.0b013e318212faa0; Kajantie E, 2019, SEMIN FETAL NEONAT M, V24, P66, DOI 10.1016/j.siny.2018.11.001; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S2; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Li WL, 2019, EPILEPSY BEHAV, V97, P83, DOI 10.1016/j.yebeh.2019.05.016; Liao LH, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00405; Lowe J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155229; Luu TM, 2016, CAN MED ASSOC J, V188, P736, DOI 10.1503/cmaj.150450; Markopoulou P, 2019, J PEDIATR-US, V210, P69, DOI 10.1016/j.jpeds.2019.02.041; Marleen S, 2018, EUR J OBSTET GYN R B, V230, P159, DOI 10.1016/j.ejogrb.2018.09.025; McBryde M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.2027; Mendonca M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6961; Morrison KM, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0515; Moutquin JM, 2003, BJOG-INT J OBSTET GY, V110, P30, DOI 10.1016/S1470-0328(03)00021-1; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Paquette K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210366; Persson M, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003207; Philips EM, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003182; Pierrat V, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n741; Raju TNK, 2017, ACTA PAEDIATR, V106, P1409, DOI 10.1111/apa.13880; Risnes K, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.32779; Robinson R, 2020, SEMIN FETAL NEONAT M, V25, DOI 10.1016/j.siny.2020.101113; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Ruiz M, 2015, J EPIDEMIOL COMMUN H, V69, P826, DOI 10.1136/jech-2014-205387; Russell J, 2020, ACAD PEDIATR, V20, P619, DOI 10.1016/j.acap.2019.09.007; Ryan A, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0355-9; de Mendonca ELSS, 2020, EARLY HUM DEV, V149, DOI 10.1016/j.earlhumdev.2020.105154; Savran O, 2018, INT J CHRONIC OBSTR, V13, P683, DOI 10.2147/COPD.S153555; Sciences AoM, 2018, MULT PRIOR GLOB HLTH; Sipola-Leppanen M, 2015, AM J EPIDEMIOL, V181, P861, DOI 10.1093/aje/kwu443; Stahlberg T, 2020, J AFFECT DISORDERS, V277, P85, DOI 10.1016/j.jad.2020.08.004; Stirland LE, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m160; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Tronnes H, 2013, PEDIAT ALLERG IMM-UK, V24, P782, DOI 10.1111/pai.12170; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082; WHO WHO, 2018, WHO FACT SHEET PRET; Willadsen TG, 2016, SCAND J PRIM HEALTH, V34, P112, DOI 10.3109/02813432.2016.1153242; Xu XL, 2017, AGEING RES REV, V37, P53, DOI 10.1016/j.arr.2017.05.003	61	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261952	10.1371/journal.pone.0261952	http://dx.doi.org/10.1371/journal.pone.0261952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972182	Green Published, gold			2022-12-27	WOS:000773555700073
J	Issafras, H; Fan, SL; Tseng, CL; Cheng, YC; Lin, PH; Xiao, LS; Huang, YJ; Tu, CH; Hsiao, YC; Li, M; Chen, YH; Ho, CH; Li, O; Wang, YL; Chen, S; Ji, ZY; Zhang, E; Mao, YT; Liu, E; Yang, SM; Jiang, WD				Issafras, Hassan; Fan, Shilong; Tseng, Chi-Ling; Cheng, Yunchih; Lin, Peihua; Xiao, Lisa; Huang, Yun-Ju; Tu, Chih-Hsiang; Hsiao, Ya-Chin; Li, Min; Chen, Yen-Hsiao; Ho, Chien-Hsin; Li, Ou; Wang, Yanling; Chen, Sandra; Ji, Zhenyu; Zhang, Eric; Mao, Yi-Ting; Liu, Eugene; Yang, Shumin; Jiang, Weidong			Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candidate for cancer immunotherapy	PLOS ONE			English	Article							CELL; BLOCKADE; LIGAND	Cancer immunotherapies, such as checkpoint blockade of programmed cell death protein-1 (PD-1), represents a breakthrough in cancer treatment, resulting in unprecedented results in terms of overall and progression-free survival. Discovery and development of novel anti PD-1 inhibitors remains a field of intense investigation, where novel monoclonal antibodies (mAbs) and novel antibody formats (e.g., novel isotype, bispecific mAb and low-molecular-weight compounds) are major source of future therapeutic candidates. HLX10, a fully humanized IgG(4) monoclonal antibody against PD-1 receptor, increased functional activities of human T-cells and showed in vitro, and anti-tumor activity in several tumor models. The combined inhibition of PD-1/PDL-1 and angiogenesis pathways using anti-VEGF antibody may enhance a sustained suppression of cancer-related angiogenesis and tumor elimination. To elucidate HLX10's mode of action, we solved the structure of HLX10 in complex with PD-1 receptor. Detailed epitope analysis showed that HLX10 has a unique mode of recognition compared to the clinically approved PD1 antibodies Pembrolizumab and Nivolumab. Notably, HLX10's epitope was closer to Pembrolizumab's epitope than Nivolumab's epitope. However, HLX10 and Pembrolizumab showed an opposite heavy chain (HC) and light chain (LC) usage, which recognizes several overlapping amino acid residues on PD-1. We compared HLX10 to Nivolumab and Pembrolizumab and it showed similar or better bioactivity in vitro and in vivo, providing a rationale for clinical evaluation in cancer immunotherapy.	[Issafras, Hassan; Lin, Peihua; Li, Ou; Wang, Yanling; Mao, Yi-Ting; Jiang, Weidong] Hengenix Inc, Fremont, CA 94538 USA; [Fan, Shilong; Li, Min] Tsinghua Univ, Natl Prot Sci Facil, Beijing, Peoples R China; [Tseng, Chi-Ling; Cheng, Yunchih; Huang, Yun-Ju; Tu, Chih-Hsiang; Hsiao, Ya-Chin; Chen, Yen-Hsiao; Ho, Chien-Hsin] HanchorBio Inc Ltd, Taipei, Taiwan; [Xiao, Lisa; Ji, Zhenyu; Zhang, Eric; Yang, Shumin; Jiang, Weidong] Shanghai Henlius Biotech Inc, Shanghai, Peoples R China; [Chen, Sandra] Anwita Biosci, San Carlos, CA USA; [Liu, Eugene] Taipei Med Univ, Taipei, Taiwan	Tsinghua University; Taipei Medical University	Issafras, H (corresponding author), Hengenix Inc, Fremont, CA 94538 USA.; Fan, SL (corresponding author), Tsinghua Univ, Natl Prot Sci Facil, Beijing, Peoples R China.	hissafras@gmail.com; fanshilong@mail.tsinghua.edu.cn			Shanghai Henlius Biotech, Inc.	Shanghai Henlius Biotech, Inc.	The authors received funding in the form of salary for this work from Shanghai Henlius Biotech, Inc. Hassan Issafras, Chi-Ling Tseng, Yunchih Cheng, Peihua Lin, Lisa Xiao, Yun-Ju Huang, Chih-Hsiang Tu, Ya-Chin Hsiao, Yen-Hsiao Chen, Chien-Hsin Ho, Ou Li, Yanling Wang, Sandra Chen, Zhenyu Ji, Eric Zhang, Yi-Ting Mao, Eugen Liu, Shumin Yang and Weidong Jiang were employees of Shanghai Henlius Biotech, Inc., P. R. China and its US subsidiary Hengenix Inc. Fremont, CA, US. Shilong Fan and Min Li received funding from Shanghai Henlius Biotech, Inc. but were not salaried employees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study. The role of the authors as articulated in the 'author contributions' section.	Ai LY, 2020, ADV EXP MED BIOL, V1248, P33, DOI 10.1007/978-981-15-3266-5_3; Arasanz H, 2017, ONCOTARGET, V8, P51936, DOI 10.18632/oncotarget.17232; Assessment Report, 2015, EMACHMP766882015, P24; Brown ME, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229206; Chen Y, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01088; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Curran MA, 2018, CANCER J, V24, P2, DOI 10.1097/PPO.0000000000000298; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Gong J, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0316-z; Horita S, 2016, SCI REP-UK, V6, DOI 10.1038/srep35297; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee WS, 2020, EXP MOL MED, V52, P1475, DOI 10.1038/s12276-020-00500-y; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Na ZK, 2017, CELL RES, V27, P147, DOI 10.1038/cr.2016.77; Patsoukis N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd2712; Patsoukis N, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0845-0; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; Tam SH, 2017, ANTIBODIES, V6, DOI 10.3390/antib6030012; Tan SG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14369; Voron T, 2015, J EXP MED, V212, P139, DOI 10.1084/jem.20140559; Yi M, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01045-x; Yi M, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0974-6; Yu JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206223; Zak KM, 2017, STRUCTURE, V25, P1163, DOI 10.1016/j.str.2017.06.011; Zak KM, 2015, STRUCTURE, V23, P2341, DOI 10.1016/j.str.2015.09.010	26	3	3	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0257972	10.1371/journal.pone.0257972	http://dx.doi.org/10.1371/journal.pone.0257972			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972111	Green Published, gold			2022-12-27	WOS:000773555700007
J	Son, M; Lee, YS; Lee, MJ; Park, Y; Bae, HR; Lee, SY; Shin, MG; Yang, S				Son, Minkook; Lee, Ye Sung; Lee, Mahn Jae; Park, YongKeun; Bae, Hae-Rahn; Lee, Seung Yeob; Shin, Myung-Geun; Yang, Sung			Effects of osmolality and solutes on the morphology of red blood cells according to three-dimensional refractive index tomography	PLOS ONE			English	Article							HUMAN ERYTHROCYTES; IN-VITRO; SHAPE; VOLUME; HEMOLYSIS; DYNAMICS; GLUCOSE; SALINE; AREA	Phosphate-buffered saline (PBS) and Alsever's solution (AS) are frequently used as media in blood-related studies, while 0.9% normal saline (NS) is frequently used in transfusion medicine. Despite the frequent use, the effects of these solutions on the shape and volume of red blood cells (RBCs) have not been reported. We collected blood samples from five healthy adults and used three-dimensional refractive index tomography to investigate the changes in the morphology of RBCs caused by changes in osmolality and solutes at the single-cell level. After diluting 2 mu L of RBCs 200-fold with each solution (PBS, AS, and 0.9% NS), 40 randomly selected RBCs were microscopically observed. RBC shape was measured considering sphericity, which is a dimensionless quantity ranging from 0 (flat) to 1 (spherical). RBCs in plasma or AS showed a biconcave shape with a small sphericity, whereas those in 0.9% NS or PBS showed a spherical shape with a large sphericity. Moreover, we confirmed that sodium chloride alone could not elicit the biconcave shape of RBCs, which could be maintained only in the presence of an osmotic pressure-maintaining substance, such as glucose or mannitol. Although 0.9% NS solution is one of the most commonly used fluids in hematology and transfusion medicine, RBCs in 0.9% NS or PBS are not biconcave. Therefore, as the debate on the use of NS continues, future clinical studies or applications should consider the effect of glucose or mannitol on the shape of RBCs.	[Son, Minkook; Yang, Sung] Gwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea; [Lee, Ye Sung; Yang, Sung] Gwangju Inst Sci & Technol, Sch Mech Engn, Gwangju, South Korea; [Lee, Mahn Jae] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Park, YongKeun] Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea; [Bae, Hae-Rahn] Dong A Univ, Dept Physiol, Coll Med, Busan, South Korea; [Lee, Seung Yeob] Jeonbuk Natl Univ, Dept Lab Med, Med Sch & Hosp, Jeonju, South Korea; [Shin, Myung-Geun] Chonnam Natl Univ, Dept Lab Med, Med Sch, Hwasun, South Korea; [Shin, Myung-Geun] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Dong A University; Jeonbuk National University; Chonnam National University; Chonnam National University	Yang, S (corresponding author), Gwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea.; Yang, S (corresponding author), Gwangju Inst Sci & Technol, Sch Mech Engn, Gwangju, South Korea.	syang@gist.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MSIT) [2020R1A5A8018367]	National Research Foundation of Korea (NRF) - Korean government (MSIT)(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) [grant number 2020R1A5A8018367]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsever JB., 1941, NY STATE J MED, V41, P126; Blumberg N, 2018, TRANSFUS APHER SCI, V57, P127, DOI 10.1016/j.transci.2018.02.021; Briggs C, 2000, CLIN LAB HAEMATOL, V22, P345, DOI 10.1046/j.1365-2257.2000.00330.x; Campbell-Lee SA., 2007, PACKED RED BLOOD CEL, Vsecond, P250; Dagur Pradeep K, 2015, Curr Protoc Cytom, V73, DOI 10.1002/0471142956.cy0501s73; Diez-Silva M, 2010, MRS BULL, V35, P382, DOI 10.1557/mrs2010.571; Disbro Wendy L, 2017, Immunohematology, V33, P105; DORWART WV, 1975, CLIN CHEM, V21, P190; ELGSAETER A, 1991, BIOCHIM BIOPHYS ACTA, V1071, P273, DOI 10.1016/0304-4157(91)90017-Q; Fung YC., 1993, BIOMECHANICS MECH PR, P112; Garcia MJ., 2009, REV COLOMB ANESTESIO, V37, P106; GEDDE MM, 1995, BLOOD, V86, P1595, DOI 10.1182/blood.V86.4.1595.bloodjournal8641595; Goodhead LK, 2017, ADV PHYSIOL EDUC, V41, P298, DOI 10.1152/advan.00083.2016; Hess JR., 2007, RED BLOOD CELL METAB, Vsecond, P205; Hur J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08675-7; Jung J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31698; Kackov S, 2013, BIOCHEM MEDICA, V23, P326; Kim Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06659; Kim Y, 2014, OPT EXPRESS, V22, P10398, DOI 10.1364/OE.22.010398; Kirkley SA, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.3557.3557; Lee S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01036-4; Li H, 2016, J ZHEJIANG UNIV-SC B, V17, P181, DOI 10.1631/jzus.B1500201; Martincic I, 2008, Immunohematology, V24, P39; Masalunga C, 2007, J PERINATOL, V27, P380, DOI 10.1038/sj.jp.7211748; Park H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34257; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Popescu G, 2008, BLOOD CELL MOL DIS, V41, P10, DOI 10.1016/j.bcmd.2008.01.010; Rasia M, 1998, BBA-BIOMEMBRANES, V1372, P198, DOI 10.1016/S0005-2736(98)00057-1; Rasouli M, 2016, CLIN BIOCHEM, V49, P936, DOI 10.1016/j.clinbiochem.2016.06.001; Reinhart SA, 2015, CLIN HEMORHEOL MICRO, V60, P437, DOI 10.3233/CH-141899; Reinhart WH, 2015, TRANSFUSION, V55, P1872, DOI 10.1111/trf.13052; Reinhart WH, 2015, MICROVASC RES, V98, P102, DOI 10.1016/j.mvr.2015.01.010; Roma PMS, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.090505; Rous P, 1916, J EXP MED, V23, P219, DOI 10.1084/jem.23.2.219; SCHJERNINGTHIESEN K, 1953, ACTA PATHOL MIC SC, V32, P198; Tomaiuolo G, 2012, CYTOM PART A, V81A, P1040, DOI 10.1002/cyto.a.22215; TRAYKOV TT, 1987, INT J MICROCIRC, V6, P35; Viskupicova J, 2015, REDOX BIOL, V5, P381, DOI 10.1016/j.redox.2015.06.011; Wadell H, 1935, J GEOL, V43, P250, DOI 10.1086/624298; Watson P, 2014, MED SCI SPORT EXER, V46, P52, DOI 10.1249/MSS.0b013e3182a0537b; WAUGH RE, 1992, BLOOD, V79, P1351; Weatherall DJ, 2011, NEW ENGL J MED, V364, P376, DOI 10.1056/NEJMcibr1012683; Yang P, 2014, TRANSFUSION, V54, P1146, DOI 10.1111/trf.12370	44	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262106	10.1371/journal.pone.0262106	http://dx.doi.org/10.1371/journal.pone.0262106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972199	gold, Green Published			2022-12-27	WOS:000773555700098
J	Yuh, MA; Kim, K; Woo, SH; Jeong, S; Oh, J; Kim, J; Hong, S				Yuh, Min Ah; Kim, Kisung; Woo, Seon Hee; Jeong, Sikyoung; Oh, Juseok; Kim, Jinwoo; Hong, Sungyoup			Effects of weather and moon phases on emergency medical use after fall injury: A population-based nationwide study	PLOS ONE			English	Article							EVENTS; TRAUMA; WINTER	Background Previous studies reported that changes in weather and phases of moon are associated with medical emergencies and injuries. However, such studies were limited to hospital or community level without explaining the combined effects of weather and moon phases. We investigated whether changes in weather and moon phases affected emergency department (ED) visits due to fall injuries (FIs) based on nationwide emergency patient registry data. Methods Nationwide daily data of ED visits after FI were collected from 11 provinces (7 metropolitan cities and 4 rural provinces) in Korea between January 2014 and December 2018. The daily number of FIs was standardized into FI per million population (FPP) in each province. A multivariate regression analysis was conducted to elucidate the relationship between weather factors and moon phases with respect to daily FPP in each province. The correlation between weather factors and FI severity was also analyzed. Results The study analyzed 666,912 patients (418,135 in metropolitan and 248,777 in rural areas) who visited EDs on weekdays. No regional difference was found in age or gender distribution between the two areas. Precipitation, minimum temperature and wind speed showed a significant association with FI in metropolitan areas. In addition, sunshine duration was also substantial risk factors for FI in rural areas. The incidence of FIs was increased on full moon days than on other days in rural areas. Injury severity was associated with weather factors such as minimum temperature, wind speed, and cloud cover. Conclusion Weather changes such as precipitation, minimum temperature, and wind speed are associated with FI in metropolitan and rural areas. In addition, sunshine duration and full moon are significantly associated with FI incidence only in rural areas. Weather factors are associated with FI severity.	[Yuh, Min Ah; Jeong, Sikyoung; Hong, Sungyoup] Catholic Univ Korea, Dept Emergency Med, Daejeon St Marys Hosp, Coll Med, Seoul, South Korea; [Kim, Kisung] BioBrain Inc, Daejeon, South Korea; [Woo, Seon Hee] Catholic Univ Korea, Coll Med, Dept Emergency Med, Incheon St Marys Hosp, Seoul, South Korea; [Oh, Juseok] Catholic Univ Korea, Coll Med, Dept Emergency Med, Uijeongbu St Marys Hosp, Seoul, South Korea; [Kim, Jinwoo] Daejeon Hlth Inst Technol, Dept Emergency Med Serv, Daejeon, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Hong, S (corresponding author), Catholic Univ Korea, Dept Emergency Med, Daejeon St Marys Hosp, Coll Med, Seoul, South Korea.	emhong@catholic.ac.kr		Hong, Sungyoup/0000-0002-3387-6194; Kim, Kiseong/0000-0001-9935-3516; Oh, Joo Suk/0000-0003-0519-9824	Daejeon St. Mary's Hospital, Clinical Research Institute [CMCDJ-P-2021013]	Daejeon St. Mary's Hospital, Clinical Research Institute	We declare that this study was supported by Daejeon St. Mary's Hospital, Clinical Research Institute Grant No. CMCDJ-P-2021013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakraborty U, 2020, BIOL RHYTHM RES, V51, P254, DOI 10.1080/09291016.2018.1526502; Das D., 2015, INT J FISH AQUAT STU, V2, P304; Gevitz K, 2017, PUBLIC HEALTH REP, V132, p53S, DOI 10.1177/0033354917706968; Lepy E, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080822; Lim YD, 2020, EUR J TRAUMA EMERG S, V46, P895, DOI 10.1007/s00068-018-1048-y; Lin LW, 2015, INJURY, V46, P1814, DOI 10.1016/j.injury.2015.02.026; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; Morency P, 2012, CAN J PUBLIC HEALTH, V103, P218, DOI 10.1007/BF03403816; Onozuka D, 2018, SCI TOTAL ENVIRON, V644, P801, DOI 10.1016/j.scitotenv.2018.07.053; Organization WH., 2008, WHO GLOB REP FALLP; PARK JOONBUM, 2017, [Journal of The Korean Society of Emergency Medicine, 대한응급의학회지], V28, P547; Pickering WHJPA., 1903, POP ASTRON, V11, P327; Ramgopal S, 2019, PREHOSP EMERG CARE, V23, P802, DOI 10.1080/10903127.2019.1593563; Redelmeier DA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5367; Smulders E, 2013, J INTELL DISABIL RES, V57, P1173, DOI 10.1111/j.1365-2788.2012.01643.x; Stomp W, 2009, J TRAUMA, V67, P1103, DOI 10.1097/TA.0b013e3181986941; Sundfor HB, 2019, ACCIDENT ANAL PREV, V125, P152, DOI 10.1016/j.aap.2019.02.004; Unguryanu TN, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176096; Yeung PY, 2011, J CLIN GERONTOL GERI, V2, P13, DOI 10.1016/j.jcgg.2011.02.002	19	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261071	10.1371/journal.pone.0261071	http://dx.doi.org/10.1371/journal.pone.0261071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34971555	Green Published, gold			2022-12-27	WOS:000773555700022
J	Zhuang, XH; Tran, T; Jin, D; Philip, R; Wu, CR				Zhuang, Xiaohua; Tran, Tam; Jin, Doris; Philip, Riya; Wu, Chaorong			Aging effects on contrast sensitivity in visual pathways: A pilot study on flicker adaptation	PLOS ONE			English	Article							GANGLION-CELLS; SAMPLING EFFICIENCY; GLAUCOMA; AMBLYOPIA; MODULATION; LUMINANCE; PARALLEL; DECLINE; VISION; LOSSES	Contrast sensitivity is reduced in older adults and is often measured at an overall perceptual level. Recent human psychophysical studies have provided paradigms to measure contrast sensitivity independently in the magnocellular (MC) and parvocellular (PC) visual pathways and have reported desensitization in the MC pathway after flicker adaptation. The current study investigates the influence of aging on contrast sensitivity and on the desensitization effect in the two visual pathways. The steady- and pulsed-pedestal paradigms were used to measure contrast sensitivity under two adaptation conditions in 45 observers. In the non-flicker adaptation condition, observers adapted to a pedestal array of four 1 degrees x1 degrees squares presented with a steady luminance; in the flicker adaptation condition, observers adapted to a square-wave modulated luminance flicker of 7.5 Hz and 50% contrast. Results showed significant age-related contrast sensitivity reductions in the MC and PC pathways, with a significantly larger decrease of contrast sensitivity for individuals older than 50 years of age in the MC pathway but not in the PC pathway. These results are consistent with the hypothesis that sensitivity reduction observed at the overall perceptual level likely comes from both the MC and PC visual pathways, with a more dramatic reduction resulting from the MC pathway for adults >50 years of age. In addition, a similar desensitization effect from flicker adaptation was observed in the MC pathway for all ages, which suggests that aging may not affect the process of visual adaptation to rapid luminance flicker.	[Zhuang, Xiaohua; Tran, Tam; Jin, Doris; Philip, Riya] Illinois Coll Optometry, Chicago, IL 60616 USA; [Wu, Chaorong] Univ Utah, Study Design & Biostat Ctr, Div Epidemiol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah	Zhuang, XH (corresponding author), Illinois Coll Optometry, Chicago, IL 60616 USA.	xzhuang@ico.edu			Illinois Society for the Prevention of Blindness Research Grant; American Academy of Optometry Foundation Beta Sigma Kappa Research Fellowship; ICO Internal Research Grant	Illinois Society for the Prevention of Blindness Research Grant; American Academy of Optometry Foundation Beta Sigma Kappa Research Fellowship; ICO Internal Research Grant	Supported to XZ from Illinois Society for the Prevention of Blindness Research Grant, American Academy of Optometry Foundation Beta Sigma Kappa Research Fellowship, and ICO Internal Research Grant.	AHMAD A, 1993, J COMP NEUROL, V334, P631, DOI 10.1002/cne.903340410; Benedek Gyorgy, 2016, Vision (Basel), V1, DOI 10.3390/vision1010007; Bennett PJ, 1999, J OPT SOC AM A, V16, P654, DOI 10.1364/JOSAA.16.000654; Bi W, 2016, INVEST OPHTH VIS SCI, V57, P387, DOI 10.1167/iovs.15-16481; Chatzistefanou KI, 2005, J AAPOS, V9, P468, DOI 10.1016/j.jaapos.2005.05.002; Conlon E, 2008, AGING NEUROPSYCHOL C, V15, P446, DOI 10.1080/13825580701878008; CROOK JM, 1988, J PHYSIOL-LONDON, V396, P205, DOI 10.1113/jphysiol.1988.sp016959; DEREFELDT G, 1979, ACTA OPHTHALMOL, V57, P679; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; Dorr M, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00234; ELLIOTT D, 1990, VISION RES, V30, P541, DOI 10.1016/0042-6989(90)90066-T; ELLIOTT DB, 1987, OPHTHAL PHYSL OPT, V7, P415, DOI 10.1111/j.1475-1313.1987.tb00771.x; Elliott SL, 2010, J VISION, V10, DOI 10.1167/10.4.4; Elliott SL, 2009, J VISION, V9, DOI 10.1167/9.2.24; Glass JM, 2007, PSYCHOL AGING, V22, P233, DOI 10.1037/0882-7974.22.2.233; Habak C, 2000, VISION RES, V40, P943, DOI 10.1016/S0042-6989(99)00235-7; Harwerth RS, 2008, INVEST OPHTH VIS SCI, V49, P4437, DOI 10.1167/iovs.08-1753; Hathibelagal AR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232784; Ichhpujani P, 2020, J GLAUCOMA, V29, P71, DOI 10.1097/IJG.0000000000001379; Jammal AA, 2020, BRIT J OPHTHALMOL, V104, P1418, DOI 10.1136/bjophthalmol-2019-315273; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; KENDELL KR, 1995, INVEST OPHTH VIS SCI, V36, P200; KIM CBY, 1994, J OPT SOC AM A, V11, P1958, DOI 10.1364/JOSAA.11.001958; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Lek JJ, 2014, INVEST OPHTH VIS SCI, V55, P3171, DOI 10.1167/iovs.13-13229; Luu CD, 2013, INVEST OPHTH VIS SCI, V54, P3560, DOI 10.1167/iovs.12-10465; McAnany JJ, 2020, ACTA OPHTHALMOL, V98, pE224, DOI 10.1111/aos.14241; McKendrick AM, 2007, INVEST OPHTH VIS SCI, V48, P2115, DOI 10.1167/iovs.06-1208; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Min SH, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.622729; Mohammadi A, 2019, J CURR OPHTHALMOL, V31, P72, DOI 10.1016/j.joco.2018.09.010; NAMEDA N, 1989, OPTOMETRY VISION SCI, V66, P760, DOI 10.1097/00006324-198911000-00007; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Owsley C, 2016, ANNU REV VIS SCI, V2, P255, DOI 10.1146/annurev-vision-111815-114550; Pardhan S, 2004, J OPT SOC AM A, V21, P169, DOI 10.1364/JOSAA.21.000169; Pardhan S, 1996, VISION RES, V36, P1641, DOI 10.1016/0042-6989(95)00214-6; Plainis S, 2005, PERCEPTION, V34, P933, DOI 10.1068/p5451; Pokorny J, 1997, J OPT SOC AM A, V14, P2477, DOI 10.1364/JOSAA.14.002477; Pokorny J, 2011, J VISION, V11, DOI 10.1167/11.5.7; Pramanik S, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05336; Resende AF, 2019, DOC OPHTHALMOL, V139, P185, DOI 10.1007/s10633-019-09707-5; Ridder A, 2017, PARKINSONISM RELAT D, V34, P15, DOI 10.1016/j.parkreldis.2016.10.006; Schubert CR, 2017, J GERONTOL A-BIOL, V72, P1087, DOI 10.1093/gerona/glx067; SEKULER R, 1982, AM J OPTOM PHYS OPT, V59, P961; SLOANE ME, 1988, J OPT SOC AM A, V5, P2181, DOI 10.1364/JOSAA.5.002181; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Thakur S, 2018, EYE, V32, P1392, DOI 10.1038/s41433-018-0099-y; TULUNAYKEESEY U, 1988, J OPT SOC AM A, V5, P2191, DOI 10.1364/JOSAA.5.002191; TYLER CW, 1989, J OPT SOC AM A, V6, P481, DOI 10.1364/JOSAA.6.000481; Yan FF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63053-0; Yuan Y, 2021, OPHTHALMIC RES, V64, P967, DOI 10.1159/000515599; Zele AJ, 2007, INVEST OPHTH VIS SCI, V48, P3622, DOI 10.1167/iovs.06-1207; Zhuang XH, 2015, VISION RES, V117, P41, DOI 10.1016/j.visres.2015.08.020; Zhuang XH, 2015, INVEST OPHTH VIS SCI, V56, P2901, DOI 10.1167/iovs.14-16067; Zhuang XH, 2012, J VISION, V12, DOI 10.1167/12.11.16	56	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261927	10.1371/journal.pone.0261927	http://dx.doi.org/10.1371/journal.pone.0261927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972163	Green Published, gold			2022-12-27	WOS:000773555700068
J	Nomikos, PA; Hall, MC; Fuller, A; Ogollah, R; Valdes, AM; Doherty, M; Walsh, DA; das Nair, R; Abhishek, A				Nomikos, Polykarpos Angelos; Hall, Michelle C.; Fuller, Amy; Ogollah, Reuben; Valdes, Ana M.; Doherty, Michael; Walsh, David Andrew; das Nair, Roshan; Abhishek, Abhishek			Acceptability of a nurse-led non-pharmacological complex intervention for knee pain: Nurse and patient views and experiences	PLOS ONE			English	Article							PRIMARY-CARE; MANAGEMENT; BARRIERS; OLDER	Objectives The overall purpose of this research programme is to develop and test the feasibility of a complex intervention for knee pain delivered by a nurse, and comprising both non-pharmacological and pharmacological interventions. In this first phase, we examined the acceptability of the non-pharmacological component of the intervention; issues faced in delivery, and resolved possible challenges to delivery. Methods Eighteen adults with chronic knee pain were recruited from the community. The intervention comprised holistic assessment, education, exercise, weight-loss advice (where appropriate) and advice on adjunctive treatments such as hot/cold treatments, footwear modification and walking aids. After nurse training, the intervention was delivered in four sessions spread over five weeks. Participants had one to one semi-structured interview at the end of the intervention. The nurse was interviewed after the last visit of the last participant. These were audio recorded and transcribed verbatim. Themes were identified by one author through framework analysis of the transcripts, and cross-checked by another. Results Most participants found the advice from the nurse easy to follow and were satisfied with the package, though some felt that too much information was provided too soon. The intervention changed their perception of managing knee pain, learning that it can be improved with self-management. However, participants thought that the most challenging part of the intervention was fitting the exercise regime into their daily routine. The nurse found discussion of goal setting to be challenging. Conclusion The nurse-led package of care is acceptable within a research setting. The results are promising and will be applied in a feasibility randomised-controlled trial.	[Nomikos, Polykarpos Angelos; Fuller, Amy; Valdes, Ana M.; Doherty, Michael; Walsh, David Andrew; Abhishek, Abhishek] Univ Nottingham, Acad Rheumatol, Sch Med, Div Rheumatol Orthopaed & Rheumatol, Nottingham, England; [Nomikos, Polykarpos Angelos; Hall, Michelle C.; Fuller, Amy; Valdes, Ana M.; Doherty, Michael; Walsh, David Andrew; Abhishek, Abhishek] Univ Nottingham, NIHR Nottingham Biomed Res Ctr, Nottingham, England; [Nomikos, Polykarpos Angelos; Hall, Michelle C.; Valdes, Ana M.; Doherty, Michael; Walsh, David Andrew; das Nair, Roshan; Abhishek, Abhishek] Univ Nottingham, Pain Ctr Versus Arthrit, Nottingham, England; [Hall, Michelle C.] Univ Nottingham, Sch Hlth Sci, Nottingham, England; [Ogollah, Reuben] Univ Nottingham, Nottingham Clin Trials Unit, Nottingham, England; [das Nair, Roshan] Nottinghamshire Healthcare Fdn NHS Trust, Inst Mental Hlth, Nottingham, England; [das Nair, Roshan] Univ Nottingham, Sch Med, Div Psychiat & Appl Psychol, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Nomikos, PA (corresponding author), Univ Nottingham, Acad Rheumatol, Sch Med, Div Rheumatol Orthopaed & Rheumatol, Nottingham, England.; Nomikos, PA (corresponding author), Univ Nottingham, NIHR Nottingham Biomed Res Ctr, Nottingham, England.; Nomikos, PA (corresponding author), Univ Nottingham, Pain Ctr Versus Arthrit, Nottingham, England.	Polykarpos.nomikos@nottingham.ac.uk		Doherty, Michael/0000-0002-5763-8326; Ogollah, Reuben/0000-0002-5777-4117; Hall, Michelle/0000-0003-2231-1507; Nomikos, Polykarpos/0000-0001-6827-4938; Fuller, Amy/0000-0002-9669-1816	NIHR Nottingham Biomedical Research Centre; University of Nottingham, UK; Pain Centre Versus Arthritis	NIHR Nottingham Biomedical Research Centre; University of Nottingham, UK; Pain Centre Versus Arthritis	This work was supported and co-funded by the NIHR Nottingham Biomedical Research Centre and the Pain Centre Versus Arthritis (Internal funding 2017-2022).The views expressed are those of author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The study is sponsored by the University of Nottingham, UK.	Ayala GX, 2011, J PUBLIC HEALTH DENT, V71, pS69, DOI 10.1111/j.1752-7325.2011.00241.x; Becker WC, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0608-2; Bellamy N, 2002, WOMAC OSTEOARTHRITIS, V5; Borrelli B, 2005, J CONSULT CLIN PSYCH, V73, P852, DOI 10.1037/0022-006X.73.5.852; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Cui AY, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100587; Denver EA, 2003, DIABETES CARE, V26, P2256, DOI 10.2337/diacare.26.8.2256; Doherty M, 2018, LANCET, V392, P1403, DOI 10.1016/S0140-6736(18)32158-5; Driscoll A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009889.pub2; Egerton T, 2017, OSTEOARTHR CARTILAGE, V25, P625, DOI 10.1016/j.joca.2016.12.002; Egerton T, 2018, BMC RHEUMATOL, V2, DOI 10.1186/s41927-018-0037-4; Fisher P, 2006, HOMEOPATHY, V95, P215, DOI 10.1016/j.homp.2006.07.006; Fuller A, 2020, RHEUMATOLOGY, V59, P575, DOI 10.1093/rheumatology/kez333; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gignac MAM, 2006, ARTHRIT RHEUM-ARTHR, V55, P905, DOI 10.1002/art.22338; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hall M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037760; Hommel KA, 2013, EUR J GASTROEN HEPAT, V25, P469, DOI 10.1097/MEG.0b013e32835c2a1b; Martinez-Gonzalez NA, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0049-8; Metzler K., 2014, INTRO QUALITATIVE RE, Vfifth ed; Michie S, 2008, NHS HLTH TRAINER HDB; Michie S., 2014, BEHAV CHANGE WHEEL B; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Millar B, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-03195-4; National Institute for Health and Care Excellence, 2014, ANN DIAB CHECKS IND; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Nomikos PA, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045242; Porcheret M, 2007, RHEUMATOLOGY, V46, P1694, DOI 10.1093/rheumatology/kem232; Sekhon M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2031-8; Sisk JE, 2006, ANN INTERN MED, V145, P273, DOI 10.7326/0003-4819-145-4-200608150-00007; Welch G, 2010, DIABETES RES CLIN PR, V88, P1, DOI 10.1016/j.diabres.2009.12.026	31	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262422	10.1371/journal.pone.0262422	http://dx.doi.org/10.1371/journal.pone.0262422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025935	Green Published, gold, Green Submitted			2022-12-27	WOS:000796264200067
J	Soria, MA; Cervantes, SA; Siemer, AB				Soria, Maria A.; Cervantes, Silvia A.; Siemer, Ansgar B.			Calmodulin binds the N-terminus of the functional amyloid Orb2A inhibiting fibril formation	PLOS ONE			English	Article							CREB PHOSPHORYLATION; DROSOPHILA ORB2; PEPTIDES; IDENTIFICATION; RECOGNITION; TRANSLATION; PERSISTENCE; SEQUENCES; CORE	The cytoplasmic polyadenylation element-binding protein Orb2 is a key regulator of long-term memory (LTM) in Drosophila. The N-terminus of the Orb2 isoform A is required for LTM and forms cross-beta fibrils on its own. However, this N-terminus is not part of the core found in ex vivo fibrils. We previously showed that besides forming cross-beta fibrils, the N-terminus of Orb2A binds anionic lipid membranes as an amphipathic helix. Here, we show that the Orb2A N-terminus can similarly interact with calcium activated calmodulin (CaM) and that this interaction prevents fibril formation. Because CaM is a known regulator of LTM, this interaction could potentially explain the regulatory role of Orb2A in LTM.	[Soria, Maria A.; Cervantes, Silvia A.; Siemer, Ansgar B.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA; [Soria, Maria A.] Fresno Pacific Univ, Fresno, CA USA	University of Southern California	Siemer, AB (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA.	asiemer@usc.edu		Siemer, Ansgar B./0000-0003-0901-011X	National Institutes of Health [F31NS105524]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A.B.S. would like to acknowledge funding from the National Institutes of Health (www.nih.gov) award number R01GM110521. S.A.C. would like to acknowledge funding from the National Institutes of Health (www.nih.gov) award number F31NS105524. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi WA, 2017, PROTEINS, V85, P1724, DOI 10.1002/prot.25330; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Ashami K, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100804; Atkins CM, 2004, J NEUROSCI, V24, P5193, DOI 10.1523/JNEUROSCI.0854-04.2004; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Burke KA, 2013, J BIOL CHEM, V288, P14993, DOI 10.1074/jbc.M112.446237; Cervantes SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38265; CIMLER BM, 1985, J BIOL CHEM, V260, P784; Cote S, 2015, BIOPHYS J, V108, P1187, DOI 10.1016/j.bpj.2015.02.001; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; ERICKSONVIITANEN S, 1987, METHOD ENZYMOL, V139, P455; Fonda BD, 2021, J AM CHEM SOC, V143, P6657, DOI 10.1021/jacs.1c02424; Hervas R, 2020, SCIENCE, V367, P1230, DOI 10.1126/science.aba3526; Hervas R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002361; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Khan MR, 2015, CELL, V163, P1468, DOI 10.1016/j.cell.2015.11.020; Kruttner S, 2012, NEURON, V76, P383, DOI 10.1016/j.neuron.2012.08.028; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; MALENCIK DA, 1982, BIOCHEMISTRY-US, V21, P3480, DOI 10.1021/bi00257a035; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mruk K, 2014, J GEN PHYSIOL, V144, P103, DOI 10.1085/jgp.201311140; Sanhueza M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-10; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; Soria MA, 2017, BIOPHYS J, V113, P37, DOI 10.1016/j.bpj.2017.05.039; Stsiapura VI, 2007, J PHYS CHEM A, V111, P4829, DOI 10.1021/jp070590o; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Voropai E. S., 2003, Journal of Applied Spectroscopy, V70, P868, DOI 10.1023/B:JAPS.0000016303.37573.7e; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; White-Grindley E, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001786; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; XIA ZG, 1993, J NEUROCHEM, V60, P305, DOI 10.1111/j.1471-4159.1993.tb05852.x; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200	40	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0259872	10.1371/journal.pone.0259872	http://dx.doi.org/10.1371/journal.pone.0259872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025866	gold, Green Published			2022-12-27	WOS:000796264200005
J	Tanner, C; Linder, S; Sohn, M				Tanner, Carmen; Linder, Stefan; Sohn, Matthias			Does moral commitment predict resistance to corruption? experimental evidence from a bribery game	PLOS ONE			English	Article							HONESTY-HUMILITY; ORGANIZATIONAL CORRUPTION; COMPETITION; MODEL; PREFERENCES; PSYCHOLOGY; MANAGEMENT; RESOLUTION; ATTITUDES; BEHAVIOR	Corruption is ubiquitous in practice and has severe negative consequences for organizations and societies at large. Drawing on a laboratory experiment, we propose that individuals high in moral commitment are less likely to engage in corrupt behaviors and prefer foregoing financial benefits. Specifically, we posit that individuals refrain from corruption (i) the more they endorse integrity (incorruptibility) as a protected value and (ii) the higher their level of Honesty-Humility. The results of a two-step experiment largely support our expectations: people who treat compromises to integrity as unacceptable were less willing to accept bribes, and Honesty-Humility decreased bribe-giving. The findings are robust to demographic variables (e.g., age, gender, cultural background) and additional personal characteristics (e.g., risk tolerance, dispositional greed) and have important implications for ongoing theory-building efforts and business practice.	[Tanner, Carmen] Univ Zurich, Dept Banking & Finance, Zurich, Switzerland; [Tanner, Carmen] Zeppelin Univ Friedrichshafen, Chair Econ Psychol & Leadership Eth, Friedrichshafen, Germany; [Linder, Stefan] ESSEC Business Sch Paris, Chair Accounting & Management Control, Cergy Pontoise, France; [Sohn, Matthias] European Univ Viadrina, Chair Management Accounting, Frankfurt, Germany	University of Zurich; Zeppelin University; ESSEC Business School; European University Viadrina Frankfurt Oder	Tanner, C (corresponding author), Univ Zurich, Dept Banking & Finance, Zurich, Switzerland.; Tanner, C (corresponding author), Zeppelin Univ Friedrichshafen, Chair Econ Psychol & Leadership Eth, Friedrichshafen, Germany.	carmen.tanner@bf.uzh.ch		Sohn, Matthias/0000-0001-9306-1416; Tanner, Carmen/0000-0002-3925-0889	CERESSEC [043-263-1-8-05-P-1]	CERESSEC	CERESSEC supported this research by proving financial support under grant number 043-263-1-8-05-P-1 for running the study.	Abbink K, 2006, EXP ECON, V9, P103, DOI 10.1007/s10683-006-5385-z; Abbink K, 2012, RES EXP ECON, V15, P77, DOI 10.1108/S0193-2306(2012)0000015006; Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.241102; Acemoglu D, 2020, J POLIT ECON, V128, P3090, DOI 10.1086/707765; Ajzen I., 1980, UNDERSTANDING ATTITU; Aquino K, 2002, J PERS SOC PSYCHOL, V83, P1423, DOI 10.1037//0022-3514.83.6.1423; Armantier O, 2012, RES EXP ECON, V15, P117, DOI 10.1108/S0193-2306(2012)0000015007; Ashforth BE, 2003, RES ORGAN BEHAV, V25, P1, DOI 10.1016/S0191-3085(03)25001-2; Ashton MC, 2007, PERS SOC PSYCHOL REV, V11, P150, DOI 10.1177/1088868306294907; Atran S, 2007, SCIENCE, V317, P1039, DOI 10.1126/science.1144241; BANDURA A, 1986, J SOC CLIN PSYCHOL, V4, P359, DOI 10.1521/jscp.1986.4.3.359; Baron J, 1997, ORGAN BEHAV HUM DEC, V70, P1, DOI 10.1006/obhd.1997.2690; Barr A, 2010, J PUBLIC ECON, V94, P862, DOI 10.1016/j.jpubeco.2010.07.006; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Beets SD, 2005, J BUS ETHICS, V57, P65, DOI 10.1007/s10551-004-3824-3; Beugre CD, 2010, J BUS PSYCHOL, V25, P533, DOI 10.1007/s10869-010-9176-3; Bhattacherjee A, 2018, GOV INFORM Q, V35, P703, DOI 10.1016/j.giq.2018.07.006; Blake J., 1999, LOCAL ENVIRON, V4, P257, DOI [10.1080/13549839908725599, DOI 10.1080/13549839908725599]; BLASI A, 1980, PSYCHOL BULL, V88, P1, DOI 10.1037/0033-2909.88.1.1; Brown SP, 1998, J MARKETING, V62, P88, DOI 10.2307/1252289; Bryan CJ, 2013, J EXP PSYCHOL GEN, V142, P1001, DOI 10.1037/a0030655; Burroughs JE, 2002, J CONSUM RES, V29, P348, DOI 10.1086/344429; Cameron L, 2009, J PUBLIC ECON, V93, P843, DOI 10.1016/j.jpubeco.2009.03.004; Christ MH, 2013, J MANAG ACOUNT RES, V25, P169, DOI 10.2308/jmar-50443; Clark-Wilson A, 2017, COMM COM INF SC, V739, P3, DOI 10.1007/978-3-319-63184-4_1; Clarke GRG, 2004, J PUBLIC ECON, V88, P2067, DOI 10.1016/j.jpubeco.2003.07.002; Cohen TR, 2014, RES ORGAN BEHAV, V34, P43, DOI 10.1016/j.riob.2014.08.003; Cohen TR, 2012, CURR DIR PSYCHOL SCI, V21, P355, DOI 10.1177/0963721412454874; de Quidt J, 2018, AM ECON REV, V108, P3266, DOI 10.1257/aer.20171330; de Vries RE, 2015, PERS INDIV DIFFER, V86, P112, DOI 10.1016/j.paid.2015.06.008; Dimant E, 2018, J ECON SURV, V32, P335, DOI 10.1111/joes.12198; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Dong B, 2012, J ECON PSYCHOL, V33, P609, DOI 10.1016/j.joep.2011.12.001; Falk A, 2006, AM ECON REV, V96, P1611, DOI 10.1257/aer.96.5.1611; Fan CS, 2009, J PUBLIC ECON, V93, P14, DOI 10.1016/j.jpubeco.2008.09.001; Fehr E, 2002, ECON J, V112, pC1, DOI 10.1111/1468-0297.00027; Fisar M, 2016, J BEHAV EXP ECON, V63, P69, DOI 10.1016/j.socec.2016.05.004; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fisman R, 2007, J POLIT ECON, V115, P1020, DOI 10.1086/527495; Folger R, 2001, RES SOC ISS MAN SER, P3; Gardner G.T., 1996, ENV PROBLEMS HUMAN B; Gewirtz J., 1984, MORALITY MORAL BEHAV, P128; Gibson R., 2016, HDB VALUE PERSPECTIV, P223; Gibson R, 2013, AM ECON REV, V103, P532, DOI 10.1257/aer.103.1.532; Ginges J, 2007, P NATL ACAD SCI USA, V104, P7357, DOI 10.1073/pnas.0701768104; GLYNN TJ, 1986, J COMMUNITY PSYCHOL, V14, P341, DOI 10.1002/1520-6629(198610)14:4<341::AID-JCOP2290140403>3.0.CO;2-0; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Gorsira M, 2018, J BUS ETHICS, V151, P179, DOI 10.1007/s10551-016-3219-2; Graycar A, 2011, HANDBOOK OF GLOBAL RESEARCH AND PRACTICE IN CORRUPTION, P3; Hauser C, 2021, BUS SOC, V60, P1468, DOI 10.1177/0007650319898474; Hauser C, 2019, J BUS ETHICS, V159, P281, DOI 10.1007/s10551-018-3808-3; Heck DW, 2018, JUDGM DECIS MAK, V13, P356; Hilbig BE, 2015, J RES PERS, V57, P72, DOI 10.1016/j.jrp.2015.04.003; Hilbig BE, 2013, PERS INDIV DIFFER, V54, P598, DOI 10.1016/j.paid.2012.11.008; Hilbig BE, 2009, J RES PERS, V43, P516, DOI 10.1016/j.jrp.2009.01.003; Hossein AT., 2020, BUSINESS SOC, P1, DOI 10.1177%2F0007650320928502; Hunt J, 2006, INTERNATIONAL HANDBOOK ON THE ECONOMICS OF CORRUPTION, P323; JAWORSKI BJ, 1992, ACCOUNT ORG SOC, V17, P17, DOI 10.1016/0361-3682(92)90034-P; Kant Immanuel, 1797, METAPHYSIK SITTEN; Klein SA, 2020, J RES PERS, V88, DOI 10.1016/j.jrp.2020.104006; Klein SA, 2017, JUDGM DECIS MAK, V12, P563; Kleinlogel EP, 2018, PERS SOC PSYCHOL B, V44, P158, DOI 10.1177/0146167217733071; Kobis NC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131830; Krekels G, 2015, PERS INDIV DIFFER, V74, P225, DOI 10.1016/j.paid.2014.10.036; Lambsdorff JG, 2006, INTERNATIONAL HANDBOOK ON THE ECONOMICS OF CORRUPTION, P3; Lange D, 2008, ACAD MANAGE REV, V33, P710; Lee K, 2004, MULTIVAR BEHAV RES, V39, P329, DOI 10.1207/s15327906mbr3902_8; Li Y, 2015, ASIA PAC J MANAG, V32, P311, DOI 10.1007/s10490-014-9406-8; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; Montada L., 1998, SOCIAL JUSTICE RES, V11, P81, DOI [10.1023/A:1023299119352, DOI 10.1023/A:1023299119352]; Mudrack PE, 2012, J BUS ETHICS, V108, P347, DOI 10.1007/s10551-011-1094-4; Mussel P, 2015, SOC NEUROSCI-UK, V10, P126, DOI 10.1080/17470919.2014.965340; Nam T, 2018, GOV INFORM Q, V35, P273, DOI 10.1016/j.giq.2018.01.005; Olken BA, 2012, ANNU REV ECON, V4, P479, DOI 10.1146/annurev-economics-080511-110917; Palanski Michael E., 2007, European Management Journal, V25, P171, DOI 10.1016/j.emj.2007.04.006; Paldam M., 2002, EUR J POLIT ECON, V18, P215, DOI [10.1016/S0176-2680(02)00078-2, DOI 10.1016/S0176-2680(02)00078-2]; Perugini M, 2009, J RES PERS, V43, P747, DOI 10.1016/j.jrp.2009.03.015; Rabl T, 2008, J BUS ETHICS, V82, P477, DOI 10.1007/s10551-008-9898-6; Schlenker BR, 2008, J SOC CLIN PSYCHOL, V27, P1078, DOI 10.1521/jscp.2008.27.10.1078; Scigala KA, 2019, SOC PSYCHOL PERS SCI, V10, P1019, DOI 10.1177/1948550618813419; Serra D, 2012, RES EXP ECON, V15, P1, DOI 10.1108/S0193-2306(2012)0000015003; Seuntjens TG, 2019, PERS INDIV DIFFER, V138, P147, DOI 10.1016/j.paid.2018.09.027; Shu LL, 2011, PERS SOC PSYCHOL B, V37, P330, DOI 10.1177/0146167211398138; Sinnott-Armstrong W., 2008, MORAL PSYCHOL, P35; Skitka LJ, 2002, PERS SOC PSYCHOL B, V28, P1419, DOI 10.1177/014616702236873; Steidlmeier P, 1999, J BUS ETHICS, V20, P121, DOI 10.1023/A:1005960026519; Swamy A, 2001, J DEV ECON, V64, P25, DOI 10.1016/S0304-3878(00)00123-1; Tang TLP, 2008, MANAGE DECIS, V46, P243, DOI 10.1108/00251740810854140; Tanner C, 2004, PSYCHON B REV, V11, P185, DOI 10.3758/BF03206481; Tanner C, 2014, LIBR ETHICS APPL PHI, V32, P119, DOI 10.1007/978-3-319-01369-5_7; Tanner C, 2009, DIAGNOSTICA, V55, P174, DOI 10.1026/0012-1924.55.3.174; Tavits M, 2010, SOC FORCES, V88, P1257; Tetlock PE, 2000, J PERS SOC PSYCHOL, V78, P853, DOI 10.1037/0022-3514.78.5.853; Thielmann I, 2021, SOC PSYCHOL PERS SCI, V12, P363, DOI 10.1177/1948550620905218; Torgler B, 2010, CONTEMP ECON POLICY, V28, P554, DOI 10.1111/j.1465-7287.2009.00188.x; Van Lange PAM, 2013, ORGAN BEHAV HUM DEC, V120, P125, DOI 10.1016/j.obhdp.2012.11.003; Volkema R.J., 2001, BUSINESS SOC, V40, P7, DOI [DOI 10.1177/000765030104000103, 10.1177%2F000765030104000103, 10.1177/000765030104000103]; Vranka MA, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01511; Zettler I, 2020, PERSPECT PSYCHOL SCI, V15, P723, DOI 10.1177/1745691619895036	99	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262201	10.1371/journal.pone.0262201	http://dx.doi.org/10.1371/journal.pone.0262201			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015764	gold, Green Published			2022-12-27	WOS:000814820600011
J	Houskeeper, HF; Rosenthal, IS; Cavanaugh, KC; Pawlak, C; Trouille, L; Byrnes, JEK; Bell, TW; Cavanaugh, KC				Houskeeper, Henry F.; Rosenthal, Isaac S.; Cavanaugh, Katherine C.; Pawlak, Camille; Trouille, Laura; Byrnes, Jarrett E. K.; Bell, Tom W.; Cavanaugh, Kyle C.			Automated satellite remote sensing of giant kelp at the Falkland Islands (Islas Malvinas)	PLOS ONE			English	Article							MACROCYSTIS-PYRIFERA; CITIZEN SCIENCE; ENVIRONMENTAL CONTROLS; LAMINARIALES; PERSISTENCE; PHAEOPHYTA; EVOLUTION; PATTERNS; ECOTYPES; FRONDS	Giant kelp populations that support productive and diverse coastal ecosystems at temperate and subpolar latitudes of both hemispheres are vulnerable to changing climate conditions as well as direct human impacts. Observations of giant kelp forests are spatially and temporally uneven, with disproportionate coverage in the northern hemisphere, despite the size and comparable density of southern hemisphere kelp forests. Satellite imagery enables the mapping of existing and historical giant kelp populations in understudied regions, but automating the detection of giant kelp using satellite imagery requires approaches that are robust to the optical complexity of the shallow, nearshore environment. We present and compare two approaches for automating the detection of giant kelp in satellite datasets: one based on crowd sourcing of satellite imagery classifications and another based on a decision tree paired with a spectral unmixing algorithm (automated using Google Earth Engine). Both approaches are applied to satellite imagery (Landsat) of the Falkland Islands or Islas Malvinas (FLK), an archipelago in the southern Atlantic Ocean that supports expansive giant kelp ecosystems. The performance of each method is evaluated by comparing the automated classifications with a subset of expert-annotated imagery (8 images spanning the majority of our continuous timeseries, cumulatively covering over 2,700 km of coastline, and including all relevant sensors). Using the remote sensing approaches evaluated herein, we present the first continuous timeseries of giant kelp observations in the FLK region using Landsat imagery spanning over three decades. We do not detect evidence of long-term change in the FLK region, although we observe a recent decline in total canopy area from 2017-2021. Using a nitrate model based on nearby ocean state measurements obtained from ships and incorporating satellite sea surface temperature products, we find that the area of giant kelp forests in the FLK region is positively correlated with the nitrate content observed during the prior year. Our results indicate that giant kelp classifications using citizen science are approximately consistent with classifications based on a state-of-the-art automated spectral approach. Despite differences in accuracy and sensitivity, both approaches find high interannual variability that impedes the detection of potential long-term changes in giant kelp canopy area, although recent canopy area declines are notable and should continue to be monitored carefully.	[Houskeeper, Henry F.; Cavanaugh, Katherine C.; Pawlak, Camille; Cavanaugh, Kyle C.] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90024 USA; [Rosenthal, Isaac S.] Univ Massachusetts, Sch Environm, Boston, MA USA; [Trouille, Laura] Adler Planetarium, Chicago, IL USA; [Byrnes, Jarrett E. K.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Bell, Tom W.] Woods Hole Oceanog Inst, Appl Ocean Phys & Engn, Woods Hole, MA USA	University of California System; University of California Los Angeles; University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; Woods Hole Oceanographic Institution	Houskeeper, HF (corresponding author), Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90024 USA.	hhouskee@g.ucla.edu	Houskeeper, Henry/ACE-6594-2022	Pawlak, Camille/0000-0003-0740-3956; Houskeeper, Henry/0000-0001-5848-5440	National Aeronautics and Space Administration as part of the Citizen Science for Earth Systems Program [80NSSC18M0103]; National Science Foundation through the Santa Barbara Coastal Long-Term Environmental Research [OCE 0620276, 1232779]	National Aeronautics and Space Administration as part of the Citizen Science for Earth Systems Program; National Science Foundation through the Santa Barbara Coastal Long-Term Environmental Research	This work was funded by the National Aeronautics and Space Administration as part of the Citizen Science for Earth Systems Program (https://earthdata.nasa.gov/esds/competitiveprograms/csesp) with grant #80NSSC18M0103 (awarded to JEKB), which also provided salary to HFH, and by the National Science Foundation through the Santa Barbara Coastal Long-Term Environmental Research (https://sbclter.msi.ucsb.edu) program with grants #OCE 0620276 and 1232779. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NJ, 2014, NAT CLIM CHANGE, V4, P564, DOI [10.1038/nclimate2235, 10.1038/NCLIMATE2235]; Bayley D. T. I., 2021, One Ecosystem, V6, DOI 10.3897/oneeco.6.e62811; Beaton EC, 2020, POLAR BIOL, V43, P573, DOI 10.1007/s00300-020-02662-x; Bell TW, 2020, REMOTE SENS ENVIRON, V238, DOI [10.1016/j.rse.2018.06.03, 10.1016/j.rse.2018.06.039]; Bell TW, 2015, J BIOGEOGR, V42, P2010, DOI 10.1111/jbi.12550; Bennett S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10280; Berry HD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0229703; Bonney R, 2016, PUBLIC UNDERST SCI, V25, P2, DOI 10.1177/0963662515607406; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Caselle JE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195167; Castorani MCN, 2015, ECOLOGY, V96, P3141, DOI 10.1890/15-0283.1; Cavanaugh KC, 2011, MAR ECOL PROG SER, V429, P1, DOI 10.3354/meps09141; Cavanaugh KC, 2010, MAR ECOL PROG SER, V403, P13, DOI 10.3354/meps08467; Finger DJI, 2021, REMOTE SENS ENVIRON, V254, DOI 10.1016/j.rse.2020.112243; Friedlander AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229259; Friedlander AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189930; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Graham MH, 2007, OCEANOGR MAR BIOL, V45, P39; Hamilton SL, 2020, ECOLOGY, V101, DOI 10.1002/ecy.3031; Hijmans R. J., 2015, PACKAGE RASTER; Hooker SB, 2021, CONT SHELF RES, V219, DOI 10.1016/j.csr.2021.104357; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; King NG, 2019, J EXP MAR BIOL ECOL, V514, P10, DOI 10.1016/j.jembe.2019.03.004; Kosmala M, 2016, FRONT ECOL ENVIRON, V14, P551, DOI 10.1002/fee.1436; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; Kudela RM, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11182071; Lamy T, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2987; Macaya EC, 2010, MAR ECOL PROG SER, V420, P103, DOI 10.3354/meps08893; McPherson ML, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01827-6; Miller RJ, 2018, P ROY SOC B-BIOL SCI, V285, DOI [10.1098/rspb.2017.2571, 10.1098/rspb.]; Mora-Soto A, 2021, J BIOGEOGR, V48, P2562, DOI 10.1111/jbi.14221; Mora-Soto A, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12040694; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Oliver ECJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03732-9; Reed DC, 2016, MAR FRESHWATER RES, V67, P14, DOI 10.1071/MF14158; Regnauld H, 2008, GEOMORPHOLOGIE, P33; Roberts DA, 1998, REMOTE SENS ENVIRON, V65, P267, DOI 10.1016/S0034-4257(98)00037-6; Rogers-Bennett L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51114-y; Rosenthal IS, 2018, ARXIV PREPRINT ARXIV; Schiel DR, 2015, BIOL ECOLOGY GIANT K; Siegel DA, 2000, APPL OPTICS, V39, P3582, DOI 10.1364/AO.39.003582; Smale DA, 2020, NEW PHYTOL, V225, P1447, DOI 10.1111/nph.16107; Thomsen MS, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00084; Upton J, 2002, AQUAT CONSERV, V12, P15, DOI 10.1002/aqc.496; VANTUSSENBROEK BI, 1989, BRIT PHYCOL J, V24, P137, DOI 10.1080/00071618900650131; VANTUSSENBROEK BI, 1989, MAR BIOL, V102, P545, DOI 10.1007/BF00438357; VANTUSSENBROEK BI, 1989, PHYCOLOGIA, V28, P169, DOI 10.2216/i0031-8884-28-2-169.1; VANTUSSENBROEK BI, 1989, MAR BIOL, V100, P419, DOI 10.1007/BF00391158; Vihinen M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S2; Woodworth PL, 1996, MAR GEOD, V19, P1, DOI DOI 10.1080/; Young M, 2016, ECOL MONOGR, V86, P45, DOI 10.1890/15-0267.1	52	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0257933	10.1371/journal.pone.0257933	http://dx.doi.org/10.1371/journal.pone.0257933			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990455	Green Published, Green Submitted, gold			2022-12-27	WOS:000815783800003
J	Li, XJ; Ye, YC; Zhang, YS; Wu, JM				Li, Xiao-Jun; Ye, Yan-Cheng; Zhang, Yan-Shan; Wu, Jia-Ming			Empirical modeling of the percent depth dose for megavoltage photon beams	PLOS ONE			English	Article							RATIO	Introduction This study presents an empirical method to model the high-energy photon beam percent depth dose (PDD) curve by using the home-generated buildup function and tail function (buildup-tail function) in radiation therapy. The modeling parameters n and p of buildup-tail function can be used to characterize the Collimator Scatter Factor (So either in a square field or in the different individual upper jaw and lower jaw setting separately for individual monitor unit check. Methods and materials The PDD curves for four high-energy photon beams were modeled by the buildup and tail function in this study. The buildup function was a quadratic function in the form of d/root d(2)+n with the main parameter of d (depth in water) and n, while the tail function was in the form of e(-mu d) and was composed by an exponential function with the main parameter of d and mu. The PDD was the product of buildup and tail function, PDD = d/root d(2)+n . e(-mu d). The PDD of four-photon energies was characterized by the buildup-tail function by adjusting the parameters n and mu. The S-c of 6 MV and 10 MV can then be expressed simply by the modeling parameters n and mu. Results The main parameters n increases in buildup-tail function when photon energy increased. The physical meaning of the parameter n expresses the beam hardening of photon energy in PDD. The fitting results of parameters n in the buildup function are 0.17, 0.208, 0.495, 1.2 of four-photon energies, 4 MV, 6 MV, 10 MV, 18 MV, respectively. The parameter mu can be treated as attenuation coefficient in tail function and decreases when photon energy increased. The fitting results of parameters p in the tail function are 0.065, 0.0515, 0.0458, 0.0422 of four-photon energies, 4 MV, 6 MV, 10 MV, 18 MV, respectively. The values of n and mu obtained from the fitted buildup-tail function were applied into an analytical formula of S-c = n(E) (S)(0.63)mu to get the collimator to scatter factor S-c for 6 and 10 MV photon beam, while n(E), mu(E), S denotes n, mu at photon energy E of field size S, respectively. The calculated S-c were compared with the measured data and showed agreement at different field sizes to within +/- 1.5%. Conclusions We proposed a model incorporating a two-parameter formula which can improve the fitting accuracy to be better than 1.5% maximum error for describing the PDD in different photon energies used in clinical setting. This model can be used to parameterize the S-c factors for some clinical requirements. The modeling parameters n and mu can be used to predict the S-c in either square field or individual jaws opening asymmetrically for treatment monitor unit double-check in dose calculation. The technique developed in this study can also be used for systematic or random errors in the QA program, thus improves the clinical dose computation accuracy for patient treatment.	[Li, Xiao-Jun; Ye, Yan-Cheng; Zhang, Yan-Shan; Wu, Jia-Ming] Wuwei Canc Hosp, Heavy Ion Ctr, Wuwei City, Gansu, Peoples R China; [Li, Xiao-Jun; Ye, Yan-Cheng; Zhang, Yan-Shan; Wu, Jia-Ming] Gansu Wuwei Acad Med Sci, Wuwei City, Gansu, Peoples R China; [Li, Xiao-Jun; Ye, Yan-Cheng; Zhang, Yan-Shan; Wu, Jia-Ming] Gansu Wuwei Tumor Hosp, Wuwei City, Gansu, Peoples R China; [Wu, Jia-Ming] Chengde Med Univ, Dept Med Phys, Chengde City, Hebei, Peoples R China; [Wu, Jia-Ming] Yee Zen Gen Hosp, Dept Radiat Oncol, Taoyuan, Taiwan	Chengde Medical University	Li, XJ; Wu, JM (corresponding author), Wuwei Canc Hosp, Heavy Ion Ctr, Wuwei City, Gansu, Peoples R China.; Li, XJ; Wu, JM (corresponding author), Gansu Wuwei Acad Med Sci, Wuwei City, Gansu, Peoples R China.; Li, XJ; Wu, JM (corresponding author), Gansu Wuwei Tumor Hosp, Wuwei City, Gansu, Peoples R China.; Wu, JM (corresponding author), Chengde Med Univ, Dept Med Phys, Chengde City, Hebei, Peoples R China.; Wu, JM (corresponding author), Yee Zen Gen Hosp, Dept Radiat Oncol, Taoyuan, Taiwan.	anglweli@qq.com; jiaming.wu@chmsc.com		li, xiaojun/0000-0002-1885-4747	Key R&D plan of Science and Technology Program of Gansu Province, China [19YF3FH001]	Key R&D plan of Science and Technology Program of Gansu Province, China	This work was supported by the Funding: Key R&D plan of Science and Technology Program of Gansu Province, China. (19YF3FH001).	Brunckhorst E., 2008, IAEATECDOC1583, P1; Cashmore J, 2008, PHYS MED BIOL, V53, P1933, DOI 10.1088/0031-9155/53/7/009; Dutreix A, 1997, ESTRO PHYS CLIN RADI, V3; Garcia-Garduno OA, 2016, APPL RADIAT ISOTOPES, V107, P121, DOI 10.1016/j.apradiso.2015.09.016; Gibbons JP, 2014, MED PHYS, V41, DOI 10.1118/1.4864244; KASE KR, 1986, MED PHYS, V13, P530, DOI 10.1118/1.595857; Khan FM., 2010, PHYS RAD THERAPY, V4th ed, P140; Lewis D, 2012, MED PHYS, V39, P6339, DOI 10.1118/1.4754797; Niroomand-Rad A, 2020, MED PHYS, V47, P5986, DOI 10.1002/mp.14497; Padilla-Cabal F, 2015, J RADIOTHER PRACT, V14, P311, DOI 10.1017/S146039691500014X; Wang KKH, 2010, MED PHYS, V37, P5270, DOI 10.1118/1.3480480; Zhu TC, 2009, MED PHYS, V36, P5261, DOI 10.1118/1.3227367	12	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261042	10.1371/journal.pone.0261042	http://dx.doi.org/10.1371/journal.pone.0261042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990461	Green Published, gold			2022-12-27	WOS:000815783800005
J	Iezadi, S; Gholipour, K; Khanijahani, A; Alizadeh, M; Samadirad, B; Azizi, H; Azizinia, F				Iezadi, Shabnam; Gholipour, Kamal; Khanijahani, Ahmad; Alizadeh, Mahasti; Samadirad, Bahram; Azizi, Hanie; Azizinia, Farzad			Development, validation, and pilot implementation of the minimum datasheet for a domestic violence registry system: The case of a developing country	PLOS ONE			English	Article							PREVALENCE; VALIDITY; ACCESS; HEALTH; ABUSE	Background Domestic violence (DV) is a universal issue and an important public health priority. Establishing a DV Registry System (DVRS) can help to systematically integrate data from several sources and provide valid and reliable information on the scope and severity of harms. The main objective of this study was to develop, validate, and pilot-test a minimum datasheet for a DVRS to register DV victims in medical facilities. Materials and methods This study was conducted in two main phases. Phase one includes developing the datasheet for registration of DV in the DVRS. In phase two, the datasheet designed in the previous step was used in a pilot implementation of the DVRS for 12 months to find practical challenges. The preliminary datasheet was first developed using information on similar registry programs and guidelines of the World Health Organization (WHO) and then reviewed by four expert panels. Through a two-round Delphi technique, experts evaluated the instrument using the Content Validity Index (CVI) and Content Validity Ratio (CVR). The consistency of the responses was evaluated by test-retest analysis. Finally, two physicians in two forensic medical clinics registered the victims of physical and/or sexual violence perpetrated by a family member. Results Preliminary datasheet consisted of 31 items. In the first round of Delphi, fifteen items had good content validity (I-CVI and CVR) and were kept, and seven items were moved to the next round. Also, in the first round of Delphi, experts suggested adding three items, including history of the violence, custody of the child, and custody of the elderly. All items evaluated in the second round were kept due to good CVR and CVI scores. As a result of Test-retest correlation coefficients for self-reprted items, two items including perpetrator's alcohol and drug use status were excluded (r(30) = +.43, and +.38, p< .01, two-tailed, respectively). Finally, 24 items were included in the datasheet including 15 items for individuals' characteristics (victims' characteristics and perpetrators' characteristics), eight items for incidents' characteristics, and one item for past history of violence experience. A total of 369 cases were registered from September 23, 2019, to July 21, 2020. The majority of the reported cases were female (82%) and were 19-40 years old. No physical and/or sexual violence was reported from rural areas, which calls upon researchers to explore how services for detecting and treating the victims can be made accessible to these areas. Conclusion DVRS can show trends in DV by age, sex, the context of the violence, and incidence characteristics at every point in time. This is particularly valuable in planning and prioritizing research areas and interventions for DV prevention. Additionally, DVRS can be linked to other disease registry programs which can contribute to continuity and coordination of care, and major research in the future. Although a DVRS can be a promising initiative in identifying the areas in need of urgent interventions, there is no guarantee for its proper implementation due to limited resources and other challenges.	[Iezadi, Shabnam] Iran Univ Med Sci, Hosp Management Res Ctr, Hlth Management Res Inst, Tehran, Iran; [Gholipour, Kamal] Tabriz Univ Med Sci, Social Determinants Hlth Res Ctr, Sch Management & Med Informat, Dept Hlth Policy & Management, Tabriz, Iran; [Khanijahani, Ahmad] Duquesne Univ, John G Rangos Sch Hlth Sci, Dept Hlth Adm & Publ Hlth, Pittsburgh, PA USA; [Alizadeh, Mahasti] Tabriz Univ Med Sci, Social Determinants Hlth Res Ctr, Tabriz, Iran; [Samadirad, Bahram] Iranian Legal Med Org, Forens Med Res Ctr, Tehran, Iran; [Azizi, Hanie] Tabriz Univ Med Sci, Med Educ Res Ctr, Hlth Management & Safety Promot Res Inst, Tabriz, Iran; [Azizinia, Farzad] Tabriz Univ Med Sci, Sch Med, Tabriz, Iran	Iran University of Medical Sciences; Tabriz University of Medical Science; Duquesne University; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Gholipour, K (corresponding author), Tabriz Univ Med Sci, Social Determinants Hlth Res Ctr, Sch Management & Med Informat, Dept Hlth Policy & Management, Tabriz, Iran.	gholipourk@tbzmed.ac.ir	Gholipour, Kamal/L-1269-2017; samadirad, bahram/F-4710-2017	Gholipour, Kamal/0000-0002-6595-4150; Azizi, Hanieh/0000-0002-4480-820X; samadirad, bahram/0000-0002-7770-4298	Tabriz University of Medical Sciences, Tabriz, Iran [60207]	Tabriz University of Medical Sciences, Tabriz, Iran	This study was funded by the Tabriz University of Medical Sciences, Tabriz, Iran (Grant Number: 60207) and Mahasti Alizadeh was the main recipient of the fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACT, 2017, DOM FAM VIOL DAT COL; Allnock D., 2013, NO ONE NOTICED NO ON; American Academy of Family Physicians (AAFP), 2014, VIOL POS PAP; [Anonymous], 2019, NAT VIOL DEATH REP S; Arias-Rivera S, 2020, AGGRESS VIOLENT BEH, V52, DOI 10.1016/j.avb.2020.101426; Artz L., 2016, OPTIMUS STUDY S AFRI; Basile KC, 2011, NATL INTIMATE PARTNE; Bogal-Allbritten R, 1990, HUMAN SERVICES RURAL, V14, P6; Bradbury-Jones C, 2020, J CLIN NURS, V29, P2047, DOI 10.1111/jocn.15296; Canan SN, 2020, ARCH SEX BEHAV, V49, P1067, DOI 10.1007/s10508-019-01543-7; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Chan KL, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00282; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Council NR., 1996, UNDERSTANDING VIOLEN; Dahlberg Linda L., 2006, Ciênc. saúde coletiva, V11, P277; de Melo RA, 2021, J INTERPERS VIOLENCE, V36, pNP6218, DOI 10.1177/0886260518812793; Durham-Pressley Christine, 2018, Nursing, V48, P56, DOI 10.1097/01.NURSE.0000527617.52655.2f; Garcia-Moreno C, 2005, SCIENCE, V310, P1282, DOI 10.1126/science.1121400; Garcia-Moreno C, 2013, PREVALENCE HLTH EFFE; Gharacheh M, 2020, J BIOSOC SCI, V52, P168, DOI 10.1017/S0021932019000336; Haque MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212428; Hecker T, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0828-3; HOLLANDER JE, 1995, ANN EMERG MED, V25, P675, DOI 10.1016/S0196-0644(95)70183-4; Honarvar Behnam, 2020, J Prev Med Public Health, V53, P89, DOI 10.3961/jpmph.19.210; Horton EE, 2017, INT J QUAL HEALTH C, V29, P98, DOI 10.1093/intqhc/mzw142; Iezadi S, 2022, J INTERPERS VIOLENCE, V37, pNP8582, DOI 10.1177/0886260520978181; Johnson SM, 2017, VIOLENCE VICTIMS, V32, P78, DOI 10.1891/0886-6708.VV-D-15-00110; Johnston L., 2007, GUIDE HEALTHCARE STA; Jones L, 2012, LANCET, V380, P899, DOI 10.1016/S0140-6736(12)60692-8; Khoshmohabat H, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.24686; King C, 2020, CHILD ABUSE NEGLECT, V101, DOI 10.1016/j.chiabu.2020.104363; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Meinck F, 2017, PSYCHOL HEALTH MED, V22, P94, DOI 10.1080/13548506.2016.1271950; Mukaka MM, 2012, MALAWI MED J, V24, P69; Naghavi A, 2019, FRONT PSYCHOL, P10, DOI [10.3389/fpsyg.2019.00010, DOI 10.3389/FPSYG.2019.00010]; Nkuba M., 2019, MENTAL HLTH PREVENTI, V13, P159, DOI [10.1016/j.mhp.2019.01.003, DOI 10.1016/J.MHP.2019.01.003]; Organization WH, 2001, INJURY SURVEILLANCE; Peek-Asa C, 2011, J WOMENS HEALTH, V20, P1743, DOI 10.1089/jwh.2011.2891; Pereira Paulo Celso, 2009, Psic.: Teor. e Pesq., V25, P19, DOI 10.1590/S0102-37722009000100003; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Roberson C., 2016, FAMILY VIOLENCE LEGA; Shivasabesan G, 2019, WORLD J SURG, V43, P2426, DOI 10.1007/s00268-019-05039-2; Vieira MA, 2016, REV LAT-AM ENFERM, V24, DOI 10.1590/1518-8345.0834.2710; Walby S, 2001, BRIT J CRIMINOL, V41, P502, DOI 10.1093/bjc/41.3.502; Ward Elizabeth, 2002, Inj Control Saf Promot, V9, P241, DOI 10.1076/icsp.9.4.241.13681; Women U, 2016, FACTS FIG END VIOL W, P28; World Health Organization, 2004, EC DIM INT VIOL; World Health Organization, 2002, WORLD REPORT VIOLENC, P6; Yunus RM, 2019, TRAUMA VIOLENCE ABUS, V20, P197, DOI 10.1177/1524838017692798; Zakar R., 2012, THESIS GERMANY; Zakar R, 2016, J FAM VIOLENCE, V31, P15, DOI 10.1007/s10896-015-9742-6	51	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261460	10.1371/journal.pone.0261460	http://dx.doi.org/10.1371/journal.pone.0261460			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972149	gold, Green Published			2022-12-27	WOS:000773555700034
J	Storms, SM; Lowe, JF				Storms, Suzanna M.; Lowe, James F.			Active environmental surveillance of SARS-CoV-2 in Midwestern United States meatpacking plants	PLOS ONE			English	Article							CORONAVIRUSES; VIRUS; SARS	This pilot project investigated environmental SARS-CoV-2 presence in seven Midwestern meatpacking plants from May 2020 to January 2021. This study investigated social distancing and infection control practices and incorporated environmental sampling of surfaces and air in employee common areas. All plants increased their social distancing efforts, increased the frequency of cleaning and disinfecting worker areas, and screened for symptomatic people to prevent entry into the workplace. 575 samples from common areas were collected and evaluated with RT-qPCR for the presence of SARS-CoV-2. 42/367 surface samples were positive, while no virus was detected in air samples. Case positive data from the counties surrounding each plant showed peak positive SARS-CoV-2 cases from 12-55 days before the virus was detected in the plant, indicating that environmental sampling is likely a lagging indicator of community and plant infection.	[Storms, Suzanna M.] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA; [Lowe, James F.] Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Lowe, JF (corresponding author), Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Urbana, IL 61801 USA.	jlowe@illinois.edu		Storms, Suzanna/0000-0001-8505-876X	Illinois Pork Producers Association	Illinois Pork Producers Association	This research was funded in part by the Illinois Pork Producers Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://ilpork.com/.	Abdulkarim Abdulrahman, 2020, INFEZ MED, DOI [10.1101/2020.12.07.20245233, DOI 10.1101/2020.12.07.20245233]; Buchan BW, 2020, AM J CLIN PATHOL, V154, P479, DOI 10.1093/ajcp/aqaa133; Byambasuren O., 2020, J ASS MED MICROBIOL, V5, P223, DOI [10.3138/jammi-2020-0030, DOI 10.3138/JAMMI-2020-0030]; CDC, 2019, NOV COR; Colaneri M, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.05.009; Fischer J., LONGHORN VACCINES DI; Hung IFN, 2004, EMERG INFECT DIS, V10, P1550, DOI 10.3201/eid1009.040058; Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022; Krebs C. K., 2020, SECURITY USDOH; Lowe J, 2014, EMERG INFECT DIS, V20, P872, DOI 10.3201/eid2005.131628; Lowe JF, 2020, PORK BEEF SLAUGHTER; Nissen K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76442-2; Otter JA, 2016, J HOSP INFECT, V92, P235, DOI 10.1016/j.jhin.2015.08.027; Spackman E, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-35; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]	15	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261704	10.1371/journal.pone.0261704	http://dx.doi.org/10.1371/journal.pone.0261704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972125	Green Published, gold			2022-12-27	WOS:000773555700048
J	Tolley, EE; Martinez, A; Zissette, S; Palanee-Phillips, T; Mathebula, F; Tenza, S; Hartmann, M; Montgomery, ET				Tolley, Elizabeth E.; Martinez, Andres; Zissette, Seth; Palanee-Phillips, Thesla; Mathebula, Florence; Tenza, Siyanda; Hartmann, Miriam; Montgomery, Elizabeth T.			Evidence for use of a healthy relationships assessment tool in the CHARISMA pilot study	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; PREEXPOSURE PROPHYLAXIS; HIV PREVENTION; WOMEN; INFECTION; QUESTIONS; ADHERENCE; POWER; PREP	Introduction The CHARISMA intervention, nested within the MTN-025/HOPE vaginal ring trial in Johannesburg, South Africa, seeks to facilitate women's use of HIV prevention products by promoting partner dialogue and mitigating intimate partner violence (IPV). We developed "HEART", a lay counselor-administered relationship assessment tool, for the CHARISMA pilot. The five-scale tool assesses participants' endorsement of Traditional Values (TV), her HIV Prevention Readiness (HPR) and levels of partner support (PS), abuse and control (PAC), and resistance to HIV prevention (PR), guiding decisions about which of three counselling modules to offer (partner communication/A; ring disclosure/B; and IPV prevention/C). Methods We correlated baseline scores on HEART subscales with a) independent measures of relationship stability, disclosure and IPV to assess construct validity, and b) with specific modules offered to determine how HEART was used in the pilot. We examined changes in HEART scores at three and six months. Finally, we ran separate growth models for each subscale to examine changes in scores, accounting for partnership changes and counseling module(s) received. Results Baseline HEART scores correlated as predicted among subscales and with other measures. Reliabilities for four subscales were 0.75 or higher. Women who disclosed study participation and ring use scored higher on PS and lower on PR. Women experiencing IPV scored lower on PS, and higher on PAC and PR. During the pilot, 82% of women received one and 17% received two or more modules; over half received the IPV module. Women with higher PAC and PR scores were more likely to receive the IPV than the communication or disclosure modules. Over time, the TV, PAC and PR scores decreased, and PS score increased. Receiving the IPV module was associated with a decreased PAC score. Conclusions These data offer preliminary evidence for HEART construct and predictive validity and support its further evaluation to guide implementation and monitor the impact of the CHARISMA intervention in a randomized controlled evaluation.	[Tolley, Elizabeth E.; Martinez, Andres; Zissette, Seth] FHI 360, Behav Epidemiol & Sci, Durham, NC 27701 USA; [Tolley, Elizabeth E.] Univ N Carolina, Maternal & Child Hlth Dept, Chapel Hill, NC 27515 USA; [Palanee-Phillips, Thesla; Mathebula, Florence; Tenza, Siyanda] Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Hartmann, Miriam; Montgomery, Elizabeth T.] RTI, Womens Global Hlth Imperat, Berkeley, CA USA	FHI 360; University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; Research Triangle Institute	Tolley, EE (corresponding author), FHI 360, Behav Epidemiol & Sci, Durham, NC 27701 USA.; Tolley, EE (corresponding author), Univ N Carolina, Maternal & Child Hlth Dept, Chapel Hill, NC 27515 USA.	btolley@fhi360.org		Hartmann, Miriam/0000-0001-8109-9679; Montgomery, Elizabeth/0000-0002-5477-4445; Zissette, Seth/0000-0002-6502-2986	National Institute of Allergy and Infectious Diseases components of the U.S. National Institutes of Health (NIH) [UM1AI068633, UM1AI068615, UM1AI106707]; Eunice Kennedy Shriver National Institute of Child Health and Human Development components of the U.S. National Institutes of Health (NIH); National Institute of Mental Health components of the U.S. National Institutes of Health (NIH);  [AID-OAA-A-15-00032]	National Institute of Allergy and Infectious Diseases components of the U.S. National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development components of the U.S. National Institutes of Health (NIH); National Institute of Mental Health components of the U.S. National Institutes of Health (NIH); 	This program is made possible by the generous assistance from the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID). The CHARISMA project was funded through award AID-OAA-A-15-00032 to EM. CHARISMA was conducted in the Wits RHI site of the HOPE study which was designed and implemented by the Microbicide Trials Network (MTN) funded by the National Institute of Allergy and Infectious Diseases through individual grants (UM1AI068633, UM1AI068615 and UM1AI106707), with cofunding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, PEPFAR, USAID or the United States Government.	Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Cabral A, 2018, JAIDS-J ACQ IMM DEF, V77, P154, DOI 10.1097/QAI.0000000000001574; Celum CL, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25298; Corneli A, 2014, JAIDS-J ACQ IMM DEF, V67, P555, DOI 10.1097/QAI.0000000000000362; Corneli AL, 2014, JAIDS-J ACQ IMM DEF, V66, P324, DOI 10.1097/QAI.0000000000000158; Delany-Moretlwe S, 2018, LANCET INFECT DIS, V18, P1241, DOI 10.1016/s1473-3099(18)30428-6; DeVellis RF., 2017, SCALE DEV THEORY APP, P262; Feldhaus KM, 1997, JAMA-J AM MED ASSOC, V277, P1357, DOI 10.1001/jama.277.17.1357; Fulfer JL, 2007, J INTERPERS VIOLENCE, V22, P238, DOI 10.1177/0886260506295814; Hartmann M, 2019, AIDS EDUC PREV, V31, P433, DOI 10.1521/aeap.2019.31.5.433; Hegarty Kelsey, 2005, Violence Vict, V20, P529, DOI 10.1891/088667005780927548; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Karim SA, 2014, BJOG-INT J OBSTET GY, V121, P27, DOI 10.1111/1471-0528.12842; Lanham Michele, 2014, J Int AIDS Soc, V17, P19159, DOI 10.7448/IAS.17.3.19159; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCleary-Sills J, 2016, GLOB PUBLIC HEALTH, V11, P224, DOI 10.1080/17441692.2015.1047391; Montgomery ET, 2015, AIDS BEHAV, V19, P784, DOI 10.1007/s10461-014-0950-5; Montgomery ET., 2016, AIDS BEHAV; Montgomery ET, 2020, C RETR OPP INF MARCH, P1015; Mugwanya KK, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002885; Myers L., 2019, IAPAC JUN MIAM FL201; Pintye J., 2020, J ACQUIR IMMUNE DEFI; Pipes RB, 1997, SEX ROLES, V36, P585, DOI 10.1023/A:1025665907856; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Roberts ST, 2016, JAIDS-J ACQ IMM DEF, V73, P313, DOI 10.1097/QAI.0000000000001093; Sila J, 2020, AIDS PATIENT CARE ST, V34, P336, DOI 10.1089/apc.2020.0037; Stephenson R, 2012, GLOB PUBLIC HEALTH, V7, P618, DOI 10.1080/17441692.2012.672581; Stewart RC, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-180; Tapsoba JD, 2021, AIDS CARE, V33, P712, DOI 10.1080/09540121.2020.1822505; Tolley EE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242881; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Wilson EK, 2021, BMC WOMENS HEALTH, V21, DOI 10.1186/s12905-021-01262-z; Woodsong C, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18505, 10.7448/IAS.17.3.19158]	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261526	10.1371/journal.pone.0261526	http://dx.doi.org/10.1371/journal.pone.0261526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972141	gold, Green Published			2022-12-27	WOS:000773555700039
J	Riedinger, C; Campbell, J; Klein, WMP; Ferrer, RA; Usher-Smith, JA				Riedinger, Christiane; Campbell, Jackie; Klein, William M. P.; Ferrer, Rebecca A.; Usher-Smith, Juliet A.			Analysis of the components of cancer risk perception and links with intention and behaviour: A UK-based study	PLOS ONE			English	Article							FEAR APPEALS; METAANALYSIS; MODEL; REASON; DONT	Risk perception refers to how individuals interpret their susceptibility to threats, and has been hypothesised as an important predictor of intentions and behaviour in many theories of health behaviour change. However, its components, optimal measurement, and effects are not yet fully understood. The TRIRISK model, developed in the US, conceptualises risk perception as deliberative, affective and experiential components. In this study, we aimed to assess the replicability of the TRIRISK model in a UK sample by confirmatory factor analysis (CFA), explore the inherent factor structure of risk perception in the UK sample by exploratory factor analysis (EFA), and assess the associations of EFA-based factors with intentions to change behaviour and subsequent behaviour change. Data were derived from an online randomised controlled trial assessing cancer risk perception using the TRIRISK instrument and intention and lifestyle measures before and after communication of cancer risk. In the CFA analysis, the TRIRISK model of risk perception did not provide a good fit for the UK data. A revised model developed using EFA consisted of two separate "numerical" and "self-reflective" factors of deliberative risk perception, and a third factor combining affective with a subset of experiential items. This model provided a better fit to the data when cross-validated. Using multivariable regression analysis, we found that the self-reflective and affective-experiential factors of the model identified in this study were reliable predictors of intentions to prevent cancer. There were no associations of any of the risk perception factors with behaviour change. This study confirms that risk perception is clearly a multidimensional construct, having identified self-reflective risk perception as a new distinct component with predictive validity for intention. Furthermore, we highlight the practical implications of our findings for the design of interventions incorporating risk perception aimed at behaviour change in the context of cancer prevention.	[Riedinger, Christiane; Usher-Smith, Juliet A.] Univ Cambridge, Dept Publ Hlth & Primary Care, Prevent Grp, Primary Care Unit,Clin Sch, Cambridge, England; [Campbell, Jackie] Univ Northampton, Fac Hlth Educ & Soc, Northampton, England; [Klein, William M. P.; Ferrer, Rebecca A.] NCI, Behav Res Program, Rockville, MD USA	University of Cambridge; University of Northampton; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Riedinger, C (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Prevent Grp, Primary Care Unit,Clin Sch, Cambridge, England.	cr426@medschl.cam.ac.uk		Usher-Smith, Juliet/0000-0002-8501-2531; Campbell, Jackie/0000-0002-1456-7994; Riedinger, Christiane/0000-0002-9310-9894	Cancer Research UK Prevention Fellowship [C55650/A21464]; NIHR Academic Clinical Fellowship - Cancer Research UK Prevention Fellowship [C55650/A21464]	Cancer Research UK Prevention Fellowship; NIHR Academic Clinical Fellowship - Cancer Research UK Prevention Fellowship	This study was funded by the Cancer Research UK Prevention Fellowship (C55650/A21464). CR was supported by an NIHR Academic Clinical Fellowship. JC, WMPK and RAF received no specific funding or this project. JAUS was funded by the Cancer Research UK Prevention Fellowship (C55650/A21464).	[Anonymous], 1974, Health Education Monograph, V2, P324; ASPINWALL LG, 1991, HEALTH PSYCHOL, V10, P432, DOI 10.1037/0278-6133.10.6.432; Beatty P, 1998, MEMORY, V6, P407; Bending GD, 2000, BIOL FERT SOILS, V31, P78, DOI 10.1007/s003740050627; Bontempo RN, 1997, RISK ANAL, V17, P479, DOI 10.1111/j.1539-6924.1997.tb00888.x; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; DENESRAJ V, 1994, J PERS SOC PSYCHOL, V66, P819, DOI 10.1037/0022-3514.66.5.819; Falk R. F., 1992, PRIMER SOFT MODELING; Faries MD, 2016, AM J LIFESTYLE MED, V10, P322, DOI 10.1177/1559827616638017; Ferrer RA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191994; Ferrer RA, 2016, ANN BEHAV MED, V50, P653, DOI 10.1007/s12160-016-9790-z; Ferrer RA, 2015, CURR OPIN PSYCHOL, V5, P85, DOI 10.1016/j.copsyc.2015.03.012; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; French DP, 2017, ANN BEHAV MED, V51, P718, DOI 10.1007/s12160-017-9895-z; Gottlieb N H, 1987, Am J Health Promot, V2, P37, DOI 10.4278/0890-1171-2.1.37; Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1111/j.1539-6924.1998.tb01123.x; Han PKJ, 2009, HEALTH EXPECT, V12, P4, DOI 10.1111/j.1369-7625.2008.00524.x; Hay JL, 2006, PREV MED, V42, P401, DOI 10.1016/j.ypmed.2006.03.002; Hollands GJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1102; Ijaz K, 2020, INT J HUM-COMPUT INT, V36, P1195, DOI 10.1080/10447318.2020.1726107; Islami F, 2018, CA-CANCER J CLIN, V68, P31, DOI 10.3322/caac.21440; Janssen E, 2011, BRIT J HEALTH PSYCH, V16, P92, DOI 10.1348/135910710X514120; Joreskog K, 2013, LISREL 8 STRUCTURAL; KAISER HF, 1974, EDUC PSYCHOL MEAS, V34, P111, DOI 10.1177/001316447403400115; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kline R.B., 2015, PRINCIPLES PRACTICE, V4th ed., DOI DOI 10.1038/156278A0; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Leventhal H., 1970, ADV EXP SOC PSYCHOL, V5, P119, DOI [https://doi.org/10.1016/S0065-2601(08)60091-X, DOI 10.1016/S0065-2601(08)60091-X]; Loewenstein G., 2003, ROLE AFFECT DECISION; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Masson G, 2020, PREV MED, V138, DOI 10.1016/j.ypmed.2020.106154; Milne S, 2000, J APPL SOC PSYCHOL, V30, P106, DOI 10.1111/j.1559-1816.2000.tb02308.x; Nerenz, 1980, CONTRIBUTIONS MED PS, V2, P7, DOI DOI 10.1093/GERONJ/46.4.P181; Pituch K.A., 2015, APPL MULTIVARIATE ST, DOI DOI 10.4324/9781315814919; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; SHAFIR E, 1993, COGNITION, V49, P11, DOI 10.1016/0010-0277(93)90034-S; Sheeran P, 2016, SOC PERSONAL PSYCHOL, V10, P503, DOI 10.1111/spc3.12265; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Stevens J., 1996, APPL MULTIVARIATE ST, V3rd Edn.; Turner JR, 2013, ENCY BEHAV MED, P1689, DOI [DOI 10.1007/978-1-4419-1005-9_866, 10.1007/978-1-4419-1005-9_866]; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293; Usher-Smith JA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5712-2; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; Wilson RS, 2019, RISK ANAL, V39, P777, DOI 10.1111/risa.13207; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276	47	2	2	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262197	10.1371/journal.pone.0262197	http://dx.doi.org/10.1371/journal.pone.0262197			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025940	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000796264200053
J	Hamamoto, Y; Suzuki, S; Sugiura, M				Hamamoto, Yumi; Suzuki, Shinsuke; Sugiura, Motoaki			Two components of body-image disturbance are differentially associated with distinct eating disorder characteristics in healthy young women	PLOS ONE			English	Article							SIZE OVER-ESTIMATION; ANOREXIA-NERVOSA; PERCEPTUAL COMPONENT; FIXATION PATTERNS; BULIMIA-NERVOSA; VALIDATION; INVENTORY; WEIGHT; SHAPE	Body-image disturbance comprises two components. The first is perceptual in nature, and is measured by a discrepancy between one's actual body and perceived self-image ("perceived-actual discrepancy"). The other component is affective, and is measured by a discrepancy between one's perceived self-image and ideal body image ("perceived-ideal discrepancy"). The present study evaluated the relationships between body-image disturbance and characteristics of eating disorders such as symptoms and related personality traits. In a psychophysiological experiment, female university students (mean +/- SD age = 21.0 +/- 1.38 years) were presented with silhouette images of their own bodies that were distorted in terms of width. The participants were asked whether each silhouette image was more overweight than their actual or ideal body images. Eating-disorder characteristics were assessed using six factors from the Japanese version of the Eating Disorder Inventory 2 (EDI2). We found that perceived-actual discrepancies correlated with negative self-evaluation (i.e., factor 3 of the EDI2), whereas perceived-ideal discrepancies correlated with dissatisfaction with one's own body (i.e., factor 2 of EDI2). These results imply that distinct psychological mechanisms underlie the two components of body-image disturbance.	[Hamamoto, Yumi] Tohoku Univ, Sch Med, Sendai, Miyagi, Japan; [Hamamoto, Yumi; Suzuki, Shinsuke; Sugiura, Motoaki] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan; [Suzuki, Shinsuke] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi, Japan; [Suzuki, Shinsuke] Univ Melbourne, Dept Finance, Brain Minds & Markets Lab, Carlton, Vic, Australia; [Sugiura, Motoaki] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; University of Melbourne; Tohoku University	Hamamoto, Y (corresponding author), Tohoku Univ, Sch Med, Sendai, Miyagi, Japan.; Hamamoto, Y (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan.	yumi.hamamoto.q2@dc.tohoku.ac.jp		Hamamoto, Yumi/0000-0002-7166-6059	Japan Society for the Promotion of Science [16H01873, 17H05933]; Division for Interdisciplinary Advanced Research and Education Selective Examination, Tohoku University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Division for Interdisciplinary Advanced Research and Education Selective Examination, Tohoku University	This study was supported by KAKENHI 16H01873 (MS) and 17H05933 (SS) from Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html).YH received the financial support from the Division for Interdisciplinary Advanced Research and Education Selective Examination, Tohoku University (http://www.iiare.tohoku.ac.jp/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspen V, 2013, COGNITION EMOTION, V27, P820, DOI 10.1080/02699931.2012.749777; Benninghoven D, 2007, BODY IMAGE, V4, P51, DOI 10.1016/j.bodyim.2006.12.002; BRUCH H, 1962, PSYCHOSOM MED, V24, P187, DOI 10.1097/00006842-196203000-00009; Burke MA, 2017, ECON HUM BIOL, V27, P198, DOI 10.1016/j.ehb.2017.06.002; Calzo JP, 2012, J ADOLESCENT HEALTH, V51, P517, DOI 10.1016/j.jadohealth.2012.02.021; Carey M, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00635; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; Cornelissen KK, 2019, BODY IMAGE, V31, P35, DOI 10.1016/j.bodyim.2019.08.001; Cornelissen KK, 2016, INT J EAT DISORDER, V49, P507, DOI 10.1002/eat.22505; Cornelissen KK, 2015, BODY IMAGE, V13, P75, DOI 10.1016/j.bodyim.2015.01.001; Cornelissen PL, 2013, BODY IMAGE, V10, P103, DOI 10.1016/j.bodyim.2012.09.003; Fairburn C.G., 2008, COGNITIVE BEHAV THER; Fan YO, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-314; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fitzgibbon ML, 2003, INT J EAT DISORDER, V34, P83, DOI 10.1002/eat.10160; Franko DL, 1999, J ADOLESCENCE, V22, P389, DOI 10.1006/jado.1999.0230; Gardner RM, 1996, BRIT J PSYCHOL, V87, P327, DOI 10.1111/j.2044-8295.1996.tb02593.x; Garner D. M., 2004, PROFESSIONAL MANUAL; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Garner DM, 1991, EATING DISORDER INVE; Gaudio S, 2012, NEUROSCI BIOBEHAV R, V36, P1839, DOI 10.1016/j.neubiorev.2012.05.003; GLEGHORN AA, 1987, J PSYCHOPATHOL BEHAV, V9, P203, DOI 10.1007/BF00960575; Hamamoto Y, 2019, PSYCHOTHER PSYCHOSOM, V88, P53; Irvine KR, 2019, BODY IMAGE, V29, P31, DOI 10.1016/j.bodyim.2019.02.006; Irvinea KR, 2020, BODY IMAGE, V33, P232, DOI 10.1016/j.bodyim.2020.03.007; Keizer A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163921; Kodama N, 2018, BIOPSYCHOSOC MED, V12, DOI 10.1186/s13030-018-0134-z; Legenbauer T, 2014, Z KINDER JUG-PSYCH, V42, P51, DOI 10.1024/1422-4917/a000269; Lewer M, 2016, EAT WEIGHT DISORD-ST, V21, P115, DOI 10.1007/s40519-015-0200-5; Mohr HM, 2010, PSYCHOL MED, V40, P1519, DOI 10.1017/S0033291709991826; Mohr HM, 2016, PERCEPTION, V45, P725, DOI 10.1177/0301006616633385; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; Nevonen L, 2001, Eat Weight Disord, V6, P59; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Porras-Garcia B, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00956; Porras-Garcia B, 2020, EUR EAT DISORD REV, V28, P454, DOI 10.1002/erv.2730; Probst M, 1998, INT J EAT DISORDER, V24, P167, DOI 10.1002/(SICI)1098-108X(199809)24:2&lt;167::AID-EAT6&gt;3.0.CO;2-C; Racine SE, 2012, INT J EAT DISORDER, V45, P333, DOI 10.1002/eat.20941; Sato Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061108; SCHOEMAKER C, 1994, INT J EAT DISORDER, V15, P387, DOI 10.1002/eat.2260150409; Shimura M., 1994, JPN J BEHAV THER, V20, P8; Stice E, 2018, BEHAV RES THER, V105, P52, DOI 10.1016/j.brat.2018.03.005; Stice E, 2011, BEHAV RES THER, V49, P622, DOI 10.1016/j.brat.2011.06.009; Tazaki S, 2007, JAPANESE J HLTH PSYC, V20, P56; Thaler A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192152; Waldman A, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-17; WATTS S, 1980, J AFFECT DISORDERS, V2, P257, DOI 10.1016/0165-0327(80)90027-0	48	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262513	10.1371/journal.pone.0262513	http://dx.doi.org/10.1371/journal.pone.0262513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020770	gold, Green Published			2022-12-27	WOS:000834207700046
J	Monari, N; Orwa, J; Agwanda, A				Monari, Naomi; Orwa, James; Agwanda, Alfred			Adolescent fertility and its determinants in Kenya: Evidence from Kenya demographic and health survey 2014	PLOS ONE			English	Article								Background Adolescent fertility in Kenya is vital in the development and execution of reproductive health policies and programs. One of the specific objectives of the Kenyan Adolescent Sexual Reproductive Health (ASRH) policy developed in 2015 is to decrease early and unintended pregnancies in an attempt to reduce adolescent fertility. We aimed to establish determinants of adolescent fertility in Kenya. Methods The Kenya Demographic and Health Survey (KDHS) 2014 data set was utilized. Adolescent's number of children ever born was the dependent variable. The Chi-square test was utilized to determine the relationship between dependent and independent variables. A Proportional-odds model was performed to establish determinants of adolescent fertility at a 5% significance level. Results Over 40% of the adolescent girls who had sex below 17 years had given birth i.e, current age 15-17 years (40.9%) and <15 years (44.9%) had given birth. In addition, 70.7% of the married adolescents had given birth compared to 8.1% of the unmarried adolescents. Moreover, 65.1% of the adolescents who were using contraceptives had given birth compared to only 9% of the adolescents who were not using a contraceptive. Approximately 29.4% of the adolescents who had no education had given birth compared to 9.1% who had attained secondary education. Age at first sex (18-19 years: OR: 0.221, 95% CI: 0.124-0.392; 15-17 years: OR: 0.530, 95% CI: 0.379-0.742), current age (18-19 years: OR: 4.727, 95% CI: 3.318-6.733), current marital status (Not married: OR:0.212, 95% CI: 0.150-4.780), and current contraceptive use (Using: OR 3.138, 95% CI: 2.257-4.362) were associated with adolescent fertility. Conclusion The study established that age at first sex, current age, marital status, and contraceptive use are the main determinants of adolescent childbearing. The stated determinants should be targeted by the government to control the adolescent birth rate in Kenya. Consequently, delaying the age at first sex, discouraging adolescent marriage, and increasing secondary school enrollment among adolescent girls are recommended strategies to control adolescent fertility in Kenya.	[Monari, Naomi; Orwa, James; Agwanda, Alfred] Univ Nairobi, Populat Studies & Res Inst, Nairobi, Kenya	University of Nairobi	Monari, N (corresponding author), Univ Nairobi, Populat Studies & Res Inst, Nairobi, Kenya.	naomi.monari@gmail.com		MONARI, NAOMI/0000-0001-5295-8753				Alemayehu T, 2010, ETHIOP J HEALTH DEV, V24, P30; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Bongaarts J, 2013, FERTILITY BIOL BEHAV; DAVIS K, 1956, ECON DEV CULT CHANGE, V4, P211, DOI 10.1086/449714; Eyasu AM., 2016, OPEN ACCESS LIB J, V3, P1; Gupta N, 1999, INT FAM PLAN PERSPEC, V25, P125, DOI 10.2307/2991961; Huda FauziaAkhter., 2014, PREVELENCE UNINTENDE, DOI [10.31899/rh4.1050, DOI 10.31899/RH4.1050]; Kassa GM, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0745-4; Kenya National Bureau of Statistics (KNBS) and ICF Micro, 2014, KENYA DEMOGRAPHIC HL; Laelago T, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0677-x; Loaiza E., 2013, ADOLESCENT PREGNANCY; Mahy M., 2002, TRENDS DIFFERENTIALS; Nyarko SH, 2012, INT J SCI BASIC APPL, V5, P21; Obare F, 2016, ADOLESCENT SEXUAL RE; Olorinola IO., ADOLESCENT FERTILITY; Palamuleni ME., 2017, GEND BEHAV, V15, P10126; Raharjo BB, 2019, KEMAS JURNAL KESEHAT, V15, P141; United Nations Department of Economic and Social Affairs Population Division, 2020, INT MIGR STOCK 2020; United Nations (UN), 2013, AD FERT INT C POP DE; Westoff CF., 2006, STALL FERTILITY TRAN; World Health Organization, 2014, HIGH PRIOR TARG PROD; WorldAtlas, HIGH TEEN PREGN RAT	23	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262016	10.1371/journal.pone.0262016	http://dx.doi.org/10.1371/journal.pone.0262016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020765	gold, Green Published			2022-12-27	WOS:000834207700032
J	Reimann, MW; Riihimaki, H; Smith, JP; Pokorny, C; Levi, R; Zochowski, M				Reimann, Michael W.; Riihimaki, Henri; Smith, Jason P.; Pokorny, Christoph; Levi, Ran; Zochowski, Michal			Topology of synaptic connectivity constrains neuronal stimulus representation, predicting two complementary coding strategies	PLOS ONE			English	Article							VARIABILITY; DIVERSE	In motor-related brain regions, movement intention has been successfully decoded from invivo spike train by isolating a lower-dimension manifold that the high-dimensional spiking activity is constrained to. The mechanism enforcing this constraint remains unclear, although it has been hypothesized to be implemented by the connectivity of the sampled neurons. We test this idea and explore the interactions between local synaptic connectivity and its ability to encode information in a lower dimensional manifold through simulations of a detailed microcircuit model with realistic sources of noise. We confirm that even in isolation such a model can encode the identity of different stimuli in a lower-dimensional space. We then demonstrate that the reliability of the encoding depends on the connectivity between the sampled neurons by specifically sampling populations whose connectivity maximizes certain topological metrics. Finally, we developed an alternative method for determining stimulus identity from the activity of neurons by combining their spike trains with their recurrent connectivity. We found that this method performs better for sampled groups of neurons that perform worse under the classical approach, predicting the possibility of two separate encoding strategies in a single microcircuit.	[Reimann, Michael W.; Levi, Ran] Ecole Polytech Fed Lausanne EPFL, Blue Brain Project, Geneva, Switzerland; [Riihimaki, Henri; Smith, Jason P.; Pokorny, Christoph; Zochowski, Michal] Univ Aberdeen, Aberdeen, Scotland; [Smith, Jason P.] Nottingham Trent Univ, Nottingham, England; [Pokorny, Christoph] Univ Latvia, Riga, Latvia	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Aberdeen; Nottingham Trent University; University of Latvia	Reimann, MW (corresponding author), Ecole Polytech Fed Lausanne EPFL, Blue Brain Project, Geneva, Switzerland.	michael.reimann@epfl.ch		Lazovskis, Janis/0000-0002-3285-7522	Swiss government's ETH Board of the Swiss Federal Institutes of Technology; EPSRC [EP/P025072, 832]; Ecole Polytechnique Federale de Lausanne	Swiss government's ETH Board of the Swiss Federal Institutes of Technology; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Ecole Polytechnique Federale de Lausanne	This study was supported by funding to the Blue Brain Project, a research center of the Ecole polytechnique federale de Lausanne (EPFL), from the Swiss government's ETH Board of the Swiss Federal Institutes of Technology. RL is supported by an EPSRC grant EP/P025072/and a collaboration agreement 832 with Ecole Polytechnique Federale de Lausanne.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Allen WE, 2019, SCIENCE, V364, P253, DOI 10.1126/science.aav3932; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Chung F. R.-K., 1996, CBMS REGIONAL C SERI, V92; Chung F, 2005, ANN COMB, V9, P1, DOI 10.1007/s00026-005-0237-z; Conceicao P, 2021, ARXIV; Desbordes G, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00151; Diestel R., 2000, GRAPH THEORY; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Gal E, 2017, NAT NEUROSCI, V20, P1004, DOI 10.1038/nn.4576; Gallego JA, 2017, NEURON, V94, P978, DOI 10.1016/j.neuron.2017.05.025; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Hatcher A, 2002, ALGEBRAIC TOPOLOGY; Iacaruso MF, 2017, NATURE, V547, P449, DOI 10.1038/nature23019; Lidl R., 1997, ENCY MATH ITS APPL, V20; Ling DSF, 1999, J NEUROPHYSIOL, V82, P1793, DOI 10.1152/jn.1999.82.4.1793; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Masulli P, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2022-y; Meyer HS, 2010, CEREB CORTEX, V20, P2287, DOI 10.1093/cercor/bhq069; Nolte M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11633-8; Okun M, 2015, NATURE, V521, P511, DOI 10.1038/nature14273; Petersen RS, 2008, NEURON, V60, P890, DOI 10.1016/j.neuron.2008.09.041; Ramaswamy S, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00044; Reimann MW, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00048; Reimann MW, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00120; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Reyes-Puerta V, 2015, CEREB CORTEX, V25, P2001, DOI 10.1093/cercor/bhu007; Ribrault C, 2011, NAT REV NEUROSCI, V12, P375, DOI 10.1038/nrn3025; Riihimaki H, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03659-3; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Simkus CRL, 2002, J PHYSIOL-LONDON, V545, P509, DOI 10.1113/jphysiol.2002.022095; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stringer C, 2019, SCIENCE, V364, P255, DOI 10.1126/science.aav7893; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P14419, DOI 10.1073/pnas.1004906107; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Vijaymeena MK., 2016, MACH LEARN APPL, V3, P19, DOI [10.5121/mlaij.2016.3103, DOI 10.5121/MLAIJ.2016.3103]; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weber JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11380	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261702	10.1371/journal.pone.0261702	http://dx.doi.org/10.1371/journal.pone.0261702			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020728	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000834207700021
J	Vannini, I; Ferracin, M; Fabbri, F; Fabbri, M				Vannini, Ivan; Ferracin, Manuela; Fabbri, Francesco; Fabbri, Muller			Overexpression of ultraconserved region 83-induces lung cancer tumorigenesis	PLOS ONE			English	Article							LONG NONCODING RNAS; ELEMENTS; EXPRESSION	The expression of non-coding RNAs (ncRNAs) is dysregulated in human cancers. The transcribed ultraconserved regions (T-UCRs) express long ncRNAs involved in human carcinogenesis. T-UCRs are non-coding genomic sequence that are 100% conserved across humans, rats and mice. Conservation of genomic sequences across species intrinsically implies an essential functional role and so we considered the expression of T-UCRs in lung cancer. Using a custom microarray we analyzed the global expression of T-UCRs. Among these T-UCRs, the greatest variation was observed for antisense ultraconserved element 83 (uc.83-), which was upregulated in human lung cancer tissues compared with adjacent non cancerous tissues. Even though uc.83- is located within the long intergenic non-protein coding RNA 1876 (LINC01876) gene, we found that the transcribed uc.83- is expressed independently of LINC01876 and was cloned as a 1143-bp RNA gene. In this study, functional analysis confirmed important effects of uc.83-on genes involved in cell growth of human cells. siRNA against uc.83- decreased the growth of lung cancer cells while the upregulation through a vector overexpressing the uc.83- RNA increased cell proliferation. We also show the oncogenic function of uc.83- is mediated by the phosphorylation of AKT and ERK 1/2, two important biomarkers of lung cancer cell proliferation. Based on our findings, inhibition against uc.83- could be a future therapeutic treatment for NSCLC to achieve simultaneous blockade of pathways involved in lung carcinogenesis.	[Vannini, Ivan; Fabbri, Francesco] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Biosci Lab, Meldola, Italy; [Ferracin, Manuela] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy; [Fabbri, Muller] Childrens Natl Hosp, Ctr Canc & Immunol Res, Washington, DC USA	University of Bologna; Children's National Health System	Vannini, I (corresponding author), IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Biosci Lab, Meldola, Italy.	ivan.vannini@irst.emr.it	Vannini, Ivan/T-7226-2019; Ferracin, Manuela/K-2097-2016; Fabbri, Francesco/K-1751-2018	Vannini, Ivan/0000-0002-9279-1801; Ferracin, Manuela/0000-0002-1595-6887; Fabbri, Francesco/0000-0002-7885-3025	National Institutes of Health [R01CA215753, R01CA219024]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, R01CA215753, Professor Muller Fabbri National Institutes of Health, R01CA219024, Professor Muller Fabbrihttps://www.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altorki NK, 2019, NAT REV CANCER, V19, P9, DOI 10.1038/s41568-018-0081-9; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bomben R, 2019, BRIT J HAEMATOL, V184, P1045, DOI 10.1111/bjh.15237; Braconi C, 2011, P NATL ACAD SCI USA, V108, P786, DOI 10.1073/pnas.1011098108; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chi YJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091015; Ciuffreda L, 2014, CURR PHARM DESIGN, V20, P3944, DOI 10.2174/13816128113196660763; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Diederichs S, 2016, EMBO MOL MED, V8, P442, DOI 10.15252/emmm.201506055; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fernandes JCR, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5010017; Gardiner EJ, 2006, J CHEM INF MODEL, V46, P753, DOI 10.1021/ci050384i; Honma R, 2017, GASTRIC CANCER, V20, P960, DOI 10.1007/s10120-017-0714-9; Johnsson P, 2014, BBA-GEN SUBJECTS, V1840, P1063, DOI 10.1016/j.bbagen.2013.10.035; Kopp F, 2019, J GENE MED, V21, DOI 10.1002/jgm.3104; Olivieri M, 2016, ONCOTARGET, V7, P20636, DOI 10.18632/oncotarget.7833; Rossi S, 2008, MAMM GENOME, V19, P526, DOI 10.1007/s00335-008-9119-8; Sciamanna I, 2013, ONCOTARGET, V4, P2271, DOI 10.18632/oncotarget.1403; Sekino Y, 2019, ONCOL REP, V41, P3111, DOI 10.3892/or.2019.7039; Seo Danbi, 2020, Genomics & Informatics, V18, pe36, DOI 10.5808/GI.2020.18.4.e36; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Slack FJ, 2019, CELL, V179, P1033, DOI 10.1016/j.cell.2019.10.017; Sonenshein GE, 1997, SEMIN CANCER BIOL, V8, P113, DOI 10.1006/scbi.1997.0062; Tan AC, 2020, THORAC CANCER, V11, P511, DOI 10.1111/1759-7714.13328; Vannini I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01562-9; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yang RX, 2008, CARCINOGENESIS, V29, P351, DOI 10.1093/carcin/bgm290; Zhou H, 2020, LIFE SCI, V261, DOI 10.1016/j.lfs.2020.118362	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0261464	10.1371/journal.pone.0261464	http://dx.doi.org/10.1371/journal.pone.0261464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015757	Green Published, gold			2022-12-27	WOS:000814820600003
J	Beheshti, K; Endris, C; Goodwin, P; Pavlak, A; Wasson, K				Beheshti, Kathryn; Endris, Charlie; Goodwin, Peter; Pavlak, Annabelle; Wasson, Kerstin			Burrowing crabs and physical factors hasten marsh recovery at panne edges	PLOS ONE			English	Article							SALT-MARSH; DIE-OFF; CALIFORNIA ESTUARY; CONSUMER CONTROL; ENGLAND; VEGETATION; ECOSYSTEM; COLLAPSE; DRIVEN; HERBIVORY	Salt marsh loss is projected to increase as sea-level rise accelerates with global climate change. Salt marsh loss occurs along both lateral creek and channel edges and in the marsh interior, when pannes expand and coalesce. Often, edge loss is attributed to erosive processes whereas dieback in the marsh interior is linked to excessive inundation or deposition of wrack, but remains poorly understood. We conducted a two-year field investigation in a central California estuary to identify key factors associated with panne contraction or expansion. Our study explored how an abundant burrowing crab, shown to have strong negative effects on marsh biomass near creek edges, affects panne dynamics. We also explored which physical panne attributes best predicted their dynamics. To our knowledge, ours is the first study of panne dynamics in a California marsh, despite how ubiquitous pannes are as a feature of marshes in the region and how often extensive marsh dieback occurs via panne expansion. Overall, we found that pannes contracted during the study period, but with variable rates of marsh recovery across pannes. Our model incorporating both physical and biological factors explained 86% of the variation in panne contraction. The model revealed a positive effect of crab activity, sediment accretion, and a composite of depth and elevation on panne contraction, and a negative effect of panne size and distance to nearest panne. The positive crab effects detected in pannes contrast with negative effects we detected near creek edges in a previous study, highlighting the context-dependence of top-down and bioturbation effects in marshes. As global change continues and the magnitude and frequency of disturbances increases, understanding the dynamics of marsh loss in the marsh interior as well as creek banks will be critical for the management of these coastal habitats.	[Beheshti, Kathryn; Pavlak, Annabelle; Wasson, Kerstin] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Beheshti, Kathryn] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 95064 USA; [Endris, Charlie; Wasson, Kerstin] Elkhorn Slough Natl Estuarine Res Reserve, Watsonville, CA USA; [Goodwin, Peter] Univ Maryland, Ctr Environm Sci, Cambridge, MD USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Barbara; University System of Maryland; University of Maryland Center for Environmental Science	Beheshti, K (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.; Beheshti, K (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 95064 USA.	katbeheshti@ucsb.edu	Goodwin, Peter/AAP-1649-2021; Beheshti, Kathryn/GMW-8610-2022	Beheshti, Kathryn/0000-0001-7991-4371; Endris, Charlie/0000-0001-8727-8723				Alldred M, 2020, ESTUAR COAST, V43, P801, DOI 10.1007/s12237-020-00700-9; Altieri AH, 2012, ECOLOGY, V93, P1402, DOI 10.1890/11-1314.1; Angelini C, 2018, OECOLOGIA, V187, P205, DOI 10.1007/s00442-018-4112-8; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Beheshti KM, 2021, ECOSPHERE, V12, DOI 10.1002/ecs2.3703; Bertness MD, 2008, CONSERV BIOL, V22, P618, DOI 10.1111/j.1523-1739.2008.00962.x; BERTNESS MD, 1985, ECOLOGY, V66, P1042, DOI 10.2307/1940564; Boyer KE, 2001, WETLANDS, V21, P315, DOI 10.1672/0277-5212(2001)021[0315:SVIASC]2.0.CO;2; Bromberg KD, 2005, ESTUARIES, V28, P823, DOI 10.1007/BF02696012; Brophy LS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218558; Buffington KJ, 2016, REMOTE SENS ENVIRON, V186, P616, DOI 10.1016/j.rse.2016.09.020; Caffrey JM, 2002, MAR ECOL PROG SER, V233, P39, DOI 10.3354/meps233039; Caffrey JM, 2002, CHANGES CALIFORNIA E, P25; Caffrey JM, 2002, CHANGES CALIFORNIA E, P29; Cahoon D.R., 2010, NATL WETLANDS NEWSLE, V32, P8; Cahoon DR, 2019, ESTUAR COAST, V42, P1, DOI 10.1007/s12237-018-0448-x; Chapple D, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00243; Crotty SM, 2020, P NATL ACAD SCI USA, V117, P17891, DOI 10.1073/pnas.1917869117; Crotty SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183058; Daleo P, 2011, OIKOS, V120, P842, DOI 10.1111/j.1600-0706.2010.19202.x; Day JW, 2011, ECOL ENG, V37, P229, DOI 10.1016/j.ecoleng.2010.11.021; Escapa M, 2008, ESTUAR COAST SHELF S, V80, P365, DOI 10.1016/j.ecss.2008.08.020; Escapa M, 2015, GEOMORPHOLOGY, V228, P147, DOI 10.1016/j.geomorph.2014.08.032; Fagherazzi S, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001139; Fagherazzi S, 2013, OCEANOGRAPHY, V26, P70, DOI 10.5670/oceanog.2013.47; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Ganju NK, 2019, ESTUAR COAST, V42, P917, DOI 10.1007/s12237-019-00531-3; Ganju NK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14156; Gardner RC, 2015, 2589447 SSRN, DOI [10.1111/j.1523-1739.2008.00962.x, DOI 10.1111/J.1523-1739.2008.00962.X]; Garwood JC, 2015, CONT SHELF RES, V104, P37, DOI 10.1016/j.csr.2015.05.004; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Gil MA, 2017, ECOLOGY, V98, P534, DOI 10.1002/ecy.1668; Goudie A, 2013, ESTUAR COAST SHELF S, V129, P112, DOI 10.1016/j.ecss.2013.05.015; He Q, 2016, ECOL MONOGR, V86, P278, DOI 10.1002/ecm.1221; Herbert D, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10020436; Himmelstein J, 2021, FRONT MAR SCI, V8, DOI 10.3389/fmars.2021.704768; Hoffman BA, 1997, J COASTAL RES, V13, P147; Holdredge C, 2010, MAR ECOL PROG SER, V399, P253, DOI 10.3354/meps08331; Holdredge C, 2009, CONSERV BIOL, V23, P672, DOI 10.1111/j.1523-1739.2008.01137.x; Janousek CN, 2019, ESTUAR COAST, V42, P85, DOI 10.1007/s12237-018-0420-9; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Kirwan ML, 2007, P NATL ACAD SCI USA, V104, P6118, DOI 10.1073/pnas.0700958104; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Koop-Jakobsen K, 2019, FRONT ENV SCI-SWITZ, V7, DOI 10.3389/fenvs.2019.00137; Li HX, 2020, INT J DIGIT EARTH, V13, P1467, DOI 10.1080/17538947.2020.1729263; Linhoss AC, 2016, J COASTAL RES, V32, P1116, DOI [10.2112/JCOASTRES-D-15-00115.1, 10.2112/jcoastres-d-15-00115.1]; Lund J, 2018, J WATER RES PLAN MAN, V144, DOI 10.1061/(ASCE)WR.1943-5452.0000984; Mariotti G, 2013, P NATL ACAD SCI USA, V110, P5353, DOI 10.1073/pnas.1219600110; Maron JL, 2014, J ECOL, V102, P1485, DOI 10.1111/1365-2745.12305; Millette TL, 2010, J COASTAL RES, V26, P809, DOI 10.2112/JCOASTRES-D-09-00101.1; NYMAN JA, 1993, MAR ECOL PROG SER, V96, P269, DOI 10.3354/meps096269; PETERSON W, 2015, WARM BLOB CONTINUES, V23, P44; Pethick JS, 1974, J BIOGEOGR, V1, P57, DOI DOI 10.2307/3038068; Raposa KB, 2018, PEERJ, V6, DOI 10.7717/peerj.4876; REDFIELD AC, 1972, ECOL MONOGR, V42, P201, DOI 10.2307/1942263; Schepers L, 2017, LIMNOL OCEANOGR, V62, P137, DOI 10.1002/lno.10381; SHUMWAY SW, 1995, ANN BOT-LONDON, V76, P225, DOI 10.1006/anbo.1995.1091; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Singh D, 2018, GEOPHYS RES LETT, V45, P9972, DOI 10.1029/2018GL078844; Tolhurst TJ, 2006, CONT SHELF RES, V26, P351, DOI 10.1016/j.csr.2005.11.007; Van Dyke E, 2005, ESTUARIES, V28, P173, DOI 10.1007/BF02732853; Vu HD, 2017, ECOLOGY, V98, P162, DOI 10.1002/ecy.1628; Walker JB, 2021, ECOLOGY, V102, DOI 10.1002/ecy.3244; Wasson K, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2813; Wasson K, 2017, BIOL CONSERV, V212, P1, DOI 10.1016/j.biocon.2017.05.019; Wasson K, 2015, MAR POLICY, V58, P60, DOI 10.1016/j.marpol.2015.04.002; Wilson CA, 2014, GEOMORPHOLOGY, V213, P99, DOI 10.1016/j.geomorph.2014.01.002; Wilson KR, 2010, J COASTAL RES, V26, P1007, DOI 10.2112/JCOASTRES-D-10-00007.1; Wilson KR, 2009, ESTUAR COAST, V32, P855, DOI 10.1007/s12237-009-9203-7; Yapp RH, 1917, J ECOL, V5, P65, DOI 10.2307/2255644; ZEDLER JB, 1983, ESTUARIES, V6, P346, DOI 10.2307/1351393; Zedler JB, 2004, IBIS, V146, P92, DOI 10.1111/j.1474-919X.2004.00333.x; Zedler JB., 1982, FWSOBS 8154; Zhu ZC, 2020, LIMNOL OCEANOGR, V65, P51, DOI 10.1002/lno.11249	74	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0249330	10.1371/journal.pone.0249330	http://dx.doi.org/10.1371/journal.pone.0249330			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986154	Green Submitted, gold, Green Published			2022-12-27	WOS:000765956200001
J	Greenhouse-Tucknott, A; Butterworth, JB; Wrightson, JG; Harrison, NA; Dekerle, J				Greenhouse-Tucknott, Aaron; Butterworth, Jake B.; Wrightson, James G.; Harrison, Neil A.; Dekerle, Jeanne			Effect of the subjective intensity of fatigue and interoception on perceptual regulation and performance during sustained physical activity	PLOS ONE			English	Article							MUSCLE FATIGUE; SELF-EFFICACY; EXERCISE TOLERANCE; FEEDBACK; BRAIN; RECOMMENDATIONS; SLEEPINESS; ANXIETY; CORTEX; HEART	Background The subjective experience of fatigue impairs an individual's ability to sustain physical endurance performance. However, precise understanding of the specific role perceived fatigue plays in the central regulation of performance remains unclear. Here, we examined whether the subjective intensity of a perceived state of fatigue, pre-induced through prior upper body activity, differentially impacted performance and altered perceived effort and affect experienced during a sustained, isometric contraction in lower body. We also explored whether (cardiac) interoception predicted the intensity of experienced perceptual and affective responses and moderated the relationships between constructs during physical activity. Methods Using a repeated-measures study design, thirty male participants completed three experimental conditions, with the intensity of a pre-induced state of fatigue manipulated to evoke moderate (MOD), severe (SEV) and minimal (control; CON) intensity of perceptions prior to performance of the sustained contraction. Results Performance of the sustained contraction was significantly impaired under a perceived state of fatigue, with reductions of 10% and 14% observed in the MOD and SEV conditions, respectively. Performance impairment was accompanied by greater perceived effort and more negative affective valence reported during the contraction. However, effects were limited to comparisons to CON, with no difference evident between the two experimental trials (i.e. MOD vs. SEV). Individuals' awareness of their accuracy in judging resting heartbeats was shown to predict the subjective intensity of fatigue experienced during the endurance task. However, interoception did not moderate the relationships evident between fatigue and both perceived effort and affective valence. Conclusions A perceived state of fatigue limits endurance performance, influencing both how effortful activity is perceived to be and the affective experience of activity. Though awareness of interoceptive representations of bodily states may be important to the subjective experience of fatigue, interoception does not modulate the relationships between perceived fatigue and other perceptual (i.e. effort) and affective constructs.	[Greenhouse-Tucknott, Aaron; Butterworth, Jake B.; Wrightson, James G.; Dekerle, Jeanne] Univ Brighton, Sch Sport & Hlth Sci, Fatigue & Exercise Lab, Brighton, E Sussex, England; [Wrightson, James G.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Harrison, Neil A.] Cardiff Univ, Cardiff Univ Brain Res Imaging Ctr CUBRIC, Cardiff, Wales; [Harrison, Neil A.] Univ Sussex, Brighton & Sussex Med Sch, Dept Neurosci, Brighton, E Sussex, England	University of Brighton; University of Calgary; Cardiff University; University of Brighton; University of Sussex	Greenhouse-Tucknott, A (corresponding author), Univ Brighton, Sch Sport & Hlth Sci, Fatigue & Exercise Lab, Brighton, E Sussex, England.	A.Greenhouse-Tucknott@brighton.ac.uk	Dekerle, Jeanne/M-8367-2019	Dekerle, Jeanne/0000-0002-4482-4576; Greenhouse-Tucknott, Aaron/0000-0002-9257-521X				Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Aboodarda SJ, 2020, J PHYSIOL-LONDON, V598, P285, DOI 10.1113/JP278943; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Amann M, 2013, J APPL PHYSIOL, V115, P355, DOI 10.1152/japplphysiol.00049.2013; Andre N, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00079; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Behm DG, 2021, SPORTS MED, V51, P1893, DOI 10.1007/s40279-021-01456-3; Bekrater-Bodmann R, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.562016; Benoit CE, 2019, NEUROPSYCHOLOGIA, V123, P30, DOI 10.1016/j.neuropsychologia.2018.06.017; Borg G., 1998, BORGS PERCEIVED EXER; Borg G., 1986, PERCEPTION EXERTION, P3; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brick NE, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00159; Smirmaul BDC, 2012, BRIT J SPORT MED, V46, P308, DOI 10.1136/bjsm.2010.071407; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Machado DGD, 2019, PHYSIOL BEHAV, V204, P234, DOI 10.1016/j.physbeh.2019.02.038; de Koning JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015863; de Morree H. M., 2015, HDB BIOBEHAVIORAL AP, P255, DOI [10.1007/978-1-4939-1236-0_17, DOI 10.1007/978-1-4939-1236-0_17]; Dimitrov GV, 2008, J ELECTROMYOGR KINES, V18, P35, DOI 10.1016/j.jelekin.2006.07.002; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; Ede A, 2017, PSYCHOL SPORT EXERC, V28, P31, DOI 10.1016/j.psychsport.2016.10.002; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Enoka RM, 2016, MED SCI SPORT EXER, V48, P2228, DOI 10.1249/MSS.0000000000000929; Frick RW, 1998, BEHAV RES METH INS C, V30, P690, DOI 10.3758/BF03209488; Gallucci M, 2019, GAMLJ GEN ANAL LINEA; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Garfinkel SN, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0014; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Garfinkel SN, 2013, SOC COGN AFFECT NEUR, V8, P231, DOI 10.1093/scan/nss140; Green DM, 1966, SIGNAL DETECTION THE; Greenhouse-Tucknott A, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13602; Greenhouse-Tucknott A, 2020, UNITY PATHOLOGICAL E; Halper LR, 2016, PSYCHOL SPORT EXERC, V22, P170, DOI 10.1016/j.psychsport.2015.08.007; Halperin I, 2020, SPORTS MED, V50, P679, DOI 10.1007/s40279-019-01229-z; Halperin I, 2015, EUR J APPL PHYSIOL, V115, P2031, DOI 10.1007/s00421-015-3249-y; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; Harris S, 2019, PSYCHOL SPORT EXERC, V44, P1, DOI 10.1016/j.psychsport.2019.04.005; Herbert BM, 2007, PSYCHOPHYSIOLOGY, V44, P194, DOI 10.1111/j.1469-8986.2007.00493.x; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hockey G. R. J., 2011, COGNITIVE FATIGUE MU, P167, DOI [10.1037/12343-008, DOI 10.1037/12343-008]; Hockey R., 2013, PSYCHOL FATIGUE WORK; Hureau TJ, 2018, EUR J SPORT SCI, V18, P13, DOI 10.1080/17461391.2016.1252428; Hutchinson JC, 2008, J APPL SPORT PSYCHOL, V20, P457, DOI 10.1080/10413200802351151; Inzlicht M, 2018, TRENDS COGN SCI, V22, P337, DOI 10.1016/j.tics.2018.01.007; Iodice P, 2019, P NATL ACAD SCI USA, V116, P13897, DOI 10.1073/pnas.1821032116; Jacquet T, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.588253; Joffily M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003094; Johnson MA, 2015, J APPL PHYSIOL, V119, P840, DOI 10.1152/japplphysiol.00072.2015; KATKIN ES, 1983, PSYCHOPHYSIOLOGY, V20, P452; Kennedy A, 2013, EUR J APPL PHYSIOL, V113, P559, DOI 10.1007/s00421-012-2462-1; Kleckner IR, 2015, PSYCHOPHYSIOLOGY, V52, P1432, DOI 10.1111/psyp.12503; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Koller M, 2016, J STAT SOFTW, V75, P1, DOI 10.18637/jss.v075.i06; Koteles F, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13620; Krupp LB, 1996, CURR OPIN NEUROL, V9, P456, DOI 10.1097/00019052-199612000-00011; Kuppuswamy A, 2017, BRAIN, V140, P2240, DOI 10.1093/brain/awx153; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Marcora S, 2009, J APPL PHYSIOL, V106, P2060, DOI 10.1152/japplphysiol.90378.2008; Marcora SM, 2008, EUR J APPL PHYSIOL, V104, P929, DOI 10.1007/s00421-008-0818-3; Marcora SM, 2010, EUR J APPL PHYSIOL, V109, P763, DOI 10.1007/s00421-010-1418-6; Marcora SM., ENCY PERCEPTION, V2010, P380, DOI DOI 10.4135/9781412972000.N119; Massin O., 2017, MOTIV SCI, V3, P230, DOI [10.1037/, DOI 10.1037/MOT0000066]; McAuley E, 1999, HEALTH PSYCHOL, V18, P288, DOI 10.1037/0278-6133.18.3.288; McMorris T, 2018, NEUROSCI BIOBEHAV R, V93, P93, DOI 10.1016/j.neubiorev.2018.03.024; Micklewright D, 2017, SPORTS MED, V47, P2375, DOI 10.1007/s40279-017-0711-5; Morgan PT, 2019, AM J PHYSIOL-REG I, V317, pR346, DOI 10.1152/ajpregu.00084.2019; Motl RW, 2006, J PAIN, V7, P301, DOI 10.1016/j.jpain.2005.11.009; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pezzulo G, 2018, TRENDS COGN SCI, V22, P294, DOI 10.1016/j.tics.2018.01.009; Pigeon WR, 2003, J PSYCHOSOM RES, V54, P61, DOI 10.1016/S0022-3999(02)00542-1; Preston J., 2009, OXFORD HDB HUMAN ACT, P469; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Robertson CV, 2016, J APPL PHYSIOL, V120, P464, DOI 10.1152/japplphysiol.00363.2015; Ryum T, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00924; Smith MR, 2019, J PSYCHOL, V153, P759, DOI 10.1080/00223980.2019.1611530; Staiano W, 2018, PROG BRAIN RES, V240, P175, DOI 10.1016/bs.pbr.2018.09.012; Steele J., 2021, WHAT IS PERCEPTION E, DOI [10.31234/osf.io/kbyhm, DOI 10.31234/OSF.IO/KBYHM]; Stephan KE, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00550; Tanaka M, 2014, BRAIN RES, V1542, P49, DOI 10.1016/j.brainres.2013.10.018; The Jamovi Project, 2020, JAMOVI; Venhorst A, 2018, SPORTS MED, V48, P2479, DOI 10.1007/s40279-018-0986-1; Weinberg R., 1979, J SPORT EXERC PSYCHO, V1, P320; Weinberg RS, 1981, J SPORT PSYCHOL, V3; Wiens S, 2001, BIOL PSYCHOL, V58, P159, DOI 10.1016/S0301-0511(01)00110-7; Zenon A, 2019, NEUROPSYCHOLOGIA, V123, P5, DOI 10.1016/j.neuropsychologia.2018.09.013	90	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262303	10.1371/journal.pone.0262303	http://dx.doi.org/10.1371/journal.pone.0262303			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZO8DB	34986186	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000765956200039
J	Mariac, C; Duponchelle, F; Miranda, G; Ramallo, C; Wallace, R; Tarifa, G; Garcia-Davila, C; Ortega, H; Pinto, J; Renno, JF				Mariac, Cedric; Duponchelle, Fabrice; Miranda, Guido; Ramallo, Camila; Wallace, Robert; Tarifa, Gabriel; Garcia-Davila, Carmen; Ortega, Hernan; Pinto, Julio; Renno, Jean-Francois			Unveiling biogeographical patterns of the ichthyofauna in the Tuichi basin, a biodiversity hotspot in the Bolivian Amazon, using environmental DNA	PLOS ONE			English	Article							CONSERVATION; EDNA; POPULATION; HYDROPOWER; DIVERSITY; PACKAGE; SURFACE; FUTURE; WATERS; ANDES	To date, more than 2400 valid fish species have been recorded in the Amazon basin. However, some regions remain poorly documented. This is the case in the Beni basin and in particular in one of its main sub-basins, the Tuichi, an Andean foothills rivers flowing through the Madidi National Park in the Bolivian Amazonia. The knowledge of its ichthyological diversity is, however, essential for the management and protection of aquatic ecosystems, which are threatened by the development of infrastructures (dams, factories and cities), mining and deforestation. Environmental DNA (eDNA) has been relatively little used so far in the Amazon basin. We sampled eDNA from water in 34 sites in lakes and rivers in the Beni basin including 22 sites in the Tuichi sub-basin, during the dry season. To assess the biogeographical patterns of the amazonian ichthyofauna, we implemented a metabarcoding approach using two pairs of specific primers designed and developed in our laboratory to amplify two partially overlapping CO1 fragments, one of 185bp and another of 285bp. We detected 252 fish taxa (207 at species level) among which 57 are newly identified for the Beni watershed. Species compositions are significantly different between lakes and rivers but also between rivers according to their hydrographic rank and altitude. Furthermore, the diversity patterns are related to the different hydro-ecoregions through which the Tuichi flows. The eDNA approach makes it possible to identify and complete the inventory of the ichthyofauna in this still poorly documented Amazon basin. However, taxonomic identification remains constrained by the lack of reference barcodes in public databases and does not allow the assignment of all OTUs. Our results can be taken into account in conservation and management strategies and could serve as a baseline for future studies, including on other Andean tributaries.	[Mariac, Cedric; Renno, Jean-Francois] Univ Montpellier, CIRAD, DIADE, IRD, Montpellier, France; [Mariac, Cedric; Duponchelle, Fabrice; Miranda, Guido; Garcia-Davila, Carmen; Renno, Jean-Francois] UAGRM, IRD, IIAP, Lab Mixte Int Evolut & Domesticat Ichtyofaune Ama, Paris, France; [Duponchelle, Fabrice] Univ Montpellier, CNRS, IFREMER, IRD,MARBEC, Montpellier, France; [Miranda, Guido; Ramallo, Camila; Wallace, Robert; Tarifa, Gabriel] Wildlife Conservat Soc, Bolivia Program, La Paz, Bolivia; [Miranda, Guido; Pinto, Julio] Univ Mayor San Andres, Inst Ecol, Unidad Limnol, La Paz, Bolivia; [Garcia-Davila, Carmen] Inst Invest Amazonia Peruana IIAP, Lab Biol & Genet Mol LBGM, Iquitos, Peru; [Ortega, Hernan] Univ Nacl Mayor San Marcos, Museo Hist Nat, Dept Ictiol, Lima, Peru	CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidad Mayor de San Andres; Universidad Nacional Mayor de San Marcos	Mariac, C (corresponding author), Univ Montpellier, CIRAD, DIADE, IRD, Montpellier, France.; Mariac, C (corresponding author), UAGRM, IRD, IIAP, Lab Mixte Int Evolut & Domesticat Ichtyofaune Ama, Paris, France.	cedric.mariac@ird.fr	MARIAC, Cedric/H-9868-2017	MARIAC, Cedric/0000-0001-6439-115X	Programa Nacional de Investigacion Cientifica y Estudios Avanzados (PROCIENCA) [017-2018-FONDECYT]; Gordon and Betty Moore Foundation [GBMF331.07]; Laboratoire Mixte International -Evolution et Domestication de l'Ichtyofaune Amazonienne	Programa Nacional de Investigacion Cientifica y Estudios Avanzados (PROCIENCA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Laboratoire Mixte International -Evolution et Domestication de l'Ichtyofaune Amazonienne	CGD has been supported by Programa Nacional de Investigacion Cientifica y Estudios Avanzados (PROCIENCA) [grant number 017-2018-FONDECYT]. GM, RW, GT, CR has been supported by Gordon and Betty Moore Foundation [grant number GBMF331.07]. CM, FD, JFR, CDG has been supported by Laboratoire Mixte International -Evolution et Domestication de l'Ichtyofaune Amazonienne (No grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EP, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1642; Anderson EP, 2011, CONSERV BIOL, V25, P30, DOI 10.1111/j.1523-1739.2010.01568.x; Guimaraes KLA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209430; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Boussarie G, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9661; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Cantera I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39399-5; Carvajal-Quintero JD, 2015, ECOL EVOL, V5, P2608, DOI 10.1002/ece3.1539; Carvajal-Vallejos FM., 2017, BASES TECNICAS MANEJ, DOI [10.1371/journal.pone.0170009, DOI 10.1371/JOURNAL.PONE.0170009]; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; Castello L, 2013, CONSERV LETT, V6, P217, DOI 10.1111/conl.12008; Cilleros K, 2019, MOL ECOL RESOUR, V19, P27, DOI 10.1111/1755-0998.12900; Civade R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157366; Curtis AN, 2021, DIVERS DISTRIB, V27, P1918, DOI 10.1111/ddi.13196; Deiner K, 2017, METHODS ECOL EVOL, V8, P1888, DOI 10.1111/2041-210X.12836; Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Doble C.J., 2020, ENV DNA, V2, P24, DOI [DOI 10.1002/EDN3.43, 10.1002/edn3.43]; Doi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122763; Doria CRC, 2018, REV FISH SCI AQUAC, V26, P494, DOI 10.1080/23308249.2018.1463511; Dougherty MM, 2016, J APPL ECOL, V53, P722, DOI 10.1111/1365-2664.12621; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Duponchelle F, 2021, AQUAT CONSERV, V31, P1087, DOI 10.1002/aqc.3550; Elbrecht V, 2017, METHODS ECOL EVOL, V8, P622, DOI 10.1111/2041-210X.12687; Escudie F, 2018, BIOINFORMATICS, V34, P1287, DOI 10.1093/bioinformatics/btx791; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Forsberg BR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182254; Freeman MC, 2003, AM FISH S S, V35, P255; Froese R, 2010, FISHBASE WORLD WIDE; Galan M, 2018, MOL ECOL RESOUR, V18, P474, DOI 10.1111/1755-0998.12749; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Goulding M., 1980, P1; Harrison JB, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1409; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Hugueny B, 2010, AM FISH S S, V73, P29; Hunter ME, 2018, ENDANGER SPECIES RES, V35, P101, DOI 10.3354/esr00880; Hurd LE, 2016, BIOL CONSERV, V195, P118, DOI 10.1016/j.biocon.2016.01.005; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Jackman J.M., 2021, ENV DNA, V3, P837; Jaramillo-Villa U, 2010, J FISH BIOL, V76, P2401, DOI 10.1111/j.1095-8649.2010.02629.x; Jerde CL, 2019, MOL ECOL RESOUR, V19, P19, DOI 10.1111/1755-0998.12929; Jezequel C, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0436-4; Jezequel C, 2020, CONSERV BIOL, V34, P956, DOI 10.1111/cobi.13466; Jo T., 2022, ENV DNA, V4, P271, DOI [10.1002/edn3.253, DOI 10.1002/EDN3.253]; Kemp BM, 2005, FORENSIC SCI INT, V154, P53, DOI 10.1016/j.forsciint.2004.11.017; Lacoursiere-Roussel A, 2016, GENOME, V59, P991, DOI 10.1139/gen-2015-0218; Latrubesse EM, 2017, NATURE, V546, P363, DOI 10.1038/nature22333; Lawson Handley L., 2019, ENV DNA, V1, P26, DOI [DOI 10.1002/EDN3.5, 10.1002/edn3.5]; Lees AC, 2016, BIODIVERS CONSERV, V25, P451, DOI 10.1007/s10531-016-1072-3; Leroy B, 2019, J BIOGEOGR, V46, P2407, DOI 10.1111/jbi.13674; Li J., 2019, ENV DNA, V1, P238, DOI DOI 10.1002/EDN3.24; Linke S, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0300-6; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Manel S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14409-7; Maurice-Bourgoin L, 2003, J PHYS IV, V107, P855, DOI 10.1051/jp4:20030432; McDevitt AD, 2019, J FISH BIOL, V95, P679, DOI 10.1111/jfb.14053; McKnight D.T., 2019, ENV DNA, V1, P14, DOI [DOI 10.1002/EDN3.11, 10.1002/edn3.11]; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Melo BF, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00107; Miranda-Chumacero G, 2020, GLOB ECOL CONSERV, V24, DOI 10.1016/j.gecco.2020.e01309; Miranda-Chumacero G, 2012, BIOINVASIONS REC, V1, P129, DOI 10.3391/bir.2012.1.2.09; Oksanen J., 2022, R PACKAGE VERSION; Ortega H., 2012, LISTA ANOTADA PECES; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pochardt M, 2020, MOL ECOL RESOUR, V20, P457, DOI 10.1111/1755-0998.13123; Pont D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28424-8; Prance G.T., 1981, BRITTONIA, V33, P257, DOI [10.2307/2806336, DOI 10.2307/2806336]; Pringle CM, 2000, BIOSCIENCE, V50, P807, DOI 10.1641/0006-3568(2000)050[0807:REOHAO]2.0.CO;2; QGIS.org, 2020, OP SOURC GEOSP FDN P, DOI [10.26131/IRSA525, DOI 10.26131/IRSA525]; R Core Team, 2020, R LANG ENV STAT COMP; Reis RE, 2016, J FISH BIOL, V89, P12, DOI 10.1111/jfb.13016; Sales NG, 2021, SCI TOTAL ENVIRON, V754, DOI 10.1016/j.scitotenv.2020.142096; Santana CDde., 2021, BIORXIV, DOI [10.1038/s41598-021-97128-3, DOI 10.1038/S41598-021-97128-3]; Sarmiento J, 2014, PECES BOLIVIA BOLIVI; Sasso T, 2017, EDNA METABARCODING P, P1755; Schneider A, 2017, GEOPHYS RES LETT, V44, P2773, DOI 10.1002/2016GL071844; Shaw JLA, 2016, BIOL CONSERV, V197, P131, DOI 10.1016/j.biocon.2016.03.010; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Strahler AN., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Toomey AH, 2020, CONSERV SOC, V18, P25, DOI 10.4103/cs.cs_18_115; Wallace R., 2019, INFORME CIENTIFICO 2; Wallace R, 2020, TROP CONSERV SCI, V13, DOI 10.1177/1940082920966470; Wallace Robert, 2017, Ecología en Bolivia, V52, P1; Wasson J. G., 2002, The ecohydrology of South American rivers and wetlands, P69; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x; Zhao SL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S10-P16	92	0	0	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262357	10.1371/journal.pone.0262357	http://dx.doi.org/10.1371/journal.pone.0262357			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982802	Green Published, Green Submitted, gold			2022-12-27	WOS:000834805700031
J	Abawari, MJ; Amdisa, D; Birhanu, Z; Kebede, Y				Abawari, Mohammed Jemal; Amdisa, Demuma; Birhanu, Zewdie; Kebede, Yohannes			Response to self-care practice messages among patients with diabetes mellitus visiting Jimma University medical center facility based cross sectional design application of extended parallel process model	PLOS ONE			English	Article							FEAR APPEALS; MANAGEMENT; BEHAVIORS; KNOWLEDGE; FOOT	Objective To determine response to self-care practice message among patients with diabetes in Jimma University Medical center based on the Extended Parallel Process Model. Design A facility-based cross-sectional study was conducted. Setting Jimma University Medical Center is found in Jimma town. Participants A total of 343 patients with diabetes participated in the study; making a response rate of 93.9%. All patients with diabetes who were 18 years and above and who were on follow up and registered were included in the study and those with Gestational DM were excluded. Data analysis Multivariable logistic regression analysis. Result Responsive respondents scored high in self-care practice score as compared to other respondents. educational status, information sources, knowledge, and preferred message appeals were independent predictors of controlling the danger of diabetes. Conclusion There is a significant gap in controlling the danger of diabetes. Variables like the level of education, knowledge of diabetes mellitus, information sources, and message appeals were independent predictors of controlling the danger of diabetes. Designing message having higher efficacy while maintaining the level of threat is the best that fits the existing audience's message processing to bring about desired diabetic self-care Practice.	[Abawari, Mohammed Jemal; Amdisa, Demuma; Birhanu, Zewdie; Kebede, Yohannes] Jimma Univ, Fac Publ Hlth, Dept Hlth Behav & Soc, Jimma, Ethiopia	Jimma University	Abawari, MJ (corresponding author), Jimma Univ, Fac Publ Hlth, Dept Hlth Behav & Soc, Jimma, Ethiopia.	Mahirmohammed159@gmail.com		Kebede, Yohannes/0000-0003-3142-5266				Abate Teshager Weldegiorgis, 2018, BMC Res Notes, V11, P800, DOI 10.1186/s13104-018-3874-8; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; America Diabetes Association, 2019, IDF DIAB ATL 2019, pS15; [Anonymous], 2015, INT J CURR RES ACAD; [Anonymous], 2014, WORLD J MED MED SCI, DOI DOI 10.21203/RS.3.RS-104748/V1; Aschalew AY, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4630-4; Ayele K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035515; CACIOPPO JT, 1989, BASIC APPL SOC PSYCH, V10, P3, DOI 10.1207/s15324834basp1001_2; Chali Segni Wanna, 2018, BMC Res Notes, V11, P833, DOI 10.1186/s13104-018-3939-8; Dillard J., 1994, COMMUN MONOGR, V61; Gebre MW, 2013, ETHIOP J HEALTH DEV, V27, P249; Gould Gillian Sandra, 2015, Prev Med Rep, V2, P4, DOI 10.1016/j.pmedr.2014.10.004; Gould GS., 2017, EXPLORING ADAPTED RI, P1; Gurmu Y, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3448-4; Heisler M, 2009, AM J PREV MED, V37, pS270, DOI 10.1016/j.amepre.2009.08.016; Kilberenge W., 2010, PAN AFR MED J, V8688, P1; Lael-Monfared E, 2019, DIABETES METAB SYND, V13, P1535, DOI 10.1016/j.dsx.2019.03.008; Lanting LC, 2008, PATIENT EDUC COUNS, V72, P146, DOI 10.1016/j.pec.2008.03.008; Li R, 2014, Int J Nurs Sci, V1, P266, DOI 10.1016/j.ijnss.2014.05.023; McKay DL, 2004, HEALTH EDUC BEHAV, V31, P355, DOI 10.1177/1090198104263353; Popova L, 2012, HEALTH EDUC BEHAV, V39, P455, DOI 10.1177/1090198111418108; Roberto AJ, 2009, J HEALTH COMMUN, V14, P400, DOI 10.1080/10810730902873935; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Tesfaye T, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0150-6; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; WHO Global Report, 2016, GLOBAL REPORT DIABET, V978; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328; Witte K, 1998, HEALTH EDUC BEHAV, V25, P571, DOI 10.1177/109019819802500505; Witte K, 2001, EFFECTIVE HLTH RISK; WRIGHT P, 1980, J CONSUM RES, V7, P151, DOI 10.1086/208804; Yemane T., 2007, ETHIOP J HEALTH SCI, V17, P107	33	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261836	10.1371/journal.pone.0261836	http://dx.doi.org/10.1371/journal.pone.0261836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972154	gold, Green Published			2022-12-27	WOS:000773555700059
J	Guidetti, M; Carraro, L; Castelli, L				Guidetti, Margherita; Carraro, Luciana; Castelli, Luigi			Children's inequality aversion in intergroup contexts: The role of parents' social dominance orientation, right-wing authoritarianism and moral foundations	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; 3RD-PARTY PUNISHMENT; INDIVIDUAL-DIFFERENCES; RESOURCE-ALLOCATION; RACIAL-ATTITUDES; INGROUP MEMBERS; IDEOLOGY; PERSONALITY; SENSITIVITY; PREFERENCE	Although children are overall sensitive to inequality and prefer fair allocation of resources, they also often display ingroup favouritism. Inquiring about the factors that can shape the tension between these two driving forces in children, we focused on the role of parents. Extending the limited literature in this field, the present work examined whether individual differences in 3-to 11-year-old White children's (N = 154, 78 boys) evaluations of fair versus pro-ingroup behaviours in an intergroup context vary as a function of both mothers' and fathers' social dominance orientation (SDO), right-wing authoritarianism (RWA), and moral foundations. Parents completed a questionnaire. Children were presented with a scenario in which two ingroup members distributed candies to two other children, one White and one Black, either in an egalitarian way or displaying a clear ingroup favouritism. Afterwards, their attitudes towards the two ingroup members who had distributed the candies were assessed through both an Implicit Association Test and explicit questions. Although children displayed on average an explicit preference for the fair over the pro-ingroup target, this preference did not emerge at the implicit level. Most importantly, both children's explicit and implicit attitudes were related to mothers' SDO, indicating that at increasing level of mothers' SDO children's inequality aversion tended to drop. Overall, these results emphasize the relevance of mothers' support for social hierarchy in relation to the way in which children balance the two competing drives of equality endorsement and pro-ingroup bias.	[Guidetti, Margherita; Carraro, Luciana; Castelli, Luigi] Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy; [Guidetti, Margherita] Univ Modena & Reggio Emilia, Dipartimento Comunicaz Econ, Reggio Emilia, Italy	University of Padua; Universita di Modena e Reggio Emilia	Guidetti, M (corresponding author), Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy.; Guidetti, M (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Comunicaz Econ, Reggio Emilia, Italy.	margherita.guidetti@unimore.it		Carraro, Luciana/0000-0001-8100-4609; Castelli, Luigi/0000-0002-1472-4507; Guidetti, Margherita/0000-0002-2637-2289	Fondazione Cariparo through the Visiting Programme "Early expressions and antecedents of political orientation in young children" [CARR_PROGRAMME19_01]	Fondazione Cariparo through the Visiting Programme "Early expressions and antecedents of political orientation in young children"	This research was financially supported by the Fondazione Cariparo through the Visiting Programme "Early expressions and antecedents of political orientation in young children" (CARR_PROGRAMME19_01).	Aboud F., 1988, CHILDREN PREJUDICE; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bigler RS, 1997, CHILD DEV, V68, P530, DOI 10.1111/j.1467-8624.1997.tb01956.x; BIGLER RS, 1993, CHILD DEV, V64, P1507, DOI 10.1111/j.1467-8624.1993.tb02967.x; BIRCH LL, 1986, CHILD DEV, V57, P387, DOI 10.1111/j.1467-8624.1986.tb00038.x; Blake PR, 2014, TRENDS COGN SCI, V18, P559, DOI 10.1016/j.tics.2014.08.003; Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Block J, 2006, J RES PERS, V40, P734, DOI 10.1016/j.jrp.2005.09.005; Bobbio A., 2011, GIORNALE PSICOLOGIA, V5, P7, DOI DOI 10.1037/T65368-000; Bratt C, 2016, PERS SOC PSYCHOL B, V42, P1617, DOI 10.1177/0146167216666267; Browne M.W., 1990, MUTMUM PC USERS GUID; Browne MW., 1993, SOCIOL METHOD RES, V154, P136; Carraro L, 2015, PSICOLOG SOC, V10, P71, DOI 10.1482/79438; Castelli L, 2008, PERS SOC PSYCHOL B, V34, P807, DOI 10.1177/0146167208315210; Castelli L, 2007, DEV PSYCHOL, V43, P1347, DOI 10.1037/0012-1649.43.6.1347; Castelli L, 2021, J EXP CHILD PSYCHOL, V206, DOI 10.1016/j.jecp.2021.105102; Castelli L, 2010, EUR J SOC PSYCHOL, V40, P881, DOI 10.1002/ejsp.740; Castelli L, 2009, DEV PSYCHOL, V45, P586, DOI 10.1037/a0014619; Degner J, 2013, PSYCHOL BULL, V139, P1270, DOI 10.1037/a0031436; DeJesus JM, 2014, COGNITIVE SCI, V38, P178, DOI 10.1111/cogs.12093; Dennis TA, 2015, SOC NEUROSCI-UK, V10, P206, DOI 10.1080/17470919.2014.968290; Di Stefano G., 2005, TPM TEST PSYCHOM MET, V12, P5; Duckitt J, 2006, PERS SOC PSYCHOL B, V32, P684, DOI 10.1177/0146167205284282; Duckitt J, 2001, ADV EXP SOC PSYCHOL, V33, P41, DOI 10.1016/S0065-2601(01)80004-6; Duckitt J, 2010, J PERS, V78, P1861, DOI 10.1111/j.1467-6494.2010.00672.x; Dunham Y, 2008, TRENDS COGN SCI, V12, P248, DOI 10.1016/j.tics.2008.04.006; Dunham Y, 2006, CHILD DEV, V77, P1268, DOI 10.1111/j.1467-8624.2006.00933.x; Dunham Y, 2011, CHILD DEV, V82, P793, DOI 10.1111/j.1467-8624.2011.01577.x; Duriez B, 2009, J RES PERS, V43, P906, DOI 10.1016/j.jrp.2009.05.014; Federico CM, 2013, POLIT PSYCHOL, V34, P589, DOI 10.1111/pops.12006; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Feldman S, 1997, POLIT PSYCHOL, V18, P741, DOI 10.1111/0162-895X.00077; Fraley RC, 2012, PSYCHOL SCI, V23, P1425, DOI 10.1177/0956797612440102; Funke F, 2005, POLIT PSYCHOL, V26, P195, DOI 10.1111/j.1467-9221.2005.00415.x; Geraci A, 2011, DEVELOPMENTAL SCI, V14, P1012, DOI 10.1111/j.1467-7687.2011.01048.x; Gilligan C., 1982, DIFFERENT VOICE PSYC; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2013, ADV EXP SOC PSYCHOL, V47, P55, DOI 10.1016/B978-0-12-407236-7.00002-4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Guidetti M, 2017, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.02079; Haidt J., 2007, INNATE MIND, V3, P367, DOI DOI 10.1093/ACPROF:OSO/9780195332834.003.0019; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Haidt J, 2004, DAEDALUS-US, V133, P55, DOI 10.1162/0011526042365555; Hamann K, 2011, NATURE, V476, P328, DOI 10.1038/nature10278; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hatemi PK, 2019, AM J POLIT SCI, V63, P788, DOI 10.1111/ajps.12448; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; Jordan JJ, 2014, P NATL ACAD SCI USA, V111, P12710, DOI 10.1073/pnas.1402280111; Killen M., 2005, HDB MORAL DEV; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Kohlberg L., 1969, HDB SOCIALIZATION TH, P347, DOI DOI 10.12691/EDUCATION-3-9-16; Kteily NS, 2011, J EXP SOC PSYCHOL, V47, P208, DOI 10.1016/j.jesp.2010.09.009; Kugler M, 2014, SOC JUSTICE RES, V27, P413, DOI 10.1007/s11211-014-0223-5; Lakens D, 2021, ADV METH PRACT PSYCH, V4, DOI 10.1177/2515245920951503; McAuliffe K, 2015, COGNITION, V134, P1, DOI 10.1016/j.cognition.2014.08.013; Milojev P, 2014, SOC JUSTICE RES, V27, P149, DOI 10.1007/s11211-014-0213-7; Moore C, 2009, PSYCHOL SCI, V20, P944, DOI 10.1111/j.1467-9280.2009.02378.x; Munck IME, 1979, INT ASS EVALUATION E, V10; O'Bryan M, 2004, ADOLESCENCE, V39, P407; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; Perugini M, 2018, INT REV SOC PSYCHOL, V31, DOI 10.5334/irsp.181; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Rae JR, 2018, DEV PSYCHOL, V54, P308, DOI 10.1037/dev0000437; Roccato M, 2009, PSICOLOG SOC, V4, P157, DOI 10.1482/29215; Ruffman T, 2020, SOC DEV, V29, P1194, DOI 10.1111/sode.12438; Rutland A, 2017, CHILD DEV PERSPECT, V11, P56, DOI 10.1111/cdep.12211; Schmidt MFH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023223; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Shaw A, 2014, J EXP PSYCHOL GEN, V143, P363, DOI 10.1037/a0031247; Shaw A, 2012, J EXP PSYCHOL GEN, V141, P382, DOI 10.1037/a0025907; Sinn JS, 2017, POLIT PSYCHOL, V38, P1043, DOI 10.1111/pops.12361; Sloane S, 2012, PSYCHOL SCI, V23, P196, DOI 10.1177/0956797611422072; Smith CE, 2013, PLOS ONE, V8, DOI [10.1371/annotation/4b9340db-455b-4e0d-86e5-b6783747111f, 10.1371/journal.pone.0059510]; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stenner K., 2005, AUTHORITARIAN DYNAMI; Strupp-Levitsky M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241144; Tagar MR, 2017, PERS INDIV DIFFER, V113, P246, DOI 10.1016/j.paid.2017.03.020; Tagar MR, 2014, PSYCHOL SCI, V25, P883, DOI 10.1177/0956797613516470; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Warneken F, 2011, PSYCHOL SCI, V22, P267, DOI 10.1177/0956797610395392; Williams A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01576; Yilmaz O, 2019, GROUP PROCESS INTERG, V22, P1124, DOI 10.1177/1368430218781012	89	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261603	10.1371/journal.pone.0261603	http://dx.doi.org/10.1371/journal.pone.0261603			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972148	Green Published, gold			2022-12-27	WOS:000773555700041
J	Yan, MH; Xu, JL; Han, S; Xin, T; Wang, OY; Yi, ZM; Liu, ZX				Yan, Menghua; Xu, Jinliang; Han, Shuo; Xin, Tian; Wang, Ouyu; Yi, Zemin; Liu, Zhaoxin			Permitted speed decision of single-unit trucks with emergency braking maneuver on horizontal curves under rainy weather	PLOS ONE			English	Article							ROLLOVER PREVENTION; ADVERSE WEATHER; DRIVERS; RISK	Under adverse weather conditions, visibility and the available pavement friction are reduced. The improper selection of speed on curved road sections leads to an unreasonable distribution of longitudinal and lateral friction, which is likely to cause rear-end collisions and lateral instability accidents. This study considers the combined braking and turning maneuvers to obtain the permitted vehicle speed under rainy conditions. First, a braking distance computation model was established by simplifying the relationship curve between brake pedal force, vehicle braking deceleration, and braking time. Different from the visibility commonly used in the meteorological field, this paper defines "driver's sight distance based on real road scenarios" as a threshold to measure the longitudinal safety of the vehicle. Furthermore, the lateral friction and rollover margin is defined to characterize the vehicle's lateral stability. The corresponding relationship between rainfall intensity-water film thickness-road friction is established to better predict the safe speed based on the information issued by the weather station. It should be noted that since the road friction factor of the wet pavement not only determined the safe vehicle speed but also be determined by the vehicle speed, so we adopt Ferrari's method to solve the quartic equation about permitted vehicle speed. Finally, the braking and turning maneuvers are considered comprehensively based on the principle of friction ellipse. The results of the TruckSim simulation show that for a single-unit truck, running at the computed permitted speed, both lateral and longitudinal stability meet the requirements. The proposed permitted vehicle speed model on horizontal curves can provide driving guidance for drivers on curves under rainy weather or as a decision-making basis for road managers.	[Yan, Menghua; Xu, Jinliang; Xin, Tian; Wang, Ouyu; Yi, Zemin] Changan Univ, Sch Highway, Xian, Peoples R China; [Han, Shuo] Changan Univ, Coll Transportat Engn, Xian, Peoples R China; [Liu, Zhaoxin] Shandong Hispeed Infrastruct Construct Co Ltd, Jinan, Peoples R China	Chang'an University; Chang'an University	Xu, JL (corresponding author), Changan Univ, Sch Highway, Xian, Peoples R China.	xujinliang@chd.edu.cn		Yan, Menghua/0000-0001-8992-4805	Shandong Hi-speed Infrastructure Construction Co., Ltd.	Shandong Hi-speed Infrastructure Construction Co., Ltd.	This research was supported by Shandong Hi-speed Infrastructure Construction Co., Ltd. This project was completed by the cooperation between Chang'an University and Shandong Hi-speed Infrastructure Construction Co., Ltd. The funder provided support in the form of salaries for authors, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these author is articulated in the `author contributions' section.	AASHTO, 2018, POLICY GEOMETRIC DES; Al-Grafi Mubarak W., 2013, INT J CONTROL AUTOMA; Aly1 A. A., 2011, INTELLIGENT CONTROL, P186; Andersen J., 2008, TRANSP RES BOARD TRB; [Anonymous], 1997, NCHRP 400 NAT COOP H; Bhatnagar Y. S., 1994, 17 ARRB C GOLD COAST, V17; Billot R, 2009, TRANSPORT RES REC, P134, DOI 10.3141/2107-14; BRODSKY H, 1988, ACCIDENT ANAL PREV, V20, P161, DOI 10.1016/0001-4575(88)90001-2; Brooks JO, 2011, ACCIDENT ANAL PREV, V43, P698, DOI 10.1016/j.aap.2010.10.014; Campbell K. L., 1988, ANAL ACCIDENT RATES; Chen BC, 2001, VEHICLE SYST DYN, V36, P359, DOI 10.1076/vesd.36.4.359.3546; Chen C., 1995, TSPWP958 UCBI; Correia G, 2011, TRANSPORT RES A-POL, V45, P81, DOI 10.1016/j.tra.2010.11.001; Davis B, 2018, IN VEHICLE DYNAMIC C; Deng Z, 2018, TRANSPORT RES F-TRAF; Eisenberg D, 2004, ACCIDENT ANAL PREV, V36, P637, DOI 10.1016/S0001-4575(03)00085-X; Ellis J.R, 1983, P IUTAM S ROADS TRAC, P184; Ervin R., 1998, UMTRI983; Falero V.J, 2013, THESIS U PONTIFICIA, P76; Federal Highway Administration, HOR CURV SAF FHWA SA; FHWA, ROAD WEATH MAN OV; FHWA, 1994, FHWARD94068 US DEP T; Gallen R, 2013, IEEE T INTELL TRANSP, V14, P1558, DOI 10.1109/TITS.2013.2262523; Gibreel GM, 1999, J TRANSP ENG, V125, P305, DOI 10.1061/(ASCE)0733-947X(1999)125:4(305); Gillespie T. D., 1992, FUNDAMENTALS VEHICLE, DOI DOI 10.4271/R-114; Glaser S, 2003, ITS WORLD C MADR; Hernandez W, 2007, MECH SYST SIGNAL PR, V21, P2732, DOI 10.1016/j.ymssp.2007.02.005; Herrmann S, 2007, THESIS U STUTTGART; Hight Philip V, 1990, SAE SPECIAL PUBLICAT, P95; Hocker H.J., 1971, THESIS TU AACHEN; Hyun D., 2001, PREDICTIVE MODELING; JOHANSSON G, 1971, HUM FACTORS, V13, P23, DOI 10.1177/001872087101300104; Lamm R, 1985, ZUSAMMENFASSENDE UNT; McGee H., 1993, FHWARD93039 US DEP T; Ministry of Transport of the People's Republic of China, 2017, D202017 PRC JTG; Ministry of Transport of the People's Republic of China, 2014, B012014 PRC JTG; Mueller AS, 2012, ACCIDENT ANAL PREV, V48, P472, DOI 10.1016/j.aap.2012.03.003; Mueller AlexandraS., 2020, WHAT HUMANLIKE ERROR; National Highway Traffic Safety Administration,, 2005, TRAFF SAF FACTS; National Highway Traffic Safety Administration (NHTSA), 1998, C UPD STAT STAT SPLA; NHTSA, 2020, AUT VEH SAF; Normann O. K., 1953, P HRB, V22, P421; Peng J, 2021, ROAD MATER PAVEMENT, V22, P2641, DOI 10.1080/14680629.2020.1772350; PIARC (Permanent International Association of Road Congresses), 2003, C13 PIARC; Preston-Thomas J., 1990, Patent No. 10610; Qiu L, 2008, TRANSPORT RES REC, P139, DOI 10.3141/2055-16; Radt H.S., 1960, 600133205A SAE; Rakheja S., 1990, 902265 SAE; Schofield B, 2006, IEEE INT S COMP AID; Sullivan J.M., 2004, UMTRI200414; Sweatman P. F, 1993, OVERVIEW DYNAMIC PER; Tan C H., 2005, INVESTIGATION COMFOR; Torbic D. J., 2013, 774 NCHRP TRANSP RES; US Dept. of Transportation, 2005, WEATH REL CRASH STAT; Vasilios T, 2009, AM CONTROL C; Winkler C, 1999, UMTRI RES REV, V31; Yoon J, 2009, IEEE T VEH TECHNOL, V58, P596, DOI 10.1109/TVT.2008.927724; Yu Z., 2000, AUTOMOBILE THEORY	58	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2021	16	12							e0261975	10.1371/journal.pone.0261975	http://dx.doi.org/10.1371/journal.pone.0261975			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0C7TD	34969049	gold, Green Published			2022-12-27	WOS:000775510400026
J	Deshmukh, D; Ahmed, MR; Dominic, JA; Zaghloul, MS; Gupta, A; Achari, G; Hassan, QK				Deshmukh, Dhananjay; Ahmed, M. Razu; Dominic, John Albino; Zaghloul, Mohamed S.; Gupta, Anil; Achari, Gopal; Hassan, Quazi K.			Quantifying relations and similarities of the meteorological parameters among the weather stations in the Alberta Oil Sands region	PLOS ONE			English	Article							TEMPERATURE; NETWORK; PREDICTION; VARIABLES; AVERAGE; MODELS	Our objective was to quantify the similarity in the meteorological measurements of 17 stations under three weather networks in the Alberta oil sands region. The networks were for climate monitoring under the water quantity program (WQP) and air program, including Meteorological Towers (MT) and Edge Sites (ES). The meteorological parameters were air temperature (AT), relative humidity (RH), solar radiation (SR), barometric pressure (BP), precipitation (PR), and snow depth (SD). Among the various measures implemented for finding correlations in this study, we found that the use of Pearson's coefficient (r) and absolute average error (AAE) would be sufficient. Also, we applied the percent similarity method upon considering at least 75% of the value in finding the similarity between station pairs. Our results showed that we could optimize the networks by selecting the least number of stations (for each network) to describe the measure-variability in meteorological parameters. We identified that five stations are sufficient for the measurement of AT, one for RH, five for SR, three for BP, seven for PR, and two for SD in the WQP network. For the MT network, six for AT, two for RH, six for SR, and four for PR, and the ES network requires six for AT, three for RH, six for SR, and two for BP. This study could potentially be critical to rationalize/optimize weather networks in the study area.	[Deshmukh, Dhananjay; Ahmed, M. Razu; Dominic, John Albino; Zaghloul, Mohamed S.; Gupta, Anil; Achari, Gopal; Hassan, Quazi K.] Univ Calgary, Schulich Sch Engn, Calgary, AB, Canada; [Gupta, Anil] Univ Res Pk, Alberta Environm & Pk, Resource Stewardship Div, Calgary, AB, Canada	University of Calgary	Hassan, QK (corresponding author), Univ Calgary, Schulich Sch Engn, Calgary, AB, Canada.	qhassan@ucalgary.ca		Ahmed, M. Razu/0000-0002-4771-3353; Hassan, Quazi K./0000-0002-7034-359X	Oil Sands Monitoring (OSM) Program;  [19GRAEM25]	Oil Sands Monitoring (OSM) Program; 	This work was funded under the Oil Sands Monitoring (OSM) Program. It was independent of any position of the OSM Program. The fund was awarded to QKH having an agreement no. 19GRAEM25. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah AM, 2022, INT J CLIMATOL, V42, P3253, DOI 10.1002/joc.6911; Alberta Environment and Parks, 2018, ACC FAC ROADS; Alberta Environment and Water, 2012, GROUNDW FLOW MOD ATH; Amorim AMT, 2012, INT J CLIMATOL, V32, P941, DOI 10.1002/joc.2317; Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; [Anonymous], 2021, COEFFICIENT DETERMIN; Apogee Instruments, 2020, AFF ACC BAR PRESS SE; Belvederesi C, 2020, WATER-SUI, V12, DOI 10.3390/w12113049; Berndt C, 2018, J HYDROL-REG STUD, V15, P184, DOI 10.1016/j.ejrh.2018.02.002; BURN DH, 1991, J HYDROL, V122, P71, DOI 10.1016/0022-1694(91)90173-F; Colston JM, 2018, ENVIRON RES, V165, P91, DOI 10.1016/j.envres.2018.02.027; Consultants Hatfield., 2016, EDMONTON; DeGaetano AT, 2001, INT J CLIMATOL, V21, P791, DOI 10.1002/joc.645; Dewan A, 2021, APPL GEOGR, V135, DOI 10.1016/j.apgeog.2021.102533; Dewan A, 2021, SUSTAIN CITIES SOC, V71, DOI 10.1016/j.scs.2021.102926; Easterling DR., 1996, ORNLCDIAC87NDP019R3; Golmohammadi G, 2014, HYDROLOGY-BASEL, V1, P20, DOI 10.3390/hydrology1010020; Government of Alberta, 2020, ALB ENV MON SCI PROG; Government of Canada, 2021, 19812010 CLIM NORM A; Guttorp P., 1992, STAT ENV EARTH SCI, P39; Hassan QK, 2013, J PLANT ECOL, V6, P84, DOI 10.1093/jpe/rts010; Hinckley A, 2020, PYRANOMETERS WHAT YO; HUBBARD KG, 1994, AGR FOREST METEOROL, V68, P29, DOI 10.1016/0168-1923(94)90067-1; Hubbard KG., 2015, MICROMETEOROLOGY AGR, V47, P1, DOI [10.2134/agronmonogr47.c1, DOI 10.2134/AGRONMONOGR47.C1]; Janis MJ, 2004, J CLIMATE, V17, P151, DOI 10.1175/1520-0442(2004)017<0151:SDSFML>2.0.CO;2; Li L, 2018, SCI TOTAL ENVIRON, V615, P875, DOI 10.1016/j.scitotenv.2017.10.022; Mishra AK, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-311; Mishra AK, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000243; Montgomery K, 2006, J GEOGR, V105, P133, DOI 10.1080/00221340608978675; Mooi E, 2011, CONCISE GUIDE TO MARKET RESEARCH: THE PROCESS, DATA, AND METHODS USING IBM SPSS STATISTICS, P1, DOI 10.1007/978-3-642-12541-6; National Snow & Ice Data Center, 2020, SNOW CLIM; Olabanji MF, 2020, PHYS CHEM EARTH, V120, DOI 10.1016/j.pce.2020.102939; Ouarda T, 1996, ONTARIO HYDROMETRIC; Ramesh K, 2015, SAINS MALAYS, V44, P1389; Rathod APS, 2016, 2016 INT C EM TRENDS, V2017, P1, DOI [10.1109/ETCT.2016.7882980, DOI 10.1109/ETCT.2016.7882980]; Ratner B., 2009, J TARGET MEAS ANAL M, V17, P139, DOI [10.1057/jt.2009.5, DOI 10.1057/JT.2009.5]; Schmiedeberg C, 2014, SOC INDIC RES, V117, P387, DOI 10.1007/s11205-013-0350-7; Shawky M, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11232840; Simundic AM, 2013, BIOCHEM MEDICA, V23, P12, DOI 10.11613/BM.2013.003; Smith J., 2007, INTRODUCTION, DOI [10.1017/S0014479708006893, DOI 10.1017/S0014479708006893]; St-Hilaire A, 2003, HYDROL PROCESS, V17, P3561, DOI 10.1002/hyp.1350; Tsintikidis D, 2002, J HYDROL ENG, V7, P175, DOI 10.1061/(ASCE)1084-0699(2002)7:2(175); Veiga VB, 2015, WATER-SUI, V7, P99, DOI 10.3390/w7010099; Vose RS, 2004, J CLIMATE, V17, P2961, DOI 10.1175/1520-0442(2004)017<2961:AMTDSD>2.0.CO;2; Wang LC, 2016, RENEW SUST ENERG REV, V61, P384, DOI 10.1016/j.rser.2016.04.024; West JB, 1996, J APPL PHYSIOL, V81, P1850, DOI 10.1152/jappl.1996.81.4.1850; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Wiston M, 2018, J CLIMATOL WEATHER F, P06, DOI [10.18332/tid/85067, DOI 10.18332/TID/85067]; Wood Buffalo Environmental Association, 2000, WBEA 2000 ANN REP; Wood Buffalo Environmental Association, 2020, WBEA 2019 ANN REP; World Meteorological Organization, 2018, GUID INSTR METH OBS; World Meteorological Organization, 2003, GUID CLIM OBS NETW S; World Meteorological Organization, 2017, MAN GLOB OBS SYST; World Meteorological Organization, 2012, MAN GLOB DAT PROC FO; World Meteorological Organization, 2018, GUID CLIM PRACT; World Meteorological Organization, 2010, GUID MET INSTR METH	56	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261610	10.1371/journal.pone.0261610	http://dx.doi.org/10.1371/journal.pone.0261610			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025901	gold, Green Published			2022-12-27	WOS:000796264200021
J	Roy, P; van Peer, SE; de Witte, MM; Tytgat, GAM; Karim-Kos, HE; van Grotel, M; van de Ven, CP; Mavinkurve-Groothuis, AMC; Merks, JHM; Kuiper, RP; Hol, JA; Janssens, GOR; de Krijger, RR; Jongmans, MCJ; Drost, J; van der Steeg, AFW; Littooij, AS; Wijnen, MHWA; van Tinteren, H; van den Heuvel-Eibrink, MM				Roy, Prakriti; van Peer, Sophie E.; de Witte, Martin M.; Tytgat, Godelieve A. M.; Karim-Kos, Henrike E.; van Grotel, Martine; van de Ven, Cees P.; Mavinkurve-Groothuis, Annelies M. C.; Merks, Johannes H. M.; Kuiper, Roland P.; Hol, Janna A.; Janssens, Geert O. R.; de Krijger, Ronald R.; Jongmans, Marjolijn C. J.; Drost, Jarno; van der Steeg, Alida F. W.; Littooij, Annemieke S.; Wijnen, Marc H. W. A.; van Tinteren, Harm; van den Heuvel-Eibrink, Marry M.			Characteristics and outcome of children with renal tumors in the Netherlands: The first five-year's experience of national centralization	PLOS ONE			English	Article							CLEAR-CELL SARCOMA; MALIGNANT RHABDOID TUMORS; WILMS-TUMOR; PEDIATRIC-ONCOLOGY; INTERNATIONAL-SOCIETY; INTERMEDIATE-RISK; CHILDHOOD-CANCER; SIOP; KIDNEY; SURVIVAL	Around 6% of all childhood malignancies represent renal tumors, of which a majority includes Wilms tumor (WT). Although survival rates have improved over the last decades, specific patients are still at risk for adverse outcome. In the Netherlands, since 2015, pediatric oncology care for renal tumors has been centralized in the Princess Maxima Center for Pediatric Oncology. Here, we describe experiences of the first 5 years of centralized care and explore whether this influences the epidemiological landscape by comparing data with the Netherlands Cancer Registry (NCR). We identified all patients <19 years with a renal mass diagnosed between 01-01-2015 and 31-12-2019 in the Princess Maxima Center. Epidemiology, characteristics and management were analyzed. We identified 164 patients (including 1 patient who refused consent for registration), in our center with a suspicion of a renal tumor. The remaining 163 cases included WT (n = 118)/cystic partially differentiated nephroblastoma (n = 2)/nephrogenic rests only (n = 6) and non-WT (n = 37). In this period, the NCR included 138 children, 1 17-year-old patient was not referred to the Princess Maxima Center. Central radiology review (before starting treatment) was performed in 121/163 patients, and central pathology review in 148/152 patients that underwent surgery. Treatment stratification, according to SIOP/EpSSG protocols was pursued based on multidisciplinary consensus. Preoperative chemotherapy was administered in 133 patients, whereas 19 patients underwent upfront surgery. Surgery was performed in 152 patients, and from 133 biomaterial was stored. Centralization of care for children with renal tumors led to referral of all but 1 new renal tumor cases in the Netherlands, and leads to referral of very rare subtypes not registered in the NCR, that benefit from high quality diagnostics and multidisciplinary decision making. National centralization of care led to enhanced development of molecular diagnostics and other innovation-based treatments for the future.	[Roy, Prakriti; van Peer, Sophie E.; de Witte, Martin M.; Tytgat, Godelieve A. M.; Karim-Kos, Henrike E.; van Grotel, Martine; van de Ven, Cees P.; Mavinkurve-Groothuis, Annelies M. C.; Merks, Johannes H. M.; Kuiper, Roland P.; Hol, Janna A.; Janssens, Geert O. R.; de Krijger, Ronald R.; Jongmans, Marjolijn C. J.; Drost, Jarno; van der Steeg, Alida F. W.; Littooij, Annemieke S.; Wijnen, Marc H. W. A.; van Tinteren, Harm; van den Heuvel-Eibrink, Marry M.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Karim-Kos, Henrike E.] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands; [Kuiper, Roland P.; Jongmans, Marjolijn C. J.] Univ Med Ctr Utrecht UMCU, Dept Clin Genet, Utrecht, Netherlands; [Janssens, Geert O. R.] Univ Med Ctr Utrecht UMCU, Dept Radiat Oncol, Utrecht, Netherlands; [de Krijger, Ronald R.] Univ Med Ctr Utrecht UMCU, Dept Pathol, Utrecht, Netherlands; [Drost, Jarno] Oncode Inst, Utrecht, Netherlands; [Littooij, Annemieke S.] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Wilhelmina Childrens Hosp UMCU, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Roy, P (corresponding author), Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.	p.roy-2@prinsesmaximacentrum.nl		Tytgat, Lieve/0000-0003-4452-0748; van de ven, Cornelis/0000-0001-8745-0626; Roy, Prakriti/0000-0003-0086-6691	Stichting Kinderen Kankervrij (KiKa), Amstelveen, The Netherlands [278]; Princess Maxima Center foundation	Stichting Kinderen Kankervrij (KiKa), Amstelveen, The Netherlands; Princess Maxima Center foundation	SP is (partly) funded by Stichting Kinderen Kankervrij (KiKa), Amstelveen, The Netherlands with grant number 278 and the Princess Maxima Center foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HU, 2007, LANCET ONCOL, V8, P730, DOI 10.1016/S1470-2045(07)70241-3; Amar AM, 2001, J PEDIAT HEMATOL ONC, V23, P105, DOI 10.1097/00043426-200102000-00007; Aquina CT, 2016, SURGERY, V159, P736, DOI 10.1016/j.surg.2015.09.021; Argani P, 2002, AM J SURG PATHOL, V26, P1553, DOI 10.1097/00000478-200212000-00003; Argani P, 2000, AM J SURG PATHOL, V24, P4, DOI 10.1097/00000478-200001000-00002; Biegel JA, 1999, CANCER RES, V59, P74; Broecker B, 2000, UROL CLIN N AM, V27, P463, DOI 10.1016/S0094-0143(05)70094-X; Bruder E, 2004, AM J SURG PATHOL, V28, P1117, DOI 10.1097/01.pas.0000131558.32412.40; Custers L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21675-6; de Kraker J, 2004, LANCET, V364, P1229, DOI 10.1016/S0140-6736(04)17139-0; Furtwangler R, 2013, EUR J CANCER, V49, P3497, DOI 10.1016/j.ejca.2013.06.036; Gatta G, 2019, EJSO-EUR J SURG ONC, V45, P3, DOI 10.1016/j.ejso.2017.08.018; Geller JI, 2015, CANCER-AM CANCER SOC, V121, P2457, DOI 10.1002/cncr.29368; Gooskens SL, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26437; Gooskens SL, 2014, BRIT J CANCER, V111, P227, DOI 10.1038/bjc.2014.291; Gooskens SLM, 2012, EUR J CANCER, V48, P2219, DOI 10.1016/j.ejca.2012.04.009; Gutierrez JC, 2010, PEDIATR BLOOD CANCER, V55, P621, DOI 10.1002/pbc.22631; Hol JA, 2020, FAM CANCER, V19, P55, DOI 10.1007/s10689-019-00155-3; Hoot AC, 2004, AM J SURG PATHOL, V28, P1485, DOI 10.1097/01.pas.0000141390.14548.34; Janssens GO, 2020, LANCET CHILD ADOLESC, V4, P846, DOI 10.1016/S2352-4642(20)30183-8; JOSHI VV, 1986, ARCH PATHOL LAB MED, V110, P100; Kalapurakal JA, 2013, INT J RADIAT ONCOL, V85, P428, DOI 10.1016/j.ijrobp.2012.04.023; Karlsson J, 2016, GENE CHROMOSOME CANC, V55, P120, DOI 10.1002/gcc.22316; Knops RRG, 2013, ANN ONCOL, V24, P1749, DOI 10.1093/annonc/mds656; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; McDonald K, 2013, CLIN RADIOL, V68, P16, DOI 10.1016/j.crad.2012.05.006; Mul J, 2021, CLIN TRANSL RAD ONCO, V29, P20, DOI 10.1016/j.ctro.2021.04.007; Mul J, 2021, RADIOTHER ONCOL, V159, P249, DOI 10.1016/j.radonc.2021.04.005; Nakata K, 2020, INT J CANCER, V147, P3313, DOI 10.1002/ijc.33147; O'Meara E, 2012, J PATHOL, V227, P72, DOI 10.1002/path.3985; Pasqualini C, 2020, EUR J CANCER, V128, P38, DOI 10.1016/j.ejca.2020.01.001; Pastore G, 2006, EUR J CANCER, V42, P2103, DOI 10.1016/j.ejca.2006.05.010; Pritchard-Jones K, 2015, LANCET, V386, P1156, DOI 10.1016/S0140-6736(14)62395-3; Qureshi SS., 2020, J PEDIATR UROL, V16, pe1; Ray S, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28675; Rousseau-Merck MF, 1999, CANCER RES, V59, P3152; Samim A, 2017, PEDIATR RADIOL, V47, P1751, DOI 10.1007/s00247-017-3946-2; Segers H, 2011, EXPERT REV ANTICANC, V11, P1105, DOI [10.1586/era.11.76, 10.1586/ERA.11.76]; Seibel NL, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27450; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Ueno-Yokohata H, 2015, NAT GENET, V47, P861, DOI 10.1038/ng.3338; Van den Heuvel-Eibrink MM, 2008, PEDIATR BLOOD CANCER, V50, P1130, DOI 10.1002/pbc.21389; van den Heuvel-Eibrink MM, 2017, NAT REV UROL, V14, P743, DOI 10.1038/nrurol.2017.163; van den Heuvel-Eibrink MM, 2011, PEDIATR BLOOD CANCER, V56, P733, DOI 10.1002/pbc.22922; van der Beek JN, 2021, INT J CANCER, V148, P2724, DOI 10.1002/ijc.33476; van der Beek JN, 2020, CANCERS, V12, DOI 10.3390/cancers12071776; van Peer SE, 2021, CANCERS, V13, DOI 10.3390/cancers13050997; Vokuhl C, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26925; Vujanic GM, 2002, MED PEDIATR ONCOL, V38, P79, DOI 10.1002/mpo.1276; Vujanic GM, 2019, NAT REV UROL, V16, P563, DOI 10.1038/s41585-019-0191-5; Vujanic GM, 2018, NAT REV UROL, V15, P693, DOI 10.1038/s41585-018-0100-3; Vujanic GM, 2009, CANCER-AM CANCER SOC, V115, P1977, DOI 10.1002/cncr.24214; Wagner L, 2002, J PEDIAT HEMATOL ONC, V24, P385, DOI 10.1097/00043426-200206000-00012	53	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261729	10.1371/journal.pone.0261729	http://dx.doi.org/10.1371/journal.pone.0261729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025887	gold, Green Published			2022-12-27	WOS:000796264200025
J	Chen, TH; Lucock, M				Chen, Tianhua; Lucock, Mike			The mental health of university students during the COVID-19 pandemic: An online survey in the UK	PLOS ONE			English	Article							DEPRESSION	Higher education students' mental health has been a growing concern in recent years even before the COVID-19 pandemic. The stresses and restrictions associated with the pandemic have put university students at greater risk of developing mental health issues, which may significantly impair their academic success, social interactions and their future career and personal opportunities. This paper aimed to understand the mental health status of University students at an early stage in the pandemic and to investigate factors associated with higher levels of distress. An online survey including demographics, lifestyle/living situations, brief mental well-being history, questions relating to COVID-19 and standardised measures of depression, anxiety, resilience and quality of life was completed by 1173 students at one University in the North of England. We found high levels of anxiety and depression, with more than 50% experiencing levels above the clinical cut offs, and females scoring significantly higher than males. The survey also suggested relatively low levels of resilience which we attribute to restrictions and isolation which reduced the opportunities to engage in helpful coping strategies and activities rather than enduring personality characteristics. Higher levels of distress were associated with lower levels of exercising, higher levels of tobacco use, and a number of life events associated with the pandemic and lockdown, such as cancelled events, worsening in personal relationships and financial concerns. We discuss the importance of longer-term monitoring and mental health support for university students.	[Chen, Tianhua] Univ Huddersfield, Sch Comp & Engn, Dept Comp Sci, Huddersfield, W Yorkshire, England; [Lucock, Mike] Univ Huddersfield, Ctr Appl Res Hlth, Sch Human & Hlth Sci, Huddersfield, W Yorkshire, England	University of Huddersfield; University of Huddersfield	Chen, TH (corresponding author), Univ Huddersfield, Sch Comp & Engn, Dept Comp Sci, Huddersfield, W Yorkshire, England.	T.Chen@hud.ac.uk		Chen, Tianhua/0000-0003-4495-1871				[Anonymous], HLTH MATTERS SMOKING; [Anonymous], 2020, CORONAVIRUS STUDENTS; [Anonymous], 2009, DEPR AD REC MAN CLIN; Aristovnik A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208438; Chaudhary Amar Prashad, 2021, JMIRx Med, V2, pe28158, DOI 10.2196/28158; Evans S, 2021, PSYCHIAT RES, V298, DOI 10.1016/j.psychres.2021.113819; Harper DJ, 2022, J CONSTR PSYCHOL, V35, P1, DOI 10.1080/10720537.2020.1773362; Henderson M., 2020, MENTAL HLTH LOCKDOWN; Hewitt R., STUDENTS VIEWS IMPAC; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Hubble S., 2020, SUPPORT STUDENTS MEN; Johnstone L., IN PRESS, DOI [10.1177/0022167818793289, DOI 10.1177/0022167818793289]; Kecojevic A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239696; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Levis B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1476; Mammen G, 2013, AM J PREV MED, V45, P649, DOI 10.1016/j.amepre.2013.08.001; McManus S., 2016, MENTAL HLTH WELLBEIN; Rapanta Chrysi., 2020, POSTDIGITAL SCI EDUC, V2, P923, DOI [10.1007/s42438-020-00155-y, DOI 10.1007/S42438-020-00155-Y]; Saunders R, 2021, PSYCHOL MED, DOI 10.1017/S0033291721000957; Shah SGS, 2020, J MED INTERNET RES, V22, DOI 10.2196/22287; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Son C, 2020, J MED INTERNET RES, V22, DOI 10.2196/21279; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sun Y, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249308; Sundarasen S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176206; Taylor G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1151; Tinsley B., 2020, CORONAVIRUS IMPACT S; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Zhang Y, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103722	30	31	32	17	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262562	10.1371/journal.pone.0262562	http://dx.doi.org/10.1371/journal.pone.0262562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020758	gold, Green Published			2022-12-27	WOS:000834207700051
J	Shiraishi, T; Tominaga, T; Nonaka, T; Hashimoto, S; Hamada, K; Araki, M; Sumida, Y; Takeshita, H; Fukuoka, H; Wada, H; To, K; Yamashita, M; Tanaka, K; Sawai, T; Nagayasu, T				Shiraishi, Toshio; Tominaga, Tetsuro; Nonaka, Takashi; Hashimoto, Shintaro; Hamada, Kiyoaki; Araki, Masato; Sumida, Yorihisa; Takeshita, Hiroaki; Fukuoka, Hidetoshi; Wada, Hideo; To, Kazuo; Yamashita, Mariko; Tanaka, Kenji; Sawai, Terumitsu; Nagayasu, Takeshi			Effect of hemodialysis on short-term outcomes after colon cancer surgery	PLOS ONE			English	Article							LAPAROSCOPIC SURGERY; COLORECTAL-CANCER; COMPLICATIONS; DIALYSIS; RISK	Background Hemodialysis patients who undergo surgery have a high risk of postoperative complications. The aim of this study was to determine whether colon cancer surgery can be safely performed in hemodialysis patients. Methods This multicenter retrospective study included 1372 patients who underwent elective curative resection surgery for colon cancer between April 2016 and March 2020. Results Of the total patients, 19 (1.4%) underwent hemodialysis, of whom 19 (100%) had poor performance status and 18 had comorbidities (94.7%). Minimally invasive surgery was performed in 78.9% of hemodialysis patients. The postoperative complication rate was significantly higher in hemodialysis than non-hemodialysis patients (36.8% vs. 15.5%, p = 0.009). All postoperative complications in the hemodialysis patients were infectious type. Multivariate analysis revealed a significant association of hemodialysis with complications (odds ratio, 2.9362; 95%CI, 1.1384-7.5730; p = 0.026). Conclusion Despite recent advances in perioperative management and minimally invasive surgery, it is necessary to be aware that short-term complications can still occur, especially infectious complications in hemodialysis patients.	[Shiraishi, Toshio; Tominaga, Tetsuro; Nonaka, Takashi; Sawai, Terumitsu; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki, Japan; [Shiraishi, Toshio] Sasebo Chuo Hosp, Dept Surg, Sasebo, Nagasaki, Japan; [Hashimoto, Shintaro; Hamada, Kiyoaki; Araki, Masato; Sumida, Yorihisa] Sasebo City Gen Hosp, Dept Surg, Sasebo, Nagasaki, Japan; [Takeshita, Hiroaki] Natl Hosp Org, Dept Surg, Nagasaki Med Ctr, Nagasaki, Japan; [Fukuoka, Hidetoshi] Isahaya Gen Hosp, Dept Surg, Nagasaki, Japan; [Wada, Hideo; To, Kazuo] Ureshino Med Ctr, Dept Surg, Ureshino, Saga, Japan; [Yamashita, Mariko; Tanaka, Kenji] Saiseikai Nagasaki Hosp, Dept Surg, Nagasaki, Japan	Nagasaki University	Tominaga, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki, Japan.	tetsuro.tominaga@nagasaki-u.ac.jp						Abe H, 2014, SURG TODAY, V44, P1906, DOI 10.1007/s00595-013-0828-6; Bikbov B, 2020, LANCET, V395, P709, DOI 10.1016/S0140-6736(20)30045-3; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buia Alexander, 2015, World J Methodol, V5, P238, DOI 10.5662/wjm.v5.i4.238; Cherng YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058942; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Gajdos C, 2013, JAMA SURG, V148, P137, DOI 10.1001/2013.jamasurg.347; HAIMOV M, 1974, ANN SURG, V179, P863, DOI 10.1097/00000658-197406000-00008; Hu WH, 2015, INT J COLORECTAL DIS, V30, P1557, DOI 10.1007/s00384-015-2347-y; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; KHAN IH, 1993, KIDNEY INT, V43, pS143; Nisanevich V, 2005, ANESTHESIOLOGY, V103, P25, DOI 10.1097/00000542-200507000-00008; Obara N, 2021, ANTICANCER RES, V41, P993, DOI 10.21873/anticanres.14853; Palamuthusingam D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234402; Pierson DJ, 2006, RESP CARE, V51, P413; Queeley GL, 2018, AM HEALTH DRUG BENEF, V11, P118; Ris F, 2018, BRIT J SURG, V105, P1359, DOI 10.1002/bjs.10844; Rodrigues M, 2019, PHYSIOL REV, V99, P665, DOI 10.1152/physrev.00067.2017; Sciuto A, 2018, WORLD J GASTROENTERO, V24, P2247, DOI 10.3748/wjg.v24.i21.2247; VANHOLDER R, 1992, KIDNEY INT, V42, pS91	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262531	10.1371/journal.pone.0262531	http://dx.doi.org/10.1371/journal.pone.0262531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020769	gold, Green Published			2022-12-27	WOS:000834207700049
J	Ramirez, A; Peyvandi, S; Cox, S; Gano, D; Xu, D; Tymofiyeva, O; McQuillen, PS				Ramirez, Alice; Peyvandi, Shabnam; Cox, Stephany; Gano, Dawn; Xu, Duan; Tymofiyeva, Olga; McQuillen, Patrick S.			Neonatal brain injury influences structural connectivity and childhood functional outcomes	PLOS ONE			English	Article							SUPERIOR LONGITUDINAL FASCICULUS; CONGENITAL HEART-DISEASE; NEURODEVELOPMENTAL OUTCOMES; THERAPEUTIC HYPOTHERMIA; CHILDREN; ADOLESCENTS; MICROSTRUCTURE; TRANSPOSITION; SEGMENTATION; OPTIMIZATION	Neonatal brain injury may impact brain development and lead to lifelong functional impairments. Hypoxic-ischemic encephalopathy (HIE) and congenital heart disease (CHD) are two common causes of neonatal brain injury differing in timing and mechanism. Maturation of whole-brain neural networks can be quantified during development using diffusion magnetic resonance imaging (dMRI) in combination with graph theory metrics. DMRI of 35 subjects with CHD and 62 subjects with HIE were compared to understand differences in the effects of HIE and CHD on the development of network topological parameters and functional outcomes. CHD newborns had worse 12-18 month language (P<0.01) and 30 month cognitive (P<0.01), language (P = 0.05), motor outcomes (P = 0.01). Global efficiency, a metric of brain integration, was lower in CHD (P = 0.03) than in HIE, but transitivity, modularity and small-worldness were similar. After controlling for clinical factors known to affect neurodevelopmental outcomes, we observed that global efficiency was highly associated with 30 month motor outcomes (P = 0.02) in both groups. To explore neural correlates of adverse language outcomes in CHD, we used hypothesis-based and data-driven approaches to identify pathways with altered structural connectivity. We found that connectivity strength in the superior longitudinal fasciculus (SLF) tract 2 was inversely associated with expressive language. After false discovery rate correction, a whole connectome edge analysis identified 18 pathways that were hypoconnected in the CHD cohort as compared to HIE. In sum, our study shows that neonatal structural connectivity predicts early motor development after HIE or in subjects with CHD, and regional SLF connectivity is associated with language outcomes. Further research is needed to determine if and how brain networks change over time and whether those changes represent recovery or ongoing dysfunction. This knowledge will directly inform strategies to optimize neurologic functional outcomes after neonatal brain injury.	[Ramirez, Alice; Peyvandi, Shabnam; Cox, Stephany; Gano, Dawn; McQuillen, Patrick S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Gano, Dawn; McQuillen, Patrick S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Xu, Duan; Tymofiyeva, Olga] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McQuillen, PS (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.; McQuillen, PS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	patrick.mcquillen@ucsf.edu	Xu, Duan/GMW-4195-2022; Gano, Dawn/GYU-8867-2022	Xu, Duan/0000-0003-0550-4235; Gano, Dawn/0000-0003-4192-2362	 [P01 NS082330];  [K23 NS099422]	; 	We would further like to emphasize that the funders [PSM: P01 NS082330 (https://www.ninds.nih.gov/) and SP: K23 NS099422 (https://www.ninds.nih.gov/)] had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almairac F, 2015, BRAIN STRUCT FUNCT, V220, P1983, DOI 10.1007/s00429-014-0773-1; Bain JS, 2019, HUM BRAIN MAPP, V40, P3695, DOI 10.1002/hbm.24626; Balsamo LM, 2006, NEUROIMAGE, V31, P1306, DOI 10.1016/j.neuroimage.2006.01.027; Bellinger DC, 2003, J THORAC CARDIOV SUR, V126, P1385, DOI 10.1016/S0022-5223(03)00711-6; Bonifacio SL, 2012, AM J NEURORADIOL, V33, P2050, DOI 10.3174/ajnr.A3117; Cao M, 2017, TRENDS NEUROSCI, V40, P494, DOI 10.1016/j.tins.2017.06.003; Cao M, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00025; Clouchoux C, 2013, CEREB CORTEX, V23, P2932, DOI 10.1093/cercor/bhs281; d'Albis MA, 2018, BRAIN, V141, P3472, DOI 10.1093/brain/awy275; de Vries LS, 2010, ARCH DIS CHILD-FETAL, V95, pF220, DOI 10.1136/adc.2008.148205; Dimitropoulos A, 2013, NEUROLOGY, V81, P241, DOI 10.1212/WNL.0b013e31829bfdcf; Feldmann M, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa209; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Forbess JM, 2002, J THORAC CARDIOV SUR, V123, P631, DOI 10.1067/mtc.2002.119342; Fourdain S, 2019, EUR J PAEDIATR NEURO, V23, P491, DOI 10.1016/j.ejpn.2019.03.002; Holleran L, 2020, AM J PSYCHIAT, V177, P537, DOI 10.1176/appi.ajp.2019.19030225; Hyde C, 2021, BRAIN IMAGING BEHAV, V15, P727, DOI 10.1007/s11682-020-00280-z; INDER TE, 2018, VOLPES NEUROLOGY NEW, P510; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Latini F, 2017, BRAIN RES, V1675, P102, DOI 10.1016/j.brainres.2017.09.005; Limperopoulos C, 2010, CIRCULATION, V121, P26, DOI 10.1161/CIRCULATIONAHA.109.865568; Majnemer A, 2008, J PEDIATR-US, V153, P55, DOI 10.1016/j.jpeds.2007.12.019; Majnemer A, 2017, DEV MED CHILD NEUROL, V59, P1056, DOI 10.1111/dmcn.13520; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a; McQuillen PS, 2010, PROG PEDIATR CARDIOL, V29, P79, DOI 10.1016/j.ppedcard.2010.06.011; McQuillen PS, 2010, ANN NY ACAD SCI, V1184, P68, DOI 10.1111/j.1749-6632.2009.05116.x; Miller SP, 2005, J PEDIATR-US, V146, P453, DOI 10.1016/j.jpeds.2004.12.026; Miller SP, 2007, NEW ENGL J MED, V357, P1928, DOI 10.1056/NEJMoa067393; Mosley PE, 2019, BRAIN, V142, P3917, DOI 10.1093/brain/awz327; Muktan D, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1660-y; Nagae LM, 2012, AM J NEURORADIOL, V33, P1720, DOI 10.3174/ajnr.A3037; Naigles LR, 2017, AUTISM RES, V10, P1107, DOI 10.1002/aur.1756; Natarajan G, 2016, SEMIN PERINATOL, V40, P549, DOI 10.1053/j.semperi.2016.09.007; Olsen M, 2011, CIRCULATION, V124, P1706, DOI 10.1161/CIRCULATIONAHA.110.002832; Panigrahy A, 2015, NEUROIMAGE-CLIN, V7, P438, DOI 10.1016/j.nicl.2015.01.013; Peyvandi S, 2018, J AM COLL CARDIOL, V71, P1986, DOI 10.1016/j.jacc.2018.02.068; Peyvandi S, 2018, J THORAC CARDIOV SUR, V155, P291, DOI 10.1016/j.jtcvs.2017.08.019; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rudolph AM, 2018, PEDIATR RES, V84, P348, DOI 10.1038/s41390-018-0094-9; Saygin ZM, 2013, J NEUROSCI, V33, P13251, DOI 10.1523/JNEUROSCI.4383-12.2013; Schaefer C, 2013, DEV MED CHILD NEUROL, V55, P1143, DOI 10.1111/dmcn.12242; Schmithorst VJ, 2018, HUM BRAIN MAPP, V39, P4593, DOI 10.1002/hbm.24308; Schmithorst VJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.504; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Skeide MA, 2016, NAT REV NEUROSCI, V17, P323, DOI 10.1038/nrn.2016.23; Spencer APC, 2021, NEUROIMAGE-CLIN, V30, DOI 10.1016/j.nicl.2021.102582; Tymofiyeva O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031029; Urger SE, 2015, J CHILD NEUROL, V30, P9, DOI 10.1177/0883073813520503; Vestergaard M, 2011, J COGNITIVE NEUROSCI, V23, P2135, DOI 10.1162/jocn.2010.21592; Wang R, DIFFUSION TOOLKIT SO, V1; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wilson S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023598118; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Ziv E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078824	57	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262310	10.1371/journal.pone.0262310	http://dx.doi.org/10.1371/journal.pone.0262310			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986206	Green Published, gold			2022-12-27	WOS:000765956200040
J	Xu, ZY; Neuber, S; Nazari-Shafti, T; Liu, ZH; Dong, FQ; Stamm, C				Xu, Zhiyi; Neuber, Sebastian; Nazari-Shafti, Timo; Liu, Zihou; Dong, Fengquan; Stamm, Christof			Impact of procedural variability and study design quality on the efficacy of cell-based therapies for heart failure - a meta-analysis	PLOS ONE			English	Article							AUTOLOGOUS BONE-MARROW; MESENCHYMAL STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; NONISCHEMIC DILATED CARDIOMYOPATHY; RANDOMIZED CLINICAL-TRIAL; PLACEBO-CONTROLLED TRIAL; MONONUCLEAR-CELLS; DOUBLE-BLIND; ISCHEMIC CARDIOMYOPATHY	Background Cell-based therapy has long been considered a promising strategy for the treatment of heart failure (HF). However, its effectiveness in the clinical setting is now doubted. Because previous meta-analyses provided conflicting results, we sought to review all available data focusing on cell type and trial design. Methods and findings The electronic databases PubMed, Cochrane library, ClinicalTrials.gov, and EudraCT were searched for randomized controlled trials (RCTs) utilizing cell therapy for HF patients from January 1, 2000 to December 31, 2020. Forty-three RCTs with 2855 participants were identified. The quality of the reported study design was assessed by evaluating the risk-of-bias (ROB). Primary outcomes were defined as mortality rate and left ventricular ejection fraction (LVEF) change from baseline. Secondary outcomes included both heart function data and clinical symptoms/events. Between-study heterogeneity was assessed using the I2 index. Subgroup analysis was performed based on HF type, cell source, cell origin, cell type, cell processing, type of surgical intervention, cell delivery routes, cell dose, and follow-up duration. Only 10 of the 43 studies had a low ROB for all method- and outcome parameters. A higher ROB was associated with a greater increase in LVEF. Overall, there was no impact on mortality for up to 12 months follow-up, and a clinically irrelevant average LVEF increase by LVEF (2.4%, 95% CI = 0.75- 4.05, p = 0.004). Freshly isolated, primary cells tended to produce better outcomes than cultured cell products, but there was no clear impact of the cell source tissue, bone marrow cell phenotype or cell chricdose (raw or normalized for CD34+ cells). A meaningful increase in LVEF was only observed when cell therapy was combined with myocardial revascularization. Conclusions The published results suggest a small increase in LVEF following cell therapy for heart failure, but publication bias and methodologic shortcomings need to be taken into account. Given that cardiac cell therapy has now been pursued for 20 years without real progress, further efforts should not be made.	[Xu, Zhiyi; Neuber, Sebastian; Nazari-Shafti, Timo; Liu, Zihou; Stamm, Christof] Charite Univ Med Berlin, Berlin Inst Hlth Ctr Regenerat Therapies, Berlin, Germany; [Neuber, Sebastian; Nazari-Shafti, Timo; Stamm, Christof] German Heart Ctr Berlin, Dept Cardiothorac & Vasc Surg, Berlin, Germany; [Neuber, Sebastian; Nazari-Shafti, Timo; Stamm, Christof] German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Nazari-Shafti, Timo] Univ Med Berlin, Berlin Inst Hlth Charite, Berlin, Germany; [Dong, Fengquan] Shenzhen Univ Gen Hosp, Dept Cardiol, Shenzhen, Guangdong, Peoples R China; [Stamm, Christof] Helmholtz Zentrum Geesthacht, Inst Akt Polymere, Teltow, Germany	Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; German Centre for Cardiovascular Research; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Stamm, C (corresponding author), Charite Univ Med Berlin, Berlin Inst Hlth Ctr Regenerat Therapies, Berlin, Germany.; Stamm, C (corresponding author), German Heart Ctr Berlin, Dept Cardiothorac & Vasc Surg, Berlin, Germany.; Stamm, C (corresponding author), German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.; Stamm, C (corresponding author), Helmholtz Zentrum Geesthacht, Inst Akt Polymere, Teltow, Germany.	stamm@dhzb.de		Neuber, Sebastian/0000-0003-1833-8440; Stamm, Christof/0000-0003-3035-2106				Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Ang KL, 2008, NAT CLIN PRACT CARD, V5, P663, DOI 10.1038/ncpcardio1321; Assmus B, 2013, JAMA-J AM MED ASSOC, V309, P1622, DOI 10.1001/jama.2013.3527; Bai YY, 2010, AGEING RES REV, V9, P418, DOI 10.1016/j.arr.2010.05.001; Bartel RL, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt117; Bartolucci J, 2017, CIRC RES, V121, P1192, DOI 10.1161/CIRCRESAHA.117.310712; Bartunek J, 2017, EUR HEART J, V38, P648, DOI 10.1093/eurheartj/ehw543; Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; BELLESISLES M, 1993, EUR J HISTOCHEM, V37, P375; Boquest AC, 2005, MOL BIOL CELL, V16, P1131, DOI 10.1091/mbc.E04-10-0949; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Breathett K, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002962; Brickwedel J, 2014, INTERACT CARDIOV TH, V18, P61, DOI 10.1093/icvts/ivt434; Burns PB, 2011, PLAST RECONSTR SURG, V128, P305, DOI 10.1097/PRS.0b013e318219c171; Cambria E, 2016, TRANSFUS MED HEMOTH, V43, P275, DOI 10.1159/000448179; Cheng K, 2013, HEART LUNG CIRC, V22, P887, DOI 10.1016/j.hlc.2013.04.112; Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589; Choudhury T, 2017, EUR J HEART FAIL, V19, P138, DOI 10.1002/ejhf.676; Clifford DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037373; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; de Jong R, 2014, CIRC-CARDIOVASC INTE, V7, P156, DOI 10.1161/CIRCINTERVENTIONS.113.001009; Dib N, 2009, JACC-CARDIOVASC INTE, V2, P9, DOI 10.1016/j.jcin.2008.11.003; Duckers HJ, 2011, EUROINTERVENTION, V6, P805, DOI 10.4244/EIJV6I7A139; Eding JEC, 2015, CIRC RES, V116, P80, DOI 10.1161/CIRCRESAHA.116.304872; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fijany A, 2019, MOL BIOL REP, V46, P1459, DOI 10.1007/s11033-018-4516-x; Fisher SA, 2018, HEART, V104, P8, DOI 10.1136/heartjnl-2017-311684; Fisher SA, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007888.pub3; Fisher SA, 2015, CIRC RES, V116, P1361, DOI 10.1161/CIRCRESAHA.116.304386; Flower A, 2016, BEHAV MODIF, V40, P396, DOI 10.1177/0145445515616105; Foley T., 2012, EUR CARDIOL REV, V8, P108, DOI [10.15420/ecr.2012.8.2.108, DOI 10.15420/ECR.2012.8.2.108]; Frljak S, 2018, STEM CELL TRANSL MED, V7, P168, DOI 10.1002/sctm.17-0197; Goff ZD, 2017, JAMA INTERN MED, V177, P1387, DOI 10.1001/jamainternmed.2017.2988; Golpanian S, 2016, STEM CELL TRANSL MED, V5, P186, DOI 10.5966/sctm.2015-0101; Grayburn PA, 2014, CIRC-CARDIOVASC IMAG, V7, P220, DOI 10.1161/CIRCIMAGING.114.001675; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Hendrikx M, 2006, CIRCULATION, V114, pI101, DOI 10.1161/CIRCULATIONAHA.105.000505; Henry TD, 2017, CATHETER CARDIO INTE, V89, P169, DOI 10.1002/ccd.26601; Henry TD, 2014, CIRC RES, V115, P730, DOI 10.1161/CIRCRESAHA.115.304554; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hong KU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096725; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Hristov M, 2006, J CELL MOL MED, V10, P727, DOI 10.1111/j.1582-4934.2006.tb00432.x; Hu SS, 2011, J AM COLL CARDIOL, V57, P2409, DOI 10.1016/j.jacc.2011.01.037; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Jiang TM, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.215; Julian Higgins, 2019, COCHRANE HDB SYSTEMA, V2nd; Kanelidis AJ, 2017, CIRC RES, V120, P1139, DOI 10.1161/CIRCRESAHA.116.309819; Kresnik PK, 2016, TRANSFUSION, V56, P1792, DOI 10.1111/trf.13646; Laitinen A, 2016, CYTOTHERAPY, V18, P423, DOI 10.1016/j.jcyt.2015.11.014; Lancet Editors, 2014, LANCET, V383, P1279, DOI 10.1016/S0140-6736(14)60608-5; Lee SH, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0415-z; Lezaic L, 2015, J CARD FAIL, V21, P145, DOI 10.1016/j.cardfail.2014.11.005; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111850; Lin YH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134770; Liu B, 2014, INT J CARDIOL, V177, P764, DOI 10.1016/j.ijcard.2014.11.005; Makkar RR, 2020, EUR HEART J, V41, P3451, DOI 10.1093/eurheartj/ehaa541; Martino H, 2015, EUR HEART J, V36, P2898, DOI 10.1093/eurheartj/ehv477; Mathiasen AB, 2015, EUR HEART J, V36, P1744, DOI 10.1093/eurheartj/ehv136; Maureira P, 2012, CLIN NUCL MED, V37, P738, DOI 10.1097/RLU.0b013e318251e38a; Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Moustgaard H, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l6802; Moye L, 2014, CIRC RES, V115, P484, DOI 10.1161/CIRCRESAHA.114.304767; Nasseri BA, 2014, EUR HEART J, V35, P1263, DOI 10.1093/eurheartj/ehu007; Nazari-Shafti TZ, 2019, EUR HEART J, V40, P953, DOI 10.1093/eurheartj/ehz106; Neumann FJ, 2019, EUR HEART J, V40, P87, DOI 10.1093/eurheartj/ehy394; Noiseux N, 2016, J THORAC CARDIOV SUR, V152, P1582, DOI 10.1016/j.jtcvs.2016.07.067; Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688; Patel AN, 2016, LANCET, V387, P2412, DOI 10.1016/S0140-6736(16)30137-4; Patel AN, 2015, STEM CELL TRANSL MED, V4, P1021, DOI 10.5966/sctm.2015-0070; Patel AN, 2005, J THORAC CARDIOV SUR, V130, P1631, DOI 10.1016/j.jtcvs.2005.07.056; Patila T, 2014, J HEART LUNG TRANSPL, V33, P567, DOI 10.1016/j.healun.2014.02.009; Perin EC, 2015, CIRC RES, V117, P576, DOI 10.1161/CIRCRESAHA.115.306332; Perin EC, 2014, AM HEART J, V168, P88, DOI 10.1016/j.ahj.2014.03.022; Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418; Perin EC, 2012, AM HEART J, V163, P415, DOI 10.1016/j.ahj.2011.11.020; Perin EC, 2011, AM HEART J, V161, P1078, DOI 10.1016/j.ahj.2011.01.028; Pham P, 2016, PROG STEM CELL, V3, P87, DOI [10.15419/psc.v3i02.123, DOI 10.15419/PSC.V3I02.123]; Poglajen G, 2014, CIRC-CARDIOVASC INTE, V7, P552, DOI 10.1161/CIRCINTERVENTIONS.114.001436; Pokushalov E, 2010, J CARDIOVASC TRANSL, V3, P160, DOI 10.1007/s12265-009-9123-8; Povsic TJ, 2011, AM HEART J, V162, P654, DOI 10.1016/j.ahj.2011.07.020; Qi Z, 2018, J CLIN ULTRASOUND, V46, P512, DOI 10.1002/jcu.22609; Redaelli MB, 2018, J CRIT CARE, V48, P414, DOI 10.1016/j.jcrc.2018.09.031; Saltaji H, 2018, BMC MED RES METHODOL, V18, DOI [10.1186/s12874-018-0491-0, 10.1186/S12874-018-0491-0]; Sant'Anna RT, 2014, REV BRAS CIR CARDIOV, V29, P437, DOI 10.5935/1678-9741.20140091; Santoso T, 2014, J CARDIOVASC TRANSL, V7, P545, DOI 10.1007/s12265-014-9580-6; Savarese Gianluigi, 2017, Card Fail Rev, V3, P7, DOI 10.15420/cfr.2016:25:2; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Seth S, 2006, J AM COLL CARDIOL, V48, P2350, DOI 10.1016/j.jacc.2006.07.057; Seth S, 2010, J AM COLL CARDIOL, V55, P1643, DOI 10.1016/j.jacc.2009.11.070; Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094; Steinhoff G, 2017, EBIOMEDICINE, V22, P208, DOI 10.1016/j.ebiom.2017.07.022; Sunagawa G, 2017, EXPERT REV CARDIOVAS, V15, P377, DOI 10.1080/14779072.2017.1313114; Tardif JC, 2011, EUR HEART J, V32, P2507, DOI 10.1093/eurheartj/ehr311; Tossios P, 2008, EUR HEART J, V29, P1911, DOI 10.1093/eurheartj/ehn218; van der Spoel TIG, 2011, CARDIOVASC RES, V91, P649, DOI 10.1093/cvr/cvr113; Velazquez EJ, 2016, NEW ENGL J MED, V374, P1511, DOI 10.1056/NEJMoa1602001; Vrtovec B, 2011, J CARD FAIL, V17, P272, DOI 10.1016/j.cardfail.2010.11.007; Wang HS, 2015, CARDIOLOGY, V130, P27, DOI 10.1159/000369381; Wang Z, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-016-0450-9; Wolfien M, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102862; Xiao WT, 2017, INT HEART J, V58, P238, DOI 10.1536/ihj.16-328; Xu Jia-Ying, 2016, Chronic Dis Transl Med, V2, P92, DOI 10.1016/j.cdtm.2016.09.006; Yang YHK, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0876-3; Yasuhara S, 2010, ARTIF ORGANS, V34, P594, DOI 10.1111/j.1525-1594.2009.00980.x; Zein H, 2015, EXTRACT DATA GRAPHS, DOI [10.13140/RG.2.2. 17070.72002, DOI 10.13140/RG.2.2.17070.72002]; Zhao Q, 2008, ANN THORAC SURG, V86, P1833, DOI 10.1016/j.athoracsur.2008.08.068; Zhao XF, 2015, GENET MOL RES, V14, P3010, DOI 10.4238/2015.April.10.11; Zimmet H, 2012, EUR J HEART FAIL, V14, P91, DOI 10.1093/eurjhf/hfr148; Zwetsloot PP, 2016, CIRC RES, V118, P1223, DOI 10.1161/CIRCRESAHA.115.307676	110	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0261462	10.1371/journal.pone.0261462	http://dx.doi.org/10.1371/journal.pone.0261462			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986181	Green Published, gold			2022-12-27	WOS:000765956200011
J	Namba, H; Sugano, A; Murakami, T; Utsunomiya, H; Sato, H; Nishitsuka, K; Ishizawa, K; Kayama, T; Yamashita, H				Namba, Hiroyuki; Sugano, Akira; Murakami, Takanori; Utsunomiya, Hiroshi; Sato, Hidenori; Nishitsuka, Koichi; Ishizawa, Kenichi; Kayama, Takamasa; Yamashita, Hidetoshi			Ten-year longitudinal investigation of astigmatism: The Yamagata Study (Funagata)	PLOS ONE			English	Article							ELDERLY CHINESE POPULATION; HUMAN CORNEAL STROMA; REFRACTIVE ERRORS; RISK-FACTORS; JAPANESE POPULATION; VECTOR ANALYSIS; POWER VECTOR; ABERRATIONS; AGE; PREVALENCE	Despite numerous investigations into ocular or corneal astigmatism, the dynamic nature of astigmatism remains poorly understood. To reveal potential associations between age and astigmatism, 264 Japanese participants who underwent systemic and ophthalmological examinations in Funagata Town (Yamagata Prefecture, Japan) were evaluated over a 10-year period. Astigmatism was evaluated with regard to the cylinder power, cylinder axis, and vector analyses. Whereas the refractive cylinders showed age-related increases in patients in their 40s to 60s, the corneal cylinders did not change over 10 years. Nevertheless, cylindrical axis of the cornea demonstrated a continuous shift toward against-the-rule (ATR) astigmatism. Vector analyses revealed that the astigmatic shift toward ATR progressed continually after patients reached their 40s, although the shift did not accelerate with age. These novel insights may pave the way for the development of potential strategies for vision correction, including refractive surgeries, and vision-quality maintenance in the elderly.	[Namba, Hiroyuki; Murakami, Takanori; Utsunomiya, Hiroshi; Nishitsuka, Koichi; Yamashita, Hidetoshi] Yamagata Univ, Dept Ophthalmol & Visual Sci, Fac Med, Yamagata, Yamagata, Japan; [Sugano, Akira] Ideganka Hosp, Yamagata, Yamagata, Japan; [Murakami, Takanori] Yamagata Prefectural Cent Hosp, Dept Ophthalmol, Yamagata, Yamagata, Japan; [Sato, Hidenori] Yamagata Univ, Inst Promot Med Sci Res, Genome Informat Unit, Fac Med, Yamagata, Yamagata, Japan; [Ishizawa, Kenichi] Yamagata Univ, Dept Neurol Hematol Metab Endocrinol & Diabetol, Fac Med, Yamagata, Yamagata, Japan; [Kayama, Takamasa] Yamagata Univ, Dept Adv Med, Fac Med, Yamagata, Yamagata, Japan	Yamagata University; Yamagata Prefectural Central Hospital; Yamagata University; Yamagata University; Yamagata University	Namba, H (corresponding author), Yamagata Univ, Dept Ophthalmol & Visual Sci, Fac Med, Yamagata, Yamagata, Japan.	h-nanba@med.id.yamagata-u.ac.jp		Nishitsuka, Koichi/0000-0003-2394-9561				Alpins N, 2001, J CATARACT REFR SURG, V27, P31, DOI 10.1016/S0886-3350(00)00798-7; Alpins NA, 1997, J CATARACT REFR SURG, V23, P1503, DOI 10.1016/S0886-3350(97)80021-1; Artal P, 1998, OPT LETT, V23, P1713, DOI 10.1364/OL.23.001713; BALDWIN WR, 1981, AM J OPTOM PHYS OPT, V58, P206; CADERA W, 1992, J PEDIATR OPHTHALMOL, V29, P85; Cheng CY, 2003, INVEST OPHTH VIS SCI, V44, P4630, DOI 10.1167/iovs.03-0169; Daimon M, 2008, BIOCHEM BIOPH RES CO, V374, P576, DOI 10.1016/j.bbrc.2008.07.065; Daxer A, 1998, INVEST OPHTH VIS SCI, V39, P644; Diez Ajenjo Ma Amparo, 2015, J Optom, V8, P86, DOI 10.1016/j.optom.2014.07.006; Dubbelman M, 2006, VISION RES, V46, P993, DOI 10.1016/j.visres.2005.09.021; Faragher RGA, 1997, BRIT J OPHTHALMOL, V81, P814, DOI 10.1136/bjo.81.10.814; Guzowski M, 2003, OPHTHALMOLOGY, V110, P1364, DOI 10.1016/S0161-6420(03)00465-2; HAYASHI K, 1995, CORNEA, V14, P527; Jaffe NS., 1975, T AM ACAD OPHTHALMOL, V79, P615; Katz J, 1997, INVEST OPHTH VIS SCI, V38, P334; Kawasaki R, 2006, OPHTHALMOLOGY, V113, P1378, DOI 10.1016/j.ophtha.2006.02.052; Liu YC, 2011, INVEST OPHTH VIS SCI, V52, P9651, DOI 10.1167/iovs.11-7641; MALIK NS, 1992, BIOCHIM BIOPHYS ACTA, V1138, P222, DOI 10.1016/0925-4439(92)90041-K; Moon NJ, 2006, J KOREAN MED SCI, V21, P131, DOI 10.3346/jkms.2006.21.1.131; Morlet N, 2001, BRIT J OPHTHALMOL, V85, P1127, DOI 10.1136/bjo.85.9.1127; NAESER K, 1990, J CATARACT REFR SURG, V16, P741, DOI 10.1016/S0886-3350(13)81018-8; Nagpal K M, 2000, Indian J Ophthalmol, V48, P213; Namba H, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012894; Namba H, 2018, CORNEA, V37, P53, DOI 10.1097/ICO.0000000000001418; Namba H, 2017, CORNEA, V36, pS34, DOI 10.1097/ICO.0000000000001386; Namba H, 2015, INVEST OPHTH VIS SCI, V56, P90, DOI 10.1167/iovs.14-15261; Nanavaty MA, 2006, J CATARACT REFR SURG, V32, P1091, DOI 10.1016/j.jcrs.2006.03.021; Nishitsuka K, 2011, OPHTHAL EPIDEMIOL, V18, P244, DOI 10.3109/09286586.2011.594206; Pesudovs K, 2003, BRIT J OPHTHALMOL, V87, P964, DOI 10.1136/bjo.87.8.964; Raju P, 2004, INVEST OPHTH VIS SCI, V45, P4268, DOI 10.1167/iovs.04-0221; Read SA, 2007, INVEST OPHTH VIS SCI, V48, P112, DOI 10.1167/iovs.06-0675; Reinstein DZ, 2014, J REFRACT SURG, V30, P654, DOI 10.3928/1081597X-20140903-01; Remon Laura, 2017, J Optom, V10, P141, DOI 10.1016/j.optom.2016.07.003; Rhim JW, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-019-1297-5; Rozema JJ, 2019, OPHTHAL PHYSL OPT, V39, P183, DOI 10.1111/opo.12616; Sanfilippo PG, 2015, ACTA OPHTHALMOL, V93, pE377, DOI 10.1111/aos.12644; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Sawides L, 2010, J VISION, V10, DOI 10.1167/10.12.22; Tanabe Y, 2009, J HUM HYPERTENS, V23, P788, DOI 10.1038/jhh.2009.27; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Verzella F, 1993, Refract Corneal Surg, V9, P58; VIHLEN FS, 1983, INVEST OPHTH VIS SCI, V24, P1367; Vitalyos G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39234-x	44	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0261324	10.1371/journal.pone.0261324	http://dx.doi.org/10.1371/journal.pone.0261324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007309	gold, Green Published			2022-12-27	WOS:000741060700013
J	Anane-Fenin, B; Agbeno, EK; Osarfo, J; Anning, DAO; Boateng, AS; Ken-Amoah, S; Amanfo, AO; Derkyi-Kwarteng, L; Mouhajer, M; Amoo, SA; Ashong, J; Jeffery, E				Anane-Fenin, Betty; Agbeno, Evans Kofi; Osarfo, Joseph; Anning, Douglas Aninng Opoku; Boateng, Abigail Serwaa; Ken-Amoah, Sebastian; Amanfo, Anthony Ofori; Derkyi-Kwarteng, Leonard; Mouhajer, Mohammed; Amoo, Sarah Ama; Ashong, Joycelyn; Jeffery, Ernestina			A ten-year review of indications and outcomes of obstetric admissions to an intensive care unit in a low-resource country	PLOS ONE			English	Review							MATERNAL MORTALITY; PREGNANCY; AGE	Introduction Obstetric intensive care unit admission (ICU) suggests severe morbidity. However, there is no available data on the subject in Ghana. This retrospective review was conducted to determine the indications for obstetric ICU admission, their outcomes and factors influencing these outcomes to aid continuous quality improvement in obstetric care. Methods This was a retrospective review conducted in a tertiary hospital in Ghana. Data on participant characteristics including age and whether participant was intubated were collected from patient records for all obstetric ICU admissions from 1(st) January 2010 to 31(st) December 2019. Descriptive statistics were presented as frequencies, proportions and charts. Hazard ratios were generated for relations between obstetric ICU admission outcome and participant characteristics. A p-value <0.05 was deemed statistically significant. Results There were 443 obstetric ICU admissions over the review period making up 25.7% of all ICU admissions. The commonest indications for obstetric ICU admissions were hypertensive disorders of pregnancy (70.4%, n = 312/443), hemorrhage (14.4%, n = 64/443) and sepsis (9.3%, n = 41/443). The case fatality rates for hypertension, hemorrhage, and sepsis were 17.6%, 37.5%, and 63.4% respectively. The obstetric ICU mortality rate was 26% (115/443) over the review period. Age >= 25 years and a need for mechanical ventilation carried increased mortality risks following ICU admission while surgery in the index pregnancy was associated with a reduced risk of death. Conclusion Hypertension, haemorrhage and sepsis are the leading indications for obstetric ICU admissions. Thus, preeclampsia screening and prevention, as well as intensifying antenatal education on the danger signs of pregnancy can minimize obstetric complications. The establishment of an obstetric HDU in CCTH and the strengthening of communication between specialists and the healthcare providers in the lower facilities, are also essential for improved pregnancy outcomes. Further studies are needed to better appreciate the wider issues underlying obstetric ICU admission outcomes. Plain language summary This was a review of the reasons for admitting severely-ill pregnant women and women who had delivered within the past 42 days to the intensive care unit (ICU), the admission outcomes and risk factors associated with ICU mortality in a tertiary hospital in a low-resource country. High blood pressure and its complications, bleeding and severe infections were observed as the three most significant reasons for ICU admissions in decreasing order of significance. Pre-existing medical conditions and those arising as a result of, or aggravated by pregnancy; obstructed labour and post-operative monitoring were the other reasons for ICU admission over the study period. Overall, 26% of the admitted patients died at the ICU and maternal age of at least 25 years and the need for intubation were identified as risk factors for ICU deaths. Attention must be paid to high blood pressure during pregnancy.	[Anane-Fenin, Betty; Boateng, Abigail Serwaa; Ashong, Joycelyn] Cape Coast Teaching Hosp, Dept Obstet & Gynaecol, Cape Coast, Ghana; [Agbeno, Evans Kofi; Ken-Amoah, Sebastian; Amanfo, Anthony Ofori; Mouhajer, Mohammed] Univ Cape Coast, Dept Obstet & Gynaecol, Sch Med Sci, Cape Coast, Ghana; [Osarfo, Joseph] Univ Hlth & Allied Sci, Sch Med, Dept Community Med, Ho, Ghana; [Anning, Douglas Aninng Opoku] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Kumasi, Ghana; [Derkyi-Kwarteng, Leonard] Univ Cape Coast, Dept Pathol, Sch Med Sci, Cape Coast, Ghana; [Amoo, Sarah Ama; Jeffery, Ernestina] Cape Coast Teaching Hosp, Intens Care Unit, Cape Coast, Ghana	University of Cape Coast; Kwame Nkrumah University Science & Technology; University of Cape Coast	Anane-Fenin, B (corresponding author), Cape Coast Teaching Hosp, Dept Obstet & Gynaecol, Cape Coast, Ghana.	oparebea81@gmail.com	Opoku, Douglas Aninng/CAF-0150-2022	Opoku, Douglas Aninng/0000-0003-2321-387X; Ken-Amoah, Sebastian/0000-0001-8293-6862; Anane-Fenin, Betty/0000-0003-3020-2159				Abiodun J., 2015, GLOB SCHOLAST RES J, V1; Adelaiye SM., 2016, TROP J OBSTET GYNAEC, V33, P44; Adeniran AS, 2015, MALAWI MED J, V27, P16, DOI 10.4314/mmj.v27i1.5; Adu-Bonsaffoh K, 2013, INT J GYNECOL OBSTET, V123, P110, DOI 10.1016/j.ijgo.2013.05.017; Ahinkorah BO, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9030272; Asseffa NA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213240; Awoyesuku PA., 2020, J ADV MED MED RES, V32, P103; Bahadur BR., 2018, INT J REPROD CONTRAC, V7, P2909, DOI [10.18203/2320-1770.ijrcog20182905, DOI 10.18203/2320-1770.IJRCOG20182905]; Bas EK, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.919922; Boafor TK, 2021, AFR J REPROD HEALTH, V25, P56, DOI 10.29063/ajrh2021/v25i1.7; Bosu W K, 2012, Ghana Med J, V46, P69; Cavazos-Rehg PA, 2015, MATERN CHILD HLTH J, V19, P1202, DOI 10.1007/s10995-014-1624-7; Chawla Sushil, 2013, Med J Armed Forces India, V69, P134, DOI 10.1016/j.mjafi.2012.08.033; Crozier TM, 2011, AUST NZ J OBSTET GYN, V51, P233, DOI 10.1111/j.1479-828X.2011.01303.x; de-Graft Aikins Ama, 2007, Ghana Med J, V41, P154; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; El-Abd H., 2011, CRIT CARE, V15, pP513, DOI [10.1186/cc9933, DOI 10.1186/CC9933]; Endeshaw Gezehagn, 2015, Int Sch Res Notices, V2015, P208043, DOI 10.1155/2015/208043; Ghosh G, 2014, ETHNIC DIS, V24, P283; Githae F., 2011, E AFR MED J, V88, P356; Jain Shruti, 2016, Indian J Public Health, V60, P159, DOI 10.4103/0019-557X.184575; Kumari N., 2016, IOSR J DENT MED SCI, V15, P55, DOI [10.9790/0853-1512085557, DOI 10.9790/0853-1512085557]; Maiden MJ, 2020, BJOG-INT J OBSTET GY, V127, P1558, DOI 10.1111/1471-0528.16285; Marshall JC, 2017, J CRIT CARE, V37, P270, DOI 10.1016/j.jcrc.2016.07.015; Mjahed K, 2006, J Obstet Gynaecol, V26, P418, DOI 10.1080/01443610600720188; Motiang M, 2017, SOUTH AFR J CRIT CAR, V33, P12, DOI 10.7196/SAJCC.2017.v33i1.279; Murthy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116949; Ntuli TS, 2015, SOUTH AFR J CRIT CAR, V31, P8, DOI 10.7196/SAJCC.164; Okafor UV, 2004, INT J OBSTET ANESTH, V13, P164, DOI 10.1016/j.ijoa.2004.04.002; Pollock W, 2010, INTENS CARE MED, V36, P1465, DOI 10.1007/s00134-010-1951-0; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Prin M, 2019, INT J OBSTET ANESTH, V39, P99, DOI 10.1016/j.ijoa.2019.03.004; Ramlakhan KP, 2021, BMC WOMENS HEALTH, V21, DOI 10.1186/s12905-021-01396-0; Rudakemwa A, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03882-7; Sauer MV, 2015, FERTIL STERIL, V103, P1136, DOI 10.1016/j.fertnstert.2015.03.004; Siaw-Frimpong M, 2021, J CRIT CARE, V61, P76, DOI 10.1016/j.jcrc.2020.10.009; Sodhi K., 2018, J OBSTET ANAESTHESIA, V8, P73, DOI [10.4103/joacc.JOACC_57_17, DOI 10.4103/J0ACC.J0ACC_57_17]; Walker, 2016, DIS CONTROL PRIORITI, DOI DOI 10.1596/978-1-4648-0348-2_CH3; WHO, 2012, EV QUAL CAR SEV PREG; Witteveen T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1370-0; World Health Organization, 2012, EARL MARR AD YOUNG P; World Health Organization, 2019, MAT DEATHS DECL SLOW; Yi Hye Yeon, 2018, Obstet Gynecol Sci, V61, P209, DOI 10.5468/ogs.2018.61.2.209; Zieleskiewicz L, 2016, ANAESTH CRIT CARE PA, V35, pS51, DOI 10.1016/j.accpm.2016.06.005; Zwart JJ, 2010, INTENS CARE MED, V36, P256, DOI 10.1007/s00134-009-1707-x	45	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261974	10.1371/journal.pone.0261974	http://dx.doi.org/10.1371/journal.pone.0261974			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972184	gold, Green Published			2022-12-27	WOS:000773555700078
J	Chan, A; Ayala, JM; Alvarez, F; Piccirillo, C; Dong, G; Langlais, D; Olivier, M				Chan, Aretha; Ayala, Jose-Mauricio; Alvarez, Fernando; Piccirillo, Ciriaco; Dong, George; Langlais, David; Olivier, Martin			The role of Leishmania GP63 in the modulation of innate inflammatory response to Leishmania major infection	PLOS ONE			English	Article							TARGETED GENE DELETION; CUTANEOUS LEISHMANIASIS; VIRULENCE; RESISTANCE; EXOSOMES; MACROPHAGES; EXPRESSION; INDUCTION; CYTOKINES; DONOVANI	Leishmaniasis is a disease caused by the protozoan parasite Leishmania and is known to affect millions of individuals worldwide. In recent years, we have established the critical role played by Leishmania zinc-metalloprotease GP63 in the modulation of host macrophage signalling and functions, favouring its survival and progression within its host. Leishmania major lacking GP63 was reported to cause limited infection in mice, however, it is still unclear how GP63 may influence the innate inflammatory response and parasite survival in an in vivo context. Therefore, we were interested in analyzing the early innate inflammatory events upon Leishmania inoculation within mice and establish whether Leishmania GP63 influences this initial inflammatory response. Experimentally, L. major WT (L. major(WT)), L. major GP63 knockout (L. major(KO)), or L. major GP63 rescue (L. major(R)) were intraperitoneally inoculated in mice and the inflammatory cells recruited were characterized microscopically and by flow cytometry (number and cell type), and their infection determined. Pro-inflammatory markers such as cytokines, chemokines, and extracellular vesicles (EVs, e.g. exosomes) were monitored and proteomic analysis was performed on exosome contents. Data obtained from this study suggest that Leishmania GP63 does not significantly influence the pathogen-induced inflammatory cell recruitment, but rather their activation status and effector function. Concordantly, internalization of promastigotes during early infection could be influenced by GP63 as fewer L. major(KO) amastigotes were found within host cells and appear to maintain in host cells over time. Collectively this study provides a clear analysis of innate inflammatory events occurring during L. major infection and further establish the prominent role of the virulence factor GP63 to provide favourable conditions for host cell infection.	[Chan, Aretha; Alvarez, Fernando; Piccirillo, Ciriaco; Dong, George; Langlais, David; Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Chan, Aretha; Alvarez, Fernando; Piccirillo, Ciriaco; Dong, George; Olivier, Martin] McGill Univ, Infect Dis & Immun Global Hlth Program, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Ayala, Jose-Mauricio; Langlais, David] McGill Genome Ctr, Dept Human Genet, Montreal, PQ, Canada; [Ayala, Jose-Mauricio; Piccirillo, Ciriaco; Dong, George; Langlais, David; Olivier, Martin] McGill Res Ctr Complex Traits, Montreal, PQ, Canada; [Alvarez, Fernando; Piccirillo, Ciriaco; Olivier, Martin] FOCiS Ctr Excellence Translat Immunol, Montreal, PQ, Canada	McGill University; McGill University	Langlais, D; Olivier, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.; Olivier, M (corresponding author), McGill Univ, Infect Dis & Immun Global Hlth Program, Res Inst, Hlth Ctr, Montreal, PQ, Canada.	david.langlais@mcgill.ca; martin.olivier@mcgill.ca		Chan, Aretha/0000-0003-0841-6345	Canadian Institute of Health Research (CIHR) [PJT-159765]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2018-03849]; CIHR Ph.D. Scholarship; McGill University-CONACyT scholarship; Canada Foundation for Innovation John R. Evans Leaders Fund; Fonds de Recherche Quebec -Sante, ChercheurBoursier Junior 1 Award	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CIHR Ph.D. Scholarship(Canadian Institutes of Health Research (CIHR)); McGill University-CONACyT scholarship; Canada Foundation for Innovation John R. Evans Leaders Fund; Fonds de Recherche Quebec -Sante, ChercheurBoursier Junior 1 Award	Work performed in the M.O. laboratory is supported by grants from the Canadian Institute of Health Research (CIHR) (PJT-159765) and the Natural Sciences and Engineering Research Council of Canada Discovery Grant (RGPIN-2018-03849). GD was a recipient of a CIHR Ph.D. Scholarship. MA was a recipient of a McGill University-CONACyT scholarship. DL was supported by a Canada Foundation for Innovation John R. Evans Leaders Fund and a Fonds de Recherche Quebec -Sante, ChercheurBoursier Junior 1 Award.	Atayde VD, 2016, CELL IMMUNOL, V309, P7, DOI 10.1016/j.cellimm.2016.07.013; Baixauli F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00403; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 1998, EUR J IMMUNOL, V28, P1389, DOI 10.1002/(SICI)1521-4141(199804)28:04&lt;1389::AID-IMMU1389&gt;3.0.CO;2-1; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Brittingham A, 1999, INFECT IMMUN, V67, P4477, DOI 10.1128/IAI.67.9.4477-4484.1999; Castellano LR, 2009, HUM IMMUNOL, V70, P383, DOI 10.1016/j.humimm.2009.01.007; CHANG KP, 1978, J EXP MED, V147, P515, DOI 10.1084/jem.147.2.515; Coakley G, 2015, TRENDS PARASITOL, V31, P477, DOI 10.1016/j.pt.2015.06.009; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DESCOTEAUX A, 1992, J IMMUNOL, V149, P3008; Dowlati Y, 1996, CLIN DERMATOL, V14, P425, DOI 10.1016/0738-081X(96)00058-2; GARSIDE P, 1995, IMMUNOL TODAY, V16, P220, DOI 10.1016/0167-5699(95)80162-6; Handman E, 2002, TRENDS PARASITOL, V18, P332, DOI 10.1016/S1471-4922(02)02352-8; Hassani K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002185; Himmelrich H, 2000, J IMMUNOL, V164, P4819, DOI 10.4049/jimmunol.164.9.4819; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Isnard A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00072; Isnard A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004776; Joshi PB, 1998, MOL MICROBIOL, V27, P519, DOI 10.1046/j.1365-2958.1998.00689.x; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Kanemoto S, 2016, BIOCHEM BIOPH RES CO, V480, P166, DOI 10.1016/j.bbrc.2016.10.019; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; LACKS SA, 1980, J BIOL CHEM, V255, P7467; Laskay T, 2003, TRENDS MICROBIOL, V11, P210, DOI 10.1016/S0966-842X(03)00075-1; LASKAY T, 1995, EUR J IMMUNOL, V25, P2220, DOI 10.1002/eji.1830250816; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liew FY, 1997, PHILOS T R SOC B, V352, P1311, DOI 10.1098/rstb.1997.0115; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Matte C, 2002, J INFECT DIS, V185, P673, DOI 10.1086/339260; MELBY PC, 1994, INFECT IMMUN, V62, P837, DOI 10.1128/IAI.62.3.837-842.1994; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Miyazaki S, 2004, CLIN DIAGN LAB IMMUN, V11, P452, DOI 10.1128/CDLI.11.3.452-457.2004; Moskowitz NH, 1997, INFECT IMMUN, V65, P2448, DOI 10.1128/IAI.65.6.2448-2450.1997; MOSSER DM, 1985, J IMMUNOL, V135, P2785; Olivier M, 2012, MICROBES INFECT, V14, P1377, DOI 10.1016/j.micinf.2012.05.014; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park AY, 2002, J IMMUNOL, V168, P5771, DOI 10.4049/jimmunol.168.11.5771; Pinheiro RO, 2009, MICROBES INFECT, V11, P181, DOI 10.1016/j.micinf.2008.11.006; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; RUSSELL DG, 1987, EUR J BIOCHEM, V164, P213, DOI 10.1111/j.1432-1033.1987.tb11013.x; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Shio MT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003868; Soo CY, 2012, IMMUNOLOGY, V136, P192, DOI 10.1111/j.1365-2567.2012.03569.x; Sundar S, 2002, CLIN DIAGN LAB IMMUN, V9, P951, DOI 10.1128/CDLI.9.5.951-958.2002; Teixeira MJ, 2006, TRENDS PARASITOL, V22, P32, DOI 10.1016/j.pt.2005.11.010; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Toth Marta, 2012, Methods Mol Biol, V878, P121, DOI 10.1007/978-1-61779-854-2_8; Voth BR., 1998, MOL BIOCHEM PARASIT; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1	59	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262158	10.1371/journal.pone.0262158	http://dx.doi.org/10.1371/journal.pone.0262158			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972189	gold, Green Published			2022-12-27	WOS:000773555700102
J	Gambo, A; Moodley, I; Babashani, M; Babalola, TK; Gqaleni, N				Gambo, Aisha; Moodley, Indres; Babashani, Musa; Babalola, Tesleem K.; Gqaleni, Nceba			A double-blind, randomized controlled trial to examine the effect of Moringa oleifera leaf powder supplementation on the immune status and anthropometric parameters of adult HIV patients on antiretroviral therapy in a resource-limited setting	PLOS ONE			English	Article							HIV/AIDS	Background People living with HIV (PLHIV) in resource-limited settings are vulnerable to malnutrition. Nutritional interventions aimed at improving food insecurity and malnutrition, together with antiretroviral therapy (ART), could improve treatment outcomes. In Nigeria, there is a high awareness of the nutraceutical benefits of Moringa oleifera. Thus, this study aimed to evaluate the effects of Moringa oleifera leaf supplementation on the CD4 counts, viral load and anthropometric of HIV-positive adults on ART. Methods This was a double-blind, randomized study. Two hundred HIV-positive patients were randomly allocated to either the Moringa Oleifera group (MOG) given Moringa oleifera leaf powder or the control group (COG) given a placebo. Changes in anthropometric parameters [weight; body mass index (BMI)] and CD4 cell counts were measured monthly for six months, while HIV-1 viral loads were measured at baseline and the end of the study for both groups. Results Over the study period, the treatment by time interaction shows a significant difference in CD4 counts by treatment group (p<0.0001). A further estimate of fixed effects showed that the CD4 counts among MOG were 10.33 folds greater than COG over the study period. However, the viral load (p = 0.9558) and all the anthropometric parameters (weight; p = 0.5556 and BMI; p = 0.5145) between the two groups were not significantly different over time. All tests were conducted at 95CI. Conclusion This study revealed that Moringa oleifera leaf supplementation was associated with increased CD4 cell counts of PLHIV on ART in a resource-limited setting. Programs in low-resource settings, such as Nigeria, should consider nutritional supplementation as part of a comprehensive approach to ensure optimal treatment outcomes in PLHIV.	[Gambo, Aisha; Moodley, Indres; Babalola, Tesleem K.] Univ KwaZulu Natal, Coll Hlth Sci, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa; [Babashani, Musa] Bayero Univ Kano, Dept Med, Kano, Kano State, Nigeria; [Babashani, Musa] Aminu Kano Teaching Hosp, Kano, Kano State, Nigeria; [Gqaleni, Nceba] Univ KwaZulu Natal, Coll Hlth Sci, Sch Nursing & Publ Hlth, Discipline Tradit Med, Durban, South Africa	University of Kwazulu Natal; Bayero University; University of Kwazulu Natal	Gambo, A (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa.	gamboaishatu@yahoo.com	Gqaleni, Nceba/A-3609-2014	Gqaleni, Nceba/0000-0003-1946-3120; Gambo, Aisha/0000-0003-2605-4261	Department of Science and Innovation of South Africa [DST/CON 0196/2011]; College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa	Department of Science and Innovation of South Africa; College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa	This study was funded by the Department of Science and Innovation of South Africa (DST/CON 0196/2011) and the College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.	Addisu Tesfaw, 2018, Advances in Public Health, V2018, P6135482, DOI 10.1155/2018/6135482; Akwiwu U. N., 2019, Journal of Agriculture and Food Sciences, V16, P88, DOI 10.4314/jafs.v16i2.8; Anwar F, 2007, PHYTOTHER RES, V21, P17, DOI 10.1002/ptr.2023; ASPIRATA, 2017, NUTR AN MOR OL LEAV; Avert, 2019, HIV AIDS S AFRICA; Bahadoran Z, 2012, INT J FOOD SCI NUTR, V63, P767, DOI 10.3109/09637486.2012.665043; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Colecraft E, 2008, P NUTR SOC, V67, P109, DOI 10.1017/S0029665108006095; Contri PV, 2011, CLINICS, V66, P997, DOI 10.1590/S1807-59322011000600013; Dhakad AK, 2019, PHYTOTHER RES, V33, P2870, DOI 10.1002/ptr.6475; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feleke DG., 2017, ETHIOPIA J AIDS CLIN, V8, P1, DOI [10.4172/2155-6113.1000688, DOI 10.4172/2155-6113.1000688]; Guerra EML., 2015, HLTH HIV INFECTED PE, V2, P367; Idohou-Dossou N., 2011, African Journal of Food, Agriculture, Nutrition and Development, V11, P4985; Mancini A, 2015, MOLECULES, V20, P17339, DOI 10.3390/molecules200917339; Merck, 2021, MERCK DISCONTINUES D; Mishra SP, 2012, BULL ENVIRON PHARMAC, V2, P28; Monera TG, 2008, J INFECT DEV COUNTR, V2, P379, DOI 10.3855/jidc.201; Nnyepi MS, 2009, S AFR J CLIN NUTR, V22, P89, DOI 10.1080/16070658.2009.11734224; Obiako RO., 2018, SUBSAHARAN AFR J MED, V6, P43; Ogbuagu EN, 2016, INT J INFECT DIS, V45, P267, DOI 10.1016/j.ijid.2016.02.595; Pandey A., 2012, MED AROMAT PLANTS, V1, P101, DOI [10.4172/2167-0412.1000101, DOI 10.4172/2167-0412.1000101]; RMRDC, 2010, P NAT SUMM MOR DEV; Roche, 2007, COBAS AMPLIPREP COBA; SANAS, 2017, S AFR NAT ACCR SYST; SOP Nigeria, HIV 1 VIRAL LOAD ASS; Tete-Benissan A., 2013, Journal of Applied Biosciences, V62, P4610; Thurber MD, 2009, ECOL FOOD NUTR, V48, P212, DOI 10.1080/03670240902794598; Toh HS, 2020, INT J INFECT DIS, V91, P44, DOI 10.1016/j.ijid.2019.11.010; Tshingani K, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1920-z; UNAIDS, 2019, START FREE STAY FREE; UNAIDS, UNAIDS2000; Vergara-Jimenez M, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040091; WHO UNICEF, 2018, ARS PRIM GUID INV MI, V3rd; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	35	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261935	10.1371/journal.pone.0261935	http://dx.doi.org/10.1371/journal.pone.0261935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972169	Green Published, gold			2022-12-27	WOS:000773555700069
J	Liu, Z; Mutukumira, AN; Shen, C				Liu, Zhe; Mutukumira, Anthony N.; Shen, Cong			Food safety knowledge, attitudes, and eating behavior in the advent of the global coronavirus pandemic	PLOS ONE			English	Article							CONSUMER ATTITUDES; POWER ANALYSIS; COVID-19; IMPACTS; PROGRAM; CRISIS; RISKS	The objective of this study was to evaluate the relationships of food safety knowledge, attitude and eating behavior of consumers during national lockdowns in the advent of the COVID-19 pandemic. A total of 157 respondents completed the online survey using a structured questionnaire worldwide. Overall, the respondents exhibited good attitude and good knowledge towards public health including food safety especially on the importance of social distancing, mask wearing, well-balanced diet, physical exercise and personal hygiene, such as hand washing during the pandemic lockdowns. A Structural Equation Modeling (SEM) was used to test the relationships among food safety knowledge, attitude and behavior under the pandemic conditions. Results showed that attitude towards food safety under the coronavirus pandemic and lockdowns positively affected the eating behavior of the respondents, which exhibited a high beta (0.686) among the variables tested (p<0.05). Food safety knowledge was apparently not affected by the food safety behavior of the respondents.	[Liu, Zhe; Shen, Cong] Henan Univ Technol, Sch Management, Zhengzhou, Henan, Peoples R China; [Mutukumira, Anthony N.] Massey Univ, Sch Food & Adv Technol, Auckland, New Zealand	Henan University of Technology; Massey University	Liu, Z (corresponding author), Henan Univ Technol, Sch Management, Zhengzhou, Henan, Peoples R China.	liuzhe168@163.com	Mutukumira, Tony N./CAH-8302-2022	Mutukumira, Tony N./0000-0003-3189-2120; Shen, Cong/0000-0001-8949-0349; LIU, ZHE/0000-0002-0934-4438	Henan Association for Science and Technology [HNKJZK-2021-12B]; National Social Science Foundation of China [21BGL052]; Humanities and Social Science Project of Education Department of Henan Province [2021-ZZJH-082]; Key Research Institute of Humanities and Social Sciences at Universities of Henan Province [2017JD-02]	Henan Association for Science and Technology; National Social Science Foundation of China; Humanities and Social Science Project of Education Department of Henan Province; Key Research Institute of Humanities and Social Sciences at Universities of Henan Province	The authors wish to acknowledge the funding from Henan Association for Science and Technology (HNKJZK-2021-12B) for the research upon which this paper is based. Also, this study was supported by National Social Science Foundation of China (21BGL052), Humanities and Social Science Project of Education Department of Henan Province (2021-ZZJH-082) and Key Research Institute of Humanities and Social Sciences at Universities of Henan Province (2017JD-02). The authors would like to thank all the respondents for their feedback and support during collection of the data.	Abdul-Mutalib NA, 2012, FOOD CONTROL, V27, P289, DOI 10.1016/j.foodcont.2012.04.001; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Ansari-Lari M, 2010, FOOD CONTROL, V21, P260, DOI 10.1016/j.foodcont.2009.06.003; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; BAGOZZI RP, 1980, J MARKETING RES, V17, P133, DOI 10.2307/3151129; Baser F, 2017, FOOD CONTROL, V73, P438, DOI 10.1016/j.foodcont.2016.08.032; Bolek S, 2021, ITAL J FOOD SCI, V33, P14, DOI 10.15586/ijfs.v33i3.2048; Bolek S, 2020, TRENDS FOOD SCI TECH, V102, P242, DOI 10.1016/j.tifs.2020.03.009; Bollen K., 1989, STRUCTURAL EQUATIONS; BREWER MS, 1994, J FOOD SAFETY, V14, P63, DOI 10.1111/j.1745-4565.1994.tb00584.x; Brown RL, 1994, STRUCT EQU MODELING, V1, P287, DOI 10.1080/10705519409539983; BROWNE MW, 1995, HDB STAT MODELING SO, P311; Buccheri C, 2010, FOOD CONTROL, V21, P1367, DOI 10.1016/j.foodcont.2010.04.010; Cable J, 2021, ANN NY ACAD SCI, V1484, P3, DOI 10.1111/nyas.14482; Comrey AL., 1992, 1 COURSE FACTOR ANAL, V2nd ed., DOI DOI 10.4324/9781315827506; Ding L, 1995, STRUCT EQU MODELING, V2, P119, DOI 10.1080/10705519509540000; Djekic I, 2021, FOOD CONTROL, V122, DOI 10.1016/j.foodcont.2020.107800; Farsalinos Konstantinos, 2021, Toxicol Rep, V8, P1, DOI 10.1016/j.toxrep.2020.12.001; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254; Food and Agriculture Organization of the United Nations (FAO),World Health Organization (WHO), 1992, DECL PLAN ACT NUTR; Fox JP, 2010, STAT SOC BEHAV SC, P1, DOI 10.1007/978-1-4419-0742-4; Gorsuch R., 1983, FACTOR ANAL; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hair J.F., 2010, MULTIVARIATE DATA AN; Hair JF, 2019, EUR BUS REV, V31, P2, DOI 10.1108/EBR-11-2018-0203; Hair Jr J.F., 2016, PRIMER PARTIAL LEAST; Han S, 2021, TRENDS FOOD SCI TECH, V109, P25, DOI 10.1016/j.tifs.2021.01.004; Hossain MB, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05799; International Food Infomation Council, COVID 19 PAND TRANSF; Kline R.B., 2015, PRINCIPLES PRACTICE, V4th ed., DOI DOI 10.1038/156278A0; KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007; Lee K, 2009, GLOB INST, P1; Lim TP, 2016, FOOD CONTROL, V60, P241, DOI 10.1016/j.foodcont.2015.07.042; Liu Peipei, 2020, Biosaf Health, V2, P199, DOI 10.1016/j.bsheal.2020.11.003; Ma NL, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110405; MCINTOSH WA, 1994, APPETITE, V22, P83, DOI 10.1006/appe.1994.1007; Meer RR, 2000, J FOOD PROTECT, V63, P1725, DOI 10.4315/0362-028X-63.12.1725; Meixner O, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12187270; Memon M.A., 2020, J APPL STRUCT EQU MO, V4, P1, DOI [10.47263/JASEM.4(2)01, DOI 10.47263/JASEM.4(2)01, 10.47263/jasem.4(2)01]; Min S, 2020, J INTEGR AGR, V19, P2926, DOI 10.1016/S2095-3119(20)63388-3; Mistree D, 2021, SOC SCI MED, V276, DOI 10.1016/j.socscimed.2021.113846; MULAIK SA, 1987, MULTIVAR BEHAV RES, V22, P267, DOI 10.1207/s15327906mbr2203_3; Muthen LK., 2017, MPLUS, VEight; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Parthasarathy P, 2021, J INFECT PUBLIC HEAL, V14, P249, DOI 10.1016/j.jiph.2020.12.020; Raab C.A., 1997, INT J CONSUM STUD, V21, P117; Raykov T, 2004, BEHAV THER, V35, P299, DOI 10.1016/S0005-7894(04)80041-8; Ringle CM, 2020, INT J HUM RESOUR MAN, V31, P1617, DOI 10.1080/09585192.2017.1416655; Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007; Schindler P.S., 2019, BUSINESS RES METHODS, Vthirteen, DOI [10.1016/j.ymeth.2019.06.012, DOI 10.1016/J.YMETH.2019.06.012]; SCHWARTZ NE, 1975, J AM DIET ASSOC, V66, P28; Siddiky NA., 2021, FOOD CONTROL; Tabachnick B. G., 2001, USING MULTIVARIATE S, V4, P582, DOI DOI 10.1016/J.CSDA.2020.107164; Thomas MS, 2021, FOOD CONTROL, V130, DOI 10.1016/j.foodcont.2021.108279; Thomas MS, 2021, J FOOD PROTECT, V84, P1176, DOI 10.4315/JFP-21-006; TINSLEY HEA, 1987, J COUNS PSYCHOL, V34, P414, DOI 10.1037/0022-0167.34.4.414; Uttley J, 2019, LEUKOS, V15, P143, DOI 10.1080/15502724.2018.1533851; van de Schoot R, 2012, EUR J DEV PSYCHOL, V9, P486, DOI 10.1080/17405629.2012.686740; van der Linden WimJ., 2016, MODELS, V1; Wilcock A, 2004, TRENDS FOOD SCI TECH, V15, P56, DOI 10.1016/j.tifs.2003.08.004; World Health Organization, 2021, COVID 19 STRAT PREP; Yu CY, 2002, ANN C AM ED RES ASS; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	66	1	1	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261832	10.1371/journal.pone.0261832	http://dx.doi.org/10.1371/journal.pone.0261832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972145	gold, Green Published			2022-12-27	WOS:000773555700058
J	Lovfors, W; Ekstrom, J; Jonsson, C; Stralfors, P; Cedersund, G; Nyman, E				Lovfors, William; Ekstrom, Jona; Jonsson, Cecilia; Stralfors, Peter; Cedersund, Gunnar; Nyman, Elin			A systems biology analysis of lipolysis and fatty acid release from adipocytes in vitro and from adipose tissue in vivo	PLOS ONE			English	Article							INSULIN-RESISTANCE; MODEL; PHOSPHODIESTERASE; DESENSITIZATION; ACTIVATION; MECHANISM; OBESITY	Lipolysis and the release of fatty acids to supply energy fuel to other organs, such as between meals, during exercise, and starvation, are fundamental functions of the adipose tissue. The intracellular lipolytic pathway in adipocytes is activated by adrenaline and noradrenaline, and inhibited by insulin. Circulating fatty acids are elevated in type 2 diabetic individuals. The mechanisms behind this elevation are not fully known, and to increase the knowledge a link between the systemic circulation and intracellular lipolysis is key. However, data on lipolysis and knowledge from in vitro systems have not been linked to corresponding in vivo data and knowledge in vivo. Here, we use mathematical modelling to provide such a link. We examine mechanisms of insulin action by combining in vivo and in vitro data into an integrated mathematical model that can explain all data. Furthermore, the model can describe independent data not used for training the model. We show the usefulness of the model by simulating new and more challenging experimental setups in silico, e.g. the extracellular concentration of fatty acids during an insulin clamp, and the difference in such simulations between individuals with and without type 2 diabetes. Our work provides a new platform for model-based analysis of adipose tissue lipolysis, under both non-diabetic and type 2 diabetic conditions.	[Lovfors, William; Ekstrom, Jona; Cedersund, Gunnar; Nyman, Elin] Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden; [Lovfors, William] Linkoping Univ, Dept Math, Linkoping, Sweden; [Jonsson, Cecilia; Stralfors, Peter] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden; [Cedersund, Gunnar] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University	Nyman, E (corresponding author), Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden.	elin.nyman@liu.se		Lovfors, William/0000-0002-9058-7049	Linkoping University; Swedish Diabetes Fund; Swedish Research Council; Swedish Research Council [2019-03767, 2018-05418, 2018-03319]; Heart and Lung Foundation; Ake Wibergs Stiftelse [M19-0449]; Swedish Foundation for Strategic Research [ITM17-0245]; SciLifeLab; KAW [2020.0182]; Horizon 2020 [777107]; CENIIT [15.09, 20.08]; ELLIIT; Swedish Fund for Research without Animal Experiments	Linkoping University; Swedish Diabetes Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart and Lung Foundation(Swedish Heart-Lung Foundation); Ake Wibergs Stiftelse; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); SciLifeLab; KAW; Horizon 2020; CENIIT; ELLIIT; Swedish Fund for Research without Animal Experiments	PS acknowledges support from Linkoping University, the Swedish Diabetes Fund (a 3-years program; https://www.diabetes.se/diabetesfonden/), and the Swedish Research Council (a 5-years program; https://www.vr.se/).EN acknowledges support from the Swedish Research Council (Dnr 2019-03767), the Heart and Lung Foundation (https://www.hjart-lungfonden.se/), CENIIT (20.08; http://ceniit.lith.liu.se/en/), and Ake Wibergs Stiftelse (M19-0449; https://akewiberg.se/).GC acknowledges support from the Swedish Research Council (Dnr 2018-05418, 2018-03319), Swedish Foundation for Strategic Research (ITM17-0245; https://strategiska.se/), SciLifeLab and KAW (2020.0182; https://www.scilifelab.se/), Horizon 2020 (PRECISE4Q, 777107; https://ec.europa.eu/programmes/horizon2020/), CENIIT (15.09), ELLIIT (https://www.lu.se/forskning/starka-forskningsmiljoer/strategiskaforskningsomraden/elliit), and the Swedish Fund for Research without Animal Experiments (https://forskautandjurforsok.se/swedish-fund-forresearch-without-animal-experiments/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmera I, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.30; Arner P, 2015, OBESITY FACTS, V8, P147, DOI 10.1159/000381224; Arrestam O., 2021, DIGITAL TWIN PREDICT, DOI [10.1101/2021.11.04.467307, DOI 10.1101/2021.11.04.467307]; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Cedersund G, 2009, EUR J PHARM SCI, V36, P91, DOI 10.1016/j.ejps.2008.10.027; Cedersund G, 2012, FEBS J, V279, P3513, DOI 10.1111/j.1742-4658.2012.08725.x; Corral-Acero J, 2020, EUR HEART J, V41, P4556, DOI 10.1093/eurheartj/ehaa159; Dano S, 2006, FEBS J, V273, P4862, DOI 10.1111/j.1742-4658.2006.05485.x; Degerman E, 2011, CURR OPIN PHARMACOL, V11, P676, DOI 10.1016/j.coph.2011.09.015; Egea JA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-136; Lopez-Palau NE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69629-0; ERIKSSON H, 1995, BBA-MOL CELL RES, V1266, P101, DOI 10.1016/0167-4889(94)00237-9; Golse N, 2021, J HEPATOL, V74, P661, DOI 10.1016/j.jhep.2020.10.036; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Herrgardh T, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.619254; HIGGINS J, 1964, P NATL ACAD SCI USA, V51, P989, DOI 10.1073/pnas.51.6.989; Jonsson C, 2019, BIOCHEM J, V476, P2883, DOI 10.1042/BCJ20190594; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kim J, 2008, J THEOR BIOL, V251, P523, DOI 10.1016/j.jtbi.2007.12.005; Lovfors W, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101221; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Marion-Latard F, 2001, AM J PHYSIOL-REG I, V280, pR166, DOI 10.1152/ajpregu.2001.280.1.R166; Murillo AL, 2019, MATH BIOSCI ENG, V16, P5765, DOI 10.3934/mbe.2019288; Nyman E, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0075; Nyman E, 2015, FEBS J, V282, P951, DOI 10.1111/febs.13194; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Nyman E, 2012, TRENDS ENDOCRIN MET, V23, P107, DOI 10.1016/j.tem.2011.12.007; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; O'Donovan SD, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007400; Pratt AC, 2015, MATH BIOSCI, V262, P167, DOI 10.1016/j.mbs.2014.12.012; Rajan MR, 2016, J BIOL CHEM, V291, P15806, DOI 10.1074/jbc.M116.715763; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; SCHMITZPEIFFER C, 1992, CELL SIGNAL, V4, P37, DOI 10.1016/0898-6568(92)90006-T; Schwartz SM, 2020, FRONT COMP SCI-SWITZ, V2, DOI 10.3389/fcomp.2020.00031; SELKOV EE, 1968, EUR J BIOCHEM, V4, P79, DOI 10.1111/j.1432-1033.1968.tb00175.x; Shamanna P, 2020, DIABETES THER, V11, P2703, DOI 10.1007/s13300-020-00931-w; Sips FLP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135665; Smith JMD, 2009, OBESITY, V17, P632, DOI 10.1038/oby.2008.604; Stallknecht B, 1997, J PHYSIOL-LONDON, V500, P271, DOI 10.1113/jphysiol.1997.sp022017; Stich V, 2003, AM J PHYSIOL-ENDOC M, V285, pE599, DOI 10.1152/ajpendo.00502.2002; Wiener N., 1950, B AM ACAD ARTS SCI, V3, P2, DOI 10.2307/3822945	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261681	10.1371/journal.pone.0261681	http://dx.doi.org/10.1371/journal.pone.0261681			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972146	Green Published, gold, Green Submitted			2022-12-27	WOS:000773555700045
J	Zewude, B; Habtegiorgis, T				Zewude, Bewunetu; Habtegiorgis, Tewodros			Victimizations and surviving of workplace violence against waitresses in southern Ethiopia	PLOS ONE			English	Article								Women are obliged to take on vulnerable forms of employment that fail to protect their basic labor rights. Exposure to workplace violence is especially high for those women who work within the agriculture, the hotels, restaurants and catering, the transport as well as the manufacturing sectors. In this context, we explored workplace violence against women working as waitresses in various hotels, restaurants, cafeterias and grocery stores of Wolaita Sodo town, southern Ethiopia. Cross-sectional study was undertaken with descriptive and exploratory study designs. Qualitative data were collected by using in-depth interview method in which 16 waitresses were interviewed. Data were voice recorded, transcribed, and analyzed searching themes and patterns in the data. While we found that waitresses are highly exposed to workplace violence, the level of exposure to the violence varies across various circumstances, including working in large and small towns, the situation of the owners/supervisors, public's insight of the position, waitresses' ability to speak the local language, the role of the waitresses, customers' behavior and the specific context in which waitresses work. Waitresses were generally exposed to all forms of violence including spitting, throwing objects, simple physical assault, touching on private parts, and intimidation, among which verbal abuse and emotional exploitations are found to be the most common. Furthermore, the results revealed that though waitresses rarely experienced violence from female customers, the most common perpetrators involved in the practice were males. Amid widespread exposure of waitresses to all forms of workplace violence, ignorance, mostly motivated by fear of losing one's job, has been the common way waitresses respond to the violence. The study implies the vulnerability state of waitresses partly due to lack of adequate awareness regarding the rights and obligations expected of an employee when working in such organizations. This is again exacerbated by the lack of formal employment procedures in such organizations. Therefore, awareness creation and supervisory activities are expected from the media, workers' and social security office of the government, police and other concerned bodies.	[Zewude, Bewunetu; Habtegiorgis, Tewodros] Wolaita Sodo Univ, Dept Sociol, Sodo, Ethiopia		Zewude, B (corresponding author), Wolaita Sodo Univ, Dept Sociol, Sodo, Ethiopia.	bewunetuzewude@gmail.com		Habtegiorgis, Tewodros/0000-0002-2715-1509; Zewude, Bewunetu/0000-0003-0640-915X				Action aid, 2012, THEORY CHANGE TACKLI; Alam A, 2010, SARHAD J AGR, V27, P329; Ali R., 2014, J SOCIAL SCI RES, V4, P604; Amnesty International, 2004, ITS OUR HANDS STOP V; Amoako J., 2019, THESIS UNI, V951; Amponsah-Tawiah K, 2016, SAF HEALTH WORK-KR, V7, P225, DOI 10.1016/j.shaw.2016.01.002; [Anonymous], INT J HLTH SCI RES; Aytac S, 2011, INT J OCCUP SAF ERGO, V17, P385, DOI 10.1080/10803548.2011.11076902; Banerjee Bratati, 2009, Indian J Community Med, V34, P89, DOI 10.4103/0970-0218.51224; Berhane Y., 2004, ETHIOP J HEALTH DEV, V18, P131, DOI [10.4314/ejhd.v18i3.9951, DOI 10.4314/EJHD.V18I3.9951]; Botha D, 2016, SA J HUM RESOUR MANA, V14, DOI 10.4102/sajhrm.v14i1.753; Canadian Center for Occupational Health and Safety (CCOHS), 2021, VIOLENCE HARASSMENT; Coyle D., 2014, WOMENS INSECURITIES; EU-OSHA, 2014, NEW RISKS TRENDS SAF; EU-OSHA, 2013, RISKS TRENDS SAF HLT; Fredrickson C, 2014, 7 REASONS EMPLOYEES; Gatimu C, 2015, OCCASIONAL PAPER, V6; ILO, 2010, WOM WORK GEND ISS OC; Kane P, INTRO WOMEN WORK CHA; Kumie A, 2016, ETHIOP J HEALTH DEV, V30, P17; Lippel K, 2018, U OXFORD HUM RTS HUB, V1, P143; Lu J.L, 2011, J INT WOMENS STUDIES, V12, P68; Melak M., 2012, THESIS ADDIS ABABA U; Morrison A., 2004, WORLD BANK POLICY RE; Mukanangana F, 2014, AFR J REPROD HEALTH, V18, P110; Pedro S, 2013, UNIVERSIDADE AUTONOM, P1; Rajbhandari R., 2015, INT J HLTH SCI RES, VVol. 5, P274; Rutgers, 2021, CONTR FACTORSVIOLENT; Tsegahun T, 2008, STATUS GENDER BASED; TUC, 2017, GENDER OCCUPATIONAL; UNDP, 2018, ETHIOPIA NAT HUM DEV; UWONET, 2011, GENDER BASED VIOLENC; WHO, 2001, OCC HLTH MAN PRIM HL; WHO (World Health Organization), 2004, GEND HLTH WORK GEND	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261883	10.1371/journal.pone.0261883	http://dx.doi.org/10.1371/journal.pone.0261883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972175	gold, Green Published			2022-12-27	WOS:000773555700064
